data_2jqf_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jqf _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' R' R ' 30' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 121.177 0.513 . . . . 43.36 110.202 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' R' R ' 31' ' ' LEU . . . . . . . . . . . . . 65.3 mt -134.91 140.56 45.85 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.312 -0.867 . . . . 22.93 110.283 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 32' ' ' THR . . . . . . . . . . . . . 69.6 m -87.55 110.57 20.45 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.376 -0.828 . . . . 22.34 109.984 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 33' ' ' LEU . . . . . 0.462 HD23 ' CE2' ' R' ' 62' ' ' TYR . 80.1 mt -62.35 -172.79 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.266 -0.896 . . . . 21.39 110.226 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 34' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -74.65 -29.41 61.25 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.333 -0.855 . . . . 34.4 110.386 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 35' ' ' ASN . . . . . . . . . . . . . 48.3 p30 -77.73 -1.87 33.38 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.324 -0.86 . . . . 30.28 110.633 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.2 -16.56 59.42 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.776 -1.329 . . . . 36.25 109.776 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 37' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -59.02 161.81 4.76 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.285 -1.127 . . . . 53.8 110.383 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 38' ' ' LYS . . . . . . . . . . . . . 56.9 mttt -117.84 135.78 53.86 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.43 -0.794 . . . . 49.91 110.108 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 39' ' ' LYS . . . . . 0.417 ' HG2' ' CZ ' ' R' ' 41' ' ' PHE . 8.1 ttmt -138.75 143.69 39.12 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.432 -0.792 . . . . 35.69 110.223 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 40' ' ' THR . . . . . . . . . . . . . 23.7 m -102.57 127.98 49.42 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.309 -0.87 . . . . 34.84 110.193 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 41' ' ' PHE . . . . . 0.417 ' CZ ' ' HG2' ' R' ' 39' ' ' LYS . 96.6 m-85 -113.09 132.66 55.34 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.402 -0.811 . . . . 34.42 110.147 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 42' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -93.25 140.95 28.98 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.31 -0.869 . . . . 51.46 110.204 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 43' ' ' SER . . . . . . . . . . . . . 54.5 m -70.81 141.89 51.33 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.453 -0.779 . . . . 41.84 110.206 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.74 125.41 29.53 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.296 -0.877 . . . . 33.82 109.934 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 45' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.16 151.05 54.74 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.59 1.31 . . . . 30.27 110.649 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 46' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.23 109.84 13.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.456 -0.777 . . . . 35.1 110.033 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 47' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -120.28 -34.84 3.56 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.298 -0.876 . . . . 42.81 110.503 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 48' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -105.77 45.18 0.98 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.221 -0.925 . . . . 49.97 110.176 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 49' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 50.29 34.72 9.28 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.414 -0.804 . . . . 61.32 110.173 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 50' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -86.25 43.74 1.08 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.333 -0.854 . . . . 51.5 110.703 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.08 -46.11 78.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.184 -0.948 . . . . 38.77 109.558 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 52' ' ' TRP . . . . . 0.483 ' CD2' ' N ' ' R' ' 53' ' ' LEU . 68.2 p-90 -58.39 -38.43 77.31 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.419 -0.801 . . . . 26.24 110.055 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 53' ' ' LEU . . . . . 0.483 ' N ' ' CD2' ' R' ' 52' ' ' TRP . 23.2 tp -66.68 -46.68 74.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.4 -0.813 . . . . 26.75 110.013 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 54' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -55.2 -41.61 72.22 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.372 -0.83 . . . . 35.02 110.156 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.17 -46.08 92.0 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.337 -0.852 . . . . 24.47 110.145 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 56' ' ' ILE . . . . . . . . . . . . . 76.2 mt -62.23 -42.21 94.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.322 -0.861 . . . . 26.03 109.906 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 57' ' ' LEU . . . . . . . . . . . . . 22.4 mt -60.31 -45.6 92.83 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.325 -0.859 . . . . 26.77 109.68 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 58' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -63.97 -46.49 84.4 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.426 -0.796 . . . . 22.32 109.561 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 59' ' ' LEU . . . . . 0.429 ' HA ' ' HE2' ' R' ' 151' ' ' PHE . 23.9 tp -61.43 -37.75 84.65 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.316 -0.865 . . . . 20.55 109.396 179.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 60' ' ' PHE . . . . . 0.447 ' CE2' HD22 ' R' ' 111' ' ' LEU . 2.8 m-85 -61.08 -44.78 96.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.628 -0.67 . . . . 20.08 109.907 179.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 61' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -63.16 -36.15 82.65 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.481 -0.762 . . . . 18.8 110.472 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 62' ' ' TYR . . . . . 0.462 ' CE2' HD23 ' R' ' 33' ' ' LEU . 9.2 t80 -63.04 -41.78 99.58 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.207 -0.933 . . . . 26.45 110.26 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 63' ' ' VAL . . . . . . . . . . . . . 30.2 m -93.38 20.38 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.304 -0.872 . . . . 29.75 110.188 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 64' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 52.91 75.6 0.23 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.303 -0.873 . . . . 35.52 110.546 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 65' ' ' GLU . . . . . 0.424 ' HG2' ' CD2' ' R' ' 60' ' ' PHE . 14.3 tp10 -116.29 104.05 52.35 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.457 -0.777 . . . . 29.89 109.901 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 66' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.55 -5.83 17.74 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.79 1.416 . . . . 21.37 111.094 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 67' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -52.11 -61.56 2.19 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.103 -0.998 . . . . 23.85 110.331 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 68' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -98.12 36.56 1.56 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.25 -0.906 . . . . 28.07 110.438 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 69' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -72.36 -33.26 67.13 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.346 -0.846 . . . . 43.76 110.144 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 70' ' ' TRP . . . . . 0.477 ' CE2' ' CG2' ' R' ' 71' ' ' VAL . 47.9 p-90 -73.42 -3.84 29.88 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.275 -0.891 . . . . 33.06 110.716 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 71' ' ' VAL . . . . . 0.477 ' CG2' ' CE2' ' R' ' 70' ' ' TRP . 40.7 t -109.79 -27.45 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.194 -0.941 . . . . 31.7 109.685 179.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 72' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -86.62 -48.83 7.98 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.358 -0.839 . . . . 33.58 110.282 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 73' ' ' SER . . . . . . . . . . . . . 69.9 m -89.7 51.08 2.01 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.27 -0.893 . . . . 50.82 110.36 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 74' ' ' SER . . . . . . . . . . . . . 15.8 t -125.92 138.3 31.8 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.338 -0.851 . . . . 34.74 110.221 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.38 -24.97 15.93 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 O-C-N 123.641 1.337 . . . . 35.7 110.348 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 76' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -91.68 153.16 19.85 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.37 -0.831 . . . . 66.48 110.379 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 77' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -81.48 95.22 7.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.292 -0.88 . . . . 46.72 110.102 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 78' ' ' LEU . . . . . . . . . . . . . 96.3 mt -96.44 28.0 3.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.331 -0.856 . . . . 37.55 110.182 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 79' ' ' THR . . . . . . . . . . . . . 29.7 m -56.2 -54.67 42.44 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.379 -0.825 . . . . 37.36 110.295 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 80' ' ' LEU . . . . . . . . . . . . . 16.0 mt -60.82 -23.27 64.96 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.347 -0.845 . . . . 35.83 110.543 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 81' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -79.46 -39.12 32.98 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.184 -0.948 . . . . 44.03 110.32 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.5 -28.58 66.17 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.292 -0.88 . . . . 32.54 110.202 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 83' ' ' ILE . . . . . . . . . . . . . 78.1 mt -70.15 -46.06 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.34 -0.85 . . . . 32.02 110.302 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 84' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -55.22 -52.08 64.52 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.164 -0.96 . . . . 34.09 110.596 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 85' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -54.83 -46.87 74.64 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.235 -0.915 . . . . 25.94 110.28 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 86' ' ' LEU . . . . . . . . . . . . . 24.0 mt -58.63 -43.85 89.81 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.299 -0.876 . . . . 16.2 109.936 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 87' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -65.34 -35.26 80.43 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.466 -0.771 . . . . 49.09 110.286 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 88' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -78.43 -19.04 54.07 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.247 -0.908 . . . . 28.61 110.493 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 89' ' ' LEU . . . . . . . . . . . . . 32.6 mt -96.18 -29.41 14.07 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.207 -0.933 . . . . 26.16 110.197 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 90' ' ' THR . . . . . . . . . . . . . 58.7 p -105.7 -34.59 7.66 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.285 -0.884 . . . . 33.33 109.778 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.85 16.1 58.6 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.821 -1.312 . . . . 31.13 109.821 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 92' ' ' LEU . . . . . . . . . . . . . 97.0 mt -100.1 155.29 17.81 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.169 -1.195 . . . . 42.52 110.21 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 93' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -86.28 91.56 8.51 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.46 -0.775 . . . . 68.46 109.984 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 94' ' ' LEU . . . . . 0.446 ' HB3' ' CZ2' ' R' ' 52' ' ' TRP . 48.1 mt -99.41 53.01 0.95 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.18 -0.95 . . . . 44.63 110.364 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 95' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.44 -38.69 6.39 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.3 -0.875 . . . . 67.16 110.399 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 96' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -113.93 44.29 1.67 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.404 -0.81 . . . . 67.02 110.326 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 97' ' ' GLY . . . . . . . . . . . . . . . 99.12 150.78 26.03 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.614 -1.395 . . . . 49.48 109.614 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 98' ' ' GLY . . . . . . . . . . . . . . . -166.21 160.03 33.46 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.253 -1.539 . . . . 36.57 109.253 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 99' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -72.58 121.1 7.13 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.684 1.36 . . . . 30.41 110.435 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 100' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.25 -31.65 11.49 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 O-C-N 123.645 1.339 . . . . 29.94 110.54 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.96 -38.48 76.13 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.301 -0.875 . . . . 23.64 110.263 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.62 -40.8 66.17 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.322 -0.861 . . . . 20.31 110.362 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 103' ' ' VAL . . . . . . . . . . . . . 63.7 t -58.16 -40.06 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.219 -0.925 . . . . 16.33 109.996 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 104' ' ' ILE . . . . . . . . . . . . . 81.9 mt -71.7 -30.57 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.397 -0.814 . . . . 24.77 109.93 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 105' ' ' TRP . . . . . 0.439 ' O ' ' HD3' ' R' ' 108' ' ' LYS . 70.6 t-105 -82.42 0.84 40.28 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.345 -0.847 . . . . 23.28 110.273 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 106' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -105.08 -10.38 17.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.116 -0.99 . . . . 28.26 110.125 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 107' ' ' ILE . . . . . . . . . . . . . 36.8 pt -126.83 34.97 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.211 -0.931 . . . . 18.77 110.05 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 108' ' ' LYS . . . . . 0.481 ' HG2' ' HB ' ' R' ' 115' ' ' ILE . 9.3 mtpp -61.05 -48.44 81.72 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.548 -0.72 . . . . 42.5 110.025 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 109' ' ' HIS . . . . . 0.432 ' CD2' ' HG ' ' R' ' 110' ' ' LEU . 50.8 p-80 -66.02 -12.85 58.07 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.527 -0.733 . . . . 20.07 110.698 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 110' ' ' LEU . . . . . 0.432 ' HG ' ' CD2' ' R' ' 109' ' ' HIS . 80.6 mt -94.79 -17.25 22.31 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.076 -1.015 . . . . 15.69 110.207 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 111' ' ' LEU . . . . . 0.447 HD22 ' CE2' ' R' ' 60' ' ' PHE . 10.3 mt -94.13 144.15 25.75 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.342 -0.849 . . . . 25.39 111.014 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 112' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -77.71 -17.35 57.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.552 -0.717 . . . . 53.48 109.852 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 113' ' ' THR . . . . . 0.417 HG22 ' HG2' ' R' ' 123' ' ' GLU . 60.0 m -83.73 166.64 17.88 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.236 -0.915 . . . . 14.8 110.233 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 114' ' ' GLY . . . . . . . . . . . . . . . -97.96 127.16 9.13 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.994 -1.243 . . . . 16.14 109.994 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 115' ' ' ILE . . . . . 0.481 ' HB ' ' HG2' ' R' ' 108' ' ' LYS . 47.7 mm -109.11 139.31 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.441 -1.035 . . . . 13.46 109.738 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 116' ' ' GLY . . . . . . . . . . . . . . . -152.74 -155.88 7.3 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.959 -1.257 . . . . 23.9 109.959 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 117' ' ' THR . . . . . . . . . . . . . 18.8 p -134.99 -171.39 2.79 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.453 -1.028 . . . . 27.37 110.044 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.6 -58.04 9.79 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.251 -0.906 . . . . 18.76 110.064 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 119' ' ' SER . . . . . . . . . . . . . 1.1 m -56.52 -40.66 75.42 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.259 -0.901 . . . . 32.35 109.721 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 120' ' ' ARG . . . . . 0.409 ' NH1' ' NE1' ' S' ' 305' ' ' TRP . 10.0 mtm180 -110.03 86.26 4.84 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.47 -0.768 . . . . 27.12 109.716 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 121' ' ' PRO . . . . . 0.426 ' O ' ' HB2' ' R' ' 122' ' ' SER . 44.7 Cg_endo -71.26 166.44 29.25 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 O-C-N 123.784 1.413 . . . . 22.68 111.009 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 122' ' ' SER . . . . . 0.426 ' HB2' ' O ' ' R' ' 121' ' ' PRO . 38.2 t 178.58 -161.65 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.609 -0.682 . . . . 22.99 109.467 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 123' ' ' GLU . . . . . 0.417 ' HG2' HG22 ' R' ' 113' ' ' THR . 2.3 tp10 -56.5 -39.92 74.08 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.211 -0.93 . . . . 36.18 109.649 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 124' ' ' VAL . . . . . . . . . . . . . 83.8 t -142.57 136.39 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.606 -0.684 . . . . 20.64 109.383 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 125' ' ' CYS . . . . . 0.41 ' SG ' ' HA ' ' R' ' 121' ' ' PRO . 83.7 m -140.3 168.17 20.43 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.17 -0.956 . . . . 22.8 111.131 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 126' ' ' VAL . . . . . . . . . . . . . 35.9 m -122.68 159.82 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.724 -0.61 . . . . 21.24 109.613 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 127' ' ' VAL . . . . . 0.4 ' CG1' ' O ' ' R' ' 177' ' ' VAL . 31.1 m -70.89 141.86 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.283 -0.886 . . . . 19.77 110.675 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 128' ' ' ASP . . . . . . . . . . . . . 53.9 p-10 -137.73 19.41 2.87 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.327 -0.858 . . . . 29.21 110.697 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 129' ' ' GLY . . . . . . . . . . . . . . . 114.06 -0.02 24.06 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.928 -1.13 . . . . 33.86 110.441 179.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 130' ' ' THR . . . . . . . . . . . . . 58.7 m -91.9 131.88 36.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.11 -1.229 . . . . 26.41 110.046 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -62.57 120.72 11.68 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.369 -0.832 . . . . 33.08 110.258 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 132' ' ' MET . . . . . 0.427 ' HE1' ' CZ ' ' R' ' 180' ' ' PHE . 98.4 mmm -105.17 165.63 10.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.467 -0.771 . . . . 30.76 110.467 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 133' ' ' CYS . . . . . . . . . . . . . 32.8 m -141.13 158.13 44.34 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.542 -0.724 . . . . 27.0 109.973 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 134' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.45 -19.71 38.88 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.322 -0.861 . . . . 33.9 110.553 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 135' ' ' ALA . . . . . . . . . . . . . . . -92.8 8.24 40.29 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.31 -0.868 . . . . 19.37 110.802 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 136' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -93.76 -21.84 19.07 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.209 -0.932 . . . . 30.47 110.183 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 137' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -149.95 165.42 32.71 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.321 -0.862 . . . . 24.27 110.189 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 138' ' ' HIS . . . . . . . . . . . . . 15.2 p80 -117.88 15.19 14.33 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.382 -0.824 . . . . 20.91 110.452 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 139' ' ' ALA . . . . . 0.441 ' HA ' ' O ' ' R' ' 152' ' ' ALA . . . -177.22 152.4 0.87 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.207 -0.933 . . . . 15.69 110.099 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 140' ' ' GLY . . . . . 0.404 ' HA3' ' O ' ' R' ' 179' ' ' VAL . . . 161.81 175.17 32.55 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.962 -1.255 . . . . 23.76 109.962 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 141' ' ' ILE . . . . . . . . . . . . . 83.7 mt -95.5 136.54 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.473 -1.016 . . . . 25.3 109.718 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 142' ' ' PHE . . . . . 0.546 ' CD2' ' HB2' ' R' ' 172' ' ' PRO . 82.7 m-85 -120.72 -172.61 2.41 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.26 -0.9 . . . . 30.24 110.505 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 143' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -119.79 77.74 1.26 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.367 -0.833 . . . . 32.8 110.316 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 144' ' ' LYS . . . . . 0.454 ' HG3' ' CZ2' ' R' ' 170' ' ' TRP . 1.0 OUTLIER -69.62 76.87 0.43 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.43 -0.794 . . . . 49.18 109.679 179.594 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' R' R ' 145' ' ' GLY . . . . . . . . . . . . . . . 104.5 179.27 24.83 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.188 -1.565 . . . . 53.87 109.188 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 146' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -88.47 145.83 25.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.388 -1.066 . . . . 68.58 109.999 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 147' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 58.25 36.45 25.69 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.362 -0.837 . . . . 56.62 110.655 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 148' ' ' HIS . . . . . . . . . . . . . 44.7 t60 -158.61 148.13 19.28 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.219 -0.926 . . . . 44.57 110.376 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 149' ' ' ALA . . . . . . . . . . . . . . . -150.29 146.9 27.05 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.467 -0.771 . . . . 33.54 110.07 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 150' ' ' VAL . . . . . 0.428 HG23 ' HB2' ' R' ' 144' ' ' LYS . 34.2 m -142.3 161.51 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.261 -0.899 . . . . 27.61 110.36 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 151' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' R' ' 152' ' ' ALA . 5.8 t80 -86.17 155.6 20.67 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.428 -0.795 . . . . 23.04 109.904 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 152' ' ' ALA . . . . . 0.537 ' N ' ' CD1' ' R' ' 151' ' ' PHE . . . -157.29 151.5 24.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.443 -0.786 . . . . 29.61 109.611 179.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 153' ' ' CYS . . . . . 0.406 ' HA ' ' HA ' ' R' ' 139' ' ' ALA . 26.7 p -154.28 173.57 15.97 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.298 -0.876 . . . . 22.75 110.507 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 154' ' ' VAL . . . . . 0.443 ' CG2' ' CZ2' ' R' ' 159' ' ' TRP . 59.7 t -90.59 117.04 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.392 -0.817 . . . . 23.26 110.076 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 155' ' ' THR . . . . . . . . . . . . . 70.3 p -112.13 -176.63 2.97 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.358 -0.839 . . . . 17.88 110.041 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 156' ' ' SER . . . . . . . . . . . . . 78.6 p -75.92 -3.75 37.16 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.329 -0.857 . . . . 21.83 110.727 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 157' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -118.25 10.43 12.85 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.148 -0.97 . . . . 36.54 110.619 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 158' ' ' GLY . . . . . . . . . . . . . . . 117.97 -162.71 13.02 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.533 -1.427 . . . . 31.74 109.533 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 159' ' ' TRP . . . . . 0.443 ' CZ2' ' CG2' ' R' ' 154' ' ' VAL . 14.7 m95 -86.51 122.42 30.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.334 -1.098 . . . . 28.25 110.112 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 160' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -108.46 166.96 10.38 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.376 -0.827 . . . . 41.24 110.19 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 161' ' ' ALA . . . . . . . . . . . . . . . -143.22 123.42 13.74 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.362 -0.836 . . . . 27.4 110.198 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 162' ' ' ILE . . . . . 0.431 HG23 ' CZ ' ' R' ' 167' ' ' PHE . 92.0 mt -87.55 81.15 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.295 -0.878 . . . . 24.27 110.051 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 163' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' R' ' 165' ' ' GLU . 15.3 t0 -72.86 92.42 1.6 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.457 -0.777 . . . . 36.08 110.254 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 164' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 54.09 -88.94 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.489 -0.757 . . . . 46.08 110.603 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 165' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' R' ' 163' ' ' ASP . 29.7 mt-10 -124.72 35.92 4.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.088 -1.007 . . . . 50.94 110.187 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 166' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -135.75 117.3 14.84 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.388 -0.82 . . . . 47.28 110.347 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 167' ' ' PHE . . . . . 0.431 ' CZ ' HG23 ' R' ' 162' ' ' ILE . 24.4 m-85 -101.04 119.98 39.53 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.434 -0.791 . . . . 40.47 110.164 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 168' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -157.57 158.57 30.65 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.24 -0.913 . . . . 30.21 110.376 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 169' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.8 133.04 19.46 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.931 1.49 . . . . 32.76 110.474 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 170' ' ' TRP . . . . . 0.454 ' CZ2' ' HG3' ' R' ' 144' ' ' LYS . 66.9 t90 -159.81 119.37 2.89 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.461 -0.774 . . . . 32.79 109.909 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 171' ' ' THR . . . . . . . . . . . . . 46.1 m -81.1 112.61 34.16 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.448 -0.783 . . . . 36.92 110.163 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 172' ' ' PRO . . . . . 0.546 ' HB2' ' CD2' ' R' ' 142' ' ' PHE . 47.4 Cg_endo -73.71 158.75 46.68 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.66 1.348 . . . . 33.54 110.592 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 173' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -88.84 144.97 33.86 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.318 -0.864 . . . . 45.76 109.851 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 174' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.74 -10.34 26.31 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.614 1.323 . . . . 29.63 110.492 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 175' ' ' SER . . . . . . . . . . . . . 53.1 p -103.5 -17.55 15.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.281 -0.887 . . . . 35.7 110.343 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 176' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -103.5 43.26 1.1 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.202 -0.936 . . . . 39.65 110.442 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 177' ' ' VAL . . . . . 0.4 ' O ' ' CG1' ' R' ' 127' ' ' VAL . 10.5 p -117.79 127.14 75.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.326 -0.859 . . . . 20.61 110.034 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 178' ' ' LEU . . . . . . . . . . . . . 46.3 mt -91.47 -61.36 1.66 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.35 -0.844 . . . . 15.58 109.351 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 179' ' ' VAL . . . . . 0.404 ' O ' ' HA3' ' R' ' 140' ' ' GLY . 67.9 t -114.58 144.72 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.621 -0.674 . . . . 17.4 109.413 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 180' ' ' PHE . . . . . 0.427 ' CZ ' ' HE1' ' R' ' 132' ' ' MET . 43.7 p90 -152.17 163.32 39.62 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.273 -0.892 . . . . 20.16 110.602 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 181' ' ' VAL . . . . . . . . . . . . . 66.5 t -113.12 111.48 50.4 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.429 -0.795 . . . . 17.69 109.833 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 182' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.03 149.52 52.9 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.545 1.287 . . . . 17.81 110.423 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' R' R ' 183' ' ' TYR . . . . . 0.739 ' O ' ' C ' ' R' ' 184' ' ' ASP . 78.9 m-85 -59.01 175.53 0.28 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.43 -0.794 . . . . 28.01 110.526 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' R' R ' 184' ' ' ASP . . . . . 0.739 ' C ' ' O ' ' R' ' 183' ' ' TYR . 0.0 OUTLIER -12.28 -76.89 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.343 -0.848 . . . . 58.64 110.303 -178.086 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' R' R ' 185' ' ' GLN . . . . . . . . . . . . . 6.7 tm0? . . . . . 0 N--CA 1.503 2.188 0 CA-C-O 121.25 0.548 . . . . 80.42 111.723 179.409 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' R' R ' 193' ' ' LYS . . . . . . . . . . . . . 20.4 ttpp . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 120.938 0.399 . . . . 49.5 110.166 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' R' R ' 194' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.8 0 O-C-N 121.125 -0.984 . . . . 40.4 110.099 -179.926 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' S' S ' 229' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.171 0.51 . . . . 51.83 110.208 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 230' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -97.28 142.76 28.78 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.4 -0.813 . . . . 54.13 110.222 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 231' ' ' LEU . . . . . . . . . . . . . 67.8 mt -134.11 140.99 46.97 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.343 -0.848 . . . . 33.04 110.337 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 232' ' ' THR . . . . . . . . . . . . . 40.0 m -89.25 103.23 15.87 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.319 -0.863 . . . . 26.92 110.068 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 233' ' ' LEU . . . . . 0.493 HD23 ' CE2' ' S' ' 262' ' ' TYR . 79.9 mt -55.92 179.28 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.437 -0.79 . . . . 13.78 110.498 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' S' S ' 234' ' ' TYR . . . . . 0.442 ' CG ' ' N ' ' S' ' 235' ' ' ASN . 35.6 p90 -65.01 -35.65 81.89 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.393 -0.817 . . . . 26.08 110.198 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' S' S ' 235' ' ' ASN . . . . . 0.442 ' N ' ' CG ' ' S' ' 234' ' ' TYR . 50.7 p30 -74.33 -7.4 52.69 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.373 -0.829 . . . . 20.04 110.567 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' S' S ' 236' ' ' GLY . . . . . . . . . . . . . . . 95.69 -19.9 52.22 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.782 -1.327 . . . . 22.71 109.782 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 237' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -53.03 145.73 12.49 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.189 -1.183 . . . . 35.44 110.183 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 238' ' ' LYS . . . . . . . . . . . . . 44.3 mttt -102.17 127.91 48.89 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.38 -0.825 . . . . 32.56 110.361 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 239' ' ' LYS . . . . . 0.422 ' HG2' ' CZ ' ' S' ' 241' ' ' PHE . 9.0 ttmt -132.31 144.52 50.63 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.357 -0.839 . . . . 26.68 109.955 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' S' S ' 240' ' ' THR . . . . . . . . . . . . . 51.8 m -102.0 132.22 47.97 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.34 -0.85 . . . . 41.02 110.348 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 241' ' ' PHE . . . . . 0.422 ' CZ ' ' HG2' ' S' ' 239' ' ' LYS . 96.0 m-85 -117.96 137.7 52.67 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.418 -0.801 . . . . 28.62 110.186 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' S' S ' 242' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -96.42 161.78 13.77 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.392 -0.818 . . . . 47.89 110.257 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 243' ' ' SER . . . . . . . . . . . . . 72.0 m -90.5 151.52 21.33 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.372 -0.83 . . . . 45.09 110.282 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 244' ' ' ARG . . . . . . . . . . . . . 1.4 mtp85 -129.72 126.73 22.74 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.375 -0.828 . . . . 42.49 110.282 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 245' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.31 161.02 43.78 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.674 1.355 . . . . 35.68 110.544 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 246' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -132.89 97.85 4.14 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.353 -0.842 . . . . 51.88 109.853 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 247' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -110.47 -22.25 11.76 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.398 -0.813 . . . . 53.69 110.658 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 248' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -117.24 43.65 2.27 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.223 -0.923 . . . . 55.79 110.704 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 249' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 48.84 38.37 11.9 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.405 -0.809 . . . . 49.45 110.386 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 250' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -90.67 29.09 1.37 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.489 -0.757 . . . . 36.86 110.327 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 251' ' ' ALA . . . . . . . . . . . . . . . -53.91 -43.12 69.44 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.229 -0.919 . . . . 29.69 109.612 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 252' ' ' TRP . . . . . 0.408 ' CD2' ' N ' ' S' ' 253' ' ' LEU . 67.9 p-90 -61.81 -33.94 75.03 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.523 -0.736 . . . . 41.12 109.829 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' S' S ' 253' ' ' LEU . . . . . 0.408 ' N ' ' CD2' ' S' ' 252' ' ' TRP . 23.4 tp -70.17 -47.17 62.77 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.378 -0.826 . . . . 24.89 110.001 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' S' S ' 254' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -56.13 -42.47 76.96 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.445 -0.784 . . . . 35.65 109.966 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 255' ' ' ALA . . . . . . . . . . . . . . . -59.53 -48.25 82.39 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.463 -0.773 . . . . 22.73 110.071 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 256' ' ' ILE . . . . . . . . . . . . . 79.7 mt -62.24 -40.68 88.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.321 -0.862 . . . . 28.85 109.983 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 257' ' ' LEU . . . . . . . . . . . . . 19.0 mt -61.54 -44.45 97.03 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.352 -0.843 . . . . 23.07 110.183 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 258' ' ' GLN . . . . . 0.466 ' HB3' ' CD2' ' S' ' 351' ' ' PHE . 53.4 mm-40 -65.12 -45.33 85.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.371 -0.831 . . . . 29.78 109.882 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' S' S ' 259' ' ' LEU . . . . . 0.423 ' O ' HG22 ' S' ' 263' ' ' VAL . 19.9 tp -58.67 -36.41 74.13 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.344 -0.848 . . . . 17.94 109.462 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' S' S ' 260' ' ' PHE . . . . . 0.468 ' CE2' HD22 ' S' ' 311' ' ' LEU . 3.1 m-85 -62.83 -45.29 93.3 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.655 -0.653 . . . . 30.57 109.834 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' S' S ' 261' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -62.01 -29.8 70.52 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.525 -0.734 . . . . 41.34 110.033 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 262' ' ' TYR . . . . . 0.493 ' CE2' HD23 ' S' ' 233' ' ' LEU . 8.7 t80 -71.24 -44.62 64.94 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.443 -0.786 . . . . 26.03 110.093 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' S' S ' 263' ' ' VAL . . . . . 0.423 HG22 ' O ' ' S' ' 259' ' ' LEU . 33.0 m -91.99 18.24 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.336 -0.852 . . . . 22.8 110.411 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' S' S ' 264' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 52.79 70.65 0.55 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.223 -0.923 . . . . 44.03 110.611 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 265' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -111.78 109.25 55.46 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.394 -0.817 . . . . 35.61 109.654 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 266' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -75.39 0.45 9.05 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 O-C-N 123.605 1.318 . . . . 37.67 111.742 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 267' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -56.54 -67.7 0.28 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.802 -1.186 . . . . 41.49 110.165 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' S' S ' 268' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -92.91 39.89 1.05 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.148 -0.97 . . . . 50.76 110.048 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 269' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.01 -33.19 59.67 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.381 -0.825 . . . . 61.86 109.765 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' S' S ' 270' ' ' TRP . . . . . 0.482 ' CE2' ' CG2' ' S' ' 271' ' ' VAL . 51.0 p-90 -73.94 -4.28 34.2 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.268 -0.895 . . . . 39.85 110.466 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' S' S ' 271' ' ' VAL . . . . . 0.482 ' CG2' ' CE2' ' S' ' 270' ' ' TRP . 46.6 t -109.58 -32.66 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.157 -0.964 . . . . 39.18 110.07 179.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' S' S ' 272' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -78.67 -36.53 43.63 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.42 -0.8 . . . . 40.02 110.47 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 273' ' ' SER . . . . . . . . . . . . . 70.9 m -103.57 56.16 0.74 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.278 -0.889 . . . . 47.2 110.294 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 274' ' ' SER . . . . . . . . . . . . . 6.9 t -133.03 141.22 40.15 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.385 -0.822 . . . . 47.61 110.158 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 275' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.76 -18.85 21.71 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.66 1.347 . . . . 45.28 110.556 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 276' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -99.89 140.87 33.47 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.3 -0.875 . . . . 57.27 110.31 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 277' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -71.73 97.66 1.81 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.398 -0.814 . . . . 37.28 110.279 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 278' ' ' LEU . . . . . . . . . . . . . 86.3 mt -97.02 33.82 1.84 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.394 -0.816 . . . . 43.88 110.047 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 279' ' ' THR . . . . . . . . . . . . . 74.7 m -64.03 -60.1 3.65 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.484 -0.76 . . . . 50.05 110.303 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 280' ' ' LEU . . . . . . . . . . . . . 13.7 mt -51.61 -39.87 58.79 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.334 -0.854 . . . . 54.12 110.287 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 281' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.42 -49.67 74.57 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.499 -0.751 . . . . 65.28 110.177 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' S' S ' 282' ' ' ALA . . . . . . . . . . . . . . . -58.93 -33.9 71.12 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.456 -0.778 . . . . 46.51 110.571 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 283' ' ' ILE . . . . . . . . . . . . . 85.9 mt -66.39 -50.84 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.306 -0.871 . . . . 47.3 110.083 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 284' ' ' LYS . . . . . . . . . . . . . 33.8 tttp -50.52 -57.63 7.65 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.411 -0.806 . . . . 50.72 110.381 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 285' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -51.4 -46.4 62.84 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.487 -0.758 . . . . 68.47 110.283 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 286' ' ' LEU . . . . . . . . . . . . . 19.1 mt -59.95 -44.49 94.35 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.429 -0.794 . . . . 36.62 110.284 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 287' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -62.74 -35.29 79.3 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.33 -0.856 . . . . 46.64 110.077 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 288' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -76.23 -21.04 56.87 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.442 -0.787 . . . . 46.45 110.34 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 289' ' ' LEU . . . . . . . . . . . . . 30.8 mt -97.35 -21.75 17.03 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.256 -0.902 . . . . 35.09 110.485 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 290' ' ' THR . . . . . . . . . . . . . 81.3 p -114.8 -28.44 7.08 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.281 -0.887 . . . . 38.61 110.419 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 291' ' ' GLY . . . . . . . . . . . . . . . 79.4 10.97 85.41 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.833 -1.307 . . . . 36.77 109.833 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 292' ' ' LEU . . . . . . . . . . . . . 84.7 mt -96.42 145.83 25.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.247 -1.149 . . . . 35.33 109.77 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 293' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -77.37 102.32 6.74 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.222 -0.924 . . . . 48.7 110.262 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 294' ' ' LEU . . . . . 0.406 ' HB3' ' CZ2' ' S' ' 252' ' ' TRP . 55.8 mt -106.86 51.73 0.74 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.575 -0.703 . . . . 42.61 110.123 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' S' S ' 295' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -112.56 -11.11 13.63 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.296 -0.878 . . . . 55.49 110.505 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' S' S ' 296' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -144.34 48.52 1.36 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.178 -0.951 . . . . 75.68 110.308 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 297' ' ' GLY . . . . . . . . . . . . . . . 96.9 145.18 18.7 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.524 -1.43 . . . . 49.44 109.524 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 298' ' ' GLY . . . . . . . . . . . . . . . -163.8 156.93 29.0 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.807 -1.317 . . . . 41.11 109.807 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 299' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.8 118.33 5.4 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.916 1.482 . . . . 26.2 110.278 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 300' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.25 -15.48 31.64 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.587 1.309 . . . . 21.7 110.725 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 301' ' ' ALA . . . . . . . . . . . . . . . -80.73 -29.35 36.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.271 -0.893 . . . . 31.23 110.099 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 302' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.49 -40.61 18.99 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.4 -0.812 . . . . 38.99 109.982 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' S' S ' 303' ' ' VAL . . . . . 0.463 ' O ' HG12 ' S' ' 307' ' ' ILE . 58.1 t -60.74 -35.43 64.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.436 -0.79 . . . . 18.63 110.14 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' S' S ' 304' ' ' ILE . . . . . . . . . . . . . 86.0 mt -79.39 -23.65 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.37 -0.831 . . . . 25.46 110.178 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 305' ' ' TRP . . . . . 0.409 ' NE1' ' NH1' ' R' ' 120' ' ' ARG . 68.9 t-105 -88.61 -14.54 37.27 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.295 -0.878 . . . . 33.4 110.569 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' S' S ' 306' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -89.67 -13.65 36.52 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.191 -0.943 . . . . 36.97 110.388 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 307' ' ' ILE . . . . . 0.463 HG12 ' O ' ' S' ' 303' ' ' VAL . 36.9 pt -125.01 45.66 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.237 -0.915 . . . . 30.81 110.004 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' S' S ' 308' ' ' LYS . . . . . 0.403 ' HD3' ' CD2' ' S' ' 305' ' ' TRP . 1.5 mtmp? -73.64 -37.63 65.26 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.371 -0.831 . . . . 46.52 110.097 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' S' S ' 309' ' ' HIS . . . . . 0.484 ' CD2' ' HG ' ' S' ' 310' ' ' LEU . 55.6 p-80 -73.26 -8.28 55.16 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.321 -0.862 . . . . 51.03 110.062 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' S' S ' 310' ' ' LEU . . . . . 0.484 ' HG ' ' CD2' ' S' ' 309' ' ' HIS . 53.0 mt -99.28 -12.87 19.97 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.353 -0.842 . . . . 36.16 109.986 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' S' S ' 311' ' ' LEU . . . . . 0.468 HD22 ' CE2' ' S' ' 260' ' ' PHE . 10.7 mt -97.19 147.88 23.64 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.339 -0.85 . . . . 40.0 110.399 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' S' S ' 312' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -81.6 -16.3 51.98 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.275 -0.891 . . . . 54.18 109.69 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 313' ' ' THR . . . . . 0.476 HG23 ' HB3' ' S' ' 323' ' ' GLU . 92.7 m -87.97 151.65 22.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.336 -0.853 . . . . 25.61 110.098 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' S' S ' 314' ' ' GLY . . . . . . . . . . . . . . . -87.95 126.43 8.06 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.783 -1.327 . . . . 25.18 109.783 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 315' ' ' ILE . . . . . 0.411 HG23 HD11 ' S' ' 315' ' ' ILE . 50.7 mm -101.6 150.49 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.356 -1.085 . . . . 23.9 109.72 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' S' S ' 316' ' ' GLY . . . . . 0.405 ' N ' HG21 ' S' ' 315' ' ' ILE . . . -157.08 -159.25 9.37 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.957 -1.257 . . . . 23.18 109.957 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' S' S ' 317' ' ' THR . . . . . . . . . . . . . 11.2 p -133.94 -173.06 3.14 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.418 -1.048 . . . . 27.98 110.023 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.51 -56.19 25.15 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.175 -0.953 . . . . 28.1 109.926 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 319' ' ' SER . . . . . . . . . . . . . 1.2 m -59.94 -41.7 92.42 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.36 -0.838 . . . . 37.0 109.656 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 320' ' ' ARG . . . . . . . . . . . . . 12.1 mtm180 -111.67 79.91 2.64 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.529 -0.732 . . . . 52.07 109.718 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 321' ' ' PRO . . . . . 0.421 ' O ' ' HB2' ' S' ' 322' ' ' SER . 43.9 Cg_endo -71.45 171.48 16.13 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.865 1.455 . . . . 38.29 110.92 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' S' S ' 322' ' ' SER . . . . . 0.421 ' HB2' ' O ' ' S' ' 321' ' ' PRO . 41.3 t 178.68 -148.12 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.934 -0.765 . . . . 38.84 108.934 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' S' S ' 323' ' ' GLU . . . . . 0.476 ' HB3' HG23 ' S' ' 313' ' ' THR . 6.7 tp10 -62.89 -40.31 97.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.017 -1.052 . . . . 40.7 109.635 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' S' S ' 324' ' ' VAL . . . . . . . . . . . . . 72.8 t -141.25 135.01 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.402 -0.811 . . . . 20.34 109.506 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 325' ' ' CYS . . . . . 0.459 ' HB2' ' CE1' ' S' ' 380' ' ' PHE . 11.2 m -126.02 172.26 10.11 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.267 -0.895 . . . . 30.63 110.854 -179.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' S' S ' 326' ' ' VAL . . . . . . . . . . . . . 34.6 m -135.57 142.2 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.611 -0.681 . . . . 23.9 109.191 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 327' ' ' VAL . . . . . . . . . . . . . 34.5 m -56.32 124.99 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.111 -0.993 . . . . 19.48 110.456 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 328' ' ' ASP . . . . . . . . . . . . . 55.5 p-10 -119.37 11.53 12.22 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.412 -0.805 . . . . 26.43 110.417 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 329' ' ' GLY . . . . . . . . . . . . . . . 119.65 2.24 13.12 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.052 -1.219 . . . . 31.24 110.052 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 330' ' ' THR . . . . . . . . . . . . . 80.7 m -93.04 130.06 38.77 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.116 -1.226 . . . . 30.05 110.109 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 331' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -56.86 111.52 1.05 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.244 -0.91 . . . . 37.26 109.916 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 332' ' ' MET . . . . . 0.449 ' HE1' ' CZ ' ' S' ' 380' ' ' PHE . 88.0 mmm -94.09 162.53 13.83 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.234 -0.916 . . . . 26.23 110.332 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' S' S ' 333' ' ' CYS . . . . . . . . . . . . . 25.8 m -137.2 150.07 47.64 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.47 -0.769 . . . . 23.56 110.058 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 334' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.62 -24.83 9.15 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.371 -0.83 . . . . 28.93 110.428 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' S' S ' 335' ' ' ALA . . . . . . . . . . . . . . . -89.06 14.44 10.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.396 -0.815 . . . . 15.76 110.954 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 336' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -100.45 -17.25 17.26 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.124 -0.985 . . . . 34.92 110.191 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 337' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -152.4 170.85 19.08 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.412 -0.805 . . . . 19.03 110.054 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 338' ' ' HIS . . . . . . . . . . . . . 13.4 p80 -120.71 10.37 10.98 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.363 -0.835 . . . . 18.82 110.449 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 339' ' ' ALA . . . . . . . . . . . . . . . -175.95 155.18 1.58 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.221 -0.924 . . . . 17.18 110.054 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 340' ' ' GLY . . . . . . . . . . . . . . . 160.84 173.08 29.0 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.056 -1.218 . . . . 18.33 110.056 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 341' ' ' ILE . . . . . 0.441 HD12 HG22 ' S' ' 341' ' ' ILE . 83.9 mt -88.82 138.1 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.508 -0.995 . . . . 18.6 109.786 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' S' S ' 342' ' ' PHE . . . . . 0.497 ' CE1' HG23 ' S' ' 377' ' ' VAL . 70.0 m-85 -120.97 -178.46 3.75 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.256 -0.903 . . . . 23.44 110.396 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' S' S ' 343' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.82 93.33 4.16 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.412 -0.805 . . . . 35.59 110.008 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' S' S ' 344' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.8 124.98 29.52 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.219 -0.926 . . . . 38.34 110.102 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' S' S ' 345' ' ' GLY . . . . . . . . . . . . . . . 62.77 -130.83 43.09 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 108.887 -1.685 . . . . 53.46 108.887 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 346' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -132.68 150.83 52.11 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.244 -1.151 . . . . 70.91 110.066 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 347' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 53.35 35.38 20.18 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.339 -0.85 . . . . 47.32 110.352 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 348' ' ' HIS . . . . . . . . . . . . . 46.7 t60 -150.17 155.86 40.56 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.265 -0.897 . . . . 41.72 110.317 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 349' ' ' ALA . . . . . . . . . . . . . . . -149.75 151.26 33.33 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.306 -0.871 . . . . 22.91 110.487 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 350' ' ' VAL . . . . . . . . . . . . . 34.6 m -149.08 169.66 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.465 -0.772 . . . . 21.09 110.014 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 351' ' ' PHE . . . . . 0.466 ' CD2' ' HB3' ' S' ' 258' ' ' GLN . 10.7 t80 -105.42 143.66 33.28 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.284 -0.885 . . . . 25.03 110.67 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' S' S ' 352' ' ' ALA . . . . . . . . . . . . . . . -147.73 151.71 36.53 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.617 -0.677 . . . . 23.81 109.742 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 353' ' ' CYS . . . . . . . . . . . . . 26.3 p -153.35 164.85 37.42 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.346 -0.846 . . . . 25.66 110.27 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 354' ' ' VAL . . . . . 0.404 HG23 ' CZ2' ' S' ' 359' ' ' TRP . 56.4 t -75.97 118.47 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.378 -0.826 . . . . 34.27 110.025 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' S' S ' 355' ' ' THR . . . . . 0.444 HG23 ' HB2' ' S' ' 360' ' ' TYR . 51.9 p -117.83 175.11 5.81 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.243 -0.911 . . . . 25.49 110.314 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' S' S ' 356' ' ' SER . . . . . . . . . . . . . 62.3 p -62.15 -17.72 58.77 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.395 -0.815 . . . . 31.24 110.716 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 357' ' ' ASN . . . . . . . . . . . . . 46.1 m-20 -106.97 14.18 26.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.149 -0.969 . . . . 28.61 110.604 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 358' ' ' GLY . . . . . . . . . . . . . . . 111.82 -152.83 17.6 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.031 -1.228 . . . . 22.01 110.031 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 359' ' ' TRP . . . . . 0.404 ' CZ2' HG23 ' S' ' 354' ' ' VAL . 15.4 m95 -91.37 116.73 29.08 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.442 -1.034 . . . . 25.54 110.155 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' S' S ' 360' ' ' TYR . . . . . 0.444 ' HB2' HG23 ' S' ' 355' ' ' THR . 1.3 m-85 -103.48 165.79 10.82 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.276 -0.89 . . . . 40.53 110.094 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' S' S ' 361' ' ' ALA . . . . . . . . . . . . . . . -140.09 130.08 24.83 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.376 -0.828 . . . . 18.04 110.272 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 362' ' ' ILE . . . . . 0.427 HG23 ' CZ ' ' S' ' 367' ' ' PHE . 88.9 mt -95.6 83.63 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.353 -0.842 . . . . 15.64 110.023 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' S' S ' 363' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' S' ' 365' ' ' GLU . 11.8 t0 -75.18 94.46 2.96 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.364 -0.835 . . . . 35.03 110.208 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' S' S ' 364' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 53.95 -89.39 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.543 -0.723 . . . . 46.72 110.524 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 365' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' S' ' 363' ' ' ASP . 23.8 mt-10 -122.64 19.11 10.36 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.058 -1.026 . . . . 56.2 110.233 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' S' S ' 366' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -118.01 125.06 49.63 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.231 -0.918 . . . . 51.02 110.368 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 367' ' ' PHE . . . . . 0.427 ' CZ ' HG23 ' S' ' 362' ' ' ILE . 26.9 m-85 -107.06 127.08 53.15 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.321 -0.862 . . . . 37.59 110.101 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' S' S ' 368' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -165.44 159.55 13.88 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.3 -0.875 . . . . 31.47 110.427 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 369' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.83 139.63 30.75 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 O-C-N 123.872 1.459 . . . . 28.85 110.535 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 370' ' ' TRP . . . . . . . . . . . . . 67.4 t90 -167.24 113.5 0.76 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.362 -0.836 . . . . 26.94 110.007 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 371' ' ' THR . . . . . . . . . . . . . 59.4 m -74.74 113.03 20.4 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.433 -0.792 . . . . 20.19 110.057 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 372' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -73.55 157.09 49.25 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 O-C-N 123.609 1.32 . . . . 28.68 110.583 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 373' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -90.57 147.13 35.72 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.415 -0.803 . . . . 35.72 109.93 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 374' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -76.03 -6.23 17.13 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.676 1.356 . . . . 30.89 110.534 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 375' ' ' SER . . . . . . . . . . . . . 69.4 p -104.39 -17.01 14.95 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.209 -0.932 . . . . 29.41 110.414 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 376' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -106.45 42.98 1.19 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.348 -0.845 . . . . 32.89 110.24 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 377' ' ' VAL . . . . . 0.497 HG23 ' CE1' ' S' ' 342' ' ' PHE . 7.3 p -114.63 147.31 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.253 -0.905 . . . . 24.33 110.2 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' S' S ' 378' ' ' LEU . . . . . . . . . . . . . 52.2 mt -116.01 -58.02 2.15 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.426 -0.796 . . . . 24.37 109.626 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 379' ' ' VAL . . . . . . . . . . . . . 61.5 t -120.7 132.42 70.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.437 -0.789 . . . . 18.02 109.385 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 380' ' ' PHE . . . . . 0.459 ' CE1' ' HB2' ' S' ' 325' ' ' CYS . 14.5 p90 -142.59 173.92 11.11 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.427 -0.796 . . . . 29.35 110.675 -179.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' S' S ' 381' ' ' VAL . . . . . . . . . . . . . 58.1 t -120.03 107.36 39.92 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.512 -0.743 . . . . 16.34 109.413 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 382' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -71.31 145.63 48.9 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.68 1.358 . . . . 20.94 110.803 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' S' S ' 383' ' ' TYR . . . . . 0.978 ' O ' ' CB ' ' S' ' 384' ' ' ASP . 88.3 m-85 -61.11 -53.43 57.12 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.405 -0.809 . . . . 28.93 109.838 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' S' S ' 384' ' ' ASP . . . . . 0.978 ' CB ' ' O ' ' S' ' 383' ' ' TYR . 13.3 t70 . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.433 -0.792 . . . . 47.03 110.36 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 30' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 121.203 0.525 . . . . 43.36 110.212 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' R' R ' 31' ' ' LEU . . . . . . . . . . . . . 65.7 mt -134.86 140.65 45.98 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.286 -0.884 . . . . 22.93 110.306 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 32' ' ' THR . . . . . . . . . . . . . 69.1 m -87.61 110.51 20.43 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.433 -0.792 . . . . 22.34 109.962 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 33' ' ' LEU . . . . . 0.462 HD23 ' CE2' ' R' ' 62' ' ' TYR . 80.1 mt -62.35 -172.79 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.316 -0.865 . . . . 21.39 110.226 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 34' ' ' TYR . . . . . . . . . . . . . 37.0 p90 -74.65 -29.41 61.25 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.333 -0.855 . . . . 34.4 110.386 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 35' ' ' ASN . . . . . . . . . . . . . 48.3 p30 -77.79 -1.83 33.39 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.314 -0.866 . . . . 30.28 110.643 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.25 -16.56 59.48 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.784 -1.326 . . . . 36.25 109.784 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 37' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -59.04 161.79 4.82 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.373 -1.075 . . . . 53.8 110.405 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 38' ' ' LYS . . . . . . . . . . . . . 57.2 mttt -117.8 135.7 53.9 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.405 -0.809 . . . . 49.91 110.19 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 39' ' ' LYS . . . . . 0.415 ' HG2' ' CZ ' ' R' ' 41' ' ' PHE . 8.1 ttmt -138.73 143.66 39.17 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.319 -0.863 . . . . 35.69 110.235 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 40' ' ' THR . . . . . . . . . . . . . 23.4 m -102.56 127.91 49.43 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.287 -0.883 . . . . 34.84 110.308 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 41' ' ' PHE . . . . . 0.415 ' CZ ' ' HG2' ' R' ' 39' ' ' LYS . 96.6 m-85 -113.04 132.6 55.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.413 -0.804 . . . . 34.42 110.179 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 42' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -93.24 140.95 28.98 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.348 -0.845 . . . . 51.46 110.204 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 43' ' ' SER . . . . . . . . . . . . . 54.2 m -70.81 141.9 51.33 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.453 -0.779 . . . . 41.84 110.206 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.76 125.39 29.55 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.308 -0.87 . . . . 33.82 109.962 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 45' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.15 151.06 54.8 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.563 1.297 . . . . 30.27 110.66 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 46' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.28 109.92 13.97 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.415 -0.803 . . . . 35.1 109.999 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 47' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -120.34 -34.88 3.54 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.367 -0.833 . . . . 42.81 110.489 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 48' ' ' HIS . . . . . . . . . . . . . 73.3 m80 -105.76 45.23 0.98 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.328 -0.857 . . . . 49.97 110.263 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 49' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 50.27 34.68 9.16 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.345 -0.847 . . . . 61.32 110.199 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 50' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -86.29 43.8 1.09 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.426 -0.796 . . . . 51.5 110.706 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.11 -46.14 78.65 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.325 -0.86 . . . . 38.77 109.502 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 52' ' ' TRP . . . . . 0.483 ' CD2' ' N ' ' R' ' 53' ' ' LEU . 68.2 p-90 -58.35 -38.43 77.18 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.504 -0.747 . . . . 26.24 110.055 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 53' ' ' LEU . . . . . 0.483 ' N ' ' CD2' ' R' ' 52' ' ' TRP . 23.1 tp -66.68 -46.72 74.72 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.362 -0.836 . . . . 26.75 109.958 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 54' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -55.15 -41.66 72.11 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.341 -0.85 . . . . 35.02 110.14 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.24 -46.04 92.03 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.369 -0.832 . . . . 24.47 110.141 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 56' ' ' ILE . . . . . . . . . . . . . 76.1 mt -62.1 -42.32 94.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.213 -0.93 . . . . 26.03 109.92 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 57' ' ' LEU . . . . . . . . . . . . . 22.4 mt -60.31 -45.63 92.71 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.336 -0.853 . . . . 26.77 109.68 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 58' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -63.92 -46.48 84.59 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.521 -0.737 . . . . 22.32 109.594 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 59' ' ' LEU . . . . . 0.43 ' HA ' ' HE2' ' R' ' 151' ' ' PHE . 23.9 tp -61.45 -37.74 84.65 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.337 -0.852 . . . . 20.55 109.373 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 60' ' ' PHE . . . . . 0.447 ' CE2' HD22 ' R' ' 111' ' ' LEU . 2.8 m-85 -61.04 -44.84 96.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.628 -0.67 . . . . 20.08 109.921 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 61' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -63.0 -36.22 82.83 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.504 -0.747 . . . . 18.8 110.532 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 62' ' ' TYR . . . . . 0.462 ' CE2' HD23 ' R' ' 33' ' ' LEU . 9.2 t80 -63.16 -41.73 99.31 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.157 -0.964 . . . . 26.45 110.213 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 63' ' ' VAL . . . . . . . . . . . . . 30.4 m -93.34 20.3 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.199 -0.938 . . . . 29.75 110.185 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 64' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 52.94 75.56 0.24 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.369 -0.832 . . . . 35.52 110.556 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 65' ' ' GLU . . . . . 0.423 ' HG2' ' CD2' ' R' ' 60' ' ' PHE . 14.3 tp10 -116.29 104.02 52.38 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.424 -0.797 . . . . 29.89 109.866 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 66' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.48 -5.89 17.86 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.708 1.372 . . . . 21.37 111.109 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 67' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -52.09 -61.52 2.21 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.144 -0.973 . . . . 23.85 110.375 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 68' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -98.11 36.51 1.56 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.312 -0.867 . . . . 28.07 110.512 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 69' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -72.33 -33.23 67.18 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.296 -0.878 . . . . 43.76 110.18 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 70' ' ' TRP . . . . . 0.475 ' CE2' ' CG2' ' R' ' 71' ' ' VAL . 47.9 p-90 -73.4 -3.94 30.46 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.29 -0.881 . . . . 33.06 110.7 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 71' ' ' VAL . . . . . 0.475 ' CG2' ' CE2' ' R' ' 70' ' ' TRP . 40.9 t -109.75 -27.45 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.23 -0.919 . . . . 31.7 109.647 179.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 72' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -86.58 -48.84 7.99 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.407 -0.808 . . . . 33.58 110.294 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 73' ' ' SER . . . . . . . . . . . . . 69.9 m -89.63 50.96 1.99 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.338 -0.851 . . . . 50.82 110.379 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 74' ' ' SER . . . . . . . . . . . . . 16.0 t -125.82 138.32 31.77 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.226 -0.921 . . . . 34.74 110.265 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.33 -24.98 16.01 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.672 1.354 . . . . 35.7 110.336 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 76' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -91.71 153.2 19.8 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.476 -0.765 . . . . 66.48 110.343 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 77' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -81.47 95.26 7.03 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.298 -0.876 . . . . 46.72 110.114 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 78' ' ' LEU . . . . . . . . . . . . . 96.3 mt -96.43 27.93 3.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.338 -0.851 . . . . 37.55 110.191 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 79' ' ' THR . . . . . . . . . . . . . 29.5 m -56.2 -54.65 42.65 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.329 -0.857 . . . . 37.36 110.295 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 80' ' ' LEU . . . . . . . . . . . . . 15.9 mt -60.81 -23.29 64.95 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.337 -0.852 . . . . 35.83 110.549 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 81' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -79.5 -39.12 32.82 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.229 -0.919 . . . . 44.03 110.321 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.49 -28.6 66.2 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.224 -0.923 . . . . 32.54 110.256 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 83' ' ' ILE . . . . . . . . . . . . . 78.2 mt -70.16 -46.12 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.308 -0.87 . . . . 32.02 110.302 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 84' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -55.15 -52.08 64.42 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.193 -0.942 . . . . 34.09 110.611 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 85' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -54.83 -46.85 74.64 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.206 -0.934 . . . . 25.94 110.249 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 86' ' ' LEU . . . . . . . . . . . . . 24.0 mt -58.7 -43.81 90.17 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.332 -0.855 . . . . 16.2 109.91 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 87' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -65.38 -35.17 80.16 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.391 -0.818 . . . . 49.09 110.251 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 88' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -78.48 -19.08 53.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.345 -0.847 . . . . 28.61 110.522 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 89' ' ' LEU . . . . . . . . . . . . . 32.7 mt -96.15 -29.4 14.09 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.304 -0.872 . . . . 26.16 110.22 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 90' ' ' THR . . . . . . . . . . . . . 60.4 p -105.7 -34.55 7.67 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.284 -0.885 . . . . 33.33 109.763 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.77 16.18 58.6 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.862 -1.295 . . . . 31.13 109.862 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 92' ' ' LEU . . . . . . . . . . . . . 97.1 mt -100.18 155.19 17.89 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.213 -1.169 . . . . 42.52 110.229 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 93' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -86.17 91.64 8.51 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.567 -0.708 . . . . 68.46 110.038 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 94' ' ' LEU . . . . . 0.447 ' HB3' ' CZ2' ' R' ' 52' ' ' TRP . 48.3 mt -99.46 53.0 0.94 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.289 -0.882 . . . . 44.63 110.33 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 95' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.44 -38.71 6.38 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.3 -0.875 . . . . 67.16 110.395 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 96' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -113.9 44.32 1.66 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.364 -0.835 . . . . 67.02 110.238 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 97' ' ' GLY . . . . . . . . . . . . . . . 99.12 150.78 26.03 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.634 -1.387 . . . . 49.48 109.634 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 98' ' ' GLY . . . . . . . . . . . . . . . -166.22 160.07 33.5 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.294 -1.522 . . . . 36.57 109.294 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 99' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.59 121.07 7.1 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.645 1.34 . . . . 30.41 110.413 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 100' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.25 -31.67 11.48 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 O-C-N 123.645 1.339 . . . . 29.94 110.53 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.02 -38.4 75.91 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.226 -0.921 . . . . 23.64 110.233 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.67 -40.71 66.07 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.358 -0.839 . . . . 20.31 110.386 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 103' ' ' VAL . . . . . . . . . . . . . 64.3 t -58.25 -40.02 76.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.195 -0.941 . . . . 16.33 109.984 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 104' ' ' ILE . . . . . . . . . . . . . 81.6 mt -71.68 -30.6 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.397 -0.814 . . . . 24.77 109.966 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 105' ' ' TRP . . . . . 0.441 ' O ' ' HD3' ' R' ' 108' ' ' LYS . 70.5 t-105 -82.41 0.85 40.15 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.292 -0.88 . . . . 23.28 110.31 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 106' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -105.07 -10.35 17.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.171 -0.956 . . . . 28.26 110.118 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 107' ' ' ILE . . . . . . . . . . . . . 36.7 pt -126.88 35.08 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.254 -0.904 . . . . 18.77 109.966 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 108' ' ' LYS . . . . . 0.481 ' HG2' ' HB ' ' R' ' 115' ' ' ILE . 9.2 mtpp -61.12 -48.41 81.78 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.56 -0.713 . . . . 42.5 110.049 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 109' ' ' HIS . . . . . 0.432 ' CD2' ' HG ' ' R' ' 110' ' ' LEU . 50.8 p-80 -66.02 -12.85 58.07 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.456 -0.777 . . . . 20.07 110.698 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 110' ' ' LEU . . . . . 0.432 ' HG ' ' CD2' ' R' ' 109' ' ' HIS . 80.3 mt -94.79 -17.25 22.31 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.076 -1.015 . . . . 15.69 110.207 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 111' ' ' LEU . . . . . 0.447 HD22 ' CE2' ' R' ' 60' ' ' PHE . 10.3 mt -94.13 144.16 25.74 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.342 -0.849 . . . . 25.39 111.014 -179.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 112' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -77.71 -17.36 57.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.51 -0.744 . . . . 53.48 109.846 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 113' ' ' THR . . . . . 0.416 HG22 ' HG2' ' R' ' 123' ' ' GLU . 59.8 m -83.76 166.67 17.83 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.273 -0.892 . . . . 14.8 110.193 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 114' ' ' GLY . . . . . . . . . . . . . . . -97.99 127.1 9.11 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.042 -1.223 . . . . 16.14 110.042 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 115' ' ' ILE . . . . . 0.481 ' HB ' ' HG2' ' R' ' 108' ' ' LYS . 47.7 mm -109.01 139.46 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.503 -0.998 . . . . 13.46 109.674 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 116' ' ' GLY . . . . . . . . . . . . . . . -152.84 -155.89 7.31 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.932 -1.267 . . . . 23.9 109.932 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 117' ' ' THR . . . . . . . . . . . . . 18.5 p -135.03 -171.39 2.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.451 -1.029 . . . . 27.37 110.079 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.52 -58.14 9.32 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.246 -0.909 . . . . 18.76 110.074 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 119' ' ' SER . . . . . . . . . . . . . 1.2 m -56.51 -40.48 75.09 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.351 -0.843 . . . . 32.35 109.838 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 120' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 -110.12 86.21 4.9 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.411 -0.806 . . . . 27.12 109.69 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 121' ' ' PRO . . . . . 0.426 ' O ' ' HB2' ' R' ' 122' ' ' SER . 44.0 Cg_endo -71.26 166.49 29.09 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 O-C-N 123.903 1.475 . . . . 22.68 111.035 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 122' ' ' SER . . . . . 0.426 ' HB2' ' O ' ' R' ' 121' ' ' PRO . 38.6 t 178.55 -161.7 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.609 -0.682 . . . . 22.99 109.455 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 123' ' ' GLU . . . . . 0.416 ' HG2' HG22 ' R' ' 113' ' ' THR . 2.3 tp10 -56.44 -40.01 74.06 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.216 -0.928 . . . . 36.18 109.63 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 124' ' ' VAL . . . . . . . . . . . . . 82.2 t -142.5 136.4 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.62 -0.675 . . . . 20.64 109.457 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 125' ' ' CYS . . . . . 0.409 ' SG ' ' HA ' ' R' ' 121' ' ' PRO . 83.0 m -140.23 168.21 20.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.193 -0.942 . . . . 22.8 111.206 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 126' ' ' VAL . . . . . . . . . . . . . 35.9 m -122.78 159.72 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.733 -0.604 . . . . 21.24 109.574 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 127' ' ' VAL . . . . . 0.4 ' CG1' ' O ' ' R' ' 177' ' ' VAL . 30.4 m -70.76 141.82 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.305 -0.872 . . . . 19.77 110.734 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 128' ' ' ASP . . . . . . . . . . . . . 53.8 p-10 -137.74 19.41 2.87 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.417 -0.802 . . . . 29.21 110.66 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 129' ' ' GLY . . . . . . . . . . . . . . . 114.0 0.04 24.14 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.939 -1.124 . . . . 33.86 110.527 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 130' ' ' THR . . . . . . . . . . . . . 58.4 m -91.94 131.81 36.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.135 -1.215 . . . . 26.41 110.046 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -62.43 120.64 11.46 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.317 -0.865 . . . . 33.08 110.336 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 132' ' ' MET . . . . . 0.426 ' HE1' ' CZ ' ' R' ' 180' ' ' PHE . 98.5 mmm -105.24 165.64 10.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.482 -0.761 . . . . 30.76 110.409 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 133' ' ' CYS . . . . . . . . . . . . . 32.2 m -141.12 158.23 44.2 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.451 -0.78 . . . . 27.0 109.956 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 134' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.53 -19.74 40.24 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.232 -0.918 . . . . 33.9 110.515 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 135' ' ' ALA . . . . . . . . . . . . . . . -92.66 8.11 40.55 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.344 -0.848 . . . . 19.37 110.833 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 136' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -93.7 -21.88 19.08 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.165 -0.96 . . . . 30.47 110.178 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 137' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -149.91 165.3 33.01 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.351 -0.843 . . . . 24.27 110.241 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 138' ' ' HIS . . . . . . . . . . . . . 15.1 p80 -117.79 15.18 14.41 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.422 -0.798 . . . . 20.91 110.417 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 139' ' ' ALA . . . . . 0.44 ' HA ' ' O ' ' R' ' 152' ' ' ALA . . . -177.23 152.4 0.87 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.187 -0.946 . . . . 15.69 110.157 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 140' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' R' ' 179' ' ' VAL . . . 161.83 175.09 32.49 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.881 -1.288 . . . . 23.76 109.881 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 141' ' ' ILE . . . . . . . . . . . . . 83.7 mt -95.5 136.63 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.435 -1.038 . . . . 25.3 109.691 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 142' ' ' PHE . . . . . 0.546 ' CD2' ' HB2' ' R' ' 172' ' ' PRO . 82.9 m-85 -120.77 -172.66 2.43 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.27 -0.894 . . . . 30.24 110.524 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 143' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -119.78 77.73 1.26 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.426 -0.796 . . . . 32.8 110.295 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 144' ' ' LYS . . . . . 0.453 ' HG3' ' CZ2' ' R' ' 170' ' ' TRP . 1.0 OUTLIER -69.55 76.78 0.42 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.437 -0.789 . . . . 49.18 109.68 179.541 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' R' R ' 145' ' ' GLY . . . . . . . . . . . . . . . 104.62 179.24 24.71 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.139 -1.584 . . . . 53.87 109.139 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 146' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -88.46 145.83 25.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.388 -1.066 . . . . 68.58 110.053 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 147' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 58.27 36.46 25.66 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.256 -0.902 . . . . 56.62 110.611 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 148' ' ' HIS . . . . . . . . . . . . . 44.6 t60 -158.58 148.14 19.33 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.205 -0.934 . . . . 44.57 110.422 179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 149' ' ' ALA . . . . . . . . . . . . . . . -150.27 146.83 27.02 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.467 -0.771 . . . . 33.54 110.082 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 150' ' ' VAL . . . . . 0.428 HG23 ' HB2' ' R' ' 144' ' ' LYS . 34.2 m -142.28 161.54 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.231 -0.918 . . . . 27.61 110.309 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 151' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' R' ' 152' ' ' ALA . 5.8 t80 -86.21 155.53 20.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.4 -0.812 . . . . 23.04 109.907 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 152' ' ' ALA . . . . . 0.537 ' N ' ' CD1' ' R' ' 151' ' ' PHE . . . -157.22 151.53 25.05 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.499 -0.75 . . . . 29.61 109.565 179.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 153' ' ' CYS . . . . . 0.407 ' HA ' ' HA ' ' R' ' 139' ' ' ALA . 26.7 p -154.33 173.54 16.04 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.234 -0.916 . . . . 22.75 110.556 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 154' ' ' VAL . . . . . 0.442 ' CG2' ' CZ2' ' R' ' 159' ' ' TRP . 60.0 t -90.56 116.97 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.443 -0.785 . . . . 23.26 110.078 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 155' ' ' THR . . . . . . . . . . . . . 70.7 p -112.08 -176.65 2.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.347 -0.846 . . . . 17.88 110.034 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 156' ' ' SER . . . . . . . . . . . . . 78.5 p -75.98 -3.64 36.72 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.329 -0.857 . . . . 21.83 110.697 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 157' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -118.32 10.48 12.8 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.159 -0.963 . . . . 36.54 110.603 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 158' ' ' GLY . . . . . . . . . . . . . . . 117.99 -162.62 13.05 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.547 -1.421 . . . . 31.74 109.547 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 159' ' ' TRP . . . . . 0.442 ' CZ2' ' CG2' ' R' ' 154' ' ' VAL . 14.8 m95 -86.6 122.4 30.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.285 -1.127 . . . . 28.25 110.092 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 160' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -108.4 167.01 10.34 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.448 -0.783 . . . . 41.24 110.212 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 161' ' ' ALA . . . . . . . . . . . . . . . -143.24 123.43 13.72 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.355 -0.841 . . . . 27.4 110.208 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 162' ' ' ILE . . . . . 0.431 HG23 ' CZ ' ' R' ' 167' ' ' PHE . 92.1 mt -87.6 81.17 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.362 -0.837 . . . . 24.27 110.078 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 163' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' R' ' 165' ' ' GLU . 15.4 t0 -72.92 92.36 1.62 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.438 -0.789 . . . . 36.08 110.246 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 164' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 54.13 -88.94 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.542 -0.724 . . . . 46.08 110.565 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 165' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' R' ' 163' ' ' ASP . 29.6 mt-10 -124.75 36.01 4.68 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.052 -1.03 . . . . 50.94 110.199 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 166' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -135.8 117.32 14.82 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.397 -0.814 . . . . 47.28 110.324 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 167' ' ' PHE . . . . . 0.431 ' CZ ' HG23 ' R' ' 162' ' ' ILE . 24.3 m-85 -100.98 119.95 39.48 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.434 -0.791 . . . . 40.47 110.134 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 168' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -157.6 158.54 30.6 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.29 -0.881 . . . . 30.21 110.399 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 169' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.8 133.04 19.46 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.931 1.49 . . . . 32.76 110.474 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 170' ' ' TRP . . . . . 0.453 ' CZ2' ' HG3' ' R' ' 144' ' ' LYS . 67.0 t90 -159.78 119.3 2.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.416 -0.802 . . . . 32.79 109.928 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 171' ' ' THR . . . . . . . . . . . . . 46.6 m -81.06 112.6 33.95 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.437 -0.789 . . . . 36.92 110.184 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 172' ' ' PRO . . . . . 0.546 ' HB2' ' CD2' ' R' ' 142' ' ' PHE . 47.2 Cg_endo -73.74 158.83 46.48 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.66 1.348 . . . . 33.54 110.519 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 173' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -88.84 144.97 33.85 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.362 -0.836 . . . . 45.76 109.911 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 174' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.73 -10.41 26.44 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 O-C-N 123.675 1.355 . . . . 29.63 110.499 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 175' ' ' SER . . . . . . . . . . . . . 53.1 p -103.48 -17.47 15.2 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.299 -0.876 . . . . 35.7 110.369 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 176' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -103.5 43.19 1.1 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.24 -0.913 . . . . 39.65 110.423 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 177' ' ' VAL . . . . . 0.4 ' O ' ' CG1' ' R' ' 127' ' ' VAL . 10.5 p -117.72 127.17 75.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.368 -0.832 . . . . 20.61 110.041 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 178' ' ' LEU . . . . . . . . . . . . . 45.9 mt -91.5 -61.23 1.69 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.424 -0.798 . . . . 15.58 109.464 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 179' ' ' VAL . . . . . 0.403 ' O ' ' HA3' ' R' ' 140' ' ' GLY . 67.4 t -114.6 144.7 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.579 -0.7 . . . . 17.4 109.443 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 180' ' ' PHE . . . . . 0.426 ' CZ ' ' HE1' ' R' ' 132' ' ' MET . 43.4 p90 -152.11 163.37 39.48 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.273 -0.892 . . . . 20.16 110.562 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 181' ' ' VAL . . . . . . . . . . . . . 66.9 t -113.2 111.49 50.17 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.468 -0.77 . . . . 17.69 109.795 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 182' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.03 149.51 52.86 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.577 1.304 . . . . 17.81 110.423 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' R' R ' 183' ' ' TYR . . . . . 0.706 ' O ' ' C ' ' R' ' 184' ' ' ASP . 79.0 m-85 -59.01 175.54 0.28 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.459 -0.775 . . . . 28.01 110.549 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 184' ' ' ASP . . . . . 0.706 ' C ' ' O ' ' R' ' 183' ' ' TYR . 6.0 t70 -18.36 -82.2 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.3 -0.875 . . . . 58.64 110.232 -178.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' R' R ' 185' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 . . . . . 0 N--CA 1.504 2.232 0 CA-C-O 121.272 0.558 . . . . 80.42 111.721 179.566 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' R' R ' 193' ' ' LYS . . . . . . . . . . . . . 15.0 pttt . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 120.898 0.38 . . . . 49.5 110.157 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' R' R ' 194' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.835 0 O-C-N 121.144 -0.973 . . . . 40.4 110.156 179.92 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' S' S ' 229' ' ' MET . . . . . . . . . . . . . 5.8 mtm . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 121.176 0.513 . . . . 51.83 110.191 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' S' S ' 230' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -97.27 142.73 28.8 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.318 -0.864 . . . . 54.13 110.161 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 231' ' ' LEU . . . . . . . . . . . . . 67.9 mt -134.12 141.04 46.98 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.391 -0.818 . . . . 33.04 110.343 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 232' ' ' THR . . . . . . . . . . . . . 40.7 m -89.26 103.26 15.9 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.381 -0.824 . . . . 26.92 110.04 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 233' ' ' LEU . . . . . 0.498 HD23 ' CE2' ' S' ' 262' ' ' TYR . 79.9 mt -56.0 179.31 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.43 -0.794 . . . . 13.78 110.463 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' S' S ' 234' ' ' TYR . . . . . 0.446 ' CG ' ' N ' ' S' ' 235' ' ' ASN . 35.6 p90 -65.02 -35.69 81.99 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.361 -0.837 . . . . 26.08 110.148 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' S' S ' 235' ' ' ASN . . . . . 0.446 ' N ' ' CG ' ' S' ' 234' ' ' TYR . 50.7 p30 -74.3 -7.44 52.78 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.428 -0.795 . . . . 20.04 110.596 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' S' S ' 236' ' ' GLY . . . . . . . . . . . . . . . 95.76 -19.92 52.15 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.781 -1.328 . . . . 22.71 109.781 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 237' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -52.98 145.65 12.48 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.18 -1.188 . . . . 35.44 110.276 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 238' ' ' LYS . . . . . . . . . . . . . 44.4 mttt -102.18 127.91 48.91 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.396 -0.815 . . . . 32.56 110.434 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 239' ' ' LYS . . . . . 0.414 ' HG2' ' CZ ' ' S' ' 241' ' ' PHE . 9.0 ttmt -132.26 144.54 50.68 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.391 -0.818 . . . . 26.68 110.004 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' S' S ' 240' ' ' THR . . . . . . . . . . . . . 51.9 m -102.02 132.2 48.01 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.307 -0.871 . . . . 41.02 110.355 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 241' ' ' PHE . . . . . 0.414 ' CZ ' ' HG2' ' S' ' 239' ' ' LYS . 96.1 m-85 -117.91 137.62 52.69 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.379 -0.826 . . . . 28.62 110.253 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' S' S ' 242' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -96.35 161.83 13.76 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.34 -0.85 . . . . 47.89 110.188 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 243' ' ' SER . . . . . . . . . . . . . 72.1 m -90.57 151.56 21.27 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.29 -0.881 . . . . 45.09 110.29 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 244' ' ' ARG . . . . . . . . . . . . . 1.4 mtp85 -129.77 126.73 22.7 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.416 -0.802 . . . . 42.49 110.263 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 245' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.35 160.98 43.77 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.617 1.325 . . . . 35.68 110.551 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 246' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -132.84 97.77 4.13 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.325 -0.859 . . . . 51.88 109.873 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 247' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -110.45 -22.24 11.77 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.32 -0.863 . . . . 53.69 110.649 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 248' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -117.26 43.67 2.27 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.182 -0.949 . . . . 55.79 110.708 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 249' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 48.78 38.46 11.88 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.485 -0.759 . . . . 49.45 110.363 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 250' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -90.57 28.95 1.38 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.552 -0.717 . . . . 36.86 110.325 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 251' ' ' ALA . . . . . . . . . . . . . . . -53.79 -43.19 69.08 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.286 -0.884 . . . . 29.69 109.621 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 252' ' ' TRP . . . . . 0.416 ' CZ2' ' HB3' ' S' ' 294' ' ' LEU . 67.8 p-90 -61.82 -33.9 74.98 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.51 -0.744 . . . . 41.12 109.802 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' S' S ' 253' ' ' LEU . . . . . 0.402 ' N ' ' CD2' ' S' ' 252' ' ' TRP . 23.4 tp -70.15 -47.3 62.27 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.422 -0.799 . . . . 24.89 109.955 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' S' S ' 254' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -56.06 -42.43 76.61 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.308 -0.87 . . . . 35.65 110.031 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 255' ' ' ALA . . . . . . . . . . . . . . . -59.61 -48.19 82.63 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.427 -0.795 . . . . 22.73 110.042 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 256' ' ' ILE . . . . . . . . . . . . . 79.7 mt -62.35 -40.6 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.308 -0.87 . . . . 28.85 110.014 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 257' ' ' LEU . . . . . . . . . . . . . 19.4 mt -61.52 -44.49 96.97 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.286 -0.884 . . . . 23.07 110.216 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 258' ' ' GLN . . . . . 0.469 ' HB3' ' CD2' ' S' ' 351' ' ' PHE . 53.4 mm-40 -65.05 -45.35 85.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.382 -0.824 . . . . 29.78 109.947 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' S' S ' 259' ' ' LEU . . . . . 0.431 ' O ' HG22 ' S' ' 263' ' ' VAL . 19.8 tp -58.66 -36.41 74.11 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.299 -0.876 . . . . 17.94 109.405 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' S' S ' 260' ' ' PHE . . . . . 0.47 ' CE2' HD22 ' S' ' 311' ' ' LEU . 3.1 m-85 -62.86 -45.22 93.57 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.593 -0.692 . . . . 30.57 109.872 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' S' S ' 261' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -62.06 -29.81 70.55 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.383 -0.823 . . . . 41.34 109.995 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 262' ' ' TYR . . . . . 0.498 ' CE2' HD23 ' S' ' 233' ' ' LEU . 8.6 t80 -71.24 -44.59 65.02 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.37 -0.831 . . . . 26.03 110.086 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' S' S ' 263' ' ' VAL . . . . . 0.431 HG22 ' O ' ' S' ' 259' ' ' LEU . 33.2 m -92.1 18.34 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.417 -0.802 . . . . 22.8 110.35 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' S' S ' 264' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 52.78 70.67 0.55 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.292 -0.88 . . . . 44.03 110.59 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 265' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -111.8 109.18 55.45 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.375 -0.828 . . . . 35.61 109.622 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 266' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -75.25 0.39 9.06 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 123.65 1.342 . . . . 37.67 111.826 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 267' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -56.52 -67.71 0.28 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.76 -1.213 . . . . 41.49 110.17 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' S' S ' 268' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -92.92 39.92 1.05 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.197 -0.939 . . . . 50.76 110.095 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 269' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.01 -33.17 59.67 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.428 -0.795 . . . . 61.86 109.795 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' S' S ' 270' ' ' TRP . . . . . 0.491 ' CE2' ' CG2' ' S' ' 271' ' ' VAL . 50.9 p-90 -73.96 -4.26 34.1 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.28 -0.888 . . . . 39.85 110.501 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' S' S ' 271' ' ' VAL . . . . . 0.491 ' CG2' ' CE2' ' S' ' 270' ' ' TRP . 46.4 t -109.48 -32.82 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.121 -0.987 . . . . 39.18 110.058 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' S' S ' 272' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -78.59 -36.57 44.14 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.327 -0.858 . . . . 40.02 110.538 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 273' ' ' SER . . . . . . . . . . . . . 71.2 m -103.51 56.11 0.74 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.267 -0.896 . . . . 47.2 110.388 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 274' ' ' SER . . . . . . . . . . . . . 6.9 t -133.04 141.25 40.24 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.298 -0.876 . . . . 47.61 110.129 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 275' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.7 -18.88 21.84 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 O-C-N 123.72 1.379 . . . . 45.28 110.533 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 276' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -99.94 140.89 33.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.294 -0.879 . . . . 57.27 110.314 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 277' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -71.75 97.7 1.82 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.387 -0.821 . . . . 37.28 110.254 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 278' ' ' LEU . . . . . . . . . . . . . 86.3 mt -97.03 33.84 1.84 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.382 -0.824 . . . . 43.88 110.001 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 279' ' ' THR . . . . . . . . . . . . . 76.4 m -63.99 -60.17 3.58 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.416 -0.802 . . . . 50.05 110.282 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 280' ' ' LEU . . . . . . . . . . . . . 13.7 mt -51.51 -39.99 58.7 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.32 -0.862 . . . . 54.12 110.283 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 281' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.38 -49.64 74.74 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.435 -0.79 . . . . 65.28 110.161 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' S' S ' 282' ' ' ALA . . . . . . . . . . . . . . . -59.04 -33.9 71.3 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.438 -0.789 . . . . 46.51 110.499 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 283' ' ' ILE . . . . . . . . . . . . . 85.6 mt -66.25 -50.93 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.288 -0.883 . . . . 47.3 110.118 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 284' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -50.56 -57.56 7.85 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.388 -0.82 . . . . 50.72 110.405 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 285' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -51.41 -46.43 62.91 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.471 -0.768 . . . . 68.47 110.252 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 286' ' ' LEU . . . . . . . . . . . . . 19.1 mt -60.02 -44.49 94.57 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.403 -0.811 . . . . 36.62 110.202 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 287' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -62.71 -35.33 79.39 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.387 -0.82 . . . . 46.64 110.076 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 288' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -76.22 -21.04 56.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.353 -0.842 . . . . 46.45 110.292 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 289' ' ' LEU . . . . . . . . . . . . . 31.0 mt -97.29 -21.78 17.05 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.254 -0.904 . . . . 35.09 110.568 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 290' ' ' THR . . . . . . . . . . . . . 81.3 p -114.76 -28.44 7.09 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.252 -0.905 . . . . 38.61 110.403 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 291' ' ' GLY . . . . . . . . . . . . . . . 79.37 10.96 85.44 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.847 -1.301 . . . . 36.77 109.847 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 292' ' ' LEU . . . . . . . . . . . . . 84.7 mt -96.43 145.82 25.32 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.271 -1.135 . . . . 35.33 109.803 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 293' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -77.36 102.39 6.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.163 -0.96 . . . . 48.7 110.257 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 294' ' ' LEU . . . . . 0.416 ' HB3' ' CZ2' ' S' ' 252' ' ' TRP . 56.2 mt -107.03 51.8 0.73 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.526 -0.734 . . . . 42.61 110.074 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' S' S ' 295' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -112.51 -11.21 13.64 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.343 -0.848 . . . . 55.49 110.523 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' S' S ' 296' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -144.33 48.62 1.36 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.123 -0.986 . . . . 75.68 110.291 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 297' ' ' GLY . . . . . . . . . . . . . . . 96.85 145.09 18.53 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.555 -1.418 . . . . 49.44 109.555 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 298' ' ' GLY . . . . . . . . . . . . . . . -163.77 157.03 29.14 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.77 -1.332 . . . . 41.11 109.77 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 299' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.91 118.31 5.38 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 123.917 1.483 . . . . 26.2 110.304 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 300' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.26 -15.43 31.63 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 O-C-N 123.616 1.324 . . . . 21.7 110.693 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 301' ' ' ALA . . . . . . . . . . . . . . . -80.75 -29.37 36.28 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.192 -0.942 . . . . 31.23 110.073 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 302' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.45 -40.72 18.93 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.409 -0.807 . . . . 38.99 109.969 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' S' S ' 303' ' ' VAL . . . . . 0.471 ' O ' HG12 ' S' ' 307' ' ' ILE . 58.0 t -60.67 -35.5 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.364 -0.835 . . . . 18.63 110.095 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' S' S ' 304' ' ' ILE . . . . . . . . . . . . . 86.1 mt -79.42 -23.58 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.431 -0.793 . . . . 25.46 110.153 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 305' ' ' TRP . . . . . . . . . . . . . 68.8 t-105 -88.69 -14.53 37.1 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.32 -0.862 . . . . 33.4 110.503 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 306' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -89.68 -13.62 36.56 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.168 -0.957 . . . . 36.97 110.378 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 307' ' ' ILE . . . . . 0.471 HG12 ' O ' ' S' ' 303' ' ' VAL . 36.9 pt -125.1 45.59 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.266 -0.896 . . . . 30.81 110.045 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' S' S ' 308' ' ' LYS . . . . . . . . . . . . . 1.5 mtmp? -73.5 -37.79 65.56 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.366 -0.834 . . . . 46.52 110.086 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 309' ' ' HIS . . . . . 0.488 ' CD2' ' HG ' ' S' ' 310' ' ' LEU . 55.5 p-80 -73.14 -8.38 55.51 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.284 -0.885 . . . . 51.03 110.097 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' S' S ' 310' ' ' LEU . . . . . 0.488 ' HG ' ' CD2' ' S' ' 309' ' ' HIS . 52.9 mt -99.25 -12.91 19.96 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.311 -0.868 . . . . 36.16 109.944 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' S' S ' 311' ' ' LEU . . . . . 0.47 HD22 ' CE2' ' S' ' 260' ' ' PHE . 10.8 mt -97.12 147.88 23.61 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.282 -0.886 . . . . 40.0 110.406 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' S' S ' 312' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -81.66 -16.3 51.79 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.28 -0.888 . . . . 54.18 109.68 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 313' ' ' THR . . . . . 0.472 HG23 ' HB3' ' S' ' 323' ' ' GLU . 92.6 m -87.9 151.63 22.68 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.322 -0.861 . . . . 25.61 110.125 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' S' S ' 314' ' ' GLY . . . . . . . . . . . . . . . -87.93 126.42 8.05 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.791 -1.324 . . . . 25.18 109.791 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 315' ' ' ILE . . . . . . . . . . . . . 50.7 mm -101.62 150.48 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.377 -1.072 . . . . 23.9 109.722 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 316' ' ' GLY . . . . . . . . . . . . . . . -157.1 -159.26 9.38 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.006 -1.237 . . . . 23.18 110.006 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 317' ' ' THR . . . . . . . . . . . . . 11.1 p -133.89 -173.0 3.12 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.367 -1.078 . . . . 27.98 110.044 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.51 -56.26 24.12 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.239 -0.913 . . . . 28.1 109.885 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 319' ' ' SER . . . . . . . . . . . . . 1.2 m -59.93 -41.69 92.34 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.372 -0.83 . . . . 37.0 109.604 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 320' ' ' ARG . . . . . . . . . . . . . 12.1 mtm180 -111.71 79.84 2.64 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.483 -0.761 . . . . 52.07 109.717 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 321' ' ' PRO . . . . . 0.436 ' O ' ' HB2' ' S' ' 322' ' ' SER . 44.1 Cg_endo -71.44 171.47 16.13 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.853 1.449 . . . . 38.29 110.928 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' S' S ' 322' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' S' ' 321' ' ' PRO . 41.5 t 178.73 -148.14 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.021 -0.733 . . . . 38.84 109.021 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' S' S ' 323' ' ' GLU . . . . . 0.472 ' HB3' HG23 ' S' ' 313' ' ' THR . 6.7 tp10 -62.86 -40.26 96.93 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.947 -1.096 . . . . 40.7 109.733 179.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' S' S ' 324' ' ' VAL . . . . . . . . . . . . . 73.2 t -141.26 135.0 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.502 -0.749 . . . . 20.34 109.462 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 325' ' ' CYS . . . . . 0.448 ' HB2' ' CE1' ' S' ' 380' ' ' PHE . 11.2 m -125.99 172.14 10.19 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.275 -0.891 . . . . 30.63 110.886 -179.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' S' S ' 326' ' ' VAL . . . . . . . . . . . . . 34.6 m -135.41 142.21 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.62 -0.675 . . . . 23.9 109.237 179.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 327' ' ' VAL . . . . . . . . . . . . . 34.5 m -56.32 125.03 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.104 -0.998 . . . . 19.48 110.4 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 328' ' ' ASP . . . . . . . . . . . . . 55.6 p-10 -119.4 11.47 12.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.494 -0.754 . . . . 26.43 110.461 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 329' ' ' GLY . . . . . . . . . . . . . . . 119.68 2.31 13.04 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.027 -1.229 . . . . 31.24 110.027 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 330' ' ' THR . . . . . . . . . . . . . 77.4 m -92.98 130.01 38.7 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.104 -1.233 . . . . 30.05 110.132 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 331' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -56.81 111.54 1.05 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.321 -0.862 . . . . 37.26 110.005 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 332' ' ' MET . . . . . 0.455 ' HE1' ' CZ ' ' S' ' 380' ' ' PHE . 88.1 mmm -94.09 162.56 13.83 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.336 -0.852 . . . . 26.23 110.347 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' S' S ' 333' ' ' CYS . . . . . . . . . . . . . 26.1 m -137.26 149.95 47.48 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.419 -0.801 . . . . 23.56 110.07 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 334' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.54 -24.85 8.93 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.23 -0.919 . . . . 28.93 110.435 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' S' S ' 335' ' ' ALA . . . . . . . . . . . . . . . -89.05 14.4 10.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.32 -0.863 . . . . 15.76 110.896 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 336' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -100.49 -17.19 17.26 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.191 -0.943 . . . . 34.92 110.13 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 337' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -152.33 170.86 19.03 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.295 -0.878 . . . . 19.03 110.068 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 338' ' ' HIS . . . . . . . . . . . . . 13.4 p80 -120.71 10.33 10.96 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.354 -0.841 . . . . 18.82 110.432 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 339' ' ' ALA . . . . . . . . . . . . . . . -175.96 155.17 1.57 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.291 -0.88 . . . . 17.18 110.065 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 340' ' ' GLY . . . . . 0.401 ' CA ' ' O ' ' S' ' 379' ' ' VAL . . . 160.87 173.09 29.05 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 110.067 -1.213 . . . . 18.33 110.067 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' S' S ' 341' ' ' ILE . . . . . 0.438 HD12 HG22 ' S' ' 341' ' ' ILE . 84.2 mt -88.85 138.14 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.444 -1.033 . . . . 18.6 109.766 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' S' S ' 342' ' ' PHE . . . . . 0.503 ' CE1' HG23 ' S' ' 377' ' ' VAL . 70.0 m-85 -120.99 -178.48 3.76 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.214 -0.929 . . . . 23.44 110.375 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' S' S ' 343' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.83 93.38 4.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.484 -0.76 . . . . 35.59 109.973 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' S' S ' 344' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.82 125.01 29.56 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.229 -0.919 . . . . 38.34 110.107 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' S' S ' 345' ' ' GLY . . . . . . . . . . . . . . . 62.72 -130.86 43.27 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 108.87 -1.692 . . . . 53.46 108.87 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 346' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -132.66 150.9 52.09 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.212 -1.17 . . . . 70.91 110.065 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 347' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 53.25 35.4 19.97 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.34 -0.85 . . . . 47.32 110.395 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 348' ' ' HIS . . . . . . . . . . . . . 46.6 t60 -150.11 155.85 40.58 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.279 -0.888 . . . . 41.72 110.369 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 349' ' ' ALA . . . . . . . . . . . . . . . -149.8 151.24 33.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.281 -0.887 . . . . 22.91 110.543 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 350' ' ' VAL . . . . . . . . . . . . . 34.6 m -149.05 169.61 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.421 -0.8 . . . . 21.09 110.017 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 351' ' ' PHE . . . . . 0.469 ' CD2' ' HB3' ' S' ' 258' ' ' GLN . 10.7 t80 -105.36 143.67 33.19 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.249 -0.907 . . . . 25.03 110.693 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' S' S ' 352' ' ' ALA . . . . . . . . . . . . . . . -147.74 151.72 36.55 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.52 -0.738 . . . . 23.81 109.807 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 353' ' ' CYS . . . . . . . . . . . . . 26.2 p -153.4 164.86 37.42 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.271 -0.893 . . . . 25.66 110.175 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 354' ' ' VAL . . . . . 0.402 HG23 ' CZ2' ' S' ' 359' ' ' TRP . 57.3 t -76.0 118.56 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.39 -0.819 . . . . 34.27 109.994 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' S' S ' 355' ' ' THR . . . . . 0.444 HG23 ' HB2' ' S' ' 360' ' ' TYR . 52.3 p -117.86 175.07 5.83 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.294 -0.879 . . . . 25.49 110.306 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' S' S ' 356' ' ' SER . . . . . . . . . . . . . 62.3 p -62.1 -17.78 58.73 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.41 -0.806 . . . . 31.24 110.698 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 357' ' ' ASN . . . . . . . . . . . . . 45.8 m-20 -106.96 14.17 26.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.158 -0.964 . . . . 28.61 110.564 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 358' ' ' GLY . . . . . . . . . . . . . . . 111.87 -152.88 17.6 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.043 -1.223 . . . . 22.01 110.043 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 359' ' ' TRP . . . . . 0.402 ' CZ2' HG23 ' S' ' 354' ' ' VAL . 15.3 m95 -91.4 116.74 29.09 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.43 -1.041 . . . . 25.54 110.109 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' S' S ' 360' ' ' TYR . . . . . 0.444 ' HB2' HG23 ' S' ' 355' ' ' THR . 1.3 m-85 -103.54 165.88 10.77 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.344 -0.847 . . . . 40.53 109.997 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' S' S ' 361' ' ' ALA . . . . . . . . . . . . . . . -140.07 130.02 24.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.427 -0.796 . . . . 18.04 110.279 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 362' ' ' ILE . . . . . 0.416 HG23 ' CZ ' ' S' ' 367' ' ' PHE . 89.2 mt -95.59 83.64 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.379 -0.826 . . . . 15.64 110.13 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' S' S ' 363' ' ' ASP . . . . . 0.416 ' O ' ' N ' ' S' ' 365' ' ' GLU . 11.9 t0 -75.26 94.52 3.01 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.305 -0.872 . . . . 35.03 110.149 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' S' S ' 364' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 53.88 -89.4 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.518 -0.739 . . . . 46.72 110.458 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 365' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' S' ' 363' ' ' ASP . 23.8 mt-10 -122.62 19.14 10.37 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.126 -0.984 . . . . 56.2 110.24 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' S' S ' 366' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -117.96 125.03 49.64 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.281 -0.887 . . . . 51.02 110.446 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 367' ' ' PHE . . . . . 0.416 ' CZ ' HG23 ' S' ' 362' ' ' ILE . 26.9 m-85 -107.06 127.12 53.19 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.349 -0.844 . . . . 37.59 110.142 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' S' S ' 368' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -165.44 159.55 13.89 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.278 -0.889 . . . . 31.47 110.39 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 369' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.9 139.59 30.48 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 O-C-N 123.859 1.452 . . . . 28.85 110.52 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 370' ' ' TRP . . . . . . . . . . . . . 67.4 t90 -167.2 113.64 0.77 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.387 -0.821 . . . . 26.94 110.006 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 371' ' ' THR . . . . . . . . . . . . . 59.7 m -74.85 113.06 20.86 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.417 -0.802 . . . . 20.19 110.0 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 372' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -73.55 157.13 49.21 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 O-C-N 123.636 1.335 . . . . 28.68 110.571 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 373' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -90.57 147.16 35.77 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.382 -0.824 . . . . 35.72 109.873 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 374' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -76.05 -6.37 17.27 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 O-C-N 123.628 1.331 . . . . 30.89 110.473 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 375' ' ' SER . . . . . . . . . . . . . 69.0 p -104.28 -16.93 15.03 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.277 -0.889 . . . . 29.41 110.477 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 376' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -106.47 43.02 1.19 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.302 -0.874 . . . . 32.89 110.228 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 377' ' ' VAL . . . . . 0.503 HG23 ' CE1' ' S' ' 342' ' ' PHE . 7.3 p -114.62 147.23 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.273 -0.892 . . . . 24.33 110.274 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' S' S ' 378' ' ' LEU . . . . . . . . . . . . . 52.2 mt -116.03 -57.92 2.16 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.446 -0.784 . . . . 24.37 109.642 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 379' ' ' VAL . . . . . 0.401 ' O ' ' CA ' ' S' ' 340' ' ' GLY . 60.5 t -120.73 132.32 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.403 -0.811 . . . . 18.02 109.48 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' S' S ' 380' ' ' PHE . . . . . 0.455 ' CZ ' ' HE1' ' S' ' 332' ' ' MET . 14.3 p90 -142.5 173.92 11.1 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.417 -0.802 . . . . 29.35 110.658 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' S' S ' 381' ' ' VAL . . . . . . . . . . . . . 57.9 t -120.0 107.32 40.02 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.485 -0.759 . . . . 16.34 109.458 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 382' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.28 145.63 49.05 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 O-C-N 123.562 1.296 . . . . 20.94 110.726 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 383' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -61.16 -53.43 57.06 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.387 -0.82 . . . . 28.93 109.833 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' S' S ' 384' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.457 -0.777 . . . . 47.03 110.426 -177.04 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' R' R ' 30' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 . . . . . 0 N--CA 1.493 1.719 0 CA-C-O 121.207 0.527 . . . . 43.36 110.249 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' R' R ' 31' ' ' LEU . . . . . . . . . . . . . 65.3 mt -134.91 140.6 45.89 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.282 -0.886 . . . . 22.93 110.283 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 32' ' ' THR . . . . . . . . . . . . . 70.3 m -87.62 110.49 20.43 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.391 -0.818 . . . . 22.34 109.982 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 33' ' ' LEU . . . . . 0.461 HD23 ' CE2' ' R' ' 62' ' ' TYR . 80.1 mt -62.28 -172.78 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.295 -0.878 . . . . 21.39 110.221 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 34' ' ' TYR . . . . . . . . . . . . . 37.0 p90 -74.66 -29.36 61.22 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.266 -0.896 . . . . 34.4 110.414 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 35' ' ' ASN . . . . . . . . . . . . . 48.3 p30 -77.77 -1.92 33.79 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.289 -0.882 . . . . 30.28 110.633 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.29 -16.56 59.51 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.742 -1.343 . . . . 36.25 109.742 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 37' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -59.02 161.82 4.76 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.285 -1.127 . . . . 53.8 110.368 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 38' ' ' LYS . . . . . . . . . . . . . 56.8 mttt -117.85 135.73 53.9 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.367 -0.833 . . . . 49.91 110.132 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 39' ' ' LYS . . . . . 0.417 ' HG2' ' CZ ' ' R' ' 41' ' ' PHE . 8.0 ttmt -138.72 143.68 39.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.375 -0.828 . . . . 35.69 110.255 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 40' ' ' THR . . . . . . . . . . . . . 23.4 m -102.55 127.95 49.41 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.424 -0.798 . . . . 34.84 110.198 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 41' ' ' PHE . . . . . 0.417 ' CZ ' ' HG2' ' R' ' 39' ' ' LYS . 96.6 m-85 -113.0 132.69 55.27 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.41 -0.806 . . . . 34.42 110.179 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 42' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -93.34 140.97 28.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.328 -0.857 . . . . 51.46 110.229 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 43' ' ' SER . . . . . . . . . . . . . 54.3 m -70.84 141.9 51.28 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.461 -0.774 . . . . 41.84 110.192 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.77 125.4 29.54 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.367 -0.833 . . . . 33.82 109.957 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 45' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.15 151.05 54.77 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.517 1.272 . . . . 30.27 110.646 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 46' ' ' ASN . . . . . . . . . . . . . 52.2 t-20 -124.24 109.91 13.99 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.534 -0.728 . . . . 35.1 109.997 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 47' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -120.32 -34.84 3.56 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.292 -0.88 . . . . 42.81 110.537 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 48' ' ' HIS . . . . . . . . . . . . . 73.3 m80 -105.86 45.23 0.98 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.346 -0.846 . . . . 49.97 110.24 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 49' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 50.32 34.62 9.22 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.491 -0.755 . . . . 61.32 110.158 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 50' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -86.15 43.77 1.08 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.388 -0.82 . . . . 51.5 110.747 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.07 -46.1 78.93 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.243 -0.911 . . . . 38.77 109.571 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 52' ' ' TRP . . . . . 0.483 ' CD2' ' N ' ' R' ' 53' ' ' LEU . 68.1 p-90 -58.46 -38.34 77.34 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.57 -0.706 . . . . 26.24 110.048 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 53' ' ' LEU . . . . . 0.483 ' N ' ' CD2' ' R' ' 52' ' ' TRP . 23.2 tp -66.72 -46.68 74.75 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.323 -0.861 . . . . 26.75 110.013 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 54' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -55.25 -41.53 72.29 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.363 -0.836 . . . . 35.02 110.23 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.16 -46.12 91.83 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.44 -0.788 . . . . 24.47 110.196 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 56' ' ' ILE . . . . . . . . . . . . . 76.1 mt -62.12 -42.26 94.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.292 -0.88 . . . . 26.03 109.927 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 57' ' ' LEU . . . . . . . . . . . . . 22.3 mt -60.35 -45.61 92.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.251 -0.906 . . . . 26.77 109.661 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 58' ' ' GLN . . . . . . . . . . . . . 57.7 mm-40 -63.87 -46.52 84.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.427 -0.796 . . . . 22.32 109.625 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 59' ' ' LEU . . . . . 0.43 ' HA ' ' HE2' ' R' ' 151' ' ' PHE . 24.0 tp -61.33 -37.82 84.67 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.334 -0.854 . . . . 20.55 109.443 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 60' ' ' PHE . . . . . 0.448 ' CE2' HD22 ' R' ' 111' ' ' LEU . 2.8 m-85 -61.1 -44.7 96.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.567 -0.708 . . . . 20.08 109.933 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 61' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -63.1 -36.13 82.57 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.441 -0.787 . . . . 18.8 110.541 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 62' ' ' TYR . . . . . 0.461 ' CE2' HD23 ' R' ' 33' ' ' LEU . 9.2 t80 -63.22 -41.73 99.16 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.233 -0.917 . . . . 26.45 110.155 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 63' ' ' VAL . . . . . . . . . . . . . 30.4 m -93.36 20.34 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.275 -0.891 . . . . 29.75 110.19 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 64' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 52.92 75.63 0.23 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.328 -0.857 . . . . 35.52 110.559 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 65' ' ' GLU . . . . . 0.425 ' HG2' ' CD2' ' R' ' 60' ' ' PHE . 14.3 tp10 -116.36 104.14 52.15 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.344 -0.847 . . . . 29.89 109.865 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 66' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.6 -5.84 17.74 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.806 1.424 . . . . 21.37 111.064 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 67' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -52.09 -61.52 2.21 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.147 -0.97 . . . . 23.85 110.375 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 68' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -98.2 36.69 1.55 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.326 -0.859 . . . . 28.07 110.488 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 69' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -72.43 -33.17 66.91 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.225 -0.922 . . . . 43.76 110.175 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 70' ' ' TRP . . . . . 0.476 ' CE2' ' CG2' ' R' ' 71' ' ' VAL . 47.7 p-90 -73.41 -3.98 30.74 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.334 -0.854 . . . . 33.06 110.71 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 71' ' ' VAL . . . . . 0.476 ' CG2' ' CE2' ' R' ' 70' ' ' TRP . 40.5 t -109.73 -27.41 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.223 -0.923 . . . . 31.7 109.756 179.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 72' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -86.54 -48.79 8.06 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.407 -0.808 . . . . 33.58 110.383 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 73' ' ' SER . . . . . . . . . . . . . 70.0 m -89.71 51.06 2.0 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.394 -0.816 . . . . 50.82 110.304 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 74' ' ' SER . . . . . . . . . . . . . 15.9 t -125.96 138.29 31.79 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.238 -0.914 . . . . 34.74 110.24 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.36 -24.96 15.98 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.742 1.391 . . . . 35.7 110.343 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 76' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -91.72 153.15 19.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.33 -0.856 . . . . 66.48 110.355 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 77' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -81.47 95.27 7.03 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.391 -0.818 . . . . 46.72 110.043 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 78' ' ' LEU . . . . . . . . . . . . . 96.3 mt -96.49 27.99 3.55 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.389 -0.82 . . . . 37.55 110.191 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 79' ' ' THR . . . . . . . . . . . . . 29.6 m -56.27 -54.58 43.7 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.225 -0.922 . . . . 37.36 110.302 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 80' ' ' LEU . . . . . . . . . . . . . 15.9 mt -60.97 -23.16 65.13 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.33 -0.856 . . . . 35.83 110.511 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 81' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -79.5 -39.11 32.85 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.101 -0.999 . . . . 44.03 110.356 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.51 -28.64 66.22 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.257 -0.902 . . . . 32.54 110.169 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 83' ' ' ILE . . . . . . . . . . . . . 77.8 mt -70.08 -46.12 73.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.275 -0.891 . . . . 32.02 110.352 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 84' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -55.09 -52.17 64.08 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.208 -0.932 . . . . 34.09 110.56 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 85' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -54.79 -46.88 74.53 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.209 -0.932 . . . . 25.94 110.279 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 86' ' ' LEU . . . . . . . . . . . . . 23.7 mt -58.75 -43.76 90.38 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.365 -0.835 . . . . 16.2 109.853 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 87' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -65.33 -35.25 80.4 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.494 -0.754 . . . . 49.09 110.317 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 88' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -78.41 -19.05 54.09 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.282 -0.886 . . . . 28.61 110.529 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 89' ' ' LEU . . . . . . . . . . . . . 32.6 mt -96.21 -29.35 14.09 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.248 -0.907 . . . . 26.16 110.201 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 90' ' ' THR . . . . . . . . . . . . . 60.7 p -105.69 -34.71 7.62 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.255 -0.903 . . . . 33.33 109.75 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.88 16.15 58.47 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.85 -1.3 . . . . 31.13 109.85 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 92' ' ' LEU . . . . . . . . . . . . . 97.1 mt -100.18 155.21 17.87 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.213 -1.169 . . . . 42.52 110.186 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 93' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -86.19 91.59 8.5 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.481 -0.762 . . . . 68.46 110.038 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 94' ' ' LEU . . . . . 0.447 ' HB3' ' CZ2' ' R' ' 52' ' ' TRP . 48.1 mt -99.37 53.03 0.95 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.204 -0.935 . . . . 44.63 110.377 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 95' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.57 -38.59 6.38 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.262 -0.898 . . . . 67.16 110.369 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 96' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -113.93 44.23 1.68 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.364 -0.835 . . . . 67.02 110.244 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 97' ' ' GLY . . . . . . . . . . . . . . . 99.12 150.8 26.05 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.614 -1.395 . . . . 49.48 109.614 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 98' ' ' GLY . . . . . . . . . . . . . . . -166.27 160.01 33.44 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.265 -1.534 . . . . 36.57 109.265 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 99' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -72.57 121.12 7.15 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.75 1.395 . . . . 30.41 110.384 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 100' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.3 -31.68 11.34 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.619 1.326 . . . . 29.94 110.493 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.01 -38.45 75.96 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.34 -0.85 . . . . 23.64 110.294 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.63 -40.77 66.16 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.353 -0.842 . . . . 20.31 110.382 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 103' ' ' VAL . . . . . . . . . . . . . 63.1 t -58.01 -40.21 75.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.202 -0.936 . . . . 16.33 110.023 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 104' ' ' ILE . . . . . . . . . . . . . 81.7 mt -71.62 -30.6 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.384 -0.823 . . . . 24.77 109.941 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 105' ' ' TRP . . . . . 0.439 ' O ' ' HD3' ' R' ' 108' ' ' LYS . 70.6 t-105 -82.26 0.72 40.08 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.311 -0.868 . . . . 23.28 110.376 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 106' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -104.98 -10.5 17.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.118 -0.989 . . . . 28.26 110.112 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 107' ' ' ILE . . . . . . . . . . . . . 36.6 pt -126.81 35.0 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.225 -0.922 . . . . 18.77 109.994 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 108' ' ' LYS . . . . . 0.481 ' HG2' ' HB ' ' R' ' 115' ' ' ILE . 9.2 mtpp -61.02 -48.54 81.32 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.499 -0.751 . . . . 42.5 110.011 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 109' ' ' HIS . . . . . 0.432 ' CD2' ' HG ' ' R' ' 110' ' ' LEU . 50.8 p-80 -66.0 -12.84 57.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.518 -0.738 . . . . 20.07 110.64 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 110' ' ' LEU . . . . . 0.432 ' HG ' ' CD2' ' R' ' 109' ' ' HIS . 80.4 mt -94.8 -17.39 22.17 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.116 -0.99 . . . . 15.69 110.156 179.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 111' ' ' LEU . . . . . 0.448 HD22 ' CE2' ' R' ' 60' ' ' PHE . 10.4 mt -94.06 144.12 25.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.299 -0.876 . . . . 25.39 111.046 -179.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 112' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -77.66 -17.43 57.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.634 -0.666 . . . . 53.48 109.854 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 113' ' ' THR . . . . . 0.418 HG22 ' HG2' ' R' ' 123' ' ' GLU . 60.0 m -83.63 166.66 17.97 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.379 -0.826 . . . . 14.8 110.257 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 114' ' ' GLY . . . . . . . . . . . . . . . -97.97 127.14 9.13 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.041 -1.224 . . . . 16.14 110.041 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 115' ' ' ILE . . . . . 0.481 ' HB ' ' HG2' ' R' ' 108' ' ' LYS . 47.7 mm -109.1 139.37 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.457 -1.025 . . . . 13.46 109.727 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 116' ' ' GLY . . . . . . . . . . . . . . . -152.75 -155.81 7.27 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.876 -1.29 . . . . 23.9 109.876 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 117' ' ' THR . . . . . . . . . . . . . 18.7 p -135.05 -171.4 2.79 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.432 -1.04 . . . . 27.37 110.072 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.5 -58.12 9.42 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.23 -0.918 . . . . 18.76 110.031 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 119' ' ' SER . . . . . 0.606 ' HA ' ' CB ' ' R' ' 194' ' ' ALA . 1.1 m -56.56 -40.6 75.44 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.259 -0.901 . . . . 32.35 109.764 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 120' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 -110.05 86.29 4.9 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.47 -0.768 . . . . 27.12 109.636 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 121' ' ' PRO . . . . . 0.428 ' O ' ' HB2' ' R' ' 122' ' ' SER . 44.2 Cg_endo -71.26 166.44 29.25 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 O-C-N 123.819 1.431 . . . . 22.68 111.009 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 122' ' ' SER . . . . . 0.428 ' HB2' ' O ' ' R' ' 121' ' ' PRO . 38.1 t 178.58 -161.65 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.609 -0.682 . . . . 22.99 109.493 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 123' ' ' GLU . . . . . 0.418 ' HG2' HG22 ' R' ' 113' ' ' THR . 2.3 tp10 -56.45 -39.97 74.01 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.19 -0.944 . . . . 36.18 109.701 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 124' ' ' VAL . . . . . . . . . . . . . 82.6 t -142.5 136.41 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.498 -0.751 . . . . 20.64 109.393 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 125' ' ' CYS . . . . . 0.411 ' SG ' ' HA ' ' R' ' 121' ' ' PRO . 83.4 m -140.32 168.15 20.49 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.304 -0.873 . . . . 22.8 111.131 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 126' ' ' VAL . . . . . . . . . . . . . 35.8 m -122.68 159.7 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.714 -0.616 . . . . 21.24 109.676 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 127' ' ' VAL . . . . . 0.401 HG11 ' O ' ' R' ' 177' ' ' VAL . 30.6 m -70.81 141.8 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.359 -0.838 . . . . 19.77 110.7 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 128' ' ' ASP . . . . . . . . . . . . . 53.9 p-10 -137.63 19.38 2.89 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.333 -0.855 . . . . 29.21 110.714 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 129' ' ' GLY . . . . . . . . . . . . . . . 113.97 0.08 24.18 Favored Glycine 0 N--CA 1.493 2.458 0 C-N-CA 120.0 -1.095 . . . . 33.86 110.468 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 130' ' ' THR . . . . . . . . . . . . . 58.1 m -91.82 131.87 36.85 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.171 -1.193 . . . . 26.41 110.072 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -62.58 120.65 11.56 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.312 -0.868 . . . . 33.08 110.284 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 132' ' ' MET . . . . . 0.427 ' HE1' ' CZ ' ' R' ' 180' ' ' PHE . 98.4 mmm -105.16 165.62 10.97 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.543 -0.723 . . . . 30.76 110.415 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 133' ' ' CYS . . . . . . . . . . . . . 32.4 m -141.14 158.13 44.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.511 -0.743 . . . . 27.0 109.912 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 134' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.48 -19.68 39.12 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.347 -0.846 . . . . 33.9 110.538 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 135' ' ' ALA . . . . . . . . . . . . . . . -92.79 8.22 40.37 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.261 -0.899 . . . . 19.37 110.801 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 136' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -93.72 -21.87 19.08 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.109 -0.994 . . . . 30.47 110.195 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 137' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -149.9 165.45 32.56 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.421 -0.8 . . . . 24.27 110.227 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 138' ' ' HIS . . . . . . . . . . . . . 15.1 p80 -117.88 15.09 14.33 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.418 -0.801 . . . . 20.91 110.412 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 139' ' ' ALA . . . . . 0.442 ' HA ' ' O ' ' R' ' 152' ' ' ALA . . . -177.19 152.35 0.87 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.187 -0.946 . . . . 15.69 110.171 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 140' ' ' GLY . . . . . 0.404 ' HA3' ' O ' ' R' ' 179' ' ' VAL . . . 161.82 175.18 32.58 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.918 -1.273 . . . . 23.76 109.918 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 141' ' ' ILE . . . . . . . . . . . . . 83.7 mt -95.54 136.57 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.447 -1.031 . . . . 25.3 109.702 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 142' ' ' PHE . . . . . 0.546 ' CD2' ' HB2' ' R' ' 172' ' ' PRO . 82.2 m-85 -120.66 -172.58 2.41 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.276 -0.89 . . . . 30.24 110.566 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 143' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -119.84 77.78 1.27 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.455 -0.778 . . . . 32.8 110.298 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 144' ' ' LYS . . . . . 0.454 ' HG3' ' CZ2' ' R' ' 170' ' ' TRP . 1.0 OUTLIER -69.66 76.84 0.43 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.43 -0.794 . . . . 49.18 109.635 179.651 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' R' R ' 145' ' ' GLY . . . . . . . . . . . . . . . 104.57 179.26 24.76 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.168 -1.573 . . . . 53.87 109.168 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 146' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -88.5 145.79 25.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.388 -1.066 . . . . 68.58 110.049 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 147' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 58.29 36.51 25.68 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.392 -0.818 . . . . 56.62 110.655 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 148' ' ' HIS . . . . . . . . . . . . . 45.0 t60 -158.68 148.08 19.14 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.205 -0.934 . . . . 44.57 110.377 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 149' ' ' ALA . . . . . . . . . . . . . . . -150.3 146.93 27.06 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.467 -0.771 . . . . 33.54 110.072 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 150' ' ' VAL . . . . . 0.427 HG23 ' HB2' ' R' ' 144' ' ' LYS . 34.2 m -142.38 161.45 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.273 -0.892 . . . . 27.61 110.305 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 151' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' R' ' 152' ' ' ALA . 5.9 t80 -86.15 155.58 20.7 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.42 -0.8 . . . . 23.04 109.867 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 152' ' ' ALA . . . . . 0.537 ' N ' ' CD1' ' R' ' 151' ' ' PHE . . . -157.31 151.59 24.95 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.455 -0.778 . . . . 29.61 109.565 178.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 153' ' ' CYS . . . . . 0.407 ' HA ' ' HA ' ' R' ' 139' ' ' ALA . 26.7 p -154.33 173.56 16.02 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.334 -0.854 . . . . 22.75 110.49 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 154' ' ' VAL . . . . . 0.443 ' CG2' ' CZ2' ' R' ' 159' ' ' TRP . 60.4 t -90.6 116.97 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.337 -0.852 . . . . 23.26 110.083 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 155' ' ' THR . . . . . . . . . . . . . 69.3 p -112.05 -176.65 2.98 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.257 -0.902 . . . . 17.88 110.102 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 156' ' ' SER . . . . . . . . . . . . . 78.4 p -75.96 -3.69 36.96 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.394 -0.816 . . . . 21.83 110.721 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 157' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -118.32 10.58 12.84 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.046 -1.034 . . . . 36.54 110.613 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 158' ' ' GLY . . . . . . . . . . . . . . . 117.98 -162.65 13.04 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.592 -1.403 . . . . 31.74 109.592 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 159' ' ' TRP . . . . . 0.443 ' CZ2' ' CG2' ' R' ' 154' ' ' VAL . 14.7 m95 -86.55 122.42 30.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.312 -1.111 . . . . 28.25 110.112 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 160' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -108.46 166.94 10.39 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.413 -0.805 . . . . 41.24 110.19 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 161' ' ' ALA . . . . . . . . . . . . . . . -143.21 123.48 13.79 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.367 -0.833 . . . . 27.4 110.14 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 162' ' ' ILE . . . . . 0.431 HG23 ' CZ ' ' R' ' 167' ' ' PHE . 92.1 mt -87.6 81.14 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.354 -0.841 . . . . 24.27 110.106 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 163' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' R' ' 165' ' ' GLU . 15.3 t0 -72.72 92.33 1.54 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.443 -0.786 . . . . 36.08 110.332 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 164' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 54.1 -88.93 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.496 -0.752 . . . . 46.08 110.565 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 165' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' R' ' 163' ' ' ASP . 29.7 mt-10 -124.72 35.96 4.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.017 -1.052 . . . . 50.94 110.187 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 166' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -135.8 117.34 14.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.339 -0.85 . . . . 47.28 110.309 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 167' ' ' PHE . . . . . 0.431 ' CZ ' HG23 ' R' ' 162' ' ' ILE . 24.3 m-85 -101.07 119.92 39.45 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.412 -0.805 . . . . 40.47 110.127 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 168' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -157.58 158.51 30.6 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.305 -0.872 . . . . 30.21 110.407 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 169' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.77 133.06 19.54 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 O-C-N 123.868 1.457 . . . . 32.76 110.474 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 170' ' ' TRP . . . . . 0.454 ' CZ2' ' HG3' ' R' ' 144' ' ' LYS . 67.0 t90 -159.81 119.3 2.88 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.41 -0.806 . . . . 32.79 109.984 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 171' ' ' THR . . . . . . . . . . . . . 45.7 m -81.08 112.62 34.19 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.444 -0.785 . . . . 36.92 110.219 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 172' ' ' PRO . . . . . 0.546 ' HB2' ' CD2' ' R' ' 142' ' ' PHE . 46.9 Cg_endo -73.75 158.83 46.45 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.68 1.358 . . . . 33.54 110.533 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 173' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -88.9 144.96 33.71 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.366 -0.833 . . . . 45.76 109.843 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 174' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -71.71 -10.4 26.46 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 O-C-N 123.553 1.291 . . . . 29.63 110.438 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 175' ' ' SER . . . . . . . . . . . . . 53.0 p -103.36 -17.69 15.16 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.234 -0.916 . . . . 35.7 110.404 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 176' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -103.44 43.13 1.1 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.233 -0.917 . . . . 39.65 110.4 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 177' ' ' VAL . . . . . 0.401 ' O ' HG11 ' R' ' 127' ' ' VAL . 10.4 p -117.69 127.2 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.409 -0.807 . . . . 20.61 110.021 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 178' ' ' LEU . . . . . . . . . . . . . 46.3 mt -91.52 -61.29 1.68 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.35 -0.844 . . . . 15.58 109.376 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 179' ' ' VAL . . . . . 0.404 ' O ' ' HA3' ' R' ' 140' ' ' GLY . 67.1 t -114.62 144.67 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.6 -0.688 . . . . 17.4 109.444 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 180' ' ' PHE . . . . . 0.427 ' CZ ' ' HE1' ' R' ' 132' ' ' MET . 43.7 p90 -152.09 163.37 39.47 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.338 -0.851 . . . . 20.16 110.562 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 181' ' ' VAL . . . . . . . . . . . . . 66.4 t -113.19 111.48 50.22 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.511 -0.743 . . . . 17.69 109.836 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 182' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.11 149.54 52.44 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.546 1.287 . . . . 17.81 110.374 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 183' ' ' TYR . . . . . 0.736 ' O ' ' C ' ' R' ' 184' ' ' ASP . 79.2 m-85 -58.99 175.47 0.28 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.464 -0.772 . . . . 28.01 110.522 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' R' R ' 184' ' ' ASP . . . . . 0.736 ' C ' ' O ' ' R' ' 183' ' ' TYR . 0.0 OUTLIER -13.05 -76.29 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.303 -0.873 . . . . 58.64 110.221 -178.029 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' R' R ' 185' ' ' GLN . . . . . . . . . . . . . 16.8 tm0? . . . . . 0 N--CA 1.503 2.217 0 CA-C-O 121.265 0.555 . . . . 80.42 111.773 179.171 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' R' R ' 193' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 120.873 0.368 . . . . 49.5 110.245 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' R' R ' 194' ' ' ALA . . . . . 0.606 ' CB ' ' HA ' ' R' ' 119' ' ' SER . . . . . . . . 0 N--CA 1.495 1.777 0 O-C-N 121.162 -0.961 . . . . 40.4 110.136 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 229' ' ' MET . . . . . . . . . . . . . 28.8 mtm . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.188 0.518 . . . . 51.83 110.235 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' S' S ' 230' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -97.34 142.69 28.9 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.409 -0.807 . . . . 54.13 110.195 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 231' ' ' LEU . . . . . . . . . . . . . 68.0 mt -134.02 141.02 47.06 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.413 -0.805 . . . . 33.04 110.344 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 232' ' ' THR . . . . . . . . . . . . . 40.2 m -89.27 103.29 15.93 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.432 -0.792 . . . . 26.92 109.973 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 233' ' ' LEU . . . . . 0.503 HD23 ' CE2' ' S' ' 262' ' ' TYR . 79.7 mt -55.92 179.36 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.471 -0.768 . . . . 13.78 110.494 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' S' S ' 234' ' ' TYR . . . . . 0.44 ' CG ' ' N ' ' S' ' 235' ' ' ASN . 35.4 p90 -65.13 -35.61 81.67 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.355 -0.841 . . . . 26.08 110.17 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' S' S ' 235' ' ' ASN . . . . . 0.44 ' N ' ' CG ' ' S' ' 234' ' ' TYR . 50.7 p30 -74.3 -7.5 52.99 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.299 -0.876 . . . . 20.04 110.504 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' S' S ' 236' ' ' GLY . . . . . . . . . . . . . . . 95.8 -20.02 51.72 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.76 -1.336 . . . . 22.71 109.76 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 237' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -53.02 145.77 12.41 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.19 -1.182 . . . . 35.44 110.145 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 238' ' ' LYS . . . . . . . . . . . . . 44.3 mttt -102.18 127.87 48.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.395 -0.815 . . . . 32.56 110.362 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 239' ' ' LYS . . . . . 0.419 ' HG2' ' CZ ' ' S' ' 241' ' ' PHE . 8.9 ttmt -132.29 144.45 50.59 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.474 -0.766 . . . . 26.68 109.959 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' S' S ' 240' ' ' THR . . . . . . . . . . . . . 52.4 m -101.98 132.22 47.93 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.237 -0.915 . . . . 41.02 110.375 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 241' ' ' PHE . . . . . 0.419 ' CZ ' ' HG2' ' S' ' 239' ' ' LYS . 96.1 m-85 -117.95 137.75 52.63 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.348 -0.845 . . . . 28.62 110.203 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' S' S ' 242' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -96.47 161.78 13.76 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.38 -0.825 . . . . 47.89 110.149 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 243' ' ' SER . . . . . . . . . . . . . 72.1 m -90.59 151.62 21.23 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.31 -0.869 . . . . 45.09 110.211 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 244' ' ' ARG . . . . . . . . . . . . . 1.4 mtp85 -129.82 126.72 22.66 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.324 -0.86 . . . . 42.49 110.204 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 245' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.3 160.94 43.97 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 O-C-N 123.635 1.334 . . . . 35.68 110.559 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 246' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -132.82 97.84 4.15 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.327 -0.858 . . . . 51.88 109.871 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 247' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -110.49 -22.18 11.79 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.376 -0.828 . . . . 53.69 110.647 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 248' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -117.29 43.66 2.28 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.237 -0.914 . . . . 55.79 110.717 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 249' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 48.8 38.43 11.89 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.444 -0.785 . . . . 49.45 110.333 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 250' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -90.69 29.14 1.37 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.53 -0.731 . . . . 36.86 110.297 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 251' ' ' ALA . . . . . . . . . . . . . . . -53.9 -43.18 69.46 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.172 -0.955 . . . . 29.69 109.564 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 252' ' ' TRP . . . . . 0.418 ' CZ2' ' HB3' ' S' ' 294' ' ' LEU . 68.0 p-90 -61.81 -33.91 74.97 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.491 -0.755 . . . . 41.12 109.868 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' S' S ' 253' ' ' LEU . . . . . 0.406 ' N ' ' CD2' ' S' ' 252' ' ' TRP . 23.3 tp -70.14 -47.26 62.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.321 -0.862 . . . . 24.89 109.962 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' S' S ' 254' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -56.12 -42.49 76.94 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.343 -0.848 . . . . 35.65 109.991 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 255' ' ' ALA . . . . . . . . . . . . . . . -59.56 -48.24 82.44 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.439 -0.788 . . . . 22.73 110.046 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 256' ' ' ILE . . . . . . . . . . . . . 79.7 mt -62.22 -40.68 88.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.337 -0.852 . . . . 28.85 109.988 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 257' ' ' LEU . . . . . . . . . . . . . 19.1 mt -61.52 -44.51 96.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.356 -0.84 . . . . 23.07 110.162 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 258' ' ' GLN . . . . . 0.466 ' HB3' ' CD2' ' S' ' 351' ' ' PHE . 53.4 mm-40 -65.07 -45.37 85.55 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.422 -0.799 . . . . 29.78 109.87 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' S' S ' 259' ' ' LEU . . . . . 0.432 ' O ' HG22 ' S' ' 263' ' ' VAL . 19.9 tp -58.71 -36.34 74.09 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.331 -0.856 . . . . 17.94 109.452 179.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' S' S ' 260' ' ' PHE . . . . . 0.47 ' CE2' HD22 ' S' ' 311' ' ' LEU . 3.1 m-85 -62.84 -45.2 93.7 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.56 -0.713 . . . . 30.57 109.825 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' S' S ' 261' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -62.18 -29.79 70.62 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.475 -0.766 . . . . 41.34 109.901 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 262' ' ' TYR . . . . . 0.503 ' CE2' HD23 ' S' ' 233' ' ' LEU . 8.6 t80 -71.17 -44.69 65.0 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.435 -0.79 . . . . 26.03 110.129 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' S' S ' 263' ' ' VAL . . . . . 0.432 HG22 ' O ' ' S' ' 259' ' ' LEU . 33.1 m -92.0 18.29 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.352 -0.843 . . . . 22.8 110.384 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' S' S ' 264' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 52.72 70.69 0.55 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.206 -0.934 . . . . 44.03 110.641 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 265' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -111.82 109.24 55.36 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.375 -0.828 . . . . 35.61 109.649 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 266' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -75.33 0.46 9.01 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.631 1.332 . . . . 37.67 111.772 -179.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 267' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -56.56 -67.63 0.29 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.779 -1.201 . . . . 41.49 110.17 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' S' S ' 268' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -92.94 39.91 1.05 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.193 -0.942 . . . . 50.76 110.091 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 269' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.05 -33.1 59.6 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.417 -0.802 . . . . 61.86 109.816 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' S' S ' 270' ' ' TRP . . . . . 0.488 ' CE2' ' CG2' ' S' ' 271' ' ' VAL . 51.0 p-90 -73.98 -4.31 34.49 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.327 -0.858 . . . . 39.85 110.478 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' S' S ' 271' ' ' VAL . . . . . 0.488 ' CG2' ' CE2' ' S' ' 270' ' ' TRP . 46.6 t -109.56 -32.69 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.154 -0.966 . . . . 39.18 110.045 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' S' S ' 272' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -78.71 -36.49 43.34 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.365 -0.834 . . . . 40.02 110.518 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 273' ' ' SER . . . . . . . . . . . . . 71.2 m -103.52 56.17 0.74 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.317 -0.864 . . . . 47.2 110.345 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 274' ' ' SER . . . . . . . . . . . . . 6.9 t -133.13 141.19 39.9 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.334 -0.854 . . . . 47.61 110.12 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 275' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.65 -18.9 21.97 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.603 1.317 . . . . 45.28 110.603 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 276' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -99.94 140.9 33.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.248 -0.908 . . . . 57.27 110.272 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 277' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -71.71 97.67 1.8 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.48 -0.763 . . . . 37.28 110.263 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 278' ' ' LEU . . . . . . . . . . . . . 86.4 mt -96.98 33.77 1.85 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.484 -0.76 . . . . 43.88 110.003 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 279' ' ' THR . . . . . . . . . . . . . 75.3 m -64.05 -60.12 3.62 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.398 -0.814 . . . . 50.05 110.275 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 280' ' ' LEU . . . . . . . . . . . . . 13.7 mt -51.6 -39.77 58.58 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.301 -0.874 . . . . 54.12 110.334 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 281' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.49 -49.7 74.34 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.475 -0.766 . . . . 65.28 110.125 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' S' S ' 282' ' ' ALA . . . . . . . . . . . . . . . -58.89 -34.0 71.16 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.491 -0.756 . . . . 46.51 110.513 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 283' ' ' ILE . . . . . . . . . . . . . 85.5 mt -66.26 -50.91 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.242 -0.911 . . . . 47.3 110.149 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 284' ' ' LYS . . . . . . . . . . . . . 33.8 tttp -50.52 -57.52 7.92 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.414 -0.804 . . . . 50.72 110.476 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 285' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -51.43 -46.45 62.98 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.469 -0.77 . . . . 68.47 110.293 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 286' ' ' LEU . . . . . . . . . . . . . 19.2 mt -59.93 -44.49 94.3 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.426 -0.796 . . . . 36.62 110.26 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 287' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -62.8 -35.25 79.27 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.342 -0.849 . . . . 46.64 110.067 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 288' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -76.21 -21.04 56.9 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.382 -0.823 . . . . 46.45 110.329 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 289' ' ' LEU . . . . . . . . . . . . . 30.9 mt -97.24 -21.78 17.07 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.308 -0.87 . . . . 35.09 110.559 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 290' ' ' THR . . . . . . . . . . . . . 81.3 p -114.82 -28.47 7.06 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.275 -0.89 . . . . 38.61 110.367 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 291' ' ' GLY . . . . . . . . . . . . . . . 79.35 11.1 85.31 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.829 -1.308 . . . . 36.77 109.829 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 292' ' ' LEU . . . . . . . . . . . . . 84.6 mt -96.46 145.77 25.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.233 -1.157 . . . . 35.33 109.815 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 293' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -77.34 102.4 6.75 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.144 -0.973 . . . . 48.7 110.235 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 294' ' ' LEU . . . . . 0.418 ' HB3' ' CZ2' ' S' ' 252' ' ' TRP . 55.1 mt -106.89 51.73 0.73 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.498 -0.751 . . . . 42.61 110.128 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' S' S ' 295' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -112.56 -11.11 13.63 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.356 -0.84 . . . . 55.49 110.518 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' S' S ' 296' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -144.32 48.44 1.36 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.093 -1.004 . . . . 75.68 110.363 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 297' ' ' GLY . . . . . . . . . . . . . . . 96.9 145.15 18.66 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.477 -1.449 . . . . 49.44 109.477 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 298' ' ' GLY . . . . . . . . . . . . . . . -163.8 156.99 29.09 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.804 -1.318 . . . . 41.11 109.804 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 299' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.82 118.26 5.37 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 124.018 1.536 . . . . 26.2 110.32 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 300' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.26 -15.4 31.63 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.609 1.321 . . . . 21.7 110.736 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 301' ' ' ALA . . . . . . . . . . . . . . . -80.68 -29.44 36.57 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.237 -0.914 . . . . 31.23 110.129 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 302' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.45 -40.62 19.05 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.404 -0.81 . . . . 38.99 110.031 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' S' S ' 303' ' ' VAL . . . . . 0.471 ' O ' HG12 ' S' ' 307' ' ' ILE . 57.6 t -60.69 -35.53 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.36 -0.838 . . . . 18.63 110.135 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' S' S ' 304' ' ' ILE . . . . . . . . . . . . . 85.9 mt -79.36 -23.72 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.265 -0.897 . . . . 25.46 110.129 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 305' ' ' TRP . . . . . . . . . . . . . 68.7 t-105 -88.55 -14.6 37.29 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.261 -0.899 . . . . 33.4 110.588 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 306' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -89.64 -13.65 36.63 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.204 -0.935 . . . . 36.97 110.403 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 307' ' ' ILE . . . . . 0.471 HG12 ' O ' ' S' ' 303' ' ' VAL . 36.8 pt -125.06 45.65 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.198 -0.939 . . . . 30.81 109.997 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' S' S ' 308' ' ' LYS . . . . . . . . . . . . . 1.5 mtmp? -73.52 -37.82 65.53 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.336 -0.852 . . . . 46.52 110.108 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 309' ' ' HIS . . . . . 0.49 ' CD2' ' HG ' ' S' ' 310' ' ' LEU . 55.5 p-80 -73.21 -8.26 55.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.331 -0.855 . . . . 51.03 110.078 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' S' S ' 310' ' ' LEU . . . . . 0.49 ' HG ' ' CD2' ' S' ' 309' ' ' HIS . 52.8 mt -99.31 -12.81 20.0 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.245 -0.909 . . . . 36.16 110.009 179.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' S' S ' 311' ' ' LEU . . . . . 0.47 HD22 ' CE2' ' S' ' 260' ' ' PHE . 10.8 mt -97.18 147.87 23.65 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.378 -0.826 . . . . 40.0 110.458 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' S' S ' 312' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -81.65 -16.25 52.0 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.363 -0.836 . . . . 54.18 109.722 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 313' ' ' THR . . . . . 0.477 HG23 ' HB3' ' S' ' 323' ' ' GLU . 92.6 m -87.92 151.65 22.66 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.386 -0.821 . . . . 25.61 110.119 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' S' S ' 314' ' ' GLY . . . . . . . . . . . . . . . -87.93 126.34 8.02 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.849 -1.3 . . . . 25.18 109.849 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 315' ' ' ILE . . . . . . . . . . . . . 50.7 mm -101.66 150.5 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.409 -1.053 . . . . 23.9 109.727 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 316' ' ' GLY . . . . . . . . . . . . . . . -157.06 -159.29 9.39 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.928 -1.269 . . . . 23.18 109.928 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 317' ' ' THR . . . . . . . . . . . . . 11.1 p -133.87 -172.99 3.12 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.422 -1.046 . . . . 27.98 110.025 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.54 -56.25 24.33 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.215 -0.928 . . . . 28.1 109.908 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 319' ' ' SER . . . . . . . . . . . . . 1.2 m -59.91 -41.68 92.25 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.343 -0.848 . . . . 37.0 109.65 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 320' ' ' ARG . . . . . . . . . . . . . 12.2 mtm180 -111.7 79.95 2.67 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.438 -0.789 . . . . 52.07 109.646 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 321' ' ' PRO . . . . . 0.436 ' O ' ' HB2' ' S' ' 322' ' ' SER . 43.6 Cg_endo -71.5 171.51 16.11 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.772 1.406 . . . . 38.29 110.867 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' S' S ' 322' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' S' ' 321' ' ' PRO . 41.3 t 178.69 -148.1 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.907 -0.775 . . . . 38.84 108.907 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' S' S ' 323' ' ' GLU . . . . . 0.477 ' HB3' HG23 ' S' ' 313' ' ' THR . 6.7 tp10 -62.86 -40.26 96.96 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.048 -1.033 . . . . 40.7 109.707 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' S' S ' 324' ' ' VAL . . . . . . . . . . . . . 72.7 t -141.33 135.01 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.411 -0.806 . . . . 20.34 109.49 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 325' ' ' CYS . . . . . 0.451 ' HB2' ' CE1' ' S' ' 380' ' ' PHE . 11.3 m -125.94 172.22 10.1 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.323 -0.861 . . . . 30.63 110.84 -179.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' S' S ' 326' ' ' VAL . . . . . . . . . . . . . 34.6 m -135.53 142.26 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 109.186 -0.672 . . . . 23.9 109.186 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 327' ' ' VAL . . . . . . . . . . . . . 34.5 m -56.41 125.01 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.096 -1.002 . . . . 19.48 110.419 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 328' ' ' ASP . . . . . . . . . . . . . 55.5 p-10 -119.43 11.54 12.18 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.461 -0.774 . . . . 26.43 110.445 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 329' ' ' GLY . . . . . . . . . . . . . . . 119.69 2.27 13.05 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.041 -1.223 . . . . 31.24 110.041 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 330' ' ' THR . . . . . . . . . . . . . 80.1 m -93.04 129.99 38.79 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.117 -1.225 . . . . 30.05 110.107 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 331' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -56.68 111.47 1.02 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.311 -0.868 . . . . 37.26 110.011 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 332' ' ' MET . . . . . 0.455 ' HE1' ' CZ ' ' S' ' 380' ' ' PHE . 88.0 mmm -94.1 162.57 13.82 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.234 -0.916 . . . . 26.23 110.356 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' S' S ' 333' ' ' CYS . . . . . . . . . . . . . 25.6 m -137.24 150.01 47.55 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.513 -0.742 . . . . 23.56 110.015 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 334' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.57 -24.82 8.96 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.342 -0.849 . . . . 28.93 110.488 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' S' S ' 335' ' ' ALA . . . . . . . . . . . . . . . -89.12 14.52 10.58 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.427 -0.796 . . . . 15.76 110.942 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 336' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -100.45 -17.28 17.25 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.164 -0.96 . . . . 34.92 110.242 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 337' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -152.36 170.88 19.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.329 -0.857 . . . . 19.03 110.072 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 338' ' ' HIS . . . . . 0.401 ' HB3' ' CZ ' ' S' ' 383' ' ' TYR . 13.5 p80 -120.71 10.47 11.0 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.356 -0.84 . . . . 18.82 110.508 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' S' S ' 339' ' ' ALA . . . . . . . . . . . . . . . -176.0 155.18 1.56 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.193 -0.942 . . . . 17.18 110.079 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 340' ' ' GLY . . . . . . . . . . . . . . . 160.82 173.05 28.93 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.089 -1.204 . . . . 18.33 110.089 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 341' ' ' ILE . . . . . 0.448 HD12 HG22 ' S' ' 341' ' ' ILE . 83.9 mt -88.76 138.07 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.493 -1.004 . . . . 18.6 109.864 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' S' S ' 342' ' ' PHE . . . . . 0.504 ' CE1' HG23 ' S' ' 377' ' ' VAL . 70.0 m-85 -120.94 -178.43 3.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.195 -0.941 . . . . 23.44 110.444 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' S' S ' 343' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.91 93.37 4.17 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.44 -0.787 . . . . 35.59 110.001 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' S' S ' 344' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.86 125.09 29.67 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.334 -0.854 . . . . 38.34 109.999 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' S' S ' 345' ' ' GLY . . . . . . . . . . . . . . . 62.71 -130.83 43.26 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 108.928 -1.669 . . . . 53.46 108.928 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 346' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -132.72 150.9 52.1 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.23 -1.159 . . . . 70.91 110.018 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 347' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 53.26 35.44 20.1 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.319 -0.863 . . . . 47.32 110.442 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 348' ' ' HIS . . . . . . . . . . . . . 46.9 t60 -150.16 155.83 40.5 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.383 -0.823 . . . . 41.72 110.36 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 349' ' ' ALA . . . . . . . . . . . . . . . -149.79 151.25 33.26 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.427 -0.796 . . . . 22.91 110.481 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 350' ' ' VAL . . . . . . . . . . . . . 34.6 m -148.99 169.66 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.534 -0.729 . . . . 21.09 110.072 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 351' ' ' PHE . . . . . 0.466 ' CD2' ' HB3' ' S' ' 258' ' ' GLN . 10.7 t80 -105.44 143.54 33.46 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.246 -0.909 . . . . 25.03 110.709 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' S' S ' 352' ' ' ALA . . . . . . . . . . . . . . . -147.66 151.69 36.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.634 -0.666 . . . . 23.81 109.766 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 353' ' ' CYS . . . . . . . . . . . . . 26.3 p -153.3 164.9 37.29 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.341 -0.849 . . . . 25.66 110.315 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 354' ' ' VAL . . . . . 0.406 HG23 ' CZ2' ' S' ' 359' ' ' TRP . 57.5 t -76.05 118.52 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.359 -0.838 . . . . 34.27 109.904 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' S' S ' 355' ' ' THR . . . . . 0.442 HG23 ' HB2' ' S' ' 360' ' ' TYR . 51.7 p -117.91 175.15 5.8 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.298 -0.876 . . . . 25.49 110.283 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' S' S ' 356' ' ' SER . . . . . . . . . . . . . 62.3 p -62.12 -17.75 58.7 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.393 -0.817 . . . . 31.24 110.731 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 357' ' ' ASN . . . . . . . . . . . . . 46.0 m-20 -106.98 14.16 26.77 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.104 -0.997 . . . . 28.61 110.559 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 358' ' ' GLY . . . . . . . . . . . . . . . 111.88 -152.9 17.6 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 110.005 -1.238 . . . . 22.01 110.005 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 359' ' ' TRP . . . . . 0.406 ' CZ2' HG23 ' S' ' 354' ' ' VAL . 15.5 m95 -91.22 116.63 28.97 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.446 -1.032 . . . . 25.54 110.273 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' S' S ' 360' ' ' TYR . . . . . 0.442 ' HB2' HG23 ' S' ' 355' ' ' THR . 1.3 m-85 -103.47 165.81 10.81 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.375 -0.828 . . . . 40.53 110.104 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' S' S ' 361' ' ' ALA . . . . . . . . . . . . . . . -140.04 130.07 24.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.379 -0.826 . . . . 18.04 110.297 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 362' ' ' ILE . . . . . 0.412 HG23 ' CZ ' ' S' ' 367' ' ' PHE . 88.7 mt -95.63 83.62 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.415 -0.803 . . . . 15.64 110.065 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' S' S ' 363' ' ' ASP . . . . . 0.416 ' O ' ' N ' ' S' ' 365' ' ' GLU . 11.8 t0 -75.2 94.43 2.96 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.334 -0.854 . . . . 35.03 110.216 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' S' S ' 364' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 54.01 -89.34 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.493 -0.754 . . . . 46.72 110.508 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 365' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' S' ' 363' ' ' ASP . 23.7 mt-10 -122.68 19.09 10.33 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.081 -1.012 . . . . 56.2 110.202 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' S' S ' 366' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -117.97 125.04 49.64 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.217 -0.927 . . . . 51.02 110.342 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 367' ' ' PHE . . . . . 0.412 ' CZ ' HG23 ' S' ' 362' ' ' ILE . 26.9 m-85 -106.99 127.12 53.17 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.392 -0.817 . . . . 37.59 110.093 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' S' S ' 368' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -165.49 159.58 13.8 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.323 -0.861 . . . . 31.47 110.423 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 369' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.92 139.61 30.44 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 O-C-N 123.85 1.447 . . . . 28.85 110.497 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 370' ' ' TRP . . . . . . . . . . . . . 67.5 t90 -167.19 113.57 0.77 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.408 -0.807 . . . . 26.94 109.936 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 371' ' ' THR . . . . . . . . . . . . . 59.3 m -74.8 113.04 20.59 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.372 -0.83 . . . . 20.19 110.02 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 372' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.49 157.06 49.55 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 O-C-N 123.578 1.304 . . . . 28.68 110.597 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 373' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -90.64 147.18 35.72 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.423 -0.798 . . . . 35.72 109.87 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 374' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -76.04 -6.25 17.15 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 O-C-N 123.713 1.375 . . . . 30.89 110.465 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 375' ' ' SER . . . . . . . . . . . . . 68.2 p -104.36 -17.0 14.97 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.297 -0.877 . . . . 29.41 110.46 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 376' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -106.5 43.0 1.19 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.299 -0.876 . . . . 32.89 110.256 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 377' ' ' VAL . . . . . 0.504 HG23 ' CE1' ' S' ' 342' ' ' PHE . 7.4 p -114.62 147.25 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.348 -0.845 . . . . 24.33 110.26 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' S' S ' 378' ' ' LEU . . . . . . . . . . . . . 53.0 mt -116.05 -57.93 2.16 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.456 -0.778 . . . . 24.37 109.573 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 379' ' ' VAL . . . . . . . . . . . . . 61.5 t -120.73 132.39 70.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.454 -0.779 . . . . 18.02 109.409 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 380' ' ' PHE . . . . . 0.455 ' CZ ' ' HE1' ' S' ' 332' ' ' MET . 14.5 p90 -142.59 173.94 11.09 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.38 -0.825 . . . . 29.35 110.646 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' S' S ' 381' ' ' VAL . . . . . . . . . . . . . 57.8 t -120.02 107.35 39.94 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.486 -0.759 . . . . 16.34 109.412 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 382' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.38 145.67 48.61 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 O-C-N 123.636 1.335 . . . . 20.94 110.762 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' S' S ' 383' ' ' TYR . . . . . 0.401 ' CZ ' ' HB3' ' S' ' 338' ' ' HIS . 88.0 m-85 -61.12 -53.45 56.86 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.344 -0.848 . . . . 28.93 109.825 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' S' S ' 384' ' ' ASP . . . . . . . . . . . . . 3.9 p30 . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.431 -0.793 . . . . 47.03 110.332 -176.496 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' R' R ' 30' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 . . . . . 0 N--CA 1.493 1.719 0 CA-C-O 121.161 0.505 . . . . 43.36 110.262 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' R' R ' 31' ' ' LEU . . . . . . . . . . . . . 65.6 mt -134.91 140.58 45.87 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.312 -0.867 . . . . 22.93 110.268 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 32' ' ' THR . . . . . . . . . . . . . 69.3 m -87.55 110.57 20.45 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.319 -0.863 . . . . 22.34 109.984 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 33' ' ' LEU . . . . . 0.46 HD23 ' CE2' ' R' ' 62' ' ' TYR . 80.1 mt -62.38 -172.76 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.299 -0.876 . . . . 21.39 110.202 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 34' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -74.6 -29.49 61.33 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.333 -0.855 . . . . 34.4 110.365 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 35' ' ' ASN . . . . . . . . . . . . . 48.3 p30 -77.72 -1.89 33.46 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.384 -0.822 . . . . 30.28 110.649 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.28 -16.55 59.53 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.698 -1.361 . . . . 36.25 109.698 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 37' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -59.04 161.77 4.82 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.338 -1.095 . . . . 53.8 110.368 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 38' ' ' LYS . . . . . . . . . . . . . 57.1 mttt -117.78 135.73 53.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.393 -0.817 . . . . 49.91 110.181 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 39' ' ' LYS . . . . . 0.416 ' HG2' ' CZ ' ' R' ' 41' ' ' PHE . 8.1 ttmt -138.68 143.74 39.29 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.423 -0.798 . . . . 35.69 110.198 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 40' ' ' THR . . . . . . . . . . . . . 23.6 m -102.63 128.05 49.47 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.343 -0.848 . . . . 34.84 110.188 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 41' ' ' PHE . . . . . 0.416 ' CZ ' ' HG2' ' R' ' 39' ' ' LYS . 96.6 m-85 -113.08 132.64 55.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.381 -0.824 . . . . 34.42 110.14 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 42' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -93.32 140.9 29.04 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.366 -0.834 . . . . 51.46 110.215 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 43' ' ' SER . . . . . . . . . . . . . 54.6 m -70.76 141.92 51.42 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.397 -0.815 . . . . 41.84 110.187 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.8 125.34 29.6 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.305 -0.872 . . . . 33.82 109.978 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 45' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.15 151.05 54.79 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.517 1.272 . . . . 30.27 110.649 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 46' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.24 109.92 13.99 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.456 -0.777 . . . . 35.1 109.989 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 47' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -120.27 -34.93 3.54 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.325 -0.859 . . . . 42.81 110.545 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 48' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -105.74 45.16 0.98 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.181 -0.949 . . . . 49.97 110.275 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 49' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 50.35 34.65 9.32 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.432 -0.793 . . . . 61.32 110.182 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 50' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -86.22 43.81 1.09 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.349 -0.844 . . . . 51.5 110.661 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.14 -46.08 78.73 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.225 -0.922 . . . . 38.77 109.539 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 52' ' ' TRP . . . . . 0.483 ' CD2' ' N ' ' R' ' 53' ' ' LEU . 68.2 p-90 -58.37 -38.42 77.21 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.419 -0.801 . . . . 26.24 110.082 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 53' ' ' LEU . . . . . 0.483 ' N ' ' CD2' ' R' ' 52' ' ' TRP . 23.0 tp -66.71 -46.71 74.65 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.456 -0.777 . . . . 26.75 109.939 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 54' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -55.18 -41.68 72.24 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.321 -0.862 . . . . 35.02 110.128 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.19 -46.03 92.14 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.4 -0.812 . . . . 24.47 110.189 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 56' ' ' ILE . . . . . . . . . . . . . 76.3 mt -62.14 -42.25 94.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.332 -0.855 . . . . 26.03 109.937 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 57' ' ' LEU . . . . . . . . . . . . . 22.4 mt -60.3 -45.67 92.57 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.299 -0.876 . . . . 26.77 109.661 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 58' ' ' GLN . . . . . . . . . . . . . 57.9 mm-40 -63.92 -46.48 84.59 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.481 -0.762 . . . . 22.32 109.594 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 59' ' ' LEU . . . . . 0.429 ' HA ' ' HE2' ' R' ' 151' ' ' PHE . 23.9 tp -61.43 -37.73 84.6 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.306 -0.871 . . . . 20.55 109.396 179.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 60' ' ' PHE . . . . . 0.447 ' CE2' HD22 ' R' ' 111' ' ' LEU . 2.8 m-85 -61.08 -44.76 96.88 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.664 -0.648 . . . . 20.08 109.927 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 61' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -63.1 -36.17 82.71 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.479 -0.763 . . . . 18.8 110.486 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 62' ' ' TYR . . . . . 0.46 ' CE2' HD23 ' R' ' 33' ' ' LEU . 9.1 t80 -63.11 -41.76 99.41 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.266 -0.896 . . . . 26.45 110.226 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 63' ' ' VAL . . . . . . . . . . . . . 30.5 m -93.4 20.45 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.295 -0.878 . . . . 29.75 110.218 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 64' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 52.87 75.58 0.23 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.344 -0.848 . . . . 35.52 110.58 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 65' ' ' GLU . . . . . 0.425 ' HG2' ' CD2' ' R' ' 60' ' ' PHE . 14.2 tp10 -116.29 104.07 52.33 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.377 -0.827 . . . . 29.89 109.888 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 66' ' ' PRO . . . . . 0.4 ' HA ' ' HB2' ' R' ' 69' ' ' ASP . 46.9 Cg_endo -73.53 -5.86 17.79 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 123.806 1.424 . . . . 21.37 111.124 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 67' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -52.09 -61.52 2.21 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.144 -0.973 . . . . 23.85 110.375 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 68' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -98.11 36.53 1.56 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.326 -0.859 . . . . 28.07 110.475 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 69' ' ' ASP . . . . . 0.4 ' HB2' ' HA ' ' R' ' 66' ' ' PRO . 11.7 t0 -72.3 -33.31 67.31 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.382 -0.824 . . . . 43.76 110.169 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 70' ' ' TRP . . . . . 0.477 ' CE2' ' CG2' ' R' ' 71' ' ' VAL . 47.9 p-90 -73.34 -3.88 29.9 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.313 -0.867 . . . . 33.06 110.705 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 71' ' ' VAL . . . . . 0.477 ' CG2' ' CE2' ' R' ' 70' ' ' TRP . 40.8 t -109.79 -27.48 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.132 -0.98 . . . . 31.7 109.717 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 72' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -86.56 -48.79 8.05 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.381 -0.824 . . . . 33.58 110.312 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 73' ' ' SER . . . . . . . . . . . . . 70.1 m -89.78 51.13 2.01 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.292 -0.88 . . . . 50.82 110.284 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 74' ' ' SER . . . . . . . . . . . . . 15.8 t -125.95 138.3 31.8 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.348 -0.845 . . . . 34.74 110.168 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.36 -25.01 15.92 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 O-C-N 123.669 1.352 . . . . 35.7 110.319 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 76' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -91.7 153.16 19.85 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.437 -0.789 . . . . 66.48 110.342 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 77' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -81.51 95.16 7.03 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.374 -0.829 . . . . 46.72 110.091 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 78' ' ' LEU . . . . . . . . . . . . . 96.4 mt -96.41 27.97 3.53 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.464 -0.772 . . . . 37.55 110.167 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 79' ' ' THR . . . . . . . . . . . . . 29.6 m -56.19 -54.56 43.76 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.27 -0.894 . . . . 37.36 110.312 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 80' ' ' LEU . . . . . . . . . . . . . 15.8 mt -60.93 -23.23 65.12 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.348 -0.845 . . . . 35.83 110.46 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 81' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -79.5 -39.18 32.67 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.209 -0.932 . . . . 44.03 110.298 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.43 -28.68 66.33 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.187 -0.945 . . . . 32.54 110.159 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 83' ' ' ILE . . . . . . . . . . . . . 78.3 mt -70.16 -45.99 73.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.307 -0.87 . . . . 32.02 110.3 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 84' ' ' LYS . . . . . . . . . . . . . 36.0 tttm -55.22 -52.08 64.52 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.179 -0.951 . . . . 34.09 110.596 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 85' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -54.81 -46.83 74.57 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.224 -0.923 . . . . 25.94 110.301 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 86' ' ' LEU . . . . . . . . . . . . . 24.0 mt -58.66 -43.88 90.0 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.312 -0.867 . . . . 16.2 109.878 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 87' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -65.36 -35.21 80.28 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.442 -0.786 . . . . 49.09 110.28 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 88' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -78.43 -19.04 54.07 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.247 -0.908 . . . . 28.61 110.493 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 89' ' ' LEU . . . . . . . . . . . . . 32.6 mt -96.21 -29.37 14.07 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.188 -0.945 . . . . 26.16 110.201 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 90' ' ' THR . . . . . . . . . . . . . 59.8 p -105.69 -34.6 7.66 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.211 -0.931 . . . . 33.33 109.795 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.78 16.06 58.75 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.857 -1.297 . . . . 31.13 109.857 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 92' ' ' LEU . . . . . . . . . . . . . 97.0 mt -100.07 155.24 17.83 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.141 -1.211 . . . . 42.52 110.281 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 93' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -86.17 91.54 8.47 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.485 -0.759 . . . . 68.46 109.99 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 94' ' ' LEU . . . . . 0.446 ' HB3' ' CZ2' ' R' ' 52' ' ' TRP . 47.8 mt -99.46 53.04 0.94 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.162 -0.961 . . . . 44.63 110.342 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 95' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.48 -38.68 6.38 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.332 -0.855 . . . . 67.16 110.381 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 96' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -113.96 44.25 1.68 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.392 -0.818 . . . . 67.02 110.254 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 97' ' ' GLY . . . . . . . . . . . . . . . 99.2 150.83 26.02 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.599 -1.401 . . . . 49.48 109.599 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 98' ' ' GLY . . . . . . . . . . . . . . . -166.23 160.03 33.46 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.253 -1.539 . . . . 36.57 109.253 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 99' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.54 121.09 7.14 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.641 1.337 . . . . 30.41 110.492 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 100' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.33 -31.57 11.38 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.678 1.357 . . . . 29.94 110.492 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.0 -38.51 75.98 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.357 -0.839 . . . . 23.64 110.227 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.67 -40.72 66.09 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.377 -0.827 . . . . 20.31 110.353 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 103' ' ' VAL . . . . . . . . . . . . . 63.9 t -58.14 -40.13 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.185 -0.947 . . . . 16.33 109.986 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 104' ' ' ILE . . . . . . . . . . . . . 82.1 mt -71.71 -30.54 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.399 -0.813 . . . . 24.77 109.899 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 105' ' ' TRP . . . . . 0.44 ' O ' ' HD3' ' R' ' 108' ' ' LYS . 70.5 t-105 -82.41 0.88 40.02 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.292 -0.88 . . . . 23.28 110.31 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 106' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -105.08 -10.42 17.18 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.152 -0.967 . . . . 28.26 110.043 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 107' ' ' ILE . . . . . . . . . . . . . 36.7 pt -126.81 34.96 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.225 -0.922 . . . . 18.77 110.047 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 108' ' ' LYS . . . . . 0.481 ' HG2' ' HB ' ' R' ' 115' ' ' ILE . 9.2 mtpp -61.03 -48.43 81.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.565 -0.709 . . . . 42.5 110.055 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 109' ' ' HIS . . . . . 0.432 ' CD2' ' HG ' ' R' ' 110' ' ' LEU . 50.7 p-80 -66.06 -12.84 58.12 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.461 -0.774 . . . . 20.07 110.646 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 110' ' ' LEU . . . . . 0.432 ' HG ' ' CD2' ' R' ' 109' ' ' HIS . 80.6 mt -94.84 -17.21 22.29 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.115 -0.991 . . . . 15.69 110.181 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 111' ' ' LEU . . . . . 0.447 HD22 ' CE2' ' R' ' 60' ' ' PHE . 10.3 mt -94.19 144.16 25.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.376 -0.827 . . . . 25.39 110.971 -179.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 112' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -77.73 -17.33 57.71 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.525 -0.734 . . . . 53.48 109.811 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 113' ' ' THR . . . . . 0.416 HG22 ' HG2' ' R' ' 123' ' ' GLU . 60.3 m -83.76 166.6 17.88 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.355 -0.841 . . . . 14.8 110.22 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 114' ' ' GLY . . . . . . . . . . . . . . . -97.94 127.14 9.13 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.995 -1.242 . . . . 16.14 109.995 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 115' ' ' ILE . . . . . 0.481 ' HB ' ' HG2' ' R' ' 108' ' ' LYS . 48.0 mm -109.13 139.32 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.54 -0.976 . . . . 13.46 109.645 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 116' ' ' GLY . . . . . . . . . . . . . . . -152.71 -155.83 7.28 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.955 -1.258 . . . . 23.9 109.955 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 117' ' ' THR . . . . . . . . . . . . . 18.9 p -134.99 -171.4 2.79 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.467 -1.019 . . . . 27.37 110.152 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.52 -58.07 9.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.338 -0.851 . . . . 18.76 110.091 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 119' ' ' SER . . . . . . . . . . . . . 1.1 m -56.59 -40.51 75.4 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.332 -0.855 . . . . 32.35 109.784 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 120' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 -110.09 86.2 4.86 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.456 -0.777 . . . . 27.12 109.708 179.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 121' ' ' PRO . . . . . 0.428 ' O ' ' HB2' ' R' ' 122' ' ' SER . 44.6 Cg_endo -71.21 166.4 29.34 Favored 'Trans proline' 0 C--N 1.311 -1.419 0 O-C-N 123.799 1.42 . . . . 22.68 111.086 -179.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 122' ' ' SER . . . . . 0.428 ' HB2' ' O ' ' R' ' 121' ' ' PRO . 38.3 t 178.61 -161.69 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.619 -0.675 . . . . 22.99 109.436 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 123' ' ' GLU . . . . . 0.416 ' HG2' HG22 ' R' ' 113' ' ' THR . 2.3 tp10 -56.38 -40.03 73.92 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.192 -0.943 . . . . 36.18 109.724 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 124' ' ' VAL . . . . . . . . . . . . . 82.6 t -142.51 136.5 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.506 -0.746 . . . . 20.64 109.39 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 125' ' ' CYS . . . . . 0.409 ' SG ' ' HA ' ' R' ' 121' ' ' PRO . 83.4 m -140.37 168.17 20.43 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.219 -0.925 . . . . 22.8 111.131 -179.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 126' ' ' VAL . . . . . . . . . . . . . 35.8 m -122.72 159.77 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.724 -0.61 . . . . 21.24 109.695 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 127' ' ' VAL . . . . . 0.4 HG11 ' O ' ' R' ' 177' ' ' VAL . 30.5 m -70.81 141.86 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.273 -0.892 . . . . 19.77 110.708 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 128' ' ' ASP . . . . . . . . . . . . . 53.9 p-10 -137.73 19.41 2.87 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.336 -0.853 . . . . 29.21 110.697 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 129' ' ' GLY . . . . . . . . . . . . . . . 114.01 -0.05 24.13 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.963 -1.113 . . . . 33.86 110.503 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 130' ' ' THR . . . . . . . . . . . . . 58.5 m -91.84 131.81 36.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.12 -1.223 . . . . 26.41 110.117 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -62.52 120.65 11.54 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.372 -0.83 . . . . 33.08 110.302 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 132' ' ' MET . . . . . 0.426 ' HE1' ' CZ ' ' R' ' 180' ' ' PHE . 98.4 mmm -105.12 165.63 10.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.437 -0.79 . . . . 30.76 110.467 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 133' ' ' CYS . . . . . . . . . . . . . 32.4 m -141.12 158.13 44.34 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.511 -0.743 . . . . 27.0 109.988 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 134' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.45 -19.76 39.41 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.217 -0.927 . . . . 33.9 110.467 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 135' ' ' ALA . . . . . . . . . . . . . . . -92.72 8.16 40.48 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.278 -0.889 . . . . 19.37 110.749 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 136' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -93.77 -21.78 19.1 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.14 -0.975 . . . . 30.47 110.186 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 137' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -149.93 165.34 32.93 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.338 -0.851 . . . . 24.27 110.252 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 138' ' ' HIS . . . . . . . . . . . . . 15.2 p80 -117.81 15.03 14.39 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.393 -0.817 . . . . 20.91 110.419 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 139' ' ' ALA . . . . . 0.441 ' HA ' ' O ' ' R' ' 152' ' ' ALA . . . -177.15 152.41 0.88 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.163 -0.96 . . . . 15.69 110.181 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 140' ' ' GLY . . . . . 0.404 ' HA3' ' O ' ' R' ' 179' ' ' VAL . . . 161.85 175.18 32.6 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.964 -1.254 . . . . 23.76 109.964 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 141' ' ' ILE . . . . . . . . . . . . . 83.4 mt -95.49 136.56 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.398 -1.06 . . . . 25.3 109.681 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 142' ' ' PHE . . . . . 0.546 ' CD2' ' HB2' ' R' ' 172' ' ' PRO . 83.0 m-85 -120.74 -172.58 2.41 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.336 -0.852 . . . . 30.24 110.552 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 143' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -119.8 77.8 1.27 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.437 -0.789 . . . . 32.8 110.281 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 144' ' ' LYS . . . . . 0.454 ' HG3' ' CZ2' ' R' ' 170' ' ' TRP . 1.0 OUTLIER -69.67 76.82 0.44 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.285 -0.884 . . . . 49.18 109.69 179.56 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' R' R ' 145' ' ' GLY . . . . . . . . . . . . . . . 104.57 179.28 24.75 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.168 -1.573 . . . . 53.87 109.168 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 146' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -88.48 145.82 25.54 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.417 -1.049 . . . . 68.58 109.989 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 147' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 58.25 36.52 25.75 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.405 -0.809 . . . . 56.62 110.623 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 148' ' ' HIS . . . . . . . . . . . . . 45.1 t60 -158.72 148.1 19.09 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.208 -0.933 . . . . 44.57 110.371 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 149' ' ' ALA . . . . . . . . . . . . . . . -150.26 146.93 27.1 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.441 -0.787 . . . . 33.54 110.023 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 150' ' ' VAL . . . . . 0.428 HG23 ' HB2' ' R' ' 144' ' ' LYS . 34.2 m -142.35 161.51 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.273 -0.892 . . . . 27.61 110.276 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 151' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' R' ' 152' ' ' ALA . 5.9 t80 -86.25 155.61 20.62 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.383 -0.823 . . . . 23.04 109.926 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 152' ' ' ALA . . . . . 0.537 ' N ' ' CD1' ' R' ' 151' ' ' PHE . . . -157.25 151.56 25.01 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.457 -0.777 . . . . 29.61 109.623 179.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 153' ' ' CYS . . . . . 0.407 ' HA ' ' HA ' ' R' ' 139' ' ' ALA . 26.7 p -154.31 173.57 16.0 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.335 -0.853 . . . . 22.75 110.507 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 154' ' ' VAL . . . . . 0.443 ' CG2' ' CZ2' ' R' ' 159' ' ' TRP . 60.0 t -90.61 117.02 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.422 -0.799 . . . . 23.26 110.051 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 155' ' ' THR . . . . . . . . . . . . . 69.7 p -112.1 -176.64 2.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.345 -0.847 . . . . 17.88 110.118 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 156' ' ' SER . . . . . . . . . . . . . 78.6 p -75.9 -3.77 37.17 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.382 -0.824 . . . . 21.83 110.674 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 157' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -118.29 10.48 12.83 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.171 -0.955 . . . . 36.54 110.646 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 158' ' ' GLY . . . . . . . . . . . . . . . 118.0 -162.68 13.04 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.54 -1.424 . . . . 31.74 109.54 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 159' ' ' TRP . . . . . 0.443 ' CZ2' ' CG2' ' R' ' 154' ' ' VAL . 14.7 m95 -86.58 122.44 30.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.368 -1.078 . . . . 28.25 110.099 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 160' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -108.45 166.95 10.39 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.37 -0.831 . . . . 41.24 110.22 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 161' ' ' ALA . . . . . . . . . . . . . . . -143.22 123.49 13.79 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.43 -0.794 . . . . 27.4 110.163 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 162' ' ' ILE . . . . . 0.431 HG23 ' CZ ' ' R' ' 167' ' ' PHE . 92.6 mt -87.68 81.23 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.375 -0.828 . . . . 24.27 109.989 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 163' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' R' ' 165' ' ' GLU . 15.4 t0 -72.76 92.32 1.56 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.404 -0.81 . . . . 36.08 110.278 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 164' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 54.06 -88.92 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.507 -0.745 . . . . 46.08 110.6 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 165' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' R' ' 163' ' ' ASP . 29.6 mt-10 -124.71 35.88 4.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.13 -0.981 . . . . 50.94 110.219 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 166' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -135.75 117.3 14.85 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.431 -0.793 . . . . 47.28 110.255 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 167' ' ' PHE . . . . . 0.431 ' CZ ' HG23 ' R' ' 162' ' ' ILE . 24.3 m-85 -101.04 120.05 39.63 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.375 -0.828 . . . . 40.47 110.081 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 168' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -157.62 158.45 30.52 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.223 -0.923 . . . . 30.21 110.407 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 169' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.67 133.01 19.63 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 O-C-N 123.868 1.457 . . . . 32.76 110.561 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 170' ' ' TRP . . . . . 0.454 ' CZ2' ' HG3' ' R' ' 144' ' ' LYS . 67.2 t90 -159.77 119.27 2.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.453 -0.779 . . . . 32.79 109.955 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 171' ' ' THR . . . . . . . . . . . . . 47.4 m -81.06 112.66 34.48 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.488 -0.757 . . . . 36.92 110.163 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 172' ' ' PRO . . . . . 0.546 ' HB2' ' CD2' ' R' ' 142' ' ' PHE . 45.9 Cg_endo -73.74 158.79 46.5 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 O-C-N 123.681 1.358 . . . . 33.54 110.525 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 173' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -88.87 144.98 33.8 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.344 -0.848 . . . . 45.76 109.951 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 174' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -71.71 -10.4 26.46 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.596 1.314 . . . . 29.63 110.445 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 175' ' ' SER . . . . . . . . . . . . . 53.1 p -103.5 -17.55 15.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.281 -0.887 . . . . 35.7 110.343 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 176' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -103.48 43.16 1.1 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.202 -0.936 . . . . 39.65 110.4 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 177' ' ' VAL . . . . . 0.4 ' O ' HG11 ' R' ' 127' ' ' VAL . 10.5 p -117.68 127.16 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.336 -0.852 . . . . 20.61 109.971 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 178' ' ' LEU . . . . . . . . . . . . . 46.0 mt -91.45 -61.41 1.65 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.36 -0.837 . . . . 15.58 109.37 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 179' ' ' VAL . . . . . 0.404 ' O ' ' HA3' ' R' ' 140' ' ' GLY . 67.0 t -114.53 144.64 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.625 -0.672 . . . . 17.4 109.496 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 180' ' ' PHE . . . . . 0.426 ' CZ ' ' HE1' ' R' ' 132' ' ' MET . 43.6 p90 -152.13 163.41 39.41 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.282 -0.886 . . . . 20.16 110.537 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 181' ' ' VAL . . . . . . . . . . . . . 66.4 t -113.2 111.48 50.17 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.342 -0.849 . . . . 17.69 109.842 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 182' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.05 149.47 52.68 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.574 1.302 . . . . 17.81 110.446 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' R' R ' 183' ' ' TYR . . . . . 0.698 ' O ' ' C ' ' R' ' 184' ' ' ASP . 79.5 m-85 -59.06 175.46 0.29 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.434 -0.791 . . . . 28.01 110.561 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 184' ' ' ASP . . . . . 0.698 ' C ' ' O ' ' R' ' 183' ' ' TYR . 4.5 m-20 -18.96 -83.16 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.345 -0.847 . . . . 58.64 110.228 -178.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' R' R ' 185' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 . . . . . 0 N--CA 1.503 2.176 0 CA-C-O 121.252 0.549 . . . . 80.42 111.802 179.526 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' R' R ' 193' ' ' LYS . . . . . . . . . . . . . 66.2 mttt . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 120.856 0.36 . . . . 49.5 110.16 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' R' R ' 194' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.8 0 O-C-N 121.177 -0.952 . . . . 40.4 110.119 179.973 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' S' S ' 229' ' ' MET . . . . . . . . . . . . . 2.6 ptp . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.2 0.524 . . . . 51.83 110.251 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' S' S ' 230' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -97.3 142.66 28.92 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.39 -0.819 . . . . 54.13 110.182 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 231' ' ' LEU . . . . . . . . . . . . . 67.8 mt -134.05 141.02 47.04 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.339 -0.851 . . . . 33.04 110.386 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 232' ' ' THR . . . . . . . . . . . . . 40.4 m -89.24 103.28 15.92 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.354 -0.841 . . . . 26.92 110.019 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 233' ' ' LEU . . . . . 0.501 HD23 ' CE2' ' S' ' 262' ' ' TYR . 79.8 mt -55.91 179.28 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.538 -0.726 . . . . 13.78 110.5 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' S' S ' 234' ' ' TYR . . . . . 0.444 ' CG ' ' N ' ' S' ' 235' ' ' ASN . 35.5 p90 -65.05 -35.61 81.7 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.347 -0.846 . . . . 26.08 110.167 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' S' S ' 235' ' ' ASN . . . . . 0.444 ' N ' ' CG ' ' S' ' 234' ' ' TYR . 50.6 p30 -74.43 -7.28 52.41 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.313 -0.867 . . . . 20.04 110.581 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' S' S ' 236' ' ' GLY . . . . . . . . . . . . . . . 95.66 -19.9 52.21 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.788 -1.325 . . . . 22.71 109.788 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 237' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -53.08 145.74 12.67 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.212 -1.17 . . . . 35.44 110.189 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 238' ' ' LYS . . . . . . . . . . . . . 44.5 mttt -102.17 127.87 48.91 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.38 -0.825 . . . . 32.56 110.418 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 239' ' ' LYS . . . . . 0.414 ' HG2' ' CZ ' ' S' ' 241' ' ' PHE . 9.0 ttmt -132.32 144.5 50.61 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.407 -0.808 . . . . 26.68 109.958 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' S' S ' 240' ' ' THR . . . . . . . . . . . . . 50.8 m -102.0 132.16 47.99 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.29 -0.881 . . . . 41.02 110.417 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 241' ' ' PHE . . . . . 0.414 ' CZ ' ' HG2' ' S' ' 239' ' ' LYS . 96.1 m-85 -117.84 137.61 52.65 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.347 -0.846 . . . . 28.62 110.213 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' S' S ' 242' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -96.39 161.78 13.77 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.396 -0.815 . . . . 47.89 110.269 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 243' ' ' SER . . . . . . . . . . . . . 72.7 m -90.6 151.58 21.25 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.356 -0.84 . . . . 45.09 110.211 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 244' ' ' ARG . . . . . . . . . . . . . 1.4 mtp85 -129.76 126.83 22.75 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.374 -0.829 . . . . 42.49 110.212 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 245' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.39 161.03 43.57 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 O-C-N 123.664 1.35 . . . . 35.68 110.543 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 246' ' ' ASN . . . . . . . . . . . . . 51.3 t-20 -132.93 97.9 4.15 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.477 -0.764 . . . . 51.88 109.81 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 247' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -110.43 -22.31 11.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.316 -0.865 . . . . 53.69 110.645 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 248' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -117.24 43.73 2.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.202 -0.936 . . . . 55.79 110.751 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 249' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 48.83 38.31 11.72 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.429 -0.794 . . . . 49.45 110.416 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 250' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -90.54 28.95 1.37 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.582 -0.699 . . . . 36.86 110.363 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 251' ' ' ALA . . . . . . . . . . . . . . . -53.8 -43.13 69.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.217 -0.927 . . . . 29.69 109.585 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 252' ' ' TRP . . . . . 0.418 ' CZ2' ' HB3' ' S' ' 294' ' ' LEU . 67.9 p-90 -61.88 -33.89 75.02 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.622 -0.674 . . . . 41.12 109.802 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' S' S ' 253' ' ' LEU . . . . . 0.407 ' N ' ' CD2' ' S' ' 252' ' ' TRP . 23.4 tp -70.21 -47.24 62.35 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.386 -0.821 . . . . 24.89 109.939 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' S' S ' 254' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -56.11 -42.43 76.8 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.507 -0.745 . . . . 35.65 109.979 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 255' ' ' ALA . . . . . . . . . . . . . . . -59.58 -48.19 82.64 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.459 -0.776 . . . . 22.73 110.038 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 256' ' ' ILE . . . . . . . . . . . . . 79.9 mt -62.35 -40.69 88.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.261 -0.9 . . . . 28.85 109.926 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 257' ' ' LEU . . . . . . . . . . . . . 19.4 mt -61.49 -44.47 97.02 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.41 -0.806 . . . . 23.07 110.172 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 258' ' ' GLN . . . . . 0.467 ' HB3' ' CD2' ' S' ' 351' ' ' PHE . 53.3 mm-40 -65.12 -45.36 85.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.458 -0.776 . . . . 29.78 109.896 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' S' S ' 259' ' ' LEU . . . . . 0.43 ' O ' HG22 ' S' ' 263' ' ' VAL . 19.9 tp -58.64 -36.35 73.98 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.322 -0.861 . . . . 17.94 109.51 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' S' S ' 260' ' ' PHE . . . . . 0.468 ' CE2' HD22 ' S' ' 311' ' ' LEU . 3.1 m-85 -62.83 -45.27 93.41 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.593 -0.692 . . . . 30.57 109.812 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' S' S ' 261' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -62.03 -29.89 70.59 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.452 -0.78 . . . . 41.34 110.022 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 262' ' ' TYR . . . . . 0.501 ' CE2' HD23 ' S' ' 233' ' ' LEU . 8.6 t80 -71.15 -44.65 65.12 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.416 -0.803 . . . . 26.03 110.113 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' S' S ' 263' ' ' VAL . . . . . 0.43 HG22 ' O ' ' S' ' 259' ' ' LEU . 33.0 m -92.03 18.3 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.398 -0.814 . . . . 22.8 110.395 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' S' S ' 264' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 52.74 70.61 0.56 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.282 -0.886 . . . . 44.03 110.686 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 265' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -111.75 109.22 55.54 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.373 -0.83 . . . . 35.61 109.669 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 266' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -75.3 0.32 9.17 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.676 1.356 . . . . 37.67 111.79 -179.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 267' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -56.5 -67.63 0.29 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.843 -1.161 . . . . 41.49 110.212 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' S' S ' 268' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -92.96 39.82 1.05 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.138 -0.976 . . . . 50.76 110.057 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 269' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.97 -33.2 59.76 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.424 -0.797 . . . . 61.86 109.737 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' S' S ' 270' ' ' TRP . . . . . 0.482 ' CE2' ' CG2' ' S' ' 271' ' ' VAL . 51.0 p-90 -73.92 -4.3 34.24 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.285 -0.884 . . . . 39.85 110.47 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' S' S ' 271' ' ' VAL . . . . . 0.482 ' CG2' ' CE2' ' S' ' 270' ' ' TRP . 46.4 t -109.56 -32.67 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.114 -0.991 . . . . 39.18 110.085 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' S' S ' 272' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -78.74 -36.46 43.16 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.39 -0.819 . . . . 40.02 110.498 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 273' ' ' SER . . . . . . . . . . . . . 71.0 m -103.58 56.12 0.74 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.346 -0.846 . . . . 47.2 110.276 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 274' ' ' SER . . . . . . . . . . . . . 6.9 t -133.06 141.25 40.2 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.31 -0.869 . . . . 47.61 110.137 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 275' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.71 -18.92 21.8 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.719 1.378 . . . . 45.28 110.541 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 276' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -99.9 140.87 33.49 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.264 -0.897 . . . . 57.27 110.279 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 277' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -71.73 97.65 1.8 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.466 -0.771 . . . . 37.28 110.287 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 278' ' ' LEU . . . . . . . . . . . . . 86.8 mt -97.03 33.87 1.84 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.435 -0.79 . . . . 43.88 109.961 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 279' ' ' THR . . . . . . . . . . . . . 77.8 m -64.1 -60.14 3.59 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.477 -0.764 . . . . 50.05 110.239 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 280' ' ' LEU . . . . . . . . . . . . . 13.6 mt -51.59 -39.89 58.78 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.441 -0.787 . . . . 54.12 110.299 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 281' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.31 -49.72 74.5 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.454 -0.779 . . . . 65.28 110.161 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' S' S ' 282' ' ' ALA . . . . . . . . . . . . . . . -59.03 -33.84 71.21 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.467 -0.771 . . . . 46.51 110.515 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 283' ' ' ILE . . . . . . . . . . . . . 86.0 mt -66.43 -50.88 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.246 -0.909 . . . . 47.3 110.028 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 284' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -50.52 -57.65 7.61 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.461 -0.774 . . . . 50.72 110.361 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 285' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -51.3 -46.38 62.51 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.494 -0.754 . . . . 68.47 110.367 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 286' ' ' LEU . . . . . . . . . . . . . 19.0 mt -60.09 -44.41 94.82 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.435 -0.79 . . . . 36.62 110.242 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 287' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -62.79 -35.29 79.4 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.251 -0.906 . . . . 46.64 110.05 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 288' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -76.21 -21.04 56.92 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.493 -0.754 . . . . 46.45 110.311 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 289' ' ' LEU . . . . . . . . . . . . . 30.7 mt -97.33 -21.65 17.1 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.251 -0.906 . . . . 35.09 110.553 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 290' ' ' THR . . . . . . . . . . . . . 81.4 p -114.84 -28.4 7.08 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.254 -0.904 . . . . 38.61 110.462 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 291' ' ' GLY . . . . . . . . . . . . . . . 79.41 10.96 85.41 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.793 -1.323 . . . . 36.77 109.793 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 292' ' ' LEU . . . . . . . . . . . . . 84.7 mt -96.44 145.77 25.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.25 -1.147 . . . . 35.33 109.779 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 293' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -77.36 102.33 6.74 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.26 -0.9 . . . . 48.7 110.296 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 294' ' ' LEU . . . . . 0.418 ' HB3' ' CZ2' ' S' ' 252' ' ' TRP . 55.3 mt -106.83 51.71 0.74 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.572 -0.705 . . . . 42.61 110.136 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' S' S ' 295' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -112.58 -11.14 13.62 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.287 -0.883 . . . . 55.49 110.539 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' S' S ' 296' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -144.26 48.51 1.37 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.151 -0.968 . . . . 75.68 110.315 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 297' ' ' GLY . . . . . . . . . . . . . . . 96.91 145.13 18.63 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.502 -1.439 . . . . 49.44 109.502 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 298' ' ' GLY . . . . . . . . . . . . . . . -163.82 156.9 28.96 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.84 -1.304 . . . . 41.11 109.84 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 299' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -73.7 118.21 5.36 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 O-C-N 123.932 1.49 . . . . 26.2 110.341 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 300' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.2 -15.42 31.81 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 O-C-N 123.567 1.299 . . . . 21.7 110.728 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 301' ' ' ALA . . . . . . . . . . . . . . . -80.75 -29.35 36.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.258 -0.901 . . . . 31.23 110.133 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 302' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.47 -40.65 18.97 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.426 -0.796 . . . . 38.99 109.943 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' S' S ' 303' ' ' VAL . . . . . 0.473 ' O ' HG12 ' S' ' 307' ' ' ILE . 57.7 t -60.69 -35.53 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.427 -0.795 . . . . 18.63 110.122 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' S' S ' 304' ' ' ILE . . . . . . . . . . . . . 86.0 mt -79.3 -23.67 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.341 -0.849 . . . . 25.46 110.178 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 305' ' ' TRP . . . . . . . . . . . . . 68.9 t-105 -88.69 -14.47 37.24 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.252 -0.905 . . . . 33.4 110.56 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 306' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -89.76 -13.59 36.41 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.215 -0.928 . . . . 36.97 110.363 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 307' ' ' ILE . . . . . 0.473 HG12 ' O ' ' S' ' 303' ' ' VAL . 36.9 pt -125.06 45.57 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.182 -0.949 . . . . 30.81 110.04 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' S' S ' 308' ' ' LYS . . . . . . . . . . . . . 1.5 mtmp? -73.52 -37.73 65.55 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.357 -0.84 . . . . 46.52 110.157 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 309' ' ' HIS . . . . . 0.49 ' CD2' ' HG ' ' S' ' 310' ' ' LEU . 55.5 p-80 -73.16 -8.3 55.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.401 -0.812 . . . . 51.03 110.136 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' S' S ' 310' ' ' LEU . . . . . 0.49 ' HG ' ' CD2' ' S' ' 309' ' ' HIS . 52.9 mt -99.32 -12.83 19.97 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.3 -0.875 . . . . 36.16 109.958 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' S' S ' 311' ' ' LEU . . . . . 0.468 HD22 ' CE2' ' S' ' 260' ' ' PHE . 10.7 mt -97.24 147.87 23.68 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.373 -0.829 . . . . 40.0 110.441 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' S' S ' 312' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -81.58 -16.26 52.14 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.266 -0.896 . . . . 54.18 109.747 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 313' ' ' THR . . . . . 0.48 HG23 ' HB3' ' S' ' 323' ' ' GLU . 92.6 m -87.95 151.67 22.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.332 -0.855 . . . . 25.61 110.134 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' S' S ' 314' ' ' GLY . . . . . . . . . . . . . . . -87.94 126.39 8.04 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.776 -1.33 . . . . 25.18 109.776 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 315' ' ' ILE . . . . . . . . . . . . . 50.7 mm -101.63 150.51 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.427 -1.043 . . . . 23.9 109.757 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 316' ' ' GLY . . . . . . . . . . . . . . . -157.1 -159.21 9.35 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.006 -1.237 . . . . 23.18 110.006 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 317' ' ' THR . . . . . . . . . . . . . 10.9 p -133.95 -173.03 3.13 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.485 -1.009 . . . . 27.98 109.921 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.6 -56.11 26.17 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.176 -0.953 . . . . 28.1 109.921 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 319' ' ' SER . . . . . . . . . . . . . 1.2 m -60.06 -41.61 92.7 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.331 -0.855 . . . . 37.0 109.593 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 320' ' ' ARG . . . . . . . . . . . . . 12.2 mtm180 -111.71 79.86 2.64 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.525 -0.734 . . . . 52.07 109.719 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 321' ' ' PRO . . . . . 0.433 ' O ' ' HB2' ' S' ' 322' ' ' SER . 44.1 Cg_endo -71.43 171.54 15.99 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.936 1.492 . . . . 38.29 110.901 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' S' S ' 322' ' ' SER . . . . . 0.433 ' HB2' ' O ' ' S' ' 321' ' ' PRO . 41.2 t 178.64 -148.14 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.905 -0.776 . . . . 38.84 108.905 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' S' S ' 323' ' ' GLU . . . . . 0.48 ' HB3' HG23 ' S' ' 313' ' ' THR . 6.7 tp10 -62.85 -40.28 96.99 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.971 -1.081 . . . . 40.7 109.668 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' S' S ' 324' ' ' VAL . . . . . . . . . . . . . 73.0 t -141.3 135.03 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.399 -0.813 . . . . 20.34 109.471 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 325' ' ' CYS . . . . . 0.45 ' HB2' ' CE1' ' S' ' 380' ' ' PHE . 11.4 m -126.03 172.19 10.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.294 -0.878 . . . . 30.63 110.805 -179.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' S' S ' 326' ' ' VAL . . . . . . . . . . . . . 34.5 m -135.47 142.23 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.641 -0.662 . . . . 23.9 109.235 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 327' ' ' VAL . . . . . . . . . . . . . 34.5 m -56.37 125.04 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.078 -1.014 . . . . 19.48 110.42 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 328' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -119.38 11.47 12.21 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.442 -0.786 . . . . 26.43 110.411 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 329' ' ' GLY . . . . . . . . . . . . . . . 119.7 2.21 13.06 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.064 -1.214 . . . . 31.24 110.064 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 330' ' ' THR . . . . . . . . . . . . . 81.9 m -93.02 130.03 38.74 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.067 -1.255 . . . . 30.05 110.093 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 331' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -56.8 111.57 1.06 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.315 -0.866 . . . . 37.26 109.948 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 332' ' ' MET . . . . . 0.45 ' HE1' ' CZ ' ' S' ' 380' ' ' PHE . 87.9 mmm -94.16 162.58 13.8 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.268 -0.895 . . . . 26.23 110.322 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' S' S ' 333' ' ' CYS . . . . . . . . . . . . . 26.0 m -137.25 150.05 47.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.456 -0.778 . . . . 23.56 110.014 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 334' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.56 -24.93 9.15 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.296 -0.878 . . . . 28.93 110.429 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' S' S ' 335' ' ' ALA . . . . . . . . . . . . . . . -89.02 14.45 10.6 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.38 -0.825 . . . . 15.76 110.986 -179.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 336' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -100.53 -17.18 17.23 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.135 -0.978 . . . . 34.92 110.167 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 337' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -152.37 170.86 19.04 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.369 -0.832 . . . . 19.03 110.151 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 338' ' ' HIS . . . . . 0.4 ' HB3' ' CZ ' ' S' ' 383' ' ' TYR . 13.4 p80 -120.72 10.42 10.98 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.37 -0.831 . . . . 18.82 110.47 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' S' S ' 339' ' ' ALA . . . . . . . . . . . . . . . -175.97 155.19 1.57 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.26 -0.9 . . . . 17.18 110.116 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 340' ' ' GLY . . . . . . . . . . . . . . . 160.8 173.08 28.95 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 110.099 -1.201 . . . . 18.33 110.099 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 341' ' ' ILE . . . . . . . . . . . . . 83.8 mt -88.79 138.07 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.504 -0.998 . . . . 18.6 109.824 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 342' ' ' PHE . . . . . 0.504 ' CE1' HG23 ' S' ' 377' ' ' VAL . 69.9 m-85 -120.92 -178.42 3.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.25 -0.906 . . . . 23.44 110.419 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' S' S ' 343' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.81 93.32 4.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.505 -0.747 . . . . 35.59 110.093 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' S' S ' 344' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.83 125.11 29.68 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.34 -0.85 . . . . 38.34 110.013 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' S' S ' 345' ' ' GLY . . . . . . . . . . . . . . . 62.78 -130.86 43.09 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 108.858 -1.697 . . . . 53.46 108.858 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 346' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -132.74 150.87 52.11 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.14 -1.212 . . . . 70.91 110.023 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 347' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 53.3 35.32 19.89 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.294 -0.879 . . . . 47.32 110.452 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 348' ' ' HIS . . . . . . . . . . . . . 46.6 t60 -150.1 155.9 40.67 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.28 -0.888 . . . . 41.72 110.375 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 349' ' ' ALA . . . . . . . . . . . . . . . -149.79 151.25 33.26 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.331 -0.855 . . . . 22.91 110.536 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 350' ' ' VAL . . . . . . . . . . . . . 34.6 m -149.01 169.65 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.417 -0.802 . . . . 21.09 110.018 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 351' ' ' PHE . . . . . 0.467 ' CD2' ' HB3' ' S' ' 258' ' ' GLN . 10.7 t80 -105.41 143.62 33.32 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.237 -0.914 . . . . 25.03 110.689 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' S' S ' 352' ' ' ALA . . . . . . . . . . . . . . . -147.74 151.75 36.59 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.674 -0.641 . . . . 23.81 109.673 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 353' ' ' CYS . . . . . . . . . . . . . 26.3 p -153.36 164.78 37.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.28 -0.888 . . . . 25.66 110.283 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 354' ' ' VAL . . . . . 0.405 HG23 ' CZ2' ' S' ' 359' ' ' TRP . 57.0 t -76.02 118.55 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.36 -0.838 . . . . 34.27 109.959 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' S' S ' 355' ' ' THR . . . . . 0.437 HG23 ' HB2' ' S' ' 360' ' ' TYR . 51.7 p -117.88 175.17 5.79 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.257 -0.902 . . . . 25.49 110.271 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' S' S ' 356' ' ' SER . . . . . . . . . . . . . 62.1 p -62.22 -17.69 59.0 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.328 -0.858 . . . . 31.24 110.718 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 357' ' ' ASN . . . . . . . . . . . . . 46.0 m-20 -106.93 14.18 26.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.206 -0.934 . . . . 28.61 110.637 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 358' ' ' GLY . . . . . . . . . . . . . . . 111.86 -152.88 17.6 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.99 -1.244 . . . . 22.01 109.99 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 359' ' ' TRP . . . . . 0.405 ' CZ2' HG23 ' S' ' 354' ' ' VAL . 15.3 m95 -91.33 116.73 29.07 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.44 -1.035 . . . . 25.54 110.14 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' S' S ' 360' ' ' TYR . . . . . 0.437 ' HB2' HG23 ' S' ' 355' ' ' THR . 1.3 m-85 -103.53 165.81 10.81 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.29 -0.881 . . . . 40.53 110.064 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' S' S ' 361' ' ' ALA . . . . . . . . . . . . . . . -140.06 130.1 24.89 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.389 -0.819 . . . . 18.04 110.295 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 362' ' ' ILE . . . . . 0.417 HG23 ' CZ ' ' S' ' 367' ' ' PHE . 88.9 mt -95.66 83.74 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.307 -0.87 . . . . 15.64 109.959 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' S' S ' 363' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' S' ' 365' ' ' GLU . 11.9 t0 -75.24 94.48 2.99 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.403 -0.81 . . . . 35.03 110.227 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' S' S ' 364' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 53.93 -89.37 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.535 -0.728 . . . . 46.72 110.544 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 365' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' S' ' 363' ' ' ASP . 23.8 mt-10 -122.59 19.09 10.4 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.109 -0.994 . . . . 56.2 110.285 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' S' S ' 366' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -117.96 125.03 49.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.228 -0.92 . . . . 51.02 110.361 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 367' ' ' PHE . . . . . 0.417 ' CZ ' HG23 ' S' ' 362' ' ' ILE . 26.9 m-85 -107.0 127.01 53.07 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.406 -0.808 . . . . 37.59 110.168 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' S' S ' 368' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -165.43 159.58 13.92 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.246 -0.909 . . . . 31.47 110.445 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 369' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.88 139.66 30.64 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 O-C-N 123.866 1.456 . . . . 28.85 110.546 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 370' ' ' TRP . . . . . . . . . . . . . 67.3 t90 -167.24 113.51 0.76 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.44 -0.787 . . . . 26.94 109.933 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 371' ' ' THR . . . . . . . . . . . . . 59.6 m -74.75 113.08 20.94 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.379 -0.826 . . . . 20.19 110.034 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 372' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -73.57 157.06 49.21 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 O-C-N 123.597 1.314 . . . . 28.68 110.611 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 373' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -90.6 147.11 35.62 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.442 -0.786 . . . . 35.72 109.947 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 374' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -76.04 -6.15 17.05 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.665 1.35 . . . . 30.89 110.528 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 375' ' ' SER . . . . . . . . . . . . . 68.8 p -104.4 -16.96 14.96 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.19 -0.944 . . . . 29.41 110.474 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 376' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -106.56 43.08 1.18 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.327 -0.858 . . . . 32.89 110.24 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 377' ' ' VAL . . . . . 0.504 HG23 ' CE1' ' S' ' 342' ' ' PHE . 7.3 p -114.64 147.3 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.34 -0.85 . . . . 24.33 110.235 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' S' S ' 378' ' ' LEU . . . . . . . . . . . . . 52.3 mt -116.09 -58.01 2.15 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.441 -0.787 . . . . 24.37 109.582 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 379' ' ' VAL . . . . . . . . . . . . . 61.1 t -120.67 132.41 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.371 -0.831 . . . . 18.02 109.453 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 380' ' ' PHE . . . . . 0.45 ' CE1' ' HB2' ' S' ' 325' ' ' CYS . 14.2 p90 -142.62 173.9 11.12 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.347 -0.845 . . . . 29.35 110.714 -179.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' S' S ' 381' ' ' VAL . . . . . . . . . . . . . 58.3 t -120.02 107.32 39.98 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.586 -0.697 . . . . 16.34 109.395 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 382' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -71.26 145.62 49.11 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 O-C-N 123.598 1.315 . . . . 20.94 110.78 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' S' S ' 383' ' ' TYR . . . . . 0.4 ' CZ ' ' HB3' ' S' ' 338' ' ' HIS . 88.3 m-85 -61.01 -53.49 56.54 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.309 -0.869 . . . . 28.93 109.878 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' S' S ' 384' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.486 -0.759 . . . . 47.03 110.333 -176.922 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' R' R ' 30' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 121.23 0.538 . . . . 43.36 110.212 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' R' R ' 31' ' ' LEU . . . . . . . . . . . . . 65.6 mt -134.91 140.58 45.87 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.282 -0.886 . . . . 22.93 110.269 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 32' ' ' THR . . . . . . . . . . . . . 69.6 m -87.54 110.61 20.47 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.439 -0.788 . . . . 22.34 109.971 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 33' ' ' LEU . . . . . 0.461 HD23 ' CE2' ' R' ' 62' ' ' TYR . 80.1 mt -62.5 -172.73 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.408 -0.808 . . . . 21.39 110.215 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 34' ' ' TYR . . . . . . . . . . . . . 37.0 p90 -74.65 -29.39 61.24 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.352 -0.842 . . . . 34.4 110.386 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 35' ' ' ASN . . . . . . . . . . . . . 48.3 p30 -77.78 -1.91 33.78 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.332 -0.855 . . . . 30.28 110.585 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.26 -16.59 59.4 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.754 -1.338 . . . . 36.25 109.754 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 37' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -58.97 161.81 4.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.315 -1.109 . . . . 53.8 110.383 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 38' ' ' LYS . . . . . . . . . . . . . 56.9 mttt -117.87 135.71 53.92 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.39 -0.818 . . . . 49.91 110.151 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 39' ' ' LYS . . . . . 0.415 ' HG2' ' CZ ' ' R' ' 41' ' ' PHE . 8.1 ttmt -138.74 143.73 39.16 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.388 -0.82 . . . . 35.69 110.182 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 40' ' ' THR . . . . . . . . . . . . . 23.7 m -102.57 128.01 49.41 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.305 -0.872 . . . . 34.84 110.193 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 41' ' ' PHE . . . . . 0.415 ' CZ ' ' HG2' ' R' ' 39' ' ' LYS . 96.6 m-85 -113.12 132.66 55.36 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.381 -0.824 . . . . 34.42 110.14 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 42' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -93.29 140.86 29.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.331 -0.856 . . . . 51.46 110.255 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 43' ' ' SER . . . . . . . . . . . . . 53.6 m -70.73 141.89 51.48 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.421 -0.799 . . . . 41.84 110.186 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.74 125.37 29.59 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.361 -0.837 . . . . 33.82 110.013 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 45' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.11 151.13 55.13 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.596 1.314 . . . . 30.27 110.625 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 46' ' ' ASN . . . . . . . . . . . . . 52.2 t-20 -124.3 109.87 13.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.48 -0.762 . . . . 35.1 110.033 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 47' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -120.29 -34.88 3.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.285 -0.884 . . . . 42.81 110.55 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 48' ' ' HIS . . . . . . . . . . . . . 73.3 m80 -105.86 45.23 0.98 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.213 -0.929 . . . . 49.97 110.24 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 49' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 50.29 34.68 9.22 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.447 -0.783 . . . . 61.32 110.149 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 50' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -86.21 43.78 1.08 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.32 -0.862 . . . . 51.5 110.744 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.08 -46.14 78.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.193 -0.942 . . . . 38.77 109.476 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 52' ' ' TRP . . . . . 0.484 ' CD2' ' N ' ' R' ' 53' ' ' LEU . 68.1 p-90 -58.42 -38.43 77.4 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.595 -0.691 . . . . 26.24 110.036 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 53' ' ' LEU . . . . . 0.484 ' N ' ' CD2' ' R' ' 52' ' ' TRP . 23.2 tp -66.75 -46.66 74.71 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.439 -0.788 . . . . 26.75 109.991 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 54' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -55.11 -41.64 71.91 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.369 -0.832 . . . . 35.02 110.208 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.19 -46.03 92.16 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.396 -0.815 . . . . 24.47 110.172 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 56' ' ' ILE . . . . . . . . . . . . . 76.1 mt -62.26 -42.22 94.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.346 -0.846 . . . . 26.03 109.857 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 57' ' ' LEU . . . . . . . . . . . . . 22.5 mt -60.24 -45.67 92.45 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.364 -0.835 . . . . 26.77 109.655 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 58' ' ' GLN . . . . . . . . . . . . . 57.7 mm-40 -63.95 -46.53 84.29 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.456 -0.777 . . . . 22.32 109.592 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 59' ' ' LEU . . . . . 0.429 ' HA ' ' HE2' ' R' ' 151' ' ' PHE . 23.9 tp -61.34 -37.81 84.64 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.365 -0.834 . . . . 20.55 109.427 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 60' ' ' PHE . . . . . 0.447 ' CE2' HD22 ' R' ' 111' ' ' LEU . 2.8 m-85 -61.06 -44.74 96.92 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.67 -0.644 . . . . 20.08 109.913 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 61' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -63.07 -36.19 82.77 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.45 -0.781 . . . . 18.8 110.528 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 62' ' ' TYR . . . . . 0.461 ' CE2' HD23 ' R' ' 33' ' ' LEU . 9.3 t80 -63.06 -41.8 99.53 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.158 -0.964 . . . . 26.45 110.217 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 63' ' ' VAL . . . . . . . . . . . . . 30.2 m -93.37 20.43 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.247 -0.908 . . . . 29.75 110.263 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 64' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 52.87 75.53 0.24 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.335 -0.853 . . . . 35.52 110.582 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 65' ' ' GLU . . . . . 0.425 ' HG2' ' CD2' ' R' ' 60' ' ' PHE . 14.3 tp10 -116.22 104.06 52.45 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.45 -0.782 . . . . 29.89 109.948 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 66' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.55 -5.81 17.71 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.864 1.455 . . . . 21.37 111.089 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 67' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -52.15 -61.47 2.25 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.169 -0.957 . . . . 23.85 110.39 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 68' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -98.13 36.51 1.57 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.34 -0.85 . . . . 28.07 110.475 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 69' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -72.33 -33.23 67.18 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.312 -0.867 . . . . 43.76 110.18 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 70' ' ' TRP . . . . . 0.476 ' CE2' ' CG2' ' R' ' 71' ' ' VAL . 47.7 p-90 -73.39 -3.9 30.17 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.293 -0.879 . . . . 33.06 110.739 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 71' ' ' VAL . . . . . 0.476 ' CG2' ' CE2' ' R' ' 70' ' ' TRP . 40.8 t -109.79 -27.5 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.237 -0.914 . . . . 31.7 109.679 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 72' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -86.42 -49.0 7.94 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.395 -0.815 . . . . 33.58 110.299 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 73' ' ' SER . . . . . . . . . . . . . 69.8 m -89.57 50.99 2.0 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.274 -0.892 . . . . 50.82 110.39 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 74' ' ' SER . . . . . . . . . . . . . 15.9 t -125.85 138.28 31.71 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.21 -0.931 . . . . 34.74 110.262 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.33 -25.02 15.98 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.702 1.369 . . . . 35.7 110.308 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 76' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -91.7 153.23 19.79 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.364 -0.835 . . . . 66.48 110.3 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 77' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -81.56 95.29 7.09 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.332 -0.855 . . . . 46.72 110.064 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 78' ' ' LEU . . . . . . . . . . . . . 96.3 mt -96.45 27.96 3.55 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.443 -0.786 . . . . 37.55 110.186 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 79' ' ' THR . . . . . . . . . . . . . 29.7 m -56.24 -54.62 43.14 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.337 -0.852 . . . . 37.36 110.286 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 80' ' ' LEU . . . . . . . . . . . . . 15.9 mt -60.9 -23.26 65.08 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.379 -0.826 . . . . 35.83 110.514 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 81' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -79.41 -39.15 33.15 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.142 -0.974 . . . . 44.03 110.37 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.48 -28.54 66.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.288 -0.882 . . . . 32.54 110.291 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 83' ' ' ILE . . . . . . . . . . . . . 78.2 mt -70.18 -46.06 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.237 -0.915 . . . . 32.02 110.302 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 84' ' ' LYS . . . . . . . . . . . . . 36.0 tttm -55.29 -52.05 64.69 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.164 -0.96 . . . . 34.09 110.532 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 85' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -54.71 -46.98 74.25 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.313 -0.867 . . . . 25.94 110.308 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 86' ' ' LEU . . . . . . . . . . . . . 24.1 mt -58.62 -43.82 89.78 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.346 -0.846 . . . . 16.2 109.965 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 87' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -65.3 -35.27 80.48 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.466 -0.771 . . . . 49.09 110.349 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 88' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -78.5 -18.93 54.08 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.283 -0.886 . . . . 28.61 110.523 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 89' ' ' LEU . . . . . . . . . . . . . 32.8 mt -96.25 -29.34 14.07 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.26 -0.9 . . . . 26.16 110.238 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 90' ' ' THR . . . . . . . . . . . . . 58.2 p -105.72 -34.57 7.66 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.226 -0.921 . . . . 33.33 109.806 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.73 16.12 58.75 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.937 -1.265 . . . . 31.13 109.937 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 92' ' ' LEU . . . . . . . . . . . . . 97.1 mt -100.14 155.2 17.87 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.103 -1.234 . . . . 42.52 110.237 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 93' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -86.18 91.65 8.51 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.567 -0.708 . . . . 68.46 109.911 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 94' ' ' LEU . . . . . 0.446 ' HB3' ' CZ2' ' R' ' 52' ' ' TRP . 47.7 mt -99.49 53.11 0.94 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.272 -0.893 . . . . 44.63 110.319 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 95' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.49 -38.67 6.38 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.331 -0.856 . . . . 67.16 110.399 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 96' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -113.93 44.23 1.68 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.332 -0.855 . . . . 67.02 110.255 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 97' ' ' GLY . . . . . . . . . . . . . . . 99.15 150.81 26.04 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.674 -1.37 . . . . 49.48 109.674 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 98' ' ' GLY . . . . . . . . . . . . . . . -166.26 160.03 33.47 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.311 -1.516 . . . . 36.57 109.311 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 99' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -72.59 121.14 7.17 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 123.741 1.39 . . . . 30.41 110.435 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 100' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.37 -31.67 11.17 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 O-C-N 123.58 1.305 . . . . 29.94 110.452 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.9 -38.46 76.32 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.228 -0.92 . . . . 23.64 110.327 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.73 -40.72 65.88 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.373 -0.829 . . . . 20.31 110.323 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 103' ' ' VAL . . . . . . . . . . . . . 63.3 t -58.13 -40.05 75.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.21 -0.931 . . . . 16.33 110.065 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 104' ' ' ILE . . . . . . . . . . . . . 81.9 mt -71.71 -30.51 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.397 -0.814 . . . . 24.77 109.956 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 105' ' ' TRP . . . . . 0.441 ' O ' ' HD3' ' R' ' 108' ' ' LYS . 70.6 t-105 -82.51 0.9 40.35 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.323 -0.861 . . . . 23.28 110.292 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 106' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -105.09 -10.38 17.2 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.144 -0.973 . . . . 28.26 110.123 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 107' ' ' ILE . . . . . . . . . . . . . 36.7 pt -126.83 35.02 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.181 -0.949 . . . . 18.77 110.033 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 108' ' ' LYS . . . . . 0.48 ' HG2' ' HB ' ' R' ' 115' ' ' ILE . 9.3 mtpp -61.03 -48.48 81.56 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.516 -0.74 . . . . 42.5 110.037 179.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 109' ' ' HIS . . . . . 0.432 ' CD2' ' HG ' ' R' ' 110' ' ' LEU . 50.9 p-80 -66.06 -12.83 58.06 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.499 -0.75 . . . . 20.07 110.688 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 110' ' ' LEU . . . . . 0.432 ' HG ' ' CD2' ' R' ' 109' ' ' HIS . 80.3 mt -94.8 -17.3 22.25 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.083 -1.011 . . . . 15.69 110.196 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 111' ' ' LEU . . . . . 0.447 HD22 ' CE2' ' R' ' 60' ' ' PHE . 10.3 mt -94.09 144.15 25.74 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.342 -0.849 . . . . 25.39 111.008 -179.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 112' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -77.67 -17.43 57.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.487 -0.758 . . . . 53.48 109.823 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 113' ' ' THR . . . . . 0.418 HG22 ' HG2' ' R' ' 123' ' ' GLU . 60.5 m -83.67 166.64 17.94 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.308 -0.87 . . . . 14.8 110.247 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 114' ' ' GLY . . . . . . . . . . . . . . . -98.0 127.12 9.12 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.042 -1.223 . . . . 16.14 110.042 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 115' ' ' ILE . . . . . 0.48 ' HB ' ' HG2' ' R' ' 108' ' ' LYS . 47.8 mm -109.02 139.34 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.478 -1.013 . . . . 13.46 109.741 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 116' ' ' GLY . . . . . . . . . . . . . . . -152.71 -155.8 7.26 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.011 -1.236 . . . . 23.9 110.011 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 117' ' ' THR . . . . . . . . . . . . . 18.8 p -135.03 -171.33 2.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.514 -0.992 . . . . 27.37 110.059 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.62 -58.06 9.72 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.216 -0.927 . . . . 18.76 110.083 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 119' ' ' SER . . . . . . . . . . . . . 1.1 m -56.55 -40.56 75.36 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.251 -0.905 . . . . 32.35 109.815 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 120' ' ' ARG . . . . . 0.417 ' NH1' ' NE1' ' S' ' 305' ' ' TRP . 10.0 mtm180 -110.07 86.29 4.91 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.43 -0.794 . . . . 27.12 109.716 179.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 121' ' ' PRO . . . . . 0.427 ' O ' ' HB2' ' R' ' 122' ' ' SER . 44.0 Cg_endo -71.32 166.53 28.98 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 O-C-N 123.86 1.453 . . . . 22.68 110.998 -179.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 122' ' ' SER . . . . . 0.427 ' HB2' ' O ' ' R' ' 121' ' ' PRO . 38.3 t 178.53 -161.72 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.6 -0.687 . . . . 22.99 109.461 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 123' ' ' GLU . . . . . 0.418 ' HG2' HG22 ' R' ' 113' ' ' THR . 2.3 tp10 -56.45 -39.98 74.04 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.211 -0.93 . . . . 36.18 109.622 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 124' ' ' VAL . . . . . . . . . . . . . 83.5 t -142.54 136.44 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.597 -0.689 . . . . 20.64 109.428 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 125' ' ' CYS . . . . . 0.409 ' SG ' ' HA ' ' R' ' 121' ' ' PRO . 83.4 m -140.32 168.16 20.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.145 -0.972 . . . . 22.8 111.171 -179.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 126' ' ' VAL . . . . . . . . . . . . . 35.8 m -122.72 159.77 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.724 -0.61 . . . . 21.24 109.695 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 127' ' ' VAL . . . . . 0.4 ' CG1' ' O ' ' R' ' 177' ' ' VAL . 30.8 m -70.83 141.85 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.293 -0.879 . . . . 19.77 110.681 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 128' ' ' ASP . . . . . . . . . . . . . 54.0 p-10 -137.68 19.34 2.88 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.405 -0.809 . . . . 29.21 110.702 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 129' ' ' GLY . . . . . . . . . . . . . . . 113.99 0.02 24.14 Favored Glycine 0 N--CA 1.493 2.458 0 C-N-CA 119.977 -1.106 . . . . 33.86 110.472 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 130' ' ' THR . . . . . . . . . . . . . 58.3 m -91.76 131.83 36.85 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.084 -1.244 . . . . 26.41 110.07 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -62.59 120.66 11.59 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.35 -0.844 . . . . 33.08 110.312 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 132' ' ' MET . . . . . 0.427 ' HE1' ' CZ ' ' R' ' 180' ' ' PHE . 98.4 mmm -105.22 165.64 10.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.395 -0.816 . . . . 30.76 110.377 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 133' ' ' CYS . . . . . . . . . . . . . 32.6 m -141.16 158.14 44.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.507 -0.745 . . . . 27.0 109.932 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 134' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.57 -19.6 39.54 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.388 -0.82 . . . . 33.9 110.498 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 135' ' ' ALA . . . . . . . . . . . . . . . -92.79 8.16 40.62 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.294 -0.879 . . . . 19.37 110.755 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 136' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -93.74 -21.86 19.07 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.207 -0.933 . . . . 30.47 110.216 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 137' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -149.94 165.35 32.89 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.351 -0.843 . . . . 24.27 110.231 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 138' ' ' HIS . . . . . . . . . . . . . 15.1 p80 -117.82 15.15 14.38 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.429 -0.794 . . . . 20.91 110.452 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 139' ' ' ALA . . . . . 0.44 ' HA ' ' O ' ' R' ' 152' ' ' ALA . . . -177.16 152.49 0.89 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.167 -0.958 . . . . 15.69 110.137 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 140' ' ' GLY . . . . . 0.404 ' HA3' ' O ' ' R' ' 179' ' ' VAL . . . 161.74 175.1 32.41 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 110.007 -1.237 . . . . 23.76 110.007 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 141' ' ' ILE . . . . . . . . . . . . . 83.6 mt -95.48 136.57 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.447 -1.031 . . . . 25.3 109.682 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 142' ' ' PHE . . . . . 0.547 ' CD2' ' HB2' ' R' ' 172' ' ' PRO . 82.6 m-85 -120.75 -172.66 2.43 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.33 -0.856 . . . . 30.24 110.54 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 143' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -119.75 77.84 1.27 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.459 -0.776 . . . . 32.8 110.304 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 144' ' ' LYS . . . . . 0.454 ' HG3' ' CZ2' ' R' ' 170' ' ' TRP . 1.0 OUTLIER -69.67 76.93 0.44 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.381 -0.824 . . . . 49.18 109.653 179.573 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' R' R ' 145' ' ' GLY . . . . . . . . . . . . . . . 104.52 179.23 24.81 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.16 -1.576 . . . . 53.87 109.16 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 146' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -88.44 145.86 25.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.319 -1.107 . . . . 68.58 109.999 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 147' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 58.19 36.58 25.88 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.294 -0.879 . . . . 56.62 110.633 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 148' ' ' HIS . . . . . . . . . . . . . 45.1 t60 -158.67 148.11 19.17 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.243 -0.911 . . . . 44.57 110.398 179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 149' ' ' ALA . . . . . . . . . . . . . . . -150.25 146.9 27.08 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.451 -0.781 . . . . 33.54 110.061 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 150' ' ' VAL . . . . . 0.428 HG23 ' HB2' ' R' ' 144' ' ' LYS . 34.2 m -142.38 161.51 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.246 -0.909 . . . . 27.61 110.322 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 151' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' R' ' 152' ' ' ALA . 5.9 t80 -86.18 155.57 20.68 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.383 -0.823 . . . . 23.04 109.901 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 152' ' ' ALA . . . . . 0.537 ' N ' ' CD1' ' R' ' 151' ' ' PHE . . . -157.31 151.56 24.92 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.447 -0.783 . . . . 29.61 109.53 178.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 153' ' ' CYS . . . . . 0.406 ' HA ' ' HA ' ' R' ' 139' ' ' ALA . 26.7 p -154.28 173.56 15.99 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.28 -0.888 . . . . 22.75 110.539 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 154' ' ' VAL . . . . . 0.443 ' CG2' ' CZ2' ' R' ' 159' ' ' TRP . 59.9 t -90.52 117.04 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.429 -0.794 . . . . 23.26 110.057 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 155' ' ' THR . . . . . . . . . . . . . 71.0 p -112.18 -176.62 2.96 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.361 -0.837 . . . . 17.88 110.058 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 156' ' ' SER . . . . . . . . . . . . . 78.4 p -75.96 -3.68 36.89 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.32 -0.863 . . . . 21.83 110.716 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 157' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -118.33 10.57 12.82 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.096 -1.002 . . . . 36.54 110.625 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 158' ' ' GLY . . . . . . . . . . . . . . . 117.83 -162.6 13.01 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.55 -1.42 . . . . 31.74 109.55 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 159' ' ' TRP . . . . . 0.443 ' CZ2' ' CG2' ' R' ' 154' ' ' VAL . 14.6 m95 -86.63 122.54 30.7 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.386 -1.067 . . . . 28.25 110.061 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 160' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -108.48 166.92 10.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.346 -0.846 . . . . 41.24 110.25 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 161' ' ' ALA . . . . . . . . . . . . . . . -143.25 123.39 13.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.435 -0.791 . . . . 27.4 110.182 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 162' ' ' ILE . . . . . 0.431 HG23 ' CZ ' ' R' ' 167' ' ' PHE . 92.6 mt -87.57 81.24 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.398 -0.814 . . . . 24.27 110.055 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 163' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' R' ' 165' ' ' GLU . 15.3 t0 -72.85 92.37 1.6 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.458 -0.776 . . . . 36.08 110.237 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 164' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 54.09 -88.97 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.489 -0.757 . . . . 46.08 110.603 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 165' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' R' ' 163' ' ' ASP . 29.6 mt-10 -124.72 36.0 4.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.109 -0.994 . . . . 50.94 110.194 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 166' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -135.69 117.3 14.91 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.405 -0.81 . . . . 47.28 110.361 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 167' ' ' PHE . . . . . 0.431 ' CZ ' HG23 ' R' ' 162' ' ' ILE . 24.2 m-85 -101.06 119.91 39.43 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.367 -0.833 . . . . 40.47 110.178 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 168' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -157.51 158.56 30.71 Favored Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 121.235 -0.916 . . . . 30.21 110.454 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 169' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.77 133.05 19.52 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 O-C-N 123.866 1.456 . . . . 32.76 110.531 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 170' ' ' TRP . . . . . 0.454 ' CZ2' ' HG3' ' R' ' 144' ' ' LYS . 67.2 t90 -159.78 119.27 2.88 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.444 -0.785 . . . . 32.79 109.958 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 171' ' ' THR . . . . . . . . . . . . . 45.5 m -81.08 112.58 33.87 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.423 -0.798 . . . . 36.92 110.219 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 172' ' ' PRO . . . . . 0.547 ' HB2' ' CD2' ' R' ' 142' ' ' PHE . 46.8 Cg_endo -73.77 158.81 46.39 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.634 1.334 . . . . 33.54 110.556 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 173' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -88.85 144.93 33.77 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.409 -0.807 . . . . 45.76 109.913 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 174' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.72 -10.35 26.37 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.649 1.342 . . . . 29.63 110.505 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 175' ' ' SER . . . . . . . . . . . . . 53.0 p -103.41 -17.63 15.17 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.273 -0.892 . . . . 35.7 110.367 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 176' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -103.58 43.3 1.09 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.261 -0.899 . . . . 39.65 110.362 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 177' ' ' VAL . . . . . 0.4 ' O ' ' CG1' ' R' ' 127' ' ' VAL . 10.5 p -117.78 127.23 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.266 -0.896 . . . . 20.61 110.006 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 178' ' ' LEU . . . . . . . . . . . . . 46.4 mt -91.6 -61.25 1.68 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.368 -0.832 . . . . 15.58 109.364 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 179' ' ' VAL . . . . . 0.404 ' O ' ' HA3' ' R' ' 140' ' ' GLY . 67.5 t -114.6 144.67 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.66 -0.65 . . . . 17.4 109.444 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 180' ' ' PHE . . . . . 0.427 ' CZ ' ' HE1' ' R' ' 132' ' ' MET . 43.4 p90 -152.13 163.36 39.53 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.33 -0.856 . . . . 20.16 110.517 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 181' ' ' VAL . . . . . . . . . . . . . 65.9 t -113.1 111.5 50.44 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.363 -0.836 . . . . 17.69 109.848 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 182' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.09 149.57 52.62 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 O-C-N 123.638 1.336 . . . . 17.81 110.403 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 183' ' ' TYR . . . . . 0.688 ' O ' ' C ' ' R' ' 184' ' ' ASP . 78.9 m-85 -59.13 175.44 0.3 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.401 -0.812 . . . . 28.01 110.54 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 184' ' ' ASP . . . . . 0.688 ' C ' ' O ' ' R' ' 183' ' ' TYR . 2.3 m-20 -20.0 -84.04 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.315 -0.866 . . . . 58.64 110.242 -178.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' R' R ' 185' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 . . . . . 0 N--CA 1.502 2.173 0 CA-C-O 121.22 0.533 . . . . 80.42 111.75 179.617 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' R' R ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 120.823 0.344 . . . . 49.5 110.16 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' R' R ' 194' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.862 0 O-C-N 121.218 -0.927 . . . . 40.4 110.144 179.906 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' S' S ' 229' ' ' MET . . . . . . . . . . . . . 5.1 mtm . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.188 0.518 . . . . 51.83 110.216 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' S' S ' 230' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -97.29 142.71 28.84 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.34 -0.85 . . . . 54.13 110.199 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 231' ' ' LEU . . . . . . . . . . . . . 67.3 mt -134.07 140.98 47.0 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.388 -0.82 . . . . 33.04 110.364 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 232' ' ' THR . . . . . . . . . . . . . 40.3 m -89.26 103.28 15.92 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.305 -0.872 . . . . 26.92 110.032 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 233' ' ' LEU . . . . . 0.489 HD23 ' CE2' ' S' ' 262' ' ' TYR . 79.8 mt -55.88 179.24 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.437 -0.79 . . . . 13.78 110.463 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' S' S ' 234' ' ' TYR . . . . . 0.448 ' CG ' ' N ' ' S' ' 235' ' ' ASN . 35.5 p90 -65.01 -35.66 81.9 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.384 -0.823 . . . . 26.08 110.168 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' S' S ' 235' ' ' ASN . . . . . 0.448 ' N ' ' CG ' ' S' ' 234' ' ' TYR . 50.6 p30 -74.38 -7.35 52.6 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.336 -0.852 . . . . 20.04 110.5 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' S' S ' 236' ' ' GLY . . . . . . . . . . . . . . . 95.69 -19.9 52.18 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.777 -1.329 . . . . 22.71 109.777 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 237' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -52.94 145.68 12.33 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.2 -1.176 . . . . 35.44 110.236 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 238' ' ' LYS . . . . . . . . . . . . . 44.5 mttt -102.18 127.92 48.91 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.358 -0.839 . . . . 32.56 110.41 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 239' ' ' LYS . . . . . 0.416 ' HG2' ' CZ ' ' S' ' 241' ' ' PHE . 9.0 ttmt -132.29 144.55 50.67 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.371 -0.831 . . . . 26.68 109.919 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' S' S ' 240' ' ' THR . . . . . . . . . . . . . 52.1 m -102.07 132.18 48.09 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.304 -0.872 . . . . 41.02 110.334 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 241' ' ' PHE . . . . . 0.416 ' CZ ' ' HG2' ' S' ' 239' ' ' LYS . 96.0 m-85 -117.94 137.66 52.68 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.335 -0.853 . . . . 28.62 110.21 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' S' S ' 242' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -96.32 161.78 13.79 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.302 -0.874 . . . . 47.89 110.198 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 243' ' ' SER . . . . . . . . . . . . . 71.5 m -90.58 151.47 21.3 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.332 -0.855 . . . . 45.09 110.227 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 244' ' ' ARG . . . . . . . . . . . . . 1.4 mtp85 -129.69 126.77 22.78 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.349 -0.844 . . . . 42.49 110.247 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 245' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.35 161.0 43.74 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.74 1.389 . . . . 35.68 110.561 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 246' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -132.87 97.87 4.15 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.408 -0.807 . . . . 51.88 109.867 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 247' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -110.49 -22.22 11.77 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.321 -0.862 . . . . 53.69 110.655 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 248' ' ' HIS . . . . . . . . . . . . . 76.5 m80 -117.21 43.61 2.28 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.16 -0.963 . . . . 55.79 110.761 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 249' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 48.77 38.46 11.85 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.417 -0.802 . . . . 49.45 110.39 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 250' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -90.65 29.02 1.38 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.496 -0.753 . . . . 36.86 110.364 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 251' ' ' ALA . . . . . . . . . . . . . . . -53.79 -43.23 69.12 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.281 -0.887 . . . . 29.69 109.563 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 252' ' ' TRP . . . . . 0.416 ' CZ2' ' HB3' ' S' ' 294' ' ' LEU . 67.9 p-90 -61.76 -33.95 74.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.602 -0.686 . . . . 41.12 109.886 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' S' S ' 253' ' ' LEU . . . . . . . . . . . . . 23.4 tp -70.11 -47.23 62.66 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.446 -0.783 . . . . 24.89 110.016 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 254' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -56.16 -42.44 77.03 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.299 -0.875 . . . . 35.65 109.975 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 255' ' ' ALA . . . . . . . . . . . . . . . -59.57 -48.1 82.97 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.447 -0.783 . . . . 22.73 110.141 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 256' ' ' ILE . . . . . . . . . . . . . 79.7 mt -62.32 -40.7 88.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.273 -0.892 . . . . 28.85 109.924 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 257' ' ' LEU . . . . . . . . . . . . . 19.0 mt -61.54 -44.48 96.98 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.354 -0.841 . . . . 23.07 110.168 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 258' ' ' GLN . . . . . 0.469 ' HB3' ' CD2' ' S' ' 351' ' ' PHE . 53.4 mm-40 -65.09 -45.33 85.66 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.398 -0.814 . . . . 29.78 109.953 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' S' S ' 259' ' ' LEU . . . . . 0.43 ' O ' HG22 ' S' ' 263' ' ' VAL . 19.9 tp -58.73 -36.27 74.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.285 -0.885 . . . . 17.94 109.484 179.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' S' S ' 260' ' ' PHE . . . . . 0.468 ' CE2' HD22 ' S' ' 311' ' ' LEU . 3.1 m-85 -62.89 -45.24 93.44 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.663 -0.648 . . . . 30.57 109.808 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' S' S ' 261' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -62.08 -29.82 70.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.454 -0.779 . . . . 41.34 110.015 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 262' ' ' TYR . . . . . 0.489 ' CE2' HD23 ' S' ' 233' ' ' LEU . 8.7 t80 -71.17 -44.6 65.17 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.416 -0.802 . . . . 26.03 110.137 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' S' S ' 263' ' ' VAL . . . . . 0.43 HG22 ' O ' ' S' ' 259' ' ' LEU . 33.0 m -92.06 18.23 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.385 -0.822 . . . . 22.8 110.412 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' S' S ' 264' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 52.76 70.67 0.55 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.291 -0.881 . . . . 44.03 110.568 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 265' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -111.77 109.16 55.53 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.257 -0.902 . . . . 35.61 109.716 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 266' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -75.24 0.37 9.08 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.579 1.305 . . . . 37.67 111.728 -179.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 267' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -56.53 -67.65 0.29 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.806 -1.184 . . . . 41.49 110.203 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' S' S ' 268' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -92.91 39.85 1.05 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.164 -0.96 . . . . 50.76 110.098 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 269' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.0 -33.16 59.7 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.322 -0.861 . . . . 61.86 109.83 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' S' S ' 270' ' ' TRP . . . . . 0.492 ' CE2' ' CG2' ' S' ' 271' ' ' VAL . 51.0 p-90 -73.97 -4.28 34.28 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.208 -0.932 . . . . 39.85 110.489 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' S' S ' 271' ' ' VAL . . . . . 0.492 ' CG2' ' CE2' ' S' ' 270' ' ' TRP . 46.5 t -109.5 -32.77 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.129 -0.982 . . . . 39.18 110.051 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' S' S ' 272' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -78.65 -36.47 43.83 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.384 -0.822 . . . . 40.02 110.514 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 273' ' ' SER . . . . . . . . . . . . . 70.9 m -103.59 56.08 0.74 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.269 -0.894 . . . . 47.2 110.291 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 274' ' ' SER . . . . . . . . . . . . . 6.9 t -133.04 141.23 40.17 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.371 -0.83 . . . . 47.61 110.108 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 275' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.74 -18.92 21.7 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 O-C-N 123.617 1.325 . . . . 45.28 110.583 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 276' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -99.88 140.88 33.46 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.247 -0.908 . . . . 57.27 110.288 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 277' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -71.66 97.56 1.75 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.368 -0.832 . . . . 37.28 110.272 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 278' ' ' LEU . . . . . . . . . . . . . 86.5 mt -96.97 33.87 1.83 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.329 -0.857 . . . . 43.88 110.023 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 279' ' ' THR . . . . . . . . . . . . . 78.1 m -64.12 -60.08 3.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.505 -0.747 . . . . 50.05 110.273 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 280' ' ' LEU . . . . . . . . . . . . . 13.7 mt -51.58 -39.92 58.8 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.352 -0.843 . . . . 54.12 110.255 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 281' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.41 -49.65 74.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.467 -0.77 . . . . 65.28 110.108 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' S' S ' 282' ' ' ALA . . . . . . . . . . . . . . . -58.95 -33.95 71.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.439 -0.788 . . . . 46.51 110.512 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 283' ' ' ILE . . . . . . . . . . . . . 86.0 mt -66.39 -50.82 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.358 -0.839 . . . . 47.3 110.092 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 284' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -50.52 -57.63 7.67 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.444 -0.785 . . . . 50.72 110.358 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 285' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -51.41 -46.36 62.89 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.578 -0.701 . . . . 68.47 110.346 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 286' ' ' LEU . . . . . . . . . . . . . 19.0 mt -59.96 -44.53 94.37 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.448 -0.782 . . . . 36.62 110.245 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 287' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -62.78 -35.21 79.09 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.288 -0.883 . . . . 46.64 110.083 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 288' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -76.25 -21.03 56.82 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.361 -0.837 . . . . 46.45 110.307 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 289' ' ' LEU . . . . . . . . . . . . . 30.7 mt -97.35 -21.73 17.04 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.288 -0.883 . . . . 35.09 110.524 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 290' ' ' THR . . . . . . . . . . . . . 81.3 p -114.78 -28.35 7.12 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.246 -0.909 . . . . 38.61 110.455 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 291' ' ' GLY . . . . . . . . . . . . . . . 79.31 10.99 85.45 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.856 -1.298 . . . . 36.77 109.856 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 292' ' ' LEU . . . . . . . . . . . . . 84.8 mt -96.41 145.81 25.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.304 -1.116 . . . . 35.33 109.799 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 293' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -77.32 102.4 6.73 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.15 -0.969 . . . . 48.7 110.302 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 294' ' ' LEU . . . . . 0.416 ' HB3' ' CZ2' ' S' ' 252' ' ' TRP . 55.7 mt -106.93 51.71 0.73 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.521 -0.737 . . . . 42.61 110.1 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' S' S ' 295' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -112.51 -11.11 13.65 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.365 -0.834 . . . . 55.49 110.531 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' S' S ' 296' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -144.37 48.55 1.36 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.167 -0.958 . . . . 75.68 110.261 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 297' ' ' GLY . . . . . . . . . . . . . . . 96.84 145.2 18.73 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.467 -1.453 . . . . 49.44 109.467 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 298' ' ' GLY . . . . . . . . . . . . . . . -163.86 156.99 29.1 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.8 -1.32 . . . . 41.11 109.8 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 299' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.86 118.28 5.37 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 124.008 1.531 . . . . 26.2 110.209 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 300' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.29 -15.49 31.52 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 O-C-N 123.584 1.307 . . . . 21.7 110.665 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 301' ' ' ALA . . . . . . . . . . . . . . . -80.63 -29.34 36.76 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.295 -0.878 . . . . 31.23 110.13 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 302' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.56 -40.62 18.89 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.391 -0.818 . . . . 38.99 109.941 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' S' S ' 303' ' ' VAL . . . . . 0.466 ' O ' HG12 ' S' ' 307' ' ' ILE . 58.0 t -60.7 -35.47 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.487 -0.758 . . . . 18.63 110.167 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' S' S ' 304' ' ' ILE . . . . . . . . . . . . . 86.1 mt -79.35 -23.61 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.44 -0.787 . . . . 25.46 110.229 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 305' ' ' TRP . . . . . 0.417 ' NE1' ' NH1' ' R' ' 120' ' ' ARG . 68.8 t-105 -88.64 -14.56 37.17 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.31 -0.869 . . . . 33.4 110.599 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' S' S ' 306' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -89.67 -13.62 36.59 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.291 -0.88 . . . . 36.97 110.394 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 307' ' ' ILE . . . . . 0.466 HG12 ' O ' ' S' ' 303' ' ' VAL . 36.9 pt -125.02 45.69 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.255 -0.903 . . . . 30.81 110.043 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' S' S ' 308' ' ' LYS . . . . . . . . . . . . . 1.5 mtmp? -73.63 -37.76 65.26 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.373 -0.83 . . . . 46.52 110.064 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 309' ' ' HIS . . . . . 0.485 ' CD2' ' HG ' ' S' ' 310' ' ' LEU . 55.6 p-80 -73.15 -8.21 54.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.263 -0.898 . . . . 51.03 110.187 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' S' S ' 310' ' ' LEU . . . . . 0.485 ' HG ' ' CD2' ' S' ' 309' ' ' HIS . 53.0 mt -99.31 -12.84 19.97 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.317 -0.864 . . . . 36.16 109.969 179.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' S' S ' 311' ' ' LEU . . . . . 0.468 HD22 ' CE2' ' S' ' 260' ' ' PHE . 10.8 mt -97.21 147.9 23.63 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.377 -0.827 . . . . 40.0 110.355 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' S' S ' 312' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -81.67 -16.23 51.97 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.262 -0.899 . . . . 54.18 109.698 179.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 313' ' ' THR . . . . . 0.466 HG23 ' HB3' ' S' ' 323' ' ' GLU . 92.7 m -87.97 151.63 22.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.38 -0.825 . . . . 25.61 110.149 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' S' S ' 314' ' ' GLY . . . . . . . . . . . . . . . -87.86 126.33 8.0 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.83 -1.308 . . . . 25.18 109.83 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 315' ' ' ILE . . . . . 0.4 HG21 ' N ' ' S' ' 316' ' ' GLY . 50.6 mm -101.58 150.53 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.416 -1.049 . . . . 23.9 109.724 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' S' S ' 316' ' ' GLY . . . . . 0.4 ' N ' HG21 ' S' ' 315' ' ' ILE . . . -157.1 -159.23 9.36 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.026 -1.23 . . . . 23.18 110.026 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' S' S ' 317' ' ' THR . . . . . . . . . . . . . 11.2 p -133.95 -173.04 3.14 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.442 -1.034 . . . . 27.98 109.967 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.58 -56.16 25.44 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.191 -0.943 . . . . 28.1 109.927 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 319' ' ' SER . . . . . . . . . . . . . 1.2 m -59.9 -41.69 92.2 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.382 -0.824 . . . . 37.0 109.664 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 320' ' ' ARG . . . . . . . . . . . . . 12.1 mtm180 -111.69 79.85 2.63 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.445 -0.784 . . . . 52.07 109.652 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 321' ' ' PRO . . . . . 0.435 ' O ' ' HB2' ' S' ' 322' ' ' SER . 43.9 Cg_endo -71.44 171.6 15.88 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.83 1.437 . . . . 38.29 110.937 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' S' S ' 322' ' ' SER . . . . . 0.435 ' HB2' ' O ' ' S' ' 321' ' ' PRO . 41.3 t 178.58 -148.13 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.924 -0.769 . . . . 38.84 108.924 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' S' S ' 323' ' ' GLU . . . . . 0.466 ' HB3' HG23 ' S' ' 313' ' ' THR . 6.7 tp10 -62.82 -40.33 97.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.946 -1.096 . . . . 40.7 109.682 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' S' S ' 324' ' ' VAL . . . . . . . . . . . . . 73.5 t -141.28 134.97 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.427 -0.796 . . . . 20.34 109.507 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 325' ' ' CYS . . . . . 0.447 ' HB2' ' CE1' ' S' ' 380' ' ' PHE . 11.3 m -125.98 172.13 10.2 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.385 -0.822 . . . . 30.63 110.827 -179.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' S' S ' 326' ' ' VAL . . . . . . . . . . . . . 34.5 m -135.41 142.25 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 109.204 -0.665 . . . . 23.9 109.204 179.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 327' ' ' VAL . . . . . . . . . . . . . 34.5 m -56.34 125.04 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.054 -1.029 . . . . 19.48 110.43 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 328' ' ' ASP . . . . . . . . . . . . . 55.6 p-10 -119.43 11.59 12.2 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.451 -0.781 . . . . 26.43 110.411 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 329' ' ' GLY . . . . . . . . . . . . . . . 119.58 2.26 13.2 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.088 -1.205 . . . . 31.24 110.088 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 330' ' ' THR . . . . . . . . . . . . . 78.3 m -93.02 129.99 38.76 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.064 -1.256 . . . . 30.05 110.183 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 331' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -56.8 111.54 1.05 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.217 -0.927 . . . . 37.26 109.935 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 332' ' ' MET . . . . . 0.456 ' HE1' ' CZ ' ' S' ' 380' ' ' PHE . 87.9 mmm -94.04 162.57 13.83 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.212 -0.93 . . . . 26.23 110.347 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' S' S ' 333' ' ' CYS . . . . . . . . . . . . . 24.9 m -137.3 150.07 47.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.483 -0.761 . . . . 23.56 109.961 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 334' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.57 -24.93 9.16 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.334 -0.854 . . . . 28.93 110.457 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' S' S ' 335' ' ' ALA . . . . . . . . . . . . . . . -88.95 14.39 10.61 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.379 -0.826 . . . . 15.76 110.977 -179.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 336' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -100.51 -17.23 17.23 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.149 -0.969 . . . . 34.92 110.137 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 337' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -152.37 170.86 19.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.418 -0.801 . . . . 19.03 110.055 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 338' ' ' HIS . . . . . 0.401 ' HB3' ' CZ ' ' S' ' 383' ' ' TYR . 13.5 p80 -120.7 10.38 10.99 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.318 -0.864 . . . . 18.82 110.465 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' S' S ' 339' ' ' ALA . . . . . . . . . . . . . . . -176.04 155.17 1.54 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.274 -0.891 . . . . 17.18 110.09 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 340' ' ' GLY . . . . . 0.404 ' CA ' ' O ' ' S' ' 379' ' ' VAL . . . 160.87 173.11 29.07 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.013 -1.235 . . . . 18.33 110.013 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' S' S ' 341' ' ' ILE . . . . . 0.424 HD12 HG22 ' S' ' 341' ' ' ILE . 83.9 mt -88.84 138.14 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.498 -1.001 . . . . 18.6 109.819 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' S' S ' 342' ' ' PHE . . . . . 0.499 ' CE1' HG23 ' S' ' 377' ' ' VAL . 70.0 m-85 -120.99 -178.48 3.76 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.299 -0.875 . . . . 23.44 110.453 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' S' S ' 343' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.8 93.4 4.19 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.408 -0.807 . . . . 35.59 110.002 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' S' S ' 344' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.85 125.02 29.58 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.26 -0.9 . . . . 38.34 110.109 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' S' S ' 345' ' ' GLY . . . . . . . . . . . . . . . 62.77 -130.87 43.13 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 108.821 -1.711 . . . . 53.46 108.821 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 346' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -132.68 150.84 52.1 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.326 -1.102 . . . . 70.91 110.037 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 347' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 53.27 35.39 19.98 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.353 -0.842 . . . . 47.32 110.433 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 348' ' ' HIS . . . . . . . . . . . . . 46.5 t60 -150.08 155.94 40.76 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.329 -0.857 . . . . 41.72 110.303 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 349' ' ' ALA . . . . . . . . . . . . . . . -149.88 151.25 33.15 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.326 -0.859 . . . . 22.91 110.441 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 350' ' ' VAL . . . . . . . . . . . . . 34.6 m -149.1 169.64 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.514 -0.741 . . . . 21.09 110.023 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 351' ' ' PHE . . . . . 0.469 ' CD2' ' HB3' ' S' ' 258' ' ' GLN . 10.7 t80 -105.39 143.62 33.3 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.155 -0.966 . . . . 25.03 110.713 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' S' S ' 352' ' ' ALA . . . . . . . . . . . . . . . -147.79 151.71 36.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.667 -0.645 . . . . 23.81 109.715 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 353' ' ' CYS . . . . . . . . . . . . . 26.3 p -153.25 164.91 37.24 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.368 -0.832 . . . . 25.66 110.343 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 354' ' ' VAL . . . . . . . . . . . . . 56.5 t -76.05 118.53 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.361 -0.837 . . . . 34.27 109.98 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 355' ' ' THR . . . . . 0.445 HG23 ' HB2' ' S' ' 360' ' ' TYR . 52.7 p -117.86 175.14 5.8 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.251 -0.905 . . . . 25.49 110.332 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' S' S ' 356' ' ' SER . . . . . . . . . . . . . 62.0 p -62.18 -17.72 58.89 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.345 -0.847 . . . . 31.24 110.71 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 357' ' ' ASN . . . . . . . . . . . . . 45.9 m-20 -107.01 14.22 26.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.201 -0.937 . . . . 28.61 110.611 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 358' ' ' GLY . . . . . . . . . . . . . . . 111.91 -152.98 17.58 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.984 -1.246 . . . . 22.01 109.984 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 359' ' ' TRP . . . . . . . . . . . . . 15.4 m95 -91.24 116.68 29.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.371 -1.076 . . . . 25.54 110.17 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 360' ' ' TYR . . . . . 0.445 ' HB2' HG23 ' S' ' 355' ' ' THR . 1.3 m-85 -103.47 165.79 10.82 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.327 -0.858 . . . . 40.53 110.107 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' S' S ' 361' ' ' ALA . . . . . . . . . . . . . . . -140.06 130.11 24.9 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.462 -0.774 . . . . 18.04 110.271 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 362' ' ' ILE . . . . . 0.42 HG23 ' CZ ' ' S' ' 367' ' ' PHE . 88.8 mt -95.6 83.67 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.283 -0.885 . . . . 15.64 110.062 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' S' S ' 363' ' ' ASP . . . . . 0.418 ' O ' ' N ' ' S' ' 365' ' ' GLU . 11.9 t0 -75.25 94.47 3.0 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.298 -0.876 . . . . 35.03 110.213 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' S' S ' 364' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 53.88 -89.28 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.547 -0.721 . . . . 46.72 110.621 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 365' ' ' GLU . . . . . 0.418 ' N ' ' O ' ' S' ' 363' ' ' ASP . 23.8 mt-10 -122.7 19.15 10.3 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.091 -1.006 . . . . 56.2 110.267 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' S' S ' 366' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -117.97 124.99 49.54 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.17 -0.957 . . . . 51.02 110.421 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 367' ' ' PHE . . . . . 0.42 ' CZ ' HG23 ' S' ' 362' ' ' ILE . 26.9 m-85 -107.0 127.08 53.13 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.435 -0.791 . . . . 37.59 110.133 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' S' S ' 368' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -165.47 159.46 13.82 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.229 -0.919 . . . . 31.47 110.414 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 369' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.68 139.62 31.19 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 O-C-N 123.903 1.475 . . . . 28.85 110.505 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 370' ' ' TRP . . . . . . . . . . . . . 67.6 t90 -167.21 113.49 0.76 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.405 -0.81 . . . . 26.94 110.008 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 371' ' ' THR . . . . . . . . . . . . . 59.8 m -74.78 113.08 20.99 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.317 -0.864 . . . . 20.19 110.025 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 372' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -73.56 157.13 49.17 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.61 1.321 . . . . 28.68 110.609 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 373' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -90.58 147.14 35.73 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.444 -0.785 . . . . 35.72 109.922 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 374' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -76.0 -6.3 17.23 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 O-C-N 123.632 1.332 . . . . 30.89 110.502 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 375' ' ' SER . . . . . . . . . . . . . 68.6 p -104.36 -16.94 14.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.207 -0.933 . . . . 29.41 110.436 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 376' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -106.55 43.1 1.18 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.348 -0.845 . . . . 32.89 110.198 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 377' ' ' VAL . . . . . 0.499 HG23 ' CE1' ' S' ' 342' ' ' PHE . 7.3 p -114.68 147.3 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.297 -0.877 . . . . 24.33 110.207 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' S' S ' 378' ' ' LEU . . . . . . . . . . . . . 52.7 mt -116.02 -58.0 2.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.354 -0.841 . . . . 24.37 109.626 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 379' ' ' VAL . . . . . 0.404 ' O ' ' CA ' ' S' ' 340' ' ' GLY . 61.2 t -120.66 132.42 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.418 -0.801 . . . . 18.02 109.456 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' S' S ' 380' ' ' PHE . . . . . 0.456 ' CZ ' ' HE1' ' S' ' 332' ' ' MET . 14.4 p90 -142.59 173.89 11.13 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.399 -0.813 . . . . 29.35 110.614 -179.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' S' S ' 381' ' ' VAL . . . . . . . . . . . . . 57.7 t -120.01 107.29 40.06 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.523 -0.735 . . . . 16.34 109.453 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 382' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -71.2 145.62 49.4 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 O-C-N 123.611 1.322 . . . . 20.94 110.786 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' S' S ' 383' ' ' TYR . . . . . 0.401 ' CZ ' ' HB3' ' S' ' 338' ' ' HIS . 88.4 m-85 -61.1 -53.47 56.72 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.323 -0.861 . . . . 28.93 109.877 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' S' S ' 384' ' ' ASP . . . . . . . . . . . . . 1.5 t70 . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.356 -0.84 . . . . 47.03 110.357 -176.784 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' R' R ' 30' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 121.152 0.501 . . . . 43.36 110.212 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' R' R ' 31' ' ' LEU . . . . . . . . . . . . . 65.5 mt -134.88 140.63 45.94 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.337 -0.852 . . . . 22.93 110.269 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 32' ' ' THR . . . . . . . . . . . . . 70.6 m -87.61 110.64 20.53 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.33 -0.856 . . . . 22.34 109.9 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 33' ' ' LEU . . . . . 0.46 HD23 ' CE2' ' R' ' 62' ' ' TYR . 80.1 mt -62.45 -172.79 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.307 -0.87 . . . . 21.39 110.202 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' R' R ' 34' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -74.55 -29.54 61.4 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.355 -0.841 . . . . 34.4 110.388 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 35' ' ' ASN . . . . . . . . . . . . . 48.3 p30 -77.68 -1.87 33.25 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.348 -0.845 . . . . 30.28 110.637 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.21 -16.56 59.44 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.733 -1.347 . . . . 36.25 109.733 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 37' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -59.04 161.77 4.83 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.357 -1.084 . . . . 53.8 110.315 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 38' ' ' LYS . . . . . . . . . . . . . 56.9 mttt -117.78 135.81 53.81 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.426 -0.796 . . . . 49.91 110.132 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 39' ' ' LYS . . . . . 0.417 ' HG2' ' CZ ' ' R' ' 41' ' ' PHE . 8.1 ttmt -138.76 143.68 39.11 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.468 -0.77 . . . . 35.69 110.228 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' R' R ' 40' ' ' THR . . . . . . . . . . . . . 23.6 m -102.57 127.98 49.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.41 -0.806 . . . . 34.84 110.221 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 41' ' ' PHE . . . . . 0.417 ' CZ ' ' HG2' ' R' ' 39' ' ' LYS . 96.6 m-85 -113.02 132.75 55.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.442 -0.786 . . . . 34.42 110.11 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' R' R ' 42' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -93.3 140.85 29.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.336 -0.852 . . . . 51.46 110.284 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 43' ' ' SER . . . . . . . . . . . . . 54.3 m -70.82 141.91 51.32 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.412 -0.805 . . . . 41.84 110.217 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.71 125.4 29.56 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.303 -0.873 . . . . 33.82 110.012 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' R' R ' 45' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.12 151.09 55.01 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.59 1.31 . . . . 30.27 110.655 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 46' ' ' ASN . . . . . . . . . . . . . 52.0 t-20 -124.34 109.9 13.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.447 -0.783 . . . . 35.1 110.054 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 47' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -120.28 -34.88 3.56 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.311 -0.868 . . . . 42.81 110.54 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 48' ' ' HIS . . . . . . . . . . . . . 73.3 m80 -105.72 45.17 0.98 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.262 -0.899 . . . . 49.97 110.211 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 49' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 50.25 34.69 9.14 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.329 -0.857 . . . . 61.32 110.186 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 50' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -86.28 43.82 1.09 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.333 -0.854 . . . . 51.5 110.623 -179.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.14 -46.08 78.75 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.225 -0.922 . . . . 38.77 109.539 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 52' ' ' TRP . . . . . 0.484 ' CD2' ' N ' ' R' ' 53' ' ' LEU . 68.2 p-90 -58.41 -38.44 77.39 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.413 -0.805 . . . . 26.24 110.002 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' R' R ' 53' ' ' LEU . . . . . 0.484 ' N ' ' CD2' ' R' ' 52' ' ' TRP . 23.1 tp -66.73 -46.65 74.79 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.351 -0.843 . . . . 26.75 109.984 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' R' R ' 54' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -55.23 -41.65 72.36 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.354 -0.841 . . . . 35.02 110.113 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.14 -46.1 91.92 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.377 -0.827 . . . . 24.47 110.163 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 56' ' ' ILE . . . . . . . . . . . . . 76.1 mt -62.18 -42.23 94.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.332 -0.855 . . . . 26.03 109.888 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 57' ' ' LEU . . . . . . . . . . . . . 22.5 mt -60.36 -45.56 93.07 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.3 -0.875 . . . . 26.77 109.702 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 58' ' ' GLN . . . . . . . . . . . . . 57.7 mm-40 -63.91 -46.51 84.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.476 -0.765 . . . . 22.32 109.59 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 59' ' ' LEU . . . . . 0.43 ' HA ' ' HE2' ' R' ' 151' ' ' PHE . 24.0 tp -61.45 -37.75 84.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.291 -0.881 . . . . 20.55 109.396 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' R' R ' 60' ' ' PHE . . . . . 0.447 ' CE2' HD22 ' R' ' 111' ' ' LEU . 2.8 m-85 -61.13 -44.75 96.85 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.628 -0.67 . . . . 20.08 109.866 179.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' R' R ' 61' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -63.11 -36.19 82.78 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.49 -0.756 . . . . 18.8 110.442 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 62' ' ' TYR . . . . . 0.46 ' CE2' HD23 ' R' ' 33' ' ' LEU . 9.2 t80 -63.04 -41.8 99.58 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.271 -0.893 . . . . 26.45 110.26 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' R' R ' 63' ' ' VAL . . . . . . . . . . . . . 30.0 m -93.34 20.33 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.263 -0.898 . . . . 29.75 110.307 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 64' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 52.96 75.5 0.24 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.328 -0.857 . . . . 35.52 110.51 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 65' ' ' GLU . . . . . 0.424 ' HG2' ' CD2' ' R' ' 60' ' ' PHE . 14.3 tp10 -116.17 104.09 52.5 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.423 -0.798 . . . . 29.89 109.944 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' R' R ' 66' ' ' PRO . . . . . 0.4 ' HA ' ' HB2' ' R' ' 69' ' ' ASP . 47.9 Cg_endo -73.46 -5.92 17.92 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.79 1.416 . . . . 21.37 111.147 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' R' R ' 67' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -52.1 -61.6 2.16 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.038 -1.039 . . . . 23.85 110.331 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' R' R ' 68' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -98.07 36.57 1.55 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.32 -0.862 . . . . 28.07 110.466 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 69' ' ' ASP . . . . . 0.4 ' HB2' ' HA ' ' R' ' 66' ' ' PRO . 11.7 t0 -72.33 -33.27 67.21 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.342 -0.849 . . . . 43.76 110.155 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' R' R ' 70' ' ' TRP . . . . . 0.475 ' CE2' ' CG2' ' R' ' 71' ' ' VAL . 47.7 p-90 -73.42 -3.91 30.33 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.334 -0.854 . . . . 33.06 110.717 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' R' R ' 71' ' ' VAL . . . . . 0.475 ' CG2' ' CE2' ' R' ' 70' ' ' TRP . 40.8 t -109.8 -27.47 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.112 -0.992 . . . . 31.7 109.659 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' R' R ' 72' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -86.56 -48.79 8.05 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.407 -0.808 . . . . 33.58 110.353 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 73' ' ' SER . . . . . . . . . . . . . 69.8 m -89.75 51.06 2.0 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.394 -0.816 . . . . 50.82 110.351 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 74' ' ' SER . . . . . . . . . . . . . 15.9 t -125.95 138.21 31.63 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.278 -0.889 . . . . 34.74 110.24 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -73.24 -25.01 16.19 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 O-C-N 123.728 1.383 . . . . 35.7 110.373 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 76' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -91.66 153.12 19.9 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.383 -0.823 . . . . 66.48 110.428 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 77' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -81.4 95.24 6.98 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.368 -0.832 . . . . 46.72 110.117 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 78' ' ' LEU . . . . . . . . . . . . . 96.4 mt -96.45 28.0 3.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.381 -0.825 . . . . 37.55 110.182 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 79' ' ' THR . . . . . . . . . . . . . 29.6 m -56.2 -54.64 42.82 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.337 -0.852 . . . . 37.36 110.295 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 80' ' ' LEU . . . . . . . . . . . . . 15.8 mt -60.95 -23.14 65.07 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.348 -0.845 . . . . 35.83 110.51 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 81' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -79.52 -39.14 32.68 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.133 -0.98 . . . . 44.03 110.381 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.4 -28.7 66.4 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.26 -0.9 . . . . 32.54 110.303 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 83' ' ' ILE . . . . . . . . . . . . . 77.7 mt -70.09 -46.06 73.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.253 -0.905 . . . . 32.02 110.342 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 84' ' ' LYS . . . . . . . . . . . . . 36.0 tttm -55.22 -52.06 64.57 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.179 -0.951 . . . . 34.09 110.596 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 85' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -54.8 -46.86 74.54 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.191 -0.943 . . . . 25.94 110.305 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 86' ' ' LEU . . . . . . . . . . . . . 24.2 mt -58.71 -43.76 90.16 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.267 -0.896 . . . . 16.2 109.957 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 87' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -65.36 -35.27 80.45 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.393 -0.817 . . . . 49.09 110.305 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 88' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -78.4 -19.06 54.09 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.284 -0.885 . . . . 28.61 110.509 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 89' ' ' LEU . . . . . . . . . . . . . 32.4 mt -96.16 -29.43 14.06 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.225 -0.922 . . . . 26.16 110.2 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 90' ' ' THR . . . . . . . . . . . . . 59.9 p -105.77 -34.58 7.64 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.3 -0.875 . . . . 33.33 109.724 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.85 16.1 58.6 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.821 -1.312 . . . . 31.13 109.821 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 92' ' ' LEU . . . . . . . . . . . . . 97.1 mt -100.11 155.19 17.87 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.169 -1.195 . . . . 42.52 110.246 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 93' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -86.15 91.59 8.48 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.471 -0.768 . . . . 68.46 110.006 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 94' ' ' LEU . . . . . 0.446 ' HB3' ' CZ2' ' R' ' 52' ' ' TRP . 48.2 mt -99.41 53.08 0.95 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.176 -0.952 . . . . 44.63 110.364 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' R' R ' 95' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.52 -38.7 6.36 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.226 -0.921 . . . . 67.16 110.376 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' R' R ' 96' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -113.85 44.11 1.69 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.332 -0.855 . . . . 67.02 110.325 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 97' ' ' GLY . . . . . . . . . . . . . . . 99.24 150.83 25.99 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.599 -1.401 . . . . 49.48 109.599 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 98' ' ' GLY . . . . . . . . . . . . . . . -166.27 160.03 33.46 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.267 -1.533 . . . . 36.57 109.267 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 99' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.57 121.11 7.14 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.74 1.39 . . . . 30.41 110.462 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 100' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.32 -31.52 11.46 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.637 1.335 . . . . 29.94 110.545 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.07 -38.49 75.77 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.296 -0.878 . . . . 23.64 110.184 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.71 -40.66 66.0 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.335 -0.853 . . . . 20.31 110.411 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' R' R ' 103' ' ' VAL . . . . . . . . . . . . . 63.3 t -58.15 -40.13 76.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.227 -0.92 . . . . 16.33 109.986 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 104' ' ' ILE . . . . . . . . . . . . . 82.0 mt -71.72 -30.47 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.374 -0.829 . . . . 24.77 109.951 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 105' ' ' TRP . . . . . 0.44 ' O ' ' HD3' ' R' ' 108' ' ' LYS . 70.6 t-105 -82.44 0.81 40.5 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.304 -0.873 . . . . 23.28 110.273 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' R' R ' 106' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -105.05 -10.37 17.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.171 -0.956 . . . . 28.26 110.146 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 107' ' ' ILE . . . . . . . . . . . . . 36.8 pt -126.82 34.9 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.184 -0.947 . . . . 18.77 110.076 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 108' ' ' LYS . . . . . 0.48 ' HG2' ' HB ' ' R' ' 115' ' ' ILE . 9.2 mtpp -60.97 -48.5 81.52 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.516 -0.74 . . . . 42.5 110.06 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' R' R ' 109' ' ' HIS . . . . . 0.432 ' CD2' ' HG ' ' R' ' 110' ' ' LEU . 50.8 p-80 -66.02 -12.87 58.26 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.511 -0.743 . . . . 20.07 110.698 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' R' R ' 110' ' ' LEU . . . . . 0.432 ' HG ' ' CD2' ' R' ' 109' ' ' HIS . 80.5 mt -94.71 -17.38 22.27 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.042 -1.036 . . . . 15.69 110.194 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' R' R ' 111' ' ' LEU . . . . . 0.447 HD22 ' CE2' ' R' ' 60' ' ' PHE . 10.3 mt -94.09 144.17 25.72 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.368 -0.832 . . . . 25.39 111.016 -179.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' R' R ' 112' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -77.71 -17.35 57.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.552 -0.717 . . . . 53.48 109.835 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 113' ' ' THR . . . . . 0.418 HG22 ' HG2' ' R' ' 123' ' ' GLU . 59.6 m -83.71 166.71 17.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.347 -0.846 . . . . 14.8 110.29 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' R' R ' 114' ' ' GLY . . . . . . . . . . . . . . . -97.98 127.16 9.13 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.947 -1.261 . . . . 16.14 109.947 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 115' ' ' ILE . . . . . 0.48 ' HB ' ' HG2' ' R' ' 108' ' ' LYS . 47.7 mm -109.17 139.36 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.525 -0.985 . . . . 13.46 109.725 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' R' R ' 116' ' ' GLY . . . . . . . . . . . . . . . -152.72 -155.87 7.29 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.933 -1.267 . . . . 23.9 109.933 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 117' ' ' THR . . . . . . . . . . . . . 18.9 p -135.03 -171.36 2.78 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.484 -1.01 . . . . 27.37 110.072 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.6 -58.04 9.77 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.297 -0.877 . . . . 18.76 110.064 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 119' ' ' SER . . . . . 0.427 ' HA ' ' CB ' ' R' ' 194' ' ' ALA . 1.1 m -56.56 -40.56 75.37 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.266 -0.896 . . . . 32.35 109.787 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' R' R ' 120' ' ' ARG . . . . . 0.419 ' NH1' ' CE2' ' S' ' 305' ' ' TRP . 10.0 mtm180 -110.08 86.23 4.87 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.487 -0.758 . . . . 27.12 109.673 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' R' R ' 121' ' ' PRO . . . . . 0.427 ' O ' ' HB2' ' R' ' 122' ' ' SER . 44.3 Cg_endo -71.24 166.41 29.32 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.874 1.46 . . . . 22.68 111.03 -179.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' R' R ' 122' ' ' SER . . . . . 0.427 ' HB2' ' O ' ' R' ' 121' ' ' PRO . 38.5 t 178.61 -161.64 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.61 -0.681 . . . . 22.99 109.513 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' R' R ' 123' ' ' GLU . . . . . 0.418 ' HG2' HG22 ' R' ' 113' ' ' THR . 2.3 tp10 -56.45 -39.95 74.0 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.211 -0.93 . . . . 36.18 109.762 179.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' R' R ' 124' ' ' VAL . . . . . . . . . . . . . 84.6 t -142.55 136.48 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.534 -0.729 . . . . 20.64 109.43 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 125' ' ' CYS . . . . . 0.41 ' SG ' ' HA ' ' R' ' 121' ' ' PRO . 82.9 m -140.31 168.2 20.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.161 -0.962 . . . . 22.8 111.136 -179.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' R' R ' 126' ' ' VAL . . . . . . . . . . . . . 35.9 m -122.74 159.8 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.714 -0.616 . . . . 21.24 109.664 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 127' ' ' VAL . . . . . 0.4 HG11 ' O ' ' R' ' 177' ' ' VAL . 30.7 m -70.86 141.82 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.293 -0.879 . . . . 19.77 110.657 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' R' R ' 128' ' ' ASP . . . . . . . . . . . . . 53.9 p-10 -137.73 19.38 2.87 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.327 -0.858 . . . . 29.21 110.687 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 129' ' ' GLY . . . . . . . . . . . . . . . 114.11 0.0 23.98 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.965 -1.112 . . . . 33.86 110.469 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 130' ' ' THR . . . . . . . . . . . . . 58.6 m -91.93 131.85 36.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.105 -1.233 . . . . 26.41 110.046 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -62.56 120.65 11.56 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.38 -0.825 . . . . 33.08 110.302 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 132' ' ' MET . . . . . 0.426 ' HE1' ' CZ ' ' R' ' 180' ' ' PHE . 98.4 mmm -105.21 165.66 10.94 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.395 -0.816 . . . . 30.76 110.435 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' R' R ' 133' ' ' CYS . . . . . . . . . . . . . 32.5 m -141.17 158.12 44.33 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.493 -0.754 . . . . 27.0 109.969 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 134' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.54 -19.68 39.82 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.347 -0.846 . . . . 33.9 110.444 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' R' R ' 135' ' ' ALA . . . . . . . . . . . . . . . -92.72 8.2 40.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.182 -0.949 . . . . 19.37 110.882 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 136' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -93.76 -21.74 19.13 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.143 -0.973 . . . . 30.47 110.266 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 137' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -149.98 165.38 32.85 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.341 -0.85 . . . . 24.27 110.204 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 138' ' ' HIS . . . . . . . . . . . . . 15.1 p80 -117.87 15.2 14.33 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.398 -0.814 . . . . 20.91 110.404 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 139' ' ' ALA . . . . . 0.441 ' HA ' ' O ' ' R' ' 152' ' ' ALA . . . -177.23 152.35 0.86 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.198 -0.939 . . . . 15.69 110.184 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' R' R ' 140' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' R' ' 179' ' ' VAL . . . 161.81 175.15 32.53 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.928 -1.269 . . . . 23.76 109.928 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' R' R ' 141' ' ' ILE . . . . . . . . . . . . . 83.7 mt -95.51 136.56 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.358 -1.084 . . . . 25.3 109.713 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 142' ' ' PHE . . . . . 0.546 ' CD2' ' HB2' ' R' ' 172' ' ' PRO . 83.0 m-85 -120.73 -172.52 2.4 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.375 -0.828 . . . . 30.24 110.528 -179.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' R' R ' 143' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -119.86 77.73 1.26 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.417 -0.802 . . . . 32.8 110.289 -179.902 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' R' R ' 144' ' ' LYS . . . . . 0.454 ' HG3' ' CZ2' ' R' ' 170' ' ' TRP . 1.0 OUTLIER -69.5 76.82 0.41 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.437 -0.789 . . . . 49.18 109.676 179.575 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' R' R ' 145' ' ' GLY . . . . . . . . . . . . . . . 104.48 179.24 24.86 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.203 -1.559 . . . . 53.87 109.203 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 146' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -88.47 145.85 25.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.358 -1.083 . . . . 68.58 109.982 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 147' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 58.21 36.47 25.78 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.26 -0.9 . . . . 56.62 110.665 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 148' ' ' HIS . . . . . . . . . . . . . 44.6 t60 -158.61 148.17 19.31 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.193 -0.942 . . . . 44.57 110.376 179.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 149' ' ' ALA . . . . . . . . . . . . . . . -150.29 146.92 27.06 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.427 -0.796 . . . . 33.54 110.078 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 150' ' ' VAL . . . . . 0.428 HG23 ' HB2' ' R' ' 144' ' ' LYS . 34.2 m -142.38 161.47 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.234 -0.916 . . . . 27.61 110.301 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' R' R ' 151' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' R' ' 152' ' ' ALA . 5.9 t80 -86.18 155.57 20.68 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.402 -0.811 . . . . 23.04 109.918 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' R' R ' 152' ' ' ALA . . . . . 0.537 ' N ' ' CD1' ' R' ' 151' ' ' PHE . . . -157.28 151.57 24.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.438 -0.789 . . . . 29.61 109.601 179.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' R' R ' 153' ' ' CYS . . . . . 0.405 ' HA ' ' HA ' ' R' ' 139' ' ' ALA . 26.7 p -154.28 173.61 15.93 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.268 -0.895 . . . . 22.75 110.407 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' R' R ' 154' ' ' VAL . . . . . 0.443 ' CG2' ' CZ2' ' R' ' 159' ' ' TRP . 60.3 t -90.63 117.03 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.383 -0.823 . . . . 23.26 110.061 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' R' R ' 155' ' ' THR . . . . . . . . . . . . . 70.3 p -112.13 -176.62 2.97 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.356 -0.84 . . . . 17.88 110.041 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 156' ' ' SER . . . . . . . . . . . . . 78.5 p -75.92 -3.74 37.08 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.33 -0.856 . . . . 21.83 110.678 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 157' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -118.3 10.51 12.83 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.207 -0.933 . . . . 36.54 110.652 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 158' ' ' GLY . . . . . . . . . . . . . . . 117.96 -162.58 13.06 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.559 -1.416 . . . . 31.74 109.559 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 159' ' ' TRP . . . . . 0.443 ' CZ2' ' CG2' ' R' ' 154' ' ' VAL . 14.6 m95 -86.68 122.5 30.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.35 -1.088 . . . . 28.25 110.109 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' R' R ' 160' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -108.46 166.94 10.39 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.345 -0.847 . . . . 41.24 110.19 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 161' ' ' ALA . . . . . . . . . . . . . . . -143.18 123.5 13.84 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.403 -0.81 . . . . 27.4 110.151 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 162' ' ' ILE . . . . . 0.431 HG23 ' CZ ' ' R' ' 167' ' ' PHE . 92.2 mt -87.63 81.11 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.373 -0.829 . . . . 24.27 110.078 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' R' R ' 163' ' ' ASP . . . . . 0.415 ' O ' ' N ' ' R' ' 165' ' ' GLU . 15.3 t0 -72.74 92.35 1.55 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.389 -0.819 . . . . 36.08 110.277 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' R' R ' 164' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 54.06 -88.89 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.526 -0.734 . . . . 46.08 110.556 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 165' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' R' ' 163' ' ' ASP . 29.6 mt-10 -124.72 35.82 4.72 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.151 -0.968 . . . . 50.94 110.148 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' R' R ' 166' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -135.67 117.36 14.99 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.362 -0.836 . . . . 47.28 110.353 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 167' ' ' PHE . . . . . 0.431 ' CZ ' HG23 ' R' ' 162' ' ' ILE . 24.4 m-85 -101.12 119.96 39.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.401 -0.812 . . . . 40.47 110.083 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' R' R ' 168' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -157.51 158.61 30.74 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.25 -0.906 . . . . 30.21 110.466 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 169' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.81 133.07 19.48 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.928 1.488 . . . . 32.76 110.5 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 170' ' ' TRP . . . . . 0.454 ' CZ2' ' HG3' ' R' ' 144' ' ' LYS . 67.1 t90 -159.83 119.35 2.88 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.34 -0.85 . . . . 32.79 109.965 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' R' R ' 171' ' ' THR . . . . . . . . . . . . . 46.9 m -81.09 112.58 33.91 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.431 -0.793 . . . . 36.92 110.155 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 172' ' ' PRO . . . . . 0.546 ' HB2' ' CD2' ' R' ' 142' ' ' PHE . 47.0 Cg_endo -73.67 158.76 46.79 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.622 1.328 . . . . 33.54 110.548 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' R' R ' 173' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -88.91 145.03 33.81 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.324 -0.86 . . . . 45.76 109.86 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 174' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -71.85 -10.28 26.07 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 O-C-N 123.71 1.374 . . . . 29.63 110.41 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 175' ' ' SER . . . . . . . . . . . . . 53.0 p -103.44 -17.64 15.15 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.348 -0.845 . . . . 35.7 110.366 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 176' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -103.51 43.29 1.09 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.268 -0.895 . . . . 39.65 110.418 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 177' ' ' VAL . . . . . 0.4 ' O ' HG11 ' R' ' 127' ' ' VAL . 10.7 p -117.72 127.06 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.3 -0.875 . . . . 20.61 110.094 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' R' R ' 178' ' ' LEU . . . . . . . . . . . . . 46.2 mt -91.42 -61.3 1.68 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.349 -0.845 . . . . 15.58 109.392 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 179' ' ' VAL . . . . . 0.403 ' O ' ' HA3' ' R' ' 140' ' ' GLY . 68.6 t -114.64 144.76 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.561 -0.712 . . . . 17.4 109.384 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' R' R ' 180' ' ' PHE . . . . . 0.426 ' CZ ' ' HE1' ' R' ' 132' ' ' MET . 43.6 p90 -152.15 163.36 39.54 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.197 -0.94 . . . . 20.16 110.63 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' R' R ' 181' ' ' VAL . . . . . . . . . . . . . 66.2 t -113.17 111.44 50.27 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.375 -0.828 . . . . 17.69 109.836 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 182' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.03 149.49 52.84 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.532 1.28 . . . . 17.81 110.409 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' R' R ' 183' ' ' TYR . . . . . 0.712 ' O ' ' C ' ' R' ' 184' ' ' ASP . 79.1 m-85 -59.03 175.52 0.28 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.458 -0.776 . . . . 28.01 110.504 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' R' R ' 184' ' ' ASP . . . . . 0.712 ' C ' ' O ' ' R' ' 183' ' ' TYR . 15.0 t70 -17.26 -81.98 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.353 -0.842 . . . . 58.64 110.313 -178.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' R' R ' 185' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 . . . . . 0 N--CA 1.503 2.2 0 CA-C-O 121.277 0.56 . . . . 80.42 111.791 179.553 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' R' R ' 193' ' ' LYS . . . . . . . . . . . . . 26.8 tptt . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 120.907 0.384 . . . . 49.5 110.145 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' R' R ' 194' ' ' ALA . . . . . 0.427 ' CB ' ' HA ' ' R' ' 119' ' ' SER . . . . . . . . 0 N--CA 1.496 1.835 0 O-C-N 121.12 -0.988 . . . . 40.4 110.082 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 229' ' ' MET . . . . . . . . . . . . . 15.9 mmm . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.231 0.539 . . . . 51.83 110.228 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' S' S ' 230' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -97.31 142.76 28.8 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.292 -0.88 . . . . 54.13 110.133 -178.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 231' ' ' LEU . . . . . . . . . . . . . 68.3 mt -134.13 141.05 46.97 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.306 -0.871 . . . . 33.04 110.372 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 232' ' ' THR . . . . . . . . . . . . . 40.3 m -89.28 103.25 15.89 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.362 -0.836 . . . . 26.92 110.0 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 233' ' ' LEU . . . . . 0.494 HD23 ' CE2' ' S' ' 262' ' ' TYR . 79.7 mt -55.88 179.3 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.418 -0.801 . . . . 13.78 110.493 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' S' S ' 234' ' ' TYR . . . . . 0.448 ' CG ' ' N ' ' S' ' 235' ' ' ASN . 35.5 p90 -64.96 -35.73 82.13 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.453 -0.779 . . . . 26.08 110.213 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' S' S ' 235' ' ' ASN . . . . . 0.448 ' N ' ' CG ' ' S' ' 234' ' ' TYR . 50.7 p30 -74.29 -7.42 52.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.289 -0.882 . . . . 20.04 110.601 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' S' S ' 236' ' ' GLY . . . . . . . . . . . . . . . 95.74 -19.91 52.21 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.748 -1.341 . . . . 22.71 109.748 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 237' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -53.08 145.74 12.65 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.243 -1.151 . . . . 35.44 110.165 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 238' ' ' LYS . . . . . . . . . . . . . 44.5 mttt -102.15 127.97 48.84 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.391 -0.818 . . . . 32.56 110.337 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 239' ' ' LYS . . . . . 0.422 ' HG2' ' CZ ' ' S' ' 241' ' ' PHE . 9.0 ttmt -132.29 144.49 50.63 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.391 -0.818 . . . . 26.68 109.949 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' S' S ' 240' ' ' THR . . . . . . . . . . . . . 51.3 m -102.06 132.2 48.07 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.329 -0.857 . . . . 41.02 110.39 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 241' ' ' PHE . . . . . 0.422 ' CZ ' ' HG2' ' S' ' 239' ' ' LYS . 96.1 m-85 -117.88 137.72 52.6 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.364 -0.835 . . . . 28.62 110.195 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' S' S ' 242' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -96.44 161.83 13.75 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.365 -0.835 . . . . 47.89 110.163 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 243' ' ' SER . . . . . . . . . . . . . 72.4 m -90.59 151.58 21.25 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.295 -0.878 . . . . 45.09 110.241 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 244' ' ' ARG . . . . . . . . . . . . . 1.4 mtp85 -129.81 126.75 22.69 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.402 -0.811 . . . . 42.49 110.162 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 245' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.37 161.05 43.57 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 O-C-N 123.666 1.351 . . . . 35.68 110.503 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 246' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -132.94 97.88 4.14 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.391 -0.818 . . . . 51.88 109.82 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 247' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -110.5 -22.23 11.77 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.4 -0.813 . . . . 53.69 110.643 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 248' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -117.21 43.63 2.28 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.178 -0.951 . . . . 55.79 110.774 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 249' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 48.77 38.43 11.79 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.443 -0.785 . . . . 49.45 110.381 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 250' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -90.62 29.07 1.36 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.521 -0.737 . . . . 36.86 110.31 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 251' ' ' ALA . . . . . . . . . . . . . . . -53.9 -43.13 69.42 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.322 -0.861 . . . . 29.69 109.56 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 252' ' ' TRP . . . . . 0.408 ' CZ2' ' HB3' ' S' ' 294' ' ' LEU . 67.8 p-90 -61.83 -33.97 75.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.556 -0.715 . . . . 41.12 109.832 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' S' S ' 253' ' ' LEU . . . . . 0.407 ' N ' ' CD2' ' S' ' 252' ' ' TRP . 23.3 tp -70.11 -47.14 63.07 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.335 -0.853 . . . . 24.89 110.002 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' S' S ' 254' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -56.23 -42.51 77.41 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.326 -0.859 . . . . 35.65 109.909 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 255' ' ' ALA . . . . . . . . . . . . . . . -59.47 -48.13 82.83 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.402 -0.811 . . . . 22.73 110.115 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 256' ' ' ILE . . . . . . . . . . . . . 79.9 mt -62.31 -40.72 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.326 -0.858 . . . . 28.85 109.986 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 257' ' ' LEU . . . . . . . . . . . . . 19.1 mt -61.49 -44.52 96.92 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.405 -0.809 . . . . 23.07 110.186 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 258' ' ' GLN . . . . . 0.471 ' HB3' ' CD2' ' S' ' 351' ' ' PHE . 53.5 mm-40 -65.04 -45.3 85.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.402 -0.811 . . . . 29.78 109.993 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' S' S ' 259' ' ' LEU . . . . . 0.422 ' O ' HG22 ' S' ' 263' ' ' VAL . 20.0 tp -58.71 -36.41 74.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.236 -0.915 . . . . 17.94 109.453 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' S' S ' 260' ' ' PHE . . . . . 0.468 ' CE2' HD22 ' S' ' 311' ' ' LEU . 3.1 m-85 -62.77 -45.35 93.07 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.624 -0.673 . . . . 30.57 109.857 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' S' S ' 261' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -62.01 -29.8 70.52 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.432 -0.792 . . . . 41.34 109.98 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 262' ' ' TYR . . . . . 0.494 ' CE2' HD23 ' S' ' 233' ' ' LEU . 8.7 t80 -71.15 -44.68 65.06 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.415 -0.803 . . . . 26.03 110.102 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' S' S ' 263' ' ' VAL . . . . . 0.422 HG22 ' O ' ' S' ' 259' ' ' LEU . 33.0 m -91.93 18.19 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.293 -0.88 . . . . 22.8 110.403 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' S' S ' 264' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 52.75 70.71 0.55 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.26 -0.9 . . . . 44.03 110.586 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 265' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -111.79 109.17 55.5 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.332 -0.855 . . . . 35.61 109.716 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 266' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -75.33 0.48 8.99 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 O-C-N 123.637 1.335 . . . . 37.67 111.768 -179.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 267' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -56.58 -67.71 0.28 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.797 -1.189 . . . . 41.49 110.18 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' S' S ' 268' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -92.81 39.83 1.04 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.177 -0.952 . . . . 50.76 110.124 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 269' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.99 -33.21 59.72 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.424 -0.798 . . . . 61.86 109.806 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' S' S ' 270' ' ' TRP . . . . . 0.486 ' CE2' ' CG2' ' S' ' 271' ' ' VAL . 50.9 p-90 -73.9 -4.35 34.5 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.279 -0.888 . . . . 39.85 110.5 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' S' S ' 271' ' ' VAL . . . . . 0.486 ' CG2' ' CE2' ' S' ' 270' ' ' TRP . 46.5 t -109.49 -32.68 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.15 -0.969 . . . . 39.18 110.088 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' S' S ' 272' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -78.68 -36.53 43.56 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.443 -0.786 . . . . 40.02 110.489 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 273' ' ' SER . . . . . . . . . . . . . 71.0 m -103.53 56.07 0.74 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.292 -0.88 . . . . 47.2 110.314 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 274' ' ' SER . . . . . . . . . . . . . 6.9 t -133.01 141.24 40.23 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.317 -0.865 . . . . 47.61 110.159 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 275' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.72 -18.92 21.78 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 123.678 1.357 . . . . 45.28 110.526 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 276' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -99.98 140.9 33.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.246 -0.909 . . . . 57.27 110.299 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 277' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -71.7 97.67 1.79 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.355 -0.841 . . . . 37.28 110.284 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 278' ' ' LEU . . . . . . . . . . . . . 86.4 mt -96.99 33.8 1.84 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.441 -0.787 . . . . 43.88 110.014 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 279' ' ' THR . . . . . . . . . . . . . 76.9 m -64.02 -60.23 3.5 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.457 -0.777 . . . . 50.05 110.203 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 280' ' ' LEU . . . . . . . . . . . . . 13.7 mt -51.53 -39.87 58.55 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.343 -0.848 . . . . 54.12 110.316 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 281' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.39 -49.71 74.44 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.457 -0.777 . . . . 65.28 110.178 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' S' S ' 282' ' ' ALA . . . . . . . . . . . . . . . -58.88 -33.98 71.12 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.514 -0.741 . . . . 46.51 110.557 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 283' ' ' ILE . . . . . . . . . . . . . 85.9 mt -66.37 -50.86 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.328 -0.857 . . . . 47.3 110.101 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 284' ' ' LYS . . . . . . . . . . . . . 33.6 tttp -50.46 -57.68 7.48 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.422 -0.799 . . . . 50.72 110.381 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 285' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -51.31 -46.5 62.58 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.494 -0.754 . . . . 68.47 110.312 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 286' ' ' LEU . . . . . . . . . . . . . 19.1 mt -59.89 -44.5 94.2 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.379 -0.825 . . . . 36.62 110.3 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 287' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -62.81 -35.26 79.33 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.319 -0.863 . . . . 46.64 110.043 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 288' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -76.17 -21.11 56.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.405 -0.809 . . . . 46.45 110.381 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 289' ' ' LEU . . . . . . . . . . . . . 30.8 mt -97.26 -21.76 17.07 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.244 -0.91 . . . . 35.09 110.582 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 290' ' ' THR . . . . . . . . . . . . . 81.5 p -114.76 -28.52 7.06 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.25 -0.906 . . . . 38.61 110.429 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 291' ' ' GLY . . . . . . . . . . . . . . . 79.38 11.11 85.27 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.789 -1.324 . . . . 36.77 109.789 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 292' ' ' LEU . . . . . . . . . . . . . 84.5 mt -96.48 145.76 25.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.336 -1.096 . . . . 35.33 109.77 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 293' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -77.3 102.33 6.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.222 -0.923 . . . . 48.7 110.316 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 294' ' ' LEU . . . . . 0.408 ' HB3' ' CZ2' ' S' ' 252' ' ' TRP . 55.4 mt -106.86 51.7 0.74 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.503 -0.748 . . . . 42.61 110.136 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' S' S ' 295' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -112.48 -11.2 13.65 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.377 -0.827 . . . . 55.49 110.498 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' S' S ' 296' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -144.29 48.45 1.37 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.059 -1.025 . . . . 75.68 110.338 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 297' ' ' GLY . . . . . . . . . . . . . . . 96.91 145.12 18.6 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.48 -1.448 . . . . 49.44 109.48 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 298' ' ' GLY . . . . . . . . . . . . . . . -163.79 156.93 29.01 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.775 -1.33 . . . . 41.11 109.775 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 299' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.8 118.3 5.39 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 O-C-N 123.992 1.522 . . . . 26.2 110.277 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 300' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.21 -15.56 31.76 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 O-C-N 123.616 1.324 . . . . 21.7 110.692 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 301' ' ' ALA . . . . . . . . . . . . . . . -80.65 -29.36 36.69 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.175 -0.953 . . . . 31.23 110.133 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 302' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.43 -40.64 19.05 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.503 -0.748 . . . . 38.99 109.975 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' S' S ' 303' ' ' VAL . . . . . 0.457 ' O ' HG12 ' S' ' 307' ' ' ILE . 58.2 t -60.7 -35.46 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.435 -0.791 . . . . 18.63 110.177 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' S' S ' 304' ' ' ILE . . . . . . . . . . . . . 86.1 mt -79.43 -23.56 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.423 -0.798 . . . . 25.46 110.19 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 305' ' ' TRP . . . . . 0.419 ' CE2' ' NH1' ' R' ' 120' ' ' ARG . 68.8 t-105 -88.65 -14.52 37.21 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.224 -0.923 . . . . 33.4 110.581 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' S' S ' 306' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -89.76 -13.52 36.54 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.142 -0.974 . . . . 36.97 110.399 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 307' ' ' ILE . . . . . 0.457 HG12 ' O ' ' S' ' 303' ' ' VAL . 36.8 pt -125.05 45.71 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.164 -0.96 . . . . 30.81 110.071 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' S' S ' 308' ' ' LYS . . . . . 0.405 ' HD3' ' CD2' ' S' ' 305' ' ' TRP . 1.5 mtmp? -73.59 -37.75 65.36 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.378 -0.826 . . . . 46.52 110.077 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' S' S ' 309' ' ' HIS . . . . . 0.488 ' CD2' ' HG ' ' S' ' 310' ' ' LEU . 55.5 p-80 -73.17 -8.28 55.08 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.35 -0.844 . . . . 51.03 110.161 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' S' S ' 310' ' ' LEU . . . . . 0.488 ' HG ' ' CD2' ' S' ' 309' ' ' HIS . 53.0 mt -99.32 -12.92 19.89 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.347 -0.845 . . . . 36.16 109.943 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' S' S ' 311' ' ' LEU . . . . . 0.468 HD22 ' CE2' ' S' ' 260' ' ' PHE . 10.8 mt -97.12 147.85 23.64 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.381 -0.824 . . . . 40.0 110.429 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' S' S ' 312' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -81.59 -16.32 51.97 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.322 -0.861 . . . . 54.18 109.748 179.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 313' ' ' THR . . . . . 0.471 HG23 ' HB3' ' S' ' 323' ' ' GLU . 92.9 m -87.94 151.66 22.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.337 -0.852 . . . . 25.61 110.115 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' S' S ' 314' ' ' GLY . . . . . . . . . . . . . . . -87.95 126.38 8.04 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.768 -1.333 . . . . 25.18 109.768 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 315' ' ' ILE . . . . . 0.427 HG23 HD11 ' S' ' 315' ' ' ILE . 50.7 mm -101.66 150.48 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.441 -1.034 . . . . 23.9 109.725 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' S' S ' 316' ' ' GLY . . . . . 0.405 ' N ' HG21 ' S' ' 315' ' ' ILE . . . -157.04 -159.31 9.4 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.931 -1.268 . . . . 23.18 109.931 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' S' S ' 317' ' ' THR . . . . . . . . . . . . . 11.2 p -133.9 -172.98 3.12 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.468 -1.019 . . . . 27.98 110.044 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.59 -56.19 25.06 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.163 -0.961 . . . . 28.1 109.874 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 319' ' ' SER . . . . . . . . . . . . . 1.2 m -59.93 -41.63 92.19 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.326 -0.859 . . . . 37.0 109.663 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 320' ' ' ARG . . . . . . . . . . . . . 12.1 mtm180 -111.73 79.8 2.64 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.466 -0.771 . . . . 52.07 109.655 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 321' ' ' PRO . . . . . 0.428 ' O ' ' HB2' ' S' ' 322' ' ' SER . 44.4 Cg_endo -71.38 171.51 16.01 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.783 1.412 . . . . 38.29 110.979 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' S' S ' 322' ' ' SER . . . . . 0.428 ' HB2' ' O ' ' S' ' 321' ' ' PRO . 41.3 t 178.67 -148.15 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.956 -0.757 . . . . 38.84 108.956 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' S' S ' 323' ' ' GLU . . . . . 0.471 ' HB3' HG23 ' S' ' 313' ' ' THR . 6.7 tp10 -62.87 -40.29 97.05 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.043 -1.036 . . . . 40.7 109.64 179.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' S' S ' 324' ' ' VAL . . . . . . . . . . . . . 73.6 t -141.27 134.99 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.35 -0.844 . . . . 20.34 109.469 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 325' ' ' CYS . . . . . 0.458 ' HB2' ' CE1' ' S' ' 380' ' ' PHE . 11.1 m -125.99 172.26 10.09 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.312 -0.868 . . . . 30.63 110.924 -179.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' S' S ' 326' ' ' VAL . . . . . . . . . . . . . 34.5 m -135.56 142.16 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 109.175 -0.676 . . . . 23.9 109.175 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 327' ' ' VAL . . . . . . . . . . . . . 34.6 m -56.37 125.02 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.112 -0.992 . . . . 19.48 110.39 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 328' ' ' ASP . . . . . . . . . . . . . 55.7 p-10 -119.4 11.61 12.23 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.418 -0.801 . . . . 26.43 110.439 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 329' ' ' GLY . . . . . . . . . . . . . . . 119.59 2.3 13.17 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.068 -1.213 . . . . 31.24 110.068 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 330' ' ' THR . . . . . . . . . . . . . 81.0 m -92.97 129.94 38.71 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.101 -1.235 . . . . 30.05 110.133 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 331' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -56.77 111.5 1.04 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.302 -0.873 . . . . 37.26 109.992 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 332' ' ' MET . . . . . 0.449 ' HE1' ' CZ ' ' S' ' 380' ' ' PHE . 87.9 mmm -94.08 162.58 13.82 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.235 -0.915 . . . . 26.23 110.334 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' S' S ' 333' ' ' CYS . . . . . . . . . . . . . 26.4 m -137.15 150.05 47.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.42 -0.8 . . . . 23.56 110.078 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 334' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.6 -24.9 9.18 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.228 -0.92 . . . . 28.93 110.508 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' S' S ' 335' ' ' ALA . . . . . . . . . . . . . . . -89.02 14.45 10.58 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.319 -0.863 . . . . 15.76 110.964 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 336' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -100.49 -17.15 17.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.134 -0.979 . . . . 34.92 110.214 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 337' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -152.42 170.81 19.21 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.39 -0.819 . . . . 19.03 110.154 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 338' ' ' HIS . . . . . . . . . . . . . 13.5 p80 -120.73 10.4 10.97 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.394 -0.816 . . . . 18.82 110.411 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 339' ' ' ALA . . . . . . . . . . . . . . . -176.04 155.16 1.54 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.206 -0.934 . . . . 17.18 110.09 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 340' ' ' GLY . . . . . . . . . . . . . . . 160.85 173.05 28.97 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.001 -1.24 . . . . 18.33 110.001 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 341' ' ' ILE . . . . . 0.445 HD12 HG22 ' S' ' 341' ' ' ILE . 83.9 mt -88.8 138.08 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.393 -1.063 . . . . 18.6 109.839 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' S' S ' 342' ' ' PHE . . . . . 0.493 ' CE1' HG23 ' S' ' 377' ' ' VAL . 69.9 m-85 -120.93 -178.49 3.75 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.219 -0.926 . . . . 23.44 110.412 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' S' S ' 343' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.84 93.4 4.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.397 -0.814 . . . . 35.59 110.07 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' S' S ' 344' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.82 125.04 29.59 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.236 -0.915 . . . . 38.34 110.046 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' S' S ' 345' ' ' GLY . . . . . . . . . . . . . . . 62.85 -130.85 42.89 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 108.788 -1.725 . . . . 53.46 108.788 -179.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 346' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -132.7 150.88 52.1 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.173 -1.192 . . . . 70.91 110.011 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 347' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 53.31 35.36 20.02 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.236 -0.915 . . . . 47.32 110.393 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 348' ' ' HIS . . . . . . . . . . . . . 46.6 t60 -150.11 155.89 40.66 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.317 -0.865 . . . . 41.72 110.312 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 349' ' ' ALA . . . . . . . . . . . . . . . -149.79 151.3 33.34 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.324 -0.86 . . . . 22.91 110.442 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 350' ' ' VAL . . . . . . . . . . . . . 34.6 m -149.14 169.55 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.448 -0.782 . . . . 21.09 109.995 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 351' ' ' PHE . . . . . 0.471 ' CD2' ' HB3' ' S' ' 258' ' ' GLN . 10.7 t80 -105.27 143.58 33.25 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.19 -0.944 . . . . 25.03 110.716 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' S' S ' 352' ' ' ALA . . . . . . . . . . . . . . . -147.7 151.74 36.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.584 -0.698 . . . . 23.81 109.741 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 353' ' ' CYS . . . . . . . . . . . . . 26.3 p -153.34 164.84 37.43 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.295 -0.878 . . . . 25.66 110.225 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 354' ' ' VAL . . . . . 0.404 HG23 ' CZ2' ' S' ' 359' ' ' TRP . 57.2 t -76.04 118.47 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.376 -0.828 . . . . 34.27 109.943 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' S' S ' 355' ' ' THR . . . . . 0.441 HG23 ' HB2' ' S' ' 360' ' ' TYR . 52.3 p -117.82 175.1 5.82 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.257 -0.902 . . . . 25.49 110.346 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' S' S ' 356' ' ' SER . . . . . . . . . . . . . 62.2 p -62.2 -17.61 58.65 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.456 -0.778 . . . . 31.24 110.699 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 357' ' ' ASN . . . . . . . . . . . . . 45.8 m-20 -107.05 14.22 26.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.896 . . . . 28.61 110.552 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 358' ' ' GLY . . . . . . . . . . . . . . . 111.86 -152.92 17.59 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.013 -1.235 . . . . 22.01 110.013 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 359' ' ' TRP . . . . . 0.404 ' CZ2' HG23 ' S' ' 354' ' ' VAL . 15.3 m95 -91.3 116.65 29.0 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.38 -1.071 . . . . 25.54 110.23 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' S' S ' 360' ' ' TYR . . . . . 0.441 ' HB2' HG23 ' S' ' 355' ' ' THR . 1.3 m-85 -103.53 165.79 10.82 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.257 -0.902 . . . . 40.53 110.091 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' S' S ' 361' ' ' ALA . . . . . . . . . . . . . . . -140.01 129.99 24.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.353 -0.842 . . . . 18.04 110.295 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 362' ' ' ILE . . . . . 0.425 HG23 ' CZ ' ' S' ' 367' ' ' PHE . 88.9 mt -95.54 83.61 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.375 -0.828 . . . . 15.64 110.081 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' S' S ' 363' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' S' ' 365' ' ' GLU . 11.9 t0 -75.19 94.48 2.96 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.42 -0.8 . . . . 35.03 110.186 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' S' S ' 364' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 53.92 -89.3 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.53 -0.731 . . . . 46.72 110.537 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 365' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' S' ' 363' ' ' ASP . 23.7 mt-10 -122.69 19.1 10.32 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.046 -1.033 . . . . 56.2 110.223 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' S' S ' 366' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -117.91 124.88 49.34 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.21 -0.932 . . . . 51.02 110.44 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 367' ' ' PHE . . . . . 0.425 ' CZ ' HG23 ' S' ' 362' ' ' ILE . 26.9 m-85 -106.89 127.05 53.09 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.326 -0.859 . . . . 37.59 110.18 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' S' S ' 368' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -165.47 159.5 13.83 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.293 -0.879 . . . . 31.47 110.415 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 369' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.76 139.59 30.9 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 O-C-N 123.891 1.469 . . . . 28.85 110.557 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 370' ' ' TRP . . . . . . . . . . . . . 67.4 t90 -167.25 113.52 0.76 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.422 -0.799 . . . . 26.94 110.001 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 371' ' ' THR . . . . . . . . . . . . . 59.8 m -74.81 113.08 21.02 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.376 -0.828 . . . . 20.19 110.041 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 372' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.59 157.11 49.04 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.644 1.339 . . . . 28.68 110.529 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 373' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -90.58 147.15 35.74 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.411 -0.806 . . . . 35.72 109.934 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 374' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -76.03 -6.27 17.18 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 O-C-N 123.681 1.359 . . . . 30.89 110.461 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 375' ' ' SER . . . . . . . . . . . . . 70.5 p -104.39 -17.0 14.95 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.227 -0.921 . . . . 29.41 110.428 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 376' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -106.48 43.09 1.18 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.358 -0.839 . . . . 32.89 110.26 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 377' ' ' VAL . . . . . 0.493 HG23 ' CE1' ' S' ' 342' ' ' PHE . 7.3 p -114.71 147.29 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.294 -0.879 . . . . 24.33 110.223 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' S' S ' 378' ' ' LEU . . . . . . . . . . . . . 52.5 mt -115.99 -57.96 2.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.381 -0.824 . . . . 24.37 109.611 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 379' ' ' VAL . . . . . . . . . . . . . 61.0 t -120.76 132.38 70.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.404 -0.81 . . . . 18.02 109.424 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 380' ' ' PHE . . . . . 0.458 ' CE1' ' HB2' ' S' ' 325' ' ' CYS . 14.6 p90 -142.61 173.96 11.07 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.376 -0.828 . . . . 29.35 110.704 -179.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' S' S ' 381' ' ' VAL . . . . . . . . . . . . . 57.7 t -120.12 107.31 39.79 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.459 -0.776 . . . . 16.34 109.43 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 382' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -71.19 145.6 49.43 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.613 1.322 . . . . 20.94 110.79 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' S' S ' 383' ' ' TYR . . . . . 0.959 ' O ' ' CB ' ' S' ' 384' ' ' ASP . 88.5 m-85 -61.04 -53.57 55.61 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.317 -0.865 . . . . 28.93 109.826 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' S' S ' 384' ' ' ASP . . . . . 0.959 ' CB ' ' O ' ' S' ' 383' ' ' TYR . 7.0 t70 . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.46 -0.775 . . . . 47.03 110.366 176.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 30' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 121.14 0.495 . . . . 43.36 110.287 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' R' R ' 31' ' ' LEU . . . . . . . . . . . . . 65.3 mt -134.86 140.61 45.95 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.308 -0.87 . . . . 22.93 110.306 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 32' ' ' THR . . . . . . . . . . . . . 68.4 m -87.59 110.59 20.49 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.408 -0.807 . . . . 22.34 109.971 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 33' ' ' LEU . . . . . 0.462 HD23 ' CE2' ' R' ' 62' ' ' TYR . 80.0 mt -62.38 -172.79 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.314 -0.866 . . . . 21.39 110.226 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' R' R ' 34' ' ' TYR . . . . . . . . . . . . . 37.0 p90 -74.68 -29.4 61.21 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.333 -0.855 . . . . 34.4 110.38 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 35' ' ' ASN . . . . . . . . . . . . . 48.3 p30 -77.79 -1.79 33.2 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.356 -0.84 . . . . 30.28 110.699 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.24 -16.55 59.49 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.691 -1.364 . . . . 36.25 109.691 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 37' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -59.04 161.81 4.79 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.314 -1.11 . . . . 53.8 110.368 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 38' ' ' LYS . . . . . . . . . . . . . 56.9 mttt -117.86 135.8 53.86 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.445 -0.784 . . . . 49.91 110.146 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 39' ' ' LYS . . . . . 0.417 ' HG2' ' CZ ' ' R' ' 41' ' ' PHE . 8.1 ttmt -138.75 143.64 39.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.404 -0.81 . . . . 35.69 110.223 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' R' R ' 40' ' ' THR . . . . . . . . . . . . . 23.5 m -102.54 127.96 49.39 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.302 -0.874 . . . . 34.84 110.228 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 41' ' ' PHE . . . . . 0.417 ' CZ ' ' HG2' ' R' ' 39' ' ' LYS . 96.6 m-85 -113.04 132.65 55.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.378 -0.826 . . . . 34.42 110.172 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' R' R ' 42' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -93.36 140.95 28.99 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.331 -0.856 . . . . 51.46 110.221 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 43' ' ' SER . . . . . . . . . . . . . 54.3 m -70.76 141.93 51.42 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.55 -0.719 . . . . 41.84 110.205 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.75 125.37 29.59 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.469 -0.769 . . . . 33.82 110.013 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' R' R ' 45' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.11 151.13 55.13 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.59 1.31 . . . . 30.27 110.625 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 46' ' ' ASN . . . . . . . . . . . . . 52.2 t-20 -124.28 109.84 13.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.459 -0.776 . . . . 35.1 110.071 179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 47' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -120.27 -34.86 3.56 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.395 -0.816 . . . . 42.81 110.551 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 48' ' ' HIS . . . . . . . . . . . . . 73.3 m80 -105.73 45.1 0.99 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.187 -0.946 . . . . 49.97 110.235 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 49' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 50.32 34.72 9.38 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.4 -0.813 . . . . 61.32 110.149 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 50' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -86.32 43.87 1.1 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.323 -0.861 . . . . 51.5 110.66 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.12 -46.11 78.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.165 -0.959 . . . . 38.77 109.541 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 52' ' ' TRP . . . . . 0.483 ' CD2' ' N ' ' R' ' 53' ' ' LEU . 68.2 p-90 -58.4 -38.4 77.27 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.482 -0.761 . . . . 26.24 110.055 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' R' R ' 53' ' ' LEU . . . . . 0.483 ' N ' ' CD2' ' R' ' 52' ' ' TRP . 23.1 tp -66.73 -46.66 74.76 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.456 -0.777 . . . . 26.75 109.946 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' R' R ' 54' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -55.23 -41.54 72.24 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.405 -0.809 . . . . 35.02 110.132 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.26 -46.11 91.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.352 -0.842 . . . . 24.47 110.114 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 56' ' ' ILE . . . . . . . . . . . . . 76.6 mt -62.09 -42.33 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.259 -0.901 . . . . 26.03 109.906 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 57' ' ' LEU . . . . . . . . . . . . . 22.5 mt -60.26 -45.69 92.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.28 -0.888 . . . . 26.77 109.657 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 58' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -63.87 -46.51 84.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.341 -0.849 . . . . 22.32 109.582 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 59' ' ' LEU . . . . . 0.43 ' HA ' ' HE2' ' R' ' 151' ' ' PHE . 24.0 tp -61.43 -37.73 84.6 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.306 -0.871 . . . . 20.55 109.396 179.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' R' R ' 60' ' ' PHE . . . . . 0.448 ' CE2' HD22 ' R' ' 111' ' ' LEU . 2.8 m-85 -61.11 -44.72 96.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.617 -0.677 . . . . 20.08 109.913 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' R' R ' 61' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -63.17 -36.23 82.93 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.498 -0.751 . . . . 18.8 110.408 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 62' ' ' TYR . . . . . 0.462 ' CE2' HD23 ' R' ' 33' ' ' LEU . 9.2 t80 -63.04 -41.74 99.58 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.226 -0.921 . . . . 26.45 110.247 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' R' R ' 63' ' ' VAL . . . . . . . . . . . . . 30.8 m -93.42 20.32 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.308 -0.87 . . . . 29.75 110.266 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 64' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 53.03 75.44 0.24 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.316 -0.865 . . . . 35.52 110.561 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 65' ' ' GLU . . . . . 0.425 ' HG2' ' CD2' ' R' ' 60' ' ' PHE . 14.3 tp10 -116.19 104.01 52.55 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.391 -0.818 . . . . 29.89 109.958 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' R' R ' 66' ' ' PRO . . . . . 0.4 ' HA ' ' HB2' ' R' ' 69' ' ' ASP . 46.6 Cg_endo -73.47 -5.88 17.85 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.708 1.372 . . . . 21.37 111.068 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' R' R ' 67' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -52.11 -61.58 2.17 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.054 -1.029 . . . . 23.85 110.341 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' R' R ' 68' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -98.06 36.52 1.56 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.314 -0.866 . . . . 28.07 110.474 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 69' ' ' ASP . . . . . 0.4 ' HB2' ' HA ' ' R' ' 66' ' ' PRO . 11.7 t0 -72.3 -33.25 67.27 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.307 -0.871 . . . . 43.76 110.205 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' R' R ' 70' ' ' TRP . . . . . 0.476 ' CE2' ' CG2' ' R' ' 71' ' ' VAL . 48.0 p-90 -73.49 -3.85 30.18 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.332 -0.855 . . . . 33.06 110.686 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' R' R ' 71' ' ' VAL . . . . . 0.476 ' CG2' ' CE2' ' R' ' 70' ' ' TRP . 40.8 t -109.83 -27.41 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.175 -0.953 . . . . 31.7 109.674 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' R' R ' 72' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -86.58 -48.88 7.96 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.358 -0.839 . . . . 33.58 110.278 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 73' ' ' SER . . . . . . . . . . . . . 70.2 m -89.67 51.12 2.02 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.312 -0.868 . . . . 50.82 110.308 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 74' ' ' SER . . . . . . . . . . . . . 15.9 t -125.96 138.33 31.88 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.282 -0.886 . . . . 34.74 110.189 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.38 -24.99 15.89 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 O-C-N 123.603 1.317 . . . . 35.7 110.32 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 76' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -91.74 153.24 19.76 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.461 -0.775 . . . . 66.48 110.356 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 77' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -81.56 95.23 7.07 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.33 -0.856 . . . . 46.72 110.097 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 78' ' ' LEU . . . . . . . . . . . . . 96.4 mt -96.43 28.01 3.52 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.398 -0.814 . . . . 37.55 110.187 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 79' ' ' THR . . . . . . . . . . . . . 29.9 m -56.21 -54.62 43.08 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.226 -0.921 . . . . 37.36 110.301 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 80' ' ' LEU . . . . . . . . . . . . . 15.9 mt -60.88 -23.28 65.07 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.449 -0.782 . . . . 35.83 110.511 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 81' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -79.44 -39.11 33.07 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.154 -0.966 . . . . 44.03 110.38 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.45 -28.66 66.3 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.292 -0.88 . . . . 32.54 110.211 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 83' ' ' ILE . . . . . . . . . . . . . 78.2 mt -70.13 -46.09 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.236 -0.915 . . . . 32.02 110.265 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 84' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -55.23 -52.09 64.49 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.237 -0.914 . . . . 34.09 110.521 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 85' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -54.82 -46.87 74.63 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.238 -0.914 . . . . 25.94 110.28 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 86' ' ' LEU . . . . . . . . . . . . . 24.0 mt -58.71 -43.73 90.17 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.299 -0.876 . . . . 16.2 109.923 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 87' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -65.43 -35.11 79.95 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.472 -0.768 . . . . 49.09 110.33 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 88' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -78.5 -19.06 53.85 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.276 -0.89 . . . . 28.61 110.479 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 89' ' ' LEU . . . . . . . . . . . . . 32.8 mt -96.18 -29.43 14.05 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.236 -0.915 . . . . 26.16 110.197 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 90' ' ' THR . . . . . . . . . . . . . 59.4 p -105.63 -34.72 7.65 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.259 -0.901 . . . . 33.33 109.764 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.89 16.08 58.55 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.821 -1.312 . . . . 31.13 109.821 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 92' ' ' LEU . . . . . . . . . . . . . 97.1 mt -100.06 155.23 17.83 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.147 -1.208 . . . . 42.52 110.23 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 93' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -86.21 91.62 8.51 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.49 -0.756 . . . . 68.46 110.017 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 94' ' ' LEU . . . . . 0.446 ' HB3' ' CZ2' ' R' ' 52' ' ' TRP . 48.3 mt -99.48 53.03 0.94 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.222 -0.924 . . . . 44.63 110.32 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' R' R ' 95' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.43 -38.8 6.35 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.262 -0.899 . . . . 67.16 110.385 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' R' R ' 96' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -113.83 44.23 1.67 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.251 -0.906 . . . . 67.02 110.352 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 97' ' ' GLY . . . . . . . . . . . . . . . 99.16 150.78 26.0 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.614 -1.395 . . . . 49.48 109.614 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 98' ' ' GLY . . . . . . . . . . . . . . . -166.26 160.03 33.47 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.286 -1.526 . . . . 36.57 109.286 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 99' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.49 121.03 7.1 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 O-C-N 123.703 1.37 . . . . 30.41 110.47 -179.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 100' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.22 -31.72 11.47 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 O-C-N 123.645 1.339 . . . . 29.94 110.552 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.9 -38.49 76.32 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.228 -0.92 . . . . 23.64 110.291 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.64 -40.71 66.19 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.411 -0.805 . . . . 20.31 110.386 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' R' R ' 103' ' ' VAL . . . . . . . . . . . . . 64.0 t -58.25 -40.07 76.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.225 -0.922 . . . . 16.33 109.984 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 104' ' ' ILE . . . . . . . . . . . . . 81.6 mt -71.63 -30.6 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.388 -0.82 . . . . 24.77 109.939 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 105' ' ' TRP . . . . . 0.44 ' O ' ' HD3' ' R' ' 108' ' ' LYS . 70.5 t-105 -82.35 0.82 40.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.292 -0.88 . . . . 23.28 110.321 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' R' R ' 106' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -105.07 -10.49 17.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.136 -0.977 . . . . 28.26 110.086 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 107' ' ' ILE . . . . . . . . . . . . . 36.8 pt -126.83 35.06 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.208 -0.933 . . . . 18.77 110.033 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 108' ' ' LYS . . . . . 0.48 ' HG2' ' HB ' ' R' ' 115' ' ' ILE . 9.2 mtpp -61.16 -48.43 81.64 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.528 -0.732 . . . . 42.5 109.987 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' R' R ' 109' ' ' HIS . . . . . 0.432 ' CD2' ' HG ' ' R' ' 110' ' ' LEU . 50.9 p-80 -66.01 -12.88 58.3 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.461 -0.774 . . . . 20.07 110.652 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' R' R ' 110' ' ' LEU . . . . . 0.432 ' HG ' ' CD2' ' R' ' 109' ' ' HIS . 80.6 mt -94.81 -17.26 22.28 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.084 -1.01 . . . . 15.69 110.192 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' R' R ' 111' ' ' LEU . . . . . 0.448 HD22 ' CE2' ' R' ' 60' ' ' PHE . 10.3 mt -94.15 144.11 25.78 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.34 -0.85 . . . . 25.39 111.002 -179.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' R' R ' 112' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -77.7 -17.33 57.75 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.521 -0.737 . . . . 53.48 109.865 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 113' ' ' THR . . . . . 0.417 HG22 ' HG2' ' R' ' 123' ' ' GLU . 60.4 m -83.71 166.68 17.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.311 -0.868 . . . . 14.8 110.201 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' R' R ' 114' ' ' GLY . . . . . . . . . . . . . . . -98.01 127.15 9.13 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.962 -1.255 . . . . 16.14 109.962 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 115' ' ' ILE . . . . . 0.48 ' HB ' ' HG2' ' R' ' 108' ' ' LYS . 47.9 mm -109.05 139.35 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.424 -1.045 . . . . 13.46 109.71 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' R' R ' 116' ' ' GLY . . . . . . . . . . . . . . . -152.76 -155.9 7.31 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.856 -1.298 . . . . 23.9 109.856 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 117' ' ' THR . . . . . . . . . . . . . 18.8 p -135.03 -171.35 2.78 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.53 -0.982 . . . . 27.37 110.097 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.6 -58.04 9.79 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.359 -0.838 . . . . 18.76 110.064 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 119' ' ' SER . . . . . 0.682 ' HA ' ' CB ' ' R' ' 194' ' ' ALA . 1.1 m -56.55 -40.59 75.39 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.259 -0.901 . . . . 32.35 109.741 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' R' R ' 120' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 -110.11 86.25 4.92 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.435 -0.791 . . . . 27.12 109.68 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 121' ' ' PRO . . . . . 0.427 ' O ' ' HB2' ' R' ' 122' ' ' SER . 44.3 Cg_endo -71.2 166.47 29.12 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.863 1.454 . . . . 22.68 111.046 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' R' R ' 122' ' ' SER . . . . . 0.427 ' HB2' ' O ' ' R' ' 121' ' ' PRO . 38.4 t 178.56 -161.67 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.649 -0.657 . . . . 22.99 109.456 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' R' R ' 123' ' ' GLU . . . . . 0.417 ' HG2' HG22 ' R' ' 113' ' ' THR . 2.3 tp10 -56.45 -39.92 73.94 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.211 -0.93 . . . . 36.18 109.701 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' R' R ' 124' ' ' VAL . . . . . . . . . . . . . 84.2 t -142.58 136.41 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.579 -0.701 . . . . 20.64 109.389 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 125' ' ' CYS . . . . . 0.409 ' SG ' ' HA ' ' R' ' 121' ' ' PRO . 83.3 m -140.26 168.23 20.29 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.252 -0.905 . . . . 22.8 111.166 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' R' R ' 126' ' ' VAL . . . . . . . . . . . . . 35.8 m -122.73 159.73 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.671 -0.643 . . . . 21.24 109.568 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 127' ' ' VAL . . . . . 0.4 ' CG1' ' O ' ' R' ' 177' ' ' VAL . 30.6 m -70.8 141.91 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.294 -0.879 . . . . 19.77 110.7 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' R' R ' 128' ' ' ASP . . . . . . . . . . . . . 53.9 p-10 -137.77 19.4 2.86 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.337 -0.852 . . . . 29.21 110.642 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 129' ' ' GLY . . . . . . . . . . . . . . . 113.98 0.03 24.16 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.963 -1.113 . . . . 33.86 110.498 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 130' ' ' THR . . . . . . . . . . . . . 58.1 m -91.86 131.81 36.92 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.14 -1.212 . . . . 26.41 110.082 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -62.52 120.7 11.62 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.36 -0.838 . . . . 33.08 110.287 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 132' ' ' MET . . . . . 0.427 ' HE1' ' CZ ' ' R' ' 180' ' ' PHE . 98.5 mmm -105.26 165.62 10.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.467 -0.771 . . . . 30.76 110.435 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' R' R ' 133' ' ' CYS . . . . . . . . . . . . . 32.8 m -141.09 158.11 44.37 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.511 -0.743 . . . . 27.0 109.973 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 134' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.45 -19.74 39.11 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.268 -0.895 . . . . 33.9 110.51 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' R' R ' 135' ' ' ALA . . . . . . . . . . . . . . . -92.69 8.07 40.77 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.231 -0.918 . . . . 19.37 110.779 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 136' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -93.71 -21.76 19.15 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.187 -0.946 . . . . 30.47 110.272 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 137' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -149.96 165.34 32.94 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.365 -0.835 . . . . 24.27 110.241 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 138' ' ' HIS . . . . . . . . . . . . . 15.1 p80 -117.84 15.11 14.37 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.362 -0.836 . . . . 20.91 110.369 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 139' ' ' ALA . . . . . 0.442 ' HA ' ' O ' ' R' ' 152' ' ' ALA . . . -177.16 152.46 0.88 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.158 -0.964 . . . . 15.69 110.12 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' R' R ' 140' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' R' ' 179' ' ' VAL . . . 161.8 175.2 32.57 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.975 -1.25 . . . . 23.76 109.975 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' R' R ' 141' ' ' ILE . . . . . . . . . . . . . 83.7 mt -95.55 136.61 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.372 -1.075 . . . . 25.3 109.673 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 142' ' ' PHE . . . . . 0.547 ' CD2' ' HB2' ' R' ' 172' ' ' PRO . 82.8 m-85 -120.77 -172.63 2.42 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.287 -0.883 . . . . 30.24 110.545 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' R' R ' 143' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -119.75 77.75 1.26 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.444 -0.785 . . . . 32.8 110.246 -179.84 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' R' R ' 144' ' ' LYS . . . . . 0.453 ' HG3' ' CZ2' ' R' ' 170' ' ' TRP . 1.0 OUTLIER -69.59 76.86 0.42 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.393 -0.817 . . . . 49.18 109.707 179.502 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' R' R ' 145' ' ' GLY . . . . . . . . . . . . . . . 104.52 179.32 24.8 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.131 -1.588 . . . . 53.87 109.131 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 146' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -88.52 145.81 25.53 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.361 -1.082 . . . . 68.58 110.023 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 147' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 58.24 36.52 25.77 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.314 -0.866 . . . . 56.62 110.623 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 148' ' ' HIS . . . . . . . . . . . . . 44.5 t60 -158.65 148.17 19.24 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.194 -0.941 . . . . 44.57 110.376 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 149' ' ' ALA . . . . . . . . . . . . . . . -150.29 146.88 27.04 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.427 -0.796 . . . . 33.54 110.079 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 150' ' ' VAL . . . . . 0.427 HG23 ' HB2' ' R' ' 144' ' ' LYS . 34.2 m -142.32 161.5 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.277 -0.889 . . . . 27.61 110.356 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' R' R ' 151' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' R' ' 152' ' ' ALA . 5.9 t80 -86.14 155.62 20.69 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.401 -0.812 . . . . 23.04 109.924 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' R' R ' 152' ' ' ALA . . . . . 0.537 ' N ' ' CD1' ' R' ' 151' ' ' PHE . . . -157.33 151.51 24.81 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.517 -0.739 . . . . 29.61 109.625 179.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' R' R ' 153' ' ' CYS . . . . . 0.405 ' HA ' ' HA ' ' R' ' 139' ' ' ALA . 26.7 p -154.3 173.61 15.93 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.233 -0.917 . . . . 22.75 110.453 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' R' R ' 154' ' ' VAL . . . . . 0.442 ' CG2' ' CZ2' ' R' ' 159' ' ' TRP . 60.2 t -90.68 117.04 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.37 -0.831 . . . . 23.26 110.101 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' R' R ' 155' ' ' THR . . . . . . . . . . . . . 69.8 p -112.1 -176.63 2.97 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.302 -0.873 . . . . 17.88 110.041 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 156' ' ' SER . . . . . . . . . . . . . 78.5 p -75.94 -3.69 36.88 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.329 -0.857 . . . . 21.83 110.735 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 157' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -118.25 10.38 12.83 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.109 -0.994 . . . . 36.54 110.635 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 158' ' ' GLY . . . . . . . . . . . . . . . 117.9 -162.7 13.0 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.585 -1.406 . . . . 31.74 109.585 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 159' ' ' TRP . . . . . 0.442 ' CZ2' ' CG2' ' R' ' 154' ' ' VAL . 14.8 m95 -86.51 122.42 30.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.334 -1.098 . . . . 28.25 110.112 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' R' R ' 160' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -108.42 166.96 10.38 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.384 -0.822 . . . . 41.24 110.251 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 161' ' ' ALA . . . . . . . . . . . . . . . -143.33 123.51 13.72 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.495 -0.753 . . . . 27.4 110.117 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 162' ' ' ILE . . . . . 0.43 HG23 ' CZ ' ' R' ' 167' ' ' PHE . 92.2 mt -87.54 81.14 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.406 -0.809 . . . . 24.27 110.072 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' R' R ' 163' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' R' ' 165' ' ' GLU . 15.3 t0 -72.81 92.47 1.59 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.422 -0.799 . . . . 36.08 110.234 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' R' R ' 164' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 54.09 -89.03 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.521 -0.737 . . . . 46.08 110.574 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 165' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' R' ' 163' ' ' ASP . 29.7 mt-10 -124.68 35.94 4.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.151 -0.968 . . . . 50.94 110.196 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' R' R ' 166' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -135.72 117.28 14.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.427 -0.796 . . . . 47.28 110.358 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 167' ' ' PHE . . . . . 0.43 ' CZ ' HG23 ' R' ' 162' ' ' ILE . 24.4 m-85 -101.02 120.0 39.56 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.396 -0.815 . . . . 40.47 110.164 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' R' R ' 168' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -157.56 158.48 30.6 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.199 -0.938 . . . . 30.21 110.436 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 169' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.74 133.01 19.51 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 O-C-N 123.9 1.474 . . . . 32.76 110.471 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 170' ' ' TRP . . . . . 0.453 ' CZ2' ' HG3' ' R' ' 144' ' ' LYS . 66.9 t90 -159.83 119.42 2.89 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.471 -0.768 . . . . 32.79 109.925 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' R' R ' 171' ' ' THR . . . . . . . . . . . . . 46.3 m -81.14 112.62 34.41 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.419 -0.801 . . . . 36.92 110.188 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 172' ' ' PRO . . . . . 0.547 ' HB2' ' CD2' ' R' ' 142' ' ' PHE . 47.5 Cg_endo -73.75 158.82 46.44 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.68 1.358 . . . . 33.54 110.552 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' R' R ' 173' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -88.88 144.98 33.78 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.429 -0.795 . . . . 45.76 109.951 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 174' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -71.8 -10.32 26.2 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.639 1.336 . . . . 29.63 110.404 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 175' ' ' SER . . . . . . . . . . . . . 53.1 p -103.47 -17.58 15.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.275 -0.891 . . . . 35.7 110.34 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 176' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -103.5 43.21 1.1 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.256 -0.903 . . . . 39.65 110.419 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 177' ' ' VAL . . . . . 0.4 ' O ' ' CG1' ' R' ' 127' ' ' VAL . 10.4 p -117.77 127.19 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.367 -0.833 . . . . 20.61 109.961 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' R' R ' 178' ' ' LEU . . . . . . . . . . . . . 46.0 mt -91.53 -61.15 1.71 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.373 -0.829 . . . . 15.58 109.419 179.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 179' ' ' VAL . . . . . 0.403 ' O ' ' HA3' ' R' ' 140' ' ' GLY . 67.9 t -114.73 144.64 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.602 -0.686 . . . . 17.4 109.419 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' R' R ' 180' ' ' PHE . . . . . 0.427 ' CZ ' ' HE1' ' R' ' 132' ' ' MET . 43.8 p90 -152.12 163.37 39.5 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.271 -0.893 . . . . 20.16 110.551 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' R' R ' 181' ' ' VAL . . . . . . . . . . . . . 66.8 t -113.16 111.52 50.26 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.456 -0.778 . . . . 17.69 109.833 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 182' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.06 149.48 52.61 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.577 1.304 . . . . 17.81 110.366 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 183' ' ' TYR . . . . . 0.735 ' O ' ' C ' ' R' ' 184' ' ' ASP . 79.1 m-85 -59.03 175.51 0.28 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.432 -0.792 . . . . 28.01 110.571 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' R' R ' 184' ' ' ASP . . . . . 0.735 ' C ' ' O ' ' R' ' 183' ' ' TYR . 1.9 m-20 -13.08 -75.98 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.442 -0.786 . . . . 58.64 110.297 -178.021 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' R' R ' 185' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.503 2.213 0 CA-C-O 121.185 0.517 . . . . 80.42 111.807 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' R' R ' 193' ' ' LYS . . . . . . . . . . . . . 49.1 mmtt . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 120.949 0.404 . . . . 49.5 110.112 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' R' R ' 194' ' ' ALA . . . . . 0.682 ' CB ' ' HA ' ' R' ' 119' ' ' SER . . . . . . . . 0 N--CA 1.495 1.796 0 O-C-N 121.117 -0.989 . . . . 40.4 110.102 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 229' ' ' MET . . . . . . . . . . . . . 2.4 ptt? . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.173 0.511 . . . . 51.83 110.202 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' S' S ' 230' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -97.32 142.75 28.81 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.369 -0.832 . . . . 54.13 110.183 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 231' ' ' LEU . . . . . . . . . . . . . 68.2 mt -134.09 141.0 46.99 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.312 -0.868 . . . . 33.04 110.325 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 232' ' ' THR . . . . . . . . . . . . . 40.0 m -89.22 103.27 15.9 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.438 -0.789 . . . . 26.92 110.039 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 233' ' ' LEU . . . . . 0.499 HD23 ' CE2' ' S' ' 262' ' ' TYR . 79.9 mt -55.91 179.29 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.471 -0.768 . . . . 13.78 110.483 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' S' S ' 234' ' ' TYR . . . . . 0.447 ' CG ' ' N ' ' S' ' 235' ' ' ASN . 35.5 p90 -65.02 -35.68 81.95 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.412 -0.805 . . . . 26.08 110.163 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' S' S ' 235' ' ' ASN . . . . . 0.447 ' N ' ' CG ' ' S' ' 234' ' ' TYR . 50.7 p30 -74.35 -7.38 52.65 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.357 -0.839 . . . . 20.04 110.511 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' S' S ' 236' ' ' GLY . . . . . . . . . . . . . . . 95.71 -20.0 51.78 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.769 -1.332 . . . . 22.71 109.769 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 237' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -52.91 145.64 12.29 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.216 -1.167 . . . . 35.44 110.215 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 238' ' ' LYS . . . . . . . . . . . . . 44.2 mttt -102.17 127.99 48.86 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.438 -0.789 . . . . 32.56 110.341 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 239' ' ' LYS . . . . . 0.414 ' HG2' ' CZ ' ' S' ' 241' ' ' PHE . 9.0 ttmt -132.35 144.45 50.55 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.371 -0.83 . . . . 26.68 110.002 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' S' S ' 240' ' ' THR . . . . . . . . . . . . . 52.5 m -101.95 132.23 47.89 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.307 -0.871 . . . . 41.02 110.36 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 241' ' ' PHE . . . . . 0.414 ' CZ ' ' HG2' ' S' ' 239' ' ' LYS . 96.0 m-85 -117.97 137.69 52.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.431 -0.793 . . . . 28.62 110.188 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' S' S ' 242' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -96.36 161.79 13.78 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.32 -0.862 . . . . 47.89 110.241 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 243' ' ' SER . . . . . . . . . . . . . 71.5 m -90.58 151.57 21.26 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.376 -0.827 . . . . 45.09 110.207 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 244' ' ' ARG . . . . . . . . . . . . . 1.4 mtp85 -129.73 126.7 22.72 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.307 -0.871 . . . . 42.49 110.301 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 245' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.33 161.03 43.71 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 O-C-N 123.651 1.343 . . . . 35.68 110.538 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 246' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -132.9 97.91 4.16 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.381 -0.824 . . . . 51.88 109.827 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 247' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -110.47 -22.2 11.78 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.364 -0.835 . . . . 53.69 110.68 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 248' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -117.28 43.65 2.28 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.187 -0.946 . . . . 55.79 110.719 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 249' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 48.84 38.38 11.9 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.402 -0.811 . . . . 49.45 110.338 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 250' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -90.6 28.94 1.38 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.544 -0.722 . . . . 36.86 110.385 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 251' ' ' ALA . . . . . . . . . . . . . . . -53.75 -43.24 68.97 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.271 -0.893 . . . . 29.69 109.643 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 252' ' ' TRP . . . . . 0.416 ' CZ2' ' HB3' ' S' ' 294' ' ' LEU . 67.9 p-90 -61.74 -33.95 74.97 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.465 -0.772 . . . . 41.12 109.812 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' S' S ' 253' ' ' LEU . . . . . 0.402 ' N ' ' CD2' ' S' ' 252' ' ' TRP . 23.3 tp -70.14 -47.21 62.68 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.349 -0.845 . . . . 24.89 109.995 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' S' S ' 254' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -56.16 -42.45 77.04 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.31 -0.869 . . . . 35.65 109.956 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 255' ' ' ALA . . . . . . . . . . . . . . . -59.58 -48.17 82.7 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.432 -0.793 . . . . 22.73 110.025 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 256' ' ' ILE . . . . . . . . . . . . . 79.6 mt -62.34 -40.66 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.341 -0.85 . . . . 28.85 109.957 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 257' ' ' LEU . . . . . . . . . . . . . 19.2 mt -61.57 -44.47 96.96 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.359 -0.838 . . . . 23.07 110.17 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 258' ' ' GLN . . . . . 0.467 ' HB3' ' CD2' ' S' ' 351' ' ' PHE . 53.5 mm-40 -65.06 -45.41 85.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.42 -0.8 . . . . 29.78 109.851 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' S' S ' 259' ' ' LEU . . . . . 0.43 ' O ' HG22 ' S' ' 263' ' ' VAL . 19.8 tp -58.72 -36.33 74.11 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.36 -0.838 . . . . 17.94 109.433 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' S' S ' 260' ' ' PHE . . . . . 0.465 ' CE2' HD22 ' S' ' 311' ' ' LEU . 3.1 m-85 -62.81 -45.27 93.4 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.619 -0.676 . . . . 30.57 109.833 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' S' S ' 261' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -62.18 -29.67 70.52 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.476 -0.765 . . . . 41.34 110.006 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 262' ' ' TYR . . . . . 0.499 ' CE2' HD23 ' S' ' 233' ' ' LEU . 8.7 t80 -71.29 -44.61 64.86 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.418 -0.802 . . . . 26.03 110.067 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' S' S ' 263' ' ' VAL . . . . . 0.43 HG22 ' O ' ' S' ' 259' ' ' LEU . 33.0 m -92.02 18.28 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.366 -0.834 . . . . 22.8 110.38 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' S' S ' 264' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 52.76 70.63 0.56 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.217 -0.927 . . . . 44.03 110.678 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 265' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -111.84 109.19 55.34 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.383 -0.823 . . . . 35.61 109.657 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 266' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -75.29 0.37 9.11 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.592 1.312 . . . . 37.67 111.793 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 267' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -56.45 -67.71 0.28 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.74 -1.225 . . . . 41.49 110.164 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' S' S ' 268' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -92.93 39.87 1.05 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.201 -0.937 . . . . 50.76 110.071 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 269' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.95 -33.26 59.8 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.375 -0.828 . . . . 61.86 109.765 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' S' S ' 270' ' ' TRP . . . . . 0.49 ' CE2' ' CG2' ' S' ' 271' ' ' VAL . 51.0 p-90 -73.9 -4.37 34.59 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.312 -0.867 . . . . 39.85 110.483 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' S' S ' 271' ' ' VAL . . . . . 0.49 ' CG2' ' CE2' ' S' ' 270' ' ' TRP . 46.4 t -109.49 -32.66 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.151 -0.968 . . . . 39.18 110.073 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' S' S ' 272' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -78.6 -36.53 44.09 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.325 -0.859 . . . . 40.02 110.523 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 273' ' ' SER . . . . . . . . . . . . . 70.8 m -103.6 56.11 0.74 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.264 -0.898 . . . . 47.2 110.286 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 274' ' ' SER . . . . . . . . . . . . . 6.9 t -133.03 141.25 40.25 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.35 -0.844 . . . . 47.61 110.155 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 275' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.7 -18.89 21.85 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 O-C-N 123.629 1.331 . . . . 45.28 110.594 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 276' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -99.86 140.85 33.47 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.317 -0.864 . . . . 57.27 110.314 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 277' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -71.68 97.69 1.79 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.476 -0.765 . . . . 37.28 110.309 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 278' ' ' LEU . . . . . . . . . . . . . 86.7 mt -97.0 33.76 1.85 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.397 -0.815 . . . . 43.88 109.984 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 279' ' ' THR . . . . . . . . . . . . . 74.8 m -63.98 -60.19 3.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.481 -0.762 . . . . 50.05 110.24 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 280' ' ' LEU . . . . . . . . . . . . . 13.6 mt -51.58 -39.9 58.77 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.31 -0.869 . . . . 54.12 110.254 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 281' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.35 -49.71 74.47 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.526 -0.734 . . . . 65.28 110.143 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' S' S ' 282' ' ' ALA . . . . . . . . . . . . . . . -58.99 -33.86 71.17 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.548 -0.72 . . . . 46.51 110.506 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 283' ' ' ILE . . . . . . . . . . . . . 85.7 mt -66.35 -50.84 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.287 -0.883 . . . . 47.3 110.138 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 284' ' ' LYS . . . . . . . . . . . . . 33.6 tttp -50.6 -57.57 7.87 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.487 -0.758 . . . . 50.72 110.384 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 285' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -51.35 -46.42 62.68 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.494 -0.754 . . . . 68.47 110.352 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 286' ' ' LEU . . . . . . . . . . . . . 19.0 mt -59.96 -44.48 94.41 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.417 -0.802 . . . . 36.62 110.287 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 287' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -62.76 -35.26 79.24 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.326 -0.859 . . . . 46.64 110.088 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 288' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -76.26 -21.06 56.78 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.437 -0.789 . . . . 46.45 110.263 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 289' ' ' LEU . . . . . . . . . . . . . 30.7 mt -97.33 -21.69 17.07 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.281 -0.887 . . . . 35.09 110.54 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 290' ' ' THR . . . . . . . . . . . . . 81.3 p -114.77 -28.49 7.07 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.249 -0.907 . . . . 38.61 110.435 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 291' ' ' GLY . . . . . . . . . . . . . . . 79.44 11.05 85.3 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.879 -1.288 . . . . 36.77 109.879 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 292' ' ' LEU . . . . . . . . . . . . . 84.9 mt -96.55 145.82 25.36 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.238 -1.154 . . . . 35.33 109.754 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 293' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -77.32 102.29 6.68 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.161 -0.962 . . . . 48.7 110.275 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 294' ' ' LEU . . . . . 0.416 ' HB3' ' CZ2' ' S' ' 252' ' ' TRP . 55.2 mt -106.84 51.75 0.73 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.472 -0.768 . . . . 42.61 110.117 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' S' S ' 295' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -112.53 -11.2 13.63 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.326 -0.859 . . . . 55.49 110.485 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' S' S ' 296' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -144.34 48.56 1.36 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.177 -0.952 . . . . 75.68 110.271 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 297' ' ' GLY . . . . . . . . . . . . . . . 96.88 145.19 18.73 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.457 -1.457 . . . . 49.44 109.457 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 298' ' ' GLY . . . . . . . . . . . . . . . -163.85 156.94 29.02 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.849 -1.3 . . . . 41.11 109.849 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 299' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.81 118.27 5.37 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 123.91 1.479 . . . . 26.2 110.291 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 300' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.18 -15.57 31.86 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.529 1.278 . . . . 21.7 110.647 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 301' ' ' ALA . . . . . . . . . . . . . . . -80.7 -29.32 36.49 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.256 -0.903 . . . . 31.23 110.117 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 302' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.5 -40.62 18.96 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.406 -0.809 . . . . 38.99 109.993 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' S' S ' 303' ' ' VAL . . . . . 0.469 ' O ' HG12 ' S' ' 307' ' ' ILE . 57.2 t -60.69 -35.52 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.398 -0.814 . . . . 18.63 110.147 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' S' S ' 304' ' ' ILE . . . . . . . . . . . . . 86.0 mt -79.33 -23.65 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.405 -0.809 . . . . 25.46 110.179 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 305' ' ' TRP . . . . . . . . . . . . . 68.9 t-105 -88.63 -14.53 37.24 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.32 -0.863 . . . . 33.4 110.521 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 306' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -89.72 -13.56 36.59 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.218 -0.926 . . . . 36.97 110.369 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 307' ' ' ILE . . . . . 0.469 HG12 ' O ' ' S' ' 303' ' ' VAL . 36.9 pt -125.08 45.62 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.21 -0.931 . . . . 30.81 110.059 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' S' S ' 308' ' ' LYS . . . . . . . . . . . . . 1.5 mtmp? -73.5 -37.75 65.58 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.339 -0.851 . . . . 46.52 110.12 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 309' ' ' HIS . . . . . 0.487 ' CD2' ' HG ' ' S' ' 310' ' ' LEU . 55.5 p-80 -73.22 -8.26 55.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.318 -0.864 . . . . 51.03 110.065 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' S' S ' 310' ' ' LEU . . . . . 0.487 ' HG ' ' CD2' ' S' ' 309' ' ' HIS . 52.6 mt -99.31 -12.92 19.9 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.312 -0.867 . . . . 36.16 109.975 179.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' S' S ' 311' ' ' LEU . . . . . 0.465 HD22 ' CE2' ' S' ' 260' ' ' PHE . 10.8 mt -97.13 147.83 23.66 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.367 -0.833 . . . . 40.0 110.499 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' S' S ' 312' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -81.6 -16.24 52.15 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.31 -0.869 . . . . 54.18 109.682 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 313' ' ' THR . . . . . 0.472 HG23 ' HB3' ' S' ' 323' ' ' GLU . 92.7 m -87.95 151.66 22.64 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.371 -0.83 . . . . 25.61 110.098 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' S' S ' 314' ' ' GLY . . . . . . . . . . . . . . . -87.93 126.41 8.05 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.842 -1.303 . . . . 25.18 109.842 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 315' ' ' ILE . . . . . 0.402 HG21 ' N ' ' S' ' 316' ' ' GLY . 50.8 mm -101.65 150.51 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.411 -1.052 . . . . 23.9 109.704 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' S' S ' 316' ' ' GLY . . . . . 0.402 ' N ' HG21 ' S' ' 315' ' ' ILE . . . -157.09 -159.31 9.41 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.932 -1.267 . . . . 23.18 109.932 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' S' S ' 317' ' ' THR . . . . . . . . . . . . . 11.1 p -133.92 -173.01 3.13 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.447 -1.031 . . . . 27.98 109.958 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.58 -56.19 25.08 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.265 -0.897 . . . . 28.1 109.858 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 319' ' ' SER . . . . . . . . . . . . . 1.2 m -59.93 -41.61 92.16 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.427 -0.796 . . . . 37.0 109.675 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 320' ' ' ARG . . . . . . . . . . . . . 12.1 mtm180 -111.72 79.85 2.65 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.529 -0.732 . . . . 52.07 109.726 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 321' ' ' PRO . . . . . 0.436 ' O ' ' HB2' ' S' ' 322' ' ' SER . 43.9 Cg_endo -71.44 171.51 16.05 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.883 1.465 . . . . 38.29 110.927 -179.429 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' S' S ' 322' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' S' ' 321' ' ' PRO . 41.4 t 178.68 -148.15 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.966 -0.753 . . . . 38.84 108.966 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' S' S ' 323' ' ' GLU . . . . . 0.472 ' HB3' HG23 ' S' ' 313' ' ' THR . 6.7 tp10 -62.85 -40.32 97.1 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.063 -1.023 . . . . 40.7 109.679 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' S' S ' 324' ' ' VAL . . . . . . . . . . . . . 72.7 t -141.27 135.03 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.396 -0.815 . . . . 20.34 109.46 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 325' ' ' CYS . . . . . 0.451 ' HB2' ' CE1' ' S' ' 380' ' ' PHE . 11.5 m -126.0 172.19 10.16 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.336 -0.853 . . . . 30.63 110.833 -179.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' S' S ' 326' ' ' VAL . . . . . . . . . . . . . 34.5 m -135.45 142.19 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.58 -0.7 . . . . 23.9 109.285 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 327' ' ' VAL . . . . . . . . . . . . . 34.5 m -56.35 124.93 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.092 -1.005 . . . . 19.48 110.47 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 328' ' ' ASP . . . . . . . . . . . . . 55.6 p-10 -119.28 11.48 12.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.45 -0.781 . . . . 26.43 110.465 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 329' ' ' GLY . . . . . . . . . . . . . . . 119.71 2.23 13.04 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.025 -1.23 . . . . 31.24 110.025 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 330' ' ' THR . . . . . . . . . . . . . 80.1 m -92.98 130.03 38.69 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.045 -1.268 . . . . 30.05 110.109 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 331' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -56.81 111.46 1.03 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.261 -0.899 . . . . 37.26 109.955 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 332' ' ' MET . . . . . 0.455 ' HE1' ' CZ ' ' S' ' 380' ' ' PHE . 88.1 mmm -94.11 162.57 13.82 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.278 -0.889 . . . . 26.23 110.351 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' S' S ' 333' ' ' CYS . . . . . . . . . . . . . 26.2 m -137.19 150.07 47.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.535 -0.728 . . . . 23.56 110.019 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 334' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.68 -24.75 9.15 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.339 -0.851 . . . . 28.93 110.522 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' S' S ' 335' ' ' ALA . . . . . . . . . . . . . . . -89.08 14.42 10.75 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.383 -0.823 . . . . 15.76 110.947 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 336' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -100.49 -17.14 17.28 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.1 -1.0 . . . . 34.92 110.186 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 337' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -152.46 170.85 19.12 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.299 -0.875 . . . . 19.03 110.017 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 338' ' ' HIS . . . . . 0.4 ' HB3' ' CZ ' ' S' ' 383' ' ' TYR . 13.5 p80 -120.76 10.44 10.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.416 -0.803 . . . . 18.82 110.497 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' S' S ' 339' ' ' ALA . . . . . . . . . . . . . . . -175.97 155.24 1.58 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.293 -0.879 . . . . 17.18 110.103 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 340' ' ' GLY . . . . . 0.401 ' CA ' ' O ' ' S' ' 379' ' ' VAL . . . 160.8 173.09 28.97 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.07 -1.212 . . . . 18.33 110.07 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' S' S ' 341' ' ' ILE . . . . . 0.434 HD12 HG22 ' S' ' 341' ' ' ILE . 84.4 mt -88.88 138.15 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.505 -0.997 . . . . 18.6 109.757 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' S' S ' 342' ' ' PHE . . . . . 0.502 ' CE1' HG23 ' S' ' 377' ' ' VAL . 70.0 m-85 -120.98 -178.41 3.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.26 -0.9 . . . . 23.44 110.428 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' S' S ' 343' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.85 93.42 4.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.41 -0.806 . . . . 35.59 109.989 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' S' S ' 344' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.78 125.0 29.52 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.269 -0.894 . . . . 38.34 110.148 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' S' S ' 345' ' ' GLY . . . . . . . . . . . . . . . 62.79 -130.81 43.02 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 108.847 -1.701 . . . . 53.46 108.847 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 346' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -132.79 150.8 52.12 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.199 -1.177 . . . . 70.91 110.073 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 347' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 53.35 35.36 20.14 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.335 -0.853 . . . . 47.32 110.437 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 348' ' ' HIS . . . . . . . . . . . . . 46.2 t60 -150.15 155.82 40.49 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.294 -0.879 . . . . 41.72 110.311 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 349' ' ' ALA . . . . . . . . . . . . . . . -149.74 151.32 33.43 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.346 -0.846 . . . . 22.91 110.463 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 350' ' ' VAL . . . . . . . . . . . . . 34.6 m -149.11 169.6 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.443 -0.785 . . . . 21.09 110.024 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 351' ' ' PHE . . . . . 0.467 ' CD2' ' HB3' ' S' ' 258' ' ' GLN . 10.7 t80 -105.35 143.54 33.37 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.215 -0.928 . . . . 25.03 110.706 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' S' S ' 352' ' ' ALA . . . . . . . . . . . . . . . -147.66 151.69 36.59 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.646 -0.659 . . . . 23.81 109.732 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 353' ' ' CYS . . . . . . . . . . . . . 26.3 p -153.34 164.87 37.36 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.291 -0.881 . . . . 25.66 110.246 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 354' ' ' VAL . . . . . 0.404 HG23 ' CZ2' ' S' ' 359' ' ' TRP . 56.8 t -75.99 118.5 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.381 -0.824 . . . . 34.27 109.967 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' S' S ' 355' ' ' THR . . . . . 0.444 HG23 ' HB2' ' S' ' 360' ' ' TYR . 51.5 p -117.81 175.11 5.81 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.282 -0.886 . . . . 25.49 110.307 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' S' S ' 356' ' ' SER . . . . . . . . . . . . . 62.0 p -62.15 -17.67 58.6 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.455 -0.778 . . . . 31.24 110.748 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 357' ' ' ASN . . . . . . . . . . . . . 45.8 m-20 -107.03 14.28 26.56 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.145 -0.972 . . . . 28.61 110.531 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 358' ' ' GLY . . . . . . . . . . . . . . . 111.86 -152.85 17.61 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.045 -1.222 . . . . 22.01 110.045 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 359' ' ' TRP . . . . . 0.404 ' CZ2' HG23 ' S' ' 354' ' ' VAL . 15.4 m95 -91.35 116.73 29.08 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.45 -1.029 . . . . 25.54 110.176 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' S' S ' 360' ' ' TYR . . . . . 0.444 ' HB2' HG23 ' S' ' 355' ' ' THR . 1.3 m-85 -103.52 165.83 10.8 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.338 -0.851 . . . . 40.53 110.032 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' S' S ' 361' ' ' ALA . . . . . . . . . . . . . . . -140.1 130.1 24.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.361 -0.837 . . . . 18.04 110.268 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 362' ' ' ILE . . . . . 0.415 HG23 ' CZ ' ' S' ' 367' ' ' PHE . 89.1 mt -95.61 83.64 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.409 -0.807 . . . . 15.64 110.061 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' S' S ' 363' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' S' ' 365' ' ' GLU . 11.8 t0 -75.25 94.51 3.01 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.422 -0.799 . . . . 35.03 110.201 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' S' S ' 364' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 53.98 -89.43 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.551 -0.718 . . . . 46.72 110.511 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 365' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' S' ' 363' ' ' ASP . 23.7 mt-10 -122.7 19.2 10.31 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.075 -1.016 . . . . 56.2 110.245 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' S' S ' 366' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -117.98 124.96 49.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.169 -0.957 . . . . 51.02 110.395 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 367' ' ' PHE . . . . . 0.415 ' CZ ' HG23 ' S' ' 362' ' ' ILE . 26.8 m-85 -107.03 127.05 53.12 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.344 -0.847 . . . . 37.59 110.137 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' S' S ' 368' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -165.38 159.5 13.99 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.247 -0.908 . . . . 31.47 110.481 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 369' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.8 139.61 30.8 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.859 1.452 . . . . 28.85 110.538 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 370' ' ' TRP . . . . . . . . . . . . . 67.6 t90 -167.2 113.56 0.76 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.347 -0.846 . . . . 26.94 109.942 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 371' ' ' THR . . . . . . . . . . . . . 59.9 m -74.81 113.02 20.37 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.417 -0.802 . . . . 20.19 110.01 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 372' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -73.52 157.09 49.39 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 O-C-N 123.597 1.314 . . . . 28.68 110.624 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 373' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -90.56 147.15 35.76 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.492 -0.755 . . . . 35.72 109.896 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 374' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -76.03 -6.27 17.18 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 O-C-N 123.652 1.343 . . . . 30.89 110.459 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 375' ' ' SER . . . . . . . . . . . . . 68.6 p -104.41 -16.9 14.97 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.22 -0.925 . . . . 29.41 110.451 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 376' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -106.51 43.02 1.19 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.231 -0.918 . . . . 32.89 110.217 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 377' ' ' VAL . . . . . 0.502 HG23 ' CE1' ' S' ' 342' ' ' PHE . 7.3 p -114.65 147.27 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.374 -0.829 . . . . 24.33 110.216 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' S' S ' 378' ' ' LEU . . . . . . . . . . . . . 52.3 mt -115.99 -58.01 2.15 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.348 -0.845 . . . . 24.37 109.638 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 379' ' ' VAL . . . . . 0.401 ' O ' ' CA ' ' S' ' 340' ' ' GLY . 61.3 t -120.64 132.4 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.471 -0.768 . . . . 18.02 109.443 179.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' S' S ' 380' ' ' PHE . . . . . 0.455 ' CZ ' ' HE1' ' S' ' 332' ' ' MET . 14.4 p90 -142.63 174.0 11.03 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.309 -0.869 . . . . 29.35 110.634 -179.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' S' S ' 381' ' ' VAL . . . . . . . . . . . . . 58.4 t -120.1 107.32 39.81 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.578 -0.701 . . . . 16.34 109.398 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 382' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -71.26 145.65 49.16 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 O-C-N 123.626 1.329 . . . . 20.94 110.759 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' S' S ' 383' ' ' TYR . . . . . 0.4 ' CZ ' ' HB3' ' S' ' 338' ' ' HIS . 88.3 m-85 -61.08 -53.47 56.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.398 -0.814 . . . . 28.93 109.869 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' S' S ' 384' ' ' ASP . . . . . . . . . . . . . 9.7 t0 . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.482 -0.761 . . . . 47.03 110.358 -176.083 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' R' R ' 30' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.127 0.489 . . . . 43.36 110.247 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' R' R ' 31' ' ' LEU . . . . . . . . . . . . . 65.4 mt -134.86 140.54 45.9 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.293 -0.879 . . . . 22.93 110.332 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 32' ' ' THR . . . . . . . . . . . . . 69.0 m -87.55 110.61 20.48 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.337 -0.852 . . . . 22.34 109.983 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 33' ' ' LEU . . . . . 0.461 HD23 ' CE2' ' R' ' 62' ' ' TYR . 80.2 mt -62.52 -172.74 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.237 -0.915 . . . . 21.39 110.209 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' R' R ' 34' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -74.59 -29.4 61.31 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.375 -0.828 . . . . 34.4 110.41 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 35' ' ' ASN . . . . . . . . . . . . . 48.2 p30 -77.84 -1.74 33.11 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.322 -0.861 . . . . 30.28 110.665 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.1 -16.53 59.4 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.8 -1.32 . . . . 36.25 109.8 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 37' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -59.0 161.81 4.73 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.256 -1.144 . . . . 53.8 110.383 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 38' ' ' LYS . . . . . . . . . . . . . 57.0 mttt -117.86 135.8 53.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.43 -0.794 . . . . 49.91 110.175 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 39' ' ' LYS . . . . . 0.417 ' HG2' ' CZ ' ' R' ' 41' ' ' PHE . 8.1 ttmt -138.77 143.65 39.07 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.427 -0.796 . . . . 35.69 110.241 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' R' R ' 40' ' ' THR . . . . . . . . . . . . . 23.6 m -102.56 127.97 49.41 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.424 -0.798 . . . . 34.84 110.226 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 41' ' ' PHE . . . . . 0.417 ' CZ ' ' HG2' ' R' ' 39' ' ' LYS . 96.6 m-85 -113.09 132.63 55.35 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.386 -0.821 . . . . 34.42 110.21 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' R' R ' 42' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -93.21 140.86 29.06 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.348 -0.845 . . . . 51.46 110.263 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 43' ' ' SER . . . . . . . . . . . . . 54.2 m -70.74 141.83 51.47 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.511 -0.743 . . . . 41.84 110.196 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.78 125.38 29.56 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.347 -0.845 . . . . 33.82 109.984 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' R' R ' 45' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.11 151.05 55.03 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 123.611 1.321 . . . . 30.27 110.649 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 46' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.27 109.95 14.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.456 -0.777 . . . . 35.1 110.011 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 47' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -120.33 -34.84 3.56 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.339 -0.85 . . . . 42.81 110.493 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 48' ' ' HIS . . . . . . . . . . . . . 73.3 m80 -105.79 45.23 0.98 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.221 -0.925 . . . . 49.97 110.216 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 49' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 50.28 34.73 9.26 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.358 -0.839 . . . . 61.32 110.197 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 50' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -86.3 43.78 1.09 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.379 -0.826 . . . . 51.5 110.685 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.1 -46.12 78.73 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.199 -0.938 . . . . 38.77 109.474 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 52' ' ' TRP . . . . . 0.484 ' CD2' ' N ' ' R' ' 53' ' ' LEU . 68.1 p-90 -58.38 -38.42 77.25 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.455 -0.778 . . . . 26.24 110.055 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' R' R ' 53' ' ' LEU . . . . . 0.484 ' N ' ' CD2' ' R' ' 52' ' ' TRP . 23.1 tp -66.75 -46.62 74.81 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.424 -0.798 . . . . 26.75 109.984 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' R' R ' 54' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -55.35 -41.52 72.65 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.304 -0.872 . . . . 35.02 110.111 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.17 -46.08 91.99 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.448 -0.782 . . . . 24.47 110.157 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 56' ' ' ILE . . . . . . . . . . . . . 76.0 mt -62.2 -42.28 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.322 -0.861 . . . . 26.03 109.888 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 57' ' ' LEU . . . . . . . . . . . . . 22.4 mt -60.27 -45.63 92.63 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.28 -0.888 . . . . 26.77 109.68 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 58' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -63.87 -46.59 84.25 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.481 -0.762 . . . . 22.32 109.571 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 59' ' ' LEU . . . . . 0.43 ' HA ' ' HE2' ' R' ' 151' ' ' PHE . 24.0 tp -61.34 -37.84 84.73 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.317 -0.864 . . . . 20.55 109.389 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' R' R ' 60' ' ' PHE . . . . . 0.447 ' CE2' HD22 ' R' ' 111' ' ' LEU . 2.8 m-85 -61.05 -44.72 96.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.635 -0.666 . . . . 20.08 109.913 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' R' R ' 61' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -63.18 -36.15 82.66 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.488 -0.758 . . . . 18.8 110.443 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 62' ' ' TYR . . . . . 0.461 ' CE2' HD23 ' R' ' 33' ' ' LEU . 9.1 t80 -63.09 -41.81 99.48 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.234 -0.916 . . . . 26.45 110.199 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' R' R ' 63' ' ' VAL . . . . . . . . . . . . . 30.5 m -93.38 20.35 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.422 -0.799 . . . . 29.75 110.252 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 64' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 53.03 75.56 0.24 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.316 -0.865 . . . . 35.52 110.531 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 65' ' ' GLU . . . . . 0.424 ' HG2' ' CD2' ' R' ' 60' ' ' PHE . 14.3 tp10 -116.3 104.06 52.33 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.348 -0.845 . . . . 29.89 109.901 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' R' R ' 66' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.57 -5.8 17.69 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.775 1.408 . . . . 21.37 111.093 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 67' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -52.13 -61.44 2.27 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.116 -0.99 . . . . 23.85 110.43 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' R' R ' 68' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -98.23 36.58 1.57 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.306 -0.871 . . . . 28.07 110.484 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 69' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -72.3 -33.35 67.32 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.23 -0.918 . . . . 43.76 110.097 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 70' ' ' TRP . . . . . 0.477 ' CE2' ' CG2' ' R' ' 71' ' ' VAL . 47.7 p-90 -73.24 -4.03 30.5 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.313 -0.867 . . . . 33.06 110.74 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' R' R ' 71' ' ' VAL . . . . . 0.477 ' CG2' ' CE2' ' R' ' 70' ' ' TRP . 40.8 t -109.78 -27.41 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.078 -1.014 . . . . 31.7 109.674 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' R' R ' 72' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -86.62 -48.76 8.04 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.347 -0.845 . . . . 33.58 110.288 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 73' ' ' SER . . . . . . . . . . . . . 69.9 m -89.75 51.12 2.01 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.283 -0.886 . . . . 50.82 110.295 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 74' ' ' SER . . . . . . . . . . . . . 15.7 t -125.99 138.27 31.78 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.335 -0.853 . . . . 34.74 110.208 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.31 -25.02 16.02 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.737 1.388 . . . . 35.7 110.341 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 76' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -91.66 153.16 19.87 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.398 -0.814 . . . . 66.48 110.428 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 77' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -81.5 95.2 7.04 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.364 -0.835 . . . . 46.72 110.035 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 78' ' ' LEU . . . . . . . . . . . . . 96.3 mt -96.4 27.91 3.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.385 -0.822 . . . . 37.55 110.22 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 79' ' ' THR . . . . . . . . . . . . . 29.4 m -56.18 -54.64 42.78 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.317 -0.865 . . . . 37.36 110.295 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 80' ' ' LEU . . . . . . . . . . . . . 15.8 mt -60.97 -23.13 65.1 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.351 -0.843 . . . . 35.83 110.478 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 81' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -79.55 -39.08 32.7 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.147 -0.971 . . . . 44.03 110.331 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.5 -28.67 66.25 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.227 -0.921 . . . . 32.54 110.23 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 83' ' ' ILE . . . . . . . . . . . . . 78.2 mt -70.04 -46.1 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.221 -0.925 . . . . 32.02 110.342 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 84' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -55.21 -52.02 64.71 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.232 -0.918 . . . . 34.09 110.607 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 85' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -54.85 -46.81 74.7 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.203 -0.936 . . . . 25.94 110.269 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 86' ' ' LEU . . . . . . . . . . . . . 23.9 mt -58.74 -43.77 90.33 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.312 -0.867 . . . . 16.2 109.905 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 87' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -65.38 -35.16 80.12 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.529 -0.732 . . . . 49.09 110.251 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 88' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -78.46 -19.03 54.0 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.381 -0.825 . . . . 28.61 110.51 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 89' ' ' LEU . . . . . . . . . . . . . 32.5 mt -96.24 -29.38 14.05 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.261 -0.899 . . . . 26.16 110.167 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 90' ' ' THR . . . . . . . . . . . . . 59.2 p -105.68 -34.66 7.64 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.327 -0.858 . . . . 33.33 109.747 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.91 16.06 58.55 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.835 -1.306 . . . . 31.13 109.835 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 92' ' ' LEU . . . . . . . . . . . . . 97.0 mt -100.07 155.18 17.86 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.112 -1.228 . . . . 42.52 110.266 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 93' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -86.2 91.66 8.52 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.489 -0.757 . . . . 68.46 109.948 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 94' ' ' LEU . . . . . 0.447 ' HB3' ' CZ2' ' R' ' 52' ' ' TRP . 48.2 mt -99.51 53.0 0.94 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.147 -0.971 . . . . 44.63 110.368 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' R' R ' 95' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.54 -38.67 6.37 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.348 -0.845 . . . . 67.16 110.34 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' R' R ' 96' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -113.83 44.11 1.69 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.316 -0.865 . . . . 67.02 110.337 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 97' ' ' GLY . . . . . . . . . . . . . . . 99.2 150.87 26.06 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.598 -1.401 . . . . 49.48 109.598 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 98' ' ' GLY . . . . . . . . . . . . . . . -166.28 159.99 33.42 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.245 -1.542 . . . . 36.57 109.245 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 99' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.56 121.12 7.15 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 O-C-N 123.703 1.37 . . . . 30.41 110.435 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 100' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.27 -31.7 11.39 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.567 1.299 . . . . 29.94 110.506 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.97 -38.41 76.06 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.226 -0.921 . . . . 23.64 110.266 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.69 -40.82 65.94 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.367 -0.833 . . . . 20.31 110.324 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' R' R ' 103' ' ' VAL . . . . . . . . . . . . . 63.9 t -58.08 -40.15 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.281 -0.887 . . . . 16.33 109.934 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 104' ' ' ILE . . . . . . . . . . . . . 81.7 mt -71.7 -30.49 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.388 -0.82 . . . . 24.77 109.985 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 105' ' ' TRP . . . . . 0.44 ' O ' ' HD3' ' R' ' 108' ' ' LYS . 70.6 t-105 -82.42 0.81 40.39 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.345 -0.847 . . . . 23.28 110.33 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' R' R ' 106' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -105.05 -10.38 17.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.143 -0.973 . . . . 28.26 110.146 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 107' ' ' ILE . . . . . . . . . . . . . 36.8 pt -126.81 35.0 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.225 -0.922 . . . . 18.77 110.01 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 108' ' ' LYS . . . . . 0.48 ' HG2' ' HB ' ' R' ' 115' ' ' ILE . 9.2 mtpp -61.06 -48.47 81.59 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.528 -0.733 . . . . 42.5 110.031 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' R' R ' 109' ' ' HIS . . . . . 0.432 ' CD2' ' HG ' ' R' ' 110' ' ' LEU . 50.8 p-80 -66.01 -12.86 58.1 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.503 -0.748 . . . . 20.07 110.696 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' R' R ' 110' ' ' LEU . . . . . 0.432 ' HG ' ' CD2' ' R' ' 109' ' ' HIS . 80.8 mt -94.84 -17.31 22.2 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.145 -0.972 . . . . 15.69 110.181 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' R' R ' 111' ' ' LEU . . . . . 0.447 HD22 ' CE2' ' R' ' 60' ' ' PHE . 10.4 mt -94.1 144.14 25.75 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.341 -0.85 . . . . 25.39 111.004 -179.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' R' R ' 112' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -77.71 -17.36 57.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.451 -0.781 . . . . 53.48 109.846 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 113' ' ' THR . . . . . 0.418 HG22 ' HG2' ' R' ' 123' ' ' GLU . 60.5 m -83.72 166.68 17.86 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.251 -0.906 . . . . 14.8 110.22 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' R' R ' 114' ' ' GLY . . . . . . . . . . . . . . . -97.96 127.16 9.13 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.994 -1.243 . . . . 16.14 109.994 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 115' ' ' ILE . . . . . 0.48 ' HB ' ' HG2' ' R' ' 108' ' ' LYS . 47.8 mm -109.09 139.36 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.475 -1.015 . . . . 13.46 109.71 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' R' R ' 116' ' ' GLY . . . . . . . . . . . . . . . -152.78 -155.81 7.27 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.964 -1.254 . . . . 23.9 109.964 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 117' ' ' THR . . . . . . . . . . . . . 18.9 p -135.06 -171.46 2.81 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.467 -1.019 . . . . 27.37 110.02 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.5 -58.09 9.53 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.337 -0.852 . . . . 18.76 110.064 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 119' ' ' SER . . . . . . . . . . . . . 1.1 m -56.54 -40.65 75.46 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.267 -0.896 . . . . 32.35 109.69 179.655 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 120' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 -110.02 86.19 4.77 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.458 -0.776 . . . . 27.12 109.643 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 121' ' ' PRO . . . . . 0.426 ' O ' ' HB2' ' R' ' 122' ' ' SER . 44.3 Cg_endo -71.26 166.55 28.9 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.817 1.43 . . . . 22.68 111.02 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' R' R ' 122' ' ' SER . . . . . 0.426 ' HB2' ' O ' ' R' ' 121' ' ' PRO . 38.6 t 178.55 -161.67 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.643 -0.661 . . . . 22.99 109.447 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' R' R ' 123' ' ' GLU . . . . . 0.418 ' HG2' HG22 ' R' ' 113' ' ' THR . 2.3 tp10 -56.47 -39.95 74.06 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.211 -0.93 . . . . 36.18 109.673 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' R' R ' 124' ' ' VAL . . . . . . . . . . . . . 84.2 t -142.52 136.43 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.471 -0.768 . . . . 20.64 109.333 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 125' ' ' CYS . . . . . 0.41 ' SG ' ' HA ' ' R' ' 121' ' ' PRO . 83.4 m -140.32 168.16 20.46 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.245 -0.91 . . . . 22.8 111.206 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' R' R ' 126' ' ' VAL . . . . . . . . . . . . . 35.9 m -122.68 159.75 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.713 -0.617 . . . . 21.24 109.595 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 127' ' ' VAL . . . . . 0.4 ' CG1' ' O ' ' R' ' 177' ' ' VAL . 30.5 m -70.83 141.83 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.29 -0.881 . . . . 19.77 110.708 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' R' R ' 128' ' ' ASP . . . . . . . . . . . . . 53.8 p-10 -137.7 19.42 2.87 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.37 -0.831 . . . . 29.21 110.664 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 129' ' ' GLY . . . . . . . . . . . . . . . 114.08 0.05 24.02 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.967 -1.111 . . . . 33.86 110.403 179.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 130' ' ' THR . . . . . . . . . . . . . 58.7 m -91.91 131.83 36.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.145 -1.209 . . . . 26.41 110.08 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -62.51 120.66 11.53 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.338 -0.852 . . . . 33.08 110.224 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 132' ' ' MET . . . . . 0.426 ' HE1' ' CZ ' ' R' ' 180' ' ' PHE . 98.3 mmm -105.16 165.67 10.93 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.558 -0.714 . . . . 30.76 110.472 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' R' R ' 133' ' ' CYS . . . . . . . . . . . . . 32.3 m -141.22 158.09 44.36 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.52 -0.737 . . . . 27.0 109.907 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 134' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.41 -19.76 38.86 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.312 -0.868 . . . . 33.9 110.453 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' R' R ' 135' ' ' ALA . . . . . . . . . . . . . . . -92.77 8.18 40.5 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.257 -0.902 . . . . 19.37 110.78 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 136' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -93.72 -21.81 19.11 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.198 -0.939 . . . . 30.47 110.228 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 137' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -149.94 165.28 33.11 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.319 -0.863 . . . . 24.27 110.22 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 138' ' ' HIS . . . . . . . . . . . . . 15.3 p80 -117.73 15.08 14.46 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.429 -0.794 . . . . 20.91 110.459 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 139' ' ' ALA . . . . . 0.441 ' HA ' ' O ' ' R' ' 152' ' ' ALA . . . -177.16 152.46 0.88 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.306 -0.871 . . . . 15.69 110.08 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' R' R ' 140' ' ' GLY . . . . . 0.405 ' HA3' ' O ' ' R' ' 179' ' ' VAL . . . 161.74 175.14 32.45 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 110.0 -1.24 . . . . 23.76 110.0 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' R' R ' 141' ' ' ILE . . . . . . . . . . . . . 83.8 mt -95.48 136.58 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.371 -1.076 . . . . 25.3 109.674 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 142' ' ' PHE . . . . . 0.546 ' CD2' ' HB2' ' R' ' 172' ' ' PRO . 82.6 m-85 -120.73 -172.59 2.41 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.27 -0.894 . . . . 30.24 110.512 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' R' R ' 143' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -119.81 77.72 1.26 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.43 -0.794 . . . . 32.8 110.301 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' R' R ' 144' ' ' LYS . . . . . 0.454 ' HG3' ' CZ2' ' R' ' 170' ' ' TRP . 1.0 OUTLIER -69.54 76.83 0.41 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.363 -0.835 . . . . 49.18 109.728 179.549 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' R' R ' 145' ' ' GLY . . . . . . . . . . . . . . . 104.57 179.32 24.74 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.202 -1.559 . . . . 53.87 109.202 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 146' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -88.49 145.83 25.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.369 -1.077 . . . . 68.58 110.006 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 147' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 58.26 36.45 25.68 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.347 -0.845 . . . . 56.62 110.655 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 148' ' ' HIS . . . . . . . . . . . . . 45.1 t60 -158.67 148.09 19.16 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.267 -0.895 . . . . 44.57 110.359 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 149' ' ' ALA . . . . . . . . . . . . . . . -150.27 146.91 27.07 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.484 -0.76 . . . . 33.54 110.072 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 150' ' ' VAL . . . . . 0.428 HG23 ' HB2' ' R' ' 144' ' ' LYS . 34.2 m -142.32 161.51 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.263 -0.898 . . . . 27.61 110.322 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' R' R ' 151' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' R' ' 152' ' ' ALA . 5.9 t80 -86.24 155.63 20.62 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.401 -0.812 . . . . 23.04 109.881 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' R' R ' 152' ' ' ALA . . . . . 0.537 ' N ' ' CD1' ' R' ' 151' ' ' PHE . . . -157.31 151.51 24.83 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.45 -0.781 . . . . 29.61 109.589 179.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' R' R ' 153' ' ' CYS . . . . . 0.407 ' HA ' ' HA ' ' R' ' 139' ' ' ALA . 26.7 p -154.27 173.6 15.93 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.347 -0.846 . . . . 22.75 110.444 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' R' R ' 154' ' ' VAL . . . . . 0.443 ' CG2' ' CZ2' ' R' ' 159' ' ' TRP . 59.7 t -90.64 117.03 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.425 -0.797 . . . . 23.26 110.061 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' R' R ' 155' ' ' THR . . . . . . . . . . . . . 69.9 p -112.11 -176.6 2.96 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.313 -0.867 . . . . 17.88 110.065 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 156' ' ' SER . . . . . . . . . . . . . 78.5 p -75.98 -3.66 36.86 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.27 -0.894 . . . . 21.83 110.672 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 157' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -118.36 10.53 12.79 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.138 -0.976 . . . . 36.54 110.59 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 158' ' ' GLY . . . . . . . . . . . . . . . 117.92 -162.68 13.01 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.567 -1.413 . . . . 31.74 109.567 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 159' ' ' TRP . . . . . 0.443 ' CZ2' ' CG2' ' R' ' 154' ' ' VAL . 14.7 m95 -86.56 122.45 30.5 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.389 -1.065 . . . . 28.25 110.147 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' R' R ' 160' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -108.45 166.91 10.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.305 -0.872 . . . . 41.24 110.218 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 161' ' ' ALA . . . . . . . . . . . . . . . -143.21 123.48 13.79 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.403 -0.81 . . . . 27.4 110.14 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 162' ' ' ILE . . . . . 0.43 HG23 ' CZ ' ' R' ' 167' ' ' PHE . 92.3 mt -87.59 81.14 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.324 -0.86 . . . . 24.27 110.015 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' R' R ' 163' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' R' ' 165' ' ' GLU . 15.3 t0 -72.78 92.41 1.57 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.406 -0.809 . . . . 36.08 110.262 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' R' R ' 164' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 54.07 -88.97 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.564 -0.71 . . . . 46.08 110.603 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 165' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' R' ' 163' ' ' ASP . 29.8 mt-10 -124.72 36.03 4.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.083 -1.011 . . . . 50.94 110.194 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' R' R ' 166' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -135.75 117.33 14.88 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.388 -0.82 . . . . 47.28 110.347 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 167' ' ' PHE . . . . . 0.43 ' CZ ' HG23 ' R' ' 162' ' ' ILE . 24.5 m-85 -101.1 119.96 39.51 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.427 -0.795 . . . . 40.47 110.132 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' R' R ' 168' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -157.49 158.59 30.76 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.216 -0.927 . . . . 30.21 110.423 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 169' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.79 132.98 19.38 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 O-C-N 123.831 1.437 . . . . 32.76 110.527 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 170' ' ' TRP . . . . . 0.454 ' CZ2' ' HG3' ' R' ' 144' ' ' LYS . 67.0 t90 -159.78 119.37 2.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.384 -0.823 . . . . 32.79 109.909 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' R' R ' 171' ' ' THR . . . . . . . . . . . . . 47.5 m -81.12 112.62 34.35 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.448 -0.783 . . . . 36.92 110.141 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 172' ' ' PRO . . . . . 0.546 ' HB2' ' CD2' ' R' ' 142' ' ' PHE . 48.0 Cg_endo -73.7 158.83 46.62 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.596 1.314 . . . . 33.54 110.545 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' R' R ' 173' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -88.92 144.93 33.64 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.415 -0.803 . . . . 45.76 109.904 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 174' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.72 -10.34 26.35 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 O-C-N 123.517 1.272 . . . . 29.63 110.497 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 175' ' ' SER . . . . . . . . . . . . . 52.9 p -103.42 -17.63 15.16 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.348 -0.845 . . . . 35.7 110.396 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 176' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -103.48 43.18 1.1 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.213 -0.93 . . . . 39.65 110.4 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 177' ' ' VAL . . . . . 0.4 ' O ' ' CG1' ' R' ' 127' ' ' VAL . 10.7 p -117.71 127.17 75.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.368 -0.832 . . . . 20.61 110.043 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' R' R ' 178' ' ' LEU . . . . . . . . . . . . . 46.1 mt -91.56 -61.24 1.69 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.362 -0.836 . . . . 15.58 109.378 179.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 179' ' ' VAL . . . . . 0.405 ' O ' ' HA3' ' R' ' 140' ' ' GLY . 67.8 t -114.67 144.69 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.676 -0.64 . . . . 17.4 109.391 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' R' R ' 180' ' ' PHE . . . . . 0.426 ' CZ ' ' HE1' ' R' ' 132' ' ' MET . 43.6 p90 -152.17 163.41 39.45 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.268 -0.895 . . . . 20.16 110.529 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' R' R ' 181' ' ' VAL . . . . . . . . . . . . . 66.6 t -113.2 111.49 50.19 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.488 -0.758 . . . . 17.69 109.862 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 182' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.06 149.49 52.61 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 O-C-N 123.606 1.319 . . . . 17.81 110.456 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' R' R ' 183' ' ' TYR . . . . . 0.709 ' O ' ' C ' ' R' ' 184' ' ' ASP . 79.5 m-85 -58.92 175.45 0.28 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.463 -0.773 . . . . 28.01 110.535 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' R' R ' 184' ' ' ASP . . . . . 0.709 ' C ' ' O ' ' R' ' 183' ' ' TYR . 6.1 m-20 -17.71 -82.75 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.313 -0.867 . . . . 58.64 110.271 -178.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' R' R ' 185' ' ' GLN . . . . . . . . . . . . . 49.2 mm-40 . . . . . 0 N--CA 1.503 2.183 0 CA-C-O 121.23 0.538 . . . . 80.42 111.783 179.547 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' R' R ' 193' ' ' LYS . . . . . . . . . . . . . 28.0 mtmt . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 120.888 0.375 . . . . 49.5 110.192 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' R' R ' 194' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.76 0 O-C-N 121.172 -0.955 . . . . 40.4 110.127 179.929 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' S' S ' 229' ' ' MET . . . . . 0.457 ' HG3' ' N ' ' S' ' 230' ' ' GLU . 3.3 ptt? . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.181 0.515 . . . . 51.83 110.233 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 230' ' ' GLU . . . . . 0.457 ' N ' ' HG3' ' S' ' 229' ' ' MET . 33.2 tt0 -97.29 142.75 28.79 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.432 -0.793 . . . . 54.13 110.196 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' S' S ' 231' ' ' LEU . . . . . . . . . . . . . 68.0 mt -134.12 141.05 46.99 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.352 -0.842 . . . . 33.04 110.334 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 232' ' ' THR . . . . . . . . . . . . . 40.3 m -89.26 103.24 15.88 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.343 -0.848 . . . . 26.92 110.041 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 233' ' ' LEU . . . . . 0.495 HD23 ' CE2' ' S' ' 262' ' ' TYR . 79.7 mt -55.87 179.29 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.531 -0.731 . . . . 13.78 110.543 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' S' S ' 234' ' ' TYR . . . . . 0.448 ' CG ' ' N ' ' S' ' 235' ' ' ASN . 35.5 p90 -65.02 -35.63 81.81 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.426 -0.797 . . . . 26.08 110.189 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' S' S ' 235' ' ' ASN . . . . . 0.448 ' N ' ' CG ' ' S' ' 234' ' ' TYR . 50.6 p30 -74.36 -7.47 52.96 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.345 -0.847 . . . . 20.04 110.531 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' S' S ' 236' ' ' GLY . . . . . . . . . . . . . . . 95.79 -19.96 51.97 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.764 -1.334 . . . . 22.71 109.764 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 237' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -52.95 145.63 12.45 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.258 -1.142 . . . . 35.44 110.235 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 238' ' ' LYS . . . . . . . . . . . . . 44.4 mttt -102.1 127.85 48.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.349 -0.845 . . . . 32.56 110.426 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 239' ' ' LYS . . . . . 0.412 ' HG2' ' CZ ' ' S' ' 241' ' ' PHE . 9.0 ttmt -132.29 144.51 50.64 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.41 -0.806 . . . . 26.68 109.992 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' S' S ' 240' ' ' THR . . . . . . . . . . . . . 51.7 m -102.08 132.17 48.12 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.362 -0.836 . . . . 41.02 110.37 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 241' ' ' PHE . . . . . 0.412 ' CZ ' ' HG2' ' S' ' 239' ' ' LYS . 96.0 m-85 -117.85 137.66 52.63 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.379 -0.826 . . . . 28.62 110.196 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' S' S ' 242' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -96.29 161.87 13.75 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.288 -0.883 . . . . 47.89 110.295 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 243' ' ' SER . . . . . . . . . . . . . 71.9 m -90.64 151.52 21.25 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.362 -0.836 . . . . 45.09 110.309 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 244' ' ' ARG . . . . . . . . . . . . . 1.4 mtp85 -129.85 126.78 22.67 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.415 -0.803 . . . . 42.49 110.199 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 245' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.37 161.0 43.7 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 O-C-N 123.639 1.336 . . . . 35.68 110.507 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 246' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -132.86 97.87 4.15 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.359 -0.838 . . . . 51.88 109.822 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 247' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -110.47 -22.21 11.78 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.378 -0.826 . . . . 53.69 110.664 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 248' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -117.29 43.74 2.26 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.225 -0.922 . . . . 55.79 110.714 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 249' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 48.77 38.41 11.76 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.447 -0.783 . . . . 49.45 110.417 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 250' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -90.61 28.99 1.38 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.526 -0.734 . . . . 36.86 110.358 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 251' ' ' ALA . . . . . . . . . . . . . . . -53.78 -43.18 69.03 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.311 -0.868 . . . . 29.69 109.575 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 252' ' ' TRP . . . . . 0.414 ' CZ2' ' HB3' ' S' ' 294' ' ' LEU . 67.9 p-90 -61.83 -34.01 75.19 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.451 -0.78 . . . . 41.12 109.79 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' S' S ' 253' ' ' LEU . . . . . . . . . . . . . 23.3 tp -70.14 -47.23 62.59 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.433 -0.792 . . . . 24.89 109.906 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 254' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -56.12 -42.41 76.81 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.395 -0.816 . . . . 35.65 109.956 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 255' ' ' ALA . . . . . . . . . . . . . . . -59.63 -48.09 83.02 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.464 -0.773 . . . . 22.73 110.074 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 256' ' ' ILE . . . . . . . . . . . . . 79.6 mt -62.37 -40.62 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.315 -0.866 . . . . 28.85 109.928 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 257' ' ' LEU . . . . . . . . . . . . . 19.2 mt -61.56 -44.45 97.01 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.403 -0.81 . . . . 23.07 110.244 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 258' ' ' GLN . . . . . 0.471 ' HB3' ' CD2' ' S' ' 351' ' ' PHE . 53.1 mm-40 -65.05 -45.37 85.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.384 -0.823 . . . . 29.78 109.918 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' S' S ' 259' ' ' LEU . . . . . 0.433 ' O ' HG22 ' S' ' 263' ' ' VAL . 19.8 tp -58.69 -36.38 74.11 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.291 -0.881 . . . . 17.94 109.435 179.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' S' S ' 260' ' ' PHE . . . . . 0.47 ' CE2' HD22 ' S' ' 311' ' ' LEU . 3.1 m-85 -62.83 -45.27 93.41 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.603 -0.686 . . . . 30.57 109.84 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' S' S ' 261' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -62.12 -29.81 70.59 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.46 -0.775 . . . . 41.34 109.898 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 262' ' ' TYR . . . . . 0.495 ' CE2' HD23 ' S' ' 233' ' ' LEU . 8.6 t80 -71.22 -44.63 64.99 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.41 -0.806 . . . . 26.03 110.085 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' S' S ' 263' ' ' VAL . . . . . 0.433 HG22 ' O ' ' S' ' 259' ' ' LEU . 33.1 m -92.06 18.29 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.352 -0.842 . . . . 22.8 110.373 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' S' S ' 264' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 52.77 70.64 0.55 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.199 -0.938 . . . . 44.03 110.653 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 265' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -111.81 109.12 55.47 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.303 -0.873 . . . . 35.61 109.637 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 266' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -75.31 0.39 9.08 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 O-C-N 123.578 1.304 . . . . 37.67 111.753 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 267' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -56.48 -67.73 0.28 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.85 -1.156 . . . . 41.49 110.173 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' S' S ' 268' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -92.86 39.94 1.05 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.148 -0.97 . . . . 50.76 110.132 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 269' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.1 -33.19 59.49 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.307 -0.87 . . . . 61.86 109.727 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' S' S ' 270' ' ' TRP . . . . . 0.493 ' CE2' ' CG2' ' S' ' 271' ' ' VAL . 50.9 p-90 -73.85 -4.41 34.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.322 -0.861 . . . . 39.85 110.46 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' S' S ' 271' ' ' VAL . . . . . 0.493 ' CG2' ' CE2' ' S' ' 270' ' ' TRP . 46.6 t -109.49 -32.72 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.117 -0.989 . . . . 39.18 110.156 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' S' S ' 272' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -78.6 -36.6 44.06 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.387 -0.821 . . . . 40.02 110.486 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 273' ' ' SER . . . . . . . . . . . . . 71.2 m -103.48 56.16 0.74 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.336 -0.853 . . . . 47.2 110.306 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 274' ' ' SER . . . . . . . . . . . . . 6.9 t -133.06 141.27 40.29 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.336 -0.853 . . . . 47.61 110.14 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 275' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -73.85 -18.83 21.51 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.684 1.36 . . . . 45.28 110.485 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 276' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -99.87 140.87 33.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.238 -0.913 . . . . 57.27 110.317 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 277' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -71.73 97.67 1.8 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.388 -0.82 . . . . 37.28 110.322 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 278' ' ' LEU . . . . . . . . . . . . . 86.8 mt -97.04 33.84 1.85 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.358 -0.839 . . . . 43.88 109.987 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 279' ' ' THR . . . . . . . . . . . . . 75.3 m -64.03 -60.09 3.67 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.424 -0.797 . . . . 50.05 110.347 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 280' ' ' LEU . . . . . . . . . . . . . 13.7 mt -51.59 -39.91 58.84 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.363 -0.836 . . . . 54.12 110.246 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 281' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.42 -49.68 74.5 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.474 -0.766 . . . . 65.28 110.141 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' S' S ' 282' ' ' ALA . . . . . . . . . . . . . . . -58.97 -33.86 71.14 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.466 -0.771 . . . . 46.51 110.555 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 283' ' ' ILE . . . . . . . . . . . . . 85.7 mt -66.37 -50.86 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.273 -0.892 . . . . 47.3 110.087 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 284' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -50.59 -57.56 7.88 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.43 -0.794 . . . . 50.72 110.387 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 285' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -51.46 -46.32 63.02 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.503 -0.748 . . . . 68.47 110.332 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 286' ' ' LEU . . . . . . . . . . . . . 19.1 mt -59.96 -44.53 94.39 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.42 -0.8 . . . . 36.62 110.312 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 287' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -62.71 -35.26 79.16 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.372 -0.83 . . . . 46.64 110.099 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 288' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -76.24 -21.08 56.79 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.37 -0.831 . . . . 46.45 110.28 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 289' ' ' LEU . . . . . . . . . . . . . 30.8 mt -97.31 -21.75 17.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.286 -0.884 . . . . 35.09 110.487 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 290' ' ' THR . . . . . . . . . . . . . 81.2 p -114.74 -28.45 7.1 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.221 -0.925 . . . . 38.61 110.422 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 291' ' ' GLY . . . . . . . . . . . . . . . 79.43 10.93 85.43 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.823 -1.311 . . . . 36.77 109.823 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 292' ' ' LEU . . . . . . . . . . . . . 84.8 mt -96.44 145.84 25.31 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.226 -1.161 . . . . 35.33 109.726 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 293' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -77.37 102.41 6.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.196 -0.94 . . . . 48.7 110.232 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 294' ' ' LEU . . . . . 0.414 ' HB3' ' CZ2' ' S' ' 252' ' ' TRP . 56.2 mt -106.99 51.74 0.73 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.539 -0.726 . . . . 42.61 110.066 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' S' S ' 295' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -112.51 -11.17 13.65 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.362 -0.836 . . . . 55.49 110.524 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' S' S ' 296' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -144.36 48.53 1.36 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.127 -0.983 . . . . 75.68 110.321 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 297' ' ' GLY . . . . . . . . . . . . . . . 96.87 145.22 18.78 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.511 -1.436 . . . . 49.44 109.511 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 298' ' ' GLY . . . . . . . . . . . . . . . -163.83 156.96 29.05 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.744 -1.342 . . . . 41.11 109.744 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 299' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.84 118.26 5.36 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 123.943 1.497 . . . . 26.2 110.293 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 300' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.33 -15.38 31.4 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 O-C-N 123.647 1.34 . . . . 21.7 110.675 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 301' ' ' ALA . . . . . . . . . . . . . . . -80.69 -29.31 36.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.238 -0.914 . . . . 31.23 110.182 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 302' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.48 -40.7 18.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.404 -0.81 . . . . 38.99 109.966 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' S' S ' 303' ' ' VAL . . . . . 0.468 ' O ' HG12 ' S' ' 307' ' ' ILE . 56.9 t -60.61 -35.48 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.399 -0.813 . . . . 18.63 110.153 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' S' S ' 304' ' ' ILE . . . . . . . . . . . . . 86.5 mt -79.43 -23.65 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.449 -0.782 . . . . 25.46 110.124 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 305' ' ' TRP . . . . . . . . . . . . . 68.9 t-105 -88.59 -14.69 36.97 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.234 -0.916 . . . . 33.4 110.501 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 306' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -89.61 -13.52 36.96 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.179 -0.95 . . . . 36.97 110.438 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 307' ' ' ILE . . . . . 0.468 HG12 ' O ' ' S' ' 303' ' ' VAL . 36.8 pt -125.14 45.66 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.237 -0.915 . . . . 30.81 110.005 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' S' S ' 308' ' ' LYS . . . . . . . . . . . . . 1.5 mtmp? -73.52 -37.71 65.56 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.35 -0.844 . . . . 46.52 110.169 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 309' ' ' HIS . . . . . 0.484 ' CD2' ' HG ' ' S' ' 310' ' ' LEU . 55.6 p-80 -73.25 -8.26 55.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.407 -0.808 . . . . 51.03 110.057 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' S' S ' 310' ' ' LEU . . . . . 0.484 ' HG ' ' CD2' ' S' ' 309' ' ' HIS . 52.8 mt -99.25 -12.91 19.96 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.29 -0.881 . . . . 36.16 109.962 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' S' S ' 311' ' ' LEU . . . . . 0.47 HD22 ' CE2' ' S' ' 260' ' ' PHE . 10.8 mt -97.14 147.77 23.73 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.278 -0.889 . . . . 40.0 110.471 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' S' S ' 312' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -81.58 -16.29 52.08 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.282 -0.886 . . . . 54.18 109.771 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 313' ' ' THR . . . . . 0.468 HG23 ' HB3' ' S' ' 323' ' ' GLU . 92.4 m -87.94 151.64 22.66 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.378 -0.826 . . . . 25.61 110.151 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' S' S ' 314' ' ' GLY . . . . . . . . . . . . . . . -87.88 126.42 8.04 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.815 -1.314 . . . . 25.18 109.815 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 315' ' ' ILE . . . . . . . . . . . . . 50.6 mm -101.62 150.47 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.346 -1.091 . . . . 23.9 109.702 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 316' ' ' GLY . . . . . . . . . . . . . . . -157.13 -159.23 9.36 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 110.021 -1.232 . . . . 23.18 110.021 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 317' ' ' THR . . . . . . . . . . . . . 11.0 p -133.96 -173.04 3.14 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.311 -1.111 . . . . 27.98 109.923 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.57 -56.18 25.19 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.2 -0.937 . . . . 28.1 109.899 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 319' ' ' SER . . . . . . . . . . . . . 1.2 m -59.98 -41.61 92.4 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.321 -0.862 . . . . 37.0 109.621 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 320' ' ' ARG . . . . . . . . . . . . . 12.2 mtm180 -111.67 79.88 2.62 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.481 -0.762 . . . . 52.07 109.657 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 321' ' ' PRO . . . . . 0.435 ' O ' ' HB2' ' S' ' 322' ' ' SER . 43.9 Cg_endo -71.41 171.54 15.98 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.869 1.457 . . . . 38.29 110.9 -179.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' S' S ' 322' ' ' SER . . . . . 0.435 ' HB2' ' O ' ' S' ' 321' ' ' PRO . 41.2 t 178.62 -148.17 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.89 -0.781 . . . . 38.84 108.89 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' S' S ' 323' ' ' GLU . . . . . 0.468 ' HB3' HG23 ' S' ' 313' ' ' THR . 6.7 tp10 -62.82 -40.26 96.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.003 -1.061 . . . . 40.7 109.734 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' S' S ' 324' ' ' VAL . . . . . . . . . . . . . 72.9 t -141.33 134.98 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.427 -0.795 . . . . 20.34 109.5 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 325' ' ' CYS . . . . . 0.449 ' HB2' ' CE1' ' S' ' 380' ' ' PHE . 11.1 m -125.95 172.21 10.11 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.249 -0.907 . . . . 30.63 110.826 -179.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' S' S ' 326' ' ' VAL . . . . . . . . . . . . . 34.5 m -135.49 142.18 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 109.216 -0.661 . . . . 23.9 109.216 179.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 327' ' ' VAL . . . . . . . . . . . . . 34.5 m -56.29 124.94 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.133 -0.979 . . . . 19.48 110.432 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 328' ' ' ASP . . . . . . . . . . . . . 55.7 p-10 -119.37 11.54 12.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.432 -0.792 . . . . 26.43 110.422 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 329' ' ' GLY . . . . . . . . . . . . . . . 119.67 2.13 13.14 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.074 -1.21 . . . . 31.24 110.074 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 330' ' ' THR . . . . . . . . . . . . . 79.4 m -92.9 130.02 38.63 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.082 -1.246 . . . . 30.05 110.122 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 331' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -56.89 111.53 1.06 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.321 -0.862 . . . . 37.26 109.991 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 332' ' ' MET . . . . . 0.457 ' HE1' ' CZ ' ' S' ' 380' ' ' PHE . 88.1 mmm -94.1 162.49 13.85 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.267 -0.896 . . . . 26.23 110.344 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' S' S ' 333' ' ' CYS . . . . . . . . . . . . . 25.8 m -137.19 150.11 47.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.475 -0.766 . . . . 23.56 110.025 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 334' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.66 -24.76 9.12 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.289 -0.882 . . . . 28.93 110.5 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' S' S ' 335' ' ' ALA . . . . . . . . . . . . . . . -89.1 14.49 10.64 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.388 -0.82 . . . . 15.76 110.973 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 336' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -100.48 -17.25 17.24 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.133 -0.979 . . . . 34.92 110.143 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 337' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -152.41 170.83 19.14 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.333 -0.854 . . . . 19.03 110.077 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 338' ' ' HIS . . . . . 0.401 ' HB3' ' CZ ' ' S' ' 383' ' ' TYR . 13.5 p80 -120.65 10.42 11.03 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.333 -0.854 . . . . 18.82 110.479 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' S' S ' 339' ' ' ALA . . . . . . . . . . . . . . . -175.98 155.16 1.56 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.204 -0.935 . . . . 17.18 110.146 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 340' ' ' GLY . . . . . 0.405 ' CA ' ' O ' ' S' ' 379' ' ' VAL . . . 160.81 173.06 28.94 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.036 -1.226 . . . . 18.33 110.036 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' S' S ' 341' ' ' ILE . . . . . 0.433 HD12 HG22 ' S' ' 341' ' ' ILE . 84.2 mt -88.78 138.07 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.489 -1.006 . . . . 18.6 109.787 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' S' S ' 342' ' ' PHE . . . . . 0.5 ' CE1' HG23 ' S' ' 377' ' ' VAL . 69.9 m-85 -120.97 -178.43 3.74 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.222 -0.924 . . . . 23.44 110.407 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' S' S ' 343' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.84 93.41 4.19 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.532 -0.73 . . . . 35.59 110.024 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' S' S ' 344' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.87 125.04 29.62 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.301 -0.874 . . . . 38.34 110.067 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' S' S ' 345' ' ' GLY . . . . . . . . . . . . . . . 62.75 -130.86 43.17 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 108.874 -1.69 . . . . 53.46 108.874 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 346' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -132.68 150.89 52.1 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.246 -1.149 . . . . 70.91 110.043 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 347' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 53.19 35.44 19.92 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.321 -0.862 . . . . 47.32 110.45 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 348' ' ' HIS . . . . . . . . . . . . . 46.4 t60 -150.18 155.87 40.56 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.204 -0.935 . . . . 41.72 110.311 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 349' ' ' ALA . . . . . . . . . . . . . . . -149.82 151.22 33.17 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.314 -0.866 . . . . 22.91 110.527 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 350' ' ' VAL . . . . . . . . . . . . . 34.6 m -149.0 169.67 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.463 -0.773 . . . . 21.09 110.058 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 351' ' ' PHE . . . . . 0.471 ' CD2' ' HB3' ' S' ' 258' ' ' GLN . 10.7 t80 -105.43 143.59 33.38 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.178 -0.951 . . . . 25.03 110.682 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' S' S ' 352' ' ' ALA . . . . . . . . . . . . . . . -147.67 151.78 36.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.64 -0.662 . . . . 23.81 109.704 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 353' ' ' CYS . . . . . . . . . . . . . 26.2 p -153.37 164.85 37.42 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.324 -0.86 . . . . 25.66 110.185 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 354' ' ' VAL . . . . . 0.4 HG23 ' CZ2' ' S' ' 359' ' ' TRP . 56.6 t -75.94 118.49 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.351 -0.843 . . . . 34.27 110.008 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' S' S ' 355' ' ' THR . . . . . 0.442 HG23 ' HB2' ' S' ' 360' ' ' TYR . 52.5 p -117.86 175.1 5.82 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.196 -0.94 . . . . 25.49 110.327 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' S' S ' 356' ' ' SER . . . . . . . . . . . . . 62.9 p -62.09 -17.75 58.59 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.474 -0.766 . . . . 31.24 110.749 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 357' ' ' ASN . . . . . . . . . . . . . 46.2 m-20 -106.96 14.21 26.74 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.143 -0.973 . . . . 28.61 110.564 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 358' ' ' GLY . . . . . . . . . . . . . . . 111.85 -152.93 17.58 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.979 -1.248 . . . . 22.01 109.979 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 359' ' ' TRP . . . . . 0.4 ' CZ2' HG23 ' S' ' 354' ' ' VAL . 15.1 m95 -91.44 116.76 29.11 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.387 -1.067 . . . . 25.54 110.138 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' S' S ' 360' ' ' TYR . . . . . 0.442 ' HB2' HG23 ' S' ' 355' ' ' THR . 1.3 m-85 -103.49 165.83 10.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.318 -0.864 . . . . 40.53 110.108 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' S' S ' 361' ' ' ALA . . . . . . . . . . . . . . . -140.07 130.09 24.86 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.39 -0.819 . . . . 18.04 110.262 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 362' ' ' ILE . . . . . 0.419 HG23 ' CZ ' ' S' ' 367' ' ' PHE . 89.0 mt -95.7 83.83 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.307 -0.871 . . . . 15.64 109.984 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' S' S ' 363' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' S' ' 365' ' ' GLU . 11.9 t0 -75.37 94.51 3.07 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.352 -0.843 . . . . 35.03 110.16 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' S' S ' 364' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 54.0 -89.44 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.468 -0.77 . . . . 46.72 110.45 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 365' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' S' ' 363' ' ' ASP . 23.8 mt-10 -122.55 18.99 10.44 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.077 -1.014 . . . . 56.2 110.218 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' S' S ' 366' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -117.82 124.98 49.7 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.303 -0.873 . . . . 51.02 110.418 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 367' ' ' PHE . . . . . 0.419 ' CZ ' HG23 ' S' ' 362' ' ' ILE . 26.9 m-85 -106.98 127.08 53.13 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.361 -0.837 . . . . 37.59 110.133 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' S' S ' 368' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -165.47 159.61 13.85 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.303 -0.873 . . . . 31.47 110.437 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 369' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.83 139.57 30.66 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 O-C-N 123.864 1.455 . . . . 28.85 110.536 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 370' ' ' TRP . . . . . . . . . . . . . 67.5 t90 -167.23 113.6 0.76 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.376 -0.827 . . . . 26.94 109.957 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 371' ' ' THR . . . . . . . . . . . . . 59.5 m -74.83 113.04 20.6 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.411 -0.805 . . . . 20.19 110.059 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 372' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -73.46 157.16 49.53 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 O-C-N 123.548 1.288 . . . . 28.68 110.613 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 373' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -90.57 147.12 35.68 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.449 -0.782 . . . . 35.72 109.896 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 374' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -76.02 -6.38 17.3 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.669 1.352 . . . . 30.89 110.474 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 375' ' ' SER . . . . . . . . . . . . . 68.5 p -104.32 -16.88 15.02 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.289 -0.882 . . . . 29.41 110.498 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 376' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -106.53 43.09 1.18 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.222 -0.924 . . . . 32.89 110.227 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 377' ' ' VAL . . . . . 0.5 HG23 ' CE1' ' S' ' 342' ' ' PHE . 7.2 p -114.68 147.31 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.343 -0.848 . . . . 24.33 110.228 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' S' S ' 378' ' ' LEU . . . . . . . . . . . . . 51.7 mt -116.03 -58.0 2.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.401 -0.812 . . . . 24.37 109.626 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 379' ' ' VAL . . . . . 0.405 ' O ' ' CA ' ' S' ' 340' ' ' GLY . 61.4 t -120.69 132.37 70.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.39 -0.819 . . . . 18.02 109.357 179.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' S' S ' 380' ' ' PHE . . . . . 0.457 ' CZ ' ' HE1' ' S' ' 332' ' ' MET . 14.5 p90 -142.54 174.03 11.0 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.367 -0.833 . . . . 29.35 110.646 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' S' S ' 381' ' ' VAL . . . . . . . . . . . . . 57.8 t -120.09 107.39 39.74 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.51 -0.744 . . . . 16.34 109.394 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 382' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.42 145.65 48.34 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 O-C-N 123.608 1.32 . . . . 20.94 110.775 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' S' S ' 383' ' ' TYR . . . . . 0.401 ' CZ ' ' HB3' ' S' ' 338' ' ' HIS . 88.1 m-85 -61.05 -53.54 55.86 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.335 -0.853 . . . . 28.93 109.823 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' S' S ' 384' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.361 -0.837 . . . . 47.03 110.408 -176.226 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' R' R ' 30' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 121.177 0.513 . . . . 43.36 110.202 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' R' R ' 31' ' ' LEU . . . . . . . . . . . . . 65.3 mt -134.9 140.53 45.84 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.312 -0.867 . . . . 22.93 110.318 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 32' ' ' THR . . . . . . . . . . . . . 68.3 m -87.46 110.59 20.41 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.4 -0.812 . . . . 22.34 109.986 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 33' ' ' LEU . . . . . 0.462 HD23 ' CE2' ' R' ' 62' ' ' TYR . 80.2 mt -62.46 -172.76 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.33 -0.856 . . . . 21.39 110.148 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' R' R ' 34' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -74.68 -29.4 61.21 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.333 -0.855 . . . . 34.4 110.328 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 35' ' ' ASN . . . . . . . . . . . . . 48.4 p30 -77.7 -1.89 33.41 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.324 -0.86 . . . . 30.28 110.686 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.2 -16.55 59.46 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.776 -1.329 . . . . 36.25 109.776 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 37' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -59.04 161.81 4.79 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.322 -1.105 . . . . 53.8 110.368 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 38' ' ' LYS . . . . . . . . . . . . . 56.9 mttt -117.86 135.76 53.88 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.445 -0.784 . . . . 49.91 110.146 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 39' ' ' LYS . . . . . 0.415 ' HG2' ' CZ ' ' R' ' 41' ' ' PHE . 8.0 ttmt -138.69 143.71 39.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.388 -0.82 . . . . 35.69 110.27 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' R' R ' 40' ' ' THR . . . . . . . . . . . . . 23.6 m -102.6 127.94 49.48 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.387 -0.82 . . . . 34.84 110.223 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 41' ' ' PHE . . . . . 0.415 ' CZ ' ' HG2' ' R' ' 39' ' ' LYS . 96.6 m-85 -113.06 132.62 55.33 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.426 -0.796 . . . . 34.42 110.14 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' R' R ' 42' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -93.28 140.97 28.96 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.335 -0.853 . . . . 51.46 110.264 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 43' ' ' SER . . . . . . . . . . . . . 54.8 m -70.9 141.92 51.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.445 -0.784 . . . . 41.84 110.202 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.77 125.46 29.45 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.311 -0.868 . . . . 33.82 109.932 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' R' R ' 45' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.17 151.01 54.59 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 O-C-N 123.616 1.324 . . . . 30.27 110.646 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 46' ' ' ASN . . . . . . . . . . . . . 52.2 t-20 -124.21 109.9 13.98 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.545 -0.722 . . . . 35.1 110.088 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 47' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -120.25 -34.92 3.55 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.335 -0.853 . . . . 42.81 110.542 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 48' ' ' HIS . . . . . . . . . . . . . 73.3 m80 -105.74 45.15 0.98 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.322 -0.861 . . . . 49.97 110.223 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 49' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 50.28 34.71 9.23 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.358 -0.839 . . . . 61.32 110.173 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 50' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -86.26 43.77 1.09 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.402 -0.811 . . . . 51.5 110.685 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.12 -46.06 78.87 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.131 -0.981 . . . . 38.77 109.53 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 52' ' ' TRP . . . . . 0.484 ' CD2' ' N ' ' R' ' 53' ' ' LEU . 68.3 p-90 -58.43 -38.37 77.32 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.519 -0.738 . . . . 26.24 110.098 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' R' R ' 53' ' ' LEU . . . . . 0.484 ' N ' ' CD2' ' R' ' 52' ' ' TRP . 23.0 tp -66.63 -46.75 74.79 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.4 -0.813 . . . . 26.75 110.016 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' R' R ' 54' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -55.27 -41.57 72.4 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.341 -0.85 . . . . 35.02 110.078 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.19 -46.03 92.14 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.426 -0.796 . . . . 24.47 110.219 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 56' ' ' ILE . . . . . . . . . . . . . 76.3 mt -62.15 -42.31 94.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.246 -0.909 . . . . 26.03 109.907 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 57' ' ' LEU . . . . . . . . . . . . . 22.3 mt -60.27 -45.68 92.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.4 -0.813 . . . . 26.77 109.661 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 58' ' ' GLN . . . . . . . . . . . . . 57.7 mm-40 -63.87 -46.51 84.64 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.525 -0.734 . . . . 22.32 109.622 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 59' ' ' LEU . . . . . 0.429 ' HA ' ' HE2' ' R' ' 151' ' ' PHE . 24.0 tp -61.45 -37.74 84.64 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.334 -0.854 . . . . 20.55 109.404 179.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' R' R ' 60' ' ' PHE . . . . . 0.447 ' CE2' HD22 ' R' ' 111' ' ' LEU . 2.8 m-85 -61.13 -44.75 96.85 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.631 -0.668 . . . . 20.08 109.866 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' R' R ' 61' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -63.08 -36.19 82.78 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.492 -0.755 . . . . 18.8 110.511 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 62' ' ' TYR . . . . . 0.462 ' CE2' HD23 ' R' ' 33' ' ' LEU . 9.2 t80 -63.14 -41.7 99.33 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.226 -0.921 . . . . 26.45 110.218 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' R' R ' 63' ' ' VAL . . . . . . . . . . . . . 30.2 m -93.36 20.27 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.289 -0.882 . . . . 29.75 110.232 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 64' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 52.91 75.61 0.23 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.343 -0.848 . . . . 35.52 110.549 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 65' ' ' GLU . . . . . 0.425 ' HG2' ' CD2' ' R' ' 60' ' ' PHE . 14.2 tp10 -116.3 104.1 52.28 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.44 -0.787 . . . . 29.89 109.9 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' R' R ' 66' ' ' PRO . . . . . 0.4 ' HA ' ' HB2' ' R' ' 69' ' ' ASP . 47.4 Cg_endo -73.55 -5.83 17.74 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.79 1.416 . . . . 21.37 111.07 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' R' R ' 67' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -52.11 -61.56 2.19 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.099 -1.0 . . . . 23.85 110.331 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' R' R ' 68' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -98.12 36.52 1.56 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.275 -0.891 . . . . 28.07 110.442 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 69' ' ' ASP . . . . . 0.4 ' HB2' ' HA ' ' R' ' 66' ' ' PRO . 11.8 t0 -72.3 -33.29 67.3 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.303 -0.873 . . . . 43.76 110.169 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' R' R ' 70' ' ' TRP . . . . . 0.476 ' CE2' ' CG2' ' R' ' 71' ' ' VAL . 47.9 p-90 -73.32 -3.91 29.99 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.34 -0.85 . . . . 33.06 110.739 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' R' R ' 71' ' ' VAL . . . . . 0.476 ' CG2' ' CE2' ' R' ' 70' ' ' TRP . 40.7 t -109.78 -27.49 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.237 -0.914 . . . . 31.7 109.658 179.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' R' R ' 72' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -86.55 -48.87 7.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.407 -0.808 . . . . 33.58 110.267 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 73' ' ' SER . . . . . . . . . . . . . 70.1 m -89.73 51.01 1.99 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.29 -0.881 . . . . 50.82 110.362 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 74' ' ' SER . . . . . . . . . . . . . 15.8 t -125.89 138.37 31.92 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.303 -0.873 . . . . 34.74 110.206 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.38 -24.99 15.89 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 O-C-N 123.669 1.352 . . . . 35.7 110.32 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 76' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -91.7 153.16 19.85 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.422 -0.799 . . . . 66.48 110.342 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 77' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -81.47 95.23 7.03 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.374 -0.829 . . . . 46.72 110.061 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 78' ' ' LEU . . . . . . . . . . . . . 96.3 mt -96.46 27.97 3.55 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.473 -0.767 . . . . 37.55 110.191 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 79' ' ' THR . . . . . . . . . . . . . 29.8 m -56.31 -54.5 44.72 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.26 -0.9 . . . . 37.36 110.283 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 80' ' ' LEU . . . . . . . . . . . . . 15.9 mt -61.04 -23.09 65.17 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.439 -0.788 . . . . 35.83 110.513 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 81' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -79.48 -39.21 32.69 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.162 -0.961 . . . . 44.03 110.349 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.4 -28.64 66.34 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.315 -0.866 . . . . 32.54 110.278 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 83' ' ' ILE . . . . . . . . . . . . . 78.2 mt -70.11 -46.09 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.307 -0.87 . . . . 32.02 110.265 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 84' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -55.19 -52.07 64.51 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.222 -0.924 . . . . 34.09 110.596 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 85' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -54.81 -46.89 74.59 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.279 -0.888 . . . . 25.94 110.299 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 86' ' ' LEU . . . . . . . . . . . . . 24.0 mt -58.6 -43.85 89.67 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.339 -0.851 . . . . 16.2 109.936 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 87' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -65.37 -35.17 80.15 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.435 -0.791 . . . . 49.09 110.304 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 88' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -78.47 -19.03 53.99 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.257 -0.902 . . . . 28.61 110.556 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 89' ' ' LEU . . . . . . . . . . . . . 32.5 mt -96.18 -29.41 14.07 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.207 -0.933 . . . . 26.16 110.197 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 90' ' ' THR . . . . . . . . . . . . . 59.0 p -105.7 -34.55 7.67 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.303 -0.873 . . . . 33.33 109.778 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.78 16.02 58.81 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.857 -1.297 . . . . 31.13 109.857 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 92' ' ' LEU . . . . . . . . . . . . . 97.0 mt -100.04 155.24 17.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.153 -1.204 . . . . 42.52 110.229 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 93' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -86.28 91.63 8.54 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.538 -0.726 . . . . 68.46 109.991 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 94' ' ' LEU . . . . . 0.447 ' HB3' ' CZ2' ' R' ' 52' ' ' TRP . 48.2 mt -99.47 52.99 0.94 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.183 -0.948 . . . . 44.63 110.282 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' R' R ' 95' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.48 -38.67 6.38 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.263 -0.898 . . . . 67.16 110.381 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' R' R ' 96' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -113.91 44.25 1.68 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.364 -0.835 . . . . 67.02 110.278 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 97' ' ' GLY . . . . . . . . . . . . . . . 99.12 150.77 26.02 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.653 -1.379 . . . . 49.48 109.653 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 98' ' ' GLY . . . . . . . . . . . . . . . -166.28 159.99 33.42 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.329 -1.508 . . . . 36.57 109.329 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 99' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -72.55 121.11 7.15 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 123.732 1.385 . . . . 30.41 110.413 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 100' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.39 -31.5 11.31 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 O-C-N 123.621 1.327 . . . . 29.94 110.514 -179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.05 -38.45 75.81 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.293 -0.879 . . . . 23.64 110.294 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.6 -40.69 66.32 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.353 -0.842 . . . . 20.31 110.446 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' R' R ' 103' ' ' VAL . . . . . . . . . . . . . 63.7 t -58.19 -40.08 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.225 -0.922 . . . . 16.33 109.986 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 104' ' ' ILE . . . . . . . . . . . . . 81.8 mt -71.71 -30.54 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.427 -0.796 . . . . 24.77 109.968 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 105' ' ' TRP . . . . . 0.44 ' O ' ' HD3' ' R' ' 108' ' ' LYS . 70.5 t-105 -82.43 0.89 40.08 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.277 -0.89 . . . . 23.28 110.26 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' R' R ' 106' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -105.11 -10.45 17.14 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.173 -0.954 . . . . 28.26 110.03 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 107' ' ' ILE . . . . . . . . . . . . . 36.8 pt -126.85 34.98 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.184 -0.947 . . . . 18.77 110.026 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 108' ' ' LYS . . . . . 0.481 ' HG2' ' HB ' ' R' ' 115' ' ' ILE . 9.3 mtpp -61.02 -48.49 81.57 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.493 -0.755 . . . . 42.5 110.031 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' R' R ' 109' ' ' HIS . . . . . 0.432 ' CD2' ' HG ' ' R' ' 110' ' ' LEU . 50.7 p-80 -66.02 -12.87 58.26 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.511 -0.743 . . . . 20.07 110.698 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' R' R ' 110' ' ' LEU . . . . . 0.432 ' HG ' ' CD2' ' R' ' 109' ' ' HIS . 80.1 mt -94.72 -17.38 22.26 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.071 -1.018 . . . . 15.69 110.183 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' R' R ' 111' ' ' LEU . . . . . 0.447 HD22 ' CE2' ' R' ' 60' ' ' PHE . 10.4 mt -94.05 144.12 25.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.324 -0.86 . . . . 25.39 111.052 -179.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' R' R ' 112' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -77.67 -17.43 57.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.518 -0.739 . . . . 53.48 109.84 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 113' ' ' THR . . . . . 0.418 HG22 ' HG2' ' R' ' 123' ' ' GLU . 60.2 m -83.69 166.62 17.94 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.282 -0.886 . . . . 14.8 110.186 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' R' R ' 114' ' ' GLY . . . . . . . . . . . . . . . -97.99 127.12 9.12 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.968 -1.253 . . . . 16.14 109.968 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 115' ' ' ILE . . . . . 0.481 ' HB ' ' HG2' ' R' ' 108' ' ' LYS . 47.8 mm -109.07 139.32 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.534 -0.98 . . . . 13.46 109.71 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' R' R ' 116' ' ' GLY . . . . . . . . . . . . . . . -152.76 -155.78 7.26 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.926 -1.27 . . . . 23.9 109.926 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 117' ' ' THR . . . . . . . . . . . . . 18.7 p -135.06 -171.4 2.79 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.418 -1.048 . . . . 27.37 110.095 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.59 -58.05 9.73 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.276 -0.89 . . . . 18.76 110.057 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 119' ' ' SER . . . . . 0.55 ' HA ' ' CB ' ' R' ' 194' ' ' ALA . 1.1 m -56.59 -40.53 75.43 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.332 -0.855 . . . . 32.35 109.784 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' R' R ' 120' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 -110.12 86.3 4.97 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.435 -0.791 . . . . 27.12 109.675 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 121' ' ' PRO . . . . . 0.427 ' O ' ' HB2' ' R' ' 122' ' ' SER . 44.7 Cg_endo -71.26 166.51 29.03 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.874 1.46 . . . . 22.68 111.035 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' R' R ' 122' ' ' SER . . . . . 0.427 ' HB2' ' O ' ' R' ' 121' ' ' PRO . 38.4 t 178.57 -161.69 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.584 -0.698 . . . . 22.99 109.436 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' R' R ' 123' ' ' GLU . . . . . 0.418 ' HG2' HG22 ' R' ' 113' ' ' THR . 2.3 tp10 -56.42 -39.94 73.89 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.225 -0.922 . . . . 36.18 109.732 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' R' R ' 124' ' ' VAL . . . . . . . . . . . . . 84.1 t -142.55 136.42 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.484 -0.76 . . . . 20.64 109.314 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 125' ' ' CYS . . . . . 0.409 ' SG ' ' HA ' ' R' ' 121' ' ' PRO . 83.2 m -140.28 168.19 20.37 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.187 -0.946 . . . . 22.8 111.193 -179.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' R' R ' 126' ' ' VAL . . . . . . . . . . . . . 35.9 m -122.78 159.83 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.828 -0.545 . . . . 21.24 109.647 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 127' ' ' VAL . . . . . 0.401 ' CG1' ' O ' ' R' ' 177' ' ' VAL . 30.5 m -70.86 141.83 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.337 -0.852 . . . . 19.77 110.695 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' R' R ' 128' ' ' ASP . . . . . . . . . . . . . 53.9 p-10 -137.7 19.44 2.87 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.319 -0.863 . . . . 29.21 110.665 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 129' ' ' GLY . . . . . . . . . . . . . . . 113.97 0.06 24.18 Favored Glycine 0 N--CA 1.492 2.399 0 C-N-CA 119.993 -1.098 . . . . 33.86 110.487 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 130' ' ' THR . . . . . . . . . . . . . 58.9 m -91.9 131.85 36.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.202 -1.176 . . . . 26.41 109.998 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -62.53 120.72 11.66 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.408 -0.808 . . . . 33.08 110.284 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 132' ' ' MET . . . . . 0.427 ' HE1' ' CZ ' ' R' ' 180' ' ' PHE . 98.4 mmm -105.22 165.67 10.94 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.425 -0.797 . . . . 30.76 110.445 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' R' R ' 133' ' ' CYS . . . . . . . . . . . . . 31.7 m -141.17 158.21 44.21 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.493 -0.754 . . . . 27.0 109.912 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 134' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.48 -19.8 40.09 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.362 -0.836 . . . . 33.9 110.407 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' R' R ' 135' ' ' ALA . . . . . . . . . . . . . . . -92.74 8.14 40.57 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.282 -0.887 . . . . 19.37 110.78 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 136' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -93.71 -21.72 19.17 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.255 -0.903 . . . . 30.47 110.272 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 137' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -149.98 165.42 32.74 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.314 -0.866 . . . . 24.27 110.189 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 138' ' ' HIS . . . . . . . . . . . . . 15.2 p80 -117.86 15.11 14.35 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.398 -0.814 . . . . 20.91 110.459 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 139' ' ' ALA . . . . . 0.442 ' HA ' ' O ' ' R' ' 152' ' ' ALA . . . -177.14 152.44 0.89 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.278 -0.889 . . . . 15.69 110.098 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' R' R ' 140' ' ' GLY . . . . . 0.404 ' HA3' ' O ' ' R' ' 179' ' ' VAL . . . 161.8 175.15 32.52 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.998 -1.241 . . . . 23.76 109.998 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' R' R ' 141' ' ' ILE . . . . . . . . . . . . . 83.5 mt -95.49 136.54 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.514 -0.992 . . . . 25.3 109.718 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 142' ' ' PHE . . . . . 0.547 ' CD2' ' HB2' ' R' ' 172' ' ' PRO . 82.6 m-85 -120.7 -172.58 2.41 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.26 -0.9 . . . . 30.24 110.511 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' R' R ' 143' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -119.79 77.71 1.26 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.437 -0.789 . . . . 32.8 110.321 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' R' R ' 144' ' ' LYS . . . . . 0.453 ' HG3' ' CZ2' ' R' ' 170' ' ' TRP . 1.0 OUTLIER -69.58 76.86 0.42 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.369 -0.832 . . . . 49.18 109.625 179.626 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' R' R ' 145' ' ' GLY . . . . . . . . . . . . . . . 104.55 179.31 24.76 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.174 -1.571 . . . . 53.87 109.174 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 146' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -88.53 145.85 25.5 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.253 -1.145 . . . . 68.58 110.023 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 147' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 58.17 36.57 25.92 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.288 -0.883 . . . . 56.62 110.633 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 148' ' ' HIS . . . . . . . . . . . . . 45.0 t60 -158.67 148.12 19.17 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.229 -0.92 . . . . 44.57 110.372 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 149' ' ' ALA . . . . . . . . . . . . . . . -150.27 146.89 27.06 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.45 -0.781 . . . . 33.54 110.091 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 150' ' ' VAL . . . . . 0.428 HG23 ' HB2' ' R' ' 144' ' ' LYS . 34.2 m -142.34 161.5 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.273 -0.892 . . . . 27.61 110.318 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' R' R ' 151' ' ' PHE . . . . . 0.538 ' CD1' ' N ' ' R' ' 152' ' ' ALA . 5.9 t80 -86.19 155.62 20.66 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.41 -0.806 . . . . 23.04 109.867 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' R' R ' 152' ' ' ALA . . . . . 0.538 ' N ' ' CD1' ' R' ' 151' ' ' PHE . . . -157.28 151.51 24.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.409 -0.807 . . . . 29.61 109.612 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' R' R ' 153' ' ' CYS . . . . . 0.405 ' HA ' ' HA ' ' R' ' 139' ' ' ALA . 26.7 p -154.29 173.62 15.92 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.227 -0.921 . . . . 22.75 110.507 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' R' R ' 154' ' ' VAL . . . . . 0.443 ' CG2' ' CZ2' ' R' ' 159' ' ' TRP . 59.7 t -90.64 117.03 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.322 -0.861 . . . . 23.26 110.042 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' R' R ' 155' ' ' THR . . . . . . . . . . . . . 70.5 p -112.17 -176.66 2.98 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.361 -0.837 . . . . 17.88 110.025 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 156' ' ' SER . . . . . . . . . . . . . 78.6 p -75.96 -3.66 36.78 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.32 -0.863 . . . . 21.83 110.707 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 157' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -118.27 10.38 12.81 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.159 -0.963 . . . . 36.54 110.635 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 158' ' ' GLY . . . . . . . . . . . . . . . 117.94 -162.68 13.02 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.556 -1.417 . . . . 31.74 109.556 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 159' ' ' TRP . . . . . 0.443 ' CZ2' ' CG2' ' R' ' 154' ' ' VAL . 14.7 m95 -86.56 122.44 30.49 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.389 -1.065 . . . . 28.25 110.147 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' R' R ' 160' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -108.47 167.03 10.33 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.404 -0.81 . . . . 41.24 110.175 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 161' ' ' ALA . . . . . . . . . . . . . . . -143.23 123.48 13.77 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.344 -0.847 . . . . 27.4 110.173 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 162' ' ' ILE . . . . . 0.431 HG23 ' CZ ' ' R' ' 167' ' ' PHE . 92.0 mt -87.62 81.13 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.343 -0.848 . . . . 24.27 110.101 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' R' R ' 163' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' R' ' 165' ' ' GLU . 15.3 t0 -72.84 92.42 1.59 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.518 -0.739 . . . . 36.08 110.254 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' R' R ' 164' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 54.15 -89.0 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.463 -0.773 . . . . 46.08 110.574 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 165' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' R' ' 163' ' ' ASP . 29.7 mt-10 -124.76 36.03 4.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.088 -1.007 . . . . 50.94 110.192 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' R' R ' 166' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -135.82 117.23 14.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.4 -0.812 . . . . 47.28 110.34 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 167' ' ' PHE . . . . . 0.431 ' CZ ' HG23 ' R' ' 162' ' ' ILE . 24.4 m-85 -100.94 119.96 39.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.457 -0.777 . . . . 40.47 110.172 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' R' R ' 168' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -157.6 158.54 30.61 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.213 -0.929 . . . . 30.21 110.399 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 169' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.81 132.99 19.36 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.931 1.49 . . . . 32.76 110.505 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 170' ' ' TRP . . . . . 0.453 ' CZ2' ' HG3' ' R' ' 144' ' ' LYS . 66.9 t90 -159.78 119.37 2.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.383 -0.823 . . . . 32.79 109.909 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' R' R ' 171' ' ' THR . . . . . . . . . . . . . 46.9 m -81.1 112.58 33.94 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.471 -0.768 . . . . 36.92 110.197 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 172' ' ' PRO . . . . . 0.547 ' HB2' ' CD2' ' R' ' 142' ' ' PHE . 46.5 Cg_endo -73.69 158.87 46.6 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.634 1.334 . . . . 33.54 110.504 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' R' R ' 173' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -88.93 144.97 33.67 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.358 -0.839 . . . . 45.76 109.882 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 174' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -71.71 -10.41 26.47 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.614 1.323 . . . . 29.63 110.507 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 175' ' ' SER . . . . . . . . . . . . . 53.0 p -103.44 -17.55 15.19 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.293 -0.88 . . . . 35.7 110.37 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 176' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -103.56 43.32 1.09 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.25 -0.906 . . . . 39.65 110.379 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 177' ' ' VAL . . . . . 0.401 ' O ' ' CG1' ' R' ' 127' ' ' VAL . 10.4 p -117.86 127.08 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.324 -0.86 . . . . 20.61 110.07 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' R' R ' 178' ' ' LEU . . . . . . . . . . . . . 45.6 mt -91.45 -61.31 1.68 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.361 -0.837 . . . . 15.58 109.395 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 179' ' ' VAL . . . . . 0.404 ' O ' ' HA3' ' R' ' 140' ' ' GLY . 68.3 t -114.59 144.78 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.621 -0.674 . . . . 17.4 109.409 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' R' R ' 180' ' ' PHE . . . . . 0.427 ' CZ ' ' HE1' ' R' ' 132' ' ' MET . 43.5 p90 -152.21 163.34 39.6 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.328 -0.858 . . . . 20.16 110.474 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' R' R ' 181' ' ' VAL . . . . . . . . . . . . . 66.3 t -113.16 111.48 50.29 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.467 -0.771 . . . . 17.69 109.833 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 182' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.03 149.52 52.9 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.532 1.28 . . . . 17.81 110.423 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' R' R ' 183' ' ' TYR . . . . . 0.739 ' O ' ' C ' ' R' ' 184' ' ' ASP . 79.0 m-85 -59.03 175.47 0.28 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.43 -0.794 . . . . 28.01 110.539 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' R' R ' 184' ' ' ASP . . . . . 0.739 ' C ' ' O ' ' R' ' 183' ' ' TYR . 1.0 OUTLIER -11.78 -75.82 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.452 -0.78 . . . . 58.64 110.296 -177.936 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' R' R ' 185' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 . . . . . 0 N--CA 1.503 2.177 0 CA-C-O 121.247 0.546 . . . . 80.42 111.757 179.236 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' R' R ' 193' ' ' LYS . . . . . . . . . . . . . 14.3 ptmt . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 120.895 0.379 . . . . 49.5 110.179 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' R' R ' 194' ' ' ALA . . . . . 0.55 ' CB ' ' HA ' ' R' ' 119' ' ' SER . . . . . . . . 0 N--CA 1.496 1.869 0 O-C-N 121.141 -0.975 . . . . 40.4 110.079 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 229' ' ' MET . . . . . . . . . . . . . 1.5 tpt . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.226 0.536 . . . . 51.83 110.21 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' S' S ' 230' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -97.27 142.75 28.78 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.372 -0.83 . . . . 54.13 110.22 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 231' ' ' LEU . . . . . . . . . . . . . 67.9 mt -134.06 141.07 47.05 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.363 -0.836 . . . . 33.04 110.299 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 232' ' ' THR . . . . . . . . . . . . . 40.0 m -89.27 103.27 15.91 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.345 -0.847 . . . . 26.92 110.093 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 233' ' ' LEU . . . . . 0.502 HD23 ' CE2' ' S' ' 262' ' ' TYR . 79.8 mt -55.84 179.29 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.476 -0.765 . . . . 13.78 110.491 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' S' S ' 234' ' ' TYR . . . . . 0.444 ' CG ' ' N ' ' S' ' 235' ' ' ASN . 35.4 p90 -65.12 -35.61 81.67 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.354 -0.841 . . . . 26.08 110.119 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' S' S ' 235' ' ' ASN . . . . . 0.444 ' N ' ' CG ' ' S' ' 234' ' ' TYR . 50.7 p30 -74.28 -7.5 53.0 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.377 -0.827 . . . . 20.04 110.506 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' S' S ' 236' ' ' GLY . . . . . . . . . . . . . . . 95.81 -20.01 51.79 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.747 -1.341 . . . . 22.71 109.747 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 237' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -52.96 145.74 12.26 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.182 -1.187 . . . . 35.44 110.165 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 238' ' ' LYS . . . . . . . . . . . . . 44.4 mttt -102.17 127.9 48.91 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.397 -0.814 . . . . 32.56 110.374 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 239' ' ' LYS . . . . . 0.417 ' HG2' ' CZ ' ' S' ' 241' ' ' PHE . 9.0 ttmt -132.27 144.52 50.66 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.373 -0.829 . . . . 26.68 109.959 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' S' S ' 240' ' ' THR . . . . . . . . . . . . . 52.5 m -102.05 132.22 48.04 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.339 -0.851 . . . . 41.02 110.305 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 241' ' ' PHE . . . . . 0.417 ' CZ ' ' HG2' ' S' ' 239' ' ' LYS . 96.0 m-85 -117.98 137.67 52.7 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.346 -0.846 . . . . 28.62 110.169 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' S' S ' 242' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -96.36 161.78 13.78 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.451 -0.781 . . . . 47.89 110.224 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 243' ' ' SER . . . . . . . . . . . . . 72.4 m -90.65 151.52 21.24 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.333 -0.854 . . . . 45.09 110.225 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 244' ' ' ARG . . . . . . . . . . . . . 1.4 mtp85 -129.76 126.74 22.71 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.335 -0.853 . . . . 42.49 110.274 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 245' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.31 161.0 43.83 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 123.603 1.317 . . . . 35.68 110.503 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 246' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -132.89 97.88 4.15 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.323 -0.861 . . . . 51.88 109.821 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 247' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -110.47 -22.21 11.78 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.317 -0.865 . . . . 53.69 110.636 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 248' ' ' HIS . . . . . . . . . . . . . 76.5 m80 -117.26 43.75 2.26 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.235 -0.916 . . . . 55.79 110.774 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 249' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 48.8 38.36 11.72 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.459 -0.775 . . . . 49.45 110.382 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 250' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -90.62 29.05 1.37 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.462 -0.773 . . . . 36.86 110.277 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 251' ' ' ALA . . . . . . . . . . . . . . . -53.84 -43.21 69.28 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.244 -0.91 . . . . 29.69 109.577 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 252' ' ' TRP . . . . . 0.418 ' CZ2' ' HB3' ' S' ' 294' ' ' LEU . 67.9 p-90 -61.77 -33.86 74.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.508 -0.745 . . . . 41.12 109.89 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' S' S ' 253' ' ' LEU . . . . . 0.407 ' N ' ' CD2' ' S' ' 252' ' ' TRP . 23.2 tp -70.12 -47.26 62.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.412 -0.805 . . . . 24.89 110.025 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' S' S ' 254' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -56.1 -42.47 76.82 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.419 -0.801 . . . . 35.65 110.03 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 255' ' ' ALA . . . . . . . . . . . . . . . -59.49 -48.25 82.37 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.438 -0.789 . . . . 22.73 110.1 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 256' ' ' ILE . . . . . . . . . . . . . 80.1 mt -62.25 -40.65 88.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.289 -0.882 . . . . 28.85 110.02 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 257' ' ' LEU . . . . . . . . . . . . . 19.1 mt -61.54 -44.53 96.87 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.365 -0.834 . . . . 23.07 110.144 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 258' ' ' GLN . . . . . 0.467 ' HB3' ' CD2' ' S' ' 351' ' ' PHE . 53.3 mm-40 -65.01 -45.39 85.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.389 -0.82 . . . . 29.78 109.92 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' S' S ' 259' ' ' LEU . . . . . 0.433 ' O ' HG22 ' S' ' 263' ' ' VAL . 19.8 tp -58.66 -36.42 74.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.43 -0.794 . . . . 17.94 109.444 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' S' S ' 260' ' ' PHE . . . . . 0.47 ' CE2' HD22 ' S' ' 311' ' ' LEU . 3.1 m-85 -62.79 -45.22 93.64 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.647 -0.658 . . . . 30.57 109.849 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' S' S ' 261' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -62.16 -29.77 70.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.509 -0.744 . . . . 41.34 109.979 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 262' ' ' TYR . . . . . 0.502 ' CE2' HD23 ' S' ' 233' ' ' LEU . 8.7 t80 -71.19 -44.71 64.92 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.433 -0.792 . . . . 26.03 110.074 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' S' S ' 263' ' ' VAL . . . . . 0.433 HG22 ' O ' ' S' ' 259' ' ' LEU . 33.1 m -92.02 18.28 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.438 -0.788 . . . . 22.8 110.355 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' S' S ' 264' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 52.7 70.76 0.54 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.287 -0.883 . . . . 44.03 110.604 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 265' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -111.84 109.22 55.33 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.295 -0.878 . . . . 35.61 109.628 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 266' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -75.33 0.4 9.08 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 123.55 1.289 . . . . 37.67 111.807 -179.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 267' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -56.48 -67.69 0.28 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.764 -1.21 . . . . 41.49 110.199 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' S' S ' 268' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -92.9 39.89 1.05 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.159 -0.963 . . . . 50.76 110.047 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 269' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.02 -33.29 59.67 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.426 -0.796 . . . . 61.86 109.762 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' S' S ' 270' ' ' TRP . . . . . 0.482 ' CE2' ' CG2' ' S' ' 271' ' ' VAL . 50.9 p-90 -73.83 -4.27 33.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.298 -0.876 . . . . 39.85 110.527 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' S' S ' 271' ' ' VAL . . . . . 0.482 ' CG2' ' CE2' ' S' ' 270' ' ' TRP . 46.4 t -109.67 -32.62 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.146 -0.971 . . . . 39.18 110.065 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' S' S ' 272' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -78.71 -36.5 43.33 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.35 -0.844 . . . . 40.02 110.524 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 273' ' ' SER . . . . . . . . . . . . . 71.2 m -103.49 56.03 0.74 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.295 -0.878 . . . . 47.2 110.369 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 274' ' ' SER . . . . . . . . . . . . . 6.9 t -133.01 141.26 40.3 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.329 -0.857 . . . . 47.61 110.113 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 275' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.77 -18.86 21.68 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 O-C-N 123.633 1.333 . . . . 45.28 110.547 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 276' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -99.96 140.85 33.58 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.327 -0.858 . . . . 57.27 110.248 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 277' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -71.76 97.69 1.82 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.396 -0.815 . . . . 37.28 110.251 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 278' ' ' LEU . . . . . . . . . . . . . 86.4 mt -96.93 33.74 1.84 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.39 -0.819 . . . . 43.88 110.037 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 279' ' ' THR . . . . . . . . . . . . . 76.3 m -64.02 -60.15 3.6 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.436 -0.79 . . . . 50.05 110.269 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 280' ' ' LEU . . . . . . . . . . . . . 13.6 mt -51.53 -39.98 58.77 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.314 -0.866 . . . . 54.12 110.241 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 281' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.27 -49.75 74.43 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.494 -0.754 . . . . 65.28 110.174 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' S' S ' 282' ' ' ALA . . . . . . . . . . . . . . . -58.95 -33.91 71.15 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.44 -0.788 . . . . 46.51 110.554 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 283' ' ' ILE . . . . . . . . . . . . . 85.6 mt -66.3 -50.88 64.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.319 -0.863 . . . . 47.3 110.125 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 284' ' ' LYS . . . . . . . . . . . . . 33.8 tttp -50.6 -57.57 7.88 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.318 -0.864 . . . . 50.72 110.344 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 285' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -51.47 -46.33 63.07 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.465 -0.772 . . . . 68.47 110.257 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 286' ' ' LEU . . . . . . . . . . . . . 19.2 mt -60.02 -44.56 94.5 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.372 -0.83 . . . . 36.62 110.275 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 287' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -62.7 -35.22 79.0 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.289 -0.882 . . . . 46.64 110.1 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 288' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -76.31 -20.96 56.78 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.4 -0.812 . . . . 46.45 110.34 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 289' ' ' LEU . . . . . . . . . . . . . 30.7 mt -97.38 -21.69 17.05 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.302 -0.874 . . . . 35.09 110.494 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 290' ' ' THR . . . . . . . . . . . . . 81.2 p -114.76 -28.49 7.08 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.325 -0.859 . . . . 38.61 110.406 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 291' ' ' GLY . . . . . . . . . . . . . . . 79.35 11.08 85.33 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.9 -1.28 . . . . 36.77 109.9 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 292' ' ' LEU . . . . . . . . . . . . . 84.7 mt -96.51 145.82 25.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.286 -1.126 . . . . 35.33 109.722 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 293' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -77.35 102.34 6.73 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.194 -0.941 . . . . 48.7 110.273 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 294' ' ' LEU . . . . . 0.418 ' HB3' ' CZ2' ' S' ' 252' ' ' TRP . 56.1 mt -106.96 51.72 0.73 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.51 -0.744 . . . . 42.61 110.085 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' S' S ' 295' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -112.43 -11.27 13.67 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.274 -0.891 . . . . 55.49 110.56 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' S' S ' 296' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -144.24 48.55 1.37 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.187 -0.946 . . . . 75.68 110.319 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 297' ' ' GLY . . . . . . . . . . . . . . . 96.88 145.18 18.72 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.505 -1.438 . . . . 49.44 109.505 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 298' ' ' GLY . . . . . . . . . . . . . . . -163.85 156.98 29.09 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.823 -1.311 . . . . 41.11 109.823 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 299' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -73.73 118.21 5.36 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 O-C-N 123.941 1.495 . . . . 26.2 110.314 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 300' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.23 -15.42 31.72 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 123.538 1.283 . . . . 21.7 110.684 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 301' ' ' ALA . . . . . . . . . . . . . . . -80.73 -29.33 36.37 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.259 -0.9 . . . . 31.23 110.091 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 302' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.58 -40.57 18.91 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.512 -0.742 . . . . 38.99 109.953 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' S' S ' 303' ' ' VAL . . . . . 0.472 ' O ' HG12 ' S' ' 307' ' ' ILE . 58.5 t -60.68 -35.48 64.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.372 -0.83 . . . . 18.63 110.177 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' S' S ' 304' ' ' ILE . . . . . . . . . . . . . 86.3 mt -79.39 -23.58 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.418 -0.801 . . . . 25.46 110.177 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 305' ' ' TRP . . . . . 0.4 ' CD2' ' HD3' ' S' ' 308' ' ' LYS . 68.8 t-105 -88.67 -14.62 36.92 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.194 -0.942 . . . . 33.4 110.5 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' S' S ' 306' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -89.7 -13.57 36.6 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.237 -0.915 . . . . 36.97 110.391 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 307' ' ' ILE . . . . . 0.472 HG12 ' O ' ' S' ' 303' ' ' VAL . 36.9 pt -125.03 45.67 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.276 -0.89 . . . . 30.81 110.036 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' S' S ' 308' ' ' LYS . . . . . 0.4 ' HD3' ' CD2' ' S' ' 305' ' ' TRP . 1.5 mtmp? -73.58 -37.72 65.39 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.366 -0.834 . . . . 46.52 110.1 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' S' S ' 309' ' ' HIS . . . . . 0.49 ' CD2' ' HG ' ' S' ' 310' ' ' LEU . 55.6 p-80 -73.27 -8.2 54.79 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.333 -0.854 . . . . 51.03 110.105 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' S' S ' 310' ' ' LEU . . . . . 0.49 ' HG ' ' CD2' ' S' ' 309' ' ' HIS . 53.2 mt -99.32 -12.87 19.94 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.265 -0.897 . . . . 36.16 109.973 179.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' S' S ' 311' ' ' LEU . . . . . 0.47 HD22 ' CE2' ' S' ' 260' ' ' PHE . 10.8 mt -97.14 147.88 23.61 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.421 -0.8 . . . . 40.0 110.431 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' S' S ' 312' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -81.65 -16.28 51.89 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.273 -0.892 . . . . 54.18 109.69 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 313' ' ' THR . . . . . 0.478 HG23 ' HB3' ' S' ' 323' ' ' GLU . 92.8 m -87.92 151.57 22.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.329 -0.857 . . . . 25.61 110.117 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' S' S ' 314' ' ' GLY . . . . . . . . . . . . . . . -87.81 126.4 8.03 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.861 -1.296 . . . . 25.18 109.861 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 315' ' ' ILE . . . . . . . . . . . . . 50.7 mm -101.69 150.45 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.407 -1.055 . . . . 23.9 109.703 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 316' ' ' GLY . . . . . . . . . . . . . . . -157.04 -159.25 9.37 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.982 -1.247 . . . . 23.18 109.982 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 317' ' ' THR . . . . . . . . . . . . . 11.0 p -133.94 -173.04 3.14 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.446 -1.032 . . . . 27.98 109.949 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.52 -56.2 24.94 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.142 -0.974 . . . . 28.1 109.939 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 319' ' ' SER . . . . . . . . . . . . . 1.2 m -59.99 -41.62 92.43 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.405 -0.81 . . . . 37.0 109.673 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 320' ' ' ARG . . . . . . . . . . . . . 12.2 mtm180 -111.68 79.89 2.64 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.592 -0.692 . . . . 52.07 109.666 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 321' ' ' PRO . . . . . 0.435 ' O ' ' HB2' ' S' ' 322' ' ' SER . 44.1 Cg_endo -71.31 171.52 15.93 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.876 1.461 . . . . 38.29 110.966 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' S' S ' 322' ' ' SER . . . . . 0.435 ' HB2' ' O ' ' S' ' 321' ' ' PRO . 41.3 t 178.65 -148.13 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.927 -0.768 . . . . 38.84 108.927 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' S' S ' 323' ' ' GLU . . . . . 0.478 ' HB3' HG23 ' S' ' 313' ' ' THR . 6.7 tp10 -62.84 -40.29 96.96 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.011 -1.055 . . . . 40.7 109.724 179.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' S' S ' 324' ' ' VAL . . . . . . . . . . . . . 72.9 t -141.28 135.03 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.416 -0.802 . . . . 20.34 109.456 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 325' ' ' CYS . . . . . 0.45 ' HB2' ' CE1' ' S' ' 380' ' ' PHE . 11.3 m -126.03 172.26 10.12 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.258 -0.901 . . . . 30.63 110.805 -179.129 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' S' S ' 326' ' ' VAL . . . . . . . . . . . . . 34.6 m -135.56 142.24 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 109.189 -0.671 . . . . 23.9 109.189 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 327' ' ' VAL . . . . . . . . . . . . . 34.5 m -56.27 124.93 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.037 -1.04 . . . . 19.48 110.437 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 328' ' ' ASP . . . . . . . . . . . . . 55.6 p-10 -119.36 11.49 12.23 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.467 -0.77 . . . . 26.43 110.403 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 329' ' ' GLY . . . . . . . . . . . . . . . 119.63 2.24 13.14 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.043 -1.223 . . . . 31.24 110.043 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 330' ' ' THR . . . . . . . . . . . . . 80.9 m -93.02 129.93 38.78 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.044 -1.268 . . . . 30.05 110.111 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 331' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -56.73 111.49 1.03 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.262 -0.899 . . . . 37.26 110.02 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 332' ' ' MET . . . . . 0.452 ' HE1' ' CZ ' ' S' ' 380' ' ' PHE . 88.1 mmm -94.11 162.64 13.79 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.285 -0.884 . . . . 26.23 110.345 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' S' S ' 333' ' ' CYS . . . . . . . . . . . . . 25.3 m -137.34 150.07 47.46 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.487 -0.758 . . . . 23.56 109.96 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 334' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.58 -24.89 9.1 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.33 -0.856 . . . . 28.93 110.46 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' S' S ' 335' ' ' ALA . . . . . . . . . . . . . . . -88.99 14.44 10.57 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.302 -0.874 . . . . 15.76 110.957 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 336' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -100.48 -17.19 17.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.166 -0.959 . . . . 34.92 110.206 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 337' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -152.37 170.84 19.1 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.382 -0.824 . . . . 19.03 110.095 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 338' ' ' HIS . . . . . 0.401 ' HB3' ' CZ ' ' S' ' 383' ' ' TYR . 13.5 p80 -120.71 10.34 10.97 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.365 -0.834 . . . . 18.82 110.484 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' S' S ' 339' ' ' ALA . . . . . . . . . . . . . . . -176.01 155.17 1.55 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.289 -0.882 . . . . 17.18 110.131 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 340' ' ' GLY . . . . . . . . . . . . . . . 160.85 173.07 29.0 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.01 -1.236 . . . . 18.33 110.01 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 341' ' ' ILE . . . . . . . . . . . . . 83.7 mt -88.77 138.1 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.523 -0.986 . . . . 18.6 109.862 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 342' ' ' PHE . . . . . 0.506 ' CE1' HG23 ' S' ' 377' ' ' VAL . 70.0 m-85 -120.93 -178.48 3.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.184 -0.947 . . . . 23.44 110.447 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' S' S ' 343' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.9 93.41 4.18 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.428 -0.795 . . . . 35.59 110.06 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' S' S ' 344' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.93 125.01 29.59 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.268 -0.895 . . . . 38.34 110.054 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' S' S ' 345' ' ' GLY . . . . . . . . . . . . . . . 62.91 -130.88 42.76 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 108.821 -1.712 . . . . 53.46 108.821 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 346' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -132.73 150.85 52.11 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.214 -1.168 . . . . 70.91 110.07 179.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 347' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 53.28 35.43 20.12 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.307 -0.871 . . . . 47.32 110.374 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 348' ' ' HIS . . . . . . . . . . . . . 46.6 t60 -150.15 155.83 40.52 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.248 -0.908 . . . . 41.72 110.346 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 349' ' ' ALA . . . . . . . . . . . . . . . -149.74 151.28 33.36 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.33 -0.856 . . . . 22.91 110.544 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 350' ' ' VAL . . . . . . . . . . . . . 34.6 m -149.06 169.64 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.448 -0.782 . . . . 21.09 110.06 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 351' ' ' PHE . . . . . 0.467 ' CD2' ' HB3' ' S' ' 258' ' ' GLN . 10.8 t80 -105.4 143.62 33.32 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.26 -0.9 . . . . 25.03 110.687 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' S' S ' 352' ' ' ALA . . . . . . . . . . . . . . . -147.74 151.72 36.54 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.58 -0.7 . . . . 23.81 109.75 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 353' ' ' CYS . . . . . . . . . . . . . 26.3 p -153.29 164.97 37.16 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.302 -0.874 . . . . 25.66 110.245 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 354' ' ' VAL . . . . . 0.406 HG23 ' CZ2' ' S' ' 359' ' ' TRP . 58.0 t -76.15 118.56 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.4 -0.812 . . . . 34.27 109.941 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' S' S ' 355' ' ' THR . . . . . 0.437 HG23 ' HB2' ' S' ' 360' ' ' TYR . 51.7 p -117.85 175.09 5.82 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.199 -0.938 . . . . 25.49 110.29 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' S' S ' 356' ' ' SER . . . . . . . . . . . . . 62.1 p -62.17 -17.65 58.65 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.465 -0.772 . . . . 31.24 110.743 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 357' ' ' ASN . . . . . . . . . . . . . 46.0 m-20 -107.02 14.2 26.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.154 -0.966 . . . . 28.61 110.611 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 358' ' ' GLY . . . . . . . . . . . . . . . 111.88 -152.88 17.6 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.997 -1.241 . . . . 22.01 109.997 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 359' ' ' TRP . . . . . 0.406 ' CZ2' HG23 ' S' ' 354' ' ' VAL . 15.5 m95 -91.36 116.64 29.0 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.33 -1.1 . . . . 25.54 110.205 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' S' S ' 360' ' ' TYR . . . . . 0.437 ' HB2' HG23 ' S' ' 355' ' ' THR . 1.3 m-85 -103.47 165.75 10.85 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.338 -0.852 . . . . 40.53 110.105 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' S' S ' 361' ' ' ALA . . . . . . . . . . . . . . . -139.97 130.08 25.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.37 -0.831 . . . . 18.04 110.333 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 362' ' ' ILE . . . . . 0.411 HG23 ' CZ ' ' S' ' 367' ' ' PHE . 88.8 mt -95.59 83.65 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.316 -0.865 . . . . 15.64 110.054 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' S' S ' 363' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' S' ' 365' ' ' GLU . 11.9 t0 -75.25 94.45 2.99 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.334 -0.854 . . . . 35.03 110.241 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' S' S ' 364' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 54.03 -89.42 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.484 -0.76 . . . . 46.72 110.547 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 365' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' S' ' 363' ' ' ASP . 23.8 mt-10 -122.6 19.06 10.4 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.048 -1.032 . . . . 56.2 110.251 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' S' S ' 366' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -118.01 125.0 49.52 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.207 -0.933 . . . . 51.02 110.308 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 367' ' ' PHE . . . . . 0.411 ' CZ ' HG23 ' S' ' 362' ' ' ILE . 27.0 m-85 -106.94 127.05 53.09 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.355 -0.841 . . . . 37.59 110.155 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' S' S ' 368' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -165.4 159.52 13.97 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.253 -0.904 . . . . 31.47 110.461 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 369' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.91 139.58 30.42 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.869 1.457 . . . . 28.85 110.495 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 370' ' ' TRP . . . . . . . . . . . . . 67.6 t90 -167.13 113.63 0.77 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.463 -0.773 . . . . 26.94 109.973 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 371' ' ' THR . . . . . . . . . . . . . 59.6 m -74.84 113.02 20.41 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.338 -0.851 . . . . 20.19 109.986 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 372' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.58 157.08 49.15 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 O-C-N 123.573 1.301 . . . . 28.68 110.546 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 373' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -90.52 147.08 35.65 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.436 -0.79 . . . . 35.72 109.987 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 374' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -75.95 -6.25 17.21 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.687 1.362 . . . . 30.89 110.533 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 375' ' ' SER . . . . . . . . . . . . . 68.9 p -104.4 -16.94 14.97 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.288 -0.882 . . . . 29.41 110.484 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 376' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -106.54 43.05 1.19 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.285 -0.884 . . . . 32.89 110.257 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 377' ' ' VAL . . . . . 0.506 HG23 ' CE1' ' S' ' 342' ' ' PHE . 7.3 p -114.72 147.29 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.314 -0.866 . . . . 24.33 110.17 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' S' S ' 378' ' ' LEU . . . . . . . . . . . . . 52.1 mt -115.97 -58.02 2.15 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.386 -0.821 . . . . 24.37 109.623 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 379' ' ' VAL . . . . . . . . . . . . . 62.0 t -120.64 132.4 70.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.452 -0.78 . . . . 18.02 109.44 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 380' ' ' PHE . . . . . 0.452 ' CZ ' ' HE1' ' S' ' 332' ' ' MET . 14.2 p90 -142.59 173.97 11.06 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.375 -0.828 . . . . 29.35 110.665 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' S' S ' 381' ' ' VAL . . . . . . . . . . . . . 58.1 t -120.12 107.34 39.76 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.493 -0.755 . . . . 16.34 109.382 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 382' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.28 145.6 48.95 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 O-C-N 123.669 1.352 . . . . 20.94 110.79 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' S' S ' 383' ' ' TYR . . . . . 0.401 ' CZ ' ' HB3' ' S' ' 338' ' ' HIS . 88.3 m-85 -61.05 -53.42 57.36 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.37 -0.831 . . . . 28.93 109.912 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' S' S ' 384' ' ' ASP . . . . . . . . . . . . . 27.4 t0 . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.362 -0.836 . . . . 47.03 110.358 -176.558 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' R' R ' 30' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.133 0.492 . . . . 43.36 110.308 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' R' R ' 31' ' ' LEU . . . . . . . . . . . . . 65.5 mt -134.87 140.67 45.98 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.338 -0.851 . . . . 22.93 110.271 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 32' ' ' THR . . . . . . . . . . . . . 71.1 m -87.7 110.61 20.56 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.352 -0.843 . . . . 22.34 109.935 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 33' ' ' LEU . . . . . 0.461 HD23 ' CE2' ' R' ' 62' ' ' TYR . 80.1 mt -62.39 -172.78 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.274 -0.891 . . . . 21.39 110.209 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' R' R ' 34' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -74.6 -29.52 61.34 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.333 -0.855 . . . . 34.4 110.365 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 35' ' ' ASN . . . . . . . . . . . . . 48.4 p30 -77.65 -1.95 33.51 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.348 -0.845 . . . . 30.28 110.689 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.28 -16.55 59.53 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.698 -1.361 . . . . 36.25 109.698 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 37' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -58.95 161.75 4.73 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.314 -1.11 . . . . 53.8 110.344 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 38' ' ' LYS . . . . . . . . . . . . . 56.9 mttt -117.83 135.76 53.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.315 -0.866 . . . . 49.91 110.142 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 39' ' ' LYS . . . . . 0.416 ' HG2' ' CZ ' ' R' ' 41' ' ' PHE . 8.1 ttmt -138.69 143.66 39.24 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.388 -0.82 . . . . 35.69 110.19 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' R' R ' 40' ' ' THR . . . . . . . . . . . . . 23.7 m -102.56 127.98 49.41 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.387 -0.82 . . . . 34.84 110.193 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 41' ' ' PHE . . . . . 0.416 ' CZ ' ' HG2' ' R' ' 39' ' ' LYS . 96.6 m-85 -113.09 132.71 55.32 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.402 -0.811 . . . . 34.42 110.11 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' R' R ' 42' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -93.24 140.89 29.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.346 -0.846 . . . . 51.46 110.247 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 43' ' ' SER . . . . . . . . . . . . . 53.9 m -70.74 141.91 51.47 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.502 -0.749 . . . . 41.84 110.196 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.75 125.37 29.58 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.263 -0.898 . . . . 33.82 109.986 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' R' R ' 45' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.16 151.05 54.74 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.543 1.286 . . . . 30.27 110.649 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 46' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.28 109.91 13.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.478 -0.764 . . . . 35.1 110.004 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 47' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -120.32 -34.93 3.54 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.217 -0.927 . . . . 42.81 110.466 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 48' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -105.7 45.18 0.98 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.239 -0.913 . . . . 49.97 110.201 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 49' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 50.28 34.66 9.17 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.341 -0.849 . . . . 61.32 110.195 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 50' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -86.24 43.83 1.09 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.423 -0.798 . . . . 51.5 110.719 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.12 -46.11 78.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.276 -0.89 . . . . 38.77 109.541 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 52' ' ' TRP . . . . . 0.483 ' CD2' ' N ' ' R' ' 53' ' ' LEU . 68.2 p-90 -58.39 -38.37 77.2 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.525 -0.734 . . . . 26.24 110.114 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' R' R ' 53' ' ' LEU . . . . . 0.483 ' N ' ' CD2' ' R' ' 52' ' ' TRP . 23.2 tp -66.72 -46.7 74.63 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.373 -0.83 . . . . 26.75 109.958 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' R' R ' 54' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -55.27 -41.55 72.38 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.405 -0.809 . . . . 35.02 110.142 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.17 -46.11 91.86 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.337 -0.852 . . . . 24.47 110.145 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 56' ' ' ILE . . . . . . . . . . . . . 76.4 mt -62.17 -42.24 94.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.332 -0.855 . . . . 26.03 109.924 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 57' ' ' LEU . . . . . . . . . . . . . 22.5 mt -60.24 -45.71 92.31 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.364 -0.835 . . . . 26.77 109.658 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 58' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -63.9 -46.57 84.25 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.508 -0.745 . . . . 22.32 109.559 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 59' ' ' LEU . . . . . 0.429 ' HA ' ' HE2' ' R' ' 151' ' ' PHE . 23.8 tp -61.43 -37.71 84.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.306 -0.871 . . . . 20.55 109.424 179.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' R' R ' 60' ' ' PHE . . . . . 0.447 ' CE2' HD22 ' R' ' 111' ' ' LEU . 2.8 m-85 -61.08 -44.69 96.98 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.62 -0.675 . . . . 20.08 109.95 179.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' R' R ' 61' ' ' ARG . . . . . . . . . . . . . 5.6 tpt180 -63.22 -36.18 82.81 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.397 -0.814 . . . . 18.8 110.41 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 62' ' ' TYR . . . . . 0.461 ' CE2' HD23 ' R' ' 33' ' ' LEU . 9.1 t80 -63.03 -41.8 99.62 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.13 -0.981 . . . . 26.45 110.248 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' R' R ' 63' ' ' VAL . . . . . . . . . . . . . 30.7 m -93.35 20.3 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.238 -0.914 . . . . 29.75 110.221 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 64' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 53.02 75.56 0.24 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.322 -0.861 . . . . 35.52 110.541 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 65' ' ' GLU . . . . . 0.424 ' HG2' ' CD2' ' R' ' 60' ' ' PHE . 14.3 tp10 -116.28 104.01 52.41 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.348 -0.845 . . . . 29.89 109.893 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' R' R ' 66' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.58 -5.75 17.6 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.875 1.46 . . . . 21.37 111.111 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 67' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -52.17 -61.5 2.23 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.054 -1.029 . . . . 23.85 110.314 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' R' R ' 68' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -98.14 36.48 1.57 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.314 -0.866 . . . . 28.07 110.466 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 69' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -72.25 -33.34 67.43 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.387 -0.821 . . . . 43.76 110.088 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 70' ' ' TRP . . . . . 0.476 ' CE2' ' CG2' ' R' ' 71' ' ' VAL . 47.8 p-90 -73.32 -3.94 30.2 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.34 -0.85 . . . . 33.06 110.71 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' R' R ' 71' ' ' VAL . . . . . 0.476 ' CG2' ' CE2' ' R' ' 70' ' ' TRP . 40.8 t -109.81 -27.45 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.241 -0.912 . . . . 31.7 109.674 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' R' R ' 72' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -86.52 -48.86 8.01 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.407 -0.808 . . . . 33.58 110.32 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 73' ' ' SER . . . . . . . . . . . . . 70.1 m -89.69 50.99 1.99 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.336 -0.853 . . . . 50.82 110.344 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 74' ' ' SER . . . . . . . . . . . . . 15.8 t -125.88 138.28 31.73 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.362 -0.836 . . . . 34.74 110.257 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.29 -25.02 16.06 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 O-C-N 123.735 1.387 . . . . 35.7 110.341 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 76' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -91.59 153.25 19.87 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.398 -0.814 . . . . 66.48 110.368 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 77' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -81.62 95.29 7.14 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.374 -0.829 . . . . 46.72 110.046 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 78' ' ' LEU . . . . . . . . . . . . . 96.3 mt -96.46 27.95 3.56 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.467 -0.771 . . . . 37.55 110.216 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 79' ' ' THR . . . . . . . . . . . . . 29.7 m -56.18 -54.65 42.61 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.325 -0.86 . . . . 37.36 110.295 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 80' ' ' LEU . . . . . . . . . . . . . 15.9 mt -60.92 -23.16 65.04 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.256 -0.902 . . . . 35.83 110.513 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 81' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -79.54 -39.08 32.72 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.165 -0.959 . . . . 44.03 110.331 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.47 -28.66 66.28 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.262 -0.899 . . . . 32.54 110.245 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 83' ' ' ILE . . . . . . . . . . . . . 78.1 mt -70.11 -46.1 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.307 -0.87 . . . . 32.02 110.302 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 84' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -55.19 -52.11 64.39 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.177 -0.952 . . . . 34.09 110.547 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 85' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -54.74 -46.93 74.35 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.272 -0.893 . . . . 25.94 110.235 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 86' ' ' LEU . . . . . . . . . . . . . 24.2 mt -58.67 -43.91 90.02 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.318 -0.864 . . . . 16.2 109.904 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 87' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -65.32 -35.13 80.06 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.471 -0.768 . . . . 49.09 110.346 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 88' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -78.45 -19.12 53.84 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.308 -0.87 . . . . 28.61 110.497 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 89' ' ' LEU . . . . . . . . . . . . . 32.8 mt -96.16 -29.45 14.05 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.207 -0.933 . . . . 26.16 110.239 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 90' ' ' THR . . . . . . . . . . . . . 59.6 p -105.64 -34.61 7.68 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.241 -0.912 . . . . 33.33 109.819 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.79 16.16 58.61 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.862 -1.295 . . . . 31.13 109.862 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 92' ' ' LEU . . . . . . . . . . . . . 97.0 mt -100.12 155.29 17.81 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.172 -1.193 . . . . 42.52 110.21 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 93' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -86.26 91.63 8.53 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.432 -0.793 . . . . 68.46 109.948 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 94' ' ' LEU . . . . . 0.447 ' HB3' ' CZ2' ' R' ' 52' ' ' TRP . 47.7 mt -99.47 53.03 0.94 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.162 -0.961 . . . . 44.63 110.355 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' R' R ' 95' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.47 -38.66 6.39 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.253 -0.904 . . . . 67.16 110.399 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' R' R ' 96' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -113.9 44.23 1.68 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -0.922 . . . . 67.02 110.291 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 97' ' ' GLY . . . . . . . . . . . . . . . 99.14 150.79 26.02 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.733 -1.347 . . . . 49.48 109.733 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 98' ' ' GLY . . . . . . . . . . . . . . . -166.26 160.05 33.49 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.227 -1.549 . . . . 36.57 109.227 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 99' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.58 121.1 7.13 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.65 1.342 . . . . 30.41 110.435 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 100' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.27 -31.59 11.53 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 O-C-N 123.649 1.342 . . . . 29.94 110.561 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.01 -38.47 75.95 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.239 -0.913 . . . . 23.64 110.256 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.66 -40.74 66.09 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.284 -0.885 . . . . 20.31 110.358 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' R' R ' 103' ' ' VAL . . . . . . . . . . . . . 63.6 t -58.19 -40.09 76.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.227 -0.92 . . . . 16.33 109.996 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 104' ' ' ILE . . . . . . . . . . . . . 81.9 mt -71.72 -30.39 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.418 -0.801 . . . . 24.77 110.049 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 105' ' ' TRP . . . . . 0.439 ' O ' ' HD3' ' R' ' 108' ' ' LYS . 70.6 t-105 -82.49 0.89 40.35 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.34 -0.85 . . . . 23.28 110.254 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' R' R ' 106' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -105.16 -10.36 17.16 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.108 -0.995 . . . . 28.26 110.028 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 107' ' ' ILE . . . . . . . . . . . . . 36.8 pt -126.8 34.96 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.268 -0.895 . . . . 18.77 110.008 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 108' ' ' LYS . . . . . 0.481 ' HG2' ' HB ' ' R' ' 115' ' ' ILE . 9.2 mtpp -61.02 -48.5 81.5 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.589 -0.694 . . . . 42.5 110.037 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' R' R ' 109' ' ' HIS . . . . . 0.433 ' CD2' ' HG ' ' R' ' 110' ' ' LEU . 50.7 p-80 -66.02 -12.84 58.0 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.473 -0.767 . . . . 20.07 110.655 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' R' R ' 110' ' ' LEU . . . . . 0.433 ' HG ' ' CD2' ' R' ' 109' ' ' HIS . 80.7 mt -94.78 -17.35 22.22 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.121 -0.987 . . . . 15.69 110.171 179.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' R' R ' 111' ' ' LEU . . . . . 0.447 HD22 ' CE2' ' R' ' 60' ' ' PHE . 10.4 mt -94.06 144.14 25.74 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.342 -0.849 . . . . 25.39 111.05 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' R' R ' 112' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -77.7 -17.35 57.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.51 -0.744 . . . . 53.48 109.859 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 113' ' ' THR . . . . . 0.416 HG22 ' HG2' ' R' ' 123' ' ' GLU . 59.7 m -83.69 166.66 17.9 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.308 -0.87 . . . . 14.8 110.299 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' R' R ' 114' ' ' GLY . . . . . . . . . . . . . . . -98.06 127.16 9.14 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.015 -1.234 . . . . 16.14 110.015 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 115' ' ' ILE . . . . . 0.481 ' HB ' ' HG2' ' R' ' 108' ' ' LYS . 47.8 mm -109.08 139.44 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.464 -1.021 . . . . 13.46 109.7 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' R' R ' 116' ' ' GLY . . . . . . . . . . . . . . . -152.74 -155.85 7.29 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.926 -1.27 . . . . 23.9 109.926 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 117' ' ' THR . . . . . . . . . . . . . 18.6 p -135.02 -171.39 2.79 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.413 -1.051 . . . . 27.37 110.044 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.61 -57.96 10.11 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.251 -0.906 . . . . 18.76 110.107 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 119' ' ' SER . . . . . . . . . . . . . 1.2 m -56.58 -40.61 75.51 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.326 -0.859 . . . . 32.35 109.791 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 120' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 -110.04 86.2 4.81 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.442 -0.786 . . . . 27.12 109.682 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 121' ' ' PRO . . . . . 0.428 ' O ' ' HB2' ' R' ' 122' ' ' SER . 44.3 Cg_endo -71.23 166.5 29.06 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.813 1.428 . . . . 22.68 110.981 -179.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' R' R ' 122' ' ' SER . . . . . 0.428 ' HB2' ' O ' ' R' ' 121' ' ' PRO . 38.7 t 178.51 -161.69 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.481 -0.762 . . . . 22.99 109.492 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' R' R ' 123' ' ' GLU . . . . . 0.416 ' HG2' HG22 ' R' ' 113' ' ' THR . 2.3 tp10 -56.5 -39.97 74.18 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.19 -0.944 . . . . 36.18 109.649 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' R' R ' 124' ' ' VAL . . . . . . . . . . . . . 82.3 t -142.44 136.5 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.584 -0.698 . . . . 20.64 109.403 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 125' ' ' CYS . . . . . 0.409 ' SG ' ' HA ' ' R' ' 121' ' ' PRO . 83.4 m -140.35 168.21 20.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.219 -0.925 . . . . 22.8 111.163 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' R' R ' 126' ' ' VAL . . . . . . . . . . . . . 35.8 m -122.76 159.8 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.747 -0.596 . . . . 21.24 109.664 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 127' ' ' VAL . . . . . 0.401 HG11 ' O ' ' R' ' 177' ' ' VAL . 30.7 m -70.87 141.86 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.266 -0.896 . . . . 19.77 110.675 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' R' R ' 128' ' ' ASP . . . . . . . . . . . . . 53.9 p-10 -137.73 19.4 2.87 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.336 -0.853 . . . . 29.21 110.669 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 129' ' ' GLY . . . . . . . . . . . . . . . 114.03 0.01 24.1 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.893 -1.146 . . . . 33.86 110.461 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 130' ' ' THR . . . . . . . . . . . . . 58.1 m -91.77 131.91 36.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.207 -1.172 . . . . 26.41 110.099 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -62.62 120.69 11.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.356 -0.84 . . . . 33.08 110.274 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 132' ' ' MET . . . . . 0.426 ' HE1' ' CZ ' ' R' ' 180' ' ' PHE . 98.4 mmm -105.18 165.58 11.0 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.468 -0.77 . . . . 30.76 110.409 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' R' R ' 133' ' ' CYS . . . . . . . . . . . . . 32.5 m -141.17 158.12 44.33 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.538 -0.726 . . . . 27.0 109.969 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 134' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.5 -19.65 39.07 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.322 -0.861 . . . . 33.9 110.544 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' R' R ' 135' ' ' ALA . . . . . . . . . . . . . . . -92.74 8.15 40.54 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.31 -0.868 . . . . 19.37 110.826 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 136' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -93.75 -21.74 19.13 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.174 -0.954 . . . . 30.47 110.245 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 137' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -149.98 165.35 32.95 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.407 -0.808 . . . . 24.27 110.215 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 138' ' ' HIS . . . . . . . . . . . . . 15.1 p80 -117.81 15.04 14.39 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.4 -0.813 . . . . 20.91 110.494 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 139' ' ' ALA . . . . . 0.44 ' HA ' ' O ' ' R' ' 152' ' ' ALA . . . -177.14 152.46 0.89 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.257 -0.902 . . . . 15.69 110.139 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' R' R ' 140' ' ' GLY . . . . . 0.405 ' HA3' ' O ' ' R' ' 179' ' ' VAL . . . 161.78 175.12 32.46 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.889 -1.285 . . . . 23.76 109.889 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' R' R ' 141' ' ' ILE . . . . . . . . . . . . . 83.8 mt -95.51 136.58 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.473 -1.016 . . . . 25.3 109.682 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 142' ' ' PHE . . . . . 0.546 ' CD2' ' HB2' ' R' ' 172' ' ' PRO . 82.9 m-85 -120.74 -172.66 2.43 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.287 -0.883 . . . . 30.24 110.547 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' R' R ' 143' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -119.79 77.75 1.26 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.499 -0.751 . . . . 32.8 110.292 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' R' R ' 144' ' ' LYS . . . . . 0.452 ' HG3' ' CZ2' ' R' ' 170' ' ' TRP . 1.0 OUTLIER -69.54 76.88 0.41 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.448 -0.783 . . . . 49.18 109.653 179.562 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' R' R ' 145' ' ' GLY . . . . . . . . . . . . . . . 104.51 179.25 24.82 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.157 -1.577 . . . . 53.87 109.157 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 146' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -88.52 145.8 25.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.363 -1.081 . . . . 68.58 109.995 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 147' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 58.31 36.51 25.64 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.346 -0.846 . . . . 56.62 110.607 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 148' ' ' HIS . . . . . . . . . . . . . 44.8 t60 -158.69 148.13 19.16 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.183 -0.948 . . . . 44.57 110.419 179.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 149' ' ' ALA . . . . . . . . . . . . . . . -150.29 146.83 27.01 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.445 -0.784 . . . . 33.54 110.057 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 150' ' ' VAL . . . . . 0.428 HG23 ' HB2' ' R' ' 144' ' ' LYS . 34.2 m -142.3 161.55 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.261 -0.9 . . . . 27.61 110.36 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' R' R ' 151' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' R' ' 152' ' ' ALA . 5.8 t80 -86.22 155.54 20.66 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.392 -0.818 . . . . 23.04 109.873 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' R' R ' 152' ' ' ALA . . . . . 0.537 ' N ' ' CD1' ' R' ' 151' ' ' PHE . . . -157.26 151.54 24.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.421 -0.799 . . . . 29.61 109.575 179.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' R' R ' 153' ' ' CYS . . . . . 0.405 ' HA ' ' HA ' ' R' ' 139' ' ' ALA . 26.7 p -154.27 173.61 15.91 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.34 -0.85 . . . . 22.75 110.542 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' R' R ' 154' ' ' VAL . . . . . 0.443 ' CG2' ' CZ2' ' R' ' 159' ' ' TRP . 59.7 t -90.6 117.1 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.453 -0.78 . . . . 23.26 110.052 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' R' R ' 155' ' ' THR . . . . . . . . . . . . . 69.3 p -112.17 -176.62 2.97 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.359 -0.838 . . . . 17.88 110.041 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 156' ' ' SER . . . . . . . . . . . . . 78.5 p -75.96 -3.76 37.35 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.32 -0.863 . . . . 21.83 110.633 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 157' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -118.22 10.46 12.88 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.06 -1.025 . . . . 36.54 110.612 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 158' ' ' GLY . . . . . . . . . . . . . . . 117.97 -162.63 13.05 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.527 -1.429 . . . . 31.74 109.527 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 159' ' ' TRP . . . . . 0.443 ' CZ2' ' CG2' ' R' ' 154' ' ' VAL . 14.7 m95 -86.6 122.57 30.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.354 -1.086 . . . . 28.25 110.035 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' R' R ' 160' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -108.48 166.96 10.38 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.42 -0.8 . . . . 41.24 110.201 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 161' ' ' ALA . . . . . . . . . . . . . . . -143.23 123.47 13.77 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.461 -0.775 . . . . 27.4 110.163 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 162' ' ' ILE . . . . . 0.431 HG23 ' CZ ' ' R' ' 167' ' ' PHE . 92.0 mt -87.59 81.12 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.317 -0.864 . . . . 24.27 110.051 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' R' R ' 163' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' R' ' 165' ' ' GLU . 15.4 t0 -72.74 92.39 1.56 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.422 -0.799 . . . . 36.08 110.254 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' R' R ' 164' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 54.13 -89.0 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.515 -0.741 . . . . 46.08 110.574 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 165' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' R' ' 163' ' ' ASP . 29.7 mt-10 -124.76 36.02 4.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.088 -1.007 . . . . 50.94 110.192 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' R' R ' 166' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -135.81 117.29 14.77 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.416 -0.803 . . . . 47.28 110.266 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 167' ' ' PHE . . . . . 0.431 ' CZ ' HG23 ' R' ' 162' ' ' ILE . 24.4 m-85 -101.04 120.02 39.59 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.387 -0.821 . . . . 40.47 110.155 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' R' R ' 168' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -157.52 158.53 30.68 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.273 -0.892 . . . . 30.21 110.433 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 169' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.77 132.98 19.42 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 O-C-N 123.863 1.454 . . . . 32.76 110.471 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 170' ' ' TRP . . . . . 0.452 ' CZ2' ' HG3' ' R' ' 144' ' ' LYS . 67.1 t90 -159.78 119.43 2.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.398 -0.814 . . . . 32.79 109.946 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' R' R ' 171' ' ' THR . . . . . . . . . . . . . 45.9 m -81.13 112.57 33.91 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.405 -0.809 . . . . 36.92 110.188 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 172' ' ' PRO . . . . . 0.546 ' HB2' ' CD2' ' R' ' 142' ' ' PHE . 47.2 Cg_endo -73.76 158.78 46.46 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 O-C-N 123.796 1.419 . . . . 33.54 110.551 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' R' R ' 173' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -88.84 144.96 33.83 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.361 -0.837 . . . . 45.76 109.951 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 174' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.74 -10.33 26.3 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 O-C-N 123.621 1.327 . . . . 29.63 110.497 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 175' ' ' SER . . . . . . . . . . . . . 53.0 p -103.53 -17.47 15.18 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.317 -0.864 . . . . 35.7 110.306 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 176' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -103.6 43.23 1.1 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.286 -0.884 . . . . 39.65 110.32 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 177' ' ' VAL . . . . . 0.401 ' O ' HG11 ' R' ' 127' ' ' VAL . 10.6 p -117.74 127.12 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.397 -0.815 . . . . 20.61 110.095 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' R' R ' 178' ' ' LEU . . . . . . . . . . . . . 46.2 mt -91.47 -61.25 1.69 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.305 -0.872 . . . . 15.58 109.389 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 179' ' ' VAL . . . . . 0.405 ' O ' ' HA3' ' R' ' 140' ' ' GLY . 67.9 t -114.67 144.66 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.643 -0.661 . . . . 17.4 109.441 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' R' R ' 180' ' ' PHE . . . . . 0.426 ' CZ ' ' HE1' ' R' ' 132' ' ' MET . 43.6 p90 -152.17 163.43 39.4 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.239 -0.913 . . . . 20.16 110.519 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' R' R ' 181' ' ' VAL . . . . . . . . . . . . . 66.6 t -113.19 111.47 50.22 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.342 -0.849 . . . . 17.69 109.756 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 182' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.05 149.56 52.83 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 O-C-N 123.507 1.267 . . . . 17.81 110.374 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 183' ' ' TYR . . . . . 0.698 ' O ' ' C ' ' R' ' 184' ' ' ASP . 79.5 m-85 -59.05 175.47 0.29 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.4 -0.813 . . . . 28.01 110.526 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' R' R ' 184' ' ' ASP . . . . . 0.698 ' C ' ' O ' ' R' ' 183' ' ' TYR . 1.1 m-20 -19.01 -82.88 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.425 -0.797 . . . . 58.64 110.319 -178.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' R' R ' 185' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 . . . . . 0 N--CA 1.502 2.16 0 CA-C-O 121.273 0.559 . . . . 80.42 111.777 179.479 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' R' R ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 120.948 0.404 . . . . 49.5 110.14 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' R' R ' 194' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.826 0 O-C-N 121.123 -0.986 . . . . 40.4 110.059 179.996 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' S' S ' 229' ' ' MET . . . . . . . . . . . . . 24.8 ptp . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.229 0.538 . . . . 51.83 110.219 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' S' S ' 230' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -97.24 142.78 28.72 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.336 -0.852 . . . . 54.13 110.208 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 231' ' ' LEU . . . . . . . . . . . . . 68.0 mt -134.14 141.04 46.96 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.247 -0.908 . . . . 33.04 110.355 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 232' ' ' THR . . . . . . . . . . . . . 40.0 m -89.22 103.18 15.83 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.414 -0.804 . . . . 26.92 110.037 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 233' ' ' LEU . . . . . 0.498 HD23 ' CE2' ' S' ' 262' ' ' TYR . 79.7 mt -55.91 179.26 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.467 -0.771 . . . . 13.78 110.457 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' S' S ' 234' ' ' TYR . . . . . 0.448 ' CG ' ' N ' ' S' ' 235' ' ' ASN . 35.7 p90 -65.02 -35.65 81.85 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.347 -0.845 . . . . 26.08 110.169 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' S' S ' 235' ' ' ASN . . . . . 0.448 ' N ' ' CG ' ' S' ' 234' ' ' TYR . 50.7 p30 -74.31 -7.46 52.87 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.292 -0.88 . . . . 20.04 110.524 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' S' S ' 236' ' ' GLY . . . . . . . . . . . . . . . 95.8 -20.03 51.7 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.76 -1.336 . . . . 22.71 109.76 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 237' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -52.9 145.72 12.13 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.234 -1.157 . . . . 35.44 110.226 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 238' ' ' LYS . . . . . . . . . . . . . 44.4 mttt -102.2 127.87 48.96 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.389 -0.82 . . . . 32.56 110.416 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 239' ' ' LYS . . . . . 0.413 ' HG2' ' CZ ' ' S' ' 241' ' ' PHE . 9.1 ttmt -132.25 144.49 50.65 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.377 -0.827 . . . . 26.68 110.036 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' S' S ' 240' ' ' THR . . . . . . . . . . . . . 51.5 m -102.01 132.16 48.01 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.328 -0.858 . . . . 41.02 110.41 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 241' ' ' PHE . . . . . 0.413 ' CZ ' ' HG2' ' S' ' 239' ' ' LYS . 96.0 m-85 -117.87 137.66 52.64 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.419 -0.801 . . . . 28.62 110.184 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' S' S ' 242' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -96.39 161.74 13.8 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.371 -0.831 . . . . 47.89 110.25 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 243' ' ' SER . . . . . . . . . . . . . 71.6 m -90.47 151.49 21.36 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.245 -0.909 . . . . 45.09 110.298 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 244' ' ' ARG . . . . . . . . . . . . . 1.4 mtp85 -129.76 126.78 22.73 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.371 -0.83 . . . . 42.49 110.266 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 245' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.37 161.05 43.56 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.652 1.343 . . . . 35.68 110.542 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 246' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -132.86 97.88 4.15 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.443 -0.786 . . . . 51.88 109.866 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 247' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -110.52 -22.23 11.75 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.395 -0.815 . . . . 53.69 110.664 -179.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 248' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -117.28 43.77 2.25 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.108 -0.995 . . . . 55.79 110.804 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 249' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 48.68 38.49 11.63 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.4 -0.813 . . . . 49.45 110.339 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 250' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -90.65 28.99 1.38 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.521 -0.737 . . . . 36.86 110.309 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 251' ' ' ALA . . . . . . . . . . . . . . . -53.79 -43.16 69.07 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.271 -0.893 . . . . 29.69 109.619 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 252' ' ' TRP . . . . . 0.416 ' CZ2' ' HB3' ' S' ' 294' ' ' LEU . 67.8 p-90 -61.81 -33.94 75.04 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.537 -0.727 . . . . 41.12 109.83 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' S' S ' 253' ' ' LEU . . . . . 0.4 ' N ' ' CD2' ' S' ' 252' ' ' TRP . 23.2 tp -70.16 -47.25 62.43 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.37 -0.831 . . . . 24.89 109.953 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' S' S ' 254' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -56.1 -42.44 76.8 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.417 -0.802 . . . . 35.65 109.96 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 255' ' ' ALA . . . . . . . . . . . . . . . -59.63 -48.18 82.69 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.399 -0.813 . . . . 22.73 110.081 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 256' ' ' ILE . . . . . . . . . . . . . 79.7 mt -62.25 -40.7 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.304 -0.873 . . . . 28.85 109.979 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 257' ' ' LEU . . . . . . . . . . . . . 19.1 mt -61.48 -44.5 96.98 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.257 -0.902 . . . . 23.07 110.154 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 258' ' ' GLN . . . . . 0.468 ' HB3' ' CD2' ' S' ' 351' ' ' PHE . 53.5 mm-40 -65.14 -45.33 85.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.39 -0.818 . . . . 29.78 109.919 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' S' S ' 259' ' ' LEU . . . . . 0.432 ' O ' HG22 ' S' ' 263' ' ' VAL . 19.7 tp -58.66 -36.35 74.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.337 -0.852 . . . . 17.94 109.474 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' S' S ' 260' ' ' PHE . . . . . 0.468 ' CE2' HD22 ' S' ' 311' ' ' LEU . 3.1 m-85 -62.9 -45.24 93.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.622 -0.674 . . . . 30.57 109.82 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' S' S ' 261' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -62.08 -29.81 70.56 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.386 -0.821 . . . . 41.34 109.987 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 262' ' ' TYR . . . . . 0.498 ' CE2' HD23 ' S' ' 233' ' ' LEU . 8.6 t80 -71.16 -44.67 65.05 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.367 -0.833 . . . . 26.03 110.1 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' S' S ' 263' ' ' VAL . . . . . 0.432 HG22 ' O ' ' S' ' 259' ' ' LEU . 33.1 m -92.02 18.15 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.374 -0.829 . . . . 22.8 110.334 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' S' S ' 264' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 52.85 70.69 0.55 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.206 -0.934 . . . . 44.03 110.589 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 265' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -111.86 109.19 55.3 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.397 -0.814 . . . . 35.61 109.602 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 266' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -75.34 0.44 9.04 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.657 1.346 . . . . 37.67 111.8 -179.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 267' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -56.46 -67.73 0.28 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.781 -1.2 . . . . 41.49 110.192 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' S' S ' 268' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -92.94 39.95 1.05 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.15 -0.968 . . . . 50.76 110.063 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 269' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.04 -33.22 59.6 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.348 -0.845 . . . . 61.86 109.775 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' S' S ' 270' ' ' TRP . . . . . 0.492 ' CE2' ' CG2' ' S' ' 271' ' ' VAL . 50.9 p-90 -73.91 -4.31 34.28 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.33 -0.856 . . . . 39.85 110.493 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' S' S ' 271' ' ' VAL . . . . . 0.492 ' CG2' ' CE2' ' S' ' 270' ' ' TRP . 46.6 t -109.59 -32.66 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.187 -0.946 . . . . 39.18 110.058 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' S' S ' 272' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -78.68 -36.52 43.51 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.327 -0.858 . . . . 40.02 110.519 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 273' ' ' SER . . . . . . . . . . . . . 71.1 m -103.55 56.16 0.74 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.347 -0.846 . . . . 47.2 110.291 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 274' ' ' SER . . . . . . . . . . . . . 6.8 t -133.09 141.24 40.13 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.382 -0.824 . . . . 47.61 110.153 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 275' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.76 -18.82 21.75 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 123.639 1.337 . . . . 45.28 110.544 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 276' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -99.9 140.88 33.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.221 -0.924 . . . . 57.27 110.327 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 277' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -71.79 97.63 1.83 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.428 -0.795 . . . . 37.28 110.234 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 278' ' ' LEU . . . . . . . . . . . . . 86.0 mt -96.96 33.85 1.83 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.388 -0.82 . . . . 43.88 110.087 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 279' ' ' THR . . . . . . . . . . . . . 77.8 m -64.09 -60.19 3.54 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.471 -0.768 . . . . 50.05 110.194 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 280' ' ' LEU . . . . . . . . . . . . . 13.7 mt -51.51 -39.91 58.57 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.247 -0.908 . . . . 54.12 110.304 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 281' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.39 -49.69 74.52 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.444 -0.785 . . . . 65.28 110.132 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' S' S ' 282' ' ' ALA . . . . . . . . . . . . . . . -59.02 -33.89 71.27 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.478 -0.764 . . . . 46.51 110.488 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 283' ' ' ILE . . . . . . . . . . . . . 85.7 mt -66.34 -50.87 64.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.305 -0.872 . . . . 47.3 110.072 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 284' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -50.61 -57.56 7.92 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.416 -0.803 . . . . 50.72 110.359 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 285' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -51.42 -46.35 62.89 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.523 -0.736 . . . . 68.47 110.34 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 286' ' ' LEU . . . . . . . . . . . . . 19.1 mt -59.97 -44.47 94.44 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.464 -0.773 . . . . 36.62 110.309 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 287' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -62.83 -35.25 79.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.279 -0.888 . . . . 46.64 110.009 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 288' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -76.26 -20.99 56.85 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.42 -0.8 . . . . 46.45 110.328 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 289' ' ' LEU . . . . . . . . . . . . . 30.7 mt -97.33 -21.73 17.05 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.342 -0.849 . . . . 35.09 110.52 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 290' ' ' THR . . . . . . . . . . . . . 81.3 p -114.78 -28.5 7.07 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.214 -0.929 . . . . 38.61 110.373 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 291' ' ' GLY . . . . . . . . . . . . . . . 79.38 11.05 85.34 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.886 -1.286 . . . . 36.77 109.886 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 292' ' ' LEU . . . . . . . . . . . . . 84.5 mt -96.45 145.77 25.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.222 -1.164 . . . . 35.33 109.768 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 293' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -77.36 102.37 6.76 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.25 -0.906 . . . . 48.7 110.272 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 294' ' ' LEU . . . . . 0.416 ' HB3' ' CZ2' ' S' ' 252' ' ' TRP . 55.3 mt -106.86 51.72 0.74 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.55 -0.719 . . . . 42.61 110.11 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' S' S ' 295' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -112.57 -11.09 13.63 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.325 -0.859 . . . . 55.49 110.573 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' S' S ' 296' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -144.38 48.53 1.36 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.163 -0.96 . . . . 75.68 110.292 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 297' ' ' GLY . . . . . . . . . . . . . . . 96.84 145.21 18.76 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.509 -1.437 . . . . 49.44 109.509 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 298' ' ' GLY . . . . . . . . . . . . . . . -163.83 156.93 29.01 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.805 -1.318 . . . . 41.11 109.805 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 299' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.77 118.25 5.37 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 123.955 1.502 . . . . 26.2 110.293 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 300' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.24 -15.42 31.68 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 O-C-N 123.577 1.304 . . . . 21.7 110.734 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 301' ' ' ALA . . . . . . . . . . . . . . . -80.71 -29.34 36.45 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.276 -0.89 . . . . 31.23 110.14 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 302' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.57 -40.57 18.93 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.405 -0.809 . . . . 38.99 109.926 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' S' S ' 303' ' ' VAL . . . . . 0.468 ' O ' HG12 ' S' ' 307' ' ' ILE . 58.1 t -60.73 -35.47 64.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.375 -0.828 . . . . 18.63 110.143 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' S' S ' 304' ' ' ILE . . . . . . . . . . . . . 86.2 mt -79.45 -23.55 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.463 -0.773 . . . . 25.46 110.193 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 305' ' ' TRP . . . . . . . . . . . . . 68.7 t-105 -88.63 -14.6 37.1 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.253 -0.904 . . . . 33.4 110.601 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 306' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -89.69 -13.57 36.64 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.227 -0.92 . . . . 36.97 110.435 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 307' ' ' ILE . . . . . 0.468 HG12 ' O ' ' S' ' 303' ' ' VAL . 36.8 pt -125.09 45.66 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.218 -0.926 . . . . 30.81 110.066 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' S' S ' 308' ' ' LYS . . . . . . . . . . . . . 1.5 mtmp? -73.52 -37.77 65.52 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.355 -0.841 . . . . 46.52 110.084 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 309' ' ' HIS . . . . . 0.487 ' CD2' ' HG ' ' S' ' 310' ' ' LEU . 55.5 p-80 -73.1 -8.34 55.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.303 -0.873 . . . . 51.03 110.129 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' S' S ' 310' ' ' LEU . . . . . 0.487 ' HG ' ' CD2' ' S' ' 309' ' ' HIS . 52.6 mt -99.27 -12.94 19.92 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.295 -0.878 . . . . 36.16 109.971 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' S' S ' 311' ' ' LEU . . . . . 0.468 HD22 ' CE2' ' S' ' 260' ' ' PHE . 10.8 mt -97.11 147.81 23.67 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.314 -0.866 . . . . 40.0 110.452 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' S' S ' 312' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -81.54 -16.33 52.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.345 -0.847 . . . . 54.18 109.763 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 313' ' ' THR . . . . . 0.47 HG23 ' HB3' ' S' ' 323' ' ' GLU . 92.5 m -87.88 151.53 22.76 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.375 -0.828 . . . . 25.61 110.159 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' S' S ' 314' ' ' GLY . . . . . . . . . . . . . . . -87.83 126.38 8.02 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.836 -1.306 . . . . 25.18 109.836 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 315' ' ' ILE . . . . . . . . . . . . . 50.7 mm -101.64 150.53 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.35 -1.088 . . . . 23.9 109.71 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 316' ' ' GLY . . . . . . . . . . . . . . . -157.12 -159.32 9.42 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.923 -1.271 . . . . 23.18 109.923 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 317' ' ' THR . . . . . . . . . . . . . 11.2 p -133.88 -173.06 3.14 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.417 -1.049 . . . . 27.98 110.013 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.55 -56.23 24.63 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.199 -0.938 . . . . 28.1 109.892 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 319' ' ' SER . . . . . . . . . . . . . 1.2 m -59.9 -41.67 92.17 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.405 -0.809 . . . . 37.0 109.632 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 320' ' ' ARG . . . . . . . . . . . . . 12.2 mtm180 -111.69 79.85 2.62 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.471 -0.768 . . . . 52.07 109.679 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 321' ' ' PRO . . . . . 0.436 ' O ' ' HB2' ' S' ' 322' ' ' SER . 44.1 Cg_endo -71.43 171.46 16.14 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.79 1.416 . . . . 38.29 110.903 -179.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' S' S ' 322' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' S' ' 321' ' ' PRO . 41.3 t 178.7 -148.08 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.928 -0.767 . . . . 38.84 108.928 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' S' S ' 323' ' ' GLU . . . . . 0.47 ' HB3' HG23 ' S' ' 313' ' ' THR . 6.7 tp10 -62.87 -40.34 97.2 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.944 -1.098 . . . . 40.7 109.664 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' S' S ' 324' ' ' VAL . . . . . . . . . . . . . 72.7 t -141.24 135.02 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.433 -0.792 . . . . 20.34 109.463 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 325' ' ' CYS . . . . . 0.446 ' HB2' ' CE1' ' S' ' 380' ' ' PHE . 11.1 m -126.02 172.24 10.13 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.246 -0.909 . . . . 30.63 110.867 -179.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' S' S ' 326' ' ' VAL . . . . . . . . . . . . . 34.5 m -135.51 142.16 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.651 -0.656 . . . . 23.9 109.248 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 327' ' ' VAL . . . . . . . . . . . . . 34.6 m -56.32 125.04 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.015 -1.053 . . . . 19.48 110.388 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 328' ' ' ASP . . . . . . . . . . . . . 55.5 p-10 -119.41 11.46 12.18 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.496 -0.753 . . . . 26.43 110.427 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 329' ' ' GLY . . . . . . . . . . . . . . . 119.75 2.2 12.99 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.973 -1.251 . . . . 31.24 109.973 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 330' ' ' THR . . . . . . . . . . . . . 78.8 m -92.94 130.02 38.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.093 -1.239 . . . . 30.05 110.136 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 331' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -56.85 111.48 1.04 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.207 -0.933 . . . . 37.26 109.927 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 332' ' ' MET . . . . . 0.456 ' HE1' ' CZ ' ' S' ' 380' ' ' PHE . 88.1 mmm -93.99 162.54 13.85 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.275 -0.89 . . . . 26.23 110.42 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' S' S ' 333' ' ' CYS . . . . . . . . . . . . . 25.7 m -137.25 150.0 47.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.398 -0.814 . . . . 23.56 110.072 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 334' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.51 -24.93 8.96 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.282 -0.886 . . . . 28.93 110.438 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' S' S ' 335' ' ' ALA . . . . . . . . . . . . . . . -89.02 14.43 10.66 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.358 -0.839 . . . . 15.76 110.975 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 336' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -100.49 -17.21 17.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.092 -1.005 . . . . 34.92 110.185 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 337' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -152.47 170.84 19.15 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.363 -0.836 . . . . 19.03 110.084 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 338' ' ' HIS . . . . . 0.4 ' HB3' ' CZ ' ' S' ' 383' ' ' TYR . 13.3 p80 -120.68 10.44 11.01 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.367 -0.833 . . . . 18.82 110.441 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' S' S ' 339' ' ' ALA . . . . . . . . . . . . . . . -175.99 155.18 1.56 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.205 -0.934 . . . . 17.18 110.091 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 340' ' ' GLY . . . . . 0.401 ' CA ' ' O ' ' S' ' 379' ' ' VAL . . . 160.82 173.09 28.99 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 110.088 -1.205 . . . . 18.33 110.088 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' S' S ' 341' ' ' ILE . . . . . 0.435 HD12 HG22 ' S' ' 341' ' ' ILE . 84.2 mt -88.76 138.05 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.434 -1.039 . . . . 18.6 109.78 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' S' S ' 342' ' ' PHE . . . . . 0.501 ' CE1' HG23 ' S' ' 377' ' ' VAL . 70.0 m-85 -120.99 -178.47 3.75 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.187 -0.945 . . . . 23.44 110.401 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' S' S ' 343' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.81 93.46 4.21 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.431 -0.793 . . . . 35.59 110.053 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' S' S ' 344' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.89 125.05 29.63 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.268 -0.895 . . . . 38.34 110.049 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' S' S ' 345' ' ' GLY . . . . . . . . . . . . . . . 62.75 -130.73 43.08 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 108.857 -1.697 . . . . 53.46 108.857 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 346' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -132.76 150.87 52.11 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.252 -1.146 . . . . 70.91 109.976 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 347' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 53.33 35.38 20.13 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.355 -0.841 . . . . 47.32 110.357 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 348' ' ' HIS . . . . . . . . . . . . . 46.4 t60 -150.19 155.89 40.59 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.208 -0.932 . . . . 41.72 110.333 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 349' ' ' ALA . . . . . . . . . . . . . . . -149.76 151.23 33.26 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.243 -0.911 . . . . 22.91 110.458 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 350' ' ' VAL . . . . . . . . . . . . . 34.6 m -149.06 169.58 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.384 -0.822 . . . . 21.09 110.057 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 351' ' ' PHE . . . . . 0.468 ' CD2' ' HB3' ' S' ' 258' ' ' GLN . 10.8 t80 -105.31 143.58 33.29 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.279 -0.888 . . . . 25.03 110.748 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' S' S ' 352' ' ' ALA . . . . . . . . . . . . . . . -147.74 151.66 36.45 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.566 -0.709 . . . . 23.81 109.777 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 353' ' ' CYS . . . . . . . . . . . . . 26.3 p -153.25 164.88 37.31 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.348 -0.845 . . . . 25.66 110.274 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 354' ' ' VAL . . . . . 0.402 HG23 ' CZ2' ' S' ' 359' ' ' TRP . 57.6 t -76.07 118.44 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.387 -0.82 . . . . 34.27 109.972 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' S' S ' 355' ' ' THR . . . . . 0.442 HG23 ' HB2' ' S' ' 360' ' ' TYR . 52.3 p -117.81 175.12 5.8 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.236 -0.915 . . . . 25.49 110.364 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' S' S ' 356' ' ' SER . . . . . . . . . . . . . 62.5 p -62.19 -17.65 58.74 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.462 -0.774 . . . . 31.24 110.704 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 357' ' ' ASN . . . . . . . . . . . . . 46.3 m-20 -107.0 14.16 26.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.15 -0.969 . . . . 28.61 110.608 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 358' ' ' GLY . . . . . . . . . . . . . . . 111.83 -152.88 17.59 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.031 -1.227 . . . . 22.01 110.031 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 359' ' ' TRP . . . . . 0.402 ' CZ2' HG23 ' S' ' 354' ' ' VAL . 15.5 m95 -91.32 116.69 29.04 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.396 -1.061 . . . . 25.54 110.148 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' S' S ' 360' ' ' TYR . . . . . 0.442 ' HB2' HG23 ' S' ' 355' ' ' THR . 1.3 m-85 -103.48 165.8 10.82 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.341 -0.849 . . . . 40.53 110.069 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' S' S ' 361' ' ' ALA . . . . . . . . . . . . . . . -140.09 130.07 24.81 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.393 -0.817 . . . . 18.04 110.296 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 362' ' ' ILE . . . . . 0.417 HG23 ' CZ ' ' S' ' 367' ' ' PHE . 89.1 mt -95.58 83.8 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.4 -0.813 . . . . 15.64 109.998 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' S' S ' 363' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' S' ' 365' ' ' GLU . 11.9 t0 -75.27 94.51 3.02 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.337 -0.852 . . . . 35.03 110.202 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' S' S ' 364' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 53.86 -89.34 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.545 -0.722 . . . . 46.72 110.575 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 365' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' S' ' 363' ' ' ASP . 23.8 mt-10 -122.67 19.1 10.34 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.082 -1.011 . . . . 56.2 110.271 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' S' S ' 366' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -117.95 125.05 49.68 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.26 -0.9 . . . . 51.02 110.406 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 367' ' ' PHE . . . . . 0.417 ' CZ ' HG23 ' S' ' 362' ' ' ILE . 26.8 m-85 -107.03 127.0 53.07 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.357 -0.84 . . . . 37.59 110.112 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' S' S ' 368' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -165.39 159.56 13.98 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.303 -0.873 . . . . 31.47 110.452 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 369' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.89 139.63 30.59 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 O-C-N 123.831 1.437 . . . . 28.85 110.509 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 370' ' ' TRP . . . . . . . . . . . . . 67.4 t90 -167.22 113.53 0.76 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.402 -0.812 . . . . 26.94 109.987 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 371' ' ' THR . . . . . . . . . . . . . 59.1 m -74.8 113.04 20.62 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.406 -0.808 . . . . 20.19 110.049 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 372' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -73.46 157.16 49.55 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 O-C-N 123.662 1.348 . . . . 28.68 110.625 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 373' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -90.67 147.19 35.69 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.391 -0.818 . . . . 35.72 109.832 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 374' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -76.02 -6.28 17.2 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.701 1.369 . . . . 30.89 110.506 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 375' ' ' SER . . . . . . . . . . . . . 70.4 p -104.42 -16.88 14.97 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.235 -0.916 . . . . 29.41 110.43 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 376' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -106.53 43.14 1.18 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.23 -0.919 . . . . 32.89 110.257 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 377' ' ' VAL . . . . . 0.501 HG23 ' CE1' ' S' ' 342' ' ' PHE . 7.3 p -114.7 147.26 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.311 -0.868 . . . . 24.33 110.163 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' S' S ' 378' ' ' LEU . . . . . . . . . . . . . 52.2 mt -115.96 -58.08 2.15 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.406 -0.809 . . . . 24.37 109.633 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 379' ' ' VAL . . . . . 0.401 ' O ' ' CA ' ' S' ' 340' ' ' GLY . 61.0 t -120.65 132.33 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.443 -0.786 . . . . 18.02 109.48 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' S' S ' 380' ' ' PHE . . . . . 0.456 ' CZ ' ' HE1' ' S' ' 332' ' ' MET . 14.3 p90 -142.54 173.92 11.1 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.398 -0.814 . . . . 29.35 110.622 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' S' S ' 381' ' ' VAL . . . . . . . . . . . . . 58.0 t -120.05 107.38 39.85 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.53 -0.731 . . . . 16.34 109.391 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 382' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.32 145.58 48.69 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.698 1.367 . . . . 20.94 110.738 -179.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' S' S ' 383' ' ' TYR . . . . . 0.4 ' CZ ' ' HB3' ' S' ' 338' ' ' HIS . 88.4 m-85 -61.02 -53.51 56.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.389 -0.819 . . . . 28.93 109.891 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' S' S ' 384' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.389 -0.82 . . . . 47.03 110.342 -177.046 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' R' R ' 29' ' ' MET . . . . . . . . . . . . . 15.6 mtt . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.164 0.507 . . . . 32.14 110.224 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' R' R ' 30' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -96.36 141.15 30.02 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.382 -0.824 . . . . 43.36 110.202 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 31' ' ' LEU . . . . . . . . . . . . . 65.3 mt -134.91 140.56 45.85 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.312 -0.867 . . . . 22.93 110.283 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 32' ' ' THR . . . . . . . . . . . . . 69.6 m -87.55 110.57 20.45 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.376 -0.828 . . . . 22.34 109.984 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 33' ' ' LEU . . . . . 0.462 HD23 ' CE2' ' R' ' 62' ' ' TYR . 80.1 mt -62.35 -172.79 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.266 -0.896 . . . . 21.39 110.226 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 34' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -74.65 -29.41 61.25 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.333 -0.855 . . . . 34.4 110.386 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 35' ' ' ASN . . . . . . . . . . . . . 48.3 p30 -77.73 -1.87 33.38 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.324 -0.86 . . . . 30.28 110.633 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.2 -16.56 59.42 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.776 -1.329 . . . . 36.25 109.776 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 37' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -59.02 161.81 4.76 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.285 -1.127 . . . . 53.8 110.383 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 38' ' ' LYS . . . . . . . . . . . . . 56.9 mttt -117.84 135.78 53.86 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.43 -0.794 . . . . 49.91 110.108 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 39' ' ' LYS . . . . . 0.417 ' HG2' ' CZ ' ' R' ' 41' ' ' PHE . 8.1 ttmt -138.75 143.69 39.12 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.432 -0.792 . . . . 35.69 110.223 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 40' ' ' THR . . . . . . . . . . . . . 23.7 m -102.57 127.98 49.42 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.309 -0.87 . . . . 34.84 110.193 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 41' ' ' PHE . . . . . 0.417 ' CZ ' ' HG2' ' R' ' 39' ' ' LYS . 96.6 m-85 -113.09 132.66 55.34 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.402 -0.811 . . . . 34.42 110.147 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 42' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -93.25 140.95 28.98 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.31 -0.869 . . . . 51.46 110.204 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 43' ' ' SER . . . . . . . . . . . . . 54.5 m -70.81 141.89 51.33 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.453 -0.779 . . . . 41.84 110.206 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.74 125.41 29.53 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.296 -0.877 . . . . 33.82 109.934 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 45' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.16 151.05 54.74 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.59 1.31 . . . . 30.27 110.649 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 46' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.23 109.84 13.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.456 -0.777 . . . . 35.1 110.033 179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 47' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -120.28 -34.84 3.56 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.298 -0.876 . . . . 42.81 110.503 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 48' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -105.77 45.18 0.98 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.221 -0.925 . . . . 49.97 110.176 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 49' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 50.29 34.72 9.28 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.414 -0.804 . . . . 61.32 110.173 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 50' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -86.25 43.74 1.08 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.333 -0.854 . . . . 51.5 110.703 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 51' ' ' ALA . . . . . 0.515 ' HB1' ' C ' ' S' ' 401' ' ' LYS . . . -66.08 -46.11 78.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.184 -0.948 . . . . 38.77 109.558 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 52' ' ' TRP . . . . . 0.483 ' CD2' ' N ' ' R' ' 53' ' ' LEU . 68.2 p-90 -58.39 -38.43 77.31 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.419 -0.801 . . . . 26.24 110.055 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 53' ' ' LEU . . . . . 0.483 ' N ' ' CD2' ' R' ' 52' ' ' TRP . 23.2 tp -66.68 -46.68 74.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.4 -0.813 . . . . 26.75 110.013 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 54' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -55.2 -41.61 72.22 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.372 -0.83 . . . . 35.02 110.156 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.17 -46.08 92.0 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.337 -0.852 . . . . 24.47 110.145 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 56' ' ' ILE . . . . . . . . . . . . . 76.2 mt -62.23 -42.21 94.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.322 -0.861 . . . . 26.03 109.906 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 57' ' ' LEU . . . . . . . . . . . . . 22.4 mt -60.31 -45.6 92.83 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.325 -0.859 . . . . 26.77 109.68 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 58' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -63.97 -46.49 84.4 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.426 -0.796 . . . . 22.32 109.561 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 59' ' ' LEU . . . . . 0.429 ' HA ' ' HE2' ' R' ' 151' ' ' PHE . 23.9 tp -61.43 -37.75 84.65 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.316 -0.865 . . . . 20.55 109.396 179.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 60' ' ' PHE . . . . . 0.447 ' CE2' HD22 ' R' ' 111' ' ' LEU . 2.8 m-85 -61.08 -44.78 96.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.628 -0.67 . . . . 20.08 109.907 179.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 61' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -63.16 -36.15 82.65 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.481 -0.762 . . . . 18.8 110.472 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 62' ' ' TYR . . . . . 0.462 ' CE2' HD23 ' R' ' 33' ' ' LEU . 9.2 t80 -63.04 -41.78 99.58 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.207 -0.933 . . . . 26.45 110.26 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 63' ' ' VAL . . . . . . . . . . . . . 30.2 m -93.38 20.38 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.304 -0.872 . . . . 29.75 110.188 179.708 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 64' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 52.91 75.6 0.23 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.303 -0.873 . . . . 35.52 110.546 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 65' ' ' GLU . . . . . 0.424 ' HG2' ' CD2' ' R' ' 60' ' ' PHE . 14.3 tp10 -116.29 104.05 52.35 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.457 -0.777 . . . . 29.89 109.901 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 66' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.55 -5.83 17.74 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.79 1.416 . . . . 21.37 111.094 -179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 67' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -52.11 -61.56 2.19 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.103 -0.998 . . . . 23.85 110.331 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 68' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -98.12 36.56 1.56 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.25 -0.906 . . . . 28.07 110.438 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 69' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -72.36 -33.26 67.13 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.346 -0.846 . . . . 43.76 110.144 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 70' ' ' TRP . . . . . 0.477 ' CE2' ' CG2' ' R' ' 71' ' ' VAL . 47.9 p-90 -73.42 -3.84 29.88 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.275 -0.891 . . . . 33.06 110.716 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 71' ' ' VAL . . . . . 0.477 ' CG2' ' CE2' ' R' ' 70' ' ' TRP . 40.7 t -109.79 -27.45 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.194 -0.941 . . . . 31.7 109.685 179.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 72' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -86.62 -48.83 7.98 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.358 -0.839 . . . . 33.58 110.282 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 73' ' ' SER . . . . . . . . . . . . . 69.9 m -89.7 51.08 2.01 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.27 -0.893 . . . . 50.82 110.36 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 74' ' ' SER . . . . . . . . . . . . . 15.8 t -125.92 138.3 31.8 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.338 -0.851 . . . . 34.74 110.221 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.38 -24.97 15.93 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 O-C-N 123.641 1.337 . . . . 35.7 110.348 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 76' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -91.68 153.16 19.85 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.37 -0.831 . . . . 66.48 110.379 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 77' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -81.48 95.22 7.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.292 -0.88 . . . . 46.72 110.102 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 78' ' ' LEU . . . . . . . . . . . . . 96.3 mt -96.44 28.0 3.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.331 -0.856 . . . . 37.55 110.182 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 79' ' ' THR . . . . . . . . . . . . . 29.7 m -56.2 -54.67 42.44 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.379 -0.825 . . . . 37.36 110.295 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 80' ' ' LEU . . . . . . . . . . . . . 16.0 mt -60.82 -23.27 64.96 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.347 -0.845 . . . . 35.83 110.543 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 81' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -79.46 -39.12 32.98 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.184 -0.948 . . . . 44.03 110.32 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.5 -28.58 66.17 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.292 -0.88 . . . . 32.54 110.202 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 83' ' ' ILE . . . . . . . . . . . . . 78.1 mt -70.15 -46.06 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.34 -0.85 . . . . 32.02 110.302 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 84' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -55.22 -52.08 64.52 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.164 -0.96 . . . . 34.09 110.596 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 85' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -54.83 -46.87 74.64 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.235 -0.915 . . . . 25.94 110.28 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 86' ' ' LEU . . . . . . . . . . . . . 24.0 mt -58.63 -43.85 89.81 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.299 -0.876 . . . . 16.2 109.936 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 87' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -65.34 -35.26 80.43 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.466 -0.771 . . . . 49.09 110.286 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 88' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -78.43 -19.04 54.07 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.247 -0.908 . . . . 28.61 110.493 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 89' ' ' LEU . . . . . . . . . . . . . 32.6 mt -96.18 -29.41 14.07 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.207 -0.933 . . . . 26.16 110.197 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 90' ' ' THR . . . . . . . . . . . . . 58.7 p -105.7 -34.59 7.66 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.285 -0.884 . . . . 33.33 109.778 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.85 16.1 58.6 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.821 -1.312 . . . . 31.13 109.821 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 92' ' ' LEU . . . . . . . . . . . . . 97.0 mt -100.1 155.29 17.81 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.169 -1.195 . . . . 42.52 110.21 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 93' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -86.28 91.56 8.51 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.46 -0.775 . . . . 68.46 109.984 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 94' ' ' LEU . . . . . 0.446 ' HB3' ' CZ2' ' R' ' 52' ' ' TRP . 48.1 mt -99.41 53.01 0.95 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.18 -0.95 . . . . 44.63 110.364 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 95' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.44 -38.69 6.39 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.3 -0.875 . . . . 67.16 110.399 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 96' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -113.93 44.29 1.67 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.404 -0.81 . . . . 67.02 110.326 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 97' ' ' GLY . . . . . . . . . . . . . . . 99.12 150.78 26.03 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.614 -1.395 . . . . 49.48 109.614 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 98' ' ' GLY . . . . . . . . . . . . . . . -166.21 160.03 33.46 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.253 -1.539 . . . . 36.57 109.253 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 99' ' ' PRO . . . . . 0.751 ' HA ' ' O ' ' S' ' 396' ' ' VAL . 45.1 Cg_endo -72.58 121.1 7.13 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.684 1.36 . . . . 30.41 110.435 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 100' ' ' PRO . . . . . 0.602 ' HD3' ' HD3' ' S' ' 401' ' ' LYS . 45.7 Cg_endo -72.25 -31.65 11.49 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 O-C-N 123.645 1.339 . . . . 29.94 110.54 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.96 -38.48 76.13 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.301 -0.875 . . . . 23.64 110.263 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.62 -40.8 66.17 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.322 -0.861 . . . . 20.31 110.362 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 103' ' ' VAL . . . . . . . . . . . . . 63.7 t -58.16 -40.06 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.219 -0.925 . . . . 16.33 109.996 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 104' ' ' ILE . . . . . . . . . . . . . 81.9 mt -71.7 -30.57 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.397 -0.814 . . . . 24.77 109.93 179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 105' ' ' TRP . . . . . 0.439 ' O ' ' HD3' ' R' ' 108' ' ' LYS . 70.6 t-105 -82.42 0.84 40.28 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.345 -0.847 . . . . 23.28 110.273 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 106' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -105.08 -10.38 17.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.116 -0.99 . . . . 28.26 110.125 179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 107' ' ' ILE . . . . . . . . . . . . . 36.8 pt -126.83 34.97 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.211 -0.931 . . . . 18.77 110.05 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 108' ' ' LYS . . . . . 0.481 ' HG2' ' HB ' ' R' ' 115' ' ' ILE . 9.3 mtpp -61.05 -48.44 81.72 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.548 -0.72 . . . . 42.5 110.025 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 109' ' ' HIS . . . . . 0.432 ' CD2' ' HG ' ' R' ' 110' ' ' LEU . 50.8 p-80 -66.02 -12.85 58.07 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.527 -0.733 . . . . 20.07 110.698 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 110' ' ' LEU . . . . . 0.432 ' HG ' ' CD2' ' R' ' 109' ' ' HIS . 80.6 mt -94.79 -17.25 22.31 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.076 -1.015 . . . . 15.69 110.207 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 111' ' ' LEU . . . . . 0.447 HD22 ' CE2' ' R' ' 60' ' ' PHE . 10.3 mt -94.13 144.15 25.75 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.342 -0.849 . . . . 25.39 111.014 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 112' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -77.71 -17.35 57.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.552 -0.717 . . . . 53.48 109.852 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 113' ' ' THR . . . . . 0.417 HG22 ' HG2' ' R' ' 123' ' ' GLU . 60.0 m -83.73 166.64 17.88 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.236 -0.915 . . . . 14.8 110.233 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 114' ' ' GLY . . . . . . . . . . . . . . . -97.96 127.16 9.13 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.994 -1.243 . . . . 16.14 109.994 -179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 115' ' ' ILE . . . . . 0.481 ' HB ' ' HG2' ' R' ' 108' ' ' LYS . 47.7 mm -109.11 139.31 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.441 -1.035 . . . . 13.46 109.738 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 116' ' ' GLY . . . . . . . . . . . . . . . -152.74 -155.88 7.3 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.959 -1.257 . . . . 23.9 109.959 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 117' ' ' THR . . . . . . . . . . . . . 18.8 p -134.99 -171.39 2.79 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.453 -1.028 . . . . 27.37 110.044 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.6 -58.04 9.79 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.251 -0.906 . . . . 18.76 110.064 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 119' ' ' SER . . . . . 0.481 ' CB ' ' HB ' ' R' ' 196' ' ' VAL . 1.1 m -56.52 -40.66 75.42 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.259 -0.901 . . . . 32.35 109.721 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 120' ' ' ARG . . . . . 0.409 ' NH1' ' NE1' ' S' ' 305' ' ' TRP . 10.0 mtm180 -110.03 86.26 4.84 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.47 -0.768 . . . . 27.12 109.716 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 121' ' ' PRO . . . . . 0.426 ' O ' ' HB2' ' R' ' 122' ' ' SER . 44.7 Cg_endo -71.26 166.44 29.25 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 O-C-N 123.784 1.413 . . . . 22.68 111.009 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 122' ' ' SER . . . . . 0.426 ' HB2' ' O ' ' R' ' 121' ' ' PRO . 38.2 t 178.58 -161.65 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.609 -0.682 . . . . 22.99 109.467 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 123' ' ' GLU . . . . . 0.417 ' HG2' HG22 ' R' ' 113' ' ' THR . 2.3 tp10 -56.5 -39.92 74.08 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.211 -0.93 . . . . 36.18 109.649 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 124' ' ' VAL . . . . . . . . . . . . . 83.8 t -142.57 136.39 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.606 -0.684 . . . . 20.64 109.383 179.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 125' ' ' CYS . . . . . 0.41 ' SG ' ' HA ' ' R' ' 121' ' ' PRO . 83.7 m -140.3 168.17 20.43 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.17 -0.956 . . . . 22.8 111.131 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 126' ' ' VAL . . . . . . . . . . . . . 35.9 m -122.68 159.82 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.724 -0.61 . . . . 21.24 109.613 179.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 127' ' ' VAL . . . . . 0.4 ' CG1' ' O ' ' R' ' 177' ' ' VAL . 31.1 m -70.89 141.86 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.283 -0.886 . . . . 19.77 110.675 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 128' ' ' ASP . . . . . . . . . . . . . 53.9 p-10 -137.73 19.41 2.87 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.327 -0.858 . . . . 29.21 110.697 179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 129' ' ' GLY . . . . . . . . . . . . . . . 114.06 -0.02 24.06 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.928 -1.13 . . . . 33.86 110.441 179.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 130' ' ' THR . . . . . . . . . . . . . 58.7 m -91.9 131.88 36.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.11 -1.229 . . . . 26.41 110.046 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -62.57 120.72 11.68 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.369 -0.832 . . . . 33.08 110.258 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 132' ' ' MET . . . . . 0.427 ' HE1' ' CZ ' ' R' ' 180' ' ' PHE . 98.4 mmm -105.17 165.63 10.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.467 -0.771 . . . . 30.76 110.467 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 133' ' ' CYS . . . . . . . . . . . . . 32.8 m -141.13 158.13 44.34 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.542 -0.724 . . . . 27.0 109.973 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 134' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.45 -19.71 38.88 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.322 -0.861 . . . . 33.9 110.553 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 135' ' ' ALA . . . . . . . . . . . . . . . -92.8 8.24 40.29 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.31 -0.868 . . . . 19.37 110.802 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 136' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -93.76 -21.84 19.07 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.209 -0.932 . . . . 30.47 110.183 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 137' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -149.95 165.42 32.71 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.321 -0.862 . . . . 24.27 110.189 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 138' ' ' HIS . . . . . . . . . . . . . 15.2 p80 -117.88 15.19 14.33 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.382 -0.824 . . . . 20.91 110.452 179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 139' ' ' ALA . . . . . 0.441 ' HA ' ' O ' ' R' ' 152' ' ' ALA . . . -177.22 152.4 0.87 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.207 -0.933 . . . . 15.69 110.099 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 140' ' ' GLY . . . . . 0.404 ' HA3' ' O ' ' R' ' 179' ' ' VAL . . . 161.81 175.17 32.55 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.962 -1.255 . . . . 23.76 109.962 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 141' ' ' ILE . . . . . . . . . . . . . 83.7 mt -95.5 136.54 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.473 -1.016 . . . . 25.3 109.718 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 142' ' ' PHE . . . . . 0.546 ' CD2' ' HB2' ' R' ' 172' ' ' PRO . 82.7 m-85 -120.72 -172.61 2.41 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.26 -0.9 . . . . 30.24 110.505 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 143' ' ' LEU . . . . . 0.559 HD21 ' NH2' ' S' ' 398' ' ' ARG . 0.5 OUTLIER -119.79 77.74 1.26 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.367 -0.833 . . . . 32.8 110.316 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' R' R ' 144' ' ' LYS . . . . . 0.454 ' HG3' ' CZ2' ' R' ' 170' ' ' TRP . 1.0 OUTLIER -69.62 76.87 0.43 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.43 -0.794 . . . . 49.18 109.679 179.594 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' R' R ' 145' ' ' GLY . . . . . . . . . . . . . . . 104.5 179.27 24.83 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.188 -1.565 . . . . 53.87 109.188 -179.537 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 146' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -88.47 145.83 25.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.388 -1.066 . . . . 68.58 109.999 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 147' ' ' GLU . . . . . 0.697 ' HA ' ' CB ' ' S' ' 398' ' ' ARG . 10.9 mt-10 58.25 36.45 25.69 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.362 -0.837 . . . . 56.62 110.655 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 148' ' ' HIS . . . . . 0.635 ' HA ' ' O ' ' S' ' 400' ' ' LEU . 44.7 t60 -158.61 148.13 19.28 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.219 -0.926 . . . . 44.57 110.376 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 149' ' ' ALA . . . . . 0.662 ' HB3' ' HE3' ' S' ' 401' ' ' LYS . . . -150.29 146.9 27.05 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.467 -0.771 . . . . 33.54 110.07 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 150' ' ' VAL . . . . . 0.428 HG23 ' HB2' ' R' ' 144' ' ' LYS . 34.2 m -142.3 161.51 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.261 -0.899 . . . . 27.61 110.36 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 151' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' R' ' 152' ' ' ALA . 5.8 t80 -86.17 155.6 20.67 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.428 -0.795 . . . . 23.04 109.904 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 152' ' ' ALA . . . . . 0.537 ' N ' ' CD1' ' R' ' 151' ' ' PHE . . . -157.29 151.5 24.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.443 -0.786 . . . . 29.61 109.611 179.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 153' ' ' CYS . . . . . 0.406 ' HA ' ' HA ' ' R' ' 139' ' ' ALA . 26.7 p -154.28 173.57 15.97 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.298 -0.876 . . . . 22.75 110.507 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 154' ' ' VAL . . . . . 0.443 ' CG2' ' CZ2' ' R' ' 159' ' ' TRP . 59.7 t -90.59 117.04 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.392 -0.817 . . . . 23.26 110.076 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 155' ' ' THR . . . . . . . . . . . . . 70.3 p -112.13 -176.63 2.97 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.358 -0.839 . . . . 17.88 110.041 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 156' ' ' SER . . . . . . . . . . . . . 78.6 p -75.92 -3.75 37.16 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.329 -0.857 . . . . 21.83 110.727 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 157' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -118.25 10.43 12.85 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.148 -0.97 . . . . 36.54 110.619 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 158' ' ' GLY . . . . . . . . . . . . . . . 117.97 -162.71 13.02 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.533 -1.427 . . . . 31.74 109.533 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 159' ' ' TRP . . . . . 0.443 ' CZ2' ' CG2' ' R' ' 154' ' ' VAL . 14.7 m95 -86.51 122.42 30.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.334 -1.098 . . . . 28.25 110.112 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 160' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -108.46 166.96 10.38 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.376 -0.827 . . . . 41.24 110.19 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 161' ' ' ALA . . . . . . . . . . . . . . . -143.22 123.42 13.74 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.362 -0.836 . . . . 27.4 110.198 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 162' ' ' ILE . . . . . 0.431 HG23 ' CZ ' ' R' ' 167' ' ' PHE . 92.0 mt -87.55 81.15 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.295 -0.878 . . . . 24.27 110.051 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 163' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' R' ' 165' ' ' GLU . 15.3 t0 -72.86 92.42 1.6 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.457 -0.777 . . . . 36.08 110.254 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 164' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 54.09 -88.94 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.489 -0.757 . . . . 46.08 110.603 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 165' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' R' ' 163' ' ' ASP . 29.7 mt-10 -124.72 35.92 4.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.088 -1.007 . . . . 50.94 110.187 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 166' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -135.75 117.3 14.84 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.388 -0.82 . . . . 47.28 110.347 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 167' ' ' PHE . . . . . 0.431 ' CZ ' HG23 ' R' ' 162' ' ' ILE . 24.4 m-85 -101.04 119.98 39.53 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.434 -0.791 . . . . 40.47 110.164 179.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 168' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -157.57 158.57 30.65 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.24 -0.913 . . . . 30.21 110.376 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 169' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.8 133.04 19.46 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.931 1.49 . . . . 32.76 110.474 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 170' ' ' TRP . . . . . 0.454 ' CZ2' ' HG3' ' R' ' 144' ' ' LYS . 66.9 t90 -159.81 119.37 2.89 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.461 -0.774 . . . . 32.79 109.909 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 171' ' ' THR . . . . . . . . . . . . . 46.1 m -81.1 112.61 34.16 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.448 -0.783 . . . . 36.92 110.163 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 172' ' ' PRO . . . . . 0.546 ' HB2' ' CD2' ' R' ' 142' ' ' PHE . 47.4 Cg_endo -73.71 158.75 46.68 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.66 1.348 . . . . 33.54 110.592 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 173' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -88.84 144.97 33.86 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.318 -0.864 . . . . 45.76 109.851 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 174' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.74 -10.34 26.31 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.614 1.323 . . . . 29.63 110.492 179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 175' ' ' SER . . . . . . . . . . . . . 53.1 p -103.5 -17.55 15.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.281 -0.887 . . . . 35.7 110.343 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 176' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -103.5 43.26 1.1 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.202 -0.936 . . . . 39.65 110.442 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 177' ' ' VAL . . . . . 0.4 ' O ' ' CG1' ' R' ' 127' ' ' VAL . 10.5 p -117.79 127.14 75.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.326 -0.859 . . . . 20.61 110.034 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 178' ' ' LEU . . . . . . . . . . . . . 46.3 mt -91.47 -61.36 1.66 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.35 -0.844 . . . . 15.58 109.351 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 179' ' ' VAL . . . . . 0.404 ' O ' ' HA3' ' R' ' 140' ' ' GLY . 67.9 t -114.58 144.72 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.621 -0.674 . . . . 17.4 109.413 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 180' ' ' PHE . . . . . 0.427 ' CZ ' ' HE1' ' R' ' 132' ' ' MET . 43.7 p90 -152.17 163.32 39.62 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.273 -0.892 . . . . 20.16 110.602 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 181' ' ' VAL . . . . . . . . . . . . . 66.5 t -113.12 111.48 50.4 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.429 -0.795 . . . . 17.69 109.833 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 182' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.03 149.52 52.9 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.545 1.287 . . . . 17.81 110.423 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' R' R ' 183' ' ' TYR . . . . . 0.739 ' O ' ' C ' ' R' ' 184' ' ' ASP . 78.9 m-85 -59.01 175.53 0.28 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.43 -0.794 . . . . 28.01 110.526 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 184' ' ' ASP . . . . . 0.739 ' C ' ' O ' ' R' ' 183' ' ' TYR . 0.0 OUTLIER -12.28 -76.89 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.343 -0.848 . . . . 58.64 110.303 -178.086 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' R' R ' 185' ' ' GLN . . . . . . . . . . . . . 6.7 tm0? . . . . . 0 N--CA 1.503 2.188 0 CA-C-O 121.25 0.548 . . . . 80.42 111.723 179.409 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' R' R ' 193' ' ' LYS . . . . . . . . . . . . . 20.4 ttpp . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 120.938 0.399 . . . . 49.5 110.166 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' R' R ' 194' ' ' ALA . . . . . 0.44 ' O ' ' HG3' ' R' ' 197' ' ' GLN . . . 174.32 -165.57 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.125 -0.984 . . . . 40.4 110.099 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 195' ' ' LYS . . . . . 0.469 ' O ' ' OG ' ' R' ' 119' ' ' SER . 24.8 mmtt -79.5 174.5 11.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.441 -0.787 . . . . 34.6 110.31 179.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 196' ' ' VAL . . . . . 0.58 HG23 ' HA ' ' S' ' 328' ' ' ASP . 2.5 t 51.56 25.31 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.249 -0.907 . . . . 33.27 110.629 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 197' ' ' GLN . . . . . 0.44 ' HG3' ' O ' ' R' ' 194' ' ' ALA . 0.0 OUTLIER -162.48 27.62 0.11 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.124 -0.985 . . . . 41.58 110.709 179.778 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' R' R ' 198' ' ' ARG . . . . . 0.422 ' O ' ' HG3' ' S' ' 299' ' ' PRO . 0.0 OUTLIER -124.98 149.99 47.13 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.199 -0.938 . . . . 38.65 110.203 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' R' R ' 199' ' ' LYS . . . . . 0.619 ' HA ' ' HD3' ' S' ' 299' ' ' PRO . 27.9 mmtm -82.22 99.24 9.17 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.372 -0.83 . . . . 36.77 109.954 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' R' R ' 200' ' ' LEU . . . . . 0.405 ' CD1' ' NH1' ' R' ' 198' ' ' ARG . 0.4 OUTLIER -81.59 -153.29 0.1 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.433 -0.792 . . . . 33.08 110.095 179.697 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' R' R ' 201' ' ' LYS . . . . . 0.458 ' HA ' ' CA ' ' S' ' 297' ' ' GLY . 63.2 mttt . . . . . 0 N--CA 1.492 1.673 0 O-C-N 121.364 -0.835 . . . . 44.32 110.234 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 229' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.171 0.51 . . . . 51.83 110.208 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 230' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -97.28 142.76 28.78 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.4 -0.813 . . . . 54.13 110.222 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 231' ' ' LEU . . . . . . . . . . . . . 67.8 mt -134.11 140.99 46.97 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.343 -0.848 . . . . 33.04 110.337 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 232' ' ' THR . . . . . . . . . . . . . 40.0 m -89.25 103.23 15.87 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.319 -0.863 . . . . 26.92 110.068 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 233' ' ' LEU . . . . . 0.493 HD23 ' CE2' ' S' ' 262' ' ' TYR . 79.9 mt -55.92 179.28 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.437 -0.79 . . . . 13.78 110.498 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' S' S ' 234' ' ' TYR . . . . . 0.442 ' CG ' ' N ' ' S' ' 235' ' ' ASN . 35.6 p90 -65.01 -35.65 81.89 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.393 -0.817 . . . . 26.08 110.198 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' S' S ' 235' ' ' ASN . . . . . 0.442 ' N ' ' CG ' ' S' ' 234' ' ' TYR . 50.7 p30 -74.33 -7.4 52.69 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.373 -0.829 . . . . 20.04 110.567 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' S' S ' 236' ' ' GLY . . . . . . . . . . . . . . . 95.69 -19.9 52.22 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.782 -1.327 . . . . 22.71 109.782 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 237' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -53.03 145.73 12.49 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.189 -1.183 . . . . 35.44 110.183 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 238' ' ' LYS . . . . . . . . . . . . . 44.3 mttt -102.17 127.91 48.89 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.38 -0.825 . . . . 32.56 110.361 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 239' ' ' LYS . . . . . 0.422 ' HG2' ' CZ ' ' S' ' 241' ' ' PHE . 9.0 ttmt -132.31 144.52 50.63 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.357 -0.839 . . . . 26.68 109.955 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' S' S ' 240' ' ' THR . . . . . . . . . . . . . 51.8 m -102.0 132.22 47.97 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.34 -0.85 . . . . 41.02 110.348 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 241' ' ' PHE . . . . . 0.422 ' CZ ' ' HG2' ' S' ' 239' ' ' LYS . 96.0 m-85 -117.96 137.7 52.67 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.418 -0.801 . . . . 28.62 110.186 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' S' S ' 242' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -96.42 161.78 13.77 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.392 -0.818 . . . . 47.89 110.257 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 243' ' ' SER . . . . . . . . . . . . . 72.0 m -90.5 151.52 21.33 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.372 -0.83 . . . . 45.09 110.282 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 244' ' ' ARG . . . . . . . . . . . . . 1.4 mtp85 -129.72 126.73 22.74 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.375 -0.828 . . . . 42.49 110.282 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 245' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.31 161.02 43.78 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.674 1.355 . . . . 35.68 110.544 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 246' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -132.89 97.85 4.14 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.353 -0.842 . . . . 51.88 109.853 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 247' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -110.47 -22.25 11.76 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.398 -0.813 . . . . 53.69 110.658 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 248' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -117.24 43.65 2.27 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.223 -0.923 . . . . 55.79 110.704 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 249' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 48.84 38.37 11.9 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.405 -0.809 . . . . 49.45 110.386 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 250' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -90.67 29.09 1.37 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.489 -0.757 . . . . 36.86 110.327 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 251' ' ' ALA . . . . . . . . . . . . . . . -53.91 -43.12 69.44 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.229 -0.919 . . . . 29.69 109.612 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 252' ' ' TRP . . . . . 0.408 ' CD2' ' N ' ' S' ' 253' ' ' LEU . 67.9 p-90 -61.81 -33.94 75.03 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.523 -0.736 . . . . 41.12 109.829 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' S' S ' 253' ' ' LEU . . . . . 0.408 ' N ' ' CD2' ' S' ' 252' ' ' TRP . 23.4 tp -70.17 -47.17 62.77 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.378 -0.826 . . . . 24.89 110.001 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' S' S ' 254' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -56.13 -42.47 76.96 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.445 -0.784 . . . . 35.65 109.966 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 255' ' ' ALA . . . . . . . . . . . . . . . -59.53 -48.25 82.39 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.463 -0.773 . . . . 22.73 110.071 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 256' ' ' ILE . . . . . . . . . . . . . 79.7 mt -62.24 -40.68 88.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.321 -0.862 . . . . 28.85 109.983 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 257' ' ' LEU . . . . . . . . . . . . . 19.0 mt -61.54 -44.45 97.03 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.352 -0.843 . . . . 23.07 110.183 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 258' ' ' GLN . . . . . 0.466 ' HB3' ' CD2' ' S' ' 351' ' ' PHE . 53.4 mm-40 -65.12 -45.33 85.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.371 -0.831 . . . . 29.78 109.882 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' S' S ' 259' ' ' LEU . . . . . 0.423 ' O ' HG22 ' S' ' 263' ' ' VAL . 19.9 tp -58.67 -36.41 74.13 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.344 -0.848 . . . . 17.94 109.462 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' S' S ' 260' ' ' PHE . . . . . 0.468 ' CE2' HD22 ' S' ' 311' ' ' LEU . 3.1 m-85 -62.83 -45.29 93.3 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.655 -0.653 . . . . 30.57 109.834 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' S' S ' 261' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -62.01 -29.8 70.52 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.525 -0.734 . . . . 41.34 110.033 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 262' ' ' TYR . . . . . 0.493 ' CE2' HD23 ' S' ' 233' ' ' LEU . 8.7 t80 -71.24 -44.62 64.94 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.443 -0.786 . . . . 26.03 110.093 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' S' S ' 263' ' ' VAL . . . . . 0.423 HG22 ' O ' ' S' ' 259' ' ' LEU . 33.0 m -91.99 18.24 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.336 -0.852 . . . . 22.8 110.411 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' S' S ' 264' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 52.79 70.65 0.55 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.223 -0.923 . . . . 44.03 110.611 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 265' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -111.78 109.25 55.46 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.394 -0.817 . . . . 35.61 109.654 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 266' ' ' PRO . . . . . . . . . . . . . 48.6 Cg_endo -75.39 0.45 9.05 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 O-C-N 123.605 1.318 . . . . 37.67 111.742 -179.111 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 267' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -56.54 -67.7 0.28 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.802 -1.186 . . . . 41.49 110.165 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' S' S ' 268' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -92.91 39.89 1.05 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.148 -0.97 . . . . 50.76 110.048 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 269' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.01 -33.19 59.67 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.381 -0.825 . . . . 61.86 109.765 179.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' S' S ' 270' ' ' TRP . . . . . 0.482 ' CE2' ' CG2' ' S' ' 271' ' ' VAL . 51.0 p-90 -73.94 -4.28 34.2 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.268 -0.895 . . . . 39.85 110.466 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' S' S ' 271' ' ' VAL . . . . . 0.482 ' CG2' ' CE2' ' S' ' 270' ' ' TRP . 46.6 t -109.58 -32.66 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.157 -0.964 . . . . 39.18 110.07 179.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' S' S ' 272' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -78.67 -36.53 43.63 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.42 -0.8 . . . . 40.02 110.47 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 273' ' ' SER . . . . . . . . . . . . . 70.9 m -103.57 56.16 0.74 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.278 -0.889 . . . . 47.2 110.294 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 274' ' ' SER . . . . . . . . . . . . . 6.9 t -133.03 141.22 40.15 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.385 -0.822 . . . . 47.61 110.158 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 275' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.76 -18.85 21.71 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.66 1.347 . . . . 45.28 110.556 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 276' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -99.89 140.87 33.47 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.3 -0.875 . . . . 57.27 110.31 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 277' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -71.73 97.66 1.81 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.398 -0.814 . . . . 37.28 110.279 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 278' ' ' LEU . . . . . . . . . . . . . 86.3 mt -97.02 33.82 1.84 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.394 -0.816 . . . . 43.88 110.047 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 279' ' ' THR . . . . . . . . . . . . . 74.7 m -64.03 -60.1 3.65 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.484 -0.76 . . . . 50.05 110.303 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 280' ' ' LEU . . . . . . . . . . . . . 13.7 mt -51.61 -39.87 58.79 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.334 -0.854 . . . . 54.12 110.287 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 281' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.42 -49.67 74.57 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.499 -0.751 . . . . 65.28 110.177 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' S' S ' 282' ' ' ALA . . . . . . . . . . . . . . . -58.93 -33.9 71.12 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.456 -0.778 . . . . 46.51 110.571 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 283' ' ' ILE . . . . . . . . . . . . . 85.9 mt -66.39 -50.84 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.306 -0.871 . . . . 47.3 110.083 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 284' ' ' LYS . . . . . . . . . . . . . 33.8 tttp -50.52 -57.63 7.65 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.411 -0.806 . . . . 50.72 110.381 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 285' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -51.4 -46.4 62.84 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.487 -0.758 . . . . 68.47 110.283 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 286' ' ' LEU . . . . . . . . . . . . . 19.1 mt -59.95 -44.49 94.35 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.429 -0.794 . . . . 36.62 110.284 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 287' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -62.74 -35.29 79.3 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.33 -0.856 . . . . 46.64 110.077 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 288' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -76.23 -21.04 56.87 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.442 -0.787 . . . . 46.45 110.34 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 289' ' ' LEU . . . . . . . . . . . . . 30.8 mt -97.35 -21.75 17.03 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.256 -0.902 . . . . 35.09 110.485 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 290' ' ' THR . . . . . . . . . . . . . 81.3 p -114.8 -28.44 7.08 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.281 -0.887 . . . . 38.61 110.419 -179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 291' ' ' GLY . . . . . . . . . . . . . . . 79.4 10.97 85.41 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.833 -1.307 . . . . 36.77 109.833 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 292' ' ' LEU . . . . . . . . . . . . . 84.7 mt -96.42 145.83 25.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.247 -1.149 . . . . 35.33 109.77 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 293' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -77.37 102.32 6.74 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.222 -0.924 . . . . 48.7 110.262 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 294' ' ' LEU . . . . . 0.406 ' HB3' ' CZ2' ' S' ' 252' ' ' TRP . 55.8 mt -106.86 51.73 0.74 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.575 -0.703 . . . . 42.61 110.123 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' S' S ' 295' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -112.56 -11.11 13.63 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.296 -0.878 . . . . 55.49 110.505 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' S' S ' 296' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -144.34 48.52 1.36 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.178 -0.951 . . . . 75.68 110.308 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 297' ' ' GLY . . . . . 0.458 ' CA ' ' HA ' ' R' ' 201' ' ' LYS . . . 96.9 145.18 18.7 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.524 -1.43 . . . . 49.44 109.524 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' S' S ' 298' ' ' GLY . . . . . . . . . . . . . . . -163.8 156.93 29.0 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.807 -1.317 . . . . 41.11 109.807 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 299' ' ' PRO . . . . . 0.619 ' HD3' ' HA ' ' R' ' 199' ' ' LYS . 47.9 Cg_endo -73.8 118.33 5.4 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.916 1.482 . . . . 26.2 110.278 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' S' S ' 300' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.25 -15.48 31.64 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.587 1.309 . . . . 21.7 110.725 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 301' ' ' ALA . . . . . . . . . . . . . . . -80.73 -29.35 36.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.271 -0.893 . . . . 31.23 110.099 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 302' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.49 -40.61 18.99 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.4 -0.812 . . . . 38.99 109.982 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' S' S ' 303' ' ' VAL . . . . . 0.463 ' O ' HG12 ' S' ' 307' ' ' ILE . 58.1 t -60.74 -35.43 64.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.436 -0.79 . . . . 18.63 110.14 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' S' S ' 304' ' ' ILE . . . . . . . . . . . . . 86.0 mt -79.39 -23.65 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.37 -0.831 . . . . 25.46 110.178 179.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 305' ' ' TRP . . . . . 0.409 ' NE1' ' NH1' ' R' ' 120' ' ' ARG . 68.9 t-105 -88.61 -14.54 37.27 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.295 -0.878 . . . . 33.4 110.569 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' S' S ' 306' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -89.67 -13.65 36.52 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.191 -0.943 . . . . 36.97 110.388 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 307' ' ' ILE . . . . . 0.463 HG12 ' O ' ' S' ' 303' ' ' VAL . 36.9 pt -125.01 45.66 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.237 -0.915 . . . . 30.81 110.004 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' S' S ' 308' ' ' LYS . . . . . 0.403 ' HD3' ' CD2' ' S' ' 305' ' ' TRP . 1.5 mtmp? -73.64 -37.63 65.26 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.371 -0.831 . . . . 46.52 110.097 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' S' S ' 309' ' ' HIS . . . . . 0.484 ' CD2' ' HG ' ' S' ' 310' ' ' LEU . 55.6 p-80 -73.26 -8.28 55.16 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.321 -0.862 . . . . 51.03 110.062 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' S' S ' 310' ' ' LEU . . . . . 0.484 ' HG ' ' CD2' ' S' ' 309' ' ' HIS . 53.0 mt -99.28 -12.87 19.97 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.353 -0.842 . . . . 36.16 109.986 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' S' S ' 311' ' ' LEU . . . . . 0.468 HD22 ' CE2' ' S' ' 260' ' ' PHE . 10.7 mt -97.19 147.88 23.64 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.339 -0.85 . . . . 40.0 110.399 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' S' S ' 312' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -81.6 -16.3 51.98 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.275 -0.891 . . . . 54.18 109.69 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 313' ' ' THR . . . . . 0.476 HG23 ' HB3' ' S' ' 323' ' ' GLU . 92.7 m -87.97 151.65 22.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.336 -0.853 . . . . 25.61 110.098 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' S' S ' 314' ' ' GLY . . . . . . . . . . . . . . . -87.95 126.43 8.06 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.783 -1.327 . . . . 25.18 109.783 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 315' ' ' ILE . . . . . 0.411 HG23 HD11 ' S' ' 315' ' ' ILE . 50.7 mm -101.6 150.49 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.356 -1.085 . . . . 23.9 109.72 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' S' S ' 316' ' ' GLY . . . . . 0.405 ' N ' HG21 ' S' ' 315' ' ' ILE . . . -157.08 -159.25 9.37 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.957 -1.257 . . . . 23.18 109.957 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' S' S ' 317' ' ' THR . . . . . . . . . . . . . 11.2 p -133.94 -173.06 3.14 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.418 -1.048 . . . . 27.98 110.023 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.51 -56.19 25.15 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.175 -0.953 . . . . 28.1 109.926 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 319' ' ' SER . . . . . . . . . . . . . 1.2 m -59.94 -41.7 92.42 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.36 -0.838 . . . . 37.0 109.656 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 320' ' ' ARG . . . . . . . . . . . . . 12.1 mtm180 -111.67 79.91 2.64 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.529 -0.732 . . . . 52.07 109.718 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 321' ' ' PRO . . . . . 0.421 ' O ' ' HB2' ' S' ' 322' ' ' SER . 43.9 Cg_endo -71.45 171.48 16.13 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.865 1.455 . . . . 38.29 110.92 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' S' S ' 322' ' ' SER . . . . . 0.421 ' HB2' ' O ' ' S' ' 321' ' ' PRO . 41.3 t 178.68 -148.12 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.934 -0.765 . . . . 38.84 108.934 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' S' S ' 323' ' ' GLU . . . . . 0.476 ' HB3' HG23 ' S' ' 313' ' ' THR . 6.7 tp10 -62.89 -40.31 97.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.017 -1.052 . . . . 40.7 109.635 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' S' S ' 324' ' ' VAL . . . . . . . . . . . . . 72.8 t -141.25 135.01 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.402 -0.811 . . . . 20.34 109.506 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 325' ' ' CYS . . . . . 0.459 ' HB2' ' CE1' ' S' ' 380' ' ' PHE . 11.2 m -126.02 172.26 10.11 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.267 -0.895 . . . . 30.63 110.854 -179.117 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' S' S ' 326' ' ' VAL . . . . . . . . . . . . . 34.6 m -135.57 142.2 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.611 -0.681 . . . . 23.9 109.191 179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 327' ' ' VAL . . . . . . . . . . . . . 34.5 m -56.32 124.99 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.111 -0.993 . . . . 19.48 110.456 -179.704 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 328' ' ' ASP . . . . . 0.58 ' HA ' HG23 ' R' ' 196' ' ' VAL . 55.5 p-10 -119.37 11.53 12.22 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.412 -0.805 . . . . 26.43 110.417 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' S' S ' 329' ' ' GLY . . . . . . . . . . . . . . . 119.65 2.24 13.12 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.052 -1.219 . . . . 31.24 110.052 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 330' ' ' THR . . . . . . . . . . . . . 80.7 m -93.04 130.06 38.77 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.116 -1.226 . . . . 30.05 110.109 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 331' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -56.86 111.52 1.05 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.244 -0.91 . . . . 37.26 109.916 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 332' ' ' MET . . . . . 0.449 ' HE1' ' CZ ' ' S' ' 380' ' ' PHE . 88.0 mmm -94.09 162.53 13.83 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.234 -0.916 . . . . 26.23 110.332 -179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' S' S ' 333' ' ' CYS . . . . . . . . . . . . . 25.8 m -137.2 150.07 47.64 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.47 -0.769 . . . . 23.56 110.058 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 334' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.62 -24.83 9.15 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.371 -0.83 . . . . 28.93 110.428 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' S' S ' 335' ' ' ALA . . . . . . . . . . . . . . . -89.06 14.44 10.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.396 -0.815 . . . . 15.76 110.954 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 336' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -100.45 -17.25 17.26 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.124 -0.985 . . . . 34.92 110.191 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 337' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -152.4 170.85 19.08 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.412 -0.805 . . . . 19.03 110.054 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 338' ' ' HIS . . . . . . . . . . . . . 13.4 p80 -120.71 10.37 10.98 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.363 -0.835 . . . . 18.82 110.449 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 339' ' ' ALA . . . . . . . . . . . . . . . -175.95 155.18 1.58 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.221 -0.924 . . . . 17.18 110.054 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 340' ' ' GLY . . . . . . . . . . . . . . . 160.84 173.08 29.0 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.056 -1.218 . . . . 18.33 110.056 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 341' ' ' ILE . . . . . 0.441 HD12 HG22 ' S' ' 341' ' ' ILE . 83.9 mt -88.82 138.1 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.508 -0.995 . . . . 18.6 109.786 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' S' S ' 342' ' ' PHE . . . . . 0.497 ' CE1' HG23 ' S' ' 377' ' ' VAL . 70.0 m-85 -120.97 -178.46 3.75 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.256 -0.903 . . . . 23.44 110.396 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' S' S ' 343' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.82 93.33 4.16 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.412 -0.805 . . . . 35.59 110.008 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' S' S ' 344' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.8 124.98 29.52 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.219 -0.926 . . . . 38.34 110.102 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' S' S ' 345' ' ' GLY . . . . . . . . . . . . . . . 62.77 -130.83 43.09 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 108.887 -1.685 . . . . 53.46 108.887 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 346' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -132.68 150.83 52.11 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.244 -1.151 . . . . 70.91 110.066 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 347' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 53.35 35.38 20.18 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.339 -0.85 . . . . 47.32 110.352 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 348' ' ' HIS . . . . . . . . . . . . . 46.7 t60 -150.17 155.86 40.56 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.265 -0.897 . . . . 41.72 110.317 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 349' ' ' ALA . . . . . . . . . . . . . . . -149.75 151.26 33.33 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.306 -0.871 . . . . 22.91 110.487 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 350' ' ' VAL . . . . . . . . . . . . . 34.6 m -149.08 169.66 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.465 -0.772 . . . . 21.09 110.014 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 351' ' ' PHE . . . . . 0.466 ' CD2' ' HB3' ' S' ' 258' ' ' GLN . 10.7 t80 -105.42 143.66 33.28 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.284 -0.885 . . . . 25.03 110.67 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' S' S ' 352' ' ' ALA . . . . . . . . . . . . . . . -147.73 151.71 36.53 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.617 -0.677 . . . . 23.81 109.742 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 353' ' ' CYS . . . . . . . . . . . . . 26.3 p -153.35 164.85 37.42 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.346 -0.846 . . . . 25.66 110.27 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 354' ' ' VAL . . . . . 0.404 HG23 ' CZ2' ' S' ' 359' ' ' TRP . 56.4 t -75.97 118.47 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.378 -0.826 . . . . 34.27 110.025 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' S' S ' 355' ' ' THR . . . . . 0.444 HG23 ' HB2' ' S' ' 360' ' ' TYR . 51.9 p -117.83 175.11 5.81 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.243 -0.911 . . . . 25.49 110.314 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' S' S ' 356' ' ' SER . . . . . . . . . . . . . 62.3 p -62.15 -17.72 58.77 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.395 -0.815 . . . . 31.24 110.716 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 357' ' ' ASN . . . . . . . . . . . . . 46.1 m-20 -106.97 14.18 26.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.149 -0.969 . . . . 28.61 110.604 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 358' ' ' GLY . . . . . . . . . . . . . . . 111.82 -152.83 17.6 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.031 -1.228 . . . . 22.01 110.031 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 359' ' ' TRP . . . . . 0.404 ' CZ2' HG23 ' S' ' 354' ' ' VAL . 15.4 m95 -91.37 116.73 29.08 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.442 -1.034 . . . . 25.54 110.155 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' S' S ' 360' ' ' TYR . . . . . 0.444 ' HB2' HG23 ' S' ' 355' ' ' THR . 1.3 m-85 -103.48 165.79 10.82 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.276 -0.89 . . . . 40.53 110.094 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' S' S ' 361' ' ' ALA . . . . . . . . . . . . . . . -140.09 130.08 24.83 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.376 -0.828 . . . . 18.04 110.272 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 362' ' ' ILE . . . . . 0.427 HG23 ' CZ ' ' S' ' 367' ' ' PHE . 88.9 mt -95.6 83.63 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.353 -0.842 . . . . 15.64 110.023 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' S' S ' 363' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' S' ' 365' ' ' GLU . 11.8 t0 -75.18 94.46 2.96 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.364 -0.835 . . . . 35.03 110.208 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' S' S ' 364' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 53.95 -89.39 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.543 -0.723 . . . . 46.72 110.524 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 365' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' S' ' 363' ' ' ASP . 23.8 mt-10 -122.64 19.11 10.36 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.058 -1.026 . . . . 56.2 110.233 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' S' S ' 366' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -118.01 125.06 49.63 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.231 -0.918 . . . . 51.02 110.368 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 367' ' ' PHE . . . . . 0.427 ' CZ ' HG23 ' S' ' 362' ' ' ILE . 26.9 m-85 -107.06 127.08 53.15 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.321 -0.862 . . . . 37.59 110.101 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' S' S ' 368' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -165.44 159.55 13.88 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.3 -0.875 . . . . 31.47 110.427 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 369' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.83 139.63 30.75 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 O-C-N 123.872 1.459 . . . . 28.85 110.535 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 370' ' ' TRP . . . . . . . . . . . . . 67.4 t90 -167.24 113.5 0.76 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.362 -0.836 . . . . 26.94 110.007 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 371' ' ' THR . . . . . . . . . . . . . 59.4 m -74.74 113.03 20.4 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.433 -0.792 . . . . 20.19 110.057 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 372' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -73.55 157.09 49.25 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 O-C-N 123.609 1.32 . . . . 28.68 110.583 -179.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 373' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -90.57 147.13 35.72 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.415 -0.803 . . . . 35.72 109.93 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 374' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -76.03 -6.23 17.13 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.676 1.356 . . . . 30.89 110.534 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 375' ' ' SER . . . . . . . . . . . . . 69.4 p -104.39 -17.01 14.95 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.209 -0.932 . . . . 29.41 110.414 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 376' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -106.45 42.98 1.19 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.348 -0.845 . . . . 32.89 110.24 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 377' ' ' VAL . . . . . 0.497 HG23 ' CE1' ' S' ' 342' ' ' PHE . 7.3 p -114.63 147.31 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.253 -0.905 . . . . 24.33 110.2 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' S' S ' 378' ' ' LEU . . . . . . . . . . . . . 52.2 mt -116.01 -58.02 2.15 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.426 -0.796 . . . . 24.37 109.626 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 379' ' ' VAL . . . . . . . . . . . . . 61.5 t -120.7 132.42 70.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.437 -0.789 . . . . 18.02 109.385 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 380' ' ' PHE . . . . . 0.459 ' CE1' ' HB2' ' S' ' 325' ' ' CYS . 14.5 p90 -142.59 173.92 11.11 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.427 -0.796 . . . . 29.35 110.675 -179.3 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' S' S ' 381' ' ' VAL . . . . . . . . . . . . . 58.1 t -120.03 107.36 39.92 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.512 -0.743 . . . . 16.34 109.413 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 382' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -71.31 145.63 48.9 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.68 1.358 . . . . 20.94 110.803 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' S' S ' 383' ' ' TYR . . . . . 0.978 ' O ' ' CB ' ' S' ' 384' ' ' ASP . 88.3 m-85 -61.11 -53.43 57.12 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.405 -0.809 . . . . 28.93 109.838 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' S' S ' 384' ' ' ASP . . . . . 0.978 ' CB ' ' O ' ' S' ' 383' ' ' TYR . 13.3 t70 112.65 111.0 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.433 -0.792 . . . . 47.03 110.36 178.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' S' S ' 385' ' ' GLN . . . . . 0.525 ' HB2' ' O ' ' S' ' 384' ' ' ASP . 17.6 tt0 176.62 -33.21 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.462 -0.774 . . . . 46.69 110.197 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' S' S ' 386' ' ' GLU . . . . . 0.509 ' C ' ' H ' ' S' ' 388' ' ' LEU . 2.4 mt-10 -142.4 135.81 14.26 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.337 -0.852 . . . . 50.25 109.595 179.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' S' S ' 387' ' ' PRO . . . . . 0.627 ' O ' ' C ' ' S' ' 388' ' ' LEU . 52.1 Cg_endo -71.71 33.45 0.26 Allowed 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.67 1.352 . . . . 34.39 110.582 -178.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' S' S ' 388' ' ' LEU . . . . . 0.627 ' C ' ' O ' ' S' ' 387' ' ' PRO . 16.3 mt 24.16 95.83 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.489 -0.757 . . . . 38.01 110.099 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' S' S ' 389' ' ' ASN . . . . . 0.619 ' CG ' ' O ' ' S' ' 388' ' ' LEU . 8.1 p30 46.76 -167.99 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.4 -0.812 . . . . 45.82 110.157 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' S' S ' 390' ' ' GLY . . . . . 0.597 ' HA2' ' CE2' ' S' ' 392' ' ' TRP . . . 122.48 46.41 0.29 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.597 -1.401 . . . . 33.46 109.597 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' S' S ' 391' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.3 -42.16 99.13 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.352 -1.087 . . . . 56.58 110.166 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' S' S ' 392' ' ' TRP . . . . . 0.597 ' CE2' ' HA2' ' S' ' 390' ' ' GLY . 1.8 p90 -51.97 -24.41 6.46 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.354 -0.841 . . . . 31.43 110.346 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' S' S ' 393' ' ' LYS . . . . . 0.433 ' N ' ' CD1' ' S' ' 392' ' ' TRP . 16.8 tttt -43.76 -50.69 7.63 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.289 -0.882 . . . . 39.42 110.375 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' S' S ' 394' ' ' ALA . . . . . 0.455 ' O ' ' HD3' ' S' ' 398' ' ' ARG . . . -70.43 -29.06 65.56 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.272 -0.892 . . . . 34.33 110.081 178.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' S' S ' 395' ' ' LYS . . . . . 0.693 ' C ' ' NH1' ' S' ' 398' ' ' ARG . 0.2 OUTLIER -73.04 4.41 4.33 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.429 -0.795 . . . . 60.09 110.214 179.193 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' S' S ' 396' ' ' VAL . . . . . 0.751 ' O ' ' HA ' ' R' ' 99' ' ' PRO . 34.4 t -111.14 -47.82 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.325 -0.859 . . . . 35.5 110.553 179.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' S' S ' 397' ' ' GLN . . . . . 0.481 ' C ' ' HG3' ' S' ' 398' ' ' ARG . 21.5 tt0 -109.66 117.51 34.12 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.182 -0.949 . . . . 49.96 110.623 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' S' S ' 398' ' ' ARG . . . . . 0.697 ' CB ' ' HA ' ' R' ' 147' ' ' GLU . 76.2 mtm-85 -151.13 -149.67 0.31 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.266 -0.896 . . . . 43.42 110.73 -179.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' S' S ' 399' ' ' LYS . . . . . 0.616 ' C ' ' H ' ' S' ' 401' ' ' LYS . 11.3 mtpp -94.87 -88.63 0.25 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.381 -0.824 . . . . 55.31 110.058 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' S' S ' 400' ' ' LEU . . . . . 0.635 ' O ' ' HA ' ' R' ' 148' ' ' HIS . 8.4 mt -64.92 28.15 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.344 -0.848 . . . . 41.03 110.32 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' S' S ' 401' ' ' LYS . . . . . 0.662 ' HE3' ' HB3' ' R' ' 149' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.652 0 O-C-N 121.315 -0.865 . . . . 61.97 110.212 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 29' ' ' MET . . . . . . . . . . . . . 21.6 mtm . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.202 0.525 . . . . 32.14 110.252 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' R' R ' 30' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -96.34 141.19 29.96 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.358 -0.838 . . . . 43.36 110.212 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 31' ' ' LEU . . . . . . . . . . . . . 65.7 mt -134.86 140.65 45.98 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.286 -0.884 . . . . 22.93 110.306 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 32' ' ' THR . . . . . . . . . . . . . 69.1 m -87.61 110.51 20.43 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.433 -0.792 . . . . 22.34 109.962 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 33' ' ' LEU . . . . . 0.462 HD23 ' CE2' ' R' ' 62' ' ' TYR . 80.1 mt -62.35 -172.79 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.316 -0.865 . . . . 21.39 110.226 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 34' ' ' TYR . . . . . . . . . . . . . 37.0 p90 -74.65 -29.41 61.25 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.333 -0.855 . . . . 34.4 110.386 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 35' ' ' ASN . . . . . . . . . . . . . 48.3 p30 -77.79 -1.83 33.39 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.314 -0.866 . . . . 30.28 110.643 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.25 -16.56 59.48 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.784 -1.326 . . . . 36.25 109.784 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 37' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -59.04 161.79 4.82 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.373 -1.075 . . . . 53.8 110.405 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 38' ' ' LYS . . . . . . . . . . . . . 57.2 mttt -117.8 135.7 53.9 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.405 -0.809 . . . . 49.91 110.19 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 39' ' ' LYS . . . . . 0.415 ' HG2' ' CZ ' ' R' ' 41' ' ' PHE . 8.1 ttmt -138.73 143.66 39.17 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.319 -0.863 . . . . 35.69 110.235 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 40' ' ' THR . . . . . . . . . . . . . 23.4 m -102.56 127.91 49.43 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.287 -0.883 . . . . 34.84 110.308 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 41' ' ' PHE . . . . . 0.415 ' CZ ' ' HG2' ' R' ' 39' ' ' LYS . 96.6 m-85 -113.04 132.6 55.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.413 -0.804 . . . . 34.42 110.179 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 42' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -93.24 140.95 28.98 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.348 -0.845 . . . . 51.46 110.204 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 43' ' ' SER . . . . . . . . . . . . . 54.2 m -70.81 141.9 51.33 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.453 -0.779 . . . . 41.84 110.206 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.76 125.39 29.55 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.308 -0.87 . . . . 33.82 109.962 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 45' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.15 151.06 54.8 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.563 1.297 . . . . 30.27 110.66 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 46' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.28 109.92 13.97 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.415 -0.803 . . . . 35.1 109.999 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 47' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -120.34 -34.88 3.54 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.367 -0.833 . . . . 42.81 110.489 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 48' ' ' HIS . . . . . . . . . . . . . 73.3 m80 -105.76 45.23 0.98 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.328 -0.857 . . . . 49.97 110.263 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 49' ' ' ASP . . . . . 0.477 ' OD1' ' CA ' ' S' ' 401' ' ' LYS . 37.6 m-20 50.27 34.68 9.16 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.345 -0.847 . . . . 61.32 110.199 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 50' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -86.29 43.8 1.09 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.426 -0.796 . . . . 51.5 110.706 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 51' ' ' ALA . . . . . 0.651 ' CB ' ' HB2' ' S' ' 400' ' ' LEU . . . -66.11 -46.14 78.65 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.325 -0.86 . . . . 38.77 109.502 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 52' ' ' TRP . . . . . 0.483 ' CD2' ' N ' ' R' ' 53' ' ' LEU . 68.2 p-90 -58.35 -38.43 77.18 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.504 -0.747 . . . . 26.24 110.055 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 53' ' ' LEU . . . . . 0.483 ' N ' ' CD2' ' R' ' 52' ' ' TRP . 23.1 tp -66.68 -46.72 74.72 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.362 -0.836 . . . . 26.75 109.958 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 54' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -55.15 -41.66 72.11 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.341 -0.85 . . . . 35.02 110.14 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.24 -46.04 92.03 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.369 -0.832 . . . . 24.47 110.141 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 56' ' ' ILE . . . . . . . . . . . . . 76.1 mt -62.1 -42.32 94.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.213 -0.93 . . . . 26.03 109.92 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 57' ' ' LEU . . . . . . . . . . . . . 22.4 mt -60.31 -45.63 92.71 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.336 -0.853 . . . . 26.77 109.68 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 58' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -63.92 -46.48 84.59 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.521 -0.737 . . . . 22.32 109.594 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 59' ' ' LEU . . . . . 0.43 ' HA ' ' HE2' ' R' ' 151' ' ' PHE . 23.9 tp -61.45 -37.74 84.65 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.337 -0.852 . . . . 20.55 109.373 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 60' ' ' PHE . . . . . 0.447 ' CE2' HD22 ' R' ' 111' ' ' LEU . 2.8 m-85 -61.04 -44.84 96.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.628 -0.67 . . . . 20.08 109.921 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 61' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -63.0 -36.22 82.83 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.504 -0.747 . . . . 18.8 110.532 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 62' ' ' TYR . . . . . 0.462 ' CE2' HD23 ' R' ' 33' ' ' LEU . 9.2 t80 -63.16 -41.73 99.31 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.157 -0.964 . . . . 26.45 110.213 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 63' ' ' VAL . . . . . . . . . . . . . 30.4 m -93.34 20.3 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.199 -0.938 . . . . 29.75 110.185 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 64' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 52.94 75.56 0.24 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.369 -0.832 . . . . 35.52 110.556 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 65' ' ' GLU . . . . . 0.423 ' HG2' ' CD2' ' R' ' 60' ' ' PHE . 14.3 tp10 -116.29 104.02 52.38 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.424 -0.797 . . . . 29.89 109.866 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 66' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.48 -5.89 17.86 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.708 1.372 . . . . 21.37 111.109 -179.556 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 67' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -52.09 -61.52 2.21 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.144 -0.973 . . . . 23.85 110.375 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 68' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -98.11 36.51 1.56 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.312 -0.867 . . . . 28.07 110.512 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 69' ' ' ASP . . . . . . . . . . . . . 11.8 t0 -72.33 -33.23 67.18 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.296 -0.878 . . . . 43.76 110.18 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 70' ' ' TRP . . . . . 0.475 ' CE2' ' CG2' ' R' ' 71' ' ' VAL . 47.9 p-90 -73.4 -3.94 30.46 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.29 -0.881 . . . . 33.06 110.7 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 71' ' ' VAL . . . . . 0.475 ' CG2' ' CE2' ' R' ' 70' ' ' TRP . 40.9 t -109.75 -27.45 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.23 -0.919 . . . . 31.7 109.647 179.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 72' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -86.58 -48.84 7.99 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.407 -0.808 . . . . 33.58 110.294 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 73' ' ' SER . . . . . . . . . . . . . 69.9 m -89.63 50.96 1.99 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.338 -0.851 . . . . 50.82 110.379 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 74' ' ' SER . . . . . . . . . . . . . 16.0 t -125.82 138.32 31.77 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.226 -0.921 . . . . 34.74 110.265 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.33 -24.98 16.01 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.672 1.354 . . . . 35.7 110.336 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 76' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -91.71 153.2 19.8 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.476 -0.765 . . . . 66.48 110.343 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 77' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -81.47 95.26 7.03 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.298 -0.876 . . . . 46.72 110.114 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 78' ' ' LEU . . . . . . . . . . . . . 96.3 mt -96.43 27.93 3.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.338 -0.851 . . . . 37.55 110.191 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 79' ' ' THR . . . . . . . . . . . . . 29.5 m -56.2 -54.65 42.65 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.329 -0.857 . . . . 37.36 110.295 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 80' ' ' LEU . . . . . . . . . . . . . 15.9 mt -60.81 -23.29 64.95 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.337 -0.852 . . . . 35.83 110.549 -179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 81' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -79.5 -39.12 32.82 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.229 -0.919 . . . . 44.03 110.321 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.49 -28.6 66.2 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.224 -0.923 . . . . 32.54 110.256 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 83' ' ' ILE . . . . . . . . . . . . . 78.2 mt -70.16 -46.12 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.308 -0.87 . . . . 32.02 110.302 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 84' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -55.15 -52.08 64.42 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.193 -0.942 . . . . 34.09 110.611 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 85' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -54.83 -46.85 74.64 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.206 -0.934 . . . . 25.94 110.249 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 86' ' ' LEU . . . . . . . . . . . . . 24.0 mt -58.7 -43.81 90.17 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.332 -0.855 . . . . 16.2 109.91 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 87' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -65.38 -35.17 80.16 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.391 -0.818 . . . . 49.09 110.251 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 88' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -78.48 -19.08 53.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.345 -0.847 . . . . 28.61 110.522 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 89' ' ' LEU . . . . . . . . . . . . . 32.7 mt -96.15 -29.4 14.09 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.304 -0.872 . . . . 26.16 110.22 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 90' ' ' THR . . . . . . . . . . . . . 60.4 p -105.7 -34.55 7.67 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.284 -0.885 . . . . 33.33 109.763 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.77 16.18 58.6 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.862 -1.295 . . . . 31.13 109.862 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 92' ' ' LEU . . . . . . . . . . . . . 97.1 mt -100.18 155.19 17.89 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.213 -1.169 . . . . 42.52 110.229 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 93' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -86.17 91.64 8.51 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.567 -0.708 . . . . 68.46 110.038 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 94' ' ' LEU . . . . . 0.447 ' HB3' ' CZ2' ' R' ' 52' ' ' TRP . 48.3 mt -99.46 53.0 0.94 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.289 -0.882 . . . . 44.63 110.33 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 95' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.44 -38.71 6.38 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.3 -0.875 . . . . 67.16 110.395 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 96' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -113.9 44.32 1.66 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.364 -0.835 . . . . 67.02 110.238 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 97' ' ' GLY . . . . . 0.59 ' HA3' ' CB ' ' S' ' 399' ' ' LYS . . . 99.12 150.78 26.03 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.634 -1.387 . . . . 49.48 109.634 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 98' ' ' GLY . . . . . . . . . . . . . . . -166.22 160.07 33.5 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.294 -1.522 . . . . 36.57 109.294 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 99' ' ' PRO . . . . . 0.888 ' HA ' ' O ' ' S' ' 396' ' ' VAL . 45.7 Cg_endo -72.59 121.07 7.1 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.645 1.34 . . . . 30.41 110.413 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 100' ' ' PRO . . . . . 0.432 ' HD3' ' NH1' ' S' ' 398' ' ' ARG . 45.8 Cg_endo -72.25 -31.67 11.48 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 O-C-N 123.645 1.339 . . . . 29.94 110.53 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 101' ' ' ALA . . . . . 0.45 ' HB2' HG22 ' S' ' 396' ' ' VAL . . . -70.02 -38.4 75.91 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.226 -0.921 . . . . 23.64 110.233 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.67 -40.71 66.07 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.358 -0.839 . . . . 20.31 110.386 -179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 103' ' ' VAL . . . . . . . . . . . . . 64.3 t -58.25 -40.02 76.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.195 -0.941 . . . . 16.33 109.984 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 104' ' ' ILE . . . . . . . . . . . . . 81.6 mt -71.68 -30.6 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.397 -0.814 . . . . 24.77 109.966 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 105' ' ' TRP . . . . . 0.441 ' O ' ' HD3' ' R' ' 108' ' ' LYS . 70.5 t-105 -82.41 0.85 40.15 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.292 -0.88 . . . . 23.28 110.31 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 106' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -105.07 -10.35 17.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.171 -0.956 . . . . 28.26 110.118 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 107' ' ' ILE . . . . . . . . . . . . . 36.7 pt -126.88 35.08 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.254 -0.904 . . . . 18.77 109.966 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 108' ' ' LYS . . . . . 0.481 ' HG2' ' HB ' ' R' ' 115' ' ' ILE . 9.2 mtpp -61.12 -48.41 81.78 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.56 -0.713 . . . . 42.5 110.049 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 109' ' ' HIS . . . . . 0.432 ' CD2' ' HG ' ' R' ' 110' ' ' LEU . 50.8 p-80 -66.02 -12.85 58.07 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.456 -0.777 . . . . 20.07 110.698 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 110' ' ' LEU . . . . . 0.432 ' HG ' ' CD2' ' R' ' 109' ' ' HIS . 80.3 mt -94.79 -17.25 22.31 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.076 -1.015 . . . . 15.69 110.207 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 111' ' ' LEU . . . . . 0.447 HD22 ' CE2' ' R' ' 60' ' ' PHE . 10.3 mt -94.13 144.16 25.74 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.342 -0.849 . . . . 25.39 111.014 -179.177 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 112' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -77.71 -17.36 57.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.51 -0.744 . . . . 53.48 109.846 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 113' ' ' THR . . . . . 0.416 HG22 ' HG2' ' R' ' 123' ' ' GLU . 59.8 m -83.76 166.67 17.83 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.273 -0.892 . . . . 14.8 110.193 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 114' ' ' GLY . . . . . . . . . . . . . . . -97.99 127.1 9.11 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.042 -1.223 . . . . 16.14 110.042 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 115' ' ' ILE . . . . . 0.481 ' HB ' ' HG2' ' R' ' 108' ' ' LYS . 47.7 mm -109.01 139.46 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.503 -0.998 . . . . 13.46 109.674 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 116' ' ' GLY . . . . . . . . . . . . . . . -152.84 -155.89 7.31 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.932 -1.267 . . . . 23.9 109.932 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 117' ' ' THR . . . . . . . . . . . . . 18.5 p -135.03 -171.39 2.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.451 -1.029 . . . . 27.37 110.079 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.52 -58.14 9.32 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.246 -0.909 . . . . 18.76 110.074 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 119' ' ' SER . . . . . 0.5 ' CB ' ' HB ' ' R' ' 196' ' ' VAL . 1.2 m -56.51 -40.48 75.09 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.351 -0.843 . . . . 32.35 109.838 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 120' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 -110.12 86.21 4.9 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.411 -0.806 . . . . 27.12 109.69 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 121' ' ' PRO . . . . . 0.426 ' O ' ' HB2' ' R' ' 122' ' ' SER . 44.0 Cg_endo -71.26 166.49 29.09 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 O-C-N 123.903 1.475 . . . . 22.68 111.035 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 122' ' ' SER . . . . . 0.426 ' HB2' ' O ' ' R' ' 121' ' ' PRO . 38.6 t 178.55 -161.7 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.609 -0.682 . . . . 22.99 109.455 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 123' ' ' GLU . . . . . 0.416 ' HG2' HG22 ' R' ' 113' ' ' THR . 2.3 tp10 -56.44 -40.01 74.06 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.216 -0.928 . . . . 36.18 109.63 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 124' ' ' VAL . . . . . . . . . . . . . 82.2 t -142.5 136.4 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.62 -0.675 . . . . 20.64 109.457 179.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 125' ' ' CYS . . . . . 0.409 ' SG ' ' HA ' ' R' ' 121' ' ' PRO . 83.0 m -140.23 168.21 20.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.193 -0.942 . . . . 22.8 111.206 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 126' ' ' VAL . . . . . . . . . . . . . 35.9 m -122.78 159.72 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.733 -0.604 . . . . 21.24 109.574 179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 127' ' ' VAL . . . . . 0.4 ' CG1' ' O ' ' R' ' 177' ' ' VAL . 30.4 m -70.76 141.82 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.305 -0.872 . . . . 19.77 110.734 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 128' ' ' ASP . . . . . . . . . . . . . 53.8 p-10 -137.74 19.41 2.87 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.417 -0.802 . . . . 29.21 110.66 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 129' ' ' GLY . . . . . . . . . . . . . . . 114.0 0.04 24.14 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.939 -1.124 . . . . 33.86 110.527 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 130' ' ' THR . . . . . . . . . . . . . 58.4 m -91.94 131.81 36.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.135 -1.215 . . . . 26.41 110.046 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -62.43 120.64 11.46 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.317 -0.865 . . . . 33.08 110.336 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 132' ' ' MET . . . . . 0.426 ' HE1' ' CZ ' ' R' ' 180' ' ' PHE . 98.5 mmm -105.24 165.64 10.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.482 -0.761 . . . . 30.76 110.409 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 133' ' ' CYS . . . . . . . . . . . . . 32.2 m -141.12 158.23 44.2 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.451 -0.78 . . . . 27.0 109.956 179.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 134' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.53 -19.74 40.24 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.232 -0.918 . . . . 33.9 110.515 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 135' ' ' ALA . . . . . . . . . . . . . . . -92.66 8.11 40.55 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.344 -0.848 . . . . 19.37 110.833 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 136' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -93.7 -21.88 19.08 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.165 -0.96 . . . . 30.47 110.178 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 137' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -149.91 165.3 33.01 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.351 -0.843 . . . . 24.27 110.241 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 138' ' ' HIS . . . . . . . . . . . . . 15.1 p80 -117.79 15.18 14.41 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.422 -0.798 . . . . 20.91 110.417 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 139' ' ' ALA . . . . . 0.44 ' HA ' ' O ' ' R' ' 152' ' ' ALA . . . -177.23 152.4 0.87 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.187 -0.946 . . . . 15.69 110.157 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 140' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' R' ' 179' ' ' VAL . . . 161.83 175.09 32.49 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.881 -1.288 . . . . 23.76 109.881 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 141' ' ' ILE . . . . . . . . . . . . . 83.7 mt -95.5 136.63 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.435 -1.038 . . . . 25.3 109.691 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 142' ' ' PHE . . . . . 0.546 ' CD2' ' HB2' ' R' ' 172' ' ' PRO . 82.9 m-85 -120.77 -172.66 2.43 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.27 -0.894 . . . . 30.24 110.524 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 143' ' ' LEU . . . . . 0.629 HD21 ' HD2' ' S' ' 398' ' ' ARG . 0.5 OUTLIER -119.78 77.73 1.26 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.426 -0.796 . . . . 32.8 110.295 -179.879 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' R' R ' 144' ' ' LYS . . . . . 0.453 ' HG3' ' CZ2' ' R' ' 170' ' ' TRP . 1.0 OUTLIER -69.55 76.78 0.42 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.437 -0.789 . . . . 49.18 109.68 179.541 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' R' R ' 145' ' ' GLY . . . . . . . . . . . . . . . 104.62 179.24 24.71 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.139 -1.584 . . . . 53.87 109.139 -179.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 146' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -88.46 145.83 25.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.388 -1.066 . . . . 68.58 110.053 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 147' ' ' GLU . . . . . 0.705 ' HA ' ' HB2' ' S' ' 398' ' ' ARG . 10.9 mt-10 58.27 36.46 25.66 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.256 -0.902 . . . . 56.62 110.611 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 148' ' ' HIS . . . . . 0.51 ' ND1' HD21 ' S' ' 400' ' ' LEU . 44.6 t60 -158.58 148.14 19.33 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.205 -0.934 . . . . 44.57 110.422 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 149' ' ' ALA . . . . . 0.594 ' HB3' ' HD3' ' S' ' 398' ' ' ARG . . . -150.27 146.83 27.02 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.467 -0.771 . . . . 33.54 110.082 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 150' ' ' VAL . . . . . 0.428 HG23 ' HB2' ' R' ' 144' ' ' LYS . 34.2 m -142.28 161.54 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.231 -0.918 . . . . 27.61 110.309 179.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 151' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' R' ' 152' ' ' ALA . 5.8 t80 -86.21 155.53 20.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.4 -0.812 . . . . 23.04 109.907 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 152' ' ' ALA . . . . . 0.537 ' N ' ' CD1' ' R' ' 151' ' ' PHE . . . -157.22 151.53 25.05 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.499 -0.75 . . . . 29.61 109.565 179.05 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 153' ' ' CYS . . . . . 0.407 ' HA ' ' HA ' ' R' ' 139' ' ' ALA . 26.7 p -154.33 173.54 16.04 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.234 -0.916 . . . . 22.75 110.556 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 154' ' ' VAL . . . . . 0.442 ' CG2' ' CZ2' ' R' ' 159' ' ' TRP . 60.0 t -90.56 116.97 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.443 -0.785 . . . . 23.26 110.078 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 155' ' ' THR . . . . . . . . . . . . . 70.7 p -112.08 -176.65 2.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.347 -0.846 . . . . 17.88 110.034 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 156' ' ' SER . . . . . . . . . . . . . 78.5 p -75.98 -3.64 36.72 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.329 -0.857 . . . . 21.83 110.697 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 157' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -118.32 10.48 12.8 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.159 -0.963 . . . . 36.54 110.603 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 158' ' ' GLY . . . . . . . . . . . . . . . 117.99 -162.62 13.05 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.547 -1.421 . . . . 31.74 109.547 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 159' ' ' TRP . . . . . 0.442 ' CZ2' ' CG2' ' R' ' 154' ' ' VAL . 14.8 m95 -86.6 122.4 30.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.285 -1.127 . . . . 28.25 110.092 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 160' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -108.4 167.01 10.34 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.448 -0.783 . . . . 41.24 110.212 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 161' ' ' ALA . . . . . . . . . . . . . . . -143.24 123.43 13.72 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.355 -0.841 . . . . 27.4 110.208 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 162' ' ' ILE . . . . . 0.431 HG23 ' CZ ' ' R' ' 167' ' ' PHE . 92.1 mt -87.6 81.17 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.362 -0.837 . . . . 24.27 110.078 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 163' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' R' ' 165' ' ' GLU . 15.4 t0 -72.92 92.36 1.62 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.438 -0.789 . . . . 36.08 110.246 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 164' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 54.13 -88.94 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.542 -0.724 . . . . 46.08 110.565 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 165' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' R' ' 163' ' ' ASP . 29.6 mt-10 -124.75 36.01 4.68 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.052 -1.03 . . . . 50.94 110.199 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 166' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -135.8 117.32 14.82 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.397 -0.814 . . . . 47.28 110.324 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 167' ' ' PHE . . . . . 0.431 ' CZ ' HG23 ' R' ' 162' ' ' ILE . 24.3 m-85 -100.98 119.95 39.48 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.434 -0.791 . . . . 40.47 110.134 179.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 168' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -157.6 158.54 30.6 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.29 -0.881 . . . . 30.21 110.399 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 169' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.8 133.04 19.46 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.931 1.49 . . . . 32.76 110.474 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 170' ' ' TRP . . . . . 0.453 ' CZ2' ' HG3' ' R' ' 144' ' ' LYS . 67.0 t90 -159.78 119.3 2.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.416 -0.802 . . . . 32.79 109.928 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 171' ' ' THR . . . . . . . . . . . . . 46.6 m -81.06 112.6 33.95 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.437 -0.789 . . . . 36.92 110.184 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 172' ' ' PRO . . . . . 0.546 ' HB2' ' CD2' ' R' ' 142' ' ' PHE . 47.2 Cg_endo -73.74 158.83 46.48 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.66 1.348 . . . . 33.54 110.519 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 173' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -88.84 144.97 33.85 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.362 -0.836 . . . . 45.76 109.911 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 174' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.73 -10.41 26.44 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 O-C-N 123.675 1.355 . . . . 29.63 110.499 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 175' ' ' SER . . . . . . . . . . . . . 53.1 p -103.48 -17.47 15.2 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.299 -0.876 . . . . 35.7 110.369 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 176' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -103.5 43.19 1.1 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.24 -0.913 . . . . 39.65 110.423 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 177' ' ' VAL . . . . . 0.4 ' O ' ' CG1' ' R' ' 127' ' ' VAL . 10.5 p -117.72 127.17 75.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.368 -0.832 . . . . 20.61 110.041 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 178' ' ' LEU . . . . . . . . . . . . . 45.9 mt -91.5 -61.23 1.69 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.424 -0.798 . . . . 15.58 109.464 179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 179' ' ' VAL . . . . . 0.403 ' O ' ' HA3' ' R' ' 140' ' ' GLY . 67.4 t -114.6 144.7 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.579 -0.7 . . . . 17.4 109.443 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 180' ' ' PHE . . . . . 0.426 ' CZ ' ' HE1' ' R' ' 132' ' ' MET . 43.4 p90 -152.11 163.37 39.48 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.273 -0.892 . . . . 20.16 110.562 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 181' ' ' VAL . . . . . . . . . . . . . 66.9 t -113.2 111.49 50.17 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.468 -0.77 . . . . 17.69 109.795 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 182' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.03 149.51 52.86 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.577 1.304 . . . . 17.81 110.423 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 183' ' ' TYR . . . . . 0.706 ' O ' ' C ' ' R' ' 184' ' ' ASP . 79.0 m-85 -59.01 175.54 0.28 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.459 -0.775 . . . . 28.01 110.549 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 184' ' ' ASP . . . . . 0.706 ' C ' ' O ' ' R' ' 183' ' ' TYR . 6.0 t70 -18.36 -82.2 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.3 -0.875 . . . . 58.64 110.232 -178.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 185' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 . . . . . 0 N--CA 1.504 2.232 0 CA-C-O 121.272 0.558 . . . . 80.42 111.721 179.566 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' R' R ' 193' ' ' LYS . . . . . . . . . . . . . 15.0 pttt . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 120.898 0.38 . . . . 49.5 110.157 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' R' R ' 194' ' ' ALA . . . . . . . . . . . . . . . -169.84 -163.95 0.4 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.144 -0.973 . . . . 40.4 110.156 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 195' ' ' LYS . . . . . . . . . . . . . 20.4 mtpp -74.88 -66.33 0.76 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.416 -0.802 . . . . 34.6 110.304 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 196' ' ' VAL . . . . . 0.5 ' HB ' ' CB ' ' R' ' 119' ' ' SER . 35.0 t -81.37 63.16 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.279 -0.888 . . . . 33.27 110.601 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 197' ' ' GLN . . . . . 0.534 ' HG3' ' O ' ' R' ' 197' ' ' GLN . 11.5 tp60 -168.24 25.19 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.147 -0.971 . . . . 41.58 110.725 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 198' ' ' ARG . . . . . . . . . . . . . 20.2 mtp180 -123.89 164.99 18.15 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.073 -1.017 . . . . 38.65 110.22 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 199' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.34 70.94 1.53 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.391 -0.818 . . . . 36.77 109.909 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' R' R ' 200' ' ' LEU . . . . . . . . . . . . . 4.3 mp -64.55 -168.84 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.387 -0.82 . . . . 33.08 110.132 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' R' R ' 201' ' ' LYS . . . . . 0.53 ' HA ' ' HA3' ' S' ' 297' ' ' GLY . 26.3 mmtt . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.309 -0.869 . . . . 44.32 110.305 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 229' ' ' MET . . . . . . . . . . . . . 5.8 mtm . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 121.176 0.513 . . . . 51.83 110.191 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' S' S ' 230' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -97.27 142.73 28.8 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.318 -0.864 . . . . 54.13 110.161 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 231' ' ' LEU . . . . . . . . . . . . . 67.9 mt -134.12 141.04 46.98 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.391 -0.818 . . . . 33.04 110.343 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 232' ' ' THR . . . . . . . . . . . . . 40.7 m -89.26 103.26 15.9 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.381 -0.824 . . . . 26.92 110.04 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 233' ' ' LEU . . . . . 0.498 HD23 ' CE2' ' S' ' 262' ' ' TYR . 79.9 mt -56.0 179.31 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.43 -0.794 . . . . 13.78 110.463 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' S' S ' 234' ' ' TYR . . . . . 0.446 ' CG ' ' N ' ' S' ' 235' ' ' ASN . 35.6 p90 -65.02 -35.69 81.99 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.361 -0.837 . . . . 26.08 110.148 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' S' S ' 235' ' ' ASN . . . . . 0.446 ' N ' ' CG ' ' S' ' 234' ' ' TYR . 50.7 p30 -74.3 -7.44 52.78 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.428 -0.795 . . . . 20.04 110.596 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' S' S ' 236' ' ' GLY . . . . . . . . . . . . . . . 95.76 -19.92 52.15 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.781 -1.328 . . . . 22.71 109.781 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 237' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -52.98 145.65 12.48 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.18 -1.188 . . . . 35.44 110.276 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 238' ' ' LYS . . . . . . . . . . . . . 44.4 mttt -102.18 127.91 48.91 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.396 -0.815 . . . . 32.56 110.434 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 239' ' ' LYS . . . . . 0.414 ' HG2' ' CZ ' ' S' ' 241' ' ' PHE . 9.0 ttmt -132.26 144.54 50.68 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.391 -0.818 . . . . 26.68 110.004 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' S' S ' 240' ' ' THR . . . . . . . . . . . . . 51.9 m -102.02 132.2 48.01 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.307 -0.871 . . . . 41.02 110.355 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 241' ' ' PHE . . . . . 0.414 ' CZ ' ' HG2' ' S' ' 239' ' ' LYS . 96.1 m-85 -117.91 137.62 52.69 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.379 -0.826 . . . . 28.62 110.253 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' S' S ' 242' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -96.35 161.83 13.76 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.34 -0.85 . . . . 47.89 110.188 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 243' ' ' SER . . . . . . . . . . . . . 72.1 m -90.57 151.56 21.27 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.29 -0.881 . . . . 45.09 110.29 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 244' ' ' ARG . . . . . . . . . . . . . 1.4 mtp85 -129.77 126.73 22.7 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.416 -0.802 . . . . 42.49 110.263 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 245' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.35 160.98 43.77 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.617 1.325 . . . . 35.68 110.551 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 246' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -132.84 97.77 4.13 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.325 -0.859 . . . . 51.88 109.873 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 247' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -110.45 -22.24 11.77 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.32 -0.863 . . . . 53.69 110.649 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 248' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -117.26 43.67 2.27 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.182 -0.949 . . . . 55.79 110.708 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 249' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 48.78 38.46 11.88 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.485 -0.759 . . . . 49.45 110.363 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 250' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -90.57 28.95 1.38 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.552 -0.717 . . . . 36.86 110.325 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 251' ' ' ALA . . . . . . . . . . . . . . . -53.79 -43.19 69.08 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.286 -0.884 . . . . 29.69 109.621 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 252' ' ' TRP . . . . . 0.416 ' CZ2' ' HB3' ' S' ' 294' ' ' LEU . 67.8 p-90 -61.82 -33.9 74.98 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.51 -0.744 . . . . 41.12 109.802 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' S' S ' 253' ' ' LEU . . . . . 0.402 ' N ' ' CD2' ' S' ' 252' ' ' TRP . 23.4 tp -70.15 -47.3 62.27 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.422 -0.799 . . . . 24.89 109.955 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' S' S ' 254' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -56.06 -42.43 76.61 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.308 -0.87 . . . . 35.65 110.031 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 255' ' ' ALA . . . . . . . . . . . . . . . -59.61 -48.19 82.63 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.427 -0.795 . . . . 22.73 110.042 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 256' ' ' ILE . . . . . . . . . . . . . 79.7 mt -62.35 -40.6 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.308 -0.87 . . . . 28.85 110.014 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 257' ' ' LEU . . . . . . . . . . . . . 19.4 mt -61.52 -44.49 96.97 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.286 -0.884 . . . . 23.07 110.216 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 258' ' ' GLN . . . . . 0.469 ' HB3' ' CD2' ' S' ' 351' ' ' PHE . 53.4 mm-40 -65.05 -45.35 85.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.382 -0.824 . . . . 29.78 109.947 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' S' S ' 259' ' ' LEU . . . . . 0.431 ' O ' HG22 ' S' ' 263' ' ' VAL . 19.8 tp -58.66 -36.41 74.11 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.299 -0.876 . . . . 17.94 109.405 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' S' S ' 260' ' ' PHE . . . . . 0.47 ' CE2' HD22 ' S' ' 311' ' ' LEU . 3.1 m-85 -62.86 -45.22 93.57 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.593 -0.692 . . . . 30.57 109.872 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' S' S ' 261' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -62.06 -29.81 70.55 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.383 -0.823 . . . . 41.34 109.995 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 262' ' ' TYR . . . . . 0.498 ' CE2' HD23 ' S' ' 233' ' ' LEU . 8.6 t80 -71.24 -44.59 65.02 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.37 -0.831 . . . . 26.03 110.086 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' S' S ' 263' ' ' VAL . . . . . 0.431 HG22 ' O ' ' S' ' 259' ' ' LEU . 33.2 m -92.1 18.34 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.417 -0.802 . . . . 22.8 110.35 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' S' S ' 264' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 52.78 70.67 0.55 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.292 -0.88 . . . . 44.03 110.59 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 265' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -111.8 109.18 55.45 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.375 -0.828 . . . . 35.61 109.622 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 266' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -75.25 0.39 9.06 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 123.65 1.342 . . . . 37.67 111.826 -179.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 267' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -56.52 -67.71 0.28 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.76 -1.213 . . . . 41.49 110.17 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' S' S ' 268' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -92.92 39.92 1.05 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.197 -0.939 . . . . 50.76 110.095 179.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 269' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.01 -33.17 59.67 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.428 -0.795 . . . . 61.86 109.795 179.533 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' S' S ' 270' ' ' TRP . . . . . 0.491 ' CE2' ' CG2' ' S' ' 271' ' ' VAL . 50.9 p-90 -73.96 -4.26 34.1 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.28 -0.888 . . . . 39.85 110.501 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' S' S ' 271' ' ' VAL . . . . . 0.491 ' CG2' ' CE2' ' S' ' 270' ' ' TRP . 46.4 t -109.48 -32.82 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.121 -0.987 . . . . 39.18 110.058 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' S' S ' 272' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -78.59 -36.57 44.14 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.327 -0.858 . . . . 40.02 110.538 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 273' ' ' SER . . . . . . . . . . . . . 71.2 m -103.51 56.11 0.74 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.267 -0.896 . . . . 47.2 110.388 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 274' ' ' SER . . . . . . . . . . . . . 6.9 t -133.04 141.25 40.24 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.298 -0.876 . . . . 47.61 110.129 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 275' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.7 -18.88 21.84 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 O-C-N 123.72 1.379 . . . . 45.28 110.533 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 276' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -99.94 140.89 33.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.294 -0.879 . . . . 57.27 110.314 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 277' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -71.75 97.7 1.82 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.387 -0.821 . . . . 37.28 110.254 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 278' ' ' LEU . . . . . . . . . . . . . 86.3 mt -97.03 33.84 1.84 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.382 -0.824 . . . . 43.88 110.001 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 279' ' ' THR . . . . . . . . . . . . . 76.4 m -63.99 -60.17 3.58 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.416 -0.802 . . . . 50.05 110.282 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 280' ' ' LEU . . . . . . . . . . . . . 13.7 mt -51.51 -39.99 58.7 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.32 -0.862 . . . . 54.12 110.283 179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 281' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.38 -49.64 74.74 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.435 -0.79 . . . . 65.28 110.161 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' S' S ' 282' ' ' ALA . . . . . . . . . . . . . . . -59.04 -33.9 71.3 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.438 -0.789 . . . . 46.51 110.499 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 283' ' ' ILE . . . . . . . . . . . . . 85.6 mt -66.25 -50.93 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.288 -0.883 . . . . 47.3 110.118 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 284' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -50.56 -57.56 7.85 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.388 -0.82 . . . . 50.72 110.405 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 285' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -51.41 -46.43 62.91 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.471 -0.768 . . . . 68.47 110.252 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 286' ' ' LEU . . . . . . . . . . . . . 19.1 mt -60.02 -44.49 94.57 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.403 -0.811 . . . . 36.62 110.202 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 287' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -62.71 -35.33 79.39 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.387 -0.82 . . . . 46.64 110.076 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 288' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -76.22 -21.04 56.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.353 -0.842 . . . . 46.45 110.292 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 289' ' ' LEU . . . . . . . . . . . . . 31.0 mt -97.29 -21.78 17.05 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.254 -0.904 . . . . 35.09 110.568 -179.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 290' ' ' THR . . . . . . . . . . . . . 81.3 p -114.76 -28.44 7.09 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.252 -0.905 . . . . 38.61 110.403 -179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 291' ' ' GLY . . . . . . . . . . . . . . . 79.37 10.96 85.44 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.847 -1.301 . . . . 36.77 109.847 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 292' ' ' LEU . . . . . . . . . . . . . 84.7 mt -96.43 145.82 25.32 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.271 -1.135 . . . . 35.33 109.803 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 293' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -77.36 102.39 6.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.163 -0.96 . . . . 48.7 110.257 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 294' ' ' LEU . . . . . 0.416 ' HB3' ' CZ2' ' S' ' 252' ' ' TRP . 56.2 mt -107.03 51.8 0.73 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.526 -0.734 . . . . 42.61 110.074 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' S' S ' 295' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -112.51 -11.21 13.64 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.343 -0.848 . . . . 55.49 110.523 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' S' S ' 296' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -144.33 48.62 1.36 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.123 -0.986 . . . . 75.68 110.291 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 297' ' ' GLY . . . . . 0.53 ' HA3' ' HA ' ' R' ' 201' ' ' LYS . . . 96.85 145.09 18.53 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.555 -1.418 . . . . 49.44 109.555 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' S' S ' 298' ' ' GLY . . . . . . . . . . . . . . . -163.77 157.03 29.14 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.77 -1.332 . . . . 41.11 109.77 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 299' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.91 118.31 5.38 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 123.917 1.483 . . . . 26.2 110.304 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 300' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.26 -15.43 31.63 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 O-C-N 123.616 1.324 . . . . 21.7 110.693 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 301' ' ' ALA . . . . . . . . . . . . . . . -80.75 -29.37 36.28 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.192 -0.942 . . . . 31.23 110.073 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 302' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.45 -40.72 18.93 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.409 -0.807 . . . . 38.99 109.969 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' S' S ' 303' ' ' VAL . . . . . 0.471 ' O ' HG12 ' S' ' 307' ' ' ILE . 58.0 t -60.67 -35.5 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.364 -0.835 . . . . 18.63 110.095 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' S' S ' 304' ' ' ILE . . . . . . . . . . . . . 86.1 mt -79.42 -23.58 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.431 -0.793 . . . . 25.46 110.153 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 305' ' ' TRP . . . . . . . . . . . . . 68.8 t-105 -88.69 -14.53 37.1 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.32 -0.862 . . . . 33.4 110.503 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 306' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -89.68 -13.62 36.56 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.168 -0.957 . . . . 36.97 110.378 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 307' ' ' ILE . . . . . 0.471 HG12 ' O ' ' S' ' 303' ' ' VAL . 36.9 pt -125.1 45.59 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.266 -0.896 . . . . 30.81 110.045 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' S' S ' 308' ' ' LYS . . . . . . . . . . . . . 1.5 mtmp? -73.5 -37.79 65.56 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.366 -0.834 . . . . 46.52 110.086 -179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 309' ' ' HIS . . . . . 0.488 ' CD2' ' HG ' ' S' ' 310' ' ' LEU . 55.5 p-80 -73.14 -8.38 55.51 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.284 -0.885 . . . . 51.03 110.097 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' S' S ' 310' ' ' LEU . . . . . 0.488 ' HG ' ' CD2' ' S' ' 309' ' ' HIS . 52.9 mt -99.25 -12.91 19.96 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.311 -0.868 . . . . 36.16 109.944 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' S' S ' 311' ' ' LEU . . . . . 0.47 HD22 ' CE2' ' S' ' 260' ' ' PHE . 10.8 mt -97.12 147.88 23.61 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.282 -0.886 . . . . 40.0 110.406 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' S' S ' 312' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -81.66 -16.3 51.79 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.28 -0.888 . . . . 54.18 109.68 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 313' ' ' THR . . . . . 0.472 HG23 ' HB3' ' S' ' 323' ' ' GLU . 92.6 m -87.9 151.63 22.68 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.322 -0.861 . . . . 25.61 110.125 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' S' S ' 314' ' ' GLY . . . . . . . . . . . . . . . -87.93 126.42 8.05 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.791 -1.324 . . . . 25.18 109.791 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 315' ' ' ILE . . . . . . . . . . . . . 50.7 mm -101.62 150.48 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.377 -1.072 . . . . 23.9 109.722 179.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 316' ' ' GLY . . . . . . . . . . . . . . . -157.1 -159.26 9.38 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.006 -1.237 . . . . 23.18 110.006 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 317' ' ' THR . . . . . . . . . . . . . 11.1 p -133.89 -173.0 3.12 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.367 -1.078 . . . . 27.98 110.044 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.51 -56.26 24.12 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.239 -0.913 . . . . 28.1 109.885 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 319' ' ' SER . . . . . . . . . . . . . 1.2 m -59.93 -41.69 92.34 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.372 -0.83 . . . . 37.0 109.604 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 320' ' ' ARG . . . . . . . . . . . . . 12.1 mtm180 -111.71 79.84 2.64 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.483 -0.761 . . . . 52.07 109.717 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 321' ' ' PRO . . . . . 0.754 ' CG ' ' O ' ' S' ' 386' ' ' GLU . 44.1 Cg_endo -71.44 171.47 16.13 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.853 1.449 . . . . 38.29 110.928 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' S' S ' 322' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' S' ' 321' ' ' PRO . 41.5 t 178.73 -148.14 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.021 -0.733 . . . . 38.84 109.021 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' S' S ' 323' ' ' GLU . . . . . 0.472 ' HB3' HG23 ' S' ' 313' ' ' THR . 6.7 tp10 -62.86 -40.26 96.93 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.947 -1.096 . . . . 40.7 109.733 179.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' S' S ' 324' ' ' VAL . . . . . . . . . . . . . 73.2 t -141.26 135.0 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.502 -0.749 . . . . 20.34 109.462 179.337 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 325' ' ' CYS . . . . . 0.448 ' HB2' ' CE1' ' S' ' 380' ' ' PHE . 11.2 m -125.99 172.14 10.19 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.275 -0.891 . . . . 30.63 110.886 -179.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' S' S ' 326' ' ' VAL . . . . . . . . . . . . . 34.6 m -135.41 142.21 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.62 -0.675 . . . . 23.9 109.237 179.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 327' ' ' VAL . . . . . . . . . . . . . 34.5 m -56.32 125.03 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.104 -0.998 . . . . 19.48 110.4 -179.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 328' ' ' ASP . . . . . . . . . . . . . 55.6 p-10 -119.4 11.47 12.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.494 -0.754 . . . . 26.43 110.461 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 329' ' ' GLY . . . . . . . . . . . . . . . 119.68 2.31 13.04 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.027 -1.229 . . . . 31.24 110.027 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 330' ' ' THR . . . . . . . . . . . . . 77.4 m -92.98 130.01 38.7 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.104 -1.233 . . . . 30.05 110.132 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 331' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -56.81 111.54 1.05 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.321 -0.862 . . . . 37.26 110.005 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 332' ' ' MET . . . . . 0.455 ' HE1' ' CZ ' ' S' ' 380' ' ' PHE . 88.1 mmm -94.09 162.56 13.83 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.336 -0.852 . . . . 26.23 110.347 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' S' S ' 333' ' ' CYS . . . . . . . . . . . . . 26.1 m -137.26 149.95 47.48 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.419 -0.801 . . . . 23.56 110.07 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 334' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.54 -24.85 8.93 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.23 -0.919 . . . . 28.93 110.435 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' S' S ' 335' ' ' ALA . . . . . . . . . . . . . . . -89.05 14.4 10.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.32 -0.863 . . . . 15.76 110.896 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 336' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -100.49 -17.19 17.26 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.191 -0.943 . . . . 34.92 110.13 179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 337' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -152.33 170.86 19.03 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.295 -0.878 . . . . 19.03 110.068 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 338' ' ' HIS . . . . . . . . . . . . . 13.4 p80 -120.71 10.33 10.96 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.354 -0.841 . . . . 18.82 110.432 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 339' ' ' ALA . . . . . . . . . . . . . . . -175.96 155.17 1.57 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.291 -0.88 . . . . 17.18 110.065 -179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 340' ' ' GLY . . . . . 0.401 ' CA ' ' O ' ' S' ' 379' ' ' VAL . . . 160.87 173.09 29.05 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 110.067 -1.213 . . . . 18.33 110.067 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' S' S ' 341' ' ' ILE . . . . . 0.438 HD12 HG22 ' S' ' 341' ' ' ILE . 84.2 mt -88.85 138.14 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.444 -1.033 . . . . 18.6 109.766 179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' S' S ' 342' ' ' PHE . . . . . 0.503 ' CE1' HG23 ' S' ' 377' ' ' VAL . 70.0 m-85 -120.99 -178.48 3.76 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.214 -0.929 . . . . 23.44 110.375 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' S' S ' 343' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.83 93.38 4.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.484 -0.76 . . . . 35.59 109.973 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' S' S ' 344' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.82 125.01 29.56 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.229 -0.919 . . . . 38.34 110.107 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' S' S ' 345' ' ' GLY . . . . . . . . . . . . . . . 62.72 -130.86 43.27 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 108.87 -1.692 . . . . 53.46 108.87 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 346' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -132.66 150.9 52.09 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.212 -1.17 . . . . 70.91 110.065 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 347' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 53.25 35.4 19.97 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.34 -0.85 . . . . 47.32 110.395 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 348' ' ' HIS . . . . . . . . . . . . . 46.6 t60 -150.11 155.85 40.58 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.279 -0.888 . . . . 41.72 110.369 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 349' ' ' ALA . . . . . . . . . . . . . . . -149.8 151.24 33.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.281 -0.887 . . . . 22.91 110.543 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 350' ' ' VAL . . . . . . . . . . . . . 34.6 m -149.05 169.61 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.421 -0.8 . . . . 21.09 110.017 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 351' ' ' PHE . . . . . 0.469 ' CD2' ' HB3' ' S' ' 258' ' ' GLN . 10.7 t80 -105.36 143.67 33.19 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.249 -0.907 . . . . 25.03 110.693 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' S' S ' 352' ' ' ALA . . . . . . . . . . . . . . . -147.74 151.72 36.55 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.52 -0.738 . . . . 23.81 109.807 179.586 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 353' ' ' CYS . . . . . . . . . . . . . 26.2 p -153.4 164.86 37.42 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.271 -0.893 . . . . 25.66 110.175 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 354' ' ' VAL . . . . . 0.402 HG23 ' CZ2' ' S' ' 359' ' ' TRP . 57.3 t -76.0 118.56 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.39 -0.819 . . . . 34.27 109.994 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' S' S ' 355' ' ' THR . . . . . 0.444 HG23 ' HB2' ' S' ' 360' ' ' TYR . 52.3 p -117.86 175.07 5.83 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.294 -0.879 . . . . 25.49 110.306 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' S' S ' 356' ' ' SER . . . . . . . . . . . . . 62.3 p -62.1 -17.78 58.73 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.41 -0.806 . . . . 31.24 110.698 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 357' ' ' ASN . . . . . . . . . . . . . 45.8 m-20 -106.96 14.17 26.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.158 -0.964 . . . . 28.61 110.564 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 358' ' ' GLY . . . . . . . . . . . . . . . 111.87 -152.88 17.6 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.043 -1.223 . . . . 22.01 110.043 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 359' ' ' TRP . . . . . 0.402 ' CZ2' HG23 ' S' ' 354' ' ' VAL . 15.3 m95 -91.4 116.74 29.09 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.43 -1.041 . . . . 25.54 110.109 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' S' S ' 360' ' ' TYR . . . . . 0.444 ' HB2' HG23 ' S' ' 355' ' ' THR . 1.3 m-85 -103.54 165.88 10.77 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.344 -0.847 . . . . 40.53 109.997 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' S' S ' 361' ' ' ALA . . . . . . . . . . . . . . . -140.07 130.02 24.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.427 -0.796 . . . . 18.04 110.279 -179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 362' ' ' ILE . . . . . 0.416 HG23 ' CZ ' ' S' ' 367' ' ' PHE . 89.2 mt -95.59 83.64 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.379 -0.826 . . . . 15.64 110.13 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' S' S ' 363' ' ' ASP . . . . . 0.416 ' O ' ' N ' ' S' ' 365' ' ' GLU . 11.9 t0 -75.26 94.52 3.01 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.305 -0.872 . . . . 35.03 110.149 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' S' S ' 364' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 53.88 -89.4 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.518 -0.739 . . . . 46.72 110.458 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 365' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' S' ' 363' ' ' ASP . 23.8 mt-10 -122.62 19.14 10.37 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.126 -0.984 . . . . 56.2 110.24 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' S' S ' 366' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -117.96 125.03 49.64 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.281 -0.887 . . . . 51.02 110.446 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 367' ' ' PHE . . . . . 0.416 ' CZ ' HG23 ' S' ' 362' ' ' ILE . 26.9 m-85 -107.06 127.12 53.19 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.349 -0.844 . . . . 37.59 110.142 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' S' S ' 368' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -165.44 159.55 13.89 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.278 -0.889 . . . . 31.47 110.39 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 369' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.9 139.59 30.48 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 O-C-N 123.859 1.452 . . . . 28.85 110.52 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 370' ' ' TRP . . . . . . . . . . . . . 67.4 t90 -167.2 113.64 0.77 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.387 -0.821 . . . . 26.94 110.006 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 371' ' ' THR . . . . . . . . . . . . . 59.7 m -74.85 113.06 20.86 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.417 -0.802 . . . . 20.19 110.0 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 372' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -73.55 157.13 49.21 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 O-C-N 123.636 1.335 . . . . 28.68 110.571 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 373' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -90.57 147.16 35.77 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.382 -0.824 . . . . 35.72 109.873 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 374' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -76.05 -6.37 17.27 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 O-C-N 123.628 1.331 . . . . 30.89 110.473 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 375' ' ' SER . . . . . . . . . . . . . 69.0 p -104.28 -16.93 15.03 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.277 -0.889 . . . . 29.41 110.477 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 376' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -106.47 43.02 1.19 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.302 -0.874 . . . . 32.89 110.228 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 377' ' ' VAL . . . . . 0.503 HG23 ' CE1' ' S' ' 342' ' ' PHE . 7.3 p -114.62 147.23 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.273 -0.892 . . . . 24.33 110.274 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' S' S ' 378' ' ' LEU . . . . . . . . . . . . . 52.2 mt -116.03 -57.92 2.16 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.446 -0.784 . . . . 24.37 109.642 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 379' ' ' VAL . . . . . 0.401 ' O ' ' CA ' ' S' ' 340' ' ' GLY . 60.5 t -120.73 132.32 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.403 -0.811 . . . . 18.02 109.48 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' S' S ' 380' ' ' PHE . . . . . 0.455 ' CZ ' ' HE1' ' S' ' 332' ' ' MET . 14.3 p90 -142.5 173.92 11.1 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.417 -0.802 . . . . 29.35 110.658 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' S' S ' 381' ' ' VAL . . . . . . . . . . . . . 57.9 t -120.0 107.32 40.02 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.485 -0.759 . . . . 16.34 109.458 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 382' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.28 145.63 49.05 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 O-C-N 123.562 1.296 . . . . 20.94 110.726 -179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 383' ' ' TYR . . . . . . . . . . . . . 88.2 m-85 -61.16 -53.43 57.06 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.387 -0.82 . . . . 28.93 109.833 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 384' ' ' ASP . . . . . 0.422 ' C ' ' H ' ' S' ' 386' ' ' GLU . 10.0 m-20 -107.36 130.69 54.76 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.457 -0.777 . . . . 47.03 110.426 -177.04 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' S' S ' 385' ' ' GLN . . . . . 0.455 ' O ' ' C ' ' S' ' 386' ' ' GLU . 0.4 OUTLIER -63.13 -1.8 1.12 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.432 -0.793 . . . . 46.69 110.163 177.87 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' S' S ' 386' ' ' GLU . . . . . 0.754 ' O ' ' CG ' ' S' ' 321' ' ' PRO . 9.1 pt-20 -40.86 151.62 0.26 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.332 -0.855 . . . . 50.25 109.599 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' S' S ' 387' ' ' PRO . . . . . 0.675 ' O ' ' N ' ' S' ' 389' ' ' ASN . 46.2 Cg_endo -70.23 23.33 0.19 Allowed 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.656 1.345 . . . . 34.39 110.615 -177.541 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' S' S ' 388' ' ' LEU . . . . . 0.559 ' H ' ' C ' ' S' ' 386' ' ' GLU . 4.2 mt 43.4 -83.65 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.393 -0.817 . . . . 38.01 110.105 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' S' S ' 389' ' ' ASN . . . . . 0.675 ' N ' ' O ' ' S' ' 387' ' ' PRO . 2.4 m120 -156.04 76.96 0.94 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.442 -0.786 . . . . 45.82 110.083 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' S' S ' 390' ' ' GLY . . . . . . . . . . . . . . . -118.32 92.19 0.54 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.621 -1.392 . . . . 33.46 109.621 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 391' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -81.29 -33.36 32.7 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.398 -1.06 . . . . 56.58 110.13 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 392' ' ' TRP . . . . . 0.439 ' CE3' ' HA ' ' S' ' 393' ' ' LYS . 42.8 p-90 -58.23 -18.85 29.27 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.371 -0.83 . . . . 31.43 110.383 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' S' S ' 393' ' ' LYS . . . . . 0.633 ' O ' HG12 ' S' ' 396' ' ' VAL . 0.0 OUTLIER -46.7 -46.73 20.36 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.304 -0.873 . . . . 39.42 110.334 179.769 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' S' S ' 394' ' ' ALA . . . . . . . . . . . . . . . -79.35 -16.57 56.08 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.369 -0.832 . . . . 34.33 110.092 178.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' S' S ' 395' ' ' LYS . . . . . 0.616 ' CA ' HD13 ' R' ' 143' ' ' LEU . 20.2 mmtt -77.96 -16.43 58.16 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.372 -0.83 . . . . 60.09 110.255 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' S' S ' 396' ' ' VAL . . . . . 0.888 ' O ' ' HA ' ' R' ' 99' ' ' PRO . 7.6 p -100.97 -41.49 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.347 -0.846 . . . . 35.5 110.566 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' S' S ' 397' ' ' GLN . . . . . 0.512 ' N ' HG11 ' S' ' 396' ' ' VAL . 1.2 pp0? -77.12 -2.4 34.07 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.152 -0.968 . . . . 49.96 110.637 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' S' S ' 398' ' ' ARG . . . . . 0.705 ' HB2' ' HA ' ' R' ' 147' ' ' GLU . 0.0 OUTLIER -45.27 157.62 0.08 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.307 -0.871 . . . . 43.42 110.71 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' S' S ' 399' ' ' LYS . . . . . 0.59 ' CB ' ' HA3' ' R' ' 97' ' ' GLY . 0.8 OUTLIER -142.58 118.16 10.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.299 -0.875 . . . . 55.31 110.06 179.737 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' S' S ' 400' ' ' LEU . . . . . 0.651 ' HB2' ' CB ' ' R' ' 51' ' ' ALA . 1.0 OUTLIER -35.13 -43.8 0.22 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.305 -0.872 . . . . 41.03 110.239 -179.939 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' S' S ' 401' ' ' LYS . . . . . 0.477 ' CA ' ' OD1' ' R' ' 49' ' ' ASP . 4.8 tmmt? . . . . . 0 N--CA 1.493 1.683 0 O-C-N 121.23 -0.919 . . . . 61.97 110.15 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.152 0.501 . . . . 32.14 110.291 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 30' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -96.27 141.18 29.92 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.382 -0.824 . . . . 43.36 110.249 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 31' ' ' LEU . . . . . . . . . . . . . 65.3 mt -134.91 140.6 45.89 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.282 -0.886 . . . . 22.93 110.283 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 32' ' ' THR . . . . . . . . . . . . . 70.3 m -87.62 110.49 20.43 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.391 -0.818 . . . . 22.34 109.982 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 33' ' ' LEU . . . . . 0.461 HD23 ' CE2' ' R' ' 62' ' ' TYR . 80.1 mt -62.28 -172.78 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.295 -0.878 . . . . 21.39 110.221 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 34' ' ' TYR . . . . . . . . . . . . . 37.0 p90 -74.66 -29.36 61.22 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.266 -0.896 . . . . 34.4 110.414 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 35' ' ' ASN . . . . . . . . . . . . . 48.3 p30 -77.77 -1.92 33.79 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.289 -0.882 . . . . 30.28 110.633 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.29 -16.56 59.51 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.742 -1.343 . . . . 36.25 109.742 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 37' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -59.02 161.82 4.76 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.285 -1.127 . . . . 53.8 110.368 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 38' ' ' LYS . . . . . . . . . . . . . 56.8 mttt -117.85 135.73 53.9 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.367 -0.833 . . . . 49.91 110.132 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 39' ' ' LYS . . . . . 0.417 ' HG2' ' CZ ' ' R' ' 41' ' ' PHE . 8.0 ttmt -138.72 143.68 39.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.375 -0.828 . . . . 35.69 110.255 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 40' ' ' THR . . . . . . . . . . . . . 23.4 m -102.55 127.95 49.41 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.424 -0.798 . . . . 34.84 110.198 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 41' ' ' PHE . . . . . 0.417 ' CZ ' ' HG2' ' R' ' 39' ' ' LYS . 96.6 m-85 -113.0 132.69 55.27 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.41 -0.806 . . . . 34.42 110.179 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 42' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -93.34 140.97 28.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.328 -0.857 . . . . 51.46 110.229 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 43' ' ' SER . . . . . . . . . . . . . 54.3 m -70.84 141.9 51.28 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.461 -0.774 . . . . 41.84 110.192 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.77 125.4 29.54 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.367 -0.833 . . . . 33.82 109.957 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 45' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.15 151.05 54.77 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.517 1.272 . . . . 30.27 110.646 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 46' ' ' ASN . . . . . . . . . . . . . 52.2 t-20 -124.24 109.91 13.99 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.534 -0.728 . . . . 35.1 109.997 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 47' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -120.32 -34.84 3.56 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.292 -0.88 . . . . 42.81 110.537 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 48' ' ' HIS . . . . . . . . . . . . . 73.3 m80 -105.86 45.23 0.98 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.346 -0.846 . . . . 49.97 110.24 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 49' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 50.32 34.62 9.22 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.491 -0.755 . . . . 61.32 110.158 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 50' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -86.15 43.77 1.08 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.388 -0.82 . . . . 51.5 110.747 -179.649 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 51' ' ' ALA . . . . . 0.496 ' HB1' ' C ' ' S' ' 401' ' ' LYS . . . -66.07 -46.1 78.93 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.243 -0.911 . . . . 38.77 109.571 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 52' ' ' TRP . . . . . 0.483 ' CD2' ' N ' ' R' ' 53' ' ' LEU . 68.1 p-90 -58.46 -38.34 77.34 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.57 -0.706 . . . . 26.24 110.048 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 53' ' ' LEU . . . . . 0.483 ' N ' ' CD2' ' R' ' 52' ' ' TRP . 23.2 tp -66.72 -46.68 74.75 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.323 -0.861 . . . . 26.75 110.013 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 54' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -55.25 -41.53 72.29 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.363 -0.836 . . . . 35.02 110.23 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.16 -46.12 91.83 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.44 -0.788 . . . . 24.47 110.196 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 56' ' ' ILE . . . . . . . . . . . . . 76.1 mt -62.12 -42.26 94.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.292 -0.88 . . . . 26.03 109.927 179.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 57' ' ' LEU . . . . . . . . . . . . . 22.3 mt -60.35 -45.61 92.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.251 -0.906 . . . . 26.77 109.661 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 58' ' ' GLN . . . . . . . . . . . . . 57.7 mm-40 -63.87 -46.52 84.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.427 -0.796 . . . . 22.32 109.625 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 59' ' ' LEU . . . . . 0.43 ' HA ' ' HE2' ' R' ' 151' ' ' PHE . 24.0 tp -61.33 -37.82 84.67 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.334 -0.854 . . . . 20.55 109.443 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 60' ' ' PHE . . . . . 0.448 ' CE2' HD22 ' R' ' 111' ' ' LEU . 2.8 m-85 -61.1 -44.7 96.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.567 -0.708 . . . . 20.08 109.933 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 61' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -63.1 -36.13 82.57 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.441 -0.787 . . . . 18.8 110.541 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 62' ' ' TYR . . . . . 0.461 ' CE2' HD23 ' R' ' 33' ' ' LEU . 9.2 t80 -63.22 -41.73 99.16 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.233 -0.917 . . . . 26.45 110.155 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 63' ' ' VAL . . . . . . . . . . . . . 30.4 m -93.36 20.34 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.275 -0.891 . . . . 29.75 110.19 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 64' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 52.92 75.63 0.23 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.328 -0.857 . . . . 35.52 110.559 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 65' ' ' GLU . . . . . 0.425 ' HG2' ' CD2' ' R' ' 60' ' ' PHE . 14.3 tp10 -116.36 104.14 52.15 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.344 -0.847 . . . . 29.89 109.865 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 66' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.6 -5.84 17.74 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.806 1.424 . . . . 21.37 111.064 -179.531 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 67' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -52.09 -61.52 2.21 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.147 -0.97 . . . . 23.85 110.375 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 68' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -98.2 36.69 1.55 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.326 -0.859 . . . . 28.07 110.488 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 69' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -72.43 -33.17 66.91 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.225 -0.922 . . . . 43.76 110.175 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 70' ' ' TRP . . . . . 0.476 ' CE2' ' CG2' ' R' ' 71' ' ' VAL . 47.7 p-90 -73.41 -3.98 30.74 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.334 -0.854 . . . . 33.06 110.71 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 71' ' ' VAL . . . . . 0.476 ' CG2' ' CE2' ' R' ' 70' ' ' TRP . 40.5 t -109.73 -27.41 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.223 -0.923 . . . . 31.7 109.756 179.127 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 72' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -86.54 -48.79 8.06 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.407 -0.808 . . . . 33.58 110.383 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 73' ' ' SER . . . . . . . . . . . . . 70.0 m -89.71 51.06 2.0 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.394 -0.816 . . . . 50.82 110.304 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 74' ' ' SER . . . . . . . . . . . . . 15.9 t -125.96 138.29 31.79 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.238 -0.914 . . . . 34.74 110.24 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.36 -24.96 15.98 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.742 1.391 . . . . 35.7 110.343 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 76' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -91.72 153.15 19.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.33 -0.856 . . . . 66.48 110.355 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 77' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -81.47 95.27 7.03 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.391 -0.818 . . . . 46.72 110.043 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 78' ' ' LEU . . . . . . . . . . . . . 96.3 mt -96.49 27.99 3.55 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.389 -0.82 . . . . 37.55 110.191 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 79' ' ' THR . . . . . . . . . . . . . 29.6 m -56.27 -54.58 43.7 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.225 -0.922 . . . . 37.36 110.302 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 80' ' ' LEU . . . . . . . . . . . . . 15.9 mt -60.97 -23.16 65.13 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.33 -0.856 . . . . 35.83 110.511 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 81' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -79.5 -39.11 32.85 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.101 -0.999 . . . . 44.03 110.356 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.51 -28.64 66.22 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.257 -0.902 . . . . 32.54 110.169 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 83' ' ' ILE . . . . . . . . . . . . . 77.8 mt -70.08 -46.12 73.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.275 -0.891 . . . . 32.02 110.352 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 84' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -55.09 -52.17 64.08 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.208 -0.932 . . . . 34.09 110.56 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 85' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -54.79 -46.88 74.53 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.209 -0.932 . . . . 25.94 110.279 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 86' ' ' LEU . . . . . . . . . . . . . 23.7 mt -58.75 -43.76 90.38 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.365 -0.835 . . . . 16.2 109.853 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 87' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -65.33 -35.25 80.4 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.494 -0.754 . . . . 49.09 110.317 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 88' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -78.41 -19.05 54.09 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.282 -0.886 . . . . 28.61 110.529 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 89' ' ' LEU . . . . . . . . . . . . . 32.6 mt -96.21 -29.35 14.09 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.248 -0.907 . . . . 26.16 110.201 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 90' ' ' THR . . . . . . . . . . . . . 60.7 p -105.69 -34.71 7.62 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.255 -0.903 . . . . 33.33 109.75 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.88 16.15 58.47 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.85 -1.3 . . . . 31.13 109.85 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 92' ' ' LEU . . . . . . . . . . . . . 97.1 mt -100.18 155.21 17.87 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.213 -1.169 . . . . 42.52 110.186 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 93' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -86.19 91.59 8.5 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.481 -0.762 . . . . 68.46 110.038 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 94' ' ' LEU . . . . . 0.447 ' HB3' ' CZ2' ' R' ' 52' ' ' TRP . 48.1 mt -99.37 53.03 0.95 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.204 -0.935 . . . . 44.63 110.377 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 95' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.57 -38.59 6.38 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.262 -0.898 . . . . 67.16 110.369 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 96' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -113.93 44.23 1.68 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.364 -0.835 . . . . 67.02 110.244 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 97' ' ' GLY . . . . . 0.563 ' HA3' ' HA ' ' S' ' 399' ' ' LYS . . . 99.12 150.8 26.05 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.614 -1.395 . . . . 49.48 109.614 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 98' ' ' GLY . . . . . . . . . . . . . . . -166.27 160.01 33.44 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.265 -1.534 . . . . 36.57 109.265 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 99' ' ' PRO . . . . . 1.029 ' HA ' ' O ' ' S' ' 396' ' ' VAL . 44.5 Cg_endo -72.57 121.12 7.15 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.75 1.395 . . . . 30.41 110.384 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 100' ' ' PRO . . . . . 0.477 ' HD2' HG23 ' S' ' 396' ' ' VAL . 45.4 Cg_endo -72.3 -31.68 11.34 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.619 1.326 . . . . 29.94 110.493 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.01 -38.45 75.96 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.34 -0.85 . . . . 23.64 110.294 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.63 -40.77 66.16 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.353 -0.842 . . . . 20.31 110.382 -179.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 103' ' ' VAL . . . . . . . . . . . . . 63.1 t -58.01 -40.21 75.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.202 -0.936 . . . . 16.33 110.023 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 104' ' ' ILE . . . . . . . . . . . . . 81.7 mt -71.62 -30.6 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.384 -0.823 . . . . 24.77 109.941 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 105' ' ' TRP . . . . . 0.439 ' O ' ' HD3' ' R' ' 108' ' ' LYS . 70.6 t-105 -82.26 0.72 40.08 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.311 -0.868 . . . . 23.28 110.376 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 106' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -104.98 -10.5 17.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.118 -0.989 . . . . 28.26 110.112 179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 107' ' ' ILE . . . . . . . . . . . . . 36.6 pt -126.81 35.0 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.225 -0.922 . . . . 18.77 109.994 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 108' ' ' LYS . . . . . 0.481 ' HG2' ' HB ' ' R' ' 115' ' ' ILE . 9.2 mtpp -61.02 -48.54 81.32 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.499 -0.751 . . . . 42.5 110.011 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 109' ' ' HIS . . . . . 0.432 ' CD2' ' HG ' ' R' ' 110' ' ' LEU . 50.8 p-80 -66.0 -12.84 57.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.518 -0.738 . . . . 20.07 110.64 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 110' ' ' LEU . . . . . 0.432 ' HG ' ' CD2' ' R' ' 109' ' ' HIS . 80.4 mt -94.8 -17.39 22.17 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.116 -0.99 . . . . 15.69 110.156 179.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 111' ' ' LEU . . . . . 0.448 HD22 ' CE2' ' R' ' 60' ' ' PHE . 10.4 mt -94.06 144.12 25.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.299 -0.876 . . . . 25.39 111.046 -179.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 112' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -77.66 -17.43 57.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.634 -0.666 . . . . 53.48 109.854 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 113' ' ' THR . . . . . 0.418 HG22 ' HG2' ' R' ' 123' ' ' GLU . 60.0 m -83.63 166.66 17.97 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.379 -0.826 . . . . 14.8 110.257 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 114' ' ' GLY . . . . . . . . . . . . . . . -97.97 127.14 9.13 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.041 -1.224 . . . . 16.14 110.041 -179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 115' ' ' ILE . . . . . 0.481 ' HB ' ' HG2' ' R' ' 108' ' ' LYS . 47.7 mm -109.1 139.37 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.457 -1.025 . . . . 13.46 109.727 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 116' ' ' GLY . . . . . . . . . . . . . . . -152.75 -155.81 7.27 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.876 -1.29 . . . . 23.9 109.876 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 117' ' ' THR . . . . . . . . . . . . . 18.7 p -135.05 -171.4 2.79 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.432 -1.04 . . . . 27.37 110.072 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.5 -58.12 9.42 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.23 -0.918 . . . . 18.76 110.031 179.742 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 119' ' ' SER . . . . . 0.635 ' O ' ' HB2' ' R' ' 197' ' ' GLN . 1.1 m -56.56 -40.6 75.44 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.259 -0.901 . . . . 32.35 109.764 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 120' ' ' ARG . . . . . 0.407 ' HG2' ' OE1' ' R' ' 197' ' ' GLN . 10.0 mtm180 -110.05 86.29 4.9 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.47 -0.768 . . . . 27.12 109.636 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 121' ' ' PRO . . . . . 0.428 ' O ' ' HB2' ' R' ' 122' ' ' SER . 44.2 Cg_endo -71.26 166.44 29.25 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 O-C-N 123.819 1.431 . . . . 22.68 111.009 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 122' ' ' SER . . . . . 0.428 ' HB2' ' O ' ' R' ' 121' ' ' PRO . 38.1 t 178.58 -161.65 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.609 -0.682 . . . . 22.99 109.493 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 123' ' ' GLU . . . . . 0.418 ' HG2' HG22 ' R' ' 113' ' ' THR . 2.3 tp10 -56.45 -39.97 74.01 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.19 -0.944 . . . . 36.18 109.701 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 124' ' ' VAL . . . . . . . . . . . . . 82.6 t -142.5 136.41 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.498 -0.751 . . . . 20.64 109.393 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 125' ' ' CYS . . . . . 0.411 ' SG ' ' HA ' ' R' ' 121' ' ' PRO . 83.4 m -140.32 168.15 20.49 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.304 -0.873 . . . . 22.8 111.131 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 126' ' ' VAL . . . . . . . . . . . . . 35.8 m -122.68 159.7 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.714 -0.616 . . . . 21.24 109.676 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 127' ' ' VAL . . . . . 0.401 HG11 ' O ' ' R' ' 177' ' ' VAL . 30.6 m -70.81 141.8 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.359 -0.838 . . . . 19.77 110.7 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 128' ' ' ASP . . . . . . . . . . . . . 53.9 p-10 -137.63 19.38 2.89 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.333 -0.855 . . . . 29.21 110.714 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 129' ' ' GLY . . . . . . . . . . . . . . . 113.97 0.08 24.18 Favored Glycine 0 N--CA 1.493 2.458 0 C-N-CA 120.0 -1.095 . . . . 33.86 110.468 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 130' ' ' THR . . . . . . . . . . . . . 58.1 m -91.82 131.87 36.85 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.171 -1.193 . . . . 26.41 110.072 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -62.58 120.65 11.56 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.312 -0.868 . . . . 33.08 110.284 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 132' ' ' MET . . . . . 0.427 ' HE1' ' CZ ' ' R' ' 180' ' ' PHE . 98.4 mmm -105.16 165.62 10.97 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.543 -0.723 . . . . 30.76 110.415 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 133' ' ' CYS . . . . . . . . . . . . . 32.4 m -141.14 158.13 44.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.511 -0.743 . . . . 27.0 109.912 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 134' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.48 -19.68 39.12 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.347 -0.846 . . . . 33.9 110.538 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 135' ' ' ALA . . . . . . . . . . . . . . . -92.79 8.22 40.37 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.261 -0.899 . . . . 19.37 110.801 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 136' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -93.72 -21.87 19.08 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.109 -0.994 . . . . 30.47 110.195 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 137' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -149.9 165.45 32.56 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.421 -0.8 . . . . 24.27 110.227 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 138' ' ' HIS . . . . . . . . . . . . . 15.1 p80 -117.88 15.09 14.33 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.418 -0.801 . . . . 20.91 110.412 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 139' ' ' ALA . . . . . 0.442 ' HA ' ' O ' ' R' ' 152' ' ' ALA . . . -177.19 152.35 0.87 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.187 -0.946 . . . . 15.69 110.171 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 140' ' ' GLY . . . . . 0.404 ' HA3' ' O ' ' R' ' 179' ' ' VAL . . . 161.82 175.18 32.58 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.918 -1.273 . . . . 23.76 109.918 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 141' ' ' ILE . . . . . . . . . . . . . 83.7 mt -95.54 136.57 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.447 -1.031 . . . . 25.3 109.702 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 142' ' ' PHE . . . . . 0.546 ' CD2' ' HB2' ' R' ' 172' ' ' PRO . 82.2 m-85 -120.66 -172.58 2.41 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.276 -0.89 . . . . 30.24 110.566 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 143' ' ' LEU . . . . . 0.55 HD13 ' CB ' ' S' ' 395' ' ' LYS . 0.5 OUTLIER -119.84 77.78 1.27 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.455 -0.778 . . . . 32.8 110.298 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' R' R ' 144' ' ' LYS . . . . . 0.454 ' HG3' ' CZ2' ' R' ' 170' ' ' TRP . 1.0 OUTLIER -69.66 76.84 0.43 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.43 -0.794 . . . . 49.18 109.635 179.651 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' R' R ' 145' ' ' GLY . . . . . . . . . . . . . . . 104.57 179.26 24.76 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.168 -1.573 . . . . 53.87 109.168 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 146' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -88.5 145.79 25.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.388 -1.066 . . . . 68.58 110.049 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 147' ' ' GLU . . . . . 0.781 ' HA ' ' CB ' ' S' ' 398' ' ' ARG . 10.9 mt-10 58.29 36.51 25.68 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.392 -0.818 . . . . 56.62 110.655 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 148' ' ' HIS . . . . . 0.589 ' HA ' ' O ' ' S' ' 400' ' ' LEU . 45.0 t60 -158.68 148.08 19.14 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.205 -0.934 . . . . 44.57 110.377 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 149' ' ' ALA . . . . . 0.501 ' HB3' ' HE2' ' S' ' 401' ' ' LYS . . . -150.3 146.93 27.06 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.467 -0.771 . . . . 33.54 110.072 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 150' ' ' VAL . . . . . 0.427 HG23 ' HB2' ' R' ' 144' ' ' LYS . 34.2 m -142.38 161.45 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.273 -0.892 . . . . 27.61 110.305 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 151' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' R' ' 152' ' ' ALA . 5.9 t80 -86.15 155.58 20.7 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.42 -0.8 . . . . 23.04 109.867 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 152' ' ' ALA . . . . . 0.537 ' N ' ' CD1' ' R' ' 151' ' ' PHE . . . -157.31 151.59 24.95 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.455 -0.778 . . . . 29.61 109.565 178.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 153' ' ' CYS . . . . . 0.407 ' HA ' ' HA ' ' R' ' 139' ' ' ALA . 26.7 p -154.33 173.56 16.02 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.334 -0.854 . . . . 22.75 110.49 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 154' ' ' VAL . . . . . 0.443 ' CG2' ' CZ2' ' R' ' 159' ' ' TRP . 60.4 t -90.6 116.97 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.337 -0.852 . . . . 23.26 110.083 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 155' ' ' THR . . . . . . . . . . . . . 69.3 p -112.05 -176.65 2.98 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.257 -0.902 . . . . 17.88 110.102 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 156' ' ' SER . . . . . . . . . . . . . 78.4 p -75.96 -3.69 36.96 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.394 -0.816 . . . . 21.83 110.721 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 157' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -118.32 10.58 12.84 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.046 -1.034 . . . . 36.54 110.613 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 158' ' ' GLY . . . . . . . . . . . . . . . 117.98 -162.65 13.04 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.592 -1.403 . . . . 31.74 109.592 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 159' ' ' TRP . . . . . 0.443 ' CZ2' ' CG2' ' R' ' 154' ' ' VAL . 14.7 m95 -86.55 122.42 30.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.312 -1.111 . . . . 28.25 110.112 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 160' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -108.46 166.94 10.39 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.413 -0.805 . . . . 41.24 110.19 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 161' ' ' ALA . . . . . . . . . . . . . . . -143.21 123.48 13.79 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.367 -0.833 . . . . 27.4 110.14 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 162' ' ' ILE . . . . . 0.431 HG23 ' CZ ' ' R' ' 167' ' ' PHE . 92.1 mt -87.6 81.14 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.354 -0.841 . . . . 24.27 110.106 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 163' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' R' ' 165' ' ' GLU . 15.3 t0 -72.72 92.33 1.54 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.443 -0.786 . . . . 36.08 110.332 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 164' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 54.1 -88.93 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.496 -0.752 . . . . 46.08 110.565 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 165' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' R' ' 163' ' ' ASP . 29.7 mt-10 -124.72 35.96 4.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.017 -1.052 . . . . 50.94 110.187 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 166' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -135.8 117.34 14.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.339 -0.85 . . . . 47.28 110.309 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 167' ' ' PHE . . . . . 0.431 ' CZ ' HG23 ' R' ' 162' ' ' ILE . 24.3 m-85 -101.07 119.92 39.45 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.412 -0.805 . . . . 40.47 110.127 179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 168' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -157.58 158.51 30.6 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.305 -0.872 . . . . 30.21 110.407 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 169' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.77 133.06 19.54 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 O-C-N 123.868 1.457 . . . . 32.76 110.474 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 170' ' ' TRP . . . . . 0.454 ' CZ2' ' HG3' ' R' ' 144' ' ' LYS . 67.0 t90 -159.81 119.3 2.88 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.41 -0.806 . . . . 32.79 109.984 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 171' ' ' THR . . . . . . . . . . . . . 45.7 m -81.08 112.62 34.19 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.444 -0.785 . . . . 36.92 110.219 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 172' ' ' PRO . . . . . 0.546 ' HB2' ' CD2' ' R' ' 142' ' ' PHE . 46.9 Cg_endo -73.75 158.83 46.45 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.68 1.358 . . . . 33.54 110.533 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 173' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -88.9 144.96 33.71 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.366 -0.833 . . . . 45.76 109.843 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 174' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -71.71 -10.4 26.46 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 O-C-N 123.553 1.291 . . . . 29.63 110.438 179.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 175' ' ' SER . . . . . . . . . . . . . 53.0 p -103.36 -17.69 15.16 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.234 -0.916 . . . . 35.7 110.404 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 176' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -103.44 43.13 1.1 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.233 -0.917 . . . . 39.65 110.4 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 177' ' ' VAL . . . . . 0.401 ' O ' HG11 ' R' ' 127' ' ' VAL . 10.4 p -117.69 127.2 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.409 -0.807 . . . . 20.61 110.021 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 178' ' ' LEU . . . . . . . . . . . . . 46.3 mt -91.52 -61.29 1.68 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.35 -0.844 . . . . 15.58 109.376 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 179' ' ' VAL . . . . . 0.404 ' O ' ' HA3' ' R' ' 140' ' ' GLY . 67.1 t -114.62 144.67 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.6 -0.688 . . . . 17.4 109.444 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 180' ' ' PHE . . . . . 0.427 ' CZ ' ' HE1' ' R' ' 132' ' ' MET . 43.7 p90 -152.09 163.37 39.47 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.338 -0.851 . . . . 20.16 110.562 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 181' ' ' VAL . . . . . . . . . . . . . 66.4 t -113.19 111.48 50.22 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.511 -0.743 . . . . 17.69 109.836 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 182' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.11 149.54 52.44 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.546 1.287 . . . . 17.81 110.374 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 183' ' ' TYR . . . . . 0.736 ' O ' ' C ' ' R' ' 184' ' ' ASP . 79.2 m-85 -58.99 175.47 0.28 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.464 -0.772 . . . . 28.01 110.522 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 184' ' ' ASP . . . . . 0.736 ' C ' ' O ' ' R' ' 183' ' ' TYR . 0.0 OUTLIER -13.05 -76.29 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.303 -0.873 . . . . 58.64 110.221 -178.029 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' R' R ' 185' ' ' GLN . . . . . . . . . . . . . 16.8 tm0? . . . . . 0 N--CA 1.503 2.217 0 CA-C-O 121.265 0.555 . . . . 80.42 111.773 179.171 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' R' R ' 193' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 120.873 0.368 . . . . 49.5 110.245 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 194' ' ' ALA . . . . . 0.606 ' CB ' ' HA ' ' R' ' 119' ' ' SER . . . -172.7 -142.04 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.162 -0.961 . . . . 40.4 110.136 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 195' ' ' LYS . . . . . . . . . . . . . 3.1 mtpm? -103.87 -52.07 3.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.316 -0.865 . . . . 34.6 110.324 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 196' ' ' VAL . . . . . 0.51 ' HB ' ' CB ' ' R' ' 119' ' ' SER . 30.2 t -89.71 56.27 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.254 -0.904 . . . . 33.27 110.64 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 197' ' ' GLN . . . . . 0.635 ' HB2' ' O ' ' R' ' 119' ' ' SER . 29.1 tp60 -155.98 -33.7 0.09 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.165 -0.959 . . . . 41.58 110.676 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 198' ' ' ARG . . . . . . . . . . . . . 21.0 mtm180 -62.03 158.88 15.47 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.175 -0.953 . . . . 38.65 110.219 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' R' R ' 199' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -104.69 68.99 0.87 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.453 -0.779 . . . . 36.77 109.925 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' R' R ' 200' ' ' LEU . . . . . 0.429 ' CD1' ' HG2' ' R' ' 201' ' ' LYS . 0.5 OUTLIER -53.52 178.07 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.425 -0.797 . . . . 33.08 110.176 -179.74 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' R' R ' 201' ' ' LYS . . . . . 0.815 ' C ' ' HA3' ' S' ' 297' ' ' GLY . 10.4 mmmm . . . . . 0 N--CA 1.492 1.669 0 O-C-N 121.36 -0.837 . . . . 44.32 110.288 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 229' ' ' MET . . . . . . . . . . . . . 28.8 mtm . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.188 0.518 . . . . 51.83 110.235 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' S' S ' 230' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -97.34 142.69 28.9 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.409 -0.807 . . . . 54.13 110.195 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 231' ' ' LEU . . . . . . . . . . . . . 68.0 mt -134.02 141.02 47.06 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.413 -0.805 . . . . 33.04 110.344 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 232' ' ' THR . . . . . . . . . . . . . 40.2 m -89.27 103.29 15.93 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.432 -0.792 . . . . 26.92 109.973 179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 233' ' ' LEU . . . . . 0.503 HD23 ' CE2' ' S' ' 262' ' ' TYR . 79.7 mt -55.92 179.36 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.471 -0.768 . . . . 13.78 110.494 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' S' S ' 234' ' ' TYR . . . . . 0.44 ' CG ' ' N ' ' S' ' 235' ' ' ASN . 35.4 p90 -65.13 -35.61 81.67 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.355 -0.841 . . . . 26.08 110.17 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' S' S ' 235' ' ' ASN . . . . . 0.44 ' N ' ' CG ' ' S' ' 234' ' ' TYR . 50.7 p30 -74.3 -7.5 52.99 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.299 -0.876 . . . . 20.04 110.504 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' S' S ' 236' ' ' GLY . . . . . . . . . . . . . . . 95.8 -20.02 51.72 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.76 -1.336 . . . . 22.71 109.76 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 237' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -53.02 145.77 12.41 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.19 -1.182 . . . . 35.44 110.145 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 238' ' ' LYS . . . . . . . . . . . . . 44.3 mttt -102.18 127.87 48.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.395 -0.815 . . . . 32.56 110.362 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 239' ' ' LYS . . . . . 0.419 ' HG2' ' CZ ' ' S' ' 241' ' ' PHE . 8.9 ttmt -132.29 144.45 50.59 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.474 -0.766 . . . . 26.68 109.959 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' S' S ' 240' ' ' THR . . . . . . . . . . . . . 52.4 m -101.98 132.22 47.93 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.237 -0.915 . . . . 41.02 110.375 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 241' ' ' PHE . . . . . 0.419 ' CZ ' ' HG2' ' S' ' 239' ' ' LYS . 96.1 m-85 -117.95 137.75 52.63 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.348 -0.845 . . . . 28.62 110.203 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' S' S ' 242' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -96.47 161.78 13.76 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.38 -0.825 . . . . 47.89 110.149 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 243' ' ' SER . . . . . . . . . . . . . 72.1 m -90.59 151.62 21.23 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.31 -0.869 . . . . 45.09 110.211 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 244' ' ' ARG . . . . . . . . . . . . . 1.4 mtp85 -129.82 126.72 22.66 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.324 -0.86 . . . . 42.49 110.204 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 245' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.3 160.94 43.97 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 O-C-N 123.635 1.334 . . . . 35.68 110.559 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 246' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -132.82 97.84 4.15 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.327 -0.858 . . . . 51.88 109.871 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 247' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -110.49 -22.18 11.79 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.376 -0.828 . . . . 53.69 110.647 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 248' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -117.29 43.66 2.28 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.237 -0.914 . . . . 55.79 110.717 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 249' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 48.8 38.43 11.89 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.444 -0.785 . . . . 49.45 110.333 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 250' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -90.69 29.14 1.37 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.53 -0.731 . . . . 36.86 110.297 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 251' ' ' ALA . . . . . 0.6 ' HB1' ' CE ' ' R' ' 201' ' ' LYS . . . -53.9 -43.18 69.46 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.172 -0.955 . . . . 29.69 109.564 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' S' S ' 252' ' ' TRP . . . . . 0.418 ' CZ2' ' HB3' ' S' ' 294' ' ' LEU . 68.0 p-90 -61.81 -33.91 74.97 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.491 -0.755 . . . . 41.12 109.868 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' S' S ' 253' ' ' LEU . . . . . 0.406 ' N ' ' CD2' ' S' ' 252' ' ' TRP . 23.3 tp -70.14 -47.26 62.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.321 -0.862 . . . . 24.89 109.962 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' S' S ' 254' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -56.12 -42.49 76.94 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.343 -0.848 . . . . 35.65 109.991 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 255' ' ' ALA . . . . . . . . . . . . . . . -59.56 -48.24 82.44 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.439 -0.788 . . . . 22.73 110.046 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 256' ' ' ILE . . . . . . . . . . . . . 79.7 mt -62.22 -40.68 88.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.337 -0.852 . . . . 28.85 109.988 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 257' ' ' LEU . . . . . . . . . . . . . 19.1 mt -61.52 -44.51 96.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.356 -0.84 . . . . 23.07 110.162 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 258' ' ' GLN . . . . . 0.466 ' HB3' ' CD2' ' S' ' 351' ' ' PHE . 53.4 mm-40 -65.07 -45.37 85.55 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.422 -0.799 . . . . 29.78 109.87 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' S' S ' 259' ' ' LEU . . . . . 0.432 ' O ' HG22 ' S' ' 263' ' ' VAL . 19.9 tp -58.71 -36.34 74.09 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.331 -0.856 . . . . 17.94 109.452 179.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' S' S ' 260' ' ' PHE . . . . . 0.47 ' CE2' HD22 ' S' ' 311' ' ' LEU . 3.1 m-85 -62.84 -45.2 93.7 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.56 -0.713 . . . . 30.57 109.825 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' S' S ' 261' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -62.18 -29.79 70.62 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.475 -0.766 . . . . 41.34 109.901 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 262' ' ' TYR . . . . . 0.503 ' CE2' HD23 ' S' ' 233' ' ' LEU . 8.6 t80 -71.17 -44.69 65.0 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.435 -0.79 . . . . 26.03 110.129 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' S' S ' 263' ' ' VAL . . . . . 0.432 HG22 ' O ' ' S' ' 259' ' ' LEU . 33.1 m -92.0 18.29 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.352 -0.843 . . . . 22.8 110.384 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' S' S ' 264' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 52.72 70.69 0.55 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.206 -0.934 . . . . 44.03 110.641 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 265' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -111.82 109.24 55.36 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.375 -0.828 . . . . 35.61 109.649 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 266' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -75.33 0.46 9.01 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.631 1.332 . . . . 37.67 111.772 -179.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 267' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -56.56 -67.63 0.29 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.779 -1.201 . . . . 41.49 110.17 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' S' S ' 268' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -92.94 39.91 1.05 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.193 -0.942 . . . . 50.76 110.091 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 269' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.05 -33.1 59.6 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.417 -0.802 . . . . 61.86 109.816 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' S' S ' 270' ' ' TRP . . . . . 0.488 ' CE2' ' CG2' ' S' ' 271' ' ' VAL . 51.0 p-90 -73.98 -4.31 34.49 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.327 -0.858 . . . . 39.85 110.478 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' S' S ' 271' ' ' VAL . . . . . 0.488 ' CG2' ' CE2' ' S' ' 270' ' ' TRP . 46.6 t -109.56 -32.69 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.154 -0.966 . . . . 39.18 110.045 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' S' S ' 272' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -78.71 -36.49 43.34 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.365 -0.834 . . . . 40.02 110.518 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 273' ' ' SER . . . . . . . . . . . . . 71.2 m -103.52 56.17 0.74 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.317 -0.864 . . . . 47.2 110.345 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 274' ' ' SER . . . . . . . . . . . . . 6.9 t -133.13 141.19 39.9 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.334 -0.854 . . . . 47.61 110.12 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 275' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.65 -18.9 21.97 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.603 1.317 . . . . 45.28 110.603 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 276' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -99.94 140.9 33.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.248 -0.908 . . . . 57.27 110.272 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 277' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -71.71 97.67 1.8 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.48 -0.763 . . . . 37.28 110.263 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 278' ' ' LEU . . . . . . . . . . . . . 86.4 mt -96.98 33.77 1.85 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.484 -0.76 . . . . 43.88 110.003 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 279' ' ' THR . . . . . . . . . . . . . 75.3 m -64.05 -60.12 3.62 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.398 -0.814 . . . . 50.05 110.275 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 280' ' ' LEU . . . . . . . . . . . . . 13.7 mt -51.6 -39.77 58.58 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.301 -0.874 . . . . 54.12 110.334 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 281' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.49 -49.7 74.34 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.475 -0.766 . . . . 65.28 110.125 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' S' S ' 282' ' ' ALA . . . . . . . . . . . . . . . -58.89 -34.0 71.16 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.491 -0.756 . . . . 46.51 110.513 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 283' ' ' ILE . . . . . . . . . . . . . 85.5 mt -66.26 -50.91 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.242 -0.911 . . . . 47.3 110.149 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 284' ' ' LYS . . . . . . . . . . . . . 33.8 tttp -50.52 -57.52 7.92 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.414 -0.804 . . . . 50.72 110.476 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 285' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -51.43 -46.45 62.98 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.469 -0.77 . . . . 68.47 110.293 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 286' ' ' LEU . . . . . . . . . . . . . 19.2 mt -59.93 -44.49 94.3 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.426 -0.796 . . . . 36.62 110.26 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 287' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -62.8 -35.25 79.27 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.342 -0.849 . . . . 46.64 110.067 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 288' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -76.21 -21.04 56.9 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.382 -0.823 . . . . 46.45 110.329 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 289' ' ' LEU . . . . . . . . . . . . . 30.9 mt -97.24 -21.78 17.07 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.308 -0.87 . . . . 35.09 110.559 -179.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 290' ' ' THR . . . . . . . . . . . . . 81.3 p -114.82 -28.47 7.06 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.275 -0.89 . . . . 38.61 110.367 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 291' ' ' GLY . . . . . . . . . . . . . . . 79.35 11.1 85.31 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.829 -1.308 . . . . 36.77 109.829 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 292' ' ' LEU . . . . . . . . . . . . . 84.6 mt -96.46 145.77 25.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.233 -1.157 . . . . 35.33 109.815 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 293' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -77.34 102.4 6.75 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.144 -0.973 . . . . 48.7 110.235 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 294' ' ' LEU . . . . . 0.418 ' HB3' ' CZ2' ' S' ' 252' ' ' TRP . 55.1 mt -106.89 51.73 0.73 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.498 -0.751 . . . . 42.61 110.128 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' S' S ' 295' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -112.56 -11.11 13.63 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.356 -0.84 . . . . 55.49 110.518 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' S' S ' 296' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -144.32 48.44 1.36 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.093 -1.004 . . . . 75.68 110.363 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 297' ' ' GLY . . . . . 0.815 ' HA3' ' C ' ' R' ' 201' ' ' LYS . . . 96.9 145.15 18.66 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.477 -1.449 . . . . 49.44 109.477 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' S' S ' 298' ' ' GLY . . . . . 0.648 ' N ' ' HB2' ' R' ' 201' ' ' LYS . . . -163.8 156.99 29.09 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.804 -1.318 . . . . 41.11 109.804 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' S' S ' 299' ' ' PRO . . . . . 0.427 ' HB3' ' CD2' ' R' ' 200' ' ' LEU . 47.4 Cg_endo -73.82 118.26 5.37 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 124.018 1.536 . . . . 26.2 110.32 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' S' S ' 300' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.26 -15.4 31.63 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.609 1.321 . . . . 21.7 110.736 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 301' ' ' ALA . . . . . . . . . . . . . . . -80.68 -29.44 36.57 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.237 -0.914 . . . . 31.23 110.129 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 302' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.45 -40.62 19.05 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.404 -0.81 . . . . 38.99 110.031 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' S' S ' 303' ' ' VAL . . . . . 0.471 ' O ' HG12 ' S' ' 307' ' ' ILE . 57.6 t -60.69 -35.53 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.36 -0.838 . . . . 18.63 110.135 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' S' S ' 304' ' ' ILE . . . . . . . . . . . . . 85.9 mt -79.36 -23.72 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.265 -0.897 . . . . 25.46 110.129 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 305' ' ' TRP . . . . . . . . . . . . . 68.7 t-105 -88.55 -14.6 37.29 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.261 -0.899 . . . . 33.4 110.588 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 306' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -89.64 -13.65 36.63 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.204 -0.935 . . . . 36.97 110.403 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 307' ' ' ILE . . . . . 0.471 HG12 ' O ' ' S' ' 303' ' ' VAL . 36.8 pt -125.06 45.65 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.198 -0.939 . . . . 30.81 109.997 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' S' S ' 308' ' ' LYS . . . . . . . . . . . . . 1.5 mtmp? -73.52 -37.82 65.53 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.336 -0.852 . . . . 46.52 110.108 -179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 309' ' ' HIS . . . . . 0.49 ' CD2' ' HG ' ' S' ' 310' ' ' LEU . 55.5 p-80 -73.21 -8.26 55.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.331 -0.855 . . . . 51.03 110.078 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' S' S ' 310' ' ' LEU . . . . . 0.49 ' HG ' ' CD2' ' S' ' 309' ' ' HIS . 52.8 mt -99.31 -12.81 20.0 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.245 -0.909 . . . . 36.16 110.009 179.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' S' S ' 311' ' ' LEU . . . . . 0.47 HD22 ' CE2' ' S' ' 260' ' ' PHE . 10.8 mt -97.18 147.87 23.65 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.378 -0.826 . . . . 40.0 110.458 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' S' S ' 312' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -81.65 -16.25 52.0 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.363 -0.836 . . . . 54.18 109.722 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 313' ' ' THR . . . . . 0.477 HG23 ' HB3' ' S' ' 323' ' ' GLU . 92.6 m -87.92 151.65 22.66 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.386 -0.821 . . . . 25.61 110.119 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' S' S ' 314' ' ' GLY . . . . . . . . . . . . . . . -87.93 126.34 8.02 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.849 -1.3 . . . . 25.18 109.849 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 315' ' ' ILE . . . . . . . . . . . . . 50.7 mm -101.66 150.5 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.409 -1.053 . . . . 23.9 109.727 179.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 316' ' ' GLY . . . . . . . . . . . . . . . -157.06 -159.29 9.39 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.928 -1.269 . . . . 23.18 109.928 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 317' ' ' THR . . . . . . . . . . . . . 11.1 p -133.87 -172.99 3.12 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.422 -1.046 . . . . 27.98 110.025 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.54 -56.25 24.33 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.215 -0.928 . . . . 28.1 109.908 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 319' ' ' SER . . . . . . . . . . . . . 1.2 m -59.91 -41.68 92.25 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.343 -0.848 . . . . 37.0 109.65 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 320' ' ' ARG . . . . . . . . . . . . . 12.2 mtm180 -111.7 79.95 2.67 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.438 -0.789 . . . . 52.07 109.646 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 321' ' ' PRO . . . . . 1.058 ' HG2' ' O ' ' S' ' 386' ' ' GLU . 43.6 Cg_endo -71.5 171.51 16.11 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.772 1.406 . . . . 38.29 110.867 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' S' S ' 322' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' S' ' 321' ' ' PRO . 41.3 t 178.69 -148.1 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.907 -0.775 . . . . 38.84 108.907 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' S' S ' 323' ' ' GLU . . . . . 0.477 ' HB3' HG23 ' S' ' 313' ' ' THR . 6.7 tp10 -62.86 -40.26 96.96 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.048 -1.033 . . . . 40.7 109.707 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' S' S ' 324' ' ' VAL . . . . . . . . . . . . . 72.7 t -141.33 135.01 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.411 -0.806 . . . . 20.34 109.49 179.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 325' ' ' CYS . . . . . 0.451 ' HB2' ' CE1' ' S' ' 380' ' ' PHE . 11.3 m -125.94 172.22 10.1 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.323 -0.861 . . . . 30.63 110.84 -179.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' S' S ' 326' ' ' VAL . . . . . . . . . . . . . 34.6 m -135.53 142.26 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 109.186 -0.672 . . . . 23.9 109.186 179.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 327' ' ' VAL . . . . . . . . . . . . . 34.5 m -56.41 125.01 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.096 -1.002 . . . . 19.48 110.419 -179.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 328' ' ' ASP . . . . . . . . . . . . . 55.5 p-10 -119.43 11.54 12.18 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.461 -0.774 . . . . 26.43 110.445 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 329' ' ' GLY . . . . . . . . . . . . . . . 119.69 2.27 13.05 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.041 -1.223 . . . . 31.24 110.041 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 330' ' ' THR . . . . . . . . . . . . . 80.1 m -93.04 129.99 38.79 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.117 -1.225 . . . . 30.05 110.107 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 331' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -56.68 111.47 1.02 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.311 -0.868 . . . . 37.26 110.011 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 332' ' ' MET . . . . . 0.455 ' HE1' ' CZ ' ' S' ' 380' ' ' PHE . 88.0 mmm -94.1 162.57 13.82 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.234 -0.916 . . . . 26.23 110.356 -179.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' S' S ' 333' ' ' CYS . . . . . . . . . . . . . 25.6 m -137.24 150.01 47.55 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.513 -0.742 . . . . 23.56 110.015 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 334' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.57 -24.82 8.96 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.342 -0.849 . . . . 28.93 110.488 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' S' S ' 335' ' ' ALA . . . . . . . . . . . . . . . -89.12 14.52 10.58 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.427 -0.796 . . . . 15.76 110.942 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 336' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -100.45 -17.28 17.25 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.164 -0.96 . . . . 34.92 110.242 179.442 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 337' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -152.36 170.88 19.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.329 -0.857 . . . . 19.03 110.072 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 338' ' ' HIS . . . . . 0.401 ' HB3' ' CZ ' ' S' ' 383' ' ' TYR . 13.5 p80 -120.71 10.47 11.0 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.356 -0.84 . . . . 18.82 110.508 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' S' S ' 339' ' ' ALA . . . . . . . . . . . . . . . -176.0 155.18 1.56 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.193 -0.942 . . . . 17.18 110.079 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 340' ' ' GLY . . . . . . . . . . . . . . . 160.82 173.05 28.93 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.089 -1.204 . . . . 18.33 110.089 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 341' ' ' ILE . . . . . 0.448 HD12 HG22 ' S' ' 341' ' ' ILE . 83.9 mt -88.76 138.07 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.493 -1.004 . . . . 18.6 109.864 179.642 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' S' S ' 342' ' ' PHE . . . . . 0.504 ' CE1' HG23 ' S' ' 377' ' ' VAL . 70.0 m-85 -120.94 -178.43 3.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.195 -0.941 . . . . 23.44 110.444 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' S' S ' 343' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.91 93.37 4.17 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.44 -0.787 . . . . 35.59 110.001 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' S' S ' 344' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.86 125.09 29.67 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.334 -0.854 . . . . 38.34 109.999 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' S' S ' 345' ' ' GLY . . . . . . . . . . . . . . . 62.71 -130.83 43.26 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 108.928 -1.669 . . . . 53.46 108.928 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 346' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -132.72 150.9 52.1 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.23 -1.159 . . . . 70.91 110.018 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 347' ' ' GLU . . . . . 0.523 ' O ' ' HD2' ' R' ' 201' ' ' LYS . 18.0 mt-10 53.26 35.44 20.1 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.319 -0.863 . . . . 47.32 110.442 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' S' S ' 348' ' ' HIS . . . . . 0.4 ' HA ' ' HE3' ' R' ' 201' ' ' LYS . 46.9 t60 -150.16 155.83 40.5 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.383 -0.823 . . . . 41.72 110.36 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' S' S ' 349' ' ' ALA . . . . . . . . . . . . . . . -149.79 151.25 33.26 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.427 -0.796 . . . . 22.91 110.481 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 350' ' ' VAL . . . . . . . . . . . . . 34.6 m -148.99 169.66 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.534 -0.729 . . . . 21.09 110.072 179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 351' ' ' PHE . . . . . 0.466 ' CD2' ' HB3' ' S' ' 258' ' ' GLN . 10.7 t80 -105.44 143.54 33.46 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.246 -0.909 . . . . 25.03 110.709 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' S' S ' 352' ' ' ALA . . . . . . . . . . . . . . . -147.66 151.69 36.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.634 -0.666 . . . . 23.81 109.766 179.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 353' ' ' CYS . . . . . . . . . . . . . 26.3 p -153.3 164.9 37.29 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.341 -0.849 . . . . 25.66 110.315 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 354' ' ' VAL . . . . . 0.406 HG23 ' CZ2' ' S' ' 359' ' ' TRP . 57.5 t -76.05 118.52 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.359 -0.838 . . . . 34.27 109.904 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' S' S ' 355' ' ' THR . . . . . 0.442 HG23 ' HB2' ' S' ' 360' ' ' TYR . 51.7 p -117.91 175.15 5.8 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.298 -0.876 . . . . 25.49 110.283 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' S' S ' 356' ' ' SER . . . . . . . . . . . . . 62.3 p -62.12 -17.75 58.7 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.393 -0.817 . . . . 31.24 110.731 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 357' ' ' ASN . . . . . . . . . . . . . 46.0 m-20 -106.98 14.16 26.77 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.104 -0.997 . . . . 28.61 110.559 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 358' ' ' GLY . . . . . . . . . . . . . . . 111.88 -152.9 17.6 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 110.005 -1.238 . . . . 22.01 110.005 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 359' ' ' TRP . . . . . 0.406 ' CZ2' HG23 ' S' ' 354' ' ' VAL . 15.5 m95 -91.22 116.63 28.97 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.446 -1.032 . . . . 25.54 110.273 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' S' S ' 360' ' ' TYR . . . . . 0.442 ' HB2' HG23 ' S' ' 355' ' ' THR . 1.3 m-85 -103.47 165.81 10.81 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.375 -0.828 . . . . 40.53 110.104 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' S' S ' 361' ' ' ALA . . . . . . . . . . . . . . . -140.04 130.07 24.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.379 -0.826 . . . . 18.04 110.297 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 362' ' ' ILE . . . . . 0.412 HG23 ' CZ ' ' S' ' 367' ' ' PHE . 88.7 mt -95.63 83.62 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.415 -0.803 . . . . 15.64 110.065 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' S' S ' 363' ' ' ASP . . . . . 0.416 ' O ' ' N ' ' S' ' 365' ' ' GLU . 11.8 t0 -75.2 94.43 2.96 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.334 -0.854 . . . . 35.03 110.216 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' S' S ' 364' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 54.01 -89.34 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.493 -0.754 . . . . 46.72 110.508 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 365' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' S' ' 363' ' ' ASP . 23.7 mt-10 -122.68 19.09 10.33 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.081 -1.012 . . . . 56.2 110.202 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' S' S ' 366' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -117.97 125.04 49.64 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.217 -0.927 . . . . 51.02 110.342 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 367' ' ' PHE . . . . . 0.412 ' CZ ' HG23 ' S' ' 362' ' ' ILE . 26.9 m-85 -106.99 127.12 53.17 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.392 -0.817 . . . . 37.59 110.093 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' S' S ' 368' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -165.49 159.58 13.8 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.323 -0.861 . . . . 31.47 110.423 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 369' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.92 139.61 30.44 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 O-C-N 123.85 1.447 . . . . 28.85 110.497 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 370' ' ' TRP . . . . . . . . . . . . . 67.5 t90 -167.19 113.57 0.77 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.408 -0.807 . . . . 26.94 109.936 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 371' ' ' THR . . . . . . . . . . . . . 59.3 m -74.8 113.04 20.59 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.372 -0.83 . . . . 20.19 110.02 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 372' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -73.49 157.06 49.55 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 O-C-N 123.578 1.304 . . . . 28.68 110.597 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 373' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -90.64 147.18 35.72 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.423 -0.798 . . . . 35.72 109.87 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 374' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -76.04 -6.25 17.15 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 O-C-N 123.713 1.375 . . . . 30.89 110.465 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 375' ' ' SER . . . . . . . . . . . . . 68.2 p -104.36 -17.0 14.97 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.297 -0.877 . . . . 29.41 110.46 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 376' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -106.5 43.0 1.19 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.299 -0.876 . . . . 32.89 110.256 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 377' ' ' VAL . . . . . 0.504 HG23 ' CE1' ' S' ' 342' ' ' PHE . 7.4 p -114.62 147.25 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.348 -0.845 . . . . 24.33 110.26 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' S' S ' 378' ' ' LEU . . . . . . . . . . . . . 53.0 mt -116.05 -57.93 2.16 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.456 -0.778 . . . . 24.37 109.573 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 379' ' ' VAL . . . . . . . . . . . . . 61.5 t -120.73 132.39 70.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.454 -0.779 . . . . 18.02 109.409 179.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 380' ' ' PHE . . . . . 0.455 ' CZ ' ' HE1' ' S' ' 332' ' ' MET . 14.5 p90 -142.59 173.94 11.09 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.38 -0.825 . . . . 29.35 110.646 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' S' S ' 381' ' ' VAL . . . . . . . . . . . . . 57.8 t -120.02 107.35 39.94 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.486 -0.759 . . . . 16.34 109.412 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 382' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.38 145.67 48.61 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 O-C-N 123.636 1.335 . . . . 20.94 110.762 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 383' ' ' TYR . . . . . 0.401 ' CZ ' ' HB3' ' S' ' 338' ' ' HIS . 88.0 m-85 -61.12 -53.45 56.86 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.344 -0.848 . . . . 28.93 109.825 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' S' S ' 384' ' ' ASP . . . . . 0.419 ' C ' ' H ' ' S' ' 386' ' ' GLU . 3.9 p30 -99.65 125.06 45.42 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.431 -0.793 . . . . 47.03 110.332 -176.496 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' S' S ' 385' ' ' GLN . . . . . 0.413 ' O ' ' O ' ' S' ' 386' ' ' GLU . 3.2 pt20 -67.82 2.68 1.83 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.46 -0.775 . . . . 46.69 110.158 177.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' S' S ' 386' ' ' GLU . . . . . 1.058 ' O ' ' HG2' ' S' ' 321' ' ' PRO . 2.9 mt-10 -47.83 171.68 0.08 OUTLIER Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.43 -0.794 . . . . 50.25 109.525 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' S' S ' 387' ' ' PRO . . . . . 0.568 ' O ' ' C ' ' S' ' 388' ' ' LEU . 51.3 Cg_endo -71.55 -10.19 26.35 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 O-C-N 123.66 1.347 . . . . 34.39 110.621 -177.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' S' S ' 388' ' ' LEU . . . . . 0.633 ' O ' ' HB2' ' S' ' 389' ' ' ASN . 59.5 mt 31.05 85.19 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.393 -0.817 . . . . 38.01 110.105 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' S' S ' 389' ' ' ASN . . . . . 0.633 ' HB2' ' O ' ' S' ' 388' ' ' LEU . 22.9 m-20 71.26 170.52 0.32 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.375 -0.828 . . . . 45.82 110.131 -179.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' S' S ' 390' ' ' GLY . . . . . 0.489 ' O ' ' CB ' ' S' ' 391' ' ' GLU . . . 147.15 -87.28 0.16 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.6 -1.4 . . . . 33.46 109.6 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' S' S ' 391' ' ' GLU . . . . . 0.489 ' CB ' ' O ' ' S' ' 390' ' ' GLY . 0.9 OUTLIER 68.23 -63.84 0.32 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.322 -1.105 . . . . 56.58 110.116 179.834 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' S' S ' 392' ' ' TRP . . . . . 0.446 ' N ' ' O ' ' S' ' 390' ' ' GLY . 1.6 m-90 -48.84 -26.1 2.24 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.322 -0.861 . . . . 31.43 110.401 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' S' S ' 393' ' ' LYS . . . . . 0.458 ' O ' HG12 ' S' ' 396' ' ' VAL . 16.6 ttpt -51.96 -60.22 3.43 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.376 -0.828 . . . . 39.42 110.411 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' S' S ' 394' ' ' ALA . . . . . . . . . . . . . . . -68.72 -12.23 61.18 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.296 -0.878 . . . . 34.33 110.135 179.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' S' S ' 395' ' ' LYS . . . . . 0.55 ' CB ' HD13 ' R' ' 143' ' ' LEU . 0.0 OUTLIER -86.94 -22.62 25.51 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.362 -0.836 . . . . 60.09 110.29 179.74 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' S' S ' 396' ' ' VAL . . . . . 1.029 ' O ' ' HA ' ' R' ' 99' ' ' PRO . 8.9 p -94.87 -28.64 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.356 -0.84 . . . . 35.5 110.533 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' S' S ' 397' ' ' GLN . . . . . 0.543 ' N ' HG11 ' S' ' 396' ' ' VAL . 1.5 pt20 -109.95 96.29 6.14 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.18 -0.95 . . . . 49.96 110.657 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' S' S ' 398' ' ' ARG . . . . . 0.781 ' CB ' ' HA ' ' R' ' 147' ' ' GLU . 10.2 mmt180 -149.11 170.66 17.91 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.318 -0.864 . . . . 43.42 110.739 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' S' S ' 399' ' ' LYS . . . . . 0.679 ' C ' ' H ' ' S' ' 401' ' ' LYS . 0.6 OUTLIER -57.58 -86.6 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.36 -0.838 . . . . 55.31 110.108 -179.207 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' S' S ' 400' ' ' LEU . . . . . 0.589 ' O ' ' HA ' ' R' ' 148' ' ' HIS . 2.6 mt -60.59 15.65 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.352 -0.843 . . . . 41.03 110.352 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' S' S ' 401' ' ' LYS . . . . . 0.679 ' H ' ' C ' ' S' ' 399' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.331 -0.856 . . . . 61.97 110.216 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.28 0.562 . . . . 32.14 110.246 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 30' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -96.31 141.18 29.95 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.277 -0.889 . . . . 43.36 110.262 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 31' ' ' LEU . . . . . . . . . . . . . 65.6 mt -134.91 140.58 45.87 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.312 -0.867 . . . . 22.93 110.268 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 32' ' ' THR . . . . . . . . . . . . . 69.3 m -87.55 110.57 20.45 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.319 -0.863 . . . . 22.34 109.984 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 33' ' ' LEU . . . . . 0.46 HD23 ' CE2' ' R' ' 62' ' ' TYR . 80.1 mt -62.38 -172.76 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.299 -0.876 . . . . 21.39 110.202 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 34' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -74.6 -29.49 61.33 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.333 -0.855 . . . . 34.4 110.365 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 35' ' ' ASN . . . . . . . . . . . . . 48.3 p30 -77.72 -1.89 33.46 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.384 -0.822 . . . . 30.28 110.649 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.28 -16.55 59.53 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.698 -1.361 . . . . 36.25 109.698 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 37' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -59.04 161.77 4.82 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.338 -1.095 . . . . 53.8 110.368 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 38' ' ' LYS . . . . . . . . . . . . . 57.1 mttt -117.78 135.73 53.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.393 -0.817 . . . . 49.91 110.181 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 39' ' ' LYS . . . . . 0.416 ' HG2' ' CZ ' ' R' ' 41' ' ' PHE . 8.1 ttmt -138.68 143.74 39.29 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.423 -0.798 . . . . 35.69 110.198 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 40' ' ' THR . . . . . . . . . . . . . 23.6 m -102.63 128.05 49.47 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.343 -0.848 . . . . 34.84 110.188 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 41' ' ' PHE . . . . . 0.416 ' CZ ' ' HG2' ' R' ' 39' ' ' LYS . 96.6 m-85 -113.08 132.64 55.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.381 -0.824 . . . . 34.42 110.14 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 42' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -93.32 140.9 29.04 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.366 -0.834 . . . . 51.46 110.215 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 43' ' ' SER . . . . . . . . . . . . . 54.6 m -70.76 141.92 51.42 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.397 -0.815 . . . . 41.84 110.187 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.8 125.34 29.6 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.305 -0.872 . . . . 33.82 109.978 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 45' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.15 151.05 54.79 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.517 1.272 . . . . 30.27 110.649 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 46' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.24 109.92 13.99 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.456 -0.777 . . . . 35.1 109.989 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 47' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -120.27 -34.93 3.54 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.325 -0.859 . . . . 42.81 110.545 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 48' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -105.74 45.16 0.98 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.181 -0.949 . . . . 49.97 110.275 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 49' ' ' ASP . . . . . 0.545 ' CB ' ' HA ' ' S' ' 401' ' ' LYS . 37.5 m-20 50.35 34.65 9.32 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.432 -0.793 . . . . 61.32 110.182 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 50' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -86.22 43.81 1.09 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.349 -0.844 . . . . 51.5 110.661 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 51' ' ' ALA . . . . . 0.912 ' HB1' ' CB ' ' S' ' 400' ' ' LEU . . . -66.14 -46.08 78.73 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.225 -0.922 . . . . 38.77 109.539 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 52' ' ' TRP . . . . . 0.857 ' CA ' HD23 ' S' ' 400' ' ' LEU . 68.2 p-90 -58.37 -38.42 77.21 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.419 -0.801 . . . . 26.24 110.082 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 53' ' ' LEU . . . . . 0.483 ' N ' ' CD2' ' R' ' 52' ' ' TRP . 23.0 tp -66.71 -46.71 74.65 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.456 -0.777 . . . . 26.75 109.939 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 54' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -55.18 -41.68 72.24 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.321 -0.862 . . . . 35.02 110.128 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.19 -46.03 92.14 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.4 -0.812 . . . . 24.47 110.189 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 56' ' ' ILE . . . . . . . . . . . . . 76.3 mt -62.14 -42.25 94.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.332 -0.855 . . . . 26.03 109.937 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 57' ' ' LEU . . . . . . . . . . . . . 22.4 mt -60.3 -45.67 92.57 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.299 -0.876 . . . . 26.77 109.661 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 58' ' ' GLN . . . . . . . . . . . . . 57.9 mm-40 -63.92 -46.48 84.59 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.481 -0.762 . . . . 22.32 109.594 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 59' ' ' LEU . . . . . 0.429 ' HA ' ' HE2' ' R' ' 151' ' ' PHE . 23.9 tp -61.43 -37.73 84.6 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.306 -0.871 . . . . 20.55 109.396 179.295 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 60' ' ' PHE . . . . . 0.447 ' CE2' HD22 ' R' ' 111' ' ' LEU . 2.8 m-85 -61.08 -44.76 96.88 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.664 -0.648 . . . . 20.08 109.927 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 61' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -63.1 -36.17 82.71 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.479 -0.763 . . . . 18.8 110.486 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 62' ' ' TYR . . . . . 0.46 ' CE2' HD23 ' R' ' 33' ' ' LEU . 9.1 t80 -63.11 -41.76 99.41 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.266 -0.896 . . . . 26.45 110.226 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 63' ' ' VAL . . . . . . . . . . . . . 30.5 m -93.4 20.45 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.295 -0.878 . . . . 29.75 110.218 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 64' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 52.87 75.58 0.23 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.344 -0.848 . . . . 35.52 110.58 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 65' ' ' GLU . . . . . 0.425 ' HG2' ' CD2' ' R' ' 60' ' ' PHE . 14.2 tp10 -116.29 104.07 52.33 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.377 -0.827 . . . . 29.89 109.888 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 66' ' ' PRO . . . . . 0.4 ' HA ' ' HB2' ' R' ' 69' ' ' ASP . 46.9 Cg_endo -73.53 -5.86 17.79 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 123.806 1.424 . . . . 21.37 111.124 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 67' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -52.09 -61.52 2.21 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.144 -0.973 . . . . 23.85 110.375 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 68' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -98.11 36.53 1.56 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.326 -0.859 . . . . 28.07 110.475 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 69' ' ' ASP . . . . . 0.4 ' HB2' ' HA ' ' R' ' 66' ' ' PRO . 11.7 t0 -72.3 -33.31 67.31 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.382 -0.824 . . . . 43.76 110.169 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 70' ' ' TRP . . . . . 0.477 ' CE2' ' CG2' ' R' ' 71' ' ' VAL . 47.9 p-90 -73.34 -3.88 29.9 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.313 -0.867 . . . . 33.06 110.705 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 71' ' ' VAL . . . . . 0.477 ' CG2' ' CE2' ' R' ' 70' ' ' TRP . 40.8 t -109.79 -27.48 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.132 -0.98 . . . . 31.7 109.717 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 72' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -86.56 -48.79 8.05 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.381 -0.824 . . . . 33.58 110.312 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 73' ' ' SER . . . . . . . . . . . . . 70.1 m -89.78 51.13 2.01 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.292 -0.88 . . . . 50.82 110.284 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 74' ' ' SER . . . . . . . . . . . . . 15.8 t -125.95 138.3 31.8 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.348 -0.845 . . . . 34.74 110.168 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.36 -25.01 15.92 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 O-C-N 123.669 1.352 . . . . 35.7 110.319 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 76' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -91.7 153.16 19.85 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.437 -0.789 . . . . 66.48 110.342 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 77' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -81.51 95.16 7.03 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.374 -0.829 . . . . 46.72 110.091 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 78' ' ' LEU . . . . . . . . . . . . . 96.4 mt -96.41 27.97 3.53 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.464 -0.772 . . . . 37.55 110.167 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 79' ' ' THR . . . . . . . . . . . . . 29.6 m -56.19 -54.56 43.76 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.27 -0.894 . . . . 37.36 110.312 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 80' ' ' LEU . . . . . . . . . . . . . 15.8 mt -60.93 -23.23 65.12 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.348 -0.845 . . . . 35.83 110.46 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 81' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -79.5 -39.18 32.67 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.209 -0.932 . . . . 44.03 110.298 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.43 -28.68 66.33 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.187 -0.945 . . . . 32.54 110.159 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 83' ' ' ILE . . . . . . . . . . . . . 78.3 mt -70.16 -45.99 73.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.307 -0.87 . . . . 32.02 110.3 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 84' ' ' LYS . . . . . . . . . . . . . 36.0 tttm -55.22 -52.08 64.52 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.179 -0.951 . . . . 34.09 110.596 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 85' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -54.81 -46.83 74.57 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.224 -0.923 . . . . 25.94 110.301 -179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 86' ' ' LEU . . . . . . . . . . . . . 24.0 mt -58.66 -43.88 90.0 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.312 -0.867 . . . . 16.2 109.878 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 87' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -65.36 -35.21 80.28 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.442 -0.786 . . . . 49.09 110.28 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 88' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -78.43 -19.04 54.07 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.247 -0.908 . . . . 28.61 110.493 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 89' ' ' LEU . . . . . . . . . . . . . 32.6 mt -96.21 -29.37 14.07 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.188 -0.945 . . . . 26.16 110.201 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 90' ' ' THR . . . . . . . . . . . . . 59.8 p -105.69 -34.6 7.66 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.211 -0.931 . . . . 33.33 109.795 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.78 16.06 58.75 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.857 -1.297 . . . . 31.13 109.857 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 92' ' ' LEU . . . . . . . . . . . . . 97.0 mt -100.07 155.24 17.83 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.141 -1.211 . . . . 42.52 110.281 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 93' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -86.17 91.54 8.47 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.485 -0.759 . . . . 68.46 109.99 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 94' ' ' LEU . . . . . 0.446 ' HB3' ' CZ2' ' R' ' 52' ' ' TRP . 47.8 mt -99.46 53.04 0.94 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.162 -0.961 . . . . 44.63 110.342 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 95' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.48 -38.68 6.38 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.332 -0.855 . . . . 67.16 110.381 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 96' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -113.96 44.25 1.68 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.392 -0.818 . . . . 67.02 110.254 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 97' ' ' GLY . . . . . 0.509 ' HA3' ' HA ' ' S' ' 399' ' ' LYS . . . 99.2 150.83 26.02 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.599 -1.401 . . . . 49.48 109.599 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 98' ' ' GLY . . . . . . . . . . . . . . . -166.23 160.03 33.46 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.253 -1.539 . . . . 36.57 109.253 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 99' ' ' PRO . . . . . 0.658 ' HA ' ' O ' ' S' ' 396' ' ' VAL . 45.7 Cg_endo -72.54 121.09 7.14 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.641 1.337 . . . . 30.41 110.492 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 100' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.33 -31.57 11.38 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.678 1.357 . . . . 29.94 110.492 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 101' ' ' ALA . . . . . 0.471 ' HB2' HG22 ' S' ' 396' ' ' VAL . . . -70.0 -38.51 75.98 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.357 -0.839 . . . . 23.64 110.227 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.67 -40.72 66.09 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.377 -0.827 . . . . 20.31 110.353 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 103' ' ' VAL . . . . . . . . . . . . . 63.9 t -58.14 -40.13 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.185 -0.947 . . . . 16.33 109.986 179.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 104' ' ' ILE . . . . . . . . . . . . . 82.1 mt -71.71 -30.54 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.399 -0.813 . . . . 24.77 109.899 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 105' ' ' TRP . . . . . 0.44 ' O ' ' HD3' ' R' ' 108' ' ' LYS . 70.5 t-105 -82.41 0.88 40.02 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.292 -0.88 . . . . 23.28 110.31 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 106' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -105.08 -10.42 17.18 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.152 -0.967 . . . . 28.26 110.043 179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 107' ' ' ILE . . . . . . . . . . . . . 36.7 pt -126.81 34.96 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.225 -0.922 . . . . 18.77 110.047 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 108' ' ' LYS . . . . . 0.481 ' HG2' ' HB ' ' R' ' 115' ' ' ILE . 9.2 mtpp -61.03 -48.43 81.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.565 -0.709 . . . . 42.5 110.055 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 109' ' ' HIS . . . . . 0.432 ' CD2' ' HG ' ' R' ' 110' ' ' LEU . 50.7 p-80 -66.06 -12.84 58.12 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.461 -0.774 . . . . 20.07 110.646 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 110' ' ' LEU . . . . . 0.432 ' HG ' ' CD2' ' R' ' 109' ' ' HIS . 80.6 mt -94.84 -17.21 22.29 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.115 -0.991 . . . . 15.69 110.181 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 111' ' ' LEU . . . . . 0.447 HD22 ' CE2' ' R' ' 60' ' ' PHE . 10.3 mt -94.19 144.16 25.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.376 -0.827 . . . . 25.39 110.971 -179.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 112' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -77.73 -17.33 57.71 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.525 -0.734 . . . . 53.48 109.811 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 113' ' ' THR . . . . . 0.416 HG22 ' HG2' ' R' ' 123' ' ' GLU . 60.3 m -83.76 166.6 17.88 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.355 -0.841 . . . . 14.8 110.22 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 114' ' ' GLY . . . . . . . . . . . . . . . -97.94 127.14 9.13 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.995 -1.242 . . . . 16.14 109.995 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 115' ' ' ILE . . . . . 0.481 ' HB ' ' HG2' ' R' ' 108' ' ' LYS . 48.0 mm -109.13 139.32 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.54 -0.976 . . . . 13.46 109.645 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 116' ' ' GLY . . . . . . . . . . . . . . . -152.71 -155.83 7.28 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.955 -1.258 . . . . 23.9 109.955 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 117' ' ' THR . . . . . . . . . . . . . 18.9 p -134.99 -171.4 2.79 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.467 -1.019 . . . . 27.37 110.152 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.52 -58.07 9.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.338 -0.851 . . . . 18.76 110.091 179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 119' ' ' SER . . . . . 0.466 ' OG ' ' HB ' ' R' ' 196' ' ' VAL . 1.1 m -56.59 -40.51 75.4 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.332 -0.855 . . . . 32.35 109.784 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 120' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 -110.09 86.2 4.86 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.456 -0.777 . . . . 27.12 109.708 179.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 121' ' ' PRO . . . . . 0.428 ' O ' ' HB2' ' R' ' 122' ' ' SER . 44.6 Cg_endo -71.21 166.4 29.34 Favored 'Trans proline' 0 C--N 1.311 -1.419 0 O-C-N 123.799 1.42 . . . . 22.68 111.086 -179.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 122' ' ' SER . . . . . 0.428 ' HB2' ' O ' ' R' ' 121' ' ' PRO . 38.3 t 178.61 -161.69 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.619 -0.675 . . . . 22.99 109.436 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 123' ' ' GLU . . . . . 0.416 ' HG2' HG22 ' R' ' 113' ' ' THR . 2.3 tp10 -56.38 -40.03 73.92 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.192 -0.943 . . . . 36.18 109.724 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 124' ' ' VAL . . . . . . . . . . . . . 82.6 t -142.51 136.5 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.506 -0.746 . . . . 20.64 109.39 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 125' ' ' CYS . . . . . 0.409 ' SG ' ' HA ' ' R' ' 121' ' ' PRO . 83.4 m -140.37 168.17 20.43 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.219 -0.925 . . . . 22.8 111.131 -179.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 126' ' ' VAL . . . . . . . . . . . . . 35.8 m -122.72 159.77 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.724 -0.61 . . . . 21.24 109.695 179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 127' ' ' VAL . . . . . 0.4 HG11 ' O ' ' R' ' 177' ' ' VAL . 30.5 m -70.81 141.86 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.273 -0.892 . . . . 19.77 110.708 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 128' ' ' ASP . . . . . . . . . . . . . 53.9 p-10 -137.73 19.41 2.87 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.336 -0.853 . . . . 29.21 110.697 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 129' ' ' GLY . . . . . . . . . . . . . . . 114.01 -0.05 24.13 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.963 -1.113 . . . . 33.86 110.503 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 130' ' ' THR . . . . . . . . . . . . . 58.5 m -91.84 131.81 36.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.12 -1.223 . . . . 26.41 110.117 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -62.52 120.65 11.54 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.372 -0.83 . . . . 33.08 110.302 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 132' ' ' MET . . . . . 0.426 ' HE1' ' CZ ' ' R' ' 180' ' ' PHE . 98.4 mmm -105.12 165.63 10.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.437 -0.79 . . . . 30.76 110.467 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 133' ' ' CYS . . . . . . . . . . . . . 32.4 m -141.12 158.13 44.34 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.511 -0.743 . . . . 27.0 109.988 179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 134' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.45 -19.76 39.41 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.217 -0.927 . . . . 33.9 110.467 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 135' ' ' ALA . . . . . . . . . . . . . . . -92.72 8.16 40.48 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.278 -0.889 . . . . 19.37 110.749 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 136' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -93.77 -21.78 19.1 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.14 -0.975 . . . . 30.47 110.186 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 137' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -149.93 165.34 32.93 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.338 -0.851 . . . . 24.27 110.252 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 138' ' ' HIS . . . . . . . . . . . . . 15.2 p80 -117.81 15.03 14.39 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.393 -0.817 . . . . 20.91 110.419 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 139' ' ' ALA . . . . . 0.441 ' HA ' ' O ' ' R' ' 152' ' ' ALA . . . -177.15 152.41 0.88 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.163 -0.96 . . . . 15.69 110.181 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 140' ' ' GLY . . . . . 0.404 ' HA3' ' O ' ' R' ' 179' ' ' VAL . . . 161.85 175.18 32.6 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.964 -1.254 . . . . 23.76 109.964 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 141' ' ' ILE . . . . . . . . . . . . . 83.4 mt -95.49 136.56 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.398 -1.06 . . . . 25.3 109.681 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 142' ' ' PHE . . . . . 0.546 ' CD2' ' HB2' ' R' ' 172' ' ' PRO . 83.0 m-85 -120.74 -172.58 2.41 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.336 -0.852 . . . . 30.24 110.552 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 143' ' ' LEU . . . . . 0.647 ' CD1' ' HB3' ' S' ' 395' ' ' LYS . 0.5 OUTLIER -119.8 77.8 1.27 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.437 -0.789 . . . . 32.8 110.281 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' R' R ' 144' ' ' LYS . . . . . 0.454 ' HG3' ' CZ2' ' R' ' 170' ' ' TRP . 1.0 OUTLIER -69.67 76.82 0.44 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.285 -0.884 . . . . 49.18 109.69 179.56 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' R' R ' 145' ' ' GLY . . . . . . . . . . . . . . . 104.57 179.28 24.75 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.168 -1.573 . . . . 53.87 109.168 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 146' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -88.48 145.82 25.54 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.417 -1.049 . . . . 68.58 109.989 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 147' ' ' GLU . . . . . 0.828 ' O ' ' HA ' ' S' ' 400' ' ' LEU . 10.8 mt-10 58.25 36.52 25.75 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.405 -0.809 . . . . 56.62 110.623 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 148' ' ' HIS . . . . . 0.572 ' HA ' ' HA ' ' S' ' 400' ' ' LEU . 45.1 t60 -158.72 148.1 19.09 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.208 -0.933 . . . . 44.57 110.371 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 149' ' ' ALA . . . . . 0.616 ' CB ' ' CD2' ' S' ' 400' ' ' LEU . . . -150.26 146.93 27.1 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.441 -0.787 . . . . 33.54 110.023 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 150' ' ' VAL . . . . . 0.428 HG23 ' HB2' ' R' ' 144' ' ' LYS . 34.2 m -142.35 161.51 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.273 -0.892 . . . . 27.61 110.276 179.726 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 151' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' R' ' 152' ' ' ALA . 5.9 t80 -86.25 155.61 20.62 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.383 -0.823 . . . . 23.04 109.926 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 152' ' ' ALA . . . . . 0.537 ' N ' ' CD1' ' R' ' 151' ' ' PHE . . . -157.25 151.56 25.01 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.457 -0.777 . . . . 29.61 109.623 179.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 153' ' ' CYS . . . . . 0.407 ' HA ' ' HA ' ' R' ' 139' ' ' ALA . 26.7 p -154.31 173.57 16.0 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.335 -0.853 . . . . 22.75 110.507 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 154' ' ' VAL . . . . . 0.443 ' CG2' ' CZ2' ' R' ' 159' ' ' TRP . 60.0 t -90.61 117.02 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.422 -0.799 . . . . 23.26 110.051 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 155' ' ' THR . . . . . . . . . . . . . 69.7 p -112.1 -176.64 2.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.345 -0.847 . . . . 17.88 110.118 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 156' ' ' SER . . . . . . . . . . . . . 78.6 p -75.9 -3.77 37.17 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.382 -0.824 . . . . 21.83 110.674 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 157' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -118.29 10.48 12.83 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.171 -0.955 . . . . 36.54 110.646 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 158' ' ' GLY . . . . . . . . . . . . . . . 118.0 -162.68 13.04 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.54 -1.424 . . . . 31.74 109.54 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 159' ' ' TRP . . . . . 0.443 ' CZ2' ' CG2' ' R' ' 154' ' ' VAL . 14.7 m95 -86.58 122.44 30.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.368 -1.078 . . . . 28.25 110.099 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 160' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -108.45 166.95 10.39 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.37 -0.831 . . . . 41.24 110.22 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 161' ' ' ALA . . . . . . . . . . . . . . . -143.22 123.49 13.79 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.43 -0.794 . . . . 27.4 110.163 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 162' ' ' ILE . . . . . 0.431 HG23 ' CZ ' ' R' ' 167' ' ' PHE . 92.6 mt -87.68 81.23 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.375 -0.828 . . . . 24.27 109.989 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 163' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' R' ' 165' ' ' GLU . 15.4 t0 -72.76 92.32 1.56 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.404 -0.81 . . . . 36.08 110.278 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 164' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 54.06 -88.92 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.507 -0.745 . . . . 46.08 110.6 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 165' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' R' ' 163' ' ' ASP . 29.6 mt-10 -124.71 35.88 4.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.13 -0.981 . . . . 50.94 110.219 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 166' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -135.75 117.3 14.85 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.431 -0.793 . . . . 47.28 110.255 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 167' ' ' PHE . . . . . 0.431 ' CZ ' HG23 ' R' ' 162' ' ' ILE . 24.3 m-85 -101.04 120.05 39.63 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.375 -0.828 . . . . 40.47 110.081 179.874 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 168' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -157.62 158.45 30.52 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.223 -0.923 . . . . 30.21 110.407 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 169' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.67 133.01 19.63 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 O-C-N 123.868 1.457 . . . . 32.76 110.561 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 170' ' ' TRP . . . . . 0.454 ' CZ2' ' HG3' ' R' ' 144' ' ' LYS . 67.2 t90 -159.77 119.27 2.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.453 -0.779 . . . . 32.79 109.955 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 171' ' ' THR . . . . . . . . . . . . . 47.4 m -81.06 112.66 34.48 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.488 -0.757 . . . . 36.92 110.163 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 172' ' ' PRO . . . . . 0.546 ' HB2' ' CD2' ' R' ' 142' ' ' PHE . 45.9 Cg_endo -73.74 158.79 46.5 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 O-C-N 123.681 1.358 . . . . 33.54 110.525 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 173' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -88.87 144.98 33.8 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.344 -0.848 . . . . 45.76 109.951 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 174' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -71.71 -10.4 26.46 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.596 1.314 . . . . 29.63 110.445 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 175' ' ' SER . . . . . . . . . . . . . 53.1 p -103.5 -17.55 15.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.281 -0.887 . . . . 35.7 110.343 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 176' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -103.48 43.16 1.1 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.202 -0.936 . . . . 39.65 110.4 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 177' ' ' VAL . . . . . 0.4 ' O ' HG11 ' R' ' 127' ' ' VAL . 10.5 p -117.68 127.16 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.336 -0.852 . . . . 20.61 109.971 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 178' ' ' LEU . . . . . . . . . . . . . 46.0 mt -91.45 -61.41 1.65 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.36 -0.837 . . . . 15.58 109.37 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 179' ' ' VAL . . . . . 0.404 ' O ' ' HA3' ' R' ' 140' ' ' GLY . 67.0 t -114.53 144.64 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.625 -0.672 . . . . 17.4 109.496 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 180' ' ' PHE . . . . . 0.426 ' CZ ' ' HE1' ' R' ' 132' ' ' MET . 43.6 p90 -152.13 163.41 39.41 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.282 -0.886 . . . . 20.16 110.537 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 181' ' ' VAL . . . . . . . . . . . . . 66.4 t -113.2 111.48 50.17 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.342 -0.849 . . . . 17.69 109.842 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 182' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.05 149.47 52.68 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.574 1.302 . . . . 17.81 110.446 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 183' ' ' TYR . . . . . 0.698 ' O ' ' C ' ' R' ' 184' ' ' ASP . 79.5 m-85 -59.06 175.46 0.29 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.434 -0.791 . . . . 28.01 110.561 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 184' ' ' ASP . . . . . 0.698 ' C ' ' O ' ' R' ' 183' ' ' TYR . 4.5 m-20 -18.96 -83.16 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.345 -0.847 . . . . 58.64 110.228 -178.274 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 185' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 . . . . . 0 N--CA 1.503 2.176 0 CA-C-O 121.252 0.549 . . . . 80.42 111.802 179.526 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' R' R ' 193' ' ' LYS . . . . . . . . . . . . . 66.2 mttt . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 120.856 0.36 . . . . 49.5 110.16 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' R' R ' 194' ' ' ALA . . . . . . . . . . . . . . . -170.98 -159.86 0.18 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.177 -0.952 . . . . 40.4 110.119 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 195' ' ' LYS . . . . . . . . . . . . . 8.4 ttpt -82.59 -55.38 4.49 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.388 -0.82 . . . . 34.6 110.338 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 196' ' ' VAL . . . . . 0.466 ' HB ' ' OG ' ' R' ' 119' ' ' SER . 41.8 t -88.9 48.67 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.233 -0.917 . . . . 33.27 110.62 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 197' ' ' GLN . . . . . 0.463 ' CG ' ' O ' ' R' ' 197' ' ' GLN . 7.7 tt0 -149.1 14.3 0.9 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.147 -0.971 . . . . 41.58 110.664 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 198' ' ' ARG . . . . . . . . . . . . . 9.1 ptt180 -106.37 178.4 4.57 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.155 -0.965 . . . . 38.65 110.215 -179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' R' R ' 199' ' ' LYS . . . . . 0.516 ' O ' ' HD3' ' S' ' 299' ' ' PRO . 13.2 mtpp -89.9 -52.6 4.89 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.433 -0.792 . . . . 36.77 109.98 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 200' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 62.04 159.88 0.07 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.371 -0.831 . . . . 33.08 110.107 179.787 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' R' R ' 201' ' ' LYS . . . . . 0.632 ' C ' ' HA3' ' S' ' 297' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.695 0 O-C-N 121.379 -0.825 . . . . 44.32 110.328 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' S' S ' 229' ' ' MET . . . . . . . . . . . . . 2.6 ptp . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.2 0.524 . . . . 51.83 110.251 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' S' S ' 230' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -97.3 142.66 28.92 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.39 -0.819 . . . . 54.13 110.182 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 231' ' ' LEU . . . . . . . . . . . . . 67.8 mt -134.05 141.02 47.04 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.339 -0.851 . . . . 33.04 110.386 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 232' ' ' THR . . . . . . . . . . . . . 40.4 m -89.24 103.28 15.92 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.354 -0.841 . . . . 26.92 110.019 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 233' ' ' LEU . . . . . 0.501 HD23 ' CE2' ' S' ' 262' ' ' TYR . 79.8 mt -55.91 179.28 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.538 -0.726 . . . . 13.78 110.5 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' S' S ' 234' ' ' TYR . . . . . 0.444 ' CG ' ' N ' ' S' ' 235' ' ' ASN . 35.5 p90 -65.05 -35.61 81.7 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.347 -0.846 . . . . 26.08 110.167 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' S' S ' 235' ' ' ASN . . . . . 0.444 ' N ' ' CG ' ' S' ' 234' ' ' TYR . 50.6 p30 -74.43 -7.28 52.41 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.313 -0.867 . . . . 20.04 110.581 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' S' S ' 236' ' ' GLY . . . . . . . . . . . . . . . 95.66 -19.9 52.21 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.788 -1.325 . . . . 22.71 109.788 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 237' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -53.08 145.74 12.67 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.212 -1.17 . . . . 35.44 110.189 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 238' ' ' LYS . . . . . . . . . . . . . 44.5 mttt -102.17 127.87 48.91 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.38 -0.825 . . . . 32.56 110.418 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 239' ' ' LYS . . . . . 0.414 ' HG2' ' CZ ' ' S' ' 241' ' ' PHE . 9.0 ttmt -132.32 144.5 50.61 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.407 -0.808 . . . . 26.68 109.958 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' S' S ' 240' ' ' THR . . . . . . . . . . . . . 50.8 m -102.0 132.16 47.99 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.29 -0.881 . . . . 41.02 110.417 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 241' ' ' PHE . . . . . 0.414 ' CZ ' ' HG2' ' S' ' 239' ' ' LYS . 96.1 m-85 -117.84 137.61 52.65 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.347 -0.846 . . . . 28.62 110.213 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' S' S ' 242' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -96.39 161.78 13.77 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.396 -0.815 . . . . 47.89 110.269 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 243' ' ' SER . . . . . . . . . . . . . 72.7 m -90.6 151.58 21.25 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.356 -0.84 . . . . 45.09 110.211 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 244' ' ' ARG . . . . . . . . . . . . . 1.4 mtp85 -129.76 126.83 22.75 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.374 -0.829 . . . . 42.49 110.212 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 245' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.39 161.03 43.57 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 O-C-N 123.664 1.35 . . . . 35.68 110.543 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 246' ' ' ASN . . . . . . . . . . . . . 51.3 t-20 -132.93 97.9 4.15 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.477 -0.764 . . . . 51.88 109.81 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 247' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -110.43 -22.31 11.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.316 -0.865 . . . . 53.69 110.645 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 248' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -117.24 43.73 2.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.202 -0.936 . . . . 55.79 110.751 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 249' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 48.83 38.31 11.72 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.429 -0.794 . . . . 49.45 110.416 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 250' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -90.54 28.95 1.37 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.582 -0.699 . . . . 36.86 110.363 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 251' ' ' ALA . . . . . . . . . . . . . . . -53.8 -43.13 69.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.217 -0.927 . . . . 29.69 109.585 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 252' ' ' TRP . . . . . 0.418 ' CZ2' ' HB3' ' S' ' 294' ' ' LEU . 67.9 p-90 -61.88 -33.89 75.02 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.622 -0.674 . . . . 41.12 109.802 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' S' S ' 253' ' ' LEU . . . . . 0.407 ' N ' ' CD2' ' S' ' 252' ' ' TRP . 23.4 tp -70.21 -47.24 62.35 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.386 -0.821 . . . . 24.89 109.939 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' S' S ' 254' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -56.11 -42.43 76.8 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.507 -0.745 . . . . 35.65 109.979 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 255' ' ' ALA . . . . . . . . . . . . . . . -59.58 -48.19 82.64 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.459 -0.776 . . . . 22.73 110.038 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 256' ' ' ILE . . . . . . . . . . . . . 79.9 mt -62.35 -40.69 88.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.261 -0.9 . . . . 28.85 109.926 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 257' ' ' LEU . . . . . . . . . . . . . 19.4 mt -61.49 -44.47 97.02 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.41 -0.806 . . . . 23.07 110.172 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 258' ' ' GLN . . . . . 0.467 ' HB3' ' CD2' ' S' ' 351' ' ' PHE . 53.3 mm-40 -65.12 -45.36 85.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.458 -0.776 . . . . 29.78 109.896 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' S' S ' 259' ' ' LEU . . . . . 0.43 ' O ' HG22 ' S' ' 263' ' ' VAL . 19.9 tp -58.64 -36.35 73.98 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.322 -0.861 . . . . 17.94 109.51 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' S' S ' 260' ' ' PHE . . . . . 0.468 ' CE2' HD22 ' S' ' 311' ' ' LEU . 3.1 m-85 -62.83 -45.27 93.41 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.593 -0.692 . . . . 30.57 109.812 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' S' S ' 261' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -62.03 -29.89 70.59 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.452 -0.78 . . . . 41.34 110.022 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 262' ' ' TYR . . . . . 0.501 ' CE2' HD23 ' S' ' 233' ' ' LEU . 8.6 t80 -71.15 -44.65 65.12 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.416 -0.803 . . . . 26.03 110.113 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' S' S ' 263' ' ' VAL . . . . . 0.43 HG22 ' O ' ' S' ' 259' ' ' LEU . 33.0 m -92.03 18.3 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.398 -0.814 . . . . 22.8 110.395 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' S' S ' 264' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 52.74 70.61 0.56 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.282 -0.886 . . . . 44.03 110.686 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 265' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -111.75 109.22 55.54 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.373 -0.83 . . . . 35.61 109.669 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 266' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -75.3 0.32 9.17 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.676 1.356 . . . . 37.67 111.79 -179.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 267' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -56.5 -67.63 0.29 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.843 -1.161 . . . . 41.49 110.212 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' S' S ' 268' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -92.96 39.82 1.05 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.138 -0.976 . . . . 50.76 110.057 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 269' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.97 -33.2 59.76 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.424 -0.797 . . . . 61.86 109.737 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' S' S ' 270' ' ' TRP . . . . . 0.482 ' CE2' ' CG2' ' S' ' 271' ' ' VAL . 51.0 p-90 -73.92 -4.3 34.24 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.285 -0.884 . . . . 39.85 110.47 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' S' S ' 271' ' ' VAL . . . . . 0.482 ' CG2' ' CE2' ' S' ' 270' ' ' TRP . 46.4 t -109.56 -32.67 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.114 -0.991 . . . . 39.18 110.085 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' S' S ' 272' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -78.74 -36.46 43.16 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.39 -0.819 . . . . 40.02 110.498 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 273' ' ' SER . . . . . . . . . . . . . 71.0 m -103.58 56.12 0.74 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.346 -0.846 . . . . 47.2 110.276 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 274' ' ' SER . . . . . . . . . . . . . 6.9 t -133.06 141.25 40.2 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.31 -0.869 . . . . 47.61 110.137 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 275' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.71 -18.92 21.8 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.719 1.378 . . . . 45.28 110.541 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 276' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -99.9 140.87 33.49 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.264 -0.897 . . . . 57.27 110.279 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 277' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -71.73 97.65 1.8 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.466 -0.771 . . . . 37.28 110.287 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 278' ' ' LEU . . . . . . . . . . . . . 86.8 mt -97.03 33.87 1.84 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.435 -0.79 . . . . 43.88 109.961 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 279' ' ' THR . . . . . . . . . . . . . 77.8 m -64.1 -60.14 3.59 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.477 -0.764 . . . . 50.05 110.239 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 280' ' ' LEU . . . . . . . . . . . . . 13.6 mt -51.59 -39.89 58.78 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.441 -0.787 . . . . 54.12 110.299 179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 281' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.31 -49.72 74.5 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.454 -0.779 . . . . 65.28 110.161 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' S' S ' 282' ' ' ALA . . . . . . . . . . . . . . . -59.03 -33.84 71.21 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.467 -0.771 . . . . 46.51 110.515 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 283' ' ' ILE . . . . . . . . . . . . . 86.0 mt -66.43 -50.88 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.246 -0.909 . . . . 47.3 110.028 -179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 284' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -50.52 -57.65 7.61 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.461 -0.774 . . . . 50.72 110.361 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 285' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -51.3 -46.38 62.51 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.494 -0.754 . . . . 68.47 110.367 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 286' ' ' LEU . . . . . . . . . . . . . 19.0 mt -60.09 -44.41 94.82 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.435 -0.79 . . . . 36.62 110.242 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 287' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -62.79 -35.29 79.4 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.251 -0.906 . . . . 46.64 110.05 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 288' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -76.21 -21.04 56.92 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.493 -0.754 . . . . 46.45 110.311 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 289' ' ' LEU . . . . . . . . . . . . . 30.7 mt -97.33 -21.65 17.1 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.251 -0.906 . . . . 35.09 110.553 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 290' ' ' THR . . . . . . . . . . . . . 81.4 p -114.84 -28.4 7.08 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.254 -0.904 . . . . 38.61 110.462 -179.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 291' ' ' GLY . . . . . . . . . . . . . . . 79.41 10.96 85.41 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.793 -1.323 . . . . 36.77 109.793 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 292' ' ' LEU . . . . . . . . . . . . . 84.7 mt -96.44 145.77 25.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.25 -1.147 . . . . 35.33 109.779 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 293' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -77.36 102.33 6.74 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.26 -0.9 . . . . 48.7 110.296 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 294' ' ' LEU . . . . . 0.418 ' HB3' ' CZ2' ' S' ' 252' ' ' TRP . 55.3 mt -106.83 51.71 0.74 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.572 -0.705 . . . . 42.61 110.136 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' S' S ' 295' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -112.58 -11.14 13.62 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.287 -0.883 . . . . 55.49 110.539 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' S' S ' 296' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -144.26 48.51 1.37 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.151 -0.968 . . . . 75.68 110.315 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 297' ' ' GLY . . . . . 0.632 ' HA3' ' C ' ' R' ' 201' ' ' LYS . . . 96.91 145.13 18.63 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.502 -1.439 . . . . 49.44 109.502 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' S' S ' 298' ' ' GLY . . . . . 0.437 ' N ' ' HB3' ' R' ' 201' ' ' LYS . . . -163.82 156.9 28.96 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.84 -1.304 . . . . 41.11 109.84 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' S' S ' 299' ' ' PRO . . . . . 0.516 ' HD3' ' O ' ' R' ' 199' ' ' LYS . 47.8 Cg_endo -73.7 118.21 5.36 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 O-C-N 123.932 1.49 . . . . 26.2 110.341 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' S' S ' 300' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.2 -15.42 31.81 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 O-C-N 123.567 1.299 . . . . 21.7 110.728 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 301' ' ' ALA . . . . . . . . . . . . . . . -80.75 -29.35 36.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.258 -0.901 . . . . 31.23 110.133 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 302' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.47 -40.65 18.97 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.426 -0.796 . . . . 38.99 109.943 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' S' S ' 303' ' ' VAL . . . . . 0.473 ' O ' HG12 ' S' ' 307' ' ' ILE . 57.7 t -60.69 -35.53 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.427 -0.795 . . . . 18.63 110.122 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' S' S ' 304' ' ' ILE . . . . . . . . . . . . . 86.0 mt -79.3 -23.67 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.341 -0.849 . . . . 25.46 110.178 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 305' ' ' TRP . . . . . . . . . . . . . 68.9 t-105 -88.69 -14.47 37.24 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.252 -0.905 . . . . 33.4 110.56 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 306' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -89.76 -13.59 36.41 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.215 -0.928 . . . . 36.97 110.363 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 307' ' ' ILE . . . . . 0.473 HG12 ' O ' ' S' ' 303' ' ' VAL . 36.9 pt -125.06 45.57 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.182 -0.949 . . . . 30.81 110.04 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' S' S ' 308' ' ' LYS . . . . . . . . . . . . . 1.5 mtmp? -73.52 -37.73 65.55 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.357 -0.84 . . . . 46.52 110.157 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 309' ' ' HIS . . . . . 0.49 ' CD2' ' HG ' ' S' ' 310' ' ' LEU . 55.5 p-80 -73.16 -8.3 55.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.401 -0.812 . . . . 51.03 110.136 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' S' S ' 310' ' ' LEU . . . . . 0.49 ' HG ' ' CD2' ' S' ' 309' ' ' HIS . 52.9 mt -99.32 -12.83 19.97 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.3 -0.875 . . . . 36.16 109.958 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' S' S ' 311' ' ' LEU . . . . . 0.468 HD22 ' CE2' ' S' ' 260' ' ' PHE . 10.7 mt -97.24 147.87 23.68 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.373 -0.829 . . . . 40.0 110.441 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' S' S ' 312' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -81.58 -16.26 52.14 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.266 -0.896 . . . . 54.18 109.747 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 313' ' ' THR . . . . . 0.48 HG23 ' HB3' ' S' ' 323' ' ' GLU . 92.6 m -87.95 151.67 22.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.332 -0.855 . . . . 25.61 110.134 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' S' S ' 314' ' ' GLY . . . . . . . . . . . . . . . -87.94 126.39 8.04 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.776 -1.33 . . . . 25.18 109.776 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 315' ' ' ILE . . . . . . . . . . . . . 50.7 mm -101.63 150.51 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.427 -1.043 . . . . 23.9 109.757 179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 316' ' ' GLY . . . . . . . . . . . . . . . -157.1 -159.21 9.35 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.006 -1.237 . . . . 23.18 110.006 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 317' ' ' THR . . . . . . . . . . . . . 10.9 p -133.95 -173.03 3.13 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.485 -1.009 . . . . 27.98 109.921 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.6 -56.11 26.17 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.176 -0.953 . . . . 28.1 109.921 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 319' ' ' SER . . . . . . . . . . . . . 1.2 m -60.06 -41.61 92.7 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.331 -0.855 . . . . 37.0 109.593 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 320' ' ' ARG . . . . . . . . . . . . . 12.2 mtm180 -111.71 79.86 2.64 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.525 -0.734 . . . . 52.07 109.719 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 321' ' ' PRO . . . . . 0.674 ' CG ' ' O ' ' S' ' 386' ' ' GLU . 44.1 Cg_endo -71.43 171.54 15.99 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.936 1.492 . . . . 38.29 110.901 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' S' S ' 322' ' ' SER . . . . . 0.433 ' HB2' ' O ' ' S' ' 321' ' ' PRO . 41.2 t 178.64 -148.14 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.905 -0.776 . . . . 38.84 108.905 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' S' S ' 323' ' ' GLU . . . . . 0.48 ' HB3' HG23 ' S' ' 313' ' ' THR . 6.7 tp10 -62.85 -40.28 96.99 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.971 -1.081 . . . . 40.7 109.668 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' S' S ' 324' ' ' VAL . . . . . . . . . . . . . 73.0 t -141.3 135.03 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.399 -0.813 . . . . 20.34 109.471 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 325' ' ' CYS . . . . . 0.45 ' HB2' ' CE1' ' S' ' 380' ' ' PHE . 11.4 m -126.03 172.19 10.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.294 -0.878 . . . . 30.63 110.805 -179.082 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' S' S ' 326' ' ' VAL . . . . . . . . . . . . . 34.5 m -135.47 142.23 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.641 -0.662 . . . . 23.9 109.235 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 327' ' ' VAL . . . . . . . . . . . . . 34.5 m -56.37 125.04 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.078 -1.014 . . . . 19.48 110.42 -179.724 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 328' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -119.38 11.47 12.21 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.442 -0.786 . . . . 26.43 110.411 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 329' ' ' GLY . . . . . . . . . . . . . . . 119.7 2.21 13.06 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.064 -1.214 . . . . 31.24 110.064 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 330' ' ' THR . . . . . . . . . . . . . 81.9 m -93.02 130.03 38.74 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.067 -1.255 . . . . 30.05 110.093 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 331' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -56.8 111.57 1.06 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.315 -0.866 . . . . 37.26 109.948 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 332' ' ' MET . . . . . 0.45 ' HE1' ' CZ ' ' S' ' 380' ' ' PHE . 87.9 mmm -94.16 162.58 13.8 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.268 -0.895 . . . . 26.23 110.322 -179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' S' S ' 333' ' ' CYS . . . . . . . . . . . . . 26.0 m -137.25 150.05 47.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.456 -0.778 . . . . 23.56 110.014 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 334' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.56 -24.93 9.15 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.296 -0.878 . . . . 28.93 110.429 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' S' S ' 335' ' ' ALA . . . . . . . . . . . . . . . -89.02 14.45 10.6 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.38 -0.825 . . . . 15.76 110.986 -179.343 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 336' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -100.53 -17.18 17.23 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.135 -0.978 . . . . 34.92 110.167 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 337' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -152.37 170.86 19.04 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.369 -0.832 . . . . 19.03 110.151 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 338' ' ' HIS . . . . . 0.4 ' HB3' ' CZ ' ' S' ' 383' ' ' TYR . 13.4 p80 -120.72 10.42 10.98 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.37 -0.831 . . . . 18.82 110.47 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' S' S ' 339' ' ' ALA . . . . . . . . . . . . . . . -175.97 155.19 1.57 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.26 -0.9 . . . . 17.18 110.116 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 340' ' ' GLY . . . . . . . . . . . . . . . 160.8 173.08 28.95 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 110.099 -1.201 . . . . 18.33 110.099 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 341' ' ' ILE . . . . . . . . . . . . . 83.8 mt -88.79 138.07 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.504 -0.998 . . . . 18.6 109.824 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 342' ' ' PHE . . . . . 0.504 ' CE1' HG23 ' S' ' 377' ' ' VAL . 69.9 m-85 -120.92 -178.42 3.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.25 -0.906 . . . . 23.44 110.419 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' S' S ' 343' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.81 93.32 4.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.505 -0.747 . . . . 35.59 110.093 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' S' S ' 344' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.83 125.11 29.68 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.34 -0.85 . . . . 38.34 110.013 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' S' S ' 345' ' ' GLY . . . . . . . . . . . . . . . 62.78 -130.86 43.09 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 108.858 -1.697 . . . . 53.46 108.858 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 346' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -132.74 150.87 52.11 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.14 -1.212 . . . . 70.91 110.023 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 347' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 53.3 35.32 19.89 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.294 -0.879 . . . . 47.32 110.452 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 348' ' ' HIS . . . . . . . . . . . . . 46.6 t60 -150.1 155.9 40.67 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.28 -0.888 . . . . 41.72 110.375 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 349' ' ' ALA . . . . . . . . . . . . . . . -149.79 151.25 33.26 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.331 -0.855 . . . . 22.91 110.536 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 350' ' ' VAL . . . . . . . . . . . . . 34.6 m -149.01 169.65 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.417 -0.802 . . . . 21.09 110.018 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 351' ' ' PHE . . . . . 0.467 ' CD2' ' HB3' ' S' ' 258' ' ' GLN . 10.7 t80 -105.41 143.62 33.32 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.237 -0.914 . . . . 25.03 110.689 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' S' S ' 352' ' ' ALA . . . . . . . . . . . . . . . -147.74 151.75 36.59 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.674 -0.641 . . . . 23.81 109.673 179.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 353' ' ' CYS . . . . . . . . . . . . . 26.3 p -153.36 164.78 37.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.28 -0.888 . . . . 25.66 110.283 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 354' ' ' VAL . . . . . 0.405 HG23 ' CZ2' ' S' ' 359' ' ' TRP . 57.0 t -76.02 118.55 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.36 -0.838 . . . . 34.27 109.959 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' S' S ' 355' ' ' THR . . . . . 0.437 HG23 ' HB2' ' S' ' 360' ' ' TYR . 51.7 p -117.88 175.17 5.79 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.257 -0.902 . . . . 25.49 110.271 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' S' S ' 356' ' ' SER . . . . . . . . . . . . . 62.1 p -62.22 -17.69 59.0 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.328 -0.858 . . . . 31.24 110.718 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 357' ' ' ASN . . . . . . . . . . . . . 46.0 m-20 -106.93 14.18 26.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.206 -0.934 . . . . 28.61 110.637 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 358' ' ' GLY . . . . . . . . . . . . . . . 111.86 -152.88 17.6 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.99 -1.244 . . . . 22.01 109.99 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 359' ' ' TRP . . . . . 0.405 ' CZ2' HG23 ' S' ' 354' ' ' VAL . 15.3 m95 -91.33 116.73 29.07 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.44 -1.035 . . . . 25.54 110.14 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' S' S ' 360' ' ' TYR . . . . . 0.437 ' HB2' HG23 ' S' ' 355' ' ' THR . 1.3 m-85 -103.53 165.81 10.81 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.29 -0.881 . . . . 40.53 110.064 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' S' S ' 361' ' ' ALA . . . . . . . . . . . . . . . -140.06 130.1 24.89 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.389 -0.819 . . . . 18.04 110.295 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 362' ' ' ILE . . . . . 0.417 HG23 ' CZ ' ' S' ' 367' ' ' PHE . 88.9 mt -95.66 83.74 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.307 -0.87 . . . . 15.64 109.959 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' S' S ' 363' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' S' ' 365' ' ' GLU . 11.9 t0 -75.24 94.48 2.99 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.403 -0.81 . . . . 35.03 110.227 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' S' S ' 364' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 53.93 -89.37 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.535 -0.728 . . . . 46.72 110.544 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 365' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' S' ' 363' ' ' ASP . 23.8 mt-10 -122.59 19.09 10.4 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.109 -0.994 . . . . 56.2 110.285 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' S' S ' 366' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -117.96 125.03 49.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.228 -0.92 . . . . 51.02 110.361 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 367' ' ' PHE . . . . . 0.417 ' CZ ' HG23 ' S' ' 362' ' ' ILE . 26.9 m-85 -107.0 127.01 53.07 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.406 -0.808 . . . . 37.59 110.168 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' S' S ' 368' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -165.43 159.58 13.92 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.246 -0.909 . . . . 31.47 110.445 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 369' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.88 139.66 30.64 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 O-C-N 123.866 1.456 . . . . 28.85 110.546 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 370' ' ' TRP . . . . . . . . . . . . . 67.3 t90 -167.24 113.51 0.76 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.44 -0.787 . . . . 26.94 109.933 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 371' ' ' THR . . . . . . . . . . . . . 59.6 m -74.75 113.08 20.94 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.379 -0.826 . . . . 20.19 110.034 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 372' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -73.57 157.06 49.21 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 O-C-N 123.597 1.314 . . . . 28.68 110.611 -179.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 373' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -90.6 147.11 35.62 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.442 -0.786 . . . . 35.72 109.947 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 374' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -76.04 -6.15 17.05 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.665 1.35 . . . . 30.89 110.528 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 375' ' ' SER . . . . . . . . . . . . . 68.8 p -104.4 -16.96 14.96 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.19 -0.944 . . . . 29.41 110.474 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 376' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -106.56 43.08 1.18 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.327 -0.858 . . . . 32.89 110.24 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 377' ' ' VAL . . . . . 0.504 HG23 ' CE1' ' S' ' 342' ' ' PHE . 7.3 p -114.64 147.3 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.34 -0.85 . . . . 24.33 110.235 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' S' S ' 378' ' ' LEU . . . . . . . . . . . . . 52.3 mt -116.09 -58.01 2.15 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.441 -0.787 . . . . 24.37 109.582 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 379' ' ' VAL . . . . . . . . . . . . . 61.1 t -120.67 132.41 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.371 -0.831 . . . . 18.02 109.453 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 380' ' ' PHE . . . . . 0.45 ' CE1' ' HB2' ' S' ' 325' ' ' CYS . 14.2 p90 -142.62 173.9 11.12 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.347 -0.845 . . . . 29.35 110.714 -179.341 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' S' S ' 381' ' ' VAL . . . . . . . . . . . . . 58.3 t -120.02 107.32 39.98 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.586 -0.697 . . . . 16.34 109.395 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 382' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -71.26 145.62 49.11 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 O-C-N 123.598 1.315 . . . . 20.94 110.78 -179.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 383' ' ' TYR . . . . . 0.4 ' CZ ' ' HB3' ' S' ' 338' ' ' HIS . 88.3 m-85 -61.01 -53.49 56.54 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.309 -0.869 . . . . 28.93 109.878 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' S' S ' 384' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -106.38 126.54 52.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.486 -0.759 . . . . 47.03 110.333 -176.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' S' S ' 385' ' ' GLN . . . . . 0.445 ' O ' ' C ' ' S' ' 386' ' ' GLU . 5.0 pt20 -61.34 -4.86 1.37 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.407 -0.808 . . . . 46.69 110.294 177.528 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' S' S ' 386' ' ' GLU . . . . . 0.674 ' O ' ' CG ' ' S' ' 321' ' ' PRO . 25.5 mt-10 -40.98 150.67 0.29 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.308 -0.87 . . . . 50.25 109.563 179.327 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' S' S ' 387' ' ' PRO . . . . . 0.773 ' O ' ' O ' ' S' ' 389' ' ' ASN . 50.0 Cg_endo -71.58 24.96 0.24 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.644 1.339 . . . . 34.39 110.609 -177.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' S' S ' 388' ' ' LEU . . . . . 0.731 ' C ' ' O ' ' S' ' 387' ' ' PRO . 1.2 pp -11.27 100.61 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.487 -0.758 . . . . 38.01 110.085 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' S' S ' 389' ' ' ASN . . . . . 0.773 ' O ' ' O ' ' S' ' 387' ' ' PRO . 1.4 t-20 76.0 157.58 0.19 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.346 -0.846 . . . . 45.82 110.116 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' S' S ' 390' ' ' GLY . . . . . 0.49 ' O ' ' CB ' ' S' ' 391' ' ' GLU . . . 151.66 -86.42 0.14 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.624 -1.39 . . . . 33.46 109.624 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' S' S ' 391' ' ' GLU . . . . . 0.49 ' CB ' ' O ' ' S' ' 390' ' ' GLY . 6.1 tt0 67.79 -63.06 0.32 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.351 -1.088 . . . . 56.58 110.123 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' S' S ' 392' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -51.78 -23.68 4.97 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.348 -0.845 . . . . 31.43 110.41 179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' S' S ' 393' ' ' LYS . . . . . 0.488 ' O ' HG11 ' S' ' 396' ' ' VAL . 0.0 OUTLIER -50.76 -36.1 35.06 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.241 -0.912 . . . . 39.42 110.368 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' S' S ' 394' ' ' ALA . . . . . 0.443 ' O ' ' CG ' ' S' ' 398' ' ' ARG . . . -86.91 -15.05 40.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.341 -0.85 . . . . 34.33 110.109 179.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' S' S ' 395' ' ' LYS . . . . . 0.647 ' HB3' ' CD1' ' R' ' 143' ' ' LEU . 21.2 mmmt -80.16 -25.31 39.85 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.467 -0.771 . . . . 60.09 110.258 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' S' S ' 396' ' ' VAL . . . . . 0.658 ' O ' ' HA ' ' R' ' 99' ' ' PRO . 8.8 p -85.31 -36.32 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.27 -0.894 . . . . 35.5 110.56 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' S' S ' 397' ' ' GLN . . . . . 0.401 ' N ' ' CG1' ' S' ' 396' ' ' VAL . 22.7 tt0 -123.96 95.46 4.57 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.136 -0.978 . . . . 49.96 110.653 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' S' S ' 398' ' ' ARG . . . . . 0.602 ' HD3' ' HA ' ' R' ' 147' ' ' GLU . 0.0 OUTLIER -149.26 32.05 0.74 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.232 -0.918 . . . . 43.42 110.723 -179.57 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' S' S ' 399' ' ' LYS . . . . . 0.578 ' O ' ' HB3' ' R' ' 147' ' ' GLU . 6.0 ttpm? 52.3 106.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.454 -0.779 . . . . 55.31 110.033 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' S' S ' 400' ' ' LEU . . . . . 0.912 ' CB ' ' HB1' ' R' ' 51' ' ' ALA . 7.5 mp -80.23 -33.42 38.04 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.3 -0.875 . . . . 41.03 110.272 -178.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' S' S ' 401' ' ' LYS . . . . . 0.545 ' HA ' ' CB ' ' R' ' 49' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.694 0 O-C-N 121.348 -0.845 . . . . 61.97 110.214 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 29' ' ' MET . . . . . . . . . . . . . 2.0 mpp? . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.136 0.493 . . . . 32.14 110.314 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' R' R ' 30' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -96.4 141.19 30.01 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.386 -0.821 . . . . 43.36 110.212 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 31' ' ' LEU . . . . . . . . . . . . . 65.6 mt -134.91 140.58 45.87 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.282 -0.886 . . . . 22.93 110.269 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 32' ' ' THR . . . . . . . . . . . . . 69.6 m -87.54 110.61 20.47 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.439 -0.788 . . . . 22.34 109.971 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 33' ' ' LEU . . . . . 0.461 HD23 ' CE2' ' R' ' 62' ' ' TYR . 80.1 mt -62.5 -172.73 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.408 -0.808 . . . . 21.39 110.215 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 34' ' ' TYR . . . . . . . . . . . . . 37.0 p90 -74.65 -29.39 61.24 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.352 -0.842 . . . . 34.4 110.386 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 35' ' ' ASN . . . . . . . . . . . . . 48.3 p30 -77.78 -1.91 33.78 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.332 -0.855 . . . . 30.28 110.585 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.26 -16.59 59.4 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.754 -1.338 . . . . 36.25 109.754 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 37' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -58.97 161.81 4.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.315 -1.109 . . . . 53.8 110.383 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 38' ' ' LYS . . . . . . . . . . . . . 56.9 mttt -117.87 135.71 53.92 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.39 -0.818 . . . . 49.91 110.151 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 39' ' ' LYS . . . . . 0.415 ' HG2' ' CZ ' ' R' ' 41' ' ' PHE . 8.1 ttmt -138.74 143.73 39.16 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.388 -0.82 . . . . 35.69 110.182 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 40' ' ' THR . . . . . . . . . . . . . 23.7 m -102.57 128.01 49.41 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.305 -0.872 . . . . 34.84 110.193 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 41' ' ' PHE . . . . . 0.415 ' CZ ' ' HG2' ' R' ' 39' ' ' LYS . 96.6 m-85 -113.12 132.66 55.36 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.381 -0.824 . . . . 34.42 110.14 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 42' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -93.29 140.86 29.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.331 -0.856 . . . . 51.46 110.255 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 43' ' ' SER . . . . . . . . . . . . . 53.6 m -70.73 141.89 51.48 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.421 -0.799 . . . . 41.84 110.186 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.74 125.37 29.59 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.361 -0.837 . . . . 33.82 110.013 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 45' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.11 151.13 55.13 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.596 1.314 . . . . 30.27 110.625 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 46' ' ' ASN . . . . . . . . . . . . . 52.2 t-20 -124.3 109.87 13.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.48 -0.762 . . . . 35.1 110.033 179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 47' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -120.29 -34.88 3.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.285 -0.884 . . . . 42.81 110.55 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 48' ' ' HIS . . . . . . . . . . . . . 73.3 m80 -105.86 45.23 0.98 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.213 -0.929 . . . . 49.97 110.24 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 49' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 50.29 34.68 9.22 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.447 -0.783 . . . . 61.32 110.149 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 50' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -86.21 43.78 1.08 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.32 -0.862 . . . . 51.5 110.744 -179.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 51' ' ' ALA . . . . . 0.722 ' HB2' ' CB ' ' S' ' 400' ' ' LEU . . . -66.08 -46.14 78.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.193 -0.942 . . . . 38.77 109.476 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 52' ' ' TRP . . . . . 0.484 ' CD2' ' N ' ' R' ' 53' ' ' LEU . 68.1 p-90 -58.42 -38.43 77.4 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.595 -0.691 . . . . 26.24 110.036 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 53' ' ' LEU . . . . . 0.484 ' N ' ' CD2' ' R' ' 52' ' ' TRP . 23.2 tp -66.75 -46.66 74.71 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.439 -0.788 . . . . 26.75 109.991 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 54' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -55.11 -41.64 71.91 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.369 -0.832 . . . . 35.02 110.208 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.19 -46.03 92.16 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.396 -0.815 . . . . 24.47 110.172 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 56' ' ' ILE . . . . . . . . . . . . . 76.1 mt -62.26 -42.22 94.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.346 -0.846 . . . . 26.03 109.857 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 57' ' ' LEU . . . . . . . . . . . . . 22.5 mt -60.24 -45.67 92.45 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.364 -0.835 . . . . 26.77 109.655 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 58' ' ' GLN . . . . . . . . . . . . . 57.7 mm-40 -63.95 -46.53 84.29 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.456 -0.777 . . . . 22.32 109.592 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 59' ' ' LEU . . . . . 0.429 ' HA ' ' HE2' ' R' ' 151' ' ' PHE . 23.9 tp -61.34 -37.81 84.64 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.365 -0.834 . . . . 20.55 109.427 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 60' ' ' PHE . . . . . 0.447 ' CE2' HD22 ' R' ' 111' ' ' LEU . 2.8 m-85 -61.06 -44.74 96.92 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.67 -0.644 . . . . 20.08 109.913 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 61' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -63.07 -36.19 82.77 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.45 -0.781 . . . . 18.8 110.528 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 62' ' ' TYR . . . . . 0.461 ' CE2' HD23 ' R' ' 33' ' ' LEU . 9.3 t80 -63.06 -41.8 99.53 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.158 -0.964 . . . . 26.45 110.217 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 63' ' ' VAL . . . . . . . . . . . . . 30.2 m -93.37 20.43 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.247 -0.908 . . . . 29.75 110.263 179.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 64' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 52.87 75.53 0.24 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.335 -0.853 . . . . 35.52 110.582 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 65' ' ' GLU . . . . . 0.425 ' HG2' ' CD2' ' R' ' 60' ' ' PHE . 14.3 tp10 -116.22 104.06 52.45 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.45 -0.782 . . . . 29.89 109.948 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 66' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.55 -5.81 17.71 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.864 1.455 . . . . 21.37 111.089 -179.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 67' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -52.15 -61.47 2.25 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.169 -0.957 . . . . 23.85 110.39 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 68' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -98.13 36.51 1.57 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.34 -0.85 . . . . 28.07 110.475 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 69' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -72.33 -33.23 67.18 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.312 -0.867 . . . . 43.76 110.18 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 70' ' ' TRP . . . . . 0.476 ' CE2' ' CG2' ' R' ' 71' ' ' VAL . 47.7 p-90 -73.39 -3.9 30.17 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.293 -0.879 . . . . 33.06 110.739 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 71' ' ' VAL . . . . . 0.476 ' CG2' ' CE2' ' R' ' 70' ' ' TRP . 40.8 t -109.79 -27.5 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.237 -0.914 . . . . 31.7 109.679 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 72' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -86.42 -49.0 7.94 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.395 -0.815 . . . . 33.58 110.299 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 73' ' ' SER . . . . . . . . . . . . . 69.8 m -89.57 50.99 2.0 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.274 -0.892 . . . . 50.82 110.39 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 74' ' ' SER . . . . . . . . . . . . . 15.9 t -125.85 138.28 31.71 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.21 -0.931 . . . . 34.74 110.262 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.33 -25.02 15.98 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.702 1.369 . . . . 35.7 110.308 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 76' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -91.7 153.23 19.79 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.364 -0.835 . . . . 66.48 110.3 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 77' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -81.56 95.29 7.09 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.332 -0.855 . . . . 46.72 110.064 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 78' ' ' LEU . . . . . . . . . . . . . 96.3 mt -96.45 27.96 3.55 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.443 -0.786 . . . . 37.55 110.186 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 79' ' ' THR . . . . . . . . . . . . . 29.7 m -56.24 -54.62 43.14 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.337 -0.852 . . . . 37.36 110.286 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 80' ' ' LEU . . . . . . . . . . . . . 15.9 mt -60.9 -23.26 65.08 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.379 -0.826 . . . . 35.83 110.514 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 81' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -79.41 -39.15 33.15 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.142 -0.974 . . . . 44.03 110.37 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.48 -28.54 66.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.288 -0.882 . . . . 32.54 110.291 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 83' ' ' ILE . . . . . . . . . . . . . 78.2 mt -70.18 -46.06 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.237 -0.915 . . . . 32.02 110.302 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 84' ' ' LYS . . . . . . . . . . . . . 36.0 tttm -55.29 -52.05 64.69 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.164 -0.96 . . . . 34.09 110.532 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 85' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -54.71 -46.98 74.25 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.313 -0.867 . . . . 25.94 110.308 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 86' ' ' LEU . . . . . . . . . . . . . 24.1 mt -58.62 -43.82 89.78 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.346 -0.846 . . . . 16.2 109.965 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 87' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -65.3 -35.27 80.48 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.466 -0.771 . . . . 49.09 110.349 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 88' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -78.5 -18.93 54.08 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.283 -0.886 . . . . 28.61 110.523 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 89' ' ' LEU . . . . . . . . . . . . . 32.8 mt -96.25 -29.34 14.07 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.26 -0.9 . . . . 26.16 110.238 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 90' ' ' THR . . . . . . . . . . . . . 58.2 p -105.72 -34.57 7.66 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.226 -0.921 . . . . 33.33 109.806 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.73 16.12 58.75 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.937 -1.265 . . . . 31.13 109.937 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 92' ' ' LEU . . . . . . . . . . . . . 97.1 mt -100.14 155.2 17.87 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.103 -1.234 . . . . 42.52 110.237 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 93' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -86.18 91.65 8.51 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.567 -0.708 . . . . 68.46 109.911 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 94' ' ' LEU . . . . . 0.446 ' HB3' ' CZ2' ' R' ' 52' ' ' TRP . 47.7 mt -99.49 53.11 0.94 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.272 -0.893 . . . . 44.63 110.319 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 95' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.49 -38.67 6.38 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.331 -0.856 . . . . 67.16 110.399 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 96' ' ' GLU . . . . . 0.434 ' O ' ' CE ' ' S' ' 399' ' ' LYS . 24.4 mt-10 -113.93 44.23 1.68 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.332 -0.855 . . . . 67.02 110.255 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 97' ' ' GLY . . . . . 0.807 ' HA3' ' CB ' ' S' ' 399' ' ' LYS . . . 99.15 150.81 26.04 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.674 -1.37 . . . . 49.48 109.674 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 98' ' ' GLY . . . . . . . . . . . . . . . -166.26 160.03 33.47 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.311 -1.516 . . . . 36.57 109.311 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 99' ' ' PRO . . . . . 0.603 ' CB ' HG23 ' S' ' 396' ' ' VAL . 45.0 Cg_endo -72.59 121.14 7.17 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 123.741 1.39 . . . . 30.41 110.435 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 100' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -72.37 -31.67 11.17 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 O-C-N 123.58 1.305 . . . . 29.94 110.452 -179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 101' ' ' ALA . . . . . 0.849 ' HB2' HG22 ' S' ' 396' ' ' VAL . . . -69.9 -38.46 76.32 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.228 -0.92 . . . . 23.64 110.327 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.73 -40.72 65.88 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.373 -0.829 . . . . 20.31 110.323 -179.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 103' ' ' VAL . . . . . . . . . . . . . 63.3 t -58.13 -40.05 75.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.21 -0.931 . . . . 16.33 110.065 179.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 104' ' ' ILE . . . . . . . . . . . . . 81.9 mt -71.71 -30.51 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.397 -0.814 . . . . 24.77 109.956 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 105' ' ' TRP . . . . . 0.441 ' O ' ' HD3' ' R' ' 108' ' ' LYS . 70.6 t-105 -82.51 0.9 40.35 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.323 -0.861 . . . . 23.28 110.292 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 106' ' ' ASN . . . . . . . . . . . . . 6.8 m-80 -105.09 -10.38 17.2 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.144 -0.973 . . . . 28.26 110.123 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 107' ' ' ILE . . . . . . . . . . . . . 36.7 pt -126.83 35.02 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.181 -0.949 . . . . 18.77 110.033 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 108' ' ' LYS . . . . . 0.48 ' HG2' ' HB ' ' R' ' 115' ' ' ILE . 9.3 mtpp -61.03 -48.48 81.56 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.516 -0.74 . . . . 42.5 110.037 179.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 109' ' ' HIS . . . . . 0.432 ' CD2' ' HG ' ' R' ' 110' ' ' LEU . 50.9 p-80 -66.06 -12.83 58.06 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.499 -0.75 . . . . 20.07 110.688 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 110' ' ' LEU . . . . . 0.432 ' HG ' ' CD2' ' R' ' 109' ' ' HIS . 80.3 mt -94.8 -17.3 22.25 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.083 -1.011 . . . . 15.69 110.196 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 111' ' ' LEU . . . . . 0.447 HD22 ' CE2' ' R' ' 60' ' ' PHE . 10.3 mt -94.09 144.15 25.74 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.342 -0.849 . . . . 25.39 111.008 -179.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 112' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -77.67 -17.43 57.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.487 -0.758 . . . . 53.48 109.823 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 113' ' ' THR . . . . . 0.418 HG22 ' HG2' ' R' ' 123' ' ' GLU . 60.5 m -83.67 166.64 17.94 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.308 -0.87 . . . . 14.8 110.247 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 114' ' ' GLY . . . . . . . . . . . . . . . -98.0 127.12 9.12 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.042 -1.223 . . . . 16.14 110.042 -179.637 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 115' ' ' ILE . . . . . 0.48 ' HB ' ' HG2' ' R' ' 108' ' ' LYS . 47.8 mm -109.02 139.34 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.478 -1.013 . . . . 13.46 109.741 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 116' ' ' GLY . . . . . . . . . . . . . . . -152.71 -155.8 7.26 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.011 -1.236 . . . . 23.9 110.011 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 117' ' ' THR . . . . . . . . . . . . . 18.8 p -135.03 -171.33 2.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.514 -0.992 . . . . 27.37 110.059 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.62 -58.06 9.72 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.216 -0.927 . . . . 18.76 110.083 179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 119' ' ' SER . . . . . 0.562 ' HB3' ' HB ' ' R' ' 196' ' ' VAL . 1.1 m -56.55 -40.56 75.36 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.251 -0.905 . . . . 32.35 109.815 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 120' ' ' ARG . . . . . 0.417 ' NH1' ' NE1' ' S' ' 305' ' ' TRP . 10.0 mtm180 -110.07 86.29 4.91 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.43 -0.794 . . . . 27.12 109.716 179.337 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 121' ' ' PRO . . . . . 0.427 ' O ' ' HB2' ' R' ' 122' ' ' SER . 44.0 Cg_endo -71.32 166.53 28.98 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 O-C-N 123.86 1.453 . . . . 22.68 110.998 -179.394 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 122' ' ' SER . . . . . 0.427 ' HB2' ' O ' ' R' ' 121' ' ' PRO . 38.3 t 178.53 -161.72 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.6 -0.687 . . . . 22.99 109.461 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 123' ' ' GLU . . . . . 0.418 ' HG2' HG22 ' R' ' 113' ' ' THR . 2.3 tp10 -56.45 -39.98 74.04 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.211 -0.93 . . . . 36.18 109.622 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 124' ' ' VAL . . . . . . . . . . . . . 83.5 t -142.54 136.44 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.597 -0.689 . . . . 20.64 109.428 179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 125' ' ' CYS . . . . . 0.409 ' SG ' ' HA ' ' R' ' 121' ' ' PRO . 83.4 m -140.32 168.16 20.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.145 -0.972 . . . . 22.8 111.171 -179.276 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 126' ' ' VAL . . . . . . . . . . . . . 35.8 m -122.72 159.77 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.724 -0.61 . . . . 21.24 109.695 179.646 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 127' ' ' VAL . . . . . 0.4 ' CG1' ' O ' ' R' ' 177' ' ' VAL . 30.8 m -70.83 141.85 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.293 -0.879 . . . . 19.77 110.681 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 128' ' ' ASP . . . . . . . . . . . . . 54.0 p-10 -137.68 19.34 2.88 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.405 -0.809 . . . . 29.21 110.702 179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 129' ' ' GLY . . . . . . . . . . . . . . . 113.99 0.02 24.14 Favored Glycine 0 N--CA 1.493 2.458 0 C-N-CA 119.977 -1.106 . . . . 33.86 110.472 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 130' ' ' THR . . . . . . . . . . . . . 58.3 m -91.76 131.83 36.85 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.084 -1.244 . . . . 26.41 110.07 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -62.59 120.66 11.59 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.35 -0.844 . . . . 33.08 110.312 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 132' ' ' MET . . . . . 0.427 ' HE1' ' CZ ' ' R' ' 180' ' ' PHE . 98.4 mmm -105.22 165.64 10.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.395 -0.816 . . . . 30.76 110.377 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 133' ' ' CYS . . . . . . . . . . . . . 32.6 m -141.16 158.14 44.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.507 -0.745 . . . . 27.0 109.932 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 134' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.57 -19.6 39.54 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.388 -0.82 . . . . 33.9 110.498 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 135' ' ' ALA . . . . . . . . . . . . . . . -92.79 8.16 40.62 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.294 -0.879 . . . . 19.37 110.755 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 136' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -93.74 -21.86 19.07 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.207 -0.933 . . . . 30.47 110.216 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 137' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -149.94 165.35 32.89 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.351 -0.843 . . . . 24.27 110.231 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 138' ' ' HIS . . . . . . . . . . . . . 15.1 p80 -117.82 15.15 14.38 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.429 -0.794 . . . . 20.91 110.452 179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 139' ' ' ALA . . . . . 0.44 ' HA ' ' O ' ' R' ' 152' ' ' ALA . . . -177.16 152.49 0.89 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.167 -0.958 . . . . 15.69 110.137 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 140' ' ' GLY . . . . . 0.404 ' HA3' ' O ' ' R' ' 179' ' ' VAL . . . 161.74 175.1 32.41 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 110.007 -1.237 . . . . 23.76 110.007 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 141' ' ' ILE . . . . . . . . . . . . . 83.6 mt -95.48 136.57 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.447 -1.031 . . . . 25.3 109.682 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 142' ' ' PHE . . . . . 0.547 ' CD2' ' HB2' ' R' ' 172' ' ' PRO . 82.6 m-85 -120.75 -172.66 2.43 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.33 -0.856 . . . . 30.24 110.54 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 143' ' ' LEU . . . . . 0.622 ' CD1' ' HB3' ' S' ' 395' ' ' LYS . 0.5 OUTLIER -119.75 77.84 1.27 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.459 -0.776 . . . . 32.8 110.304 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' R' R ' 144' ' ' LYS . . . . . 0.454 ' HG3' ' CZ2' ' R' ' 170' ' ' TRP . 1.0 OUTLIER -69.67 76.93 0.44 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.381 -0.824 . . . . 49.18 109.653 179.573 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' R' R ' 145' ' ' GLY . . . . . . . . . . . . . . . 104.52 179.23 24.81 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.16 -1.576 . . . . 53.87 109.16 -179.597 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 146' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -88.44 145.86 25.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.319 -1.107 . . . . 68.58 109.999 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 147' ' ' GLU . . . . . 0.735 ' HA ' ' CB ' ' S' ' 398' ' ' ARG . 10.9 mt-10 58.19 36.58 25.88 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.294 -0.879 . . . . 56.62 110.633 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 148' ' ' HIS . . . . . 0.601 ' HA ' ' O ' ' S' ' 399' ' ' LYS . 45.1 t60 -158.67 148.11 19.17 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.243 -0.911 . . . . 44.57 110.398 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 149' ' ' ALA . . . . . . . . . . . . . . . -150.25 146.9 27.08 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.451 -0.781 . . . . 33.54 110.061 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 150' ' ' VAL . . . . . 0.428 HG23 ' HB2' ' R' ' 144' ' ' LYS . 34.2 m -142.38 161.51 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.246 -0.909 . . . . 27.61 110.322 179.641 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 151' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' R' ' 152' ' ' ALA . 5.9 t80 -86.18 155.57 20.68 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.383 -0.823 . . . . 23.04 109.901 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 152' ' ' ALA . . . . . 0.537 ' N ' ' CD1' ' R' ' 151' ' ' PHE . . . -157.31 151.56 24.92 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.447 -0.783 . . . . 29.61 109.53 178.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 153' ' ' CYS . . . . . 0.406 ' HA ' ' HA ' ' R' ' 139' ' ' ALA . 26.7 p -154.28 173.56 15.99 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.28 -0.888 . . . . 22.75 110.539 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 154' ' ' VAL . . . . . 0.443 ' CG2' ' CZ2' ' R' ' 159' ' ' TRP . 59.9 t -90.52 117.04 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.429 -0.794 . . . . 23.26 110.057 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 155' ' ' THR . . . . . . . . . . . . . 71.0 p -112.18 -176.62 2.96 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.361 -0.837 . . . . 17.88 110.058 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 156' ' ' SER . . . . . . . . . . . . . 78.4 p -75.96 -3.68 36.89 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.32 -0.863 . . . . 21.83 110.716 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 157' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -118.33 10.57 12.82 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.096 -1.002 . . . . 36.54 110.625 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 158' ' ' GLY . . . . . . . . . . . . . . . 117.83 -162.6 13.01 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.55 -1.42 . . . . 31.74 109.55 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 159' ' ' TRP . . . . . 0.443 ' CZ2' ' CG2' ' R' ' 154' ' ' VAL . 14.6 m95 -86.63 122.54 30.7 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.386 -1.067 . . . . 28.25 110.061 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 160' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -108.48 166.92 10.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.346 -0.846 . . . . 41.24 110.25 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 161' ' ' ALA . . . . . . . . . . . . . . . -143.25 123.39 13.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.435 -0.791 . . . . 27.4 110.182 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 162' ' ' ILE . . . . . 0.431 HG23 ' CZ ' ' R' ' 167' ' ' PHE . 92.6 mt -87.57 81.24 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.398 -0.814 . . . . 24.27 110.055 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 163' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' R' ' 165' ' ' GLU . 15.3 t0 -72.85 92.37 1.6 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.458 -0.776 . . . . 36.08 110.237 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 164' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 54.09 -88.97 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.489 -0.757 . . . . 46.08 110.603 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 165' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' R' ' 163' ' ' ASP . 29.6 mt-10 -124.72 36.0 4.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.109 -0.994 . . . . 50.94 110.194 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 166' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -135.69 117.3 14.91 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.405 -0.81 . . . . 47.28 110.361 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 167' ' ' PHE . . . . . 0.431 ' CZ ' HG23 ' R' ' 162' ' ' ILE . 24.2 m-85 -101.06 119.91 39.43 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.367 -0.833 . . . . 40.47 110.178 179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 168' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -157.51 158.56 30.71 Favored Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 121.235 -0.916 . . . . 30.21 110.454 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 169' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.77 133.05 19.52 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 O-C-N 123.866 1.456 . . . . 32.76 110.531 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 170' ' ' TRP . . . . . 0.454 ' CZ2' ' HG3' ' R' ' 144' ' ' LYS . 67.2 t90 -159.78 119.27 2.88 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.444 -0.785 . . . . 32.79 109.958 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 171' ' ' THR . . . . . . . . . . . . . 45.5 m -81.08 112.58 33.87 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.423 -0.798 . . . . 36.92 110.219 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 172' ' ' PRO . . . . . 0.547 ' HB2' ' CD2' ' R' ' 142' ' ' PHE . 46.8 Cg_endo -73.77 158.81 46.39 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.634 1.334 . . . . 33.54 110.556 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 173' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -88.85 144.93 33.77 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.409 -0.807 . . . . 45.76 109.913 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 174' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.72 -10.35 26.37 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.649 1.342 . . . . 29.63 110.505 179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 175' ' ' SER . . . . . . . . . . . . . 53.0 p -103.41 -17.63 15.17 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.273 -0.892 . . . . 35.7 110.367 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 176' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -103.58 43.3 1.09 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.261 -0.899 . . . . 39.65 110.362 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 177' ' ' VAL . . . . . 0.4 ' O ' ' CG1' ' R' ' 127' ' ' VAL . 10.5 p -117.78 127.23 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.266 -0.896 . . . . 20.61 110.006 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 178' ' ' LEU . . . . . 0.621 HD23 ' HB ' ' S' ' 396' ' ' VAL . 46.4 mt -91.6 -61.25 1.68 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.368 -0.832 . . . . 15.58 109.364 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 179' ' ' VAL . . . . . 0.404 ' O ' ' HA3' ' R' ' 140' ' ' GLY . 67.5 t -114.6 144.67 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.66 -0.65 . . . . 17.4 109.444 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 180' ' ' PHE . . . . . 0.427 ' CZ ' ' HE1' ' R' ' 132' ' ' MET . 43.4 p90 -152.13 163.36 39.53 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.33 -0.856 . . . . 20.16 110.517 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 181' ' ' VAL . . . . . . . . . . . . . 65.9 t -113.1 111.5 50.44 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.363 -0.836 . . . . 17.69 109.848 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 182' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.09 149.57 52.62 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 O-C-N 123.638 1.336 . . . . 17.81 110.403 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 183' ' ' TYR . . . . . 0.688 ' O ' ' C ' ' R' ' 184' ' ' ASP . 78.9 m-85 -59.13 175.44 0.3 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.401 -0.812 . . . . 28.01 110.54 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 184' ' ' ASP . . . . . 0.688 ' C ' ' O ' ' R' ' 183' ' ' TYR . 2.3 m-20 -20.0 -84.04 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.315 -0.866 . . . . 58.64 110.242 -178.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 185' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 . . . . . 0 N--CA 1.502 2.173 0 CA-C-O 121.22 0.533 . . . . 80.42 111.75 179.617 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' R' R ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 120.823 0.344 . . . . 49.5 110.16 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 194' ' ' ALA . . . . . 0.414 ' CB ' ' HG2' ' R' ' 197' ' ' GLN . . . -168.93 -155.21 0.14 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.218 -0.927 . . . . 40.4 110.144 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 195' ' ' LYS . . . . . . . . . . . . . 17.1 mtmt -89.5 -52.35 5.07 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.386 -0.821 . . . . 34.6 110.278 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 196' ' ' VAL . . . . . 0.562 ' HB ' ' HB3' ' R' ' 119' ' ' SER . 23.1 t -93.51 59.6 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.254 -0.904 . . . . 33.27 110.585 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 197' ' ' GLN . . . . . 0.414 ' HG2' ' CB ' ' R' ' 194' ' ' ALA . 3.2 pp0? -164.62 21.21 0.06 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.143 -0.973 . . . . 41.58 110.717 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 198' ' ' ARG . . . . . . . . . . . . . 9.5 ptt-85 -120.08 165.44 14.72 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.112 -0.993 . . . . 38.65 110.23 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 199' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.78 81.36 2.28 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.478 -0.764 . . . . 36.77 109.921 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' R' R ' 200' ' ' LEU . . . . . . . . . . . . . 3.3 tp -69.07 -159.14 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.443 -0.786 . . . . 33.08 110.135 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' R' R ' 201' ' ' LYS . . . . . 0.567 ' HA ' ' HA3' ' S' ' 297' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 O-C-N 121.393 -0.817 . . . . 44.32 110.29 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' S' S ' 229' ' ' MET . . . . . . . . . . . . . 5.1 mtm . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.188 0.518 . . . . 51.83 110.216 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' S' S ' 230' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -97.29 142.71 28.84 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.34 -0.85 . . . . 54.13 110.199 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 231' ' ' LEU . . . . . . . . . . . . . 67.3 mt -134.07 140.98 47.0 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.388 -0.82 . . . . 33.04 110.364 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 232' ' ' THR . . . . . . . . . . . . . 40.3 m -89.26 103.28 15.92 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.305 -0.872 . . . . 26.92 110.032 179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 233' ' ' LEU . . . . . 0.489 HD23 ' CE2' ' S' ' 262' ' ' TYR . 79.8 mt -55.88 179.24 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.437 -0.79 . . . . 13.78 110.463 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' S' S ' 234' ' ' TYR . . . . . 0.448 ' CG ' ' N ' ' S' ' 235' ' ' ASN . 35.5 p90 -65.01 -35.66 81.9 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.384 -0.823 . . . . 26.08 110.168 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' S' S ' 235' ' ' ASN . . . . . 0.448 ' N ' ' CG ' ' S' ' 234' ' ' TYR . 50.6 p30 -74.38 -7.35 52.6 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.336 -0.852 . . . . 20.04 110.5 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' S' S ' 236' ' ' GLY . . . . . . . . . . . . . . . 95.69 -19.9 52.18 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.777 -1.329 . . . . 22.71 109.777 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 237' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -52.94 145.68 12.33 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.2 -1.176 . . . . 35.44 110.236 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 238' ' ' LYS . . . . . . . . . . . . . 44.5 mttt -102.18 127.92 48.91 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.358 -0.839 . . . . 32.56 110.41 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 239' ' ' LYS . . . . . 0.416 ' HG2' ' CZ ' ' S' ' 241' ' ' PHE . 9.0 ttmt -132.29 144.55 50.67 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.371 -0.831 . . . . 26.68 109.919 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' S' S ' 240' ' ' THR . . . . . . . . . . . . . 52.1 m -102.07 132.18 48.09 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.304 -0.872 . . . . 41.02 110.334 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 241' ' ' PHE . . . . . 0.416 ' CZ ' ' HG2' ' S' ' 239' ' ' LYS . 96.0 m-85 -117.94 137.66 52.68 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.335 -0.853 . . . . 28.62 110.21 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' S' S ' 242' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -96.32 161.78 13.79 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.302 -0.874 . . . . 47.89 110.198 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 243' ' ' SER . . . . . . . . . . . . . 71.5 m -90.58 151.47 21.3 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.332 -0.855 . . . . 45.09 110.227 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 244' ' ' ARG . . . . . . . . . . . . . 1.4 mtp85 -129.69 126.77 22.78 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.349 -0.844 . . . . 42.49 110.247 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 245' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.35 161.0 43.74 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.74 1.389 . . . . 35.68 110.561 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 246' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -132.87 97.87 4.15 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.408 -0.807 . . . . 51.88 109.867 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 247' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -110.49 -22.22 11.77 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.321 -0.862 . . . . 53.69 110.655 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 248' ' ' HIS . . . . . . . . . . . . . 76.5 m80 -117.21 43.61 2.28 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.16 -0.963 . . . . 55.79 110.761 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 249' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 48.77 38.46 11.85 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.417 -0.802 . . . . 49.45 110.39 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 250' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -90.65 29.02 1.38 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.496 -0.753 . . . . 36.86 110.364 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 251' ' ' ALA . . . . . . . . . . . . . . . -53.79 -43.23 69.12 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.281 -0.887 . . . . 29.69 109.563 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 252' ' ' TRP . . . . . 0.416 ' CZ2' ' HB3' ' S' ' 294' ' ' LEU . 67.9 p-90 -61.76 -33.95 74.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.602 -0.686 . . . . 41.12 109.886 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' S' S ' 253' ' ' LEU . . . . . . . . . . . . . 23.4 tp -70.11 -47.23 62.66 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.446 -0.783 . . . . 24.89 110.016 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 254' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -56.16 -42.44 77.03 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.299 -0.875 . . . . 35.65 109.975 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 255' ' ' ALA . . . . . . . . . . . . . . . -59.57 -48.1 82.97 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.447 -0.783 . . . . 22.73 110.141 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 256' ' ' ILE . . . . . . . . . . . . . 79.7 mt -62.32 -40.7 88.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.273 -0.892 . . . . 28.85 109.924 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 257' ' ' LEU . . . . . . . . . . . . . 19.0 mt -61.54 -44.48 96.98 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.354 -0.841 . . . . 23.07 110.168 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 258' ' ' GLN . . . . . 0.469 ' HB3' ' CD2' ' S' ' 351' ' ' PHE . 53.4 mm-40 -65.09 -45.33 85.66 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.398 -0.814 . . . . 29.78 109.953 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' S' S ' 259' ' ' LEU . . . . . 0.43 ' O ' HG22 ' S' ' 263' ' ' VAL . 19.9 tp -58.73 -36.27 74.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.285 -0.885 . . . . 17.94 109.484 179.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' S' S ' 260' ' ' PHE . . . . . 0.468 ' CE2' HD22 ' S' ' 311' ' ' LEU . 3.1 m-85 -62.89 -45.24 93.44 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.663 -0.648 . . . . 30.57 109.808 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' S' S ' 261' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -62.08 -29.82 70.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.454 -0.779 . . . . 41.34 110.015 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 262' ' ' TYR . . . . . 0.489 ' CE2' HD23 ' S' ' 233' ' ' LEU . 8.7 t80 -71.17 -44.6 65.17 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.416 -0.802 . . . . 26.03 110.137 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' S' S ' 263' ' ' VAL . . . . . 0.43 HG22 ' O ' ' S' ' 259' ' ' LEU . 33.0 m -92.06 18.23 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.385 -0.822 . . . . 22.8 110.412 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' S' S ' 264' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 52.76 70.67 0.55 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.291 -0.881 . . . . 44.03 110.568 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 265' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -111.77 109.16 55.53 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.257 -0.902 . . . . 35.61 109.716 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 266' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -75.24 0.37 9.08 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.579 1.305 . . . . 37.67 111.728 -179.108 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 267' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -56.53 -67.65 0.29 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.806 -1.184 . . . . 41.49 110.203 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' S' S ' 268' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -92.91 39.85 1.05 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.164 -0.96 . . . . 50.76 110.098 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 269' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.0 -33.16 59.7 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.322 -0.861 . . . . 61.86 109.83 179.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' S' S ' 270' ' ' TRP . . . . . 0.492 ' CE2' ' CG2' ' S' ' 271' ' ' VAL . 51.0 p-90 -73.97 -4.28 34.28 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.208 -0.932 . . . . 39.85 110.489 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' S' S ' 271' ' ' VAL . . . . . 0.492 ' CG2' ' CE2' ' S' ' 270' ' ' TRP . 46.5 t -109.5 -32.77 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.129 -0.982 . . . . 39.18 110.051 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' S' S ' 272' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -78.65 -36.47 43.83 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.384 -0.822 . . . . 40.02 110.514 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 273' ' ' SER . . . . . . . . . . . . . 70.9 m -103.59 56.08 0.74 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.269 -0.894 . . . . 47.2 110.291 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 274' ' ' SER . . . . . . . . . . . . . 6.9 t -133.04 141.23 40.17 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.371 -0.83 . . . . 47.61 110.108 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 275' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.74 -18.92 21.7 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 O-C-N 123.617 1.325 . . . . 45.28 110.583 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 276' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -99.88 140.88 33.46 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.247 -0.908 . . . . 57.27 110.288 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 277' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -71.66 97.56 1.75 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.368 -0.832 . . . . 37.28 110.272 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 278' ' ' LEU . . . . . . . . . . . . . 86.5 mt -96.97 33.87 1.83 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.329 -0.857 . . . . 43.88 110.023 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 279' ' ' THR . . . . . . . . . . . . . 78.1 m -64.12 -60.08 3.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.505 -0.747 . . . . 50.05 110.273 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 280' ' ' LEU . . . . . . . . . . . . . 13.7 mt -51.58 -39.92 58.8 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.352 -0.843 . . . . 54.12 110.255 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 281' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.41 -49.65 74.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.467 -0.77 . . . . 65.28 110.108 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' S' S ' 282' ' ' ALA . . . . . . . . . . . . . . . -58.95 -33.95 71.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.439 -0.788 . . . . 46.51 110.512 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 283' ' ' ILE . . . . . . . . . . . . . 86.0 mt -66.39 -50.82 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.358 -0.839 . . . . 47.3 110.092 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 284' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -50.52 -57.63 7.67 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.444 -0.785 . . . . 50.72 110.358 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 285' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -51.41 -46.36 62.89 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.578 -0.701 . . . . 68.47 110.346 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 286' ' ' LEU . . . . . . . . . . . . . 19.0 mt -59.96 -44.53 94.37 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.448 -0.782 . . . . 36.62 110.245 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 287' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -62.78 -35.21 79.09 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.288 -0.883 . . . . 46.64 110.083 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 288' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -76.25 -21.03 56.82 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.361 -0.837 . . . . 46.45 110.307 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 289' ' ' LEU . . . . . . . . . . . . . 30.7 mt -97.35 -21.73 17.04 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.288 -0.883 . . . . 35.09 110.524 -179.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 290' ' ' THR . . . . . . . . . . . . . 81.3 p -114.78 -28.35 7.12 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.246 -0.909 . . . . 38.61 110.455 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 291' ' ' GLY . . . . . . . . . . . . . . . 79.31 10.99 85.45 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.856 -1.298 . . . . 36.77 109.856 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 292' ' ' LEU . . . . . . . . . . . . . 84.8 mt -96.41 145.81 25.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.304 -1.116 . . . . 35.33 109.799 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 293' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -77.32 102.4 6.73 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.15 -0.969 . . . . 48.7 110.302 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 294' ' ' LEU . . . . . 0.416 ' HB3' ' CZ2' ' S' ' 252' ' ' TRP . 55.7 mt -106.93 51.71 0.73 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.521 -0.737 . . . . 42.61 110.1 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' S' S ' 295' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -112.51 -11.11 13.65 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.365 -0.834 . . . . 55.49 110.531 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' S' S ' 296' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -144.37 48.55 1.36 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.167 -0.958 . . . . 75.68 110.261 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 297' ' ' GLY . . . . . 0.567 ' HA3' ' HA ' ' R' ' 201' ' ' LYS . . . 96.84 145.2 18.73 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.467 -1.453 . . . . 49.44 109.467 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' S' S ' 298' ' ' GLY . . . . . . . . . . . . . . . -163.86 156.99 29.1 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.8 -1.32 . . . . 41.11 109.8 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 299' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.86 118.28 5.37 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 124.008 1.531 . . . . 26.2 110.209 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 300' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.29 -15.49 31.52 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 O-C-N 123.584 1.307 . . . . 21.7 110.665 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 301' ' ' ALA . . . . . . . . . . . . . . . -80.63 -29.34 36.76 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.295 -0.878 . . . . 31.23 110.13 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 302' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.56 -40.62 18.89 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.391 -0.818 . . . . 38.99 109.941 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' S' S ' 303' ' ' VAL . . . . . 0.466 ' O ' HG12 ' S' ' 307' ' ' ILE . 58.0 t -60.7 -35.47 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.487 -0.758 . . . . 18.63 110.167 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' S' S ' 304' ' ' ILE . . . . . . . . . . . . . 86.1 mt -79.35 -23.61 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.44 -0.787 . . . . 25.46 110.229 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 305' ' ' TRP . . . . . 0.417 ' NE1' ' NH1' ' R' ' 120' ' ' ARG . 68.8 t-105 -88.64 -14.56 37.17 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.31 -0.869 . . . . 33.4 110.599 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' S' S ' 306' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -89.67 -13.62 36.59 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.291 -0.88 . . . . 36.97 110.394 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 307' ' ' ILE . . . . . 0.466 HG12 ' O ' ' S' ' 303' ' ' VAL . 36.9 pt -125.02 45.69 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.255 -0.903 . . . . 30.81 110.043 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' S' S ' 308' ' ' LYS . . . . . . . . . . . . . 1.5 mtmp? -73.63 -37.76 65.26 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.373 -0.83 . . . . 46.52 110.064 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 309' ' ' HIS . . . . . 0.485 ' CD2' ' HG ' ' S' ' 310' ' ' LEU . 55.6 p-80 -73.15 -8.21 54.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.263 -0.898 . . . . 51.03 110.187 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' S' S ' 310' ' ' LEU . . . . . 0.485 ' HG ' ' CD2' ' S' ' 309' ' ' HIS . 53.0 mt -99.31 -12.84 19.97 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.317 -0.864 . . . . 36.16 109.969 179.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' S' S ' 311' ' ' LEU . . . . . 0.468 HD22 ' CE2' ' S' ' 260' ' ' PHE . 10.8 mt -97.21 147.9 23.63 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.377 -0.827 . . . . 40.0 110.355 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' S' S ' 312' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -81.67 -16.23 51.97 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.262 -0.899 . . . . 54.18 109.698 179.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 313' ' ' THR . . . . . 0.466 HG23 ' HB3' ' S' ' 323' ' ' GLU . 92.7 m -87.97 151.63 22.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.38 -0.825 . . . . 25.61 110.149 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' S' S ' 314' ' ' GLY . . . . . . . . . . . . . . . -87.86 126.33 8.0 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.83 -1.308 . . . . 25.18 109.83 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 315' ' ' ILE . . . . . 0.4 HG21 ' N ' ' S' ' 316' ' ' GLY . 50.6 mm -101.58 150.53 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.416 -1.049 . . . . 23.9 109.724 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' S' S ' 316' ' ' GLY . . . . . 0.4 ' N ' HG21 ' S' ' 315' ' ' ILE . . . -157.1 -159.23 9.36 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.026 -1.23 . . . . 23.18 110.026 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' S' S ' 317' ' ' THR . . . . . . . . . . . . . 11.2 p -133.95 -173.04 3.14 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.442 -1.034 . . . . 27.98 109.967 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.58 -56.16 25.44 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.191 -0.943 . . . . 28.1 109.927 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 319' ' ' SER . . . . . . . . . . . . . 1.2 m -59.9 -41.69 92.2 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.382 -0.824 . . . . 37.0 109.664 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 320' ' ' ARG . . . . . . . . . . . . . 12.1 mtm180 -111.69 79.85 2.63 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.445 -0.784 . . . . 52.07 109.652 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 321' ' ' PRO . . . . . 0.814 ' CG ' ' O ' ' S' ' 386' ' ' GLU . 43.9 Cg_endo -71.44 171.6 15.88 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.83 1.437 . . . . 38.29 110.937 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' S' S ' 322' ' ' SER . . . . . 0.435 ' HB2' ' O ' ' S' ' 321' ' ' PRO . 41.3 t 178.58 -148.13 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.924 -0.769 . . . . 38.84 108.924 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' S' S ' 323' ' ' GLU . . . . . 0.466 ' HB3' HG23 ' S' ' 313' ' ' THR . 6.7 tp10 -62.82 -40.33 97.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.946 -1.096 . . . . 40.7 109.682 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' S' S ' 324' ' ' VAL . . . . . . . . . . . . . 73.5 t -141.28 134.97 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.427 -0.796 . . . . 20.34 109.507 179.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 325' ' ' CYS . . . . . 0.447 ' HB2' ' CE1' ' S' ' 380' ' ' PHE . 11.3 m -125.98 172.13 10.2 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.385 -0.822 . . . . 30.63 110.827 -179.049 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' S' S ' 326' ' ' VAL . . . . . . . . . . . . . 34.5 m -135.41 142.25 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 109.204 -0.665 . . . . 23.9 109.204 179.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 327' ' ' VAL . . . . . . . . . . . . . 34.5 m -56.34 125.04 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.054 -1.029 . . . . 19.48 110.43 -179.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 328' ' ' ASP . . . . . . . . . . . . . 55.6 p-10 -119.43 11.59 12.2 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.451 -0.781 . . . . 26.43 110.411 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 329' ' ' GLY . . . . . . . . . . . . . . . 119.58 2.26 13.2 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.088 -1.205 . . . . 31.24 110.088 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 330' ' ' THR . . . . . . . . . . . . . 78.3 m -93.02 129.99 38.76 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.064 -1.256 . . . . 30.05 110.183 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 331' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -56.8 111.54 1.05 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.217 -0.927 . . . . 37.26 109.935 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 332' ' ' MET . . . . . 0.456 ' HE1' ' CZ ' ' S' ' 380' ' ' PHE . 87.9 mmm -94.04 162.57 13.83 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.212 -0.93 . . . . 26.23 110.347 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' S' S ' 333' ' ' CYS . . . . . . . . . . . . . 24.9 m -137.3 150.07 47.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.483 -0.761 . . . . 23.56 109.961 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 334' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.57 -24.93 9.16 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.334 -0.854 . . . . 28.93 110.457 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' S' S ' 335' ' ' ALA . . . . . . . . . . . . . . . -88.95 14.39 10.61 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.379 -0.826 . . . . 15.76 110.977 -179.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 336' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -100.51 -17.23 17.23 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.149 -0.969 . . . . 34.92 110.137 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 337' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -152.37 170.86 19.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.418 -0.801 . . . . 19.03 110.055 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 338' ' ' HIS . . . . . 0.401 ' HB3' ' CZ ' ' S' ' 383' ' ' TYR . 13.5 p80 -120.7 10.38 10.99 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.318 -0.864 . . . . 18.82 110.465 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' S' S ' 339' ' ' ALA . . . . . . . . . . . . . . . -176.04 155.17 1.54 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.274 -0.891 . . . . 17.18 110.09 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 340' ' ' GLY . . . . . 0.404 ' CA ' ' O ' ' S' ' 379' ' ' VAL . . . 160.87 173.11 29.07 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.013 -1.235 . . . . 18.33 110.013 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' S' S ' 341' ' ' ILE . . . . . 0.424 HD12 HG22 ' S' ' 341' ' ' ILE . 83.9 mt -88.84 138.14 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.498 -1.001 . . . . 18.6 109.819 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' S' S ' 342' ' ' PHE . . . . . 0.499 ' CE1' HG23 ' S' ' 377' ' ' VAL . 70.0 m-85 -120.99 -178.48 3.76 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.299 -0.875 . . . . 23.44 110.453 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' S' S ' 343' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.8 93.4 4.19 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.408 -0.807 . . . . 35.59 110.002 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' S' S ' 344' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.85 125.02 29.58 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.26 -0.9 . . . . 38.34 110.109 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' S' S ' 345' ' ' GLY . . . . . . . . . . . . . . . 62.77 -130.87 43.13 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 108.821 -1.711 . . . . 53.46 108.821 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 346' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -132.68 150.84 52.1 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.326 -1.102 . . . . 70.91 110.037 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 347' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 53.27 35.39 19.98 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.353 -0.842 . . . . 47.32 110.433 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 348' ' ' HIS . . . . . . . . . . . . . 46.5 t60 -150.08 155.94 40.76 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.329 -0.857 . . . . 41.72 110.303 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 349' ' ' ALA . . . . . . . . . . . . . . . -149.88 151.25 33.15 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.326 -0.859 . . . . 22.91 110.441 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 350' ' ' VAL . . . . . . . . . . . . . 34.6 m -149.1 169.64 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.514 -0.741 . . . . 21.09 110.023 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 351' ' ' PHE . . . . . 0.469 ' CD2' ' HB3' ' S' ' 258' ' ' GLN . 10.7 t80 -105.39 143.62 33.3 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.155 -0.966 . . . . 25.03 110.713 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' S' S ' 352' ' ' ALA . . . . . . . . . . . . . . . -147.79 151.71 36.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.667 -0.645 . . . . 23.81 109.715 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 353' ' ' CYS . . . . . . . . . . . . . 26.3 p -153.25 164.91 37.24 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.368 -0.832 . . . . 25.66 110.343 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 354' ' ' VAL . . . . . . . . . . . . . 56.5 t -76.05 118.53 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.361 -0.837 . . . . 34.27 109.98 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 355' ' ' THR . . . . . 0.445 HG23 ' HB2' ' S' ' 360' ' ' TYR . 52.7 p -117.86 175.14 5.8 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.251 -0.905 . . . . 25.49 110.332 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' S' S ' 356' ' ' SER . . . . . . . . . . . . . 62.0 p -62.18 -17.72 58.89 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.345 -0.847 . . . . 31.24 110.71 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 357' ' ' ASN . . . . . . . . . . . . . 45.9 m-20 -107.01 14.22 26.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.201 -0.937 . . . . 28.61 110.611 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 358' ' ' GLY . . . . . . . . . . . . . . . 111.91 -152.98 17.58 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.984 -1.246 . . . . 22.01 109.984 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 359' ' ' TRP . . . . . . . . . . . . . 15.4 m95 -91.24 116.68 29.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.371 -1.076 . . . . 25.54 110.17 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 360' ' ' TYR . . . . . 0.445 ' HB2' HG23 ' S' ' 355' ' ' THR . 1.3 m-85 -103.47 165.79 10.82 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.327 -0.858 . . . . 40.53 110.107 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' S' S ' 361' ' ' ALA . . . . . . . . . . . . . . . -140.06 130.11 24.9 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.462 -0.774 . . . . 18.04 110.271 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 362' ' ' ILE . . . . . 0.42 HG23 ' CZ ' ' S' ' 367' ' ' PHE . 88.8 mt -95.6 83.67 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.283 -0.885 . . . . 15.64 110.062 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' S' S ' 363' ' ' ASP . . . . . 0.418 ' O ' ' N ' ' S' ' 365' ' ' GLU . 11.9 t0 -75.25 94.47 3.0 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.298 -0.876 . . . . 35.03 110.213 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' S' S ' 364' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 53.88 -89.28 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.547 -0.721 . . . . 46.72 110.621 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 365' ' ' GLU . . . . . 0.418 ' N ' ' O ' ' S' ' 363' ' ' ASP . 23.8 mt-10 -122.7 19.15 10.3 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.091 -1.006 . . . . 56.2 110.267 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' S' S ' 366' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -117.97 124.99 49.54 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.17 -0.957 . . . . 51.02 110.421 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 367' ' ' PHE . . . . . 0.42 ' CZ ' HG23 ' S' ' 362' ' ' ILE . 26.9 m-85 -107.0 127.08 53.13 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.435 -0.791 . . . . 37.59 110.133 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' S' S ' 368' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -165.47 159.46 13.82 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.229 -0.919 . . . . 31.47 110.414 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 369' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.68 139.62 31.19 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 O-C-N 123.903 1.475 . . . . 28.85 110.505 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 370' ' ' TRP . . . . . . . . . . . . . 67.6 t90 -167.21 113.49 0.76 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.405 -0.81 . . . . 26.94 110.008 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 371' ' ' THR . . . . . . . . . . . . . 59.8 m -74.78 113.08 20.99 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.317 -0.864 . . . . 20.19 110.025 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 372' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -73.56 157.13 49.17 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.61 1.321 . . . . 28.68 110.609 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 373' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -90.58 147.14 35.73 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.444 -0.785 . . . . 35.72 109.922 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 374' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -76.0 -6.3 17.23 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 O-C-N 123.632 1.332 . . . . 30.89 110.502 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 375' ' ' SER . . . . . . . . . . . . . 68.6 p -104.36 -16.94 14.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.207 -0.933 . . . . 29.41 110.436 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 376' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -106.55 43.1 1.18 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.348 -0.845 . . . . 32.89 110.198 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 377' ' ' VAL . . . . . 0.499 HG23 ' CE1' ' S' ' 342' ' ' PHE . 7.3 p -114.68 147.3 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.297 -0.877 . . . . 24.33 110.207 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' S' S ' 378' ' ' LEU . . . . . . . . . . . . . 52.7 mt -116.02 -58.0 2.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.354 -0.841 . . . . 24.37 109.626 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 379' ' ' VAL . . . . . 0.404 ' O ' ' CA ' ' S' ' 340' ' ' GLY . 61.2 t -120.66 132.42 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.418 -0.801 . . . . 18.02 109.456 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' S' S ' 380' ' ' PHE . . . . . 0.456 ' CZ ' ' HE1' ' S' ' 332' ' ' MET . 14.4 p90 -142.59 173.89 11.13 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.399 -0.813 . . . . 29.35 110.614 -179.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' S' S ' 381' ' ' VAL . . . . . . . . . . . . . 57.7 t -120.01 107.29 40.06 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.523 -0.735 . . . . 16.34 109.453 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 382' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -71.2 145.62 49.4 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 O-C-N 123.611 1.322 . . . . 20.94 110.786 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' S' S ' 383' ' ' TYR . . . . . 0.401 ' CZ ' ' HB3' ' S' ' 338' ' ' HIS . 88.4 m-85 -61.1 -53.47 56.72 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.323 -0.861 . . . . 28.93 109.877 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' S' S ' 384' ' ' ASP . . . . . 0.485 ' C ' ' H ' ' S' ' 386' ' ' GLU . 1.5 t70 -107.93 130.93 55.0 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.356 -0.84 . . . . 47.03 110.357 -176.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' S' S ' 385' ' ' GLN . . . . . 0.433 ' O ' ' C ' ' S' ' 386' ' ' GLU . 6.2 pt20 -66.35 5.5 0.55 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.437 -0.789 . . . . 46.69 110.281 177.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' S' S ' 386' ' ' GLU . . . . . 0.814 ' O ' ' CG ' ' S' ' 321' ' ' PRO . 14.7 pt-20 -42.37 161.38 0.17 Allowed Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.319 -0.863 . . . . 50.25 109.576 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' S' S ' 387' ' ' PRO . . . . . 0.55 ' O ' ' C ' ' S' ' 388' ' ' LEU . 37.9 Cg_endo -66.45 -12.51 36.01 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 123.725 1.381 . . . . 34.39 110.576 -177.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' S' S ' 388' ' ' LEU . . . . . 0.56 ' O ' ' CB ' ' S' ' 389' ' ' ASN . 1.9 tt 31.89 78.91 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.443 -0.785 . . . . 38.01 110.09 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' S' S ' 389' ' ' ASN . . . . . 0.56 ' CB ' ' O ' ' S' ' 388' ' ' LEU . 6.2 t-20 73.75 169.23 0.3 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.343 -0.848 . . . . 45.82 110.079 -179.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' S' S ' 390' ' ' GLY . . . . . 0.565 ' O ' ' HB2' ' S' ' 391' ' ' GLU . . . 151.18 -81.18 0.19 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.668 -1.373 . . . . 33.46 109.668 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' S' S ' 391' ' ' GLU . . . . . 0.565 ' HB2' ' O ' ' S' ' 390' ' ' GLY . 17.4 mt-10 65.53 -64.46 0.19 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.399 -1.06 . . . . 56.58 110.104 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' S' S ' 392' ' ' TRP . . . . . 0.508 ' N ' ' O ' ' S' ' 390' ' ' GLY . 33.9 p-90 -53.54 -22.25 7.94 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.292 -0.88 . . . . 31.43 110.361 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' S' S ' 393' ' ' LYS . . . . . 0.562 ' O ' HG13 ' S' ' 396' ' ' VAL . 0.1 OUTLIER -46.32 -52.61 12.42 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.271 -0.893 . . . . 39.42 110.381 -179.989 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' S' S ' 394' ' ' ALA . . . . . 0.558 ' O ' ' CD ' ' S' ' 398' ' ' ARG . . . -76.02 -38.28 57.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.25 -0.906 . . . . 34.33 110.107 179.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' S' S ' 395' ' ' LYS . . . . . 0.622 ' HB3' ' CD1' ' R' ' 143' ' ' LEU . 4.7 mmmm -41.87 -51.33 4.32 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.456 -0.777 . . . . 60.09 110.26 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' S' S ' 396' ' ' VAL . . . . . 0.849 HG22 ' HB2' ' R' ' 101' ' ' ALA . 7.3 p -69.08 -53.36 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.342 -0.849 . . . . 35.5 110.56 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' S' S ' 397' ' ' GLN . . . . . 0.538 ' H ' ' CG1' ' S' ' 396' ' ' VAL . 14.2 tt0 -78.16 58.38 2.02 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.142 -0.974 . . . . 49.96 110.707 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' S' S ' 398' ' ' ARG . . . . . 0.735 ' CB ' ' HA ' ' R' ' 147' ' ' GLU . 0.0 OUTLIER -119.12 -3.86 10.59 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.231 -0.918 . . . . 43.42 110.679 -178.817 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' S' S ' 399' ' ' LYS . . . . . 0.807 ' CB ' ' HA3' ' R' ' 97' ' ' GLY . 0.3 OUTLIER 41.56 -150.48 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.421 -0.8 . . . . 55.31 110.127 178.782 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' S' S ' 400' ' ' LEU . . . . . 0.722 ' CB ' ' HB2' ' R' ' 51' ' ' ALA . 0.0 OUTLIER -120.31 -43.56 2.51 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.399 -0.813 . . . . 41.03 110.286 179.341 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' S' S ' 401' ' ' LYS . . . . . 0.437 ' N ' ' CD2' ' S' ' 400' ' ' LEU . 4.3 tttt . . . . . 0 N--CA 1.493 1.677 0 O-C-N 121.352 -0.843 . . . . 61.97 110.194 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 29' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.193 0.521 . . . . 32.14 110.255 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 30' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -96.34 141.16 30.0 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.367 -0.833 . . . . 43.36 110.212 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 31' ' ' LEU . . . . . . . . . . . . . 65.5 mt -134.88 140.63 45.94 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.337 -0.852 . . . . 22.93 110.269 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 32' ' ' THR . . . . . . . . . . . . . 70.6 m -87.61 110.64 20.53 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.33 -0.856 . . . . 22.34 109.9 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 33' ' ' LEU . . . . . 0.46 HD23 ' CE2' ' R' ' 62' ' ' TYR . 80.1 mt -62.45 -172.79 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.307 -0.87 . . . . 21.39 110.202 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' R' R ' 34' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -74.55 -29.54 61.4 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.355 -0.841 . . . . 34.4 110.388 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 35' ' ' ASN . . . . . . . . . . . . . 48.3 p30 -77.68 -1.87 33.25 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.348 -0.845 . . . . 30.28 110.637 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.21 -16.56 59.44 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.733 -1.347 . . . . 36.25 109.733 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 37' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -59.04 161.77 4.83 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.357 -1.084 . . . . 53.8 110.315 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 38' ' ' LYS . . . . . . . . . . . . . 56.9 mttt -117.78 135.81 53.81 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.426 -0.796 . . . . 49.91 110.132 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 39' ' ' LYS . . . . . 0.417 ' HG2' ' CZ ' ' R' ' 41' ' ' PHE . 8.1 ttmt -138.76 143.68 39.11 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.468 -0.77 . . . . 35.69 110.228 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' R' R ' 40' ' ' THR . . . . . . . . . . . . . 23.6 m -102.57 127.98 49.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.41 -0.806 . . . . 34.84 110.221 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 41' ' ' PHE . . . . . 0.417 ' CZ ' ' HG2' ' R' ' 39' ' ' LYS . 96.6 m-85 -113.02 132.75 55.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.442 -0.786 . . . . 34.42 110.11 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' R' R ' 42' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -93.3 140.85 29.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.336 -0.852 . . . . 51.46 110.284 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 43' ' ' SER . . . . . . . . . . . . . 54.3 m -70.82 141.91 51.32 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.412 -0.805 . . . . 41.84 110.217 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.71 125.4 29.56 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.303 -0.873 . . . . 33.82 110.012 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' R' R ' 45' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.12 151.09 55.01 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.59 1.31 . . . . 30.27 110.655 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 46' ' ' ASN . . . . . 0.479 ' ND2' ' CD2' ' S' ' 400' ' ' LEU . 52.0 t-20 -124.34 109.9 13.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.447 -0.783 . . . . 35.1 110.054 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' R' R ' 47' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -120.28 -34.88 3.56 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.311 -0.868 . . . . 42.81 110.54 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 48' ' ' HIS . . . . . . . . . . . . . 73.3 m80 -105.72 45.17 0.98 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.262 -0.899 . . . . 49.97 110.211 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 49' ' ' ASP . . . . . 0.495 ' OD1' ' CB ' ' S' ' 401' ' ' LYS . 37.7 m-20 50.25 34.69 9.14 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.329 -0.857 . . . . 61.32 110.186 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' R' R ' 50' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -86.28 43.82 1.09 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.333 -0.854 . . . . 51.5 110.623 -179.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 51' ' ' ALA . . . . . 0.526 ' HB2' ' HB2' ' S' ' 400' ' ' LEU . . . -66.14 -46.08 78.75 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.225 -0.922 . . . . 38.77 109.539 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' R' R ' 52' ' ' TRP . . . . . 0.484 ' CD2' ' N ' ' R' ' 53' ' ' LEU . 68.2 p-90 -58.41 -38.44 77.39 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.413 -0.805 . . . . 26.24 110.002 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' R' R ' 53' ' ' LEU . . . . . 0.484 ' N ' ' CD2' ' R' ' 52' ' ' TRP . 23.1 tp -66.73 -46.65 74.79 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.351 -0.843 . . . . 26.75 109.984 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' R' R ' 54' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -55.23 -41.65 72.36 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.354 -0.841 . . . . 35.02 110.113 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.14 -46.1 91.92 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.377 -0.827 . . . . 24.47 110.163 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 56' ' ' ILE . . . . . . . . . . . . . 76.1 mt -62.18 -42.23 94.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.332 -0.855 . . . . 26.03 109.888 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 57' ' ' LEU . . . . . . . . . . . . . 22.5 mt -60.36 -45.56 93.07 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.3 -0.875 . . . . 26.77 109.702 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 58' ' ' GLN . . . . . . . . . . . . . 57.7 mm-40 -63.91 -46.51 84.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.476 -0.765 . . . . 22.32 109.59 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 59' ' ' LEU . . . . . 0.43 ' HA ' ' HE2' ' R' ' 151' ' ' PHE . 24.0 tp -61.45 -37.75 84.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.291 -0.881 . . . . 20.55 109.396 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' R' R ' 60' ' ' PHE . . . . . 0.447 ' CE2' HD22 ' R' ' 111' ' ' LEU . 2.8 m-85 -61.13 -44.75 96.85 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.628 -0.67 . . . . 20.08 109.866 179.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' R' R ' 61' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -63.11 -36.19 82.78 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.49 -0.756 . . . . 18.8 110.442 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 62' ' ' TYR . . . . . 0.46 ' CE2' HD23 ' R' ' 33' ' ' LEU . 9.2 t80 -63.04 -41.8 99.58 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.271 -0.893 . . . . 26.45 110.26 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' R' R ' 63' ' ' VAL . . . . . . . . . . . . . 30.0 m -93.34 20.33 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.263 -0.898 . . . . 29.75 110.307 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 64' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 52.96 75.5 0.24 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.328 -0.857 . . . . 35.52 110.51 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 65' ' ' GLU . . . . . 0.424 ' HG2' ' CD2' ' R' ' 60' ' ' PHE . 14.3 tp10 -116.17 104.09 52.5 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.423 -0.798 . . . . 29.89 109.944 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' R' R ' 66' ' ' PRO . . . . . 0.4 ' HA ' ' HB2' ' R' ' 69' ' ' ASP . 47.9 Cg_endo -73.46 -5.92 17.92 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.79 1.416 . . . . 21.37 111.147 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' R' R ' 67' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -52.1 -61.6 2.16 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.038 -1.039 . . . . 23.85 110.331 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' R' R ' 68' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -98.07 36.57 1.55 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.32 -0.862 . . . . 28.07 110.466 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 69' ' ' ASP . . . . . 0.4 ' HB2' ' HA ' ' R' ' 66' ' ' PRO . 11.7 t0 -72.33 -33.27 67.21 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.342 -0.849 . . . . 43.76 110.155 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' R' R ' 70' ' ' TRP . . . . . 0.475 ' CE2' ' CG2' ' R' ' 71' ' ' VAL . 47.7 p-90 -73.42 -3.91 30.33 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.334 -0.854 . . . . 33.06 110.717 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' R' R ' 71' ' ' VAL . . . . . 0.475 ' CG2' ' CE2' ' R' ' 70' ' ' TRP . 40.8 t -109.8 -27.47 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.112 -0.992 . . . . 31.7 109.659 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' R' R ' 72' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -86.56 -48.79 8.05 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.407 -0.808 . . . . 33.58 110.353 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 73' ' ' SER . . . . . . . . . . . . . 69.8 m -89.75 51.06 2.0 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.394 -0.816 . . . . 50.82 110.351 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 74' ' ' SER . . . . . . . . . . . . . 15.9 t -125.95 138.21 31.63 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.278 -0.889 . . . . 34.74 110.24 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -73.24 -25.01 16.19 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 O-C-N 123.728 1.383 . . . . 35.7 110.373 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 76' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -91.66 153.12 19.9 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.383 -0.823 . . . . 66.48 110.428 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 77' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -81.4 95.24 6.98 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.368 -0.832 . . . . 46.72 110.117 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 78' ' ' LEU . . . . . . . . . . . . . 96.4 mt -96.45 28.0 3.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.381 -0.825 . . . . 37.55 110.182 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 79' ' ' THR . . . . . . . . . . . . . 29.6 m -56.2 -54.64 42.82 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.337 -0.852 . . . . 37.36 110.295 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 80' ' ' LEU . . . . . . . . . . . . . 15.8 mt -60.95 -23.14 65.07 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.348 -0.845 . . . . 35.83 110.51 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 81' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -79.52 -39.14 32.68 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.133 -0.98 . . . . 44.03 110.381 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.4 -28.7 66.4 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.26 -0.9 . . . . 32.54 110.303 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 83' ' ' ILE . . . . . . . . . . . . . 77.7 mt -70.09 -46.06 73.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.253 -0.905 . . . . 32.02 110.342 179.999 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 84' ' ' LYS . . . . . . . . . . . . . 36.0 tttm -55.22 -52.06 64.57 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.179 -0.951 . . . . 34.09 110.596 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 85' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -54.8 -46.86 74.54 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.191 -0.943 . . . . 25.94 110.305 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 86' ' ' LEU . . . . . . . . . . . . . 24.2 mt -58.71 -43.76 90.16 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.267 -0.896 . . . . 16.2 109.957 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 87' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -65.36 -35.27 80.45 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.393 -0.817 . . . . 49.09 110.305 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 88' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -78.4 -19.06 54.09 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.284 -0.885 . . . . 28.61 110.509 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 89' ' ' LEU . . . . . . . . . . . . . 32.4 mt -96.16 -29.43 14.06 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.225 -0.922 . . . . 26.16 110.2 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 90' ' ' THR . . . . . . . . . . . . . 59.9 p -105.77 -34.58 7.64 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.3 -0.875 . . . . 33.33 109.724 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.85 16.1 58.6 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.821 -1.312 . . . . 31.13 109.821 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 92' ' ' LEU . . . . . . . . . . . . . 97.1 mt -100.11 155.19 17.87 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.169 -1.195 . . . . 42.52 110.246 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 93' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -86.15 91.59 8.48 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.471 -0.768 . . . . 68.46 110.006 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 94' ' ' LEU . . . . . 0.446 ' HB3' ' CZ2' ' R' ' 52' ' ' TRP . 48.2 mt -99.41 53.08 0.95 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.176 -0.952 . . . . 44.63 110.364 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' R' R ' 95' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.52 -38.7 6.36 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.226 -0.921 . . . . 67.16 110.376 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' R' R ' 96' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -113.85 44.11 1.69 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.332 -0.855 . . . . 67.02 110.325 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 97' ' ' GLY . . . . . 0.63 ' HA3' ' CB ' ' S' ' 399' ' ' LYS . . . 99.24 150.83 25.99 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.599 -1.401 . . . . 49.48 109.599 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' R' R ' 98' ' ' GLY . . . . . . . . . . . . . . . -166.27 160.03 33.46 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.267 -1.533 . . . . 36.57 109.267 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 99' ' ' PRO . . . . . 0.867 ' HA ' ' O ' ' S' ' 396' ' ' VAL . 45.5 Cg_endo -72.57 121.11 7.14 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.74 1.39 . . . . 30.41 110.462 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' R' R ' 100' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.32 -31.52 11.46 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.637 1.335 . . . . 29.94 110.545 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 101' ' ' ALA . . . . . 0.81 ' HB2' HG23 ' S' ' 396' ' ' VAL . . . -70.07 -38.49 75.77 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.296 -0.878 . . . . 23.64 110.184 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' R' R ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.71 -40.66 66.0 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.335 -0.853 . . . . 20.31 110.411 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' R' R ' 103' ' ' VAL . . . . . . . . . . . . . 63.3 t -58.15 -40.13 76.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.227 -0.92 . . . . 16.33 109.986 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 104' ' ' ILE . . . . . . . . . . . . . 82.0 mt -71.72 -30.47 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.374 -0.829 . . . . 24.77 109.951 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 105' ' ' TRP . . . . . 0.44 ' O ' ' HD3' ' R' ' 108' ' ' LYS . 70.6 t-105 -82.44 0.81 40.5 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.304 -0.873 . . . . 23.28 110.273 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' R' R ' 106' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -105.05 -10.37 17.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.171 -0.956 . . . . 28.26 110.146 179.612 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 107' ' ' ILE . . . . . . . . . . . . . 36.8 pt -126.82 34.9 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.184 -0.947 . . . . 18.77 110.076 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 108' ' ' LYS . . . . . 0.48 ' HG2' ' HB ' ' R' ' 115' ' ' ILE . 9.2 mtpp -60.97 -48.5 81.52 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.516 -0.74 . . . . 42.5 110.06 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' R' R ' 109' ' ' HIS . . . . . 0.432 ' CD2' ' HG ' ' R' ' 110' ' ' LEU . 50.8 p-80 -66.02 -12.87 58.26 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.511 -0.743 . . . . 20.07 110.698 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' R' R ' 110' ' ' LEU . . . . . 0.432 ' HG ' ' CD2' ' R' ' 109' ' ' HIS . 80.5 mt -94.71 -17.38 22.27 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.042 -1.036 . . . . 15.69 110.194 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' R' R ' 111' ' ' LEU . . . . . 0.447 HD22 ' CE2' ' R' ' 60' ' ' PHE . 10.3 mt -94.09 144.17 25.72 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.368 -0.832 . . . . 25.39 111.016 -179.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' R' R ' 112' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -77.71 -17.35 57.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.552 -0.717 . . . . 53.48 109.835 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 113' ' ' THR . . . . . 0.418 HG22 ' HG2' ' R' ' 123' ' ' GLU . 59.6 m -83.71 166.71 17.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.347 -0.846 . . . . 14.8 110.29 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' R' R ' 114' ' ' GLY . . . . . . . . . . . . . . . -97.98 127.16 9.13 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.947 -1.261 . . . . 16.14 109.947 -179.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 115' ' ' ILE . . . . . 0.48 ' HB ' ' HG2' ' R' ' 108' ' ' LYS . 47.7 mm -109.17 139.36 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.525 -0.985 . . . . 13.46 109.725 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' R' R ' 116' ' ' GLY . . . . . . . . . . . . . . . -152.72 -155.87 7.29 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.933 -1.267 . . . . 23.9 109.933 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 117' ' ' THR . . . . . . . . . . . . . 18.9 p -135.03 -171.36 2.78 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.484 -1.01 . . . . 27.37 110.072 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.6 -58.04 9.77 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.297 -0.877 . . . . 18.76 110.064 179.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 119' ' ' SER . . . . . 0.582 ' HB3' ' HB ' ' R' ' 196' ' ' VAL . 1.1 m -56.56 -40.56 75.37 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.266 -0.896 . . . . 32.35 109.787 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' R' R ' 120' ' ' ARG . . . . . 0.419 ' NH1' ' CE2' ' S' ' 305' ' ' TRP . 10.0 mtm180 -110.08 86.23 4.87 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.487 -0.758 . . . . 27.12 109.673 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' R' R ' 121' ' ' PRO . . . . . 0.427 ' O ' ' HB2' ' R' ' 122' ' ' SER . 44.3 Cg_endo -71.24 166.41 29.32 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.874 1.46 . . . . 22.68 111.03 -179.481 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' R' R ' 122' ' ' SER . . . . . 0.427 ' HB2' ' O ' ' R' ' 121' ' ' PRO . 38.5 t 178.61 -161.64 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.61 -0.681 . . . . 22.99 109.513 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' R' R ' 123' ' ' GLU . . . . . 0.418 ' HG2' HG22 ' R' ' 113' ' ' THR . 2.3 tp10 -56.45 -39.95 74.0 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.211 -0.93 . . . . 36.18 109.762 179.574 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' R' R ' 124' ' ' VAL . . . . . . . . . . . . . 84.6 t -142.55 136.48 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.534 -0.729 . . . . 20.64 109.43 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 125' ' ' CYS . . . . . 0.41 ' SG ' ' HA ' ' R' ' 121' ' ' PRO . 82.9 m -140.31 168.2 20.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.161 -0.962 . . . . 22.8 111.136 -179.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' R' R ' 126' ' ' VAL . . . . . . . . . . . . . 35.9 m -122.74 159.8 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.714 -0.616 . . . . 21.24 109.664 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 127' ' ' VAL . . . . . 0.4 HG11 ' O ' ' R' ' 177' ' ' VAL . 30.7 m -70.86 141.82 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.293 -0.879 . . . . 19.77 110.657 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' R' R ' 128' ' ' ASP . . . . . . . . . . . . . 53.9 p-10 -137.73 19.38 2.87 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.327 -0.858 . . . . 29.21 110.687 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 129' ' ' GLY . . . . . . . . . . . . . . . 114.11 0.0 23.98 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.965 -1.112 . . . . 33.86 110.469 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 130' ' ' THR . . . . . . . . . . . . . 58.6 m -91.93 131.85 36.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.105 -1.233 . . . . 26.41 110.046 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -62.56 120.65 11.56 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.38 -0.825 . . . . 33.08 110.302 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 132' ' ' MET . . . . . 0.426 ' HE1' ' CZ ' ' R' ' 180' ' ' PHE . 98.4 mmm -105.21 165.66 10.94 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.395 -0.816 . . . . 30.76 110.435 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' R' R ' 133' ' ' CYS . . . . . . . . . . . . . 32.5 m -141.17 158.12 44.33 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.493 -0.754 . . . . 27.0 109.969 179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 134' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.54 -19.68 39.82 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.347 -0.846 . . . . 33.9 110.444 -179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' R' R ' 135' ' ' ALA . . . . . . . . . . . . . . . -92.72 8.2 40.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.182 -0.949 . . . . 19.37 110.882 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 136' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -93.76 -21.74 19.13 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.143 -0.973 . . . . 30.47 110.266 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 137' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -149.98 165.38 32.85 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.341 -0.85 . . . . 24.27 110.204 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 138' ' ' HIS . . . . . . . . . . . . . 15.1 p80 -117.87 15.2 14.33 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.398 -0.814 . . . . 20.91 110.404 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 139' ' ' ALA . . . . . 0.441 ' HA ' ' O ' ' R' ' 152' ' ' ALA . . . -177.23 152.35 0.86 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.198 -0.939 . . . . 15.69 110.184 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' R' R ' 140' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' R' ' 179' ' ' VAL . . . 161.81 175.15 32.53 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.928 -1.269 . . . . 23.76 109.928 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' R' R ' 141' ' ' ILE . . . . . . . . . . . . . 83.7 mt -95.51 136.56 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.358 -1.084 . . . . 25.3 109.713 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 142' ' ' PHE . . . . . 0.546 ' CD2' ' HB2' ' R' ' 172' ' ' PRO . 83.0 m-85 -120.73 -172.52 2.4 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.375 -0.828 . . . . 30.24 110.528 -179.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' R' R ' 143' ' ' LEU . . . . . 0.597 HD13 ' O ' ' S' ' 395' ' ' LYS . 0.5 OUTLIER -119.86 77.73 1.26 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.417 -0.802 . . . . 32.8 110.289 -179.902 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' R' R ' 144' ' ' LYS . . . . . 0.454 ' HG3' ' CZ2' ' R' ' 170' ' ' TRP . 1.0 OUTLIER -69.5 76.82 0.41 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.437 -0.789 . . . . 49.18 109.676 179.575 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' R' R ' 145' ' ' GLY . . . . . . . . . . . . . . . 104.48 179.24 24.86 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.203 -1.559 . . . . 53.87 109.203 -179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 146' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -88.47 145.85 25.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.358 -1.083 . . . . 68.58 109.982 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 147' ' ' GLU . . . . . 0.622 ' O ' ' C ' ' S' ' 399' ' ' LYS . 10.9 mt-10 58.21 36.47 25.78 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.26 -0.9 . . . . 56.62 110.665 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' R' R ' 148' ' ' HIS . . . . . 0.478 ' CE1' HD13 ' S' ' 400' ' ' LEU . 44.6 t60 -158.61 148.17 19.31 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.193 -0.942 . . . . 44.57 110.376 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' R' R ' 149' ' ' ALA . . . . . 0.472 ' HB3' ' NH1' ' S' ' 398' ' ' ARG . . . -150.29 146.92 27.06 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.427 -0.796 . . . . 33.54 110.078 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' R' R ' 150' ' ' VAL . . . . . 0.428 HG23 ' HB2' ' R' ' 144' ' ' LYS . 34.2 m -142.38 161.47 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.234 -0.916 . . . . 27.61 110.301 179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' R' R ' 151' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' R' ' 152' ' ' ALA . 5.9 t80 -86.18 155.57 20.68 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.402 -0.811 . . . . 23.04 109.918 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' R' R ' 152' ' ' ALA . . . . . 0.537 ' N ' ' CD1' ' R' ' 151' ' ' PHE . . . -157.28 151.57 24.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.438 -0.789 . . . . 29.61 109.601 179.011 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' R' R ' 153' ' ' CYS . . . . . 0.405 ' HA ' ' HA ' ' R' ' 139' ' ' ALA . 26.7 p -154.28 173.61 15.93 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.268 -0.895 . . . . 22.75 110.407 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' R' R ' 154' ' ' VAL . . . . . 0.443 ' CG2' ' CZ2' ' R' ' 159' ' ' TRP . 60.3 t -90.63 117.03 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.383 -0.823 . . . . 23.26 110.061 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' R' R ' 155' ' ' THR . . . . . . . . . . . . . 70.3 p -112.13 -176.62 2.97 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.356 -0.84 . . . . 17.88 110.041 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 156' ' ' SER . . . . . . . . . . . . . 78.5 p -75.92 -3.74 37.08 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.33 -0.856 . . . . 21.83 110.678 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 157' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -118.3 10.51 12.83 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.207 -0.933 . . . . 36.54 110.652 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 158' ' ' GLY . . . . . . . . . . . . . . . 117.96 -162.58 13.06 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.559 -1.416 . . . . 31.74 109.559 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 159' ' ' TRP . . . . . 0.443 ' CZ2' ' CG2' ' R' ' 154' ' ' VAL . 14.6 m95 -86.68 122.5 30.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.35 -1.088 . . . . 28.25 110.109 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' R' R ' 160' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -108.46 166.94 10.39 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.345 -0.847 . . . . 41.24 110.19 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 161' ' ' ALA . . . . . . . . . . . . . . . -143.18 123.5 13.84 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.403 -0.81 . . . . 27.4 110.151 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 162' ' ' ILE . . . . . 0.431 HG23 ' CZ ' ' R' ' 167' ' ' PHE . 92.2 mt -87.63 81.11 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.373 -0.829 . . . . 24.27 110.078 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' R' R ' 163' ' ' ASP . . . . . 0.415 ' O ' ' N ' ' R' ' 165' ' ' GLU . 15.3 t0 -72.74 92.35 1.55 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.389 -0.819 . . . . 36.08 110.277 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' R' R ' 164' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 54.06 -88.89 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.526 -0.734 . . . . 46.08 110.556 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 165' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' R' ' 163' ' ' ASP . 29.6 mt-10 -124.72 35.82 4.72 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.151 -0.968 . . . . 50.94 110.148 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' R' R ' 166' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -135.67 117.36 14.99 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.362 -0.836 . . . . 47.28 110.353 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 167' ' ' PHE . . . . . 0.431 ' CZ ' HG23 ' R' ' 162' ' ' ILE . 24.4 m-85 -101.12 119.96 39.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.401 -0.812 . . . . 40.47 110.083 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' R' R ' 168' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -157.51 158.61 30.74 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.25 -0.906 . . . . 30.21 110.466 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 169' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.81 133.07 19.48 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.928 1.488 . . . . 32.76 110.5 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 170' ' ' TRP . . . . . 0.454 ' CZ2' ' HG3' ' R' ' 144' ' ' LYS . 67.1 t90 -159.83 119.35 2.88 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.34 -0.85 . . . . 32.79 109.965 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' R' R ' 171' ' ' THR . . . . . . . . . . . . . 46.9 m -81.09 112.58 33.91 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.431 -0.793 . . . . 36.92 110.155 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 172' ' ' PRO . . . . . 0.546 ' HB2' ' CD2' ' R' ' 142' ' ' PHE . 47.0 Cg_endo -73.67 158.76 46.79 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.622 1.328 . . . . 33.54 110.548 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' R' R ' 173' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -88.91 145.03 33.81 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.324 -0.86 . . . . 45.76 109.86 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 174' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -71.85 -10.28 26.07 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 O-C-N 123.71 1.374 . . . . 29.63 110.41 179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 175' ' ' SER . . . . . . . . . . . . . 53.0 p -103.44 -17.64 15.15 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.348 -0.845 . . . . 35.7 110.366 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 176' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -103.51 43.29 1.09 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.268 -0.895 . . . . 39.65 110.418 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 177' ' ' VAL . . . . . 0.4 ' O ' HG11 ' R' ' 127' ' ' VAL . 10.7 p -117.72 127.06 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.3 -0.875 . . . . 20.61 110.094 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' R' R ' 178' ' ' LEU . . . . . . . . . . . . . 46.2 mt -91.42 -61.3 1.68 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.349 -0.845 . . . . 15.58 109.392 179.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 179' ' ' VAL . . . . . 0.403 ' O ' ' HA3' ' R' ' 140' ' ' GLY . 68.6 t -114.64 144.76 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.561 -0.712 . . . . 17.4 109.384 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' R' R ' 180' ' ' PHE . . . . . 0.426 ' CZ ' ' HE1' ' R' ' 132' ' ' MET . 43.6 p90 -152.15 163.36 39.54 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.197 -0.94 . . . . 20.16 110.63 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' R' R ' 181' ' ' VAL . . . . . . . . . . . . . 66.2 t -113.17 111.44 50.27 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.375 -0.828 . . . . 17.69 109.836 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 182' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.03 149.49 52.84 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.532 1.28 . . . . 17.81 110.409 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 183' ' ' TYR . . . . . 0.712 ' O ' ' C ' ' R' ' 184' ' ' ASP . 79.1 m-85 -59.03 175.52 0.28 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.458 -0.776 . . . . 28.01 110.504 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' R' R ' 184' ' ' ASP . . . . . 0.712 ' C ' ' O ' ' R' ' 183' ' ' TYR . 15.0 t70 -17.26 -81.98 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.353 -0.842 . . . . 58.64 110.313 -178.083 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' R' R ' 185' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 . . . . . 0 N--CA 1.503 2.2 0 CA-C-O 121.277 0.56 . . . . 80.42 111.791 179.553 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' R' R ' 193' ' ' LYS . . . . . . . . . . . . . 26.8 tptt . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 120.907 0.384 . . . . 49.5 110.145 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' R' R ' 194' ' ' ALA . . . . . 0.427 ' CB ' ' HA ' ' R' ' 119' ' ' SER . . . -174.45 -155.74 0.06 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.12 -0.988 . . . . 40.4 110.082 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' R' R ' 195' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.29 -27.05 13.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.427 -0.796 . . . . 34.6 110.266 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' R' R ' 196' ' ' VAL . . . . . 0.582 ' HB ' ' HB3' ' R' ' 119' ' ' SER . 2.0 t -109.8 31.08 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.262 -0.899 . . . . 33.27 110.637 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' R' R ' 197' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -147.92 38.07 0.9 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.098 -1.001 . . . . 41.58 110.648 -179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' R' R ' 198' ' ' ARG . . . . . . . . . . . . . 6.1 ptt-85 -129.85 149.67 51.48 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.135 -0.978 . . . . 38.65 110.227 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' R' R ' 199' ' ' LYS . . . . . 0.597 ' HA ' ' HD3' ' S' ' 299' ' ' PRO . 28.5 mtpt -84.02 103.98 13.71 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.462 -0.774 . . . . 36.77 109.992 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' R' R ' 200' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -85.98 -153.26 0.18 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.303 -0.873 . . . . 33.08 110.195 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' R' R ' 201' ' ' LYS . . . . . 0.417 ' HA ' ' CA ' ' S' ' 297' ' ' GLY . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.675 0 O-C-N 121.348 -0.845 . . . . 44.32 110.304 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' S' S ' 229' ' ' MET . . . . . . . . . . . . . 15.9 mmm . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.231 0.539 . . . . 51.83 110.228 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' S' S ' 230' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -97.31 142.76 28.8 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.292 -0.88 . . . . 54.13 110.133 -178.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 231' ' ' LEU . . . . . . . . . . . . . 68.3 mt -134.13 141.05 46.97 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.306 -0.871 . . . . 33.04 110.372 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 232' ' ' THR . . . . . . . . . . . . . 40.3 m -89.28 103.25 15.89 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.362 -0.836 . . . . 26.92 110.0 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 233' ' ' LEU . . . . . 0.494 HD23 ' CE2' ' S' ' 262' ' ' TYR . 79.7 mt -55.88 179.3 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.418 -0.801 . . . . 13.78 110.493 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' S' S ' 234' ' ' TYR . . . . . 0.448 ' CG ' ' N ' ' S' ' 235' ' ' ASN . 35.5 p90 -64.96 -35.73 82.13 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.453 -0.779 . . . . 26.08 110.213 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' S' S ' 235' ' ' ASN . . . . . 0.448 ' N ' ' CG ' ' S' ' 234' ' ' TYR . 50.7 p30 -74.29 -7.42 52.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.289 -0.882 . . . . 20.04 110.601 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' S' S ' 236' ' ' GLY . . . . . . . . . . . . . . . 95.74 -19.91 52.21 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.748 -1.341 . . . . 22.71 109.748 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 237' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -53.08 145.74 12.65 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.243 -1.151 . . . . 35.44 110.165 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 238' ' ' LYS . . . . . . . . . . . . . 44.5 mttt -102.15 127.97 48.84 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.391 -0.818 . . . . 32.56 110.337 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 239' ' ' LYS . . . . . 0.422 ' HG2' ' CZ ' ' S' ' 241' ' ' PHE . 9.0 ttmt -132.29 144.49 50.63 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.391 -0.818 . . . . 26.68 109.949 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' S' S ' 240' ' ' THR . . . . . . . . . . . . . 51.3 m -102.06 132.2 48.07 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.329 -0.857 . . . . 41.02 110.39 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 241' ' ' PHE . . . . . 0.422 ' CZ ' ' HG2' ' S' ' 239' ' ' LYS . 96.1 m-85 -117.88 137.72 52.6 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.364 -0.835 . . . . 28.62 110.195 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' S' S ' 242' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -96.44 161.83 13.75 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.365 -0.835 . . . . 47.89 110.163 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 243' ' ' SER . . . . . . . . . . . . . 72.4 m -90.59 151.58 21.25 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.295 -0.878 . . . . 45.09 110.241 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 244' ' ' ARG . . . . . . . . . . . . . 1.4 mtp85 -129.81 126.75 22.69 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.402 -0.811 . . . . 42.49 110.162 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 245' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.37 161.05 43.57 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 O-C-N 123.666 1.351 . . . . 35.68 110.503 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 246' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -132.94 97.88 4.14 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.391 -0.818 . . . . 51.88 109.82 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 247' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -110.5 -22.23 11.77 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.4 -0.813 . . . . 53.69 110.643 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 248' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -117.21 43.63 2.28 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.178 -0.951 . . . . 55.79 110.774 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 249' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 48.77 38.43 11.79 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.443 -0.785 . . . . 49.45 110.381 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 250' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -90.62 29.07 1.36 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.521 -0.737 . . . . 36.86 110.31 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 251' ' ' ALA . . . . . . . . . . . . . . . -53.9 -43.13 69.42 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.322 -0.861 . . . . 29.69 109.56 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 252' ' ' TRP . . . . . 0.408 ' CZ2' ' HB3' ' S' ' 294' ' ' LEU . 67.8 p-90 -61.83 -33.97 75.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.556 -0.715 . . . . 41.12 109.832 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' S' S ' 253' ' ' LEU . . . . . 0.407 ' N ' ' CD2' ' S' ' 252' ' ' TRP . 23.3 tp -70.11 -47.14 63.07 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.335 -0.853 . . . . 24.89 110.002 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' S' S ' 254' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -56.23 -42.51 77.41 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.326 -0.859 . . . . 35.65 109.909 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 255' ' ' ALA . . . . . . . . . . . . . . . -59.47 -48.13 82.83 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.402 -0.811 . . . . 22.73 110.115 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 256' ' ' ILE . . . . . . . . . . . . . 79.9 mt -62.31 -40.72 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.326 -0.858 . . . . 28.85 109.986 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 257' ' ' LEU . . . . . . . . . . . . . 19.1 mt -61.49 -44.52 96.92 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.405 -0.809 . . . . 23.07 110.186 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 258' ' ' GLN . . . . . 0.471 ' HB3' ' CD2' ' S' ' 351' ' ' PHE . 53.5 mm-40 -65.04 -45.3 85.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.402 -0.811 . . . . 29.78 109.993 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' S' S ' 259' ' ' LEU . . . . . 0.422 ' O ' HG22 ' S' ' 263' ' ' VAL . 20.0 tp -58.71 -36.41 74.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.236 -0.915 . . . . 17.94 109.453 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' S' S ' 260' ' ' PHE . . . . . 0.468 ' CE2' HD22 ' S' ' 311' ' ' LEU . 3.1 m-85 -62.77 -45.35 93.07 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.624 -0.673 . . . . 30.57 109.857 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' S' S ' 261' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -62.01 -29.8 70.52 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.432 -0.792 . . . . 41.34 109.98 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 262' ' ' TYR . . . . . 0.494 ' CE2' HD23 ' S' ' 233' ' ' LEU . 8.7 t80 -71.15 -44.68 65.06 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.415 -0.803 . . . . 26.03 110.102 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' S' S ' 263' ' ' VAL . . . . . 0.422 HG22 ' O ' ' S' ' 259' ' ' LEU . 33.0 m -91.93 18.19 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.293 -0.88 . . . . 22.8 110.403 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' S' S ' 264' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 52.75 70.71 0.55 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.26 -0.9 . . . . 44.03 110.586 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 265' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -111.79 109.17 55.5 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.332 -0.855 . . . . 35.61 109.716 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 266' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -75.33 0.48 8.99 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 O-C-N 123.637 1.335 . . . . 37.67 111.768 -179.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 267' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -56.58 -67.71 0.28 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.797 -1.189 . . . . 41.49 110.18 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' S' S ' 268' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -92.81 39.83 1.04 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.177 -0.952 . . . . 50.76 110.124 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 269' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.99 -33.21 59.72 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.424 -0.798 . . . . 61.86 109.806 179.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' S' S ' 270' ' ' TRP . . . . . 0.486 ' CE2' ' CG2' ' S' ' 271' ' ' VAL . 50.9 p-90 -73.9 -4.35 34.5 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.279 -0.888 . . . . 39.85 110.5 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' S' S ' 271' ' ' VAL . . . . . 0.486 ' CG2' ' CE2' ' S' ' 270' ' ' TRP . 46.5 t -109.49 -32.68 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.15 -0.969 . . . . 39.18 110.088 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' S' S ' 272' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -78.68 -36.53 43.56 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.443 -0.786 . . . . 40.02 110.489 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 273' ' ' SER . . . . . . . . . . . . . 71.0 m -103.53 56.07 0.74 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.292 -0.88 . . . . 47.2 110.314 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 274' ' ' SER . . . . . . . . . . . . . 6.9 t -133.01 141.24 40.23 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.317 -0.865 . . . . 47.61 110.159 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 275' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.72 -18.92 21.78 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 123.678 1.357 . . . . 45.28 110.526 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 276' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -99.98 140.9 33.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.246 -0.909 . . . . 57.27 110.299 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 277' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -71.7 97.67 1.79 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.355 -0.841 . . . . 37.28 110.284 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 278' ' ' LEU . . . . . . . . . . . . . 86.4 mt -96.99 33.8 1.84 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.441 -0.787 . . . . 43.88 110.014 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 279' ' ' THR . . . . . . . . . . . . . 76.9 m -64.02 -60.23 3.5 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.457 -0.777 . . . . 50.05 110.203 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 280' ' ' LEU . . . . . . . . . . . . . 13.7 mt -51.53 -39.87 58.55 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.343 -0.848 . . . . 54.12 110.316 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 281' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.39 -49.71 74.44 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.457 -0.777 . . . . 65.28 110.178 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' S' S ' 282' ' ' ALA . . . . . . . . . . . . . . . -58.88 -33.98 71.12 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.514 -0.741 . . . . 46.51 110.557 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 283' ' ' ILE . . . . . . . . . . . . . 85.9 mt -66.37 -50.86 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.328 -0.857 . . . . 47.3 110.101 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 284' ' ' LYS . . . . . . . . . . . . . 33.6 tttp -50.46 -57.68 7.48 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.422 -0.799 . . . . 50.72 110.381 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 285' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -51.31 -46.5 62.58 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.494 -0.754 . . . . 68.47 110.312 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 286' ' ' LEU . . . . . . . . . . . . . 19.1 mt -59.89 -44.5 94.2 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.379 -0.825 . . . . 36.62 110.3 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 287' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -62.81 -35.26 79.33 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.319 -0.863 . . . . 46.64 110.043 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 288' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -76.17 -21.11 56.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.405 -0.809 . . . . 46.45 110.381 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 289' ' ' LEU . . . . . . . . . . . . . 30.8 mt -97.26 -21.76 17.07 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.244 -0.91 . . . . 35.09 110.582 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 290' ' ' THR . . . . . . . . . . . . . 81.5 p -114.76 -28.52 7.06 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.25 -0.906 . . . . 38.61 110.429 -179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 291' ' ' GLY . . . . . . . . . . . . . . . 79.38 11.11 85.27 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.789 -1.324 . . . . 36.77 109.789 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 292' ' ' LEU . . . . . . . . . . . . . 84.5 mt -96.48 145.76 25.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.336 -1.096 . . . . 35.33 109.77 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 293' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -77.3 102.33 6.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.222 -0.923 . . . . 48.7 110.316 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 294' ' ' LEU . . . . . 0.408 ' HB3' ' CZ2' ' S' ' 252' ' ' TRP . 55.4 mt -106.86 51.7 0.74 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.503 -0.748 . . . . 42.61 110.136 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' S' S ' 295' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -112.48 -11.2 13.65 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.377 -0.827 . . . . 55.49 110.498 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' S' S ' 296' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -144.29 48.45 1.37 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.059 -1.025 . . . . 75.68 110.338 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 297' ' ' GLY . . . . . 0.417 ' CA ' ' HA ' ' R' ' 201' ' ' LYS . . . 96.91 145.12 18.6 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.48 -1.448 . . . . 49.44 109.48 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' S' S ' 298' ' ' GLY . . . . . . . . . . . . . . . -163.79 156.93 29.01 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.775 -1.33 . . . . 41.11 109.775 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 299' ' ' PRO . . . . . 0.597 ' HD3' ' HA ' ' R' ' 199' ' ' LYS . 46.6 Cg_endo -73.8 118.3 5.39 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 O-C-N 123.992 1.522 . . . . 26.2 110.277 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' S' S ' 300' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.21 -15.56 31.76 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 O-C-N 123.616 1.324 . . . . 21.7 110.692 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 301' ' ' ALA . . . . . . . . . . . . . . . -80.65 -29.36 36.69 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.175 -0.953 . . . . 31.23 110.133 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 302' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.43 -40.64 19.05 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.503 -0.748 . . . . 38.99 109.975 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' S' S ' 303' ' ' VAL . . . . . 0.457 ' O ' HG12 ' S' ' 307' ' ' ILE . 58.2 t -60.7 -35.46 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.435 -0.791 . . . . 18.63 110.177 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' S' S ' 304' ' ' ILE . . . . . . . . . . . . . 86.1 mt -79.43 -23.56 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.423 -0.798 . . . . 25.46 110.19 179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 305' ' ' TRP . . . . . 0.419 ' CE2' ' NH1' ' R' ' 120' ' ' ARG . 68.8 t-105 -88.65 -14.52 37.21 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.224 -0.923 . . . . 33.4 110.581 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' S' S ' 306' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -89.76 -13.52 36.54 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.142 -0.974 . . . . 36.97 110.399 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 307' ' ' ILE . . . . . 0.457 HG12 ' O ' ' S' ' 303' ' ' VAL . 36.8 pt -125.05 45.71 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.164 -0.96 . . . . 30.81 110.071 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' S' S ' 308' ' ' LYS . . . . . 0.405 ' HD3' ' CD2' ' S' ' 305' ' ' TRP . 1.5 mtmp? -73.59 -37.75 65.36 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.378 -0.826 . . . . 46.52 110.077 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' S' S ' 309' ' ' HIS . . . . . 0.488 ' CD2' ' HG ' ' S' ' 310' ' ' LEU . 55.5 p-80 -73.17 -8.28 55.08 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.35 -0.844 . . . . 51.03 110.161 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' S' S ' 310' ' ' LEU . . . . . 0.488 ' HG ' ' CD2' ' S' ' 309' ' ' HIS . 53.0 mt -99.32 -12.92 19.89 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.347 -0.845 . . . . 36.16 109.943 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' S' S ' 311' ' ' LEU . . . . . 0.468 HD22 ' CE2' ' S' ' 260' ' ' PHE . 10.8 mt -97.12 147.85 23.64 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.381 -0.824 . . . . 40.0 110.429 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' S' S ' 312' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -81.59 -16.32 51.97 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.322 -0.861 . . . . 54.18 109.748 179.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 313' ' ' THR . . . . . 0.471 HG23 ' HB3' ' S' ' 323' ' ' GLU . 92.9 m -87.94 151.66 22.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.337 -0.852 . . . . 25.61 110.115 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' S' S ' 314' ' ' GLY . . . . . . . . . . . . . . . -87.95 126.38 8.04 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.768 -1.333 . . . . 25.18 109.768 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 315' ' ' ILE . . . . . 0.427 HG23 HD11 ' S' ' 315' ' ' ILE . 50.7 mm -101.66 150.48 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.441 -1.034 . . . . 23.9 109.725 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' S' S ' 316' ' ' GLY . . . . . 0.405 ' N ' HG21 ' S' ' 315' ' ' ILE . . . -157.04 -159.31 9.4 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.931 -1.268 . . . . 23.18 109.931 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' S' S ' 317' ' ' THR . . . . . . . . . . . . . 11.2 p -133.9 -172.98 3.12 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.468 -1.019 . . . . 27.98 110.044 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.59 -56.19 25.06 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.163 -0.961 . . . . 28.1 109.874 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 319' ' ' SER . . . . . 0.431 ' OG ' ' CZ2' ' S' ' 392' ' ' TRP . 1.2 m -59.93 -41.63 92.19 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.326 -0.859 . . . . 37.0 109.663 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' S' S ' 320' ' ' ARG . . . . . . . . . . . . . 12.1 mtm180 -111.73 79.8 2.64 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.466 -0.771 . . . . 52.07 109.655 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 321' ' ' PRO . . . . . 0.428 ' O ' ' HB2' ' S' ' 322' ' ' SER . 44.4 Cg_endo -71.38 171.51 16.01 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.783 1.412 . . . . 38.29 110.979 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' S' S ' 322' ' ' SER . . . . . 0.428 ' HB2' ' O ' ' S' ' 321' ' ' PRO . 41.3 t 178.67 -148.15 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.956 -0.757 . . . . 38.84 108.956 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' S' S ' 323' ' ' GLU . . . . . 0.471 ' HB3' HG23 ' S' ' 313' ' ' THR . 6.7 tp10 -62.87 -40.29 97.05 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.043 -1.036 . . . . 40.7 109.64 179.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' S' S ' 324' ' ' VAL . . . . . . . . . . . . . 73.6 t -141.27 134.99 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.35 -0.844 . . . . 20.34 109.469 179.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 325' ' ' CYS . . . . . 0.458 ' HB2' ' CE1' ' S' ' 380' ' ' PHE . 11.1 m -125.99 172.26 10.09 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.312 -0.868 . . . . 30.63 110.924 -179.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' S' S ' 326' ' ' VAL . . . . . . . . . . . . . 34.5 m -135.56 142.16 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 109.175 -0.676 . . . . 23.9 109.175 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 327' ' ' VAL . . . . . 0.52 ' O ' ' CG2' ' R' ' 196' ' ' VAL . 34.6 m -56.37 125.02 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.112 -0.992 . . . . 19.48 110.39 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' S' S ' 328' ' ' ASP . . . . . 0.544 ' HA ' HG21 ' R' ' 196' ' ' VAL . 55.7 p-10 -119.4 11.61 12.23 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.418 -0.801 . . . . 26.43 110.439 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' S' S ' 329' ' ' GLY . . . . . . . . . . . . . . . 119.59 2.3 13.17 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.068 -1.213 . . . . 31.24 110.068 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 330' ' ' THR . . . . . . . . . . . . . 81.0 m -92.97 129.94 38.71 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.101 -1.235 . . . . 30.05 110.133 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 331' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -56.77 111.5 1.04 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.302 -0.873 . . . . 37.26 109.992 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 332' ' ' MET . . . . . 0.449 ' HE1' ' CZ ' ' S' ' 380' ' ' PHE . 87.9 mmm -94.08 162.58 13.82 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.235 -0.915 . . . . 26.23 110.334 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' S' S ' 333' ' ' CYS . . . . . . . . . . . . . 26.4 m -137.15 150.05 47.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.42 -0.8 . . . . 23.56 110.078 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 334' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.6 -24.9 9.18 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.228 -0.92 . . . . 28.93 110.508 179.833 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' S' S ' 335' ' ' ALA . . . . . . . . . . . . . . . -89.02 14.45 10.58 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.319 -0.863 . . . . 15.76 110.964 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 336' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -100.49 -17.15 17.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.134 -0.979 . . . . 34.92 110.214 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 337' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -152.42 170.81 19.21 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.39 -0.819 . . . . 19.03 110.154 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 338' ' ' HIS . . . . . . . . . . . . . 13.5 p80 -120.73 10.4 10.97 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.394 -0.816 . . . . 18.82 110.411 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 339' ' ' ALA . . . . . . . . . . . . . . . -176.04 155.16 1.54 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.206 -0.934 . . . . 17.18 110.09 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 340' ' ' GLY . . . . . . . . . . . . . . . 160.85 173.05 28.97 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.001 -1.24 . . . . 18.33 110.001 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 341' ' ' ILE . . . . . 0.445 HD12 HG22 ' S' ' 341' ' ' ILE . 83.9 mt -88.8 138.08 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.393 -1.063 . . . . 18.6 109.839 179.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' S' S ' 342' ' ' PHE . . . . . 0.493 ' CE1' HG23 ' S' ' 377' ' ' VAL . 69.9 m-85 -120.93 -178.49 3.75 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.219 -0.926 . . . . 23.44 110.412 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' S' S ' 343' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.84 93.4 4.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.397 -0.814 . . . . 35.59 110.07 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' S' S ' 344' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.82 125.04 29.59 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.236 -0.915 . . . . 38.34 110.046 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' S' S ' 345' ' ' GLY . . . . . . . . . . . . . . . 62.85 -130.85 42.89 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 108.788 -1.725 . . . . 53.46 108.788 -179.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 346' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -132.7 150.88 52.1 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.173 -1.192 . . . . 70.91 110.011 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 347' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 53.31 35.36 20.02 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.236 -0.915 . . . . 47.32 110.393 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 348' ' ' HIS . . . . . . . . . . . . . 46.6 t60 -150.11 155.89 40.66 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.317 -0.865 . . . . 41.72 110.312 -179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 349' ' ' ALA . . . . . . . . . . . . . . . -149.79 151.3 33.34 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.324 -0.86 . . . . 22.91 110.442 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 350' ' ' VAL . . . . . . . . . . . . . 34.6 m -149.14 169.55 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.448 -0.782 . . . . 21.09 109.995 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 351' ' ' PHE . . . . . 0.471 ' CD2' ' HB3' ' S' ' 258' ' ' GLN . 10.7 t80 -105.27 143.58 33.25 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.19 -0.944 . . . . 25.03 110.716 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' S' S ' 352' ' ' ALA . . . . . . . . . . . . . . . -147.7 151.74 36.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.584 -0.698 . . . . 23.81 109.741 179.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 353' ' ' CYS . . . . . . . . . . . . . 26.3 p -153.34 164.84 37.43 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.295 -0.878 . . . . 25.66 110.225 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 354' ' ' VAL . . . . . 0.404 HG23 ' CZ2' ' S' ' 359' ' ' TRP . 57.2 t -76.04 118.47 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.376 -0.828 . . . . 34.27 109.943 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' S' S ' 355' ' ' THR . . . . . 0.441 HG23 ' HB2' ' S' ' 360' ' ' TYR . 52.3 p -117.82 175.1 5.82 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.257 -0.902 . . . . 25.49 110.346 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' S' S ' 356' ' ' SER . . . . . . . . . . . . . 62.2 p -62.2 -17.61 58.65 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.456 -0.778 . . . . 31.24 110.699 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 357' ' ' ASN . . . . . . . . . . . . . 45.8 m-20 -107.05 14.22 26.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.896 . . . . 28.61 110.552 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 358' ' ' GLY . . . . . . . . . . . . . . . 111.86 -152.92 17.59 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.013 -1.235 . . . . 22.01 110.013 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 359' ' ' TRP . . . . . 0.404 ' CZ2' HG23 ' S' ' 354' ' ' VAL . 15.3 m95 -91.3 116.65 29.0 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.38 -1.071 . . . . 25.54 110.23 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' S' S ' 360' ' ' TYR . . . . . 0.441 ' HB2' HG23 ' S' ' 355' ' ' THR . 1.3 m-85 -103.53 165.79 10.82 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.257 -0.902 . . . . 40.53 110.091 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' S' S ' 361' ' ' ALA . . . . . . . . . . . . . . . -140.01 129.99 24.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.353 -0.842 . . . . 18.04 110.295 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 362' ' ' ILE . . . . . 0.425 HG23 ' CZ ' ' S' ' 367' ' ' PHE . 88.9 mt -95.54 83.61 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.375 -0.828 . . . . 15.64 110.081 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' S' S ' 363' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' S' ' 365' ' ' GLU . 11.9 t0 -75.19 94.48 2.96 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.42 -0.8 . . . . 35.03 110.186 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' S' S ' 364' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 53.92 -89.3 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.53 -0.731 . . . . 46.72 110.537 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 365' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' S' ' 363' ' ' ASP . 23.7 mt-10 -122.69 19.1 10.32 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.046 -1.033 . . . . 56.2 110.223 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' S' S ' 366' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -117.91 124.88 49.34 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.21 -0.932 . . . . 51.02 110.44 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 367' ' ' PHE . . . . . 0.425 ' CZ ' HG23 ' S' ' 362' ' ' ILE . 26.9 m-85 -106.89 127.05 53.09 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.326 -0.859 . . . . 37.59 110.18 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' S' S ' 368' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -165.47 159.5 13.83 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.293 -0.879 . . . . 31.47 110.415 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 369' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -72.76 139.59 30.9 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 O-C-N 123.891 1.469 . . . . 28.85 110.557 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 370' ' ' TRP . . . . . . . . . . . . . 67.4 t90 -167.25 113.52 0.76 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.422 -0.799 . . . . 26.94 110.001 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 371' ' ' THR . . . . . . . . . . . . . 59.8 m -74.81 113.08 21.02 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.376 -0.828 . . . . 20.19 110.041 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 372' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.59 157.11 49.04 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.644 1.339 . . . . 28.68 110.529 -179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 373' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -90.58 147.15 35.74 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.411 -0.806 . . . . 35.72 109.934 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 374' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -76.03 -6.27 17.18 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 O-C-N 123.681 1.359 . . . . 30.89 110.461 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 375' ' ' SER . . . . . . . . . . . . . 70.5 p -104.39 -17.0 14.95 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.227 -0.921 . . . . 29.41 110.428 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 376' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -106.48 43.09 1.18 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.358 -0.839 . . . . 32.89 110.26 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 377' ' ' VAL . . . . . 0.493 HG23 ' CE1' ' S' ' 342' ' ' PHE . 7.3 p -114.71 147.29 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.294 -0.879 . . . . 24.33 110.223 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' S' S ' 378' ' ' LEU . . . . . . . . . . . . . 52.5 mt -115.99 -57.96 2.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.381 -0.824 . . . . 24.37 109.611 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 379' ' ' VAL . . . . . . . . . . . . . 61.0 t -120.76 132.38 70.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.404 -0.81 . . . . 18.02 109.424 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 380' ' ' PHE . . . . . 0.458 ' CE1' ' HB2' ' S' ' 325' ' ' CYS . 14.6 p90 -142.61 173.96 11.07 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.376 -0.828 . . . . 29.35 110.704 -179.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' S' S ' 381' ' ' VAL . . . . . . . . . . . . . 57.7 t -120.12 107.31 39.79 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.459 -0.776 . . . . 16.34 109.43 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 382' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -71.19 145.6 49.43 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.613 1.322 . . . . 20.94 110.79 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 383' ' ' TYR . . . . . 0.959 ' O ' ' CB ' ' S' ' 384' ' ' ASP . 88.5 m-85 -61.04 -53.57 55.61 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.317 -0.865 . . . . 28.93 109.826 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' S' S ' 384' ' ' ASP . . . . . 0.959 ' CB ' ' O ' ' S' ' 383' ' ' TYR . 7.0 t70 111.08 -156.87 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.46 -0.775 . . . . 47.03 110.366 176.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' S' S ' 385' ' ' GLN . . . . . 0.405 ' CB ' ' O ' ' S' ' 384' ' ' ASP . 7.7 tm0? 62.27 11.55 4.56 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.435 -0.791 . . . . 46.69 110.261 -178.336 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' S' S ' 386' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -174.3 129.96 0.48 Allowed Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.316 -0.865 . . . . 50.25 109.56 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 387' ' ' PRO . . . . . 0.553 ' O ' ' N ' ' S' ' 389' ' ' ASN . 55.7 Cg_endo -73.17 0.61 7.67 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.668 1.351 . . . . 34.39 110.576 -179.02 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' S' S ' 388' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 62.02 -70.3 0.05 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.436 -0.79 . . . . 38.01 110.132 -179.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' S' S ' 389' ' ' ASN . . . . . 0.553 ' N ' ' O ' ' S' ' 387' ' ' PRO . 3.2 m-80 -132.57 -164.81 1.51 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.391 -0.818 . . . . 45.82 110.059 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' S' S ' 390' ' ' GLY . . . . . 0.526 ' O ' ' CD2' ' S' ' 392' ' ' TRP . . . 152.25 -92.73 0.14 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.603 -1.399 . . . . 33.46 109.603 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' S' S ' 391' ' ' GLU . . . . . 0.481 ' CB ' ' O ' ' S' ' 390' ' ' GLY . 1.5 tp10 66.89 -65.85 0.2 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.331 -1.099 . . . . 56.58 110.152 -179.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' S' S ' 392' ' ' TRP . . . . . 0.526 ' CD2' ' O ' ' S' ' 390' ' ' GLY . 1.6 p90 -62.2 -17.57 58.56 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.298 -0.876 . . . . 31.43 110.313 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' S' S ' 393' ' ' LYS . . . . . 0.657 ' O ' HG13 ' S' ' 396' ' ' VAL . 3.0 ptmm? -52.17 -36.95 53.19 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.322 -0.861 . . . . 39.42 110.374 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' S' S ' 394' ' ' ALA . . . . . . . . . . . . . . . -85.99 -20.34 29.04 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.444 -0.785 . . . . 34.33 110.075 178.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' S' S ' 395' ' ' LYS . . . . . 0.597 ' O ' HD13 ' R' ' 143' ' ' LEU . 18.4 mttp -75.67 -14.56 60.36 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.374 -0.829 . . . . 60.09 110.308 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' S' S ' 396' ' ' VAL . . . . . 0.867 ' O ' ' HA ' ' R' ' 99' ' ' PRO . 8.8 p -95.99 -46.95 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.378 -0.826 . . . . 35.5 110.54 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' S' S ' 397' ' ' GLN . . . . . 0.441 ' N ' ' CG1' ' S' ' 396' ' ' VAL . 2.4 tt0 -71.17 -7.26 45.54 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.148 -0.97 . . . . 49.96 110.607 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' S' S ' 398' ' ' ARG . . . . . 0.674 ' HD3' ' O ' ' S' ' 398' ' ' ARG . 0.0 OUTLIER -39.61 157.74 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.222 -0.924 . . . . 43.42 110.695 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' S' S ' 399' ' ' LYS . . . . . 0.63 ' CB ' ' HA3' ' R' ' 97' ' ' GLY . 0.0 OUTLIER -146.05 120.64 9.77 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.492 -0.755 . . . . 55.31 110.027 179.852 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' S' S ' 400' ' ' LEU . . . . . 0.565 ' C ' ' O ' ' S' ' 399' ' ' LYS . 19.9 tp -30.93 -48.51 0.11 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.307 -0.871 . . . . 41.03 110.26 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' S' S ' 401' ' ' LYS . . . . . 0.495 ' CB ' ' OD1' ' R' ' 49' ' ' ASP . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.684 0 O-C-N 121.359 -0.838 . . . . 61.97 110.174 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' R' R ' 29' ' ' MET . . . . . . . . . . . . . 22.0 ptp . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.14 0.495 . . . . 32.14 110.303 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' R' R ' 30' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -96.33 141.13 30.03 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.412 -0.805 . . . . 43.36 110.287 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 31' ' ' LEU . . . . . . . . . . . . . 65.3 mt -134.86 140.61 45.95 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.308 -0.87 . . . . 22.93 110.306 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 32' ' ' THR . . . . . . . . . . . . . 68.4 m -87.59 110.59 20.49 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.408 -0.807 . . . . 22.34 109.971 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 33' ' ' LEU . . . . . 0.462 HD23 ' CE2' ' R' ' 62' ' ' TYR . 80.0 mt -62.38 -172.79 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.314 -0.866 . . . . 21.39 110.226 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' R' R ' 34' ' ' TYR . . . . . . . . . . . . . 37.0 p90 -74.68 -29.4 61.21 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.333 -0.855 . . . . 34.4 110.38 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 35' ' ' ASN . . . . . . . . . . . . . 48.3 p30 -77.79 -1.79 33.2 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.356 -0.84 . . . . 30.28 110.699 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.24 -16.55 59.49 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.691 -1.364 . . . . 36.25 109.691 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 37' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -59.04 161.81 4.79 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.314 -1.11 . . . . 53.8 110.368 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 38' ' ' LYS . . . . . . . . . . . . . 56.9 mttt -117.86 135.8 53.86 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.445 -0.784 . . . . 49.91 110.146 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 39' ' ' LYS . . . . . 0.417 ' HG2' ' CZ ' ' R' ' 41' ' ' PHE . 8.1 ttmt -138.75 143.64 39.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.404 -0.81 . . . . 35.69 110.223 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' R' R ' 40' ' ' THR . . . . . . . . . . . . . 23.5 m -102.54 127.96 49.39 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.302 -0.874 . . . . 34.84 110.228 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 41' ' ' PHE . . . . . 0.417 ' CZ ' ' HG2' ' R' ' 39' ' ' LYS . 96.6 m-85 -113.04 132.65 55.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.378 -0.826 . . . . 34.42 110.172 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' R' R ' 42' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -93.36 140.95 28.99 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.331 -0.856 . . . . 51.46 110.221 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 43' ' ' SER . . . . . . . . . . . . . 54.3 m -70.76 141.93 51.42 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.55 -0.719 . . . . 41.84 110.205 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.75 125.37 29.59 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.469 -0.769 . . . . 33.82 110.013 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' R' R ' 45' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.11 151.13 55.13 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.59 1.31 . . . . 30.27 110.625 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 46' ' ' ASN . . . . . 0.676 HD22 ' HG ' ' S' ' 400' ' ' LEU . 52.2 t-20 -124.28 109.84 13.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.459 -0.776 . . . . 35.1 110.071 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' R' R ' 47' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -120.27 -34.86 3.56 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.395 -0.816 . . . . 42.81 110.551 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 48' ' ' HIS . . . . . . . . . . . . . 73.3 m80 -105.73 45.1 0.99 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.187 -0.946 . . . . 49.97 110.235 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 49' ' ' ASP . . . . . 0.734 ' HB3' ' HB2' ' S' ' 399' ' ' LYS . 37.6 m-20 50.32 34.72 9.38 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.4 -0.813 . . . . 61.32 110.149 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' R' R ' 50' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -86.32 43.87 1.1 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.323 -0.861 . . . . 51.5 110.66 -179.572 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 51' ' ' ALA . . . . . 0.498 ' HB2' ' CD2' ' S' ' 400' ' ' LEU . . . -66.12 -46.11 78.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.165 -0.959 . . . . 38.77 109.541 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' R' R ' 52' ' ' TRP . . . . . 0.483 ' CD2' ' N ' ' R' ' 53' ' ' LEU . 68.2 p-90 -58.4 -38.4 77.27 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.482 -0.761 . . . . 26.24 110.055 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' R' R ' 53' ' ' LEU . . . . . 0.483 ' N ' ' CD2' ' R' ' 52' ' ' TRP . 23.1 tp -66.73 -46.66 74.76 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.456 -0.777 . . . . 26.75 109.946 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' R' R ' 54' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -55.23 -41.54 72.24 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.405 -0.809 . . . . 35.02 110.132 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.26 -46.11 91.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.352 -0.842 . . . . 24.47 110.114 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 56' ' ' ILE . . . . . . . . . . . . . 76.6 mt -62.09 -42.33 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.259 -0.901 . . . . 26.03 109.906 179.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 57' ' ' LEU . . . . . . . . . . . . . 22.5 mt -60.26 -45.69 92.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.28 -0.888 . . . . 26.77 109.657 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 58' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -63.87 -46.51 84.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.341 -0.849 . . . . 22.32 109.582 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 59' ' ' LEU . . . . . 0.43 ' HA ' ' HE2' ' R' ' 151' ' ' PHE . 24.0 tp -61.43 -37.73 84.6 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.306 -0.871 . . . . 20.55 109.396 179.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' R' R ' 60' ' ' PHE . . . . . 0.448 ' CE2' HD22 ' R' ' 111' ' ' LEU . 2.8 m-85 -61.11 -44.72 96.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.617 -0.677 . . . . 20.08 109.913 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' R' R ' 61' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -63.17 -36.23 82.93 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.498 -0.751 . . . . 18.8 110.408 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 62' ' ' TYR . . . . . 0.462 ' CE2' HD23 ' R' ' 33' ' ' LEU . 9.2 t80 -63.04 -41.74 99.58 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.226 -0.921 . . . . 26.45 110.247 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' R' R ' 63' ' ' VAL . . . . . . . . . . . . . 30.8 m -93.42 20.32 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.308 -0.87 . . . . 29.75 110.266 179.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 64' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 53.03 75.44 0.24 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.316 -0.865 . . . . 35.52 110.561 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 65' ' ' GLU . . . . . 0.425 ' HG2' ' CD2' ' R' ' 60' ' ' PHE . 14.3 tp10 -116.19 104.01 52.55 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.391 -0.818 . . . . 29.89 109.958 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' R' R ' 66' ' ' PRO . . . . . 0.4 ' HA ' ' HB2' ' R' ' 69' ' ' ASP . 46.6 Cg_endo -73.47 -5.88 17.85 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.708 1.372 . . . . 21.37 111.068 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' R' R ' 67' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -52.11 -61.58 2.17 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.054 -1.029 . . . . 23.85 110.341 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' R' R ' 68' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -98.06 36.52 1.56 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.314 -0.866 . . . . 28.07 110.474 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 69' ' ' ASP . . . . . 0.4 ' HB2' ' HA ' ' R' ' 66' ' ' PRO . 11.7 t0 -72.3 -33.25 67.27 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.307 -0.871 . . . . 43.76 110.205 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' R' R ' 70' ' ' TRP . . . . . 0.476 ' CE2' ' CG2' ' R' ' 71' ' ' VAL . 48.0 p-90 -73.49 -3.85 30.18 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.332 -0.855 . . . . 33.06 110.686 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' R' R ' 71' ' ' VAL . . . . . 0.476 ' CG2' ' CE2' ' R' ' 70' ' ' TRP . 40.8 t -109.83 -27.41 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.175 -0.953 . . . . 31.7 109.674 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' R' R ' 72' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -86.58 -48.88 7.96 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.358 -0.839 . . . . 33.58 110.278 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 73' ' ' SER . . . . . . . . . . . . . 70.2 m -89.67 51.12 2.02 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.312 -0.868 . . . . 50.82 110.308 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 74' ' ' SER . . . . . . . . . . . . . 15.9 t -125.96 138.33 31.88 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.282 -0.886 . . . . 34.74 110.189 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.38 -24.99 15.89 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 O-C-N 123.603 1.317 . . . . 35.7 110.32 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 76' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -91.74 153.24 19.76 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.461 -0.775 . . . . 66.48 110.356 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 77' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -81.56 95.23 7.07 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.33 -0.856 . . . . 46.72 110.097 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 78' ' ' LEU . . . . . . . . . . . . . 96.4 mt -96.43 28.01 3.52 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.398 -0.814 . . . . 37.55 110.187 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 79' ' ' THR . . . . . . . . . . . . . 29.9 m -56.21 -54.62 43.08 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.226 -0.921 . . . . 37.36 110.301 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 80' ' ' LEU . . . . . . . . . . . . . 15.9 mt -60.88 -23.28 65.07 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.449 -0.782 . . . . 35.83 110.511 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 81' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -79.44 -39.11 33.07 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.154 -0.966 . . . . 44.03 110.38 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.45 -28.66 66.3 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.292 -0.88 . . . . 32.54 110.211 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 83' ' ' ILE . . . . . . . . . . . . . 78.2 mt -70.13 -46.09 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.236 -0.915 . . . . 32.02 110.265 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 84' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -55.23 -52.09 64.49 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.237 -0.914 . . . . 34.09 110.521 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 85' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -54.82 -46.87 74.63 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.238 -0.914 . . . . 25.94 110.28 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 86' ' ' LEU . . . . . . . . . . . . . 24.0 mt -58.71 -43.73 90.17 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.299 -0.876 . . . . 16.2 109.923 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 87' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -65.43 -35.11 79.95 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.472 -0.768 . . . . 49.09 110.33 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 88' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -78.5 -19.06 53.85 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.276 -0.89 . . . . 28.61 110.479 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 89' ' ' LEU . . . . . . . . . . . . . 32.8 mt -96.18 -29.43 14.05 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.236 -0.915 . . . . 26.16 110.197 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 90' ' ' THR . . . . . . . . . . . . . 59.4 p -105.63 -34.72 7.65 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.259 -0.901 . . . . 33.33 109.764 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.89 16.08 58.55 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.821 -1.312 . . . . 31.13 109.821 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 92' ' ' LEU . . . . . . . . . . . . . 97.1 mt -100.06 155.23 17.83 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.147 -1.208 . . . . 42.52 110.23 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 93' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -86.21 91.62 8.51 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.49 -0.756 . . . . 68.46 110.017 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 94' ' ' LEU . . . . . 0.446 ' HB3' ' CZ2' ' R' ' 52' ' ' TRP . 48.3 mt -99.48 53.03 0.94 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.222 -0.924 . . . . 44.63 110.32 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' R' R ' 95' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.43 -38.8 6.35 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.262 -0.899 . . . . 67.16 110.385 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' R' R ' 96' ' ' GLU . . . . . 0.428 ' O ' ' HE2' ' S' ' 399' ' ' LYS . 24.7 mt-10 -113.83 44.23 1.67 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.251 -0.906 . . . . 67.02 110.352 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' R' R ' 97' ' ' GLY . . . . . 0.79 ' CA ' ' HB3' ' S' ' 399' ' ' LYS . . . 99.16 150.78 26.0 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.614 -1.395 . . . . 49.48 109.614 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' R' R ' 98' ' ' GLY . . . . . . . . . . . . . . . -166.26 160.03 33.47 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.286 -1.526 . . . . 36.57 109.286 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 99' ' ' PRO . . . . . 0.591 ' HA ' ' O ' ' S' ' 396' ' ' VAL . 45.8 Cg_endo -72.49 121.03 7.1 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 O-C-N 123.703 1.37 . . . . 30.41 110.47 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' R' R ' 100' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.22 -31.72 11.47 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 O-C-N 123.645 1.339 . . . . 29.94 110.552 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 101' ' ' ALA . . . . . . . . . . . . . . . -69.9 -38.49 76.32 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.228 -0.92 . . . . 23.64 110.291 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.64 -40.71 66.19 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.411 -0.805 . . . . 20.31 110.386 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' R' R ' 103' ' ' VAL . . . . . . . . . . . . . 64.0 t -58.25 -40.07 76.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.225 -0.922 . . . . 16.33 109.984 179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 104' ' ' ILE . . . . . . . . . . . . . 81.6 mt -71.63 -30.6 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.388 -0.82 . . . . 24.77 109.939 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 105' ' ' TRP . . . . . 0.44 ' O ' ' HD3' ' R' ' 108' ' ' LYS . 70.5 t-105 -82.35 0.82 40.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.292 -0.88 . . . . 23.28 110.321 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' R' R ' 106' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -105.07 -10.49 17.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.136 -0.977 . . . . 28.26 110.086 179.688 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 107' ' ' ILE . . . . . . . . . . . . . 36.8 pt -126.83 35.06 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.208 -0.933 . . . . 18.77 110.033 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 108' ' ' LYS . . . . . 0.48 ' HG2' ' HB ' ' R' ' 115' ' ' ILE . 9.2 mtpp -61.16 -48.43 81.64 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.528 -0.732 . . . . 42.5 109.987 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' R' R ' 109' ' ' HIS . . . . . 0.432 ' CD2' ' HG ' ' R' ' 110' ' ' LEU . 50.9 p-80 -66.01 -12.88 58.3 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.461 -0.774 . . . . 20.07 110.652 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' R' R ' 110' ' ' LEU . . . . . 0.432 ' HG ' ' CD2' ' R' ' 109' ' ' HIS . 80.6 mt -94.81 -17.26 22.28 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.084 -1.01 . . . . 15.69 110.192 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' R' R ' 111' ' ' LEU . . . . . 0.448 HD22 ' CE2' ' R' ' 60' ' ' PHE . 10.3 mt -94.15 144.11 25.78 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.34 -0.85 . . . . 25.39 111.002 -179.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' R' R ' 112' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -77.7 -17.33 57.75 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.521 -0.737 . . . . 53.48 109.865 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 113' ' ' THR . . . . . 0.417 HG22 ' HG2' ' R' ' 123' ' ' GLU . 60.4 m -83.71 166.68 17.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.311 -0.868 . . . . 14.8 110.201 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' R' R ' 114' ' ' GLY . . . . . . . . . . . . . . . -98.01 127.15 9.13 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.962 -1.255 . . . . 16.14 109.962 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 115' ' ' ILE . . . . . 0.48 ' HB ' ' HG2' ' R' ' 108' ' ' LYS . 47.9 mm -109.05 139.35 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.424 -1.045 . . . . 13.46 109.71 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' R' R ' 116' ' ' GLY . . . . . . . . . . . . . . . -152.76 -155.9 7.31 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.856 -1.298 . . . . 23.9 109.856 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 117' ' ' THR . . . . . . . . . . . . . 18.8 p -135.03 -171.35 2.78 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.53 -0.982 . . . . 27.37 110.097 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.6 -58.04 9.79 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.359 -0.838 . . . . 18.76 110.064 179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 119' ' ' SER . . . . . 0.682 ' HA ' ' CB ' ' R' ' 194' ' ' ALA . 1.1 m -56.55 -40.59 75.39 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.259 -0.901 . . . . 32.35 109.741 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' R' R ' 120' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 -110.11 86.25 4.92 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.435 -0.791 . . . . 27.12 109.68 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 121' ' ' PRO . . . . . 0.427 ' O ' ' HB2' ' R' ' 122' ' ' SER . 44.3 Cg_endo -71.2 166.47 29.12 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.863 1.454 . . . . 22.68 111.046 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' R' R ' 122' ' ' SER . . . . . 0.427 ' HB2' ' O ' ' R' ' 121' ' ' PRO . 38.4 t 178.56 -161.67 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.649 -0.657 . . . . 22.99 109.456 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' R' R ' 123' ' ' GLU . . . . . 0.417 ' HG2' HG22 ' R' ' 113' ' ' THR . 2.3 tp10 -56.45 -39.92 73.94 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.211 -0.93 . . . . 36.18 109.701 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' R' R ' 124' ' ' VAL . . . . . . . . . . . . . 84.2 t -142.58 136.41 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.579 -0.701 . . . . 20.64 109.389 179.323 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 125' ' ' CYS . . . . . 0.409 ' SG ' ' HA ' ' R' ' 121' ' ' PRO . 83.3 m -140.26 168.23 20.29 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.252 -0.905 . . . . 22.8 111.166 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' R' R ' 126' ' ' VAL . . . . . . . . . . . . . 35.8 m -122.73 159.73 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.671 -0.643 . . . . 21.24 109.568 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 127' ' ' VAL . . . . . 0.4 ' CG1' ' O ' ' R' ' 177' ' ' VAL . 30.6 m -70.8 141.91 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.294 -0.879 . . . . 19.77 110.7 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' R' R ' 128' ' ' ASP . . . . . . . . . . . . . 53.9 p-10 -137.77 19.4 2.86 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.337 -0.852 . . . . 29.21 110.642 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 129' ' ' GLY . . . . . . . . . . . . . . . 113.98 0.03 24.16 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.963 -1.113 . . . . 33.86 110.498 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 130' ' ' THR . . . . . . . . . . . . . 58.1 m -91.86 131.81 36.92 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.14 -1.212 . . . . 26.41 110.082 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -62.52 120.7 11.62 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.36 -0.838 . . . . 33.08 110.287 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 132' ' ' MET . . . . . 0.427 ' HE1' ' CZ ' ' R' ' 180' ' ' PHE . 98.5 mmm -105.26 165.62 10.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.467 -0.771 . . . . 30.76 110.435 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' R' R ' 133' ' ' CYS . . . . . . . . . . . . . 32.8 m -141.09 158.11 44.37 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.511 -0.743 . . . . 27.0 109.973 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 134' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.45 -19.74 39.11 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.268 -0.895 . . . . 33.9 110.51 -179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' R' R ' 135' ' ' ALA . . . . . . . . . . . . . . . -92.69 8.07 40.77 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.231 -0.918 . . . . 19.37 110.779 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 136' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -93.71 -21.76 19.15 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.187 -0.946 . . . . 30.47 110.272 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 137' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -149.96 165.34 32.94 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.365 -0.835 . . . . 24.27 110.241 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 138' ' ' HIS . . . . . . . . . . . . . 15.1 p80 -117.84 15.11 14.37 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.362 -0.836 . . . . 20.91 110.369 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 139' ' ' ALA . . . . . 0.442 ' HA ' ' O ' ' R' ' 152' ' ' ALA . . . -177.16 152.46 0.88 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.158 -0.964 . . . . 15.69 110.12 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' R' R ' 140' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' R' ' 179' ' ' VAL . . . 161.8 175.2 32.57 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.975 -1.25 . . . . 23.76 109.975 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' R' R ' 141' ' ' ILE . . . . . . . . . . . . . 83.7 mt -95.55 136.61 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.372 -1.075 . . . . 25.3 109.673 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 142' ' ' PHE . . . . . 0.547 ' CD2' ' HB2' ' R' ' 172' ' ' PRO . 82.8 m-85 -120.77 -172.63 2.42 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.287 -0.883 . . . . 30.24 110.545 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' R' R ' 143' ' ' LEU . . . . . 0.731 HD13 ' CB ' ' S' ' 395' ' ' LYS . 0.5 OUTLIER -119.75 77.75 1.26 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.444 -0.785 . . . . 32.8 110.246 -179.84 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' R' R ' 144' ' ' LYS . . . . . 0.453 ' HG3' ' CZ2' ' R' ' 170' ' ' TRP . 1.0 OUTLIER -69.59 76.86 0.42 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.393 -0.817 . . . . 49.18 109.707 179.502 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' R' R ' 145' ' ' GLY . . . . . . . . . . . . . . . 104.52 179.32 24.8 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.131 -1.588 . . . . 53.87 109.131 -179.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 146' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -88.52 145.81 25.53 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.361 -1.082 . . . . 68.58 110.023 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 147' ' ' GLU . . . . . 0.859 ' HA ' ' CB ' ' S' ' 398' ' ' ARG . 10.9 mt-10 58.24 36.52 25.77 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.314 -0.866 . . . . 56.62 110.623 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' R' R ' 148' ' ' HIS . . . . . 0.569 ' CE1' ' CD2' ' S' ' 400' ' ' LEU . 44.5 t60 -158.65 148.17 19.24 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.194 -0.941 . . . . 44.57 110.376 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' R' R ' 149' ' ' ALA . . . . . . . . . . . . . . . -150.29 146.88 27.04 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.427 -0.796 . . . . 33.54 110.079 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 150' ' ' VAL . . . . . 0.427 HG23 ' HB2' ' R' ' 144' ' ' LYS . 34.2 m -142.32 161.5 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.277 -0.889 . . . . 27.61 110.356 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' R' R ' 151' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' R' ' 152' ' ' ALA . 5.9 t80 -86.14 155.62 20.69 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.401 -0.812 . . . . 23.04 109.924 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' R' R ' 152' ' ' ALA . . . . . 0.537 ' N ' ' CD1' ' R' ' 151' ' ' PHE . . . -157.33 151.51 24.81 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.517 -0.739 . . . . 29.61 109.625 179.02 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' R' R ' 153' ' ' CYS . . . . . 0.405 ' HA ' ' HA ' ' R' ' 139' ' ' ALA . 26.7 p -154.3 173.61 15.93 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.233 -0.917 . . . . 22.75 110.453 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' R' R ' 154' ' ' VAL . . . . . 0.442 ' CG2' ' CZ2' ' R' ' 159' ' ' TRP . 60.2 t -90.68 117.04 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.37 -0.831 . . . . 23.26 110.101 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' R' R ' 155' ' ' THR . . . . . . . . . . . . . 69.8 p -112.1 -176.63 2.97 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.302 -0.873 . . . . 17.88 110.041 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 156' ' ' SER . . . . . . . . . . . . . 78.5 p -75.94 -3.69 36.88 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.329 -0.857 . . . . 21.83 110.735 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 157' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -118.25 10.38 12.83 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.109 -0.994 . . . . 36.54 110.635 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 158' ' ' GLY . . . . . . . . . . . . . . . 117.9 -162.7 13.0 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.585 -1.406 . . . . 31.74 109.585 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 159' ' ' TRP . . . . . 0.442 ' CZ2' ' CG2' ' R' ' 154' ' ' VAL . 14.8 m95 -86.51 122.42 30.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.334 -1.098 . . . . 28.25 110.112 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' R' R ' 160' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -108.42 166.96 10.38 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.384 -0.822 . . . . 41.24 110.251 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 161' ' ' ALA . . . . . . . . . . . . . . . -143.33 123.51 13.72 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.495 -0.753 . . . . 27.4 110.117 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 162' ' ' ILE . . . . . 0.43 HG23 ' CZ ' ' R' ' 167' ' ' PHE . 92.2 mt -87.54 81.14 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.406 -0.809 . . . . 24.27 110.072 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' R' R ' 163' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' R' ' 165' ' ' GLU . 15.3 t0 -72.81 92.47 1.59 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.422 -0.799 . . . . 36.08 110.234 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' R' R ' 164' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 54.09 -89.03 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.521 -0.737 . . . . 46.08 110.574 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 165' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' R' ' 163' ' ' ASP . 29.7 mt-10 -124.68 35.94 4.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.151 -0.968 . . . . 50.94 110.196 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' R' R ' 166' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -135.72 117.28 14.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.427 -0.796 . . . . 47.28 110.358 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 167' ' ' PHE . . . . . 0.43 ' CZ ' HG23 ' R' ' 162' ' ' ILE . 24.4 m-85 -101.02 120.0 39.56 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.396 -0.815 . . . . 40.47 110.164 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' R' R ' 168' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -157.56 158.48 30.6 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.199 -0.938 . . . . 30.21 110.436 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 169' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.74 133.01 19.51 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 O-C-N 123.9 1.474 . . . . 32.76 110.471 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 170' ' ' TRP . . . . . 0.453 ' CZ2' ' HG3' ' R' ' 144' ' ' LYS . 66.9 t90 -159.83 119.42 2.89 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.471 -0.768 . . . . 32.79 109.925 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' R' R ' 171' ' ' THR . . . . . . . . . . . . . 46.3 m -81.14 112.62 34.41 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.419 -0.801 . . . . 36.92 110.188 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 172' ' ' PRO . . . . . 0.547 ' HB2' ' CD2' ' R' ' 142' ' ' PHE . 47.5 Cg_endo -73.75 158.82 46.44 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.68 1.358 . . . . 33.54 110.552 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' R' R ' 173' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -88.88 144.98 33.78 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.429 -0.795 . . . . 45.76 109.951 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 174' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -71.8 -10.32 26.2 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.639 1.336 . . . . 29.63 110.404 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 175' ' ' SER . . . . . . . . . . . . . 53.1 p -103.47 -17.58 15.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.275 -0.891 . . . . 35.7 110.34 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 176' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -103.5 43.21 1.1 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.256 -0.903 . . . . 39.65 110.419 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 177' ' ' VAL . . . . . 0.4 ' O ' ' CG1' ' R' ' 127' ' ' VAL . 10.4 p -117.77 127.19 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.367 -0.833 . . . . 20.61 109.961 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' R' R ' 178' ' ' LEU . . . . . 0.465 ' CD2' HG12 ' S' ' 396' ' ' VAL . 46.0 mt -91.53 -61.15 1.71 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.373 -0.829 . . . . 15.58 109.419 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' R' R ' 179' ' ' VAL . . . . . 0.403 ' O ' ' HA3' ' R' ' 140' ' ' GLY . 67.9 t -114.73 144.64 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.602 -0.686 . . . . 17.4 109.419 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' R' R ' 180' ' ' PHE . . . . . 0.427 ' CZ ' ' HE1' ' R' ' 132' ' ' MET . 43.8 p90 -152.12 163.37 39.5 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.271 -0.893 . . . . 20.16 110.551 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' R' R ' 181' ' ' VAL . . . . . . . . . . . . . 66.8 t -113.16 111.52 50.26 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.456 -0.778 . . . . 17.69 109.833 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 182' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.06 149.48 52.61 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.577 1.304 . . . . 17.81 110.366 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 183' ' ' TYR . . . . . 0.735 ' O ' ' C ' ' R' ' 184' ' ' ASP . 79.1 m-85 -59.03 175.51 0.28 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.432 -0.792 . . . . 28.01 110.571 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' R' R ' 184' ' ' ASP . . . . . 0.735 ' C ' ' O ' ' R' ' 183' ' ' TYR . 1.9 m-20 -13.08 -75.98 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.442 -0.786 . . . . 58.64 110.297 -178.021 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' R' R ' 185' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.503 2.213 0 CA-C-O 121.185 0.517 . . . . 80.42 111.807 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 193' ' ' LYS . . . . . 0.406 ' HA ' ' NE2' ' R' ' 197' ' ' GLN . 49.1 mmtt . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 120.949 0.404 . . . . 49.5 110.112 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 194' ' ' ALA . . . . . 0.682 ' CB ' ' HA ' ' R' ' 119' ' ' SER . . . -178.03 -149.79 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.117 -0.989 . . . . 40.4 110.102 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' R' R ' 195' ' ' LYS . . . . . . . . . . . . . 1.2 mmmp? -86.64 -88.29 0.13 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.369 -0.832 . . . . 34.6 110.304 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 196' ' ' VAL . . . . . 0.588 HG23 ' CB ' ' R' ' 119' ' ' SER . 27.0 m -70.01 69.49 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.239 -0.913 . . . . 33.27 110.614 -179.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' R' R ' 197' ' ' GLN . . . . . 0.538 ' CB ' ' O ' ' R' ' 119' ' ' SER . 0.0 OUTLIER -157.37 -29.74 0.08 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.154 -0.966 . . . . 41.58 110.72 179.895 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' R' R ' 198' ' ' ARG . . . . . . . . . . . . . 1.6 ttm180 -75.75 165.64 24.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.041 -1.037 . . . . 38.65 110.17 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 199' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -94.85 73.41 3.55 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.364 -0.835 . . . . 36.77 109.925 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 200' ' ' LEU . . . . . . . . . . . . . 38.2 mt -60.97 -173.04 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.359 -0.838 . . . . 33.08 110.15 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' R' R ' 201' ' ' LYS . . . . . 0.477 ' HA ' ' CA ' ' S' ' 297' ' ' GLY . 11.5 tttt . . . . . 0 N--CA 1.492 1.661 0 O-C-N 121.342 -0.849 . . . . 44.32 110.281 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 229' ' ' MET . . . . . . . . . . . . . 2.4 ptt? . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.173 0.511 . . . . 51.83 110.202 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' S' S ' 230' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -97.32 142.75 28.81 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.369 -0.832 . . . . 54.13 110.183 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 231' ' ' LEU . . . . . . . . . . . . . 68.2 mt -134.09 141.0 46.99 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.312 -0.868 . . . . 33.04 110.325 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 232' ' ' THR . . . . . . . . . . . . . 40.0 m -89.22 103.27 15.9 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.438 -0.789 . . . . 26.92 110.039 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 233' ' ' LEU . . . . . 0.499 HD23 ' CE2' ' S' ' 262' ' ' TYR . 79.9 mt -55.91 179.29 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.471 -0.768 . . . . 13.78 110.483 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' S' S ' 234' ' ' TYR . . . . . 0.447 ' CG ' ' N ' ' S' ' 235' ' ' ASN . 35.5 p90 -65.02 -35.68 81.95 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.412 -0.805 . . . . 26.08 110.163 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' S' S ' 235' ' ' ASN . . . . . 0.447 ' N ' ' CG ' ' S' ' 234' ' ' TYR . 50.7 p30 -74.35 -7.38 52.65 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.357 -0.839 . . . . 20.04 110.511 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' S' S ' 236' ' ' GLY . . . . . . . . . . . . . . . 95.71 -20.0 51.78 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.769 -1.332 . . . . 22.71 109.769 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 237' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -52.91 145.64 12.29 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.216 -1.167 . . . . 35.44 110.215 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 238' ' ' LYS . . . . . . . . . . . . . 44.2 mttt -102.17 127.99 48.86 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.438 -0.789 . . . . 32.56 110.341 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 239' ' ' LYS . . . . . 0.414 ' HG2' ' CZ ' ' S' ' 241' ' ' PHE . 9.0 ttmt -132.35 144.45 50.55 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.371 -0.83 . . . . 26.68 110.002 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' S' S ' 240' ' ' THR . . . . . . . . . . . . . 52.5 m -101.95 132.23 47.89 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.307 -0.871 . . . . 41.02 110.36 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 241' ' ' PHE . . . . . 0.414 ' CZ ' ' HG2' ' S' ' 239' ' ' LYS . 96.0 m-85 -117.97 137.69 52.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.431 -0.793 . . . . 28.62 110.188 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' S' S ' 242' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -96.36 161.79 13.78 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.32 -0.862 . . . . 47.89 110.241 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 243' ' ' SER . . . . . . . . . . . . . 71.5 m -90.58 151.57 21.26 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.376 -0.827 . . . . 45.09 110.207 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 244' ' ' ARG . . . . . . . . . . . . . 1.4 mtp85 -129.73 126.7 22.72 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.307 -0.871 . . . . 42.49 110.301 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 245' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.33 161.03 43.71 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 O-C-N 123.651 1.343 . . . . 35.68 110.538 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 246' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -132.9 97.91 4.16 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.381 -0.824 . . . . 51.88 109.827 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 247' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -110.47 -22.2 11.78 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.364 -0.835 . . . . 53.69 110.68 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 248' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -117.28 43.65 2.28 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.187 -0.946 . . . . 55.79 110.719 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 249' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 48.84 38.38 11.9 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.402 -0.811 . . . . 49.45 110.338 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 250' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -90.6 28.94 1.38 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.544 -0.722 . . . . 36.86 110.385 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 251' ' ' ALA . . . . . . . . . . . . . . . -53.75 -43.24 68.97 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.271 -0.893 . . . . 29.69 109.643 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 252' ' ' TRP . . . . . 0.416 ' CZ2' ' HB3' ' S' ' 294' ' ' LEU . 67.9 p-90 -61.74 -33.95 74.97 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.465 -0.772 . . . . 41.12 109.812 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' S' S ' 253' ' ' LEU . . . . . 0.402 ' N ' ' CD2' ' S' ' 252' ' ' TRP . 23.3 tp -70.14 -47.21 62.68 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.349 -0.845 . . . . 24.89 109.995 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' S' S ' 254' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -56.16 -42.45 77.04 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.31 -0.869 . . . . 35.65 109.956 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 255' ' ' ALA . . . . . . . . . . . . . . . -59.58 -48.17 82.7 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.432 -0.793 . . . . 22.73 110.025 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 256' ' ' ILE . . . . . . . . . . . . . 79.6 mt -62.34 -40.66 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.341 -0.85 . . . . 28.85 109.957 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 257' ' ' LEU . . . . . . . . . . . . . 19.2 mt -61.57 -44.47 96.96 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.359 -0.838 . . . . 23.07 110.17 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 258' ' ' GLN . . . . . 0.467 ' HB3' ' CD2' ' S' ' 351' ' ' PHE . 53.5 mm-40 -65.06 -45.41 85.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.42 -0.8 . . . . 29.78 109.851 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' S' S ' 259' ' ' LEU . . . . . 0.43 ' O ' HG22 ' S' ' 263' ' ' VAL . 19.8 tp -58.72 -36.33 74.11 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.36 -0.838 . . . . 17.94 109.433 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' S' S ' 260' ' ' PHE . . . . . 0.465 ' CE2' HD22 ' S' ' 311' ' ' LEU . 3.1 m-85 -62.81 -45.27 93.4 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.619 -0.676 . . . . 30.57 109.833 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' S' S ' 261' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -62.18 -29.67 70.52 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.476 -0.765 . . . . 41.34 110.006 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 262' ' ' TYR . . . . . 0.499 ' CE2' HD23 ' S' ' 233' ' ' LEU . 8.7 t80 -71.29 -44.61 64.86 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.418 -0.802 . . . . 26.03 110.067 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' S' S ' 263' ' ' VAL . . . . . 0.43 HG22 ' O ' ' S' ' 259' ' ' LEU . 33.0 m -92.02 18.28 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.366 -0.834 . . . . 22.8 110.38 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' S' S ' 264' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 52.76 70.63 0.56 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.217 -0.927 . . . . 44.03 110.678 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 265' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -111.84 109.19 55.34 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.383 -0.823 . . . . 35.61 109.657 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 266' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -75.29 0.37 9.11 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.592 1.312 . . . . 37.67 111.793 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 267' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -56.45 -67.71 0.28 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.74 -1.225 . . . . 41.49 110.164 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' S' S ' 268' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -92.93 39.87 1.05 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.201 -0.937 . . . . 50.76 110.071 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 269' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -75.95 -33.26 59.8 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.375 -0.828 . . . . 61.86 109.765 179.567 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' S' S ' 270' ' ' TRP . . . . . 0.49 ' CE2' ' CG2' ' S' ' 271' ' ' VAL . 51.0 p-90 -73.9 -4.37 34.59 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.312 -0.867 . . . . 39.85 110.483 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' S' S ' 271' ' ' VAL . . . . . 0.49 ' CG2' ' CE2' ' S' ' 270' ' ' TRP . 46.4 t -109.49 -32.66 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.151 -0.968 . . . . 39.18 110.073 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' S' S ' 272' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -78.6 -36.53 44.09 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.325 -0.859 . . . . 40.02 110.523 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 273' ' ' SER . . . . . . . . . . . . . 70.8 m -103.6 56.11 0.74 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.264 -0.898 . . . . 47.2 110.286 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 274' ' ' SER . . . . . . . . . . . . . 6.9 t -133.03 141.25 40.25 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.35 -0.844 . . . . 47.61 110.155 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 275' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.7 -18.89 21.85 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 O-C-N 123.629 1.331 . . . . 45.28 110.594 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 276' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -99.86 140.85 33.47 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.317 -0.864 . . . . 57.27 110.314 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 277' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -71.68 97.69 1.79 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.476 -0.765 . . . . 37.28 110.309 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 278' ' ' LEU . . . . . . . . . . . . . 86.7 mt -97.0 33.76 1.85 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.397 -0.815 . . . . 43.88 109.984 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 279' ' ' THR . . . . . . . . . . . . . 74.8 m -63.98 -60.19 3.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.481 -0.762 . . . . 50.05 110.24 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 280' ' ' LEU . . . . . . . . . . . . . 13.6 mt -51.58 -39.9 58.77 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.31 -0.869 . . . . 54.12 110.254 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 281' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.35 -49.71 74.47 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.526 -0.734 . . . . 65.28 110.143 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' S' S ' 282' ' ' ALA . . . . . . . . . . . . . . . -58.99 -33.86 71.17 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.548 -0.72 . . . . 46.51 110.506 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 283' ' ' ILE . . . . . . . . . . . . . 85.7 mt -66.35 -50.84 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.287 -0.883 . . . . 47.3 110.138 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 284' ' ' LYS . . . . . . . . . . . . . 33.6 tttp -50.6 -57.57 7.87 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.487 -0.758 . . . . 50.72 110.384 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 285' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -51.35 -46.42 62.68 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.494 -0.754 . . . . 68.47 110.352 179.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 286' ' ' LEU . . . . . . . . . . . . . 19.0 mt -59.96 -44.48 94.41 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.417 -0.802 . . . . 36.62 110.287 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 287' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -62.76 -35.26 79.24 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.326 -0.859 . . . . 46.64 110.088 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 288' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -76.26 -21.06 56.78 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.437 -0.789 . . . . 46.45 110.263 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 289' ' ' LEU . . . . . . . . . . . . . 30.7 mt -97.33 -21.69 17.07 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.281 -0.887 . . . . 35.09 110.54 -179.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 290' ' ' THR . . . . . . . . . . . . . 81.3 p -114.77 -28.49 7.07 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.249 -0.907 . . . . 38.61 110.435 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 291' ' ' GLY . . . . . . . . . . . . . . . 79.44 11.05 85.3 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.879 -1.288 . . . . 36.77 109.879 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 292' ' ' LEU . . . . . . . . . . . . . 84.9 mt -96.55 145.82 25.36 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.238 -1.154 . . . . 35.33 109.754 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 293' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -77.32 102.29 6.68 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.161 -0.962 . . . . 48.7 110.275 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 294' ' ' LEU . . . . . 0.416 ' HB3' ' CZ2' ' S' ' 252' ' ' TRP . 55.2 mt -106.84 51.75 0.73 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.472 -0.768 . . . . 42.61 110.117 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' S' S ' 295' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -112.53 -11.2 13.63 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.326 -0.859 . . . . 55.49 110.485 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' S' S ' 296' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -144.34 48.56 1.36 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.177 -0.952 . . . . 75.68 110.271 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 297' ' ' GLY . . . . . 0.477 ' CA ' ' HA ' ' R' ' 201' ' ' LYS . . . 96.88 145.19 18.73 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.457 -1.457 . . . . 49.44 109.457 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' S' S ' 298' ' ' GLY . . . . . . . . . . . . . . . -163.85 156.94 29.02 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.849 -1.3 . . . . 41.11 109.849 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 299' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.81 118.27 5.37 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 123.91 1.479 . . . . 26.2 110.291 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 300' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.18 -15.57 31.86 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.529 1.278 . . . . 21.7 110.647 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 301' ' ' ALA . . . . . . . . . . . . . . . -80.7 -29.32 36.49 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.256 -0.903 . . . . 31.23 110.117 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 302' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.5 -40.62 18.96 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.406 -0.809 . . . . 38.99 109.993 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' S' S ' 303' ' ' VAL . . . . . 0.469 ' O ' HG12 ' S' ' 307' ' ' ILE . 57.2 t -60.69 -35.52 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.398 -0.814 . . . . 18.63 110.147 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' S' S ' 304' ' ' ILE . . . . . . . . . . . . . 86.0 mt -79.33 -23.65 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.405 -0.809 . . . . 25.46 110.179 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 305' ' ' TRP . . . . . . . . . . . . . 68.9 t-105 -88.63 -14.53 37.24 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.32 -0.863 . . . . 33.4 110.521 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 306' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -89.72 -13.56 36.59 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.218 -0.926 . . . . 36.97 110.369 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 307' ' ' ILE . . . . . 0.469 HG12 ' O ' ' S' ' 303' ' ' VAL . 36.9 pt -125.08 45.62 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.21 -0.931 . . . . 30.81 110.059 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' S' S ' 308' ' ' LYS . . . . . . . . . . . . . 1.5 mtmp? -73.5 -37.75 65.58 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.339 -0.851 . . . . 46.52 110.12 -179.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 309' ' ' HIS . . . . . 0.487 ' CD2' ' HG ' ' S' ' 310' ' ' LEU . 55.5 p-80 -73.22 -8.26 55.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.318 -0.864 . . . . 51.03 110.065 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' S' S ' 310' ' ' LEU . . . . . 0.487 ' HG ' ' CD2' ' S' ' 309' ' ' HIS . 52.6 mt -99.31 -12.92 19.9 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.312 -0.867 . . . . 36.16 109.975 179.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' S' S ' 311' ' ' LEU . . . . . 0.465 HD22 ' CE2' ' S' ' 260' ' ' PHE . 10.8 mt -97.13 147.83 23.66 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.367 -0.833 . . . . 40.0 110.499 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' S' S ' 312' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -81.6 -16.24 52.15 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.31 -0.869 . . . . 54.18 109.682 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 313' ' ' THR . . . . . 0.472 HG23 ' HB3' ' S' ' 323' ' ' GLU . 92.7 m -87.95 151.66 22.64 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.371 -0.83 . . . . 25.61 110.098 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' S' S ' 314' ' ' GLY . . . . . . . . . . . . . . . -87.93 126.41 8.05 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.842 -1.303 . . . . 25.18 109.842 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 315' ' ' ILE . . . . . 0.402 HG21 ' N ' ' S' ' 316' ' ' GLY . 50.8 mm -101.65 150.51 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.411 -1.052 . . . . 23.9 109.704 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' S' S ' 316' ' ' GLY . . . . . 0.402 ' N ' HG21 ' S' ' 315' ' ' ILE . . . -157.09 -159.31 9.41 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.932 -1.267 . . . . 23.18 109.932 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' S' S ' 317' ' ' THR . . . . . . . . . . . . . 11.1 p -133.92 -173.01 3.13 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.447 -1.031 . . . . 27.98 109.958 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.58 -56.19 25.08 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.265 -0.897 . . . . 28.1 109.858 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 319' ' ' SER . . . . . . . . . . . . . 1.2 m -59.93 -41.61 92.16 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.427 -0.796 . . . . 37.0 109.675 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 320' ' ' ARG . . . . . . . . . . . . . 12.1 mtm180 -111.72 79.85 2.65 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.529 -0.732 . . . . 52.07 109.726 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 321' ' ' PRO . . . . . 0.861 ' HG2' ' O ' ' S' ' 386' ' ' GLU . 43.9 Cg_endo -71.44 171.51 16.05 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.883 1.465 . . . . 38.29 110.927 -179.429 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' S' S ' 322' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' S' ' 321' ' ' PRO . 41.4 t 178.68 -148.15 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.966 -0.753 . . . . 38.84 108.966 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' S' S ' 323' ' ' GLU . . . . . 0.472 ' HB3' HG23 ' S' ' 313' ' ' THR . 6.7 tp10 -62.85 -40.32 97.1 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.063 -1.023 . . . . 40.7 109.679 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' S' S ' 324' ' ' VAL . . . . . . . . . . . . . 72.7 t -141.27 135.03 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.396 -0.815 . . . . 20.34 109.46 179.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 325' ' ' CYS . . . . . 0.451 ' HB2' ' CE1' ' S' ' 380' ' ' PHE . 11.5 m -126.0 172.19 10.16 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.336 -0.853 . . . . 30.63 110.833 -179.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' S' S ' 326' ' ' VAL . . . . . . . . . . . . . 34.5 m -135.45 142.19 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.58 -0.7 . . . . 23.9 109.285 179.187 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 327' ' ' VAL . . . . . . . . . . . . . 34.5 m -56.35 124.93 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.092 -1.005 . . . . 19.48 110.47 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 328' ' ' ASP . . . . . . . . . . . . . 55.6 p-10 -119.28 11.48 12.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.45 -0.781 . . . . 26.43 110.465 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 329' ' ' GLY . . . . . . . . . . . . . . . 119.71 2.23 13.04 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.025 -1.23 . . . . 31.24 110.025 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 330' ' ' THR . . . . . . . . . . . . . 80.1 m -92.98 130.03 38.69 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.045 -1.268 . . . . 30.05 110.109 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 331' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -56.81 111.46 1.03 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.261 -0.899 . . . . 37.26 109.955 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 332' ' ' MET . . . . . 0.455 ' HE1' ' CZ ' ' S' ' 380' ' ' PHE . 88.1 mmm -94.11 162.57 13.82 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.278 -0.889 . . . . 26.23 110.351 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' S' S ' 333' ' ' CYS . . . . . . . . . . . . . 26.2 m -137.19 150.07 47.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.535 -0.728 . . . . 23.56 110.019 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 334' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.68 -24.75 9.15 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.339 -0.851 . . . . 28.93 110.522 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' S' S ' 335' ' ' ALA . . . . . . . . . . . . . . . -89.08 14.42 10.75 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.383 -0.823 . . . . 15.76 110.947 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 336' ' ' ASP . . . . . . . . . . . . . 70.4 m-20 -100.49 -17.14 17.28 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.1 -1.0 . . . . 34.92 110.186 179.546 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 337' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -152.46 170.85 19.12 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.299 -0.875 . . . . 19.03 110.017 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 338' ' ' HIS . . . . . 0.4 ' HB3' ' CZ ' ' S' ' 383' ' ' TYR . 13.5 p80 -120.76 10.44 10.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.416 -0.803 . . . . 18.82 110.497 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' S' S ' 339' ' ' ALA . . . . . . . . . . . . . . . -175.97 155.24 1.58 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.293 -0.879 . . . . 17.18 110.103 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 340' ' ' GLY . . . . . 0.401 ' CA ' ' O ' ' S' ' 379' ' ' VAL . . . 160.8 173.09 28.97 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.07 -1.212 . . . . 18.33 110.07 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' S' S ' 341' ' ' ILE . . . . . 0.434 HD12 HG22 ' S' ' 341' ' ' ILE . 84.4 mt -88.88 138.15 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.505 -0.997 . . . . 18.6 109.757 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' S' S ' 342' ' ' PHE . . . . . 0.502 ' CE1' HG23 ' S' ' 377' ' ' VAL . 70.0 m-85 -120.98 -178.41 3.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.26 -0.9 . . . . 23.44 110.428 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' S' S ' 343' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.85 93.42 4.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.41 -0.806 . . . . 35.59 109.989 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' S' S ' 344' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.78 125.0 29.52 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.269 -0.894 . . . . 38.34 110.148 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' S' S ' 345' ' ' GLY . . . . . . . . . . . . . . . 62.79 -130.81 43.02 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 108.847 -1.701 . . . . 53.46 108.847 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 346' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -132.79 150.8 52.12 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.199 -1.177 . . . . 70.91 110.073 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 347' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 53.35 35.36 20.14 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.335 -0.853 . . . . 47.32 110.437 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 348' ' ' HIS . . . . . . . . . . . . . 46.2 t60 -150.15 155.82 40.49 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.294 -0.879 . . . . 41.72 110.311 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 349' ' ' ALA . . . . . . . . . . . . . . . -149.74 151.32 33.43 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.346 -0.846 . . . . 22.91 110.463 -179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 350' ' ' VAL . . . . . . . . . . . . . 34.6 m -149.11 169.6 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.443 -0.785 . . . . 21.09 110.024 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 351' ' ' PHE . . . . . 0.467 ' CD2' ' HB3' ' S' ' 258' ' ' GLN . 10.7 t80 -105.35 143.54 33.37 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.215 -0.928 . . . . 25.03 110.706 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' S' S ' 352' ' ' ALA . . . . . . . . . . . . . . . -147.66 151.69 36.59 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.646 -0.659 . . . . 23.81 109.732 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 353' ' ' CYS . . . . . . . . . . . . . 26.3 p -153.34 164.87 37.36 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.291 -0.881 . . . . 25.66 110.246 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 354' ' ' VAL . . . . . 0.404 HG23 ' CZ2' ' S' ' 359' ' ' TRP . 56.8 t -75.99 118.5 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.381 -0.824 . . . . 34.27 109.967 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' S' S ' 355' ' ' THR . . . . . 0.444 HG23 ' HB2' ' S' ' 360' ' ' TYR . 51.5 p -117.81 175.11 5.81 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.282 -0.886 . . . . 25.49 110.307 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' S' S ' 356' ' ' SER . . . . . . . . . . . . . 62.0 p -62.15 -17.67 58.6 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.455 -0.778 . . . . 31.24 110.748 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 357' ' ' ASN . . . . . . . . . . . . . 45.8 m-20 -107.03 14.28 26.56 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.145 -0.972 . . . . 28.61 110.531 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 358' ' ' GLY . . . . . . . . . . . . . . . 111.86 -152.85 17.61 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.045 -1.222 . . . . 22.01 110.045 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 359' ' ' TRP . . . . . 0.404 ' CZ2' HG23 ' S' ' 354' ' ' VAL . 15.4 m95 -91.35 116.73 29.08 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.45 -1.029 . . . . 25.54 110.176 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' S' S ' 360' ' ' TYR . . . . . 0.444 ' HB2' HG23 ' S' ' 355' ' ' THR . 1.3 m-85 -103.52 165.83 10.8 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.338 -0.851 . . . . 40.53 110.032 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' S' S ' 361' ' ' ALA . . . . . . . . . . . . . . . -140.1 130.1 24.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.361 -0.837 . . . . 18.04 110.268 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 362' ' ' ILE . . . . . 0.415 HG23 ' CZ ' ' S' ' 367' ' ' PHE . 89.1 mt -95.61 83.64 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.409 -0.807 . . . . 15.64 110.061 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' S' S ' 363' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' S' ' 365' ' ' GLU . 11.8 t0 -75.25 94.51 3.01 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.422 -0.799 . . . . 35.03 110.201 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' S' S ' 364' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 53.98 -89.43 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.551 -0.718 . . . . 46.72 110.511 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 365' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' S' ' 363' ' ' ASP . 23.7 mt-10 -122.7 19.2 10.31 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.075 -1.016 . . . . 56.2 110.245 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' S' S ' 366' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -117.98 124.96 49.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.169 -0.957 . . . . 51.02 110.395 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 367' ' ' PHE . . . . . 0.415 ' CZ ' HG23 ' S' ' 362' ' ' ILE . 26.8 m-85 -107.03 127.05 53.12 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.344 -0.847 . . . . 37.59 110.137 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' S' S ' 368' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -165.38 159.5 13.99 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.247 -0.908 . . . . 31.47 110.481 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 369' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.8 139.61 30.8 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.859 1.452 . . . . 28.85 110.538 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 370' ' ' TRP . . . . . . . . . . . . . 67.6 t90 -167.2 113.56 0.76 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.347 -0.846 . . . . 26.94 109.942 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 371' ' ' THR . . . . . . . . . . . . . 59.9 m -74.81 113.02 20.37 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.417 -0.802 . . . . 20.19 110.01 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 372' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -73.52 157.09 49.39 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 O-C-N 123.597 1.314 . . . . 28.68 110.624 -179.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 373' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -90.56 147.15 35.76 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.492 -0.755 . . . . 35.72 109.896 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 374' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -76.03 -6.27 17.18 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 O-C-N 123.652 1.343 . . . . 30.89 110.459 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 375' ' ' SER . . . . . . . . . . . . . 68.6 p -104.41 -16.9 14.97 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.22 -0.925 . . . . 29.41 110.451 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 376' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -106.51 43.02 1.19 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.231 -0.918 . . . . 32.89 110.217 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 377' ' ' VAL . . . . . 0.502 HG23 ' CE1' ' S' ' 342' ' ' PHE . 7.3 p -114.65 147.27 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.374 -0.829 . . . . 24.33 110.216 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' S' S ' 378' ' ' LEU . . . . . . . . . . . . . 52.3 mt -115.99 -58.01 2.15 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.348 -0.845 . . . . 24.37 109.638 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 379' ' ' VAL . . . . . 0.401 ' O ' ' CA ' ' S' ' 340' ' ' GLY . 61.3 t -120.64 132.4 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.471 -0.768 . . . . 18.02 109.443 179.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' S' S ' 380' ' ' PHE . . . . . 0.455 ' CZ ' ' HE1' ' S' ' 332' ' ' MET . 14.4 p90 -142.63 174.0 11.03 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.309 -0.869 . . . . 29.35 110.634 -179.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' S' S ' 381' ' ' VAL . . . . . . . . . . . . . 58.4 t -120.1 107.32 39.81 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.578 -0.701 . . . . 16.34 109.398 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 382' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -71.26 145.65 49.16 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 O-C-N 123.626 1.329 . . . . 20.94 110.759 -179.374 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' S' S ' 383' ' ' TYR . . . . . 0.4 ' CZ ' ' HB3' ' S' ' 338' ' ' HIS . 88.3 m-85 -61.08 -53.47 56.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.398 -0.814 . . . . 28.93 109.869 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' S' S ' 384' ' ' ASP . . . . . 0.401 ' C ' ' H ' ' S' ' 386' ' ' GLU . 9.7 t0 -103.65 130.03 51.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.482 -0.761 . . . . 47.03 110.358 -176.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' S' S ' 385' ' ' GLN . . . . . 0.409 ' O ' ' O ' ' S' ' 386' ' ' GLU . 2.6 tt0 -69.13 3.67 2.01 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.421 -0.799 . . . . 46.69 110.22 177.199 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' S' S ' 386' ' ' GLU . . . . . 0.861 ' O ' ' HG2' ' S' ' 321' ' ' PRO . 16.0 pt-20 -44.69 165.79 0.14 Allowed Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.348 -0.845 . . . . 50.25 109.572 179.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' S' S ' 387' ' ' PRO . . . . . 0.553 ' O ' ' C ' ' S' ' 388' ' ' LEU . 38.7 Cg_endo -67.4 -11.43 32.13 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.752 1.396 . . . . 34.39 110.61 -177.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' S' S ' 388' ' ' LEU . . . . . 0.574 ' O ' ' CB ' ' S' ' 389' ' ' ASN . 0.2 OUTLIER 32.18 80.99 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.428 -0.795 . . . . 38.01 110.137 -179.681 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' S' S ' 389' ' ' ASN . . . . . 0.574 ' CB ' ' O ' ' S' ' 388' ' ' LEU . 2.9 t30 75.03 169.14 0.29 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.274 -0.891 . . . . 45.82 110.155 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' S' S ' 390' ' ' GLY . . . . . 0.488 ' O ' ' CB ' ' S' ' 391' ' ' GLU . . . 147.19 -91.51 0.15 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.622 -1.391 . . . . 33.46 109.622 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' S' S ' 391' ' ' GLU . . . . . 0.488 ' CB ' ' O ' ' S' ' 390' ' ' GLY . 2.5 tt0 68.73 -66.49 0.24 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.377 -1.072 . . . . 56.58 110.153 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' S' S ' 392' ' ' TRP . . . . . 0.492 ' O ' HG11 ' S' ' 396' ' ' VAL . 41.7 p-90 -50.89 -26.56 6.0 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.385 -0.822 . . . . 31.43 110.342 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' S' S ' 393' ' ' LYS . . . . . 0.462 ' HA ' ' CE3' ' S' ' 392' ' ' TRP . 1.9 ptmt -63.91 -22.41 66.91 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.289 -0.882 . . . . 39.42 110.324 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' S' S ' 394' ' ' ALA . . . . . 0.448 ' O ' ' CG ' ' S' ' 398' ' ' ARG . . . -93.43 -18.02 22.81 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.371 -0.83 . . . . 34.33 110.068 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' S' S ' 395' ' ' LYS . . . . . 0.731 ' CB ' HD13 ' R' ' 143' ' ' LEU . 10.5 mmtt -94.03 2.4 56.05 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.459 -0.776 . . . . 60.09 110.231 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' S' S ' 396' ' ' VAL . . . . . 0.591 ' O ' ' HA ' ' R' ' 99' ' ' PRO . 32.6 m -113.94 -38.8 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.335 -0.853 . . . . 35.5 110.616 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' S' S ' 397' ' ' GLN . . . . . 0.584 ' HA ' ' N ' ' R' ' 99' ' ' PRO . 1.6 pp0? -84.81 39.97 0.78 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.128 -0.983 . . . . 49.96 110.641 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' S' S ' 398' ' ' ARG . . . . . 0.859 ' CB ' ' HA ' ' R' ' 147' ' ' GLU . 0.9 OUTLIER -116.0 -144.13 0.38 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.254 -0.904 . . . . 43.42 110.737 -179.77 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' S' S ' 399' ' ' LYS . . . . . 0.79 ' HB3' ' CA ' ' R' ' 97' ' ' GLY . 0.5 OUTLIER 175.94 177.87 0.21 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.405 -0.809 . . . . 55.31 110.051 -179.666 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' S' S ' 400' ' ' LEU . . . . . 0.676 ' HG ' HD22 ' R' ' 46' ' ' ASN . 0.8 OUTLIER -42.95 -30.9 0.45 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.329 -0.857 . . . . 41.03 110.292 178.291 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' S' S ' 401' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.683 0 O-C-N 121.329 -0.857 . . . . 61.97 110.126 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 29' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.213 0.53 . . . . 32.14 110.248 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 30' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -96.35 141.15 30.01 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.324 -0.86 . . . . 43.36 110.247 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 31' ' ' LEU . . . . . . . . . . . . . 65.4 mt -134.86 140.54 45.9 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.293 -0.879 . . . . 22.93 110.332 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 32' ' ' THR . . . . . . . . . . . . . 69.0 m -87.55 110.61 20.48 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.337 -0.852 . . . . 22.34 109.983 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 33' ' ' LEU . . . . . 0.461 HD23 ' CE2' ' R' ' 62' ' ' TYR . 80.2 mt -62.52 -172.74 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.237 -0.915 . . . . 21.39 110.209 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' R' R ' 34' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -74.59 -29.4 61.31 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.375 -0.828 . . . . 34.4 110.41 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 35' ' ' ASN . . . . . . . . . . . . . 48.2 p30 -77.84 -1.74 33.11 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.322 -0.861 . . . . 30.28 110.665 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.1 -16.53 59.4 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.8 -1.32 . . . . 36.25 109.8 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 37' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -59.0 161.81 4.73 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.256 -1.144 . . . . 53.8 110.383 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 38' ' ' LYS . . . . . . . . . . . . . 57.0 mttt -117.86 135.8 53.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.43 -0.794 . . . . 49.91 110.175 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 39' ' ' LYS . . . . . 0.417 ' HG2' ' CZ ' ' R' ' 41' ' ' PHE . 8.1 ttmt -138.77 143.65 39.07 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.427 -0.796 . . . . 35.69 110.241 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' R' R ' 40' ' ' THR . . . . . . . . . . . . . 23.6 m -102.56 127.97 49.41 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.424 -0.798 . . . . 34.84 110.226 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 41' ' ' PHE . . . . . 0.417 ' CZ ' ' HG2' ' R' ' 39' ' ' LYS . 96.6 m-85 -113.09 132.63 55.35 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.386 -0.821 . . . . 34.42 110.21 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' R' R ' 42' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -93.21 140.86 29.06 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.348 -0.845 . . . . 51.46 110.263 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 43' ' ' SER . . . . . . . . . . . . . 54.2 m -70.74 141.83 51.47 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.511 -0.743 . . . . 41.84 110.196 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.78 125.38 29.56 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.347 -0.845 . . . . 33.82 109.984 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' R' R ' 45' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.11 151.05 55.03 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 123.611 1.321 . . . . 30.27 110.649 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 46' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.27 109.95 14.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.456 -0.777 . . . . 35.1 110.011 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 47' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -120.33 -34.84 3.56 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.339 -0.85 . . . . 42.81 110.493 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 48' ' ' HIS . . . . . . . . . . . . . 73.3 m80 -105.79 45.23 0.98 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.221 -0.925 . . . . 49.97 110.216 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 49' ' ' ASP . . . . . 0.436 ' OD1' ' CA ' ' S' ' 401' ' ' LYS . 37.7 m-20 50.28 34.73 9.26 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.358 -0.839 . . . . 61.32 110.197 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' R' R ' 50' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -86.3 43.78 1.09 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.379 -0.826 . . . . 51.5 110.685 -179.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 51' ' ' ALA . . . . . 0.682 ' CB ' ' HB2' ' S' ' 400' ' ' LEU . . . -66.1 -46.12 78.73 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.199 -0.938 . . . . 38.77 109.474 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' R' R ' 52' ' ' TRP . . . . . 0.501 ' HB3' ' NH1' ' S' ' 398' ' ' ARG . 68.1 p-90 -58.38 -38.42 77.25 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.455 -0.778 . . . . 26.24 110.055 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' R' R ' 53' ' ' LEU . . . . . 0.484 ' N ' ' CD2' ' R' ' 52' ' ' TRP . 23.1 tp -66.75 -46.62 74.81 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.424 -0.798 . . . . 26.75 109.984 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' R' R ' 54' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -55.35 -41.52 72.65 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.304 -0.872 . . . . 35.02 110.111 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.17 -46.08 91.99 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.448 -0.782 . . . . 24.47 110.157 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 56' ' ' ILE . . . . . . . . . . . . . 76.0 mt -62.2 -42.28 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.322 -0.861 . . . . 26.03 109.888 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 57' ' ' LEU . . . . . . . . . . . . . 22.4 mt -60.27 -45.63 92.63 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.28 -0.888 . . . . 26.77 109.68 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 58' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -63.87 -46.59 84.25 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.481 -0.762 . . . . 22.32 109.571 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 59' ' ' LEU . . . . . 0.43 ' HA ' ' HE2' ' R' ' 151' ' ' PHE . 24.0 tp -61.34 -37.84 84.73 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.317 -0.864 . . . . 20.55 109.389 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' R' R ' 60' ' ' PHE . . . . . 0.447 ' CE2' HD22 ' R' ' 111' ' ' LEU . 2.8 m-85 -61.05 -44.72 96.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.635 -0.666 . . . . 20.08 109.913 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' R' R ' 61' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -63.18 -36.15 82.66 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.488 -0.758 . . . . 18.8 110.443 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 62' ' ' TYR . . . . . 0.461 ' CE2' HD23 ' R' ' 33' ' ' LEU . 9.1 t80 -63.09 -41.81 99.48 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.234 -0.916 . . . . 26.45 110.199 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' R' R ' 63' ' ' VAL . . . . . . . . . . . . . 30.5 m -93.38 20.35 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.422 -0.799 . . . . 29.75 110.252 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 64' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 53.03 75.56 0.24 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.316 -0.865 . . . . 35.52 110.531 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 65' ' ' GLU . . . . . 0.424 ' HG2' ' CD2' ' R' ' 60' ' ' PHE . 14.3 tp10 -116.3 104.06 52.33 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.348 -0.845 . . . . 29.89 109.901 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' R' R ' 66' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.57 -5.8 17.69 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.775 1.408 . . . . 21.37 111.093 -179.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 67' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -52.13 -61.44 2.27 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.116 -0.99 . . . . 23.85 110.43 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' R' R ' 68' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -98.23 36.58 1.57 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.306 -0.871 . . . . 28.07 110.484 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 69' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -72.3 -33.35 67.32 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.23 -0.918 . . . . 43.76 110.097 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 70' ' ' TRP . . . . . 0.477 ' CE2' ' CG2' ' R' ' 71' ' ' VAL . 47.7 p-90 -73.24 -4.03 30.5 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.313 -0.867 . . . . 33.06 110.74 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' R' R ' 71' ' ' VAL . . . . . 0.477 ' CG2' ' CE2' ' R' ' 70' ' ' TRP . 40.8 t -109.78 -27.41 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.078 -1.014 . . . . 31.7 109.674 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' R' R ' 72' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -86.62 -48.76 8.04 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.347 -0.845 . . . . 33.58 110.288 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 73' ' ' SER . . . . . . . . . . . . . 69.9 m -89.75 51.12 2.01 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.283 -0.886 . . . . 50.82 110.295 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 74' ' ' SER . . . . . . . . . . . . . 15.7 t -125.99 138.27 31.78 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.335 -0.853 . . . . 34.74 110.208 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.31 -25.02 16.02 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.737 1.388 . . . . 35.7 110.341 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 76' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -91.66 153.16 19.87 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.398 -0.814 . . . . 66.48 110.428 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 77' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -81.5 95.2 7.04 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.364 -0.835 . . . . 46.72 110.035 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 78' ' ' LEU . . . . . . . . . . . . . 96.3 mt -96.4 27.91 3.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.385 -0.822 . . . . 37.55 110.22 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 79' ' ' THR . . . . . . . . . . . . . 29.4 m -56.18 -54.64 42.78 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.317 -0.865 . . . . 37.36 110.295 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 80' ' ' LEU . . . . . . . . . . . . . 15.8 mt -60.97 -23.13 65.1 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.351 -0.843 . . . . 35.83 110.478 -179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 81' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -79.55 -39.08 32.7 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.147 -0.971 . . . . 44.03 110.331 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.5 -28.67 66.25 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.227 -0.921 . . . . 32.54 110.23 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 83' ' ' ILE . . . . . . . . . . . . . 78.2 mt -70.04 -46.1 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.221 -0.925 . . . . 32.02 110.342 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 84' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -55.21 -52.02 64.71 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.232 -0.918 . . . . 34.09 110.607 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 85' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -54.85 -46.81 74.7 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.203 -0.936 . . . . 25.94 110.269 -179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 86' ' ' LEU . . . . . . . . . . . . . 23.9 mt -58.74 -43.77 90.33 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.312 -0.867 . . . . 16.2 109.905 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 87' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -65.38 -35.16 80.12 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.529 -0.732 . . . . 49.09 110.251 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 88' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -78.46 -19.03 54.0 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.381 -0.825 . . . . 28.61 110.51 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 89' ' ' LEU . . . . . . . . . . . . . 32.5 mt -96.24 -29.38 14.05 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.261 -0.899 . . . . 26.16 110.167 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 90' ' ' THR . . . . . . . . . . . . . 59.2 p -105.68 -34.66 7.64 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.327 -0.858 . . . . 33.33 109.747 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.91 16.06 58.55 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.835 -1.306 . . . . 31.13 109.835 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 92' ' ' LEU . . . . . . . . . . . . . 97.0 mt -100.07 155.18 17.86 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.112 -1.228 . . . . 42.52 110.266 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 93' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -86.2 91.66 8.52 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.489 -0.757 . . . . 68.46 109.948 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 94' ' ' LEU . . . . . 0.447 ' HB3' ' CZ2' ' R' ' 52' ' ' TRP . 48.2 mt -99.51 53.0 0.94 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.147 -0.971 . . . . 44.63 110.368 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' R' R ' 95' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.54 -38.67 6.37 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.348 -0.845 . . . . 67.16 110.34 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' R' R ' 96' ' ' GLU . . . . . 0.411 ' O ' ' CD ' ' S' ' 399' ' ' LYS . 24.7 mt-10 -113.83 44.11 1.69 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.316 -0.865 . . . . 67.02 110.337 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' R' R ' 97' ' ' GLY . . . . . 0.56 ' HA3' ' CB ' ' S' ' 399' ' ' LYS . . . 99.2 150.87 26.06 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.598 -1.401 . . . . 49.48 109.598 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' R' R ' 98' ' ' GLY . . . . . . . . . . . . . . . -166.28 159.99 33.42 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.245 -1.542 . . . . 36.57 109.245 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 99' ' ' PRO . . . . . 0.524 ' CB ' ' HB ' ' S' ' 396' ' ' VAL . 44.9 Cg_endo -72.56 121.12 7.15 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 O-C-N 123.703 1.37 . . . . 30.41 110.435 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' R' R ' 100' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.27 -31.7 11.39 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.567 1.299 . . . . 29.94 110.506 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 101' ' ' ALA . . . . . 0.451 ' HB2' HG12 ' S' ' 396' ' ' VAL . . . -69.97 -38.41 76.06 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.226 -0.921 . . . . 23.64 110.266 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' R' R ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.69 -40.82 65.94 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.367 -0.833 . . . . 20.31 110.324 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' R' R ' 103' ' ' VAL . . . . . . . . . . . . . 63.9 t -58.08 -40.15 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.281 -0.887 . . . . 16.33 109.934 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 104' ' ' ILE . . . . . . . . . . . . . 81.7 mt -71.7 -30.49 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.388 -0.82 . . . . 24.77 109.985 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 105' ' ' TRP . . . . . 0.44 ' O ' ' HD3' ' R' ' 108' ' ' LYS . 70.6 t-105 -82.42 0.81 40.39 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.345 -0.847 . . . . 23.28 110.33 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' R' R ' 106' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -105.05 -10.38 17.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.143 -0.973 . . . . 28.26 110.146 179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 107' ' ' ILE . . . . . . . . . . . . . 36.8 pt -126.81 35.0 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.225 -0.922 . . . . 18.77 110.01 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 108' ' ' LYS . . . . . 0.48 ' HG2' ' HB ' ' R' ' 115' ' ' ILE . 9.2 mtpp -61.06 -48.47 81.59 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.528 -0.733 . . . . 42.5 110.031 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' R' R ' 109' ' ' HIS . . . . . 0.432 ' CD2' ' HG ' ' R' ' 110' ' ' LEU . 50.8 p-80 -66.01 -12.86 58.1 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.503 -0.748 . . . . 20.07 110.696 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' R' R ' 110' ' ' LEU . . . . . 0.432 ' HG ' ' CD2' ' R' ' 109' ' ' HIS . 80.8 mt -94.84 -17.31 22.2 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.145 -0.972 . . . . 15.69 110.181 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' R' R ' 111' ' ' LEU . . . . . 0.447 HD22 ' CE2' ' R' ' 60' ' ' PHE . 10.4 mt -94.1 144.14 25.75 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.341 -0.85 . . . . 25.39 111.004 -179.204 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' R' R ' 112' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -77.71 -17.36 57.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.451 -0.781 . . . . 53.48 109.846 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 113' ' ' THR . . . . . 0.418 HG22 ' HG2' ' R' ' 123' ' ' GLU . 60.5 m -83.72 166.68 17.86 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.251 -0.906 . . . . 14.8 110.22 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' R' R ' 114' ' ' GLY . . . . . . . . . . . . . . . -97.96 127.16 9.13 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.994 -1.243 . . . . 16.14 109.994 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 115' ' ' ILE . . . . . 0.48 ' HB ' ' HG2' ' R' ' 108' ' ' LYS . 47.8 mm -109.09 139.36 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.475 -1.015 . . . . 13.46 109.71 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' R' R ' 116' ' ' GLY . . . . . . . . . . . . . . . -152.78 -155.81 7.27 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.964 -1.254 . . . . 23.9 109.964 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 117' ' ' THR . . . . . . . . . . . . . 18.9 p -135.06 -171.46 2.81 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.467 -1.019 . . . . 27.37 110.02 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.5 -58.09 9.53 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.337 -0.852 . . . . 18.76 110.064 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 119' ' ' SER . . . . . 0.541 ' HB3' ' HB ' ' R' ' 196' ' ' VAL . 1.1 m -56.54 -40.65 75.46 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.267 -0.896 . . . . 32.35 109.69 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' R' R ' 120' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 -110.02 86.19 4.77 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.458 -0.776 . . . . 27.12 109.643 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 121' ' ' PRO . . . . . 0.426 ' O ' ' HB2' ' R' ' 122' ' ' SER . 44.3 Cg_endo -71.26 166.55 28.9 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.817 1.43 . . . . 22.68 111.02 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' R' R ' 122' ' ' SER . . . . . 0.426 ' HB2' ' O ' ' R' ' 121' ' ' PRO . 38.6 t 178.55 -161.67 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.643 -0.661 . . . . 22.99 109.447 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' R' R ' 123' ' ' GLU . . . . . 0.418 ' HG2' HG22 ' R' ' 113' ' ' THR . 2.3 tp10 -56.47 -39.95 74.06 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.211 -0.93 . . . . 36.18 109.673 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' R' R ' 124' ' ' VAL . . . . . . . . . . . . . 84.2 t -142.52 136.43 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.471 -0.768 . . . . 20.64 109.333 179.362 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 125' ' ' CYS . . . . . 0.41 ' SG ' ' HA ' ' R' ' 121' ' ' PRO . 83.4 m -140.32 168.16 20.46 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.245 -0.91 . . . . 22.8 111.206 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' R' R ' 126' ' ' VAL . . . . . . . . . . . . . 35.9 m -122.68 159.75 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.713 -0.617 . . . . 21.24 109.595 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 127' ' ' VAL . . . . . 0.4 ' CG1' ' O ' ' R' ' 177' ' ' VAL . 30.5 m -70.83 141.83 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.29 -0.881 . . . . 19.77 110.708 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' R' R ' 128' ' ' ASP . . . . . . . . . . . . . 53.8 p-10 -137.7 19.42 2.87 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.37 -0.831 . . . . 29.21 110.664 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 129' ' ' GLY . . . . . . . . . . . . . . . 114.08 0.05 24.02 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.967 -1.111 . . . . 33.86 110.403 179.274 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 130' ' ' THR . . . . . . . . . . . . . 58.7 m -91.91 131.83 36.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.145 -1.209 . . . . 26.41 110.08 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -62.51 120.66 11.53 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.338 -0.852 . . . . 33.08 110.224 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 132' ' ' MET . . . . . 0.426 ' HE1' ' CZ ' ' R' ' 180' ' ' PHE . 98.3 mmm -105.16 165.67 10.93 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.558 -0.714 . . . . 30.76 110.472 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' R' R ' 133' ' ' CYS . . . . . . . . . . . . . 32.3 m -141.22 158.09 44.36 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.52 -0.737 . . . . 27.0 109.907 179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 134' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.41 -19.76 38.86 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.312 -0.868 . . . . 33.9 110.453 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' R' R ' 135' ' ' ALA . . . . . . . . . . . . . . . -92.77 8.18 40.5 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.257 -0.902 . . . . 19.37 110.78 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 136' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -93.72 -21.81 19.11 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.198 -0.939 . . . . 30.47 110.228 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 137' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -149.94 165.28 33.11 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.319 -0.863 . . . . 24.27 110.22 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 138' ' ' HIS . . . . . . . . . . . . . 15.3 p80 -117.73 15.08 14.46 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.429 -0.794 . . . . 20.91 110.459 179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 139' ' ' ALA . . . . . 0.441 ' HA ' ' O ' ' R' ' 152' ' ' ALA . . . -177.16 152.46 0.88 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.306 -0.871 . . . . 15.69 110.08 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' R' R ' 140' ' ' GLY . . . . . 0.405 ' HA3' ' O ' ' R' ' 179' ' ' VAL . . . 161.74 175.14 32.45 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 110.0 -1.24 . . . . 23.76 110.0 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' R' R ' 141' ' ' ILE . . . . . . . . . . . . . 83.8 mt -95.48 136.58 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.371 -1.076 . . . . 25.3 109.674 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 142' ' ' PHE . . . . . 0.546 ' CD2' ' HB2' ' R' ' 172' ' ' PRO . 82.6 m-85 -120.73 -172.59 2.41 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.27 -0.894 . . . . 30.24 110.512 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' R' R ' 143' ' ' LEU . . . . . 0.718 HD12 ' HB3' ' S' ' 395' ' ' LYS . 0.5 OUTLIER -119.81 77.72 1.26 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.43 -0.794 . . . . 32.8 110.301 -179.924 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' R' R ' 144' ' ' LYS . . . . . 0.454 ' HG3' ' CZ2' ' R' ' 170' ' ' TRP . 1.0 OUTLIER -69.54 76.83 0.41 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.363 -0.835 . . . . 49.18 109.728 179.549 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' R' R ' 145' ' ' GLY . . . . . . . . . . . . . . . 104.57 179.32 24.74 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.202 -1.559 . . . . 53.87 109.202 -179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 146' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -88.49 145.83 25.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.369 -1.077 . . . . 68.58 110.006 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 147' ' ' GLU . . . . . 0.632 ' HA ' ' O ' ' S' ' 398' ' ' ARG . 10.9 mt-10 58.26 36.45 25.68 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.347 -0.845 . . . . 56.62 110.655 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' R' R ' 148' ' ' HIS . . . . . 0.4 ' HD1' ' HB2' ' S' ' 400' ' ' LEU . 45.1 t60 -158.67 148.09 19.16 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.267 -0.895 . . . . 44.57 110.359 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' R' R ' 149' ' ' ALA . . . . . 0.589 ' HB3' ' NE ' ' S' ' 398' ' ' ARG . . . -150.27 146.91 27.07 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.484 -0.76 . . . . 33.54 110.072 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' R' R ' 150' ' ' VAL . . . . . 0.428 HG23 ' HB2' ' R' ' 144' ' ' LYS . 34.2 m -142.32 161.51 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.263 -0.898 . . . . 27.61 110.322 179.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' R' R ' 151' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' R' ' 152' ' ' ALA . 5.9 t80 -86.24 155.63 20.62 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.401 -0.812 . . . . 23.04 109.881 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' R' R ' 152' ' ' ALA . . . . . 0.537 ' N ' ' CD1' ' R' ' 151' ' ' PHE . . . -157.31 151.51 24.83 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.45 -0.781 . . . . 29.61 109.589 179.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' R' R ' 153' ' ' CYS . . . . . 0.407 ' HA ' ' HA ' ' R' ' 139' ' ' ALA . 26.7 p -154.27 173.6 15.93 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.347 -0.846 . . . . 22.75 110.444 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' R' R ' 154' ' ' VAL . . . . . 0.443 ' CG2' ' CZ2' ' R' ' 159' ' ' TRP . 59.7 t -90.64 117.03 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.425 -0.797 . . . . 23.26 110.061 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' R' R ' 155' ' ' THR . . . . . . . . . . . . . 69.9 p -112.11 -176.6 2.96 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.313 -0.867 . . . . 17.88 110.065 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 156' ' ' SER . . . . . . . . . . . . . 78.5 p -75.98 -3.66 36.86 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.27 -0.894 . . . . 21.83 110.672 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 157' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -118.36 10.53 12.79 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.138 -0.976 . . . . 36.54 110.59 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 158' ' ' GLY . . . . . . . . . . . . . . . 117.92 -162.68 13.01 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.567 -1.413 . . . . 31.74 109.567 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 159' ' ' TRP . . . . . 0.443 ' CZ2' ' CG2' ' R' ' 154' ' ' VAL . 14.7 m95 -86.56 122.45 30.5 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.389 -1.065 . . . . 28.25 110.147 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' R' R ' 160' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -108.45 166.91 10.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.305 -0.872 . . . . 41.24 110.218 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 161' ' ' ALA . . . . . . . . . . . . . . . -143.21 123.48 13.79 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.403 -0.81 . . . . 27.4 110.14 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 162' ' ' ILE . . . . . 0.43 HG23 ' CZ ' ' R' ' 167' ' ' PHE . 92.3 mt -87.59 81.14 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.324 -0.86 . . . . 24.27 110.015 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' R' R ' 163' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' R' ' 165' ' ' GLU . 15.3 t0 -72.78 92.41 1.57 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.406 -0.809 . . . . 36.08 110.262 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' R' R ' 164' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 54.07 -88.97 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.564 -0.71 . . . . 46.08 110.603 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 165' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' R' ' 163' ' ' ASP . 29.8 mt-10 -124.72 36.03 4.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.083 -1.011 . . . . 50.94 110.194 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' R' R ' 166' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -135.75 117.33 14.88 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.388 -0.82 . . . . 47.28 110.347 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 167' ' ' PHE . . . . . 0.43 ' CZ ' HG23 ' R' ' 162' ' ' ILE . 24.5 m-85 -101.1 119.96 39.51 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.427 -0.795 . . . . 40.47 110.132 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' R' R ' 168' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -157.49 158.59 30.76 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.216 -0.927 . . . . 30.21 110.423 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 169' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.79 132.98 19.38 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 O-C-N 123.831 1.437 . . . . 32.76 110.527 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 170' ' ' TRP . . . . . 0.454 ' CZ2' ' HG3' ' R' ' 144' ' ' LYS . 67.0 t90 -159.78 119.37 2.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.384 -0.823 . . . . 32.79 109.909 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' R' R ' 171' ' ' THR . . . . . . . . . . . . . 47.5 m -81.12 112.62 34.35 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.448 -0.783 . . . . 36.92 110.141 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 172' ' ' PRO . . . . . 0.546 ' HB2' ' CD2' ' R' ' 142' ' ' PHE . 48.0 Cg_endo -73.7 158.83 46.62 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.596 1.314 . . . . 33.54 110.545 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' R' R ' 173' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -88.92 144.93 33.64 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.415 -0.803 . . . . 45.76 109.904 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 174' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.72 -10.34 26.35 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 O-C-N 123.517 1.272 . . . . 29.63 110.497 179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 175' ' ' SER . . . . . . . . . . . . . 52.9 p -103.42 -17.63 15.16 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.348 -0.845 . . . . 35.7 110.396 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 176' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -103.48 43.18 1.1 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.213 -0.93 . . . . 39.65 110.4 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 177' ' ' VAL . . . . . 0.4 ' O ' ' CG1' ' R' ' 127' ' ' VAL . 10.7 p -117.71 127.17 75.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.368 -0.832 . . . . 20.61 110.043 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' R' R ' 178' ' ' LEU . . . . . 0.407 HD23 HG12 ' S' ' 396' ' ' VAL . 46.1 mt -91.56 -61.24 1.69 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.362 -0.836 . . . . 15.58 109.378 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' R' R ' 179' ' ' VAL . . . . . 0.405 ' O ' ' HA3' ' R' ' 140' ' ' GLY . 67.8 t -114.67 144.69 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.676 -0.64 . . . . 17.4 109.391 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' R' R ' 180' ' ' PHE . . . . . 0.426 ' CZ ' ' HE1' ' R' ' 132' ' ' MET . 43.6 p90 -152.17 163.41 39.45 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.268 -0.895 . . . . 20.16 110.529 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' R' R ' 181' ' ' VAL . . . . . . . . . . . . . 66.6 t -113.2 111.49 50.19 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.488 -0.758 . . . . 17.69 109.862 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 182' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.06 149.49 52.61 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 O-C-N 123.606 1.319 . . . . 17.81 110.456 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 183' ' ' TYR . . . . . 0.709 ' O ' ' C ' ' R' ' 184' ' ' ASP . 79.5 m-85 -58.92 175.45 0.28 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.463 -0.773 . . . . 28.01 110.535 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' R' R ' 184' ' ' ASP . . . . . 0.709 ' C ' ' O ' ' R' ' 183' ' ' TYR . 6.1 m-20 -17.71 -82.75 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.313 -0.867 . . . . 58.64 110.271 -178.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' R' R ' 185' ' ' GLN . . . . . . . . . . . . . 49.2 mm-40 . . . . . 0 N--CA 1.503 2.183 0 CA-C-O 121.23 0.538 . . . . 80.42 111.783 179.547 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' R' R ' 193' ' ' LYS . . . . . . . . . . . . . 28.0 mtmt . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 120.888 0.375 . . . . 49.5 110.192 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' R' R ' 194' ' ' ALA . . . . . . . . . . . . . . . -173.18 -156.94 0.09 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.172 -0.955 . . . . 40.4 110.127 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 195' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.77 -51.54 5.04 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.397 -0.814 . . . . 34.6 110.285 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' R' R ' 196' ' ' VAL . . . . . 0.541 ' HB ' ' HB3' ' R' ' 119' ' ' SER . 21.3 t -92.11 48.94 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.186 -0.946 . . . . 33.27 110.615 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' R' R ' 197' ' ' GLN . . . . . 0.555 ' HG3' ' O ' ' R' ' 197' ' ' GLN . 5.1 tp60 -166.41 61.11 0.1 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.12 -0.988 . . . . 41.58 110.684 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' R' R ' 198' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -174.45 128.77 0.34 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.064 -1.022 . . . . 38.65 110.17 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 199' ' ' LYS . . . . . . . . . . . . . 19.6 mtmt -46.95 147.68 1.29 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.394 -0.816 . . . . 36.77 109.937 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 200' ' ' LEU . . . . . . . . . . . . . 14.1 mt -134.27 -95.66 0.28 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.437 -0.79 . . . . 33.08 110.065 -179.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' R' R ' 201' ' ' LYS . . . . . 0.613 ' C ' ' H ' ' S' ' 298' ' ' GLY . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.696 0 O-C-N 121.448 -0.782 . . . . 44.32 110.304 -178.859 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' S' S ' 229' ' ' MET . . . . . 0.457 ' HG3' ' N ' ' S' ' 230' ' ' GLU . 3.3 ptt? . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.181 0.515 . . . . 51.83 110.233 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 230' ' ' GLU . . . . . 0.457 ' N ' ' HG3' ' S' ' 229' ' ' MET . 33.2 tt0 -97.29 142.75 28.79 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.432 -0.793 . . . . 54.13 110.196 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' S' S ' 231' ' ' LEU . . . . . . . . . . . . . 68.0 mt -134.12 141.05 46.99 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.352 -0.842 . . . . 33.04 110.334 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 232' ' ' THR . . . . . . . . . . . . . 40.3 m -89.26 103.24 15.88 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.343 -0.848 . . . . 26.92 110.041 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 233' ' ' LEU . . . . . 0.495 HD23 ' CE2' ' S' ' 262' ' ' TYR . 79.7 mt -55.87 179.29 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.531 -0.731 . . . . 13.78 110.543 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' S' S ' 234' ' ' TYR . . . . . 0.448 ' CG ' ' N ' ' S' ' 235' ' ' ASN . 35.5 p90 -65.02 -35.63 81.81 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.426 -0.797 . . . . 26.08 110.189 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' S' S ' 235' ' ' ASN . . . . . 0.448 ' N ' ' CG ' ' S' ' 234' ' ' TYR . 50.6 p30 -74.36 -7.47 52.96 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.345 -0.847 . . . . 20.04 110.531 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' S' S ' 236' ' ' GLY . . . . . . . . . . . . . . . 95.79 -19.96 51.97 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.764 -1.334 . . . . 22.71 109.764 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 237' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -52.95 145.63 12.45 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.258 -1.142 . . . . 35.44 110.235 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 238' ' ' LYS . . . . . . . . . . . . . 44.4 mttt -102.1 127.85 48.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.349 -0.845 . . . . 32.56 110.426 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 239' ' ' LYS . . . . . 0.412 ' HG2' ' CZ ' ' S' ' 241' ' ' PHE . 9.0 ttmt -132.29 144.51 50.64 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.41 -0.806 . . . . 26.68 109.992 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' S' S ' 240' ' ' THR . . . . . . . . . . . . . 51.7 m -102.08 132.17 48.12 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.362 -0.836 . . . . 41.02 110.37 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 241' ' ' PHE . . . . . 0.412 ' CZ ' ' HG2' ' S' ' 239' ' ' LYS . 96.0 m-85 -117.85 137.66 52.63 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.379 -0.826 . . . . 28.62 110.196 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' S' S ' 242' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -96.29 161.87 13.75 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.288 -0.883 . . . . 47.89 110.295 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 243' ' ' SER . . . . . . . . . . . . . 71.9 m -90.64 151.52 21.25 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.362 -0.836 . . . . 45.09 110.309 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 244' ' ' ARG . . . . . . . . . . . . . 1.4 mtp85 -129.85 126.78 22.67 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.415 -0.803 . . . . 42.49 110.199 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 245' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.37 161.0 43.7 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 O-C-N 123.639 1.336 . . . . 35.68 110.507 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 246' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -132.86 97.87 4.15 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.359 -0.838 . . . . 51.88 109.822 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 247' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -110.47 -22.21 11.78 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.378 -0.826 . . . . 53.69 110.664 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 248' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -117.29 43.74 2.26 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.225 -0.922 . . . . 55.79 110.714 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 249' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 48.77 38.41 11.76 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.447 -0.783 . . . . 49.45 110.417 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 250' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -90.61 28.99 1.38 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.526 -0.734 . . . . 36.86 110.358 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 251' ' ' ALA . . . . . . . . . . . . . . . -53.78 -43.18 69.03 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.311 -0.868 . . . . 29.69 109.575 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 252' ' ' TRP . . . . . 0.414 ' CZ2' ' HB3' ' S' ' 294' ' ' LEU . 67.9 p-90 -61.83 -34.01 75.19 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.451 -0.78 . . . . 41.12 109.79 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' S' S ' 253' ' ' LEU . . . . . . . . . . . . . 23.3 tp -70.14 -47.23 62.59 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.433 -0.792 . . . . 24.89 109.906 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 254' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -56.12 -42.41 76.81 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.395 -0.816 . . . . 35.65 109.956 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 255' ' ' ALA . . . . . . . . . . . . . . . -59.63 -48.09 83.02 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.464 -0.773 . . . . 22.73 110.074 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 256' ' ' ILE . . . . . . . . . . . . . 79.6 mt -62.37 -40.62 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.315 -0.866 . . . . 28.85 109.928 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 257' ' ' LEU . . . . . . . . . . . . . 19.2 mt -61.56 -44.45 97.01 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.403 -0.81 . . . . 23.07 110.244 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 258' ' ' GLN . . . . . 0.471 ' HB3' ' CD2' ' S' ' 351' ' ' PHE . 53.1 mm-40 -65.05 -45.37 85.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.384 -0.823 . . . . 29.78 109.918 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' S' S ' 259' ' ' LEU . . . . . 0.433 ' O ' HG22 ' S' ' 263' ' ' VAL . 19.8 tp -58.69 -36.38 74.11 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.291 -0.881 . . . . 17.94 109.435 179.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' S' S ' 260' ' ' PHE . . . . . 0.47 ' CE2' HD22 ' S' ' 311' ' ' LEU . 3.1 m-85 -62.83 -45.27 93.41 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.603 -0.686 . . . . 30.57 109.84 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' S' S ' 261' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -62.12 -29.81 70.59 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.46 -0.775 . . . . 41.34 109.898 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 262' ' ' TYR . . . . . 0.495 ' CE2' HD23 ' S' ' 233' ' ' LEU . 8.6 t80 -71.22 -44.63 64.99 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.41 -0.806 . . . . 26.03 110.085 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' S' S ' 263' ' ' VAL . . . . . 0.433 HG22 ' O ' ' S' ' 259' ' ' LEU . 33.1 m -92.06 18.29 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.352 -0.842 . . . . 22.8 110.373 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' S' S ' 264' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 52.77 70.64 0.55 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.199 -0.938 . . . . 44.03 110.653 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 265' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -111.81 109.12 55.47 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.303 -0.873 . . . . 35.61 109.637 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 266' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -75.31 0.39 9.08 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 O-C-N 123.578 1.304 . . . . 37.67 111.753 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 267' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -56.48 -67.73 0.28 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.85 -1.156 . . . . 41.49 110.173 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' S' S ' 268' ' ' PHE . . . . . . . . . . . . . 22.6 m-85 -92.86 39.94 1.05 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.148 -0.97 . . . . 50.76 110.132 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 269' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.1 -33.19 59.49 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.307 -0.87 . . . . 61.86 109.727 179.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' S' S ' 270' ' ' TRP . . . . . 0.493 ' CE2' ' CG2' ' S' ' 271' ' ' VAL . 50.9 p-90 -73.85 -4.41 34.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.322 -0.861 . . . . 39.85 110.46 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' S' S ' 271' ' ' VAL . . . . . 0.493 ' CG2' ' CE2' ' S' ' 270' ' ' TRP . 46.6 t -109.49 -32.72 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.117 -0.989 . . . . 39.18 110.156 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' S' S ' 272' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -78.6 -36.6 44.06 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.387 -0.821 . . . . 40.02 110.486 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 273' ' ' SER . . . . . . . . . . . . . 71.2 m -103.48 56.16 0.74 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.336 -0.853 . . . . 47.2 110.306 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 274' ' ' SER . . . . . . . . . . . . . 6.9 t -133.06 141.27 40.29 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.336 -0.853 . . . . 47.61 110.14 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 275' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -73.85 -18.83 21.51 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.684 1.36 . . . . 45.28 110.485 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 276' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -99.87 140.87 33.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.238 -0.913 . . . . 57.27 110.317 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 277' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -71.73 97.67 1.8 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.388 -0.82 . . . . 37.28 110.322 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 278' ' ' LEU . . . . . . . . . . . . . 86.8 mt -97.04 33.84 1.85 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.358 -0.839 . . . . 43.88 109.987 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 279' ' ' THR . . . . . . . . . . . . . 75.3 m -64.03 -60.09 3.67 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.424 -0.797 . . . . 50.05 110.347 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 280' ' ' LEU . . . . . . . . . . . . . 13.7 mt -51.59 -39.91 58.84 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.363 -0.836 . . . . 54.12 110.246 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 281' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.42 -49.68 74.5 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.474 -0.766 . . . . 65.28 110.141 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' S' S ' 282' ' ' ALA . . . . . . . . . . . . . . . -58.97 -33.86 71.14 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.466 -0.771 . . . . 46.51 110.555 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 283' ' ' ILE . . . . . . . . . . . . . 85.7 mt -66.37 -50.86 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.273 -0.892 . . . . 47.3 110.087 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 284' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -50.59 -57.56 7.88 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.43 -0.794 . . . . 50.72 110.387 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 285' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -51.46 -46.32 63.02 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.503 -0.748 . . . . 68.47 110.332 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 286' ' ' LEU . . . . . . . . . . . . . 19.1 mt -59.96 -44.53 94.39 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.42 -0.8 . . . . 36.62 110.312 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 287' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -62.71 -35.26 79.16 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.372 -0.83 . . . . 46.64 110.099 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 288' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -76.24 -21.08 56.79 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.37 -0.831 . . . . 46.45 110.28 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 289' ' ' LEU . . . . . . . . . . . . . 30.8 mt -97.31 -21.75 17.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.286 -0.884 . . . . 35.09 110.487 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 290' ' ' THR . . . . . . . . . . . . . 81.2 p -114.74 -28.45 7.1 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.221 -0.925 . . . . 38.61 110.422 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 291' ' ' GLY . . . . . . . . . . . . . . . 79.43 10.93 85.43 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.823 -1.311 . . . . 36.77 109.823 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 292' ' ' LEU . . . . . . . . . . . . . 84.8 mt -96.44 145.84 25.31 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.226 -1.161 . . . . 35.33 109.726 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 293' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -77.37 102.41 6.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.196 -0.94 . . . . 48.7 110.232 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 294' ' ' LEU . . . . . 0.414 ' HB3' ' CZ2' ' S' ' 252' ' ' TRP . 56.2 mt -106.99 51.74 0.73 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.539 -0.726 . . . . 42.61 110.066 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' S' S ' 295' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -112.51 -11.17 13.65 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.362 -0.836 . . . . 55.49 110.524 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' S' S ' 296' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -144.36 48.53 1.36 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.127 -0.983 . . . . 75.68 110.321 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 297' ' ' GLY . . . . . . . . . . . . . . . 96.87 145.22 18.78 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.511 -1.436 . . . . 49.44 109.511 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 298' ' ' GLY . . . . . 0.613 ' H ' ' C ' ' R' ' 201' ' ' LYS . . . -163.83 156.96 29.05 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.744 -1.342 . . . . 41.11 109.744 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' S' S ' 299' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.84 118.26 5.36 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 123.943 1.497 . . . . 26.2 110.293 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 300' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.33 -15.38 31.4 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 O-C-N 123.647 1.34 . . . . 21.7 110.675 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 301' ' ' ALA . . . . . . . . . . . . . . . -80.69 -29.31 36.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.238 -0.914 . . . . 31.23 110.182 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 302' ' ' LEU . . . . . 0.442 HD11 HG11 ' R' ' 196' ' ' VAL . 0.0 OUTLIER -83.48 -40.7 18.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.404 -0.81 . . . . 38.99 109.966 179.793 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' S' S ' 303' ' ' VAL . . . . . 0.468 ' O ' HG12 ' S' ' 307' ' ' ILE . 56.9 t -60.61 -35.48 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.399 -0.813 . . . . 18.63 110.153 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' S' S ' 304' ' ' ILE . . . . . . . . . . . . . 86.5 mt -79.43 -23.65 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.449 -0.782 . . . . 25.46 110.124 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 305' ' ' TRP . . . . . . . . . . . . . 68.9 t-105 -88.59 -14.69 36.97 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.234 -0.916 . . . . 33.4 110.501 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 306' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -89.61 -13.52 36.96 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.179 -0.95 . . . . 36.97 110.438 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 307' ' ' ILE . . . . . 0.468 HG12 ' O ' ' S' ' 303' ' ' VAL . 36.8 pt -125.14 45.66 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.237 -0.915 . . . . 30.81 110.005 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' S' S ' 308' ' ' LYS . . . . . . . . . . . . . 1.5 mtmp? -73.52 -37.71 65.56 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.35 -0.844 . . . . 46.52 110.169 -179.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 309' ' ' HIS . . . . . 0.484 ' CD2' ' HG ' ' S' ' 310' ' ' LEU . 55.6 p-80 -73.25 -8.26 55.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.407 -0.808 . . . . 51.03 110.057 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' S' S ' 310' ' ' LEU . . . . . 0.484 ' HG ' ' CD2' ' S' ' 309' ' ' HIS . 52.8 mt -99.25 -12.91 19.96 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.29 -0.881 . . . . 36.16 109.962 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' S' S ' 311' ' ' LEU . . . . . 0.47 HD22 ' CE2' ' S' ' 260' ' ' PHE . 10.8 mt -97.14 147.77 23.73 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.278 -0.889 . . . . 40.0 110.471 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' S' S ' 312' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -81.58 -16.29 52.08 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.282 -0.886 . . . . 54.18 109.771 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 313' ' ' THR . . . . . 0.468 HG23 ' HB3' ' S' ' 323' ' ' GLU . 92.4 m -87.94 151.64 22.66 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.378 -0.826 . . . . 25.61 110.151 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' S' S ' 314' ' ' GLY . . . . . . . . . . . . . . . -87.88 126.42 8.04 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.815 -1.314 . . . . 25.18 109.815 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 315' ' ' ILE . . . . . . . . . . . . . 50.6 mm -101.62 150.47 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.346 -1.091 . . . . 23.9 109.702 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 316' ' ' GLY . . . . . . . . . . . . . . . -157.13 -159.23 9.36 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 110.021 -1.232 . . . . 23.18 110.021 179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 317' ' ' THR . . . . . . . . . . . . . 11.0 p -133.96 -173.04 3.14 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.311 -1.111 . . . . 27.98 109.923 -179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.57 -56.18 25.19 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.2 -0.937 . . . . 28.1 109.899 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 319' ' ' SER . . . . . . . . . . . . . 1.2 m -59.98 -41.61 92.4 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.321 -0.862 . . . . 37.0 109.621 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 320' ' ' ARG . . . . . . . . . . . . . 12.2 mtm180 -111.67 79.88 2.62 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.481 -0.762 . . . . 52.07 109.657 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 321' ' ' PRO . . . . . 1.046 ' HG2' ' O ' ' S' ' 386' ' ' GLU . 43.9 Cg_endo -71.41 171.54 15.98 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.869 1.457 . . . . 38.29 110.9 -179.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' S' S ' 322' ' ' SER . . . . . 0.435 ' HB2' ' O ' ' S' ' 321' ' ' PRO . 41.2 t 178.62 -148.17 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.89 -0.781 . . . . 38.84 108.89 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' S' S ' 323' ' ' GLU . . . . . 0.468 ' HB3' HG23 ' S' ' 313' ' ' THR . 6.7 tp10 -62.82 -40.26 96.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.003 -1.061 . . . . 40.7 109.734 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' S' S ' 324' ' ' VAL . . . . . . . . . . . . . 72.9 t -141.33 134.98 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.427 -0.795 . . . . 20.34 109.5 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 325' ' ' CYS . . . . . 0.449 ' HB2' ' CE1' ' S' ' 380' ' ' PHE . 11.1 m -125.95 172.21 10.11 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.249 -0.907 . . . . 30.63 110.826 -179.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' S' S ' 326' ' ' VAL . . . . . . . . . . . . . 34.5 m -135.49 142.18 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 109.216 -0.661 . . . . 23.9 109.216 179.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 327' ' ' VAL . . . . . . . . . . . . . 34.5 m -56.29 124.94 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.133 -0.979 . . . . 19.48 110.432 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 328' ' ' ASP . . . . . . . . . . . . . 55.7 p-10 -119.37 11.54 12.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.432 -0.792 . . . . 26.43 110.422 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 329' ' ' GLY . . . . . . . . . . . . . . . 119.67 2.13 13.14 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.074 -1.21 . . . . 31.24 110.074 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 330' ' ' THR . . . . . . . . . . . . . 79.4 m -92.9 130.02 38.63 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.082 -1.246 . . . . 30.05 110.122 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 331' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -56.89 111.53 1.06 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.321 -0.862 . . . . 37.26 109.991 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 332' ' ' MET . . . . . 0.457 ' HE1' ' CZ ' ' S' ' 380' ' ' PHE . 88.1 mmm -94.1 162.49 13.85 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.267 -0.896 . . . . 26.23 110.344 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' S' S ' 333' ' ' CYS . . . . . . . . . . . . . 25.8 m -137.19 150.11 47.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.475 -0.766 . . . . 23.56 110.025 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 334' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.66 -24.76 9.12 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.289 -0.882 . . . . 28.93 110.5 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' S' S ' 335' ' ' ALA . . . . . . . . . . . . . . . -89.1 14.49 10.64 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.388 -0.82 . . . . 15.76 110.973 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 336' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -100.48 -17.25 17.24 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.133 -0.979 . . . . 34.92 110.143 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 337' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -152.41 170.83 19.14 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.333 -0.854 . . . . 19.03 110.077 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 338' ' ' HIS . . . . . 0.401 ' HB3' ' CZ ' ' S' ' 383' ' ' TYR . 13.5 p80 -120.65 10.42 11.03 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.333 -0.854 . . . . 18.82 110.479 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' S' S ' 339' ' ' ALA . . . . . . . . . . . . . . . -175.98 155.16 1.56 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.204 -0.935 . . . . 17.18 110.146 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 340' ' ' GLY . . . . . 0.405 ' CA ' ' O ' ' S' ' 379' ' ' VAL . . . 160.81 173.06 28.94 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.036 -1.226 . . . . 18.33 110.036 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' S' S ' 341' ' ' ILE . . . . . 0.433 HD12 HG22 ' S' ' 341' ' ' ILE . 84.2 mt -88.78 138.07 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.489 -1.006 . . . . 18.6 109.787 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' S' S ' 342' ' ' PHE . . . . . 0.5 ' CE1' HG23 ' S' ' 377' ' ' VAL . 69.9 m-85 -120.97 -178.43 3.74 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.222 -0.924 . . . . 23.44 110.407 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' S' S ' 343' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.84 93.41 4.19 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.532 -0.73 . . . . 35.59 110.024 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' S' S ' 344' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.87 125.04 29.62 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.301 -0.874 . . . . 38.34 110.067 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' S' S ' 345' ' ' GLY . . . . . . . . . . . . . . . 62.75 -130.86 43.17 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 108.874 -1.69 . . . . 53.46 108.874 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 346' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -132.68 150.89 52.1 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.246 -1.149 . . . . 70.91 110.043 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 347' ' ' GLU . . . . . 0.504 ' C ' ' HG2' ' R' ' 201' ' ' LYS . 18.0 mt-10 53.19 35.44 19.92 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.321 -0.862 . . . . 47.32 110.45 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' S' S ' 348' ' ' HIS . . . . . 0.442 ' N ' ' HG2' ' R' ' 201' ' ' LYS . 46.4 t60 -150.18 155.87 40.56 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.204 -0.935 . . . . 41.72 110.311 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' S' S ' 349' ' ' ALA . . . . . . . . . . . . . . . -149.82 151.22 33.17 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.314 -0.866 . . . . 22.91 110.527 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 350' ' ' VAL . . . . . . . . . . . . . 34.6 m -149.0 169.67 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.463 -0.773 . . . . 21.09 110.058 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 351' ' ' PHE . . . . . 0.471 ' CD2' ' HB3' ' S' ' 258' ' ' GLN . 10.7 t80 -105.43 143.59 33.38 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.178 -0.951 . . . . 25.03 110.682 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' S' S ' 352' ' ' ALA . . . . . . . . . . . . . . . -147.67 151.78 36.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.64 -0.662 . . . . 23.81 109.704 179.585 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 353' ' ' CYS . . . . . . . . . . . . . 26.2 p -153.37 164.85 37.42 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.324 -0.86 . . . . 25.66 110.185 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 354' ' ' VAL . . . . . 0.4 HG23 ' CZ2' ' S' ' 359' ' ' TRP . 56.6 t -75.94 118.49 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.351 -0.843 . . . . 34.27 110.008 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' S' S ' 355' ' ' THR . . . . . 0.442 HG23 ' HB2' ' S' ' 360' ' ' TYR . 52.5 p -117.86 175.1 5.82 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.196 -0.94 . . . . 25.49 110.327 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' S' S ' 356' ' ' SER . . . . . . . . . . . . . 62.9 p -62.09 -17.75 58.59 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.474 -0.766 . . . . 31.24 110.749 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 357' ' ' ASN . . . . . . . . . . . . . 46.2 m-20 -106.96 14.21 26.74 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.143 -0.973 . . . . 28.61 110.564 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 358' ' ' GLY . . . . . . . . . . . . . . . 111.85 -152.93 17.58 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.979 -1.248 . . . . 22.01 109.979 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 359' ' ' TRP . . . . . 0.4 ' CZ2' HG23 ' S' ' 354' ' ' VAL . 15.1 m95 -91.44 116.76 29.11 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.387 -1.067 . . . . 25.54 110.138 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' S' S ' 360' ' ' TYR . . . . . 0.442 ' HB2' HG23 ' S' ' 355' ' ' THR . 1.3 m-85 -103.49 165.83 10.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.318 -0.864 . . . . 40.53 110.108 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' S' S ' 361' ' ' ALA . . . . . . . . . . . . . . . -140.07 130.09 24.86 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.39 -0.819 . . . . 18.04 110.262 -179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 362' ' ' ILE . . . . . 0.419 HG23 ' CZ ' ' S' ' 367' ' ' PHE . 89.0 mt -95.7 83.83 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.307 -0.871 . . . . 15.64 109.984 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' S' S ' 363' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' S' ' 365' ' ' GLU . 11.9 t0 -75.37 94.51 3.07 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.352 -0.843 . . . . 35.03 110.16 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' S' S ' 364' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 54.0 -89.44 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.468 -0.77 . . . . 46.72 110.45 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 365' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' S' ' 363' ' ' ASP . 23.8 mt-10 -122.55 18.99 10.44 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.077 -1.014 . . . . 56.2 110.218 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' S' S ' 366' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -117.82 124.98 49.7 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.303 -0.873 . . . . 51.02 110.418 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 367' ' ' PHE . . . . . 0.419 ' CZ ' HG23 ' S' ' 362' ' ' ILE . 26.9 m-85 -106.98 127.08 53.13 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.361 -0.837 . . . . 37.59 110.133 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' S' S ' 368' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -165.47 159.61 13.85 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.303 -0.873 . . . . 31.47 110.437 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 369' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.83 139.57 30.66 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 O-C-N 123.864 1.455 . . . . 28.85 110.536 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 370' ' ' TRP . . . . . . . . . . . . . 67.5 t90 -167.23 113.6 0.76 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.376 -0.827 . . . . 26.94 109.957 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 371' ' ' THR . . . . . . . . . . . . . 59.5 m -74.83 113.04 20.6 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.411 -0.805 . . . . 20.19 110.059 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 372' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -73.46 157.16 49.53 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 O-C-N 123.548 1.288 . . . . 28.68 110.613 -179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 373' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -90.57 147.12 35.68 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.449 -0.782 . . . . 35.72 109.896 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 374' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -76.02 -6.38 17.3 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.669 1.352 . . . . 30.89 110.474 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 375' ' ' SER . . . . . . . . . . . . . 68.5 p -104.32 -16.88 15.02 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.289 -0.882 . . . . 29.41 110.498 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 376' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -106.53 43.09 1.18 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.222 -0.924 . . . . 32.89 110.227 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 377' ' ' VAL . . . . . 0.5 HG23 ' CE1' ' S' ' 342' ' ' PHE . 7.2 p -114.68 147.31 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.343 -0.848 . . . . 24.33 110.228 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' S' S ' 378' ' ' LEU . . . . . . . . . . . . . 51.7 mt -116.03 -58.0 2.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.401 -0.812 . . . . 24.37 109.626 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 379' ' ' VAL . . . . . 0.405 ' O ' ' CA ' ' S' ' 340' ' ' GLY . 61.4 t -120.69 132.37 70.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.39 -0.819 . . . . 18.02 109.357 179.316 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' S' S ' 380' ' ' PHE . . . . . 0.457 ' CZ ' ' HE1' ' S' ' 332' ' ' MET . 14.5 p90 -142.54 174.03 11.0 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.367 -0.833 . . . . 29.35 110.646 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' S' S ' 381' ' ' VAL . . . . . . . . . . . . . 57.8 t -120.09 107.39 39.74 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.51 -0.744 . . . . 16.34 109.394 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 382' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.42 145.65 48.34 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 O-C-N 123.608 1.32 . . . . 20.94 110.775 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 383' ' ' TYR . . . . . 0.401 ' CZ ' ' HB3' ' S' ' 338' ' ' HIS . 88.1 m-85 -61.05 -53.54 55.86 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.335 -0.853 . . . . 28.93 109.823 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' S' S ' 384' ' ' ASP . . . . . 0.405 ' C ' ' H ' ' S' ' 386' ' ' GLU . 4.2 m-20 -99.9 127.92 46.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.361 -0.837 . . . . 47.03 110.408 -176.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' S' S ' 385' ' ' GLN . . . . . 0.413 ' O ' ' O ' ' S' ' 386' ' ' GLU . 6.5 mm-40 -68.96 3.2 2.13 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.485 -0.759 . . . . 46.69 110.165 177.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' S' S ' 386' ' ' GLU . . . . . 1.046 ' O ' ' HG2' ' S' ' 321' ' ' PRO . 0.4 OUTLIER -47.24 170.7 0.08 OUTLIER Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.355 -0.841 . . . . 50.25 109.557 179.556 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' S' S ' 387' ' ' PRO . . . . . 0.55 ' O ' ' C ' ' S' ' 388' ' ' LEU . 49.1 Cg_endo -70.99 -9.76 26.29 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 O-C-N 123.593 1.312 . . . . 34.39 110.637 -178.031 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' S' S ' 388' ' ' LEU . . . . . 0.581 ' O ' ' HB2' ' S' ' 389' ' ' ASN . 83.5 mt 31.66 84.32 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.466 -0.771 . . . . 38.01 110.151 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' S' S ' 389' ' ' ASN . . . . . 0.581 ' HB2' ' O ' ' S' ' 388' ' ' LEU . 24.9 m-20 68.72 171.08 0.29 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.297 -0.877 . . . . 45.82 110.152 -178.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' S' S ' 390' ' ' GLY . . . . . 0.592 ' O ' ' HB2' ' S' ' 391' ' ' GLU . . . 149.16 -76.87 0.24 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.636 -1.386 . . . . 33.46 109.636 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' S' S ' 391' ' ' GLU . . . . . 0.592 ' HB2' ' O ' ' S' ' 390' ' ' GLY . 6.9 mt-10 62.83 -63.19 0.11 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.374 -1.074 . . . . 56.58 110.176 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' S' S ' 392' ' ' TRP . . . . . 0.586 ' N ' ' O ' ' S' ' 390' ' ' GLY . 0.0 OUTLIER -50.68 -23.86 2.94 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.345 -0.847 . . . . 31.43 110.366 179.709 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' S' S ' 393' ' ' LYS . . . . . 0.495 ' O ' HG21 ' S' ' 396' ' ' VAL . 0.1 OUTLIER -51.29 -41.91 60.79 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.299 -0.876 . . . . 39.42 110.39 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' S' S ' 394' ' ' ALA . . . . . . . . . . . . . . . -79.37 -19.44 50.18 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.288 -0.883 . . . . 34.33 110.125 178.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' S' S ' 395' ' ' LYS . . . . . 0.718 ' HB3' HD12 ' R' ' 143' ' ' LEU . 11.6 mmmt -68.36 -51.21 46.88 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.444 -0.785 . . . . 60.09 110.285 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' S' S ' 396' ' ' VAL . . . . . 0.643 ' CG2' ' H ' ' S' ' 397' ' ' GLN . 8.9 m -53.86 -68.17 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.286 -0.884 . . . . 35.5 110.539 179.377 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' S' S ' 397' ' ' GLN . . . . . 0.643 ' H ' ' CG2' ' S' ' 396' ' ' VAL . 0.8 OUTLIER -70.26 60.77 0.2 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.15 -0.969 . . . . 49.96 110.596 178.915 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' S' S ' 398' ' ' ARG . . . . . 0.726 ' HG2' ' N ' ' S' ' 399' ' ' LYS . 0.0 OUTLIER -78.91 -38.79 36.5 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.325 -0.859 . . . . 43.42 110.716 -177.964 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' S' S ' 399' ' ' LYS . . . . . 0.726 ' N ' ' HG2' ' S' ' 398' ' ' ARG . 57.2 tttt 59.46 100.65 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.389 -0.819 . . . . 55.31 110.03 -178.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' S' S ' 400' ' ' LEU . . . . . 0.682 ' HB2' ' CB ' ' R' ' 51' ' ' ALA . 0.2 OUTLIER -45.11 -40.26 6.75 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.346 -0.846 . . . . 41.03 110.258 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' S' S ' 401' ' ' LYS . . . . . 0.436 ' CA ' ' OD1' ' R' ' 49' ' ' ASP . 15.0 tttt . . . . . 0 N--CA 1.492 1.666 0 O-C-N 121.382 -0.824 . . . . 61.97 110.208 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 29' ' ' MET . . . . . 0.458 ' HG3' ' N ' ' R' ' 30' ' ' GLU . 21.8 ptt? . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.174 0.511 . . . . 32.14 110.259 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 30' ' ' GLU . . . . . 0.458 ' N ' ' HG3' ' R' ' 29' ' ' MET . 41.7 tt0 -96.36 141.15 30.02 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.37 -0.831 . . . . 43.36 110.202 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' R' R ' 31' ' ' LEU . . . . . . . . . . . . . 65.3 mt -134.9 140.53 45.84 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.312 -0.867 . . . . 22.93 110.318 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 32' ' ' THR . . . . . . . . . . . . . 68.3 m -87.46 110.59 20.41 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.4 -0.812 . . . . 22.34 109.986 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 33' ' ' LEU . . . . . 0.462 HD23 ' CE2' ' R' ' 62' ' ' TYR . 80.2 mt -62.46 -172.76 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.33 -0.856 . . . . 21.39 110.148 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' R' R ' 34' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -74.68 -29.4 61.21 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.333 -0.855 . . . . 34.4 110.328 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 35' ' ' ASN . . . . . . . . . . . . . 48.4 p30 -77.7 -1.89 33.41 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.324 -0.86 . . . . 30.28 110.686 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.2 -16.55 59.46 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.776 -1.329 . . . . 36.25 109.776 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 37' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -59.04 161.81 4.79 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.322 -1.105 . . . . 53.8 110.368 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 38' ' ' LYS . . . . . . . . . . . . . 56.9 mttt -117.86 135.76 53.88 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.445 -0.784 . . . . 49.91 110.146 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 39' ' ' LYS . . . . . 0.415 ' HG2' ' CZ ' ' R' ' 41' ' ' PHE . 8.0 ttmt -138.69 143.71 39.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.388 -0.82 . . . . 35.69 110.27 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' R' R ' 40' ' ' THR . . . . . . . . . . . . . 23.6 m -102.6 127.94 49.48 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.387 -0.82 . . . . 34.84 110.223 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 41' ' ' PHE . . . . . 0.415 ' CZ ' ' HG2' ' R' ' 39' ' ' LYS . 96.6 m-85 -113.06 132.62 55.33 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.426 -0.796 . . . . 34.42 110.14 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' R' R ' 42' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -93.28 140.97 28.96 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.335 -0.853 . . . . 51.46 110.264 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 43' ' ' SER . . . . . . . . . . . . . 54.8 m -70.9 141.92 51.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.445 -0.784 . . . . 41.84 110.202 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.77 125.46 29.45 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.311 -0.868 . . . . 33.82 109.932 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' R' R ' 45' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.17 151.01 54.59 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 O-C-N 123.616 1.324 . . . . 30.27 110.646 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 46' ' ' ASN . . . . . . . . . . . . . 52.2 t-20 -124.21 109.9 13.98 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.545 -0.722 . . . . 35.1 110.088 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 47' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -120.25 -34.92 3.55 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.335 -0.853 . . . . 42.81 110.542 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 48' ' ' HIS . . . . . . . . . . . . . 73.3 m80 -105.74 45.15 0.98 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.322 -0.861 . . . . 49.97 110.223 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 49' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 50.28 34.71 9.23 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.358 -0.839 . . . . 61.32 110.173 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 50' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -86.26 43.77 1.09 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.402 -0.811 . . . . 51.5 110.685 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 51' ' ' ALA . . . . . 0.704 ' HB1' ' C ' ' S' ' 401' ' ' LYS . . . -66.12 -46.06 78.87 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.131 -0.981 . . . . 38.77 109.53 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' R' R ' 52' ' ' TRP . . . . . 0.484 ' CD2' ' N ' ' R' ' 53' ' ' LEU . 68.3 p-90 -58.43 -38.37 77.32 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.519 -0.738 . . . . 26.24 110.098 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' R' R ' 53' ' ' LEU . . . . . 0.484 ' N ' ' CD2' ' R' ' 52' ' ' TRP . 23.0 tp -66.63 -46.75 74.79 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.4 -0.813 . . . . 26.75 110.016 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' R' R ' 54' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -55.27 -41.57 72.4 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.341 -0.85 . . . . 35.02 110.078 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.19 -46.03 92.14 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.426 -0.796 . . . . 24.47 110.219 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 56' ' ' ILE . . . . . . . . . . . . . 76.3 mt -62.15 -42.31 94.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.246 -0.909 . . . . 26.03 109.907 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 57' ' ' LEU . . . . . . . . . . . . . 22.3 mt -60.27 -45.68 92.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.4 -0.813 . . . . 26.77 109.661 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 58' ' ' GLN . . . . . . . . . . . . . 57.7 mm-40 -63.87 -46.51 84.64 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.525 -0.734 . . . . 22.32 109.622 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 59' ' ' LEU . . . . . 0.429 ' HA ' ' HE2' ' R' ' 151' ' ' PHE . 24.0 tp -61.45 -37.74 84.64 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.334 -0.854 . . . . 20.55 109.404 179.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' R' R ' 60' ' ' PHE . . . . . 0.447 ' CE2' HD22 ' R' ' 111' ' ' LEU . 2.8 m-85 -61.13 -44.75 96.85 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.631 -0.668 . . . . 20.08 109.866 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' R' R ' 61' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -63.08 -36.19 82.78 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.492 -0.755 . . . . 18.8 110.511 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 62' ' ' TYR . . . . . 0.462 ' CE2' HD23 ' R' ' 33' ' ' LEU . 9.2 t80 -63.14 -41.7 99.33 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.226 -0.921 . . . . 26.45 110.218 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' R' R ' 63' ' ' VAL . . . . . . . . . . . . . 30.2 m -93.36 20.27 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.289 -0.882 . . . . 29.75 110.232 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 64' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 52.91 75.61 0.23 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.343 -0.848 . . . . 35.52 110.549 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 65' ' ' GLU . . . . . 0.425 ' HG2' ' CD2' ' R' ' 60' ' ' PHE . 14.2 tp10 -116.3 104.1 52.28 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.44 -0.787 . . . . 29.89 109.9 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' R' R ' 66' ' ' PRO . . . . . 0.4 ' HA ' ' HB2' ' R' ' 69' ' ' ASP . 47.4 Cg_endo -73.55 -5.83 17.74 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.79 1.416 . . . . 21.37 111.07 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' R' R ' 67' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -52.11 -61.56 2.19 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.099 -1.0 . . . . 23.85 110.331 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' R' R ' 68' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -98.12 36.52 1.56 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.275 -0.891 . . . . 28.07 110.442 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 69' ' ' ASP . . . . . 0.4 ' HB2' ' HA ' ' R' ' 66' ' ' PRO . 11.8 t0 -72.3 -33.29 67.3 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.303 -0.873 . . . . 43.76 110.169 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' R' R ' 70' ' ' TRP . . . . . 0.476 ' CE2' ' CG2' ' R' ' 71' ' ' VAL . 47.9 p-90 -73.32 -3.91 29.99 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.34 -0.85 . . . . 33.06 110.739 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' R' R ' 71' ' ' VAL . . . . . 0.476 ' CG2' ' CE2' ' R' ' 70' ' ' TRP . 40.7 t -109.78 -27.49 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.237 -0.914 . . . . 31.7 109.658 179.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' R' R ' 72' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -86.55 -48.87 7.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.407 -0.808 . . . . 33.58 110.267 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 73' ' ' SER . . . . . . . . . . . . . 70.1 m -89.73 51.01 1.99 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.29 -0.881 . . . . 50.82 110.362 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 74' ' ' SER . . . . . . . . . . . . . 15.8 t -125.89 138.37 31.92 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.303 -0.873 . . . . 34.74 110.206 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.38 -24.99 15.89 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 O-C-N 123.669 1.352 . . . . 35.7 110.32 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 76' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -91.7 153.16 19.85 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.422 -0.799 . . . . 66.48 110.342 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 77' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -81.47 95.23 7.03 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.374 -0.829 . . . . 46.72 110.061 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 78' ' ' LEU . . . . . . . . . . . . . 96.3 mt -96.46 27.97 3.55 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.473 -0.767 . . . . 37.55 110.191 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 79' ' ' THR . . . . . . . . . . . . . 29.8 m -56.31 -54.5 44.72 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.26 -0.9 . . . . 37.36 110.283 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 80' ' ' LEU . . . . . . . . . . . . . 15.9 mt -61.04 -23.09 65.17 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.439 -0.788 . . . . 35.83 110.513 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 81' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -79.48 -39.21 32.69 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.162 -0.961 . . . . 44.03 110.349 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.4 -28.64 66.34 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.315 -0.866 . . . . 32.54 110.278 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 83' ' ' ILE . . . . . . . . . . . . . 78.2 mt -70.11 -46.09 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.307 -0.87 . . . . 32.02 110.265 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 84' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -55.19 -52.07 64.51 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.222 -0.924 . . . . 34.09 110.596 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 85' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -54.81 -46.89 74.59 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.279 -0.888 . . . . 25.94 110.299 -179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 86' ' ' LEU . . . . . . . . . . . . . 24.0 mt -58.6 -43.85 89.67 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.339 -0.851 . . . . 16.2 109.936 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 87' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -65.37 -35.17 80.15 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.435 -0.791 . . . . 49.09 110.304 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 88' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -78.47 -19.03 53.99 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.257 -0.902 . . . . 28.61 110.556 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 89' ' ' LEU . . . . . . . . . . . . . 32.5 mt -96.18 -29.41 14.07 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.207 -0.933 . . . . 26.16 110.197 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 90' ' ' THR . . . . . . . . . . . . . 59.0 p -105.7 -34.55 7.67 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.303 -0.873 . . . . 33.33 109.778 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.78 16.02 58.81 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.857 -1.297 . . . . 31.13 109.857 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 92' ' ' LEU . . . . . . . . . . . . . 97.0 mt -100.04 155.24 17.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.153 -1.204 . . . . 42.52 110.229 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 93' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -86.28 91.63 8.54 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.538 -0.726 . . . . 68.46 109.991 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 94' ' ' LEU . . . . . 0.447 ' HB3' ' CZ2' ' R' ' 52' ' ' TRP . 48.2 mt -99.47 52.99 0.94 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.183 -0.948 . . . . 44.63 110.282 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' R' R ' 95' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.48 -38.67 6.38 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.263 -0.898 . . . . 67.16 110.381 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' R' R ' 96' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -113.91 44.25 1.68 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.364 -0.835 . . . . 67.02 110.278 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 97' ' ' GLY . . . . . . . . . . . . . . . 99.12 150.77 26.02 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.653 -1.379 . . . . 49.48 109.653 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 98' ' ' GLY . . . . . 0.71 ' O ' ' HD3' ' S' ' 401' ' ' LYS . . . -166.28 159.99 33.42 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.329 -1.508 . . . . 36.57 109.329 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' R' R ' 99' ' ' PRO . . . . . 0.601 ' HA ' ' O ' ' S' ' 396' ' ' VAL . 44.6 Cg_endo -72.55 121.11 7.15 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 123.732 1.385 . . . . 30.41 110.413 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' R' R ' 100' ' ' PRO . . . . . 0.446 ' HD3' ' NZ ' ' S' ' 401' ' ' LYS . 45.4 Cg_endo -72.39 -31.5 11.31 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 O-C-N 123.621 1.327 . . . . 29.94 110.514 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' R' R ' 101' ' ' ALA . . . . . . . . . . . . . . . -70.05 -38.45 75.81 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.293 -0.879 . . . . 23.64 110.294 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.6 -40.69 66.32 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.353 -0.842 . . . . 20.31 110.446 -179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' R' R ' 103' ' ' VAL . . . . . . . . . . . . . 63.7 t -58.19 -40.08 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.225 -0.922 . . . . 16.33 109.986 179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 104' ' ' ILE . . . . . . . . . . . . . 81.8 mt -71.71 -30.54 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.427 -0.796 . . . . 24.77 109.968 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 105' ' ' TRP . . . . . 0.44 ' O ' ' HD3' ' R' ' 108' ' ' LYS . 70.5 t-105 -82.43 0.89 40.08 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.277 -0.89 . . . . 23.28 110.26 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' R' R ' 106' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -105.11 -10.45 17.14 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.173 -0.954 . . . . 28.26 110.03 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 107' ' ' ILE . . . . . . . . . . . . . 36.8 pt -126.85 34.98 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.184 -0.947 . . . . 18.77 110.026 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 108' ' ' LYS . . . . . 0.481 ' HG2' ' HB ' ' R' ' 115' ' ' ILE . 9.3 mtpp -61.02 -48.49 81.57 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.493 -0.755 . . . . 42.5 110.031 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' R' R ' 109' ' ' HIS . . . . . 0.432 ' CD2' ' HG ' ' R' ' 110' ' ' LEU . 50.7 p-80 -66.02 -12.87 58.26 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.511 -0.743 . . . . 20.07 110.698 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' R' R ' 110' ' ' LEU . . . . . 0.432 ' HG ' ' CD2' ' R' ' 109' ' ' HIS . 80.1 mt -94.72 -17.38 22.26 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.071 -1.018 . . . . 15.69 110.183 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' R' R ' 111' ' ' LEU . . . . . 0.447 HD22 ' CE2' ' R' ' 60' ' ' PHE . 10.4 mt -94.05 144.12 25.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.324 -0.86 . . . . 25.39 111.052 -179.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' R' R ' 112' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -77.67 -17.43 57.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.518 -0.739 . . . . 53.48 109.84 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 113' ' ' THR . . . . . 0.418 HG22 ' HG2' ' R' ' 123' ' ' GLU . 60.2 m -83.69 166.62 17.94 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.282 -0.886 . . . . 14.8 110.186 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' R' R ' 114' ' ' GLY . . . . . . . . . . . . . . . -97.99 127.12 9.12 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.968 -1.253 . . . . 16.14 109.968 -179.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 115' ' ' ILE . . . . . 0.481 ' HB ' ' HG2' ' R' ' 108' ' ' LYS . 47.8 mm -109.07 139.32 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.534 -0.98 . . . . 13.46 109.71 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' R' R ' 116' ' ' GLY . . . . . . . . . . . . . . . -152.76 -155.78 7.26 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.926 -1.27 . . . . 23.9 109.926 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 117' ' ' THR . . . . . . . . . . . . . 18.7 p -135.06 -171.4 2.79 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.418 -1.048 . . . . 27.37 110.095 -179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.59 -58.05 9.73 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.276 -0.89 . . . . 18.76 110.057 179.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 119' ' ' SER . . . . . 0.55 ' HA ' ' CB ' ' R' ' 194' ' ' ALA . 1.1 m -56.59 -40.53 75.43 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.332 -0.855 . . . . 32.35 109.784 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' R' R ' 120' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 -110.12 86.3 4.97 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.435 -0.791 . . . . 27.12 109.675 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 121' ' ' PRO . . . . . 0.427 ' O ' ' HB2' ' R' ' 122' ' ' SER . 44.7 Cg_endo -71.26 166.51 29.03 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.874 1.46 . . . . 22.68 111.035 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' R' R ' 122' ' ' SER . . . . . 0.427 ' HB2' ' O ' ' R' ' 121' ' ' PRO . 38.4 t 178.57 -161.69 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.584 -0.698 . . . . 22.99 109.436 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' R' R ' 123' ' ' GLU . . . . . 0.418 ' HG2' HG22 ' R' ' 113' ' ' THR . 2.3 tp10 -56.42 -39.94 73.89 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.225 -0.922 . . . . 36.18 109.732 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' R' R ' 124' ' ' VAL . . . . . . . . . . . . . 84.1 t -142.55 136.42 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.484 -0.76 . . . . 20.64 109.314 179.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 125' ' ' CYS . . . . . 0.409 ' SG ' ' HA ' ' R' ' 121' ' ' PRO . 83.2 m -140.28 168.19 20.37 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.187 -0.946 . . . . 22.8 111.193 -179.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' R' R ' 126' ' ' VAL . . . . . . . . . . . . . 35.9 m -122.78 159.83 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.828 -0.545 . . . . 21.24 109.647 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 127' ' ' VAL . . . . . 0.401 ' CG1' ' O ' ' R' ' 177' ' ' VAL . 30.5 m -70.86 141.83 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.337 -0.852 . . . . 19.77 110.695 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' R' R ' 128' ' ' ASP . . . . . . . . . . . . . 53.9 p-10 -137.7 19.44 2.87 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.319 -0.863 . . . . 29.21 110.665 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 129' ' ' GLY . . . . . . . . . . . . . . . 113.97 0.06 24.18 Favored Glycine 0 N--CA 1.492 2.399 0 C-N-CA 119.993 -1.098 . . . . 33.86 110.487 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 130' ' ' THR . . . . . . . . . . . . . 58.9 m -91.9 131.85 36.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.202 -1.176 . . . . 26.41 109.998 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -62.53 120.72 11.66 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.408 -0.808 . . . . 33.08 110.284 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 132' ' ' MET . . . . . 0.427 ' HE1' ' CZ ' ' R' ' 180' ' ' PHE . 98.4 mmm -105.22 165.67 10.94 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.425 -0.797 . . . . 30.76 110.445 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' R' R ' 133' ' ' CYS . . . . . . . . . . . . . 31.7 m -141.17 158.21 44.21 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.493 -0.754 . . . . 27.0 109.912 179.839 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 134' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.48 -19.8 40.09 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.362 -0.836 . . . . 33.9 110.407 -179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' R' R ' 135' ' ' ALA . . . . . . . . . . . . . . . -92.74 8.14 40.57 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.282 -0.887 . . . . 19.37 110.78 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 136' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -93.71 -21.72 19.17 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.255 -0.903 . . . . 30.47 110.272 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 137' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -149.98 165.42 32.74 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.314 -0.866 . . . . 24.27 110.189 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 138' ' ' HIS . . . . . . . . . . . . . 15.2 p80 -117.86 15.11 14.35 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.398 -0.814 . . . . 20.91 110.459 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 139' ' ' ALA . . . . . 0.442 ' HA ' ' O ' ' R' ' 152' ' ' ALA . . . -177.14 152.44 0.89 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.278 -0.889 . . . . 15.69 110.098 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' R' R ' 140' ' ' GLY . . . . . 0.404 ' HA3' ' O ' ' R' ' 179' ' ' VAL . . . 161.8 175.15 32.52 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.998 -1.241 . . . . 23.76 109.998 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' R' R ' 141' ' ' ILE . . . . . . . . . . . . . 83.5 mt -95.49 136.54 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.514 -0.992 . . . . 25.3 109.718 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 142' ' ' PHE . . . . . 0.547 ' CD2' ' HB2' ' R' ' 172' ' ' PRO . 82.6 m-85 -120.7 -172.58 2.41 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.26 -0.9 . . . . 30.24 110.511 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' R' R ' 143' ' ' LEU . . . . . 0.662 ' CD1' ' HB3' ' S' ' 395' ' ' LYS . 0.5 OUTLIER -119.79 77.71 1.26 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.437 -0.789 . . . . 32.8 110.321 -179.908 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' R' R ' 144' ' ' LYS . . . . . 0.453 ' HG3' ' CZ2' ' R' ' 170' ' ' TRP . 1.0 OUTLIER -69.58 76.86 0.42 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.369 -0.832 . . . . 49.18 109.625 179.626 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' R' R ' 145' ' ' GLY . . . . . . . . . . . . . . . 104.55 179.31 24.76 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.174 -1.571 . . . . 53.87 109.174 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 146' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -88.53 145.85 25.5 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.253 -1.145 . . . . 68.58 110.023 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 147' ' ' GLU . . . . . 0.874 ' HA ' ' CB ' ' S' ' 398' ' ' ARG . 10.9 mt-10 58.17 36.57 25.92 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.288 -0.883 . . . . 56.62 110.633 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' R' R ' 148' ' ' HIS . . . . . 0.46 ' N ' ' NH1' ' S' ' 398' ' ' ARG . 45.0 t60 -158.67 148.12 19.17 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.229 -0.92 . . . . 44.57 110.372 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' R' R ' 149' ' ' ALA . . . . . . . . . . . . . . . -150.27 146.89 27.06 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.45 -0.781 . . . . 33.54 110.091 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 150' ' ' VAL . . . . . 0.428 HG23 ' HB2' ' R' ' 144' ' ' LYS . 34.2 m -142.34 161.5 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.273 -0.892 . . . . 27.61 110.318 179.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' R' R ' 151' ' ' PHE . . . . . 0.538 ' CD1' ' N ' ' R' ' 152' ' ' ALA . 5.9 t80 -86.19 155.62 20.66 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.41 -0.806 . . . . 23.04 109.867 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' R' R ' 152' ' ' ALA . . . . . 0.538 ' N ' ' CD1' ' R' ' 151' ' ' PHE . . . -157.28 151.51 24.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.409 -0.807 . . . . 29.61 109.612 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' R' R ' 153' ' ' CYS . . . . . 0.405 ' HA ' ' HA ' ' R' ' 139' ' ' ALA . 26.7 p -154.29 173.62 15.92 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.227 -0.921 . . . . 22.75 110.507 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' R' R ' 154' ' ' VAL . . . . . 0.443 ' CG2' ' CZ2' ' R' ' 159' ' ' TRP . 59.7 t -90.64 117.03 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.322 -0.861 . . . . 23.26 110.042 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' R' R ' 155' ' ' THR . . . . . . . . . . . . . 70.5 p -112.17 -176.66 2.98 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.361 -0.837 . . . . 17.88 110.025 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 156' ' ' SER . . . . . . . . . . . . . 78.6 p -75.96 -3.66 36.78 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.32 -0.863 . . . . 21.83 110.707 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 157' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -118.27 10.38 12.81 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.159 -0.963 . . . . 36.54 110.635 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 158' ' ' GLY . . . . . . . . . . . . . . . 117.94 -162.68 13.02 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.556 -1.417 . . . . 31.74 109.556 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 159' ' ' TRP . . . . . 0.443 ' CZ2' ' CG2' ' R' ' 154' ' ' VAL . 14.7 m95 -86.56 122.44 30.49 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.389 -1.065 . . . . 28.25 110.147 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' R' R ' 160' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -108.47 167.03 10.33 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.404 -0.81 . . . . 41.24 110.175 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 161' ' ' ALA . . . . . . . . . . . . . . . -143.23 123.48 13.77 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.344 -0.847 . . . . 27.4 110.173 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 162' ' ' ILE . . . . . 0.431 HG23 ' CZ ' ' R' ' 167' ' ' PHE . 92.0 mt -87.62 81.13 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.343 -0.848 . . . . 24.27 110.101 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' R' R ' 163' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' R' ' 165' ' ' GLU . 15.3 t0 -72.84 92.42 1.59 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.518 -0.739 . . . . 36.08 110.254 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' R' R ' 164' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 54.15 -89.0 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.463 -0.773 . . . . 46.08 110.574 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 165' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' R' ' 163' ' ' ASP . 29.7 mt-10 -124.76 36.03 4.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.088 -1.007 . . . . 50.94 110.192 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' R' R ' 166' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -135.82 117.23 14.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.4 -0.812 . . . . 47.28 110.34 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 167' ' ' PHE . . . . . 0.431 ' CZ ' HG23 ' R' ' 162' ' ' ILE . 24.4 m-85 -100.94 119.96 39.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.457 -0.777 . . . . 40.47 110.172 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' R' R ' 168' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -157.6 158.54 30.61 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.213 -0.929 . . . . 30.21 110.399 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 169' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.81 132.99 19.36 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.931 1.49 . . . . 32.76 110.505 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 170' ' ' TRP . . . . . 0.453 ' CZ2' ' HG3' ' R' ' 144' ' ' LYS . 66.9 t90 -159.78 119.37 2.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.383 -0.823 . . . . 32.79 109.909 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' R' R ' 171' ' ' THR . . . . . . . . . . . . . 46.9 m -81.1 112.58 33.94 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.471 -0.768 . . . . 36.92 110.197 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 172' ' ' PRO . . . . . 0.547 ' HB2' ' CD2' ' R' ' 142' ' ' PHE . 46.5 Cg_endo -73.69 158.87 46.6 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.634 1.334 . . . . 33.54 110.504 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' R' R ' 173' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -88.93 144.97 33.67 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.358 -0.839 . . . . 45.76 109.882 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 174' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -71.71 -10.41 26.47 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.614 1.323 . . . . 29.63 110.507 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 175' ' ' SER . . . . . . . . . . . . . 53.0 p -103.44 -17.55 15.19 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.293 -0.88 . . . . 35.7 110.37 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 176' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -103.56 43.32 1.09 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.25 -0.906 . . . . 39.65 110.379 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 177' ' ' VAL . . . . . 0.401 ' O ' ' CG1' ' R' ' 127' ' ' VAL . 10.4 p -117.86 127.08 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.324 -0.86 . . . . 20.61 110.07 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' R' R ' 178' ' ' LEU . . . . . . . . . . . . . 45.6 mt -91.45 -61.31 1.68 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.361 -0.837 . . . . 15.58 109.395 179.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 179' ' ' VAL . . . . . 0.404 ' O ' ' HA3' ' R' ' 140' ' ' GLY . 68.3 t -114.59 144.78 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.621 -0.674 . . . . 17.4 109.409 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' R' R ' 180' ' ' PHE . . . . . 0.427 ' CZ ' ' HE1' ' R' ' 132' ' ' MET . 43.5 p90 -152.21 163.34 39.6 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.328 -0.858 . . . . 20.16 110.474 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' R' R ' 181' ' ' VAL . . . . . . . . . . . . . 66.3 t -113.16 111.48 50.29 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.467 -0.771 . . . . 17.69 109.833 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 182' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.03 149.52 52.9 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.532 1.28 . . . . 17.81 110.423 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 183' ' ' TYR . . . . . 0.739 ' O ' ' C ' ' R' ' 184' ' ' ASP . 79.0 m-85 -59.03 175.47 0.28 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.43 -0.794 . . . . 28.01 110.539 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' R' R ' 184' ' ' ASP . . . . . 0.739 ' C ' ' O ' ' R' ' 183' ' ' TYR . 1.0 OUTLIER -11.78 -75.82 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.452 -0.78 . . . . 58.64 110.296 -177.936 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' R' R ' 185' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 . . . . . 0 N--CA 1.503 2.177 0 CA-C-O 121.247 0.546 . . . . 80.42 111.757 179.236 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' R' R ' 193' ' ' LYS . . . . . . . . . . . . . 14.3 ptmt . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 120.895 0.379 . . . . 49.5 110.179 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' R' R ' 194' ' ' ALA . . . . . 0.55 ' CB ' ' HA ' ' R' ' 119' ' ' SER . . . -174.7 -148.0 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.141 -0.975 . . . . 40.4 110.079 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' R' R ' 195' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -101.31 -49.95 3.91 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.455 -0.778 . . . . 34.6 110.241 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' R' R ' 196' ' ' VAL . . . . . 0.462 ' HB ' ' CB ' ' R' ' 119' ' ' SER . 47.8 t -91.96 54.0 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.288 -0.882 . . . . 33.27 110.594 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' R' R ' 197' ' ' GLN . . . . . 0.536 ' CB ' ' O ' ' R' ' 119' ' ' SER . 0.0 OUTLIER -164.06 26.16 0.07 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.146 -0.971 . . . . 41.58 110.702 179.842 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' R' R ' 198' ' ' ARG . . . . . . . . . . . . . 4.9 mtm180 -117.41 155.46 29.59 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.063 -1.023 . . . . 38.65 110.253 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 199' ' ' LYS . . . . . 0.626 ' O ' ' HD3' ' S' ' 299' ' ' PRO . 15.2 tttp -65.25 -66.94 0.48 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.387 -0.821 . . . . 36.77 109.908 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' R' R ' 200' ' ' LEU . . . . . . . . . . . . . 1.5 tp 61.22 161.67 0.06 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.444 -0.785 . . . . 33.08 110.117 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' R' R ' 201' ' ' LYS . . . . . 0.777 ' C ' ' N ' ' S' ' 298' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.386 -0.822 . . . . 44.32 110.267 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' S' S ' 229' ' ' MET . . . . . . . . . . . . . 1.5 tpt . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.226 0.536 . . . . 51.83 110.21 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' S' S ' 230' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -97.27 142.75 28.78 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.372 -0.83 . . . . 54.13 110.22 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 231' ' ' LEU . . . . . . . . . . . . . 67.9 mt -134.06 141.07 47.05 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.363 -0.836 . . . . 33.04 110.299 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 232' ' ' THR . . . . . . . . . . . . . 40.0 m -89.27 103.27 15.91 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.345 -0.847 . . . . 26.92 110.093 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 233' ' ' LEU . . . . . 0.502 HD23 ' CE2' ' S' ' 262' ' ' TYR . 79.8 mt -55.84 179.29 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.476 -0.765 . . . . 13.78 110.491 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' S' S ' 234' ' ' TYR . . . . . 0.444 ' CG ' ' N ' ' S' ' 235' ' ' ASN . 35.4 p90 -65.12 -35.61 81.67 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.354 -0.841 . . . . 26.08 110.119 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' S' S ' 235' ' ' ASN . . . . . 0.444 ' N ' ' CG ' ' S' ' 234' ' ' TYR . 50.7 p30 -74.28 -7.5 53.0 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.377 -0.827 . . . . 20.04 110.506 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' S' S ' 236' ' ' GLY . . . . . . . . . . . . . . . 95.81 -20.01 51.79 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.747 -1.341 . . . . 22.71 109.747 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 237' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -52.96 145.74 12.26 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.182 -1.187 . . . . 35.44 110.165 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 238' ' ' LYS . . . . . . . . . . . . . 44.4 mttt -102.17 127.9 48.91 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.397 -0.814 . . . . 32.56 110.374 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 239' ' ' LYS . . . . . 0.417 ' HG2' ' CZ ' ' S' ' 241' ' ' PHE . 9.0 ttmt -132.27 144.52 50.66 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.373 -0.829 . . . . 26.68 109.959 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' S' S ' 240' ' ' THR . . . . . . . . . . . . . 52.5 m -102.05 132.22 48.04 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.339 -0.851 . . . . 41.02 110.305 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 241' ' ' PHE . . . . . 0.417 ' CZ ' ' HG2' ' S' ' 239' ' ' LYS . 96.0 m-85 -117.98 137.67 52.7 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.346 -0.846 . . . . 28.62 110.169 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' S' S ' 242' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -96.36 161.78 13.78 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.451 -0.781 . . . . 47.89 110.224 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 243' ' ' SER . . . . . . . . . . . . . 72.4 m -90.65 151.52 21.24 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.333 -0.854 . . . . 45.09 110.225 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 244' ' ' ARG . . . . . . . . . . . . . 1.4 mtp85 -129.76 126.74 22.71 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.335 -0.853 . . . . 42.49 110.274 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 245' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.31 161.0 43.83 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 123.603 1.317 . . . . 35.68 110.503 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 246' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -132.89 97.88 4.15 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.323 -0.861 . . . . 51.88 109.821 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 247' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -110.47 -22.21 11.78 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.317 -0.865 . . . . 53.69 110.636 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 248' ' ' HIS . . . . . . . . . . . . . 76.5 m80 -117.26 43.75 2.26 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.235 -0.916 . . . . 55.79 110.774 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 249' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 48.8 38.36 11.72 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.459 -0.775 . . . . 49.45 110.382 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 250' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -90.62 29.05 1.37 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.462 -0.773 . . . . 36.86 110.277 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 251' ' ' ALA . . . . . . . . . . . . . . . -53.84 -43.21 69.28 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.244 -0.91 . . . . 29.69 109.577 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 252' ' ' TRP . . . . . 0.576 ' N ' ' HZ1' ' R' ' 201' ' ' LYS . 67.9 p-90 -61.77 -33.86 74.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.508 -0.745 . . . . 41.12 109.89 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' S' S ' 253' ' ' LEU . . . . . 0.407 ' N ' ' CD2' ' S' ' 252' ' ' TRP . 23.2 tp -70.12 -47.26 62.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.412 -0.805 . . . . 24.89 110.025 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' S' S ' 254' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -56.1 -42.47 76.82 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.419 -0.801 . . . . 35.65 110.03 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 255' ' ' ALA . . . . . . . . . . . . . . . -59.49 -48.25 82.37 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.438 -0.789 . . . . 22.73 110.1 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 256' ' ' ILE . . . . . . . . . . . . . 80.1 mt -62.25 -40.65 88.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.289 -0.882 . . . . 28.85 110.02 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 257' ' ' LEU . . . . . . . . . . . . . 19.1 mt -61.54 -44.53 96.87 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.365 -0.834 . . . . 23.07 110.144 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 258' ' ' GLN . . . . . 0.467 ' HB3' ' CD2' ' S' ' 351' ' ' PHE . 53.3 mm-40 -65.01 -45.39 85.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.389 -0.82 . . . . 29.78 109.92 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' S' S ' 259' ' ' LEU . . . . . 0.433 ' O ' HG22 ' S' ' 263' ' ' VAL . 19.8 tp -58.66 -36.42 74.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.43 -0.794 . . . . 17.94 109.444 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' S' S ' 260' ' ' PHE . . . . . 0.47 ' CE2' HD22 ' S' ' 311' ' ' LEU . 3.1 m-85 -62.79 -45.22 93.64 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.647 -0.658 . . . . 30.57 109.849 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' S' S ' 261' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -62.16 -29.77 70.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.509 -0.744 . . . . 41.34 109.979 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 262' ' ' TYR . . . . . 0.502 ' CE2' HD23 ' S' ' 233' ' ' LEU . 8.7 t80 -71.19 -44.71 64.92 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.433 -0.792 . . . . 26.03 110.074 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' S' S ' 263' ' ' VAL . . . . . 0.433 HG22 ' O ' ' S' ' 259' ' ' LEU . 33.1 m -92.02 18.28 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.438 -0.788 . . . . 22.8 110.355 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' S' S ' 264' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 52.7 70.76 0.54 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.287 -0.883 . . . . 44.03 110.604 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 265' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -111.84 109.22 55.33 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.295 -0.878 . . . . 35.61 109.628 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 266' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -75.33 0.4 9.08 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 123.55 1.289 . . . . 37.67 111.807 -179.126 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 267' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -56.48 -67.69 0.28 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.764 -1.21 . . . . 41.49 110.199 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' S' S ' 268' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -92.9 39.89 1.05 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.159 -0.963 . . . . 50.76 110.047 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 269' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.02 -33.29 59.67 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.426 -0.796 . . . . 61.86 109.762 179.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' S' S ' 270' ' ' TRP . . . . . 0.482 ' CE2' ' CG2' ' S' ' 271' ' ' VAL . 50.9 p-90 -73.83 -4.27 33.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.298 -0.876 . . . . 39.85 110.527 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' S' S ' 271' ' ' VAL . . . . . 0.482 ' CG2' ' CE2' ' S' ' 270' ' ' TRP . 46.4 t -109.67 -32.62 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.146 -0.971 . . . . 39.18 110.065 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' S' S ' 272' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -78.71 -36.5 43.33 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.35 -0.844 . . . . 40.02 110.524 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 273' ' ' SER . . . . . . . . . . . . . 71.2 m -103.49 56.03 0.74 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.295 -0.878 . . . . 47.2 110.369 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 274' ' ' SER . . . . . . . . . . . . . 6.9 t -133.01 141.26 40.3 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.329 -0.857 . . . . 47.61 110.113 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 275' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.77 -18.86 21.68 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 O-C-N 123.633 1.333 . . . . 45.28 110.547 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 276' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -99.96 140.85 33.58 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.327 -0.858 . . . . 57.27 110.248 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 277' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -71.76 97.69 1.82 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.396 -0.815 . . . . 37.28 110.251 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 278' ' ' LEU . . . . . . . . . . . . . 86.4 mt -96.93 33.74 1.84 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.39 -0.819 . . . . 43.88 110.037 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 279' ' ' THR . . . . . . . . . . . . . 76.3 m -64.02 -60.15 3.6 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.436 -0.79 . . . . 50.05 110.269 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 280' ' ' LEU . . . . . . . . . . . . . 13.6 mt -51.53 -39.98 58.77 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.314 -0.866 . . . . 54.12 110.241 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 281' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.27 -49.75 74.43 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.494 -0.754 . . . . 65.28 110.174 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' S' S ' 282' ' ' ALA . . . . . . . . . . . . . . . -58.95 -33.91 71.15 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.44 -0.788 . . . . 46.51 110.554 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 283' ' ' ILE . . . . . . . . . . . . . 85.6 mt -66.3 -50.88 64.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.319 -0.863 . . . . 47.3 110.125 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 284' ' ' LYS . . . . . . . . . . . . . 33.8 tttp -50.6 -57.57 7.88 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.318 -0.864 . . . . 50.72 110.344 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 285' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -51.47 -46.33 63.07 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.465 -0.772 . . . . 68.47 110.257 179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 286' ' ' LEU . . . . . . . . . . . . . 19.2 mt -60.02 -44.56 94.5 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.372 -0.83 . . . . 36.62 110.275 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 287' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -62.7 -35.22 79.0 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.289 -0.882 . . . . 46.64 110.1 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 288' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -76.31 -20.96 56.78 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.4 -0.812 . . . . 46.45 110.34 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 289' ' ' LEU . . . . . . . . . . . . . 30.7 mt -97.38 -21.69 17.05 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.302 -0.874 . . . . 35.09 110.494 -179.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 290' ' ' THR . . . . . . . . . . . . . 81.2 p -114.76 -28.49 7.08 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.325 -0.859 . . . . 38.61 110.406 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 291' ' ' GLY . . . . . . . . . . . . . . . 79.35 11.08 85.33 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.9 -1.28 . . . . 36.77 109.9 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 292' ' ' LEU . . . . . . . . . . . . . 84.7 mt -96.51 145.82 25.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.286 -1.126 . . . . 35.33 109.722 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 293' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -77.35 102.34 6.73 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.194 -0.941 . . . . 48.7 110.273 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 294' ' ' LEU . . . . . 0.418 ' HB3' ' CZ2' ' S' ' 252' ' ' TRP . 56.1 mt -106.96 51.72 0.73 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.51 -0.744 . . . . 42.61 110.085 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' S' S ' 295' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -112.43 -11.27 13.67 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.274 -0.891 . . . . 55.49 110.56 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' S' S ' 296' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -144.24 48.55 1.37 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.187 -0.946 . . . . 75.68 110.319 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 297' ' ' GLY . . . . . . . . . . . . . . . 96.88 145.18 18.72 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.505 -1.438 . . . . 49.44 109.505 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 298' ' ' GLY . . . . . 0.777 ' N ' ' C ' ' R' ' 201' ' ' LYS . . . -163.85 156.98 29.09 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.823 -1.311 . . . . 41.11 109.823 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' S' S ' 299' ' ' PRO . . . . . 0.626 ' HD3' ' O ' ' R' ' 199' ' ' LYS . 47.7 Cg_endo -73.73 118.21 5.36 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 O-C-N 123.941 1.495 . . . . 26.2 110.314 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' S' S ' 300' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.23 -15.42 31.72 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 123.538 1.283 . . . . 21.7 110.684 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 301' ' ' ALA . . . . . . . . . . . . . . . -80.73 -29.33 36.37 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.259 -0.9 . . . . 31.23 110.091 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 302' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.58 -40.57 18.91 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.512 -0.742 . . . . 38.99 109.953 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' S' S ' 303' ' ' VAL . . . . . 0.472 ' O ' HG12 ' S' ' 307' ' ' ILE . 58.5 t -60.68 -35.48 64.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.372 -0.83 . . . . 18.63 110.177 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' S' S ' 304' ' ' ILE . . . . . . . . . . . . . 86.3 mt -79.39 -23.58 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.418 -0.801 . . . . 25.46 110.177 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 305' ' ' TRP . . . . . 0.4 ' CD2' ' HD3' ' S' ' 308' ' ' LYS . 68.8 t-105 -88.67 -14.62 36.92 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.194 -0.942 . . . . 33.4 110.5 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' S' S ' 306' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -89.7 -13.57 36.6 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.237 -0.915 . . . . 36.97 110.391 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 307' ' ' ILE . . . . . 0.472 HG12 ' O ' ' S' ' 303' ' ' VAL . 36.9 pt -125.03 45.67 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.276 -0.89 . . . . 30.81 110.036 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' S' S ' 308' ' ' LYS . . . . . 0.4 ' HD3' ' CD2' ' S' ' 305' ' ' TRP . 1.5 mtmp? -73.58 -37.72 65.39 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.366 -0.834 . . . . 46.52 110.1 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' S' S ' 309' ' ' HIS . . . . . 0.49 ' CD2' ' HG ' ' S' ' 310' ' ' LEU . 55.6 p-80 -73.27 -8.2 54.79 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.333 -0.854 . . . . 51.03 110.105 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' S' S ' 310' ' ' LEU . . . . . 0.49 ' HG ' ' CD2' ' S' ' 309' ' ' HIS . 53.2 mt -99.32 -12.87 19.94 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.265 -0.897 . . . . 36.16 109.973 179.269 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' S' S ' 311' ' ' LEU . . . . . 0.47 HD22 ' CE2' ' S' ' 260' ' ' PHE . 10.8 mt -97.14 147.88 23.61 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.421 -0.8 . . . . 40.0 110.431 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' S' S ' 312' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -81.65 -16.28 51.89 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.273 -0.892 . . . . 54.18 109.69 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 313' ' ' THR . . . . . 0.478 HG23 ' HB3' ' S' ' 323' ' ' GLU . 92.8 m -87.92 151.57 22.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.329 -0.857 . . . . 25.61 110.117 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' S' S ' 314' ' ' GLY . . . . . . . . . . . . . . . -87.81 126.4 8.03 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.861 -1.296 . . . . 25.18 109.861 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 315' ' ' ILE . . . . . . . . . . . . . 50.7 mm -101.69 150.45 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.407 -1.055 . . . . 23.9 109.703 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 316' ' ' GLY . . . . . . . . . . . . . . . -157.04 -159.25 9.37 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.982 -1.247 . . . . 23.18 109.982 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 317' ' ' THR . . . . . . . . . . . . . 11.0 p -133.94 -173.04 3.14 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.446 -1.032 . . . . 27.98 109.949 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.52 -56.2 24.94 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.142 -0.974 . . . . 28.1 109.939 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 319' ' ' SER . . . . . . . . . . . . . 1.2 m -59.99 -41.62 92.43 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.405 -0.81 . . . . 37.0 109.673 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 320' ' ' ARG . . . . . . . . . . . . . 12.2 mtm180 -111.68 79.89 2.64 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.592 -0.692 . . . . 52.07 109.666 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 321' ' ' PRO . . . . . 0.731 ' CG ' ' O ' ' S' ' 386' ' ' GLU . 44.1 Cg_endo -71.31 171.52 15.93 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.876 1.461 . . . . 38.29 110.966 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' S' S ' 322' ' ' SER . . . . . 0.435 ' HB2' ' O ' ' S' ' 321' ' ' PRO . 41.3 t 178.65 -148.13 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.927 -0.768 . . . . 38.84 108.927 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' S' S ' 323' ' ' GLU . . . . . 0.478 ' HB3' HG23 ' S' ' 313' ' ' THR . 6.7 tp10 -62.84 -40.29 96.96 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.011 -1.055 . . . . 40.7 109.724 179.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' S' S ' 324' ' ' VAL . . . . . . . . . . . . . 72.9 t -141.28 135.03 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.416 -0.802 . . . . 20.34 109.456 179.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 325' ' ' CYS . . . . . 0.45 ' HB2' ' CE1' ' S' ' 380' ' ' PHE . 11.3 m -126.03 172.26 10.12 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.258 -0.901 . . . . 30.63 110.805 -179.129 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' S' S ' 326' ' ' VAL . . . . . . . . . . . . . 34.6 m -135.56 142.24 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 109.189 -0.671 . . . . 23.9 109.189 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 327' ' ' VAL . . . . . . . . . . . . . 34.5 m -56.27 124.93 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.037 -1.04 . . . . 19.48 110.437 -179.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 328' ' ' ASP . . . . . . . . . . . . . 55.6 p-10 -119.36 11.49 12.23 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.467 -0.77 . . . . 26.43 110.403 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 329' ' ' GLY . . . . . . . . . . . . . . . 119.63 2.24 13.14 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.043 -1.223 . . . . 31.24 110.043 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 330' ' ' THR . . . . . . . . . . . . . 80.9 m -93.02 129.93 38.78 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.044 -1.268 . . . . 30.05 110.111 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 331' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -56.73 111.49 1.03 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.262 -0.899 . . . . 37.26 110.02 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 332' ' ' MET . . . . . 0.452 ' HE1' ' CZ ' ' S' ' 380' ' ' PHE . 88.1 mmm -94.11 162.64 13.79 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.285 -0.884 . . . . 26.23 110.345 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' S' S ' 333' ' ' CYS . . . . . . . . . . . . . 25.3 m -137.34 150.07 47.46 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.487 -0.758 . . . . 23.56 109.96 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 334' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.58 -24.89 9.1 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.33 -0.856 . . . . 28.93 110.46 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' S' S ' 335' ' ' ALA . . . . . . . . . . . . . . . -88.99 14.44 10.57 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.302 -0.874 . . . . 15.76 110.957 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 336' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -100.48 -17.19 17.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.166 -0.959 . . . . 34.92 110.206 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 337' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -152.37 170.84 19.1 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.382 -0.824 . . . . 19.03 110.095 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 338' ' ' HIS . . . . . 0.401 ' HB3' ' CZ ' ' S' ' 383' ' ' TYR . 13.5 p80 -120.71 10.34 10.97 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.365 -0.834 . . . . 18.82 110.484 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' S' S ' 339' ' ' ALA . . . . . . . . . . . . . . . -176.01 155.17 1.55 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.289 -0.882 . . . . 17.18 110.131 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 340' ' ' GLY . . . . . . . . . . . . . . . 160.85 173.07 29.0 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.01 -1.236 . . . . 18.33 110.01 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 341' ' ' ILE . . . . . . . . . . . . . 83.7 mt -88.77 138.1 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.523 -0.986 . . . . 18.6 109.862 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 342' ' ' PHE . . . . . 0.506 ' CE1' HG23 ' S' ' 377' ' ' VAL . 70.0 m-85 -120.93 -178.48 3.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.184 -0.947 . . . . 23.44 110.447 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' S' S ' 343' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.9 93.41 4.18 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.428 -0.795 . . . . 35.59 110.06 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' S' S ' 344' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.93 125.01 29.59 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.268 -0.895 . . . . 38.34 110.054 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' S' S ' 345' ' ' GLY . . . . . . . . . . . . . . . 62.91 -130.88 42.76 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 108.821 -1.712 . . . . 53.46 108.821 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 346' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -132.73 150.85 52.11 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.214 -1.168 . . . . 70.91 110.07 179.405 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 347' ' ' GLU . . . . . 0.534 ' C ' ' HG2' ' R' ' 201' ' ' LYS . 18.0 mt-10 53.28 35.43 20.12 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.307 -0.871 . . . . 47.32 110.374 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' S' S ' 348' ' ' HIS . . . . . 0.611 ' N ' ' HG2' ' R' ' 201' ' ' LYS . 46.6 t60 -150.15 155.83 40.52 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.248 -0.908 . . . . 41.72 110.346 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' S' S ' 349' ' ' ALA . . . . . 0.427 ' N ' ' HZ3' ' R' ' 201' ' ' LYS . . . -149.74 151.28 33.36 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.33 -0.856 . . . . 22.91 110.544 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' S' S ' 350' ' ' VAL . . . . . . . . . . . . . 34.6 m -149.06 169.64 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.448 -0.782 . . . . 21.09 110.06 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 351' ' ' PHE . . . . . 0.467 ' CD2' ' HB3' ' S' ' 258' ' ' GLN . 10.8 t80 -105.4 143.62 33.32 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.26 -0.9 . . . . 25.03 110.687 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' S' S ' 352' ' ' ALA . . . . . . . . . . . . . . . -147.74 151.72 36.54 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.58 -0.7 . . . . 23.81 109.75 179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 353' ' ' CYS . . . . . . . . . . . . . 26.3 p -153.29 164.97 37.16 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.302 -0.874 . . . . 25.66 110.245 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 354' ' ' VAL . . . . . 0.406 HG23 ' CZ2' ' S' ' 359' ' ' TRP . 58.0 t -76.15 118.56 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.4 -0.812 . . . . 34.27 109.941 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' S' S ' 355' ' ' THR . . . . . 0.437 HG23 ' HB2' ' S' ' 360' ' ' TYR . 51.7 p -117.85 175.09 5.82 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.199 -0.938 . . . . 25.49 110.29 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' S' S ' 356' ' ' SER . . . . . . . . . . . . . 62.1 p -62.17 -17.65 58.65 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.465 -0.772 . . . . 31.24 110.743 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 357' ' ' ASN . . . . . . . . . . . . . 46.0 m-20 -107.02 14.2 26.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.154 -0.966 . . . . 28.61 110.611 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 358' ' ' GLY . . . . . . . . . . . . . . . 111.88 -152.88 17.6 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.997 -1.241 . . . . 22.01 109.997 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 359' ' ' TRP . . . . . 0.406 ' CZ2' HG23 ' S' ' 354' ' ' VAL . 15.5 m95 -91.36 116.64 29.0 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.33 -1.1 . . . . 25.54 110.205 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' S' S ' 360' ' ' TYR . . . . . 0.437 ' HB2' HG23 ' S' ' 355' ' ' THR . 1.3 m-85 -103.47 165.75 10.85 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.338 -0.852 . . . . 40.53 110.105 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' S' S ' 361' ' ' ALA . . . . . . . . . . . . . . . -139.97 130.08 25.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.37 -0.831 . . . . 18.04 110.333 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 362' ' ' ILE . . . . . 0.411 HG23 ' CZ ' ' S' ' 367' ' ' PHE . 88.8 mt -95.59 83.65 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.316 -0.865 . . . . 15.64 110.054 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' S' S ' 363' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' S' ' 365' ' ' GLU . 11.9 t0 -75.25 94.45 2.99 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.334 -0.854 . . . . 35.03 110.241 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' S' S ' 364' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 54.03 -89.42 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.484 -0.76 . . . . 46.72 110.547 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 365' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' S' ' 363' ' ' ASP . 23.8 mt-10 -122.6 19.06 10.4 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.048 -1.032 . . . . 56.2 110.251 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' S' S ' 366' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -118.01 125.0 49.52 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.207 -0.933 . . . . 51.02 110.308 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 367' ' ' PHE . . . . . 0.411 ' CZ ' HG23 ' S' ' 362' ' ' ILE . 27.0 m-85 -106.94 127.05 53.09 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.355 -0.841 . . . . 37.59 110.155 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' S' S ' 368' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -165.4 159.52 13.97 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.253 -0.904 . . . . 31.47 110.461 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 369' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.91 139.58 30.42 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.869 1.457 . . . . 28.85 110.495 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 370' ' ' TRP . . . . . . . . . . . . . 67.6 t90 -167.13 113.63 0.77 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.463 -0.773 . . . . 26.94 109.973 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 371' ' ' THR . . . . . . . . . . . . . 59.6 m -74.84 113.02 20.41 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.338 -0.851 . . . . 20.19 109.986 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 372' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.58 157.08 49.15 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 O-C-N 123.573 1.301 . . . . 28.68 110.546 -179.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 373' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -90.52 147.08 35.65 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.436 -0.79 . . . . 35.72 109.987 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 374' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -75.95 -6.25 17.21 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.687 1.362 . . . . 30.89 110.533 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 375' ' ' SER . . . . . . . . . . . . . 68.9 p -104.4 -16.94 14.97 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.288 -0.882 . . . . 29.41 110.484 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 376' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -106.54 43.05 1.19 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.285 -0.884 . . . . 32.89 110.257 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 377' ' ' VAL . . . . . 0.506 HG23 ' CE1' ' S' ' 342' ' ' PHE . 7.3 p -114.72 147.29 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.314 -0.866 . . . . 24.33 110.17 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' S' S ' 378' ' ' LEU . . . . . . . . . . . . . 52.1 mt -115.97 -58.02 2.15 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.386 -0.821 . . . . 24.37 109.623 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 379' ' ' VAL . . . . . . . . . . . . . 62.0 t -120.64 132.4 70.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.452 -0.78 . . . . 18.02 109.44 179.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 380' ' ' PHE . . . . . 0.452 ' CZ ' ' HE1' ' S' ' 332' ' ' MET . 14.2 p90 -142.59 173.97 11.06 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.375 -0.828 . . . . 29.35 110.665 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' S' S ' 381' ' ' VAL . . . . . . . . . . . . . 58.1 t -120.12 107.34 39.76 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.493 -0.755 . . . . 16.34 109.382 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 382' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.28 145.6 48.95 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 O-C-N 123.669 1.352 . . . . 20.94 110.79 -179.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 383' ' ' TYR . . . . . 0.401 ' CZ ' ' HB3' ' S' ' 338' ' ' HIS . 88.3 m-85 -61.05 -53.42 57.36 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.37 -0.831 . . . . 28.93 109.912 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' S' S ' 384' ' ' ASP . . . . . 0.401 ' HB3' ' HG2' ' S' ' 386' ' ' GLU . 27.4 t0 -103.63 125.91 50.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.362 -0.836 . . . . 47.03 110.358 -176.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' S' S ' 385' ' ' GLN . . . . . 0.425 ' O ' ' C ' ' S' ' 386' ' ' GLU . 49.2 mt-30 -63.42 -4.84 3.0 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.381 -0.825 . . . . 46.69 110.194 177.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' S' S ' 386' ' ' GLU . . . . . 0.731 ' O ' ' CG ' ' S' ' 321' ' ' PRO . 19.7 pt-20 -42.83 156.62 0.25 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.338 -0.851 . . . . 50.25 109.628 179.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' S' S ' 387' ' ' PRO . . . . . 0.807 ' O ' ' O ' ' S' ' 389' ' ' ASN . 47.1 Cg_endo -70.52 24.23 0.2 Allowed 'Trans proline' 0 C--N 1.31 -1.488 0 O-C-N 123.572 1.301 . . . . 34.39 110.621 -177.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' S' S ' 388' ' ' LEU . . . . . 0.771 ' C ' ' O ' ' S' ' 387' ' ' PRO . 4.4 tp 0.1 92.26 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.399 -0.813 . . . . 38.01 110.145 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' S' S ' 389' ' ' ASN . . . . . 0.807 ' O ' ' O ' ' S' ' 387' ' ' PRO . 8.3 t-20 74.73 170.59 0.29 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.302 -0.874 . . . . 45.82 110.108 -179.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' S' S ' 390' ' ' GLY . . . . . 0.504 ' O ' ' CD2' ' S' ' 392' ' ' TRP . . . 149.49 -85.08 0.16 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.687 -1.365 . . . . 33.46 109.687 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' S' S ' 391' ' ' GLU . . . . . 0.472 ' CB ' ' O ' ' S' ' 390' ' ' GLY . 4.4 tt0 69.04 -67.52 0.21 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.384 -1.068 . . . . 56.58 110.093 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' S' S ' 392' ' ' TRP . . . . . 0.504 ' CD2' ' O ' ' S' ' 390' ' ' GLY . 0.3 OUTLIER -56.85 -18.04 11.59 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.373 -0.829 . . . . 31.43 110.359 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' S' S ' 393' ' ' LYS . . . . . 0.48 ' HG3' ' H ' ' S' ' 394' ' ' ALA . 0.0 OUTLIER -51.74 -34.34 38.8 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.253 -0.904 . . . . 39.42 110.382 179.336 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' S' S ' 394' ' ' ALA . . . . . 0.48 ' H ' ' HG3' ' S' ' 393' ' ' LYS . . . -89.44 -18.57 26.5 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.307 -0.871 . . . . 34.33 110.07 178.715 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' S' S ' 395' ' ' LYS . . . . . 0.662 ' HB3' ' CD1' ' R' ' 143' ' ' LEU . 5.3 mmtt -73.86 -10.04 59.26 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.401 -0.812 . . . . 60.09 110.298 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' S' S ' 396' ' ' VAL . . . . . 0.601 ' O ' ' HA ' ' R' ' 99' ' ' PRO . 6.6 p -104.17 -27.99 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.364 -0.835 . . . . 35.5 110.598 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' S' S ' 397' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -117.51 94.71 4.65 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.23 -0.919 . . . . 49.96 110.578 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' S' S ' 398' ' ' ARG . . . . . 0.874 ' CB ' ' HA ' ' R' ' 147' ' ' GLU . 0.0 OUTLIER -124.78 -122.51 0.26 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.197 -0.939 . . . . 43.42 110.706 -179.027 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' S' S ' 399' ' ' LYS . . . . . 0.436 ' O ' ' C ' ' S' ' 400' ' ' LEU . 0.1 OUTLIER -150.8 -67.12 0.19 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.424 -0.798 . . . . 55.31 110.025 -179.62 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' S' S ' 400' ' ' LEU . . . . . 0.629 ' CB ' ' O ' ' R' ' 147' ' ' GLU . 1.0 OUTLIER -41.87 -27.26 0.11 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.322 -0.862 . . . . 41.03 110.248 -179.723 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' S' S ' 401' ' ' LYS . . . . . 0.71 ' HD3' ' O ' ' R' ' 98' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 O-C-N 121.317 -0.865 . . . . 61.97 110.231 178.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' R' R ' 29' ' ' MET . . . . . 0.435 ' HG3' ' N ' ' R' ' 30' ' ' GLU . 4.1 ptt? . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.235 0.541 . . . . 32.14 110.239 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 30' ' ' GLU . . . . . 0.435 ' N ' ' HG3' ' R' ' 29' ' ' MET . 41.7 tt0 -96.36 141.21 29.95 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.354 -0.841 . . . . 43.36 110.308 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' R' R ' 31' ' ' LEU . . . . . . . . . . . . . 65.5 mt -134.87 140.67 45.98 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.338 -0.851 . . . . 22.93 110.271 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 32' ' ' THR . . . . . . . . . . . . . 71.1 m -87.7 110.61 20.56 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.352 -0.843 . . . . 22.34 109.935 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 33' ' ' LEU . . . . . 0.461 HD23 ' CE2' ' R' ' 62' ' ' TYR . 80.1 mt -62.39 -172.78 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.274 -0.891 . . . . 21.39 110.209 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' R' R ' 34' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -74.6 -29.52 61.34 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.333 -0.855 . . . . 34.4 110.365 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 35' ' ' ASN . . . . . . . . . . . . . 48.4 p30 -77.65 -1.95 33.51 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.348 -0.845 . . . . 30.28 110.689 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.28 -16.55 59.53 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.698 -1.361 . . . . 36.25 109.698 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 37' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -58.95 161.75 4.73 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.314 -1.11 . . . . 53.8 110.344 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 38' ' ' LYS . . . . . . . . . . . . . 56.9 mttt -117.83 135.76 53.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.315 -0.866 . . . . 49.91 110.142 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 39' ' ' LYS . . . . . 0.416 ' HG2' ' CZ ' ' R' ' 41' ' ' PHE . 8.1 ttmt -138.69 143.66 39.24 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.388 -0.82 . . . . 35.69 110.19 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' R' R ' 40' ' ' THR . . . . . . . . . . . . . 23.7 m -102.56 127.98 49.41 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.387 -0.82 . . . . 34.84 110.193 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 41' ' ' PHE . . . . . 0.416 ' CZ ' ' HG2' ' R' ' 39' ' ' LYS . 96.6 m-85 -113.09 132.71 55.32 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.402 -0.811 . . . . 34.42 110.11 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' R' R ' 42' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -93.24 140.89 29.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.346 -0.846 . . . . 51.46 110.247 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 43' ' ' SER . . . . . . . . . . . . . 53.9 m -70.74 141.91 51.47 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.502 -0.749 . . . . 41.84 110.196 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.75 125.37 29.58 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.263 -0.898 . . . . 33.82 109.986 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' R' R ' 45' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.16 151.05 54.74 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.543 1.286 . . . . 30.27 110.649 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 46' ' ' ASN . . . . . . . . . . . . . 52.1 t-20 -124.28 109.91 13.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.478 -0.764 . . . . 35.1 110.004 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 47' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -120.32 -34.93 3.54 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.217 -0.927 . . . . 42.81 110.466 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 48' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -105.7 45.18 0.98 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.239 -0.913 . . . . 49.97 110.201 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 49' ' ' ASP . . . . . 0.672 ' OD1' ' HA ' ' S' ' 401' ' ' LYS . 37.6 m-20 50.28 34.66 9.17 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.341 -0.849 . . . . 61.32 110.195 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' R' R ' 50' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -86.24 43.83 1.09 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.423 -0.798 . . . . 51.5 110.719 -179.556 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 51' ' ' ALA . . . . . 0.715 ' HB2' ' CB ' ' S' ' 400' ' ' LEU . . . -66.12 -46.11 78.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.276 -0.89 . . . . 38.77 109.541 179.447 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' R' R ' 52' ' ' TRP . . . . . 0.483 ' CD2' ' N ' ' R' ' 53' ' ' LEU . 68.2 p-90 -58.39 -38.37 77.2 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.525 -0.734 . . . . 26.24 110.114 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' R' R ' 53' ' ' LEU . . . . . 0.483 ' N ' ' CD2' ' R' ' 52' ' ' TRP . 23.2 tp -66.72 -46.7 74.63 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.373 -0.83 . . . . 26.75 109.958 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' R' R ' 54' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -55.27 -41.55 72.38 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.405 -0.809 . . . . 35.02 110.142 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.17 -46.11 91.86 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.337 -0.852 . . . . 24.47 110.145 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 56' ' ' ILE . . . . . . . . . . . . . 76.4 mt -62.17 -42.24 94.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.332 -0.855 . . . . 26.03 109.924 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 57' ' ' LEU . . . . . . . . . . . . . 22.5 mt -60.24 -45.71 92.31 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.364 -0.835 . . . . 26.77 109.658 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 58' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -63.9 -46.57 84.25 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.508 -0.745 . . . . 22.32 109.559 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 59' ' ' LEU . . . . . 0.429 ' HA ' ' HE2' ' R' ' 151' ' ' PHE . 23.8 tp -61.43 -37.71 84.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.306 -0.871 . . . . 20.55 109.424 179.262 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' R' R ' 60' ' ' PHE . . . . . 0.447 ' CE2' HD22 ' R' ' 111' ' ' LEU . 2.8 m-85 -61.08 -44.69 96.98 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.62 -0.675 . . . . 20.08 109.95 179.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' R' R ' 61' ' ' ARG . . . . . . . . . . . . . 5.6 tpt180 -63.22 -36.18 82.81 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.397 -0.814 . . . . 18.8 110.41 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 62' ' ' TYR . . . . . 0.461 ' CE2' HD23 ' R' ' 33' ' ' LEU . 9.1 t80 -63.03 -41.8 99.62 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.13 -0.981 . . . . 26.45 110.248 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' R' R ' 63' ' ' VAL . . . . . . . . . . . . . 30.7 m -93.35 20.3 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.238 -0.914 . . . . 29.75 110.221 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 64' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 53.02 75.56 0.24 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.322 -0.861 . . . . 35.52 110.541 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 65' ' ' GLU . . . . . 0.424 ' HG2' ' CD2' ' R' ' 60' ' ' PHE . 14.3 tp10 -116.28 104.01 52.41 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.348 -0.845 . . . . 29.89 109.893 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' R' R ' 66' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.58 -5.75 17.6 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.875 1.46 . . . . 21.37 111.111 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 67' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -52.17 -61.5 2.23 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.054 -1.029 . . . . 23.85 110.314 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' R' R ' 68' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -98.14 36.48 1.57 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.314 -0.866 . . . . 28.07 110.466 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 69' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -72.25 -33.34 67.43 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.387 -0.821 . . . . 43.76 110.088 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 70' ' ' TRP . . . . . 0.476 ' CE2' ' CG2' ' R' ' 71' ' ' VAL . 47.8 p-90 -73.32 -3.94 30.2 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.34 -0.85 . . . . 33.06 110.71 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' R' R ' 71' ' ' VAL . . . . . 0.476 ' CG2' ' CE2' ' R' ' 70' ' ' TRP . 40.8 t -109.81 -27.45 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.241 -0.912 . . . . 31.7 109.674 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' R' R ' 72' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -86.52 -48.86 8.01 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.407 -0.808 . . . . 33.58 110.32 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 73' ' ' SER . . . . . . . . . . . . . 70.1 m -89.69 50.99 1.99 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.336 -0.853 . . . . 50.82 110.344 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 74' ' ' SER . . . . . . . . . . . . . 15.8 t -125.88 138.28 31.73 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.362 -0.836 . . . . 34.74 110.257 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.29 -25.02 16.06 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 O-C-N 123.735 1.387 . . . . 35.7 110.341 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 76' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -91.59 153.25 19.87 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.398 -0.814 . . . . 66.48 110.368 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 77' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -81.62 95.29 7.14 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.374 -0.829 . . . . 46.72 110.046 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 78' ' ' LEU . . . . . . . . . . . . . 96.3 mt -96.46 27.95 3.56 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.467 -0.771 . . . . 37.55 110.216 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 79' ' ' THR . . . . . . . . . . . . . 29.7 m -56.18 -54.65 42.61 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.325 -0.86 . . . . 37.36 110.295 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 80' ' ' LEU . . . . . . . . . . . . . 15.9 mt -60.92 -23.16 65.04 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.256 -0.902 . . . . 35.83 110.513 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 81' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -79.54 -39.08 32.72 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.165 -0.959 . . . . 44.03 110.331 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.47 -28.66 66.28 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.262 -0.899 . . . . 32.54 110.245 179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 83' ' ' ILE . . . . . . . . . . . . . 78.1 mt -70.11 -46.1 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.307 -0.87 . . . . 32.02 110.302 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 84' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -55.19 -52.11 64.39 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.177 -0.952 . . . . 34.09 110.547 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 85' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -54.74 -46.93 74.35 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.272 -0.893 . . . . 25.94 110.235 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 86' ' ' LEU . . . . . . . . . . . . . 24.2 mt -58.67 -43.91 90.02 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.318 -0.864 . . . . 16.2 109.904 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 87' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -65.32 -35.13 80.06 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.471 -0.768 . . . . 49.09 110.346 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 88' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -78.45 -19.12 53.84 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.308 -0.87 . . . . 28.61 110.497 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 89' ' ' LEU . . . . . . . . . . . . . 32.8 mt -96.16 -29.45 14.05 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.207 -0.933 . . . . 26.16 110.239 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 90' ' ' THR . . . . . . . . . . . . . 59.6 p -105.64 -34.61 7.68 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.241 -0.912 . . . . 33.33 109.819 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.79 16.16 58.61 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.862 -1.295 . . . . 31.13 109.862 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 92' ' ' LEU . . . . . . . . . . . . . 97.0 mt -100.12 155.29 17.81 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.172 -1.193 . . . . 42.52 110.21 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 93' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -86.26 91.63 8.53 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.432 -0.793 . . . . 68.46 109.948 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 94' ' ' LEU . . . . . 0.447 ' HB3' ' CZ2' ' R' ' 52' ' ' TRP . 47.7 mt -99.47 53.03 0.94 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.162 -0.961 . . . . 44.63 110.355 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' R' R ' 95' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.47 -38.66 6.39 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.253 -0.904 . . . . 67.16 110.399 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' R' R ' 96' ' ' GLU . . . . . 0.416 ' O ' ' CE ' ' S' ' 399' ' ' LYS . 24.6 mt-10 -113.9 44.23 1.68 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -0.922 . . . . 67.02 110.291 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' R' R ' 97' ' ' GLY . . . . . 0.684 ' HA3' ' HB2' ' S' ' 399' ' ' LYS . . . 99.14 150.79 26.02 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.733 -1.347 . . . . 49.48 109.733 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' R' R ' 98' ' ' GLY . . . . . . . . . . . . . . . -166.26 160.05 33.49 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.227 -1.549 . . . . 36.57 109.227 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 99' ' ' PRO . . . . . 0.701 ' HA ' ' O ' ' S' ' 396' ' ' VAL . 45.8 Cg_endo -72.58 121.1 7.13 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.65 1.342 . . . . 30.41 110.435 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' R' R ' 100' ' ' PRO . . . . . 0.439 ' HD2' ' O ' ' S' ' 396' ' ' VAL . 45.8 Cg_endo -72.27 -31.59 11.53 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 O-C-N 123.649 1.342 . . . . 29.94 110.561 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' R' R ' 101' ' ' ALA . . . . . 0.78 ' HB2' HG21 ' S' ' 396' ' ' VAL . . . -70.01 -38.47 75.95 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.239 -0.913 . . . . 23.64 110.256 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' R' R ' 102' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.66 -40.74 66.09 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.284 -0.885 . . . . 20.31 110.358 -179.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' R' R ' 103' ' ' VAL . . . . . . . . . . . . . 63.6 t -58.19 -40.09 76.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.227 -0.92 . . . . 16.33 109.996 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 104' ' ' ILE . . . . . . . . . . . . . 81.9 mt -71.72 -30.39 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.418 -0.801 . . . . 24.77 110.049 179.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 105' ' ' TRP . . . . . 0.439 ' O ' ' HD3' ' R' ' 108' ' ' LYS . 70.6 t-105 -82.49 0.89 40.35 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.34 -0.85 . . . . 23.28 110.254 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' R' R ' 106' ' ' ASN . . . . . . . . . . . . . 6.9 m-80 -105.16 -10.36 17.16 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.108 -0.995 . . . . 28.26 110.028 179.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 107' ' ' ILE . . . . . . . . . . . . . 36.8 pt -126.8 34.96 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.268 -0.895 . . . . 18.77 110.008 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 108' ' ' LYS . . . . . 0.481 ' HG2' ' HB ' ' R' ' 115' ' ' ILE . 9.2 mtpp -61.02 -48.5 81.5 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.589 -0.694 . . . . 42.5 110.037 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' R' R ' 109' ' ' HIS . . . . . 0.433 ' CD2' ' HG ' ' R' ' 110' ' ' LEU . 50.7 p-80 -66.02 -12.84 58.0 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.473 -0.767 . . . . 20.07 110.655 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' R' R ' 110' ' ' LEU . . . . . 0.433 ' HG ' ' CD2' ' R' ' 109' ' ' HIS . 80.7 mt -94.78 -17.35 22.22 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.121 -0.987 . . . . 15.69 110.171 179.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' R' R ' 111' ' ' LEU . . . . . 0.447 HD22 ' CE2' ' R' ' 60' ' ' PHE . 10.4 mt -94.06 144.14 25.74 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.342 -0.849 . . . . 25.39 111.05 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' R' R ' 112' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -77.7 -17.35 57.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.51 -0.744 . . . . 53.48 109.859 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 113' ' ' THR . . . . . 0.416 HG22 ' HG2' ' R' ' 123' ' ' GLU . 59.7 m -83.69 166.66 17.9 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.308 -0.87 . . . . 14.8 110.299 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' R' R ' 114' ' ' GLY . . . . . . . . . . . . . . . -98.06 127.16 9.14 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.015 -1.234 . . . . 16.14 110.015 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 115' ' ' ILE . . . . . 0.481 ' HB ' ' HG2' ' R' ' 108' ' ' LYS . 47.8 mm -109.08 139.44 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.464 -1.021 . . . . 13.46 109.7 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' R' R ' 116' ' ' GLY . . . . . . . . . . . . . . . -152.74 -155.85 7.29 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.926 -1.27 . . . . 23.9 109.926 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 117' ' ' THR . . . . . . . . . . . . . 18.6 p -135.02 -171.39 2.79 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.413 -1.051 . . . . 27.37 110.044 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 118' ' ' ALA . . . . . . . . . . . . . . . -56.61 -57.96 10.11 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.251 -0.906 . . . . 18.76 110.107 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 119' ' ' SER . . . . . 0.776 ' HB3' ' HB ' ' R' ' 196' ' ' VAL . 1.2 m -56.58 -40.61 75.51 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.326 -0.859 . . . . 32.35 109.791 179.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' R' R ' 120' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 -110.04 86.2 4.81 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.442 -0.786 . . . . 27.12 109.682 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 121' ' ' PRO . . . . . 0.428 ' O ' ' HB2' ' R' ' 122' ' ' SER . 44.3 Cg_endo -71.23 166.5 29.06 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.813 1.428 . . . . 22.68 110.981 -179.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' R' R ' 122' ' ' SER . . . . . 0.428 ' HB2' ' O ' ' R' ' 121' ' ' PRO . 38.7 t 178.51 -161.69 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.481 -0.762 . . . . 22.99 109.492 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' R' R ' 123' ' ' GLU . . . . . 0.416 ' HG2' HG22 ' R' ' 113' ' ' THR . 2.3 tp10 -56.5 -39.97 74.18 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.19 -0.944 . . . . 36.18 109.649 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' R' R ' 124' ' ' VAL . . . . . . . . . . . . . 82.3 t -142.44 136.5 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.584 -0.698 . . . . 20.64 109.403 179.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 125' ' ' CYS . . . . . 0.409 ' SG ' ' HA ' ' R' ' 121' ' ' PRO . 83.4 m -140.35 168.21 20.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.219 -0.925 . . . . 22.8 111.163 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' R' R ' 126' ' ' VAL . . . . . . . . . . . . . 35.8 m -122.76 159.8 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.747 -0.596 . . . . 21.24 109.664 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 127' ' ' VAL . . . . . 0.401 HG11 ' O ' ' R' ' 177' ' ' VAL . 30.7 m -70.87 141.86 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.266 -0.896 . . . . 19.77 110.675 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' R' R ' 128' ' ' ASP . . . . . . . . . . . . . 53.9 p-10 -137.73 19.4 2.87 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.336 -0.853 . . . . 29.21 110.669 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 129' ' ' GLY . . . . . . . . . . . . . . . 114.03 0.01 24.1 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.893 -1.146 . . . . 33.86 110.461 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 130' ' ' THR . . . . . . . . . . . . . 58.1 m -91.77 131.91 36.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.207 -1.172 . . . . 26.41 110.099 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -62.62 120.69 11.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.356 -0.84 . . . . 33.08 110.274 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 132' ' ' MET . . . . . 0.426 ' HE1' ' CZ ' ' R' ' 180' ' ' PHE . 98.4 mmm -105.18 165.58 11.0 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.468 -0.77 . . . . 30.76 110.409 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' R' R ' 133' ' ' CYS . . . . . . . . . . . . . 32.5 m -141.17 158.12 44.33 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.538 -0.726 . . . . 27.0 109.969 179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 134' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.5 -19.65 39.07 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.322 -0.861 . . . . 33.9 110.544 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' R' R ' 135' ' ' ALA . . . . . . . . . . . . . . . -92.74 8.15 40.54 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.31 -0.868 . . . . 19.37 110.826 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 136' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -93.75 -21.74 19.13 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.174 -0.954 . . . . 30.47 110.245 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 137' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -149.98 165.35 32.95 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.407 -0.808 . . . . 24.27 110.215 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 138' ' ' HIS . . . . . . . . . . . . . 15.1 p80 -117.81 15.04 14.39 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.4 -0.813 . . . . 20.91 110.494 179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 139' ' ' ALA . . . . . 0.44 ' HA ' ' O ' ' R' ' 152' ' ' ALA . . . -177.14 152.46 0.89 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.257 -0.902 . . . . 15.69 110.139 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' R' R ' 140' ' ' GLY . . . . . 0.405 ' HA3' ' O ' ' R' ' 179' ' ' VAL . . . 161.78 175.12 32.46 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.889 -1.285 . . . . 23.76 109.889 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' R' R ' 141' ' ' ILE . . . . . . . . . . . . . 83.8 mt -95.51 136.58 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.473 -1.016 . . . . 25.3 109.682 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 142' ' ' PHE . . . . . 0.546 ' CD2' ' HB2' ' R' ' 172' ' ' PRO . 82.9 m-85 -120.74 -172.66 2.43 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.287 -0.883 . . . . 30.24 110.547 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' R' R ' 143' ' ' LEU . . . . . 0.699 HD21 ' HG2' ' S' ' 398' ' ' ARG . 0.5 OUTLIER -119.79 77.75 1.26 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.499 -0.751 . . . . 32.8 110.292 -179.907 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' R' R ' 144' ' ' LYS . . . . . 0.452 ' HG3' ' CZ2' ' R' ' 170' ' ' TRP . 1.0 OUTLIER -69.54 76.88 0.41 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.448 -0.783 . . . . 49.18 109.653 179.562 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' R' R ' 145' ' ' GLY . . . . . . . . . . . . . . . 104.51 179.25 24.82 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.157 -1.577 . . . . 53.87 109.157 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 146' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -88.52 145.8 25.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.363 -1.081 . . . . 68.58 109.995 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 147' ' ' GLU . . . . . 0.703 ' N ' ' HG3' ' S' ' 398' ' ' ARG . 10.9 mt-10 58.31 36.51 25.64 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.346 -0.846 . . . . 56.62 110.607 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' R' R ' 148' ' ' HIS . . . . . 0.498 ' CE1' ' HB2' ' S' ' 400' ' ' LEU . 44.8 t60 -158.69 148.13 19.16 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.183 -0.948 . . . . 44.57 110.419 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' R' R ' 149' ' ' ALA . . . . . . . . . . . . . . . -150.29 146.83 27.01 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.445 -0.784 . . . . 33.54 110.057 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 150' ' ' VAL . . . . . 0.428 HG23 ' HB2' ' R' ' 144' ' ' LYS . 34.2 m -142.3 161.55 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.261 -0.9 . . . . 27.61 110.36 179.641 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' R' R ' 151' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' R' ' 152' ' ' ALA . 5.8 t80 -86.22 155.54 20.66 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.392 -0.818 . . . . 23.04 109.873 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' R' R ' 152' ' ' ALA . . . . . 0.537 ' N ' ' CD1' ' R' ' 151' ' ' PHE . . . -157.26 151.54 24.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.421 -0.799 . . . . 29.61 109.575 179.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' R' R ' 153' ' ' CYS . . . . . 0.405 ' HA ' ' HA ' ' R' ' 139' ' ' ALA . 26.7 p -154.27 173.61 15.91 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.34 -0.85 . . . . 22.75 110.542 -179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' R' R ' 154' ' ' VAL . . . . . 0.443 ' CG2' ' CZ2' ' R' ' 159' ' ' TRP . 59.7 t -90.6 117.1 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.453 -0.78 . . . . 23.26 110.052 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' R' R ' 155' ' ' THR . . . . . . . . . . . . . 69.3 p -112.17 -176.62 2.97 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.359 -0.838 . . . . 17.88 110.041 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 156' ' ' SER . . . . . . . . . . . . . 78.5 p -75.96 -3.76 37.35 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.32 -0.863 . . . . 21.83 110.633 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 157' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -118.22 10.46 12.88 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.06 -1.025 . . . . 36.54 110.612 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 158' ' ' GLY . . . . . . . . . . . . . . . 117.97 -162.63 13.05 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.527 -1.429 . . . . 31.74 109.527 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 159' ' ' TRP . . . . . 0.443 ' CZ2' ' CG2' ' R' ' 154' ' ' VAL . 14.7 m95 -86.6 122.57 30.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.354 -1.086 . . . . 28.25 110.035 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' R' R ' 160' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -108.48 166.96 10.38 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.42 -0.8 . . . . 41.24 110.201 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 161' ' ' ALA . . . . . . . . . . . . . . . -143.23 123.47 13.77 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.461 -0.775 . . . . 27.4 110.163 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 162' ' ' ILE . . . . . 0.431 HG23 ' CZ ' ' R' ' 167' ' ' PHE . 92.0 mt -87.59 81.12 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.317 -0.864 . . . . 24.27 110.051 179.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' R' R ' 163' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' R' ' 165' ' ' GLU . 15.4 t0 -72.74 92.39 1.56 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.422 -0.799 . . . . 36.08 110.254 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' R' R ' 164' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 54.13 -89.0 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.515 -0.741 . . . . 46.08 110.574 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 165' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' R' ' 163' ' ' ASP . 29.7 mt-10 -124.76 36.02 4.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.088 -1.007 . . . . 50.94 110.192 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' R' R ' 166' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -135.81 117.29 14.77 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.416 -0.803 . . . . 47.28 110.266 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 167' ' ' PHE . . . . . 0.431 ' CZ ' HG23 ' R' ' 162' ' ' ILE . 24.4 m-85 -101.04 120.02 39.59 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.387 -0.821 . . . . 40.47 110.155 179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' R' R ' 168' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -157.52 158.53 30.68 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.273 -0.892 . . . . 30.21 110.433 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 169' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.77 132.98 19.42 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 O-C-N 123.863 1.454 . . . . 32.76 110.471 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 170' ' ' TRP . . . . . 0.452 ' CZ2' ' HG3' ' R' ' 144' ' ' LYS . 67.1 t90 -159.78 119.43 2.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.398 -0.814 . . . . 32.79 109.946 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' R' R ' 171' ' ' THR . . . . . . . . . . . . . 45.9 m -81.13 112.57 33.91 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.405 -0.809 . . . . 36.92 110.188 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 172' ' ' PRO . . . . . 0.546 ' HB2' ' CD2' ' R' ' 142' ' ' PHE . 47.2 Cg_endo -73.76 158.78 46.46 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 O-C-N 123.796 1.419 . . . . 33.54 110.551 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' R' R ' 173' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -88.84 144.96 33.83 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.361 -0.837 . . . . 45.76 109.951 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 174' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -71.74 -10.33 26.3 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 O-C-N 123.621 1.327 . . . . 29.63 110.497 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 175' ' ' SER . . . . . . . . . . . . . 53.0 p -103.53 -17.47 15.18 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.317 -0.864 . . . . 35.7 110.306 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 176' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -103.6 43.23 1.1 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.286 -0.884 . . . . 39.65 110.32 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 177' ' ' VAL . . . . . 0.401 ' O ' HG11 ' R' ' 127' ' ' VAL . 10.6 p -117.74 127.12 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.397 -0.815 . . . . 20.61 110.095 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' R' R ' 178' ' ' LEU . . . . . 0.488 HD21 ' HG3' ' S' ' 395' ' ' LYS . 46.2 mt -91.47 -61.25 1.69 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.305 -0.872 . . . . 15.58 109.389 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' R' R ' 179' ' ' VAL . . . . . 0.405 ' O ' ' HA3' ' R' ' 140' ' ' GLY . 67.9 t -114.67 144.66 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.643 -0.661 . . . . 17.4 109.441 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' R' R ' 180' ' ' PHE . . . . . 0.426 ' CZ ' ' HE1' ' R' ' 132' ' ' MET . 43.6 p90 -152.17 163.43 39.4 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.239 -0.913 . . . . 20.16 110.519 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' R' R ' 181' ' ' VAL . . . . . . . . . . . . . 66.6 t -113.19 111.47 50.22 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.342 -0.849 . . . . 17.69 109.756 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 182' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.05 149.56 52.83 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 O-C-N 123.507 1.267 . . . . 17.81 110.374 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 183' ' ' TYR . . . . . 0.698 ' O ' ' C ' ' R' ' 184' ' ' ASP . 79.5 m-85 -59.05 175.47 0.29 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.4 -0.813 . . . . 28.01 110.526 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' R' R ' 184' ' ' ASP . . . . . 0.698 ' C ' ' O ' ' R' ' 183' ' ' TYR . 1.1 m-20 -19.01 -82.88 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.425 -0.797 . . . . 58.64 110.319 -178.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' R' R ' 185' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 . . . . . 0 N--CA 1.502 2.16 0 CA-C-O 121.273 0.559 . . . . 80.42 111.777 179.479 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' R' R ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 120.948 0.404 . . . . 49.5 110.14 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 194' ' ' ALA . . . . . . . . . . . . . . . -172.22 -155.39 0.09 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.123 -0.986 . . . . 40.4 110.059 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 195' ' ' LYS . . . . . . . . . . . . . 18.6 mtmt -100.32 -47.52 4.9 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.45 -0.781 . . . . 34.6 110.25 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 196' ' ' VAL . . . . . 0.776 ' HB ' ' HB3' ' R' ' 119' ' ' SER . 32.9 t -71.27 -39.09 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.194 -0.941 . . . . 33.27 110.622 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' R' R ' 197' ' ' GLN . . . . . 0.45 ' O ' ' O ' ' R' ' 196' ' ' VAL . 3.7 tt0 -59.94 -134.34 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.149 -0.969 . . . . 41.58 110.719 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' R' R ' 198' ' ' ARG . . . . . 0.416 ' CB ' ' O ' ' R' ' 197' ' ' GLN . 8.8 ttt180 64.09 173.12 0.18 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.109 -0.994 . . . . 38.65 110.216 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' R' R ' 199' ' ' LYS . . . . . 0.651 ' O ' ' HD3' ' S' ' 299' ' ' PRO . 0.4 OUTLIER -110.75 -17.19 13.42 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.36 -0.838 . . . . 36.77 109.936 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' R' R ' 200' ' ' LEU . . . . . . . . . . . . . 1.4 mm? 46.41 -163.46 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.32 -0.862 . . . . 33.08 110.127 179.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' R' R ' 201' ' ' LYS . . . . . 0.644 ' HA ' ' HA3' ' S' ' 297' ' ' GLY . 16.4 tttm . . . . . 0 N--CA 1.493 1.698 0 O-C-N 121.384 -0.822 . . . . 44.32 110.297 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 229' ' ' MET . . . . . . . . . . . . . 24.8 ptp . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.229 0.538 . . . . 51.83 110.219 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' S' S ' 230' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -97.24 142.78 28.72 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.336 -0.852 . . . . 54.13 110.208 -179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 231' ' ' LEU . . . . . . . . . . . . . 68.0 mt -134.14 141.04 46.96 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.247 -0.908 . . . . 33.04 110.355 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 232' ' ' THR . . . . . . . . . . . . . 40.0 m -89.22 103.18 15.83 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.414 -0.804 . . . . 26.92 110.037 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 233' ' ' LEU . . . . . 0.498 HD23 ' CE2' ' S' ' 262' ' ' TYR . 79.7 mt -55.91 179.26 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.467 -0.771 . . . . 13.78 110.457 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' S' S ' 234' ' ' TYR . . . . . 0.448 ' CG ' ' N ' ' S' ' 235' ' ' ASN . 35.7 p90 -65.02 -35.65 81.85 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.347 -0.845 . . . . 26.08 110.169 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' S' S ' 235' ' ' ASN . . . . . 0.448 ' N ' ' CG ' ' S' ' 234' ' ' TYR . 50.7 p30 -74.31 -7.46 52.87 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.292 -0.88 . . . . 20.04 110.524 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' S' S ' 236' ' ' GLY . . . . . . . . . . . . . . . 95.8 -20.03 51.7 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.76 -1.336 . . . . 22.71 109.76 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 237' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -52.9 145.72 12.13 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.234 -1.157 . . . . 35.44 110.226 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 238' ' ' LYS . . . . . . . . . . . . . 44.4 mttt -102.2 127.87 48.96 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.389 -0.82 . . . . 32.56 110.416 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 239' ' ' LYS . . . . . 0.413 ' HG2' ' CZ ' ' S' ' 241' ' ' PHE . 9.1 ttmt -132.25 144.49 50.65 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.377 -0.827 . . . . 26.68 110.036 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' S' S ' 240' ' ' THR . . . . . . . . . . . . . 51.5 m -102.01 132.16 48.01 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.328 -0.858 . . . . 41.02 110.41 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 241' ' ' PHE . . . . . 0.413 ' CZ ' ' HG2' ' S' ' 239' ' ' LYS . 96.0 m-85 -117.87 137.66 52.64 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.419 -0.801 . . . . 28.62 110.184 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' S' S ' 242' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -96.39 161.74 13.8 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.371 -0.831 . . . . 47.89 110.25 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 243' ' ' SER . . . . . . . . . . . . . 71.6 m -90.47 151.49 21.36 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.245 -0.909 . . . . 45.09 110.298 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 244' ' ' ARG . . . . . . . . . . . . . 1.4 mtp85 -129.76 126.78 22.73 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.371 -0.83 . . . . 42.49 110.266 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 245' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.37 161.05 43.56 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.652 1.343 . . . . 35.68 110.542 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 246' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -132.86 97.88 4.15 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.443 -0.786 . . . . 51.88 109.866 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 247' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -110.52 -22.23 11.75 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.395 -0.815 . . . . 53.69 110.664 -179.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 248' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -117.28 43.77 2.25 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.108 -0.995 . . . . 55.79 110.804 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 249' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 48.68 38.49 11.63 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.4 -0.813 . . . . 49.45 110.339 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 250' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -90.65 28.99 1.38 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.521 -0.737 . . . . 36.86 110.309 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 251' ' ' ALA . . . . . . . . . . . . . . . -53.79 -43.16 69.07 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.271 -0.893 . . . . 29.69 109.619 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 252' ' ' TRP . . . . . 0.416 ' CZ2' ' HB3' ' S' ' 294' ' ' LEU . 67.8 p-90 -61.81 -33.94 75.04 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.537 -0.727 . . . . 41.12 109.83 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' S' S ' 253' ' ' LEU . . . . . 0.4 ' N ' ' CD2' ' S' ' 252' ' ' TRP . 23.2 tp -70.16 -47.25 62.43 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.37 -0.831 . . . . 24.89 109.953 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' S' S ' 254' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -56.1 -42.44 76.8 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.417 -0.802 . . . . 35.65 109.96 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 255' ' ' ALA . . . . . . . . . . . . . . . -59.63 -48.18 82.69 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.399 -0.813 . . . . 22.73 110.081 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 256' ' ' ILE . . . . . . . . . . . . . 79.7 mt -62.25 -40.7 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.304 -0.873 . . . . 28.85 109.979 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 257' ' ' LEU . . . . . . . . . . . . . 19.1 mt -61.48 -44.5 96.98 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.257 -0.902 . . . . 23.07 110.154 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 258' ' ' GLN . . . . . 0.468 ' HB3' ' CD2' ' S' ' 351' ' ' PHE . 53.5 mm-40 -65.14 -45.33 85.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.39 -0.818 . . . . 29.78 109.919 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' S' S ' 259' ' ' LEU . . . . . 0.432 ' O ' HG22 ' S' ' 263' ' ' VAL . 19.7 tp -58.66 -36.35 74.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.337 -0.852 . . . . 17.94 109.474 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' S' S ' 260' ' ' PHE . . . . . 0.468 ' CE2' HD22 ' S' ' 311' ' ' LEU . 3.1 m-85 -62.9 -45.24 93.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.622 -0.674 . . . . 30.57 109.82 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' S' S ' 261' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -62.08 -29.81 70.56 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.386 -0.821 . . . . 41.34 109.987 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 262' ' ' TYR . . . . . 0.498 ' CE2' HD23 ' S' ' 233' ' ' LEU . 8.6 t80 -71.16 -44.67 65.05 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.367 -0.833 . . . . 26.03 110.1 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' S' S ' 263' ' ' VAL . . . . . 0.432 HG22 ' O ' ' S' ' 259' ' ' LEU . 33.1 m -92.02 18.15 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.374 -0.829 . . . . 22.8 110.334 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' S' S ' 264' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 52.85 70.69 0.55 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.206 -0.934 . . . . 44.03 110.589 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 265' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -111.86 109.19 55.3 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.397 -0.814 . . . . 35.61 109.602 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 266' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -75.34 0.44 9.04 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.657 1.346 . . . . 37.67 111.8 -179.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 267' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -56.46 -67.73 0.28 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.781 -1.2 . . . . 41.49 110.192 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' S' S ' 268' ' ' PHE . . . . . . . . . . . . . 22.3 m-85 -92.94 39.95 1.05 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.15 -0.968 . . . . 50.76 110.063 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 269' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -76.04 -33.22 59.6 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.348 -0.845 . . . . 61.86 109.775 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' S' S ' 270' ' ' TRP . . . . . 0.492 ' CE2' ' CG2' ' S' ' 271' ' ' VAL . 50.9 p-90 -73.91 -4.31 34.28 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.33 -0.856 . . . . 39.85 110.493 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' S' S ' 271' ' ' VAL . . . . . 0.492 ' CG2' ' CE2' ' S' ' 270' ' ' TRP . 46.6 t -109.59 -32.66 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.187 -0.946 . . . . 39.18 110.058 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' S' S ' 272' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -78.68 -36.52 43.51 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.327 -0.858 . . . . 40.02 110.519 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 273' ' ' SER . . . . . . . . . . . . . 71.1 m -103.55 56.16 0.74 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.347 -0.846 . . . . 47.2 110.291 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 274' ' ' SER . . . . . . . . . . . . . 6.8 t -133.09 141.24 40.13 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.382 -0.824 . . . . 47.61 110.153 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 275' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.76 -18.82 21.75 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 123.639 1.337 . . . . 45.28 110.544 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 276' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -99.9 140.88 33.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.221 -0.924 . . . . 57.27 110.327 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 277' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -71.79 97.63 1.83 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.428 -0.795 . . . . 37.28 110.234 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 278' ' ' LEU . . . . . . . . . . . . . 86.0 mt -96.96 33.85 1.83 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.388 -0.82 . . . . 43.88 110.087 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 279' ' ' THR . . . . . . . . . . . . . 77.8 m -64.09 -60.19 3.54 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.471 -0.768 . . . . 50.05 110.194 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 280' ' ' LEU . . . . . . . . . . . . . 13.7 mt -51.51 -39.91 58.57 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.247 -0.908 . . . . 54.12 110.304 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 281' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.39 -49.69 74.52 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.444 -0.785 . . . . 65.28 110.132 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' S' S ' 282' ' ' ALA . . . . . . . . . . . . . . . -59.02 -33.89 71.27 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.478 -0.764 . . . . 46.51 110.488 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 283' ' ' ILE . . . . . . . . . . . . . 85.7 mt -66.34 -50.87 64.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.305 -0.872 . . . . 47.3 110.072 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 284' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -50.61 -57.56 7.92 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.416 -0.803 . . . . 50.72 110.359 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 285' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -51.42 -46.35 62.89 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.523 -0.736 . . . . 68.47 110.34 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 286' ' ' LEU . . . . . . . . . . . . . 19.1 mt -59.97 -44.47 94.44 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.464 -0.773 . . . . 36.62 110.309 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 287' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -62.83 -35.25 79.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.279 -0.888 . . . . 46.64 110.009 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 288' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -76.26 -20.99 56.85 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.42 -0.8 . . . . 46.45 110.328 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 289' ' ' LEU . . . . . . . . . . . . . 30.7 mt -97.33 -21.73 17.05 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.342 -0.849 . . . . 35.09 110.52 -179.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 290' ' ' THR . . . . . . . . . . . . . 81.3 p -114.78 -28.5 7.07 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.214 -0.929 . . . . 38.61 110.373 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 291' ' ' GLY . . . . . . . . . . . . . . . 79.38 11.05 85.34 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.886 -1.286 . . . . 36.77 109.886 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 292' ' ' LEU . . . . . . . . . . . . . 84.5 mt -96.45 145.77 25.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.222 -1.164 . . . . 35.33 109.768 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 293' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -77.36 102.37 6.76 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.25 -0.906 . . . . 48.7 110.272 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 294' ' ' LEU . . . . . 0.416 ' HB3' ' CZ2' ' S' ' 252' ' ' TRP . 55.3 mt -106.86 51.72 0.74 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.55 -0.719 . . . . 42.61 110.11 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' S' S ' 295' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -112.57 -11.09 13.63 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.325 -0.859 . . . . 55.49 110.573 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' S' S ' 296' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -144.38 48.53 1.36 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.163 -0.96 . . . . 75.68 110.292 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 297' ' ' GLY . . . . . 0.644 ' HA3' ' HA ' ' R' ' 201' ' ' LYS . . . 96.84 145.21 18.76 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.509 -1.437 . . . . 49.44 109.509 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' S' S ' 298' ' ' GLY . . . . . . . . . . . . . . . -163.83 156.93 29.01 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.805 -1.318 . . . . 41.11 109.805 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 299' ' ' PRO . . . . . 0.651 ' HD3' ' O ' ' R' ' 199' ' ' LYS . 47.4 Cg_endo -73.77 118.25 5.37 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 123.955 1.502 . . . . 26.2 110.293 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' S' S ' 300' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.24 -15.42 31.68 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 O-C-N 123.577 1.304 . . . . 21.7 110.734 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 301' ' ' ALA . . . . . . . . . . . . . . . -80.71 -29.34 36.45 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.276 -0.89 . . . . 31.23 110.14 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 302' ' ' LEU . . . . . 0.47 ' CD1' ' O ' ' R' ' 196' ' ' VAL . 0.0 OUTLIER -83.57 -40.57 18.93 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.405 -0.809 . . . . 38.99 109.926 179.845 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' S' S ' 303' ' ' VAL . . . . . 0.468 ' O ' HG12 ' S' ' 307' ' ' ILE . 58.1 t -60.73 -35.47 64.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.375 -0.828 . . . . 18.63 110.143 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' S' S ' 304' ' ' ILE . . . . . . . . . . . . . 86.2 mt -79.45 -23.55 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.463 -0.773 . . . . 25.46 110.193 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 305' ' ' TRP . . . . . . . . . . . . . 68.7 t-105 -88.63 -14.6 37.1 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.253 -0.904 . . . . 33.4 110.601 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 306' ' ' ASN . . . . . . . . . . . . . 10.4 m-80 -89.69 -13.57 36.64 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.227 -0.92 . . . . 36.97 110.435 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 307' ' ' ILE . . . . . 0.468 HG12 ' O ' ' S' ' 303' ' ' VAL . 36.8 pt -125.09 45.66 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.218 -0.926 . . . . 30.81 110.066 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' S' S ' 308' ' ' LYS . . . . . . . . . . . . . 1.5 mtmp? -73.52 -37.77 65.52 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.355 -0.841 . . . . 46.52 110.084 -179.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 309' ' ' HIS . . . . . 0.487 ' CD2' ' HG ' ' S' ' 310' ' ' LEU . 55.5 p-80 -73.1 -8.34 55.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.303 -0.873 . . . . 51.03 110.129 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' S' S ' 310' ' ' LEU . . . . . 0.487 ' HG ' ' CD2' ' S' ' 309' ' ' HIS . 52.6 mt -99.27 -12.94 19.92 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.295 -0.878 . . . . 36.16 109.971 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' S' S ' 311' ' ' LEU . . . . . 0.468 HD22 ' CE2' ' S' ' 260' ' ' PHE . 10.8 mt -97.11 147.81 23.67 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.314 -0.866 . . . . 40.0 110.452 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' S' S ' 312' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -81.54 -16.33 52.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.345 -0.847 . . . . 54.18 109.763 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 313' ' ' THR . . . . . 0.47 HG23 ' HB3' ' S' ' 323' ' ' GLU . 92.5 m -87.88 151.53 22.76 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.375 -0.828 . . . . 25.61 110.159 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' S' S ' 314' ' ' GLY . . . . . . . . . . . . . . . -87.83 126.38 8.02 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.836 -1.306 . . . . 25.18 109.836 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 315' ' ' ILE . . . . . . . . . . . . . 50.7 mm -101.64 150.53 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.35 -1.088 . . . . 23.9 109.71 179.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 316' ' ' GLY . . . . . . . . . . . . . . . -157.12 -159.32 9.42 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.923 -1.271 . . . . 23.18 109.923 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 317' ' ' THR . . . . . . . . . . . . . 11.2 p -133.88 -173.06 3.14 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.417 -1.049 . . . . 27.98 110.013 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.55 -56.23 24.63 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.199 -0.938 . . . . 28.1 109.892 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 319' ' ' SER . . . . . . . . . . . . . 1.2 m -59.9 -41.67 92.17 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.405 -0.809 . . . . 37.0 109.632 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 320' ' ' ARG . . . . . . . . . . . . . 12.2 mtm180 -111.69 79.85 2.62 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.471 -0.768 . . . . 52.07 109.679 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 321' ' ' PRO . . . . . 0.896 ' HG2' ' O ' ' S' ' 386' ' ' GLU . 44.1 Cg_endo -71.43 171.46 16.14 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.79 1.416 . . . . 38.29 110.903 -179.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' S' S ' 322' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' S' ' 321' ' ' PRO . 41.3 t 178.7 -148.08 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.928 -0.767 . . . . 38.84 108.928 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' S' S ' 323' ' ' GLU . . . . . 0.47 ' HB3' HG23 ' S' ' 313' ' ' THR . 6.7 tp10 -62.87 -40.34 97.2 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.944 -1.098 . . . . 40.7 109.664 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' S' S ' 324' ' ' VAL . . . . . . . . . . . . . 72.7 t -141.24 135.02 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.433 -0.792 . . . . 20.34 109.463 179.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 325' ' ' CYS . . . . . 0.446 ' HB2' ' CE1' ' S' ' 380' ' ' PHE . 11.1 m -126.02 172.24 10.13 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.246 -0.909 . . . . 30.63 110.867 -179.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' S' S ' 326' ' ' VAL . . . . . . . . . . . . . 34.5 m -135.51 142.16 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.651 -0.656 . . . . 23.9 109.248 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 327' ' ' VAL . . . . . . . . . . . . . 34.6 m -56.32 125.04 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.015 -1.053 . . . . 19.48 110.388 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 328' ' ' ASP . . . . . . . . . . . . . 55.5 p-10 -119.41 11.46 12.18 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.496 -0.753 . . . . 26.43 110.427 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 329' ' ' GLY . . . . . . . . . . . . . . . 119.75 2.2 12.99 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.973 -1.251 . . . . 31.24 109.973 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 330' ' ' THR . . . . . . . . . . . . . 78.8 m -92.94 130.02 38.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.093 -1.239 . . . . 30.05 110.136 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 331' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -56.85 111.48 1.04 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.207 -0.933 . . . . 37.26 109.927 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 332' ' ' MET . . . . . 0.456 ' HE1' ' CZ ' ' S' ' 380' ' ' PHE . 88.1 mmm -93.99 162.54 13.85 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.275 -0.89 . . . . 26.23 110.42 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' S' S ' 333' ' ' CYS . . . . . . . . . . . . . 25.7 m -137.25 150.0 47.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.398 -0.814 . . . . 23.56 110.072 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 334' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.51 -24.93 8.96 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.282 -0.886 . . . . 28.93 110.438 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' S' S ' 335' ' ' ALA . . . . . . . . . . . . . . . -89.02 14.43 10.66 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.358 -0.839 . . . . 15.76 110.975 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 336' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -100.49 -17.21 17.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.092 -1.005 . . . . 34.92 110.185 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 337' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -152.47 170.84 19.15 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.363 -0.836 . . . . 19.03 110.084 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 338' ' ' HIS . . . . . 0.4 ' HB3' ' CZ ' ' S' ' 383' ' ' TYR . 13.3 p80 -120.68 10.44 11.01 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.367 -0.833 . . . . 18.82 110.441 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' S' S ' 339' ' ' ALA . . . . . . . . . . . . . . . -175.99 155.18 1.56 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.205 -0.934 . . . . 17.18 110.091 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 340' ' ' GLY . . . . . 0.401 ' CA ' ' O ' ' S' ' 379' ' ' VAL . . . 160.82 173.09 28.99 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 110.088 -1.205 . . . . 18.33 110.088 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' S' S ' 341' ' ' ILE . . . . . 0.435 HD12 HG22 ' S' ' 341' ' ' ILE . 84.2 mt -88.76 138.05 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.434 -1.039 . . . . 18.6 109.78 179.684 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' S' S ' 342' ' ' PHE . . . . . 0.501 ' CE1' HG23 ' S' ' 377' ' ' VAL . 70.0 m-85 -120.99 -178.47 3.75 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.187 -0.945 . . . . 23.44 110.401 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' S' S ' 343' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.81 93.46 4.21 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.431 -0.793 . . . . 35.59 110.053 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' S' S ' 344' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.89 125.05 29.63 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.268 -0.895 . . . . 38.34 110.049 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' S' S ' 345' ' ' GLY . . . . . . . . . . . . . . . 62.75 -130.73 43.08 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 108.857 -1.697 . . . . 53.46 108.857 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 346' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -132.76 150.87 52.11 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.252 -1.146 . . . . 70.91 109.976 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 347' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 53.33 35.38 20.13 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.355 -0.841 . . . . 47.32 110.357 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 348' ' ' HIS . . . . . . . . . . . . . 46.4 t60 -150.19 155.89 40.59 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.208 -0.932 . . . . 41.72 110.333 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 349' ' ' ALA . . . . . . . . . . . . . . . -149.76 151.23 33.26 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.243 -0.911 . . . . 22.91 110.458 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 350' ' ' VAL . . . . . . . . . . . . . 34.6 m -149.06 169.58 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.384 -0.822 . . . . 21.09 110.057 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 351' ' ' PHE . . . . . 0.468 ' CD2' ' HB3' ' S' ' 258' ' ' GLN . 10.8 t80 -105.31 143.58 33.29 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.279 -0.888 . . . . 25.03 110.748 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' S' S ' 352' ' ' ALA . . . . . . . . . . . . . . . -147.74 151.66 36.45 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.566 -0.709 . . . . 23.81 109.777 179.614 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 353' ' ' CYS . . . . . . . . . . . . . 26.3 p -153.25 164.88 37.31 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.348 -0.845 . . . . 25.66 110.274 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 354' ' ' VAL . . . . . 0.402 HG23 ' CZ2' ' S' ' 359' ' ' TRP . 57.6 t -76.07 118.44 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.387 -0.82 . . . . 34.27 109.972 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' S' S ' 355' ' ' THR . . . . . 0.442 HG23 ' HB2' ' S' ' 360' ' ' TYR . 52.3 p -117.81 175.12 5.8 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.236 -0.915 . . . . 25.49 110.364 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' S' S ' 356' ' ' SER . . . . . . . . . . . . . 62.5 p -62.19 -17.65 58.74 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.462 -0.774 . . . . 31.24 110.704 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 357' ' ' ASN . . . . . . . . . . . . . 46.3 m-20 -107.0 14.16 26.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.15 -0.969 . . . . 28.61 110.608 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 358' ' ' GLY . . . . . . . . . . . . . . . 111.83 -152.88 17.59 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.031 -1.227 . . . . 22.01 110.031 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 359' ' ' TRP . . . . . 0.402 ' CZ2' HG23 ' S' ' 354' ' ' VAL . 15.5 m95 -91.32 116.69 29.04 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.396 -1.061 . . . . 25.54 110.148 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' S' S ' 360' ' ' TYR . . . . . 0.442 ' HB2' HG23 ' S' ' 355' ' ' THR . 1.3 m-85 -103.48 165.8 10.82 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.341 -0.849 . . . . 40.53 110.069 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' S' S ' 361' ' ' ALA . . . . . . . . . . . . . . . -140.09 130.07 24.81 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.393 -0.817 . . . . 18.04 110.296 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 362' ' ' ILE . . . . . 0.417 HG23 ' CZ ' ' S' ' 367' ' ' PHE . 89.1 mt -95.58 83.8 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.4 -0.813 . . . . 15.64 109.998 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' S' S ' 363' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' S' ' 365' ' ' GLU . 11.9 t0 -75.27 94.51 3.02 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.337 -0.852 . . . . 35.03 110.202 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' S' S ' 364' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 53.86 -89.34 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.545 -0.722 . . . . 46.72 110.575 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 365' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' S' ' 363' ' ' ASP . 23.8 mt-10 -122.67 19.1 10.34 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.082 -1.011 . . . . 56.2 110.271 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' S' S ' 366' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -117.95 125.05 49.68 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.26 -0.9 . . . . 51.02 110.406 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 367' ' ' PHE . . . . . 0.417 ' CZ ' HG23 ' S' ' 362' ' ' ILE . 26.8 m-85 -107.03 127.0 53.07 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.357 -0.84 . . . . 37.59 110.112 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' S' S ' 368' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -165.39 159.56 13.98 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.303 -0.873 . . . . 31.47 110.452 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 369' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.89 139.63 30.59 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 O-C-N 123.831 1.437 . . . . 28.85 110.509 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 370' ' ' TRP . . . . . . . . . . . . . 67.4 t90 -167.22 113.53 0.76 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.402 -0.812 . . . . 26.94 109.987 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 371' ' ' THR . . . . . . . . . . . . . 59.1 m -74.8 113.04 20.62 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.406 -0.808 . . . . 20.19 110.049 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 372' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -73.46 157.16 49.55 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 O-C-N 123.662 1.348 . . . . 28.68 110.625 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 373' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -90.67 147.19 35.69 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.391 -0.818 . . . . 35.72 109.832 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 374' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -76.02 -6.28 17.2 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.701 1.369 . . . . 30.89 110.506 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 375' ' ' SER . . . . . . . . . . . . . 70.4 p -104.42 -16.88 14.97 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.235 -0.916 . . . . 29.41 110.43 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 376' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -106.53 43.14 1.18 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.23 -0.919 . . . . 32.89 110.257 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 377' ' ' VAL . . . . . 0.501 HG23 ' CE1' ' S' ' 342' ' ' PHE . 7.3 p -114.7 147.26 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.311 -0.868 . . . . 24.33 110.163 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' S' S ' 378' ' ' LEU . . . . . . . . . . . . . 52.2 mt -115.96 -58.08 2.15 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.406 -0.809 . . . . 24.37 109.633 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 379' ' ' VAL . . . . . 0.401 ' O ' ' CA ' ' S' ' 340' ' ' GLY . 61.0 t -120.65 132.33 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.443 -0.786 . . . . 18.02 109.48 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' S' S ' 380' ' ' PHE . . . . . 0.456 ' CZ ' ' HE1' ' S' ' 332' ' ' MET . 14.3 p90 -142.54 173.92 11.1 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.398 -0.814 . . . . 29.35 110.622 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' S' S ' 381' ' ' VAL . . . . . . . . . . . . . 58.0 t -120.05 107.38 39.85 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.53 -0.731 . . . . 16.34 109.391 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 382' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.32 145.58 48.69 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.698 1.367 . . . . 20.94 110.738 -179.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' S' S ' 383' ' ' TYR . . . . . 0.4 ' CZ ' ' HB3' ' S' ' 338' ' ' HIS . 88.4 m-85 -61.02 -53.51 56.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.389 -0.819 . . . . 28.93 109.891 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' S' S ' 384' ' ' ASP . . . . . 0.497 ' C ' ' H ' ' S' ' 386' ' ' GLU . 2.1 m-20 -107.01 129.23 54.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.389 -0.82 . . . . 47.03 110.342 -177.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' S' S ' 385' ' ' GLN . . . . . 0.464 ' O ' ' O ' ' S' ' 386' ' ' GLU . 3.2 pt20 -70.22 13.79 0.15 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.403 -0.811 . . . . 46.69 110.175 177.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' S' S ' 386' ' ' GLU . . . . . 0.896 ' O ' ' HG2' ' S' ' 321' ' ' PRO . 2.6 mt-10 -48.54 176.64 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.388 -0.82 . . . . 50.25 109.602 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' S' S ' 387' ' ' PRO . . . . . 0.543 ' O ' ' C ' ' S' ' 388' ' ' LEU . 44.0 Cg_endo -69.71 -17.12 37.98 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.701 1.369 . . . . 34.39 110.581 -178.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' S' S ' 388' ' ' LEU . . . . . 0.577 ' O ' ' HB2' ' S' ' 389' ' ' ASN . 0.1 OUTLIER 33.45 81.79 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.326 -0.859 . . . . 38.01 110.143 -179.323 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' S' S ' 389' ' ' ASN . . . . . 0.577 ' HB2' ' O ' ' S' ' 388' ' ' LEU . 3.5 m120 64.29 168.79 0.17 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.376 -0.828 . . . . 45.82 110.139 -178.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' S' S ' 390' ' ' GLY . . . . . 0.51 ' O ' ' N ' ' S' ' 392' ' ' TRP . . . 151.44 -83.01 0.17 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.557 -1.417 . . . . 33.46 109.557 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' S' S ' 391' ' ' GLU . . . . . 0.415 ' CB ' ' O ' ' S' ' 390' ' ' GLY . 2.6 tp10 65.54 -62.8 0.22 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.328 -1.101 . . . . 56.58 110.08 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' S' S ' 392' ' ' TRP . . . . . 0.625 ' O ' ' HG2' ' S' ' 395' ' ' LYS . 0.0 OUTLIER -52.27 -29.34 22.64 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.325 -0.86 . . . . 31.43 110.359 179.622 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' S' S ' 393' ' ' LYS . . . . . 0.517 ' O ' HG13 ' S' ' 396' ' ' VAL . 14.1 mtmt -50.86 -48.55 60.14 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.277 -0.889 . . . . 39.42 110.418 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' S' S ' 394' ' ' ALA . . . . . 0.559 ' O ' ' HD3' ' S' ' 398' ' ' ARG . . . -78.38 -2.64 39.23 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.391 -0.818 . . . . 34.33 110.058 179.061 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' S' S ' 395' ' ' LYS . . . . . 0.663 ' HG3' HD12 ' R' ' 143' ' ' LEU . 0.1 OUTLIER -90.87 -35.94 14.48 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.416 -0.802 . . . . 60.09 110.264 179.689 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' S' S ' 396' ' ' VAL . . . . . 0.78 HG21 ' HB2' ' R' ' 101' ' ' ALA . 8.5 p -76.14 -45.94 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.365 -0.835 . . . . 35.5 110.572 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' S' S ' 397' ' ' GLN . . . . . 0.436 ' N ' ' CG1' ' S' ' 396' ' ' VAL . 0.2 OUTLIER -68.41 40.9 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.159 -0.963 . . . . 49.96 110.632 179.743 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' S' S ' 398' ' ' ARG . . . . . 0.819 ' HD2' ' N ' ' S' ' 398' ' ' ARG . 0.0 OUTLIER -81.4 -166.77 1.25 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.26 -0.9 . . . . 43.42 110.674 -179.166 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' S' S ' 399' ' ' LYS . . . . . 0.684 ' HB2' ' HA3' ' R' ' 97' ' ' GLY . 0.0 OUTLIER 171.92 124.01 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.355 -0.841 . . . . 55.31 110.075 179.897 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' S' S ' 400' ' ' LEU . . . . . 0.715 ' CB ' ' HB2' ' R' ' 51' ' ' ALA . 55.8 tp -61.44 65.31 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.3 -0.875 . . . . 41.03 110.27 179.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' S' S ' 401' ' ' LYS . . . . . 0.672 ' HA ' ' OD1' ' R' ' 49' ' ' ASP . 19.1 ttmt . . . . . 0 N--CA 1.492 1.671 0 O-C-N 121.349 -0.844 . . . . 61.97 110.189 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 30' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 121.177 0.513 . . . . 43.359999999999999 110.202 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' R' R ' 31' ' ' LEU . . . . . . . . . . . . . 65.3 mt -134.91 140.56 45.85 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.312 -0.867 . . . . 22.93 110.283 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 32' ' ' THR . . . . . . . . . . . . . 69.6 m -87.55 110.57 20.45 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.376 -0.828 . . . . 22.34 109.984 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 33' ' ' LEU . . . . . 0.595 HD22 ' CE2' ' R' ' 62' ' ' TYR . 80.1 mt -62.35 -172.79 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.266 -0.896 . . . . 21.390000000000001 110.226 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 34' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -74.65 -29.41 61.25 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.333 -0.855 . . . . 34.399999999999999 110.386 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 35' ' ' ASN . . . . . . . . . . . . . 48.3 p30 -77.73 -1.87 33.38 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.324 -0.86 . . . . 30.280000000000001 110.633 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.2 -16.56 59.42 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.776 -1.329 . . . . 36.25 109.776 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 37' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -59.02 161.81 4.76 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.285 -1.127 . . . . 53.799999999999997 110.383 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 38' ' ' LYS . . . . . . . . . . . . . 56.9 mttt -117.84 135.78 53.86 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.43 -0.794 . . . . 49.909999999999997 110.108 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 39' ' ' LYS . . . . . 0.406 ' HG2' ' CZ ' ' R' ' 41' ' ' PHE . 8.1 ttmt -138.75 143.69 39.12 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.432 -0.792 . . . . 35.689999999999998 110.223 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 40' ' ' THR . . . . . . . . . . . . . 23.7 m -102.57 127.98 49.42 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.309 -0.87 . . . . 34.840000000000003 110.193 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 41' ' ' PHE . . . . . 0.406 ' CZ ' ' HG2' ' R' ' 39' ' ' LYS . 96.6 m-85 -113.09 132.66 55.34 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.402 -0.811 . . . . 34.420000000000002 110.147 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 42' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -93.25 140.95 28.98 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.31 -0.869 . . . . 51.460000000000001 110.204 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 43' ' ' SER . . . . . . . . . . . . . 54.5 m -70.81 141.89 51.33 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.453 -0.779 . . . . 41.840000000000003 110.206 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.74 125.41 29.53 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.296 -0.877 . . . . 33.82 109.934 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 45' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.16 151.05 54.74 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.59 1.31 . . . . 30.27 110.649 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 46' ' ' ASN . . . . . 0.4 ' HA ' ' OD1' ' R' ' 50' ' ' ASN . 52.1 t-20 -124.23 109.84 13.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.456 -0.777 . . . . 35.100000000000001 110.033 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 47' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -120.28 -34.84 3.56 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.298 -0.876 . . . . 42.810000000000002 110.503 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 48' ' ' HIS . . . . . 0.439 ' NE2' HD11 ' R' ' 80' ' ' LEU . 73.4 m80 -105.77 45.18 0.98 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.221 -0.925 . . . . 49.969999999999999 110.176 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 49' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 50.29 34.72 9.28 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.414 -0.804 . . . . 61.32 110.173 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 50' ' ' ASN . . . . . 0.4 ' OD1' ' HA ' ' R' ' 46' ' ' ASN . 15.0 p-10 -86.25 43.74 1.08 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.333 -0.854 . . . . 51.5 110.703 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.08 -46.11 78.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.184 -0.948 . . . . 38.770000000000003 109.558 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 52' ' ' TRP . . . . . 0.483 ' CD2' ' N ' ' R' ' 53' ' ' LEU . 68.2 p-90 -58.39 -38.43 77.31 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.419 -0.801 . . . . 26.239999999999998 110.055 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 53' ' ' LEU . . . . . 0.483 ' N ' ' CD2' ' R' ' 52' ' ' TRP . 23.2 tp -66.68 -46.68 74.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.4 -0.813 . . . . 26.75 110.013 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 54' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -55.2 -41.61 72.22 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.372 -0.83 . . . . 35.020000000000003 110.156 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.17 -46.08 92.0 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.337 -0.852 . . . . 24.469999999999999 110.145 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 56' ' ' ILE . . . . . 0.432 HG12 HD11 ' R' ' 104' ' ' ILE . 76.2 mt -62.23 -42.21 94.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.322 -0.861 . . . . 26.030000000000001 109.906 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 57' ' ' LEU . . . . . . . . . . . . . 22.4 mt -60.31 -45.6 92.83 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.325 -0.859 . . . . 26.77 109.68 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 58' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -63.97 -46.49 84.4 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.426 -0.796 . . . . 22.32 109.561 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 59' ' ' LEU . . . . . 0.429 ' HA ' ' HE2' ' R' ' 151' ' ' PHE . 23.9 tp -61.43 -37.75 84.65 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.316 -0.865 . . . . 20.550000000000001 109.396 179.295 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 60' ' ' PHE . . . . . 0.528 ' CE2' HD21 ' R' ' 111' ' ' LEU . 2.8 m-85 -61.08 -44.78 96.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.628 -0.67 . . . . 20.079999999999998 109.907 179.304 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 61' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -63.16 -36.15 82.65 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.481 -0.762 . . . . 18.800000000000001 110.472 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 62' ' ' TYR . . . . . 0.595 ' CE2' HD22 ' R' ' 33' ' ' LEU . 9.2 t80 -63.04 -41.78 99.58 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.207 -0.933 . . . . 26.449999999999999 110.26 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 63' ' ' VAL . . . . . 0.406 ' H ' HG22 ' R' ' 63' ' ' VAL . 30.2 m -93.38 20.38 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.304 -0.872 . . . . 29.75 110.188 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 64' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 52.91 75.6 0.23 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.303 -0.873 . . . . 35.520000000000003 110.546 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 65' ' ' GLU . . . . . 0.443 ' HG2' ' CD2' ' R' ' 60' ' ' PHE . 14.3 tp10 -116.29 104.05 52.35 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.457 -0.777 . . . . 29.890000000000001 109.901 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 66' ' ' PRO . . . . . 0.48 ' HA ' ' HB2' ' R' ' 69' ' ' ASP . 46.6 Cg_endo -73.55 -5.83 17.74 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.79 1.416 . . . . 21.370000000000001 111.094 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 67' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -52.11 -61.56 2.19 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.103 -0.998 . . . . 23.850000000000001 110.331 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 68' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -98.12 36.56 1.56 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.25 -0.906 . . . . 28.07 110.438 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 69' ' ' ASP . . . . . 0.48 ' HB2' ' HA ' ' R' ' 66' ' ' PRO . 11.7 t0 -72.36 -33.26 67.13 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.346 -0.846 . . . . 43.759999999999998 110.144 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 70' ' ' TRP . . . . . 0.477 ' CE2' ' CG2' ' R' ' 71' ' ' VAL . 47.9 p-90 -73.42 -3.84 29.88 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.275 -0.891 . . . . 33.060000000000002 110.716 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 71' ' ' VAL . . . . . 0.556 HG11 ' HB2' ' R' ' 82' ' ' ALA . 40.7 t -109.79 -27.45 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.194 -0.941 . . . . 31.699999999999999 109.685 179.155 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 72' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -86.62 -48.83 7.98 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.358 -0.839 . . . . 33.579999999999998 110.282 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 73' ' ' SER . . . . . . . . . . . . . 69.9 m -89.7 51.08 2.01 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.27 -0.893 . . . . 50.82 110.36 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 74' ' ' SER . . . . . . . . . . . . . 15.8 t -125.92 138.3 31.8 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.338 -0.851 . . . . 34.740000000000002 110.221 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.38 -24.97 15.93 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 O-C-N 123.641 1.337 . . . . 35.700000000000003 110.348 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 76' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -91.68 153.16 19.85 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.37 -0.831 . . . . 66.480000000000004 110.379 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 77' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -81.48 95.22 7.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.292 -0.88 . . . . 46.719999999999999 110.102 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 78' ' ' LEU . . . . . . . . . . . . . 96.3 mt -96.44 28.0 3.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.331 -0.856 . . . . 37.549999999999997 110.182 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 79' ' ' THR . . . . . . . . . . . . . 29.7 m -56.2 -54.67 42.44 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.379 -0.825 . . . . 37.359999999999999 110.295 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 80' ' ' LEU . . . . . 0.603 ' HA ' HD12 ' R' ' 83' ' ' ILE . 16.0 mt -60.82 -23.27 64.96 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.347 -0.845 . . . . 35.829999999999998 110.543 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 81' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -79.46 -39.12 32.98 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.184 -0.948 . . . . 44.030000000000001 110.32 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 82' ' ' ALA . . . . . 0.556 ' HB2' HG11 ' R' ' 71' ' ' VAL . . . -69.5 -28.58 66.17 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.292 -0.88 . . . . 32.539999999999999 110.202 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 83' ' ' ILE . . . . . 0.603 HD12 ' HA ' ' R' ' 80' ' ' LEU . 78.1 mt -70.15 -46.06 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.34 -0.85 . . . . 32.020000000000003 110.302 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 84' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -55.22 -52.08 64.52 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.164 -0.96 . . . . 34.090000000000003 110.596 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 85' ' ' GLN . . . . . 0.532 ' HG2' HD12 ' R' ' 89' ' ' LEU . 31.9 tt0 -54.83 -46.87 74.64 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.235 -0.915 . . . . 25.940000000000001 110.28 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 86' ' ' LEU . . . . . . . . . . . . . 24.0 mt -58.63 -43.85 89.81 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.299 -0.876 . . . . 16.199999999999999 109.936 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 87' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -65.34 -35.26 80.43 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.466 -0.771 . . . . 49.090000000000003 110.286 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 88' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -78.43 -19.04 54.07 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.247 -0.908 . . . . 28.609999999999999 110.493 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 89' ' ' LEU . . . . . 0.532 HD12 ' HG2' ' R' ' 85' ' ' GLN . 32.6 mt -96.18 -29.41 14.07 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.207 -0.933 . . . . 26.16 110.197 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 90' ' ' THR . . . . . . . . . . . . . 58.7 p -105.7 -34.59 7.66 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.285 -0.884 . . . . 33.329999999999998 109.778 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.85 16.1 58.6 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.821 -1.312 . . . . 31.129999999999999 109.821 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 92' ' ' LEU . . . . . . . . . . . . . 97.0 mt -100.1 155.29 17.81 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.169 -1.195 . . . . 42.520000000000003 110.21 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 93' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -86.28 91.56 8.51 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.46 -0.775 . . . . 68.459999999999994 109.984 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 94' ' ' LEU . . . . . 0.457 ' HB3' ' CZ2' ' R' ' 52' ' ' TRP . 48.1 mt -99.41 53.01 0.95 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.18 -0.95 . . . . 44.630000000000003 110.364 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 95' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.44 -38.69 6.39 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.3 -0.875 . . . . 67.159999999999997 110.399 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 96' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -113.93 44.29 1.67 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.404 -0.81 . . . . 67.019999999999996 110.326 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 97' ' ' GLY . . . . . . . . . . . . . . . 99.12 150.78 26.03 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.614 -1.395 . . . . 49.479999999999997 109.614 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 98' ' ' GLY . . . . . . . . . . . . . . . -166.21 160.03 33.46 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.253 -1.539 . . . . 36.57 109.253 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 99' ' ' PRO . . . . . 0.79 ' O ' HG23 ' R' ' 103' ' ' VAL . 45.1 Cg_endo -72.58 121.1 7.13 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.684 1.36 . . . . 30.41 110.435 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 100' ' ' PRO . . . . . 0.412 ' HA ' HD11 ' R' ' 56' ' ' ILE . 45.7 Cg_endo -72.25 -31.65 11.49 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 O-C-N 123.645 1.339 . . . . 29.940000000000001 110.54 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 101' ' ' ALA . . . . . 0.476 ' HB2' ' HB3' ' R' ' 178' ' ' LEU . . . -69.96 -38.48 76.13 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.301 -0.875 . . . . 23.640000000000001 110.263 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 102' ' ' LEU . . . . . 0.424 HD23 HD21 ' R' ' 106' ' ' ASN . 0.1 OUTLIER -72.62 -40.8 66.17 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.322 -0.861 . . . . 20.309999999999999 110.362 -179.713 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' R' R ' 103' ' ' VAL . . . . . 0.79 HG23 ' O ' ' R' ' 99' ' ' PRO . 63.7 t -58.16 -40.06 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.219 -0.925 . . . . 16.329999999999998 109.996 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 104' ' ' ILE . . . . . 0.432 HD11 HG12 ' R' ' 56' ' ' ILE . 81.9 mt -71.7 -30.57 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.397 -0.814 . . . . 24.77 109.93 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 105' ' ' TRP . . . . . 0.462 ' O ' ' HD3' ' R' ' 108' ' ' LYS . 70.6 t-105 -82.42 0.84 40.28 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.345 -0.847 . . . . 23.280000000000001 110.273 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 106' ' ' ASN . . . . . 0.424 HD21 HD23 ' R' ' 102' ' ' LEU . 6.9 m-80 -105.08 -10.38 17.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.116 -0.99 . . . . 28.260000000000002 110.125 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 107' ' ' ILE . . . . . . . . . . . . . 36.8 pt -126.83 34.97 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.211 -0.931 . . . . 18.77 110.05 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 108' ' ' LYS . . . . . 0.502 ' HG2' ' HB ' ' R' ' 115' ' ' ILE . 9.3 mtpp -61.05 -48.44 81.72 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.548 -0.72 . . . . 42.5 110.025 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 109' ' ' HIS . . . . . 0.445 ' CD2' ' HG ' ' R' ' 110' ' ' LEU . 50.8 p-80 -66.02 -12.85 58.07 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.527 -0.733 . . . . 20.07 110.698 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 110' ' ' LEU . . . . . 0.445 ' HG ' ' CD2' ' R' ' 109' ' ' HIS . 80.6 mt -94.79 -17.25 22.31 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.076 -1.015 . . . . 15.69 110.207 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 111' ' ' LEU . . . . . 0.528 HD21 ' CE2' ' R' ' 60' ' ' PHE . 10.3 mt -94.13 144.15 25.75 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.342 -0.849 . . . . 25.390000000000001 111.014 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 112' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -77.71 -17.35 57.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.552 -0.717 . . . . 53.479999999999997 109.852 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 113' ' ' THR . . . . . 0.459 HG22 ' N ' ' R' ' 114' ' ' GLY . 60.0 m -83.73 166.64 17.88 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.236 -0.915 . . . . 14.800000000000001 110.233 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 114' ' ' GLY . . . . . 0.459 ' N ' HG22 ' R' ' 113' ' ' THR . . . -97.96 127.16 9.13 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.994 -1.243 . . . . 16.140000000000001 109.994 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 115' ' ' ILE . . . . . 0.577 HD13 ' HB ' ' R' ' 124' ' ' VAL . 47.7 mm -109.11 139.31 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.441 -1.035 . . . . 13.460000000000001 109.738 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 116' ' ' GLY . . . . . . . . . . . . . . . -152.74 -155.88 7.3 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.959 -1.257 . . . . 23.899999999999999 109.959 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 117' ' ' THR . . . . . 0.528 HG22 ' CG2' ' R' ' 126' ' ' VAL . 18.8 p -134.99 -171.39 2.79 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.453 -1.028 . . . . 27.370000000000001 110.044 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 118' ' ' ALA . . . . . 0.445 ' HB3' ' OD1' ' R' ' 128' ' ' ASP . . . -56.6 -58.04 9.79 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.251 -0.906 . . . . 18.760000000000002 110.064 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 119' ' ' SER . . . . . . . . . . . . . 1.1 m -56.52 -40.66 75.42 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.259 -0.901 . . . . 32.350000000000001 109.721 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 120' ' ' ARG . . . . . 0.409 ' NH1' ' NE1' ' S' ' 305' ' ' TRP . 10.0 mtm180 -110.03 86.26 4.84 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.47 -0.768 . . . . 27.120000000000001 109.716 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 121' ' ' PRO . . . . . 0.483 ' HA ' ' SG ' ' R' ' 125' ' ' CYS . 44.7 Cg_endo -71.26 166.44 29.25 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 O-C-N 123.784 1.413 . . . . 22.68 111.009 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 122' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' R' ' 121' ' ' PRO . 38.2 t 178.58 -161.65 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.609 -0.682 . . . . 22.989999999999998 109.467 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 123' ' ' GLU . . . . . 0.44 ' HG2' HG23 ' R' ' 113' ' ' THR . 2.3 tp10 -56.5 -39.92 74.08 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.211 -0.93 . . . . 36.18 109.649 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 124' ' ' VAL . . . . . 0.577 ' HB ' HD13 ' R' ' 115' ' ' ILE . 83.8 t -142.57 136.39 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.606 -0.684 . . . . 20.640000000000001 109.383 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 125' ' ' CYS . . . . . 0.483 ' SG ' ' HA ' ' R' ' 121' ' ' PRO . 83.7 m -140.3 168.17 20.43 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.17 -0.956 . . . . 22.800000000000001 111.131 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 126' ' ' VAL . . . . . 0.728 HG12 HG22 ' R' ' 179' ' ' VAL . 35.9 m -122.68 159.82 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.724 -0.61 . . . . 21.239999999999998 109.613 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 127' ' ' VAL . . . . . 0.71 HG11 ' O ' ' R' ' 177' ' ' VAL . 31.1 m -70.89 141.86 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.283 -0.886 . . . . 19.77 110.675 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 128' ' ' ASP . . . . . 0.445 ' OD1' ' HB3' ' R' ' 118' ' ' ALA . 53.9 p-10 -137.73 19.41 2.87 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.327 -0.858 . . . . 29.210000000000001 110.697 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 129' ' ' GLY . . . . . . . . . . . . . . . 114.06 -0.02 24.06 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.928 -1.13 . . . . 33.859999999999999 110.441 179.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 130' ' ' THR . . . . . . . . . . . . . 58.7 m -91.9 131.88 36.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.11 -1.229 . . . . 26.41 110.046 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -62.57 120.72 11.68 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.369 -0.832 . . . . 33.079999999999998 110.258 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 132' ' ' MET . . . . . 0.433 ' HE1' ' CE2' ' R' ' 180' ' ' PHE . 98.4 mmm -105.17 165.63 10.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.467 -0.771 . . . . 30.760000000000002 110.467 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 133' ' ' CYS . . . . . 0.41 ' HA ' ' HB3' ' R' ' 174' ' ' PRO . 32.8 m -141.13 158.13 44.34 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.542 -0.724 . . . . 27.0 109.973 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 134' ' ' LEU . . . . . 0.564 HD11 ' O ' ' R' ' 172' ' ' PRO . 0.1 OUTLIER -58.45 -19.71 38.88 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.322 -0.861 . . . . 33.899999999999999 110.553 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' R' R ' 135' ' ' ALA . . . . . . . . . . . . . . . -92.8 8.24 40.29 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.31 -0.868 . . . . 19.370000000000001 110.802 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 136' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -93.76 -21.84 19.07 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.209 -0.932 . . . . 30.469999999999999 110.183 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 137' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -149.95 165.42 32.71 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.321 -0.862 . . . . 24.27 110.189 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 138' ' ' HIS . . . . . 0.433 ' HA ' HG23 ' R' ' 154' ' ' VAL . 15.2 p80 -117.88 15.19 14.33 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.382 -0.824 . . . . 20.91 110.452 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 139' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' R' ' 152' ' ' ALA . . . -177.22 152.4 0.87 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.207 -0.933 . . . . 15.69 110.099 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 140' ' ' GLY . . . . . 0.427 ' HA3' ' O ' ' R' ' 179' ' ' VAL . . . 161.81 175.17 32.55 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.962 -1.255 . . . . 23.760000000000002 109.962 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 141' ' ' ILE . . . . . . . . . . . . . 83.7 mt -95.5 136.54 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.473 -1.016 . . . . 25.300000000000001 109.718 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 142' ' ' PHE . . . . . 0.576 ' CD2' ' HB2' ' R' ' 172' ' ' PRO . 82.7 m-85 -120.72 -172.61 2.41 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.26 -0.9 . . . . 30.239999999999998 110.505 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 143' ' ' LEU . . . . . 0.742 HD23 ' O ' ' R' ' 148' ' ' HIS . 0.5 OUTLIER -119.79 77.74 1.26 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.367 -0.833 . . . . 32.799999999999997 110.316 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' R' R ' 144' ' ' LYS . . . . . 0.471 ' HG3' ' CZ2' ' R' ' 170' ' ' TRP . 1.0 OUTLIER -69.62 76.87 0.43 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.43 -0.794 . . . . 49.18 109.679 179.594 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' R' R ' 145' ' ' GLY . . . . . 0.458 ' O ' HD22 ' R' ' 143' ' ' LEU . . . 104.5 179.27 24.83 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.188 -1.565 . . . . 53.869999999999997 109.188 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 146' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -88.47 145.83 25.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.388 -1.066 . . . . 68.579999999999998 109.999 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 147' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 58.25 36.45 25.69 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.362 -0.837 . . . . 56.619999999999997 110.655 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 148' ' ' HIS . . . . . 0.742 ' O ' HD23 ' R' ' 143' ' ' LEU . 44.7 t60 -158.61 148.13 19.28 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.219 -0.926 . . . . 44.57 110.376 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 149' ' ' ALA . . . . . . . . . . . . . . . -150.29 146.9 27.05 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.467 -0.771 . . . . 33.539999999999999 110.07 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 150' ' ' VAL . . . . . . . . . . . . . 34.2 m -142.3 161.51 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.261 -0.899 . . . . 27.609999999999999 110.36 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 151' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' R' ' 152' ' ' ALA . 5.8 t80 -86.17 155.6 20.67 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.428 -0.795 . . . . 23.039999999999999 109.904 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 152' ' ' ALA . . . . . 0.537 ' N ' ' CD1' ' R' ' 151' ' ' PHE . . . -157.29 151.5 24.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.443 -0.786 . . . . 29.609999999999999 109.611 179.048 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 153' ' ' CYS . . . . . . . . . . . . . 26.7 p -154.28 173.57 15.97 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.298 -0.876 . . . . 22.75 110.507 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 154' ' ' VAL . . . . . 0.613 HG22 ' CE2' ' R' ' 159' ' ' TRP . 59.7 t -90.59 117.04 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.392 -0.817 . . . . 23.260000000000002 110.076 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 155' ' ' THR . . . . . . . . . . . . . 70.3 p -112.13 -176.63 2.97 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.358 -0.839 . . . . 17.879999999999999 110.041 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 156' ' ' SER . . . . . . . . . . . . . 78.6 p -75.92 -3.75 37.16 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.329 -0.857 . . . . 21.829999999999998 110.727 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 157' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -118.25 10.43 12.85 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.148 -0.97 . . . . 36.539999999999999 110.619 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 158' ' ' GLY . . . . . . . . . . . . . . . 117.97 -162.71 13.02 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.533 -1.427 . . . . 31.739999999999998 109.533 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 159' ' ' TRP . . . . . 0.613 ' CE2' HG22 ' R' ' 154' ' ' VAL . 14.7 m95 -86.51 122.42 30.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.334 -1.098 . . . . 28.25 110.112 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 160' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -108.46 166.96 10.38 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.376 -0.827 . . . . 41.240000000000002 110.19 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 161' ' ' ALA . . . . . . . . . . . . . . . -143.22 123.42 13.74 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.362 -0.836 . . . . 27.399999999999999 110.198 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 162' ' ' ILE . . . . . . . . . . . . . 92.0 mt -87.55 81.15 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.295 -0.878 . . . . 24.27 110.051 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 163' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' R' ' 165' ' ' GLU . 15.3 t0 -72.86 92.42 1.6 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.457 -0.777 . . . . 36.079999999999998 110.254 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 164' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 54.09 -88.94 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.489 -0.757 . . . . 46.079999999999998 110.603 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 165' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' R' ' 163' ' ' ASP . 29.7 mt-10 -124.72 35.92 4.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.088 -1.007 . . . . 50.939999999999998 110.187 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 166' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -135.75 117.3 14.84 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.388 -0.82 . . . . 47.280000000000001 110.347 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 167' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -101.04 119.98 39.53 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.434 -0.791 . . . . 40.469999999999999 110.164 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 168' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -157.57 158.57 30.65 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.24 -0.913 . . . . 30.210000000000001 110.376 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 169' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.8 133.04 19.46 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.931 1.49 . . . . 32.759999999999998 110.474 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 170' ' ' TRP . . . . . 0.471 ' CZ2' ' HG3' ' R' ' 144' ' ' LYS . 66.9 t90 -159.81 119.37 2.89 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.461 -0.774 . . . . 32.789999999999999 109.909 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 171' ' ' THR . . . . . . . . . . . . . 46.1 m -81.1 112.61 34.16 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.448 -0.783 . . . . 36.920000000000002 110.163 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 172' ' ' PRO . . . . . 0.576 ' HB2' ' CD2' ' R' ' 142' ' ' PHE . 47.4 Cg_endo -73.71 158.75 46.68 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.66 1.348 . . . . 33.539999999999999 110.592 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 173' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -88.84 144.97 33.86 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.318 -0.864 . . . . 45.759999999999998 109.851 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 174' ' ' PRO . . . . . 0.41 ' HB3' ' HA ' ' R' ' 133' ' ' CYS . 46.0 Cg_endo -71.74 -10.34 26.31 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.614 1.323 . . . . 29.629999999999999 110.492 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 175' ' ' SER . . . . . . . . . . . . . 53.1 p -103.5 -17.55 15.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.281 -0.887 . . . . 35.700000000000003 110.343 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 176' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -103.5 43.26 1.1 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.202 -0.936 . . . . 39.649999999999999 110.442 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 177' ' ' VAL . . . . . 0.71 ' O ' HG11 ' R' ' 127' ' ' VAL . 10.5 p -117.79 127.14 75.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.326 -0.859 . . . . 20.609999999999999 110.034 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 178' ' ' LEU . . . . . 0.476 ' HB3' ' HB2' ' R' ' 101' ' ' ALA . 46.3 mt -91.47 -61.36 1.66 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.35 -0.844 . . . . 15.58 109.351 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 179' ' ' VAL . . . . . 0.728 HG22 HG12 ' R' ' 126' ' ' VAL . 67.9 t -114.58 144.72 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.621 -0.674 . . . . 17.399999999999999 109.413 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 180' ' ' PHE . . . . . 0.433 ' CE2' ' HE1' ' R' ' 132' ' ' MET . 43.7 p90 -152.17 163.32 39.62 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.273 -0.892 . . . . 20.16 110.602 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 181' ' ' VAL . . . . . . . . . . . . . 66.5 t -113.12 111.48 50.4 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.429 -0.795 . . . . 17.690000000000001 109.833 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 182' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.03 149.52 52.9 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.545 1.287 . . . . 17.809999999999999 110.423 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 183' ' ' TYR . . . . . 0.739 ' O ' ' C ' ' R' ' 184' ' ' ASP . 78.9 m-85 -59.01 175.53 0.28 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.43 -0.794 . . . . 28.010000000000002 110.526 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' R' R ' 184' ' ' ASP . . . . . 0.739 ' C ' ' O ' ' R' ' 183' ' ' TYR . 0.0 OUTLIER -12.28 -76.89 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.343 -0.848 . . . . 58.640000000000001 110.303 -178.086 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' R' R ' 185' ' ' GLN . . . . . . . . . . . . . 6.7 tm0? . . . . . 0 N--CA 1.503 2.188 0 CA-C-O 121.25 0.548 . . . . 80.420000000000002 111.723 179.409 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' R' R ' 193' ' ' LYS . . . . . 0.598 ' O ' ' HB2' ' R' ' 194' ' ' ALA . 20.4 ttpp . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 120.938 0.399 . . . . 49.5 110.166 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' R' R ' 194' ' ' ALA . . . . . 0.598 ' HB2' ' O ' ' R' ' 193' ' ' LYS . . . . . . . . 0 N--CA 1.495 1.8 0 O-C-N 121.125 -0.984 . . . . 40.399999999999999 110.099 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 229' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.171 0.51 . . . . 51.829999999999998 110.208 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 230' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -97.28 142.76 28.78 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.4 -0.813 . . . . 54.130000000000003 110.222 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 231' ' ' LEU . . . . . . . . . . . . . 67.8 mt -134.11 140.99 46.97 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.343 -0.848 . . . . 33.039999999999999 110.337 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 232' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' S' ' 355' ' ' THR . 40.0 m -89.25 103.23 15.87 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.319 -0.863 . . . . 26.920000000000002 110.068 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' S' S ' 233' ' ' LEU . . . . . 0.666 HD22 ' CE2' ' S' ' 262' ' ' TYR . 79.9 mt -55.92 179.28 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.437 -0.79 . . . . 13.779999999999999 110.498 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' S' S ' 234' ' ' TYR . . . . . 0.442 ' CG ' ' N ' ' S' ' 235' ' ' ASN . 35.6 p90 -65.01 -35.65 81.89 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.393 -0.817 . . . . 26.079999999999998 110.198 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' S' S ' 235' ' ' ASN . . . . . 0.442 ' N ' ' CG ' ' S' ' 234' ' ' TYR . 50.7 p30 -74.33 -7.4 52.69 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.373 -0.829 . . . . 20.039999999999999 110.567 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' S' S ' 236' ' ' GLY . . . . . . . . . . . . . . . 95.69 -19.9 52.22 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.782 -1.327 . . . . 22.710000000000001 109.782 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 237' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -53.03 145.73 12.49 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.189 -1.183 . . . . 35.439999999999998 110.183 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 238' ' ' LYS . . . . . . . . . . . . . 44.3 mttt -102.17 127.91 48.89 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.38 -0.825 . . . . 32.560000000000002 110.361 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 239' ' ' LYS . . . . . 0.412 ' HG2' ' CZ ' ' S' ' 241' ' ' PHE . 9.0 ttmt -132.31 144.52 50.63 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.357 -0.839 . . . . 26.68 109.955 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' S' S ' 240' ' ' THR . . . . . . . . . . . . . 51.8 m -102.0 132.22 47.97 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.34 -0.85 . . . . 41.020000000000003 110.348 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 241' ' ' PHE . . . . . 0.412 ' CZ ' ' HG2' ' S' ' 239' ' ' LYS . 96.0 m-85 -117.96 137.7 52.67 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.418 -0.801 . . . . 28.620000000000001 110.186 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' S' S ' 242' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -96.42 161.78 13.77 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.392 -0.818 . . . . 47.890000000000001 110.257 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 243' ' ' SER . . . . . . . . . . . . . 72.0 m -90.5 151.52 21.33 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.372 -0.83 . . . . 45.090000000000003 110.282 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 244' ' ' ARG . . . . . . . . . . . . . 1.4 mtp85 -129.72 126.73 22.74 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.375 -0.828 . . . . 42.490000000000002 110.282 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 245' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.31 161.02 43.78 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.674 1.355 . . . . 35.68 110.544 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 246' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -132.89 97.85 4.14 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.353 -0.842 . . . . 51.880000000000003 109.853 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 247' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -110.47 -22.25 11.76 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.398 -0.813 . . . . 53.689999999999998 110.658 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 248' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -117.24 43.65 2.27 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.223 -0.923 . . . . 55.789999999999999 110.704 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 249' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 48.84 38.37 11.9 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.405 -0.809 . . . . 49.450000000000003 110.386 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 250' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -90.67 29.09 1.37 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.489 -0.757 . . . . 36.859999999999999 110.327 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 251' ' ' ALA . . . . . . . . . . . . . . . -53.91 -43.12 69.44 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.229 -0.919 . . . . 29.690000000000001 109.612 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 252' ' ' TRP . . . . . 0.417 ' CZ2' ' HB3' ' S' ' 294' ' ' LEU . 67.9 p-90 -61.81 -33.94 75.03 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.523 -0.736 . . . . 41.119999999999997 109.829 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' S' S ' 253' ' ' LEU . . . . . 0.408 ' N ' ' CD2' ' S' ' 252' ' ' TRP . 23.4 tp -70.17 -47.17 62.77 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.378 -0.826 . . . . 24.890000000000001 110.001 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' S' S ' 254' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -56.13 -42.47 76.96 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.445 -0.784 . . . . 35.649999999999999 109.966 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 255' ' ' ALA . . . . . . . . . . . . . . . -59.53 -48.25 82.39 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.463 -0.773 . . . . 22.73 110.071 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 256' ' ' ILE . . . . . 0.509 HG12 HD11 ' S' ' 304' ' ' ILE . 79.7 mt -62.24 -40.68 88.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.321 -0.862 . . . . 28.850000000000001 109.983 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' S' S ' 257' ' ' LEU . . . . . . . . . . . . . 19.0 mt -61.54 -44.45 97.03 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.352 -0.843 . . . . 23.07 110.183 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 258' ' ' GLN . . . . . 0.499 ' HB3' ' CD2' ' S' ' 351' ' ' PHE . 53.4 mm-40 -65.12 -45.33 85.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.371 -0.831 . . . . 29.780000000000001 109.882 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' S' S ' 259' ' ' LEU . . . . . 0.416 ' O ' HG22 ' S' ' 263' ' ' VAL . 19.9 tp -58.67 -36.41 74.13 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.344 -0.848 . . . . 17.940000000000001 109.462 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' S' S ' 260' ' ' PHE . . . . . 0.523 ' CE2' HD21 ' S' ' 311' ' ' LEU . 3.1 m-85 -62.83 -45.29 93.3 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.655 -0.653 . . . . 30.57 109.834 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' S' S ' 261' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -62.01 -29.8 70.52 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.525 -0.734 . . . . 41.340000000000003 110.033 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 262' ' ' TYR . . . . . 0.666 ' CE2' HD22 ' S' ' 233' ' ' LEU . 8.7 t80 -71.24 -44.62 64.94 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.443 -0.786 . . . . 26.030000000000001 110.093 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' S' S ' 263' ' ' VAL . . . . . 0.416 HG22 ' O ' ' S' ' 259' ' ' LEU . 33.0 m -91.99 18.24 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.336 -0.852 . . . . 22.800000000000001 110.411 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' S' S ' 264' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 52.79 70.65 0.55 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.223 -0.923 . . . . 44.030000000000001 110.611 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 265' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -111.78 109.25 55.46 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.394 -0.817 . . . . 35.609999999999999 109.654 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 266' ' ' PRO . . . . . 0.475 ' HA ' ' HB2' ' S' ' 269' ' ' ASP . 48.6 Cg_endo -75.39 0.45 9.05 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 O-C-N 123.605 1.318 . . . . 37.670000000000002 111.742 -179.111 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' S' S ' 267' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -56.54 -67.7 0.28 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.802 -1.186 . . . . 41.490000000000002 110.165 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' S' S ' 268' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -92.91 39.89 1.05 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.148 -0.97 . . . . 50.759999999999998 110.048 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 269' ' ' ASP . . . . . 0.475 ' HB2' ' HA ' ' S' ' 266' ' ' PRO . 0.9 OUTLIER -76.01 -33.19 59.67 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.381 -0.825 . . . . 61.859999999999999 109.765 179.55 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' S' S ' 270' ' ' TRP . . . . . 0.512 ' CE2' HG23 ' S' ' 271' ' ' VAL . 51.0 p-90 -73.94 -4.28 34.2 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.268 -0.895 . . . . 39.850000000000001 110.466 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' S' S ' 271' ' ' VAL . . . . . 0.512 HG23 ' CE2' ' S' ' 270' ' ' TRP . 46.6 t -109.58 -32.66 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.157 -0.964 . . . . 39.18 110.07 179.552 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' S' S ' 272' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -78.67 -36.53 43.63 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.42 -0.8 . . . . 40.020000000000003 110.47 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 273' ' ' SER . . . . . . . . . . . . . 70.9 m -103.57 56.16 0.74 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.278 -0.889 . . . . 47.200000000000003 110.294 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 274' ' ' SER . . . . . . . . . . . . . 6.9 t -133.03 141.22 40.15 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.385 -0.822 . . . . 47.609999999999999 110.158 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 275' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.76 -18.85 21.71 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.66 1.347 . . . . 45.280000000000001 110.556 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 276' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -99.89 140.87 33.47 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.3 -0.875 . . . . 57.270000000000003 110.31 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 277' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -71.73 97.66 1.81 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.398 -0.814 . . . . 37.280000000000001 110.279 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 278' ' ' LEU . . . . . . . . . . . . . 86.3 mt -97.02 33.82 1.84 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.394 -0.816 . . . . 43.880000000000003 110.047 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 279' ' ' THR . . . . . . . . . . . . . 74.7 m -64.03 -60.1 3.65 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.484 -0.76 . . . . 50.049999999999997 110.303 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 280' ' ' LEU . . . . . 0.75 ' HA ' HD12 ' S' ' 283' ' ' ILE . 13.7 mt -51.61 -39.87 58.79 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.334 -0.854 . . . . 54.119999999999997 110.287 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' S' S ' 281' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.42 -49.67 74.57 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.499 -0.751 . . . . 65.280000000000001 110.177 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' S' S ' 282' ' ' ALA . . . . . . . . . . . . . . . -58.93 -33.9 71.12 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.456 -0.778 . . . . 46.509999999999998 110.571 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 283' ' ' ILE . . . . . 0.75 HD12 ' HA ' ' S' ' 280' ' ' LEU . 85.9 mt -66.39 -50.84 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.306 -0.871 . . . . 47.299999999999997 110.083 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' S' S ' 284' ' ' LYS . . . . . . . . . . . . . 33.8 tttp -50.52 -57.63 7.65 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.411 -0.806 . . . . 50.719999999999999 110.381 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 285' ' ' GLN . . . . . 0.538 ' HG2' HD12 ' S' ' 289' ' ' LEU . 34.4 tt0 -51.4 -46.4 62.84 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.487 -0.758 . . . . 68.469999999999999 110.283 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' S' S ' 286' ' ' LEU . . . . . . . . . . . . . 19.1 mt -59.95 -44.49 94.35 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.429 -0.794 . . . . 36.619999999999997 110.284 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 287' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -62.74 -35.29 79.3 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.33 -0.856 . . . . 46.640000000000001 110.077 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 288' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -76.23 -21.04 56.87 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.442 -0.787 . . . . 46.450000000000003 110.34 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 289' ' ' LEU . . . . . 0.538 HD12 ' HG2' ' S' ' 285' ' ' GLN . 30.8 mt -97.35 -21.75 17.03 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.256 -0.902 . . . . 35.090000000000003 110.485 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' S' S ' 290' ' ' THR . . . . . 0.416 HG22 ' HB3' ' S' ' 306' ' ' ASN . 81.3 p -114.8 -28.44 7.08 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.281 -0.887 . . . . 38.609999999999999 110.419 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' S' S ' 291' ' ' GLY . . . . . . . . . . . . . . . 79.4 10.97 85.41 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.833 -1.307 . . . . 36.770000000000003 109.833 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 292' ' ' LEU . . . . . . . . . . . . . 84.7 mt -96.42 145.83 25.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.247 -1.149 . . . . 35.329999999999998 109.77 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 293' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -77.37 102.32 6.74 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.222 -0.924 . . . . 48.700000000000003 110.262 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 294' ' ' LEU . . . . . 0.417 ' HB3' ' CZ2' ' S' ' 252' ' ' TRP . 55.8 mt -106.86 51.73 0.74 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.575 -0.703 . . . . 42.609999999999999 110.123 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' S' S ' 295' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -112.56 -11.11 13.63 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.296 -0.878 . . . . 55.490000000000002 110.505 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' S' S ' 296' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -144.34 48.52 1.36 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.178 -0.951 . . . . 75.680000000000007 110.308 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 297' ' ' GLY . . . . . . . . . . . . . . . 96.9 145.18 18.7 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.524 -1.43 . . . . 49.439999999999998 109.524 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 298' ' ' GLY . . . . . . . . . . . . . . . -163.8 156.93 29.0 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.807 -1.317 . . . . 41.109999999999999 109.807 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 299' ' ' PRO . . . . . 0.489 ' O ' HG23 ' S' ' 303' ' ' VAL . 47.9 Cg_endo -73.8 118.33 5.4 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.916 1.482 . . . . 26.199999999999999 110.278 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' S' S ' 300' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.25 -15.48 31.64 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.587 1.309 . . . . 21.699999999999999 110.725 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 301' ' ' ALA . . . . . . . . . . . . . . . -80.73 -29.35 36.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.271 -0.893 . . . . 31.23 110.099 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 302' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.49 -40.61 18.99 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.4 -0.812 . . . . 38.990000000000002 109.982 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' S' S ' 303' ' ' VAL . . . . . 0.489 HG23 ' O ' ' S' ' 299' ' ' PRO . 58.1 t -60.74 -35.43 64.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.436 -0.79 . . . . 18.629999999999999 110.14 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' S' S ' 304' ' ' ILE . . . . . 0.509 HD11 HG12 ' S' ' 256' ' ' ILE . 86.0 mt -79.39 -23.65 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.37 -0.831 . . . . 25.460000000000001 110.178 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' S' S ' 305' ' ' TRP . . . . . 0.419 ' CD2' ' HD3' ' S' ' 308' ' ' LYS . 68.9 t-105 -88.61 -14.54 37.27 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.295 -0.878 . . . . 33.399999999999999 110.569 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' S' S ' 306' ' ' ASN . . . . . 0.416 ' HB3' HG22 ' S' ' 290' ' ' THR . 10.4 m-80 -89.67 -13.65 36.52 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.191 -0.943 . . . . 36.969999999999999 110.388 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' S' S ' 307' ' ' ILE . . . . . 0.462 HG12 ' O ' ' S' ' 303' ' ' VAL . 36.9 pt -125.01 45.66 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.237 -0.915 . . . . 30.809999999999999 110.004 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' S' S ' 308' ' ' LYS . . . . . 0.419 ' HD3' ' CD2' ' S' ' 305' ' ' TRP . 1.5 mtmp? -73.64 -37.63 65.26 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.371 -0.831 . . . . 46.520000000000003 110.097 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' S' S ' 309' ' ' HIS . . . . . 0.494 ' CD2' ' HG ' ' S' ' 310' ' ' LEU . 55.6 p-80 -73.26 -8.28 55.16 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.321 -0.862 . . . . 51.030000000000001 110.062 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' S' S ' 310' ' ' LEU . . . . . 0.494 ' HG ' ' CD2' ' S' ' 309' ' ' HIS . 53.0 mt -99.28 -12.87 19.97 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.353 -0.842 . . . . 36.159999999999997 109.986 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' S' S ' 311' ' ' LEU . . . . . 0.523 HD21 ' CE2' ' S' ' 260' ' ' PHE . 10.7 mt -97.19 147.88 23.64 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.339 -0.85 . . . . 40.0 110.399 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' S' S ' 312' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -81.6 -16.3 51.98 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.275 -0.891 . . . . 54.18 109.69 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 313' ' ' THR . . . . . 0.818 HG23 ' HG2' ' S' ' 323' ' ' GLU . 92.7 m -87.97 151.65 22.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.336 -0.853 . . . . 25.609999999999999 110.098 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' S' S ' 314' ' ' GLY . . . . . . . . . . . . . . . -87.95 126.43 8.06 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.783 -1.327 . . . . 25.18 109.783 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 315' ' ' ILE . . . . . 0.643 HD13 ' HB ' ' S' ' 324' ' ' VAL . 50.7 mm -101.6 150.49 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.356 -1.085 . . . . 23.899999999999999 109.72 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' S' S ' 316' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' S' ' 325' ' ' CYS . . . -157.08 -159.25 9.37 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.957 -1.257 . . . . 23.18 109.957 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' S' S ' 317' ' ' THR . . . . . 0.421 HG22 ' CG2' ' S' ' 326' ' ' VAL . 11.2 p -133.94 -173.06 3.14 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.418 -1.048 . . . . 27.98 110.023 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' S' S ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.51 -56.19 25.15 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.175 -0.953 . . . . 28.100000000000001 109.926 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 319' ' ' SER . . . . . . . . . . . . . 1.2 m -59.94 -41.7 92.42 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.36 -0.838 . . . . 37.0 109.656 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 320' ' ' ARG . . . . . . . . . . . . . 12.1 mtm180 -111.67 79.91 2.64 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.529 -0.732 . . . . 52.07 109.718 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 321' ' ' PRO . . . . . 0.432 ' O ' ' HB2' ' S' ' 322' ' ' SER . 43.9 Cg_endo -71.45 171.48 16.13 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.865 1.455 . . . . 38.289999999999999 110.92 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' S' S ' 322' ' ' SER . . . . . 0.432 ' HB2' ' O ' ' S' ' 321' ' ' PRO . 41.3 t 178.68 -148.12 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.934 -0.765 . . . . 38.840000000000003 108.934 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' S' S ' 323' ' ' GLU . . . . . 0.818 ' HG2' HG23 ' S' ' 313' ' ' THR . 6.7 tp10 -62.89 -40.31 97.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.017 -1.052 . . . . 40.700000000000003 109.635 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' S' S ' 324' ' ' VAL . . . . . 0.643 ' HB ' HD13 ' S' ' 315' ' ' ILE . 72.8 t -141.25 135.01 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.402 -0.811 . . . . 20.34 109.506 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' S' S ' 325' ' ' CYS . . . . . 0.472 ' HB2' ' CE1' ' S' ' 380' ' ' PHE . 11.2 m -126.02 172.26 10.11 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.267 -0.895 . . . . 30.629999999999999 110.854 -179.117 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' S' S ' 326' ' ' VAL . . . . . 0.643 HG12 HG22 ' S' ' 379' ' ' VAL . 34.6 m -135.57 142.2 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.611 -0.681 . . . . 23.899999999999999 109.191 179.237 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' S' S ' 327' ' ' VAL . . . . . 0.601 HG11 ' O ' ' S' ' 377' ' ' VAL . 34.5 m -56.32 124.99 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.111 -0.993 . . . . 19.48 110.456 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' S' S ' 328' ' ' ASP . . . . . . . . . . . . . 55.5 p-10 -119.37 11.53 12.22 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.412 -0.805 . . . . 26.43 110.417 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 329' ' ' GLY . . . . . . . . . . . . . . . 119.65 2.24 13.12 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.052 -1.219 . . . . 31.239999999999998 110.052 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 330' ' ' THR . . . . . . . . . . . . . 80.7 m -93.04 130.06 38.77 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.116 -1.226 . . . . 30.050000000000001 110.109 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 331' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -56.86 111.52 1.05 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.244 -0.91 . . . . 37.259999999999998 109.916 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 332' ' ' MET . . . . . . . . . . . . . 88.0 mmm -94.09 162.53 13.83 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.234 -0.916 . . . . 26.23 110.332 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 333' ' ' CYS . . . . . . . . . . . . . 25.8 m -137.2 150.07 47.64 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.47 -0.769 . . . . 23.559999999999999 110.058 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 334' ' ' LEU . . . . . 0.562 HD11 ' O ' ' S' ' 372' ' ' PRO . 0.1 OUTLIER -52.62 -24.83 9.15 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.371 -0.83 . . . . 28.93 110.428 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' S' S ' 335' ' ' ALA . . . . . . . . . . . . . . . -89.06 14.44 10.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.396 -0.815 . . . . 15.76 110.954 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 336' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -100.45 -17.25 17.26 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.124 -0.985 . . . . 34.920000000000002 110.191 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 337' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -152.4 170.85 19.08 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.412 -0.805 . . . . 19.030000000000001 110.054 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 338' ' ' HIS . . . . . . . . . . . . . 13.4 p80 -120.71 10.37 10.98 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.363 -0.835 . . . . 18.82 110.449 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 339' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' S' ' 352' ' ' ALA . . . -175.95 155.18 1.58 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.221 -0.924 . . . . 17.18 110.054 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' S' S ' 340' ' ' GLY . . . . . . . . . . . . . . . 160.84 173.08 29.0 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.056 -1.218 . . . . 18.329999999999998 110.056 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 341' ' ' ILE . . . . . . . . . . . . . 83.9 mt -88.82 138.1 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.508 -0.995 . . . . 18.600000000000001 109.786 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 342' ' ' PHE . . . . . 0.485 ' CE2' ' HB3' ' S' ' 352' ' ' ALA . 70.0 m-85 -120.97 -178.46 3.75 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.256 -0.903 . . . . 23.440000000000001 110.396 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' S' S ' 343' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.82 93.33 4.16 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.412 -0.805 . . . . 35.590000000000003 110.008 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' S' S ' 344' ' ' LYS . . . . . 0.41 ' O ' ' HB3' ' S' ' 348' ' ' HIS . 0.3 OUTLIER -80.8 124.98 29.52 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.219 -0.926 . . . . 38.340000000000003 110.102 -179.987 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' S' S ' 345' ' ' GLY . . . . . . . . . . . . . . . 62.77 -130.83 43.09 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 108.887 -1.685 . . . . 53.460000000000001 108.887 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 346' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -132.68 150.83 52.11 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.244 -1.151 . . . . 70.909999999999997 110.066 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 347' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 53.35 35.38 20.18 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.339 -0.85 . . . . 47.32 110.352 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 348' ' ' HIS . . . . . 0.41 ' HB3' ' O ' ' S' ' 344' ' ' LYS . 46.7 t60 -150.17 155.86 40.56 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.265 -0.897 . . . . 41.719999999999999 110.317 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' S' S ' 349' ' ' ALA . . . . . 0.452 ' C ' HG13 ' S' ' 350' ' ' VAL . . . -149.75 151.26 33.33 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.306 -0.871 . . . . 22.91 110.487 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' S' S ' 350' ' ' VAL . . . . . 0.452 HG13 ' C ' ' S' ' 349' ' ' ALA . 34.6 m -149.08 169.66 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.465 -0.772 . . . . 21.09 110.014 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' S' S ' 351' ' ' PHE . . . . . 0.499 ' CD2' ' HB3' ' S' ' 258' ' ' GLN . 10.7 t80 -105.42 143.66 33.28 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.284 -0.885 . . . . 25.030000000000001 110.67 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' S' S ' 352' ' ' ALA . . . . . 0.485 ' HB3' ' CE2' ' S' ' 342' ' ' PHE . . . -147.73 151.71 36.53 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.617 -0.677 . . . . 23.809999999999999 109.742 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' S' S ' 353' ' ' CYS . . . . . . . . . . . . . 26.3 p -153.35 164.85 37.42 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.346 -0.846 . . . . 25.66 110.27 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 354' ' ' VAL . . . . . 0.562 HG22 ' CE2' ' S' ' 359' ' ' TRP . 56.4 t -75.97 118.47 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.378 -0.826 . . . . 34.270000000000003 110.025 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' S' S ' 355' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' S' ' 232' ' ' THR . 51.9 p -117.83 175.11 5.81 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.243 -0.911 . . . . 25.489999999999998 110.314 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' S' S ' 356' ' ' SER . . . . . . . . . . . . . 62.3 p -62.15 -17.72 58.77 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.395 -0.815 . . . . 31.239999999999998 110.716 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 357' ' ' ASN . . . . . . . . . . . . . 46.1 m-20 -106.97 14.18 26.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.149 -0.969 . . . . 28.609999999999999 110.604 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 358' ' ' GLY . . . . . . . . . . . . . . . 111.82 -152.83 17.6 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.031 -1.228 . . . . 22.010000000000002 110.031 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 359' ' ' TRP . . . . . 0.562 ' CE2' HG22 ' S' ' 354' ' ' VAL . 15.4 m95 -91.37 116.73 29.08 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.442 -1.034 . . . . 25.539999999999999 110.155 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' S' S ' 360' ' ' TYR . . . . . 0.421 ' HA ' ' HA ' ' S' ' 369' ' ' PRO . 1.3 m-85 -103.48 165.79 10.82 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.276 -0.89 . . . . 40.530000000000001 110.094 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' S' S ' 361' ' ' ALA . . . . . 0.433 ' HA ' ' O ' ' S' ' 351' ' ' PHE . . . -140.09 130.08 24.83 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.376 -0.828 . . . . 18.039999999999999 110.272 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' S' S ' 362' ' ' ILE . . . . . . . . . . . . . 88.9 mt -95.6 83.63 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.353 -0.842 . . . . 15.640000000000001 110.023 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 363' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' S' ' 365' ' ' GLU . 11.8 t0 -75.18 94.46 2.96 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.364 -0.835 . . . . 35.030000000000001 110.208 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' S' S ' 364' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 53.95 -89.39 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.543 -0.723 . . . . 46.719999999999999 110.524 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 365' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' S' ' 363' ' ' ASP . 23.8 mt-10 -122.64 19.11 10.36 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.058 -1.026 . . . . 56.200000000000003 110.233 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' S' S ' 366' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -118.01 125.06 49.63 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.231 -0.918 . . . . 51.020000000000003 110.368 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 367' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -107.06 127.08 53.15 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.321 -0.862 . . . . 37.590000000000003 110.101 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 368' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -165.44 159.55 13.88 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.3 -0.875 . . . . 31.469999999999999 110.427 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 369' ' ' PRO . . . . . 0.421 ' HA ' ' HA ' ' S' ' 360' ' ' TYR . 46.3 Cg_endo -72.83 139.63 30.75 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 O-C-N 123.872 1.459 . . . . 28.850000000000001 110.535 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' S' S ' 370' ' ' TRP . . . . . . . . . . . . . 67.4 t90 -167.24 113.5 0.76 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.362 -0.836 . . . . 26.940000000000001 110.007 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 371' ' ' THR . . . . . . . . . . . . . 59.4 m -74.74 113.03 20.4 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.433 -0.792 . . . . 20.190000000000001 110.057 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 372' ' ' PRO . . . . . 0.562 ' O ' HD11 ' S' ' 334' ' ' LEU . 47.7 Cg_endo -73.55 157.09 49.25 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 O-C-N 123.609 1.32 . . . . 28.68 110.583 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' S' S ' 373' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -90.57 147.13 35.72 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.415 -0.803 . . . . 35.719999999999999 109.93 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 374' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -76.03 -6.23 17.13 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.676 1.356 . . . . 30.890000000000001 110.534 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 375' ' ' SER . . . . . . . . . . . . . 69.4 p -104.39 -17.01 14.95 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.209 -0.932 . . . . 29.41 110.414 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 376' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -106.45 42.98 1.19 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.348 -0.845 . . . . 32.890000000000001 110.24 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 377' ' ' VAL . . . . . 0.601 ' O ' HG11 ' S' ' 327' ' ' VAL . 7.3 p -114.63 147.31 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.253 -0.905 . . . . 24.329999999999998 110.2 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' S' S ' 378' ' ' LEU . . . . . . . . . . . . . 52.2 mt -116.01 -58.02 2.15 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.426 -0.796 . . . . 24.370000000000001 109.626 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 379' ' ' VAL . . . . . 0.643 HG22 HG12 ' S' ' 326' ' ' VAL . 61.5 t -120.7 132.42 70.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.437 -0.789 . . . . 18.02 109.385 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' S' S ' 380' ' ' PHE . . . . . 0.472 ' CE1' ' HB2' ' S' ' 325' ' ' CYS . 14.5 p90 -142.59 173.92 11.11 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.427 -0.796 . . . . 29.350000000000001 110.675 -179.3 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' S' S ' 381' ' ' VAL . . . . . . . . . . . . . 58.1 t -120.03 107.36 39.92 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.512 -0.743 . . . . 16.34 109.413 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 382' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -71.31 145.63 48.9 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.68 1.358 . . . . 20.940000000000001 110.803 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' S' S ' 383' ' ' TYR . . . . . 0.978 ' O ' ' CB ' ' S' ' 384' ' ' ASP . 88.3 m-85 -61.11 -53.43 57.12 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.405 -0.809 . . . . 28.93 109.838 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' S' S ' 384' ' ' ASP . . . . . 0.978 ' CB ' ' O ' ' S' ' 383' ' ' TYR . 13.3 t70 . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.433 -0.792 . . . . 47.030000000000001 110.36 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 30' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 121.203 0.525 . . . . 43.359999999999999 110.212 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' R' R ' 31' ' ' LEU . . . . . . . . . . . . . 65.7 mt -134.86 140.65 45.98 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.286 -0.884 . . . . 22.93 110.306 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 32' ' ' THR . . . . . . . . . . . . . 69.1 m -87.61 110.51 20.43 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.433 -0.792 . . . . 22.34 109.962 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 33' ' ' LEU . . . . . 0.595 HD22 ' CE2' ' R' ' 62' ' ' TYR . 80.1 mt -62.35 -172.79 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.316 -0.865 . . . . 21.390000000000001 110.226 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 34' ' ' TYR . . . . . . . . . . . . . 37.0 p90 -74.65 -29.41 61.25 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.333 -0.855 . . . . 34.399999999999999 110.386 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 35' ' ' ASN . . . . . . . . . . . . . 48.3 p30 -77.79 -1.83 33.39 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.314 -0.866 . . . . 30.280000000000001 110.643 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.25 -16.56 59.48 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.784 -1.326 . . . . 36.25 109.784 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 37' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -59.04 161.79 4.82 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.373 -1.075 . . . . 53.799999999999997 110.405 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 38' ' ' LYS . . . . . . . . . . . . . 57.2 mttt -117.8 135.7 53.9 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.405 -0.809 . . . . 49.909999999999997 110.19 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 39' ' ' LYS . . . . . 0.405 ' HG2' ' CZ ' ' R' ' 41' ' ' PHE . 8.1 ttmt -138.73 143.66 39.17 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.319 -0.863 . . . . 35.689999999999998 110.235 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 40' ' ' THR . . . . . . . . . . . . . 23.4 m -102.56 127.91 49.43 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.287 -0.883 . . . . 34.840000000000003 110.308 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 41' ' ' PHE . . . . . 0.405 ' CZ ' ' HG2' ' R' ' 39' ' ' LYS . 96.6 m-85 -113.04 132.6 55.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.413 -0.804 . . . . 34.420000000000002 110.179 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 42' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -93.24 140.95 28.98 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.348 -0.845 . . . . 51.460000000000001 110.204 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 43' ' ' SER . . . . . . . . . . . . . 54.2 m -70.81 141.9 51.33 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.453 -0.779 . . . . 41.840000000000003 110.206 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.76 125.39 29.55 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.308 -0.87 . . . . 33.82 109.962 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 45' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.15 151.06 54.8 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.563 1.297 . . . . 30.27 110.66 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 46' ' ' ASN . . . . . 0.4 ' HA ' ' OD1' ' R' ' 50' ' ' ASN . 52.1 t-20 -124.28 109.92 13.97 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.415 -0.803 . . . . 35.100000000000001 109.999 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 47' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -120.34 -34.88 3.54 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.367 -0.833 . . . . 42.810000000000002 110.489 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 48' ' ' HIS . . . . . 0.44 ' NE2' HD11 ' R' ' 80' ' ' LEU . 73.3 m80 -105.76 45.23 0.98 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.328 -0.857 . . . . 49.969999999999999 110.263 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 49' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 50.27 34.68 9.16 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.345 -0.847 . . . . 61.32 110.199 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 50' ' ' ASN . . . . . 0.4 ' OD1' ' HA ' ' R' ' 46' ' ' ASN . 15.0 p-10 -86.29 43.8 1.09 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.426 -0.796 . . . . 51.5 110.706 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.11 -46.14 78.65 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.325 -0.86 . . . . 38.770000000000003 109.502 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 52' ' ' TRP . . . . . 0.483 ' CD2' ' N ' ' R' ' 53' ' ' LEU . 68.2 p-90 -58.35 -38.43 77.18 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.504 -0.747 . . . . 26.239999999999998 110.055 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 53' ' ' LEU . . . . . 0.483 ' N ' ' CD2' ' R' ' 52' ' ' TRP . 23.1 tp -66.68 -46.72 74.72 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.362 -0.836 . . . . 26.75 109.958 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 54' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -55.15 -41.66 72.11 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.341 -0.85 . . . . 35.020000000000003 110.14 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.24 -46.04 92.03 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.369 -0.832 . . . . 24.469999999999999 110.141 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 56' ' ' ILE . . . . . 0.432 HG12 HD11 ' R' ' 104' ' ' ILE . 76.1 mt -62.1 -42.32 94.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.213 -0.93 . . . . 26.030000000000001 109.92 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 57' ' ' LEU . . . . . . . . . . . . . 22.4 mt -60.31 -45.63 92.71 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.336 -0.853 . . . . 26.77 109.68 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 58' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -63.92 -46.48 84.59 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.521 -0.737 . . . . 22.32 109.594 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 59' ' ' LEU . . . . . 0.429 ' HA ' ' HE2' ' R' ' 151' ' ' PHE . 23.9 tp -61.45 -37.74 84.65 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.337 -0.852 . . . . 20.550000000000001 109.373 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 60' ' ' PHE . . . . . 0.528 ' CE2' HD21 ' R' ' 111' ' ' LEU . 2.8 m-85 -61.04 -44.84 96.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.628 -0.67 . . . . 20.079999999999998 109.921 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 61' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -63.0 -36.22 82.83 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.504 -0.747 . . . . 18.800000000000001 110.532 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 62' ' ' TYR . . . . . 0.595 ' CE2' HD22 ' R' ' 33' ' ' LEU . 9.2 t80 -63.16 -41.73 99.31 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.157 -0.964 . . . . 26.449999999999999 110.213 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 63' ' ' VAL . . . . . 0.406 ' H ' HG22 ' R' ' 63' ' ' VAL . 30.4 m -93.34 20.3 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.199 -0.938 . . . . 29.75 110.185 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 64' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 52.94 75.56 0.24 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.369 -0.832 . . . . 35.520000000000003 110.556 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 65' ' ' GLU . . . . . 0.442 ' HG2' ' CD2' ' R' ' 60' ' ' PHE . 14.3 tp10 -116.29 104.02 52.38 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.424 -0.797 . . . . 29.890000000000001 109.866 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 66' ' ' PRO . . . . . 0.481 ' HA ' ' HB2' ' R' ' 69' ' ' ASP . 46.8 Cg_endo -73.48 -5.89 17.86 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.708 1.372 . . . . 21.370000000000001 111.109 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 67' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -52.09 -61.52 2.21 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.144 -0.973 . . . . 23.850000000000001 110.375 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 68' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -98.11 36.51 1.56 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.312 -0.867 . . . . 28.07 110.512 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 69' ' ' ASP . . . . . 0.481 ' HB2' ' HA ' ' R' ' 66' ' ' PRO . 11.8 t0 -72.33 -33.23 67.18 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.296 -0.878 . . . . 43.759999999999998 110.18 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 70' ' ' TRP . . . . . 0.475 ' CE2' ' CG2' ' R' ' 71' ' ' VAL . 47.9 p-90 -73.4 -3.94 30.46 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.29 -0.881 . . . . 33.060000000000002 110.7 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 71' ' ' VAL . . . . . 0.557 HG11 ' HB2' ' R' ' 82' ' ' ALA . 40.9 t -109.75 -27.45 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.23 -0.919 . . . . 31.699999999999999 109.647 179.231 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 72' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -86.58 -48.84 7.99 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.407 -0.808 . . . . 33.579999999999998 110.294 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 73' ' ' SER . . . . . . . . . . . . . 69.9 m -89.63 50.96 1.99 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.338 -0.851 . . . . 50.82 110.379 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 74' ' ' SER . . . . . . . . . . . . . 16.0 t -125.82 138.32 31.77 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.226 -0.921 . . . . 34.740000000000002 110.265 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.33 -24.98 16.01 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.672 1.354 . . . . 35.700000000000003 110.336 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 76' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -91.71 153.2 19.8 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.476 -0.765 . . . . 66.480000000000004 110.343 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 77' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -81.47 95.26 7.03 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.298 -0.876 . . . . 46.719999999999999 110.114 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 78' ' ' LEU . . . . . . . . . . . . . 96.3 mt -96.43 27.93 3.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.338 -0.851 . . . . 37.549999999999997 110.191 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 79' ' ' THR . . . . . . . . . . . . . 29.5 m -56.2 -54.65 42.65 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.329 -0.857 . . . . 37.359999999999999 110.295 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 80' ' ' LEU . . . . . 0.603 ' HA ' HD12 ' R' ' 83' ' ' ILE . 15.9 mt -60.81 -23.29 64.95 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.337 -0.852 . . . . 35.829999999999998 110.549 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 81' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -79.5 -39.12 32.82 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.229 -0.919 . . . . 44.030000000000001 110.321 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 82' ' ' ALA . . . . . 0.557 ' HB2' HG11 ' R' ' 71' ' ' VAL . . . -69.49 -28.6 66.2 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.224 -0.923 . . . . 32.539999999999999 110.256 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 83' ' ' ILE . . . . . 0.603 HD12 ' HA ' ' R' ' 80' ' ' LEU . 78.2 mt -70.16 -46.12 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.308 -0.87 . . . . 32.020000000000003 110.302 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 84' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -55.15 -52.08 64.42 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.193 -0.942 . . . . 34.090000000000003 110.611 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 85' ' ' GLN . . . . . 0.533 ' HG2' HD12 ' R' ' 89' ' ' LEU . 31.9 tt0 -54.83 -46.85 74.64 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.206 -0.934 . . . . 25.940000000000001 110.249 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 86' ' ' LEU . . . . . . . . . . . . . 24.0 mt -58.7 -43.81 90.17 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.332 -0.855 . . . . 16.199999999999999 109.91 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 87' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -65.38 -35.17 80.16 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.391 -0.818 . . . . 49.090000000000003 110.251 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 88' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -78.48 -19.08 53.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.345 -0.847 . . . . 28.609999999999999 110.522 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 89' ' ' LEU . . . . . 0.533 HD12 ' HG2' ' R' ' 85' ' ' GLN . 32.7 mt -96.15 -29.4 14.09 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.304 -0.872 . . . . 26.16 110.22 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 90' ' ' THR . . . . . . . . . . . . . 60.4 p -105.7 -34.55 7.67 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.284 -0.885 . . . . 33.329999999999998 109.763 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.77 16.18 58.6 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.862 -1.295 . . . . 31.129999999999999 109.862 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 92' ' ' LEU . . . . . . . . . . . . . 97.1 mt -100.18 155.19 17.89 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.213 -1.169 . . . . 42.520000000000003 110.229 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 93' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -86.17 91.64 8.51 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.567 -0.708 . . . . 68.459999999999994 110.038 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 94' ' ' LEU . . . . . 0.458 ' HB3' ' CZ2' ' R' ' 52' ' ' TRP . 48.3 mt -99.46 53.0 0.94 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.289 -0.882 . . . . 44.630000000000003 110.33 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 95' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.44 -38.71 6.38 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.3 -0.875 . . . . 67.159999999999997 110.395 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 96' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -113.9 44.32 1.66 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.364 -0.835 . . . . 67.019999999999996 110.238 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 97' ' ' GLY . . . . . . . . . . . . . . . 99.12 150.78 26.03 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.634 -1.387 . . . . 49.479999999999997 109.634 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 98' ' ' GLY . . . . . . . . . . . . . . . -166.22 160.07 33.5 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.294 -1.522 . . . . 36.57 109.294 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 99' ' ' PRO . . . . . 0.79 ' O ' HG23 ' R' ' 103' ' ' VAL . 45.7 Cg_endo -72.59 121.07 7.1 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.645 1.34 . . . . 30.41 110.413 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 100' ' ' PRO . . . . . 0.412 ' HA ' HD11 ' R' ' 56' ' ' ILE . 45.8 Cg_endo -72.25 -31.67 11.48 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 O-C-N 123.645 1.339 . . . . 29.940000000000001 110.53 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 101' ' ' ALA . . . . . 0.476 ' HB2' ' HB3' ' R' ' 178' ' ' LEU . . . -70.02 -38.4 75.91 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.226 -0.921 . . . . 23.640000000000001 110.233 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 102' ' ' LEU . . . . . 0.424 HD23 HD21 ' R' ' 106' ' ' ASN . 0.1 OUTLIER -72.67 -40.71 66.07 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.358 -0.839 . . . . 20.309999999999999 110.386 -179.78 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' R' R ' 103' ' ' VAL . . . . . 0.79 HG23 ' O ' ' R' ' 99' ' ' PRO . 64.3 t -58.25 -40.02 76.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.195 -0.941 . . . . 16.329999999999998 109.984 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 104' ' ' ILE . . . . . 0.432 HD11 HG12 ' R' ' 56' ' ' ILE . 81.6 mt -71.68 -30.6 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.397 -0.814 . . . . 24.77 109.966 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 105' ' ' TRP . . . . . 0.463 ' O ' ' HD3' ' R' ' 108' ' ' LYS . 70.5 t-105 -82.41 0.85 40.15 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.292 -0.88 . . . . 23.280000000000001 110.31 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 106' ' ' ASN . . . . . 0.424 HD21 HD23 ' R' ' 102' ' ' LEU . 6.9 m-80 -105.07 -10.35 17.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.171 -0.956 . . . . 28.260000000000002 110.118 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 107' ' ' ILE . . . . . . . . . . . . . 36.7 pt -126.88 35.08 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.254 -0.904 . . . . 18.77 109.966 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 108' ' ' LYS . . . . . 0.502 ' HG2' ' HB ' ' R' ' 115' ' ' ILE . 9.2 mtpp -61.12 -48.41 81.78 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.56 -0.713 . . . . 42.5 110.049 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 109' ' ' HIS . . . . . 0.444 ' CD2' ' HG ' ' R' ' 110' ' ' LEU . 50.8 p-80 -66.02 -12.85 58.07 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.456 -0.777 . . . . 20.07 110.698 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 110' ' ' LEU . . . . . 0.444 ' HG ' ' CD2' ' R' ' 109' ' ' HIS . 80.3 mt -94.79 -17.25 22.31 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.076 -1.015 . . . . 15.69 110.207 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 111' ' ' LEU . . . . . 0.528 HD21 ' CE2' ' R' ' 60' ' ' PHE . 10.3 mt -94.13 144.16 25.74 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.342 -0.849 . . . . 25.390000000000001 111.014 -179.177 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 112' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -77.71 -17.36 57.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.51 -0.744 . . . . 53.479999999999997 109.846 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 113' ' ' THR . . . . . 0.459 HG22 ' N ' ' R' ' 114' ' ' GLY . 59.8 m -83.76 166.67 17.83 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.273 -0.892 . . . . 14.800000000000001 110.193 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 114' ' ' GLY . . . . . 0.459 ' N ' HG22 ' R' ' 113' ' ' THR . . . -97.99 127.1 9.11 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.042 -1.223 . . . . 16.140000000000001 110.042 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 115' ' ' ILE . . . . . 0.577 HD13 ' HB ' ' R' ' 124' ' ' VAL . 47.7 mm -109.01 139.46 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.503 -0.998 . . . . 13.460000000000001 109.674 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 116' ' ' GLY . . . . . . . . . . . . . . . -152.84 -155.89 7.31 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.932 -1.267 . . . . 23.899999999999999 109.932 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 117' ' ' THR . . . . . 0.53 HG22 ' CG2' ' R' ' 126' ' ' VAL . 18.5 p -135.03 -171.39 2.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.451 -1.029 . . . . 27.370000000000001 110.079 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 118' ' ' ALA . . . . . 0.445 ' HB3' ' OD1' ' R' ' 128' ' ' ASP . . . -56.52 -58.14 9.32 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.246 -0.909 . . . . 18.760000000000002 110.074 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 119' ' ' SER . . . . . . . . . . . . . 1.2 m -56.51 -40.48 75.09 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.351 -0.843 . . . . 32.350000000000001 109.838 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 120' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 -110.12 86.21 4.9 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.411 -0.806 . . . . 27.120000000000001 109.69 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 121' ' ' PRO . . . . . 0.483 ' HA ' ' SG ' ' R' ' 125' ' ' CYS . 44.0 Cg_endo -71.26 166.49 29.09 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 O-C-N 123.903 1.475 . . . . 22.68 111.035 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 122' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' R' ' 121' ' ' PRO . 38.6 t 178.55 -161.7 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.609 -0.682 . . . . 22.989999999999998 109.455 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 123' ' ' GLU . . . . . 0.442 ' HG2' HG23 ' R' ' 113' ' ' THR . 2.3 tp10 -56.44 -40.01 74.06 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.216 -0.928 . . . . 36.18 109.63 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 124' ' ' VAL . . . . . 0.577 ' HB ' HD13 ' R' ' 115' ' ' ILE . 82.2 t -142.5 136.4 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.62 -0.675 . . . . 20.640000000000001 109.457 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 125' ' ' CYS . . . . . 0.483 ' SG ' ' HA ' ' R' ' 121' ' ' PRO . 83.0 m -140.23 168.21 20.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.193 -0.942 . . . . 22.800000000000001 111.206 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 126' ' ' VAL . . . . . 0.73 HG12 HG22 ' R' ' 179' ' ' VAL . 35.9 m -122.78 159.72 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.733 -0.604 . . . . 21.239999999999998 109.574 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 127' ' ' VAL . . . . . 0.709 HG11 ' O ' ' R' ' 177' ' ' VAL . 30.4 m -70.76 141.82 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.305 -0.872 . . . . 19.77 110.734 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 128' ' ' ASP . . . . . 0.445 ' OD1' ' HB3' ' R' ' 118' ' ' ALA . 53.8 p-10 -137.74 19.41 2.87 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.417 -0.802 . . . . 29.210000000000001 110.66 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 129' ' ' GLY . . . . . . . . . . . . . . . 114.0 0.04 24.14 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.939 -1.124 . . . . 33.859999999999999 110.527 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 130' ' ' THR . . . . . . . . . . . . . 58.4 m -91.94 131.81 36.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.135 -1.215 . . . . 26.41 110.046 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -62.43 120.64 11.46 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.317 -0.865 . . . . 33.079999999999998 110.336 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 132' ' ' MET . . . . . 0.433 ' HE1' ' CE2' ' R' ' 180' ' ' PHE . 98.5 mmm -105.24 165.64 10.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.482 -0.761 . . . . 30.760000000000002 110.409 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 133' ' ' CYS . . . . . 0.411 ' HA ' ' HB3' ' R' ' 174' ' ' PRO . 32.2 m -141.12 158.23 44.2 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.451 -0.78 . . . . 27.0 109.956 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 134' ' ' LEU . . . . . 0.565 HD11 ' O ' ' R' ' 172' ' ' PRO . 0.1 OUTLIER -58.53 -19.74 40.24 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.232 -0.918 . . . . 33.899999999999999 110.515 -179.86 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' R' R ' 135' ' ' ALA . . . . . . . . . . . . . . . -92.66 8.11 40.55 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.344 -0.848 . . . . 19.370000000000001 110.833 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 136' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -93.7 -21.88 19.08 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.165 -0.96 . . . . 30.469999999999999 110.178 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 137' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -149.91 165.3 33.01 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.351 -0.843 . . . . 24.27 110.241 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 138' ' ' HIS . . . . . 0.434 ' HA ' HG23 ' R' ' 154' ' ' VAL . 15.1 p80 -117.79 15.18 14.41 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.422 -0.798 . . . . 20.91 110.417 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 139' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' R' ' 152' ' ' ALA . . . -177.23 152.4 0.87 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.187 -0.946 . . . . 15.69 110.157 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 140' ' ' GLY . . . . . 0.428 ' HA3' ' O ' ' R' ' 179' ' ' VAL . . . 161.83 175.09 32.49 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.881 -1.288 . . . . 23.760000000000002 109.881 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 141' ' ' ILE . . . . . . . . . . . . . 83.7 mt -95.5 136.63 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.435 -1.038 . . . . 25.300000000000001 109.691 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 142' ' ' PHE . . . . . 0.578 ' CD2' ' HB2' ' R' ' 172' ' ' PRO . 82.9 m-85 -120.77 -172.66 2.43 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.27 -0.894 . . . . 30.239999999999998 110.524 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 143' ' ' LEU . . . . . 0.742 HD23 ' O ' ' R' ' 148' ' ' HIS . 0.5 OUTLIER -119.78 77.73 1.26 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.426 -0.796 . . . . 32.799999999999997 110.295 -179.879 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' R' R ' 144' ' ' LYS . . . . . 0.471 ' HG3' ' CZ2' ' R' ' 170' ' ' TRP . 1.0 OUTLIER -69.55 76.78 0.42 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.437 -0.789 . . . . 49.18 109.68 179.541 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' R' R ' 145' ' ' GLY . . . . . 0.458 ' O ' HD22 ' R' ' 143' ' ' LEU . . . 104.62 179.24 24.71 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.139 -1.584 . . . . 53.869999999999997 109.139 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 146' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -88.46 145.83 25.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.388 -1.066 . . . . 68.579999999999998 110.053 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 147' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 58.27 36.46 25.66 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.256 -0.902 . . . . 56.619999999999997 110.611 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 148' ' ' HIS . . . . . 0.742 ' O ' HD23 ' R' ' 143' ' ' LEU . 44.6 t60 -158.58 148.14 19.33 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.205 -0.934 . . . . 44.57 110.422 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 149' ' ' ALA . . . . . . . . . . . . . . . -150.27 146.83 27.02 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.467 -0.771 . . . . 33.539999999999999 110.082 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 150' ' ' VAL . . . . . . . . . . . . . 34.2 m -142.28 161.54 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.231 -0.918 . . . . 27.609999999999999 110.309 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 151' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' R' ' 152' ' ' ALA . 5.8 t80 -86.21 155.53 20.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.4 -0.812 . . . . 23.039999999999999 109.907 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 152' ' ' ALA . . . . . 0.537 ' N ' ' CD1' ' R' ' 151' ' ' PHE . . . -157.22 151.53 25.05 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.499 -0.75 . . . . 29.609999999999999 109.565 179.05 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 153' ' ' CYS . . . . . . . . . . . . . 26.7 p -154.33 173.54 16.04 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.234 -0.916 . . . . 22.75 110.556 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 154' ' ' VAL . . . . . 0.614 HG22 ' CE2' ' R' ' 159' ' ' TRP . 60.0 t -90.56 116.97 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.443 -0.785 . . . . 23.260000000000002 110.078 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 155' ' ' THR . . . . . . . . . . . . . 70.7 p -112.08 -176.65 2.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.347 -0.846 . . . . 17.879999999999999 110.034 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 156' ' ' SER . . . . . . . . . . . . . 78.5 p -75.98 -3.64 36.72 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.329 -0.857 . . . . 21.829999999999998 110.697 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 157' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -118.32 10.48 12.8 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.159 -0.963 . . . . 36.539999999999999 110.603 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 158' ' ' GLY . . . . . . . . . . . . . . . 117.99 -162.62 13.05 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.547 -1.421 . . . . 31.739999999999998 109.547 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 159' ' ' TRP . . . . . 0.614 ' CE2' HG22 ' R' ' 154' ' ' VAL . 14.8 m95 -86.6 122.4 30.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.285 -1.127 . . . . 28.25 110.092 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 160' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -108.4 167.01 10.34 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.448 -0.783 . . . . 41.240000000000002 110.212 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 161' ' ' ALA . . . . . . . . . . . . . . . -143.24 123.43 13.72 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.355 -0.841 . . . . 27.399999999999999 110.208 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 162' ' ' ILE . . . . . . . . . . . . . 92.1 mt -87.6 81.17 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.362 -0.837 . . . . 24.27 110.078 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 163' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' R' ' 165' ' ' GLU . 15.4 t0 -72.92 92.36 1.62 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.438 -0.789 . . . . 36.079999999999998 110.246 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 164' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 54.13 -88.94 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.542 -0.724 . . . . 46.079999999999998 110.565 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 165' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' R' ' 163' ' ' ASP . 29.6 mt-10 -124.75 36.01 4.68 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.052 -1.03 . . . . 50.939999999999998 110.199 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 166' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -135.8 117.32 14.82 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.397 -0.814 . . . . 47.280000000000001 110.324 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 167' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -100.98 119.95 39.48 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.434 -0.791 . . . . 40.469999999999999 110.134 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 168' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -157.6 158.54 30.6 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.29 -0.881 . . . . 30.210000000000001 110.399 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 169' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.8 133.04 19.46 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.931 1.49 . . . . 32.759999999999998 110.474 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 170' ' ' TRP . . . . . 0.471 ' CZ2' ' HG3' ' R' ' 144' ' ' LYS . 67.0 t90 -159.78 119.3 2.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.416 -0.802 . . . . 32.789999999999999 109.928 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 171' ' ' THR . . . . . . . . . . . . . 46.6 m -81.06 112.6 33.95 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.437 -0.789 . . . . 36.920000000000002 110.184 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 172' ' ' PRO . . . . . 0.578 ' HB2' ' CD2' ' R' ' 142' ' ' PHE . 47.2 Cg_endo -73.74 158.83 46.48 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.66 1.348 . . . . 33.539999999999999 110.519 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 173' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -88.84 144.97 33.85 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.362 -0.836 . . . . 45.759999999999998 109.911 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 174' ' ' PRO . . . . . 0.411 ' HB3' ' HA ' ' R' ' 133' ' ' CYS . 45.9 Cg_endo -71.73 -10.41 26.44 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 O-C-N 123.675 1.355 . . . . 29.629999999999999 110.499 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 175' ' ' SER . . . . . . . . . . . . . 53.1 p -103.48 -17.47 15.2 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.299 -0.876 . . . . 35.700000000000003 110.369 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 176' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -103.5 43.19 1.1 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.24 -0.913 . . . . 39.649999999999999 110.423 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 177' ' ' VAL . . . . . 0.709 ' O ' HG11 ' R' ' 127' ' ' VAL . 10.5 p -117.72 127.17 75.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.368 -0.832 . . . . 20.609999999999999 110.041 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 178' ' ' LEU . . . . . 0.476 ' HB3' ' HB2' ' R' ' 101' ' ' ALA . 45.9 mt -91.5 -61.23 1.69 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.424 -0.798 . . . . 15.58 109.464 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 179' ' ' VAL . . . . . 0.73 HG22 HG12 ' R' ' 126' ' ' VAL . 67.4 t -114.6 144.7 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.579 -0.7 . . . . 17.399999999999999 109.443 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 180' ' ' PHE . . . . . 0.433 ' CE2' ' HE1' ' R' ' 132' ' ' MET . 43.4 p90 -152.11 163.37 39.48 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.273 -0.892 . . . . 20.16 110.562 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 181' ' ' VAL . . . . . . . . . . . . . 66.9 t -113.2 111.49 50.17 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.468 -0.77 . . . . 17.690000000000001 109.795 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 182' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.03 149.51 52.86 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.577 1.304 . . . . 17.809999999999999 110.423 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' R' R ' 183' ' ' TYR . . . . . 0.706 ' O ' ' C ' ' R' ' 184' ' ' ASP . 79.0 m-85 -59.01 175.54 0.28 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.459 -0.775 . . . . 28.010000000000002 110.549 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 184' ' ' ASP . . . . . 0.706 ' C ' ' O ' ' R' ' 183' ' ' TYR . 6.0 t70 -18.36 -82.2 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.3 -0.875 . . . . 58.640000000000001 110.232 -178.17 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' R' R ' 185' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 . . . . . 0 N--CA 1.504 2.232 0 CA-C-O 121.272 0.558 . . . . 80.420000000000002 111.721 179.566 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' R' R ' 193' ' ' LYS . . . . . . . . . . . . . 15.0 pttt . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 120.898 0.38 . . . . 49.5 110.157 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' R' R ' 194' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.835 0 O-C-N 121.144 -0.973 . . . . 40.399999999999999 110.156 179.92 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' S' S ' 229' ' ' MET . . . . . . . . . . . . . 5.8 mtm . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 121.176 0.513 . . . . 51.829999999999998 110.191 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' S' S ' 230' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -97.27 142.73 28.8 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.318 -0.864 . . . . 54.130000000000003 110.161 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' S' S ' 231' ' ' LEU . . . . . . . . . . . . . 67.9 mt -134.12 141.04 46.98 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.391 -0.818 . . . . 33.039999999999999 110.343 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' S' S ' 232' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' S' ' 355' ' ' THR . 40.7 m -89.26 103.26 15.9 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.381 -0.824 . . . . 26.920000000000002 110.04 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' S' S ' 233' ' ' LEU . . . . . 0.67 HD22 ' CE2' ' S' ' 262' ' ' TYR . 79.9 mt -56.0 179.31 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.43 -0.794 . . . . 13.779999999999999 110.463 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' S' S ' 234' ' ' TYR . . . . . 0.446 ' CG ' ' N ' ' S' ' 235' ' ' ASN . 35.6 p90 -65.02 -35.69 81.99 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.361 -0.837 . . . . 26.079999999999998 110.148 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' S' S ' 235' ' ' ASN . . . . . 0.446 ' N ' ' CG ' ' S' ' 234' ' ' TYR . 50.7 p30 -74.3 -7.44 52.78 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.428 -0.795 . . . . 20.039999999999999 110.596 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' S' S ' 236' ' ' GLY . . . . . . . . . . . . . . . 95.76 -19.92 52.15 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.781 -1.328 . . . . 22.710000000000001 109.781 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' S' S ' 237' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -52.98 145.65 12.48 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.18 -1.188 . . . . 35.439999999999998 110.276 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' S' S ' 238' ' ' LYS . . . . . . . . . . . . . 44.4 mttt -102.18 127.91 48.91 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.396 -0.815 . . . . 32.560000000000002 110.434 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' S' S ' 239' ' ' LYS . . . . . 0.409 ' HG2' ' CZ ' ' S' ' 241' ' ' PHE . 9.0 ttmt -132.26 144.54 50.68 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.391 -0.818 . . . . 26.68 110.004 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' S' S ' 240' ' ' THR . . . . . . . . . . . . . 51.9 m -102.02 132.2 48.01 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.307 -0.871 . . . . 41.020000000000003 110.355 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' S' S ' 241' ' ' PHE . . . . . 0.409 ' CZ ' ' HG2' ' S' ' 239' ' ' LYS . 96.1 m-85 -117.91 137.62 52.69 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.379 -0.826 . . . . 28.620000000000001 110.253 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' S' S ' 242' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -96.35 161.83 13.76 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.34 -0.85 . . . . 47.890000000000001 110.188 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' S' S ' 243' ' ' SER . . . . . . . . . . . . . 72.1 m -90.57 151.56 21.27 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.29 -0.881 . . . . 45.090000000000003 110.29 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' S' S ' 244' ' ' ARG . . . . . . . . . . . . . 1.4 mtp85 -129.77 126.73 22.7 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.416 -0.802 . . . . 42.490000000000002 110.263 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' S' S ' 245' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.35 160.98 43.77 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.617 1.325 . . . . 35.68 110.551 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' S' S ' 246' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -132.84 97.77 4.13 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.325 -0.859 . . . . 51.880000000000003 109.873 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' S' S ' 247' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -110.45 -22.24 11.77 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.32 -0.863 . . . . 53.689999999999998 110.649 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' S' S ' 248' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -117.26 43.67 2.27 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.182 -0.949 . . . . 55.789999999999999 110.708 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' S' S ' 249' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 48.78 38.46 11.88 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.485 -0.759 . . . . 49.450000000000003 110.363 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' S' S ' 250' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -90.57 28.95 1.38 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.552 -0.717 . . . . 36.859999999999999 110.325 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' S' S ' 251' ' ' ALA . . . . . . . . . . . . . . . -53.79 -43.19 69.08 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.286 -0.884 . . . . 29.690000000000001 109.621 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' S' S ' 252' ' ' TRP . . . . . 0.428 ' CZ2' ' HB3' ' S' ' 294' ' ' LEU . 67.8 p-90 -61.82 -33.9 74.98 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.51 -0.744 . . . . 41.119999999999997 109.802 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' S' S ' 253' ' ' LEU . . . . . 0.402 ' N ' ' CD2' ' S' ' 252' ' ' TRP . 23.4 tp -70.15 -47.3 62.27 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.422 -0.799 . . . . 24.890000000000001 109.955 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' S' S ' 254' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -56.06 -42.43 76.61 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.308 -0.87 . . . . 35.649999999999999 110.031 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' S' S ' 255' ' ' ALA . . . . . . . . . . . . . . . -59.61 -48.19 82.63 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.427 -0.795 . . . . 22.73 110.042 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' S' S ' 256' ' ' ILE . . . . . 0.504 HG12 HD11 ' S' ' 304' ' ' ILE . 79.7 mt -62.35 -40.6 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.308 -0.87 . . . . 28.850000000000001 110.014 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' S' S ' 257' ' ' LEU . . . . . 0.402 ' CD2' ' HB3' ' S' ' 268' ' ' PHE . 19.4 mt -61.52 -44.49 96.97 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.286 -0.884 . . . . 23.07 110.216 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' S' S ' 258' ' ' GLN . . . . . 0.501 ' HB3' ' CD2' ' S' ' 351' ' ' PHE . 53.4 mm-40 -65.05 -45.35 85.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.382 -0.824 . . . . 29.780000000000001 109.947 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' S' S ' 259' ' ' LEU . . . . . 0.421 ' O ' HG22 ' S' ' 263' ' ' VAL . 19.8 tp -58.66 -36.41 74.11 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.299 -0.876 . . . . 17.940000000000001 109.405 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' S' S ' 260' ' ' PHE . . . . . 0.533 ' CE2' HD21 ' S' ' 311' ' ' LEU . 3.1 m-85 -62.86 -45.22 93.57 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.593 -0.692 . . . . 30.57 109.872 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' S' S ' 261' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -62.06 -29.81 70.55 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.383 -0.823 . . . . 41.340000000000003 109.995 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' S' S ' 262' ' ' TYR . . . . . 0.67 ' CE2' HD22 ' S' ' 233' ' ' LEU . 8.6 t80 -71.24 -44.59 65.02 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.37 -0.831 . . . . 26.030000000000001 110.086 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' S' S ' 263' ' ' VAL . . . . . 0.421 HG22 ' O ' ' S' ' 259' ' ' LEU . 33.2 m -92.1 18.34 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.417 -0.802 . . . . 22.800000000000001 110.35 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' S' S ' 264' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 52.78 70.67 0.55 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.292 -0.88 . . . . 44.030000000000001 110.59 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' S' S ' 265' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -111.8 109.18 55.45 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.375 -0.828 . . . . 35.609999999999999 109.622 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' S' S ' 266' ' ' PRO . . . . . 0.478 ' HA ' ' HB2' ' S' ' 269' ' ' ASP . 49.8 Cg_endo -75.25 0.39 9.06 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 123.65 1.342 . . . . 37.670000000000002 111.826 -179.164 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' S' S ' 267' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -56.52 -67.71 0.28 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.76 -1.213 . . . . 41.490000000000002 110.17 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' S' S ' 268' ' ' PHE . . . . . 0.402 ' HB3' ' CD2' ' S' ' 257' ' ' LEU . 22.3 m-85 -92.92 39.92 1.05 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.197 -0.939 . . . . 50.759999999999998 110.095 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' S' S ' 269' ' ' ASP . . . . . 0.478 ' HB2' ' HA ' ' S' ' 266' ' ' PRO . 0.9 OUTLIER -76.01 -33.17 59.67 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.428 -0.795 . . . . 61.859999999999999 109.795 179.533 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' S' S ' 270' ' ' TRP . . . . . 0.51 ' CE2' HG23 ' S' ' 271' ' ' VAL . 50.9 p-90 -73.96 -4.26 34.1 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.28 -0.888 . . . . 39.850000000000001 110.501 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' S' S ' 271' ' ' VAL . . . . . 0.51 HG23 ' CE2' ' S' ' 270' ' ' TRP . 46.4 t -109.48 -32.82 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.121 -0.987 . . . . 39.18 110.058 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' S' S ' 272' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -78.59 -36.57 44.14 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.327 -0.858 . . . . 40.020000000000003 110.538 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' S' S ' 273' ' ' SER . . . . . . . . . . . . . 71.2 m -103.51 56.11 0.74 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.267 -0.896 . . . . 47.200000000000003 110.388 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' S' S ' 274' ' ' SER . . . . . . . . . . . . . 6.9 t -133.04 141.25 40.24 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.298 -0.876 . . . . 47.609999999999999 110.129 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' S' S ' 275' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.7 -18.88 21.84 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 O-C-N 123.72 1.379 . . . . 45.280000000000001 110.533 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' S' S ' 276' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -99.94 140.89 33.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.294 -0.879 . . . . 57.270000000000003 110.314 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' S' S ' 277' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -71.75 97.7 1.82 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.387 -0.821 . . . . 37.280000000000001 110.254 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' S' S ' 278' ' ' LEU . . . . . . . . . . . . . 86.3 mt -97.03 33.84 1.84 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.382 -0.824 . . . . 43.880000000000003 110.001 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' S' S ' 279' ' ' THR . . . . . . . . . . . . . 76.4 m -63.99 -60.17 3.58 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.416 -0.802 . . . . 50.049999999999997 110.282 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' S' S ' 280' ' ' LEU . . . . . 0.73 ' HA ' HD12 ' S' ' 283' ' ' ILE . 13.7 mt -51.51 -39.99 58.7 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.32 -0.862 . . . . 54.119999999999997 110.283 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' S' S ' 281' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.38 -49.64 74.74 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.435 -0.79 . . . . 65.280000000000001 110.161 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' S' S ' 282' ' ' ALA . . . . . . . . . . . . . . . -59.04 -33.9 71.3 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.438 -0.789 . . . . 46.509999999999998 110.499 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' S' S ' 283' ' ' ILE . . . . . 0.73 HD12 ' HA ' ' S' ' 280' ' ' LEU . 85.6 mt -66.25 -50.93 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.288 -0.883 . . . . 47.299999999999997 110.118 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' S' S ' 284' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -50.56 -57.56 7.85 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.388 -0.82 . . . . 50.719999999999999 110.405 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' S' S ' 285' ' ' GLN . . . . . 0.527 ' HG2' HD12 ' S' ' 289' ' ' LEU . 34.4 tt0 -51.41 -46.43 62.91 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.471 -0.768 . . . . 68.469999999999999 110.252 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' S' S ' 286' ' ' LEU . . . . . . . . . . . . . 19.1 mt -60.02 -44.49 94.57 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.403 -0.811 . . . . 36.619999999999997 110.202 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' S' S ' 287' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -62.71 -35.33 79.39 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.387 -0.82 . . . . 46.640000000000001 110.076 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' S' S ' 288' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -76.22 -21.04 56.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.353 -0.842 . . . . 46.450000000000003 110.292 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' S' S ' 289' ' ' LEU . . . . . 0.527 HD12 ' HG2' ' S' ' 285' ' ' GLN . 31.0 mt -97.29 -21.78 17.05 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.254 -0.904 . . . . 35.090000000000003 110.568 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' S' S ' 290' ' ' THR . . . . . 0.41 HG22 ' HB3' ' S' ' 306' ' ' ASN . 81.3 p -114.76 -28.44 7.09 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.252 -0.905 . . . . 38.609999999999999 110.403 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' S' S ' 291' ' ' GLY . . . . . . . . . . . . . . . 79.37 10.96 85.44 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.847 -1.301 . . . . 36.770000000000003 109.847 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' S' S ' 292' ' ' LEU . . . . . . . . . . . . . 84.7 mt -96.43 145.82 25.32 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.271 -1.135 . . . . 35.329999999999998 109.803 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' S' S ' 293' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -77.36 102.39 6.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.163 -0.96 . . . . 48.700000000000003 110.257 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' S' S ' 294' ' ' LEU . . . . . 0.428 ' HB3' ' CZ2' ' S' ' 252' ' ' TRP . 56.2 mt -107.03 51.8 0.73 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.526 -0.734 . . . . 42.609999999999999 110.074 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' S' S ' 295' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -112.51 -11.21 13.64 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.343 -0.848 . . . . 55.490000000000002 110.523 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' S' S ' 296' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -144.33 48.62 1.36 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.123 -0.986 . . . . 75.680000000000007 110.291 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' S' S ' 297' ' ' GLY . . . . . . . . . . . . . . . 96.85 145.09 18.53 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.555 -1.418 . . . . 49.439999999999998 109.555 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' S' S ' 298' ' ' GLY . . . . . . . . . . . . . . . -163.77 157.03 29.14 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.77 -1.332 . . . . 41.109999999999999 109.77 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' S' S ' 299' ' ' PRO . . . . . 0.486 ' O ' HG23 ' S' ' 303' ' ' VAL . 47.3 Cg_endo -73.91 118.31 5.38 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 123.917 1.483 . . . . 26.199999999999999 110.304 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' S' S ' 300' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.26 -15.43 31.63 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 O-C-N 123.616 1.324 . . . . 21.699999999999999 110.693 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' S' S ' 301' ' ' ALA . . . . . . . . . . . . . . . -80.75 -29.37 36.28 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.192 -0.942 . . . . 31.23 110.073 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' S' S ' 302' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.45 -40.72 18.93 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.409 -0.807 . . . . 38.990000000000002 109.969 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' S' S ' 303' ' ' VAL . . . . . 0.486 HG23 ' O ' ' S' ' 299' ' ' PRO . 58.0 t -60.67 -35.5 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.364 -0.835 . . . . 18.629999999999999 110.095 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' S' S ' 304' ' ' ILE . . . . . 0.524 HD12 HG21 ' S' ' 379' ' ' VAL . 86.1 mt -79.42 -23.58 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.431 -0.793 . . . . 25.460000000000001 110.153 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' S' S ' 305' ' ' TRP . . . . . 0.412 ' CD2' ' HD3' ' S' ' 308' ' ' LYS . 68.8 t-105 -88.69 -14.53 37.1 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.32 -0.862 . . . . 33.399999999999999 110.503 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' S' S ' 306' ' ' ASN . . . . . 0.41 ' HB3' HG22 ' S' ' 290' ' ' THR . 10.4 m-80 -89.68 -13.62 36.56 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.168 -0.957 . . . . 36.969999999999999 110.378 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' S' S ' 307' ' ' ILE . . . . . 0.473 HG12 ' O ' ' S' ' 303' ' ' VAL . 36.9 pt -125.1 45.59 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.266 -0.896 . . . . 30.809999999999999 110.045 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' S' S ' 308' ' ' LYS . . . . . 0.412 ' HD3' ' CD2' ' S' ' 305' ' ' TRP . 1.5 mtmp? -73.5 -37.79 65.56 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.366 -0.834 . . . . 46.520000000000003 110.086 -179.537 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' S' S ' 309' ' ' HIS . . . . . 0.496 ' CD2' ' HG ' ' S' ' 310' ' ' LEU . 55.5 p-80 -73.14 -8.38 55.51 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.284 -0.885 . . . . 51.030000000000001 110.097 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' S' S ' 310' ' ' LEU . . . . . 0.496 ' HG ' ' CD2' ' S' ' 309' ' ' HIS . 52.9 mt -99.25 -12.91 19.96 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.311 -0.868 . . . . 36.159999999999997 109.944 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' S' S ' 311' ' ' LEU . . . . . 0.533 HD21 ' CE2' ' S' ' 260' ' ' PHE . 10.8 mt -97.12 147.88 23.61 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.282 -0.886 . . . . 40.0 110.406 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' S' S ' 312' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -81.66 -16.3 51.79 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.28 -0.888 . . . . 54.18 109.68 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' S' S ' 313' ' ' THR . . . . . 0.824 HG23 ' HG2' ' S' ' 323' ' ' GLU . 92.6 m -87.9 151.63 22.68 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.322 -0.861 . . . . 25.609999999999999 110.125 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' S' S ' 314' ' ' GLY . . . . . . . . . . . . . . . -87.93 126.42 8.05 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.791 -1.324 . . . . 25.18 109.791 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' S' S ' 315' ' ' ILE . . . . . 0.669 HD13 ' HB ' ' S' ' 324' ' ' VAL . 50.7 mm -101.62 150.48 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.377 -1.072 . . . . 23.899999999999999 109.722 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' S' S ' 316' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' S' ' 325' ' ' CYS . . . -157.1 -159.26 9.38 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.006 -1.237 . . . . 23.18 110.006 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' S' S ' 317' ' ' THR . . . . . 0.423 HG22 ' CG2' ' S' ' 326' ' ' VAL . 11.1 p -133.89 -173.0 3.12 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.367 -1.078 . . . . 27.98 110.044 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' S' S ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.51 -56.26 24.12 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.239 -0.913 . . . . 28.100000000000001 109.885 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' S' S ' 319' ' ' SER . . . . . . . . . . . . . 1.2 m -59.93 -41.69 92.34 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.372 -0.83 . . . . 37.0 109.604 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' S' S ' 320' ' ' ARG . . . . . . . . . . . . . 12.1 mtm180 -111.71 79.84 2.64 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.483 -0.761 . . . . 52.07 109.717 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' S' S ' 321' ' ' PRO . . . . . 0.445 ' O ' ' HB2' ' S' ' 322' ' ' SER . 44.1 Cg_endo -71.44 171.47 16.13 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.853 1.449 . . . . 38.289999999999999 110.928 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' S' S ' 322' ' ' SER . . . . . 0.445 ' HB2' ' O ' ' S' ' 321' ' ' PRO . 41.5 t 178.73 -148.14 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.021 -0.733 . . . . 38.840000000000003 109.021 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' S' S ' 323' ' ' GLU . . . . . 0.824 ' HG2' HG23 ' S' ' 313' ' ' THR . 6.7 tp10 -62.86 -40.26 96.93 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.947 -1.096 . . . . 40.700000000000003 109.733 179.218 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' S' S ' 324' ' ' VAL . . . . . 0.669 ' HB ' HD13 ' S' ' 315' ' ' ILE . 73.2 t -141.26 135.0 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.502 -0.749 . . . . 20.34 109.462 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' S' S ' 325' ' ' CYS . . . . . 0.458 ' HB2' ' CE1' ' S' ' 380' ' ' PHE . 11.2 m -125.99 172.14 10.19 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.275 -0.891 . . . . 30.629999999999999 110.886 -179.167 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' S' S ' 326' ' ' VAL . . . . . 0.645 HG12 HG22 ' S' ' 379' ' ' VAL . 34.6 m -135.41 142.21 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.62 -0.675 . . . . 23.899999999999999 109.237 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' S' S ' 327' ' ' VAL . . . . . 0.594 HG11 ' O ' ' S' ' 377' ' ' VAL . 34.5 m -56.32 125.03 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.104 -0.998 . . . . 19.48 110.4 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' S' S ' 328' ' ' ASP . . . . . . . . . . . . . 55.6 p-10 -119.4 11.47 12.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.494 -0.754 . . . . 26.43 110.461 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' S' S ' 329' ' ' GLY . . . . . . . . . . . . . . . 119.68 2.31 13.04 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.027 -1.229 . . . . 31.239999999999998 110.027 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' S' S ' 330' ' ' THR . . . . . . . . . . . . . 77.4 m -92.98 130.01 38.7 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.104 -1.233 . . . . 30.050000000000001 110.132 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' S' S ' 331' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -56.81 111.54 1.05 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.321 -0.862 . . . . 37.259999999999998 110.005 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' S' S ' 332' ' ' MET . . . . . . . . . . . . . 88.1 mmm -94.09 162.56 13.83 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.336 -0.852 . . . . 26.23 110.347 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' S' S ' 333' ' ' CYS . . . . . . . . . . . . . 26.1 m -137.26 149.95 47.48 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.419 -0.801 . . . . 23.559999999999999 110.07 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' S' S ' 334' ' ' LEU . . . . . 0.565 HD11 ' O ' ' S' ' 372' ' ' PRO . 0.1 OUTLIER -52.54 -24.85 8.93 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.23 -0.919 . . . . 28.93 110.435 179.941 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' S' S ' 335' ' ' ALA . . . . . . . . . . . . . . . -89.05 14.4 10.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.32 -0.863 . . . . 15.76 110.896 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' S' S ' 336' ' ' ASP . . . . . 0.402 ' O ' ' HA ' ' S' ' 382' ' ' PRO . 70.4 m-20 -100.49 -17.19 17.26 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.191 -0.943 . . . . 34.920000000000002 110.13 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' S' S ' 337' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -152.33 170.86 19.03 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.295 -0.878 . . . . 19.030000000000001 110.068 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' S' S ' 338' ' ' HIS . . . . . 0.401 ' HB3' ' CZ ' ' S' ' 383' ' ' TYR . 13.4 p80 -120.71 10.33 10.96 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.354 -0.841 . . . . 18.82 110.432 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' S' S ' 339' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' S' ' 352' ' ' ALA . . . -175.96 155.17 1.57 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.291 -0.88 . . . . 17.18 110.065 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' S' S ' 340' ' ' GLY . . . . . 0.401 ' CA ' ' O ' ' S' ' 379' ' ' VAL . . . 160.87 173.09 29.05 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 110.067 -1.213 . . . . 18.329999999999998 110.067 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' S' S ' 341' ' ' ILE . . . . . . . . . . . . . 84.2 mt -88.85 138.14 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.444 -1.033 . . . . 18.600000000000001 109.766 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' S' S ' 342' ' ' PHE . . . . . 0.493 ' CE2' ' HB3' ' S' ' 352' ' ' ALA . 70.0 m-85 -120.99 -178.48 3.76 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.214 -0.929 . . . . 23.440000000000001 110.375 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' S' S ' 343' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.83 93.38 4.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.484 -0.76 . . . . 35.590000000000003 109.973 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' S' S ' 344' ' ' LYS . . . . . 0.403 ' O ' ' HB3' ' S' ' 348' ' ' HIS . 0.3 OUTLIER -80.82 125.01 29.56 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.229 -0.919 . . . . 38.340000000000003 110.107 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' S' S ' 345' ' ' GLY . . . . . . . . . . . . . . . 62.72 -130.86 43.27 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 108.87 -1.692 . . . . 53.460000000000001 108.87 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' S' S ' 346' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -132.66 150.9 52.09 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.212 -1.17 . . . . 70.909999999999997 110.065 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' S' S ' 347' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 53.25 35.4 19.97 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.34 -0.85 . . . . 47.32 110.395 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' S' S ' 348' ' ' HIS . . . . . 0.403 ' HB3' ' O ' ' S' ' 344' ' ' LYS . 46.6 t60 -150.11 155.85 40.58 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.279 -0.888 . . . . 41.719999999999999 110.369 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' S' S ' 349' ' ' ALA . . . . . 0.458 ' C ' HG13 ' S' ' 350' ' ' VAL . . . -149.8 151.24 33.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.281 -0.887 . . . . 22.91 110.543 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' S' S ' 350' ' ' VAL . . . . . 0.458 HG13 ' C ' ' S' ' 349' ' ' ALA . 34.6 m -149.05 169.61 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.421 -0.8 . . . . 21.09 110.017 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' S' S ' 351' ' ' PHE . . . . . 0.501 ' CD2' ' HB3' ' S' ' 258' ' ' GLN . 10.7 t80 -105.36 143.67 33.19 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.249 -0.907 . . . . 25.030000000000001 110.693 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' S' S ' 352' ' ' ALA . . . . . 0.493 ' HB3' ' CE2' ' S' ' 342' ' ' PHE . . . -147.74 151.72 36.55 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.52 -0.738 . . . . 23.809999999999999 109.807 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' S' S ' 353' ' ' CYS . . . . . . . . . . . . . 26.2 p -153.4 164.86 37.42 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.271 -0.893 . . . . 25.66 110.175 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' S' S ' 354' ' ' VAL . . . . . 0.55 HG22 ' CE2' ' S' ' 359' ' ' TRP . 57.3 t -76.0 118.56 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.39 -0.819 . . . . 34.270000000000003 109.994 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' S' S ' 355' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' S' ' 232' ' ' THR . 52.3 p -117.86 175.07 5.83 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.294 -0.879 . . . . 25.489999999999998 110.306 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' S' S ' 356' ' ' SER . . . . . . . . . . . . . 62.3 p -62.1 -17.78 58.73 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.41 -0.806 . . . . 31.239999999999998 110.698 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' S' S ' 357' ' ' ASN . . . . . . . . . . . . . 45.8 m-20 -106.96 14.17 26.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.158 -0.964 . . . . 28.609999999999999 110.564 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' S' S ' 358' ' ' GLY . . . . . . . . . . . . . . . 111.87 -152.88 17.6 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.043 -1.223 . . . . 22.010000000000002 110.043 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' S' S ' 359' ' ' TRP . . . . . 0.55 ' CE2' HG22 ' S' ' 354' ' ' VAL . 15.3 m95 -91.4 116.74 29.09 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.43 -1.041 . . . . 25.539999999999999 110.109 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' S' S ' 360' ' ' TYR . . . . . 0.415 ' HA ' ' HA ' ' S' ' 369' ' ' PRO . 1.3 m-85 -103.54 165.88 10.77 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.344 -0.847 . . . . 40.530000000000001 109.997 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' S' S ' 361' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' S' ' 351' ' ' PHE . . . -140.07 130.02 24.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.427 -0.796 . . . . 18.039999999999999 110.279 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' S' S ' 362' ' ' ILE . . . . . . . . . . . . . 89.2 mt -95.59 83.64 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.379 -0.826 . . . . 15.640000000000001 110.13 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' S' S ' 363' ' ' ASP . . . . . 0.416 ' O ' ' N ' ' S' ' 365' ' ' GLU . 11.9 t0 -75.26 94.52 3.01 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.305 -0.872 . . . . 35.030000000000001 110.149 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' S' S ' 364' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 53.88 -89.4 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.518 -0.739 . . . . 46.719999999999999 110.458 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' S' S ' 365' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' S' ' 363' ' ' ASP . 23.8 mt-10 -122.62 19.14 10.37 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.126 -0.984 . . . . 56.200000000000003 110.24 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' S' S ' 366' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -117.96 125.03 49.64 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.281 -0.887 . . . . 51.020000000000003 110.446 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' S' S ' 367' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -107.06 127.12 53.19 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.349 -0.844 . . . . 37.590000000000003 110.142 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' S' S ' 368' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -165.44 159.55 13.89 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.278 -0.889 . . . . 31.469999999999999 110.39 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' S' S ' 369' ' ' PRO . . . . . 0.415 ' HA ' ' HA ' ' S' ' 360' ' ' TYR . 47.0 Cg_endo -72.9 139.59 30.48 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 O-C-N 123.859 1.452 . . . . 28.850000000000001 110.52 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' S' S ' 370' ' ' TRP . . . . . . . . . . . . . 67.4 t90 -167.2 113.64 0.77 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.387 -0.821 . . . . 26.940000000000001 110.006 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' S' S ' 371' ' ' THR . . . . . . . . . . . . . 59.7 m -74.85 113.06 20.86 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.417 -0.802 . . . . 20.190000000000001 110.0 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' S' S ' 372' ' ' PRO . . . . . 0.565 ' O ' HD11 ' S' ' 334' ' ' LEU . 48.5 Cg_endo -73.55 157.13 49.21 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 O-C-N 123.636 1.335 . . . . 28.68 110.571 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' S' S ' 373' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -90.57 147.16 35.77 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.382 -0.824 . . . . 35.719999999999999 109.873 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' S' S ' 374' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -76.05 -6.37 17.27 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 O-C-N 123.628 1.331 . . . . 30.890000000000001 110.473 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' S' S ' 375' ' ' SER . . . . . . . . . . . . . 69.0 p -104.28 -16.93 15.03 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.277 -0.889 . . . . 29.41 110.477 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' S' S ' 376' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -106.47 43.02 1.19 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.302 -0.874 . . . . 32.890000000000001 110.228 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' S' S ' 377' ' ' VAL . . . . . 0.594 ' O ' HG11 ' S' ' 327' ' ' VAL . 7.3 p -114.62 147.23 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.273 -0.892 . . . . 24.329999999999998 110.274 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' S' S ' 378' ' ' LEU . . . . . . . . . . . . . 52.2 mt -116.03 -57.92 2.16 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.446 -0.784 . . . . 24.370000000000001 109.642 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' S' S ' 379' ' ' VAL . . . . . 0.645 HG22 HG12 ' S' ' 326' ' ' VAL . 60.5 t -120.73 132.32 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.403 -0.811 . . . . 18.02 109.48 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' S' S ' 380' ' ' PHE . . . . . 0.458 ' CE1' ' HB2' ' S' ' 325' ' ' CYS . 14.3 p90 -142.5 173.92 11.1 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.417 -0.802 . . . . 29.350000000000001 110.658 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' S' S ' 381' ' ' VAL . . . . . . . . . . . . . 57.9 t -120.0 107.32 40.02 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.485 -0.759 . . . . 16.34 109.458 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' S' S ' 382' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' S' ' 336' ' ' ASP . 46.0 Cg_endo -71.28 145.63 49.05 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 O-C-N 123.562 1.296 . . . . 20.940000000000001 110.726 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' S' S ' 383' ' ' TYR . . . . . 0.401 ' CZ ' ' HB3' ' S' ' 338' ' ' HIS . 88.2 m-85 -61.16 -53.43 57.06 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.387 -0.82 . . . . 28.93 109.833 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' S' S ' 384' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.457 -0.777 . . . . 47.030000000000001 110.426 -177.04 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' R' R ' 30' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 . . . . . 0 N--CA 1.493 1.719 0 CA-C-O 121.207 0.527 . . . . 43.359999999999999 110.249 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' R' R ' 31' ' ' LEU . . . . . . . . . . . . . 65.3 mt -134.91 140.6 45.89 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.282 -0.886 . . . . 22.93 110.283 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 32' ' ' THR . . . . . . . . . . . . . 70.3 m -87.62 110.49 20.43 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.391 -0.818 . . . . 22.34 109.982 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 33' ' ' LEU . . . . . 0.596 HD22 ' CE2' ' R' ' 62' ' ' TYR . 80.1 mt -62.28 -172.78 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.295 -0.878 . . . . 21.390000000000001 110.221 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 34' ' ' TYR . . . . . . . . . . . . . 37.0 p90 -74.66 -29.36 61.22 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.266 -0.896 . . . . 34.399999999999999 110.414 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 35' ' ' ASN . . . . . . . . . . . . . 48.3 p30 -77.77 -1.92 33.79 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.289 -0.882 . . . . 30.280000000000001 110.633 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.29 -16.56 59.51 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.742 -1.343 . . . . 36.25 109.742 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 37' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -59.02 161.82 4.76 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.285 -1.127 . . . . 53.799999999999997 110.368 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 38' ' ' LYS . . . . . . . . . . . . . 56.8 mttt -117.85 135.73 53.9 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.367 -0.833 . . . . 49.909999999999997 110.132 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 39' ' ' LYS . . . . . 0.406 ' HG2' ' CZ ' ' R' ' 41' ' ' PHE . 8.0 ttmt -138.72 143.68 39.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.375 -0.828 . . . . 35.689999999999998 110.255 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 40' ' ' THR . . . . . . . . . . . . . 23.4 m -102.55 127.95 49.41 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.424 -0.798 . . . . 34.840000000000003 110.198 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 41' ' ' PHE . . . . . 0.406 ' CZ ' ' HG2' ' R' ' 39' ' ' LYS . 96.6 m-85 -113.0 132.69 55.27 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.41 -0.806 . . . . 34.420000000000002 110.179 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 42' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -93.34 140.97 28.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.328 -0.857 . . . . 51.460000000000001 110.229 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 43' ' ' SER . . . . . . . . . . . . . 54.3 m -70.84 141.9 51.28 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.461 -0.774 . . . . 41.840000000000003 110.192 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.77 125.4 29.54 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.367 -0.833 . . . . 33.82 109.957 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 45' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.15 151.05 54.77 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.517 1.272 . . . . 30.27 110.646 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 46' ' ' ASN . . . . . 0.4 ' HA ' ' OD1' ' R' ' 50' ' ' ASN . 52.2 t-20 -124.24 109.91 13.99 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.534 -0.728 . . . . 35.100000000000001 109.997 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 47' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -120.32 -34.84 3.56 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.292 -0.88 . . . . 42.810000000000002 110.537 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 48' ' ' HIS . . . . . 0.439 ' NE2' HD11 ' R' ' 80' ' ' LEU . 73.3 m80 -105.86 45.23 0.98 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.346 -0.846 . . . . 49.969999999999999 110.24 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 49' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 50.32 34.62 9.22 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.491 -0.755 . . . . 61.32 110.158 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 50' ' ' ASN . . . . . 0.4 ' OD1' ' HA ' ' R' ' 46' ' ' ASN . 15.0 p-10 -86.15 43.77 1.08 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.388 -0.82 . . . . 51.5 110.747 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.07 -46.1 78.93 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.243 -0.911 . . . . 38.770000000000003 109.571 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 52' ' ' TRP . . . . . 0.483 ' CD2' ' N ' ' R' ' 53' ' ' LEU . 68.1 p-90 -58.46 -38.34 77.34 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.57 -0.706 . . . . 26.239999999999998 110.048 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 53' ' ' LEU . . . . . 0.483 ' N ' ' CD2' ' R' ' 52' ' ' TRP . 23.2 tp -66.72 -46.68 74.75 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.323 -0.861 . . . . 26.75 110.013 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 54' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -55.25 -41.53 72.29 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.363 -0.836 . . . . 35.020000000000003 110.23 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.16 -46.12 91.83 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.44 -0.788 . . . . 24.469999999999999 110.196 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 56' ' ' ILE . . . . . 0.431 HG12 HD11 ' R' ' 104' ' ' ILE . 76.1 mt -62.12 -42.26 94.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.292 -0.88 . . . . 26.030000000000001 109.927 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 57' ' ' LEU . . . . . . . . . . . . . 22.3 mt -60.35 -45.61 92.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.251 -0.906 . . . . 26.77 109.661 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 58' ' ' GLN . . . . . . . . . . . . . 57.7 mm-40 -63.87 -46.52 84.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.427 -0.796 . . . . 22.32 109.625 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 59' ' ' LEU . . . . . 0.43 ' HA ' ' HE2' ' R' ' 151' ' ' PHE . 24.0 tp -61.33 -37.82 84.67 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.334 -0.854 . . . . 20.550000000000001 109.443 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 60' ' ' PHE . . . . . 0.528 ' CE2' HD21 ' R' ' 111' ' ' LEU . 2.8 m-85 -61.1 -44.7 96.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.567 -0.708 . . . . 20.079999999999998 109.933 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 61' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -63.1 -36.13 82.57 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.441 -0.787 . . . . 18.800000000000001 110.541 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 62' ' ' TYR . . . . . 0.596 ' CE2' HD22 ' R' ' 33' ' ' LEU . 9.2 t80 -63.22 -41.73 99.16 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.233 -0.917 . . . . 26.449999999999999 110.155 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 63' ' ' VAL . . . . . 0.406 ' H ' HG22 ' R' ' 63' ' ' VAL . 30.4 m -93.36 20.34 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.275 -0.891 . . . . 29.75 110.19 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 64' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 52.92 75.63 0.23 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.328 -0.857 . . . . 35.520000000000003 110.559 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 65' ' ' GLU . . . . . 0.443 ' HG2' ' CD2' ' R' ' 60' ' ' PHE . 14.3 tp10 -116.36 104.14 52.15 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.344 -0.847 . . . . 29.890000000000001 109.865 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 66' ' ' PRO . . . . . 0.481 ' HA ' ' HB2' ' R' ' 69' ' ' ASP . 46.7 Cg_endo -73.6 -5.84 17.74 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.806 1.424 . . . . 21.370000000000001 111.064 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 67' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -52.09 -61.52 2.21 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.147 -0.97 . . . . 23.850000000000001 110.375 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 68' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -98.2 36.69 1.55 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.326 -0.859 . . . . 28.07 110.488 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 69' ' ' ASP . . . . . 0.481 ' HB2' ' HA ' ' R' ' 66' ' ' PRO . 11.7 t0 -72.43 -33.17 66.91 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.225 -0.922 . . . . 43.759999999999998 110.175 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 70' ' ' TRP . . . . . 0.476 ' CE2' ' CG2' ' R' ' 71' ' ' VAL . 47.7 p-90 -73.41 -3.98 30.74 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.334 -0.854 . . . . 33.060000000000002 110.71 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 71' ' ' VAL . . . . . 0.557 HG11 ' HB2' ' R' ' 82' ' ' ALA . 40.5 t -109.73 -27.41 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.223 -0.923 . . . . 31.699999999999999 109.756 179.127 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 72' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -86.54 -48.79 8.06 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.407 -0.808 . . . . 33.579999999999998 110.383 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 73' ' ' SER . . . . . . . . . . . . . 70.0 m -89.71 51.06 2.0 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.394 -0.816 . . . . 50.82 110.304 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 74' ' ' SER . . . . . . . . . . . . . 15.9 t -125.96 138.29 31.79 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.238 -0.914 . . . . 34.740000000000002 110.24 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.36 -24.96 15.98 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.742 1.391 . . . . 35.700000000000003 110.343 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 76' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -91.72 153.15 19.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.33 -0.856 . . . . 66.480000000000004 110.355 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 77' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -81.47 95.27 7.03 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.391 -0.818 . . . . 46.719999999999999 110.043 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 78' ' ' LEU . . . . . . . . . . . . . 96.3 mt -96.49 27.99 3.55 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.389 -0.82 . . . . 37.549999999999997 110.191 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 79' ' ' THR . . . . . . . . . . . . . 29.6 m -56.27 -54.58 43.7 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.225 -0.922 . . . . 37.359999999999999 110.302 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 80' ' ' LEU . . . . . 0.604 ' HA ' HD12 ' R' ' 83' ' ' ILE . 15.9 mt -60.97 -23.16 65.13 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.33 -0.856 . . . . 35.829999999999998 110.511 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 81' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -79.5 -39.11 32.85 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.101 -0.999 . . . . 44.030000000000001 110.356 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 82' ' ' ALA . . . . . 0.557 ' HB2' HG11 ' R' ' 71' ' ' VAL . . . -69.51 -28.64 66.22 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.257 -0.902 . . . . 32.539999999999999 110.169 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 83' ' ' ILE . . . . . 0.604 HD12 ' HA ' ' R' ' 80' ' ' LEU . 77.8 mt -70.08 -46.12 73.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.275 -0.891 . . . . 32.020000000000003 110.352 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 84' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -55.09 -52.17 64.08 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.208 -0.932 . . . . 34.090000000000003 110.56 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 85' ' ' GLN . . . . . 0.533 ' HG2' HD12 ' R' ' 89' ' ' LEU . 31.9 tt0 -54.79 -46.88 74.53 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.209 -0.932 . . . . 25.940000000000001 110.279 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 86' ' ' LEU . . . . . . . . . . . . . 23.7 mt -58.75 -43.76 90.38 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.365 -0.835 . . . . 16.199999999999999 109.853 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 87' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -65.33 -35.25 80.4 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.494 -0.754 . . . . 49.090000000000003 110.317 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 88' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -78.41 -19.05 54.09 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.282 -0.886 . . . . 28.609999999999999 110.529 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 89' ' ' LEU . . . . . 0.533 HD12 ' HG2' ' R' ' 85' ' ' GLN . 32.6 mt -96.21 -29.35 14.09 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.248 -0.907 . . . . 26.16 110.201 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 90' ' ' THR . . . . . . . . . . . . . 60.7 p -105.69 -34.71 7.62 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.255 -0.903 . . . . 33.329999999999998 109.75 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.88 16.15 58.47 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.85 -1.3 . . . . 31.129999999999999 109.85 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 92' ' ' LEU . . . . . . . . . . . . . 97.1 mt -100.18 155.21 17.87 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.213 -1.169 . . . . 42.520000000000003 110.186 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 93' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -86.19 91.59 8.5 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.481 -0.762 . . . . 68.459999999999994 110.038 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 94' ' ' LEU . . . . . 0.458 ' HB3' ' CZ2' ' R' ' 52' ' ' TRP . 48.1 mt -99.37 53.03 0.95 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.204 -0.935 . . . . 44.630000000000003 110.377 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 95' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.57 -38.59 6.38 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.262 -0.898 . . . . 67.159999999999997 110.369 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 96' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -113.93 44.23 1.68 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.364 -0.835 . . . . 67.019999999999996 110.244 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 97' ' ' GLY . . . . . . . . . . . . . . . 99.12 150.8 26.05 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.614 -1.395 . . . . 49.479999999999997 109.614 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 98' ' ' GLY . . . . . . . . . . . . . . . -166.27 160.01 33.44 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.265 -1.534 . . . . 36.57 109.265 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 99' ' ' PRO . . . . . 0.79 ' O ' HG23 ' R' ' 103' ' ' VAL . 44.5 Cg_endo -72.57 121.12 7.15 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.75 1.395 . . . . 30.41 110.384 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 100' ' ' PRO . . . . . 0.413 ' HA ' HD11 ' R' ' 56' ' ' ILE . 45.4 Cg_endo -72.3 -31.68 11.34 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.619 1.326 . . . . 29.940000000000001 110.493 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 101' ' ' ALA . . . . . 0.475 ' HB2' ' HB3' ' R' ' 178' ' ' LEU . . . -70.01 -38.45 75.96 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.34 -0.85 . . . . 23.640000000000001 110.294 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 102' ' ' LEU . . . . . 0.423 HD23 HD21 ' R' ' 106' ' ' ASN . 0.1 OUTLIER -72.63 -40.77 66.16 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.353 -0.842 . . . . 20.309999999999999 110.382 -179.757 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' R' R ' 103' ' ' VAL . . . . . 0.79 HG23 ' O ' ' R' ' 99' ' ' PRO . 63.1 t -58.01 -40.21 75.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.202 -0.936 . . . . 16.329999999999998 110.023 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 104' ' ' ILE . . . . . 0.431 HD11 HG12 ' R' ' 56' ' ' ILE . 81.7 mt -71.62 -30.6 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.384 -0.823 . . . . 24.77 109.941 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 105' ' ' TRP . . . . . 0.462 ' O ' ' HD3' ' R' ' 108' ' ' LYS . 70.6 t-105 -82.26 0.72 40.08 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.311 -0.868 . . . . 23.280000000000001 110.376 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 106' ' ' ASN . . . . . 0.423 HD21 HD23 ' R' ' 102' ' ' LEU . 6.9 m-80 -104.98 -10.5 17.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.118 -0.989 . . . . 28.260000000000002 110.112 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 107' ' ' ILE . . . . . . . . . . . . . 36.6 pt -126.81 35.0 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.225 -0.922 . . . . 18.77 109.994 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 108' ' ' LYS . . . . . 0.5 ' HG2' ' HB ' ' R' ' 115' ' ' ILE . 9.2 mtpp -61.02 -48.54 81.32 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.499 -0.751 . . . . 42.5 110.011 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 109' ' ' HIS . . . . . 0.447 ' CD2' ' HG ' ' R' ' 110' ' ' LEU . 50.8 p-80 -66.0 -12.84 57.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.518 -0.738 . . . . 20.07 110.64 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 110' ' ' LEU . . . . . 0.447 ' HG ' ' CD2' ' R' ' 109' ' ' HIS . 80.4 mt -94.8 -17.39 22.17 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.116 -0.99 . . . . 15.69 110.156 179.413 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 111' ' ' LEU . . . . . 0.528 HD21 ' CE2' ' R' ' 60' ' ' PHE . 10.4 mt -94.06 144.12 25.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.299 -0.876 . . . . 25.390000000000001 111.046 -179.183 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 112' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -77.66 -17.43 57.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.634 -0.666 . . . . 53.479999999999997 109.854 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 113' ' ' THR . . . . . 0.457 HG22 ' N ' ' R' ' 114' ' ' GLY . 60.0 m -83.63 166.66 17.97 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.379 -0.826 . . . . 14.800000000000001 110.257 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 114' ' ' GLY . . . . . 0.457 ' N ' HG22 ' R' ' 113' ' ' THR . . . -97.97 127.14 9.13 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.041 -1.224 . . . . 16.140000000000001 110.041 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 115' ' ' ILE . . . . . 0.578 HD13 ' HB ' ' R' ' 124' ' ' VAL . 47.7 mm -109.1 139.37 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.457 -1.025 . . . . 13.460000000000001 109.727 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 116' ' ' GLY . . . . . . . . . . . . . . . -152.75 -155.81 7.27 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.876 -1.29 . . . . 23.899999999999999 109.876 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 117' ' ' THR . . . . . 0.53 HG22 ' CG2' ' R' ' 126' ' ' VAL . 18.7 p -135.05 -171.4 2.79 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.432 -1.04 . . . . 27.370000000000001 110.072 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 118' ' ' ALA . . . . . 0.445 ' HB3' ' OD1' ' R' ' 128' ' ' ASP . . . -56.5 -58.12 9.42 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.23 -0.918 . . . . 18.760000000000002 110.031 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 119' ' ' SER . . . . . 0.63 ' HA ' ' HB3' ' R' ' 194' ' ' ALA . 1.1 m -56.56 -40.6 75.44 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.259 -0.901 . . . . 32.350000000000001 109.764 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 120' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 -110.05 86.29 4.9 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.47 -0.768 . . . . 27.120000000000001 109.636 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 121' ' ' PRO . . . . . 0.483 ' HA ' ' SG ' ' R' ' 125' ' ' CYS . 44.2 Cg_endo -71.26 166.44 29.25 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 O-C-N 123.819 1.431 . . . . 22.68 111.009 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 122' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' R' ' 121' ' ' PRO . 38.1 t 178.58 -161.65 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.609 -0.682 . . . . 22.989999999999998 109.493 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 123' ' ' GLU . . . . . 0.44 ' HG2' HG23 ' R' ' 113' ' ' THR . 2.3 tp10 -56.45 -39.97 74.01 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.19 -0.944 . . . . 36.18 109.701 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 124' ' ' VAL . . . . . 0.578 ' HB ' HD13 ' R' ' 115' ' ' ILE . 82.6 t -142.5 136.41 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.498 -0.751 . . . . 20.640000000000001 109.393 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 125' ' ' CYS . . . . . 0.483 ' SG ' ' HA ' ' R' ' 121' ' ' PRO . 83.4 m -140.32 168.15 20.49 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.304 -0.873 . . . . 22.800000000000001 111.131 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 126' ' ' VAL . . . . . 0.727 HG12 HG22 ' R' ' 179' ' ' VAL . 35.8 m -122.68 159.7 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.714 -0.616 . . . . 21.239999999999998 109.676 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 127' ' ' VAL . . . . . 0.709 HG11 ' O ' ' R' ' 177' ' ' VAL . 30.6 m -70.81 141.8 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.359 -0.838 . . . . 19.77 110.7 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 128' ' ' ASP . . . . . 0.445 ' OD1' ' HB3' ' R' ' 118' ' ' ALA . 53.9 p-10 -137.63 19.38 2.89 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.333 -0.855 . . . . 29.210000000000001 110.714 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 129' ' ' GLY . . . . . . . . . . . . . . . 113.97 0.08 24.18 Favored Glycine 0 N--CA 1.493 2.458 0 C-N-CA 120.0 -1.095 . . . . 33.859999999999999 110.468 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 130' ' ' THR . . . . . . . . . . . . . 58.1 m -91.82 131.87 36.85 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.171 -1.193 . . . . 26.41 110.072 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -62.58 120.65 11.56 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.312 -0.868 . . . . 33.079999999999998 110.284 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 132' ' ' MET . . . . . 0.433 ' HE1' ' CE2' ' R' ' 180' ' ' PHE . 98.4 mmm -105.16 165.62 10.97 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.543 -0.723 . . . . 30.760000000000002 110.415 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 133' ' ' CYS . . . . . 0.41 ' HA ' ' HB3' ' R' ' 174' ' ' PRO . 32.4 m -141.14 158.13 44.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.511 -0.743 . . . . 27.0 109.912 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 134' ' ' LEU . . . . . 0.563 HD11 ' O ' ' R' ' 172' ' ' PRO . 0.1 OUTLIER -58.48 -19.68 39.12 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.347 -0.846 . . . . 33.899999999999999 110.538 -179.936 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' R' R ' 135' ' ' ALA . . . . . . . . . . . . . . . -92.79 8.22 40.37 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.261 -0.899 . . . . 19.370000000000001 110.801 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 136' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -93.72 -21.87 19.08 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.109 -0.994 . . . . 30.469999999999999 110.195 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 137' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -149.9 165.45 32.56 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.421 -0.8 . . . . 24.27 110.227 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 138' ' ' HIS . . . . . 0.434 ' HA ' HG23 ' R' ' 154' ' ' VAL . 15.1 p80 -117.88 15.09 14.33 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.418 -0.801 . . . . 20.91 110.412 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 139' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' R' ' 152' ' ' ALA . . . -177.19 152.35 0.87 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.187 -0.946 . . . . 15.69 110.171 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 140' ' ' GLY . . . . . 0.428 ' HA3' ' O ' ' R' ' 179' ' ' VAL . . . 161.82 175.18 32.58 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.918 -1.273 . . . . 23.760000000000002 109.918 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 141' ' ' ILE . . . . . . . . . . . . . 83.7 mt -95.54 136.57 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.447 -1.031 . . . . 25.300000000000001 109.702 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 142' ' ' PHE . . . . . 0.577 ' CD2' ' HB2' ' R' ' 172' ' ' PRO . 82.2 m-85 -120.66 -172.58 2.41 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.276 -0.89 . . . . 30.239999999999998 110.566 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 143' ' ' LEU . . . . . 0.742 HD23 ' O ' ' R' ' 148' ' ' HIS . 0.5 OUTLIER -119.84 77.78 1.27 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.455 -0.778 . . . . 32.799999999999997 110.298 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' R' R ' 144' ' ' LYS . . . . . 0.471 ' HG3' ' CZ2' ' R' ' 170' ' ' TRP . 1.0 OUTLIER -69.66 76.84 0.43 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.43 -0.794 . . . . 49.18 109.635 179.651 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' R' R ' 145' ' ' GLY . . . . . 0.458 ' O ' HD22 ' R' ' 143' ' ' LEU . . . 104.57 179.26 24.76 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.168 -1.573 . . . . 53.869999999999997 109.168 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 146' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -88.5 145.79 25.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.388 -1.066 . . . . 68.579999999999998 110.049 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 147' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 58.29 36.51 25.68 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.392 -0.818 . . . . 56.619999999999997 110.655 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 148' ' ' HIS . . . . . 0.742 ' O ' HD23 ' R' ' 143' ' ' LEU . 45.0 t60 -158.68 148.08 19.14 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.205 -0.934 . . . . 44.57 110.377 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 149' ' ' ALA . . . . . . . . . . . . . . . -150.3 146.93 27.06 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.467 -0.771 . . . . 33.539999999999999 110.072 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 150' ' ' VAL . . . . . . . . . . . . . 34.2 m -142.38 161.45 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.273 -0.892 . . . . 27.609999999999999 110.305 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 151' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' R' ' 152' ' ' ALA . 5.9 t80 -86.15 155.58 20.7 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.42 -0.8 . . . . 23.039999999999999 109.867 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 152' ' ' ALA . . . . . 0.537 ' N ' ' CD1' ' R' ' 151' ' ' PHE . . . -157.31 151.59 24.95 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.455 -0.778 . . . . 29.609999999999999 109.565 178.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 153' ' ' CYS . . . . . . . . . . . . . 26.7 p -154.33 173.56 16.02 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.334 -0.854 . . . . 22.75 110.49 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 154' ' ' VAL . . . . . 0.613 HG22 ' CE2' ' R' ' 159' ' ' TRP . 60.4 t -90.6 116.97 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.337 -0.852 . . . . 23.260000000000002 110.083 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 155' ' ' THR . . . . . . . . . . . . . 69.3 p -112.05 -176.65 2.98 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.257 -0.902 . . . . 17.879999999999999 110.102 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 156' ' ' SER . . . . . . . . . . . . . 78.4 p -75.96 -3.69 36.96 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.394 -0.816 . . . . 21.829999999999998 110.721 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 157' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -118.32 10.58 12.84 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.046 -1.034 . . . . 36.539999999999999 110.613 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 158' ' ' GLY . . . . . . . . . . . . . . . 117.98 -162.65 13.04 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.592 -1.403 . . . . 31.739999999999998 109.592 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 159' ' ' TRP . . . . . 0.613 ' CE2' HG22 ' R' ' 154' ' ' VAL . 14.7 m95 -86.55 122.42 30.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.312 -1.111 . . . . 28.25 110.112 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 160' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -108.46 166.94 10.39 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.413 -0.805 . . . . 41.240000000000002 110.19 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 161' ' ' ALA . . . . . . . . . . . . . . . -143.21 123.48 13.79 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.367 -0.833 . . . . 27.399999999999999 110.14 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 162' ' ' ILE . . . . . . . . . . . . . 92.1 mt -87.6 81.14 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.354 -0.841 . . . . 24.27 110.106 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 163' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' R' ' 165' ' ' GLU . 15.3 t0 -72.72 92.33 1.54 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.443 -0.786 . . . . 36.079999999999998 110.332 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 164' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 54.1 -88.93 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.496 -0.752 . . . . 46.079999999999998 110.565 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 165' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' R' ' 163' ' ' ASP . 29.7 mt-10 -124.72 35.96 4.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.017 -1.052 . . . . 50.939999999999998 110.187 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 166' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -135.8 117.34 14.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.339 -0.85 . . . . 47.280000000000001 110.309 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 167' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -101.07 119.92 39.45 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.412 -0.805 . . . . 40.469999999999999 110.127 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 168' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -157.58 158.51 30.6 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.305 -0.872 . . . . 30.210000000000001 110.407 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 169' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.77 133.06 19.54 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 O-C-N 123.868 1.457 . . . . 32.759999999999998 110.474 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 170' ' ' TRP . . . . . 0.471 ' CZ2' ' HG3' ' R' ' 144' ' ' LYS . 67.0 t90 -159.81 119.3 2.88 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.41 -0.806 . . . . 32.789999999999999 109.984 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 171' ' ' THR . . . . . . . . . . . . . 45.7 m -81.08 112.62 34.19 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.444 -0.785 . . . . 36.920000000000002 110.219 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 172' ' ' PRO . . . . . 0.577 ' HB2' ' CD2' ' R' ' 142' ' ' PHE . 46.9 Cg_endo -73.75 158.83 46.45 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.68 1.358 . . . . 33.539999999999999 110.533 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 173' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -88.9 144.96 33.71 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.366 -0.833 . . . . 45.759999999999998 109.843 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 174' ' ' PRO . . . . . 0.41 ' HB3' ' HA ' ' R' ' 133' ' ' CYS . 45.2 Cg_endo -71.71 -10.4 26.46 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 O-C-N 123.553 1.291 . . . . 29.629999999999999 110.438 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 175' ' ' SER . . . . . . . . . . . . . 53.0 p -103.36 -17.69 15.16 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.234 -0.916 . . . . 35.700000000000003 110.404 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 176' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -103.44 43.13 1.1 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.233 -0.917 . . . . 39.649999999999999 110.4 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 177' ' ' VAL . . . . . 0.709 ' O ' HG11 ' R' ' 127' ' ' VAL . 10.4 p -117.69 127.2 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.409 -0.807 . . . . 20.609999999999999 110.021 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 178' ' ' LEU . . . . . 0.475 ' HB3' ' HB2' ' R' ' 101' ' ' ALA . 46.3 mt -91.52 -61.29 1.68 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.35 -0.844 . . . . 15.58 109.376 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 179' ' ' VAL . . . . . 0.727 HG22 HG12 ' R' ' 126' ' ' VAL . 67.1 t -114.62 144.67 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.6 -0.688 . . . . 17.399999999999999 109.444 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 180' ' ' PHE . . . . . 0.433 ' CE2' ' HE1' ' R' ' 132' ' ' MET . 43.7 p90 -152.09 163.37 39.47 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.338 -0.851 . . . . 20.16 110.562 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 181' ' ' VAL . . . . . . . . . . . . . 66.4 t -113.19 111.48 50.22 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.511 -0.743 . . . . 17.690000000000001 109.836 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 182' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.11 149.54 52.44 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.546 1.287 . . . . 17.809999999999999 110.374 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 183' ' ' TYR . . . . . 0.736 ' O ' ' C ' ' R' ' 184' ' ' ASP . 79.2 m-85 -58.99 175.47 0.28 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.464 -0.772 . . . . 28.010000000000002 110.522 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' R' R ' 184' ' ' ASP . . . . . 0.736 ' C ' ' O ' ' R' ' 183' ' ' TYR . 0.0 OUTLIER -13.05 -76.29 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.303 -0.873 . . . . 58.640000000000001 110.221 -178.029 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' R' R ' 185' ' ' GLN . . . . . . . . . . . . . 16.8 tm0? . . . . . 0 N--CA 1.503 2.217 0 CA-C-O 121.265 0.555 . . . . 80.420000000000002 111.773 179.171 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' R' R ' 193' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 120.873 0.368 . . . . 49.5 110.245 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' R' R ' 194' ' ' ALA . . . . . 0.63 ' HB3' ' HA ' ' R' ' 119' ' ' SER . . . . . . . . 0 N--CA 1.495 1.777 0 O-C-N 121.162 -0.961 . . . . 40.399999999999999 110.136 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' S' S ' 229' ' ' MET . . . . . . . . . . . . . 28.8 mtm . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.188 0.518 . . . . 51.829999999999998 110.235 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' S' S ' 230' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -97.34 142.69 28.9 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.409 -0.807 . . . . 54.130000000000003 110.195 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' S' S ' 231' ' ' LEU . . . . . . . . . . . . . 68.0 mt -134.02 141.02 47.06 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.413 -0.805 . . . . 33.039999999999999 110.344 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' S' S ' 232' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' S' ' 355' ' ' THR . 40.2 m -89.27 103.29 15.93 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.432 -0.792 . . . . 26.920000000000002 109.973 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' S' S ' 233' ' ' LEU . . . . . 0.667 HD22 ' CE2' ' S' ' 262' ' ' TYR . 79.7 mt -55.92 179.36 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.471 -0.768 . . . . 13.779999999999999 110.494 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' S' S ' 234' ' ' TYR . . . . . 0.44 ' CG ' ' N ' ' S' ' 235' ' ' ASN . 35.4 p90 -65.13 -35.61 81.67 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.355 -0.841 . . . . 26.079999999999998 110.17 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' S' S ' 235' ' ' ASN . . . . . 0.44 ' N ' ' CG ' ' S' ' 234' ' ' TYR . 50.7 p30 -74.3 -7.5 52.99 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.299 -0.876 . . . . 20.039999999999999 110.504 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' S' S ' 236' ' ' GLY . . . . . . . . . . . . . . . 95.8 -20.02 51.72 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.76 -1.336 . . . . 22.710000000000001 109.76 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' S' S ' 237' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -53.02 145.77 12.41 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.19 -1.182 . . . . 35.439999999999998 110.145 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' S' S ' 238' ' ' LYS . . . . . . . . . . . . . 44.3 mttt -102.18 127.87 48.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.395 -0.815 . . . . 32.560000000000002 110.362 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' S' S ' 239' ' ' LYS . . . . . 0.407 ' HG2' ' CZ ' ' S' ' 241' ' ' PHE . 8.9 ttmt -132.29 144.45 50.59 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.474 -0.766 . . . . 26.68 109.959 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' S' S ' 240' ' ' THR . . . . . . . . . . . . . 52.4 m -101.98 132.22 47.93 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.237 -0.915 . . . . 41.020000000000003 110.375 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' S' S ' 241' ' ' PHE . . . . . 0.407 ' CZ ' ' HG2' ' S' ' 239' ' ' LYS . 96.1 m-85 -117.95 137.75 52.63 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.348 -0.845 . . . . 28.620000000000001 110.203 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' S' S ' 242' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -96.47 161.78 13.76 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.38 -0.825 . . . . 47.890000000000001 110.149 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' S' S ' 243' ' ' SER . . . . . . . . . . . . . 72.1 m -90.59 151.62 21.23 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.31 -0.869 . . . . 45.090000000000003 110.211 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' S' S ' 244' ' ' ARG . . . . . . . . . . . . . 1.4 mtp85 -129.82 126.72 22.66 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.324 -0.86 . . . . 42.490000000000002 110.204 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' S' S ' 245' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.3 160.94 43.97 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 O-C-N 123.635 1.334 . . . . 35.68 110.559 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' S' S ' 246' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -132.82 97.84 4.15 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.327 -0.858 . . . . 51.880000000000003 109.871 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' S' S ' 247' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -110.49 -22.18 11.79 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.376 -0.828 . . . . 53.689999999999998 110.647 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' S' S ' 248' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -117.29 43.66 2.28 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.237 -0.914 . . . . 55.789999999999999 110.717 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' S' S ' 249' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 48.8 38.43 11.89 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.444 -0.785 . . . . 49.450000000000003 110.333 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' S' S ' 250' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -90.69 29.14 1.37 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.53 -0.731 . . . . 36.859999999999999 110.297 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' S' S ' 251' ' ' ALA . . . . . . . . . . . . . . . -53.9 -43.18 69.46 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.172 -0.955 . . . . 29.690000000000001 109.564 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' S' S ' 252' ' ' TRP . . . . . 0.428 ' CZ2' ' HB3' ' S' ' 294' ' ' LEU . 68.0 p-90 -61.81 -33.91 74.97 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.491 -0.755 . . . . 41.119999999999997 109.868 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' S' S ' 253' ' ' LEU . . . . . 0.406 ' N ' ' CD2' ' S' ' 252' ' ' TRP . 23.3 tp -70.14 -47.26 62.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.321 -0.862 . . . . 24.890000000000001 109.962 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' S' S ' 254' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -56.12 -42.49 76.94 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.343 -0.848 . . . . 35.649999999999999 109.991 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' S' S ' 255' ' ' ALA . . . . . . . . . . . . . . . -59.56 -48.24 82.44 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.439 -0.788 . . . . 22.73 110.046 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' S' S ' 256' ' ' ILE . . . . . 0.502 HG12 HD11 ' S' ' 304' ' ' ILE . 79.7 mt -62.22 -40.68 88.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.337 -0.852 . . . . 28.850000000000001 109.988 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' S' S ' 257' ' ' LEU . . . . . . . . . . . . . 19.1 mt -61.52 -44.51 96.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.356 -0.84 . . . . 23.07 110.162 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' S' S ' 258' ' ' GLN . . . . . 0.498 ' HB3' ' CD2' ' S' ' 351' ' ' PHE . 53.4 mm-40 -65.07 -45.37 85.55 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.422 -0.799 . . . . 29.780000000000001 109.87 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' S' S ' 259' ' ' LEU . . . . . 0.423 ' O ' HG22 ' S' ' 263' ' ' VAL . 19.9 tp -58.71 -36.34 74.09 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.331 -0.856 . . . . 17.940000000000001 109.452 179.215 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' S' S ' 260' ' ' PHE . . . . . 0.537 ' CE2' HD21 ' S' ' 311' ' ' LEU . 3.1 m-85 -62.84 -45.2 93.7 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.56 -0.713 . . . . 30.57 109.825 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' S' S ' 261' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -62.18 -29.79 70.62 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.475 -0.766 . . . . 41.340000000000003 109.901 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' S' S ' 262' ' ' TYR . . . . . 0.667 ' CE2' HD22 ' S' ' 233' ' ' LEU . 8.6 t80 -71.17 -44.69 65.0 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.435 -0.79 . . . . 26.030000000000001 110.129 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' S' S ' 263' ' ' VAL . . . . . 0.423 HG22 ' O ' ' S' ' 259' ' ' LEU . 33.1 m -92.0 18.29 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.352 -0.843 . . . . 22.800000000000001 110.384 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' S' S ' 264' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 52.72 70.69 0.55 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.206 -0.934 . . . . 44.030000000000001 110.641 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' S' S ' 265' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -111.82 109.24 55.36 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.375 -0.828 . . . . 35.609999999999999 109.649 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' S' S ' 266' ' ' PRO . . . . . 0.476 ' HA ' ' HB2' ' S' ' 269' ' ' ASP . 48.5 Cg_endo -75.33 0.46 9.01 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.631 1.332 . . . . 37.670000000000002 111.772 -179.102 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' S' S ' 267' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -56.56 -67.63 0.29 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.779 -1.201 . . . . 41.490000000000002 110.17 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' S' S ' 268' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -92.94 39.91 1.05 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.193 -0.942 . . . . 50.759999999999998 110.091 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' S' S ' 269' ' ' ASP . . . . . 0.476 ' HB2' ' HA ' ' S' ' 266' ' ' PRO . 0.9 OUTLIER -76.05 -33.1 59.6 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.417 -0.802 . . . . 61.859999999999999 109.816 179.546 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' S' S ' 270' ' ' TRP . . . . . 0.511 ' CE2' HG23 ' S' ' 271' ' ' VAL . 51.0 p-90 -73.98 -4.31 34.49 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.327 -0.858 . . . . 39.850000000000001 110.478 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' S' S ' 271' ' ' VAL . . . . . 0.511 HG23 ' CE2' ' S' ' 270' ' ' TRP . 46.6 t -109.56 -32.69 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.154 -0.966 . . . . 39.18 110.045 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' S' S ' 272' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -78.71 -36.49 43.34 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.365 -0.834 . . . . 40.020000000000003 110.518 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' S' S ' 273' ' ' SER . . . . . . . . . . . . . 71.2 m -103.52 56.17 0.74 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.317 -0.864 . . . . 47.200000000000003 110.345 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' S' S ' 274' ' ' SER . . . . . . . . . . . . . 6.9 t -133.13 141.19 39.9 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.334 -0.854 . . . . 47.609999999999999 110.12 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' S' S ' 275' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.65 -18.9 21.97 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.603 1.317 . . . . 45.280000000000001 110.603 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' S' S ' 276' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -99.94 140.9 33.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.248 -0.908 . . . . 57.270000000000003 110.272 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' S' S ' 277' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -71.71 97.67 1.8 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.48 -0.763 . . . . 37.280000000000001 110.263 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' S' S ' 278' ' ' LEU . . . . . . . . . . . . . 86.4 mt -96.98 33.77 1.85 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.484 -0.76 . . . . 43.880000000000003 110.003 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' S' S ' 279' ' ' THR . . . . . . . . . . . . . 75.3 m -64.05 -60.12 3.62 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.398 -0.814 . . . . 50.049999999999997 110.275 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' S' S ' 280' ' ' LEU . . . . . 0.736 ' HA ' HD12 ' S' ' 283' ' ' ILE . 13.7 mt -51.6 -39.77 58.58 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.301 -0.874 . . . . 54.119999999999997 110.334 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' S' S ' 281' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.49 -49.7 74.34 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.475 -0.766 . . . . 65.280000000000001 110.125 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' S' S ' 282' ' ' ALA . . . . . . . . . . . . . . . -58.89 -34.0 71.16 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.491 -0.756 . . . . 46.509999999999998 110.513 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' S' S ' 283' ' ' ILE . . . . . 0.736 HD12 ' HA ' ' S' ' 280' ' ' LEU . 85.5 mt -66.26 -50.91 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.242 -0.911 . . . . 47.299999999999997 110.149 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' S' S ' 284' ' ' LYS . . . . . . . . . . . . . 33.8 tttp -50.52 -57.52 7.92 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.414 -0.804 . . . . 50.719999999999999 110.476 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' S' S ' 285' ' ' GLN . . . . . 0.52 ' HG2' HD12 ' S' ' 289' ' ' LEU . 34.4 tt0 -51.43 -46.45 62.98 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.469 -0.77 . . . . 68.469999999999999 110.293 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' S' S ' 286' ' ' LEU . . . . . . . . . . . . . 19.2 mt -59.93 -44.49 94.3 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.426 -0.796 . . . . 36.619999999999997 110.26 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' S' S ' 287' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -62.8 -35.25 79.27 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.342 -0.849 . . . . 46.640000000000001 110.067 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' S' S ' 288' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -76.21 -21.04 56.9 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.382 -0.823 . . . . 46.450000000000003 110.329 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' S' S ' 289' ' ' LEU . . . . . 0.52 HD12 ' HG2' ' S' ' 285' ' ' GLN . 30.9 mt -97.24 -21.78 17.07 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.308 -0.87 . . . . 35.090000000000003 110.559 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' S' S ' 290' ' ' THR . . . . . 0.408 HG22 ' HB3' ' S' ' 306' ' ' ASN . 81.3 p -114.82 -28.47 7.06 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.275 -0.89 . . . . 38.609999999999999 110.367 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' S' S ' 291' ' ' GLY . . . . . . . . . . . . . . . 79.35 11.1 85.31 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.829 -1.308 . . . . 36.770000000000003 109.829 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' S' S ' 292' ' ' LEU . . . . . . . . . . . . . 84.6 mt -96.46 145.77 25.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.233 -1.157 . . . . 35.329999999999998 109.815 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' S' S ' 293' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -77.34 102.4 6.75 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.144 -0.973 . . . . 48.700000000000003 110.235 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' S' S ' 294' ' ' LEU . . . . . 0.428 ' HB3' ' CZ2' ' S' ' 252' ' ' TRP . 55.1 mt -106.89 51.73 0.73 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.498 -0.751 . . . . 42.609999999999999 110.128 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' S' S ' 295' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -112.56 -11.11 13.63 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.356 -0.84 . . . . 55.490000000000002 110.518 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' S' S ' 296' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -144.32 48.44 1.36 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.093 -1.004 . . . . 75.680000000000007 110.363 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' S' S ' 297' ' ' GLY . . . . . . . . . . . . . . . 96.9 145.15 18.66 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.477 -1.449 . . . . 49.439999999999998 109.477 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' S' S ' 298' ' ' GLY . . . . . . . . . . . . . . . -163.8 156.99 29.09 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.804 -1.318 . . . . 41.109999999999999 109.804 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' S' S ' 299' ' ' PRO . . . . . 0.491 ' O ' HG23 ' S' ' 303' ' ' VAL . 47.4 Cg_endo -73.82 118.26 5.37 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 124.018 1.536 . . . . 26.199999999999999 110.32 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' S' S ' 300' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.26 -15.4 31.63 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.609 1.321 . . . . 21.699999999999999 110.736 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' S' S ' 301' ' ' ALA . . . . . . . . . . . . . . . -80.68 -29.44 36.57 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.237 -0.914 . . . . 31.23 110.129 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' S' S ' 302' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.45 -40.62 19.05 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.404 -0.81 . . . . 38.990000000000002 110.031 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' S' S ' 303' ' ' VAL . . . . . 0.491 HG23 ' O ' ' S' ' 299' ' ' PRO . 57.6 t -60.69 -35.53 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.36 -0.838 . . . . 18.629999999999999 110.135 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' S' S ' 304' ' ' ILE . . . . . 0.523 HD12 HG21 ' S' ' 379' ' ' VAL . 85.9 mt -79.36 -23.72 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.265 -0.897 . . . . 25.460000000000001 110.129 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' S' S ' 305' ' ' TRP . . . . . 0.415 ' CD2' ' HD3' ' S' ' 308' ' ' LYS . 68.7 t-105 -88.55 -14.6 37.29 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.261 -0.899 . . . . 33.399999999999999 110.588 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' S' S ' 306' ' ' ASN . . . . . 0.408 ' HB3' HG22 ' S' ' 290' ' ' THR . 10.4 m-80 -89.64 -13.65 36.63 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.204 -0.935 . . . . 36.969999999999999 110.403 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' S' S ' 307' ' ' ILE . . . . . 0.472 HG12 ' O ' ' S' ' 303' ' ' VAL . 36.8 pt -125.06 45.65 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.198 -0.939 . . . . 30.809999999999999 109.997 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' S' S ' 308' ' ' LYS . . . . . 0.415 ' HD3' ' CD2' ' S' ' 305' ' ' TRP . 1.5 mtmp? -73.52 -37.82 65.53 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.336 -0.852 . . . . 46.520000000000003 110.108 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' S' S ' 309' ' ' HIS . . . . . 0.498 ' CD2' ' HG ' ' S' ' 310' ' ' LEU . 55.5 p-80 -73.21 -8.26 55.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.331 -0.855 . . . . 51.030000000000001 110.078 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' S' S ' 310' ' ' LEU . . . . . 0.498 ' HG ' ' CD2' ' S' ' 309' ' ' HIS . 52.8 mt -99.31 -12.81 20.0 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.245 -0.909 . . . . 36.159999999999997 110.009 179.281 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' S' S ' 311' ' ' LEU . . . . . 0.537 HD21 ' CE2' ' S' ' 260' ' ' PHE . 10.8 mt -97.18 147.87 23.65 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.378 -0.826 . . . . 40.0 110.458 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' S' S ' 312' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -81.65 -16.25 52.0 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.363 -0.836 . . . . 54.18 109.722 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' S' S ' 313' ' ' THR . . . . . 0.82 HG23 ' HG2' ' S' ' 323' ' ' GLU . 92.6 m -87.92 151.65 22.66 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.386 -0.821 . . . . 25.609999999999999 110.119 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' S' S ' 314' ' ' GLY . . . . . . . . . . . . . . . -87.93 126.34 8.02 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.849 -1.3 . . . . 25.18 109.849 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' S' S ' 315' ' ' ILE . . . . . 0.667 HD13 ' HB ' ' S' ' 324' ' ' VAL . 50.7 mm -101.66 150.5 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.409 -1.053 . . . . 23.899999999999999 109.727 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' S' S ' 316' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' S' ' 325' ' ' CYS . . . -157.06 -159.29 9.39 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.928 -1.269 . . . . 23.18 109.928 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' S' S ' 317' ' ' THR . . . . . 0.424 HG22 ' CG2' ' S' ' 326' ' ' VAL . 11.1 p -133.87 -172.99 3.12 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.422 -1.046 . . . . 27.98 110.025 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' S' S ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.54 -56.25 24.33 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.215 -0.928 . . . . 28.100000000000001 109.908 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' S' S ' 319' ' ' SER . . . . . . . . . . . . . 1.2 m -59.91 -41.68 92.25 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.343 -0.848 . . . . 37.0 109.65 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' S' S ' 320' ' ' ARG . . . . . . . . . . . . . 12.2 mtm180 -111.7 79.95 2.67 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.438 -0.789 . . . . 52.07 109.646 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' S' S ' 321' ' ' PRO . . . . . 0.447 ' O ' ' HB2' ' S' ' 322' ' ' SER . 43.6 Cg_endo -71.5 171.51 16.11 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.772 1.406 . . . . 38.289999999999999 110.867 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' S' S ' 322' ' ' SER . . . . . 0.447 ' HB2' ' O ' ' S' ' 321' ' ' PRO . 41.3 t 178.69 -148.1 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.907 -0.775 . . . . 38.840000000000003 108.907 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' S' S ' 323' ' ' GLU . . . . . 0.82 ' HG2' HG23 ' S' ' 313' ' ' THR . 6.7 tp10 -62.86 -40.26 96.96 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.048 -1.033 . . . . 40.700000000000003 109.707 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' S' S ' 324' ' ' VAL . . . . . 0.667 ' HB ' HD13 ' S' ' 315' ' ' ILE . 72.7 t -141.33 135.01 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.411 -0.806 . . . . 20.34 109.49 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' S' S ' 325' ' ' CYS . . . . . 0.463 ' HB2' ' CE1' ' S' ' 380' ' ' PHE . 11.3 m -125.94 172.22 10.1 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.323 -0.861 . . . . 30.629999999999999 110.84 -179.053 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' S' S ' 326' ' ' VAL . . . . . 0.646 HG12 HG22 ' S' ' 379' ' ' VAL . 34.6 m -135.53 142.26 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 109.186 -0.672 . . . . 23.899999999999999 109.186 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' S' S ' 327' ' ' VAL . . . . . 0.594 HG11 ' O ' ' S' ' 377' ' ' VAL . 34.5 m -56.41 125.01 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.096 -1.002 . . . . 19.48 110.419 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' S' S ' 328' ' ' ASP . . . . . . . . . . . . . 55.5 p-10 -119.43 11.54 12.18 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.461 -0.774 . . . . 26.43 110.445 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' S' S ' 329' ' ' GLY . . . . . . . . . . . . . . . 119.69 2.27 13.05 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.041 -1.223 . . . . 31.239999999999998 110.041 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' S' S ' 330' ' ' THR . . . . . . . . . . . . . 80.1 m -93.04 129.99 38.79 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.117 -1.225 . . . . 30.050000000000001 110.107 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' S' S ' 331' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -56.68 111.47 1.02 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.311 -0.868 . . . . 37.259999999999998 110.011 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' S' S ' 332' ' ' MET . . . . . . . . . . . . . 88.0 mmm -94.1 162.57 13.82 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.234 -0.916 . . . . 26.23 110.356 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' S' S ' 333' ' ' CYS . . . . . . . . . . . . . 25.6 m -137.24 150.01 47.55 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.513 -0.742 . . . . 23.559999999999999 110.015 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' S' S ' 334' ' ' LEU . . . . . 0.563 HD11 ' O ' ' S' ' 372' ' ' PRO . 0.1 OUTLIER -52.57 -24.82 8.96 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.342 -0.849 . . . . 28.93 110.488 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' S' S ' 335' ' ' ALA . . . . . . . . . . . . . . . -89.12 14.52 10.58 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.427 -0.796 . . . . 15.76 110.942 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' S' S ' 336' ' ' ASP . . . . . 0.404 ' O ' ' HA ' ' S' ' 382' ' ' PRO . 70.9 m-20 -100.45 -17.28 17.25 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.164 -0.96 . . . . 34.920000000000002 110.242 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' S' S ' 337' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -152.36 170.88 19.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.329 -0.857 . . . . 19.030000000000001 110.072 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' S' S ' 338' ' ' HIS . . . . . 0.401 ' HB3' ' CZ ' ' S' ' 383' ' ' TYR . 13.5 p80 -120.71 10.47 11.0 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.356 -0.84 . . . . 18.82 110.508 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' S' S ' 339' ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' S' ' 352' ' ' ALA . . . -176.0 155.18 1.56 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.193 -0.942 . . . . 17.18 110.079 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' S' S ' 340' ' ' GLY . . . . . 0.402 ' HA3' ' O ' ' S' ' 379' ' ' VAL . . . 160.82 173.05 28.93 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.089 -1.204 . . . . 18.329999999999998 110.089 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' S' S ' 341' ' ' ILE . . . . . . . . . . . . . 83.9 mt -88.76 138.07 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.493 -1.004 . . . . 18.600000000000001 109.864 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' S' S ' 342' ' ' PHE . . . . . 0.489 ' CE2' ' HB3' ' S' ' 352' ' ' ALA . 70.0 m-85 -120.94 -178.43 3.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.195 -0.941 . . . . 23.440000000000001 110.444 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' S' S ' 343' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.91 93.37 4.17 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.44 -0.787 . . . . 35.590000000000003 110.001 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' S' S ' 344' ' ' LYS . . . . . 0.4 ' O ' ' HB3' ' S' ' 348' ' ' HIS . 0.3 OUTLIER -80.86 125.09 29.67 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.334 -0.854 . . . . 38.340000000000003 109.999 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' S' S ' 345' ' ' GLY . . . . . . . . . . . . . . . 62.71 -130.83 43.26 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 108.928 -1.669 . . . . 53.460000000000001 108.928 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' S' S ' 346' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -132.72 150.9 52.1 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.23 -1.159 . . . . 70.909999999999997 110.018 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' S' S ' 347' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 53.26 35.44 20.1 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.319 -0.863 . . . . 47.32 110.442 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' S' S ' 348' ' ' HIS . . . . . 0.4 ' HB3' ' O ' ' S' ' 344' ' ' LYS . 46.9 t60 -150.16 155.83 40.5 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.383 -0.823 . . . . 41.719999999999999 110.36 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' S' S ' 349' ' ' ALA . . . . . 0.458 ' C ' HG13 ' S' ' 350' ' ' VAL . . . -149.79 151.25 33.26 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.427 -0.796 . . . . 22.91 110.481 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' S' S ' 350' ' ' VAL . . . . . 0.458 HG13 ' C ' ' S' ' 349' ' ' ALA . 34.6 m -148.99 169.66 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.534 -0.729 . . . . 21.09 110.072 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' S' S ' 351' ' ' PHE . . . . . 0.498 ' CD2' ' HB3' ' S' ' 258' ' ' GLN . 10.7 t80 -105.44 143.54 33.46 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.246 -0.909 . . . . 25.030000000000001 110.709 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' S' S ' 352' ' ' ALA . . . . . 0.489 ' HB3' ' CE2' ' S' ' 342' ' ' PHE . . . -147.66 151.69 36.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.634 -0.666 . . . . 23.809999999999999 109.766 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' S' S ' 353' ' ' CYS . . . . . . . . . . . . . 26.3 p -153.3 164.9 37.29 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.341 -0.849 . . . . 25.66 110.315 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' S' S ' 354' ' ' VAL . . . . . 0.551 HG22 ' CE2' ' S' ' 359' ' ' TRP . 57.5 t -76.05 118.52 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.359 -0.838 . . . . 34.270000000000003 109.904 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' S' S ' 355' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' S' ' 232' ' ' THR . 51.7 p -117.91 175.15 5.8 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.298 -0.876 . . . . 25.489999999999998 110.283 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' S' S ' 356' ' ' SER . . . . . . . . . . . . . 62.3 p -62.12 -17.75 58.7 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.393 -0.817 . . . . 31.239999999999998 110.731 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' S' S ' 357' ' ' ASN . . . . . . . . . . . . . 46.0 m-20 -106.98 14.16 26.77 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.104 -0.997 . . . . 28.609999999999999 110.559 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' S' S ' 358' ' ' GLY . . . . . . . . . . . . . . . 111.88 -152.9 17.6 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 110.005 -1.238 . . . . 22.010000000000002 110.005 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' S' S ' 359' ' ' TRP . . . . . 0.551 ' CE2' HG22 ' S' ' 354' ' ' VAL . 15.5 m95 -91.22 116.63 28.97 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.446 -1.032 . . . . 25.539999999999999 110.273 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' S' S ' 360' ' ' TYR . . . . . 0.42 ' HA ' ' HA ' ' S' ' 369' ' ' PRO . 1.3 m-85 -103.47 165.81 10.81 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.375 -0.828 . . . . 40.530000000000001 110.104 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' S' S ' 361' ' ' ALA . . . . . 0.426 ' HA ' ' O ' ' S' ' 351' ' ' PHE . . . -140.04 130.07 24.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.379 -0.826 . . . . 18.039999999999999 110.297 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' S' S ' 362' ' ' ILE . . . . . . . . . . . . . 88.7 mt -95.63 83.62 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.415 -0.803 . . . . 15.640000000000001 110.065 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' S' S ' 363' ' ' ASP . . . . . 0.416 ' O ' ' N ' ' S' ' 365' ' ' GLU . 11.8 t0 -75.2 94.43 2.96 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.334 -0.854 . . . . 35.030000000000001 110.216 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' S' S ' 364' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 54.01 -89.34 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.493 -0.754 . . . . 46.719999999999999 110.508 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' S' S ' 365' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' S' ' 363' ' ' ASP . 23.7 mt-10 -122.68 19.09 10.33 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.081 -1.012 . . . . 56.200000000000003 110.202 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' S' S ' 366' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -117.97 125.04 49.64 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.217 -0.927 . . . . 51.020000000000003 110.342 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' S' S ' 367' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -106.99 127.12 53.17 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.392 -0.817 . . . . 37.590000000000003 110.093 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' S' S ' 368' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -165.49 159.58 13.8 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.323 -0.861 . . . . 31.469999999999999 110.423 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' S' S ' 369' ' ' PRO . . . . . 0.42 ' HA ' ' HA ' ' S' ' 360' ' ' TYR . 46.5 Cg_endo -72.92 139.61 30.44 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 O-C-N 123.85 1.447 . . . . 28.850000000000001 110.497 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' S' S ' 370' ' ' TRP . . . . . . . . . . . . . 67.5 t90 -167.19 113.57 0.77 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.408 -0.807 . . . . 26.940000000000001 109.936 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' S' S ' 371' ' ' THR . . . . . . . . . . . . . 59.3 m -74.8 113.04 20.59 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.372 -0.83 . . . . 20.190000000000001 110.02 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' S' S ' 372' ' ' PRO . . . . . 0.563 ' O ' HD11 ' S' ' 334' ' ' LEU . 47.9 Cg_endo -73.49 157.06 49.55 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 O-C-N 123.578 1.304 . . . . 28.68 110.597 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' S' S ' 373' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -90.64 147.18 35.72 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.423 -0.798 . . . . 35.719999999999999 109.87 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' S' S ' 374' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -76.04 -6.25 17.15 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 O-C-N 123.713 1.375 . . . . 30.890000000000001 110.465 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' S' S ' 375' ' ' SER . . . . . . . . . . . . . 68.2 p -104.36 -17.0 14.97 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.297 -0.877 . . . . 29.41 110.46 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' S' S ' 376' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -106.5 43.0 1.19 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.299 -0.876 . . . . 32.890000000000001 110.256 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' S' S ' 377' ' ' VAL . . . . . 0.594 ' O ' HG11 ' S' ' 327' ' ' VAL . 7.4 p -114.62 147.25 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.348 -0.845 . . . . 24.329999999999998 110.26 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' S' S ' 378' ' ' LEU . . . . . . . . . . . . . 53.0 mt -116.05 -57.93 2.16 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.456 -0.778 . . . . 24.370000000000001 109.573 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' S' S ' 379' ' ' VAL . . . . . 0.646 HG22 HG12 ' S' ' 326' ' ' VAL . 61.5 t -120.73 132.39 70.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.454 -0.779 . . . . 18.02 109.409 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' S' S ' 380' ' ' PHE . . . . . 0.463 ' CE1' ' HB2' ' S' ' 325' ' ' CYS . 14.5 p90 -142.59 173.94 11.09 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.38 -0.825 . . . . 29.350000000000001 110.646 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' S' S ' 381' ' ' VAL . . . . . . . . . . . . . 57.8 t -120.02 107.35 39.94 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.486 -0.759 . . . . 16.34 109.412 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' S' S ' 382' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' S' ' 336' ' ' ASP . 45.4 Cg_endo -71.38 145.67 48.61 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 O-C-N 123.636 1.335 . . . . 20.940000000000001 110.762 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' S' S ' 383' ' ' TYR . . . . . 0.401 ' CZ ' ' HB3' ' S' ' 338' ' ' HIS . 88.0 m-85 -61.12 -53.45 56.86 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.344 -0.848 . . . . 28.93 109.825 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' S' S ' 384' ' ' ASP . . . . . . . . . . . . . 3.9 p30 . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.431 -0.793 . . . . 47.030000000000001 110.332 -176.496 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' R' R ' 30' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 . . . . . 0 N--CA 1.493 1.719 0 CA-C-O 121.161 0.505 . . . . 43.359999999999999 110.262 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' R' R ' 31' ' ' LEU . . . . . . . . . . . . . 65.6 mt -134.91 140.58 45.87 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.312 -0.867 . . . . 22.93 110.268 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 32' ' ' THR . . . . . . . . . . . . . 69.3 m -87.55 110.57 20.45 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.319 -0.863 . . . . 22.34 109.984 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 33' ' ' LEU . . . . . 0.594 HD22 ' CE2' ' R' ' 62' ' ' TYR . 80.1 mt -62.38 -172.76 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.299 -0.876 . . . . 21.390000000000001 110.202 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 34' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -74.6 -29.49 61.33 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.333 -0.855 . . . . 34.399999999999999 110.365 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 35' ' ' ASN . . . . . . . . . . . . . 48.3 p30 -77.72 -1.89 33.46 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.384 -0.822 . . . . 30.280000000000001 110.649 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.28 -16.55 59.53 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.698 -1.361 . . . . 36.25 109.698 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 37' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -59.04 161.77 4.82 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.338 -1.095 . . . . 53.799999999999997 110.368 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 38' ' ' LYS . . . . . . . . . . . . . 57.1 mttt -117.78 135.73 53.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.393 -0.817 . . . . 49.909999999999997 110.181 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 39' ' ' LYS . . . . . 0.405 ' HG2' ' CZ ' ' R' ' 41' ' ' PHE . 8.1 ttmt -138.68 143.74 39.29 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.423 -0.798 . . . . 35.689999999999998 110.198 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 40' ' ' THR . . . . . . . . . . . . . 23.6 m -102.63 128.05 49.47 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.343 -0.848 . . . . 34.840000000000003 110.188 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 41' ' ' PHE . . . . . 0.405 ' CZ ' ' HG2' ' R' ' 39' ' ' LYS . 96.6 m-85 -113.08 132.64 55.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.381 -0.824 . . . . 34.420000000000002 110.14 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 42' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -93.32 140.9 29.04 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.366 -0.834 . . . . 51.460000000000001 110.215 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 43' ' ' SER . . . . . . . . . . . . . 54.6 m -70.76 141.92 51.42 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.397 -0.815 . . . . 41.840000000000003 110.187 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.8 125.34 29.6 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.305 -0.872 . . . . 33.82 109.978 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 45' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.15 151.05 54.79 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.517 1.272 . . . . 30.27 110.649 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 46' ' ' ASN . . . . . 0.4 ' HA ' ' OD1' ' R' ' 50' ' ' ASN . 52.1 t-20 -124.24 109.92 13.99 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.456 -0.777 . . . . 35.100000000000001 109.989 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 47' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -120.27 -34.93 3.54 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.325 -0.859 . . . . 42.810000000000002 110.545 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 48' ' ' HIS . . . . . 0.439 ' NE2' HD11 ' R' ' 80' ' ' LEU . 73.2 m80 -105.74 45.16 0.98 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.181 -0.949 . . . . 49.969999999999999 110.275 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 49' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 50.35 34.65 9.32 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.432 -0.793 . . . . 61.32 110.182 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 50' ' ' ASN . . . . . 0.4 ' OD1' ' HA ' ' R' ' 46' ' ' ASN . 15.0 p-10 -86.22 43.81 1.09 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.349 -0.844 . . . . 51.5 110.661 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.14 -46.08 78.73 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.225 -0.922 . . . . 38.770000000000003 109.539 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 52' ' ' TRP . . . . . 0.483 ' CD2' ' N ' ' R' ' 53' ' ' LEU . 68.2 p-90 -58.37 -38.42 77.21 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.419 -0.801 . . . . 26.239999999999998 110.082 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 53' ' ' LEU . . . . . 0.483 ' N ' ' CD2' ' R' ' 52' ' ' TRP . 23.0 tp -66.71 -46.71 74.65 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.456 -0.777 . . . . 26.75 109.939 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 54' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -55.18 -41.68 72.24 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.321 -0.862 . . . . 35.020000000000003 110.128 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.19 -46.03 92.14 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.4 -0.812 . . . . 24.469999999999999 110.189 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 56' ' ' ILE . . . . . 0.431 HG12 HD11 ' R' ' 104' ' ' ILE . 76.3 mt -62.14 -42.25 94.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.332 -0.855 . . . . 26.030000000000001 109.937 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 57' ' ' LEU . . . . . . . . . . . . . 22.4 mt -60.3 -45.67 92.57 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.299 -0.876 . . . . 26.77 109.661 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 58' ' ' GLN . . . . . . . . . . . . . 57.9 mm-40 -63.92 -46.48 84.59 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.481 -0.762 . . . . 22.32 109.594 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 59' ' ' LEU . . . . . 0.429 ' HA ' ' HE2' ' R' ' 151' ' ' PHE . 23.9 tp -61.43 -37.73 84.6 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.306 -0.871 . . . . 20.550000000000001 109.396 179.295 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 60' ' ' PHE . . . . . 0.528 ' CE2' HD21 ' R' ' 111' ' ' LEU . 2.8 m-85 -61.08 -44.76 96.88 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.664 -0.648 . . . . 20.079999999999998 109.927 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 61' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -63.1 -36.17 82.71 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.479 -0.763 . . . . 18.800000000000001 110.486 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 62' ' ' TYR . . . . . 0.594 ' CE2' HD22 ' R' ' 33' ' ' LEU . 9.1 t80 -63.11 -41.76 99.41 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.266 -0.896 . . . . 26.449999999999999 110.226 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 63' ' ' VAL . . . . . 0.406 ' H ' HG22 ' R' ' 63' ' ' VAL . 30.5 m -93.4 20.45 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.295 -0.878 . . . . 29.75 110.218 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 64' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 52.87 75.58 0.23 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.344 -0.848 . . . . 35.520000000000003 110.58 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 65' ' ' GLU . . . . . 0.443 ' HG2' ' CD2' ' R' ' 60' ' ' PHE . 14.2 tp10 -116.29 104.07 52.33 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.377 -0.827 . . . . 29.890000000000001 109.888 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 66' ' ' PRO . . . . . 0.481 ' HA ' ' HB2' ' R' ' 69' ' ' ASP . 46.9 Cg_endo -73.53 -5.86 17.79 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 123.806 1.424 . . . . 21.370000000000001 111.124 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 67' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -52.09 -61.52 2.21 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.144 -0.973 . . . . 23.850000000000001 110.375 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 68' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -98.11 36.53 1.56 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.326 -0.859 . . . . 28.07 110.475 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 69' ' ' ASP . . . . . 0.481 ' HB2' ' HA ' ' R' ' 66' ' ' PRO . 11.7 t0 -72.3 -33.31 67.31 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.382 -0.824 . . . . 43.759999999999998 110.169 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 70' ' ' TRP . . . . . 0.477 ' CE2' ' CG2' ' R' ' 71' ' ' VAL . 47.9 p-90 -73.34 -3.88 29.9 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.313 -0.867 . . . . 33.060000000000002 110.705 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 71' ' ' VAL . . . . . 0.555 HG11 ' HB2' ' R' ' 82' ' ' ALA . 40.8 t -109.79 -27.48 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.132 -0.98 . . . . 31.699999999999999 109.717 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 72' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -86.56 -48.79 8.05 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.381 -0.824 . . . . 33.579999999999998 110.312 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 73' ' ' SER . . . . . . . . . . . . . 70.1 m -89.78 51.13 2.01 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.292 -0.88 . . . . 50.82 110.284 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 74' ' ' SER . . . . . . . . . . . . . 15.8 t -125.95 138.3 31.8 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.348 -0.845 . . . . 34.740000000000002 110.168 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.36 -25.01 15.92 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 O-C-N 123.669 1.352 . . . . 35.700000000000003 110.319 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 76' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -91.7 153.16 19.85 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.437 -0.789 . . . . 66.480000000000004 110.342 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 77' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -81.51 95.16 7.03 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.374 -0.829 . . . . 46.719999999999999 110.091 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 78' ' ' LEU . . . . . . . . . . . . . 96.4 mt -96.41 27.97 3.53 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.464 -0.772 . . . . 37.549999999999997 110.167 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 79' ' ' THR . . . . . . . . . . . . . 29.6 m -56.19 -54.56 43.76 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.27 -0.894 . . . . 37.359999999999999 110.312 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 80' ' ' LEU . . . . . 0.602 ' HA ' HD12 ' R' ' 83' ' ' ILE . 15.8 mt -60.93 -23.23 65.12 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.348 -0.845 . . . . 35.829999999999998 110.46 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 81' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -79.5 -39.18 32.67 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.209 -0.932 . . . . 44.030000000000001 110.298 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 82' ' ' ALA . . . . . 0.555 ' HB2' HG11 ' R' ' 71' ' ' VAL . . . -69.43 -28.68 66.33 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.187 -0.945 . . . . 32.539999999999999 110.159 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 83' ' ' ILE . . . . . 0.602 HD12 ' HA ' ' R' ' 80' ' ' LEU . 78.3 mt -70.16 -45.99 73.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.307 -0.87 . . . . 32.020000000000003 110.3 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 84' ' ' LYS . . . . . . . . . . . . . 36.0 tttm -55.22 -52.08 64.52 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.179 -0.951 . . . . 34.090000000000003 110.596 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 85' ' ' GLN . . . . . 0.533 ' HG2' HD12 ' R' ' 89' ' ' LEU . 31.9 tt0 -54.81 -46.83 74.57 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.224 -0.923 . . . . 25.940000000000001 110.301 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 86' ' ' LEU . . . . . . . . . . . . . 24.0 mt -58.66 -43.88 90.0 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.312 -0.867 . . . . 16.199999999999999 109.878 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 87' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -65.36 -35.21 80.28 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.442 -0.786 . . . . 49.090000000000003 110.28 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 88' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -78.43 -19.04 54.07 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.247 -0.908 . . . . 28.609999999999999 110.493 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 89' ' ' LEU . . . . . 0.533 HD12 ' HG2' ' R' ' 85' ' ' GLN . 32.6 mt -96.21 -29.37 14.07 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.188 -0.945 . . . . 26.16 110.201 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 90' ' ' THR . . . . . . . . . . . . . 59.8 p -105.69 -34.6 7.66 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.211 -0.931 . . . . 33.329999999999998 109.795 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.78 16.06 58.75 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.857 -1.297 . . . . 31.129999999999999 109.857 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 92' ' ' LEU . . . . . . . . . . . . . 97.0 mt -100.07 155.24 17.83 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.141 -1.211 . . . . 42.520000000000003 110.281 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 93' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -86.17 91.54 8.47 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.485 -0.759 . . . . 68.459999999999994 109.99 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 94' ' ' LEU . . . . . 0.458 ' HB3' ' CZ2' ' R' ' 52' ' ' TRP . 47.8 mt -99.46 53.04 0.94 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.162 -0.961 . . . . 44.630000000000003 110.342 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 95' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.48 -38.68 6.38 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.332 -0.855 . . . . 67.159999999999997 110.381 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 96' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -113.96 44.25 1.68 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.392 -0.818 . . . . 67.019999999999996 110.254 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 97' ' ' GLY . . . . . . . . . . . . . . . 99.2 150.83 26.02 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.599 -1.401 . . . . 49.479999999999997 109.599 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 98' ' ' GLY . . . . . . . . . . . . . . . -166.23 160.03 33.46 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.253 -1.539 . . . . 36.57 109.253 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 99' ' ' PRO . . . . . 0.792 ' O ' HG23 ' R' ' 103' ' ' VAL . 45.7 Cg_endo -72.54 121.09 7.14 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.641 1.337 . . . . 30.41 110.492 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 100' ' ' PRO . . . . . 0.413 ' HA ' HD11 ' R' ' 56' ' ' ILE . 45.8 Cg_endo -72.33 -31.57 11.38 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.678 1.357 . . . . 29.940000000000001 110.492 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 101' ' ' ALA . . . . . 0.476 ' HB2' ' HB3' ' R' ' 178' ' ' LEU . . . -70.0 -38.51 75.98 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.357 -0.839 . . . . 23.640000000000001 110.227 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 102' ' ' LEU . . . . . 0.424 HD23 HD21 ' R' ' 106' ' ' ASN . 0.1 OUTLIER -72.67 -40.72 66.09 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.377 -0.827 . . . . 20.309999999999999 110.353 -179.696 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' R' R ' 103' ' ' VAL . . . . . 0.792 HG23 ' O ' ' R' ' 99' ' ' PRO . 63.9 t -58.14 -40.13 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.185 -0.947 . . . . 16.329999999999998 109.986 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 104' ' ' ILE . . . . . 0.431 HD11 HG12 ' R' ' 56' ' ' ILE . 82.1 mt -71.71 -30.54 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.399 -0.813 . . . . 24.77 109.899 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 105' ' ' TRP . . . . . 0.462 ' O ' ' HD3' ' R' ' 108' ' ' LYS . 70.5 t-105 -82.41 0.88 40.02 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.292 -0.88 . . . . 23.280000000000001 110.31 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 106' ' ' ASN . . . . . 0.424 HD21 HD23 ' R' ' 102' ' ' LEU . 6.9 m-80 -105.08 -10.42 17.18 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.152 -0.967 . . . . 28.260000000000002 110.043 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 107' ' ' ILE . . . . . . . . . . . . . 36.7 pt -126.81 34.96 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.225 -0.922 . . . . 18.77 110.047 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 108' ' ' LYS . . . . . 0.501 ' HG2' ' HB ' ' R' ' 115' ' ' ILE . 9.2 mtpp -61.03 -48.43 81.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.565 -0.709 . . . . 42.5 110.055 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 109' ' ' HIS . . . . . 0.445 ' CD2' ' HG ' ' R' ' 110' ' ' LEU . 50.7 p-80 -66.06 -12.84 58.12 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.461 -0.774 . . . . 20.07 110.646 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 110' ' ' LEU . . . . . 0.445 ' HG ' ' CD2' ' R' ' 109' ' ' HIS . 80.6 mt -94.84 -17.21 22.29 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.115 -0.991 . . . . 15.69 110.181 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 111' ' ' LEU . . . . . 0.528 HD21 ' CE2' ' R' ' 60' ' ' PHE . 10.3 mt -94.19 144.16 25.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.376 -0.827 . . . . 25.390000000000001 110.971 -179.151 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 112' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -77.73 -17.33 57.71 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.525 -0.734 . . . . 53.479999999999997 109.811 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 113' ' ' THR . . . . . 0.459 HG22 ' N ' ' R' ' 114' ' ' GLY . 60.3 m -83.76 166.6 17.88 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.355 -0.841 . . . . 14.800000000000001 110.22 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 114' ' ' GLY . . . . . 0.459 ' N ' HG22 ' R' ' 113' ' ' THR . . . -97.94 127.14 9.13 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.995 -1.242 . . . . 16.140000000000001 109.995 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 115' ' ' ILE . . . . . 0.579 HD13 ' HB ' ' R' ' 124' ' ' VAL . 48.0 mm -109.13 139.32 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.54 -0.976 . . . . 13.460000000000001 109.645 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 116' ' ' GLY . . . . . . . . . . . . . . . -152.71 -155.83 7.28 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.955 -1.258 . . . . 23.899999999999999 109.955 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 117' ' ' THR . . . . . 0.529 HG22 ' CG2' ' R' ' 126' ' ' VAL . 18.9 p -134.99 -171.4 2.79 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.467 -1.019 . . . . 27.370000000000001 110.152 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 118' ' ' ALA . . . . . 0.447 ' HB3' ' OD1' ' R' ' 128' ' ' ASP . . . -56.52 -58.07 9.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.338 -0.851 . . . . 18.760000000000002 110.091 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 119' ' ' SER . . . . . . . . . . . . . 1.1 m -56.59 -40.51 75.4 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.332 -0.855 . . . . 32.350000000000001 109.784 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 120' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 -110.09 86.2 4.86 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.456 -0.777 . . . . 27.120000000000001 109.708 179.354 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 121' ' ' PRO . . . . . 0.481 ' HA ' ' SG ' ' R' ' 125' ' ' CYS . 44.6 Cg_endo -71.21 166.4 29.34 Favored 'Trans proline' 0 C--N 1.311 -1.419 0 O-C-N 123.799 1.42 . . . . 22.68 111.086 -179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 122' ' ' SER . . . . . 0.437 ' HB2' ' O ' ' R' ' 121' ' ' PRO . 38.3 t 178.61 -161.69 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.619 -0.675 . . . . 22.989999999999998 109.436 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 123' ' ' GLU . . . . . 0.441 ' HG2' HG23 ' R' ' 113' ' ' THR . 2.3 tp10 -56.38 -40.03 73.92 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.192 -0.943 . . . . 36.18 109.724 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 124' ' ' VAL . . . . . 0.579 ' HB ' HD13 ' R' ' 115' ' ' ILE . 82.6 t -142.51 136.5 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.506 -0.746 . . . . 20.640000000000001 109.39 179.31 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 125' ' ' CYS . . . . . 0.481 ' SG ' ' HA ' ' R' ' 121' ' ' PRO . 83.4 m -140.37 168.17 20.43 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.219 -0.925 . . . . 22.800000000000001 111.131 -179.314 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 126' ' ' VAL . . . . . 0.727 HG12 HG22 ' R' ' 179' ' ' VAL . 35.8 m -122.72 159.77 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.724 -0.61 . . . . 21.239999999999998 109.695 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 127' ' ' VAL . . . . . 0.708 HG11 ' O ' ' R' ' 177' ' ' VAL . 30.5 m -70.81 141.86 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.273 -0.892 . . . . 19.77 110.708 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 128' ' ' ASP . . . . . 0.447 ' OD1' ' HB3' ' R' ' 118' ' ' ALA . 53.9 p-10 -137.73 19.41 2.87 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.336 -0.853 . . . . 29.210000000000001 110.697 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 129' ' ' GLY . . . . . . . . . . . . . . . 114.01 -0.05 24.13 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.963 -1.113 . . . . 33.859999999999999 110.503 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 130' ' ' THR . . . . . . . . . . . . . 58.5 m -91.84 131.81 36.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.12 -1.223 . . . . 26.41 110.117 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -62.52 120.65 11.54 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.372 -0.83 . . . . 33.079999999999998 110.302 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 132' ' ' MET . . . . . 0.433 ' HE1' ' CE2' ' R' ' 180' ' ' PHE . 98.4 mmm -105.12 165.63 10.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.437 -0.79 . . . . 30.760000000000002 110.467 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 133' ' ' CYS . . . . . 0.409 ' HA ' ' HB3' ' R' ' 174' ' ' PRO . 32.4 m -141.12 158.13 44.34 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.511 -0.743 . . . . 27.0 109.988 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 134' ' ' LEU . . . . . 0.563 HD11 ' O ' ' R' ' 172' ' ' PRO . 0.1 OUTLIER -58.45 -19.76 39.41 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.217 -0.927 . . . . 33.899999999999999 110.467 -179.885 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' R' R ' 135' ' ' ALA . . . . . . . . . . . . . . . -92.72 8.16 40.48 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.278 -0.889 . . . . 19.370000000000001 110.749 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 136' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -93.77 -21.78 19.1 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.14 -0.975 . . . . 30.469999999999999 110.186 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 137' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -149.93 165.34 32.93 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.338 -0.851 . . . . 24.27 110.252 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 138' ' ' HIS . . . . . 0.434 ' HA ' HG23 ' R' ' 154' ' ' VAL . 15.2 p80 -117.81 15.03 14.39 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.393 -0.817 . . . . 20.91 110.419 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 139' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' R' ' 152' ' ' ALA . . . -177.15 152.41 0.88 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.163 -0.96 . . . . 15.69 110.181 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 140' ' ' GLY . . . . . 0.428 ' HA3' ' O ' ' R' ' 179' ' ' VAL . . . 161.85 175.18 32.6 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.964 -1.254 . . . . 23.760000000000002 109.964 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 141' ' ' ILE . . . . . . . . . . . . . 83.4 mt -95.49 136.56 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.398 -1.06 . . . . 25.300000000000001 109.681 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 142' ' ' PHE . . . . . 0.575 ' CD2' ' HB2' ' R' ' 172' ' ' PRO . 83.0 m-85 -120.74 -172.58 2.41 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.336 -0.852 . . . . 30.239999999999998 110.552 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 143' ' ' LEU . . . . . 0.742 HD23 ' O ' ' R' ' 148' ' ' HIS . 0.5 OUTLIER -119.8 77.8 1.27 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.437 -0.789 . . . . 32.799999999999997 110.281 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' R' R ' 144' ' ' LYS . . . . . 0.47 ' HG3' ' CZ2' ' R' ' 170' ' ' TRP . 1.0 OUTLIER -69.67 76.82 0.44 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.285 -0.884 . . . . 49.18 109.69 179.56 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' R' R ' 145' ' ' GLY . . . . . 0.458 ' O ' HD22 ' R' ' 143' ' ' LEU . . . 104.57 179.28 24.75 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.168 -1.573 . . . . 53.869999999999997 109.168 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 146' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -88.48 145.82 25.54 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.417 -1.049 . . . . 68.579999999999998 109.989 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 147' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 58.25 36.52 25.75 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.405 -0.809 . . . . 56.619999999999997 110.623 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 148' ' ' HIS . . . . . 0.742 ' O ' HD23 ' R' ' 143' ' ' LEU . 45.1 t60 -158.72 148.1 19.09 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.208 -0.933 . . . . 44.57 110.371 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 149' ' ' ALA . . . . . . . . . . . . . . . -150.26 146.93 27.1 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.441 -0.787 . . . . 33.539999999999999 110.023 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 150' ' ' VAL . . . . . . . . . . . . . 34.2 m -142.35 161.51 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.273 -0.892 . . . . 27.609999999999999 110.276 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 151' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' R' ' 152' ' ' ALA . 5.9 t80 -86.25 155.61 20.62 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.383 -0.823 . . . . 23.039999999999999 109.926 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 152' ' ' ALA . . . . . 0.537 ' N ' ' CD1' ' R' ' 151' ' ' PHE . . . -157.25 151.56 25.01 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.457 -0.777 . . . . 29.609999999999999 109.623 179.034 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 153' ' ' CYS . . . . . . . . . . . . . 26.7 p -154.31 173.57 16.0 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.335 -0.853 . . . . 22.75 110.507 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 154' ' ' VAL . . . . . 0.613 HG22 ' CE2' ' R' ' 159' ' ' TRP . 60.0 t -90.61 117.02 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.422 -0.799 . . . . 23.260000000000002 110.051 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 155' ' ' THR . . . . . . . . . . . . . 69.7 p -112.1 -176.64 2.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.345 -0.847 . . . . 17.879999999999999 110.118 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 156' ' ' SER . . . . . . . . . . . . . 78.6 p -75.9 -3.77 37.17 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.382 -0.824 . . . . 21.829999999999998 110.674 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 157' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -118.29 10.48 12.83 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.171 -0.955 . . . . 36.539999999999999 110.646 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 158' ' ' GLY . . . . . . . . . . . . . . . 118.0 -162.68 13.04 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.54 -1.424 . . . . 31.739999999999998 109.54 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 159' ' ' TRP . . . . . 0.613 ' CE2' HG22 ' R' ' 154' ' ' VAL . 14.7 m95 -86.58 122.44 30.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.368 -1.078 . . . . 28.25 110.099 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 160' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -108.45 166.95 10.39 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.37 -0.831 . . . . 41.240000000000002 110.22 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 161' ' ' ALA . . . . . . . . . . . . . . . -143.22 123.49 13.79 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.43 -0.794 . . . . 27.399999999999999 110.163 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 162' ' ' ILE . . . . . . . . . . . . . 92.6 mt -87.68 81.23 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.375 -0.828 . . . . 24.27 109.989 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 163' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' R' ' 165' ' ' GLU . 15.4 t0 -72.76 92.32 1.56 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.404 -0.81 . . . . 36.079999999999998 110.278 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 164' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 54.06 -88.92 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.507 -0.745 . . . . 46.079999999999998 110.6 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 165' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' R' ' 163' ' ' ASP . 29.6 mt-10 -124.71 35.88 4.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.13 -0.981 . . . . 50.939999999999998 110.219 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 166' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -135.75 117.3 14.85 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.431 -0.793 . . . . 47.280000000000001 110.255 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 167' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -101.04 120.05 39.63 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.375 -0.828 . . . . 40.469999999999999 110.081 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 168' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -157.62 158.45 30.52 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.223 -0.923 . . . . 30.210000000000001 110.407 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 169' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.67 133.01 19.63 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 O-C-N 123.868 1.457 . . . . 32.759999999999998 110.561 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 170' ' ' TRP . . . . . 0.47 ' CZ2' ' HG3' ' R' ' 144' ' ' LYS . 67.2 t90 -159.77 119.27 2.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.453 -0.779 . . . . 32.789999999999999 109.955 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 171' ' ' THR . . . . . . . . . . . . . 47.4 m -81.06 112.66 34.48 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.488 -0.757 . . . . 36.920000000000002 110.163 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 172' ' ' PRO . . . . . 0.575 ' HB2' ' CD2' ' R' ' 142' ' ' PHE . 45.9 Cg_endo -73.74 158.79 46.5 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 O-C-N 123.681 1.358 . . . . 33.539999999999999 110.525 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 173' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -88.87 144.98 33.8 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.344 -0.848 . . . . 45.759999999999998 109.951 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 174' ' ' PRO . . . . . 0.409 ' HB3' ' HA ' ' R' ' 133' ' ' CYS . 46.2 Cg_endo -71.71 -10.4 26.46 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.596 1.314 . . . . 29.629999999999999 110.445 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 175' ' ' SER . . . . . . . . . . . . . 53.1 p -103.5 -17.55 15.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.281 -0.887 . . . . 35.700000000000003 110.343 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 176' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -103.48 43.16 1.1 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.202 -0.936 . . . . 39.649999999999999 110.4 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 177' ' ' VAL . . . . . 0.708 ' O ' HG11 ' R' ' 127' ' ' VAL . 10.5 p -117.68 127.16 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.336 -0.852 . . . . 20.609999999999999 109.971 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 178' ' ' LEU . . . . . 0.476 ' HB3' ' HB2' ' R' ' 101' ' ' ALA . 46.0 mt -91.45 -61.41 1.65 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.36 -0.837 . . . . 15.58 109.37 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 179' ' ' VAL . . . . . 0.727 HG22 HG12 ' R' ' 126' ' ' VAL . 67.0 t -114.53 144.64 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.625 -0.672 . . . . 17.399999999999999 109.496 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 180' ' ' PHE . . . . . 0.433 ' CE2' ' HE1' ' R' ' 132' ' ' MET . 43.6 p90 -152.13 163.41 39.41 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.282 -0.886 . . . . 20.16 110.537 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 181' ' ' VAL . . . . . . . . . . . . . 66.4 t -113.2 111.48 50.17 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.342 -0.849 . . . . 17.690000000000001 109.842 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 182' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.05 149.47 52.68 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.574 1.302 . . . . 17.809999999999999 110.446 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' R' R ' 183' ' ' TYR . . . . . 0.698 ' O ' ' C ' ' R' ' 184' ' ' ASP . 79.5 m-85 -59.06 175.46 0.29 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.434 -0.791 . . . . 28.010000000000002 110.561 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 184' ' ' ASP . . . . . 0.698 ' C ' ' O ' ' R' ' 183' ' ' TYR . 4.5 m-20 -18.96 -83.16 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.345 -0.847 . . . . 58.640000000000001 110.228 -178.274 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' R' R ' 185' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 . . . . . 0 N--CA 1.503 2.176 0 CA-C-O 121.252 0.549 . . . . 80.420000000000002 111.802 179.526 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' R' R ' 193' ' ' LYS . . . . . . . . . . . . . 66.2 mttt . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 120.856 0.36 . . . . 49.5 110.16 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' R' R ' 194' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.8 0 O-C-N 121.177 -0.952 . . . . 40.399999999999999 110.119 179.973 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' S' S ' 229' ' ' MET . . . . . . . . . . . . . 2.6 ptp . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.2 0.524 . . . . 51.829999999999998 110.251 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' S' S ' 230' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -97.3 142.66 28.92 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.39 -0.819 . . . . 54.130000000000003 110.182 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' S' S ' 231' ' ' LEU . . . . . . . . . . . . . 67.8 mt -134.05 141.02 47.04 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.339 -0.851 . . . . 33.039999999999999 110.386 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' S' S ' 232' ' ' THR . . . . . 0.403 ' O ' ' HA ' ' S' ' 355' ' ' THR . 40.4 m -89.24 103.28 15.92 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.354 -0.841 . . . . 26.920000000000002 110.019 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' S' S ' 233' ' ' LEU . . . . . 0.67 HD22 ' CE2' ' S' ' 262' ' ' TYR . 79.8 mt -55.91 179.28 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.538 -0.726 . . . . 13.779999999999999 110.5 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' S' S ' 234' ' ' TYR . . . . . 0.444 ' CG ' ' N ' ' S' ' 235' ' ' ASN . 35.5 p90 -65.05 -35.61 81.7 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.347 -0.846 . . . . 26.079999999999998 110.167 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' S' S ' 235' ' ' ASN . . . . . 0.444 ' N ' ' CG ' ' S' ' 234' ' ' TYR . 50.6 p30 -74.43 -7.28 52.41 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.313 -0.867 . . . . 20.039999999999999 110.581 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' S' S ' 236' ' ' GLY . . . . . . . . . . . . . . . 95.66 -19.9 52.21 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.788 -1.325 . . . . 22.710000000000001 109.788 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' S' S ' 237' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -53.08 145.74 12.67 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.212 -1.17 . . . . 35.439999999999998 110.189 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' S' S ' 238' ' ' LYS . . . . . . . . . . . . . 44.5 mttt -102.17 127.87 48.91 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.38 -0.825 . . . . 32.560000000000002 110.418 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' S' S ' 239' ' ' LYS . . . . . 0.403 ' HG2' ' CZ ' ' S' ' 241' ' ' PHE . 9.0 ttmt -132.32 144.5 50.61 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.407 -0.808 . . . . 26.68 109.958 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' S' S ' 240' ' ' THR . . . . . . . . . . . . . 50.8 m -102.0 132.16 47.99 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.29 -0.881 . . . . 41.020000000000003 110.417 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' S' S ' 241' ' ' PHE . . . . . 0.403 ' CZ ' ' HG2' ' S' ' 239' ' ' LYS . 96.1 m-85 -117.84 137.61 52.65 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.347 -0.846 . . . . 28.620000000000001 110.213 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' S' S ' 242' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -96.39 161.78 13.77 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.396 -0.815 . . . . 47.890000000000001 110.269 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' S' S ' 243' ' ' SER . . . . . . . . . . . . . 72.7 m -90.6 151.58 21.25 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.356 -0.84 . . . . 45.090000000000003 110.211 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' S' S ' 244' ' ' ARG . . . . . . . . . . . . . 1.4 mtp85 -129.76 126.83 22.75 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.374 -0.829 . . . . 42.490000000000002 110.212 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' S' S ' 245' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.39 161.03 43.57 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 O-C-N 123.664 1.35 . . . . 35.68 110.543 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' S' S ' 246' ' ' ASN . . . . . . . . . . . . . 51.3 t-20 -132.93 97.9 4.15 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.477 -0.764 . . . . 51.880000000000003 109.81 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' S' S ' 247' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -110.43 -22.31 11.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.316 -0.865 . . . . 53.689999999999998 110.645 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' S' S ' 248' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -117.24 43.73 2.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.202 -0.936 . . . . 55.789999999999999 110.751 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' S' S ' 249' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 48.83 38.31 11.72 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.429 -0.794 . . . . 49.450000000000003 110.416 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' S' S ' 250' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -90.54 28.95 1.37 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.582 -0.699 . . . . 36.859999999999999 110.363 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' S' S ' 251' ' ' ALA . . . . . . . . . . . . . . . -53.8 -43.13 69.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.217 -0.927 . . . . 29.690000000000001 109.585 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' S' S ' 252' ' ' TRP . . . . . 0.427 ' CZ2' ' HB3' ' S' ' 294' ' ' LEU . 67.9 p-90 -61.88 -33.89 75.02 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.622 -0.674 . . . . 41.119999999999997 109.802 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' S' S ' 253' ' ' LEU . . . . . 0.407 ' N ' ' CD2' ' S' ' 252' ' ' TRP . 23.4 tp -70.21 -47.24 62.35 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.386 -0.821 . . . . 24.890000000000001 109.939 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' S' S ' 254' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -56.11 -42.43 76.8 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.507 -0.745 . . . . 35.649999999999999 109.979 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' S' S ' 255' ' ' ALA . . . . . . . . . . . . . . . -59.58 -48.19 82.64 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.459 -0.776 . . . . 22.73 110.038 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' S' S ' 256' ' ' ILE . . . . . 0.505 HG12 HD11 ' S' ' 304' ' ' ILE . 79.9 mt -62.35 -40.69 88.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.261 -0.9 . . . . 28.850000000000001 109.926 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' S' S ' 257' ' ' LEU . . . . . . . . . . . . . 19.4 mt -61.49 -44.47 97.02 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.41 -0.806 . . . . 23.07 110.172 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' S' S ' 258' ' ' GLN . . . . . 0.498 ' HB3' ' CD2' ' S' ' 351' ' ' PHE . 53.3 mm-40 -65.12 -45.36 85.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.458 -0.776 . . . . 29.780000000000001 109.896 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' S' S ' 259' ' ' LEU . . . . . 0.425 ' O ' HG22 ' S' ' 263' ' ' VAL . 19.9 tp -58.64 -36.35 73.98 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.322 -0.861 . . . . 17.940000000000001 109.51 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' S' S ' 260' ' ' PHE . . . . . 0.535 ' CE2' HD21 ' S' ' 311' ' ' LEU . 3.1 m-85 -62.83 -45.27 93.41 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.593 -0.692 . . . . 30.57 109.812 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' S' S ' 261' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -62.03 -29.89 70.59 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.452 -0.78 . . . . 41.340000000000003 110.022 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' S' S ' 262' ' ' TYR . . . . . 0.67 ' CE2' HD22 ' S' ' 233' ' ' LEU . 8.6 t80 -71.15 -44.65 65.12 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.416 -0.803 . . . . 26.030000000000001 110.113 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' S' S ' 263' ' ' VAL . . . . . 0.425 HG22 ' O ' ' S' ' 259' ' ' LEU . 33.0 m -92.03 18.3 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.398 -0.814 . . . . 22.800000000000001 110.395 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' S' S ' 264' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 52.74 70.61 0.56 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.282 -0.886 . . . . 44.030000000000001 110.686 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' S' S ' 265' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -111.75 109.22 55.54 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.373 -0.83 . . . . 35.609999999999999 109.669 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' S' S ' 266' ' ' PRO . . . . . 0.475 ' HA ' ' HB2' ' S' ' 269' ' ' ASP . 49.6 Cg_endo -75.3 0.32 9.17 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.676 1.356 . . . . 37.670000000000002 111.79 -179.141 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' S' S ' 267' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -56.5 -67.63 0.29 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.843 -1.161 . . . . 41.490000000000002 110.212 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' S' S ' 268' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -92.96 39.82 1.05 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.138 -0.976 . . . . 50.759999999999998 110.057 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' S' S ' 269' ' ' ASP . . . . . 0.475 ' HB2' ' HA ' ' S' ' 266' ' ' PRO . 0.9 OUTLIER -75.97 -33.2 59.76 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.424 -0.797 . . . . 61.859999999999999 109.737 179.556 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' S' S ' 270' ' ' TRP . . . . . 0.508 ' CE2' HG23 ' S' ' 271' ' ' VAL . 51.0 p-90 -73.92 -4.3 34.24 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.285 -0.884 . . . . 39.850000000000001 110.47 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' S' S ' 271' ' ' VAL . . . . . 0.508 HG23 ' CE2' ' S' ' 270' ' ' TRP . 46.4 t -109.56 -32.67 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.114 -0.991 . . . . 39.18 110.085 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' S' S ' 272' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -78.74 -36.46 43.16 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.39 -0.819 . . . . 40.020000000000003 110.498 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' S' S ' 273' ' ' SER . . . . . . . . . . . . . 71.0 m -103.58 56.12 0.74 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.346 -0.846 . . . . 47.200000000000003 110.276 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' S' S ' 274' ' ' SER . . . . . . . . . . . . . 6.9 t -133.06 141.25 40.2 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.31 -0.869 . . . . 47.609999999999999 110.137 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' S' S ' 275' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.71 -18.92 21.8 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.719 1.378 . . . . 45.280000000000001 110.541 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' S' S ' 276' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -99.9 140.87 33.49 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.264 -0.897 . . . . 57.270000000000003 110.279 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' S' S ' 277' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -71.73 97.65 1.8 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.466 -0.771 . . . . 37.280000000000001 110.287 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' S' S ' 278' ' ' LEU . . . . . . . . . . . . . 86.8 mt -97.03 33.87 1.84 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.435 -0.79 . . . . 43.880000000000003 109.961 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' S' S ' 279' ' ' THR . . . . . . . . . . . . . 77.8 m -64.1 -60.14 3.59 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.477 -0.764 . . . . 50.049999999999997 110.239 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' S' S ' 280' ' ' LEU . . . . . 0.738 ' HA ' HD12 ' S' ' 283' ' ' ILE . 13.6 mt -51.59 -39.89 58.78 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.441 -0.787 . . . . 54.119999999999997 110.299 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' S' S ' 281' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.31 -49.72 74.5 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.454 -0.779 . . . . 65.280000000000001 110.161 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' S' S ' 282' ' ' ALA . . . . . . . . . . . . . . . -59.03 -33.84 71.21 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.467 -0.771 . . . . 46.509999999999998 110.515 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' S' S ' 283' ' ' ILE . . . . . 0.738 HD12 ' HA ' ' S' ' 280' ' ' LEU . 86.0 mt -66.43 -50.88 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.246 -0.909 . . . . 47.299999999999997 110.028 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' S' S ' 284' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -50.52 -57.65 7.61 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.461 -0.774 . . . . 50.719999999999999 110.361 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' S' S ' 285' ' ' GLN . . . . . 0.518 ' HG2' HD12 ' S' ' 289' ' ' LEU . 34.3 tt0 -51.3 -46.38 62.51 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.494 -0.754 . . . . 68.469999999999999 110.367 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' S' S ' 286' ' ' LEU . . . . . . . . . . . . . 19.0 mt -60.09 -44.41 94.82 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.435 -0.79 . . . . 36.619999999999997 110.242 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' S' S ' 287' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -62.79 -35.29 79.4 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.251 -0.906 . . . . 46.640000000000001 110.05 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' S' S ' 288' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -76.21 -21.04 56.92 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.493 -0.754 . . . . 46.450000000000003 110.311 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' S' S ' 289' ' ' LEU . . . . . 0.518 HD12 ' HG2' ' S' ' 285' ' ' GLN . 30.7 mt -97.33 -21.65 17.1 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.251 -0.906 . . . . 35.090000000000003 110.553 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' S' S ' 290' ' ' THR . . . . . 0.41 HG22 ' HB3' ' S' ' 306' ' ' ASN . 81.4 p -114.84 -28.4 7.08 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.254 -0.904 . . . . 38.609999999999999 110.462 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' S' S ' 291' ' ' GLY . . . . . . . . . . . . . . . 79.41 10.96 85.41 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.793 -1.323 . . . . 36.770000000000003 109.793 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' S' S ' 292' ' ' LEU . . . . . . . . . . . . . 84.7 mt -96.44 145.77 25.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.25 -1.147 . . . . 35.329999999999998 109.779 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' S' S ' 293' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -77.36 102.33 6.74 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.26 -0.9 . . . . 48.700000000000003 110.296 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' S' S ' 294' ' ' LEU . . . . . 0.427 ' HB3' ' CZ2' ' S' ' 252' ' ' TRP . 55.3 mt -106.83 51.71 0.74 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.572 -0.705 . . . . 42.609999999999999 110.136 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' S' S ' 295' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -112.58 -11.14 13.62 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.287 -0.883 . . . . 55.490000000000002 110.539 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' S' S ' 296' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -144.26 48.51 1.37 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.151 -0.968 . . . . 75.680000000000007 110.315 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' S' S ' 297' ' ' GLY . . . . . . . . . . . . . . . 96.91 145.13 18.63 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.502 -1.439 . . . . 49.439999999999998 109.502 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' S' S ' 298' ' ' GLY . . . . . . . . . . . . . . . -163.82 156.9 28.96 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.84 -1.304 . . . . 41.109999999999999 109.84 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' S' S ' 299' ' ' PRO . . . . . 0.494 ' O ' HG23 ' S' ' 303' ' ' VAL . 47.8 Cg_endo -73.7 118.21 5.36 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 O-C-N 123.932 1.49 . . . . 26.199999999999999 110.341 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' S' S ' 300' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.2 -15.42 31.81 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 O-C-N 123.567 1.299 . . . . 21.699999999999999 110.728 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' S' S ' 301' ' ' ALA . . . . . . . . . . . . . . . -80.75 -29.35 36.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.258 -0.901 . . . . 31.23 110.133 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' S' S ' 302' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.47 -40.65 18.97 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.426 -0.796 . . . . 38.990000000000002 109.943 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' S' S ' 303' ' ' VAL . . . . . 0.494 HG23 ' O ' ' S' ' 299' ' ' PRO . 57.7 t -60.69 -35.53 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.427 -0.795 . . . . 18.629999999999999 110.122 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' S' S ' 304' ' ' ILE . . . . . 0.52 HD12 HG21 ' S' ' 379' ' ' VAL . 86.0 mt -79.3 -23.67 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.341 -0.849 . . . . 25.460000000000001 110.178 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' S' S ' 305' ' ' TRP . . . . . 0.413 ' CD2' ' HD3' ' S' ' 308' ' ' LYS . 68.9 t-105 -88.69 -14.47 37.24 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.252 -0.905 . . . . 33.399999999999999 110.56 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' S' S ' 306' ' ' ASN . . . . . 0.41 ' HB3' HG22 ' S' ' 290' ' ' THR . 10.3 m-80 -89.76 -13.59 36.41 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.215 -0.928 . . . . 36.969999999999999 110.363 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' S' S ' 307' ' ' ILE . . . . . 0.474 HG12 ' O ' ' S' ' 303' ' ' VAL . 36.9 pt -125.06 45.57 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.182 -0.949 . . . . 30.809999999999999 110.04 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' S' S ' 308' ' ' LYS . . . . . 0.413 ' HD3' ' CD2' ' S' ' 305' ' ' TRP . 1.5 mtmp? -73.52 -37.73 65.55 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.357 -0.84 . . . . 46.520000000000003 110.157 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' S' S ' 309' ' ' HIS . . . . . 0.498 ' CD2' ' HG ' ' S' ' 310' ' ' LEU . 55.5 p-80 -73.16 -8.3 55.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.401 -0.812 . . . . 51.030000000000001 110.136 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' S' S ' 310' ' ' LEU . . . . . 0.498 ' HG ' ' CD2' ' S' ' 309' ' ' HIS . 52.9 mt -99.32 -12.83 19.97 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.3 -0.875 . . . . 36.159999999999997 109.958 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' S' S ' 311' ' ' LEU . . . . . 0.535 HD21 ' CE2' ' S' ' 260' ' ' PHE . 10.7 mt -97.24 147.87 23.68 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.373 -0.829 . . . . 40.0 110.441 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' S' S ' 312' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -81.58 -16.26 52.14 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.266 -0.896 . . . . 54.18 109.747 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' S' S ' 313' ' ' THR . . . . . 0.808 HG23 ' HG2' ' S' ' 323' ' ' GLU . 92.6 m -87.95 151.67 22.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.332 -0.855 . . . . 25.609999999999999 110.134 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' S' S ' 314' ' ' GLY . . . . . . . . . . . . . . . -87.94 126.39 8.04 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.776 -1.33 . . . . 25.18 109.776 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' S' S ' 315' ' ' ILE . . . . . 0.665 HD13 ' HB ' ' S' ' 324' ' ' VAL . 50.7 mm -101.63 150.51 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.427 -1.043 . . . . 23.899999999999999 109.757 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' S' S ' 316' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' S' ' 325' ' ' CYS . . . -157.1 -159.21 9.35 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.006 -1.237 . . . . 23.18 110.006 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' S' S ' 317' ' ' THR . . . . . 0.422 HG22 ' CG2' ' S' ' 326' ' ' VAL . 10.9 p -133.95 -173.03 3.13 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.485 -1.009 . . . . 27.98 109.921 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' S' S ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.6 -56.11 26.17 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.176 -0.953 . . . . 28.100000000000001 109.921 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' S' S ' 319' ' ' SER . . . . . . . . . . . . . 1.2 m -60.06 -41.61 92.7 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.331 -0.855 . . . . 37.0 109.593 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' S' S ' 320' ' ' ARG . . . . . . . . . . . . . 12.2 mtm180 -111.71 79.86 2.64 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.525 -0.734 . . . . 52.07 109.719 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' S' S ' 321' ' ' PRO . . . . . 0.446 ' O ' ' HB2' ' S' ' 322' ' ' SER . 44.1 Cg_endo -71.43 171.54 15.99 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.936 1.492 . . . . 38.289999999999999 110.901 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' S' S ' 322' ' ' SER . . . . . 0.446 ' HB2' ' O ' ' S' ' 321' ' ' PRO . 41.2 t 178.64 -148.14 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.905 -0.776 . . . . 38.840000000000003 108.905 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' S' S ' 323' ' ' GLU . . . . . 0.808 ' HG2' HG23 ' S' ' 313' ' ' THR . 6.7 tp10 -62.85 -40.28 96.99 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.971 -1.081 . . . . 40.700000000000003 109.668 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' S' S ' 324' ' ' VAL . . . . . 0.665 ' HB ' HD13 ' S' ' 315' ' ' ILE . 73.0 t -141.3 135.03 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.399 -0.813 . . . . 20.34 109.471 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' S' S ' 325' ' ' CYS . . . . . 0.461 ' HB2' ' CE1' ' S' ' 380' ' ' PHE . 11.4 m -126.03 172.19 10.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.294 -0.878 . . . . 30.629999999999999 110.805 -179.082 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' S' S ' 326' ' ' VAL . . . . . 0.638 HG12 HG22 ' S' ' 379' ' ' VAL . 34.5 m -135.47 142.23 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.641 -0.662 . . . . 23.899999999999999 109.235 179.163 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' S' S ' 327' ' ' VAL . . . . . 0.594 HG11 ' O ' ' S' ' 377' ' ' VAL . 34.5 m -56.37 125.04 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.078 -1.014 . . . . 19.48 110.42 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' S' S ' 328' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -119.38 11.47 12.21 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.442 -0.786 . . . . 26.43 110.411 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' S' S ' 329' ' ' GLY . . . . . . . . . . . . . . . 119.7 2.21 13.06 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.064 -1.214 . . . . 31.239999999999998 110.064 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' S' S ' 330' ' ' THR . . . . . . . . . . . . . 81.9 m -93.02 130.03 38.74 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.067 -1.255 . . . . 30.050000000000001 110.093 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' S' S ' 331' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -56.8 111.57 1.06 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.315 -0.866 . . . . 37.259999999999998 109.948 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' S' S ' 332' ' ' MET . . . . . . . . . . . . . 87.9 mmm -94.16 162.58 13.8 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.268 -0.895 . . . . 26.23 110.322 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' S' S ' 333' ' ' CYS . . . . . . . . . . . . . 26.0 m -137.25 150.05 47.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.456 -0.778 . . . . 23.559999999999999 110.014 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' S' S ' 334' ' ' LEU . . . . . 0.556 HD11 ' O ' ' S' ' 372' ' ' PRO . 0.1 OUTLIER -52.56 -24.93 9.15 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.296 -0.878 . . . . 28.93 110.429 179.905 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' S' S ' 335' ' ' ALA . . . . . . . . . . . . . . . -89.02 14.45 10.6 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.38 -0.825 . . . . 15.76 110.986 -179.343 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' S' S ' 336' ' ' ASP . . . . . 0.403 ' O ' ' HA ' ' S' ' 382' ' ' PRO . 70.3 m-20 -100.53 -17.18 17.23 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.135 -0.978 . . . . 34.920000000000002 110.167 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' S' S ' 337' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -152.37 170.86 19.04 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.369 -0.832 . . . . 19.030000000000001 110.151 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' S' S ' 338' ' ' HIS . . . . . 0.402 ' HB3' ' CZ ' ' S' ' 383' ' ' TYR . 13.4 p80 -120.72 10.42 10.98 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.37 -0.831 . . . . 18.82 110.47 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' S' S ' 339' ' ' ALA . . . . . 0.41 ' HA ' ' O ' ' S' ' 352' ' ' ALA . . . -175.97 155.19 1.57 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.26 -0.9 . . . . 17.18 110.116 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' S' S ' 340' ' ' GLY . . . . . . . . . . . . . . . 160.8 173.08 28.95 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 110.099 -1.201 . . . . 18.329999999999998 110.099 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' S' S ' 341' ' ' ILE . . . . . . . . . . . . . 83.8 mt -88.79 138.07 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.504 -0.998 . . . . 18.600000000000001 109.824 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' S' S ' 342' ' ' PHE . . . . . 0.488 ' CE2' ' HB3' ' S' ' 352' ' ' ALA . 69.9 m-85 -120.92 -178.42 3.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.25 -0.906 . . . . 23.440000000000001 110.419 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' S' S ' 343' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.81 93.32 4.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.505 -0.747 . . . . 35.590000000000003 110.093 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' S' S ' 344' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.83 125.11 29.68 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.34 -0.85 . . . . 38.340000000000003 110.013 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' S' S ' 345' ' ' GLY . . . . . . . . . . . . . . . 62.78 -130.86 43.09 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 108.858 -1.697 . . . . 53.460000000000001 108.858 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' S' S ' 346' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -132.74 150.87 52.11 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.14 -1.212 . . . . 70.909999999999997 110.023 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' S' S ' 347' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 53.3 35.32 19.89 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.294 -0.879 . . . . 47.32 110.452 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' S' S ' 348' ' ' HIS . . . . . . . . . . . . . 46.6 t60 -150.1 155.9 40.67 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.28 -0.888 . . . . 41.719999999999999 110.375 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' S' S ' 349' ' ' ALA . . . . . 0.453 ' C ' HG13 ' S' ' 350' ' ' VAL . . . -149.79 151.25 33.26 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.331 -0.855 . . . . 22.91 110.536 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' S' S ' 350' ' ' VAL . . . . . 0.453 HG13 ' C ' ' S' ' 349' ' ' ALA . 34.6 m -149.01 169.65 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.417 -0.802 . . . . 21.09 110.018 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' S' S ' 351' ' ' PHE . . . . . 0.498 ' CD2' ' HB3' ' S' ' 258' ' ' GLN . 10.7 t80 -105.41 143.62 33.32 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.237 -0.914 . . . . 25.030000000000001 110.689 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' S' S ' 352' ' ' ALA . . . . . 0.488 ' HB3' ' CE2' ' S' ' 342' ' ' PHE . . . -147.74 151.75 36.59 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.674 -0.641 . . . . 23.809999999999999 109.673 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' S' S ' 353' ' ' CYS . . . . . . . . . . . . . 26.3 p -153.36 164.78 37.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.28 -0.888 . . . . 25.66 110.283 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' S' S ' 354' ' ' VAL . . . . . 0.554 HG22 ' CE2' ' S' ' 359' ' ' TRP . 57.0 t -76.02 118.55 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.36 -0.838 . . . . 34.270000000000003 109.959 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' S' S ' 355' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' S' ' 232' ' ' THR . 51.7 p -117.88 175.17 5.79 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.257 -0.902 . . . . 25.489999999999998 110.271 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' S' S ' 356' ' ' SER . . . . . . . . . . . . . 62.1 p -62.22 -17.69 59.0 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.328 -0.858 . . . . 31.239999999999998 110.718 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' S' S ' 357' ' ' ASN . . . . . . . . . . . . . 46.0 m-20 -106.93 14.18 26.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.206 -0.934 . . . . 28.609999999999999 110.637 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' S' S ' 358' ' ' GLY . . . . . . . . . . . . . . . 111.86 -152.88 17.6 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.99 -1.244 . . . . 22.010000000000002 109.99 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' S' S ' 359' ' ' TRP . . . . . 0.554 ' CE2' HG22 ' S' ' 354' ' ' VAL . 15.3 m95 -91.33 116.73 29.07 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.44 -1.035 . . . . 25.539999999999999 110.14 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' S' S ' 360' ' ' TYR . . . . . 0.43 ' HA ' ' HA ' ' S' ' 369' ' ' PRO . 1.3 m-85 -103.53 165.81 10.81 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.29 -0.881 . . . . 40.530000000000001 110.064 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' S' S ' 361' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' S' ' 351' ' ' PHE . . . -140.06 130.1 24.89 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.389 -0.819 . . . . 18.039999999999999 110.295 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' S' S ' 362' ' ' ILE . . . . . . . . . . . . . 88.9 mt -95.66 83.74 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.307 -0.87 . . . . 15.640000000000001 109.959 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' S' S ' 363' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' S' ' 365' ' ' GLU . 11.9 t0 -75.24 94.48 2.99 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.403 -0.81 . . . . 35.030000000000001 110.227 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' S' S ' 364' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 53.93 -89.37 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.535 -0.728 . . . . 46.719999999999999 110.544 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' S' S ' 365' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' S' ' 363' ' ' ASP . 23.8 mt-10 -122.59 19.09 10.4 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.109 -0.994 . . . . 56.200000000000003 110.285 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' S' S ' 366' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -117.96 125.03 49.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.228 -0.92 . . . . 51.020000000000003 110.361 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' S' S ' 367' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -107.0 127.01 53.07 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.406 -0.808 . . . . 37.590000000000003 110.168 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' S' S ' 368' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -165.43 159.58 13.92 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.246 -0.909 . . . . 31.469999999999999 110.445 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' S' S ' 369' ' ' PRO . . . . . 0.43 ' HA ' ' HA ' ' S' ' 360' ' ' TYR . 46.3 Cg_endo -72.88 139.66 30.64 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 O-C-N 123.866 1.456 . . . . 28.850000000000001 110.546 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' S' S ' 370' ' ' TRP . . . . . . . . . . . . . 67.3 t90 -167.24 113.51 0.76 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.44 -0.787 . . . . 26.940000000000001 109.933 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' S' S ' 371' ' ' THR . . . . . . . . . . . . . 59.6 m -74.75 113.08 20.94 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.379 -0.826 . . . . 20.190000000000001 110.034 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' S' S ' 372' ' ' PRO . . . . . 0.556 ' O ' HD11 ' S' ' 334' ' ' LEU . 48.0 Cg_endo -73.57 157.06 49.21 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 O-C-N 123.597 1.314 . . . . 28.68 110.611 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' S' S ' 373' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -90.6 147.11 35.62 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.442 -0.786 . . . . 35.719999999999999 109.947 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' S' S ' 374' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -76.04 -6.15 17.05 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.665 1.35 . . . . 30.890000000000001 110.528 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' S' S ' 375' ' ' SER . . . . . . . . . . . . . 68.8 p -104.4 -16.96 14.96 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.19 -0.944 . . . . 29.41 110.474 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' S' S ' 376' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -106.56 43.08 1.18 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.327 -0.858 . . . . 32.890000000000001 110.24 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' S' S ' 377' ' ' VAL . . . . . 0.594 ' O ' HG11 ' S' ' 327' ' ' VAL . 7.3 p -114.64 147.3 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.34 -0.85 . . . . 24.329999999999998 110.235 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' S' S ' 378' ' ' LEU . . . . . . . . . . . . . 52.3 mt -116.09 -58.01 2.15 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.441 -0.787 . . . . 24.370000000000001 109.582 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' S' S ' 379' ' ' VAL . . . . . 0.638 HG22 HG12 ' S' ' 326' ' ' VAL . 61.1 t -120.67 132.41 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.371 -0.831 . . . . 18.02 109.453 179.23 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' S' S ' 380' ' ' PHE . . . . . 0.461 ' CE1' ' HB2' ' S' ' 325' ' ' CYS . 14.2 p90 -142.62 173.9 11.12 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.347 -0.845 . . . . 29.350000000000001 110.714 -179.341 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' S' S ' 381' ' ' VAL . . . . . . . . . . . . . 58.3 t -120.02 107.32 39.98 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.586 -0.697 . . . . 16.34 109.395 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' S' S ' 382' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' S' ' 336' ' ' ASP . 45.6 Cg_endo -71.26 145.62 49.11 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 O-C-N 123.598 1.315 . . . . 20.940000000000001 110.78 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' S' S ' 383' ' ' TYR . . . . . 0.402 ' CZ ' ' HB3' ' S' ' 338' ' ' HIS . 88.3 m-85 -61.01 -53.49 56.54 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.309 -0.869 . . . . 28.93 109.878 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' S' S ' 384' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.486 -0.759 . . . . 47.030000000000001 110.333 -176.922 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' R' R ' 30' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 121.23 0.538 . . . . 43.359999999999999 110.212 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' R' R ' 31' ' ' LEU . . . . . . . . . . . . . 65.6 mt -134.91 140.58 45.87 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.282 -0.886 . . . . 22.93 110.269 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 32' ' ' THR . . . . . . . . . . . . . 69.6 m -87.54 110.61 20.47 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.439 -0.788 . . . . 22.34 109.971 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 33' ' ' LEU . . . . . 0.595 HD22 ' CE2' ' R' ' 62' ' ' TYR . 80.1 mt -62.5 -172.73 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.408 -0.808 . . . . 21.390000000000001 110.215 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 34' ' ' TYR . . . . . . . . . . . . . 37.0 p90 -74.65 -29.39 61.24 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.352 -0.842 . . . . 34.399999999999999 110.386 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 35' ' ' ASN . . . . . . . . . . . . . 48.3 p30 -77.78 -1.91 33.78 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.332 -0.855 . . . . 30.280000000000001 110.585 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.26 -16.59 59.4 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.754 -1.338 . . . . 36.25 109.754 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 37' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -58.97 161.81 4.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.315 -1.109 . . . . 53.799999999999997 110.383 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 38' ' ' LYS . . . . . . . . . . . . . 56.9 mttt -117.87 135.71 53.92 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.39 -0.818 . . . . 49.909999999999997 110.151 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 39' ' ' LYS . . . . . 0.406 ' HG2' ' CZ ' ' R' ' 41' ' ' PHE . 8.1 ttmt -138.74 143.73 39.16 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.388 -0.82 . . . . 35.689999999999998 110.182 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 40' ' ' THR . . . . . . . . . . . . . 23.7 m -102.57 128.01 49.41 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.305 -0.872 . . . . 34.840000000000003 110.193 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 41' ' ' PHE . . . . . 0.406 ' CZ ' ' HG2' ' R' ' 39' ' ' LYS . 96.6 m-85 -113.12 132.66 55.36 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.381 -0.824 . . . . 34.420000000000002 110.14 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 42' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -93.29 140.86 29.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.331 -0.856 . . . . 51.460000000000001 110.255 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 43' ' ' SER . . . . . . . . . . . . . 53.6 m -70.73 141.89 51.48 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.421 -0.799 . . . . 41.840000000000003 110.186 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.74 125.37 29.59 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.361 -0.837 . . . . 33.82 110.013 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 45' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.11 151.13 55.13 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.596 1.314 . . . . 30.27 110.625 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 46' ' ' ASN . . . . . 0.4 ' HA ' ' OD1' ' R' ' 50' ' ' ASN . 52.2 t-20 -124.3 109.87 13.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.48 -0.762 . . . . 35.100000000000001 110.033 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 47' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -120.29 -34.88 3.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.285 -0.884 . . . . 42.810000000000002 110.55 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 48' ' ' HIS . . . . . 0.439 ' NE2' HD11 ' R' ' 80' ' ' LEU . 73.3 m80 -105.86 45.23 0.98 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.213 -0.929 . . . . 49.969999999999999 110.24 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 49' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 50.29 34.68 9.22 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.447 -0.783 . . . . 61.32 110.149 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 50' ' ' ASN . . . . . 0.4 ' OD1' ' HA ' ' R' ' 46' ' ' ASN . 15.0 p-10 -86.21 43.78 1.08 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.32 -0.862 . . . . 51.5 110.744 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.08 -46.14 78.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.193 -0.942 . . . . 38.770000000000003 109.476 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 52' ' ' TRP . . . . . 0.484 ' CD2' ' N ' ' R' ' 53' ' ' LEU . 68.1 p-90 -58.42 -38.43 77.4 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.595 -0.691 . . . . 26.239999999999998 110.036 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 53' ' ' LEU . . . . . 0.484 ' N ' ' CD2' ' R' ' 52' ' ' TRP . 23.2 tp -66.75 -46.66 74.71 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.439 -0.788 . . . . 26.75 109.991 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 54' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -55.11 -41.64 71.91 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.369 -0.832 . . . . 35.020000000000003 110.208 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.19 -46.03 92.16 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.396 -0.815 . . . . 24.469999999999999 110.172 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 56' ' ' ILE . . . . . 0.433 HG12 HD11 ' R' ' 104' ' ' ILE . 76.1 mt -62.26 -42.22 94.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.346 -0.846 . . . . 26.030000000000001 109.857 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 57' ' ' LEU . . . . . . . . . . . . . 22.5 mt -60.24 -45.67 92.45 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.364 -0.835 . . . . 26.77 109.655 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 58' ' ' GLN . . . . . . . . . . . . . 57.7 mm-40 -63.95 -46.53 84.29 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.456 -0.777 . . . . 22.32 109.592 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 59' ' ' LEU . . . . . 0.429 ' HA ' ' HE2' ' R' ' 151' ' ' PHE . 23.9 tp -61.34 -37.81 84.64 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.365 -0.834 . . . . 20.550000000000001 109.427 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 60' ' ' PHE . . . . . 0.528 ' CE2' HD21 ' R' ' 111' ' ' LEU . 2.8 m-85 -61.06 -44.74 96.92 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.67 -0.644 . . . . 20.079999999999998 109.913 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 61' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -63.07 -36.19 82.77 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.45 -0.781 . . . . 18.800000000000001 110.528 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 62' ' ' TYR . . . . . 0.595 ' CE2' HD22 ' R' ' 33' ' ' LEU . 9.3 t80 -63.06 -41.8 99.53 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.158 -0.964 . . . . 26.449999999999999 110.217 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 63' ' ' VAL . . . . . 0.406 ' H ' HG22 ' R' ' 63' ' ' VAL . 30.2 m -93.37 20.43 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.247 -0.908 . . . . 29.75 110.263 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 64' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 52.87 75.53 0.24 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.335 -0.853 . . . . 35.520000000000003 110.582 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 65' ' ' GLU . . . . . 0.443 ' HG2' ' CD2' ' R' ' 60' ' ' PHE . 14.3 tp10 -116.22 104.06 52.45 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.45 -0.782 . . . . 29.890000000000001 109.948 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 66' ' ' PRO . . . . . 0.48 ' HA ' ' HB2' ' R' ' 69' ' ' ASP . 46.1 Cg_endo -73.55 -5.81 17.71 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.864 1.455 . . . . 21.370000000000001 111.089 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 67' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -52.15 -61.47 2.25 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.169 -0.957 . . . . 23.850000000000001 110.39 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 68' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -98.13 36.51 1.57 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.34 -0.85 . . . . 28.07 110.475 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 69' ' ' ASP . . . . . 0.48 ' HB2' ' HA ' ' R' ' 66' ' ' PRO . 11.7 t0 -72.33 -33.23 67.18 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.312 -0.867 . . . . 43.759999999999998 110.18 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 70' ' ' TRP . . . . . 0.476 ' CE2' ' CG2' ' R' ' 71' ' ' VAL . 47.7 p-90 -73.39 -3.9 30.17 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.293 -0.879 . . . . 33.060000000000002 110.739 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 71' ' ' VAL . . . . . 0.556 HG11 ' HB2' ' R' ' 82' ' ' ALA . 40.8 t -109.79 -27.5 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.237 -0.914 . . . . 31.699999999999999 109.679 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 72' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -86.42 -49.0 7.94 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.395 -0.815 . . . . 33.579999999999998 110.299 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 73' ' ' SER . . . . . . . . . . . . . 69.8 m -89.57 50.99 2.0 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.274 -0.892 . . . . 50.82 110.39 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 74' ' ' SER . . . . . . . . . . . . . 15.9 t -125.85 138.28 31.71 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.21 -0.931 . . . . 34.740000000000002 110.262 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.33 -25.02 15.98 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.702 1.369 . . . . 35.700000000000003 110.308 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 76' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -91.7 153.23 19.79 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.364 -0.835 . . . . 66.480000000000004 110.3 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 77' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -81.56 95.29 7.09 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.332 -0.855 . . . . 46.719999999999999 110.064 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 78' ' ' LEU . . . . . . . . . . . . . 96.3 mt -96.45 27.96 3.55 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.443 -0.786 . . . . 37.549999999999997 110.186 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 79' ' ' THR . . . . . . . . . . . . . 29.7 m -56.24 -54.62 43.14 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.337 -0.852 . . . . 37.359999999999999 110.286 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 80' ' ' LEU . . . . . 0.604 ' HA ' HD12 ' R' ' 83' ' ' ILE . 15.9 mt -60.9 -23.26 65.08 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.379 -0.826 . . . . 35.829999999999998 110.514 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 81' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -79.41 -39.15 33.15 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.142 -0.974 . . . . 44.030000000000001 110.37 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 82' ' ' ALA . . . . . 0.556 ' HB2' HG11 ' R' ' 71' ' ' VAL . . . -69.48 -28.54 66.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.288 -0.882 . . . . 32.539999999999999 110.291 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 83' ' ' ILE . . . . . 0.604 HD12 ' HA ' ' R' ' 80' ' ' LEU . 78.2 mt -70.18 -46.06 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.237 -0.915 . . . . 32.020000000000003 110.302 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 84' ' ' LYS . . . . . . . . . . . . . 36.0 tttm -55.29 -52.05 64.69 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.164 -0.96 . . . . 34.090000000000003 110.532 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 85' ' ' GLN . . . . . 0.531 ' HG2' HD12 ' R' ' 89' ' ' LEU . 31.9 tt0 -54.71 -46.98 74.25 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.313 -0.867 . . . . 25.940000000000001 110.308 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 86' ' ' LEU . . . . . . . . . . . . . 24.1 mt -58.62 -43.82 89.78 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.346 -0.846 . . . . 16.199999999999999 109.965 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 87' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -65.3 -35.27 80.48 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.466 -0.771 . . . . 49.090000000000003 110.349 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 88' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -78.5 -18.93 54.08 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.283 -0.886 . . . . 28.609999999999999 110.523 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 89' ' ' LEU . . . . . 0.531 HD12 ' HG2' ' R' ' 85' ' ' GLN . 32.8 mt -96.25 -29.34 14.07 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.26 -0.9 . . . . 26.16 110.238 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 90' ' ' THR . . . . . . . . . . . . . 58.2 p -105.72 -34.57 7.66 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.226 -0.921 . . . . 33.329999999999998 109.806 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.73 16.12 58.75 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.937 -1.265 . . . . 31.129999999999999 109.937 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 92' ' ' LEU . . . . . . . . . . . . . 97.1 mt -100.14 155.2 17.87 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.103 -1.234 . . . . 42.520000000000003 110.237 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 93' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -86.18 91.65 8.51 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.567 -0.708 . . . . 68.459999999999994 109.911 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 94' ' ' LEU . . . . . 0.458 ' HB3' ' CZ2' ' R' ' 52' ' ' TRP . 47.7 mt -99.49 53.11 0.94 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.272 -0.893 . . . . 44.630000000000003 110.319 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 95' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.49 -38.67 6.38 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.331 -0.856 . . . . 67.159999999999997 110.399 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 96' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -113.93 44.23 1.68 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.332 -0.855 . . . . 67.019999999999996 110.255 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 97' ' ' GLY . . . . . . . . . . . . . . . 99.15 150.81 26.04 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.674 -1.37 . . . . 49.479999999999997 109.674 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 98' ' ' GLY . . . . . . . . . . . . . . . -166.26 160.03 33.47 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.311 -1.516 . . . . 36.57 109.311 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 99' ' ' PRO . . . . . 0.792 ' O ' HG23 ' R' ' 103' ' ' VAL . 45.0 Cg_endo -72.59 121.14 7.17 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 123.741 1.39 . . . . 30.41 110.435 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 100' ' ' PRO . . . . . 0.41 ' HA ' HD11 ' R' ' 56' ' ' ILE . 44.8 Cg_endo -72.37 -31.67 11.17 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 O-C-N 123.58 1.305 . . . . 29.940000000000001 110.452 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 101' ' ' ALA . . . . . 0.475 ' HB2' ' HB3' ' R' ' 178' ' ' LEU . . . -69.9 -38.46 76.32 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.228 -0.92 . . . . 23.640000000000001 110.327 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 102' ' ' LEU . . . . . 0.425 HD23 HD21 ' R' ' 106' ' ' ASN . 0.1 OUTLIER -72.73 -40.72 65.88 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.373 -0.829 . . . . 20.309999999999999 110.323 -179.699 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' R' R ' 103' ' ' VAL . . . . . 0.792 HG23 ' O ' ' R' ' 99' ' ' PRO . 63.3 t -58.13 -40.05 75.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.21 -0.931 . . . . 16.329999999999998 110.065 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 104' ' ' ILE . . . . . 0.433 HD11 HG12 ' R' ' 56' ' ' ILE . 81.9 mt -71.71 -30.51 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.397 -0.814 . . . . 24.77 109.956 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 105' ' ' TRP . . . . . 0.462 ' O ' ' HD3' ' R' ' 108' ' ' LYS . 70.6 t-105 -82.51 0.9 40.35 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.323 -0.861 . . . . 23.280000000000001 110.292 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 106' ' ' ASN . . . . . 0.425 HD21 HD23 ' R' ' 102' ' ' LEU . 6.8 m-80 -105.09 -10.38 17.2 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.144 -0.973 . . . . 28.260000000000002 110.123 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 107' ' ' ILE . . . . . . . . . . . . . 36.7 pt -126.83 35.02 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.181 -0.949 . . . . 18.77 110.033 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 108' ' ' LYS . . . . . 0.502 ' HG2' ' HB ' ' R' ' 115' ' ' ILE . 9.3 mtpp -61.03 -48.48 81.56 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.516 -0.74 . . . . 42.5 110.037 179.494 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 109' ' ' HIS . . . . . 0.444 ' CD2' ' HG ' ' R' ' 110' ' ' LEU . 50.9 p-80 -66.06 -12.83 58.06 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.499 -0.75 . . . . 20.07 110.688 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 110' ' ' LEU . . . . . 0.444 ' HG ' ' CD2' ' R' ' 109' ' ' HIS . 80.3 mt -94.8 -17.3 22.25 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.083 -1.011 . . . . 15.69 110.196 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 111' ' ' LEU . . . . . 0.528 HD21 ' CE2' ' R' ' 60' ' ' PHE . 10.3 mt -94.09 144.15 25.74 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.342 -0.849 . . . . 25.390000000000001 111.008 -179.181 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 112' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -77.67 -17.43 57.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.487 -0.758 . . . . 53.479999999999997 109.823 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 113' ' ' THR . . . . . 0.459 HG22 ' N ' ' R' ' 114' ' ' GLY . 60.5 m -83.67 166.64 17.94 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.308 -0.87 . . . . 14.800000000000001 110.247 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 114' ' ' GLY . . . . . 0.459 ' N ' HG22 ' R' ' 113' ' ' THR . . . -98.0 127.12 9.12 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.042 -1.223 . . . . 16.140000000000001 110.042 -179.637 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 115' ' ' ILE . . . . . 0.579 HD13 ' HB ' ' R' ' 124' ' ' VAL . 47.8 mm -109.02 139.34 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.478 -1.013 . . . . 13.460000000000001 109.741 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 116' ' ' GLY . . . . . . . . . . . . . . . -152.71 -155.8 7.26 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.011 -1.236 . . . . 23.899999999999999 110.011 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 117' ' ' THR . . . . . 0.53 HG22 ' CG2' ' R' ' 126' ' ' VAL . 18.8 p -135.03 -171.33 2.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.514 -0.992 . . . . 27.370000000000001 110.059 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 118' ' ' ALA . . . . . 0.446 ' HB3' ' OD1' ' R' ' 128' ' ' ASP . . . -56.62 -58.06 9.72 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.216 -0.927 . . . . 18.760000000000002 110.083 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 119' ' ' SER . . . . . . . . . . . . . 1.1 m -56.55 -40.56 75.36 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.251 -0.905 . . . . 32.350000000000001 109.815 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 120' ' ' ARG . . . . . 0.417 ' NH1' ' NE1' ' S' ' 305' ' ' TRP . 10.0 mtm180 -110.07 86.29 4.91 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.43 -0.794 . . . . 27.120000000000001 109.716 179.337 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 121' ' ' PRO . . . . . 0.482 ' HA ' ' SG ' ' R' ' 125' ' ' CYS . 44.0 Cg_endo -71.32 166.53 28.98 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 O-C-N 123.86 1.453 . . . . 22.68 110.998 -179.394 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 122' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' R' ' 121' ' ' PRO . 38.3 t 178.53 -161.72 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.6 -0.687 . . . . 22.989999999999998 109.461 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 123' ' ' GLU . . . . . 0.442 ' HG2' HG23 ' R' ' 113' ' ' THR . 2.3 tp10 -56.45 -39.98 74.04 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.211 -0.93 . . . . 36.18 109.622 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 124' ' ' VAL . . . . . 0.579 ' HB ' HD13 ' R' ' 115' ' ' ILE . 83.5 t -142.54 136.44 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.597 -0.689 . . . . 20.640000000000001 109.428 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 125' ' ' CYS . . . . . 0.482 ' SG ' ' HA ' ' R' ' 121' ' ' PRO . 83.4 m -140.32 168.16 20.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.145 -0.972 . . . . 22.800000000000001 111.171 -179.276 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 126' ' ' VAL . . . . . 0.727 HG12 HG22 ' R' ' 179' ' ' VAL . 35.8 m -122.72 159.77 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.724 -0.61 . . . . 21.239999999999998 109.695 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 127' ' ' VAL . . . . . 0.709 HG11 ' O ' ' R' ' 177' ' ' VAL . 30.8 m -70.83 141.85 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.293 -0.879 . . . . 19.77 110.681 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 128' ' ' ASP . . . . . 0.446 ' OD1' ' HB3' ' R' ' 118' ' ' ALA . 54.0 p-10 -137.68 19.34 2.88 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.405 -0.809 . . . . 29.210000000000001 110.702 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 129' ' ' GLY . . . . . . . . . . . . . . . 113.99 0.02 24.14 Favored Glycine 0 N--CA 1.493 2.458 0 C-N-CA 119.977 -1.106 . . . . 33.859999999999999 110.472 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 130' ' ' THR . . . . . . . . . . . . . 58.3 m -91.76 131.83 36.85 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.084 -1.244 . . . . 26.41 110.07 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -62.59 120.66 11.59 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.35 -0.844 . . . . 33.079999999999998 110.312 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 132' ' ' MET . . . . . 0.433 ' HE1' ' CE2' ' R' ' 180' ' ' PHE . 98.4 mmm -105.22 165.64 10.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.395 -0.816 . . . . 30.760000000000002 110.377 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 133' ' ' CYS . . . . . 0.411 ' HA ' ' HB3' ' R' ' 174' ' ' PRO . 32.6 m -141.16 158.14 44.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.507 -0.745 . . . . 27.0 109.932 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 134' ' ' LEU . . . . . 0.563 HD11 ' O ' ' R' ' 172' ' ' PRO . 0.1 OUTLIER -58.57 -19.6 39.54 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.388 -0.82 . . . . 33.899999999999999 110.498 -179.862 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' R' R ' 135' ' ' ALA . . . . . . . . . . . . . . . -92.79 8.16 40.62 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.294 -0.879 . . . . 19.370000000000001 110.755 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 136' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -93.74 -21.86 19.07 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.207 -0.933 . . . . 30.469999999999999 110.216 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 137' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -149.94 165.35 32.89 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.351 -0.843 . . . . 24.27 110.231 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 138' ' ' HIS . . . . . 0.433 ' HA ' HG23 ' R' ' 154' ' ' VAL . 15.1 p80 -117.82 15.15 14.38 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.429 -0.794 . . . . 20.91 110.452 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 139' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' R' ' 152' ' ' ALA . . . -177.16 152.49 0.89 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.167 -0.958 . . . . 15.69 110.137 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 140' ' ' GLY . . . . . 0.427 ' HA3' ' O ' ' R' ' 179' ' ' VAL . . . 161.74 175.1 32.41 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 110.007 -1.237 . . . . 23.760000000000002 110.007 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 141' ' ' ILE . . . . . . . . . . . . . 83.6 mt -95.48 136.57 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.447 -1.031 . . . . 25.300000000000001 109.682 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 142' ' ' PHE . . . . . 0.576 ' CD2' ' HB2' ' R' ' 172' ' ' PRO . 82.6 m-85 -120.75 -172.66 2.43 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.33 -0.856 . . . . 30.239999999999998 110.54 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 143' ' ' LEU . . . . . 0.743 HD23 ' O ' ' R' ' 148' ' ' HIS . 0.5 OUTLIER -119.75 77.84 1.27 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.459 -0.776 . . . . 32.799999999999997 110.304 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' R' R ' 144' ' ' LYS . . . . . 0.471 ' HG3' ' CZ2' ' R' ' 170' ' ' TRP . 1.0 OUTLIER -69.67 76.93 0.44 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.381 -0.824 . . . . 49.18 109.653 179.573 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' R' R ' 145' ' ' GLY . . . . . 0.457 ' O ' HD22 ' R' ' 143' ' ' LEU . . . 104.52 179.23 24.81 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.16 -1.576 . . . . 53.869999999999997 109.16 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 146' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -88.44 145.86 25.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.319 -1.107 . . . . 68.579999999999998 109.999 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 147' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 58.19 36.58 25.88 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.294 -0.879 . . . . 56.619999999999997 110.633 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 148' ' ' HIS . . . . . 0.743 ' O ' HD23 ' R' ' 143' ' ' LEU . 45.1 t60 -158.67 148.11 19.17 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.243 -0.911 . . . . 44.57 110.398 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 149' ' ' ALA . . . . . . . . . . . . . . . -150.25 146.9 27.08 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.451 -0.781 . . . . 33.539999999999999 110.061 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 150' ' ' VAL . . . . . . . . . . . . . 34.2 m -142.38 161.51 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.246 -0.909 . . . . 27.609999999999999 110.322 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 151' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' R' ' 152' ' ' ALA . 5.9 t80 -86.18 155.57 20.68 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.383 -0.823 . . . . 23.039999999999999 109.901 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 152' ' ' ALA . . . . . 0.537 ' N ' ' CD1' ' R' ' 151' ' ' PHE . . . -157.31 151.56 24.92 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.447 -0.783 . . . . 29.609999999999999 109.53 178.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 153' ' ' CYS . . . . . . . . . . . . . 26.7 p -154.28 173.56 15.99 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.28 -0.888 . . . . 22.75 110.539 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 154' ' ' VAL . . . . . 0.614 HG22 ' CE2' ' R' ' 159' ' ' TRP . 59.9 t -90.52 117.04 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.429 -0.794 . . . . 23.260000000000002 110.057 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 155' ' ' THR . . . . . . . . . . . . . 71.0 p -112.18 -176.62 2.96 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.361 -0.837 . . . . 17.879999999999999 110.058 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 156' ' ' SER . . . . . . . . . . . . . 78.4 p -75.96 -3.68 36.89 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.32 -0.863 . . . . 21.829999999999998 110.716 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 157' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -118.33 10.57 12.82 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.096 -1.002 . . . . 36.539999999999999 110.625 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 158' ' ' GLY . . . . . . . . . . . . . . . 117.83 -162.6 13.01 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.55 -1.42 . . . . 31.739999999999998 109.55 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 159' ' ' TRP . . . . . 0.614 ' CE2' HG22 ' R' ' 154' ' ' VAL . 14.6 m95 -86.63 122.54 30.7 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.386 -1.067 . . . . 28.25 110.061 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 160' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -108.48 166.92 10.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.346 -0.846 . . . . 41.240000000000002 110.25 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 161' ' ' ALA . . . . . . . . . . . . . . . -143.25 123.39 13.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.435 -0.791 . . . . 27.399999999999999 110.182 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 162' ' ' ILE . . . . . . . . . . . . . 92.6 mt -87.57 81.24 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.398 -0.814 . . . . 24.27 110.055 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 163' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' R' ' 165' ' ' GLU . 15.3 t0 -72.85 92.37 1.6 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.458 -0.776 . . . . 36.079999999999998 110.237 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 164' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 54.09 -88.97 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.489 -0.757 . . . . 46.079999999999998 110.603 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 165' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' R' ' 163' ' ' ASP . 29.6 mt-10 -124.72 36.0 4.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.109 -0.994 . . . . 50.939999999999998 110.194 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 166' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -135.69 117.3 14.91 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.405 -0.81 . . . . 47.280000000000001 110.361 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 167' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -101.06 119.91 39.43 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.367 -0.833 . . . . 40.469999999999999 110.178 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 168' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -157.51 158.56 30.71 Favored Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 121.235 -0.916 . . . . 30.210000000000001 110.454 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 169' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.77 133.05 19.52 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 O-C-N 123.866 1.456 . . . . 32.759999999999998 110.531 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 170' ' ' TRP . . . . . 0.471 ' CZ2' ' HG3' ' R' ' 144' ' ' LYS . 67.2 t90 -159.78 119.27 2.88 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.444 -0.785 . . . . 32.789999999999999 109.958 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 171' ' ' THR . . . . . . . . . . . . . 45.5 m -81.08 112.58 33.87 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.423 -0.798 . . . . 36.920000000000002 110.219 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 172' ' ' PRO . . . . . 0.576 ' HB2' ' CD2' ' R' ' 142' ' ' PHE . 46.8 Cg_endo -73.77 158.81 46.39 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.634 1.334 . . . . 33.539999999999999 110.556 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 173' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -88.85 144.93 33.77 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.409 -0.807 . . . . 45.759999999999998 109.913 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 174' ' ' PRO . . . . . 0.411 ' HB3' ' HA ' ' R' ' 133' ' ' CYS . 46.0 Cg_endo -71.72 -10.35 26.37 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.649 1.342 . . . . 29.629999999999999 110.505 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 175' ' ' SER . . . . . . . . . . . . . 53.0 p -103.41 -17.63 15.17 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.273 -0.892 . . . . 35.700000000000003 110.367 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 176' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -103.58 43.3 1.09 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.261 -0.899 . . . . 39.649999999999999 110.362 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 177' ' ' VAL . . . . . 0.709 ' O ' HG11 ' R' ' 127' ' ' VAL . 10.5 p -117.78 127.23 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.266 -0.896 . . . . 20.609999999999999 110.006 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 178' ' ' LEU . . . . . 0.475 ' HB3' ' HB2' ' R' ' 101' ' ' ALA . 46.4 mt -91.6 -61.25 1.68 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.368 -0.832 . . . . 15.58 109.364 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 179' ' ' VAL . . . . . 0.727 HG22 HG12 ' R' ' 126' ' ' VAL . 67.5 t -114.6 144.67 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.66 -0.65 . . . . 17.399999999999999 109.444 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 180' ' ' PHE . . . . . 0.433 ' CE2' ' HE1' ' R' ' 132' ' ' MET . 43.4 p90 -152.13 163.36 39.53 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.33 -0.856 . . . . 20.16 110.517 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 181' ' ' VAL . . . . . . . . . . . . . 65.9 t -113.1 111.5 50.44 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.363 -0.836 . . . . 17.690000000000001 109.848 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 182' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.09 149.57 52.62 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 O-C-N 123.638 1.336 . . . . 17.809999999999999 110.403 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 183' ' ' TYR . . . . . 0.688 ' O ' ' C ' ' R' ' 184' ' ' ASP . 78.9 m-85 -59.13 175.44 0.3 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.401 -0.812 . . . . 28.010000000000002 110.54 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 184' ' ' ASP . . . . . 0.688 ' C ' ' O ' ' R' ' 183' ' ' TYR . 2.3 m-20 -20.0 -84.04 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.315 -0.866 . . . . 58.640000000000001 110.242 -178.31 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' R' R ' 185' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 . . . . . 0 N--CA 1.502 2.173 0 CA-C-O 121.22 0.533 . . . . 80.420000000000002 111.75 179.617 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' R' R ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 120.823 0.344 . . . . 49.5 110.16 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' R' R ' 194' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.862 0 O-C-N 121.218 -0.927 . . . . 40.399999999999999 110.144 179.906 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' S' S ' 229' ' ' MET . . . . . . . . . . . . . 5.1 mtm . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.188 0.518 . . . . 51.829999999999998 110.216 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' S' S ' 230' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -97.29 142.71 28.84 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.34 -0.85 . . . . 54.130000000000003 110.199 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' S' S ' 231' ' ' LEU . . . . . . . . . . . . . 67.3 mt -134.07 140.98 47.0 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.388 -0.82 . . . . 33.039999999999999 110.364 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' S' S ' 232' ' ' THR . . . . . 0.418 ' O ' ' HA ' ' S' ' 355' ' ' THR . 40.3 m -89.26 103.28 15.92 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.305 -0.872 . . . . 26.920000000000002 110.032 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' S' S ' 233' ' ' LEU . . . . . 0.671 HD22 ' CE2' ' S' ' 262' ' ' TYR . 79.8 mt -55.88 179.24 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.437 -0.79 . . . . 13.779999999999999 110.463 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' S' S ' 234' ' ' TYR . . . . . 0.448 ' CG ' ' N ' ' S' ' 235' ' ' ASN . 35.5 p90 -65.01 -35.66 81.9 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.384 -0.823 . . . . 26.079999999999998 110.168 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' S' S ' 235' ' ' ASN . . . . . 0.448 ' N ' ' CG ' ' S' ' 234' ' ' TYR . 50.6 p30 -74.38 -7.35 52.6 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.336 -0.852 . . . . 20.039999999999999 110.5 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' S' S ' 236' ' ' GLY . . . . . . . . . . . . . . . 95.69 -19.9 52.18 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.777 -1.329 . . . . 22.710000000000001 109.777 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' S' S ' 237' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -52.94 145.68 12.33 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.2 -1.176 . . . . 35.439999999999998 110.236 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' S' S ' 238' ' ' LYS . . . . . . . . . . . . . 44.5 mttt -102.18 127.92 48.91 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.358 -0.839 . . . . 32.560000000000002 110.41 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' S' S ' 239' ' ' LYS . . . . . 0.408 ' HG2' ' CZ ' ' S' ' 241' ' ' PHE . 9.0 ttmt -132.29 144.55 50.67 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.371 -0.831 . . . . 26.68 109.919 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' S' S ' 240' ' ' THR . . . . . . . . . . . . . 52.1 m -102.07 132.18 48.09 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.304 -0.872 . . . . 41.020000000000003 110.334 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' S' S ' 241' ' ' PHE . . . . . 0.408 ' CZ ' ' HG2' ' S' ' 239' ' ' LYS . 96.0 m-85 -117.94 137.66 52.68 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.335 -0.853 . . . . 28.620000000000001 110.21 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' S' S ' 242' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -96.32 161.78 13.79 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.302 -0.874 . . . . 47.890000000000001 110.198 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' S' S ' 243' ' ' SER . . . . . . . . . . . . . 71.5 m -90.58 151.47 21.3 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.332 -0.855 . . . . 45.090000000000003 110.227 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' S' S ' 244' ' ' ARG . . . . . . . . . . . . . 1.4 mtp85 -129.69 126.77 22.78 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.349 -0.844 . . . . 42.490000000000002 110.247 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' S' S ' 245' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.35 161.0 43.74 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.74 1.389 . . . . 35.68 110.561 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' S' S ' 246' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -132.87 97.87 4.15 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.408 -0.807 . . . . 51.880000000000003 109.867 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' S' S ' 247' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -110.49 -22.22 11.77 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.321 -0.862 . . . . 53.689999999999998 110.655 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' S' S ' 248' ' ' HIS . . . . . . . . . . . . . 76.5 m80 -117.21 43.61 2.28 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.16 -0.963 . . . . 55.789999999999999 110.761 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' S' S ' 249' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 48.77 38.46 11.85 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.417 -0.802 . . . . 49.450000000000003 110.39 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' S' S ' 250' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -90.65 29.02 1.38 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.496 -0.753 . . . . 36.859999999999999 110.364 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' S' S ' 251' ' ' ALA . . . . . . . . . . . . . . . -53.79 -43.23 69.12 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.281 -0.887 . . . . 29.690000000000001 109.563 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' S' S ' 252' ' ' TRP . . . . . 0.426 ' CZ2' ' HB3' ' S' ' 294' ' ' LEU . 67.9 p-90 -61.76 -33.95 74.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.602 -0.686 . . . . 41.119999999999997 109.886 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' S' S ' 253' ' ' LEU . . . . . . . . . . . . . 23.4 tp -70.11 -47.23 62.66 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.446 -0.783 . . . . 24.890000000000001 110.016 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' S' S ' 254' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -56.16 -42.44 77.03 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.299 -0.875 . . . . 35.649999999999999 109.975 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' S' S ' 255' ' ' ALA . . . . . . . . . . . . . . . -59.57 -48.1 82.97 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.447 -0.783 . . . . 22.73 110.141 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' S' S ' 256' ' ' ILE . . . . . 0.507 HG12 HD11 ' S' ' 304' ' ' ILE . 79.7 mt -62.32 -40.7 88.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.273 -0.892 . . . . 28.850000000000001 109.924 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' S' S ' 257' ' ' LEU . . . . . 0.404 ' CD2' ' HB3' ' S' ' 268' ' ' PHE . 19.0 mt -61.54 -44.48 96.98 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.354 -0.841 . . . . 23.07 110.168 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' S' S ' 258' ' ' GLN . . . . . 0.501 ' HB3' ' CD2' ' S' ' 351' ' ' PHE . 53.4 mm-40 -65.09 -45.33 85.66 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.398 -0.814 . . . . 29.780000000000001 109.953 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' S' S ' 259' ' ' LEU . . . . . 0.419 ' O ' HG22 ' S' ' 263' ' ' VAL . 19.9 tp -58.73 -36.27 74.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.285 -0.885 . . . . 17.940000000000001 109.484 179.179 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' S' S ' 260' ' ' PHE . . . . . 0.528 ' CE2' HD21 ' S' ' 311' ' ' LEU . 3.1 m-85 -62.89 -45.24 93.44 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.663 -0.648 . . . . 30.57 109.808 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' S' S ' 261' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -62.08 -29.82 70.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.454 -0.779 . . . . 41.340000000000003 110.015 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' S' S ' 262' ' ' TYR . . . . . 0.671 ' CE2' HD22 ' S' ' 233' ' ' LEU . 8.7 t80 -71.17 -44.6 65.17 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.416 -0.802 . . . . 26.030000000000001 110.137 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' S' S ' 263' ' ' VAL . . . . . 0.419 HG22 ' O ' ' S' ' 259' ' ' LEU . 33.0 m -92.06 18.23 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.385 -0.822 . . . . 22.800000000000001 110.412 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' S' S ' 264' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 52.76 70.67 0.55 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.291 -0.881 . . . . 44.030000000000001 110.568 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' S' S ' 265' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -111.77 109.16 55.53 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.257 -0.902 . . . . 35.609999999999999 109.716 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' S' S ' 266' ' ' PRO . . . . . 0.477 ' HA ' ' HB2' ' S' ' 269' ' ' ASP . 49.0 Cg_endo -75.24 0.37 9.08 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.579 1.305 . . . . 37.670000000000002 111.728 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' S' S ' 267' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -56.53 -67.65 0.29 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.806 -1.184 . . . . 41.490000000000002 110.203 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' S' S ' 268' ' ' PHE . . . . . 0.404 ' HB3' ' CD2' ' S' ' 257' ' ' LEU . 22.4 m-85 -92.91 39.85 1.05 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.164 -0.96 . . . . 50.759999999999998 110.098 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' S' S ' 269' ' ' ASP . . . . . 0.477 ' HB2' ' HA ' ' S' ' 266' ' ' PRO . 0.9 OUTLIER -76.0 -33.16 59.7 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.322 -0.861 . . . . 61.859999999999999 109.83 179.543 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' S' S ' 270' ' ' TRP . . . . . 0.505 ' CE2' HG23 ' S' ' 271' ' ' VAL . 51.0 p-90 -73.97 -4.28 34.28 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.208 -0.932 . . . . 39.850000000000001 110.489 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' S' S ' 271' ' ' VAL . . . . . 0.505 HG23 ' CE2' ' S' ' 270' ' ' TRP . 46.5 t -109.5 -32.77 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.129 -0.982 . . . . 39.18 110.051 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' S' S ' 272' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -78.65 -36.47 43.83 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.384 -0.822 . . . . 40.020000000000003 110.514 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' S' S ' 273' ' ' SER . . . . . . . . . . . . . 70.9 m -103.59 56.08 0.74 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.269 -0.894 . . . . 47.200000000000003 110.291 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' S' S ' 274' ' ' SER . . . . . . . . . . . . . 6.9 t -133.04 141.23 40.17 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.371 -0.83 . . . . 47.609999999999999 110.108 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' S' S ' 275' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.74 -18.92 21.7 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 O-C-N 123.617 1.325 . . . . 45.280000000000001 110.583 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' S' S ' 276' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -99.88 140.88 33.46 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.247 -0.908 . . . . 57.270000000000003 110.288 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' S' S ' 277' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -71.66 97.56 1.75 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.368 -0.832 . . . . 37.280000000000001 110.272 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' S' S ' 278' ' ' LEU . . . . . . . . . . . . . 86.5 mt -96.97 33.87 1.83 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.329 -0.857 . . . . 43.880000000000003 110.023 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' S' S ' 279' ' ' THR . . . . . . . . . . . . . 78.1 m -64.12 -60.08 3.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.505 -0.747 . . . . 50.049999999999997 110.273 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' S' S ' 280' ' ' LEU . . . . . 0.724 ' HA ' HD12 ' S' ' 283' ' ' ILE . 13.7 mt -51.58 -39.92 58.8 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.352 -0.843 . . . . 54.119999999999997 110.255 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' S' S ' 281' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.41 -49.65 74.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.467 -0.77 . . . . 65.280000000000001 110.108 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' S' S ' 282' ' ' ALA . . . . . . . . . . . . . . . -58.95 -33.95 71.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.439 -0.788 . . . . 46.509999999999998 110.512 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' S' S ' 283' ' ' ILE . . . . . 0.724 HD12 ' HA ' ' S' ' 280' ' ' LEU . 86.0 mt -66.39 -50.82 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.358 -0.839 . . . . 47.299999999999997 110.092 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' S' S ' 284' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -50.52 -57.63 7.67 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.444 -0.785 . . . . 50.719999999999999 110.358 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' S' S ' 285' ' ' GLN . . . . . 0.531 ' HG2' HD12 ' S' ' 289' ' ' LEU . 34.4 tt0 -51.41 -46.36 62.89 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.578 -0.701 . . . . 68.469999999999999 110.346 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' S' S ' 286' ' ' LEU . . . . . . . . . . . . . 19.0 mt -59.96 -44.53 94.37 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.448 -0.782 . . . . 36.619999999999997 110.245 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' S' S ' 287' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -62.78 -35.21 79.09 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.288 -0.883 . . . . 46.640000000000001 110.083 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' S' S ' 288' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -76.25 -21.03 56.82 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.361 -0.837 . . . . 46.450000000000003 110.307 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' S' S ' 289' ' ' LEU . . . . . 0.531 HD12 ' HG2' ' S' ' 285' ' ' GLN . 30.7 mt -97.35 -21.73 17.04 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.288 -0.883 . . . . 35.090000000000003 110.524 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' S' S ' 290' ' ' THR . . . . . 0.413 HG22 ' HB3' ' S' ' 306' ' ' ASN . 81.3 p -114.78 -28.35 7.12 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.246 -0.909 . . . . 38.609999999999999 110.455 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' S' S ' 291' ' ' GLY . . . . . . . . . . . . . . . 79.31 10.99 85.45 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.856 -1.298 . . . . 36.770000000000003 109.856 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' S' S ' 292' ' ' LEU . . . . . . . . . . . . . 84.8 mt -96.41 145.81 25.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.304 -1.116 . . . . 35.329999999999998 109.799 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' S' S ' 293' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -77.32 102.4 6.73 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.15 -0.969 . . . . 48.700000000000003 110.302 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' S' S ' 294' ' ' LEU . . . . . 0.426 ' HB3' ' CZ2' ' S' ' 252' ' ' TRP . 55.7 mt -106.93 51.71 0.73 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.521 -0.737 . . . . 42.609999999999999 110.1 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' S' S ' 295' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -112.51 -11.11 13.65 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.365 -0.834 . . . . 55.490000000000002 110.531 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' S' S ' 296' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -144.37 48.55 1.36 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.167 -0.958 . . . . 75.680000000000007 110.261 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' S' S ' 297' ' ' GLY . . . . . . . . . . . . . . . 96.84 145.2 18.73 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.467 -1.453 . . . . 49.439999999999998 109.467 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' S' S ' 298' ' ' GLY . . . . . . . . . . . . . . . -163.86 156.99 29.1 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.8 -1.32 . . . . 41.109999999999999 109.8 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' S' S ' 299' ' ' PRO . . . . . 0.484 ' O ' HG23 ' S' ' 303' ' ' VAL . 46.6 Cg_endo -73.86 118.28 5.37 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 124.008 1.531 . . . . 26.199999999999999 110.209 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' S' S ' 300' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.29 -15.49 31.52 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 O-C-N 123.584 1.307 . . . . 21.699999999999999 110.665 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' S' S ' 301' ' ' ALA . . . . . . . . . . . . . . . -80.63 -29.34 36.76 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.295 -0.878 . . . . 31.23 110.13 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' S' S ' 302' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.56 -40.62 18.89 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.391 -0.818 . . . . 38.990000000000002 109.941 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' S' S ' 303' ' ' VAL . . . . . 0.484 HG23 ' O ' ' S' ' 299' ' ' PRO . 58.0 t -60.7 -35.47 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.487 -0.758 . . . . 18.629999999999999 110.167 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' S' S ' 304' ' ' ILE . . . . . 0.522 HD12 HG21 ' S' ' 379' ' ' VAL . 86.1 mt -79.35 -23.61 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.44 -0.787 . . . . 25.460000000000001 110.229 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' S' S ' 305' ' ' TRP . . . . . 0.417 ' NE1' ' NH1' ' R' ' 120' ' ' ARG . 68.8 t-105 -88.64 -14.56 37.17 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.31 -0.869 . . . . 33.399999999999999 110.599 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' S' S ' 306' ' ' ASN . . . . . 0.413 ' HB3' HG22 ' S' ' 290' ' ' THR . 10.4 m-80 -89.67 -13.62 36.59 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.291 -0.88 . . . . 36.969999999999999 110.394 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' S' S ' 307' ' ' ILE . . . . . 0.469 HG12 ' O ' ' S' ' 303' ' ' VAL . 36.9 pt -125.02 45.69 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.255 -0.903 . . . . 30.809999999999999 110.043 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' S' S ' 308' ' ' LYS . . . . . 0.411 ' HD3' ' CD2' ' S' ' 305' ' ' TRP . 1.5 mtmp? -73.63 -37.76 65.26 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.373 -0.83 . . . . 46.520000000000003 110.064 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' S' S ' 309' ' ' HIS . . . . . 0.495 ' CD2' ' HG ' ' S' ' 310' ' ' LEU . 55.6 p-80 -73.15 -8.21 54.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.263 -0.898 . . . . 51.030000000000001 110.187 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' S' S ' 310' ' ' LEU . . . . . 0.495 ' HG ' ' CD2' ' S' ' 309' ' ' HIS . 53.0 mt -99.31 -12.84 19.97 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.317 -0.864 . . . . 36.159999999999997 109.969 179.269 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' S' S ' 311' ' ' LEU . . . . . 0.528 HD21 ' CE2' ' S' ' 260' ' ' PHE . 10.8 mt -97.21 147.9 23.63 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.377 -0.827 . . . . 40.0 110.355 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' S' S ' 312' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -81.67 -16.23 51.97 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.262 -0.899 . . . . 54.18 109.698 179.133 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' S' S ' 313' ' ' THR . . . . . 0.829 HG23 ' HG2' ' S' ' 323' ' ' GLU . 92.7 m -87.97 151.63 22.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.38 -0.825 . . . . 25.609999999999999 110.149 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' S' S ' 314' ' ' GLY . . . . . . . . . . . . . . . -87.86 126.33 8.0 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.83 -1.308 . . . . 25.18 109.83 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' S' S ' 315' ' ' ILE . . . . . 0.668 HD13 ' HB ' ' S' ' 324' ' ' VAL . 50.6 mm -101.58 150.53 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.416 -1.049 . . . . 23.899999999999999 109.724 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' S' S ' 316' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' S' ' 325' ' ' CYS . . . -157.1 -159.23 9.36 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.026 -1.23 . . . . 23.18 110.026 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' S' S ' 317' ' ' THR . . . . . 0.423 HG22 ' CG2' ' S' ' 326' ' ' VAL . 11.2 p -133.95 -173.04 3.14 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.442 -1.034 . . . . 27.98 109.967 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' S' S ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.58 -56.16 25.44 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.191 -0.943 . . . . 28.100000000000001 109.927 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' S' S ' 319' ' ' SER . . . . . . . . . . . . . 1.2 m -59.9 -41.69 92.2 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.382 -0.824 . . . . 37.0 109.664 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' S' S ' 320' ' ' ARG . . . . . . . . . . . . . 12.1 mtm180 -111.69 79.85 2.63 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.445 -0.784 . . . . 52.07 109.652 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' S' S ' 321' ' ' PRO . . . . . 0.444 ' O ' ' HB2' ' S' ' 322' ' ' SER . 43.9 Cg_endo -71.44 171.6 15.88 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.83 1.437 . . . . 38.289999999999999 110.937 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' S' S ' 322' ' ' SER . . . . . 0.444 ' HB2' ' O ' ' S' ' 321' ' ' PRO . 41.3 t 178.58 -148.13 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.924 -0.769 . . . . 38.840000000000003 108.924 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' S' S ' 323' ' ' GLU . . . . . 0.829 ' HG2' HG23 ' S' ' 313' ' ' THR . 6.7 tp10 -62.82 -40.33 97.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.946 -1.096 . . . . 40.700000000000003 109.682 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' S' S ' 324' ' ' VAL . . . . . 0.668 ' HB ' HD13 ' S' ' 315' ' ' ILE . 73.5 t -141.28 134.97 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.427 -0.796 . . . . 20.34 109.507 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' S' S ' 325' ' ' CYS . . . . . 0.46 ' HB2' ' CE1' ' S' ' 380' ' ' PHE . 11.3 m -125.98 172.13 10.2 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.385 -0.822 . . . . 30.629999999999999 110.827 -179.049 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' S' S ' 326' ' ' VAL . . . . . 0.644 HG12 HG22 ' S' ' 379' ' ' VAL . 34.5 m -135.41 142.25 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 109.204 -0.665 . . . . 23.899999999999999 109.204 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' S' S ' 327' ' ' VAL . . . . . 0.593 HG11 ' O ' ' S' ' 377' ' ' VAL . 34.5 m -56.34 125.04 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.054 -1.029 . . . . 19.48 110.43 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' S' S ' 328' ' ' ASP . . . . . . . . . . . . . 55.6 p-10 -119.43 11.59 12.2 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.451 -0.781 . . . . 26.43 110.411 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' S' S ' 329' ' ' GLY . . . . . . . . . . . . . . . 119.58 2.26 13.2 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.088 -1.205 . . . . 31.239999999999998 110.088 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' S' S ' 330' ' ' THR . . . . . . . . . . . . . 78.3 m -93.02 129.99 38.76 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.064 -1.256 . . . . 30.050000000000001 110.183 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' S' S ' 331' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -56.8 111.54 1.05 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.217 -0.927 . . . . 37.259999999999998 109.935 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' S' S ' 332' ' ' MET . . . . . . . . . . . . . 87.9 mmm -94.04 162.57 13.83 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.212 -0.93 . . . . 26.23 110.347 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' S' S ' 333' ' ' CYS . . . . . . . . . . . . . 24.9 m -137.3 150.07 47.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.483 -0.761 . . . . 23.559999999999999 109.961 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' S' S ' 334' ' ' LEU . . . . . 0.564 HD11 ' O ' ' S' ' 372' ' ' PRO . 0.1 OUTLIER -52.57 -24.93 9.16 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.334 -0.854 . . . . 28.93 110.457 179.883 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' S' S ' 335' ' ' ALA . . . . . . . . . . . . . . . -88.95 14.39 10.61 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.379 -0.826 . . . . 15.76 110.977 -179.36 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' S' S ' 336' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -100.51 -17.23 17.23 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.149 -0.969 . . . . 34.920000000000002 110.137 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' S' S ' 337' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -152.37 170.86 19.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.418 -0.801 . . . . 19.030000000000001 110.055 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' S' S ' 338' ' ' HIS . . . . . 0.401 ' HB3' ' CZ ' ' S' ' 383' ' ' TYR . 13.5 p80 -120.7 10.38 10.99 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.318 -0.864 . . . . 18.82 110.465 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' S' S ' 339' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' S' ' 352' ' ' ALA . . . -176.04 155.17 1.54 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.274 -0.891 . . . . 17.18 110.09 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' S' S ' 340' ' ' GLY . . . . . 0.404 ' CA ' ' O ' ' S' ' 379' ' ' VAL . . . 160.87 173.11 29.07 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.013 -1.235 . . . . 18.329999999999998 110.013 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' S' S ' 341' ' ' ILE . . . . . . . . . . . . . 83.9 mt -88.84 138.14 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.498 -1.001 . . . . 18.600000000000001 109.819 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' S' S ' 342' ' ' PHE . . . . . 0.494 ' CE2' ' HB3' ' S' ' 352' ' ' ALA . 70.0 m-85 -120.99 -178.48 3.76 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.299 -0.875 . . . . 23.440000000000001 110.453 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' S' S ' 343' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.8 93.4 4.19 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.408 -0.807 . . . . 35.590000000000003 110.002 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' S' S ' 344' ' ' LYS . . . . . 0.407 ' O ' ' HB3' ' S' ' 348' ' ' HIS . 0.3 OUTLIER -80.85 125.02 29.58 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.26 -0.9 . . . . 38.340000000000003 110.109 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' S' S ' 345' ' ' GLY . . . . . . . . . . . . . . . 62.77 -130.87 43.13 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 108.821 -1.711 . . . . 53.460000000000001 108.821 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' S' S ' 346' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -132.68 150.84 52.1 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.326 -1.102 . . . . 70.909999999999997 110.037 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' S' S ' 347' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 53.27 35.39 19.98 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.353 -0.842 . . . . 47.32 110.433 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' S' S ' 348' ' ' HIS . . . . . 0.407 ' HB3' ' O ' ' S' ' 344' ' ' LYS . 46.5 t60 -150.08 155.94 40.76 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.329 -0.857 . . . . 41.719999999999999 110.303 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' S' S ' 349' ' ' ALA . . . . . 0.459 ' C ' HG13 ' S' ' 350' ' ' VAL . . . -149.88 151.25 33.15 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.326 -0.859 . . . . 22.91 110.441 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' S' S ' 350' ' ' VAL . . . . . 0.459 HG13 ' C ' ' S' ' 349' ' ' ALA . 34.6 m -149.1 169.64 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.514 -0.741 . . . . 21.09 110.023 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' S' S ' 351' ' ' PHE . . . . . 0.501 ' CD2' ' HB3' ' S' ' 258' ' ' GLN . 10.7 t80 -105.39 143.62 33.3 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.155 -0.966 . . . . 25.030000000000001 110.713 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' S' S ' 352' ' ' ALA . . . . . 0.494 ' HB3' ' CE2' ' S' ' 342' ' ' PHE . . . -147.79 151.71 36.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.667 -0.645 . . . . 23.809999999999999 109.715 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' S' S ' 353' ' ' CYS . . . . . . . . . . . . . 26.3 p -153.25 164.91 37.24 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.368 -0.832 . . . . 25.66 110.343 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' S' S ' 354' ' ' VAL . . . . . 0.543 HG22 ' CE2' ' S' ' 359' ' ' TRP . 56.5 t -76.05 118.53 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.361 -0.837 . . . . 34.270000000000003 109.98 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' S' S ' 355' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' S' ' 232' ' ' THR . 52.7 p -117.86 175.14 5.8 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.251 -0.905 . . . . 25.489999999999998 110.332 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' S' S ' 356' ' ' SER . . . . . . . . . . . . . 62.0 p -62.18 -17.72 58.89 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.345 -0.847 . . . . 31.239999999999998 110.71 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' S' S ' 357' ' ' ASN . . . . . . . . . . . . . 45.9 m-20 -107.01 14.22 26.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.201 -0.937 . . . . 28.609999999999999 110.611 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' S' S ' 358' ' ' GLY . . . . . . . . . . . . . . . 111.91 -152.98 17.58 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.984 -1.246 . . . . 22.010000000000002 109.984 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' S' S ' 359' ' ' TRP . . . . . 0.543 ' CE2' HG22 ' S' ' 354' ' ' VAL . 15.4 m95 -91.24 116.68 29.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.371 -1.076 . . . . 25.539999999999999 110.17 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' S' S ' 360' ' ' TYR . . . . . 0.413 ' HA ' ' HA ' ' S' ' 369' ' ' PRO . 1.3 m-85 -103.47 165.79 10.82 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.327 -0.858 . . . . 40.530000000000001 110.107 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' S' S ' 361' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' S' ' 351' ' ' PHE . . . -140.06 130.11 24.9 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.462 -0.774 . . . . 18.039999999999999 110.271 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' S' S ' 362' ' ' ILE . . . . . . . . . . . . . 88.8 mt -95.6 83.67 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.283 -0.885 . . . . 15.640000000000001 110.062 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' S' S ' 363' ' ' ASP . . . . . 0.418 ' O ' ' N ' ' S' ' 365' ' ' GLU . 11.9 t0 -75.25 94.47 3.0 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.298 -0.876 . . . . 35.030000000000001 110.213 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' S' S ' 364' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 53.88 -89.28 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.547 -0.721 . . . . 46.719999999999999 110.621 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' S' S ' 365' ' ' GLU . . . . . 0.418 ' N ' ' O ' ' S' ' 363' ' ' ASP . 23.8 mt-10 -122.7 19.15 10.3 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.091 -1.006 . . . . 56.200000000000003 110.267 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' S' S ' 366' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -117.97 124.99 49.54 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.17 -0.957 . . . . 51.020000000000003 110.421 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' S' S ' 367' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -107.0 127.08 53.13 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.435 -0.791 . . . . 37.590000000000003 110.133 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' S' S ' 368' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -165.47 159.46 13.82 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.229 -0.919 . . . . 31.469999999999999 110.414 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' S' S ' 369' ' ' PRO . . . . . 0.413 ' HA ' ' HA ' ' S' ' 360' ' ' TYR . 46.8 Cg_endo -72.68 139.62 31.19 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 O-C-N 123.903 1.475 . . . . 28.850000000000001 110.505 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' S' S ' 370' ' ' TRP . . . . . . . . . . . . . 67.6 t90 -167.21 113.49 0.76 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.405 -0.81 . . . . 26.940000000000001 110.008 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' S' S ' 371' ' ' THR . . . . . . . . . . . . . 59.8 m -74.78 113.08 20.99 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.317 -0.864 . . . . 20.190000000000001 110.025 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' S' S ' 372' ' ' PRO . . . . . 0.564 ' O ' HD11 ' S' ' 334' ' ' LEU . 48.0 Cg_endo -73.56 157.13 49.17 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.61 1.321 . . . . 28.68 110.609 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' S' S ' 373' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -90.58 147.14 35.73 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.444 -0.785 . . . . 35.719999999999999 109.922 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' S' S ' 374' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -76.0 -6.3 17.23 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 O-C-N 123.632 1.332 . . . . 30.890000000000001 110.502 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' S' S ' 375' ' ' SER . . . . . . . . . . . . . 68.6 p -104.36 -16.94 14.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.207 -0.933 . . . . 29.41 110.436 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' S' S ' 376' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -106.55 43.1 1.18 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.348 -0.845 . . . . 32.890000000000001 110.198 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' S' S ' 377' ' ' VAL . . . . . 0.593 ' O ' HG11 ' S' ' 327' ' ' VAL . 7.3 p -114.68 147.3 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.297 -0.877 . . . . 24.329999999999998 110.207 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' S' S ' 378' ' ' LEU . . . . . . . . . . . . . 52.7 mt -116.02 -58.0 2.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.354 -0.841 . . . . 24.370000000000001 109.626 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' S' S ' 379' ' ' VAL . . . . . 0.644 HG22 HG12 ' S' ' 326' ' ' VAL . 61.2 t -120.66 132.42 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.418 -0.801 . . . . 18.02 109.456 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' S' S ' 380' ' ' PHE . . . . . 0.46 ' CE1' ' HB2' ' S' ' 325' ' ' CYS . 14.4 p90 -142.59 173.89 11.13 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.399 -0.813 . . . . 29.350000000000001 110.614 -179.261 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' S' S ' 381' ' ' VAL . . . . . . . . . . . . . 57.7 t -120.01 107.29 40.06 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.523 -0.735 . . . . 16.34 109.453 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' S' S ' 382' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -71.2 145.62 49.4 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 O-C-N 123.611 1.322 . . . . 20.940000000000001 110.786 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' S' S ' 383' ' ' TYR . . . . . 0.401 ' CZ ' ' HB3' ' S' ' 338' ' ' HIS . 88.4 m-85 -61.1 -53.47 56.72 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.323 -0.861 . . . . 28.93 109.877 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' S' S ' 384' ' ' ASP . . . . . . . . . . . . . 1.5 t70 . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.356 -0.84 . . . . 47.030000000000001 110.357 -176.784 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' R' R ' 30' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 121.152 0.501 . . . . 43.359999999999999 110.212 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' R' R ' 31' ' ' LEU . . . . . . . . . . . . . 65.5 mt -134.88 140.63 45.94 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.337 -0.852 . . . . 22.93 110.269 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' R' R ' 32' ' ' THR . . . . . . . . . . . . . 70.6 m -87.61 110.64 20.53 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.33 -0.856 . . . . 22.34 109.9 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' R' R ' 33' ' ' LEU . . . . . 0.595 HD22 ' CE2' ' R' ' 62' ' ' TYR . 80.1 mt -62.45 -172.79 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.307 -0.87 . . . . 21.390000000000001 110.202 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' R' R ' 34' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -74.55 -29.54 61.4 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.355 -0.841 . . . . 34.399999999999999 110.388 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' R' R ' 35' ' ' ASN . . . . . . . . . . . . . 48.3 p30 -77.68 -1.87 33.25 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.348 -0.845 . . . . 30.280000000000001 110.637 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' R' R ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.21 -16.56 59.44 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.733 -1.347 . . . . 36.25 109.733 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' R' R ' 37' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -59.04 161.77 4.83 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.357 -1.084 . . . . 53.799999999999997 110.315 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' R' R ' 38' ' ' LYS . . . . . . . . . . . . . 56.9 mttt -117.78 135.81 53.81 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.426 -0.796 . . . . 49.909999999999997 110.132 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' R' R ' 39' ' ' LYS . . . . . 0.404 ' HG2' ' CZ ' ' R' ' 41' ' ' PHE . 8.1 ttmt -138.76 143.68 39.11 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.468 -0.77 . . . . 35.689999999999998 110.228 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' R' R ' 40' ' ' THR . . . . . . . . . . . . . 23.6 m -102.57 127.98 49.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.41 -0.806 . . . . 34.840000000000003 110.221 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' R' R ' 41' ' ' PHE . . . . . 0.404 ' CZ ' ' HG2' ' R' ' 39' ' ' LYS . 96.6 m-85 -113.02 132.75 55.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.442 -0.786 . . . . 34.420000000000002 110.11 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' R' R ' 42' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -93.3 140.85 29.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.336 -0.852 . . . . 51.460000000000001 110.284 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' R' R ' 43' ' ' SER . . . . . . . . . . . . . 54.3 m -70.82 141.91 51.32 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.412 -0.805 . . . . 41.840000000000003 110.217 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' R' R ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.71 125.4 29.56 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.303 -0.873 . . . . 33.82 110.012 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' R' R ' 45' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.12 151.09 55.01 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.59 1.31 . . . . 30.27 110.655 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' R' R ' 46' ' ' ASN . . . . . . . . . . . . . 52.0 t-20 -124.34 109.9 13.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.447 -0.783 . . . . 35.100000000000001 110.054 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' R' R ' 47' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -120.28 -34.88 3.56 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.311 -0.868 . . . . 42.810000000000002 110.54 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' R' R ' 48' ' ' HIS . . . . . 0.441 ' NE2' HD11 ' R' ' 80' ' ' LEU . 73.3 m80 -105.72 45.17 0.98 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.262 -0.899 . . . . 49.969999999999999 110.211 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' R' R ' 49' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 50.25 34.69 9.14 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.329 -0.857 . . . . 61.32 110.186 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' R' R ' 50' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -86.28 43.82 1.09 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.333 -0.854 . . . . 51.5 110.623 -179.539 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' R' R ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.14 -46.08 78.75 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.225 -0.922 . . . . 38.770000000000003 109.539 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' R' R ' 52' ' ' TRP . . . . . 0.484 ' CD2' ' N ' ' R' ' 53' ' ' LEU . 68.2 p-90 -58.41 -38.44 77.39 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.413 -0.805 . . . . 26.239999999999998 110.002 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' R' R ' 53' ' ' LEU . . . . . 0.484 ' N ' ' CD2' ' R' ' 52' ' ' TRP . 23.1 tp -66.73 -46.65 74.79 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.351 -0.843 . . . . 26.75 109.984 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' R' R ' 54' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -55.23 -41.65 72.36 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.354 -0.841 . . . . 35.020000000000003 110.113 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' R' R ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.14 -46.1 91.92 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.377 -0.827 . . . . 24.469999999999999 110.163 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' R' R ' 56' ' ' ILE . . . . . 0.432 HG12 HD11 ' R' ' 104' ' ' ILE . 76.1 mt -62.18 -42.23 94.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.332 -0.855 . . . . 26.030000000000001 109.888 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' R' R ' 57' ' ' LEU . . . . . . . . . . . . . 22.5 mt -60.36 -45.56 93.07 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.3 -0.875 . . . . 26.77 109.702 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' R' R ' 58' ' ' GLN . . . . . . . . . . . . . 57.7 mm-40 -63.91 -46.51 84.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.476 -0.765 . . . . 22.32 109.59 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' R' R ' 59' ' ' LEU . . . . . 0.431 ' HA ' ' HE2' ' R' ' 151' ' ' PHE . 24.0 tp -61.45 -37.75 84.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.291 -0.881 . . . . 20.550000000000001 109.396 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' R' R ' 60' ' ' PHE . . . . . 0.528 ' CE2' HD21 ' R' ' 111' ' ' LEU . 2.8 m-85 -61.13 -44.75 96.85 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.628 -0.67 . . . . 20.079999999999998 109.866 179.359 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' R' R ' 61' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -63.11 -36.19 82.78 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.49 -0.756 . . . . 18.800000000000001 110.442 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' R' R ' 62' ' ' TYR . . . . . 0.595 ' CE2' HD22 ' R' ' 33' ' ' LEU . 9.2 t80 -63.04 -41.8 99.58 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.271 -0.893 . . . . 26.449999999999999 110.26 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' R' R ' 63' ' ' VAL . . . . . 0.406 ' H ' HG22 ' R' ' 63' ' ' VAL . 30.0 m -93.34 20.33 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.263 -0.898 . . . . 29.75 110.307 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' R' R ' 64' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 52.96 75.5 0.24 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.328 -0.857 . . . . 35.520000000000003 110.51 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' R' R ' 65' ' ' GLU . . . . . 0.444 ' HG2' ' CD2' ' R' ' 60' ' ' PHE . 14.3 tp10 -116.17 104.09 52.5 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.423 -0.798 . . . . 29.890000000000001 109.944 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' R' R ' 66' ' ' PRO . . . . . 0.479 ' HA ' ' HB2' ' R' ' 69' ' ' ASP . 47.9 Cg_endo -73.46 -5.92 17.92 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.79 1.416 . . . . 21.370000000000001 111.147 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' R' R ' 67' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -52.1 -61.6 2.16 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.038 -1.039 . . . . 23.850000000000001 110.331 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' R' R ' 68' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -98.07 36.57 1.55 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.32 -0.862 . . . . 28.07 110.466 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' R' R ' 69' ' ' ASP . . . . . 0.479 ' HB2' ' HA ' ' R' ' 66' ' ' PRO . 11.7 t0 -72.33 -33.27 67.21 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.342 -0.849 . . . . 43.759999999999998 110.155 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' R' R ' 70' ' ' TRP . . . . . 0.475 ' CE2' ' CG2' ' R' ' 71' ' ' VAL . 47.7 p-90 -73.42 -3.91 30.33 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.334 -0.854 . . . . 33.060000000000002 110.717 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' R' R ' 71' ' ' VAL . . . . . 0.556 HG11 ' HB2' ' R' ' 82' ' ' ALA . 40.8 t -109.8 -27.47 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.112 -0.992 . . . . 31.699999999999999 109.659 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' R' R ' 72' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -86.56 -48.79 8.05 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.407 -0.808 . . . . 33.579999999999998 110.353 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' R' R ' 73' ' ' SER . . . . . . . . . . . . . 69.8 m -89.75 51.06 2.0 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.394 -0.816 . . . . 50.82 110.351 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' R' R ' 74' ' ' SER . . . . . . . . . . . . . 15.9 t -125.95 138.21 31.63 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.278 -0.889 . . . . 34.740000000000002 110.24 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -73.24 -25.01 16.19 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 O-C-N 123.728 1.383 . . . . 35.700000000000003 110.373 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' R' R ' 76' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -91.66 153.12 19.9 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.383 -0.823 . . . . 66.480000000000004 110.428 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' R' R ' 77' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -81.4 95.24 6.98 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.368 -0.832 . . . . 46.719999999999999 110.117 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' R' R ' 78' ' ' LEU . . . . . . . . . . . . . 96.4 mt -96.45 28.0 3.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.381 -0.825 . . . . 37.549999999999997 110.182 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' R' R ' 79' ' ' THR . . . . . . . . . . . . . 29.6 m -56.2 -54.64 42.82 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.337 -0.852 . . . . 37.359999999999999 110.295 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' R' R ' 80' ' ' LEU . . . . . 0.604 ' HA ' HD12 ' R' ' 83' ' ' ILE . 15.8 mt -60.95 -23.14 65.07 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.348 -0.845 . . . . 35.829999999999998 110.51 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' R' R ' 81' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -79.52 -39.14 32.68 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.133 -0.98 . . . . 44.030000000000001 110.381 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' R' R ' 82' ' ' ALA . . . . . 0.556 ' HB2' HG11 ' R' ' 71' ' ' VAL . . . -69.4 -28.7 66.4 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.26 -0.9 . . . . 32.539999999999999 110.303 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' R' R ' 83' ' ' ILE . . . . . 0.604 HD12 ' HA ' ' R' ' 80' ' ' LEU . 77.7 mt -70.09 -46.06 73.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.253 -0.905 . . . . 32.020000000000003 110.342 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' R' R ' 84' ' ' LYS . . . . . . . . . . . . . 36.0 tttm -55.22 -52.06 64.57 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.179 -0.951 . . . . 34.090000000000003 110.596 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' R' R ' 85' ' ' GLN . . . . . 0.532 ' HG2' HD12 ' R' ' 89' ' ' LEU . 31.9 tt0 -54.8 -46.86 74.54 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.191 -0.943 . . . . 25.940000000000001 110.305 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' R' R ' 86' ' ' LEU . . . . . . . . . . . . . 24.2 mt -58.71 -43.76 90.16 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.267 -0.896 . . . . 16.199999999999999 109.957 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' R' R ' 87' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -65.36 -35.27 80.45 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.393 -0.817 . . . . 49.090000000000003 110.305 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' R' R ' 88' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -78.4 -19.06 54.09 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.284 -0.885 . . . . 28.609999999999999 110.509 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' R' R ' 89' ' ' LEU . . . . . 0.532 HD12 ' HG2' ' R' ' 85' ' ' GLN . 32.4 mt -96.16 -29.43 14.06 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.225 -0.922 . . . . 26.16 110.2 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' R' R ' 90' ' ' THR . . . . . . . . . . . . . 59.9 p -105.77 -34.58 7.64 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.3 -0.875 . . . . 33.329999999999998 109.724 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' R' R ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.85 16.1 58.6 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.821 -1.312 . . . . 31.129999999999999 109.821 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' R' R ' 92' ' ' LEU . . . . . . . . . . . . . 97.1 mt -100.11 155.19 17.87 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.169 -1.195 . . . . 42.520000000000003 110.246 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' R' R ' 93' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -86.15 91.59 8.48 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.471 -0.768 . . . . 68.459999999999994 110.006 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' R' R ' 94' ' ' LEU . . . . . 0.457 ' HB3' ' CZ2' ' R' ' 52' ' ' TRP . 48.2 mt -99.41 53.08 0.95 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.176 -0.952 . . . . 44.630000000000003 110.364 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' R' R ' 95' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.52 -38.7 6.36 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.226 -0.921 . . . . 67.159999999999997 110.376 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' R' R ' 96' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -113.85 44.11 1.69 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.332 -0.855 . . . . 67.019999999999996 110.325 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' R' R ' 97' ' ' GLY . . . . . . . . . . . . . . . 99.24 150.83 25.99 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.599 -1.401 . . . . 49.479999999999997 109.599 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' R' R ' 98' ' ' GLY . . . . . . . . . . . . . . . -166.27 160.03 33.46 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.267 -1.533 . . . . 36.57 109.267 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' R' R ' 99' ' ' PRO . . . . . 0.791 ' O ' HG23 ' R' ' 103' ' ' VAL . 45.5 Cg_endo -72.57 121.11 7.14 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.74 1.39 . . . . 30.41 110.462 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' R' R ' 100' ' ' PRO . . . . . 0.413 ' HA ' HD11 ' R' ' 56' ' ' ILE . 45.7 Cg_endo -72.32 -31.52 11.46 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.637 1.335 . . . . 29.940000000000001 110.545 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' R' R ' 101' ' ' ALA . . . . . 0.475 ' HB2' ' HB3' ' R' ' 178' ' ' LEU . . . -70.07 -38.49 75.77 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.296 -0.878 . . . . 23.640000000000001 110.184 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' R' R ' 102' ' ' LEU . . . . . 0.427 HD23 HD21 ' R' ' 106' ' ' ASN . 0.1 OUTLIER -72.71 -40.66 66.0 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.335 -0.853 . . . . 20.309999999999999 110.411 -179.71 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' R' R ' 103' ' ' VAL . . . . . 0.791 HG23 ' O ' ' R' ' 99' ' ' PRO . 63.3 t -58.15 -40.13 76.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.227 -0.92 . . . . 16.329999999999998 109.986 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' R' R ' 104' ' ' ILE . . . . . 0.432 HD11 HG12 ' R' ' 56' ' ' ILE . 82.0 mt -71.72 -30.47 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.374 -0.829 . . . . 24.77 109.951 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' R' R ' 105' ' ' TRP . . . . . 0.462 ' O ' ' HD3' ' R' ' 108' ' ' LYS . 70.6 t-105 -82.44 0.81 40.5 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.304 -0.873 . . . . 23.280000000000001 110.273 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' R' R ' 106' ' ' ASN . . . . . 0.427 HD21 HD23 ' R' ' 102' ' ' LEU . 6.9 m-80 -105.05 -10.37 17.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.171 -0.956 . . . . 28.260000000000002 110.146 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' R' R ' 107' ' ' ILE . . . . . . . . . . . . . 36.8 pt -126.82 34.9 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.184 -0.947 . . . . 18.77 110.076 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' R' R ' 108' ' ' LYS . . . . . 0.5 ' HG2' ' HB ' ' R' ' 115' ' ' ILE . 9.2 mtpp -60.97 -48.5 81.52 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.516 -0.74 . . . . 42.5 110.06 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' R' R ' 109' ' ' HIS . . . . . 0.446 ' CD2' ' HG ' ' R' ' 110' ' ' LEU . 50.8 p-80 -66.02 -12.87 58.26 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.511 -0.743 . . . . 20.07 110.698 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' R' R ' 110' ' ' LEU . . . . . 0.446 ' HG ' ' CD2' ' R' ' 109' ' ' HIS . 80.5 mt -94.71 -17.38 22.27 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.042 -1.036 . . . . 15.69 110.194 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' R' R ' 111' ' ' LEU . . . . . 0.528 HD21 ' CE2' ' R' ' 60' ' ' PHE . 10.3 mt -94.09 144.17 25.72 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.368 -0.832 . . . . 25.390000000000001 111.016 -179.181 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' R' R ' 112' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -77.71 -17.35 57.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.552 -0.717 . . . . 53.479999999999997 109.835 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' R' R ' 113' ' ' THR . . . . . 0.458 HG22 ' N ' ' R' ' 114' ' ' GLY . 59.6 m -83.71 166.71 17.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.347 -0.846 . . . . 14.800000000000001 110.29 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' R' R ' 114' ' ' GLY . . . . . 0.458 ' N ' HG22 ' R' ' 113' ' ' THR . . . -97.98 127.16 9.13 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.947 -1.261 . . . . 16.140000000000001 109.947 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' R' R ' 115' ' ' ILE . . . . . 0.576 HD13 ' HB ' ' R' ' 124' ' ' VAL . 47.7 mm -109.17 139.36 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.525 -0.985 . . . . 13.460000000000001 109.725 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' R' R ' 116' ' ' GLY . . . . . . . . . . . . . . . -152.72 -155.87 7.29 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.933 -1.267 . . . . 23.899999999999999 109.933 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' R' R ' 117' ' ' THR . . . . . 0.529 HG22 ' CG2' ' R' ' 126' ' ' VAL . 18.9 p -135.03 -171.36 2.78 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.484 -1.01 . . . . 27.370000000000001 110.072 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' R' R ' 118' ' ' ALA . . . . . 0.445 ' HB3' ' OD1' ' R' ' 128' ' ' ASP . . . -56.6 -58.04 9.77 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.297 -0.877 . . . . 18.760000000000002 110.064 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' R' R ' 119' ' ' SER . . . . . 0.461 ' HA ' ' CB ' ' R' ' 194' ' ' ALA . 1.1 m -56.56 -40.56 75.37 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.266 -0.896 . . . . 32.350000000000001 109.787 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' R' R ' 120' ' ' ARG . . . . . 0.419 ' NH1' ' CE2' ' S' ' 305' ' ' TRP . 10.0 mtm180 -110.08 86.23 4.87 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.487 -0.758 . . . . 27.120000000000001 109.673 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' R' R ' 121' ' ' PRO . . . . . 0.483 ' HA ' ' SG ' ' R' ' 125' ' ' CYS . 44.3 Cg_endo -71.24 166.41 29.32 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.874 1.46 . . . . 22.68 111.03 -179.481 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' R' R ' 122' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' R' ' 121' ' ' PRO . 38.5 t 178.61 -161.64 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.61 -0.681 . . . . 22.989999999999998 109.513 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' R' R ' 123' ' ' GLU . . . . . 0.442 ' HG2' HG23 ' R' ' 113' ' ' THR . 2.3 tp10 -56.45 -39.95 74.0 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.211 -0.93 . . . . 36.18 109.762 179.574 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' R' R ' 124' ' ' VAL . . . . . 0.576 ' HB ' HD13 ' R' ' 115' ' ' ILE . 84.6 t -142.55 136.48 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.534 -0.729 . . . . 20.640000000000001 109.43 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' R' R ' 125' ' ' CYS . . . . . 0.483 ' SG ' ' HA ' ' R' ' 121' ' ' PRO . 82.9 m -140.31 168.2 20.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.161 -0.962 . . . . 22.800000000000001 111.136 -179.254 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' R' R ' 126' ' ' VAL . . . . . 0.728 HG12 HG22 ' R' ' 179' ' ' VAL . 35.9 m -122.74 159.8 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.714 -0.616 . . . . 21.239999999999998 109.664 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' R' R ' 127' ' ' VAL . . . . . 0.709 HG11 ' O ' ' R' ' 177' ' ' VAL . 30.7 m -70.86 141.82 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.293 -0.879 . . . . 19.77 110.657 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' R' R ' 128' ' ' ASP . . . . . 0.445 ' OD1' ' HB3' ' R' ' 118' ' ' ALA . 53.9 p-10 -137.73 19.38 2.87 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.327 -0.858 . . . . 29.210000000000001 110.687 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' R' R ' 129' ' ' GLY . . . . . . . . . . . . . . . 114.11 0.0 23.98 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.965 -1.112 . . . . 33.859999999999999 110.469 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' R' R ' 130' ' ' THR . . . . . . . . . . . . . 58.6 m -91.93 131.85 36.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.105 -1.233 . . . . 26.41 110.046 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -62.56 120.65 11.56 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.38 -0.825 . . . . 33.079999999999998 110.302 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' R' R ' 132' ' ' MET . . . . . 0.434 ' HE1' ' CE2' ' R' ' 180' ' ' PHE . 98.4 mmm -105.21 165.66 10.94 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.395 -0.816 . . . . 30.760000000000002 110.435 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' R' R ' 133' ' ' CYS . . . . . 0.411 ' HA ' ' HB3' ' R' ' 174' ' ' PRO . 32.5 m -141.17 158.12 44.33 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.493 -0.754 . . . . 27.0 109.969 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' R' R ' 134' ' ' LEU . . . . . 0.563 HD11 ' O ' ' R' ' 172' ' ' PRO . 0.1 OUTLIER -58.54 -19.68 39.82 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.347 -0.846 . . . . 33.899999999999999 110.444 -179.833 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' R' R ' 135' ' ' ALA . . . . . . . . . . . . . . . -92.72 8.2 40.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.182 -0.949 . . . . 19.370000000000001 110.882 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' R' R ' 136' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -93.76 -21.74 19.13 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.143 -0.973 . . . . 30.469999999999999 110.266 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' R' R ' 137' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -149.98 165.38 32.85 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.341 -0.85 . . . . 24.27 110.204 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' R' R ' 138' ' ' HIS . . . . . 0.434 ' HA ' HG23 ' R' ' 154' ' ' VAL . 15.1 p80 -117.87 15.2 14.33 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.398 -0.814 . . . . 20.91 110.404 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' R' R ' 139' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' R' ' 152' ' ' ALA . . . -177.23 152.35 0.86 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.198 -0.939 . . . . 15.69 110.184 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' R' R ' 140' ' ' GLY . . . . . 0.427 ' HA3' ' O ' ' R' ' 179' ' ' VAL . . . 161.81 175.15 32.53 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.928 -1.269 . . . . 23.760000000000002 109.928 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' R' R ' 141' ' ' ILE . . . . . . . . . . . . . 83.7 mt -95.51 136.56 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.358 -1.084 . . . . 25.300000000000001 109.713 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' R' R ' 142' ' ' PHE . . . . . 0.576 ' CD2' ' HB2' ' R' ' 172' ' ' PRO . 83.0 m-85 -120.73 -172.52 2.4 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.375 -0.828 . . . . 30.239999999999998 110.528 -179.478 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' R' R ' 143' ' ' LEU . . . . . 0.741 HD23 ' O ' ' R' ' 148' ' ' HIS . 0.5 OUTLIER -119.86 77.73 1.26 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.417 -0.802 . . . . 32.799999999999997 110.289 -179.902 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' R' R ' 144' ' ' LYS . . . . . 0.471 ' HG3' ' CZ2' ' R' ' 170' ' ' TRP . 1.0 OUTLIER -69.5 76.82 0.41 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.437 -0.789 . . . . 49.18 109.676 179.575 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' R' R ' 145' ' ' GLY . . . . . 0.457 ' O ' HD22 ' R' ' 143' ' ' LEU . . . 104.48 179.24 24.86 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.203 -1.559 . . . . 53.869999999999997 109.203 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' R' R ' 146' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -88.47 145.85 25.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.358 -1.083 . . . . 68.579999999999998 109.982 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' R' R ' 147' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 58.21 36.47 25.78 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.26 -0.9 . . . . 56.619999999999997 110.665 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' R' R ' 148' ' ' HIS . . . . . 0.741 ' O ' HD23 ' R' ' 143' ' ' LEU . 44.6 t60 -158.61 148.17 19.31 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.193 -0.942 . . . . 44.57 110.376 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' R' R ' 149' ' ' ALA . . . . . . . . . . . . . . . -150.29 146.92 27.06 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.427 -0.796 . . . . 33.539999999999999 110.078 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' R' R ' 150' ' ' VAL . . . . . . . . . . . . . 34.2 m -142.38 161.47 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.234 -0.916 . . . . 27.609999999999999 110.301 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' R' R ' 151' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' R' ' 152' ' ' ALA . 5.9 t80 -86.18 155.57 20.68 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.402 -0.811 . . . . 23.039999999999999 109.918 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' R' R ' 152' ' ' ALA . . . . . 0.537 ' N ' ' CD1' ' R' ' 151' ' ' PHE . . . -157.28 151.57 24.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.438 -0.789 . . . . 29.609999999999999 109.601 179.011 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' R' R ' 153' ' ' CYS . . . . . . . . . . . . . 26.7 p -154.28 173.61 15.93 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.268 -0.895 . . . . 22.75 110.407 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' R' R ' 154' ' ' VAL . . . . . 0.613 HG22 ' CE2' ' R' ' 159' ' ' TRP . 60.3 t -90.63 117.03 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.383 -0.823 . . . . 23.260000000000002 110.061 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' R' R ' 155' ' ' THR . . . . . . . . . . . . . 70.3 p -112.13 -176.62 2.97 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.356 -0.84 . . . . 17.879999999999999 110.041 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' R' R ' 156' ' ' SER . . . . . . . . . . . . . 78.5 p -75.92 -3.74 37.08 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.33 -0.856 . . . . 21.829999999999998 110.678 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' R' R ' 157' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -118.3 10.51 12.83 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.207 -0.933 . . . . 36.539999999999999 110.652 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' R' R ' 158' ' ' GLY . . . . . . . . . . . . . . . 117.96 -162.58 13.06 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.559 -1.416 . . . . 31.739999999999998 109.559 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' R' R ' 159' ' ' TRP . . . . . 0.613 ' CE2' HG22 ' R' ' 154' ' ' VAL . 14.6 m95 -86.68 122.5 30.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.35 -1.088 . . . . 28.25 110.109 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' R' R ' 160' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -108.46 166.94 10.39 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.345 -0.847 . . . . 41.240000000000002 110.19 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' R' R ' 161' ' ' ALA . . . . . . . . . . . . . . . -143.18 123.5 13.84 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.403 -0.81 . . . . 27.399999999999999 110.151 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' R' R ' 162' ' ' ILE . . . . . . . . . . . . . 92.2 mt -87.63 81.11 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.373 -0.829 . . . . 24.27 110.078 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' R' R ' 163' ' ' ASP . . . . . 0.415 ' O ' ' N ' ' R' ' 165' ' ' GLU . 15.3 t0 -72.74 92.35 1.55 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.389 -0.819 . . . . 36.079999999999998 110.277 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' R' R ' 164' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 54.06 -88.89 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.526 -0.734 . . . . 46.079999999999998 110.556 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' R' R ' 165' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' R' ' 163' ' ' ASP . 29.6 mt-10 -124.72 35.82 4.72 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.151 -0.968 . . . . 50.939999999999998 110.148 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' R' R ' 166' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -135.67 117.36 14.99 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.362 -0.836 . . . . 47.280000000000001 110.353 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' R' R ' 167' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -101.12 119.96 39.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.401 -0.812 . . . . 40.469999999999999 110.083 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' R' R ' 168' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -157.51 158.61 30.74 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.25 -0.906 . . . . 30.210000000000001 110.466 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' R' R ' 169' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.81 133.07 19.48 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.928 1.488 . . . . 32.759999999999998 110.5 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' R' R ' 170' ' ' TRP . . . . . 0.471 ' CZ2' ' HG3' ' R' ' 144' ' ' LYS . 67.1 t90 -159.83 119.35 2.88 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.34 -0.85 . . . . 32.789999999999999 109.965 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' R' R ' 171' ' ' THR . . . . . . . . . . . . . 46.9 m -81.09 112.58 33.91 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.431 -0.793 . . . . 36.920000000000002 110.155 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' R' R ' 172' ' ' PRO . . . . . 0.576 ' HB2' ' CD2' ' R' ' 142' ' ' PHE . 47.0 Cg_endo -73.67 158.76 46.79 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.622 1.328 . . . . 33.539999999999999 110.548 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' R' R ' 173' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -88.91 145.03 33.81 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.324 -0.86 . . . . 45.759999999999998 109.86 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' R' R ' 174' ' ' PRO . . . . . 0.411 ' HB3' ' HA ' ' R' ' 133' ' ' CYS . 45.2 Cg_endo -71.85 -10.28 26.07 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 O-C-N 123.71 1.374 . . . . 29.629999999999999 110.41 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' R' R ' 175' ' ' SER . . . . . . . . . . . . . 53.0 p -103.44 -17.64 15.15 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.348 -0.845 . . . . 35.700000000000003 110.366 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' R' R ' 176' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -103.51 43.29 1.09 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.268 -0.895 . . . . 39.649999999999999 110.418 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' R' R ' 177' ' ' VAL . . . . . 0.709 ' O ' HG11 ' R' ' 127' ' ' VAL . 10.7 p -117.72 127.06 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.3 -0.875 . . . . 20.609999999999999 110.094 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' R' R ' 178' ' ' LEU . . . . . 0.475 ' HB3' ' HB2' ' R' ' 101' ' ' ALA . 46.2 mt -91.42 -61.3 1.68 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.349 -0.845 . . . . 15.58 109.392 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' R' R ' 179' ' ' VAL . . . . . 0.728 HG22 HG12 ' R' ' 126' ' ' VAL . 68.6 t -114.64 144.76 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.561 -0.712 . . . . 17.399999999999999 109.384 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' R' R ' 180' ' ' PHE . . . . . 0.434 ' CE2' ' HE1' ' R' ' 132' ' ' MET . 43.6 p90 -152.15 163.36 39.54 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.197 -0.94 . . . . 20.16 110.63 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' R' R ' 181' ' ' VAL . . . . . . . . . . . . . 66.2 t -113.17 111.44 50.27 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.375 -0.828 . . . . 17.690000000000001 109.836 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' R' R ' 182' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.03 149.49 52.84 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.532 1.28 . . . . 17.809999999999999 110.409 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' R' R ' 183' ' ' TYR . . . . . 0.712 ' O ' ' C ' ' R' ' 184' ' ' ASP . 79.1 m-85 -59.03 175.52 0.28 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.458 -0.776 . . . . 28.010000000000002 110.504 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' R' R ' 184' ' ' ASP . . . . . 0.712 ' C ' ' O ' ' R' ' 183' ' ' TYR . 15.0 t70 -17.26 -81.98 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.353 -0.842 . . . . 58.640000000000001 110.313 -178.083 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' R' R ' 185' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 . . . . . 0 N--CA 1.503 2.2 0 CA-C-O 121.277 0.56 . . . . 80.420000000000002 111.791 179.553 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' R' R ' 193' ' ' LYS . . . . . . . . . . . . . 26.8 tptt . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 120.907 0.384 . . . . 49.5 110.145 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' R' R ' 194' ' ' ALA . . . . . 0.461 ' CB ' ' HA ' ' R' ' 119' ' ' SER . . . . . . . . 0 N--CA 1.496 1.835 0 O-C-N 121.12 -0.988 . . . . 40.399999999999999 110.082 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 229' ' ' MET . . . . . . . . . . . . . 15.9 mmm . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.231 0.539 . . . . 51.829999999999998 110.228 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' S' S ' 230' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -97.31 142.76 28.8 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.292 -0.88 . . . . 54.130000000000003 110.133 -178.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 231' ' ' LEU . . . . . . . . . . . . . 68.3 mt -134.13 141.05 46.97 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.306 -0.871 . . . . 33.039999999999999 110.372 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 232' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' S' ' 355' ' ' THR . 40.3 m -89.28 103.25 15.89 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.362 -0.836 . . . . 26.920000000000002 110.0 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' S' S ' 233' ' ' LEU . . . . . 0.667 HD22 ' CE2' ' S' ' 262' ' ' TYR . 79.7 mt -55.88 179.3 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.418 -0.801 . . . . 13.779999999999999 110.493 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' S' S ' 234' ' ' TYR . . . . . 0.448 ' CG ' ' N ' ' S' ' 235' ' ' ASN . 35.5 p90 -64.96 -35.73 82.13 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.453 -0.779 . . . . 26.079999999999998 110.213 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' S' S ' 235' ' ' ASN . . . . . 0.448 ' N ' ' CG ' ' S' ' 234' ' ' TYR . 50.7 p30 -74.29 -7.42 52.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.289 -0.882 . . . . 20.039999999999999 110.601 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' S' S ' 236' ' ' GLY . . . . . . . . . . . . . . . 95.74 -19.91 52.21 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.748 -1.341 . . . . 22.710000000000001 109.748 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 237' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -53.08 145.74 12.65 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.243 -1.151 . . . . 35.439999999999998 110.165 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 238' ' ' LYS . . . . . . . . . . . . . 44.5 mttt -102.15 127.97 48.84 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.391 -0.818 . . . . 32.560000000000002 110.337 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 239' ' ' LYS . . . . . 0.414 ' HG2' ' CZ ' ' S' ' 241' ' ' PHE . 9.0 ttmt -132.29 144.49 50.63 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.391 -0.818 . . . . 26.68 109.949 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' S' S ' 240' ' ' THR . . . . . . . . . . . . . 51.3 m -102.06 132.2 48.07 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.329 -0.857 . . . . 41.020000000000003 110.39 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 241' ' ' PHE . . . . . 0.414 ' CZ ' ' HG2' ' S' ' 239' ' ' LYS . 96.1 m-85 -117.88 137.72 52.6 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.364 -0.835 . . . . 28.620000000000001 110.195 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' S' S ' 242' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -96.44 161.83 13.75 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.365 -0.835 . . . . 47.890000000000001 110.163 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 243' ' ' SER . . . . . . . . . . . . . 72.4 m -90.59 151.58 21.25 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.295 -0.878 . . . . 45.090000000000003 110.241 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 244' ' ' ARG . . . . . . . . . . . . . 1.4 mtp85 -129.81 126.75 22.69 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.402 -0.811 . . . . 42.490000000000002 110.162 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 245' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.37 161.05 43.57 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 O-C-N 123.666 1.351 . . . . 35.68 110.503 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 246' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -132.94 97.88 4.14 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.391 -0.818 . . . . 51.880000000000003 109.82 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 247' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -110.5 -22.23 11.77 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.4 -0.813 . . . . 53.689999999999998 110.643 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 248' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -117.21 43.63 2.28 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.178 -0.951 . . . . 55.789999999999999 110.774 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 249' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 48.77 38.43 11.79 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.443 -0.785 . . . . 49.450000000000003 110.381 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 250' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -90.62 29.07 1.36 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.521 -0.737 . . . . 36.859999999999999 110.31 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 251' ' ' ALA . . . . . . . . . . . . . . . -53.9 -43.13 69.42 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.322 -0.861 . . . . 29.690000000000001 109.56 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 252' ' ' TRP . . . . . 0.42 ' CZ2' ' HB3' ' S' ' 294' ' ' LEU . 67.8 p-90 -61.83 -33.97 75.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.556 -0.715 . . . . 41.119999999999997 109.832 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' S' S ' 253' ' ' LEU . . . . . 0.407 ' N ' ' CD2' ' S' ' 252' ' ' TRP . 23.3 tp -70.11 -47.14 63.07 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.335 -0.853 . . . . 24.890000000000001 110.002 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' S' S ' 254' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -56.23 -42.51 77.41 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.326 -0.859 . . . . 35.649999999999999 109.909 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 255' ' ' ALA . . . . . . . . . . . . . . . -59.47 -48.13 82.83 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.402 -0.811 . . . . 22.73 110.115 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 256' ' ' ILE . . . . . 0.505 HG12 HD11 ' S' ' 304' ' ' ILE . 79.9 mt -62.31 -40.72 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.326 -0.858 . . . . 28.850000000000001 109.986 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' S' S ' 257' ' ' LEU . . . . . . . . . . . . . 19.1 mt -61.49 -44.52 96.92 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.405 -0.809 . . . . 23.07 110.186 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 258' ' ' GLN . . . . . 0.502 ' HB3' ' CD2' ' S' ' 351' ' ' PHE . 53.5 mm-40 -65.04 -45.3 85.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.402 -0.811 . . . . 29.780000000000001 109.993 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' S' S ' 259' ' ' LEU . . . . . 0.415 ' O ' HG22 ' S' ' 263' ' ' VAL . 20.0 tp -58.71 -36.41 74.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.236 -0.915 . . . . 17.940000000000001 109.453 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' S' S ' 260' ' ' PHE . . . . . 0.521 ' CE2' HD21 ' S' ' 311' ' ' LEU . 3.1 m-85 -62.77 -45.35 93.07 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.624 -0.673 . . . . 30.57 109.857 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' S' S ' 261' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -62.01 -29.8 70.52 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.432 -0.792 . . . . 41.340000000000003 109.98 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 262' ' ' TYR . . . . . 0.667 ' CE2' HD22 ' S' ' 233' ' ' LEU . 8.7 t80 -71.15 -44.68 65.06 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.415 -0.803 . . . . 26.030000000000001 110.102 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' S' S ' 263' ' ' VAL . . . . . 0.415 HG22 ' O ' ' S' ' 259' ' ' LEU . 33.0 m -91.93 18.19 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.293 -0.88 . . . . 22.800000000000001 110.403 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' S' S ' 264' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 52.75 70.71 0.55 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.26 -0.9 . . . . 44.030000000000001 110.586 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 265' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -111.79 109.17 55.5 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.332 -0.855 . . . . 35.609999999999999 109.716 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 266' ' ' PRO . . . . . 0.479 ' HA ' ' HB2' ' S' ' 269' ' ' ASP . 49.9 Cg_endo -75.33 0.48 8.99 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 O-C-N 123.637 1.335 . . . . 37.670000000000002 111.768 -179.114 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' S' S ' 267' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -56.58 -67.71 0.28 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.797 -1.189 . . . . 41.490000000000002 110.18 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' S' S ' 268' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -92.81 39.83 1.04 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.177 -0.952 . . . . 50.759999999999998 110.124 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 269' ' ' ASP . . . . . 0.479 ' HB2' ' HA ' ' S' ' 266' ' ' PRO . 0.9 OUTLIER -75.99 -33.21 59.72 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.424 -0.798 . . . . 61.859999999999999 109.806 179.559 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' S' S ' 270' ' ' TRP . . . . . 0.514 ' CE2' HG23 ' S' ' 271' ' ' VAL . 50.9 p-90 -73.9 -4.35 34.5 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.279 -0.888 . . . . 39.850000000000001 110.5 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' S' S ' 271' ' ' VAL . . . . . 0.514 HG23 ' CE2' ' S' ' 270' ' ' TRP . 46.5 t -109.49 -32.68 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.15 -0.969 . . . . 39.18 110.088 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' S' S ' 272' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -78.68 -36.53 43.56 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.443 -0.786 . . . . 40.020000000000003 110.489 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 273' ' ' SER . . . . . . . . . . . . . 71.0 m -103.53 56.07 0.74 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.292 -0.88 . . . . 47.200000000000003 110.314 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 274' ' ' SER . . . . . . . . . . . . . 6.9 t -133.01 141.24 40.23 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.317 -0.865 . . . . 47.609999999999999 110.159 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 275' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.72 -18.92 21.78 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 123.678 1.357 . . . . 45.280000000000001 110.526 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 276' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -99.98 140.9 33.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.246 -0.909 . . . . 57.270000000000003 110.299 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 277' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -71.7 97.67 1.79 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.355 -0.841 . . . . 37.280000000000001 110.284 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 278' ' ' LEU . . . . . . . . . . . . . 86.4 mt -96.99 33.8 1.84 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.441 -0.787 . . . . 43.880000000000003 110.014 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 279' ' ' THR . . . . . . . . . . . . . 76.9 m -64.02 -60.23 3.5 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.457 -0.777 . . . . 50.049999999999997 110.203 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 280' ' ' LEU . . . . . 0.743 ' HA ' HD12 ' S' ' 283' ' ' ILE . 13.7 mt -51.53 -39.87 58.55 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.343 -0.848 . . . . 54.119999999999997 110.316 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' S' S ' 281' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.39 -49.71 74.44 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.457 -0.777 . . . . 65.280000000000001 110.178 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' S' S ' 282' ' ' ALA . . . . . . . . . . . . . . . -58.88 -33.98 71.12 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.514 -0.741 . . . . 46.509999999999998 110.557 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 283' ' ' ILE . . . . . 0.743 HD12 ' HA ' ' S' ' 280' ' ' LEU . 85.9 mt -66.37 -50.86 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.328 -0.857 . . . . 47.299999999999997 110.101 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' S' S ' 284' ' ' LYS . . . . . . . . . . . . . 33.6 tttp -50.46 -57.68 7.48 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.422 -0.799 . . . . 50.719999999999999 110.381 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 285' ' ' GLN . . . . . 0.535 ' HG2' HD12 ' S' ' 289' ' ' LEU . 34.3 tt0 -51.31 -46.5 62.58 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.494 -0.754 . . . . 68.469999999999999 110.312 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' S' S ' 286' ' ' LEU . . . . . . . . . . . . . 19.1 mt -59.89 -44.5 94.2 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.379 -0.825 . . . . 36.619999999999997 110.3 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 287' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -62.81 -35.26 79.33 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.319 -0.863 . . . . 46.640000000000001 110.043 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 288' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -76.17 -21.11 56.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.405 -0.809 . . . . 46.450000000000003 110.381 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 289' ' ' LEU . . . . . 0.535 HD12 ' HG2' ' S' ' 285' ' ' GLN . 30.8 mt -97.26 -21.76 17.07 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.244 -0.91 . . . . 35.090000000000003 110.582 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' S' S ' 290' ' ' THR . . . . . 0.413 HG22 ' HB3' ' S' ' 306' ' ' ASN . 81.5 p -114.76 -28.52 7.06 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.25 -0.906 . . . . 38.609999999999999 110.429 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' S' S ' 291' ' ' GLY . . . . . . . . . . . . . . . 79.38 11.11 85.27 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.789 -1.324 . . . . 36.770000000000003 109.789 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 292' ' ' LEU . . . . . . . . . . . . . 84.5 mt -96.48 145.76 25.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.336 -1.096 . . . . 35.329999999999998 109.77 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 293' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -77.3 102.33 6.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.222 -0.923 . . . . 48.700000000000003 110.316 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 294' ' ' LEU . . . . . 0.42 ' HB3' ' CZ2' ' S' ' 252' ' ' TRP . 55.4 mt -106.86 51.7 0.74 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.503 -0.748 . . . . 42.609999999999999 110.136 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' S' S ' 295' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -112.48 -11.2 13.65 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.377 -0.827 . . . . 55.490000000000002 110.498 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' S' S ' 296' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -144.29 48.45 1.37 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.059 -1.025 . . . . 75.680000000000007 110.338 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 297' ' ' GLY . . . . . . . . . . . . . . . 96.91 145.12 18.6 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.48 -1.448 . . . . 49.439999999999998 109.48 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 298' ' ' GLY . . . . . . . . . . . . . . . -163.79 156.93 29.01 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.775 -1.33 . . . . 41.109999999999999 109.775 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 299' ' ' PRO . . . . . 0.488 ' O ' HG23 ' S' ' 303' ' ' VAL . 46.6 Cg_endo -73.8 118.3 5.39 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 O-C-N 123.992 1.522 . . . . 26.199999999999999 110.277 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' S' S ' 300' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.21 -15.56 31.76 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 O-C-N 123.616 1.324 . . . . 21.699999999999999 110.692 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 301' ' ' ALA . . . . . . . . . . . . . . . -80.65 -29.36 36.69 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.175 -0.953 . . . . 31.23 110.133 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 302' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.43 -40.64 19.05 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.503 -0.748 . . . . 38.990000000000002 109.975 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' S' S ' 303' ' ' VAL . . . . . 0.488 HG23 ' O ' ' S' ' 299' ' ' PRO . 58.2 t -60.7 -35.46 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.435 -0.791 . . . . 18.629999999999999 110.177 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' S' S ' 304' ' ' ILE . . . . . 0.513 HD12 HG21 ' S' ' 379' ' ' VAL . 86.1 mt -79.43 -23.56 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.423 -0.798 . . . . 25.460000000000001 110.19 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' S' S ' 305' ' ' TRP . . . . . 0.419 ' CE2' ' NH1' ' R' ' 120' ' ' ARG . 68.8 t-105 -88.65 -14.52 37.21 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.224 -0.923 . . . . 33.399999999999999 110.581 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' S' S ' 306' ' ' ASN . . . . . 0.413 ' HB3' HG22 ' S' ' 290' ' ' THR . 10.4 m-80 -89.76 -13.52 36.54 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.142 -0.974 . . . . 36.969999999999999 110.399 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' S' S ' 307' ' ' ILE . . . . . 0.457 HG12 ' O ' ' S' ' 303' ' ' VAL . 36.8 pt -125.05 45.71 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.164 -0.96 . . . . 30.809999999999999 110.071 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' S' S ' 308' ' ' LYS . . . . . 0.419 ' HD3' ' CD2' ' S' ' 305' ' ' TRP . 1.5 mtmp? -73.59 -37.75 65.36 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.378 -0.826 . . . . 46.520000000000003 110.077 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' S' S ' 309' ' ' HIS . . . . . 0.496 ' CD2' ' HG ' ' S' ' 310' ' ' LEU . 55.5 p-80 -73.17 -8.28 55.08 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.35 -0.844 . . . . 51.030000000000001 110.161 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' S' S ' 310' ' ' LEU . . . . . 0.496 ' HG ' ' CD2' ' S' ' 309' ' ' HIS . 53.0 mt -99.32 -12.92 19.89 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.347 -0.845 . . . . 36.159999999999997 109.943 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' S' S ' 311' ' ' LEU . . . . . 0.521 HD21 ' CE2' ' S' ' 260' ' ' PHE . 10.8 mt -97.12 147.85 23.64 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.381 -0.824 . . . . 40.0 110.429 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' S' S ' 312' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -81.59 -16.32 51.97 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.322 -0.861 . . . . 54.18 109.748 179.129 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 313' ' ' THR . . . . . 0.829 HG23 ' HG2' ' S' ' 323' ' ' GLU . 92.9 m -87.94 151.66 22.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.337 -0.852 . . . . 25.609999999999999 110.115 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' S' S ' 314' ' ' GLY . . . . . . . . . . . . . . . -87.95 126.38 8.04 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.768 -1.333 . . . . 25.18 109.768 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 315' ' ' ILE . . . . . 0.647 HD13 ' HB ' ' S' ' 324' ' ' VAL . 50.7 mm -101.66 150.48 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.441 -1.034 . . . . 23.899999999999999 109.725 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' S' S ' 316' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' S' ' 325' ' ' CYS . . . -157.04 -159.31 9.4 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.931 -1.268 . . . . 23.18 109.931 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' S' S ' 317' ' ' THR . . . . . 0.424 HG22 ' CG2' ' S' ' 326' ' ' VAL . 11.2 p -133.9 -172.98 3.12 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.468 -1.019 . . . . 27.98 110.044 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' S' S ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.59 -56.19 25.06 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.163 -0.961 . . . . 28.100000000000001 109.874 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 319' ' ' SER . . . . . . . . . . . . . 1.2 m -59.93 -41.63 92.19 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.326 -0.859 . . . . 37.0 109.663 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 320' ' ' ARG . . . . . . . . . . . . . 12.1 mtm180 -111.73 79.8 2.64 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.466 -0.771 . . . . 52.07 109.655 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 321' ' ' PRO . . . . . 0.436 ' O ' ' HB2' ' S' ' 322' ' ' SER . 44.4 Cg_endo -71.38 171.51 16.01 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.783 1.412 . . . . 38.289999999999999 110.979 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' S' S ' 322' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' S' ' 321' ' ' PRO . 41.3 t 178.67 -148.15 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.956 -0.757 . . . . 38.840000000000003 108.956 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' S' S ' 323' ' ' GLU . . . . . 0.829 ' HG2' HG23 ' S' ' 313' ' ' THR . 6.7 tp10 -62.87 -40.29 97.05 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.043 -1.036 . . . . 40.700000000000003 109.64 179.301 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' S' S ' 324' ' ' VAL . . . . . 0.647 ' HB ' HD13 ' S' ' 315' ' ' ILE . 73.6 t -141.27 134.99 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.35 -0.844 . . . . 20.34 109.469 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' S' S ' 325' ' ' CYS . . . . . 0.471 ' HB2' ' CE1' ' S' ' 380' ' ' PHE . 11.1 m -125.99 172.26 10.09 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.312 -0.868 . . . . 30.629999999999999 110.924 -179.173 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' S' S ' 326' ' ' VAL . . . . . 0.646 HG12 HG22 ' S' ' 379' ' ' VAL . 34.5 m -135.56 142.16 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 109.175 -0.676 . . . . 23.899999999999999 109.175 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' S' S ' 327' ' ' VAL . . . . . 0.595 HG11 ' O ' ' S' ' 377' ' ' VAL . 34.6 m -56.37 125.02 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.112 -0.992 . . . . 19.48 110.39 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' S' S ' 328' ' ' ASP . . . . . . . . . . . . . 55.7 p-10 -119.4 11.61 12.23 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.418 -0.801 . . . . 26.43 110.439 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 329' ' ' GLY . . . . . . . . . . . . . . . 119.59 2.3 13.17 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.068 -1.213 . . . . 31.239999999999998 110.068 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 330' ' ' THR . . . . . . . . . . . . . 81.0 m -92.97 129.94 38.71 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.101 -1.235 . . . . 30.050000000000001 110.133 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 331' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -56.77 111.5 1.04 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.302 -0.873 . . . . 37.259999999999998 109.992 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 332' ' ' MET . . . . . . . . . . . . . 87.9 mmm -94.08 162.58 13.82 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.235 -0.915 . . . . 26.23 110.334 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 333' ' ' CYS . . . . . . . . . . . . . 26.4 m -137.15 150.05 47.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.42 -0.8 . . . . 23.559999999999999 110.078 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 334' ' ' LEU . . . . . 0.565 HD11 ' O ' ' S' ' 372' ' ' PRO . 0.1 OUTLIER -52.6 -24.9 9.18 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.228 -0.92 . . . . 28.93 110.508 179.833 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' S' S ' 335' ' ' ALA . . . . . . . . . . . . . . . -89.02 14.45 10.58 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.319 -0.863 . . . . 15.76 110.964 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 336' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -100.49 -17.15 17.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.134 -0.979 . . . . 34.920000000000002 110.214 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 337' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -152.42 170.81 19.21 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.39 -0.819 . . . . 19.030000000000001 110.154 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 338' ' ' HIS . . . . . . . . . . . . . 13.5 p80 -120.73 10.4 10.97 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.394 -0.816 . . . . 18.82 110.411 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 339' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' S' ' 352' ' ' ALA . . . -176.04 155.16 1.54 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.206 -0.934 . . . . 17.18 110.09 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' S' S ' 340' ' ' GLY . . . . . . . . . . . . . . . 160.85 173.05 28.97 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.001 -1.24 . . . . 18.329999999999998 110.001 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 341' ' ' ILE . . . . . . . . . . . . . 83.9 mt -88.8 138.08 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.393 -1.063 . . . . 18.600000000000001 109.839 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 342' ' ' PHE . . . . . 0.488 ' CE2' ' HB3' ' S' ' 352' ' ' ALA . 69.9 m-85 -120.93 -178.49 3.75 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.219 -0.926 . . . . 23.440000000000001 110.412 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' S' S ' 343' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.84 93.4 4.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.397 -0.814 . . . . 35.590000000000003 110.07 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' S' S ' 344' ' ' LYS . . . . . 0.41 ' O ' ' HB3' ' S' ' 348' ' ' HIS . 0.3 OUTLIER -80.82 125.04 29.59 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.236 -0.915 . . . . 38.340000000000003 110.046 -179.934 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' S' S ' 345' ' ' GLY . . . . . . . . . . . . . . . 62.85 -130.85 42.89 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 108.788 -1.725 . . . . 53.460000000000001 108.788 -179.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 346' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -132.7 150.88 52.1 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.173 -1.192 . . . . 70.909999999999997 110.011 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 347' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 53.31 35.36 20.02 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.236 -0.915 . . . . 47.32 110.393 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 348' ' ' HIS . . . . . 0.41 ' HB3' ' O ' ' S' ' 344' ' ' LYS . 46.6 t60 -150.11 155.89 40.66 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.317 -0.865 . . . . 41.719999999999999 110.312 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' S' S ' 349' ' ' ALA . . . . . 0.455 ' C ' HG13 ' S' ' 350' ' ' VAL . . . -149.79 151.3 33.34 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.324 -0.86 . . . . 22.91 110.442 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' S' S ' 350' ' ' VAL . . . . . 0.455 HG13 ' C ' ' S' ' 349' ' ' ALA . 34.6 m -149.14 169.55 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.448 -0.782 . . . . 21.09 109.995 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' S' S ' 351' ' ' PHE . . . . . 0.502 ' CD2' ' HB3' ' S' ' 258' ' ' GLN . 10.7 t80 -105.27 143.58 33.25 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.19 -0.944 . . . . 25.030000000000001 110.716 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' S' S ' 352' ' ' ALA . . . . . 0.488 ' HB3' ' CE2' ' S' ' 342' ' ' PHE . . . -147.7 151.74 36.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.584 -0.698 . . . . 23.809999999999999 109.741 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' S' S ' 353' ' ' CYS . . . . . . . . . . . . . 26.3 p -153.34 164.84 37.43 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.295 -0.878 . . . . 25.66 110.225 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 354' ' ' VAL . . . . . 0.561 HG22 ' CE2' ' S' ' 359' ' ' TRP . 57.2 t -76.04 118.47 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.376 -0.828 . . . . 34.270000000000003 109.943 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' S' S ' 355' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' S' ' 232' ' ' THR . 52.3 p -117.82 175.1 5.82 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.257 -0.902 . . . . 25.489999999999998 110.346 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' S' S ' 356' ' ' SER . . . . . . . . . . . . . 62.2 p -62.2 -17.61 58.65 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.456 -0.778 . . . . 31.239999999999998 110.699 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 357' ' ' ASN . . . . . . . . . . . . . 45.8 m-20 -107.05 14.22 26.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.896 . . . . 28.609999999999999 110.552 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 358' ' ' GLY . . . . . . . . . . . . . . . 111.86 -152.92 17.59 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.013 -1.235 . . . . 22.010000000000002 110.013 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 359' ' ' TRP . . . . . 0.561 ' CE2' HG22 ' S' ' 354' ' ' VAL . 15.3 m95 -91.3 116.65 29.0 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.38 -1.071 . . . . 25.539999999999999 110.23 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' S' S ' 360' ' ' TYR . . . . . 0.422 ' HA ' ' HA ' ' S' ' 369' ' ' PRO . 1.3 m-85 -103.53 165.79 10.82 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.257 -0.902 . . . . 40.530000000000001 110.091 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' S' S ' 361' ' ' ALA . . . . . 0.428 ' HA ' ' O ' ' S' ' 351' ' ' PHE . . . -140.01 129.99 24.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.353 -0.842 . . . . 18.039999999999999 110.295 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' S' S ' 362' ' ' ILE . . . . . . . . . . . . . 88.9 mt -95.54 83.61 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.375 -0.828 . . . . 15.640000000000001 110.081 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 363' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' S' ' 365' ' ' GLU . 11.9 t0 -75.19 94.48 2.96 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.42 -0.8 . . . . 35.030000000000001 110.186 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' S' S ' 364' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 53.92 -89.3 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.53 -0.731 . . . . 46.719999999999999 110.537 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 365' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' S' ' 363' ' ' ASP . 23.7 mt-10 -122.69 19.1 10.32 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.046 -1.033 . . . . 56.200000000000003 110.223 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' S' S ' 366' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -117.91 124.88 49.34 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.21 -0.932 . . . . 51.020000000000003 110.44 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 367' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -106.89 127.05 53.09 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.326 -0.859 . . . . 37.590000000000003 110.18 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 368' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -165.47 159.5 13.83 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.293 -0.879 . . . . 31.469999999999999 110.415 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 369' ' ' PRO . . . . . 0.422 ' HA ' ' HA ' ' S' ' 360' ' ' TYR . 46.9 Cg_endo -72.76 139.59 30.9 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 O-C-N 123.891 1.469 . . . . 28.850000000000001 110.557 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' S' S ' 370' ' ' TRP . . . . . . . . . . . . . 67.4 t90 -167.25 113.52 0.76 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.422 -0.799 . . . . 26.940000000000001 110.001 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 371' ' ' THR . . . . . . . . . . . . . 59.8 m -74.81 113.08 21.02 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.376 -0.828 . . . . 20.190000000000001 110.041 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 372' ' ' PRO . . . . . 0.565 ' O ' HD11 ' S' ' 334' ' ' LEU . 47.0 Cg_endo -73.59 157.11 49.04 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.644 1.339 . . . . 28.68 110.529 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' S' S ' 373' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -90.58 147.15 35.74 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.411 -0.806 . . . . 35.719999999999999 109.934 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 374' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -76.03 -6.27 17.18 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 O-C-N 123.681 1.359 . . . . 30.890000000000001 110.461 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 375' ' ' SER . . . . . . . . . . . . . 70.5 p -104.39 -17.0 14.95 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.227 -0.921 . . . . 29.41 110.428 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 376' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -106.48 43.09 1.18 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.358 -0.839 . . . . 32.890000000000001 110.26 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 377' ' ' VAL . . . . . 0.595 ' O ' HG11 ' S' ' 327' ' ' VAL . 7.3 p -114.71 147.29 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.294 -0.879 . . . . 24.329999999999998 110.223 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' S' S ' 378' ' ' LEU . . . . . . . . . . . . . 52.5 mt -115.99 -57.96 2.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.381 -0.824 . . . . 24.370000000000001 109.611 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 379' ' ' VAL . . . . . 0.646 HG22 HG12 ' S' ' 326' ' ' VAL . 61.0 t -120.76 132.38 70.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.404 -0.81 . . . . 18.02 109.424 179.323 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' S' S ' 380' ' ' PHE . . . . . 0.471 ' CE1' ' HB2' ' S' ' 325' ' ' CYS . 14.6 p90 -142.61 173.96 11.07 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.376 -0.828 . . . . 29.350000000000001 110.704 -179.268 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' S' S ' 381' ' ' VAL . . . . . . . . . . . . . 57.7 t -120.12 107.31 39.79 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.459 -0.776 . . . . 16.34 109.43 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 382' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -71.19 145.6 49.43 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.613 1.322 . . . . 20.940000000000001 110.79 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' S' S ' 383' ' ' TYR . . . . . 0.959 ' O ' ' CB ' ' S' ' 384' ' ' ASP . 88.5 m-85 -61.04 -53.57 55.61 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.317 -0.865 . . . . 28.93 109.826 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' S' S ' 384' ' ' ASP . . . . . 0.959 ' CB ' ' O ' ' S' ' 383' ' ' TYR . 7.0 t70 . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.46 -0.775 . . . . 47.030000000000001 110.366 176.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' R' R ' 30' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 121.14 0.495 . . . . 43.359999999999999 110.287 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' R' R ' 31' ' ' LEU . . . . . . . . . . . . . 65.3 mt -134.86 140.61 45.95 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.308 -0.87 . . . . 22.93 110.306 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' R' R ' 32' ' ' THR . . . . . . . . . . . . . 68.4 m -87.59 110.59 20.49 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.408 -0.807 . . . . 22.34 109.971 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' R' R ' 33' ' ' LEU . . . . . 0.596 HD22 ' CE2' ' R' ' 62' ' ' TYR . 80.0 mt -62.38 -172.79 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.314 -0.866 . . . . 21.390000000000001 110.226 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' R' R ' 34' ' ' TYR . . . . . . . . . . . . . 37.0 p90 -74.68 -29.4 61.21 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.333 -0.855 . . . . 34.399999999999999 110.38 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' R' R ' 35' ' ' ASN . . . . . . . . . . . . . 48.3 p30 -77.79 -1.79 33.2 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.356 -0.84 . . . . 30.280000000000001 110.699 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' R' R ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.24 -16.55 59.49 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.691 -1.364 . . . . 36.25 109.691 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' R' R ' 37' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -59.04 161.81 4.79 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.314 -1.11 . . . . 53.799999999999997 110.368 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' R' R ' 38' ' ' LYS . . . . . . . . . . . . . 56.9 mttt -117.86 135.8 53.86 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.445 -0.784 . . . . 49.909999999999997 110.146 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' R' R ' 39' ' ' LYS . . . . . 0.408 ' HG2' ' CZ ' ' R' ' 41' ' ' PHE . 8.1 ttmt -138.75 143.64 39.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.404 -0.81 . . . . 35.689999999999998 110.223 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' R' R ' 40' ' ' THR . . . . . . . . . . . . . 23.5 m -102.54 127.96 49.39 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.302 -0.874 . . . . 34.840000000000003 110.228 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' R' R ' 41' ' ' PHE . . . . . 0.408 ' CZ ' ' HG2' ' R' ' 39' ' ' LYS . 96.6 m-85 -113.04 132.65 55.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.378 -0.826 . . . . 34.420000000000002 110.172 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' R' R ' 42' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -93.36 140.95 28.99 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.331 -0.856 . . . . 51.460000000000001 110.221 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' R' R ' 43' ' ' SER . . . . . . . . . . . . . 54.3 m -70.76 141.93 51.42 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.55 -0.719 . . . . 41.840000000000003 110.205 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' R' R ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.75 125.37 29.59 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.469 -0.769 . . . . 33.82 110.013 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' R' R ' 45' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.11 151.13 55.13 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.59 1.31 . . . . 30.27 110.625 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' R' R ' 46' ' ' ASN . . . . . 0.4 ' HA ' ' OD1' ' R' ' 50' ' ' ASN . 52.2 t-20 -124.28 109.84 13.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.459 -0.776 . . . . 35.100000000000001 110.071 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' R' R ' 47' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -120.27 -34.86 3.56 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.395 -0.816 . . . . 42.810000000000002 110.551 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' R' R ' 48' ' ' HIS . . . . . 0.439 ' NE2' HD11 ' R' ' 80' ' ' LEU . 73.3 m80 -105.73 45.1 0.99 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.187 -0.946 . . . . 49.969999999999999 110.235 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' R' R ' 49' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 50.32 34.72 9.38 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.4 -0.813 . . . . 61.32 110.149 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' R' R ' 50' ' ' ASN . . . . . 0.4 ' OD1' ' HA ' ' R' ' 46' ' ' ASN . 15.0 p-10 -86.32 43.87 1.1 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.323 -0.861 . . . . 51.5 110.66 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' R' R ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.12 -46.11 78.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.165 -0.959 . . . . 38.770000000000003 109.541 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' R' R ' 52' ' ' TRP . . . . . 0.483 ' CD2' ' N ' ' R' ' 53' ' ' LEU . 68.2 p-90 -58.4 -38.4 77.27 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.482 -0.761 . . . . 26.239999999999998 110.055 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' R' R ' 53' ' ' LEU . . . . . 0.483 ' N ' ' CD2' ' R' ' 52' ' ' TRP . 23.1 tp -66.73 -46.66 74.76 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.456 -0.777 . . . . 26.75 109.946 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' R' R ' 54' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -55.23 -41.54 72.24 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.405 -0.809 . . . . 35.020000000000003 110.132 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' R' R ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.26 -46.11 91.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.352 -0.842 . . . . 24.469999999999999 110.114 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' R' R ' 56' ' ' ILE . . . . . 0.433 HG12 HD11 ' R' ' 104' ' ' ILE . 76.6 mt -62.09 -42.33 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.259 -0.901 . . . . 26.030000000000001 109.906 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' R' R ' 57' ' ' LEU . . . . . . . . . . . . . 22.5 mt -60.26 -45.69 92.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.28 -0.888 . . . . 26.77 109.657 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' R' R ' 58' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -63.87 -46.51 84.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.341 -0.849 . . . . 22.32 109.582 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' R' R ' 59' ' ' LEU . . . . . 0.43 ' HA ' ' HE2' ' R' ' 151' ' ' PHE . 24.0 tp -61.43 -37.73 84.6 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.306 -0.871 . . . . 20.550000000000001 109.396 179.295 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' R' R ' 60' ' ' PHE . . . . . 0.528 ' CE2' HD21 ' R' ' 111' ' ' LEU . 2.8 m-85 -61.11 -44.72 96.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.617 -0.677 . . . . 20.079999999999998 109.913 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' R' R ' 61' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -63.17 -36.23 82.93 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.498 -0.751 . . . . 18.800000000000001 110.408 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' R' R ' 62' ' ' TYR . . . . . 0.596 ' CE2' HD22 ' R' ' 33' ' ' LEU . 9.2 t80 -63.04 -41.74 99.58 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.226 -0.921 . . . . 26.449999999999999 110.247 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' R' R ' 63' ' ' VAL . . . . . 0.406 ' H ' HG22 ' R' ' 63' ' ' VAL . 30.8 m -93.42 20.32 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.308 -0.87 . . . . 29.75 110.266 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' R' R ' 64' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 53.03 75.44 0.24 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.316 -0.865 . . . . 35.520000000000003 110.561 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' R' R ' 65' ' ' GLU . . . . . 0.443 ' HG2' ' CD2' ' R' ' 60' ' ' PHE . 14.3 tp10 -116.19 104.01 52.55 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.391 -0.818 . . . . 29.890000000000001 109.958 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' R' R ' 66' ' ' PRO . . . . . 0.479 ' HA ' ' HB2' ' R' ' 69' ' ' ASP . 46.6 Cg_endo -73.47 -5.88 17.85 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.708 1.372 . . . . 21.370000000000001 111.068 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' R' R ' 67' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -52.11 -61.58 2.17 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.054 -1.029 . . . . 23.850000000000001 110.341 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' R' R ' 68' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -98.06 36.52 1.56 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.314 -0.866 . . . . 28.07 110.474 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' R' R ' 69' ' ' ASP . . . . . 0.479 ' HB2' ' HA ' ' R' ' 66' ' ' PRO . 11.7 t0 -72.3 -33.25 67.27 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.307 -0.871 . . . . 43.759999999999998 110.205 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' R' R ' 70' ' ' TRP . . . . . 0.476 ' CE2' ' CG2' ' R' ' 71' ' ' VAL . 48.0 p-90 -73.49 -3.85 30.18 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.332 -0.855 . . . . 33.060000000000002 110.686 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' R' R ' 71' ' ' VAL . . . . . 0.557 HG11 ' HB2' ' R' ' 82' ' ' ALA . 40.8 t -109.83 -27.41 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.175 -0.953 . . . . 31.699999999999999 109.674 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' R' R ' 72' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -86.58 -48.88 7.96 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.358 -0.839 . . . . 33.579999999999998 110.278 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' R' R ' 73' ' ' SER . . . . . . . . . . . . . 70.2 m -89.67 51.12 2.02 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.312 -0.868 . . . . 50.82 110.308 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' R' R ' 74' ' ' SER . . . . . . . . . . . . . 15.9 t -125.96 138.33 31.88 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.282 -0.886 . . . . 34.740000000000002 110.189 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.38 -24.99 15.89 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 O-C-N 123.603 1.317 . . . . 35.700000000000003 110.32 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' R' R ' 76' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -91.74 153.24 19.76 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.461 -0.775 . . . . 66.480000000000004 110.356 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' R' R ' 77' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -81.56 95.23 7.07 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.33 -0.856 . . . . 46.719999999999999 110.097 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' R' R ' 78' ' ' LEU . . . . . . . . . . . . . 96.4 mt -96.43 28.01 3.52 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.398 -0.814 . . . . 37.549999999999997 110.187 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' R' R ' 79' ' ' THR . . . . . . . . . . . . . 29.9 m -56.21 -54.62 43.08 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.226 -0.921 . . . . 37.359999999999999 110.301 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' R' R ' 80' ' ' LEU . . . . . 0.602 ' HA ' HD12 ' R' ' 83' ' ' ILE . 15.9 mt -60.88 -23.28 65.07 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.449 -0.782 . . . . 35.829999999999998 110.511 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' R' R ' 81' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -79.44 -39.11 33.07 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.154 -0.966 . . . . 44.030000000000001 110.38 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' R' R ' 82' ' ' ALA . . . . . 0.557 ' HB2' HG11 ' R' ' 71' ' ' VAL . . . -69.45 -28.66 66.3 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.292 -0.88 . . . . 32.539999999999999 110.211 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' R' R ' 83' ' ' ILE . . . . . 0.602 HD12 ' HA ' ' R' ' 80' ' ' LEU . 78.2 mt -70.13 -46.09 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.236 -0.915 . . . . 32.020000000000003 110.265 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' R' R ' 84' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -55.23 -52.09 64.49 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.237 -0.914 . . . . 34.090000000000003 110.521 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' R' R ' 85' ' ' GLN . . . . . 0.531 ' HG2' HD12 ' R' ' 89' ' ' LEU . 31.9 tt0 -54.82 -46.87 74.63 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.238 -0.914 . . . . 25.940000000000001 110.28 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' R' R ' 86' ' ' LEU . . . . . . . . . . . . . 24.0 mt -58.71 -43.73 90.17 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.299 -0.876 . . . . 16.199999999999999 109.923 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' R' R ' 87' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -65.43 -35.11 79.95 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.472 -0.768 . . . . 49.090000000000003 110.33 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' R' R ' 88' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -78.5 -19.06 53.85 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.276 -0.89 . . . . 28.609999999999999 110.479 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' R' R ' 89' ' ' LEU . . . . . 0.531 HD12 ' HG2' ' R' ' 85' ' ' GLN . 32.8 mt -96.18 -29.43 14.05 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.236 -0.915 . . . . 26.16 110.197 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' R' R ' 90' ' ' THR . . . . . . . . . . . . . 59.4 p -105.63 -34.72 7.65 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.259 -0.901 . . . . 33.329999999999998 109.764 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' R' R ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.89 16.08 58.55 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.821 -1.312 . . . . 31.129999999999999 109.821 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' R' R ' 92' ' ' LEU . . . . . . . . . . . . . 97.1 mt -100.06 155.23 17.83 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.147 -1.208 . . . . 42.520000000000003 110.23 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' R' R ' 93' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -86.21 91.62 8.51 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.49 -0.756 . . . . 68.459999999999994 110.017 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' R' R ' 94' ' ' LEU . . . . . 0.459 ' HB3' ' CZ2' ' R' ' 52' ' ' TRP . 48.3 mt -99.48 53.03 0.94 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.222 -0.924 . . . . 44.630000000000003 110.32 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' R' R ' 95' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.43 -38.8 6.35 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.262 -0.899 . . . . 67.159999999999997 110.385 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' R' R ' 96' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -113.83 44.23 1.67 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.251 -0.906 . . . . 67.019999999999996 110.352 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' R' R ' 97' ' ' GLY . . . . . . . . . . . . . . . 99.16 150.78 26.0 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.614 -1.395 . . . . 49.479999999999997 109.614 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' R' R ' 98' ' ' GLY . . . . . . . . . . . . . . . -166.26 160.03 33.47 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.286 -1.526 . . . . 36.57 109.286 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' R' R ' 99' ' ' PRO . . . . . 0.792 ' O ' HG23 ' R' ' 103' ' ' VAL . 45.8 Cg_endo -72.49 121.03 7.1 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 O-C-N 123.703 1.37 . . . . 30.41 110.47 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' R' R ' 100' ' ' PRO . . . . . 0.413 ' HA ' HD11 ' R' ' 56' ' ' ILE . 46.1 Cg_endo -72.22 -31.72 11.47 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 O-C-N 123.645 1.339 . . . . 29.940000000000001 110.552 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' R' R ' 101' ' ' ALA . . . . . 0.476 ' HB2' ' HB3' ' R' ' 178' ' ' LEU . . . -69.9 -38.49 76.32 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.228 -0.92 . . . . 23.640000000000001 110.291 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' R' R ' 102' ' ' LEU . . . . . 0.424 HD23 HD21 ' R' ' 106' ' ' ASN . 0.1 OUTLIER -72.64 -40.71 66.19 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.411 -0.805 . . . . 20.309999999999999 110.386 -179.769 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' R' R ' 103' ' ' VAL . . . . . 0.792 HG23 ' O ' ' R' ' 99' ' ' PRO . 64.0 t -58.25 -40.07 76.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.225 -0.922 . . . . 16.329999999999998 109.984 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' R' R ' 104' ' ' ILE . . . . . 0.433 HD11 HG12 ' R' ' 56' ' ' ILE . 81.6 mt -71.63 -30.6 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.388 -0.82 . . . . 24.77 109.939 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' R' R ' 105' ' ' TRP . . . . . 0.462 ' O ' ' HD3' ' R' ' 108' ' ' LYS . 70.5 t-105 -82.35 0.82 40.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.292 -0.88 . . . . 23.280000000000001 110.321 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' R' R ' 106' ' ' ASN . . . . . 0.424 HD21 HD23 ' R' ' 102' ' ' LEU . 6.9 m-80 -105.07 -10.49 17.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.136 -0.977 . . . . 28.260000000000002 110.086 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' R' R ' 107' ' ' ILE . . . . . . . . . . . . . 36.8 pt -126.83 35.06 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.208 -0.933 . . . . 18.77 110.033 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' R' R ' 108' ' ' LYS . . . . . 0.502 ' HG2' ' HB ' ' R' ' 115' ' ' ILE . 9.2 mtpp -61.16 -48.43 81.64 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.528 -0.732 . . . . 42.5 109.987 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' R' R ' 109' ' ' HIS . . . . . 0.446 ' CD2' ' HG ' ' R' ' 110' ' ' LEU . 50.9 p-80 -66.01 -12.88 58.3 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.461 -0.774 . . . . 20.07 110.652 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' R' R ' 110' ' ' LEU . . . . . 0.446 ' HG ' ' CD2' ' R' ' 109' ' ' HIS . 80.6 mt -94.81 -17.26 22.28 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.084 -1.01 . . . . 15.69 110.192 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' R' R ' 111' ' ' LEU . . . . . 0.528 HD21 ' CE2' ' R' ' 60' ' ' PHE . 10.3 mt -94.15 144.11 25.78 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.34 -0.85 . . . . 25.390000000000001 111.002 -179.16 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' R' R ' 112' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -77.7 -17.33 57.75 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.521 -0.737 . . . . 53.479999999999997 109.865 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' R' R ' 113' ' ' THR . . . . . 0.459 HG22 ' N ' ' R' ' 114' ' ' GLY . 60.4 m -83.71 166.68 17.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.311 -0.868 . . . . 14.800000000000001 110.201 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' R' R ' 114' ' ' GLY . . . . . 0.459 ' N ' HG22 ' R' ' 113' ' ' THR . . . -98.01 127.15 9.13 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.962 -1.255 . . . . 16.140000000000001 109.962 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' R' R ' 115' ' ' ILE . . . . . 0.578 HD13 ' HB ' ' R' ' 124' ' ' VAL . 47.9 mm -109.05 139.35 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.424 -1.045 . . . . 13.460000000000001 109.71 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' R' R ' 116' ' ' GLY . . . . . . . . . . . . . . . -152.76 -155.9 7.31 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.856 -1.298 . . . . 23.899999999999999 109.856 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' R' R ' 117' ' ' THR . . . . . 0.529 HG22 ' CG2' ' R' ' 126' ' ' VAL . 18.8 p -135.03 -171.35 2.78 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.53 -0.982 . . . . 27.370000000000001 110.097 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' R' R ' 118' ' ' ALA . . . . . 0.445 ' HB3' ' OD1' ' R' ' 128' ' ' ASP . . . -56.6 -58.04 9.79 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.359 -0.838 . . . . 18.760000000000002 110.064 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' R' R ' 119' ' ' SER . . . . . 0.762 ' HA ' ' HB3' ' R' ' 194' ' ' ALA . 1.1 m -56.55 -40.59 75.39 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.259 -0.901 . . . . 32.350000000000001 109.741 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' R' R ' 120' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 -110.11 86.25 4.92 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.435 -0.791 . . . . 27.120000000000001 109.68 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' R' R ' 121' ' ' PRO . . . . . 0.483 ' HA ' ' SG ' ' R' ' 125' ' ' CYS . 44.3 Cg_endo -71.2 166.47 29.12 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.863 1.454 . . . . 22.68 111.046 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' R' R ' 122' ' ' SER . . . . . 0.434 ' HB2' ' O ' ' R' ' 121' ' ' PRO . 38.4 t 178.56 -161.67 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.649 -0.657 . . . . 22.989999999999998 109.456 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' R' R ' 123' ' ' GLU . . . . . 0.44 ' HG2' HG23 ' R' ' 113' ' ' THR . 2.3 tp10 -56.45 -39.92 73.94 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.211 -0.93 . . . . 36.18 109.701 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' R' R ' 124' ' ' VAL . . . . . 0.578 ' HB ' HD13 ' R' ' 115' ' ' ILE . 84.2 t -142.58 136.41 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.579 -0.701 . . . . 20.640000000000001 109.389 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' R' R ' 125' ' ' CYS . . . . . 0.483 ' SG ' ' HA ' ' R' ' 121' ' ' PRO . 83.3 m -140.26 168.23 20.29 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.252 -0.905 . . . . 22.800000000000001 111.166 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' R' R ' 126' ' ' VAL . . . . . 0.73 HG12 HG22 ' R' ' 179' ' ' VAL . 35.8 m -122.73 159.73 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.671 -0.643 . . . . 21.239999999999998 109.568 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' R' R ' 127' ' ' VAL . . . . . 0.709 HG11 ' O ' ' R' ' 177' ' ' VAL . 30.6 m -70.8 141.91 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.294 -0.879 . . . . 19.77 110.7 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' R' R ' 128' ' ' ASP . . . . . 0.445 ' OD1' ' HB3' ' R' ' 118' ' ' ALA . 53.9 p-10 -137.77 19.4 2.86 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.337 -0.852 . . . . 29.210000000000001 110.642 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' R' R ' 129' ' ' GLY . . . . . . . . . . . . . . . 113.98 0.03 24.16 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.963 -1.113 . . . . 33.859999999999999 110.498 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' R' R ' 130' ' ' THR . . . . . . . . . . . . . 58.1 m -91.86 131.81 36.92 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.14 -1.212 . . . . 26.41 110.082 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -62.52 120.7 11.62 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.36 -0.838 . . . . 33.079999999999998 110.287 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' R' R ' 132' ' ' MET . . . . . 0.433 ' HE1' ' CE2' ' R' ' 180' ' ' PHE . 98.5 mmm -105.26 165.62 10.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.467 -0.771 . . . . 30.760000000000002 110.435 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' R' R ' 133' ' ' CYS . . . . . 0.41 ' HA ' ' HB3' ' R' ' 174' ' ' PRO . 32.8 m -141.09 158.11 44.37 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.511 -0.743 . . . . 27.0 109.973 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' R' R ' 134' ' ' LEU . . . . . 0.564 HD11 ' O ' ' R' ' 172' ' ' PRO . 0.1 OUTLIER -58.45 -19.74 39.11 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.268 -0.895 . . . . 33.899999999999999 110.51 -179.923 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' R' R ' 135' ' ' ALA . . . . . . . . . . . . . . . -92.69 8.07 40.77 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.231 -0.918 . . . . 19.370000000000001 110.779 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' R' R ' 136' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -93.71 -21.76 19.15 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.187 -0.946 . . . . 30.469999999999999 110.272 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' R' R ' 137' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -149.96 165.34 32.94 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.365 -0.835 . . . . 24.27 110.241 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' R' R ' 138' ' ' HIS . . . . . 0.433 ' HA ' HG23 ' R' ' 154' ' ' VAL . 15.1 p80 -117.84 15.11 14.37 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.362 -0.836 . . . . 20.91 110.369 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' R' R ' 139' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' R' ' 152' ' ' ALA . . . -177.16 152.46 0.88 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.158 -0.964 . . . . 15.69 110.12 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' R' R ' 140' ' ' GLY . . . . . 0.428 ' HA3' ' O ' ' R' ' 179' ' ' VAL . . . 161.8 175.2 32.57 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.975 -1.25 . . . . 23.760000000000002 109.975 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' R' R ' 141' ' ' ILE . . . . . . . . . . . . . 83.7 mt -95.55 136.61 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.372 -1.075 . . . . 25.300000000000001 109.673 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' R' R ' 142' ' ' PHE . . . . . 0.578 ' CD2' ' HB2' ' R' ' 172' ' ' PRO . 82.8 m-85 -120.77 -172.63 2.42 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.287 -0.883 . . . . 30.239999999999998 110.545 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' R' R ' 143' ' ' LEU . . . . . 0.742 HD23 ' O ' ' R' ' 148' ' ' HIS . 0.5 OUTLIER -119.75 77.75 1.26 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.444 -0.785 . . . . 32.799999999999997 110.246 -179.84 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' R' R ' 144' ' ' LYS . . . . . 0.469 ' HG3' ' CZ2' ' R' ' 170' ' ' TRP . 1.0 OUTLIER -69.59 76.86 0.42 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.393 -0.817 . . . . 49.18 109.707 179.502 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' R' R ' 145' ' ' GLY . . . . . 0.457 ' O ' HD22 ' R' ' 143' ' ' LEU . . . 104.52 179.32 24.8 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.131 -1.588 . . . . 53.869999999999997 109.131 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' R' R ' 146' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -88.52 145.81 25.53 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.361 -1.082 . . . . 68.579999999999998 110.023 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' R' R ' 147' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 58.24 36.52 25.77 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.314 -0.866 . . . . 56.619999999999997 110.623 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' R' R ' 148' ' ' HIS . . . . . 0.742 ' O ' HD23 ' R' ' 143' ' ' LEU . 44.5 t60 -158.65 148.17 19.24 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.194 -0.941 . . . . 44.57 110.376 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' R' R ' 149' ' ' ALA . . . . . . . . . . . . . . . -150.29 146.88 27.04 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.427 -0.796 . . . . 33.539999999999999 110.079 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' R' R ' 150' ' ' VAL . . . . . . . . . . . . . 34.2 m -142.32 161.5 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.277 -0.889 . . . . 27.609999999999999 110.356 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' R' R ' 151' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' R' ' 152' ' ' ALA . 5.9 t80 -86.14 155.62 20.69 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.401 -0.812 . . . . 23.039999999999999 109.924 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' R' R ' 152' ' ' ALA . . . . . 0.537 ' N ' ' CD1' ' R' ' 151' ' ' PHE . . . -157.33 151.51 24.81 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.517 -0.739 . . . . 29.609999999999999 109.625 179.02 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' R' R ' 153' ' ' CYS . . . . . . . . . . . . . 26.7 p -154.3 173.61 15.93 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.233 -0.917 . . . . 22.75 110.453 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' R' R ' 154' ' ' VAL . . . . . 0.613 HG22 ' CE2' ' R' ' 159' ' ' TRP . 60.2 t -90.68 117.04 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.37 -0.831 . . . . 23.260000000000002 110.101 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' R' R ' 155' ' ' THR . . . . . . . . . . . . . 69.8 p -112.1 -176.63 2.97 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.302 -0.873 . . . . 17.879999999999999 110.041 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' R' R ' 156' ' ' SER . . . . . . . . . . . . . 78.5 p -75.94 -3.69 36.88 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.329 -0.857 . . . . 21.829999999999998 110.735 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' R' R ' 157' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -118.25 10.38 12.83 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.109 -0.994 . . . . 36.539999999999999 110.635 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' R' R ' 158' ' ' GLY . . . . . . . . . . . . . . . 117.9 -162.7 13.0 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.585 -1.406 . . . . 31.739999999999998 109.585 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' R' R ' 159' ' ' TRP . . . . . 0.613 ' CE2' HG22 ' R' ' 154' ' ' VAL . 14.8 m95 -86.51 122.42 30.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.334 -1.098 . . . . 28.25 110.112 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' R' R ' 160' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -108.42 166.96 10.38 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.384 -0.822 . . . . 41.240000000000002 110.251 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' R' R ' 161' ' ' ALA . . . . . . . . . . . . . . . -143.33 123.51 13.72 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.495 -0.753 . . . . 27.399999999999999 110.117 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' R' R ' 162' ' ' ILE . . . . . . . . . . . . . 92.2 mt -87.54 81.14 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.406 -0.809 . . . . 24.27 110.072 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' R' R ' 163' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' R' ' 165' ' ' GLU . 15.3 t0 -72.81 92.47 1.59 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.422 -0.799 . . . . 36.079999999999998 110.234 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' R' R ' 164' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 54.09 -89.03 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.521 -0.737 . . . . 46.079999999999998 110.574 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' R' R ' 165' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' R' ' 163' ' ' ASP . 29.7 mt-10 -124.68 35.94 4.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.151 -0.968 . . . . 50.939999999999998 110.196 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' R' R ' 166' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -135.72 117.28 14.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.427 -0.796 . . . . 47.280000000000001 110.358 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' R' R ' 167' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -101.02 120.0 39.56 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.396 -0.815 . . . . 40.469999999999999 110.164 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' R' R ' 168' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -157.56 158.48 30.6 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.199 -0.938 . . . . 30.210000000000001 110.436 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' R' R ' 169' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.74 133.01 19.51 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 O-C-N 123.9 1.474 . . . . 32.759999999999998 110.471 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' R' R ' 170' ' ' TRP . . . . . 0.469 ' CZ2' ' HG3' ' R' ' 144' ' ' LYS . 66.9 t90 -159.83 119.42 2.89 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.471 -0.768 . . . . 32.789999999999999 109.925 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' R' R ' 171' ' ' THR . . . . . . . . . . . . . 46.3 m -81.14 112.62 34.41 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.419 -0.801 . . . . 36.920000000000002 110.188 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' R' R ' 172' ' ' PRO . . . . . 0.578 ' HB2' ' CD2' ' R' ' 142' ' ' PHE . 47.5 Cg_endo -73.75 158.82 46.44 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.68 1.358 . . . . 33.539999999999999 110.552 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' R' R ' 173' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -88.88 144.98 33.78 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.429 -0.795 . . . . 45.759999999999998 109.951 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' R' R ' 174' ' ' PRO . . . . . 0.41 ' HB3' ' HA ' ' R' ' 133' ' ' CYS . 45.3 Cg_endo -71.8 -10.32 26.2 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.639 1.336 . . . . 29.629999999999999 110.404 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' R' R ' 175' ' ' SER . . . . . . . . . . . . . 53.1 p -103.47 -17.58 15.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.275 -0.891 . . . . 35.700000000000003 110.34 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' R' R ' 176' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -103.5 43.21 1.1 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.256 -0.903 . . . . 39.649999999999999 110.419 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' R' R ' 177' ' ' VAL . . . . . 0.709 ' O ' HG11 ' R' ' 127' ' ' VAL . 10.4 p -117.77 127.19 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.367 -0.833 . . . . 20.609999999999999 109.961 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' R' R ' 178' ' ' LEU . . . . . 0.476 ' HB3' ' HB2' ' R' ' 101' ' ' ALA . 46.0 mt -91.53 -61.15 1.71 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.373 -0.829 . . . . 15.58 109.419 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' R' R ' 179' ' ' VAL . . . . . 0.73 HG22 HG12 ' R' ' 126' ' ' VAL . 67.9 t -114.73 144.64 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.602 -0.686 . . . . 17.399999999999999 109.419 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' R' R ' 180' ' ' PHE . . . . . 0.433 ' CE2' ' HE1' ' R' ' 132' ' ' MET . 43.8 p90 -152.12 163.37 39.5 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.271 -0.893 . . . . 20.16 110.551 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' R' R ' 181' ' ' VAL . . . . . . . . . . . . . 66.8 t -113.16 111.52 50.26 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.456 -0.778 . . . . 17.690000000000001 109.833 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' R' R ' 182' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.06 149.48 52.61 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.577 1.304 . . . . 17.809999999999999 110.366 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' R' R ' 183' ' ' TYR . . . . . 0.735 ' O ' ' C ' ' R' ' 184' ' ' ASP . 79.1 m-85 -59.03 175.51 0.28 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.432 -0.792 . . . . 28.010000000000002 110.571 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' R' R ' 184' ' ' ASP . . . . . 0.735 ' C ' ' O ' ' R' ' 183' ' ' TYR . 1.9 m-20 -13.08 -75.98 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.442 -0.786 . . . . 58.640000000000001 110.297 -178.021 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' R' R ' 185' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.503 2.213 0 CA-C-O 121.185 0.517 . . . . 80.420000000000002 111.807 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' R' R ' 193' ' ' LYS . . . . . 0.416 ' O ' ' HB2' ' R' ' 194' ' ' ALA . 49.1 mmtt . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 120.949 0.404 . . . . 49.5 110.112 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' R' R ' 194' ' ' ALA . . . . . 0.762 ' HB3' ' HA ' ' R' ' 119' ' ' SER . . . . . . . . 0 N--CA 1.495 1.796 0 O-C-N 121.117 -0.989 . . . . 40.399999999999999 110.102 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' S' S ' 229' ' ' MET . . . . . . . . . . . . . 2.4 ptt? . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.173 0.511 . . . . 51.829999999999998 110.202 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' S' S ' 230' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -97.32 142.75 28.81 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.369 -0.832 . . . . 54.130000000000003 110.183 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' S' S ' 231' ' ' LEU . . . . . . . . . . . . . 68.2 mt -134.09 141.0 46.99 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.312 -0.868 . . . . 33.039999999999999 110.325 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' S' S ' 232' ' ' THR . . . . . 0.416 ' O ' ' HA ' ' S' ' 355' ' ' THR . 40.0 m -89.22 103.27 15.9 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.438 -0.789 . . . . 26.920000000000002 110.039 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' S' S ' 233' ' ' LEU . . . . . 0.674 HD22 ' CE2' ' S' ' 262' ' ' TYR . 79.9 mt -55.91 179.29 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.471 -0.768 . . . . 13.779999999999999 110.483 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' S' S ' 234' ' ' TYR . . . . . 0.447 ' CG ' ' N ' ' S' ' 235' ' ' ASN . 35.5 p90 -65.02 -35.68 81.95 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.412 -0.805 . . . . 26.079999999999998 110.163 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' S' S ' 235' ' ' ASN . . . . . 0.447 ' N ' ' CG ' ' S' ' 234' ' ' TYR . 50.7 p30 -74.35 -7.38 52.65 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.357 -0.839 . . . . 20.039999999999999 110.511 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' S' S ' 236' ' ' GLY . . . . . . . . . . . . . . . 95.71 -20.0 51.78 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.769 -1.332 . . . . 22.710000000000001 109.769 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' S' S ' 237' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -52.91 145.64 12.29 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.216 -1.167 . . . . 35.439999999999998 110.215 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' S' S ' 238' ' ' LYS . . . . . . . . . . . . . 44.2 mttt -102.17 127.99 48.86 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.438 -0.789 . . . . 32.560000000000002 110.341 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' S' S ' 239' ' ' LYS . . . . . 0.406 ' HG2' ' CZ ' ' S' ' 241' ' ' PHE . 9.0 ttmt -132.35 144.45 50.55 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.371 -0.83 . . . . 26.68 110.002 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' S' S ' 240' ' ' THR . . . . . . . . . . . . . 52.5 m -101.95 132.23 47.89 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.307 -0.871 . . . . 41.020000000000003 110.36 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' S' S ' 241' ' ' PHE . . . . . 0.406 ' CZ ' ' HG2' ' S' ' 239' ' ' LYS . 96.0 m-85 -117.97 137.69 52.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.431 -0.793 . . . . 28.620000000000001 110.188 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' S' S ' 242' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -96.36 161.79 13.78 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.32 -0.862 . . . . 47.890000000000001 110.241 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' S' S ' 243' ' ' SER . . . . . . . . . . . . . 71.5 m -90.58 151.57 21.26 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.376 -0.827 . . . . 45.090000000000003 110.207 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' S' S ' 244' ' ' ARG . . . . . . . . . . . . . 1.4 mtp85 -129.73 126.7 22.72 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.307 -0.871 . . . . 42.490000000000002 110.301 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' S' S ' 245' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.33 161.03 43.71 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 O-C-N 123.651 1.343 . . . . 35.68 110.538 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' S' S ' 246' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -132.9 97.91 4.16 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.381 -0.824 . . . . 51.880000000000003 109.827 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' S' S ' 247' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -110.47 -22.2 11.78 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.364 -0.835 . . . . 53.689999999999998 110.68 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' S' S ' 248' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -117.28 43.65 2.28 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.187 -0.946 . . . . 55.789999999999999 110.719 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' S' S ' 249' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 48.84 38.38 11.9 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.402 -0.811 . . . . 49.450000000000003 110.338 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' S' S ' 250' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -90.6 28.94 1.38 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.544 -0.722 . . . . 36.859999999999999 110.385 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' S' S ' 251' ' ' ALA . . . . . . . . . . . . . . . -53.75 -43.24 68.97 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.271 -0.893 . . . . 29.690000000000001 109.643 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' S' S ' 252' ' ' TRP . . . . . 0.427 ' CZ2' ' HB3' ' S' ' 294' ' ' LEU . 67.9 p-90 -61.74 -33.95 74.97 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.465 -0.772 . . . . 41.119999999999997 109.812 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' S' S ' 253' ' ' LEU . . . . . 0.402 ' N ' ' CD2' ' S' ' 252' ' ' TRP . 23.3 tp -70.14 -47.21 62.68 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.349 -0.845 . . . . 24.890000000000001 109.995 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' S' S ' 254' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -56.16 -42.45 77.04 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.31 -0.869 . . . . 35.649999999999999 109.956 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' S' S ' 255' ' ' ALA . . . . . . . . . . . . . . . -59.58 -48.17 82.7 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.432 -0.793 . . . . 22.73 110.025 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' S' S ' 256' ' ' ILE . . . . . 0.503 HG12 HD11 ' S' ' 304' ' ' ILE . 79.6 mt -62.34 -40.66 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.341 -0.85 . . . . 28.850000000000001 109.957 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' S' S ' 257' ' ' LEU . . . . . 0.4 ' CD2' ' HB3' ' S' ' 268' ' ' PHE . 19.2 mt -61.57 -44.47 96.96 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.359 -0.838 . . . . 23.07 110.17 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' S' S ' 258' ' ' GLN . . . . . 0.5 ' HB3' ' CD2' ' S' ' 351' ' ' PHE . 53.5 mm-40 -65.06 -45.41 85.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.42 -0.8 . . . . 29.780000000000001 109.851 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' S' S ' 259' ' ' LEU . . . . . 0.42 ' O ' HG22 ' S' ' 263' ' ' VAL . 19.8 tp -58.72 -36.33 74.11 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.36 -0.838 . . . . 17.940000000000001 109.433 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' S' S ' 260' ' ' PHE . . . . . 0.531 ' CE2' HD21 ' S' ' 311' ' ' LEU . 3.1 m-85 -62.81 -45.27 93.4 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.619 -0.676 . . . . 30.57 109.833 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' S' S ' 261' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -62.18 -29.67 70.52 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.476 -0.765 . . . . 41.340000000000003 110.006 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' S' S ' 262' ' ' TYR . . . . . 0.674 ' CE2' HD22 ' S' ' 233' ' ' LEU . 8.7 t80 -71.29 -44.61 64.86 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.418 -0.802 . . . . 26.030000000000001 110.067 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' S' S ' 263' ' ' VAL . . . . . 0.42 HG22 ' O ' ' S' ' 259' ' ' LEU . 33.0 m -92.02 18.28 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.366 -0.834 . . . . 22.800000000000001 110.38 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' S' S ' 264' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 52.76 70.63 0.56 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.217 -0.927 . . . . 44.030000000000001 110.678 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' S' S ' 265' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -111.84 109.19 55.34 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.383 -0.823 . . . . 35.609999999999999 109.657 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' S' S ' 266' ' ' PRO . . . . . 0.476 ' HA ' ' HB2' ' S' ' 269' ' ' ASP . 49.3 Cg_endo -75.29 0.37 9.11 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.592 1.312 . . . . 37.670000000000002 111.793 -179.109 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' S' S ' 267' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -56.45 -67.71 0.28 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.74 -1.225 . . . . 41.490000000000002 110.164 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' S' S ' 268' ' ' PHE . . . . . 0.4 ' HB3' ' CD2' ' S' ' 257' ' ' LEU . 22.4 m-85 -92.93 39.87 1.05 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.201 -0.937 . . . . 50.759999999999998 110.071 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' S' S ' 269' ' ' ASP . . . . . 0.476 ' HB2' ' HA ' ' S' ' 266' ' ' PRO . 0.9 OUTLIER -75.95 -33.26 59.8 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.375 -0.828 . . . . 61.859999999999999 109.765 179.567 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' S' S ' 270' ' ' TRP . . . . . 0.506 ' CE2' HG23 ' S' ' 271' ' ' VAL . 51.0 p-90 -73.9 -4.37 34.59 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.312 -0.867 . . . . 39.850000000000001 110.483 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' S' S ' 271' ' ' VAL . . . . . 0.506 HG23 ' CE2' ' S' ' 270' ' ' TRP . 46.4 t -109.49 -32.66 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.151 -0.968 . . . . 39.18 110.073 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' S' S ' 272' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -78.6 -36.53 44.09 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.325 -0.859 . . . . 40.020000000000003 110.523 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' S' S ' 273' ' ' SER . . . . . . . . . . . . . 70.8 m -103.6 56.11 0.74 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.264 -0.898 . . . . 47.200000000000003 110.286 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' S' S ' 274' ' ' SER . . . . . . . . . . . . . 6.9 t -133.03 141.25 40.25 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.35 -0.844 . . . . 47.609999999999999 110.155 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' S' S ' 275' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.7 -18.89 21.85 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 O-C-N 123.629 1.331 . . . . 45.280000000000001 110.594 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' S' S ' 276' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -99.86 140.85 33.47 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.317 -0.864 . . . . 57.270000000000003 110.314 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' S' S ' 277' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -71.68 97.69 1.79 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.476 -0.765 . . . . 37.280000000000001 110.309 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' S' S ' 278' ' ' LEU . . . . . . . . . . . . . 86.7 mt -97.0 33.76 1.85 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.397 -0.815 . . . . 43.880000000000003 109.984 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' S' S ' 279' ' ' THR . . . . . . . . . . . . . 74.8 m -63.98 -60.19 3.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.481 -0.762 . . . . 50.049999999999997 110.24 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' S' S ' 280' ' ' LEU . . . . . 0.729 ' HA ' HD12 ' S' ' 283' ' ' ILE . 13.6 mt -51.58 -39.9 58.77 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.31 -0.869 . . . . 54.119999999999997 110.254 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' S' S ' 281' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.35 -49.71 74.47 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.526 -0.734 . . . . 65.280000000000001 110.143 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' S' S ' 282' ' ' ALA . . . . . . . . . . . . . . . -58.99 -33.86 71.17 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.548 -0.72 . . . . 46.509999999999998 110.506 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' S' S ' 283' ' ' ILE . . . . . 0.729 HD12 ' HA ' ' S' ' 280' ' ' LEU . 85.7 mt -66.35 -50.84 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.287 -0.883 . . . . 47.299999999999997 110.138 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' S' S ' 284' ' ' LYS . . . . . . . . . . . . . 33.6 tttp -50.6 -57.57 7.87 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.487 -0.758 . . . . 50.719999999999999 110.384 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' S' S ' 285' ' ' GLN . . . . . 0.524 ' HG2' HD12 ' S' ' 289' ' ' LEU . 34.4 tt0 -51.35 -46.42 62.68 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.494 -0.754 . . . . 68.469999999999999 110.352 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' S' S ' 286' ' ' LEU . . . . . . . . . . . . . 19.0 mt -59.96 -44.48 94.41 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.417 -0.802 . . . . 36.619999999999997 110.287 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' S' S ' 287' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -62.76 -35.26 79.24 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.326 -0.859 . . . . 46.640000000000001 110.088 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' S' S ' 288' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -76.26 -21.06 56.78 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.437 -0.789 . . . . 46.450000000000003 110.263 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' S' S ' 289' ' ' LEU . . . . . 0.524 HD12 ' HG2' ' S' ' 285' ' ' GLN . 30.7 mt -97.33 -21.69 17.07 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.281 -0.887 . . . . 35.090000000000003 110.54 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' S' S ' 290' ' ' THR . . . . . 0.41 HG22 ' HB3' ' S' ' 306' ' ' ASN . 81.3 p -114.77 -28.49 7.07 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.249 -0.907 . . . . 38.609999999999999 110.435 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' S' S ' 291' ' ' GLY . . . . . . . . . . . . . . . 79.44 11.05 85.3 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.879 -1.288 . . . . 36.770000000000003 109.879 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' S' S ' 292' ' ' LEU . . . . . . . . . . . . . 84.9 mt -96.55 145.82 25.36 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.238 -1.154 . . . . 35.329999999999998 109.754 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' S' S ' 293' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -77.32 102.29 6.68 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.161 -0.962 . . . . 48.700000000000003 110.275 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' S' S ' 294' ' ' LEU . . . . . 0.427 ' HB3' ' CZ2' ' S' ' 252' ' ' TRP . 55.2 mt -106.84 51.75 0.73 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.472 -0.768 . . . . 42.609999999999999 110.117 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' S' S ' 295' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -112.53 -11.2 13.63 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.326 -0.859 . . . . 55.490000000000002 110.485 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' S' S ' 296' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -144.34 48.56 1.36 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.177 -0.952 . . . . 75.680000000000007 110.271 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' S' S ' 297' ' ' GLY . . . . . . . . . . . . . . . 96.88 145.19 18.73 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.457 -1.457 . . . . 49.439999999999998 109.457 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' S' S ' 298' ' ' GLY . . . . . . . . . . . . . . . -163.85 156.94 29.02 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.849 -1.3 . . . . 41.109999999999999 109.849 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' S' S ' 299' ' ' PRO . . . . . 0.486 ' O ' HG23 ' S' ' 303' ' ' VAL . 47.5 Cg_endo -73.81 118.27 5.37 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 123.91 1.479 . . . . 26.199999999999999 110.291 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' S' S ' 300' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.18 -15.57 31.86 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.529 1.278 . . . . 21.699999999999999 110.647 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' S' S ' 301' ' ' ALA . . . . . . . . . . . . . . . -80.7 -29.32 36.49 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.256 -0.903 . . . . 31.23 110.117 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' S' S ' 302' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.5 -40.62 18.96 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.406 -0.809 . . . . 38.990000000000002 109.993 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' S' S ' 303' ' ' VAL . . . . . 0.486 HG23 ' O ' ' S' ' 299' ' ' PRO . 57.2 t -60.69 -35.52 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.398 -0.814 . . . . 18.629999999999999 110.147 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' S' S ' 304' ' ' ILE . . . . . 0.523 HD12 HG21 ' S' ' 379' ' ' VAL . 86.0 mt -79.33 -23.65 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.405 -0.809 . . . . 25.460000000000001 110.179 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' S' S ' 305' ' ' TRP . . . . . 0.413 ' CD2' ' HD3' ' S' ' 308' ' ' LYS . 68.9 t-105 -88.63 -14.53 37.24 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.32 -0.863 . . . . 33.399999999999999 110.521 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' S' S ' 306' ' ' ASN . . . . . 0.41 ' HB3' HG22 ' S' ' 290' ' ' THR . 10.3 m-80 -89.72 -13.56 36.59 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.218 -0.926 . . . . 36.969999999999999 110.369 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' S' S ' 307' ' ' ILE . . . . . 0.471 HG12 ' O ' ' S' ' 303' ' ' VAL . 36.9 pt -125.08 45.62 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.21 -0.931 . . . . 30.809999999999999 110.059 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' S' S ' 308' ' ' LYS . . . . . 0.413 ' HD3' ' CD2' ' S' ' 305' ' ' TRP . 1.5 mtmp? -73.5 -37.75 65.58 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.339 -0.851 . . . . 46.520000000000003 110.12 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' S' S ' 309' ' ' HIS . . . . . 0.496 ' CD2' ' HG ' ' S' ' 310' ' ' LEU . 55.5 p-80 -73.22 -8.26 55.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.318 -0.864 . . . . 51.030000000000001 110.065 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' S' S ' 310' ' ' LEU . . . . . 0.496 ' HG ' ' CD2' ' S' ' 309' ' ' HIS . 52.6 mt -99.31 -12.92 19.9 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.312 -0.867 . . . . 36.159999999999997 109.975 179.306 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' S' S ' 311' ' ' LEU . . . . . 0.531 HD21 ' CE2' ' S' ' 260' ' ' PHE . 10.8 mt -97.13 147.83 23.66 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.367 -0.833 . . . . 40.0 110.499 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' S' S ' 312' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -81.6 -16.24 52.15 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.31 -0.869 . . . . 54.18 109.682 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' S' S ' 313' ' ' THR . . . . . 0.829 HG23 ' HG2' ' S' ' 323' ' ' GLU . 92.7 m -87.95 151.66 22.64 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.371 -0.83 . . . . 25.609999999999999 110.098 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' S' S ' 314' ' ' GLY . . . . . . . . . . . . . . . -87.93 126.41 8.05 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.842 -1.303 . . . . 25.18 109.842 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' S' S ' 315' ' ' ILE . . . . . 0.666 HD13 ' HB ' ' S' ' 324' ' ' VAL . 50.8 mm -101.65 150.51 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.411 -1.052 . . . . 23.899999999999999 109.704 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' S' S ' 316' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' S' ' 325' ' ' CYS . . . -157.09 -159.31 9.41 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.932 -1.267 . . . . 23.18 109.932 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' S' S ' 317' ' ' THR . . . . . 0.424 HG22 ' CG2' ' S' ' 326' ' ' VAL . 11.1 p -133.92 -173.01 3.13 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.447 -1.031 . . . . 27.98 109.958 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' S' S ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.58 -56.19 25.08 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.265 -0.897 . . . . 28.100000000000001 109.858 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' S' S ' 319' ' ' SER . . . . . . . . . . . . . 1.2 m -59.93 -41.61 92.16 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.427 -0.796 . . . . 37.0 109.675 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' S' S ' 320' ' ' ARG . . . . . . . . . . . . . 12.1 mtm180 -111.72 79.85 2.65 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.529 -0.732 . . . . 52.07 109.726 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' S' S ' 321' ' ' PRO . . . . . 0.447 ' O ' ' HB2' ' S' ' 322' ' ' SER . 43.9 Cg_endo -71.44 171.51 16.05 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.883 1.465 . . . . 38.289999999999999 110.927 -179.429 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' S' S ' 322' ' ' SER . . . . . 0.447 ' HB2' ' O ' ' S' ' 321' ' ' PRO . 41.4 t 178.68 -148.15 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.966 -0.753 . . . . 38.840000000000003 108.966 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' S' S ' 323' ' ' GLU . . . . . 0.829 ' HG2' HG23 ' S' ' 313' ' ' THR . 6.7 tp10 -62.85 -40.32 97.1 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.063 -1.023 . . . . 40.700000000000003 109.679 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' S' S ' 324' ' ' VAL . . . . . 0.666 ' HB ' HD13 ' S' ' 315' ' ' ILE . 72.7 t -141.27 135.03 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.396 -0.815 . . . . 20.34 109.46 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' S' S ' 325' ' ' CYS . . . . . 0.462 ' HB2' ' CE1' ' S' ' 380' ' ' PHE . 11.5 m -126.0 172.19 10.16 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.336 -0.853 . . . . 30.629999999999999 110.833 -179.084 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' S' S ' 326' ' ' VAL . . . . . 0.65 HG12 HG22 ' S' ' 379' ' ' VAL . 34.5 m -135.45 142.19 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.58 -0.7 . . . . 23.899999999999999 109.285 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' S' S ' 327' ' ' VAL . . . . . 0.595 HG11 ' O ' ' S' ' 377' ' ' VAL . 34.5 m -56.35 124.93 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.092 -1.005 . . . . 19.48 110.47 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' S' S ' 328' ' ' ASP . . . . . . . . . . . . . 55.6 p-10 -119.28 11.48 12.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.45 -0.781 . . . . 26.43 110.465 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' S' S ' 329' ' ' GLY . . . . . . . . . . . . . . . 119.71 2.23 13.04 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.025 -1.23 . . . . 31.239999999999998 110.025 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' S' S ' 330' ' ' THR . . . . . . . . . . . . . 80.1 m -92.98 130.03 38.69 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.045 -1.268 . . . . 30.050000000000001 110.109 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' S' S ' 331' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -56.81 111.46 1.03 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.261 -0.899 . . . . 37.259999999999998 109.955 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' S' S ' 332' ' ' MET . . . . . . . . . . . . . 88.1 mmm -94.11 162.57 13.82 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.278 -0.889 . . . . 26.23 110.351 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' S' S ' 333' ' ' CYS . . . . . . . . . . . . . 26.2 m -137.19 150.07 47.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.535 -0.728 . . . . 23.559999999999999 110.019 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' S' S ' 334' ' ' LEU . . . . . 0.566 HD11 ' O ' ' S' ' 372' ' ' PRO . 0.1 OUTLIER -52.68 -24.75 9.15 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.339 -0.851 . . . . 28.93 110.522 179.881 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' S' S ' 335' ' ' ALA . . . . . . . . . . . . . . . -89.08 14.42 10.75 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.383 -0.823 . . . . 15.76 110.947 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' S' S ' 336' ' ' ASP . . . . . 0.4 ' O ' ' HA ' ' S' ' 382' ' ' PRO . 70.4 m-20 -100.49 -17.14 17.28 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.1 -1.0 . . . . 34.920000000000002 110.186 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' S' S ' 337' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -152.46 170.85 19.12 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.299 -0.875 . . . . 19.030000000000001 110.017 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' S' S ' 338' ' ' HIS . . . . . 0.402 ' HB3' ' CZ ' ' S' ' 383' ' ' TYR . 13.5 p80 -120.76 10.44 10.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.416 -0.803 . . . . 18.82 110.497 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' S' S ' 339' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' S' ' 352' ' ' ALA . . . -175.97 155.24 1.58 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.293 -0.879 . . . . 17.18 110.103 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' S' S ' 340' ' ' GLY . . . . . 0.401 ' CA ' ' O ' ' S' ' 379' ' ' VAL . . . 160.8 173.09 28.97 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.07 -1.212 . . . . 18.329999999999998 110.07 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' S' S ' 341' ' ' ILE . . . . . . . . . . . . . 84.4 mt -88.88 138.15 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.505 -0.997 . . . . 18.600000000000001 109.757 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' S' S ' 342' ' ' PHE . . . . . 0.493 ' CE2' ' HB3' ' S' ' 352' ' ' ALA . 70.0 m-85 -120.98 -178.41 3.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.26 -0.9 . . . . 23.440000000000001 110.428 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' S' S ' 343' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.85 93.42 4.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.41 -0.806 . . . . 35.590000000000003 109.989 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' S' S ' 344' ' ' LYS . . . . . 0.402 ' O ' ' HB3' ' S' ' 348' ' ' HIS . 0.3 OUTLIER -80.78 125.0 29.52 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.269 -0.894 . . . . 38.340000000000003 110.148 179.948 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' S' S ' 345' ' ' GLY . . . . . . . . . . . . . . . 62.79 -130.81 43.02 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 108.847 -1.701 . . . . 53.460000000000001 108.847 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' S' S ' 346' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -132.79 150.8 52.12 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.199 -1.177 . . . . 70.909999999999997 110.073 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' S' S ' 347' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 53.35 35.36 20.14 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.335 -0.853 . . . . 47.32 110.437 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' S' S ' 348' ' ' HIS . . . . . 0.402 ' HB3' ' O ' ' S' ' 344' ' ' LYS . 46.2 t60 -150.15 155.82 40.49 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.294 -0.879 . . . . 41.719999999999999 110.311 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' S' S ' 349' ' ' ALA . . . . . 0.46 ' C ' HG13 ' S' ' 350' ' ' VAL . . . -149.74 151.32 33.43 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.346 -0.846 . . . . 22.91 110.463 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' S' S ' 350' ' ' VAL . . . . . 0.46 HG13 ' C ' ' S' ' 349' ' ' ALA . 34.6 m -149.11 169.6 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.443 -0.785 . . . . 21.09 110.024 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' S' S ' 351' ' ' PHE . . . . . 0.5 ' CD2' ' HB3' ' S' ' 258' ' ' GLN . 10.7 t80 -105.35 143.54 33.37 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.215 -0.928 . . . . 25.030000000000001 110.706 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' S' S ' 352' ' ' ALA . . . . . 0.493 ' HB3' ' CE2' ' S' ' 342' ' ' PHE . . . -147.66 151.69 36.59 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.646 -0.659 . . . . 23.809999999999999 109.732 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' S' S ' 353' ' ' CYS . . . . . . . . . . . . . 26.3 p -153.34 164.87 37.36 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.291 -0.881 . . . . 25.66 110.246 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' S' S ' 354' ' ' VAL . . . . . 0.547 HG22 ' CE2' ' S' ' 359' ' ' TRP . 56.8 t -75.99 118.5 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.381 -0.824 . . . . 34.270000000000003 109.967 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' S' S ' 355' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' S' ' 232' ' ' THR . 51.5 p -117.81 175.11 5.81 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.282 -0.886 . . . . 25.489999999999998 110.307 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' S' S ' 356' ' ' SER . . . . . . . . . . . . . 62.0 p -62.15 -17.67 58.6 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.455 -0.778 . . . . 31.239999999999998 110.748 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' S' S ' 357' ' ' ASN . . . . . . . . . . . . . 45.8 m-20 -107.03 14.28 26.56 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.145 -0.972 . . . . 28.609999999999999 110.531 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' S' S ' 358' ' ' GLY . . . . . . . . . . . . . . . 111.86 -152.85 17.61 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.045 -1.222 . . . . 22.010000000000002 110.045 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' S' S ' 359' ' ' TRP . . . . . 0.547 ' CE2' HG22 ' S' ' 354' ' ' VAL . 15.4 m95 -91.35 116.73 29.08 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.45 -1.029 . . . . 25.539999999999999 110.176 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' S' S ' 360' ' ' TYR . . . . . 0.413 ' HA ' ' HA ' ' S' ' 369' ' ' PRO . 1.3 m-85 -103.52 165.83 10.8 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.338 -0.851 . . . . 40.530000000000001 110.032 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' S' S ' 361' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' S' ' 351' ' ' PHE . . . -140.1 130.1 24.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.361 -0.837 . . . . 18.039999999999999 110.268 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' S' S ' 362' ' ' ILE . . . . . . . . . . . . . 89.1 mt -95.61 83.64 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.409 -0.807 . . . . 15.640000000000001 110.061 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' S' S ' 363' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' S' ' 365' ' ' GLU . 11.8 t0 -75.25 94.51 3.01 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.422 -0.799 . . . . 35.030000000000001 110.201 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' S' S ' 364' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 53.98 -89.43 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.551 -0.718 . . . . 46.719999999999999 110.511 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' S' S ' 365' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' S' ' 363' ' ' ASP . 23.7 mt-10 -122.7 19.2 10.31 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.075 -1.016 . . . . 56.200000000000003 110.245 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' S' S ' 366' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -117.98 124.96 49.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.169 -0.957 . . . . 51.020000000000003 110.395 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' S' S ' 367' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -107.03 127.05 53.12 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.344 -0.847 . . . . 37.590000000000003 110.137 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' S' S ' 368' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -165.38 159.5 13.99 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.247 -0.908 . . . . 31.469999999999999 110.481 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' S' S ' 369' ' ' PRO . . . . . 0.413 ' HA ' ' HA ' ' S' ' 360' ' ' TYR . 46.8 Cg_endo -72.8 139.61 30.8 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.859 1.452 . . . . 28.850000000000001 110.538 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' S' S ' 370' ' ' TRP . . . . . . . . . . . . . 67.6 t90 -167.2 113.56 0.76 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.347 -0.846 . . . . 26.940000000000001 109.942 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' S' S ' 371' ' ' THR . . . . . . . . . . . . . 59.9 m -74.81 113.02 20.37 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.417 -0.802 . . . . 20.190000000000001 110.01 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' S' S ' 372' ' ' PRO . . . . . 0.566 ' O ' HD11 ' S' ' 334' ' ' LEU . 48.1 Cg_endo -73.52 157.09 49.39 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 O-C-N 123.597 1.314 . . . . 28.68 110.624 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' S' S ' 373' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -90.56 147.15 35.76 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.492 -0.755 . . . . 35.719999999999999 109.896 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' S' S ' 374' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -76.03 -6.27 17.18 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 O-C-N 123.652 1.343 . . . . 30.890000000000001 110.459 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' S' S ' 375' ' ' SER . . . . . . . . . . . . . 68.6 p -104.41 -16.9 14.97 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.22 -0.925 . . . . 29.41 110.451 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' S' S ' 376' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -106.51 43.02 1.19 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.231 -0.918 . . . . 32.890000000000001 110.217 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' S' S ' 377' ' ' VAL . . . . . 0.595 ' O ' HG11 ' S' ' 327' ' ' VAL . 7.3 p -114.65 147.27 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.374 -0.829 . . . . 24.329999999999998 110.216 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' S' S ' 378' ' ' LEU . . . . . . . . . . . . . 52.3 mt -115.99 -58.01 2.15 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.348 -0.845 . . . . 24.370000000000001 109.638 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' S' S ' 379' ' ' VAL . . . . . 0.65 HG22 HG12 ' S' ' 326' ' ' VAL . 61.3 t -120.64 132.4 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.471 -0.768 . . . . 18.02 109.443 179.251 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' S' S ' 380' ' ' PHE . . . . . 0.462 ' CE1' ' HB2' ' S' ' 325' ' ' CYS . 14.4 p90 -142.63 174.0 11.03 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.309 -0.869 . . . . 29.350000000000001 110.634 -179.347 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' S' S ' 381' ' ' VAL . . . . . . . . . . . . . 58.4 t -120.1 107.32 39.81 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.578 -0.701 . . . . 16.34 109.398 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' S' S ' 382' ' ' PRO . . . . . 0.4 ' HA ' ' O ' ' S' ' 336' ' ' ASP . 45.7 Cg_endo -71.26 145.65 49.16 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 O-C-N 123.626 1.329 . . . . 20.940000000000001 110.759 -179.374 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' S' S ' 383' ' ' TYR . . . . . 0.402 ' CZ ' ' HB3' ' S' ' 338' ' ' HIS . 88.3 m-85 -61.08 -53.47 56.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.398 -0.814 . . . . 28.93 109.869 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' S' S ' 384' ' ' ASP . . . . . . . . . . . . . 9.7 t0 . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.482 -0.761 . . . . 47.030000000000001 110.358 -176.083 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' R' R ' 30' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.127 0.489 . . . . 43.359999999999999 110.247 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' R' R ' 31' ' ' LEU . . . . . . . . . . . . . 65.4 mt -134.86 140.54 45.9 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.293 -0.879 . . . . 22.93 110.332 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' R' R ' 32' ' ' THR . . . . . . . . . . . . . 69.0 m -87.55 110.61 20.48 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.337 -0.852 . . . . 22.34 109.983 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' R' R ' 33' ' ' LEU . . . . . 0.594 HD22 ' CE2' ' R' ' 62' ' ' TYR . 80.2 mt -62.52 -172.74 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.237 -0.915 . . . . 21.390000000000001 110.209 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' R' R ' 34' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -74.59 -29.4 61.31 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.375 -0.828 . . . . 34.399999999999999 110.41 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' R' R ' 35' ' ' ASN . . . . . . . . . . . . . 48.2 p30 -77.84 -1.74 33.11 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.322 -0.861 . . . . 30.280000000000001 110.665 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' R' R ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.1 -16.53 59.4 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.8 -1.32 . . . . 36.25 109.8 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' R' R ' 37' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -59.0 161.81 4.73 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.256 -1.144 . . . . 53.799999999999997 110.383 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' R' R ' 38' ' ' LYS . . . . . . . . . . . . . 57.0 mttt -117.86 135.8 53.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.43 -0.794 . . . . 49.909999999999997 110.175 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' R' R ' 39' ' ' LYS . . . . . 0.404 ' HG2' ' CZ ' ' R' ' 41' ' ' PHE . 8.1 ttmt -138.77 143.65 39.07 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.427 -0.796 . . . . 35.689999999999998 110.241 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' R' R ' 40' ' ' THR . . . . . . . . . . . . . 23.6 m -102.56 127.97 49.41 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.424 -0.798 . . . . 34.840000000000003 110.226 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' R' R ' 41' ' ' PHE . . . . . 0.404 ' CZ ' ' HG2' ' R' ' 39' ' ' LYS . 96.6 m-85 -113.09 132.63 55.35 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.386 -0.821 . . . . 34.420000000000002 110.21 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' R' R ' 42' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -93.21 140.86 29.06 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.348 -0.845 . . . . 51.460000000000001 110.263 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' R' R ' 43' ' ' SER . . . . . . . . . . . . . 54.2 m -70.74 141.83 51.47 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.511 -0.743 . . . . 41.840000000000003 110.196 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' R' R ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.78 125.38 29.56 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.347 -0.845 . . . . 33.82 109.984 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' R' R ' 45' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.11 151.05 55.03 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 123.611 1.321 . . . . 30.27 110.649 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' R' R ' 46' ' ' ASN . . . . . 0.4 ' HA ' ' OD1' ' R' ' 50' ' ' ASN . 52.1 t-20 -124.27 109.95 14.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.456 -0.777 . . . . 35.100000000000001 110.011 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' R' R ' 47' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -120.33 -34.84 3.56 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.339 -0.85 . . . . 42.810000000000002 110.493 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' R' R ' 48' ' ' HIS . . . . . 0.44 ' NE2' HD11 ' R' ' 80' ' ' LEU . 73.3 m80 -105.79 45.23 0.98 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.221 -0.925 . . . . 49.969999999999999 110.216 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' R' R ' 49' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 50.28 34.73 9.26 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.358 -0.839 . . . . 61.32 110.197 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' R' R ' 50' ' ' ASN . . . . . 0.4 ' OD1' ' HA ' ' R' ' 46' ' ' ASN . 15.0 p-10 -86.3 43.78 1.09 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.379 -0.826 . . . . 51.5 110.685 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' R' R ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.1 -46.12 78.73 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.199 -0.938 . . . . 38.770000000000003 109.474 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' R' R ' 52' ' ' TRP . . . . . 0.484 ' CD2' ' N ' ' R' ' 53' ' ' LEU . 68.1 p-90 -58.38 -38.42 77.25 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.455 -0.778 . . . . 26.239999999999998 110.055 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' R' R ' 53' ' ' LEU . . . . . 0.484 ' N ' ' CD2' ' R' ' 52' ' ' TRP . 23.1 tp -66.75 -46.62 74.81 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.424 -0.798 . . . . 26.75 109.984 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' R' R ' 54' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -55.35 -41.52 72.65 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.304 -0.872 . . . . 35.020000000000003 110.111 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' R' R ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.17 -46.08 91.99 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.448 -0.782 . . . . 24.469999999999999 110.157 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' R' R ' 56' ' ' ILE . . . . . 0.431 HG12 HD11 ' R' ' 104' ' ' ILE . 76.0 mt -62.2 -42.28 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.322 -0.861 . . . . 26.030000000000001 109.888 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' R' R ' 57' ' ' LEU . . . . . . . . . . . . . 22.4 mt -60.27 -45.63 92.63 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.28 -0.888 . . . . 26.77 109.68 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' R' R ' 58' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -63.87 -46.59 84.25 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.481 -0.762 . . . . 22.32 109.571 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' R' R ' 59' ' ' LEU . . . . . 0.43 ' HA ' ' HE2' ' R' ' 151' ' ' PHE . 24.0 tp -61.34 -37.84 84.73 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.317 -0.864 . . . . 20.550000000000001 109.389 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' R' R ' 60' ' ' PHE . . . . . 0.528 ' CE2' HD21 ' R' ' 111' ' ' LEU . 2.8 m-85 -61.05 -44.72 96.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.635 -0.666 . . . . 20.079999999999998 109.913 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' R' R ' 61' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -63.18 -36.15 82.66 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.488 -0.758 . . . . 18.800000000000001 110.443 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' R' R ' 62' ' ' TYR . . . . . 0.594 ' CE2' HD22 ' R' ' 33' ' ' LEU . 9.1 t80 -63.09 -41.81 99.48 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.234 -0.916 . . . . 26.449999999999999 110.199 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' R' R ' 63' ' ' VAL . . . . . 0.406 ' H ' HG22 ' R' ' 63' ' ' VAL . 30.5 m -93.38 20.35 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.422 -0.799 . . . . 29.75 110.252 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' R' R ' 64' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 53.03 75.56 0.24 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.316 -0.865 . . . . 35.520000000000003 110.531 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' R' R ' 65' ' ' GLU . . . . . 0.442 ' HG2' ' CD2' ' R' ' 60' ' ' PHE . 14.3 tp10 -116.3 104.06 52.33 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.348 -0.845 . . . . 29.890000000000001 109.901 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' R' R ' 66' ' ' PRO . . . . . 0.48 ' HA ' ' HB2' ' R' ' 69' ' ' ASP . 46.3 Cg_endo -73.57 -5.8 17.69 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.775 1.408 . . . . 21.370000000000001 111.093 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' R' R ' 67' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -52.13 -61.44 2.27 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.116 -0.99 . . . . 23.850000000000001 110.43 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' R' R ' 68' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -98.23 36.58 1.57 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.306 -0.871 . . . . 28.07 110.484 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' R' R ' 69' ' ' ASP . . . . . 0.48 ' HB2' ' HA ' ' R' ' 66' ' ' PRO . 11.7 t0 -72.3 -33.35 67.32 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.23 -0.918 . . . . 43.759999999999998 110.097 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' R' R ' 70' ' ' TRP . . . . . 0.477 ' CE2' ' CG2' ' R' ' 71' ' ' VAL . 47.7 p-90 -73.24 -4.03 30.5 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.313 -0.867 . . . . 33.060000000000002 110.74 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' R' R ' 71' ' ' VAL . . . . . 0.556 HG11 ' HB2' ' R' ' 82' ' ' ALA . 40.8 t -109.78 -27.41 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.078 -1.014 . . . . 31.699999999999999 109.674 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' R' R ' 72' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -86.62 -48.76 8.04 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.347 -0.845 . . . . 33.579999999999998 110.288 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' R' R ' 73' ' ' SER . . . . . . . . . . . . . 69.9 m -89.75 51.12 2.01 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.283 -0.886 . . . . 50.82 110.295 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' R' R ' 74' ' ' SER . . . . . . . . . . . . . 15.7 t -125.99 138.27 31.78 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.335 -0.853 . . . . 34.740000000000002 110.208 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.31 -25.02 16.02 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.737 1.388 . . . . 35.700000000000003 110.341 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' R' R ' 76' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -91.66 153.16 19.87 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.398 -0.814 . . . . 66.480000000000004 110.428 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' R' R ' 77' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -81.5 95.2 7.04 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.364 -0.835 . . . . 46.719999999999999 110.035 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' R' R ' 78' ' ' LEU . . . . . . . . . . . . . 96.3 mt -96.4 27.91 3.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.385 -0.822 . . . . 37.549999999999997 110.22 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' R' R ' 79' ' ' THR . . . . . . . . . . . . . 29.4 m -56.18 -54.64 42.78 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.317 -0.865 . . . . 37.359999999999999 110.295 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' R' R ' 80' ' ' LEU . . . . . 0.603 ' HA ' HD12 ' R' ' 83' ' ' ILE . 15.8 mt -60.97 -23.13 65.1 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.351 -0.843 . . . . 35.829999999999998 110.478 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' R' R ' 81' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -79.55 -39.08 32.7 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.147 -0.971 . . . . 44.030000000000001 110.331 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' R' R ' 82' ' ' ALA . . . . . 0.556 ' HB2' HG11 ' R' ' 71' ' ' VAL . . . -69.5 -28.67 66.25 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.227 -0.921 . . . . 32.539999999999999 110.23 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' R' R ' 83' ' ' ILE . . . . . 0.603 HD12 ' HA ' ' R' ' 80' ' ' LEU . 78.2 mt -70.04 -46.1 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.221 -0.925 . . . . 32.020000000000003 110.342 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' R' R ' 84' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -55.21 -52.02 64.71 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.232 -0.918 . . . . 34.090000000000003 110.607 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' R' R ' 85' ' ' GLN . . . . . 0.533 ' HG2' HD12 ' R' ' 89' ' ' LEU . 31.9 tt0 -54.85 -46.81 74.7 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.203 -0.936 . . . . 25.940000000000001 110.269 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' R' R ' 86' ' ' LEU . . . . . . . . . . . . . 23.9 mt -58.74 -43.77 90.33 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.312 -0.867 . . . . 16.199999999999999 109.905 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' R' R ' 87' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -65.38 -35.16 80.12 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.529 -0.732 . . . . 49.090000000000003 110.251 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' R' R ' 88' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -78.46 -19.03 54.0 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.381 -0.825 . . . . 28.609999999999999 110.51 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' R' R ' 89' ' ' LEU . . . . . 0.533 HD12 ' HG2' ' R' ' 85' ' ' GLN . 32.5 mt -96.24 -29.38 14.05 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.261 -0.899 . . . . 26.16 110.167 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' R' R ' 90' ' ' THR . . . . . . . . . . . . . 59.2 p -105.68 -34.66 7.64 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.327 -0.858 . . . . 33.329999999999998 109.747 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' R' R ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.91 16.06 58.55 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.835 -1.306 . . . . 31.129999999999999 109.835 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' R' R ' 92' ' ' LEU . . . . . . . . . . . . . 97.0 mt -100.07 155.18 17.86 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.112 -1.228 . . . . 42.520000000000003 110.266 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' R' R ' 93' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -86.2 91.66 8.52 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.489 -0.757 . . . . 68.459999999999994 109.948 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' R' R ' 94' ' ' LEU . . . . . 0.457 ' HB3' ' CZ2' ' R' ' 52' ' ' TRP . 48.2 mt -99.51 53.0 0.94 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.147 -0.971 . . . . 44.630000000000003 110.368 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' R' R ' 95' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.54 -38.67 6.37 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.348 -0.845 . . . . 67.159999999999997 110.34 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' R' R ' 96' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -113.83 44.11 1.69 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.316 -0.865 . . . . 67.019999999999996 110.337 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' R' R ' 97' ' ' GLY . . . . . . . . . . . . . . . 99.2 150.87 26.06 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.598 -1.401 . . . . 49.479999999999997 109.598 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' R' R ' 98' ' ' GLY . . . . . . . . . . . . . . . -166.28 159.99 33.42 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.245 -1.542 . . . . 36.57 109.245 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' R' R ' 99' ' ' PRO . . . . . 0.79 ' O ' HG23 ' R' ' 103' ' ' VAL . 44.9 Cg_endo -72.56 121.12 7.15 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 O-C-N 123.703 1.37 . . . . 30.41 110.435 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' R' R ' 100' ' ' PRO . . . . . 0.411 ' HA ' HD11 ' R' ' 56' ' ' ILE . 45.8 Cg_endo -72.27 -31.7 11.39 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.567 1.299 . . . . 29.940000000000001 110.506 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' R' R ' 101' ' ' ALA . . . . . 0.476 ' HB2' ' HB3' ' R' ' 178' ' ' LEU . . . -69.97 -38.41 76.06 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.226 -0.921 . . . . 23.640000000000001 110.266 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' R' R ' 102' ' ' LEU . . . . . 0.423 HD23 HD21 ' R' ' 106' ' ' ASN . 0.1 OUTLIER -72.69 -40.82 65.94 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.367 -0.833 . . . . 20.309999999999999 110.324 -179.718 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' R' R ' 103' ' ' VAL . . . . . 0.79 HG23 ' O ' ' R' ' 99' ' ' PRO . 63.9 t -58.08 -40.15 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.281 -0.887 . . . . 16.329999999999998 109.934 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' R' R ' 104' ' ' ILE . . . . . 0.431 HD11 HG12 ' R' ' 56' ' ' ILE . 81.7 mt -71.7 -30.49 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.388 -0.82 . . . . 24.77 109.985 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' R' R ' 105' ' ' TRP . . . . . 0.461 ' O ' ' HD3' ' R' ' 108' ' ' LYS . 70.6 t-105 -82.42 0.81 40.39 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.345 -0.847 . . . . 23.280000000000001 110.33 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' R' R ' 106' ' ' ASN . . . . . 0.423 HD21 HD23 ' R' ' 102' ' ' LEU . 6.9 m-80 -105.05 -10.38 17.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.143 -0.973 . . . . 28.260000000000002 110.146 179.61 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' R' R ' 107' ' ' ILE . . . . . . . . . . . . . 36.8 pt -126.81 35.0 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.225 -0.922 . . . . 18.77 110.01 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' R' R ' 108' ' ' LYS . . . . . 0.501 ' HG2' ' HB ' ' R' ' 115' ' ' ILE . 9.2 mtpp -61.06 -48.47 81.59 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.528 -0.733 . . . . 42.5 110.031 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' R' R ' 109' ' ' HIS . . . . . 0.445 ' CD2' ' HG ' ' R' ' 110' ' ' LEU . 50.8 p-80 -66.01 -12.86 58.1 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.503 -0.748 . . . . 20.07 110.696 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' R' R ' 110' ' ' LEU . . . . . 0.445 ' HG ' ' CD2' ' R' ' 109' ' ' HIS . 80.8 mt -94.84 -17.31 22.2 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.145 -0.972 . . . . 15.69 110.181 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' R' R ' 111' ' ' LEU . . . . . 0.528 HD21 ' CE2' ' R' ' 60' ' ' PHE . 10.4 mt -94.1 144.14 25.75 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.341 -0.85 . . . . 25.390000000000001 111.004 -179.204 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' R' R ' 112' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -77.71 -17.36 57.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.451 -0.781 . . . . 53.479999999999997 109.846 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' R' R ' 113' ' ' THR . . . . . 0.457 HG22 ' N ' ' R' ' 114' ' ' GLY . 60.5 m -83.72 166.68 17.86 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.251 -0.906 . . . . 14.800000000000001 110.22 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' R' R ' 114' ' ' GLY . . . . . 0.457 ' N ' HG22 ' R' ' 113' ' ' THR . . . -97.96 127.16 9.13 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.994 -1.243 . . . . 16.140000000000001 109.994 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' R' R ' 115' ' ' ILE . . . . . 0.577 HD13 ' HB ' ' R' ' 124' ' ' VAL . 47.8 mm -109.09 139.36 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.475 -1.015 . . . . 13.460000000000001 109.71 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' R' R ' 116' ' ' GLY . . . . . . . . . . . . . . . -152.78 -155.81 7.27 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.964 -1.254 . . . . 23.899999999999999 109.964 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' R' R ' 117' ' ' THR . . . . . 0.528 HG22 ' CG2' ' R' ' 126' ' ' VAL . 18.9 p -135.06 -171.46 2.81 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.467 -1.019 . . . . 27.370000000000001 110.02 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' R' R ' 118' ' ' ALA . . . . . 0.445 ' HB3' ' OD1' ' R' ' 128' ' ' ASP . . . -56.5 -58.09 9.53 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.337 -0.852 . . . . 18.760000000000002 110.064 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' R' R ' 119' ' ' SER . . . . . 0.418 ' HA ' ' CB ' ' R' ' 194' ' ' ALA . 1.1 m -56.54 -40.65 75.46 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.267 -0.896 . . . . 32.350000000000001 109.69 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' R' R ' 120' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 -110.02 86.19 4.77 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.458 -0.776 . . . . 27.120000000000001 109.643 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' R' R ' 121' ' ' PRO . . . . . 0.482 ' HA ' ' SG ' ' R' ' 125' ' ' CYS . 44.3 Cg_endo -71.26 166.55 28.9 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.817 1.43 . . . . 22.68 111.02 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' R' R ' 122' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' R' ' 121' ' ' PRO . 38.6 t 178.55 -161.67 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.643 -0.661 . . . . 22.989999999999998 109.447 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' R' R ' 123' ' ' GLU . . . . . 0.442 ' HG2' HG23 ' R' ' 113' ' ' THR . 2.3 tp10 -56.47 -39.95 74.06 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.211 -0.93 . . . . 36.18 109.673 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' R' R ' 124' ' ' VAL . . . . . 0.577 ' HB ' HD13 ' R' ' 115' ' ' ILE . 84.2 t -142.52 136.43 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.471 -0.768 . . . . 20.640000000000001 109.333 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' R' R ' 125' ' ' CYS . . . . . 0.482 ' SG ' ' HA ' ' R' ' 121' ' ' PRO . 83.4 m -140.32 168.16 20.46 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.245 -0.91 . . . . 22.800000000000001 111.206 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' R' R ' 126' ' ' VAL . . . . . 0.729 HG12 HG22 ' R' ' 179' ' ' VAL . 35.9 m -122.68 159.75 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.713 -0.617 . . . . 21.239999999999998 109.595 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' R' R ' 127' ' ' VAL . . . . . 0.709 HG11 ' O ' ' R' ' 177' ' ' VAL . 30.5 m -70.83 141.83 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.29 -0.881 . . . . 19.77 110.708 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' R' R ' 128' ' ' ASP . . . . . 0.445 ' OD1' ' HB3' ' R' ' 118' ' ' ALA . 53.8 p-10 -137.7 19.42 2.87 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.37 -0.831 . . . . 29.210000000000001 110.664 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' R' R ' 129' ' ' GLY . . . . . . . . . . . . . . . 114.08 0.05 24.02 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.967 -1.111 . . . . 33.859999999999999 110.403 179.274 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' R' R ' 130' ' ' THR . . . . . . . . . . . . . 58.7 m -91.91 131.83 36.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.145 -1.209 . . . . 26.41 110.08 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -62.51 120.66 11.53 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.338 -0.852 . . . . 33.079999999999998 110.224 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' R' R ' 132' ' ' MET . . . . . 0.435 ' HE1' ' CE2' ' R' ' 180' ' ' PHE . 98.3 mmm -105.16 165.67 10.93 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.558 -0.714 . . . . 30.760000000000002 110.472 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' R' R ' 133' ' ' CYS . . . . . 0.411 ' HA ' ' HB3' ' R' ' 174' ' ' PRO . 32.3 m -141.22 158.09 44.36 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.52 -0.737 . . . . 27.0 109.907 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' R' R ' 134' ' ' LEU . . . . . 0.562 HD11 ' O ' ' R' ' 172' ' ' PRO . 0.1 OUTLIER -58.41 -19.76 38.86 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.312 -0.868 . . . . 33.899999999999999 110.453 -179.894 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' R' R ' 135' ' ' ALA . . . . . . . . . . . . . . . -92.77 8.18 40.5 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.257 -0.902 . . . . 19.370000000000001 110.78 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' R' R ' 136' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -93.72 -21.81 19.11 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.198 -0.939 . . . . 30.469999999999999 110.228 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' R' R ' 137' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -149.94 165.28 33.11 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.319 -0.863 . . . . 24.27 110.22 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' R' R ' 138' ' ' HIS . . . . . 0.434 ' HA ' HG23 ' R' ' 154' ' ' VAL . 15.3 p80 -117.73 15.08 14.46 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.429 -0.794 . . . . 20.91 110.459 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' R' R ' 139' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' R' ' 152' ' ' ALA . . . -177.16 152.46 0.88 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.306 -0.871 . . . . 15.69 110.08 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' R' R ' 140' ' ' GLY . . . . . 0.427 ' HA3' ' O ' ' R' ' 179' ' ' VAL . . . 161.74 175.14 32.45 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 110.0 -1.24 . . . . 23.760000000000002 110.0 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' R' R ' 141' ' ' ILE . . . . . . . . . . . . . 83.8 mt -95.48 136.58 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.371 -1.076 . . . . 25.300000000000001 109.674 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' R' R ' 142' ' ' PHE . . . . . 0.578 ' CD2' ' HB2' ' R' ' 172' ' ' PRO . 82.6 m-85 -120.73 -172.59 2.41 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.27 -0.894 . . . . 30.239999999999998 110.512 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' R' R ' 143' ' ' LEU . . . . . 0.743 HD23 ' O ' ' R' ' 148' ' ' HIS . 0.5 OUTLIER -119.81 77.72 1.26 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.43 -0.794 . . . . 32.799999999999997 110.301 -179.924 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' R' R ' 144' ' ' LYS . . . . . 0.47 ' HG3' ' CZ2' ' R' ' 170' ' ' TRP . 1.0 OUTLIER -69.54 76.83 0.41 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.363 -0.835 . . . . 49.18 109.728 179.549 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' R' R ' 145' ' ' GLY . . . . . 0.456 ' O ' HD22 ' R' ' 143' ' ' LEU . . . 104.57 179.32 24.74 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.202 -1.559 . . . . 53.869999999999997 109.202 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' R' R ' 146' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -88.49 145.83 25.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.369 -1.077 . . . . 68.579999999999998 110.006 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' R' R ' 147' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 58.26 36.45 25.68 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.347 -0.845 . . . . 56.619999999999997 110.655 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' R' R ' 148' ' ' HIS . . . . . 0.743 ' O ' HD23 ' R' ' 143' ' ' LEU . 45.1 t60 -158.67 148.09 19.16 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.267 -0.895 . . . . 44.57 110.359 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' R' R ' 149' ' ' ALA . . . . . . . . . . . . . . . -150.27 146.91 27.07 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.484 -0.76 . . . . 33.539999999999999 110.072 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' R' R ' 150' ' ' VAL . . . . . . . . . . . . . 34.2 m -142.32 161.51 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.263 -0.898 . . . . 27.609999999999999 110.322 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' R' R ' 151' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' R' ' 152' ' ' ALA . 5.9 t80 -86.24 155.63 20.62 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.401 -0.812 . . . . 23.039999999999999 109.881 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' R' R ' 152' ' ' ALA . . . . . 0.537 ' N ' ' CD1' ' R' ' 151' ' ' PHE . . . -157.31 151.51 24.83 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.45 -0.781 . . . . 29.609999999999999 109.589 179.078 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' R' R ' 153' ' ' CYS . . . . . . . . . . . . . 26.7 p -154.27 173.6 15.93 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.347 -0.846 . . . . 22.75 110.444 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' R' R ' 154' ' ' VAL . . . . . 0.615 HG22 ' CE2' ' R' ' 159' ' ' TRP . 59.7 t -90.64 117.03 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.425 -0.797 . . . . 23.260000000000002 110.061 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' R' R ' 155' ' ' THR . . . . . . . . . . . . . 69.9 p -112.11 -176.6 2.96 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.313 -0.867 . . . . 17.879999999999999 110.065 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' R' R ' 156' ' ' SER . . . . . . . . . . . . . 78.5 p -75.98 -3.66 36.86 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.27 -0.894 . . . . 21.829999999999998 110.672 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' R' R ' 157' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -118.36 10.53 12.79 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.138 -0.976 . . . . 36.539999999999999 110.59 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' R' R ' 158' ' ' GLY . . . . . . . . . . . . . . . 117.92 -162.68 13.01 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.567 -1.413 . . . . 31.739999999999998 109.567 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' R' R ' 159' ' ' TRP . . . . . 0.615 ' CE2' HG22 ' R' ' 154' ' ' VAL . 14.7 m95 -86.56 122.45 30.5 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.389 -1.065 . . . . 28.25 110.147 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' R' R ' 160' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -108.45 166.91 10.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.305 -0.872 . . . . 41.240000000000002 110.218 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' R' R ' 161' ' ' ALA . . . . . . . . . . . . . . . -143.21 123.48 13.79 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.403 -0.81 . . . . 27.399999999999999 110.14 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' R' R ' 162' ' ' ILE . . . . . . . . . . . . . 92.3 mt -87.59 81.14 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.324 -0.86 . . . . 24.27 110.015 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' R' R ' 163' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' R' ' 165' ' ' GLU . 15.3 t0 -72.78 92.41 1.57 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.406 -0.809 . . . . 36.079999999999998 110.262 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' R' R ' 164' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 54.07 -88.97 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.564 -0.71 . . . . 46.079999999999998 110.603 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' R' R ' 165' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' R' ' 163' ' ' ASP . 29.8 mt-10 -124.72 36.03 4.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.083 -1.011 . . . . 50.939999999999998 110.194 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' R' R ' 166' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -135.75 117.33 14.88 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.388 -0.82 . . . . 47.280000000000001 110.347 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' R' R ' 167' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -101.1 119.96 39.51 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.427 -0.795 . . . . 40.469999999999999 110.132 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' R' R ' 168' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -157.49 158.59 30.76 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.216 -0.927 . . . . 30.210000000000001 110.423 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' R' R ' 169' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.79 132.98 19.38 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 O-C-N 123.831 1.437 . . . . 32.759999999999998 110.527 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' R' R ' 170' ' ' TRP . . . . . 0.47 ' CZ2' ' HG3' ' R' ' 144' ' ' LYS . 67.0 t90 -159.78 119.37 2.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.384 -0.823 . . . . 32.789999999999999 109.909 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' R' R ' 171' ' ' THR . . . . . . . . . . . . . 47.5 m -81.12 112.62 34.35 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.448 -0.783 . . . . 36.920000000000002 110.141 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' R' R ' 172' ' ' PRO . . . . . 0.578 ' HB2' ' CD2' ' R' ' 142' ' ' PHE . 48.0 Cg_endo -73.7 158.83 46.62 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.596 1.314 . . . . 33.539999999999999 110.545 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' R' R ' 173' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -88.92 144.93 33.64 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.415 -0.803 . . . . 45.759999999999998 109.904 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' R' R ' 174' ' ' PRO . . . . . 0.411 ' HB3' ' HA ' ' R' ' 133' ' ' CYS . 46.0 Cg_endo -71.72 -10.34 26.35 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 O-C-N 123.517 1.272 . . . . 29.629999999999999 110.497 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' R' R ' 175' ' ' SER . . . . . . . . . . . . . 52.9 p -103.42 -17.63 15.16 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.348 -0.845 . . . . 35.700000000000003 110.396 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' R' R ' 176' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -103.48 43.18 1.1 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.213 -0.93 . . . . 39.649999999999999 110.4 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' R' R ' 177' ' ' VAL . . . . . 0.709 ' O ' HG11 ' R' ' 127' ' ' VAL . 10.7 p -117.71 127.17 75.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.368 -0.832 . . . . 20.609999999999999 110.043 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' R' R ' 178' ' ' LEU . . . . . 0.476 ' HB3' ' HB2' ' R' ' 101' ' ' ALA . 46.1 mt -91.56 -61.24 1.69 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.362 -0.836 . . . . 15.58 109.378 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' R' R ' 179' ' ' VAL . . . . . 0.729 HG22 HG12 ' R' ' 126' ' ' VAL . 67.8 t -114.67 144.69 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.676 -0.64 . . . . 17.399999999999999 109.391 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' R' R ' 180' ' ' PHE . . . . . 0.435 ' CE2' ' HE1' ' R' ' 132' ' ' MET . 43.6 p90 -152.17 163.41 39.45 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.268 -0.895 . . . . 20.16 110.529 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' R' R ' 181' ' ' VAL . . . . . . . . . . . . . 66.6 t -113.2 111.49 50.19 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.488 -0.758 . . . . 17.690000000000001 109.862 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' R' R ' 182' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.06 149.49 52.61 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 O-C-N 123.606 1.319 . . . . 17.809999999999999 110.456 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' R' R ' 183' ' ' TYR . . . . . 0.709 ' O ' ' C ' ' R' ' 184' ' ' ASP . 79.5 m-85 -58.92 175.45 0.28 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.463 -0.773 . . . . 28.010000000000002 110.535 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' R' R ' 184' ' ' ASP . . . . . 0.709 ' C ' ' O ' ' R' ' 183' ' ' TYR . 6.1 m-20 -17.71 -82.75 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.313 -0.867 . . . . 58.640000000000001 110.271 -178.169 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' R' R ' 185' ' ' GLN . . . . . . . . . . . . . 49.2 mm-40 . . . . . 0 N--CA 1.503 2.183 0 CA-C-O 121.23 0.538 . . . . 80.420000000000002 111.783 179.547 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' R' R ' 193' ' ' LYS . . . . . . . . . . . . . 28.0 mtmt . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 120.888 0.375 . . . . 49.5 110.192 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' R' R ' 194' ' ' ALA . . . . . 0.418 ' CB ' ' HA ' ' R' ' 119' ' ' SER . . . . . . . . 0 N--CA 1.494 1.76 0 O-C-N 121.172 -0.955 . . . . 40.399999999999999 110.127 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' S' S ' 229' ' ' MET . . . . . 0.469 ' HG3' ' N ' ' S' ' 230' ' ' GLU . 3.3 ptt? . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.181 0.515 . . . . 51.829999999999998 110.233 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' S' S ' 230' ' ' GLU . . . . . 0.469 ' N ' ' HG3' ' S' ' 229' ' ' MET . 33.2 tt0 -97.29 142.75 28.79 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.432 -0.793 . . . . 54.130000000000003 110.196 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' S' S ' 231' ' ' LEU . . . . . . . . . . . . . 68.0 mt -134.12 141.05 46.99 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.352 -0.842 . . . . 33.039999999999999 110.334 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' S' S ' 232' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' S' ' 355' ' ' THR . 40.3 m -89.26 103.24 15.88 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.343 -0.848 . . . . 26.920000000000002 110.041 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' S' S ' 233' ' ' LEU . . . . . 0.672 HD22 ' CE2' ' S' ' 262' ' ' TYR . 79.7 mt -55.87 179.29 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.531 -0.731 . . . . 13.779999999999999 110.543 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' S' S ' 234' ' ' TYR . . . . . 0.448 ' CG ' ' N ' ' S' ' 235' ' ' ASN . 35.5 p90 -65.02 -35.63 81.81 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.426 -0.797 . . . . 26.079999999999998 110.189 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' S' S ' 235' ' ' ASN . . . . . 0.448 ' N ' ' CG ' ' S' ' 234' ' ' TYR . 50.6 p30 -74.36 -7.47 52.96 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.345 -0.847 . . . . 20.039999999999999 110.531 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' S' S ' 236' ' ' GLY . . . . . . . . . . . . . . . 95.79 -19.96 51.97 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.764 -1.334 . . . . 22.710000000000001 109.764 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' S' S ' 237' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -52.95 145.63 12.45 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.258 -1.142 . . . . 35.439999999999998 110.235 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' S' S ' 238' ' ' LYS . . . . . . . . . . . . . 44.4 mttt -102.1 127.85 48.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.349 -0.845 . . . . 32.560000000000002 110.426 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' S' S ' 239' ' ' LYS . . . . . 0.403 ' HG2' ' CZ ' ' S' ' 241' ' ' PHE . 9.0 ttmt -132.29 144.51 50.64 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.41 -0.806 . . . . 26.68 109.992 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' S' S ' 240' ' ' THR . . . . . . . . . . . . . 51.7 m -102.08 132.17 48.12 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.362 -0.836 . . . . 41.020000000000003 110.37 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' S' S ' 241' ' ' PHE . . . . . 0.403 ' CZ ' ' HG2' ' S' ' 239' ' ' LYS . 96.0 m-85 -117.85 137.66 52.63 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.379 -0.826 . . . . 28.620000000000001 110.196 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' S' S ' 242' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -96.29 161.87 13.75 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.288 -0.883 . . . . 47.890000000000001 110.295 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' S' S ' 243' ' ' SER . . . . . . . . . . . . . 71.9 m -90.64 151.52 21.25 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.362 -0.836 . . . . 45.090000000000003 110.309 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' S' S ' 244' ' ' ARG . . . . . . . . . . . . . 1.4 mtp85 -129.85 126.78 22.67 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.415 -0.803 . . . . 42.490000000000002 110.199 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' S' S ' 245' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.37 161.0 43.7 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 O-C-N 123.639 1.336 . . . . 35.68 110.507 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' S' S ' 246' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -132.86 97.87 4.15 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.359 -0.838 . . . . 51.880000000000003 109.822 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' S' S ' 247' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -110.47 -22.21 11.78 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.378 -0.826 . . . . 53.689999999999998 110.664 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' S' S ' 248' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -117.29 43.74 2.26 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.225 -0.922 . . . . 55.789999999999999 110.714 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' S' S ' 249' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 48.77 38.41 11.76 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.447 -0.783 . . . . 49.450000000000003 110.417 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' S' S ' 250' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -90.61 28.99 1.38 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.526 -0.734 . . . . 36.859999999999999 110.358 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' S' S ' 251' ' ' ALA . . . . . . . . . . . . . . . -53.78 -43.18 69.03 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.311 -0.868 . . . . 29.690000000000001 109.575 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' S' S ' 252' ' ' TRP . . . . . 0.425 ' CZ2' ' HB3' ' S' ' 294' ' ' LEU . 67.9 p-90 -61.83 -34.01 75.19 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.451 -0.78 . . . . 41.119999999999997 109.79 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' S' S ' 253' ' ' LEU . . . . . . . . . . . . . 23.3 tp -70.14 -47.23 62.59 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.433 -0.792 . . . . 24.890000000000001 109.906 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' S' S ' 254' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -56.12 -42.41 76.81 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.395 -0.816 . . . . 35.649999999999999 109.956 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' S' S ' 255' ' ' ALA . . . . . . . . . . . . . . . -59.63 -48.09 83.02 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.464 -0.773 . . . . 22.73 110.074 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' S' S ' 256' ' ' ILE . . . . . 0.504 HG12 HD11 ' S' ' 304' ' ' ILE . 79.6 mt -62.37 -40.62 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.315 -0.866 . . . . 28.850000000000001 109.928 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' S' S ' 257' ' ' LEU . . . . . 0.403 ' CD2' ' HB3' ' S' ' 268' ' ' PHE . 19.2 mt -61.56 -44.45 97.01 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.403 -0.81 . . . . 23.07 110.244 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' S' S ' 258' ' ' GLN . . . . . 0.502 ' HB3' ' CD2' ' S' ' 351' ' ' PHE . 53.1 mm-40 -65.05 -45.37 85.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.384 -0.823 . . . . 29.780000000000001 109.918 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' S' S ' 259' ' ' LEU . . . . . 0.419 ' O ' HG22 ' S' ' 263' ' ' VAL . 19.8 tp -58.69 -36.38 74.11 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.291 -0.881 . . . . 17.940000000000001 109.435 179.227 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' S' S ' 260' ' ' PHE . . . . . 0.53 ' CE2' HD21 ' S' ' 311' ' ' LEU . 3.1 m-85 -62.83 -45.27 93.41 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.603 -0.686 . . . . 30.57 109.84 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' S' S ' 261' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -62.12 -29.81 70.59 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.46 -0.775 . . . . 41.340000000000003 109.898 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' S' S ' 262' ' ' TYR . . . . . 0.672 ' CE2' HD22 ' S' ' 233' ' ' LEU . 8.6 t80 -71.22 -44.63 64.99 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.41 -0.806 . . . . 26.030000000000001 110.085 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' S' S ' 263' ' ' VAL . . . . . 0.419 HG22 ' O ' ' S' ' 259' ' ' LEU . 33.1 m -92.06 18.29 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.352 -0.842 . . . . 22.800000000000001 110.373 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' S' S ' 264' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 52.77 70.64 0.55 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.199 -0.938 . . . . 44.030000000000001 110.653 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' S' S ' 265' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -111.81 109.12 55.47 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.303 -0.873 . . . . 35.609999999999999 109.637 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' S' S ' 266' ' ' PRO . . . . . 0.482 ' HA ' ' HB2' ' S' ' 269' ' ' ASP . 49.2 Cg_endo -75.31 0.39 9.08 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 O-C-N 123.578 1.304 . . . . 37.670000000000002 111.753 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' S' S ' 267' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -56.48 -67.73 0.28 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.85 -1.156 . . . . 41.490000000000002 110.173 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' S' S ' 268' ' ' PHE . . . . . 0.403 ' HB3' ' CD2' ' S' ' 257' ' ' LEU . 22.6 m-85 -92.86 39.94 1.05 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.148 -0.97 . . . . 50.759999999999998 110.132 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' S' S ' 269' ' ' ASP . . . . . 0.482 ' HB2' ' HA ' ' S' ' 266' ' ' PRO . 0.9 OUTLIER -76.1 -33.19 59.49 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.307 -0.87 . . . . 61.859999999999999 109.727 179.596 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' S' S ' 270' ' ' TRP . . . . . 0.509 ' CE2' HG23 ' S' ' 271' ' ' VAL . 50.9 p-90 -73.85 -4.41 34.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.322 -0.861 . . . . 39.850000000000001 110.46 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' S' S ' 271' ' ' VAL . . . . . 0.509 HG23 ' CE2' ' S' ' 270' ' ' TRP . 46.6 t -109.49 -32.72 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.117 -0.989 . . . . 39.18 110.156 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' S' S ' 272' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -78.6 -36.6 44.06 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.387 -0.821 . . . . 40.020000000000003 110.486 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' S' S ' 273' ' ' SER . . . . . . . . . . . . . 71.2 m -103.48 56.16 0.74 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.336 -0.853 . . . . 47.200000000000003 110.306 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' S' S ' 274' ' ' SER . . . . . . . . . . . . . 6.9 t -133.06 141.27 40.29 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.336 -0.853 . . . . 47.609999999999999 110.14 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' S' S ' 275' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -73.85 -18.83 21.51 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.684 1.36 . . . . 45.280000000000001 110.485 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' S' S ' 276' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -99.87 140.87 33.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.238 -0.913 . . . . 57.270000000000003 110.317 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' S' S ' 277' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -71.73 97.67 1.8 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.388 -0.82 . . . . 37.280000000000001 110.322 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' S' S ' 278' ' ' LEU . . . . . . . . . . . . . 86.8 mt -97.04 33.84 1.85 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.358 -0.839 . . . . 43.880000000000003 109.987 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' S' S ' 279' ' ' THR . . . . . . . . . . . . . 75.3 m -64.03 -60.09 3.67 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.424 -0.797 . . . . 50.049999999999997 110.347 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' S' S ' 280' ' ' LEU . . . . . 0.728 ' HA ' HD12 ' S' ' 283' ' ' ILE . 13.7 mt -51.59 -39.91 58.84 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.363 -0.836 . . . . 54.119999999999997 110.246 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' S' S ' 281' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.42 -49.68 74.5 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.474 -0.766 . . . . 65.280000000000001 110.141 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' S' S ' 282' ' ' ALA . . . . . . . . . . . . . . . -58.97 -33.86 71.14 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.466 -0.771 . . . . 46.509999999999998 110.555 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' S' S ' 283' ' ' ILE . . . . . 0.728 HD12 ' HA ' ' S' ' 280' ' ' LEU . 85.7 mt -66.37 -50.86 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.273 -0.892 . . . . 47.299999999999997 110.087 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' S' S ' 284' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -50.59 -57.56 7.88 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.43 -0.794 . . . . 50.719999999999999 110.387 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' S' S ' 285' ' ' GLN . . . . . 0.53 ' HG2' HD12 ' S' ' 289' ' ' LEU . 34.4 tt0 -51.46 -46.32 63.02 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.503 -0.748 . . . . 68.469999999999999 110.332 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' S' S ' 286' ' ' LEU . . . . . . . . . . . . . 19.1 mt -59.96 -44.53 94.39 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.42 -0.8 . . . . 36.619999999999997 110.312 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' S' S ' 287' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -62.71 -35.26 79.16 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.372 -0.83 . . . . 46.640000000000001 110.099 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' S' S ' 288' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -76.24 -21.08 56.79 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.37 -0.831 . . . . 46.450000000000003 110.28 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' S' S ' 289' ' ' LEU . . . . . 0.53 HD12 ' HG2' ' S' ' 285' ' ' GLN . 30.8 mt -97.31 -21.75 17.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.286 -0.884 . . . . 35.090000000000003 110.487 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' S' S ' 290' ' ' THR . . . . . 0.409 HG22 ' HB3' ' S' ' 306' ' ' ASN . 81.2 p -114.74 -28.45 7.1 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.221 -0.925 . . . . 38.609999999999999 110.422 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' S' S ' 291' ' ' GLY . . . . . . . . . . . . . . . 79.43 10.93 85.43 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.823 -1.311 . . . . 36.770000000000003 109.823 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' S' S ' 292' ' ' LEU . . . . . . . . . . . . . 84.8 mt -96.44 145.84 25.31 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.226 -1.161 . . . . 35.329999999999998 109.726 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' S' S ' 293' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -77.37 102.41 6.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.196 -0.94 . . . . 48.700000000000003 110.232 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' S' S ' 294' ' ' LEU . . . . . 0.425 ' HB3' ' CZ2' ' S' ' 252' ' ' TRP . 56.2 mt -106.99 51.74 0.73 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.539 -0.726 . . . . 42.609999999999999 110.066 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' S' S ' 295' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -112.51 -11.17 13.65 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.362 -0.836 . . . . 55.490000000000002 110.524 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' S' S ' 296' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -144.36 48.53 1.36 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.127 -0.983 . . . . 75.680000000000007 110.321 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' S' S ' 297' ' ' GLY . . . . . . . . . . . . . . . 96.87 145.22 18.78 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.511 -1.436 . . . . 49.439999999999998 109.511 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' S' S ' 298' ' ' GLY . . . . . . . . . . . . . . . -163.83 156.96 29.05 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.744 -1.342 . . . . 41.109999999999999 109.744 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' S' S ' 299' ' ' PRO . . . . . 0.48 ' O ' HG23 ' S' ' 303' ' ' VAL . 47.4 Cg_endo -73.84 118.26 5.36 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 123.943 1.497 . . . . 26.199999999999999 110.293 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' S' S ' 300' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.33 -15.38 31.4 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 O-C-N 123.647 1.34 . . . . 21.699999999999999 110.675 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' S' S ' 301' ' ' ALA . . . . . . . . . . . . . . . -80.69 -29.31 36.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.238 -0.914 . . . . 31.23 110.182 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' S' S ' 302' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.48 -40.7 18.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.404 -0.81 . . . . 38.990000000000002 109.966 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' S' S ' 303' ' ' VAL . . . . . 0.48 HG23 ' O ' ' S' ' 299' ' ' PRO . 56.9 t -60.61 -35.48 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.399 -0.813 . . . . 18.629999999999999 110.153 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' S' S ' 304' ' ' ILE . . . . . 0.522 HD12 HG21 ' S' ' 379' ' ' VAL . 86.5 mt -79.43 -23.65 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.449 -0.782 . . . . 25.460000000000001 110.124 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' S' S ' 305' ' ' TRP . . . . . 0.41 ' CD2' ' HD3' ' S' ' 308' ' ' LYS . 68.9 t-105 -88.59 -14.69 36.97 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.234 -0.916 . . . . 33.399999999999999 110.501 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' S' S ' 306' ' ' ASN . . . . . 0.409 ' HB3' HG22 ' S' ' 290' ' ' THR . 10.4 m-80 -89.61 -13.52 36.96 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.179 -0.95 . . . . 36.969999999999999 110.438 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' S' S ' 307' ' ' ILE . . . . . 0.471 HG12 ' O ' ' S' ' 303' ' ' VAL . 36.8 pt -125.14 45.66 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.237 -0.915 . . . . 30.809999999999999 110.005 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' S' S ' 308' ' ' LYS . . . . . 0.41 ' HD3' ' CD2' ' S' ' 305' ' ' TRP . 1.5 mtmp? -73.52 -37.71 65.56 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.35 -0.844 . . . . 46.520000000000003 110.169 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' S' S ' 309' ' ' HIS . . . . . 0.492 ' CD2' ' HG ' ' S' ' 310' ' ' LEU . 55.6 p-80 -73.25 -8.26 55.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.407 -0.808 . . . . 51.030000000000001 110.057 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' S' S ' 310' ' ' LEU . . . . . 0.492 ' HG ' ' CD2' ' S' ' 309' ' ' HIS . 52.8 mt -99.25 -12.91 19.96 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.29 -0.881 . . . . 36.159999999999997 109.962 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' S' S ' 311' ' ' LEU . . . . . 0.53 HD21 ' CE2' ' S' ' 260' ' ' PHE . 10.8 mt -97.14 147.77 23.73 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.278 -0.889 . . . . 40.0 110.471 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' S' S ' 312' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -81.58 -16.29 52.08 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.282 -0.886 . . . . 54.18 109.771 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' S' S ' 313' ' ' THR . . . . . 0.825 HG23 ' HG2' ' S' ' 323' ' ' GLU . 92.4 m -87.94 151.64 22.66 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.378 -0.826 . . . . 25.609999999999999 110.151 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' S' S ' 314' ' ' GLY . . . . . . . . . . . . . . . -87.88 126.42 8.04 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.815 -1.314 . . . . 25.18 109.815 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' S' S ' 315' ' ' ILE . . . . . 0.67 HD13 ' HB ' ' S' ' 324' ' ' VAL . 50.6 mm -101.62 150.47 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.346 -1.091 . . . . 23.899999999999999 109.702 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' S' S ' 316' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' S' ' 325' ' ' CYS . . . -157.13 -159.23 9.36 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 110.021 -1.232 . . . . 23.18 110.021 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' S' S ' 317' ' ' THR . . . . . 0.425 HG22 ' CG2' ' S' ' 326' ' ' VAL . 11.0 p -133.96 -173.04 3.14 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.311 -1.111 . . . . 27.98 109.923 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' S' S ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.57 -56.18 25.19 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.2 -0.937 . . . . 28.100000000000001 109.899 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' S' S ' 319' ' ' SER . . . . . . . . . . . . . 1.2 m -59.98 -41.61 92.4 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.321 -0.862 . . . . 37.0 109.621 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' S' S ' 320' ' ' ARG . . . . . . . . . . . . . 12.2 mtm180 -111.67 79.88 2.62 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.481 -0.762 . . . . 52.07 109.657 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' S' S ' 321' ' ' PRO . . . . . 0.443 ' O ' ' HB2' ' S' ' 322' ' ' SER . 43.9 Cg_endo -71.41 171.54 15.98 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.869 1.457 . . . . 38.289999999999999 110.9 -179.458 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' S' S ' 322' ' ' SER . . . . . 0.443 ' HB2' ' O ' ' S' ' 321' ' ' PRO . 41.2 t 178.62 -148.17 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.89 -0.781 . . . . 38.840000000000003 108.89 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' S' S ' 323' ' ' GLU . . . . . 0.825 ' HG2' HG23 ' S' ' 313' ' ' THR . 6.7 tp10 -62.82 -40.26 96.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.003 -1.061 . . . . 40.700000000000003 109.734 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' S' S ' 324' ' ' VAL . . . . . 0.67 ' HB ' HD13 ' S' ' 315' ' ' ILE . 72.9 t -141.33 134.98 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.427 -0.795 . . . . 20.34 109.5 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' S' S ' 325' ' ' CYS . . . . . 0.462 ' HB2' ' CE1' ' S' ' 380' ' ' PHE . 11.1 m -125.95 172.21 10.11 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.249 -0.907 . . . . 30.629999999999999 110.826 -179.078 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' S' S ' 326' ' ' VAL . . . . . 0.642 HG12 HG22 ' S' ' 379' ' ' VAL . 34.5 m -135.49 142.18 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 109.216 -0.661 . . . . 23.899999999999999 109.216 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' S' S ' 327' ' ' VAL . . . . . 0.594 HG11 ' O ' ' S' ' 377' ' ' VAL . 34.5 m -56.29 124.94 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.133 -0.979 . . . . 19.48 110.432 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' S' S ' 328' ' ' ASP . . . . . . . . . . . . . 55.7 p-10 -119.37 11.54 12.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.432 -0.792 . . . . 26.43 110.422 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' S' S ' 329' ' ' GLY . . . . . . . . . . . . . . . 119.67 2.13 13.14 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.074 -1.21 . . . . 31.239999999999998 110.074 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' S' S ' 330' ' ' THR . . . . . . . . . . . . . 79.4 m -92.9 130.02 38.63 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.082 -1.246 . . . . 30.050000000000001 110.122 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' S' S ' 331' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -56.89 111.53 1.06 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.321 -0.862 . . . . 37.259999999999998 109.991 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' S' S ' 332' ' ' MET . . . . . . . . . . . . . 88.1 mmm -94.1 162.49 13.85 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.267 -0.896 . . . . 26.23 110.344 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' S' S ' 333' ' ' CYS . . . . . . . . . . . . . 25.8 m -137.19 150.11 47.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.475 -0.766 . . . . 23.559999999999999 110.025 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' S' S ' 334' ' ' LEU . . . . . 0.561 HD11 ' O ' ' S' ' 372' ' ' PRO . 0.1 OUTLIER -52.66 -24.76 9.12 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.289 -0.882 . . . . 28.93 110.5 179.902 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' S' S ' 335' ' ' ALA . . . . . . . . . . . . . . . -89.1 14.49 10.64 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.388 -0.82 . . . . 15.76 110.973 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' S' S ' 336' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -100.48 -17.25 17.24 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.133 -0.979 . . . . 34.920000000000002 110.143 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' S' S ' 337' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -152.41 170.83 19.14 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.333 -0.854 . . . . 19.030000000000001 110.077 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' S' S ' 338' ' ' HIS . . . . . 0.401 ' HB3' ' CZ ' ' S' ' 383' ' ' TYR . 13.5 p80 -120.65 10.42 11.03 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.333 -0.854 . . . . 18.82 110.479 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' S' S ' 339' ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' S' ' 352' ' ' ALA . . . -175.98 155.16 1.56 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.204 -0.935 . . . . 17.18 110.146 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' S' S ' 340' ' ' GLY . . . . . 0.405 ' CA ' ' O ' ' S' ' 379' ' ' VAL . . . 160.81 173.06 28.94 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.036 -1.226 . . . . 18.329999999999998 110.036 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' S' S ' 341' ' ' ILE . . . . . . . . . . . . . 84.2 mt -88.78 138.07 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.489 -1.006 . . . . 18.600000000000001 109.787 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' S' S ' 342' ' ' PHE . . . . . 0.493 ' CE2' ' HB3' ' S' ' 352' ' ' ALA . 69.9 m-85 -120.97 -178.43 3.74 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.222 -0.924 . . . . 23.440000000000001 110.407 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' S' S ' 343' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.84 93.41 4.19 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.532 -0.73 . . . . 35.590000000000003 110.024 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' S' S ' 344' ' ' LYS . . . . . 0.406 ' O ' ' HB3' ' S' ' 348' ' ' HIS . 0.3 OUTLIER -80.87 125.04 29.62 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.301 -0.874 . . . . 38.340000000000003 110.067 -179.905 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' S' S ' 345' ' ' GLY . . . . . . . . . . . . . . . 62.75 -130.86 43.17 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 108.874 -1.69 . . . . 53.460000000000001 108.874 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' S' S ' 346' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -132.68 150.89 52.1 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.246 -1.149 . . . . 70.909999999999997 110.043 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' S' S ' 347' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 53.19 35.44 19.92 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.321 -0.862 . . . . 47.32 110.45 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' S' S ' 348' ' ' HIS . . . . . 0.406 ' HB3' ' O ' ' S' ' 344' ' ' LYS . 46.4 t60 -150.18 155.87 40.56 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.204 -0.935 . . . . 41.719999999999999 110.311 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' S' S ' 349' ' ' ALA . . . . . 0.458 ' C ' HG13 ' S' ' 350' ' ' VAL . . . -149.82 151.22 33.17 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.314 -0.866 . . . . 22.91 110.527 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' S' S ' 350' ' ' VAL . . . . . 0.458 HG13 ' C ' ' S' ' 349' ' ' ALA . 34.6 m -149.0 169.67 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.463 -0.773 . . . . 21.09 110.058 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' S' S ' 351' ' ' PHE . . . . . 0.502 ' CD2' ' HB3' ' S' ' 258' ' ' GLN . 10.7 t80 -105.43 143.59 33.38 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.178 -0.951 . . . . 25.030000000000001 110.682 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' S' S ' 352' ' ' ALA . . . . . 0.493 ' HB3' ' CE2' ' S' ' 342' ' ' PHE . . . -147.67 151.78 36.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.64 -0.662 . . . . 23.809999999999999 109.704 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' S' S ' 353' ' ' CYS . . . . . . . . . . . . . 26.2 p -153.37 164.85 37.42 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.324 -0.86 . . . . 25.66 110.185 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' S' S ' 354' ' ' VAL . . . . . 0.546 HG22 ' CE2' ' S' ' 359' ' ' TRP . 56.6 t -75.94 118.49 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.351 -0.843 . . . . 34.270000000000003 110.008 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' S' S ' 355' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' S' ' 232' ' ' THR . 52.5 p -117.86 175.1 5.82 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.196 -0.94 . . . . 25.489999999999998 110.327 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' S' S ' 356' ' ' SER . . . . . . . . . . . . . 62.9 p -62.09 -17.75 58.59 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.474 -0.766 . . . . 31.239999999999998 110.749 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' S' S ' 357' ' ' ASN . . . . . . . . . . . . . 46.2 m-20 -106.96 14.21 26.74 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.143 -0.973 . . . . 28.609999999999999 110.564 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' S' S ' 358' ' ' GLY . . . . . . . . . . . . . . . 111.85 -152.93 17.58 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.979 -1.248 . . . . 22.010000000000002 109.979 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' S' S ' 359' ' ' TRP . . . . . 0.546 ' CE2' HG22 ' S' ' 354' ' ' VAL . 15.1 m95 -91.44 116.76 29.11 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.387 -1.067 . . . . 25.539999999999999 110.138 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' S' S ' 360' ' ' TYR . . . . . 0.408 ' HA ' ' HA ' ' S' ' 369' ' ' PRO . 1.3 m-85 -103.49 165.83 10.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.318 -0.864 . . . . 40.530000000000001 110.108 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' S' S ' 361' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' S' ' 351' ' ' PHE . . . -140.07 130.09 24.86 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.39 -0.819 . . . . 18.039999999999999 110.262 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' S' S ' 362' ' ' ILE . . . . . . . . . . . . . 89.0 mt -95.7 83.83 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.307 -0.871 . . . . 15.640000000000001 109.984 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' S' S ' 363' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' S' ' 365' ' ' GLU . 11.9 t0 -75.37 94.51 3.07 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.352 -0.843 . . . . 35.030000000000001 110.16 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' S' S ' 364' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 54.0 -89.44 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.468 -0.77 . . . . 46.719999999999999 110.45 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' S' S ' 365' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' S' ' 363' ' ' ASP . 23.8 mt-10 -122.55 18.99 10.44 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.077 -1.014 . . . . 56.200000000000003 110.218 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' S' S ' 366' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -117.82 124.98 49.7 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.303 -0.873 . . . . 51.020000000000003 110.418 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' S' S ' 367' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -106.98 127.08 53.13 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.361 -0.837 . . . . 37.590000000000003 110.133 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' S' S ' 368' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -165.47 159.61 13.85 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.303 -0.873 . . . . 31.469999999999999 110.437 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' S' S ' 369' ' ' PRO . . . . . 0.408 ' HA ' ' HA ' ' S' ' 360' ' ' TYR . 46.6 Cg_endo -72.83 139.57 30.66 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 O-C-N 123.864 1.455 . . . . 28.850000000000001 110.536 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' S' S ' 370' ' ' TRP . . . . . . . . . . . . . 67.5 t90 -167.23 113.6 0.76 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.376 -0.827 . . . . 26.940000000000001 109.957 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' S' S ' 371' ' ' THR . . . . . . . . . . . . . 59.5 m -74.83 113.04 20.6 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.411 -0.805 . . . . 20.190000000000001 110.059 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' S' S ' 372' ' ' PRO . . . . . 0.561 ' O ' HD11 ' S' ' 334' ' ' LEU . 48.2 Cg_endo -73.46 157.16 49.53 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 O-C-N 123.548 1.288 . . . . 28.68 110.613 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' S' S ' 373' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -90.57 147.12 35.68 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.449 -0.782 . . . . 35.719999999999999 109.896 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' S' S ' 374' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -76.02 -6.38 17.3 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.669 1.352 . . . . 30.890000000000001 110.474 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' S' S ' 375' ' ' SER . . . . . . . . . . . . . 68.5 p -104.32 -16.88 15.02 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.289 -0.882 . . . . 29.41 110.498 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' S' S ' 376' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -106.53 43.09 1.18 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.222 -0.924 . . . . 32.890000000000001 110.227 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' S' S ' 377' ' ' VAL . . . . . 0.594 ' O ' HG11 ' S' ' 327' ' ' VAL . 7.2 p -114.68 147.31 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.343 -0.848 . . . . 24.329999999999998 110.228 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' S' S ' 378' ' ' LEU . . . . . . . . . . . . . 51.7 mt -116.03 -58.0 2.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.401 -0.812 . . . . 24.370000000000001 109.626 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' S' S ' 379' ' ' VAL . . . . . 0.642 HG22 HG12 ' S' ' 326' ' ' VAL . 61.4 t -120.69 132.37 70.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.39 -0.819 . . . . 18.02 109.357 179.316 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' S' S ' 380' ' ' PHE . . . . . 0.462 ' CE1' ' HB2' ' S' ' 325' ' ' CYS . 14.5 p90 -142.54 174.03 11.0 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.367 -0.833 . . . . 29.350000000000001 110.646 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' S' S ' 381' ' ' VAL . . . . . . . . . . . . . 57.8 t -120.09 107.39 39.74 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.51 -0.744 . . . . 16.34 109.394 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' S' S ' 382' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.42 145.65 48.34 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 O-C-N 123.608 1.32 . . . . 20.940000000000001 110.775 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' S' S ' 383' ' ' TYR . . . . . 0.401 ' CZ ' ' HB3' ' S' ' 338' ' ' HIS . 88.1 m-85 -61.05 -53.54 55.86 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.335 -0.853 . . . . 28.93 109.823 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' S' S ' 384' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.361 -0.837 . . . . 47.030000000000001 110.408 -176.226 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' R' R ' 30' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 121.177 0.513 . . . . 43.359999999999999 110.202 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' R' R ' 31' ' ' LEU . . . . . . . . . . . . . 65.3 mt -134.9 140.53 45.84 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.312 -0.867 . . . . 22.93 110.318 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' R' R ' 32' ' ' THR . . . . . . . . . . . . . 68.3 m -87.46 110.59 20.41 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.4 -0.812 . . . . 22.34 109.986 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' R' R ' 33' ' ' LEU . . . . . 0.596 HD22 ' CE2' ' R' ' 62' ' ' TYR . 80.2 mt -62.46 -172.76 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.33 -0.856 . . . . 21.390000000000001 110.148 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' R' R ' 34' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -74.68 -29.4 61.21 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.333 -0.855 . . . . 34.399999999999999 110.328 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' R' R ' 35' ' ' ASN . . . . . . . . . . . . . 48.4 p30 -77.7 -1.89 33.41 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.324 -0.86 . . . . 30.280000000000001 110.686 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' R' R ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.2 -16.55 59.46 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.776 -1.329 . . . . 36.25 109.776 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' R' R ' 37' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -59.04 161.81 4.79 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.322 -1.105 . . . . 53.799999999999997 110.368 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' R' R ' 38' ' ' LYS . . . . . . . . . . . . . 56.9 mttt -117.86 135.76 53.88 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.445 -0.784 . . . . 49.909999999999997 110.146 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' R' R ' 39' ' ' LYS . . . . . 0.406 ' HG2' ' CZ ' ' R' ' 41' ' ' PHE . 8.0 ttmt -138.69 143.71 39.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.388 -0.82 . . . . 35.689999999999998 110.27 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' R' R ' 40' ' ' THR . . . . . . . . . . . . . 23.6 m -102.6 127.94 49.48 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.387 -0.82 . . . . 34.840000000000003 110.223 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' R' R ' 41' ' ' PHE . . . . . 0.406 ' CZ ' ' HG2' ' R' ' 39' ' ' LYS . 96.6 m-85 -113.06 132.62 55.33 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.426 -0.796 . . . . 34.420000000000002 110.14 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' R' R ' 42' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -93.28 140.97 28.96 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.335 -0.853 . . . . 51.460000000000001 110.264 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' R' R ' 43' ' ' SER . . . . . . . . . . . . . 54.8 m -70.9 141.92 51.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.445 -0.784 . . . . 41.840000000000003 110.202 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' R' R ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.77 125.46 29.45 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.311 -0.868 . . . . 33.82 109.932 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' R' R ' 45' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.17 151.01 54.59 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 O-C-N 123.616 1.324 . . . . 30.27 110.646 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' R' R ' 46' ' ' ASN . . . . . . . . . . . . . 52.2 t-20 -124.21 109.9 13.98 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.545 -0.722 . . . . 35.100000000000001 110.088 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' R' R ' 47' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -120.25 -34.92 3.55 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.335 -0.853 . . . . 42.810000000000002 110.542 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' R' R ' 48' ' ' HIS . . . . . 0.44 ' NE2' HD11 ' R' ' 80' ' ' LEU . 73.3 m80 -105.74 45.15 0.98 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.322 -0.861 . . . . 49.969999999999999 110.223 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' R' R ' 49' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 50.28 34.71 9.23 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.358 -0.839 . . . . 61.32 110.173 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' R' R ' 50' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -86.26 43.77 1.09 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.402 -0.811 . . . . 51.5 110.685 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' R' R ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.12 -46.06 78.87 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.131 -0.981 . . . . 38.770000000000003 109.53 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' R' R ' 52' ' ' TRP . . . . . 0.484 ' CD2' ' N ' ' R' ' 53' ' ' LEU . 68.3 p-90 -58.43 -38.37 77.32 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.519 -0.738 . . . . 26.239999999999998 110.098 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' R' R ' 53' ' ' LEU . . . . . 0.484 ' N ' ' CD2' ' R' ' 52' ' ' TRP . 23.0 tp -66.63 -46.75 74.79 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.4 -0.813 . . . . 26.75 110.016 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' R' R ' 54' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -55.27 -41.57 72.4 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.341 -0.85 . . . . 35.020000000000003 110.078 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' R' R ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.19 -46.03 92.14 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.426 -0.796 . . . . 24.469999999999999 110.219 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' R' R ' 56' ' ' ILE . . . . . 0.432 HG12 HD11 ' R' ' 104' ' ' ILE . 76.3 mt -62.15 -42.31 94.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.246 -0.909 . . . . 26.030000000000001 109.907 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' R' R ' 57' ' ' LEU . . . . . . . . . . . . . 22.3 mt -60.27 -45.68 92.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.4 -0.813 . . . . 26.77 109.661 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' R' R ' 58' ' ' GLN . . . . . . . . . . . . . 57.7 mm-40 -63.87 -46.51 84.64 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.525 -0.734 . . . . 22.32 109.622 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' R' R ' 59' ' ' LEU . . . . . 0.428 ' HA ' ' HE2' ' R' ' 151' ' ' PHE . 24.0 tp -61.45 -37.74 84.64 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.334 -0.854 . . . . 20.550000000000001 109.404 179.283 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' R' R ' 60' ' ' PHE . . . . . 0.529 ' CE2' HD21 ' R' ' 111' ' ' LEU . 2.8 m-85 -61.13 -44.75 96.85 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.631 -0.668 . . . . 20.079999999999998 109.866 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' R' R ' 61' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -63.08 -36.19 82.78 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.492 -0.755 . . . . 18.800000000000001 110.511 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' R' R ' 62' ' ' TYR . . . . . 0.596 ' CE2' HD22 ' R' ' 33' ' ' LEU . 9.2 t80 -63.14 -41.7 99.33 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.226 -0.921 . . . . 26.449999999999999 110.218 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' R' R ' 63' ' ' VAL . . . . . 0.407 ' H ' HG22 ' R' ' 63' ' ' VAL . 30.2 m -93.36 20.27 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.289 -0.882 . . . . 29.75 110.232 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' R' R ' 64' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 52.91 75.61 0.23 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.343 -0.848 . . . . 35.520000000000003 110.549 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' R' R ' 65' ' ' GLU . . . . . 0.442 ' HG2' ' CD2' ' R' ' 60' ' ' PHE . 14.2 tp10 -116.3 104.1 52.28 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.44 -0.787 . . . . 29.890000000000001 109.9 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' R' R ' 66' ' ' PRO . . . . . 0.482 ' HA ' ' HB2' ' R' ' 69' ' ' ASP . 47.4 Cg_endo -73.55 -5.83 17.74 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.79 1.416 . . . . 21.370000000000001 111.07 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' R' R ' 67' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -52.11 -61.56 2.19 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.099 -1.0 . . . . 23.850000000000001 110.331 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' R' R ' 68' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -98.12 36.52 1.56 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.275 -0.891 . . . . 28.07 110.442 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' R' R ' 69' ' ' ASP . . . . . 0.482 ' HB2' ' HA ' ' R' ' 66' ' ' PRO . 11.8 t0 -72.3 -33.29 67.3 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.303 -0.873 . . . . 43.759999999999998 110.169 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' R' R ' 70' ' ' TRP . . . . . 0.476 ' CE2' ' CG2' ' R' ' 71' ' ' VAL . 47.9 p-90 -73.32 -3.91 29.99 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.34 -0.85 . . . . 33.060000000000002 110.739 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' R' R ' 71' ' ' VAL . . . . . 0.556 HG11 ' HB2' ' R' ' 82' ' ' ALA . 40.7 t -109.78 -27.49 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.237 -0.914 . . . . 31.699999999999999 109.658 179.202 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' R' R ' 72' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -86.55 -48.87 7.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.407 -0.808 . . . . 33.579999999999998 110.267 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' R' R ' 73' ' ' SER . . . . . . . . . . . . . 70.1 m -89.73 51.01 1.99 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.29 -0.881 . . . . 50.82 110.362 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' R' R ' 74' ' ' SER . . . . . . . . . . . . . 15.8 t -125.89 138.37 31.92 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.303 -0.873 . . . . 34.740000000000002 110.206 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.38 -24.99 15.89 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 O-C-N 123.669 1.352 . . . . 35.700000000000003 110.32 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' R' R ' 76' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -91.7 153.16 19.85 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.422 -0.799 . . . . 66.480000000000004 110.342 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' R' R ' 77' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -81.47 95.23 7.03 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.374 -0.829 . . . . 46.719999999999999 110.061 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' R' R ' 78' ' ' LEU . . . . . . . . . . . . . 96.3 mt -96.46 27.97 3.55 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.473 -0.767 . . . . 37.549999999999997 110.191 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' R' R ' 79' ' ' THR . . . . . . . . . . . . . 29.8 m -56.31 -54.5 44.72 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.26 -0.9 . . . . 37.359999999999999 110.283 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' R' R ' 80' ' ' LEU . . . . . 0.604 ' HA ' HD12 ' R' ' 83' ' ' ILE . 15.9 mt -61.04 -23.09 65.17 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.439 -0.788 . . . . 35.829999999999998 110.513 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' R' R ' 81' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -79.48 -39.21 32.69 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.162 -0.961 . . . . 44.030000000000001 110.349 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' R' R ' 82' ' ' ALA . . . . . 0.556 ' HB2' HG11 ' R' ' 71' ' ' VAL . . . -69.4 -28.64 66.34 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.315 -0.866 . . . . 32.539999999999999 110.278 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' R' R ' 83' ' ' ILE . . . . . 0.604 HD12 ' HA ' ' R' ' 80' ' ' LEU . 78.2 mt -70.11 -46.09 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.307 -0.87 . . . . 32.020000000000003 110.265 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' R' R ' 84' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -55.19 -52.07 64.51 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.222 -0.924 . . . . 34.090000000000003 110.596 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' R' R ' 85' ' ' GLN . . . . . 0.532 ' HG2' HD12 ' R' ' 89' ' ' LEU . 31.9 tt0 -54.81 -46.89 74.59 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.279 -0.888 . . . . 25.940000000000001 110.299 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' R' R ' 86' ' ' LEU . . . . . . . . . . . . . 24.0 mt -58.6 -43.85 89.67 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.339 -0.851 . . . . 16.199999999999999 109.936 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' R' R ' 87' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -65.37 -35.17 80.15 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.435 -0.791 . . . . 49.090000000000003 110.304 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' R' R ' 88' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -78.47 -19.03 53.99 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.257 -0.902 . . . . 28.609999999999999 110.556 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' R' R ' 89' ' ' LEU . . . . . 0.532 HD12 ' HG2' ' R' ' 85' ' ' GLN . 32.5 mt -96.18 -29.41 14.07 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.207 -0.933 . . . . 26.16 110.197 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' R' R ' 90' ' ' THR . . . . . . . . . . . . . 59.0 p -105.7 -34.55 7.67 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.303 -0.873 . . . . 33.329999999999998 109.778 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' R' R ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.78 16.02 58.81 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.857 -1.297 . . . . 31.129999999999999 109.857 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' R' R ' 92' ' ' LEU . . . . . . . . . . . . . 97.0 mt -100.04 155.24 17.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.153 -1.204 . . . . 42.520000000000003 110.229 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' R' R ' 93' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -86.28 91.63 8.54 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.538 -0.726 . . . . 68.459999999999994 109.991 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' R' R ' 94' ' ' LEU . . . . . 0.459 ' HB3' ' CZ2' ' R' ' 52' ' ' TRP . 48.2 mt -99.47 52.99 0.94 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.183 -0.948 . . . . 44.630000000000003 110.282 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' R' R ' 95' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.48 -38.67 6.38 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.263 -0.898 . . . . 67.159999999999997 110.381 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' R' R ' 96' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -113.91 44.25 1.68 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.364 -0.835 . . . . 67.019999999999996 110.278 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' R' R ' 97' ' ' GLY . . . . . . . . . . . . . . . 99.12 150.77 26.02 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.653 -1.379 . . . . 49.479999999999997 109.653 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' R' R ' 98' ' ' GLY . . . . . . . . . . . . . . . -166.28 159.99 33.42 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.329 -1.508 . . . . 36.57 109.329 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' R' R ' 99' ' ' PRO . . . . . 0.79 ' O ' HG23 ' R' ' 103' ' ' VAL . 44.6 Cg_endo -72.55 121.11 7.15 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 123.732 1.385 . . . . 30.41 110.413 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' R' R ' 100' ' ' PRO . . . . . 0.411 ' HA ' HD11 ' R' ' 56' ' ' ILE . 45.4 Cg_endo -72.39 -31.5 11.31 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 O-C-N 123.621 1.327 . . . . 29.940000000000001 110.514 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' R' R ' 101' ' ' ALA . . . . . 0.475 ' HB2' ' HB3' ' R' ' 178' ' ' LEU . . . -70.05 -38.45 75.81 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.293 -0.879 . . . . 23.640000000000001 110.294 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' R' R ' 102' ' ' LEU . . . . . 0.425 HD23 HD21 ' R' ' 106' ' ' ASN . 0.1 OUTLIER -72.6 -40.69 66.32 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.353 -0.842 . . . . 20.309999999999999 110.446 -179.801 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' R' R ' 103' ' ' VAL . . . . . 0.79 HG23 ' O ' ' R' ' 99' ' ' PRO . 63.7 t -58.19 -40.08 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.225 -0.922 . . . . 16.329999999999998 109.986 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' R' R ' 104' ' ' ILE . . . . . 0.432 HD11 HG12 ' R' ' 56' ' ' ILE . 81.8 mt -71.71 -30.54 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.427 -0.796 . . . . 24.77 109.968 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' R' R ' 105' ' ' TRP . . . . . 0.462 ' O ' ' HD3' ' R' ' 108' ' ' LYS . 70.5 t-105 -82.43 0.89 40.08 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.277 -0.89 . . . . 23.280000000000001 110.26 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' R' R ' 106' ' ' ASN . . . . . 0.425 HD21 HD23 ' R' ' 102' ' ' LEU . 6.9 m-80 -105.11 -10.45 17.14 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.173 -0.954 . . . . 28.260000000000002 110.03 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' R' R ' 107' ' ' ILE . . . . . . . . . . . . . 36.8 pt -126.85 34.98 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.184 -0.947 . . . . 18.77 110.026 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' R' R ' 108' ' ' LYS . . . . . 0.501 ' HG2' ' HB ' ' R' ' 115' ' ' ILE . 9.3 mtpp -61.02 -48.49 81.57 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.493 -0.755 . . . . 42.5 110.031 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' R' R ' 109' ' ' HIS . . . . . 0.445 ' CD2' ' HG ' ' R' ' 110' ' ' LEU . 50.7 p-80 -66.02 -12.87 58.26 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.511 -0.743 . . . . 20.07 110.698 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' R' R ' 110' ' ' LEU . . . . . 0.445 ' HG ' ' CD2' ' R' ' 109' ' ' HIS . 80.1 mt -94.72 -17.38 22.26 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.071 -1.018 . . . . 15.69 110.183 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' R' R ' 111' ' ' LEU . . . . . 0.529 HD21 ' CE2' ' R' ' 60' ' ' PHE . 10.4 mt -94.05 144.12 25.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.324 -0.86 . . . . 25.390000000000001 111.052 -179.184 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' R' R ' 112' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -77.67 -17.43 57.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.518 -0.739 . . . . 53.479999999999997 109.84 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' R' R ' 113' ' ' THR . . . . . 0.459 HG22 ' N ' ' R' ' 114' ' ' GLY . 60.2 m -83.69 166.62 17.94 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.282 -0.886 . . . . 14.800000000000001 110.186 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' R' R ' 114' ' ' GLY . . . . . 0.459 ' N ' HG22 ' R' ' 113' ' ' THR . . . -97.99 127.12 9.12 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.968 -1.253 . . . . 16.140000000000001 109.968 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' R' R ' 115' ' ' ILE . . . . . 0.578 HD13 ' HB ' ' R' ' 124' ' ' VAL . 47.8 mm -109.07 139.32 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.534 -0.98 . . . . 13.460000000000001 109.71 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' R' R ' 116' ' ' GLY . . . . . . . . . . . . . . . -152.76 -155.78 7.26 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.926 -1.27 . . . . 23.899999999999999 109.926 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' R' R ' 117' ' ' THR . . . . . 0.529 HG22 ' CG2' ' R' ' 126' ' ' VAL . 18.7 p -135.06 -171.4 2.79 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.418 -1.048 . . . . 27.370000000000001 110.095 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' R' R ' 118' ' ' ALA . . . . . 0.444 ' HB3' ' OD1' ' R' ' 128' ' ' ASP . . . -56.59 -58.05 9.73 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.276 -0.89 . . . . 18.760000000000002 110.057 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' R' R ' 119' ' ' SER . . . . . 0.556 ' HA ' ' CB ' ' R' ' 194' ' ' ALA . 1.1 m -56.59 -40.53 75.43 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.332 -0.855 . . . . 32.350000000000001 109.784 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' R' R ' 120' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 -110.12 86.3 4.97 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.435 -0.791 . . . . 27.120000000000001 109.675 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' R' R ' 121' ' ' PRO . . . . . 0.482 ' HA ' ' SG ' ' R' ' 125' ' ' CYS . 44.7 Cg_endo -71.26 166.51 29.03 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.874 1.46 . . . . 22.68 111.035 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' R' R ' 122' ' ' SER . . . . . 0.438 ' HB2' ' O ' ' R' ' 121' ' ' PRO . 38.4 t 178.57 -161.69 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.584 -0.698 . . . . 22.989999999999998 109.436 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' R' R ' 123' ' ' GLU . . . . . 0.44 ' HG2' HG23 ' R' ' 113' ' ' THR . 2.3 tp10 -56.42 -39.94 73.89 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.225 -0.922 . . . . 36.18 109.732 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' R' R ' 124' ' ' VAL . . . . . 0.578 ' HB ' HD13 ' R' ' 115' ' ' ILE . 84.1 t -142.55 136.42 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.484 -0.76 . . . . 20.640000000000001 109.314 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' R' R ' 125' ' ' CYS . . . . . 0.482 ' SG ' ' HA ' ' R' ' 121' ' ' PRO . 83.2 m -140.28 168.19 20.37 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.187 -0.946 . . . . 22.800000000000001 111.193 -179.405 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' R' R ' 126' ' ' VAL . . . . . 0.729 HG12 HG22 ' R' ' 179' ' ' VAL . 35.9 m -122.78 159.83 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.828 -0.545 . . . . 21.239999999999998 109.647 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' R' R ' 127' ' ' VAL . . . . . 0.71 HG11 ' O ' ' R' ' 177' ' ' VAL . 30.5 m -70.86 141.83 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.337 -0.852 . . . . 19.77 110.695 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' R' R ' 128' ' ' ASP . . . . . 0.444 ' OD1' ' HB3' ' R' ' 118' ' ' ALA . 53.9 p-10 -137.7 19.44 2.87 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.319 -0.863 . . . . 29.210000000000001 110.665 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' R' R ' 129' ' ' GLY . . . . . . . . . . . . . . . 113.97 0.06 24.18 Favored Glycine 0 N--CA 1.492 2.399 0 C-N-CA 119.993 -1.098 . . . . 33.859999999999999 110.487 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' R' R ' 130' ' ' THR . . . . . . . . . . . . . 58.9 m -91.9 131.85 36.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.202 -1.176 . . . . 26.41 109.998 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -62.53 120.72 11.66 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.408 -0.808 . . . . 33.079999999999998 110.284 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' R' R ' 132' ' ' MET . . . . . 0.435 ' HE1' ' CE2' ' R' ' 180' ' ' PHE . 98.4 mmm -105.22 165.67 10.94 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.425 -0.797 . . . . 30.760000000000002 110.445 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' R' R ' 133' ' ' CYS . . . . . 0.41 ' HA ' ' HB3' ' R' ' 174' ' ' PRO . 31.7 m -141.17 158.21 44.21 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.493 -0.754 . . . . 27.0 109.912 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' R' R ' 134' ' ' LEU . . . . . 0.564 HD11 ' O ' ' R' ' 172' ' ' PRO . 0.1 OUTLIER -58.48 -19.8 40.09 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.362 -0.836 . . . . 33.899999999999999 110.407 -179.837 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' R' R ' 135' ' ' ALA . . . . . . . . . . . . . . . -92.74 8.14 40.57 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.282 -0.887 . . . . 19.370000000000001 110.78 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' R' R ' 136' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -93.71 -21.72 19.17 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.255 -0.903 . . . . 30.469999999999999 110.272 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' R' R ' 137' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -149.98 165.42 32.74 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.314 -0.866 . . . . 24.27 110.189 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' R' R ' 138' ' ' HIS . . . . . 0.433 ' HA ' HG23 ' R' ' 154' ' ' VAL . 15.2 p80 -117.86 15.11 14.35 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.398 -0.814 . . . . 20.91 110.459 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' R' R ' 139' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' R' ' 152' ' ' ALA . . . -177.14 152.44 0.89 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.278 -0.889 . . . . 15.69 110.098 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' R' R ' 140' ' ' GLY . . . . . 0.427 ' HA3' ' O ' ' R' ' 179' ' ' VAL . . . 161.8 175.15 32.52 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.998 -1.241 . . . . 23.760000000000002 109.998 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' R' R ' 141' ' ' ILE . . . . . . . . . . . . . 83.5 mt -95.49 136.54 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.514 -0.992 . . . . 25.300000000000001 109.718 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' R' R ' 142' ' ' PHE . . . . . 0.576 ' CD2' ' HB2' ' R' ' 172' ' ' PRO . 82.6 m-85 -120.7 -172.58 2.41 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.26 -0.9 . . . . 30.239999999999998 110.511 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' R' R ' 143' ' ' LEU . . . . . 0.743 HD23 ' O ' ' R' ' 148' ' ' HIS . 0.5 OUTLIER -119.79 77.71 1.26 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.437 -0.789 . . . . 32.799999999999997 110.321 -179.908 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' R' R ' 144' ' ' LYS . . . . . 0.47 ' HG3' ' CZ2' ' R' ' 170' ' ' TRP . 1.0 OUTLIER -69.58 76.86 0.42 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.369 -0.832 . . . . 49.18 109.625 179.626 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' R' R ' 145' ' ' GLY . . . . . 0.458 ' O ' HD22 ' R' ' 143' ' ' LEU . . . 104.55 179.31 24.76 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.174 -1.571 . . . . 53.869999999999997 109.174 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' R' R ' 146' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -88.53 145.85 25.5 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.253 -1.145 . . . . 68.579999999999998 110.023 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' R' R ' 147' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 58.17 36.57 25.92 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.288 -0.883 . . . . 56.619999999999997 110.633 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' R' R ' 148' ' ' HIS . . . . . 0.743 ' O ' HD23 ' R' ' 143' ' ' LEU . 45.0 t60 -158.67 148.12 19.17 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.229 -0.92 . . . . 44.57 110.372 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' R' R ' 149' ' ' ALA . . . . . . . . . . . . . . . -150.27 146.89 27.06 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.45 -0.781 . . . . 33.539999999999999 110.091 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' R' R ' 150' ' ' VAL . . . . . . . . . . . . . 34.2 m -142.34 161.5 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.273 -0.892 . . . . 27.609999999999999 110.318 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' R' R ' 151' ' ' PHE . . . . . 0.538 ' CD1' ' N ' ' R' ' 152' ' ' ALA . 5.9 t80 -86.19 155.62 20.66 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.41 -0.806 . . . . 23.039999999999999 109.867 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' R' R ' 152' ' ' ALA . . . . . 0.538 ' N ' ' CD1' ' R' ' 151' ' ' PHE . . . -157.28 151.51 24.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.409 -0.807 . . . . 29.609999999999999 109.612 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' R' R ' 153' ' ' CYS . . . . . . . . . . . . . 26.7 p -154.29 173.62 15.92 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.227 -0.921 . . . . 22.75 110.507 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' R' R ' 154' ' ' VAL . . . . . 0.614 HG22 ' CE2' ' R' ' 159' ' ' TRP . 59.7 t -90.64 117.03 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.322 -0.861 . . . . 23.260000000000002 110.042 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' R' R ' 155' ' ' THR . . . . . . . . . . . . . 70.5 p -112.17 -176.66 2.98 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.361 -0.837 . . . . 17.879999999999999 110.025 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' R' R ' 156' ' ' SER . . . . . . . . . . . . . 78.6 p -75.96 -3.66 36.78 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.32 -0.863 . . . . 21.829999999999998 110.707 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' R' R ' 157' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -118.27 10.38 12.81 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.159 -0.963 . . . . 36.539999999999999 110.635 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' R' R ' 158' ' ' GLY . . . . . . . . . . . . . . . 117.94 -162.68 13.02 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.556 -1.417 . . . . 31.739999999999998 109.556 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' R' R ' 159' ' ' TRP . . . . . 0.614 ' CE2' HG22 ' R' ' 154' ' ' VAL . 14.7 m95 -86.56 122.44 30.49 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.389 -1.065 . . . . 28.25 110.147 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' R' R ' 160' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -108.47 167.03 10.33 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.404 -0.81 . . . . 41.240000000000002 110.175 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' R' R ' 161' ' ' ALA . . . . . . . . . . . . . . . -143.23 123.48 13.77 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.344 -0.847 . . . . 27.399999999999999 110.173 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' R' R ' 162' ' ' ILE . . . . . . . . . . . . . 92.0 mt -87.62 81.13 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.343 -0.848 . . . . 24.27 110.101 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' R' R ' 163' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' R' ' 165' ' ' GLU . 15.3 t0 -72.84 92.42 1.59 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.518 -0.739 . . . . 36.079999999999998 110.254 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' R' R ' 164' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 54.15 -89.0 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.463 -0.773 . . . . 46.079999999999998 110.574 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' R' R ' 165' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' R' ' 163' ' ' ASP . 29.7 mt-10 -124.76 36.03 4.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.088 -1.007 . . . . 50.939999999999998 110.192 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' R' R ' 166' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -135.82 117.23 14.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.4 -0.812 . . . . 47.280000000000001 110.34 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' R' R ' 167' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -100.94 119.96 39.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.457 -0.777 . . . . 40.469999999999999 110.172 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' R' R ' 168' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -157.6 158.54 30.61 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.213 -0.929 . . . . 30.210000000000001 110.399 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' R' R ' 169' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.81 132.99 19.36 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.931 1.49 . . . . 32.759999999999998 110.505 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' R' R ' 170' ' ' TRP . . . . . 0.47 ' CZ2' ' HG3' ' R' ' 144' ' ' LYS . 66.9 t90 -159.78 119.37 2.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.383 -0.823 . . . . 32.789999999999999 109.909 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' R' R ' 171' ' ' THR . . . . . . . . . . . . . 46.9 m -81.1 112.58 33.94 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.471 -0.768 . . . . 36.920000000000002 110.197 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' R' R ' 172' ' ' PRO . . . . . 0.576 ' HB2' ' CD2' ' R' ' 142' ' ' PHE . 46.5 Cg_endo -73.69 158.87 46.6 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.634 1.334 . . . . 33.539999999999999 110.504 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' R' R ' 173' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -88.93 144.97 33.67 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.358 -0.839 . . . . 45.759999999999998 109.882 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' R' R ' 174' ' ' PRO . . . . . 0.41 ' HB3' ' HA ' ' R' ' 133' ' ' CYS . 45.5 Cg_endo -71.71 -10.41 26.47 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.614 1.323 . . . . 29.629999999999999 110.507 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' R' R ' 175' ' ' SER . . . . . . . . . . . . . 53.0 p -103.44 -17.55 15.19 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.293 -0.88 . . . . 35.700000000000003 110.37 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' R' R ' 176' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -103.56 43.32 1.09 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.25 -0.906 . . . . 39.649999999999999 110.379 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' R' R ' 177' ' ' VAL . . . . . 0.71 ' O ' HG11 ' R' ' 127' ' ' VAL . 10.4 p -117.86 127.08 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.324 -0.86 . . . . 20.609999999999999 110.07 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' R' R ' 178' ' ' LEU . . . . . 0.475 ' HB3' ' HB2' ' R' ' 101' ' ' ALA . 45.6 mt -91.45 -61.31 1.68 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.361 -0.837 . . . . 15.58 109.395 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' R' R ' 179' ' ' VAL . . . . . 0.729 HG22 HG12 ' R' ' 126' ' ' VAL . 68.3 t -114.59 144.78 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.621 -0.674 . . . . 17.399999999999999 109.409 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' R' R ' 180' ' ' PHE . . . . . 0.435 ' CE2' ' HE1' ' R' ' 132' ' ' MET . 43.5 p90 -152.21 163.34 39.6 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.328 -0.858 . . . . 20.16 110.474 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' R' R ' 181' ' ' VAL . . . . . . . . . . . . . 66.3 t -113.16 111.48 50.29 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.467 -0.771 . . . . 17.690000000000001 109.833 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' R' R ' 182' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.03 149.52 52.9 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.532 1.28 . . . . 17.809999999999999 110.423 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' R' R ' 183' ' ' TYR . . . . . 0.739 ' O ' ' C ' ' R' ' 184' ' ' ASP . 79.0 m-85 -59.03 175.47 0.28 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.43 -0.794 . . . . 28.010000000000002 110.539 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' R' R ' 184' ' ' ASP . . . . . 0.739 ' C ' ' O ' ' R' ' 183' ' ' TYR . 1.0 OUTLIER -11.78 -75.82 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.452 -0.78 . . . . 58.640000000000001 110.296 -177.936 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' R' R ' 185' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 . . . . . 0 N--CA 1.503 2.177 0 CA-C-O 121.247 0.546 . . . . 80.420000000000002 111.757 179.236 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' R' R ' 193' ' ' LYS . . . . . . . . . . . . . 14.3 ptmt . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 120.895 0.379 . . . . 49.5 110.179 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' R' R ' 194' ' ' ALA . . . . . 0.556 ' CB ' ' HA ' ' R' ' 119' ' ' SER . . . . . . . . 0 N--CA 1.496 1.869 0 O-C-N 121.141 -0.975 . . . . 40.399999999999999 110.079 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' S' S ' 229' ' ' MET . . . . . . . . . . . . . 1.5 tpt . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.226 0.536 . . . . 51.829999999999998 110.21 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' S' S ' 230' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -97.27 142.75 28.78 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.372 -0.83 . . . . 54.130000000000003 110.22 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' S' S ' 231' ' ' LEU . . . . . . . . . . . . . 67.9 mt -134.06 141.07 47.05 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.363 -0.836 . . . . 33.039999999999999 110.299 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' S' S ' 232' ' ' THR . . . . . 0.407 ' O ' ' HA ' ' S' ' 355' ' ' THR . 40.0 m -89.27 103.27 15.91 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.345 -0.847 . . . . 26.920000000000002 110.093 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' S' S ' 233' ' ' LEU . . . . . 0.667 HD22 ' CE2' ' S' ' 262' ' ' TYR . 79.8 mt -55.84 179.29 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.476 -0.765 . . . . 13.779999999999999 110.491 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' S' S ' 234' ' ' TYR . . . . . 0.444 ' CG ' ' N ' ' S' ' 235' ' ' ASN . 35.4 p90 -65.12 -35.61 81.67 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.354 -0.841 . . . . 26.079999999999998 110.119 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' S' S ' 235' ' ' ASN . . . . . 0.444 ' N ' ' CG ' ' S' ' 234' ' ' TYR . 50.7 p30 -74.28 -7.5 53.0 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.377 -0.827 . . . . 20.039999999999999 110.506 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' S' S ' 236' ' ' GLY . . . . . . . . . . . . . . . 95.81 -20.01 51.79 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.747 -1.341 . . . . 22.710000000000001 109.747 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' S' S ' 237' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -52.96 145.74 12.26 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.182 -1.187 . . . . 35.439999999999998 110.165 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' S' S ' 238' ' ' LYS . . . . . . . . . . . . . 44.4 mttt -102.17 127.9 48.91 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.397 -0.814 . . . . 32.560000000000002 110.374 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' S' S ' 239' ' ' LYS . . . . . 0.405 ' HG2' ' CZ ' ' S' ' 241' ' ' PHE . 9.0 ttmt -132.27 144.52 50.66 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.373 -0.829 . . . . 26.68 109.959 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' S' S ' 240' ' ' THR . . . . . . . . . . . . . 52.5 m -102.05 132.22 48.04 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.339 -0.851 . . . . 41.020000000000003 110.305 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' S' S ' 241' ' ' PHE . . . . . 0.405 ' CZ ' ' HG2' ' S' ' 239' ' ' LYS . 96.0 m-85 -117.98 137.67 52.7 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.346 -0.846 . . . . 28.620000000000001 110.169 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' S' S ' 242' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -96.36 161.78 13.78 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.451 -0.781 . . . . 47.890000000000001 110.224 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' S' S ' 243' ' ' SER . . . . . . . . . . . . . 72.4 m -90.65 151.52 21.24 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.333 -0.854 . . . . 45.090000000000003 110.225 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' S' S ' 244' ' ' ARG . . . . . . . . . . . . . 1.4 mtp85 -129.76 126.74 22.71 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.335 -0.853 . . . . 42.490000000000002 110.274 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' S' S ' 245' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.31 161.0 43.83 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 123.603 1.317 . . . . 35.68 110.503 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' S' S ' 246' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -132.89 97.88 4.15 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.323 -0.861 . . . . 51.880000000000003 109.821 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' S' S ' 247' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -110.47 -22.21 11.78 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.317 -0.865 . . . . 53.689999999999998 110.636 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' S' S ' 248' ' ' HIS . . . . . . . . . . . . . 76.5 m80 -117.26 43.75 2.26 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.235 -0.916 . . . . 55.789999999999999 110.774 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' S' S ' 249' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 48.8 38.36 11.72 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.459 -0.775 . . . . 49.450000000000003 110.382 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' S' S ' 250' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -90.62 29.05 1.37 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.462 -0.773 . . . . 36.859999999999999 110.277 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' S' S ' 251' ' ' ALA . . . . . . . . . . . . . . . -53.84 -43.21 69.28 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.244 -0.91 . . . . 29.690000000000001 109.577 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' S' S ' 252' ' ' TRP . . . . . 0.428 ' CZ2' ' HB3' ' S' ' 294' ' ' LEU . 67.9 p-90 -61.77 -33.86 74.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.508 -0.745 . . . . 41.119999999999997 109.89 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' S' S ' 253' ' ' LEU . . . . . 0.407 ' N ' ' CD2' ' S' ' 252' ' ' TRP . 23.2 tp -70.12 -47.26 62.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.412 -0.805 . . . . 24.890000000000001 110.025 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' S' S ' 254' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -56.1 -42.47 76.82 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.419 -0.801 . . . . 35.649999999999999 110.03 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' S' S ' 255' ' ' ALA . . . . . . . . . . . . . . . -59.49 -48.25 82.37 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.438 -0.789 . . . . 22.73 110.1 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' S' S ' 256' ' ' ILE . . . . . 0.502 HG12 HD11 ' S' ' 304' ' ' ILE . 80.1 mt -62.25 -40.65 88.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.289 -0.882 . . . . 28.850000000000001 110.02 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' S' S ' 257' ' ' LEU . . . . . . . . . . . . . 19.1 mt -61.54 -44.53 96.87 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.365 -0.834 . . . . 23.07 110.144 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' S' S ' 258' ' ' GLN . . . . . 0.498 ' HB3' ' CD2' ' S' ' 351' ' ' PHE . 53.3 mm-40 -65.01 -45.39 85.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.389 -0.82 . . . . 29.780000000000001 109.92 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' S' S ' 259' ' ' LEU . . . . . 0.425 ' O ' HG22 ' S' ' 263' ' ' VAL . 19.8 tp -58.66 -36.42 74.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.43 -0.794 . . . . 17.940000000000001 109.444 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' S' S ' 260' ' ' PHE . . . . . 0.534 ' CE2' HD21 ' S' ' 311' ' ' LEU . 3.1 m-85 -62.79 -45.22 93.64 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.647 -0.658 . . . . 30.57 109.849 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' S' S ' 261' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -62.16 -29.77 70.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.509 -0.744 . . . . 41.340000000000003 109.979 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' S' S ' 262' ' ' TYR . . . . . 0.667 ' CE2' HD22 ' S' ' 233' ' ' LEU . 8.7 t80 -71.19 -44.71 64.92 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.433 -0.792 . . . . 26.030000000000001 110.074 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' S' S ' 263' ' ' VAL . . . . . 0.425 HG22 ' O ' ' S' ' 259' ' ' LEU . 33.1 m -92.02 18.28 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.438 -0.788 . . . . 22.800000000000001 110.355 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' S' S ' 264' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 52.7 70.76 0.54 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.287 -0.883 . . . . 44.030000000000001 110.604 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' S' S ' 265' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -111.84 109.22 55.33 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.295 -0.878 . . . . 35.609999999999999 109.628 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' S' S ' 266' ' ' PRO . . . . . 0.476 ' HA ' ' HB2' ' S' ' 269' ' ' ASP . 48.8 Cg_endo -75.33 0.4 9.08 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 123.55 1.289 . . . . 37.670000000000002 111.807 -179.126 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' S' S ' 267' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -56.48 -67.69 0.28 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.764 -1.21 . . . . 41.490000000000002 110.199 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' S' S ' 268' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -92.9 39.89 1.05 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.159 -0.963 . . . . 50.759999999999998 110.047 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' S' S ' 269' ' ' ASP . . . . . 0.476 ' HB2' ' HA ' ' S' ' 266' ' ' PRO . 0.9 OUTLIER -76.02 -33.29 59.67 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.426 -0.796 . . . . 61.859999999999999 109.762 179.534 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' S' S ' 270' ' ' TRP . . . . . 0.508 ' CE2' HG23 ' S' ' 271' ' ' VAL . 50.9 p-90 -73.83 -4.27 33.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.298 -0.876 . . . . 39.850000000000001 110.527 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' S' S ' 271' ' ' VAL . . . . . 0.508 HG23 ' CE2' ' S' ' 270' ' ' TRP . 46.4 t -109.67 -32.62 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.146 -0.971 . . . . 39.18 110.065 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' S' S ' 272' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -78.71 -36.5 43.33 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.35 -0.844 . . . . 40.020000000000003 110.524 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' S' S ' 273' ' ' SER . . . . . . . . . . . . . 71.2 m -103.49 56.03 0.74 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.295 -0.878 . . . . 47.200000000000003 110.369 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' S' S ' 274' ' ' SER . . . . . . . . . . . . . 6.9 t -133.01 141.26 40.3 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.329 -0.857 . . . . 47.609999999999999 110.113 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' S' S ' 275' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.77 -18.86 21.68 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 O-C-N 123.633 1.333 . . . . 45.280000000000001 110.547 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' S' S ' 276' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -99.96 140.85 33.58 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.327 -0.858 . . . . 57.270000000000003 110.248 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' S' S ' 277' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -71.76 97.69 1.82 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.396 -0.815 . . . . 37.280000000000001 110.251 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' S' S ' 278' ' ' LEU . . . . . . . . . . . . . 86.4 mt -96.93 33.74 1.84 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.39 -0.819 . . . . 43.880000000000003 110.037 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' S' S ' 279' ' ' THR . . . . . . . . . . . . . 76.3 m -64.02 -60.15 3.6 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.436 -0.79 . . . . 50.049999999999997 110.269 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' S' S ' 280' ' ' LEU . . . . . 0.739 ' HA ' HD12 ' S' ' 283' ' ' ILE . 13.6 mt -51.53 -39.98 58.77 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.314 -0.866 . . . . 54.119999999999997 110.241 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' S' S ' 281' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.27 -49.75 74.43 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.494 -0.754 . . . . 65.280000000000001 110.174 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' S' S ' 282' ' ' ALA . . . . . . . . . . . . . . . -58.95 -33.91 71.15 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.44 -0.788 . . . . 46.509999999999998 110.554 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' S' S ' 283' ' ' ILE . . . . . 0.739 HD12 ' HA ' ' S' ' 280' ' ' LEU . 85.6 mt -66.3 -50.88 64.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.319 -0.863 . . . . 47.299999999999997 110.125 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' S' S ' 284' ' ' LYS . . . . . . . . . . . . . 33.8 tttp -50.6 -57.57 7.88 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.318 -0.864 . . . . 50.719999999999999 110.344 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' S' S ' 285' ' ' GLN . . . . . 0.518 ' HG2' HD12 ' S' ' 289' ' ' LEU . 34.4 tt0 -51.47 -46.33 63.07 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.465 -0.772 . . . . 68.469999999999999 110.257 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' S' S ' 286' ' ' LEU . . . . . . . . . . . . . 19.2 mt -60.02 -44.56 94.5 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.372 -0.83 . . . . 36.619999999999997 110.275 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' S' S ' 287' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -62.7 -35.22 79.0 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.289 -0.882 . . . . 46.640000000000001 110.1 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' S' S ' 288' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -76.31 -20.96 56.78 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.4 -0.812 . . . . 46.450000000000003 110.34 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' S' S ' 289' ' ' LEU . . . . . 0.518 HD12 ' HG2' ' S' ' 285' ' ' GLN . 30.7 mt -97.38 -21.69 17.05 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.302 -0.874 . . . . 35.090000000000003 110.494 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' S' S ' 290' ' ' THR . . . . . 0.406 HG22 ' HB3' ' S' ' 306' ' ' ASN . 81.2 p -114.76 -28.49 7.08 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.325 -0.859 . . . . 38.609999999999999 110.406 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' S' S ' 291' ' ' GLY . . . . . . . . . . . . . . . 79.35 11.08 85.33 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.9 -1.28 . . . . 36.770000000000003 109.9 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' S' S ' 292' ' ' LEU . . . . . . . . . . . . . 84.7 mt -96.51 145.82 25.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.286 -1.126 . . . . 35.329999999999998 109.722 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' S' S ' 293' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -77.35 102.34 6.73 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.194 -0.941 . . . . 48.700000000000003 110.273 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' S' S ' 294' ' ' LEU . . . . . 0.428 ' HB3' ' CZ2' ' S' ' 252' ' ' TRP . 56.1 mt -106.96 51.72 0.73 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.51 -0.744 . . . . 42.609999999999999 110.085 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' S' S ' 295' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -112.43 -11.27 13.67 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.274 -0.891 . . . . 55.490000000000002 110.56 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' S' S ' 296' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -144.24 48.55 1.37 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.187 -0.946 . . . . 75.680000000000007 110.319 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' S' S ' 297' ' ' GLY . . . . . . . . . . . . . . . 96.88 145.18 18.72 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.505 -1.438 . . . . 49.439999999999998 109.505 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' S' S ' 298' ' ' GLY . . . . . . . . . . . . . . . -163.85 156.98 29.09 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.823 -1.311 . . . . 41.109999999999999 109.823 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' S' S ' 299' ' ' PRO . . . . . 0.493 ' O ' HG23 ' S' ' 303' ' ' VAL . 47.7 Cg_endo -73.73 118.21 5.36 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 O-C-N 123.941 1.495 . . . . 26.199999999999999 110.314 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' S' S ' 300' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.23 -15.42 31.72 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 123.538 1.283 . . . . 21.699999999999999 110.684 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' S' S ' 301' ' ' ALA . . . . . . . . . . . . . . . -80.73 -29.33 36.37 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.259 -0.9 . . . . 31.23 110.091 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' S' S ' 302' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.58 -40.57 18.91 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.512 -0.742 . . . . 38.990000000000002 109.953 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' S' S ' 303' ' ' VAL . . . . . 0.493 HG23 ' O ' ' S' ' 299' ' ' PRO . 58.5 t -60.68 -35.48 64.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.372 -0.83 . . . . 18.629999999999999 110.177 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' S' S ' 304' ' ' ILE . . . . . 0.518 HD12 HG21 ' S' ' 379' ' ' VAL . 86.3 mt -79.39 -23.58 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.418 -0.801 . . . . 25.460000000000001 110.177 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' S' S ' 305' ' ' TRP . . . . . 0.414 ' CD2' ' HD3' ' S' ' 308' ' ' LYS . 68.8 t-105 -88.67 -14.62 36.92 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.194 -0.942 . . . . 33.399999999999999 110.5 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' S' S ' 306' ' ' ASN . . . . . 0.406 ' HB3' HG22 ' S' ' 290' ' ' THR . 10.4 m-80 -89.7 -13.57 36.6 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.237 -0.915 . . . . 36.969999999999999 110.391 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' S' S ' 307' ' ' ILE . . . . . 0.473 HG12 ' O ' ' S' ' 303' ' ' VAL . 36.9 pt -125.03 45.67 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.276 -0.89 . . . . 30.809999999999999 110.036 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' S' S ' 308' ' ' LYS . . . . . 0.414 ' HD3' ' CD2' ' S' ' 305' ' ' TRP . 1.5 mtmp? -73.58 -37.72 65.39 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.366 -0.834 . . . . 46.520000000000003 110.1 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' S' S ' 309' ' ' HIS . . . . . 0.498 ' CD2' ' HG ' ' S' ' 310' ' ' LEU . 55.6 p-80 -73.27 -8.2 54.79 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.333 -0.854 . . . . 51.030000000000001 110.105 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' S' S ' 310' ' ' LEU . . . . . 0.498 ' HG ' ' CD2' ' S' ' 309' ' ' HIS . 53.2 mt -99.32 -12.87 19.94 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.265 -0.897 . . . . 36.159999999999997 109.973 179.269 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' S' S ' 311' ' ' LEU . . . . . 0.534 HD21 ' CE2' ' S' ' 260' ' ' PHE . 10.8 mt -97.14 147.88 23.61 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.421 -0.8 . . . . 40.0 110.431 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' S' S ' 312' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -81.65 -16.28 51.89 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.273 -0.892 . . . . 54.18 109.69 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' S' S ' 313' ' ' THR . . . . . 0.808 HG23 ' HG2' ' S' ' 323' ' ' GLU . 92.8 m -87.92 151.57 22.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.329 -0.857 . . . . 25.609999999999999 110.117 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' S' S ' 314' ' ' GLY . . . . . . . . . . . . . . . -87.81 126.4 8.03 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.861 -1.296 . . . . 25.18 109.861 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' S' S ' 315' ' ' ILE . . . . . 0.666 HD13 ' HB ' ' S' ' 324' ' ' VAL . 50.7 mm -101.69 150.45 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.407 -1.055 . . . . 23.899999999999999 109.703 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' S' S ' 316' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' S' ' 325' ' ' CYS . . . -157.04 -159.25 9.37 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.982 -1.247 . . . . 23.18 109.982 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' S' S ' 317' ' ' THR . . . . . 0.423 HG22 ' CG2' ' S' ' 326' ' ' VAL . 11.0 p -133.94 -173.04 3.14 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.446 -1.032 . . . . 27.98 109.949 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' S' S ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.52 -56.2 24.94 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.142 -0.974 . . . . 28.100000000000001 109.939 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' S' S ' 319' ' ' SER . . . . . . . . . . . . . 1.2 m -59.99 -41.62 92.43 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.405 -0.81 . . . . 37.0 109.673 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' S' S ' 320' ' ' ARG . . . . . . . . . . . . . 12.2 mtm180 -111.68 79.89 2.64 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.592 -0.692 . . . . 52.07 109.666 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' S' S ' 321' ' ' PRO . . . . . 0.447 ' O ' ' HB2' ' S' ' 322' ' ' SER . 44.1 Cg_endo -71.31 171.52 15.93 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.876 1.461 . . . . 38.289999999999999 110.966 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' S' S ' 322' ' ' SER . . . . . 0.447 ' HB2' ' O ' ' S' ' 321' ' ' PRO . 41.3 t 178.65 -148.13 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.927 -0.768 . . . . 38.840000000000003 108.927 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' S' S ' 323' ' ' GLU . . . . . 0.808 ' HG2' HG23 ' S' ' 313' ' ' THR . 6.7 tp10 -62.84 -40.29 96.96 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.011 -1.055 . . . . 40.700000000000003 109.724 179.246 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' S' S ' 324' ' ' VAL . . . . . 0.666 ' HB ' HD13 ' S' ' 315' ' ' ILE . 72.9 t -141.28 135.03 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.416 -0.802 . . . . 20.34 109.456 179.358 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' S' S ' 325' ' ' CYS . . . . . 0.462 ' HB2' ' CE1' ' S' ' 380' ' ' PHE . 11.3 m -126.03 172.26 10.12 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.258 -0.901 . . . . 30.629999999999999 110.805 -179.129 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' S' S ' 326' ' ' VAL . . . . . 0.641 HG12 HG22 ' S' ' 379' ' ' VAL . 34.6 m -135.56 142.24 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 109.189 -0.671 . . . . 23.899999999999999 109.189 179.177 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' S' S ' 327' ' ' VAL . . . . . 0.593 HG11 ' O ' ' S' ' 377' ' ' VAL . 34.5 m -56.27 124.93 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.037 -1.04 . . . . 19.48 110.437 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' S' S ' 328' ' ' ASP . . . . . . . . . . . . . 55.6 p-10 -119.36 11.49 12.23 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.467 -0.77 . . . . 26.43 110.403 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' S' S ' 329' ' ' GLY . . . . . . . . . . . . . . . 119.63 2.24 13.14 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.043 -1.223 . . . . 31.239999999999998 110.043 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' S' S ' 330' ' ' THR . . . . . . . . . . . . . 80.9 m -93.02 129.93 38.78 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.044 -1.268 . . . . 30.050000000000001 110.111 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' S' S ' 331' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -56.73 111.49 1.03 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.262 -0.899 . . . . 37.259999999999998 110.02 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' S' S ' 332' ' ' MET . . . . . . . . . . . . . 88.1 mmm -94.11 162.64 13.79 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.285 -0.884 . . . . 26.23 110.345 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' S' S ' 333' ' ' CYS . . . . . . . . . . . . . 25.3 m -137.34 150.07 47.46 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.487 -0.758 . . . . 23.559999999999999 109.96 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' S' S ' 334' ' ' LEU . . . . . 0.558 HD11 ' O ' ' S' ' 372' ' ' PRO . 0.1 OUTLIER -52.58 -24.89 9.1 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.33 -0.856 . . . . 28.93 110.46 179.916 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' S' S ' 335' ' ' ALA . . . . . . . . . . . . . . . -88.99 14.44 10.57 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.302 -0.874 . . . . 15.76 110.957 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' S' S ' 336' ' ' ASP . . . . . 0.403 ' O ' ' HA ' ' S' ' 382' ' ' PRO . 70.7 m-20 -100.48 -17.19 17.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.166 -0.959 . . . . 34.920000000000002 110.206 179.539 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' S' S ' 337' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -152.37 170.84 19.1 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.382 -0.824 . . . . 19.030000000000001 110.095 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' S' S ' 338' ' ' HIS . . . . . 0.401 ' HB3' ' CZ ' ' S' ' 383' ' ' TYR . 13.5 p80 -120.71 10.34 10.97 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.365 -0.834 . . . . 18.82 110.484 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' S' S ' 339' ' ' ALA . . . . . 0.412 ' HA ' ' O ' ' S' ' 352' ' ' ALA . . . -176.01 155.17 1.55 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.289 -0.882 . . . . 17.18 110.131 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' S' S ' 340' ' ' GLY . . . . . 0.401 ' HA3' ' O ' ' S' ' 379' ' ' VAL . . . 160.85 173.07 29.0 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.01 -1.236 . . . . 18.329999999999998 110.01 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' S' S ' 341' ' ' ILE . . . . . . . . . . . . . 83.7 mt -88.77 138.1 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.523 -0.986 . . . . 18.600000000000001 109.862 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' S' S ' 342' ' ' PHE . . . . . 0.488 ' CE2' ' HB3' ' S' ' 352' ' ' ALA . 70.0 m-85 -120.93 -178.48 3.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.184 -0.947 . . . . 23.440000000000001 110.447 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' S' S ' 343' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.9 93.41 4.18 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.428 -0.795 . . . . 35.590000000000003 110.06 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' S' S ' 344' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.93 125.01 29.59 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.268 -0.895 . . . . 38.340000000000003 110.054 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' S' S ' 345' ' ' GLY . . . . . . . . . . . . . . . 62.91 -130.88 42.76 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 108.821 -1.712 . . . . 53.460000000000001 108.821 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' S' S ' 346' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -132.73 150.85 52.11 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.214 -1.168 . . . . 70.909999999999997 110.07 179.405 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' S' S ' 347' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 53.28 35.43 20.12 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.307 -0.871 . . . . 47.32 110.374 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' S' S ' 348' ' ' HIS . . . . . . . . . . . . . 46.6 t60 -150.15 155.83 40.52 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.248 -0.908 . . . . 41.719999999999999 110.346 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' S' S ' 349' ' ' ALA . . . . . 0.452 ' C ' HG13 ' S' ' 350' ' ' VAL . . . -149.74 151.28 33.36 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.33 -0.856 . . . . 22.91 110.544 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' S' S ' 350' ' ' VAL . . . . . 0.452 HG13 ' C ' ' S' ' 349' ' ' ALA . 34.6 m -149.06 169.64 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.448 -0.782 . . . . 21.09 110.06 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' S' S ' 351' ' ' PHE . . . . . 0.498 ' CD2' ' HB3' ' S' ' 258' ' ' GLN . 10.8 t80 -105.4 143.62 33.32 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.26 -0.9 . . . . 25.030000000000001 110.687 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' S' S ' 352' ' ' ALA . . . . . 0.488 ' HB3' ' CE2' ' S' ' 342' ' ' PHE . . . -147.74 151.72 36.54 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.58 -0.7 . . . . 23.809999999999999 109.75 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' S' S ' 353' ' ' CYS . . . . . . . . . . . . . 26.3 p -153.29 164.97 37.16 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.302 -0.874 . . . . 25.66 110.245 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' S' S ' 354' ' ' VAL . . . . . 0.553 HG22 ' CE2' ' S' ' 359' ' ' TRP . 58.0 t -76.15 118.56 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.4 -0.812 . . . . 34.270000000000003 109.941 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' S' S ' 355' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' S' ' 232' ' ' THR . 51.7 p -117.85 175.09 5.82 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.199 -0.938 . . . . 25.489999999999998 110.29 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' S' S ' 356' ' ' SER . . . . . . . . . . . . . 62.1 p -62.17 -17.65 58.65 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.465 -0.772 . . . . 31.239999999999998 110.743 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' S' S ' 357' ' ' ASN . . . . . . . . . . . . . 46.0 m-20 -107.02 14.2 26.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.154 -0.966 . . . . 28.609999999999999 110.611 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' S' S ' 358' ' ' GLY . . . . . . . . . . . . . . . 111.88 -152.88 17.6 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.997 -1.241 . . . . 22.010000000000002 109.997 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' S' S ' 359' ' ' TRP . . . . . 0.553 ' CE2' HG22 ' S' ' 354' ' ' VAL . 15.5 m95 -91.36 116.64 29.0 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.33 -1.1 . . . . 25.539999999999999 110.205 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' S' S ' 360' ' ' TYR . . . . . 0.426 ' HA ' ' HA ' ' S' ' 369' ' ' PRO . 1.3 m-85 -103.47 165.75 10.85 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.338 -0.852 . . . . 40.530000000000001 110.105 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' S' S ' 361' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' S' ' 351' ' ' PHE . . . -139.97 130.08 25.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.37 -0.831 . . . . 18.039999999999999 110.333 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' S' S ' 362' ' ' ILE . . . . . . . . . . . . . 88.8 mt -95.59 83.65 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.316 -0.865 . . . . 15.640000000000001 110.054 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' S' S ' 363' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' S' ' 365' ' ' GLU . 11.9 t0 -75.25 94.45 2.99 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.334 -0.854 . . . . 35.030000000000001 110.241 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' S' S ' 364' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 54.03 -89.42 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.484 -0.76 . . . . 46.719999999999999 110.547 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' S' S ' 365' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' S' ' 363' ' ' ASP . 23.8 mt-10 -122.6 19.06 10.4 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.048 -1.032 . . . . 56.200000000000003 110.251 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' S' S ' 366' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -118.01 125.0 49.52 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.207 -0.933 . . . . 51.020000000000003 110.308 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' S' S ' 367' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -106.94 127.05 53.09 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.355 -0.841 . . . . 37.590000000000003 110.155 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' S' S ' 368' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -165.4 159.52 13.97 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.253 -0.904 . . . . 31.469999999999999 110.461 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' S' S ' 369' ' ' PRO . . . . . 0.426 ' HA ' ' HA ' ' S' ' 360' ' ' TYR . 45.6 Cg_endo -72.91 139.58 30.42 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.869 1.457 . . . . 28.850000000000001 110.495 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' S' S ' 370' ' ' TRP . . . . . . . . . . . . . 67.6 t90 -167.13 113.63 0.77 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.463 -0.773 . . . . 26.940000000000001 109.973 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' S' S ' 371' ' ' THR . . . . . . . . . . . . . 59.6 m -74.84 113.02 20.41 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.338 -0.851 . . . . 20.190000000000001 109.986 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' S' S ' 372' ' ' PRO . . . . . 0.558 ' O ' HD11 ' S' ' 334' ' ' LEU . 46.5 Cg_endo -73.58 157.08 49.15 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 O-C-N 123.573 1.301 . . . . 28.68 110.546 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' S' S ' 373' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -90.52 147.08 35.65 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.436 -0.79 . . . . 35.719999999999999 109.987 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' S' S ' 374' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -75.95 -6.25 17.21 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.687 1.362 . . . . 30.890000000000001 110.533 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' S' S ' 375' ' ' SER . . . . . . . . . . . . . 68.9 p -104.4 -16.94 14.97 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.288 -0.882 . . . . 29.41 110.484 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' S' S ' 376' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -106.54 43.05 1.19 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.285 -0.884 . . . . 32.890000000000001 110.257 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' S' S ' 377' ' ' VAL . . . . . 0.593 ' O ' HG11 ' S' ' 327' ' ' VAL . 7.3 p -114.72 147.29 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.314 -0.866 . . . . 24.329999999999998 110.17 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' S' S ' 378' ' ' LEU . . . . . . . . . . . . . 52.1 mt -115.97 -58.02 2.15 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.386 -0.821 . . . . 24.370000000000001 109.623 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' S' S ' 379' ' ' VAL . . . . . 0.641 HG22 HG12 ' S' ' 326' ' ' VAL . 62.0 t -120.64 132.4 70.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.452 -0.78 . . . . 18.02 109.44 179.281 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' S' S ' 380' ' ' PHE . . . . . 0.462 ' CE1' ' HB2' ' S' ' 325' ' ' CYS . 14.2 p90 -142.59 173.97 11.06 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.375 -0.828 . . . . 29.350000000000001 110.665 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' S' S ' 381' ' ' VAL . . . . . . . . . . . . . 58.1 t -120.12 107.34 39.76 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.493 -0.755 . . . . 16.34 109.382 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' S' S ' 382' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' S' ' 336' ' ' ASP . 46.0 Cg_endo -71.28 145.6 48.95 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 O-C-N 123.669 1.352 . . . . 20.940000000000001 110.79 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' S' S ' 383' ' ' TYR . . . . . 0.401 ' CZ ' ' HB3' ' S' ' 338' ' ' HIS . 88.3 m-85 -61.05 -53.42 57.36 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.37 -0.831 . . . . 28.93 109.912 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' S' S ' 384' ' ' ASP . . . . . . . . . . . . . 27.4 t0 . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.362 -0.836 . . . . 47.030000000000001 110.358 -176.558 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' R' R ' 30' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.133 0.492 . . . . 43.359999999999999 110.308 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' R' R ' 31' ' ' LEU . . . . . . . . . . . . . 65.5 mt -134.87 140.67 45.98 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.338 -0.851 . . . . 22.93 110.271 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' R' R ' 32' ' ' THR . . . . . . . . . . . . . 71.1 m -87.7 110.61 20.56 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.352 -0.843 . . . . 22.34 109.935 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' R' R ' 33' ' ' LEU . . . . . 0.594 HD22 ' CE2' ' R' ' 62' ' ' TYR . 80.1 mt -62.39 -172.78 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.274 -0.891 . . . . 21.390000000000001 110.209 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' R' R ' 34' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -74.6 -29.52 61.34 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.333 -0.855 . . . . 34.399999999999999 110.365 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' R' R ' 35' ' ' ASN . . . . . . . . . . . . . 48.4 p30 -77.65 -1.95 33.51 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.348 -0.845 . . . . 30.280000000000001 110.689 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' R' R ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.28 -16.55 59.53 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.698 -1.361 . . . . 36.25 109.698 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' R' R ' 37' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -58.95 161.75 4.73 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.314 -1.11 . . . . 53.799999999999997 110.344 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' R' R ' 38' ' ' LYS . . . . . . . . . . . . . 56.9 mttt -117.83 135.76 53.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.315 -0.866 . . . . 49.909999999999997 110.142 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' R' R ' 39' ' ' LYS . . . . . 0.404 ' HG2' ' CZ ' ' R' ' 41' ' ' PHE . 8.1 ttmt -138.69 143.66 39.24 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.388 -0.82 . . . . 35.689999999999998 110.19 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' R' R ' 40' ' ' THR . . . . . . . . . . . . . 23.7 m -102.56 127.98 49.41 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.387 -0.82 . . . . 34.840000000000003 110.193 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' R' R ' 41' ' ' PHE . . . . . 0.404 ' CZ ' ' HG2' ' R' ' 39' ' ' LYS . 96.6 m-85 -113.09 132.71 55.32 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.402 -0.811 . . . . 34.420000000000002 110.11 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' R' R ' 42' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -93.24 140.89 29.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.346 -0.846 . . . . 51.460000000000001 110.247 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' R' R ' 43' ' ' SER . . . . . . . . . . . . . 53.9 m -70.74 141.91 51.47 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.502 -0.749 . . . . 41.840000000000003 110.196 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' R' R ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.75 125.37 29.58 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.263 -0.898 . . . . 33.82 109.986 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' R' R ' 45' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.16 151.05 54.74 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.543 1.286 . . . . 30.27 110.649 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' R' R ' 46' ' ' ASN . . . . . 0.4 ' HA ' ' OD1' ' R' ' 50' ' ' ASN . 52.1 t-20 -124.28 109.91 13.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.478 -0.764 . . . . 35.100000000000001 110.004 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' R' R ' 47' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -120.32 -34.93 3.54 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.217 -0.927 . . . . 42.810000000000002 110.466 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' R' R ' 48' ' ' HIS . . . . . 0.44 ' NE2' HD11 ' R' ' 80' ' ' LEU . 73.2 m80 -105.7 45.18 0.98 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.239 -0.913 . . . . 49.969999999999999 110.201 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' R' R ' 49' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 50.28 34.66 9.17 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.341 -0.849 . . . . 61.32 110.195 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' R' R ' 50' ' ' ASN . . . . . 0.4 ' OD1' ' HA ' ' R' ' 46' ' ' ASN . 15.0 p-10 -86.24 43.83 1.09 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.423 -0.798 . . . . 51.5 110.719 -179.556 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' R' R ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.12 -46.11 78.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.276 -0.89 . . . . 38.770000000000003 109.541 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' R' R ' 52' ' ' TRP . . . . . 0.483 ' CD2' ' N ' ' R' ' 53' ' ' LEU . 68.2 p-90 -58.39 -38.37 77.2 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.525 -0.734 . . . . 26.239999999999998 110.114 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' R' R ' 53' ' ' LEU . . . . . 0.483 ' N ' ' CD2' ' R' ' 52' ' ' TRP . 23.2 tp -66.72 -46.7 74.63 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.373 -0.83 . . . . 26.75 109.958 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' R' R ' 54' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -55.27 -41.55 72.38 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.405 -0.809 . . . . 35.020000000000003 110.142 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' R' R ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.17 -46.11 91.86 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.337 -0.852 . . . . 24.469999999999999 110.145 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' R' R ' 56' ' ' ILE . . . . . 0.433 HG12 HD11 ' R' ' 104' ' ' ILE . 76.4 mt -62.17 -42.24 94.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.332 -0.855 . . . . 26.030000000000001 109.924 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' R' R ' 57' ' ' LEU . . . . . . . . . . . . . 22.5 mt -60.24 -45.71 92.31 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.364 -0.835 . . . . 26.77 109.658 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' R' R ' 58' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -63.9 -46.57 84.25 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.508 -0.745 . . . . 22.32 109.559 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' R' R ' 59' ' ' LEU . . . . . 0.43 ' HA ' ' HE2' ' R' ' 151' ' ' PHE . 23.8 tp -61.43 -37.71 84.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.306 -0.871 . . . . 20.550000000000001 109.424 179.262 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' R' R ' 60' ' ' PHE . . . . . 0.528 ' CE2' HD21 ' R' ' 111' ' ' LEU . 2.8 m-85 -61.08 -44.69 96.98 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.62 -0.675 . . . . 20.079999999999998 109.95 179.285 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' R' R ' 61' ' ' ARG . . . . . . . . . . . . . 5.6 tpt180 -63.22 -36.18 82.81 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.397 -0.814 . . . . 18.800000000000001 110.41 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' R' R ' 62' ' ' TYR . . . . . 0.594 ' CE2' HD22 ' R' ' 33' ' ' LEU . 9.1 t80 -63.03 -41.8 99.62 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.13 -0.981 . . . . 26.449999999999999 110.248 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' R' R ' 63' ' ' VAL . . . . . 0.407 ' H ' HG22 ' R' ' 63' ' ' VAL . 30.7 m -93.35 20.3 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.238 -0.914 . . . . 29.75 110.221 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' R' R ' 64' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 53.02 75.56 0.24 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.322 -0.861 . . . . 35.520000000000003 110.541 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' R' R ' 65' ' ' GLU . . . . . 0.442 ' HG2' ' CD2' ' R' ' 60' ' ' PHE . 14.3 tp10 -116.28 104.01 52.41 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.348 -0.845 . . . . 29.890000000000001 109.893 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' R' R ' 66' ' ' PRO . . . . . 0.482 ' HA ' ' HB2' ' R' ' 69' ' ' ASP . 46.7 Cg_endo -73.58 -5.75 17.6 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.875 1.46 . . . . 21.370000000000001 111.111 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' R' R ' 67' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -52.17 -61.5 2.23 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.054 -1.029 . . . . 23.850000000000001 110.314 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' R' R ' 68' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -98.14 36.48 1.57 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.314 -0.866 . . . . 28.07 110.466 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' R' R ' 69' ' ' ASP . . . . . 0.482 ' HB2' ' HA ' ' R' ' 66' ' ' PRO . 11.7 t0 -72.25 -33.34 67.43 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.387 -0.821 . . . . 43.759999999999998 110.088 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' R' R ' 70' ' ' TRP . . . . . 0.476 ' CE2' ' CG2' ' R' ' 71' ' ' VAL . 47.8 p-90 -73.32 -3.94 30.2 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.34 -0.85 . . . . 33.060000000000002 110.71 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' R' R ' 71' ' ' VAL . . . . . 0.556 HG11 ' HB2' ' R' ' 82' ' ' ALA . 40.8 t -109.81 -27.45 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.241 -0.912 . . . . 31.699999999999999 109.674 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' R' R ' 72' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -86.52 -48.86 8.01 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.407 -0.808 . . . . 33.579999999999998 110.32 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' R' R ' 73' ' ' SER . . . . . . . . . . . . . 70.1 m -89.69 50.99 1.99 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.336 -0.853 . . . . 50.82 110.344 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' R' R ' 74' ' ' SER . . . . . . . . . . . . . 15.8 t -125.88 138.28 31.73 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.362 -0.836 . . . . 34.740000000000002 110.257 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.29 -25.02 16.06 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 O-C-N 123.735 1.387 . . . . 35.700000000000003 110.341 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' R' R ' 76' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -91.59 153.25 19.87 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.398 -0.814 . . . . 66.480000000000004 110.368 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' R' R ' 77' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -81.62 95.29 7.14 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.374 -0.829 . . . . 46.719999999999999 110.046 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' R' R ' 78' ' ' LEU . . . . . . . . . . . . . 96.3 mt -96.46 27.95 3.56 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.467 -0.771 . . . . 37.549999999999997 110.216 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' R' R ' 79' ' ' THR . . . . . . . . . . . . . 29.7 m -56.18 -54.65 42.61 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.325 -0.86 . . . . 37.359999999999999 110.295 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' R' R ' 80' ' ' LEU . . . . . 0.603 ' HA ' HD12 ' R' ' 83' ' ' ILE . 15.9 mt -60.92 -23.16 65.04 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.256 -0.902 . . . . 35.829999999999998 110.513 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' R' R ' 81' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -79.54 -39.08 32.72 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.165 -0.959 . . . . 44.030000000000001 110.331 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' R' R ' 82' ' ' ALA . . . . . 0.556 ' HB2' HG11 ' R' ' 71' ' ' VAL . . . -69.47 -28.66 66.28 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.262 -0.899 . . . . 32.539999999999999 110.245 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' R' R ' 83' ' ' ILE . . . . . 0.603 HD12 ' HA ' ' R' ' 80' ' ' LEU . 78.1 mt -70.11 -46.1 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.307 -0.87 . . . . 32.020000000000003 110.302 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' R' R ' 84' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -55.19 -52.11 64.39 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.177 -0.952 . . . . 34.090000000000003 110.547 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' R' R ' 85' ' ' GLN . . . . . 0.532 ' HG2' HD12 ' R' ' 89' ' ' LEU . 31.9 tt0 -54.74 -46.93 74.35 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.272 -0.893 . . . . 25.940000000000001 110.235 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' R' R ' 86' ' ' LEU . . . . . . . . . . . . . 24.2 mt -58.67 -43.91 90.02 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.318 -0.864 . . . . 16.199999999999999 109.904 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' R' R ' 87' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -65.32 -35.13 80.06 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.471 -0.768 . . . . 49.090000000000003 110.346 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' R' R ' 88' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -78.45 -19.12 53.84 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.308 -0.87 . . . . 28.609999999999999 110.497 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' R' R ' 89' ' ' LEU . . . . . 0.532 HD12 ' HG2' ' R' ' 85' ' ' GLN . 32.8 mt -96.16 -29.45 14.05 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.207 -0.933 . . . . 26.16 110.239 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' R' R ' 90' ' ' THR . . . . . . . . . . . . . 59.6 p -105.64 -34.61 7.68 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.241 -0.912 . . . . 33.329999999999998 109.819 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' R' R ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.79 16.16 58.61 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.862 -1.295 . . . . 31.129999999999999 109.862 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' R' R ' 92' ' ' LEU . . . . . . . . . . . . . 97.0 mt -100.12 155.29 17.81 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.172 -1.193 . . . . 42.520000000000003 110.21 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' R' R ' 93' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -86.26 91.63 8.53 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.432 -0.793 . . . . 68.459999999999994 109.948 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' R' R ' 94' ' ' LEU . . . . . 0.459 ' HB3' ' CZ2' ' R' ' 52' ' ' TRP . 47.7 mt -99.47 53.03 0.94 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.162 -0.961 . . . . 44.630000000000003 110.355 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' R' R ' 95' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.47 -38.66 6.39 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.253 -0.904 . . . . 67.159999999999997 110.399 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' R' R ' 96' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -113.9 44.23 1.68 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -0.922 . . . . 67.019999999999996 110.291 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' R' R ' 97' ' ' GLY . . . . . . . . . . . . . . . 99.14 150.79 26.02 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.733 -1.347 . . . . 49.479999999999997 109.733 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' R' R ' 98' ' ' GLY . . . . . . . . . . . . . . . -166.26 160.05 33.49 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.227 -1.549 . . . . 36.57 109.227 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' R' R ' 99' ' ' PRO . . . . . 0.79 ' O ' HG23 ' R' ' 103' ' ' VAL . 45.8 Cg_endo -72.58 121.1 7.13 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.65 1.342 . . . . 30.41 110.435 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' R' R ' 100' ' ' PRO . . . . . 0.413 ' HA ' HD11 ' R' ' 56' ' ' ILE . 45.8 Cg_endo -72.27 -31.59 11.53 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 O-C-N 123.649 1.342 . . . . 29.940000000000001 110.561 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' R' R ' 101' ' ' ALA . . . . . 0.476 ' HB2' ' HB3' ' R' ' 178' ' ' LEU . . . -70.01 -38.47 75.95 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.239 -0.913 . . . . 23.640000000000001 110.256 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' R' R ' 102' ' ' LEU . . . . . 0.424 HD23 HD21 ' R' ' 106' ' ' ASN . 0.1 OUTLIER -72.66 -40.74 66.09 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.284 -0.885 . . . . 20.309999999999999 110.358 -179.713 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' R' R ' 103' ' ' VAL . . . . . 0.79 HG23 ' O ' ' R' ' 99' ' ' PRO . 63.6 t -58.19 -40.09 76.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.227 -0.92 . . . . 16.329999999999998 109.996 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' R' R ' 104' ' ' ILE . . . . . 0.433 HD11 HG12 ' R' ' 56' ' ' ILE . 81.9 mt -71.72 -30.39 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.418 -0.801 . . . . 24.77 110.049 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' R' R ' 105' ' ' TRP . . . . . 0.461 ' O ' ' HD3' ' R' ' 108' ' ' LYS . 70.6 t-105 -82.49 0.89 40.35 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.34 -0.85 . . . . 23.280000000000001 110.254 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' R' R ' 106' ' ' ASN . . . . . 0.424 HD21 HD23 ' R' ' 102' ' ' LEU . 6.9 m-80 -105.16 -10.36 17.16 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.108 -0.995 . . . . 28.260000000000002 110.028 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' R' R ' 107' ' ' ILE . . . . . . . . . . . . . 36.8 pt -126.8 34.96 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.268 -0.895 . . . . 18.77 110.008 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' R' R ' 108' ' ' LYS . . . . . 0.5 ' HG2' ' HB ' ' R' ' 115' ' ' ILE . 9.2 mtpp -61.02 -48.5 81.5 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.589 -0.694 . . . . 42.5 110.037 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' R' R ' 109' ' ' HIS . . . . . 0.444 ' CD2' ' HG ' ' R' ' 110' ' ' LEU . 50.7 p-80 -66.02 -12.84 58.0 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.473 -0.767 . . . . 20.07 110.655 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' R' R ' 110' ' ' LEU . . . . . 0.444 ' HG ' ' CD2' ' R' ' 109' ' ' HIS . 80.7 mt -94.78 -17.35 22.22 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.121 -0.987 . . . . 15.69 110.171 179.385 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' R' R ' 111' ' ' LEU . . . . . 0.528 HD21 ' CE2' ' R' ' 60' ' ' PHE . 10.4 mt -94.06 144.14 25.74 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.342 -0.849 . . . . 25.390000000000001 111.05 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' R' R ' 112' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -77.7 -17.35 57.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.51 -0.744 . . . . 53.479999999999997 109.859 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' R' R ' 113' ' ' THR . . . . . 0.458 HG22 ' N ' ' R' ' 114' ' ' GLY . 59.7 m -83.69 166.66 17.9 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.308 -0.87 . . . . 14.800000000000001 110.299 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' R' R ' 114' ' ' GLY . . . . . 0.458 ' N ' HG22 ' R' ' 113' ' ' THR . . . -98.06 127.16 9.14 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.015 -1.234 . . . . 16.140000000000001 110.015 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' R' R ' 115' ' ' ILE . . . . . 0.578 HD13 ' HB ' ' R' ' 124' ' ' VAL . 47.8 mm -109.08 139.44 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.464 -1.021 . . . . 13.460000000000001 109.7 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' R' R ' 116' ' ' GLY . . . . . . . . . . . . . . . -152.74 -155.85 7.29 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.926 -1.27 . . . . 23.899999999999999 109.926 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' R' R ' 117' ' ' THR . . . . . 0.529 HG22 ' CG2' ' R' ' 126' ' ' VAL . 18.6 p -135.02 -171.39 2.79 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.413 -1.051 . . . . 27.370000000000001 110.044 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' R' R ' 118' ' ' ALA . . . . . 0.445 ' HB3' ' OD1' ' R' ' 128' ' ' ASP . . . -56.61 -57.96 10.11 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.251 -0.906 . . . . 18.760000000000002 110.107 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' R' R ' 119' ' ' SER . . . . . 0.424 ' HA ' ' CB ' ' R' ' 194' ' ' ALA . 1.2 m -56.58 -40.61 75.51 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.326 -0.859 . . . . 32.350000000000001 109.791 179.558 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' R' R ' 120' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 -110.04 86.2 4.81 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.442 -0.786 . . . . 27.120000000000001 109.682 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' R' R ' 121' ' ' PRO . . . . . 0.481 ' HA ' ' SG ' ' R' ' 125' ' ' CYS . 44.3 Cg_endo -71.23 166.5 29.06 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.813 1.428 . . . . 22.68 110.981 -179.425 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' R' R ' 122' ' ' SER . . . . . 0.438 ' HB2' ' O ' ' R' ' 121' ' ' PRO . 38.7 t 178.51 -161.69 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.481 -0.762 . . . . 22.989999999999998 109.492 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' R' R ' 123' ' ' GLU . . . . . 0.441 ' HG2' HG23 ' R' ' 113' ' ' THR . 2.3 tp10 -56.5 -39.97 74.18 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.19 -0.944 . . . . 36.18 109.649 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' R' R ' 124' ' ' VAL . . . . . 0.578 ' HB ' HD13 ' R' ' 115' ' ' ILE . 82.3 t -142.44 136.5 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.584 -0.698 . . . . 20.640000000000001 109.403 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' R' R ' 125' ' ' CYS . . . . . 0.481 ' SG ' ' HA ' ' R' ' 121' ' ' PRO . 83.4 m -140.35 168.21 20.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.219 -0.925 . . . . 22.800000000000001 111.163 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' R' R ' 126' ' ' VAL . . . . . 0.729 HG12 HG22 ' R' ' 179' ' ' VAL . 35.8 m -122.76 159.8 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.747 -0.596 . . . . 21.239999999999998 109.664 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' R' R ' 127' ' ' VAL . . . . . 0.709 HG11 ' O ' ' R' ' 177' ' ' VAL . 30.7 m -70.87 141.86 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.266 -0.896 . . . . 19.77 110.675 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' R' R ' 128' ' ' ASP . . . . . 0.445 ' OD1' ' HB3' ' R' ' 118' ' ' ALA . 53.9 p-10 -137.73 19.4 2.87 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.336 -0.853 . . . . 29.210000000000001 110.669 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' R' R ' 129' ' ' GLY . . . . . . . . . . . . . . . 114.03 0.01 24.1 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.893 -1.146 . . . . 33.859999999999999 110.461 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' R' R ' 130' ' ' THR . . . . . . . . . . . . . 58.1 m -91.77 131.91 36.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.207 -1.172 . . . . 26.41 110.099 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -62.62 120.69 11.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.356 -0.84 . . . . 33.079999999999998 110.274 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' R' R ' 132' ' ' MET . . . . . 0.433 ' HE1' ' CE2' ' R' ' 180' ' ' PHE . 98.4 mmm -105.18 165.58 11.0 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.468 -0.77 . . . . 30.760000000000002 110.409 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' R' R ' 133' ' ' CYS . . . . . 0.411 ' HA ' ' HB3' ' R' ' 174' ' ' PRO . 32.5 m -141.17 158.12 44.33 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.538 -0.726 . . . . 27.0 109.969 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' R' R ' 134' ' ' LEU . . . . . 0.564 HD11 ' O ' ' R' ' 172' ' ' PRO . 0.1 OUTLIER -58.5 -19.65 39.07 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.322 -0.861 . . . . 33.899999999999999 110.544 -179.871 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' R' R ' 135' ' ' ALA . . . . . . . . . . . . . . . -92.74 8.15 40.54 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.31 -0.868 . . . . 19.370000000000001 110.826 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' R' R ' 136' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -93.75 -21.74 19.13 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.174 -0.954 . . . . 30.469999999999999 110.245 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' R' R ' 137' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -149.98 165.35 32.95 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.407 -0.808 . . . . 24.27 110.215 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' R' R ' 138' ' ' HIS . . . . . 0.433 ' HA ' HG23 ' R' ' 154' ' ' VAL . 15.1 p80 -117.81 15.04 14.39 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.4 -0.813 . . . . 20.91 110.494 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' R' R ' 139' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' R' ' 152' ' ' ALA . . . -177.14 152.46 0.89 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.257 -0.902 . . . . 15.69 110.139 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' R' R ' 140' ' ' GLY . . . . . 0.427 ' HA3' ' O ' ' R' ' 179' ' ' VAL . . . 161.78 175.12 32.46 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.889 -1.285 . . . . 23.760000000000002 109.889 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' R' R ' 141' ' ' ILE . . . . . . . . . . . . . 83.8 mt -95.51 136.58 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.473 -1.016 . . . . 25.300000000000001 109.682 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' R' R ' 142' ' ' PHE . . . . . 0.576 ' CD2' ' HB2' ' R' ' 172' ' ' PRO . 82.9 m-85 -120.74 -172.66 2.43 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.287 -0.883 . . . . 30.239999999999998 110.547 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' R' R ' 143' ' ' LEU . . . . . 0.741 HD23 ' O ' ' R' ' 148' ' ' HIS . 0.5 OUTLIER -119.79 77.75 1.26 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.499 -0.751 . . . . 32.799999999999997 110.292 -179.907 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' R' R ' 144' ' ' LYS . . . . . 0.469 ' HG3' ' CZ2' ' R' ' 170' ' ' TRP . 1.0 OUTLIER -69.54 76.88 0.41 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.448 -0.783 . . . . 49.18 109.653 179.562 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' R' R ' 145' ' ' GLY . . . . . 0.456 ' O ' HD22 ' R' ' 143' ' ' LEU . . . 104.51 179.25 24.82 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.157 -1.577 . . . . 53.869999999999997 109.157 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' R' R ' 146' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -88.52 145.8 25.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.363 -1.081 . . . . 68.579999999999998 109.995 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' R' R ' 147' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 58.31 36.51 25.64 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.346 -0.846 . . . . 56.619999999999997 110.607 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' R' R ' 148' ' ' HIS . . . . . 0.741 ' O ' HD23 ' R' ' 143' ' ' LEU . 44.8 t60 -158.69 148.13 19.16 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.183 -0.948 . . . . 44.57 110.419 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' R' R ' 149' ' ' ALA . . . . . . . . . . . . . . . -150.29 146.83 27.01 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.445 -0.784 . . . . 33.539999999999999 110.057 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' R' R ' 150' ' ' VAL . . . . . . . . . . . . . 34.2 m -142.3 161.55 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.261 -0.9 . . . . 27.609999999999999 110.36 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' R' R ' 151' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' R' ' 152' ' ' ALA . 5.8 t80 -86.22 155.54 20.66 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.392 -0.818 . . . . 23.039999999999999 109.873 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' R' R ' 152' ' ' ALA . . . . . 0.537 ' N ' ' CD1' ' R' ' 151' ' ' PHE . . . -157.26 151.54 24.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.421 -0.799 . . . . 29.609999999999999 109.575 179.02 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' R' R ' 153' ' ' CYS . . . . . . . . . . . . . 26.7 p -154.27 173.61 15.91 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.34 -0.85 . . . . 22.75 110.542 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' R' R ' 154' ' ' VAL . . . . . 0.613 HG22 ' CE2' ' R' ' 159' ' ' TRP . 59.7 t -90.6 117.1 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.453 -0.78 . . . . 23.260000000000002 110.052 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' R' R ' 155' ' ' THR . . . . . . . . . . . . . 69.3 p -112.17 -176.62 2.97 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.359 -0.838 . . . . 17.879999999999999 110.041 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' R' R ' 156' ' ' SER . . . . . . . . . . . . . 78.5 p -75.96 -3.76 37.35 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.32 -0.863 . . . . 21.829999999999998 110.633 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' R' R ' 157' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -118.22 10.46 12.88 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.06 -1.025 . . . . 36.539999999999999 110.612 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' R' R ' 158' ' ' GLY . . . . . . . . . . . . . . . 117.97 -162.63 13.05 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.527 -1.429 . . . . 31.739999999999998 109.527 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' R' R ' 159' ' ' TRP . . . . . 0.613 ' CE2' HG22 ' R' ' 154' ' ' VAL . 14.7 m95 -86.6 122.57 30.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.354 -1.086 . . . . 28.25 110.035 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' R' R ' 160' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -108.48 166.96 10.38 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.42 -0.8 . . . . 41.240000000000002 110.201 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' R' R ' 161' ' ' ALA . . . . . . . . . . . . . . . -143.23 123.47 13.77 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.461 -0.775 . . . . 27.399999999999999 110.163 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' R' R ' 162' ' ' ILE . . . . . . . . . . . . . 92.0 mt -87.59 81.12 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.317 -0.864 . . . . 24.27 110.051 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' R' R ' 163' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' R' ' 165' ' ' GLU . 15.4 t0 -72.74 92.39 1.56 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.422 -0.799 . . . . 36.079999999999998 110.254 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' R' R ' 164' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 54.13 -89.0 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.515 -0.741 . . . . 46.079999999999998 110.574 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' R' R ' 165' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' R' ' 163' ' ' ASP . 29.7 mt-10 -124.76 36.02 4.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.088 -1.007 . . . . 50.939999999999998 110.192 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' R' R ' 166' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -135.81 117.29 14.77 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.416 -0.803 . . . . 47.280000000000001 110.266 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' R' R ' 167' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -101.04 120.02 39.59 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.387 -0.821 . . . . 40.469999999999999 110.155 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' R' R ' 168' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -157.52 158.53 30.68 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.273 -0.892 . . . . 30.210000000000001 110.433 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' R' R ' 169' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.77 132.98 19.42 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 O-C-N 123.863 1.454 . . . . 32.759999999999998 110.471 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' R' R ' 170' ' ' TRP . . . . . 0.469 ' CZ2' ' HG3' ' R' ' 144' ' ' LYS . 67.1 t90 -159.78 119.43 2.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.398 -0.814 . . . . 32.789999999999999 109.946 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' R' R ' 171' ' ' THR . . . . . . . . . . . . . 45.9 m -81.13 112.57 33.91 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.405 -0.809 . . . . 36.920000000000002 110.188 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' R' R ' 172' ' ' PRO . . . . . 0.576 ' HB2' ' CD2' ' R' ' 142' ' ' PHE . 47.2 Cg_endo -73.76 158.78 46.46 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 O-C-N 123.796 1.419 . . . . 33.539999999999999 110.551 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' R' R ' 173' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -88.84 144.96 33.83 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.361 -0.837 . . . . 45.759999999999998 109.951 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' R' R ' 174' ' ' PRO . . . . . 0.411 ' HB3' ' HA ' ' R' ' 133' ' ' CYS . 45.9 Cg_endo -71.74 -10.33 26.3 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 O-C-N 123.621 1.327 . . . . 29.629999999999999 110.497 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' R' R ' 175' ' ' SER . . . . . . . . . . . . . 53.0 p -103.53 -17.47 15.18 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.317 -0.864 . . . . 35.700000000000003 110.306 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' R' R ' 176' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -103.6 43.23 1.1 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.286 -0.884 . . . . 39.649999999999999 110.32 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' R' R ' 177' ' ' VAL . . . . . 0.709 ' O ' HG11 ' R' ' 127' ' ' VAL . 10.6 p -117.74 127.12 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.397 -0.815 . . . . 20.609999999999999 110.095 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' R' R ' 178' ' ' LEU . . . . . 0.476 ' HB3' ' HB2' ' R' ' 101' ' ' ALA . 46.2 mt -91.47 -61.25 1.69 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.305 -0.872 . . . . 15.58 109.389 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' R' R ' 179' ' ' VAL . . . . . 0.729 HG22 HG12 ' R' ' 126' ' ' VAL . 67.9 t -114.67 144.66 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.643 -0.661 . . . . 17.399999999999999 109.441 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' R' R ' 180' ' ' PHE . . . . . 0.433 ' CE2' ' HE1' ' R' ' 132' ' ' MET . 43.6 p90 -152.17 163.43 39.4 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.239 -0.913 . . . . 20.16 110.519 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' R' R ' 181' ' ' VAL . . . . . . . . . . . . . 66.6 t -113.19 111.47 50.22 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.342 -0.849 . . . . 17.690000000000001 109.756 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' R' R ' 182' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.05 149.56 52.83 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 O-C-N 123.507 1.267 . . . . 17.809999999999999 110.374 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' R' R ' 183' ' ' TYR . . . . . 0.698 ' O ' ' C ' ' R' ' 184' ' ' ASP . 79.5 m-85 -59.05 175.47 0.29 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.4 -0.813 . . . . 28.010000000000002 110.526 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' R' R ' 184' ' ' ASP . . . . . 0.698 ' C ' ' O ' ' R' ' 183' ' ' TYR . 1.1 m-20 -19.01 -82.88 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.425 -0.797 . . . . 58.640000000000001 110.319 -178.344 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' R' R ' 185' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 . . . . . 0 N--CA 1.502 2.16 0 CA-C-O 121.273 0.559 . . . . 80.420000000000002 111.777 179.479 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' R' R ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 120.948 0.404 . . . . 49.5 110.14 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' R' R ' 194' ' ' ALA . . . . . 0.424 ' CB ' ' HA ' ' R' ' 119' ' ' SER . . . . . . . . 0 N--CA 1.496 1.826 0 O-C-N 121.123 -0.986 . . . . 40.399999999999999 110.059 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' S' S ' 229' ' ' MET . . . . . 0.407 ' HG3' ' N ' ' S' ' 230' ' ' GLU . 24.8 ptp . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.229 0.538 . . . . 51.829999999999998 110.219 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' S' S ' 230' ' ' GLU . . . . . 0.407 ' N ' ' HG3' ' S' ' 229' ' ' MET . 33.1 tt0 -97.24 142.78 28.72 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.336 -0.852 . . . . 54.130000000000003 110.208 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' S' S ' 231' ' ' LEU . . . . . . . . . . . . . 68.0 mt -134.14 141.04 46.96 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.247 -0.908 . . . . 33.039999999999999 110.355 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' S' S ' 232' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' S' ' 355' ' ' THR . 40.0 m -89.22 103.18 15.83 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.414 -0.804 . . . . 26.920000000000002 110.037 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' S' S ' 233' ' ' LEU . . . . . 0.673 HD22 ' CE2' ' S' ' 262' ' ' TYR . 79.7 mt -55.91 179.26 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.467 -0.771 . . . . 13.779999999999999 110.457 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' S' S ' 234' ' ' TYR . . . . . 0.448 ' CG ' ' N ' ' S' ' 235' ' ' ASN . 35.7 p90 -65.02 -35.65 81.85 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.347 -0.845 . . . . 26.079999999999998 110.169 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' S' S ' 235' ' ' ASN . . . . . 0.448 ' N ' ' CG ' ' S' ' 234' ' ' TYR . 50.7 p30 -74.31 -7.46 52.87 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.292 -0.88 . . . . 20.039999999999999 110.524 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' S' S ' 236' ' ' GLY . . . . . . . . . . . . . . . 95.8 -20.03 51.7 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.76 -1.336 . . . . 22.710000000000001 109.76 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' S' S ' 237' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -52.9 145.72 12.13 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.234 -1.157 . . . . 35.439999999999998 110.226 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' S' S ' 238' ' ' LYS . . . . . . . . . . . . . 44.4 mttt -102.2 127.87 48.96 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.389 -0.82 . . . . 32.560000000000002 110.416 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' S' S ' 239' ' ' LYS . . . . . 0.405 ' HG2' ' CZ ' ' S' ' 241' ' ' PHE . 9.1 ttmt -132.25 144.49 50.65 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.377 -0.827 . . . . 26.68 110.036 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' S' S ' 240' ' ' THR . . . . . . . . . . . . . 51.5 m -102.01 132.16 48.01 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.328 -0.858 . . . . 41.020000000000003 110.41 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' S' S ' 241' ' ' PHE . . . . . 0.405 ' CZ ' ' HG2' ' S' ' 239' ' ' LYS . 96.0 m-85 -117.87 137.66 52.64 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.419 -0.801 . . . . 28.620000000000001 110.184 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' S' S ' 242' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -96.39 161.74 13.8 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.371 -0.831 . . . . 47.890000000000001 110.25 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' S' S ' 243' ' ' SER . . . . . . . . . . . . . 71.6 m -90.47 151.49 21.36 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.245 -0.909 . . . . 45.090000000000003 110.298 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' S' S ' 244' ' ' ARG . . . . . . . . . . . . . 1.4 mtp85 -129.76 126.78 22.73 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.371 -0.83 . . . . 42.490000000000002 110.266 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' S' S ' 245' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.37 161.05 43.56 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.652 1.343 . . . . 35.68 110.542 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' S' S ' 246' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -132.86 97.88 4.15 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.443 -0.786 . . . . 51.880000000000003 109.866 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' S' S ' 247' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -110.52 -22.23 11.75 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.395 -0.815 . . . . 53.689999999999998 110.664 -179.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' S' S ' 248' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -117.28 43.77 2.25 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.108 -0.995 . . . . 55.789999999999999 110.804 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' S' S ' 249' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 48.68 38.49 11.63 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.4 -0.813 . . . . 49.450000000000003 110.339 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' S' S ' 250' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -90.65 28.99 1.38 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.521 -0.737 . . . . 36.859999999999999 110.309 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' S' S ' 251' ' ' ALA . . . . . . . . . . . . . . . -53.79 -43.16 69.07 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.271 -0.893 . . . . 29.690000000000001 109.619 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' S' S ' 252' ' ' TRP . . . . . 0.427 ' CZ2' ' HB3' ' S' ' 294' ' ' LEU . 67.8 p-90 -61.81 -33.94 75.04 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.537 -0.727 . . . . 41.119999999999997 109.83 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' S' S ' 253' ' ' LEU . . . . . 0.4 ' N ' ' CD2' ' S' ' 252' ' ' TRP . 23.2 tp -70.16 -47.25 62.43 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.37 -0.831 . . . . 24.890000000000001 109.953 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' S' S ' 254' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -56.1 -42.44 76.8 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.417 -0.802 . . . . 35.649999999999999 109.96 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' S' S ' 255' ' ' ALA . . . . . . . . . . . . . . . -59.63 -48.18 82.69 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.399 -0.813 . . . . 22.73 110.081 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' S' S ' 256' ' ' ILE . . . . . 0.503 HG12 HD11 ' S' ' 304' ' ' ILE . 79.7 mt -62.25 -40.7 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.304 -0.873 . . . . 28.850000000000001 109.979 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' S' S ' 257' ' ' LEU . . . . . 0.404 ' CD2' ' HB3' ' S' ' 268' ' ' PHE . 19.1 mt -61.48 -44.5 96.98 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.257 -0.902 . . . . 23.07 110.154 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' S' S ' 258' ' ' GLN . . . . . 0.502 ' HB3' ' CD2' ' S' ' 351' ' ' PHE . 53.5 mm-40 -65.14 -45.33 85.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.39 -0.818 . . . . 29.780000000000001 109.919 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' S' S ' 259' ' ' LEU . . . . . 0.42 ' O ' HG22 ' S' ' 263' ' ' VAL . 19.7 tp -58.66 -36.35 74.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.337 -0.852 . . . . 17.940000000000001 109.474 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' S' S ' 260' ' ' PHE . . . . . 0.528 ' CE2' HD21 ' S' ' 311' ' ' LEU . 3.1 m-85 -62.9 -45.24 93.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.622 -0.674 . . . . 30.57 109.82 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' S' S ' 261' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -62.08 -29.81 70.56 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.386 -0.821 . . . . 41.340000000000003 109.987 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' S' S ' 262' ' ' TYR . . . . . 0.673 ' CE2' HD22 ' S' ' 233' ' ' LEU . 8.6 t80 -71.16 -44.67 65.05 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.367 -0.833 . . . . 26.030000000000001 110.1 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' S' S ' 263' ' ' VAL . . . . . 0.42 HG22 ' O ' ' S' ' 259' ' ' LEU . 33.1 m -92.02 18.15 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.374 -0.829 . . . . 22.800000000000001 110.334 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' S' S ' 264' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 52.85 70.69 0.55 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.206 -0.934 . . . . 44.030000000000001 110.589 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' S' S ' 265' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -111.86 109.19 55.3 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.397 -0.814 . . . . 35.609999999999999 109.602 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' S' S ' 266' ' ' PRO . . . . . 0.481 ' HA ' ' HB2' ' S' ' 269' ' ' ASP . 49.7 Cg_endo -75.34 0.44 9.04 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.657 1.346 . . . . 37.670000000000002 111.8 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' S' S ' 267' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -56.46 -67.73 0.28 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.781 -1.2 . . . . 41.490000000000002 110.192 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' S' S ' 268' ' ' PHE . . . . . 0.404 ' HB3' ' CD2' ' S' ' 257' ' ' LEU . 22.3 m-85 -92.94 39.95 1.05 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.15 -0.968 . . . . 50.759999999999998 110.063 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' S' S ' 269' ' ' ASP . . . . . 0.481 ' HB2' ' HA ' ' S' ' 266' ' ' PRO . 0.9 OUTLIER -76.04 -33.22 59.6 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.348 -0.845 . . . . 61.859999999999999 109.775 179.519 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' S' S ' 270' ' ' TRP . . . . . 0.511 ' CE2' HG23 ' S' ' 271' ' ' VAL . 50.9 p-90 -73.91 -4.31 34.28 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.33 -0.856 . . . . 39.850000000000001 110.493 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' S' S ' 271' ' ' VAL . . . . . 0.511 HG23 ' CE2' ' S' ' 270' ' ' TRP . 46.6 t -109.59 -32.66 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.187 -0.946 . . . . 39.18 110.058 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' S' S ' 272' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -78.68 -36.52 43.51 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.327 -0.858 . . . . 40.020000000000003 110.519 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' S' S ' 273' ' ' SER . . . . . . . . . . . . . 71.1 m -103.55 56.16 0.74 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.347 -0.846 . . . . 47.200000000000003 110.291 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' S' S ' 274' ' ' SER . . . . . . . . . . . . . 6.8 t -133.09 141.24 40.13 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.382 -0.824 . . . . 47.609999999999999 110.153 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' S' S ' 275' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.76 -18.82 21.75 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 123.639 1.337 . . . . 45.280000000000001 110.544 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' S' S ' 276' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -99.9 140.88 33.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.221 -0.924 . . . . 57.270000000000003 110.327 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' S' S ' 277' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -71.79 97.63 1.83 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.428 -0.795 . . . . 37.280000000000001 110.234 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' S' S ' 278' ' ' LEU . . . . . . . . . . . . . 86.0 mt -96.96 33.85 1.83 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.388 -0.82 . . . . 43.880000000000003 110.087 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' S' S ' 279' ' ' THR . . . . . . . . . . . . . 77.8 m -64.09 -60.19 3.54 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.471 -0.768 . . . . 50.049999999999997 110.194 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' S' S ' 280' ' ' LEU . . . . . 0.729 ' HA ' HD12 ' S' ' 283' ' ' ILE . 13.7 mt -51.51 -39.91 58.57 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.247 -0.908 . . . . 54.119999999999997 110.304 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' S' S ' 281' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.39 -49.69 74.52 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.444 -0.785 . . . . 65.280000000000001 110.132 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' S' S ' 282' ' ' ALA . . . . . . . . . . . . . . . -59.02 -33.89 71.27 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.478 -0.764 . . . . 46.509999999999998 110.488 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' S' S ' 283' ' ' ILE . . . . . 0.729 HD12 ' HA ' ' S' ' 280' ' ' LEU . 85.7 mt -66.34 -50.87 64.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.305 -0.872 . . . . 47.299999999999997 110.072 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' S' S ' 284' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -50.61 -57.56 7.92 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.416 -0.803 . . . . 50.719999999999999 110.359 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' S' S ' 285' ' ' GLN . . . . . 0.529 ' HG2' HD12 ' S' ' 289' ' ' LEU . 34.3 tt0 -51.42 -46.35 62.89 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.523 -0.736 . . . . 68.469999999999999 110.34 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' S' S ' 286' ' ' LEU . . . . . . . . . . . . . 19.1 mt -59.97 -44.47 94.44 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.464 -0.773 . . . . 36.619999999999997 110.309 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' S' S ' 287' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -62.83 -35.25 79.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.279 -0.888 . . . . 46.640000000000001 110.009 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' S' S ' 288' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -76.26 -20.99 56.85 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.42 -0.8 . . . . 46.450000000000003 110.328 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' S' S ' 289' ' ' LEU . . . . . 0.529 HD12 ' HG2' ' S' ' 285' ' ' GLN . 30.7 mt -97.33 -21.73 17.05 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.342 -0.849 . . . . 35.090000000000003 110.52 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' S' S ' 290' ' ' THR . . . . . 0.409 HG22 ' HB3' ' S' ' 306' ' ' ASN . 81.3 p -114.78 -28.5 7.07 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.214 -0.929 . . . . 38.609999999999999 110.373 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' S' S ' 291' ' ' GLY . . . . . . . . . . . . . . . 79.38 11.05 85.34 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.886 -1.286 . . . . 36.770000000000003 109.886 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' S' S ' 292' ' ' LEU . . . . . . . . . . . . . 84.5 mt -96.45 145.77 25.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.222 -1.164 . . . . 35.329999999999998 109.768 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' S' S ' 293' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -77.36 102.37 6.76 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.25 -0.906 . . . . 48.700000000000003 110.272 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' S' S ' 294' ' ' LEU . . . . . 0.427 ' HB3' ' CZ2' ' S' ' 252' ' ' TRP . 55.3 mt -106.86 51.72 0.74 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.55 -0.719 . . . . 42.609999999999999 110.11 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' S' S ' 295' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -112.57 -11.09 13.63 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.325 -0.859 . . . . 55.490000000000002 110.573 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' S' S ' 296' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -144.38 48.53 1.36 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.163 -0.96 . . . . 75.680000000000007 110.292 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' S' S ' 297' ' ' GLY . . . . . . . . . . . . . . . 96.84 145.21 18.76 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.509 -1.437 . . . . 49.439999999999998 109.509 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' S' S ' 298' ' ' GLY . . . . . . . . . . . . . . . -163.83 156.93 29.01 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.805 -1.318 . . . . 41.109999999999999 109.805 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' S' S ' 299' ' ' PRO . . . . . 0.484 ' O ' HG23 ' S' ' 303' ' ' VAL . 47.4 Cg_endo -73.77 118.25 5.37 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 123.955 1.502 . . . . 26.199999999999999 110.293 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' S' S ' 300' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.24 -15.42 31.68 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 O-C-N 123.577 1.304 . . . . 21.699999999999999 110.734 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' S' S ' 301' ' ' ALA . . . . . . . . . . . . . . . -80.71 -29.34 36.45 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.276 -0.89 . . . . 31.23 110.14 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' S' S ' 302' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.57 -40.57 18.93 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.405 -0.809 . . . . 38.990000000000002 109.926 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' S' S ' 303' ' ' VAL . . . . . 0.484 HG23 ' O ' ' S' ' 299' ' ' PRO . 58.1 t -60.73 -35.47 64.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.375 -0.828 . . . . 18.629999999999999 110.143 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' S' S ' 304' ' ' ILE . . . . . 0.523 HD12 HG21 ' S' ' 379' ' ' VAL . 86.2 mt -79.45 -23.55 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.463 -0.773 . . . . 25.460000000000001 110.193 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' S' S ' 305' ' ' TRP . . . . . 0.411 ' CD2' ' HD3' ' S' ' 308' ' ' LYS . 68.7 t-105 -88.63 -14.6 37.1 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.253 -0.904 . . . . 33.399999999999999 110.601 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' S' S ' 306' ' ' ASN . . . . . 0.409 ' HB3' HG22 ' S' ' 290' ' ' THR . 10.4 m-80 -89.69 -13.57 36.64 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.227 -0.92 . . . . 36.969999999999999 110.435 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' S' S ' 307' ' ' ILE . . . . . 0.471 HG12 ' O ' ' S' ' 303' ' ' VAL . 36.8 pt -125.09 45.66 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.218 -0.926 . . . . 30.809999999999999 110.066 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' S' S ' 308' ' ' LYS . . . . . 0.411 ' HD3' ' CD2' ' S' ' 305' ' ' TRP . 1.5 mtmp? -73.52 -37.77 65.52 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.355 -0.841 . . . . 46.520000000000003 110.084 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' S' S ' 309' ' ' HIS . . . . . 0.493 ' CD2' ' HG ' ' S' ' 310' ' ' LEU . 55.5 p-80 -73.1 -8.34 55.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.303 -0.873 . . . . 51.030000000000001 110.129 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' S' S ' 310' ' ' LEU . . . . . 0.493 ' HG ' ' CD2' ' S' ' 309' ' ' HIS . 52.6 mt -99.27 -12.94 19.92 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.295 -0.878 . . . . 36.159999999999997 109.971 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' S' S ' 311' ' ' LEU . . . . . 0.528 HD21 ' CE2' ' S' ' 260' ' ' PHE . 10.8 mt -97.11 147.81 23.67 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.314 -0.866 . . . . 40.0 110.452 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' S' S ' 312' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -81.54 -16.33 52.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.345 -0.847 . . . . 54.18 109.763 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' S' S ' 313' ' ' THR . . . . . 0.823 HG23 ' HG2' ' S' ' 323' ' ' GLU . 92.5 m -87.88 151.53 22.76 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.375 -0.828 . . . . 25.609999999999999 110.159 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' S' S ' 314' ' ' GLY . . . . . . . . . . . . . . . -87.83 126.38 8.02 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.836 -1.306 . . . . 25.18 109.836 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' S' S ' 315' ' ' ILE . . . . . 0.671 HD13 ' HB ' ' S' ' 324' ' ' VAL . 50.7 mm -101.64 150.53 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.35 -1.088 . . . . 23.899999999999999 109.71 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' S' S ' 316' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' S' ' 325' ' ' CYS . . . -157.12 -159.32 9.42 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.923 -1.271 . . . . 23.18 109.923 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' S' S ' 317' ' ' THR . . . . . 0.425 HG22 ' CG2' ' S' ' 326' ' ' VAL . 11.2 p -133.88 -173.06 3.14 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.417 -1.049 . . . . 27.98 110.013 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' S' S ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.55 -56.23 24.63 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.199 -0.938 . . . . 28.100000000000001 109.892 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' S' S ' 319' ' ' SER . . . . . . . . . . . . . 1.2 m -59.9 -41.67 92.17 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.405 -0.809 . . . . 37.0 109.632 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' S' S ' 320' ' ' ARG . . . . . . . . . . . . . 12.2 mtm180 -111.69 79.85 2.62 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.471 -0.768 . . . . 52.07 109.679 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' S' S ' 321' ' ' PRO . . . . . 0.445 ' O ' ' HB2' ' S' ' 322' ' ' SER . 44.1 Cg_endo -71.43 171.46 16.14 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.79 1.416 . . . . 38.289999999999999 110.903 -179.393 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' S' S ' 322' ' ' SER . . . . . 0.445 ' HB2' ' O ' ' S' ' 321' ' ' PRO . 41.3 t 178.7 -148.08 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.928 -0.767 . . . . 38.840000000000003 108.928 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' S' S ' 323' ' ' GLU . . . . . 0.823 ' HG2' HG23 ' S' ' 313' ' ' THR . 6.7 tp10 -62.87 -40.34 97.2 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.944 -1.098 . . . . 40.700000000000003 109.664 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' S' S ' 324' ' ' VAL . . . . . 0.671 ' HB ' HD13 ' S' ' 315' ' ' ILE . 72.7 t -141.24 135.02 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.433 -0.792 . . . . 20.34 109.463 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' S' S ' 325' ' ' CYS . . . . . 0.46 ' HB2' ' CE1' ' S' ' 380' ' ' PHE . 11.1 m -126.02 172.24 10.13 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.246 -0.909 . . . . 30.629999999999999 110.867 -179.144 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' S' S ' 326' ' ' VAL . . . . . 0.643 HG12 HG22 ' S' ' 379' ' ' VAL . 34.5 m -135.51 142.16 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.651 -0.656 . . . . 23.899999999999999 109.248 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' S' S ' 327' ' ' VAL . . . . . 0.595 HG11 ' O ' ' S' ' 377' ' ' VAL . 34.6 m -56.32 125.04 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.015 -1.053 . . . . 19.48 110.388 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' S' S ' 328' ' ' ASP . . . . . . . . . . . . . 55.5 p-10 -119.41 11.46 12.18 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.496 -0.753 . . . . 26.43 110.427 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' S' S ' 329' ' ' GLY . . . . . . . . . . . . . . . 119.75 2.2 12.99 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.973 -1.251 . . . . 31.239999999999998 109.973 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' S' S ' 330' ' ' THR . . . . . . . . . . . . . 78.8 m -92.94 130.02 38.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.093 -1.239 . . . . 30.050000000000001 110.136 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' S' S ' 331' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -56.85 111.48 1.04 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.207 -0.933 . . . . 37.259999999999998 109.927 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' S' S ' 332' ' ' MET . . . . . . . . . . . . . 88.1 mmm -93.99 162.54 13.85 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.275 -0.89 . . . . 26.23 110.42 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' S' S ' 333' ' ' CYS . . . . . . . . . . . . . 25.7 m -137.25 150.0 47.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.398 -0.814 . . . . 23.559999999999999 110.072 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' S' S ' 334' ' ' LEU . . . . . 0.562 HD11 ' O ' ' S' ' 372' ' ' PRO . 0.1 OUTLIER -52.51 -24.93 8.96 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.282 -0.886 . . . . 28.93 110.438 179.921 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' S' S ' 335' ' ' ALA . . . . . . . . . . . . . . . -89.02 14.43 10.66 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.358 -0.839 . . . . 15.76 110.975 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' S' S ' 336' ' ' ASP . . . . . 0.403 ' O ' ' HA ' ' S' ' 382' ' ' PRO . 70.8 m-20 -100.49 -17.21 17.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.092 -1.005 . . . . 34.920000000000002 110.185 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' S' S ' 337' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -152.47 170.84 19.15 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.363 -0.836 . . . . 19.030000000000001 110.084 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' S' S ' 338' ' ' HIS . . . . . . . . . . . . . 13.3 p80 -120.68 10.44 11.01 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.367 -0.833 . . . . 18.82 110.441 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' S' S ' 339' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' S' ' 352' ' ' ALA . . . -175.99 155.18 1.56 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.205 -0.934 . . . . 17.18 110.091 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' S' S ' 340' ' ' GLY . . . . . 0.401 ' CA ' ' O ' ' S' ' 379' ' ' VAL . . . 160.82 173.09 28.99 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 110.088 -1.205 . . . . 18.329999999999998 110.088 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' S' S ' 341' ' ' ILE . . . . . . . . . . . . . 84.2 mt -88.76 138.05 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.434 -1.039 . . . . 18.600000000000001 109.78 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' S' S ' 342' ' ' PHE . . . . . 0.493 ' CE2' ' HB3' ' S' ' 352' ' ' ALA . 70.0 m-85 -120.99 -178.47 3.75 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.187 -0.945 . . . . 23.440000000000001 110.401 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' S' S ' 343' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.81 93.46 4.21 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.431 -0.793 . . . . 35.590000000000003 110.053 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' S' S ' 344' ' ' LYS . . . . . 0.405 ' O ' ' HB3' ' S' ' 348' ' ' HIS . 0.3 OUTLIER -80.89 125.05 29.63 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.268 -0.895 . . . . 38.340000000000003 110.049 -179.884 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' S' S ' 345' ' ' GLY . . . . . . . . . . . . . . . 62.75 -130.73 43.08 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 108.857 -1.697 . . . . 53.460000000000001 108.857 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' S' S ' 346' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -132.76 150.87 52.11 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.252 -1.146 . . . . 70.909999999999997 109.976 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' S' S ' 347' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 53.33 35.38 20.13 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.355 -0.841 . . . . 47.32 110.357 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' S' S ' 348' ' ' HIS . . . . . 0.405 ' HB3' ' O ' ' S' ' 344' ' ' LYS . 46.4 t60 -150.19 155.89 40.59 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.208 -0.932 . . . . 41.719999999999999 110.333 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' S' S ' 349' ' ' ALA . . . . . 0.459 ' C ' HG13 ' S' ' 350' ' ' VAL . . . -149.76 151.23 33.26 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.243 -0.911 . . . . 22.91 110.458 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' S' S ' 350' ' ' VAL . . . . . 0.459 HG13 ' C ' ' S' ' 349' ' ' ALA . 34.6 m -149.06 169.58 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.384 -0.822 . . . . 21.09 110.057 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' S' S ' 351' ' ' PHE . . . . . 0.502 ' CD2' ' HB3' ' S' ' 258' ' ' GLN . 10.8 t80 -105.31 143.58 33.29 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.279 -0.888 . . . . 25.030000000000001 110.748 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' S' S ' 352' ' ' ALA . . . . . 0.493 ' HB3' ' CE2' ' S' ' 342' ' ' PHE . . . -147.74 151.66 36.45 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.566 -0.709 . . . . 23.809999999999999 109.777 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' S' S ' 353' ' ' CYS . . . . . . . . . . . . . 26.3 p -153.25 164.88 37.31 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.348 -0.845 . . . . 25.66 110.274 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' S' S ' 354' ' ' VAL . . . . . 0.549 HG22 ' CE2' ' S' ' 359' ' ' TRP . 57.6 t -76.07 118.44 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.387 -0.82 . . . . 34.270000000000003 109.972 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' S' S ' 355' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' S' ' 232' ' ' THR . 52.3 p -117.81 175.12 5.8 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.236 -0.915 . . . . 25.489999999999998 110.364 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' S' S ' 356' ' ' SER . . . . . . . . . . . . . 62.5 p -62.19 -17.65 58.74 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.462 -0.774 . . . . 31.239999999999998 110.704 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' S' S ' 357' ' ' ASN . . . . . . . . . . . . . 46.3 m-20 -107.0 14.16 26.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.15 -0.969 . . . . 28.609999999999999 110.608 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' S' S ' 358' ' ' GLY . . . . . . . . . . . . . . . 111.83 -152.88 17.59 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.031 -1.227 . . . . 22.010000000000002 110.031 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' S' S ' 359' ' ' TRP . . . . . 0.549 ' CE2' HG22 ' S' ' 354' ' ' VAL . 15.5 m95 -91.32 116.69 29.04 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.396 -1.061 . . . . 25.539999999999999 110.148 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' S' S ' 360' ' ' TYR . . . . . 0.412 ' HA ' ' HA ' ' S' ' 369' ' ' PRO . 1.3 m-85 -103.48 165.8 10.82 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.341 -0.849 . . . . 40.530000000000001 110.069 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' S' S ' 361' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' S' ' 351' ' ' PHE . . . -140.09 130.07 24.81 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.393 -0.817 . . . . 18.039999999999999 110.296 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' S' S ' 362' ' ' ILE . . . . . . . . . . . . . 89.1 mt -95.58 83.8 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.4 -0.813 . . . . 15.640000000000001 109.998 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' S' S ' 363' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' S' ' 365' ' ' GLU . 11.9 t0 -75.27 94.51 3.02 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.337 -0.852 . . . . 35.030000000000001 110.202 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' S' S ' 364' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 53.86 -89.34 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.545 -0.722 . . . . 46.719999999999999 110.575 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' S' S ' 365' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' S' ' 363' ' ' ASP . 23.8 mt-10 -122.67 19.1 10.34 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.082 -1.011 . . . . 56.200000000000003 110.271 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' S' S ' 366' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -117.95 125.05 49.68 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.26 -0.9 . . . . 51.020000000000003 110.406 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' S' S ' 367' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -107.03 127.0 53.07 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.357 -0.84 . . . . 37.590000000000003 110.112 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' S' S ' 368' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -165.39 159.56 13.98 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.303 -0.873 . . . . 31.469999999999999 110.452 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' S' S ' 369' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' S' ' 360' ' ' TYR . 45.7 Cg_endo -72.89 139.63 30.59 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 O-C-N 123.831 1.437 . . . . 28.850000000000001 110.509 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' S' S ' 370' ' ' TRP . . . . . . . . . . . . . 67.4 t90 -167.22 113.53 0.76 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.402 -0.812 . . . . 26.940000000000001 109.987 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' S' S ' 371' ' ' THR . . . . . . . . . . . . . 59.1 m -74.8 113.04 20.62 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.406 -0.808 . . . . 20.190000000000001 110.049 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' S' S ' 372' ' ' PRO . . . . . 0.562 ' O ' HD11 ' S' ' 334' ' ' LEU . 48.0 Cg_endo -73.46 157.16 49.55 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 O-C-N 123.662 1.348 . . . . 28.68 110.625 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' S' S ' 373' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -90.67 147.19 35.69 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.391 -0.818 . . . . 35.719999999999999 109.832 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' S' S ' 374' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -76.02 -6.28 17.2 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.701 1.369 . . . . 30.890000000000001 110.506 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' S' S ' 375' ' ' SER . . . . . . . . . . . . . 70.4 p -104.42 -16.88 14.97 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.235 -0.916 . . . . 29.41 110.43 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' S' S ' 376' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -106.53 43.14 1.18 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.23 -0.919 . . . . 32.890000000000001 110.257 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' S' S ' 377' ' ' VAL . . . . . 0.595 ' O ' HG11 ' S' ' 327' ' ' VAL . 7.3 p -114.7 147.26 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.311 -0.868 . . . . 24.329999999999998 110.163 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' S' S ' 378' ' ' LEU . . . . . . . . . . . . . 52.2 mt -115.96 -58.08 2.15 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.406 -0.809 . . . . 24.370000000000001 109.633 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' S' S ' 379' ' ' VAL . . . . . 0.643 HG22 HG12 ' S' ' 326' ' ' VAL . 61.0 t -120.65 132.33 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.443 -0.786 . . . . 18.02 109.48 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' S' S ' 380' ' ' PHE . . . . . 0.46 ' CE1' ' HB2' ' S' ' 325' ' ' CYS . 14.3 p90 -142.54 173.92 11.1 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.398 -0.814 . . . . 29.350000000000001 110.622 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' S' S ' 381' ' ' VAL . . . . . . . . . . . . . 58.0 t -120.05 107.38 39.85 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.53 -0.731 . . . . 16.34 109.391 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' S' S ' 382' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' S' ' 336' ' ' ASP . 45.4 Cg_endo -71.32 145.58 48.69 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.698 1.367 . . . . 20.940000000000001 110.738 -179.395 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' S' S ' 383' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -61.02 -53.51 56.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.389 -0.819 . . . . 28.93 109.891 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' S' S ' 384' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.389 -0.82 . . . . 47.030000000000001 110.342 -177.046 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' R' R ' 29' ' ' MET . . . . . . . . . . . . . 15.6 mtt . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.164 0.507 . . . . 32.140000000000001 110.224 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' R' R ' 30' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -96.36 141.15 30.02 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.382 -0.824 . . . . 43.359999999999999 110.202 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 31' ' ' LEU . . . . . . . . . . . . . 65.3 mt -134.91 140.56 45.85 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.312 -0.867 . . . . 22.93 110.283 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 32' ' ' THR . . . . . . . . . . . . . 69.6 m -87.55 110.57 20.45 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.376 -0.828 . . . . 22.34 109.984 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 33' ' ' LEU . . . . . 0.595 HD22 ' CE2' ' R' ' 62' ' ' TYR . 80.1 mt -62.35 -172.79 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.266 -0.896 . . . . 21.390000000000001 110.226 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 34' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -74.65 -29.41 61.25 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.333 -0.855 . . . . 34.399999999999999 110.386 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 35' ' ' ASN . . . . . . . . . . . . . 48.3 p30 -77.73 -1.87 33.38 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.324 -0.86 . . . . 30.280000000000001 110.633 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.2 -16.56 59.42 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.776 -1.329 . . . . 36.25 109.776 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 37' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -59.02 161.81 4.76 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.285 -1.127 . . . . 53.799999999999997 110.383 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 38' ' ' LYS . . . . . . . . . . . . . 56.9 mttt -117.84 135.78 53.86 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.43 -0.794 . . . . 49.909999999999997 110.108 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 39' ' ' LYS . . . . . 0.406 ' HG2' ' CZ ' ' R' ' 41' ' ' PHE . 8.1 ttmt -138.75 143.69 39.12 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.432 -0.792 . . . . 35.689999999999998 110.223 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 40' ' ' THR . . . . . . . . . . . . . 23.7 m -102.57 127.98 49.42 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.309 -0.87 . . . . 34.840000000000003 110.193 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 41' ' ' PHE . . . . . 0.406 ' CZ ' ' HG2' ' R' ' 39' ' ' LYS . 96.6 m-85 -113.09 132.66 55.34 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.402 -0.811 . . . . 34.420000000000002 110.147 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 42' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -93.25 140.95 28.98 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.31 -0.869 . . . . 51.460000000000001 110.204 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 43' ' ' SER . . . . . . . . . . . . . 54.5 m -70.81 141.89 51.33 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.453 -0.779 . . . . 41.840000000000003 110.206 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.74 125.41 29.53 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.296 -0.877 . . . . 33.82 109.934 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 45' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.16 151.05 54.74 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.59 1.31 . . . . 30.27 110.649 -179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 46' ' ' ASN . . . . . 0.4 ' HA ' ' OD1' ' R' ' 50' ' ' ASN . 52.1 t-20 -124.23 109.84 13.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.456 -0.777 . . . . 35.100000000000001 110.033 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 47' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -120.28 -34.84 3.56 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.298 -0.876 . . . . 42.810000000000002 110.503 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 48' ' ' HIS . . . . . 0.439 ' NE2' HD11 ' R' ' 80' ' ' LEU . 73.4 m80 -105.77 45.18 0.98 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.221 -0.925 . . . . 49.969999999999999 110.176 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 49' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 50.29 34.72 9.28 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.414 -0.804 . . . . 61.32 110.173 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 50' ' ' ASN . . . . . 0.4 ' OD1' ' HA ' ' R' ' 46' ' ' ASN . 15.0 p-10 -86.25 43.74 1.08 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.333 -0.854 . . . . 51.5 110.703 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 51' ' ' ALA . . . . . 0.455 ' HB3' ' C ' ' S' ' 401' ' ' LYS . . . -66.08 -46.11 78.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.184 -0.948 . . . . 38.770000000000003 109.558 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 52' ' ' TRP . . . . . 0.483 ' CD2' ' N ' ' R' ' 53' ' ' LEU . 68.2 p-90 -58.39 -38.43 77.31 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.419 -0.801 . . . . 26.239999999999998 110.055 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 53' ' ' LEU . . . . . 0.483 ' N ' ' CD2' ' R' ' 52' ' ' TRP . 23.2 tp -66.68 -46.68 74.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.4 -0.813 . . . . 26.75 110.013 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 54' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -55.2 -41.61 72.22 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.372 -0.83 . . . . 35.020000000000003 110.156 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.17 -46.08 92.0 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.337 -0.852 . . . . 24.469999999999999 110.145 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 56' ' ' ILE . . . . . 0.432 HG12 HD11 ' R' ' 104' ' ' ILE . 76.2 mt -62.23 -42.21 94.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.322 -0.861 . . . . 26.030000000000001 109.906 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 57' ' ' LEU . . . . . . . . . . . . . 22.4 mt -60.31 -45.6 92.83 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.325 -0.859 . . . . 26.77 109.68 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 58' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -63.97 -46.49 84.4 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.426 -0.796 . . . . 22.32 109.561 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 59' ' ' LEU . . . . . 0.429 ' HA ' ' HE2' ' R' ' 151' ' ' PHE . 23.9 tp -61.43 -37.75 84.65 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.316 -0.865 . . . . 20.550000000000001 109.396 179.295 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 60' ' ' PHE . . . . . 0.528 ' CE2' HD21 ' R' ' 111' ' ' LEU . 2.8 m-85 -61.08 -44.78 96.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.628 -0.67 . . . . 20.079999999999998 109.907 179.304 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 61' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -63.16 -36.15 82.65 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.481 -0.762 . . . . 18.800000000000001 110.472 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 62' ' ' TYR . . . . . 0.595 ' CE2' HD22 ' R' ' 33' ' ' LEU . 9.2 t80 -63.04 -41.78 99.58 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.207 -0.933 . . . . 26.449999999999999 110.26 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 63' ' ' VAL . . . . . 0.406 ' H ' HG22 ' R' ' 63' ' ' VAL . 30.2 m -93.38 20.38 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.304 -0.872 . . . . 29.75 110.188 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 64' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 52.91 75.6 0.23 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.303 -0.873 . . . . 35.520000000000003 110.546 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 65' ' ' GLU . . . . . 0.443 ' HG2' ' CD2' ' R' ' 60' ' ' PHE . 14.3 tp10 -116.29 104.05 52.35 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.457 -0.777 . . . . 29.890000000000001 109.901 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 66' ' ' PRO . . . . . 0.48 ' HA ' ' HB2' ' R' ' 69' ' ' ASP . 46.6 Cg_endo -73.55 -5.83 17.74 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.79 1.416 . . . . 21.370000000000001 111.094 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 67' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -52.11 -61.56 2.19 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.103 -0.998 . . . . 23.850000000000001 110.331 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 68' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -98.12 36.56 1.56 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.25 -0.906 . . . . 28.07 110.438 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 69' ' ' ASP . . . . . 0.48 ' HB2' ' HA ' ' R' ' 66' ' ' PRO . 11.7 t0 -72.36 -33.26 67.13 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.346 -0.846 . . . . 43.759999999999998 110.144 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 70' ' ' TRP . . . . . 0.477 ' CE2' ' CG2' ' R' ' 71' ' ' VAL . 47.9 p-90 -73.42 -3.84 29.88 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.275 -0.891 . . . . 33.060000000000002 110.716 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 71' ' ' VAL . . . . . 0.556 HG11 ' HB2' ' R' ' 82' ' ' ALA . 40.7 t -109.79 -27.45 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.194 -0.941 . . . . 31.699999999999999 109.685 179.155 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 72' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -86.62 -48.83 7.98 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.358 -0.839 . . . . 33.579999999999998 110.282 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 73' ' ' SER . . . . . . . . . . . . . 69.9 m -89.7 51.08 2.01 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.27 -0.893 . . . . 50.82 110.36 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 74' ' ' SER . . . . . . . . . . . . . 15.8 t -125.92 138.3 31.8 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.338 -0.851 . . . . 34.740000000000002 110.221 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.38 -24.97 15.93 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 O-C-N 123.641 1.337 . . . . 35.700000000000003 110.348 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 76' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -91.68 153.16 19.85 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.37 -0.831 . . . . 66.480000000000004 110.379 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 77' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -81.48 95.22 7.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.292 -0.88 . . . . 46.719999999999999 110.102 179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 78' ' ' LEU . . . . . . . . . . . . . 96.3 mt -96.44 28.0 3.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.331 -0.856 . . . . 37.549999999999997 110.182 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 79' ' ' THR . . . . . . . . . . . . . 29.7 m -56.2 -54.67 42.44 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.379 -0.825 . . . . 37.359999999999999 110.295 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 80' ' ' LEU . . . . . 0.603 ' HA ' HD12 ' R' ' 83' ' ' ILE . 16.0 mt -60.82 -23.27 64.96 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.347 -0.845 . . . . 35.829999999999998 110.543 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 81' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -79.46 -39.12 32.98 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.184 -0.948 . . . . 44.030000000000001 110.32 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 82' ' ' ALA . . . . . 0.556 ' HB2' HG11 ' R' ' 71' ' ' VAL . . . -69.5 -28.58 66.17 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.292 -0.88 . . . . 32.539999999999999 110.202 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 83' ' ' ILE . . . . . 0.603 HD12 ' HA ' ' R' ' 80' ' ' LEU . 78.1 mt -70.15 -46.06 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.34 -0.85 . . . . 32.020000000000003 110.302 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 84' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -55.22 -52.08 64.52 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.164 -0.96 . . . . 34.090000000000003 110.596 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 85' ' ' GLN . . . . . 0.532 ' HG2' HD12 ' R' ' 89' ' ' LEU . 31.9 tt0 -54.83 -46.87 74.64 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.235 -0.915 . . . . 25.940000000000001 110.28 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 86' ' ' LEU . . . . . . . . . . . . . 24.0 mt -58.63 -43.85 89.81 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.299 -0.876 . . . . 16.199999999999999 109.936 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 87' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -65.34 -35.26 80.43 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.466 -0.771 . . . . 49.090000000000003 110.286 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 88' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -78.43 -19.04 54.07 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.247 -0.908 . . . . 28.609999999999999 110.493 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 89' ' ' LEU . . . . . 0.532 HD12 ' HG2' ' R' ' 85' ' ' GLN . 32.6 mt -96.18 -29.41 14.07 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.207 -0.933 . . . . 26.16 110.197 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 90' ' ' THR . . . . . . . . . . . . . 58.7 p -105.7 -34.59 7.66 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.285 -0.884 . . . . 33.329999999999998 109.778 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.85 16.1 58.6 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.821 -1.312 . . . . 31.129999999999999 109.821 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 92' ' ' LEU . . . . . . . . . . . . . 97.0 mt -100.1 155.29 17.81 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.169 -1.195 . . . . 42.520000000000003 110.21 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 93' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -86.28 91.56 8.51 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.46 -0.775 . . . . 68.459999999999994 109.984 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 94' ' ' LEU . . . . . 0.457 ' HB3' ' CZ2' ' R' ' 52' ' ' TRP . 48.1 mt -99.41 53.01 0.95 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.18 -0.95 . . . . 44.630000000000003 110.364 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 95' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.44 -38.69 6.39 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.3 -0.875 . . . . 67.159999999999997 110.399 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 96' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -113.93 44.29 1.67 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.404 -0.81 . . . . 67.019999999999996 110.326 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 97' ' ' GLY . . . . . . . . . . . . . . . 99.12 150.78 26.03 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.614 -1.395 . . . . 49.479999999999997 109.614 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 98' ' ' GLY . . . . . . . . . . . . . . . -166.21 160.03 33.46 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.253 -1.539 . . . . 36.57 109.253 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 99' ' ' PRO . . . . . 0.95 ' HB3' HG12 ' S' ' 396' ' ' VAL . 45.1 Cg_endo -72.58 121.1 7.13 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.684 1.36 . . . . 30.41 110.435 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 100' ' ' PRO . . . . . 0.642 ' HD3' ' HD3' ' S' ' 401' ' ' LYS . 45.7 Cg_endo -72.25 -31.65 11.49 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 O-C-N 123.645 1.339 . . . . 29.940000000000001 110.54 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 101' ' ' ALA . . . . . 0.476 ' HB2' ' HB3' ' R' ' 178' ' ' LEU . . . -69.96 -38.48 76.13 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.301 -0.875 . . . . 23.640000000000001 110.263 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 102' ' ' LEU . . . . . 0.424 HD23 HD21 ' R' ' 106' ' ' ASN . 0.1 OUTLIER -72.62 -40.8 66.17 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.322 -0.861 . . . . 20.309999999999999 110.362 -179.713 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' R' R ' 103' ' ' VAL . . . . . 0.79 HG23 ' O ' ' R' ' 99' ' ' PRO . 63.7 t -58.16 -40.06 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.219 -0.925 . . . . 16.329999999999998 109.996 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 104' ' ' ILE . . . . . 0.432 HD11 HG12 ' R' ' 56' ' ' ILE . 81.9 mt -71.7 -30.57 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.397 -0.814 . . . . 24.77 109.93 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 105' ' ' TRP . . . . . 0.462 ' O ' ' HD3' ' R' ' 108' ' ' LYS . 70.6 t-105 -82.42 0.84 40.28 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.345 -0.847 . . . . 23.280000000000001 110.273 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 106' ' ' ASN . . . . . 0.424 HD21 HD23 ' R' ' 102' ' ' LEU . 6.9 m-80 -105.08 -10.38 17.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.116 -0.99 . . . . 28.260000000000002 110.125 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 107' ' ' ILE . . . . . . . . . . . . . 36.8 pt -126.83 34.97 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.211 -0.931 . . . . 18.77 110.05 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 108' ' ' LYS . . . . . 0.502 ' HG2' ' HB ' ' R' ' 115' ' ' ILE . 9.3 mtpp -61.05 -48.44 81.72 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.548 -0.72 . . . . 42.5 110.025 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 109' ' ' HIS . . . . . 0.445 ' CD2' ' HG ' ' R' ' 110' ' ' LEU . 50.8 p-80 -66.02 -12.85 58.07 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.527 -0.733 . . . . 20.07 110.698 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 110' ' ' LEU . . . . . 0.445 ' HG ' ' CD2' ' R' ' 109' ' ' HIS . 80.6 mt -94.79 -17.25 22.31 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.076 -1.015 . . . . 15.69 110.207 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 111' ' ' LEU . . . . . 0.528 HD21 ' CE2' ' R' ' 60' ' ' PHE . 10.3 mt -94.13 144.15 25.75 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.342 -0.849 . . . . 25.390000000000001 111.014 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 112' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -77.71 -17.35 57.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.552 -0.717 . . . . 53.479999999999997 109.852 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 113' ' ' THR . . . . . 0.459 HG22 ' N ' ' R' ' 114' ' ' GLY . 60.0 m -83.73 166.64 17.88 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.236 -0.915 . . . . 14.800000000000001 110.233 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 114' ' ' GLY . . . . . 0.459 ' N ' HG22 ' R' ' 113' ' ' THR . . . -97.96 127.16 9.13 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.994 -1.243 . . . . 16.140000000000001 109.994 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 115' ' ' ILE . . . . . 0.577 HD13 ' HB ' ' R' ' 124' ' ' VAL . 47.7 mm -109.11 139.31 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.441 -1.035 . . . . 13.460000000000001 109.738 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 116' ' ' GLY . . . . . . . . . . . . . . . -152.74 -155.88 7.3 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.959 -1.257 . . . . 23.899999999999999 109.959 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 117' ' ' THR . . . . . 0.528 HG22 ' CG2' ' R' ' 126' ' ' VAL . 18.8 p -134.99 -171.39 2.79 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.453 -1.028 . . . . 27.370000000000001 110.044 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 118' ' ' ALA . . . . . 0.445 ' HB3' ' OD1' ' R' ' 128' ' ' ASP . . . -56.6 -58.04 9.79 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.251 -0.906 . . . . 18.760000000000002 110.064 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 119' ' ' SER . . . . . 0.491 ' CB ' ' HB ' ' R' ' 196' ' ' VAL . 1.1 m -56.52 -40.66 75.42 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.259 -0.901 . . . . 32.350000000000001 109.721 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 120' ' ' ARG . . . . . 0.409 ' NH1' ' NE1' ' S' ' 305' ' ' TRP . 10.0 mtm180 -110.03 86.26 4.84 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.47 -0.768 . . . . 27.120000000000001 109.716 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 121' ' ' PRO . . . . . 0.483 ' HA ' ' SG ' ' R' ' 125' ' ' CYS . 44.7 Cg_endo -71.26 166.44 29.25 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 O-C-N 123.784 1.413 . . . . 22.68 111.009 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 122' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' R' ' 121' ' ' PRO . 38.2 t 178.58 -161.65 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.609 -0.682 . . . . 22.989999999999998 109.467 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 123' ' ' GLU . . . . . 0.44 ' HG2' HG23 ' R' ' 113' ' ' THR . 2.3 tp10 -56.5 -39.92 74.08 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.211 -0.93 . . . . 36.18 109.649 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 124' ' ' VAL . . . . . 0.577 ' HB ' HD13 ' R' ' 115' ' ' ILE . 83.8 t -142.57 136.39 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.606 -0.684 . . . . 20.640000000000001 109.383 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 125' ' ' CYS . . . . . 0.483 ' SG ' ' HA ' ' R' ' 121' ' ' PRO . 83.7 m -140.3 168.17 20.43 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.17 -0.956 . . . . 22.800000000000001 111.131 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 126' ' ' VAL . . . . . 0.728 HG12 HG22 ' R' ' 179' ' ' VAL . 35.9 m -122.68 159.82 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.724 -0.61 . . . . 21.239999999999998 109.613 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 127' ' ' VAL . . . . . 0.71 HG11 ' O ' ' R' ' 177' ' ' VAL . 31.1 m -70.89 141.86 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.283 -0.886 . . . . 19.77 110.675 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 128' ' ' ASP . . . . . 0.445 ' OD1' ' HB3' ' R' ' 118' ' ' ALA . 53.9 p-10 -137.73 19.41 2.87 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.327 -0.858 . . . . 29.210000000000001 110.697 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 129' ' ' GLY . . . . . . . . . . . . . . . 114.06 -0.02 24.06 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.928 -1.13 . . . . 33.859999999999999 110.441 179.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 130' ' ' THR . . . . . . . . . . . . . 58.7 m -91.9 131.88 36.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.11 -1.229 . . . . 26.41 110.046 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -62.57 120.72 11.68 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.369 -0.832 . . . . 33.079999999999998 110.258 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 132' ' ' MET . . . . . 0.433 ' HE1' ' CE2' ' R' ' 180' ' ' PHE . 98.4 mmm -105.17 165.63 10.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.467 -0.771 . . . . 30.760000000000002 110.467 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 133' ' ' CYS . . . . . 0.41 ' HA ' ' HB3' ' R' ' 174' ' ' PRO . 32.8 m -141.13 158.13 44.34 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.542 -0.724 . . . . 27.0 109.973 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 134' ' ' LEU . . . . . 0.564 HD11 ' O ' ' R' ' 172' ' ' PRO . 0.1 OUTLIER -58.45 -19.71 38.88 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.322 -0.861 . . . . 33.899999999999999 110.553 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' R' R ' 135' ' ' ALA . . . . . . . . . . . . . . . -92.8 8.24 40.29 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.31 -0.868 . . . . 19.370000000000001 110.802 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 136' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -93.76 -21.84 19.07 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.209 -0.932 . . . . 30.469999999999999 110.183 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 137' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -149.95 165.42 32.71 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.321 -0.862 . . . . 24.27 110.189 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 138' ' ' HIS . . . . . 0.433 ' HA ' HG23 ' R' ' 154' ' ' VAL . 15.2 p80 -117.88 15.19 14.33 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.382 -0.824 . . . . 20.91 110.452 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 139' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' R' ' 152' ' ' ALA . . . -177.22 152.4 0.87 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.207 -0.933 . . . . 15.69 110.099 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 140' ' ' GLY . . . . . 0.427 ' HA3' ' O ' ' R' ' 179' ' ' VAL . . . 161.81 175.17 32.55 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.962 -1.255 . . . . 23.760000000000002 109.962 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 141' ' ' ILE . . . . . . . . . . . . . 83.7 mt -95.5 136.54 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.473 -1.016 . . . . 25.300000000000001 109.718 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 142' ' ' PHE . . . . . 0.576 ' CD2' ' HB2' ' R' ' 172' ' ' PRO . 82.7 m-85 -120.72 -172.61 2.41 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.26 -0.9 . . . . 30.239999999999998 110.505 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 143' ' ' LEU . . . . . 0.742 HD23 ' O ' ' R' ' 148' ' ' HIS . 0.5 OUTLIER -119.79 77.74 1.26 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.367 -0.833 . . . . 32.799999999999997 110.316 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' R' R ' 144' ' ' LYS . . . . . 0.471 ' HG3' ' CZ2' ' R' ' 170' ' ' TRP . 1.0 OUTLIER -69.62 76.87 0.43 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.43 -0.794 . . . . 49.18 109.679 179.594 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' R' R ' 145' ' ' GLY . . . . . 0.458 ' O ' HD22 ' R' ' 143' ' ' LEU . . . 104.5 179.27 24.83 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.188 -1.565 . . . . 53.869999999999997 109.188 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 146' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -88.47 145.83 25.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.388 -1.066 . . . . 68.579999999999998 109.999 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 147' ' ' GLU . . . . . 0.68 ' HA ' ' CB ' ' S' ' 398' ' ' ARG . 10.9 mt-10 58.25 36.45 25.69 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.362 -0.837 . . . . 56.619999999999997 110.655 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 148' ' ' HIS . . . . . 0.742 ' O ' HD23 ' R' ' 143' ' ' LEU . 44.7 t60 -158.61 148.13 19.28 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.219 -0.926 . . . . 44.57 110.376 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 149' ' ' ALA . . . . . 0.587 ' HB2' ' NZ ' ' S' ' 401' ' ' LYS . . . -150.29 146.9 27.05 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.467 -0.771 . . . . 33.539999999999999 110.07 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 150' ' ' VAL . . . . . . . . . . . . . 34.2 m -142.3 161.51 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.261 -0.899 . . . . 27.609999999999999 110.36 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 151' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' R' ' 152' ' ' ALA . 5.8 t80 -86.17 155.6 20.67 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.428 -0.795 . . . . 23.039999999999999 109.904 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 152' ' ' ALA . . . . . 0.537 ' N ' ' CD1' ' R' ' 151' ' ' PHE . . . -157.29 151.5 24.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.443 -0.786 . . . . 29.609999999999999 109.611 179.048 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 153' ' ' CYS . . . . . . . . . . . . . 26.7 p -154.28 173.57 15.97 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.298 -0.876 . . . . 22.75 110.507 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 154' ' ' VAL . . . . . 0.613 HG22 ' CE2' ' R' ' 159' ' ' TRP . 59.7 t -90.59 117.04 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.392 -0.817 . . . . 23.260000000000002 110.076 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 155' ' ' THR . . . . . . . . . . . . . 70.3 p -112.13 -176.63 2.97 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.358 -0.839 . . . . 17.879999999999999 110.041 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 156' ' ' SER . . . . . . . . . . . . . 78.6 p -75.92 -3.75 37.16 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.329 -0.857 . . . . 21.829999999999998 110.727 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 157' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -118.25 10.43 12.85 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.148 -0.97 . . . . 36.539999999999999 110.619 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 158' ' ' GLY . . . . . . . . . . . . . . . 117.97 -162.71 13.02 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.533 -1.427 . . . . 31.739999999999998 109.533 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 159' ' ' TRP . . . . . 0.613 ' CE2' HG22 ' R' ' 154' ' ' VAL . 14.7 m95 -86.51 122.42 30.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.334 -1.098 . . . . 28.25 110.112 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 160' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -108.46 166.96 10.38 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.376 -0.827 . . . . 41.240000000000002 110.19 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 161' ' ' ALA . . . . . . . . . . . . . . . -143.22 123.42 13.74 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.362 -0.836 . . . . 27.399999999999999 110.198 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 162' ' ' ILE . . . . . . . . . . . . . 92.0 mt -87.55 81.15 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.295 -0.878 . . . . 24.27 110.051 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 163' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' R' ' 165' ' ' GLU . 15.3 t0 -72.86 92.42 1.6 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.457 -0.777 . . . . 36.079999999999998 110.254 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 164' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 54.09 -88.94 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.489 -0.757 . . . . 46.079999999999998 110.603 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 165' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' R' ' 163' ' ' ASP . 29.7 mt-10 -124.72 35.92 4.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.088 -1.007 . . . . 50.939999999999998 110.187 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 166' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -135.75 117.3 14.84 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.388 -0.82 . . . . 47.280000000000001 110.347 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 167' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -101.04 119.98 39.53 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.434 -0.791 . . . . 40.469999999999999 110.164 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 168' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -157.57 158.57 30.65 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.24 -0.913 . . . . 30.210000000000001 110.376 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 169' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.8 133.04 19.46 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.931 1.49 . . . . 32.759999999999998 110.474 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 170' ' ' TRP . . . . . 0.471 ' CZ2' ' HG3' ' R' ' 144' ' ' LYS . 66.9 t90 -159.81 119.37 2.89 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.461 -0.774 . . . . 32.789999999999999 109.909 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 171' ' ' THR . . . . . . . . . . . . . 46.1 m -81.1 112.61 34.16 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.448 -0.783 . . . . 36.920000000000002 110.163 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 172' ' ' PRO . . . . . 0.576 ' HB2' ' CD2' ' R' ' 142' ' ' PHE . 47.4 Cg_endo -73.71 158.75 46.68 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.66 1.348 . . . . 33.539999999999999 110.592 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 173' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -88.84 144.97 33.86 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.318 -0.864 . . . . 45.759999999999998 109.851 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 174' ' ' PRO . . . . . 0.41 ' HB3' ' HA ' ' R' ' 133' ' ' CYS . 46.0 Cg_endo -71.74 -10.34 26.31 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.614 1.323 . . . . 29.629999999999999 110.492 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 175' ' ' SER . . . . . . . . . . . . . 53.1 p -103.5 -17.55 15.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.281 -0.887 . . . . 35.700000000000003 110.343 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 176' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -103.5 43.26 1.1 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.202 -0.936 . . . . 39.649999999999999 110.442 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 177' ' ' VAL . . . . . 0.71 ' O ' HG11 ' R' ' 127' ' ' VAL . 10.5 p -117.79 127.14 75.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.326 -0.859 . . . . 20.609999999999999 110.034 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 178' ' ' LEU . . . . . 0.476 ' HB3' ' HB2' ' R' ' 101' ' ' ALA . 46.3 mt -91.47 -61.36 1.66 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.35 -0.844 . . . . 15.58 109.351 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 179' ' ' VAL . . . . . 0.728 HG22 HG12 ' R' ' 126' ' ' VAL . 67.9 t -114.58 144.72 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.621 -0.674 . . . . 17.399999999999999 109.413 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 180' ' ' PHE . . . . . 0.433 ' CE2' ' HE1' ' R' ' 132' ' ' MET . 43.7 p90 -152.17 163.32 39.62 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.273 -0.892 . . . . 20.16 110.602 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 181' ' ' VAL . . . . . . . . . . . . . 66.5 t -113.12 111.48 50.4 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.429 -0.795 . . . . 17.690000000000001 109.833 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 182' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.03 149.52 52.9 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.545 1.287 . . . . 17.809999999999999 110.423 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 183' ' ' TYR . . . . . 0.739 ' O ' ' C ' ' R' ' 184' ' ' ASP . 78.9 m-85 -59.01 175.53 0.28 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.43 -0.794 . . . . 28.010000000000002 110.526 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 184' ' ' ASP . . . . . 0.739 ' C ' ' O ' ' R' ' 183' ' ' TYR . 0.0 OUTLIER -12.28 -76.89 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.343 -0.848 . . . . 58.640000000000001 110.303 -178.086 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' R' R ' 185' ' ' GLN . . . . . . . . . . . . . 6.7 tm0? . . . . . 0 N--CA 1.503 2.188 0 CA-C-O 121.25 0.548 . . . . 80.420000000000002 111.723 179.409 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' R' R ' 193' ' ' LYS . . . . . 0.598 ' O ' ' HB2' ' R' ' 194' ' ' ALA . 20.4 ttpp . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 120.938 0.399 . . . . 49.5 110.166 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' R' R ' 194' ' ' ALA . . . . . 0.598 ' HB2' ' O ' ' R' ' 193' ' ' LYS . . . 174.32 -165.57 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.125 -0.984 . . . . 40.399999999999999 110.099 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 195' ' ' LYS . . . . . 0.427 ' O ' ' OG ' ' R' ' 119' ' ' SER . 24.8 mmtt -79.5 174.5 11.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.441 -0.787 . . . . 34.600000000000001 110.31 179.267 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 196' ' ' VAL . . . . . 0.594 HG21 ' HA ' ' S' ' 328' ' ' ASP . 2.5 t 51.56 25.31 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.249 -0.907 . . . . 33.270000000000003 110.629 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 197' ' ' GLN . . . . . 0.641 ' HA ' HD11 ' S' ' 302' ' ' LEU . 0.0 OUTLIER -162.48 27.62 0.11 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.124 -0.985 . . . . 41.579999999999998 110.709 179.778 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' R' R ' 198' ' ' ARG . . . . . 0.678 ' NH1' HD13 ' R' ' 200' ' ' LEU . 0.0 OUTLIER -124.98 149.99 47.13 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.199 -0.938 . . . . 38.649999999999999 110.203 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' R' R ' 199' ' ' LYS . . . . . 0.68 ' HA ' ' HD3' ' S' ' 299' ' ' PRO . 27.9 mmtm -82.22 99.24 9.17 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.372 -0.83 . . . . 36.770000000000003 109.954 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' R' R ' 200' ' ' LEU . . . . . 0.678 HD13 ' NH1' ' R' ' 198' ' ' ARG . 0.4 OUTLIER -81.59 -153.29 0.1 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.433 -0.792 . . . . 33.079999999999998 110.095 179.697 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' R' R ' 201' ' ' LYS . . . . . 0.491 ' HA ' ' CA ' ' S' ' 297' ' ' GLY . 63.2 mttt . . . . . 0 N--CA 1.492 1.673 0 O-C-N 121.364 -0.835 . . . . 44.32 110.234 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' S' S ' 229' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.171 0.51 . . . . 51.829999999999998 110.208 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' S' S ' 230' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -97.28 142.76 28.78 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.4 -0.813 . . . . 54.130000000000003 110.222 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' S' S ' 231' ' ' LEU . . . . . . . . . . . . . 67.8 mt -134.11 140.99 46.97 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.343 -0.848 . . . . 33.039999999999999 110.337 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' S' S ' 232' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' S' ' 355' ' ' THR . 40.0 m -89.25 103.23 15.87 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.319 -0.863 . . . . 26.920000000000002 110.068 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 233' ' ' LEU . . . . . 0.666 HD22 ' CE2' ' S' ' 262' ' ' TYR . 79.9 mt -55.92 179.28 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.437 -0.79 . . . . 13.779999999999999 110.498 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 234' ' ' TYR . . . . . 0.442 ' CG ' ' N ' ' S' ' 235' ' ' ASN . 35.6 p90 -65.01 -35.65 81.89 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.393 -0.817 . . . . 26.079999999999998 110.198 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 235' ' ' ASN . . . . . 0.442 ' N ' ' CG ' ' S' ' 234' ' ' TYR . 50.7 p30 -74.33 -7.4 52.69 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.373 -0.829 . . . . 20.039999999999999 110.567 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 236' ' ' GLY . . . . . . . . . . . . . . . 95.69 -19.9 52.22 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.782 -1.327 . . . . 22.710000000000001 109.782 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' S' S ' 237' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -53.03 145.73 12.49 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.189 -1.183 . . . . 35.439999999999998 110.183 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' S' S ' 238' ' ' LYS . . . . . . . . . . . . . 44.3 mttt -102.17 127.91 48.89 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.38 -0.825 . . . . 32.560000000000002 110.361 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' S' S ' 239' ' ' LYS . . . . . 0.412 ' HG2' ' CZ ' ' S' ' 241' ' ' PHE . 9.0 ttmt -132.31 144.52 50.63 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.357 -0.839 . . . . 26.68 109.955 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 240' ' ' THR . . . . . . . . . . . . . 51.8 m -102.0 132.22 47.97 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.34 -0.85 . . . . 41.020000000000003 110.348 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' S' S ' 241' ' ' PHE . . . . . 0.412 ' CZ ' ' HG2' ' S' ' 239' ' ' LYS . 96.0 m-85 -117.96 137.7 52.67 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.418 -0.801 . . . . 28.620000000000001 110.186 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 242' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -96.42 161.78 13.77 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.392 -0.818 . . . . 47.890000000000001 110.257 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' S' S ' 243' ' ' SER . . . . . . . . . . . . . 72.0 m -90.5 151.52 21.33 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.372 -0.83 . . . . 45.090000000000003 110.282 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' S' S ' 244' ' ' ARG . . . . . . . . . . . . . 1.4 mtp85 -129.72 126.73 22.74 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.375 -0.828 . . . . 42.490000000000002 110.282 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' S' S ' 245' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.31 161.02 43.78 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.674 1.355 . . . . 35.68 110.544 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' S' S ' 246' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -132.89 97.85 4.14 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.353 -0.842 . . . . 51.880000000000003 109.853 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' S' S ' 247' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -110.47 -22.25 11.76 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.398 -0.813 . . . . 53.689999999999998 110.658 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' S' S ' 248' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -117.24 43.65 2.27 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.223 -0.923 . . . . 55.789999999999999 110.704 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' S' S ' 249' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 48.84 38.37 11.9 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.405 -0.809 . . . . 49.450000000000003 110.386 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' S' S ' 250' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -90.67 29.09 1.37 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.489 -0.757 . . . . 36.859999999999999 110.327 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' S' S ' 251' ' ' ALA . . . . . . . . . . . . . . . -53.91 -43.12 69.44 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.229 -0.919 . . . . 29.690000000000001 109.612 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' S' S ' 252' ' ' TRP . . . . . 0.417 ' CZ2' ' HB3' ' S' ' 294' ' ' LEU . 67.9 p-90 -61.81 -33.94 75.03 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.523 -0.736 . . . . 41.119999999999997 109.829 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 253' ' ' LEU . . . . . 0.408 ' N ' ' CD2' ' S' ' 252' ' ' TRP . 23.4 tp -70.17 -47.17 62.77 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.378 -0.826 . . . . 24.890000000000001 110.001 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 254' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -56.13 -42.47 76.96 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.445 -0.784 . . . . 35.649999999999999 109.966 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' S' S ' 255' ' ' ALA . . . . . . . . . . . . . . . -59.53 -48.25 82.39 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.463 -0.773 . . . . 22.73 110.071 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' S' S ' 256' ' ' ILE . . . . . 0.509 HG12 HD11 ' S' ' 304' ' ' ILE . 79.7 mt -62.24 -40.68 88.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.321 -0.862 . . . . 28.850000000000001 109.983 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 257' ' ' LEU . . . . . . . . . . . . . 19.0 mt -61.54 -44.45 97.03 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.352 -0.843 . . . . 23.07 110.183 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' S' S ' 258' ' ' GLN . . . . . 0.499 ' HB3' ' CD2' ' S' ' 351' ' ' PHE . 53.4 mm-40 -65.12 -45.33 85.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.371 -0.831 . . . . 29.780000000000001 109.882 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 259' ' ' LEU . . . . . 0.416 ' O ' HG22 ' S' ' 263' ' ' VAL . 19.9 tp -58.67 -36.41 74.13 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.344 -0.848 . . . . 17.940000000000001 109.462 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 260' ' ' PHE . . . . . 0.523 ' CE2' HD21 ' S' ' 311' ' ' LEU . 3.1 m-85 -62.83 -45.29 93.3 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.655 -0.653 . . . . 30.57 109.834 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 261' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -62.01 -29.8 70.52 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.525 -0.734 . . . . 41.340000000000003 110.033 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' S' S ' 262' ' ' TYR . . . . . 0.666 ' CE2' HD22 ' S' ' 233' ' ' LEU . 8.7 t80 -71.24 -44.62 64.94 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.443 -0.786 . . . . 26.030000000000001 110.093 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 263' ' ' VAL . . . . . 0.416 HG22 ' O ' ' S' ' 259' ' ' LEU . 33.0 m -91.99 18.24 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.336 -0.852 . . . . 22.800000000000001 110.411 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 264' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 52.79 70.65 0.55 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.223 -0.923 . . . . 44.030000000000001 110.611 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' S' S ' 265' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -111.78 109.25 55.46 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.394 -0.817 . . . . 35.609999999999999 109.654 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' S' S ' 266' ' ' PRO . . . . . 0.475 ' HA ' ' HB2' ' S' ' 269' ' ' ASP . 48.6 Cg_endo -75.39 0.45 9.05 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 O-C-N 123.605 1.318 . . . . 37.670000000000002 111.742 -179.111 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 267' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -56.54 -67.7 0.28 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.802 -1.186 . . . . 41.490000000000002 110.165 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 268' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -92.91 39.89 1.05 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.148 -0.97 . . . . 50.759999999999998 110.048 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' S' S ' 269' ' ' ASP . . . . . 0.475 ' HB2' ' HA ' ' S' ' 266' ' ' PRO . 0.9 OUTLIER -76.01 -33.19 59.67 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.381 -0.825 . . . . 61.859999999999999 109.765 179.55 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' S' S ' 270' ' ' TRP . . . . . 0.512 ' CE2' HG23 ' S' ' 271' ' ' VAL . 51.0 p-90 -73.94 -4.28 34.2 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.268 -0.895 . . . . 39.850000000000001 110.466 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 271' ' ' VAL . . . . . 0.512 HG23 ' CE2' ' S' ' 270' ' ' TRP . 46.6 t -109.58 -32.66 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.157 -0.964 . . . . 39.18 110.07 179.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 272' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -78.67 -36.53 43.63 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.42 -0.8 . . . . 40.020000000000003 110.47 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' S' S ' 273' ' ' SER . . . . . . . . . . . . . 70.9 m -103.57 56.16 0.74 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.278 -0.889 . . . . 47.200000000000003 110.294 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' S' S ' 274' ' ' SER . . . . . . . . . . . . . 6.9 t -133.03 141.22 40.15 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.385 -0.822 . . . . 47.609999999999999 110.158 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' S' S ' 275' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.76 -18.85 21.71 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.66 1.347 . . . . 45.280000000000001 110.556 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' S' S ' 276' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -99.89 140.87 33.47 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.3 -0.875 . . . . 57.270000000000003 110.31 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' S' S ' 277' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -71.73 97.66 1.81 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.398 -0.814 . . . . 37.280000000000001 110.279 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' S' S ' 278' ' ' LEU . . . . . . . . . . . . . 86.3 mt -97.02 33.82 1.84 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.394 -0.816 . . . . 43.880000000000003 110.047 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' S' S ' 279' ' ' THR . . . . . . . . . . . . . 74.7 m -64.03 -60.1 3.65 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.484 -0.76 . . . . 50.049999999999997 110.303 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' S' S ' 280' ' ' LEU . . . . . 0.75 ' HA ' HD12 ' S' ' 283' ' ' ILE . 13.7 mt -51.61 -39.87 58.79 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.334 -0.854 . . . . 54.119999999999997 110.287 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 281' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.42 -49.67 74.57 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.499 -0.751 . . . . 65.280000000000001 110.177 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 282' ' ' ALA . . . . . . . . . . . . . . . -58.93 -33.9 71.12 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.456 -0.778 . . . . 46.509999999999998 110.571 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' S' S ' 283' ' ' ILE . . . . . 0.75 HD12 ' HA ' ' S' ' 280' ' ' LEU . 85.9 mt -66.39 -50.84 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.306 -0.871 . . . . 47.299999999999997 110.083 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 284' ' ' LYS . . . . . . . . . . . . . 33.8 tttp -50.52 -57.63 7.65 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.411 -0.806 . . . . 50.719999999999999 110.381 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' S' S ' 285' ' ' GLN . . . . . 0.538 ' HG2' HD12 ' S' ' 289' ' ' LEU . 34.4 tt0 -51.4 -46.4 62.84 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.487 -0.758 . . . . 68.469999999999999 110.283 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 286' ' ' LEU . . . . . . . . . . . . . 19.1 mt -59.95 -44.49 94.35 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.429 -0.794 . . . . 36.619999999999997 110.284 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' S' S ' 287' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -62.74 -35.29 79.3 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.33 -0.856 . . . . 46.640000000000001 110.077 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' S' S ' 288' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -76.23 -21.04 56.87 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.442 -0.787 . . . . 46.450000000000003 110.34 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' S' S ' 289' ' ' LEU . . . . . 0.538 HD12 ' HG2' ' S' ' 285' ' ' GLN . 30.8 mt -97.35 -21.75 17.03 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.256 -0.902 . . . . 35.090000000000003 110.485 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 290' ' ' THR . . . . . 0.416 HG22 ' HB3' ' S' ' 306' ' ' ASN . 81.3 p -114.8 -28.44 7.08 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.281 -0.887 . . . . 38.609999999999999 110.419 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 291' ' ' GLY . . . . . . . . . . . . . . . 79.4 10.97 85.41 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.833 -1.307 . . . . 36.770000000000003 109.833 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' S' S ' 292' ' ' LEU . . . . . 0.48 HD22 ' NZ ' ' R' ' 199' ' ' LYS . 84.7 mt -96.42 145.83 25.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.247 -1.149 . . . . 35.329999999999998 109.77 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 293' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -77.37 102.32 6.74 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.222 -0.924 . . . . 48.700000000000003 110.262 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' S' S ' 294' ' ' LEU . . . . . 0.417 ' HB3' ' CZ2' ' S' ' 252' ' ' TRP . 55.8 mt -106.86 51.73 0.74 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.575 -0.703 . . . . 42.609999999999999 110.123 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 295' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -112.56 -11.11 13.63 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.296 -0.878 . . . . 55.490000000000002 110.505 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 296' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -144.34 48.52 1.36 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.178 -0.951 . . . . 75.680000000000007 110.308 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' S' S ' 297' ' ' GLY . . . . . 0.491 ' CA ' ' HA ' ' R' ' 201' ' ' LYS . . . 96.9 145.18 18.7 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.524 -1.43 . . . . 49.439999999999998 109.524 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 298' ' ' GLY . . . . . . . . . . . . . . . -163.8 156.93 29.0 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.807 -1.317 . . . . 41.109999999999999 109.807 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' S' S ' 299' ' ' PRO . . . . . 0.68 ' HD3' ' HA ' ' R' ' 199' ' ' LYS . 47.9 Cg_endo -73.8 118.33 5.4 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.916 1.482 . . . . 26.199999999999999 110.278 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 300' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.25 -15.48 31.64 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.587 1.309 . . . . 21.699999999999999 110.725 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' S' S ' 301' ' ' ALA . . . . . . . . . . . . . . . -80.73 -29.35 36.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.271 -0.893 . . . . 31.23 110.099 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' S' S ' 302' ' ' LEU . . . . . 0.641 HD11 ' HA ' ' R' ' 197' ' ' GLN . 0.0 OUTLIER -83.49 -40.61 18.99 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.4 -0.812 . . . . 38.990000000000002 109.982 179.802 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' S' S ' 303' ' ' VAL . . . . . 0.489 HG23 ' O ' ' S' ' 299' ' ' PRO . 58.1 t -60.74 -35.43 64.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.436 -0.79 . . . . 18.629999999999999 110.14 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 304' ' ' ILE . . . . . 0.509 HD11 HG12 ' S' ' 256' ' ' ILE . 86.0 mt -79.39 -23.65 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.37 -0.831 . . . . 25.460000000000001 110.178 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 305' ' ' TRP . . . . . 0.419 ' CD2' ' HD3' ' S' ' 308' ' ' LYS . 68.9 t-105 -88.61 -14.54 37.27 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.295 -0.878 . . . . 33.399999999999999 110.569 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 306' ' ' ASN . . . . . 0.416 ' HB3' HG22 ' S' ' 290' ' ' THR . 10.4 m-80 -89.67 -13.65 36.52 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.191 -0.943 . . . . 36.969999999999999 110.388 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 307' ' ' ILE . . . . . 0.462 HG12 ' O ' ' S' ' 303' ' ' VAL . 36.9 pt -125.01 45.66 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.237 -0.915 . . . . 30.809999999999999 110.004 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 308' ' ' LYS . . . . . 0.419 ' HD3' ' CD2' ' S' ' 305' ' ' TRP . 1.5 mtmp? -73.64 -37.63 65.26 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.371 -0.831 . . . . 46.520000000000003 110.097 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 309' ' ' HIS . . . . . 0.494 ' CD2' ' HG ' ' S' ' 310' ' ' LEU . 55.6 p-80 -73.26 -8.28 55.16 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.321 -0.862 . . . . 51.030000000000001 110.062 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 310' ' ' LEU . . . . . 0.494 ' HG ' ' CD2' ' S' ' 309' ' ' HIS . 53.0 mt -99.28 -12.87 19.97 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.353 -0.842 . . . . 36.159999999999997 109.986 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 311' ' ' LEU . . . . . 0.523 HD21 ' CE2' ' S' ' 260' ' ' PHE . 10.7 mt -97.19 147.88 23.64 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.339 -0.85 . . . . 40.0 110.399 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 312' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -81.6 -16.3 51.98 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.275 -0.891 . . . . 54.18 109.69 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' S' S ' 313' ' ' THR . . . . . 0.818 HG23 ' HG2' ' S' ' 323' ' ' GLU . 92.7 m -87.97 151.65 22.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.336 -0.853 . . . . 25.609999999999999 110.098 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 314' ' ' GLY . . . . . . . . . . . . . . . -87.95 126.43 8.06 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.783 -1.327 . . . . 25.18 109.783 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' S' S ' 315' ' ' ILE . . . . . 0.643 HD13 ' HB ' ' S' ' 324' ' ' VAL . 50.7 mm -101.6 150.49 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.356 -1.085 . . . . 23.899999999999999 109.72 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 316' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' S' ' 325' ' ' CYS . . . -157.08 -159.25 9.37 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.957 -1.257 . . . . 23.18 109.957 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 317' ' ' THR . . . . . 0.421 HG22 ' CG2' ' S' ' 326' ' ' VAL . 11.2 p -133.94 -173.06 3.14 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.418 -1.048 . . . . 27.98 110.023 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.51 -56.19 25.15 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.175 -0.953 . . . . 28.100000000000001 109.926 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' S' S ' 319' ' ' SER . . . . . . . . . . . . . 1.2 m -59.94 -41.7 92.42 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.36 -0.838 . . . . 37.0 109.656 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' S' S ' 320' ' ' ARG . . . . . . . . . . . . . 12.1 mtm180 -111.67 79.91 2.64 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.529 -0.732 . . . . 52.07 109.718 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' S' S ' 321' ' ' PRO . . . . . 0.432 ' O ' ' HB2' ' S' ' 322' ' ' SER . 43.9 Cg_endo -71.45 171.48 16.13 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.865 1.455 . . . . 38.289999999999999 110.92 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 322' ' ' SER . . . . . 0.432 ' HB2' ' O ' ' S' ' 321' ' ' PRO . 41.3 t 178.68 -148.12 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.934 -0.765 . . . . 38.840000000000003 108.934 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 323' ' ' GLU . . . . . 0.818 ' HG2' HG23 ' S' ' 313' ' ' THR . 6.7 tp10 -62.89 -40.31 97.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.017 -1.052 . . . . 40.700000000000003 109.635 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 324' ' ' VAL . . . . . 0.643 ' HB ' HD13 ' S' ' 315' ' ' ILE . 72.8 t -141.25 135.01 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.402 -0.811 . . . . 20.34 109.506 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 325' ' ' CYS . . . . . 0.472 ' HB2' ' CE1' ' S' ' 380' ' ' PHE . 11.2 m -126.02 172.26 10.11 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.267 -0.895 . . . . 30.629999999999999 110.854 -179.117 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 326' ' ' VAL . . . . . 0.643 HG12 HG22 ' S' ' 379' ' ' VAL . 34.6 m -135.57 142.2 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.611 -0.681 . . . . 23.899999999999999 109.191 179.237 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 327' ' ' VAL . . . . . 0.601 HG11 ' O ' ' S' ' 377' ' ' VAL . 34.5 m -56.32 124.99 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.111 -0.993 . . . . 19.48 110.456 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 328' ' ' ASP . . . . . 0.594 ' HA ' HG21 ' R' ' 196' ' ' VAL . 55.5 p-10 -119.37 11.53 12.22 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.412 -0.805 . . . . 26.43 110.417 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 329' ' ' GLY . . . . . . . . . . . . . . . 119.65 2.24 13.12 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.052 -1.219 . . . . 31.239999999999998 110.052 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' S' S ' 330' ' ' THR . . . . . . . . . . . . . 80.7 m -93.04 130.06 38.77 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.116 -1.226 . . . . 30.050000000000001 110.109 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' S' S ' 331' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -56.86 111.52 1.05 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.244 -0.91 . . . . 37.259999999999998 109.916 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' S' S ' 332' ' ' MET . . . . . . . . . . . . . 88.0 mmm -94.09 162.53 13.83 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.234 -0.916 . . . . 26.23 110.332 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' S' S ' 333' ' ' CYS . . . . . . . . . . . . . 25.8 m -137.2 150.07 47.64 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.47 -0.769 . . . . 23.559999999999999 110.058 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' S' S ' 334' ' ' LEU . . . . . 0.562 HD11 ' O ' ' S' ' 372' ' ' PRO . 0.1 OUTLIER -52.62 -24.83 9.15 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.371 -0.83 . . . . 28.93 110.428 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' S' S ' 335' ' ' ALA . . . . . . . . . . . . . . . -89.06 14.44 10.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.396 -0.815 . . . . 15.76 110.954 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' S' S ' 336' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -100.45 -17.25 17.26 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.124 -0.985 . . . . 34.920000000000002 110.191 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' S' S ' 337' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -152.4 170.85 19.08 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.412 -0.805 . . . . 19.030000000000001 110.054 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' S' S ' 338' ' ' HIS . . . . . . . . . . . . . 13.4 p80 -120.71 10.37 10.98 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.363 -0.835 . . . . 18.82 110.449 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' S' S ' 339' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' S' ' 352' ' ' ALA . . . -175.95 155.18 1.58 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.221 -0.924 . . . . 17.18 110.054 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 340' ' ' GLY . . . . . . . . . . . . . . . 160.84 173.08 29.0 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.056 -1.218 . . . . 18.329999999999998 110.056 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' S' S ' 341' ' ' ILE . . . . . . . . . . . . . 83.9 mt -88.82 138.1 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.508 -0.995 . . . . 18.600000000000001 109.786 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' S' S ' 342' ' ' PHE . . . . . 0.485 ' CE2' ' HB3' ' S' ' 352' ' ' ALA . 70.0 m-85 -120.97 -178.46 3.75 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.256 -0.903 . . . . 23.440000000000001 110.396 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 343' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.82 93.33 4.16 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.412 -0.805 . . . . 35.590000000000003 110.008 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 344' ' ' LYS . . . . . 0.41 ' O ' ' HB3' ' S' ' 348' ' ' HIS . 0.3 OUTLIER -80.8 124.98 29.52 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.219 -0.926 . . . . 38.340000000000003 110.102 -179.987 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' S' S ' 345' ' ' GLY . . . . . . . . . . . . . . . 62.77 -130.83 43.09 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 108.887 -1.685 . . . . 53.460000000000001 108.887 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' S' S ' 346' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -132.68 150.83 52.11 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.244 -1.151 . . . . 70.909999999999997 110.066 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' S' S ' 347' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 53.35 35.38 20.18 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.339 -0.85 . . . . 47.32 110.352 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' S' S ' 348' ' ' HIS . . . . . 0.41 ' HB3' ' O ' ' S' ' 344' ' ' LYS . 46.7 t60 -150.17 155.86 40.56 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.265 -0.897 . . . . 41.719999999999999 110.317 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 349' ' ' ALA . . . . . 0.452 ' C ' HG13 ' S' ' 350' ' ' VAL . . . -149.75 151.26 33.33 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.306 -0.871 . . . . 22.91 110.487 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 350' ' ' VAL . . . . . 0.452 HG13 ' C ' ' S' ' 349' ' ' ALA . 34.6 m -149.08 169.66 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.465 -0.772 . . . . 21.09 110.014 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 351' ' ' PHE . . . . . 0.499 ' CD2' ' HB3' ' S' ' 258' ' ' GLN . 10.7 t80 -105.42 143.66 33.28 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.284 -0.885 . . . . 25.030000000000001 110.67 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 352' ' ' ALA . . . . . 0.485 ' HB3' ' CE2' ' S' ' 342' ' ' PHE . . . -147.73 151.71 36.53 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.617 -0.677 . . . . 23.809999999999999 109.742 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 353' ' ' CYS . . . . . . . . . . . . . 26.3 p -153.35 164.85 37.42 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.346 -0.846 . . . . 25.66 110.27 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' S' S ' 354' ' ' VAL . . . . . 0.562 HG22 ' CE2' ' S' ' 359' ' ' TRP . 56.4 t -75.97 118.47 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.378 -0.826 . . . . 34.270000000000003 110.025 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 355' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' S' ' 232' ' ' THR . 51.9 p -117.83 175.11 5.81 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.243 -0.911 . . . . 25.489999999999998 110.314 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 356' ' ' SER . . . . . . . . . . . . . 62.3 p -62.15 -17.72 58.77 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.395 -0.815 . . . . 31.239999999999998 110.716 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' S' S ' 357' ' ' ASN . . . . . . . . . . . . . 46.1 m-20 -106.97 14.18 26.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.149 -0.969 . . . . 28.609999999999999 110.604 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' S' S ' 358' ' ' GLY . . . . . . . . . . . . . . . 111.82 -152.83 17.6 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.031 -1.228 . . . . 22.010000000000002 110.031 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' S' S ' 359' ' ' TRP . . . . . 0.562 ' CE2' HG22 ' S' ' 354' ' ' VAL . 15.4 m95 -91.37 116.73 29.08 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.442 -1.034 . . . . 25.539999999999999 110.155 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 360' ' ' TYR . . . . . 0.421 ' HA ' ' HA ' ' S' ' 369' ' ' PRO . 1.3 m-85 -103.48 165.79 10.82 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.276 -0.89 . . . . 40.530000000000001 110.094 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 361' ' ' ALA . . . . . 0.433 ' HA ' ' O ' ' S' ' 351' ' ' PHE . . . -140.09 130.08 24.83 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.376 -0.828 . . . . 18.039999999999999 110.272 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 362' ' ' ILE . . . . . . . . . . . . . 88.9 mt -95.6 83.63 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.353 -0.842 . . . . 15.640000000000001 110.023 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' S' S ' 363' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' S' ' 365' ' ' GLU . 11.8 t0 -75.18 94.46 2.96 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.364 -0.835 . . . . 35.030000000000001 110.208 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 364' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 53.95 -89.39 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.543 -0.723 . . . . 46.719999999999999 110.524 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' S' S ' 365' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' S' ' 363' ' ' ASP . 23.8 mt-10 -122.64 19.11 10.36 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.058 -1.026 . . . . 56.200000000000003 110.233 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 366' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -118.01 125.06 49.63 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.231 -0.918 . . . . 51.020000000000003 110.368 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' S' S ' 367' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -107.06 127.08 53.15 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.321 -0.862 . . . . 37.590000000000003 110.101 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' S' S ' 368' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -165.44 159.55 13.88 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.3 -0.875 . . . . 31.469999999999999 110.427 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' S' S ' 369' ' ' PRO . . . . . 0.421 ' HA ' ' HA ' ' S' ' 360' ' ' TYR . 46.3 Cg_endo -72.83 139.63 30.75 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 O-C-N 123.872 1.459 . . . . 28.850000000000001 110.535 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 370' ' ' TRP . . . . . . . . . . . . . 67.4 t90 -167.24 113.5 0.76 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.362 -0.836 . . . . 26.940000000000001 110.007 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' S' S ' 371' ' ' THR . . . . . . . . . . . . . 59.4 m -74.74 113.03 20.4 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.433 -0.792 . . . . 20.190000000000001 110.057 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' S' S ' 372' ' ' PRO . . . . . 0.562 ' O ' HD11 ' S' ' 334' ' ' LEU . 47.7 Cg_endo -73.55 157.09 49.25 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 O-C-N 123.609 1.32 . . . . 28.68 110.583 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 373' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -90.57 147.13 35.72 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.415 -0.803 . . . . 35.719999999999999 109.93 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' S' S ' 374' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -76.03 -6.23 17.13 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.676 1.356 . . . . 30.890000000000001 110.534 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' S' S ' 375' ' ' SER . . . . . . . . . . . . . 69.4 p -104.39 -17.01 14.95 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.209 -0.932 . . . . 29.41 110.414 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' S' S ' 376' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -106.45 42.98 1.19 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.348 -0.845 . . . . 32.890000000000001 110.24 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' S' S ' 377' ' ' VAL . . . . . 0.601 ' O ' HG11 ' S' ' 327' ' ' VAL . 7.3 p -114.63 147.31 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.253 -0.905 . . . . 24.329999999999998 110.2 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 378' ' ' LEU . . . . . . . . . . . . . 52.2 mt -116.01 -58.02 2.15 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.426 -0.796 . . . . 24.370000000000001 109.626 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' S' S ' 379' ' ' VAL . . . . . 0.643 HG22 HG12 ' S' ' 326' ' ' VAL . 61.5 t -120.7 132.42 70.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.437 -0.789 . . . . 18.02 109.385 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 380' ' ' PHE . . . . . 0.472 ' CE1' ' HB2' ' S' ' 325' ' ' CYS . 14.5 p90 -142.59 173.92 11.11 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.427 -0.796 . . . . 29.350000000000001 110.675 -179.3 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 381' ' ' VAL . . . . . . . . . . . . . 58.1 t -120.03 107.36 39.92 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.512 -0.743 . . . . 16.34 109.413 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' S' S ' 382' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -71.31 145.63 48.9 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.68 1.358 . . . . 20.940000000000001 110.803 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' S' S ' 383' ' ' TYR . . . . . 0.978 ' O ' ' CB ' ' S' ' 384' ' ' ASP . 88.3 m-85 -61.11 -53.43 57.12 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.405 -0.809 . . . . 28.93 109.838 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 384' ' ' ASP . . . . . 0.978 ' CB ' ' O ' ' S' ' 383' ' ' TYR . 13.3 t70 112.65 111.0 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.433 -0.792 . . . . 47.030000000000001 110.36 178.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 385' ' ' GLN . . . . . 0.531 ' HB2' ' O ' ' S' ' 384' ' ' ASP . 17.6 tt0 176.62 -33.21 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.462 -0.774 . . . . 46.689999999999998 110.197 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 386' ' ' GLU . . . . . 0.476 ' C ' ' H ' ' S' ' 388' ' ' LEU . 2.4 mt-10 -142.4 135.81 14.26 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.337 -0.852 . . . . 50.25 109.595 179.115 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 387' ' ' PRO . . . . . 0.627 ' O ' ' C ' ' S' ' 388' ' ' LEU . 52.1 Cg_endo -71.71 33.45 0.26 Allowed 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.67 1.352 . . . . 34.390000000000001 110.582 -178.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 388' ' ' LEU . . . . . 0.627 ' C ' ' O ' ' S' ' 387' ' ' PRO . 16.3 mt 24.16 95.83 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.489 -0.757 . . . . 38.009999999999998 110.099 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 389' ' ' ASN . . . . . 0.619 ' CG ' ' O ' ' S' ' 388' ' ' LEU . 8.1 p30 46.76 -167.99 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.4 -0.812 . . . . 45.82 110.157 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 390' ' ' GLY . . . . . 0.603 ' HA2' ' CE2' ' S' ' 392' ' ' TRP . . . 122.48 46.41 0.29 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.597 -1.401 . . . . 33.460000000000001 109.597 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 391' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.3 -42.16 99.13 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.352 -1.087 . . . . 56.579999999999998 110.166 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 392' ' ' TRP . . . . . 0.737 ' O ' HG23 ' S' ' 396' ' ' VAL . 1.8 p90 -51.97 -24.41 6.46 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.354 -0.841 . . . . 31.43 110.346 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 393' ' ' LYS . . . . . 0.433 ' N ' ' CD1' ' S' ' 392' ' ' TRP . 16.8 tttt -43.76 -50.69 7.63 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.289 -0.882 . . . . 39.420000000000002 110.375 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 394' ' ' ALA . . . . . 0.442 ' O ' ' HD3' ' S' ' 398' ' ' ARG . . . -70.43 -29.06 65.56 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.272 -0.892 . . . . 34.329999999999998 110.081 178.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 395' ' ' LYS . . . . . 0.693 ' C ' ' NH1' ' S' ' 398' ' ' ARG . 0.2 OUTLIER -73.04 4.41 4.33 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.429 -0.795 . . . . 60.090000000000003 110.214 179.193 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' S' S ' 396' ' ' VAL . . . . . 0.95 HG12 ' HB3' ' R' ' 99' ' ' PRO . 34.4 t -111.14 -47.82 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.325 -0.859 . . . . 35.5 110.553 179.068 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 397' ' ' GLN . . . . . 0.497 ' C ' ' HG3' ' S' ' 398' ' ' ARG . 21.5 tt0 -109.66 117.51 34.12 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.182 -0.949 . . . . 49.960000000000001 110.623 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 398' ' ' ARG . . . . . 0.693 ' NH1' ' C ' ' S' ' 395' ' ' LYS . 76.2 mtm-85 -151.13 -149.67 0.31 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.266 -0.896 . . . . 43.420000000000002 110.73 -179.063 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 399' ' ' LYS . . . . . 0.611 ' C ' ' H ' ' S' ' 401' ' ' LYS . 11.3 mtpp -94.87 -88.63 0.25 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.381 -0.824 . . . . 55.310000000000002 110.058 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 400' ' ' LEU . . . . . 0.637 ' O ' ' HA ' ' R' ' 148' ' ' HIS . 8.4 mt -64.92 28.15 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.344 -0.848 . . . . 41.030000000000001 110.32 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' S' S ' 401' ' ' LYS . . . . . 0.642 ' HD3' ' HD3' ' R' ' 100' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.652 0 O-C-N 121.315 -0.865 . . . . 61.969999999999999 110.212 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 29' ' ' MET . . . . . . . . . . . . . 21.6 mtm . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.202 0.525 . . . . 32.140000000000001 110.252 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' R' R ' 30' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -96.34 141.19 29.96 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.358 -0.838 . . . . 43.359999999999999 110.212 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 31' ' ' LEU . . . . . . . . . . . . . 65.7 mt -134.86 140.65 45.98 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.286 -0.884 . . . . 22.93 110.306 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 32' ' ' THR . . . . . . . . . . . . . 69.1 m -87.61 110.51 20.43 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.433 -0.792 . . . . 22.34 109.962 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 33' ' ' LEU . . . . . 0.595 HD22 ' CE2' ' R' ' 62' ' ' TYR . 80.1 mt -62.35 -172.79 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.316 -0.865 . . . . 21.390000000000001 110.226 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 34' ' ' TYR . . . . . . . . . . . . . 37.0 p90 -74.65 -29.41 61.25 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.333 -0.855 . . . . 34.399999999999999 110.386 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 35' ' ' ASN . . . . . . . . . . . . . 48.3 p30 -77.79 -1.83 33.39 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.314 -0.866 . . . . 30.280000000000001 110.643 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.25 -16.56 59.48 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.784 -1.326 . . . . 36.25 109.784 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 37' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -59.04 161.79 4.82 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.373 -1.075 . . . . 53.799999999999997 110.405 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 38' ' ' LYS . . . . . . . . . . . . . 57.2 mttt -117.8 135.7 53.9 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.405 -0.809 . . . . 49.909999999999997 110.19 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 39' ' ' LYS . . . . . 0.405 ' HG2' ' CZ ' ' R' ' 41' ' ' PHE . 8.1 ttmt -138.73 143.66 39.17 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.319 -0.863 . . . . 35.689999999999998 110.235 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 40' ' ' THR . . . . . . . . . . . . . 23.4 m -102.56 127.91 49.43 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.287 -0.883 . . . . 34.840000000000003 110.308 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 41' ' ' PHE . . . . . 0.405 ' CZ ' ' HG2' ' R' ' 39' ' ' LYS . 96.6 m-85 -113.04 132.6 55.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.413 -0.804 . . . . 34.420000000000002 110.179 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 42' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -93.24 140.95 28.98 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.348 -0.845 . . . . 51.460000000000001 110.204 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 43' ' ' SER . . . . . . . . . . . . . 54.2 m -70.81 141.9 51.33 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.453 -0.779 . . . . 41.840000000000003 110.206 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.76 125.39 29.55 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.308 -0.87 . . . . 33.82 109.962 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 45' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.15 151.06 54.8 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.563 1.297 . . . . 30.27 110.66 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 46' ' ' ASN . . . . . 0.4 ' HA ' ' OD1' ' R' ' 50' ' ' ASN . 52.1 t-20 -124.28 109.92 13.97 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.415 -0.803 . . . . 35.100000000000001 109.999 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 47' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -120.34 -34.88 3.54 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.367 -0.833 . . . . 42.810000000000002 110.489 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 48' ' ' HIS . . . . . 0.44 ' NE2' HD11 ' R' ' 80' ' ' LEU . 73.3 m80 -105.76 45.23 0.98 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.328 -0.857 . . . . 49.969999999999999 110.263 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 49' ' ' ASP . . . . . 0.477 ' OD1' ' CA ' ' S' ' 401' ' ' LYS . 37.6 m-20 50.27 34.68 9.16 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.345 -0.847 . . . . 61.32 110.199 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 50' ' ' ASN . . . . . 0.4 ' OD1' ' HA ' ' R' ' 46' ' ' ASN . 15.0 p-10 -86.29 43.8 1.09 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.426 -0.796 . . . . 51.5 110.706 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 51' ' ' ALA . . . . . 0.673 ' CB ' ' HB2' ' S' ' 400' ' ' LEU . . . -66.11 -46.14 78.65 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.325 -0.86 . . . . 38.770000000000003 109.502 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 52' ' ' TRP . . . . . 0.483 ' CD2' ' N ' ' R' ' 53' ' ' LEU . 68.2 p-90 -58.35 -38.43 77.18 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.504 -0.747 . . . . 26.239999999999998 110.055 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 53' ' ' LEU . . . . . 0.483 ' N ' ' CD2' ' R' ' 52' ' ' TRP . 23.1 tp -66.68 -46.72 74.72 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.362 -0.836 . . . . 26.75 109.958 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 54' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -55.15 -41.66 72.11 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.341 -0.85 . . . . 35.020000000000003 110.14 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.24 -46.04 92.03 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.369 -0.832 . . . . 24.469999999999999 110.141 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 56' ' ' ILE . . . . . 0.432 HG12 HD11 ' R' ' 104' ' ' ILE . 76.1 mt -62.1 -42.32 94.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.213 -0.93 . . . . 26.030000000000001 109.92 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 57' ' ' LEU . . . . . . . . . . . . . 22.4 mt -60.31 -45.63 92.71 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.336 -0.853 . . . . 26.77 109.68 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 58' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -63.92 -46.48 84.59 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.521 -0.737 . . . . 22.32 109.594 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 59' ' ' LEU . . . . . 0.429 ' HA ' ' HE2' ' R' ' 151' ' ' PHE . 23.9 tp -61.45 -37.74 84.65 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.337 -0.852 . . . . 20.550000000000001 109.373 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 60' ' ' PHE . . . . . 0.528 ' CE2' HD21 ' R' ' 111' ' ' LEU . 2.8 m-85 -61.04 -44.84 96.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.628 -0.67 . . . . 20.079999999999998 109.921 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 61' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -63.0 -36.22 82.83 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.504 -0.747 . . . . 18.800000000000001 110.532 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 62' ' ' TYR . . . . . 0.595 ' CE2' HD22 ' R' ' 33' ' ' LEU . 9.2 t80 -63.16 -41.73 99.31 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.157 -0.964 . . . . 26.449999999999999 110.213 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 63' ' ' VAL . . . . . 0.406 ' H ' HG22 ' R' ' 63' ' ' VAL . 30.4 m -93.34 20.3 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.199 -0.938 . . . . 29.75 110.185 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 64' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 52.94 75.56 0.24 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.369 -0.832 . . . . 35.520000000000003 110.556 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 65' ' ' GLU . . . . . 0.442 ' HG2' ' CD2' ' R' ' 60' ' ' PHE . 14.3 tp10 -116.29 104.02 52.38 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.424 -0.797 . . . . 29.890000000000001 109.866 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 66' ' ' PRO . . . . . 0.481 ' HA ' ' HB2' ' R' ' 69' ' ' ASP . 46.8 Cg_endo -73.48 -5.89 17.86 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.708 1.372 . . . . 21.370000000000001 111.109 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 67' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -52.09 -61.52 2.21 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.144 -0.973 . . . . 23.850000000000001 110.375 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 68' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -98.11 36.51 1.56 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.312 -0.867 . . . . 28.07 110.512 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 69' ' ' ASP . . . . . 0.481 ' HB2' ' HA ' ' R' ' 66' ' ' PRO . 11.8 t0 -72.33 -33.23 67.18 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.296 -0.878 . . . . 43.759999999999998 110.18 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 70' ' ' TRP . . . . . 0.475 ' CE2' ' CG2' ' R' ' 71' ' ' VAL . 47.9 p-90 -73.4 -3.94 30.46 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.29 -0.881 . . . . 33.060000000000002 110.7 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 71' ' ' VAL . . . . . 0.557 HG11 ' HB2' ' R' ' 82' ' ' ALA . 40.9 t -109.75 -27.45 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.23 -0.919 . . . . 31.699999999999999 109.647 179.231 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 72' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -86.58 -48.84 7.99 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.407 -0.808 . . . . 33.579999999999998 110.294 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 73' ' ' SER . . . . . . . . . . . . . 69.9 m -89.63 50.96 1.99 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.338 -0.851 . . . . 50.82 110.379 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 74' ' ' SER . . . . . . . . . . . . . 16.0 t -125.82 138.32 31.77 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.226 -0.921 . . . . 34.740000000000002 110.265 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.33 -24.98 16.01 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.672 1.354 . . . . 35.700000000000003 110.336 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 76' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -91.71 153.2 19.8 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.476 -0.765 . . . . 66.480000000000004 110.343 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 77' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -81.47 95.26 7.03 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.298 -0.876 . . . . 46.719999999999999 110.114 179.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 78' ' ' LEU . . . . . . . . . . . . . 96.3 mt -96.43 27.93 3.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.338 -0.851 . . . . 37.549999999999997 110.191 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 79' ' ' THR . . . . . . . . . . . . . 29.5 m -56.2 -54.65 42.65 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.329 -0.857 . . . . 37.359999999999999 110.295 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 80' ' ' LEU . . . . . 0.603 ' HA ' HD12 ' R' ' 83' ' ' ILE . 15.9 mt -60.81 -23.29 64.95 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.337 -0.852 . . . . 35.829999999999998 110.549 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 81' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -79.5 -39.12 32.82 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.229 -0.919 . . . . 44.030000000000001 110.321 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 82' ' ' ALA . . . . . 0.557 ' HB2' HG11 ' R' ' 71' ' ' VAL . . . -69.49 -28.6 66.2 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.224 -0.923 . . . . 32.539999999999999 110.256 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 83' ' ' ILE . . . . . 0.603 HD12 ' HA ' ' R' ' 80' ' ' LEU . 78.2 mt -70.16 -46.12 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.308 -0.87 . . . . 32.020000000000003 110.302 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 84' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -55.15 -52.08 64.42 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.193 -0.942 . . . . 34.090000000000003 110.611 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 85' ' ' GLN . . . . . 0.533 ' HG2' HD12 ' R' ' 89' ' ' LEU . 31.9 tt0 -54.83 -46.85 74.64 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.206 -0.934 . . . . 25.940000000000001 110.249 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 86' ' ' LEU . . . . . . . . . . . . . 24.0 mt -58.7 -43.81 90.17 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.332 -0.855 . . . . 16.199999999999999 109.91 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 87' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -65.38 -35.17 80.16 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.391 -0.818 . . . . 49.090000000000003 110.251 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 88' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -78.48 -19.08 53.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.345 -0.847 . . . . 28.609999999999999 110.522 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 89' ' ' LEU . . . . . 0.533 HD12 ' HG2' ' R' ' 85' ' ' GLN . 32.7 mt -96.15 -29.4 14.09 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.304 -0.872 . . . . 26.16 110.22 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 90' ' ' THR . . . . . . . . . . . . . 60.4 p -105.7 -34.55 7.67 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.284 -0.885 . . . . 33.329999999999998 109.763 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.77 16.18 58.6 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.862 -1.295 . . . . 31.129999999999999 109.862 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 92' ' ' LEU . . . . . . . . . . . . . 97.1 mt -100.18 155.19 17.89 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.213 -1.169 . . . . 42.520000000000003 110.229 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 93' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -86.17 91.64 8.51 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.567 -0.708 . . . . 68.459999999999994 110.038 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 94' ' ' LEU . . . . . 0.458 ' HB3' ' CZ2' ' R' ' 52' ' ' TRP . 48.3 mt -99.46 53.0 0.94 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.289 -0.882 . . . . 44.630000000000003 110.33 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 95' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.44 -38.71 6.38 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.3 -0.875 . . . . 67.159999999999997 110.395 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 96' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -113.9 44.32 1.66 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.364 -0.835 . . . . 67.019999999999996 110.238 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 97' ' ' GLY . . . . . 0.606 ' HA3' ' CB ' ' S' ' 399' ' ' LYS . . . 99.12 150.78 26.03 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.634 -1.387 . . . . 49.479999999999997 109.634 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 98' ' ' GLY . . . . . . . . . . . . . . . -166.22 160.07 33.5 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.294 -1.522 . . . . 36.57 109.294 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 99' ' ' PRO . . . . . 0.857 ' HA ' ' O ' ' S' ' 396' ' ' VAL . 45.7 Cg_endo -72.59 121.07 7.1 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.645 1.34 . . . . 30.41 110.413 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 100' ' ' PRO . . . . . 0.452 ' HD3' ' NH1' ' S' ' 398' ' ' ARG . 45.8 Cg_endo -72.25 -31.67 11.48 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 O-C-N 123.645 1.339 . . . . 29.940000000000001 110.53 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 101' ' ' ALA . . . . . 0.481 ' HB3' HG23 ' S' ' 396' ' ' VAL . . . -70.02 -38.4 75.91 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.226 -0.921 . . . . 23.640000000000001 110.233 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 102' ' ' LEU . . . . . 0.424 HD23 HD21 ' R' ' 106' ' ' ASN . 0.1 OUTLIER -72.67 -40.71 66.07 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.358 -0.839 . . . . 20.309999999999999 110.386 -179.78 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' R' R ' 103' ' ' VAL . . . . . 0.79 HG23 ' O ' ' R' ' 99' ' ' PRO . 64.3 t -58.25 -40.02 76.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.195 -0.941 . . . . 16.329999999999998 109.984 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 104' ' ' ILE . . . . . 0.432 HD11 HG12 ' R' ' 56' ' ' ILE . 81.6 mt -71.68 -30.6 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.397 -0.814 . . . . 24.77 109.966 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 105' ' ' TRP . . . . . 0.463 ' O ' ' HD3' ' R' ' 108' ' ' LYS . 70.5 t-105 -82.41 0.85 40.15 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.292 -0.88 . . . . 23.280000000000001 110.31 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 106' ' ' ASN . . . . . 0.424 HD21 HD23 ' R' ' 102' ' ' LEU . 6.9 m-80 -105.07 -10.35 17.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.171 -0.956 . . . . 28.260000000000002 110.118 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 107' ' ' ILE . . . . . . . . . . . . . 36.7 pt -126.88 35.08 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.254 -0.904 . . . . 18.77 109.966 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 108' ' ' LYS . . . . . 0.502 ' HG2' ' HB ' ' R' ' 115' ' ' ILE . 9.2 mtpp -61.12 -48.41 81.78 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.56 -0.713 . . . . 42.5 110.049 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 109' ' ' HIS . . . . . 0.444 ' CD2' ' HG ' ' R' ' 110' ' ' LEU . 50.8 p-80 -66.02 -12.85 58.07 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.456 -0.777 . . . . 20.07 110.698 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 110' ' ' LEU . . . . . 0.444 ' HG ' ' CD2' ' R' ' 109' ' ' HIS . 80.3 mt -94.79 -17.25 22.31 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.076 -1.015 . . . . 15.69 110.207 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 111' ' ' LEU . . . . . 0.528 HD21 ' CE2' ' R' ' 60' ' ' PHE . 10.3 mt -94.13 144.16 25.74 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.342 -0.849 . . . . 25.390000000000001 111.014 -179.177 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 112' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -77.71 -17.36 57.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.51 -0.744 . . . . 53.479999999999997 109.846 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 113' ' ' THR . . . . . 0.459 HG22 ' N ' ' R' ' 114' ' ' GLY . 59.8 m -83.76 166.67 17.83 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.273 -0.892 . . . . 14.800000000000001 110.193 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 114' ' ' GLY . . . . . 0.459 ' N ' HG22 ' R' ' 113' ' ' THR . . . -97.99 127.1 9.11 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.042 -1.223 . . . . 16.140000000000001 110.042 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 115' ' ' ILE . . . . . 0.577 HD13 ' HB ' ' R' ' 124' ' ' VAL . 47.7 mm -109.01 139.46 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.503 -0.998 . . . . 13.460000000000001 109.674 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 116' ' ' GLY . . . . . . . . . . . . . . . -152.84 -155.89 7.31 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.932 -1.267 . . . . 23.899999999999999 109.932 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 117' ' ' THR . . . . . 0.53 HG22 ' CG2' ' R' ' 126' ' ' VAL . 18.5 p -135.03 -171.39 2.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.451 -1.029 . . . . 27.370000000000001 110.079 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 118' ' ' ALA . . . . . 0.445 ' HB3' ' OD1' ' R' ' 128' ' ' ASP . . . -56.52 -58.14 9.32 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.246 -0.909 . . . . 18.760000000000002 110.074 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 119' ' ' SER . . . . . 0.511 ' CB ' ' HB ' ' R' ' 196' ' ' VAL . 1.2 m -56.51 -40.48 75.09 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.351 -0.843 . . . . 32.350000000000001 109.838 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 120' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 -110.12 86.21 4.9 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.411 -0.806 . . . . 27.120000000000001 109.69 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 121' ' ' PRO . . . . . 0.483 ' HA ' ' SG ' ' R' ' 125' ' ' CYS . 44.0 Cg_endo -71.26 166.49 29.09 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 O-C-N 123.903 1.475 . . . . 22.68 111.035 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 122' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' R' ' 121' ' ' PRO . 38.6 t 178.55 -161.7 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.609 -0.682 . . . . 22.989999999999998 109.455 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 123' ' ' GLU . . . . . 0.442 ' HG2' HG23 ' R' ' 113' ' ' THR . 2.3 tp10 -56.44 -40.01 74.06 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.216 -0.928 . . . . 36.18 109.63 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 124' ' ' VAL . . . . . 0.577 ' HB ' HD13 ' R' ' 115' ' ' ILE . 82.2 t -142.5 136.4 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.62 -0.675 . . . . 20.640000000000001 109.457 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 125' ' ' CYS . . . . . 0.483 ' SG ' ' HA ' ' R' ' 121' ' ' PRO . 83.0 m -140.23 168.21 20.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.193 -0.942 . . . . 22.800000000000001 111.206 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 126' ' ' VAL . . . . . 0.73 HG12 HG22 ' R' ' 179' ' ' VAL . 35.9 m -122.78 159.72 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.733 -0.604 . . . . 21.239999999999998 109.574 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 127' ' ' VAL . . . . . 0.709 HG11 ' O ' ' R' ' 177' ' ' VAL . 30.4 m -70.76 141.82 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.305 -0.872 . . . . 19.77 110.734 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 128' ' ' ASP . . . . . 0.445 ' OD1' ' HB3' ' R' ' 118' ' ' ALA . 53.8 p-10 -137.74 19.41 2.87 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.417 -0.802 . . . . 29.210000000000001 110.66 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 129' ' ' GLY . . . . . . . . . . . . . . . 114.0 0.04 24.14 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.939 -1.124 . . . . 33.859999999999999 110.527 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 130' ' ' THR . . . . . . . . . . . . . 58.4 m -91.94 131.81 36.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.135 -1.215 . . . . 26.41 110.046 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -62.43 120.64 11.46 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.317 -0.865 . . . . 33.079999999999998 110.336 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 132' ' ' MET . . . . . 0.433 ' HE1' ' CE2' ' R' ' 180' ' ' PHE . 98.5 mmm -105.24 165.64 10.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.482 -0.761 . . . . 30.760000000000002 110.409 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 133' ' ' CYS . . . . . 0.411 ' HA ' ' HB3' ' R' ' 174' ' ' PRO . 32.2 m -141.12 158.23 44.2 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.451 -0.78 . . . . 27.0 109.956 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 134' ' ' LEU . . . . . 0.565 HD11 ' O ' ' R' ' 172' ' ' PRO . 0.1 OUTLIER -58.53 -19.74 40.24 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.232 -0.918 . . . . 33.899999999999999 110.515 -179.86 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' R' R ' 135' ' ' ALA . . . . . . . . . . . . . . . -92.66 8.11 40.55 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.344 -0.848 . . . . 19.370000000000001 110.833 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 136' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -93.7 -21.88 19.08 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.165 -0.96 . . . . 30.469999999999999 110.178 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 137' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -149.91 165.3 33.01 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.351 -0.843 . . . . 24.27 110.241 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 138' ' ' HIS . . . . . 0.434 ' HA ' HG23 ' R' ' 154' ' ' VAL . 15.1 p80 -117.79 15.18 14.41 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.422 -0.798 . . . . 20.91 110.417 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 139' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' R' ' 152' ' ' ALA . . . -177.23 152.4 0.87 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.187 -0.946 . . . . 15.69 110.157 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 140' ' ' GLY . . . . . 0.428 ' HA3' ' O ' ' R' ' 179' ' ' VAL . . . 161.83 175.09 32.49 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.881 -1.288 . . . . 23.760000000000002 109.881 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 141' ' ' ILE . . . . . . . . . . . . . 83.7 mt -95.5 136.63 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.435 -1.038 . . . . 25.300000000000001 109.691 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 142' ' ' PHE . . . . . 0.578 ' CD2' ' HB2' ' R' ' 172' ' ' PRO . 82.9 m-85 -120.77 -172.66 2.43 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.27 -0.894 . . . . 30.239999999999998 110.524 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 143' ' ' LEU . . . . . 0.783 HD11 ' O ' ' S' ' 395' ' ' LYS . 0.5 OUTLIER -119.78 77.73 1.26 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.426 -0.796 . . . . 32.799999999999997 110.295 -179.879 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' R' R ' 144' ' ' LYS . . . . . 0.471 ' HG3' ' CZ2' ' R' ' 170' ' ' TRP . 1.0 OUTLIER -69.55 76.78 0.42 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.437 -0.789 . . . . 49.18 109.68 179.541 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' R' R ' 145' ' ' GLY . . . . . 0.458 ' O ' HD22 ' R' ' 143' ' ' LEU . . . 104.62 179.24 24.71 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.139 -1.584 . . . . 53.869999999999997 109.139 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 146' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -88.46 145.83 25.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.388 -1.066 . . . . 68.579999999999998 110.053 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 147' ' ' GLU . . . . . 0.754 ' HA ' ' HB2' ' S' ' 398' ' ' ARG . 10.9 mt-10 58.27 36.46 25.66 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.256 -0.902 . . . . 56.619999999999997 110.611 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 148' ' ' HIS . . . . . 0.756 ' ND1' HD23 ' S' ' 400' ' ' LEU . 44.6 t60 -158.58 148.14 19.33 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.205 -0.934 . . . . 44.57 110.422 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 149' ' ' ALA . . . . . 0.735 ' HB2' ' HD3' ' S' ' 398' ' ' ARG . . . -150.27 146.83 27.02 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.467 -0.771 . . . . 33.539999999999999 110.082 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 150' ' ' VAL . . . . . . . . . . . . . 34.2 m -142.28 161.54 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.231 -0.918 . . . . 27.609999999999999 110.309 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 151' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' R' ' 152' ' ' ALA . 5.8 t80 -86.21 155.53 20.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.4 -0.812 . . . . 23.039999999999999 109.907 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 152' ' ' ALA . . . . . 0.537 ' N ' ' CD1' ' R' ' 151' ' ' PHE . . . -157.22 151.53 25.05 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.499 -0.75 . . . . 29.609999999999999 109.565 179.05 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 153' ' ' CYS . . . . . . . . . . . . . 26.7 p -154.33 173.54 16.04 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.234 -0.916 . . . . 22.75 110.556 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 154' ' ' VAL . . . . . 0.614 HG22 ' CE2' ' R' ' 159' ' ' TRP . 60.0 t -90.56 116.97 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.443 -0.785 . . . . 23.260000000000002 110.078 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 155' ' ' THR . . . . . . . . . . . . . 70.7 p -112.08 -176.65 2.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.347 -0.846 . . . . 17.879999999999999 110.034 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 156' ' ' SER . . . . . . . . . . . . . 78.5 p -75.98 -3.64 36.72 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.329 -0.857 . . . . 21.829999999999998 110.697 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 157' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -118.32 10.48 12.8 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.159 -0.963 . . . . 36.539999999999999 110.603 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 158' ' ' GLY . . . . . . . . . . . . . . . 117.99 -162.62 13.05 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.547 -1.421 . . . . 31.739999999999998 109.547 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 159' ' ' TRP . . . . . 0.614 ' CE2' HG22 ' R' ' 154' ' ' VAL . 14.8 m95 -86.6 122.4 30.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.285 -1.127 . . . . 28.25 110.092 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 160' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -108.4 167.01 10.34 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.448 -0.783 . . . . 41.240000000000002 110.212 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 161' ' ' ALA . . . . . . . . . . . . . . . -143.24 123.43 13.72 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.355 -0.841 . . . . 27.399999999999999 110.208 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 162' ' ' ILE . . . . . . . . . . . . . 92.1 mt -87.6 81.17 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.362 -0.837 . . . . 24.27 110.078 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 163' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' R' ' 165' ' ' GLU . 15.4 t0 -72.92 92.36 1.62 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.438 -0.789 . . . . 36.079999999999998 110.246 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 164' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 54.13 -88.94 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.542 -0.724 . . . . 46.079999999999998 110.565 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 165' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' R' ' 163' ' ' ASP . 29.6 mt-10 -124.75 36.01 4.68 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.052 -1.03 . . . . 50.939999999999998 110.199 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 166' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -135.8 117.32 14.82 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.397 -0.814 . . . . 47.280000000000001 110.324 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 167' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -100.98 119.95 39.48 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.434 -0.791 . . . . 40.469999999999999 110.134 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 168' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -157.6 158.54 30.6 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.29 -0.881 . . . . 30.210000000000001 110.399 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 169' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.8 133.04 19.46 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.931 1.49 . . . . 32.759999999999998 110.474 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 170' ' ' TRP . . . . . 0.471 ' CZ2' ' HG3' ' R' ' 144' ' ' LYS . 67.0 t90 -159.78 119.3 2.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.416 -0.802 . . . . 32.789999999999999 109.928 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 171' ' ' THR . . . . . . . . . . . . . 46.6 m -81.06 112.6 33.95 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.437 -0.789 . . . . 36.920000000000002 110.184 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 172' ' ' PRO . . . . . 0.578 ' HB2' ' CD2' ' R' ' 142' ' ' PHE . 47.2 Cg_endo -73.74 158.83 46.48 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.66 1.348 . . . . 33.539999999999999 110.519 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 173' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -88.84 144.97 33.85 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.362 -0.836 . . . . 45.759999999999998 109.911 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 174' ' ' PRO . . . . . 0.411 ' HB3' ' HA ' ' R' ' 133' ' ' CYS . 45.9 Cg_endo -71.73 -10.41 26.44 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 O-C-N 123.675 1.355 . . . . 29.629999999999999 110.499 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 175' ' ' SER . . . . . . . . . . . . . 53.1 p -103.48 -17.47 15.2 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.299 -0.876 . . . . 35.700000000000003 110.369 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 176' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -103.5 43.19 1.1 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.24 -0.913 . . . . 39.649999999999999 110.423 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 177' ' ' VAL . . . . . 0.709 ' O ' HG11 ' R' ' 127' ' ' VAL . 10.5 p -117.72 127.17 75.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.368 -0.832 . . . . 20.609999999999999 110.041 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 178' ' ' LEU . . . . . 0.476 ' HB3' ' HB2' ' R' ' 101' ' ' ALA . 45.9 mt -91.5 -61.23 1.69 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.424 -0.798 . . . . 15.58 109.464 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 179' ' ' VAL . . . . . 0.73 HG22 HG12 ' R' ' 126' ' ' VAL . 67.4 t -114.6 144.7 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.579 -0.7 . . . . 17.399999999999999 109.443 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 180' ' ' PHE . . . . . 0.433 ' CE2' ' HE1' ' R' ' 132' ' ' MET . 43.4 p90 -152.11 163.37 39.48 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.273 -0.892 . . . . 20.16 110.562 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 181' ' ' VAL . . . . . . . . . . . . . 66.9 t -113.2 111.49 50.17 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.468 -0.77 . . . . 17.690000000000001 109.795 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 182' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.03 149.51 52.86 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.577 1.304 . . . . 17.809999999999999 110.423 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 183' ' ' TYR . . . . . 0.706 ' O ' ' C ' ' R' ' 184' ' ' ASP . 79.0 m-85 -59.01 175.54 0.28 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.459 -0.775 . . . . 28.010000000000002 110.549 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 184' ' ' ASP . . . . . 0.706 ' C ' ' O ' ' R' ' 183' ' ' TYR . 6.0 t70 -18.36 -82.2 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.3 -0.875 . . . . 58.640000000000001 110.232 -178.17 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 185' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 . . . . . 0 N--CA 1.504 2.232 0 CA-C-O 121.272 0.558 . . . . 80.420000000000002 111.721 179.566 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' R' R ' 193' ' ' LYS . . . . . . . . . . . . . 15.0 pttt . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 120.898 0.38 . . . . 49.5 110.157 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' R' R ' 194' ' ' ALA . . . . . . . . . . . . . . . -169.84 -163.95 0.4 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.144 -0.973 . . . . 40.399999999999999 110.156 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 195' ' ' LYS . . . . . . . . . . . . . 20.4 mtpp -74.88 -66.33 0.76 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.416 -0.802 . . . . 34.600000000000001 110.304 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 196' ' ' VAL . . . . . 0.511 ' HB ' ' CB ' ' R' ' 119' ' ' SER . 35.0 t -81.37 63.16 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.279 -0.888 . . . . 33.270000000000003 110.601 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 197' ' ' GLN . . . . . 0.516 ' O ' ' HG3' ' R' ' 197' ' ' GLN . 11.5 tp60 -168.24 25.19 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.147 -0.971 . . . . 41.579999999999998 110.725 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 198' ' ' ARG . . . . . . . . . . . . . 20.2 mtp180 -123.89 164.99 18.15 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.073 -1.017 . . . . 38.649999999999999 110.22 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 199' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.34 70.94 1.53 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.391 -0.818 . . . . 36.770000000000003 109.909 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' R' R ' 200' ' ' LEU . . . . . . . . . . . . . 4.3 mp -64.55 -168.84 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.387 -0.82 . . . . 33.079999999999998 110.132 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' R' R ' 201' ' ' LYS . . . . . 0.546 ' HA ' ' CA ' ' S' ' 297' ' ' GLY . 26.3 mmtt . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.309 -0.869 . . . . 44.32 110.305 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' S' S ' 229' ' ' MET . . . . . . . . . . . . . 5.8 mtm . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 121.176 0.513 . . . . 51.829999999999998 110.191 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' S' S ' 230' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -97.27 142.73 28.8 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.318 -0.864 . . . . 54.130000000000003 110.161 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' S' S ' 231' ' ' LEU . . . . . . . . . . . . . 67.9 mt -134.12 141.04 46.98 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.391 -0.818 . . . . 33.039999999999999 110.343 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' S' S ' 232' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' S' ' 355' ' ' THR . 40.7 m -89.26 103.26 15.9 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.381 -0.824 . . . . 26.920000000000002 110.04 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 233' ' ' LEU . . . . . 0.67 HD22 ' CE2' ' S' ' 262' ' ' TYR . 79.9 mt -56.0 179.31 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.43 -0.794 . . . . 13.779999999999999 110.463 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 234' ' ' TYR . . . . . 0.446 ' CG ' ' N ' ' S' ' 235' ' ' ASN . 35.6 p90 -65.02 -35.69 81.99 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.361 -0.837 . . . . 26.079999999999998 110.148 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 235' ' ' ASN . . . . . 0.446 ' N ' ' CG ' ' S' ' 234' ' ' TYR . 50.7 p30 -74.3 -7.44 52.78 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.428 -0.795 . . . . 20.039999999999999 110.596 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 236' ' ' GLY . . . . . . . . . . . . . . . 95.76 -19.92 52.15 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.781 -1.328 . . . . 22.710000000000001 109.781 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' S' S ' 237' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -52.98 145.65 12.48 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.18 -1.188 . . . . 35.439999999999998 110.276 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' S' S ' 238' ' ' LYS . . . . . . . . . . . . . 44.4 mttt -102.18 127.91 48.91 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.396 -0.815 . . . . 32.560000000000002 110.434 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' S' S ' 239' ' ' LYS . . . . . 0.409 ' HG2' ' CZ ' ' S' ' 241' ' ' PHE . 9.0 ttmt -132.26 144.54 50.68 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.391 -0.818 . . . . 26.68 110.004 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 240' ' ' THR . . . . . . . . . . . . . 51.9 m -102.02 132.2 48.01 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.307 -0.871 . . . . 41.020000000000003 110.355 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' S' S ' 241' ' ' PHE . . . . . 0.409 ' CZ ' ' HG2' ' S' ' 239' ' ' LYS . 96.1 m-85 -117.91 137.62 52.69 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.379 -0.826 . . . . 28.620000000000001 110.253 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 242' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -96.35 161.83 13.76 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.34 -0.85 . . . . 47.890000000000001 110.188 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' S' S ' 243' ' ' SER . . . . . . . . . . . . . 72.1 m -90.57 151.56 21.27 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.29 -0.881 . . . . 45.090000000000003 110.29 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' S' S ' 244' ' ' ARG . . . . . . . . . . . . . 1.4 mtp85 -129.77 126.73 22.7 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.416 -0.802 . . . . 42.490000000000002 110.263 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' S' S ' 245' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.35 160.98 43.77 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.617 1.325 . . . . 35.68 110.551 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' S' S ' 246' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -132.84 97.77 4.13 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.325 -0.859 . . . . 51.880000000000003 109.873 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' S' S ' 247' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -110.45 -22.24 11.77 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.32 -0.863 . . . . 53.689999999999998 110.649 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' S' S ' 248' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -117.26 43.67 2.27 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.182 -0.949 . . . . 55.789999999999999 110.708 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' S' S ' 249' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 48.78 38.46 11.88 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.485 -0.759 . . . . 49.450000000000003 110.363 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' S' S ' 250' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -90.57 28.95 1.38 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.552 -0.717 . . . . 36.859999999999999 110.325 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' S' S ' 251' ' ' ALA . . . . . . . . . . . . . . . -53.79 -43.19 69.08 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.286 -0.884 . . . . 29.690000000000001 109.621 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' S' S ' 252' ' ' TRP . . . . . 0.428 ' CZ2' ' HB3' ' S' ' 294' ' ' LEU . 67.8 p-90 -61.82 -33.9 74.98 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.51 -0.744 . . . . 41.119999999999997 109.802 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 253' ' ' LEU . . . . . 0.402 ' N ' ' CD2' ' S' ' 252' ' ' TRP . 23.4 tp -70.15 -47.3 62.27 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.422 -0.799 . . . . 24.890000000000001 109.955 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 254' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -56.06 -42.43 76.61 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.308 -0.87 . . . . 35.649999999999999 110.031 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' S' S ' 255' ' ' ALA . . . . . . . . . . . . . . . -59.61 -48.19 82.63 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.427 -0.795 . . . . 22.73 110.042 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' S' S ' 256' ' ' ILE . . . . . 0.504 HG12 HD11 ' S' ' 304' ' ' ILE . 79.7 mt -62.35 -40.6 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.308 -0.87 . . . . 28.850000000000001 110.014 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 257' ' ' LEU . . . . . 0.402 ' CD2' ' HB3' ' S' ' 268' ' ' PHE . 19.4 mt -61.52 -44.49 96.97 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.286 -0.884 . . . . 23.07 110.216 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 258' ' ' GLN . . . . . 0.501 ' HB3' ' CD2' ' S' ' 351' ' ' PHE . 53.4 mm-40 -65.05 -45.35 85.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.382 -0.824 . . . . 29.780000000000001 109.947 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 259' ' ' LEU . . . . . 0.421 ' O ' HG22 ' S' ' 263' ' ' VAL . 19.8 tp -58.66 -36.41 74.11 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.299 -0.876 . . . . 17.940000000000001 109.405 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 260' ' ' PHE . . . . . 0.533 ' CE2' HD21 ' S' ' 311' ' ' LEU . 3.1 m-85 -62.86 -45.22 93.57 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.593 -0.692 . . . . 30.57 109.872 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 261' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -62.06 -29.81 70.55 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.383 -0.823 . . . . 41.340000000000003 109.995 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' S' S ' 262' ' ' TYR . . . . . 0.67 ' CE2' HD22 ' S' ' 233' ' ' LEU . 8.6 t80 -71.24 -44.59 65.02 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.37 -0.831 . . . . 26.030000000000001 110.086 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 263' ' ' VAL . . . . . 0.421 HG22 ' O ' ' S' ' 259' ' ' LEU . 33.2 m -92.1 18.34 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.417 -0.802 . . . . 22.800000000000001 110.35 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 264' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 52.78 70.67 0.55 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.292 -0.88 . . . . 44.030000000000001 110.59 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' S' S ' 265' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -111.8 109.18 55.45 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.375 -0.828 . . . . 35.609999999999999 109.622 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' S' S ' 266' ' ' PRO . . . . . 0.478 ' HA ' ' HB2' ' S' ' 269' ' ' ASP . 49.8 Cg_endo -75.25 0.39 9.06 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 123.65 1.342 . . . . 37.670000000000002 111.826 -179.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 267' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -56.52 -67.71 0.28 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.76 -1.213 . . . . 41.490000000000002 110.17 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 268' ' ' PHE . . . . . 0.402 ' HB3' ' CD2' ' S' ' 257' ' ' LEU . 22.3 m-85 -92.92 39.92 1.05 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.197 -0.939 . . . . 50.759999999999998 110.095 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 269' ' ' ASP . . . . . 0.478 ' HB2' ' HA ' ' S' ' 266' ' ' PRO . 0.9 OUTLIER -76.01 -33.17 59.67 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.428 -0.795 . . . . 61.859999999999999 109.795 179.533 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' S' S ' 270' ' ' TRP . . . . . 0.51 ' CE2' HG23 ' S' ' 271' ' ' VAL . 50.9 p-90 -73.96 -4.26 34.1 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.28 -0.888 . . . . 39.850000000000001 110.501 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 271' ' ' VAL . . . . . 0.51 HG23 ' CE2' ' S' ' 270' ' ' TRP . 46.4 t -109.48 -32.82 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.121 -0.987 . . . . 39.18 110.058 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 272' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -78.59 -36.57 44.14 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.327 -0.858 . . . . 40.020000000000003 110.538 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' S' S ' 273' ' ' SER . . . . . . . . . . . . . 71.2 m -103.51 56.11 0.74 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.267 -0.896 . . . . 47.200000000000003 110.388 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' S' S ' 274' ' ' SER . . . . . . . . . . . . . 6.9 t -133.04 141.25 40.24 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.298 -0.876 . . . . 47.609999999999999 110.129 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' S' S ' 275' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.7 -18.88 21.84 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 O-C-N 123.72 1.379 . . . . 45.280000000000001 110.533 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' S' S ' 276' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -99.94 140.89 33.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.294 -0.879 . . . . 57.270000000000003 110.314 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' S' S ' 277' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -71.75 97.7 1.82 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.387 -0.821 . . . . 37.280000000000001 110.254 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' S' S ' 278' ' ' LEU . . . . . . . . . . . . . 86.3 mt -97.03 33.84 1.84 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.382 -0.824 . . . . 43.880000000000003 110.001 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' S' S ' 279' ' ' THR . . . . . . . . . . . . . 76.4 m -63.99 -60.17 3.58 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.416 -0.802 . . . . 50.049999999999997 110.282 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' S' S ' 280' ' ' LEU . . . . . 0.73 ' HA ' HD12 ' S' ' 283' ' ' ILE . 13.7 mt -51.51 -39.99 58.7 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.32 -0.862 . . . . 54.119999999999997 110.283 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 281' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.38 -49.64 74.74 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.435 -0.79 . . . . 65.280000000000001 110.161 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 282' ' ' ALA . . . . . . . . . . . . . . . -59.04 -33.9 71.3 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.438 -0.789 . . . . 46.509999999999998 110.499 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' S' S ' 283' ' ' ILE . . . . . 0.73 HD12 ' HA ' ' S' ' 280' ' ' LEU . 85.6 mt -66.25 -50.93 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.288 -0.883 . . . . 47.299999999999997 110.118 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 284' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -50.56 -57.56 7.85 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.388 -0.82 . . . . 50.719999999999999 110.405 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' S' S ' 285' ' ' GLN . . . . . 0.527 ' HG2' HD12 ' S' ' 289' ' ' LEU . 34.4 tt0 -51.41 -46.43 62.91 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.471 -0.768 . . . . 68.469999999999999 110.252 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 286' ' ' LEU . . . . . . . . . . . . . 19.1 mt -60.02 -44.49 94.57 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.403 -0.811 . . . . 36.619999999999997 110.202 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' S' S ' 287' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -62.71 -35.33 79.39 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.387 -0.82 . . . . 46.640000000000001 110.076 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' S' S ' 288' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -76.22 -21.04 56.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.353 -0.842 . . . . 46.450000000000003 110.292 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' S' S ' 289' ' ' LEU . . . . . 0.527 HD12 ' HG2' ' S' ' 285' ' ' GLN . 31.0 mt -97.29 -21.78 17.05 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.254 -0.904 . . . . 35.090000000000003 110.568 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 290' ' ' THR . . . . . 0.41 HG22 ' HB3' ' S' ' 306' ' ' ASN . 81.3 p -114.76 -28.44 7.09 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.252 -0.905 . . . . 38.609999999999999 110.403 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 291' ' ' GLY . . . . . . . . . . . . . . . 79.37 10.96 85.44 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.847 -1.301 . . . . 36.770000000000003 109.847 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' S' S ' 292' ' ' LEU . . . . . . . . . . . . . 84.7 mt -96.43 145.82 25.32 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.271 -1.135 . . . . 35.329999999999998 109.803 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' S' S ' 293' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -77.36 102.39 6.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.163 -0.96 . . . . 48.700000000000003 110.257 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' S' S ' 294' ' ' LEU . . . . . 0.428 ' HB3' ' CZ2' ' S' ' 252' ' ' TRP . 56.2 mt -107.03 51.8 0.73 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.526 -0.734 . . . . 42.609999999999999 110.074 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 295' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -112.51 -11.21 13.64 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.343 -0.848 . . . . 55.490000000000002 110.523 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 296' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -144.33 48.62 1.36 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.123 -0.986 . . . . 75.680000000000007 110.291 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' S' S ' 297' ' ' GLY . . . . . 0.546 ' CA ' ' HA ' ' R' ' 201' ' ' LYS . . . 96.85 145.09 18.53 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.555 -1.418 . . . . 49.439999999999998 109.555 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 298' ' ' GLY . . . . . . . . . . . . . . . -163.77 157.03 29.14 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.77 -1.332 . . . . 41.109999999999999 109.77 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' S' S ' 299' ' ' PRO . . . . . 0.486 ' O ' HG23 ' S' ' 303' ' ' VAL . 47.3 Cg_endo -73.91 118.31 5.38 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 123.917 1.483 . . . . 26.199999999999999 110.304 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 300' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.26 -15.43 31.63 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 O-C-N 123.616 1.324 . . . . 21.699999999999999 110.693 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' S' S ' 301' ' ' ALA . . . . . . . . . . . . . . . -80.75 -29.37 36.28 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.192 -0.942 . . . . 31.23 110.073 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' S' S ' 302' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.45 -40.72 18.93 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.409 -0.807 . . . . 38.990000000000002 109.969 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 303' ' ' VAL . . . . . 0.486 HG23 ' O ' ' S' ' 299' ' ' PRO . 58.0 t -60.67 -35.5 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.364 -0.835 . . . . 18.629999999999999 110.095 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 304' ' ' ILE . . . . . 0.524 HD12 HG21 ' S' ' 379' ' ' VAL . 86.1 mt -79.42 -23.58 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.431 -0.793 . . . . 25.460000000000001 110.153 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 305' ' ' TRP . . . . . 0.412 ' CD2' ' HD3' ' S' ' 308' ' ' LYS . 68.8 t-105 -88.69 -14.53 37.1 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.32 -0.862 . . . . 33.399999999999999 110.503 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 306' ' ' ASN . . . . . 0.41 ' HB3' HG22 ' S' ' 290' ' ' THR . 10.4 m-80 -89.68 -13.62 36.56 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.168 -0.957 . . . . 36.969999999999999 110.378 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 307' ' ' ILE . . . . . 0.473 HG12 ' O ' ' S' ' 303' ' ' VAL . 36.9 pt -125.1 45.59 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.266 -0.896 . . . . 30.809999999999999 110.045 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 308' ' ' LYS . . . . . 0.412 ' HD3' ' CD2' ' S' ' 305' ' ' TRP . 1.5 mtmp? -73.5 -37.79 65.56 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.366 -0.834 . . . . 46.520000000000003 110.086 -179.537 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 309' ' ' HIS . . . . . 0.496 ' CD2' ' HG ' ' S' ' 310' ' ' LEU . 55.5 p-80 -73.14 -8.38 55.51 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.284 -0.885 . . . . 51.030000000000001 110.097 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 310' ' ' LEU . . . . . 0.496 ' HG ' ' CD2' ' S' ' 309' ' ' HIS . 52.9 mt -99.25 -12.91 19.96 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.311 -0.868 . . . . 36.159999999999997 109.944 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 311' ' ' LEU . . . . . 0.533 HD21 ' CE2' ' S' ' 260' ' ' PHE . 10.8 mt -97.12 147.88 23.61 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.282 -0.886 . . . . 40.0 110.406 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 312' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -81.66 -16.3 51.79 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.28 -0.888 . . . . 54.18 109.68 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' S' S ' 313' ' ' THR . . . . . 0.824 HG23 ' HG2' ' S' ' 323' ' ' GLU . 92.6 m -87.9 151.63 22.68 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.322 -0.861 . . . . 25.609999999999999 110.125 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 314' ' ' GLY . . . . . . . . . . . . . . . -87.93 126.42 8.05 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.791 -1.324 . . . . 25.18 109.791 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' S' S ' 315' ' ' ILE . . . . . 0.669 HD13 ' HB ' ' S' ' 324' ' ' VAL . 50.7 mm -101.62 150.48 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.377 -1.072 . . . . 23.899999999999999 109.722 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 316' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' S' ' 325' ' ' CYS . . . -157.1 -159.26 9.38 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.006 -1.237 . . . . 23.18 110.006 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 317' ' ' THR . . . . . 0.423 HG22 ' CG2' ' S' ' 326' ' ' VAL . 11.1 p -133.89 -173.0 3.12 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.367 -1.078 . . . . 27.98 110.044 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.51 -56.26 24.12 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.239 -0.913 . . . . 28.100000000000001 109.885 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' S' S ' 319' ' ' SER . . . . . . . . . . . . . 1.2 m -59.93 -41.69 92.34 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.372 -0.83 . . . . 37.0 109.604 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' S' S ' 320' ' ' ARG . . . . . . . . . . . . . 12.1 mtm180 -111.71 79.84 2.64 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.483 -0.761 . . . . 52.07 109.717 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' S' S ' 321' ' ' PRO . . . . . 0.766 ' HG3' ' O ' ' S' ' 386' ' ' GLU . 44.1 Cg_endo -71.44 171.47 16.13 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.853 1.449 . . . . 38.289999999999999 110.928 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 322' ' ' SER . . . . . 0.445 ' HB2' ' O ' ' S' ' 321' ' ' PRO . 41.5 t 178.73 -148.14 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.021 -0.733 . . . . 38.840000000000003 109.021 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 323' ' ' GLU . . . . . 0.824 ' HG2' HG23 ' S' ' 313' ' ' THR . 6.7 tp10 -62.86 -40.26 96.93 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.947 -1.096 . . . . 40.700000000000003 109.733 179.218 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 324' ' ' VAL . . . . . 0.669 ' HB ' HD13 ' S' ' 315' ' ' ILE . 73.2 t -141.26 135.0 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.502 -0.749 . . . . 20.34 109.462 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 325' ' ' CYS . . . . . 0.458 ' HB2' ' CE1' ' S' ' 380' ' ' PHE . 11.2 m -125.99 172.14 10.19 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.275 -0.891 . . . . 30.629999999999999 110.886 -179.167 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 326' ' ' VAL . . . . . 0.645 HG12 HG22 ' S' ' 379' ' ' VAL . 34.6 m -135.41 142.21 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.62 -0.675 . . . . 23.899999999999999 109.237 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 327' ' ' VAL . . . . . 0.594 HG11 ' O ' ' S' ' 377' ' ' VAL . 34.5 m -56.32 125.03 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.104 -0.998 . . . . 19.48 110.4 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 328' ' ' ASP . . . . . . . . . . . . . 55.6 p-10 -119.4 11.47 12.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.494 -0.754 . . . . 26.43 110.461 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' S' S ' 329' ' ' GLY . . . . . . . . . . . . . . . 119.68 2.31 13.04 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.027 -1.229 . . . . 31.239999999999998 110.027 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' S' S ' 330' ' ' THR . . . . . . . . . . . . . 77.4 m -92.98 130.01 38.7 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.104 -1.233 . . . . 30.050000000000001 110.132 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' S' S ' 331' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -56.81 111.54 1.05 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.321 -0.862 . . . . 37.259999999999998 110.005 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' S' S ' 332' ' ' MET . . . . . . . . . . . . . 88.1 mmm -94.09 162.56 13.83 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.336 -0.852 . . . . 26.23 110.347 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' S' S ' 333' ' ' CYS . . . . . . . . . . . . . 26.1 m -137.26 149.95 47.48 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.419 -0.801 . . . . 23.559999999999999 110.07 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' S' S ' 334' ' ' LEU . . . . . 0.565 HD11 ' O ' ' S' ' 372' ' ' PRO . 0.1 OUTLIER -52.54 -24.85 8.93 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.23 -0.919 . . . . 28.93 110.435 179.941 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' S' S ' 335' ' ' ALA . . . . . . . . . . . . . . . -89.05 14.4 10.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.32 -0.863 . . . . 15.76 110.896 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' S' S ' 336' ' ' ASP . . . . . 0.402 ' O ' ' HA ' ' S' ' 382' ' ' PRO . 70.4 m-20 -100.49 -17.19 17.26 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.191 -0.943 . . . . 34.920000000000002 110.13 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 337' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -152.33 170.86 19.03 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.295 -0.878 . . . . 19.030000000000001 110.068 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' S' S ' 338' ' ' HIS . . . . . 0.401 ' HB3' ' CZ ' ' S' ' 383' ' ' TYR . 13.4 p80 -120.71 10.33 10.96 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.354 -0.841 . . . . 18.82 110.432 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 339' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' S' ' 352' ' ' ALA . . . -175.96 155.17 1.57 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.291 -0.88 . . . . 17.18 110.065 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 340' ' ' GLY . . . . . 0.401 ' CA ' ' O ' ' S' ' 379' ' ' VAL . . . 160.87 173.09 29.05 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 110.067 -1.213 . . . . 18.329999999999998 110.067 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 341' ' ' ILE . . . . . . . . . . . . . 84.2 mt -88.85 138.14 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.444 -1.033 . . . . 18.600000000000001 109.766 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' S' S ' 342' ' ' PHE . . . . . 0.493 ' CE2' ' HB3' ' S' ' 352' ' ' ALA . 70.0 m-85 -120.99 -178.48 3.76 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.214 -0.929 . . . . 23.440000000000001 110.375 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 343' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.83 93.38 4.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.484 -0.76 . . . . 35.590000000000003 109.973 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 344' ' ' LYS . . . . . 0.403 ' O ' ' HB3' ' S' ' 348' ' ' HIS . 0.3 OUTLIER -80.82 125.01 29.56 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.229 -0.919 . . . . 38.340000000000003 110.107 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' S' S ' 345' ' ' GLY . . . . . . . . . . . . . . . 62.72 -130.86 43.27 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 108.87 -1.692 . . . . 53.460000000000001 108.87 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' S' S ' 346' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -132.66 150.9 52.09 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.212 -1.17 . . . . 70.909999999999997 110.065 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' S' S ' 347' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 53.25 35.4 19.97 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.34 -0.85 . . . . 47.32 110.395 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' S' S ' 348' ' ' HIS . . . . . 0.403 ' HB3' ' O ' ' S' ' 344' ' ' LYS . 46.6 t60 -150.11 155.85 40.58 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.279 -0.888 . . . . 41.719999999999999 110.369 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 349' ' ' ALA . . . . . 0.458 ' C ' HG13 ' S' ' 350' ' ' VAL . . . -149.8 151.24 33.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.281 -0.887 . . . . 22.91 110.543 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 350' ' ' VAL . . . . . 0.458 HG13 ' C ' ' S' ' 349' ' ' ALA . 34.6 m -149.05 169.61 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.421 -0.8 . . . . 21.09 110.017 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 351' ' ' PHE . . . . . 0.501 ' CD2' ' HB3' ' S' ' 258' ' ' GLN . 10.7 t80 -105.36 143.67 33.19 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.249 -0.907 . . . . 25.030000000000001 110.693 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 352' ' ' ALA . . . . . 0.493 ' HB3' ' CE2' ' S' ' 342' ' ' PHE . . . -147.74 151.72 36.55 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.52 -0.738 . . . . 23.809999999999999 109.807 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 353' ' ' CYS . . . . . . . . . . . . . 26.2 p -153.4 164.86 37.42 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.271 -0.893 . . . . 25.66 110.175 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' S' S ' 354' ' ' VAL . . . . . 0.55 HG22 ' CE2' ' S' ' 359' ' ' TRP . 57.3 t -76.0 118.56 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.39 -0.819 . . . . 34.270000000000003 109.994 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 355' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' S' ' 232' ' ' THR . 52.3 p -117.86 175.07 5.83 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.294 -0.879 . . . . 25.489999999999998 110.306 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 356' ' ' SER . . . . . . . . . . . . . 62.3 p -62.1 -17.78 58.73 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.41 -0.806 . . . . 31.239999999999998 110.698 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' S' S ' 357' ' ' ASN . . . . . . . . . . . . . 45.8 m-20 -106.96 14.17 26.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.158 -0.964 . . . . 28.609999999999999 110.564 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' S' S ' 358' ' ' GLY . . . . . . . . . . . . . . . 111.87 -152.88 17.6 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.043 -1.223 . . . . 22.010000000000002 110.043 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' S' S ' 359' ' ' TRP . . . . . 0.55 ' CE2' HG22 ' S' ' 354' ' ' VAL . 15.3 m95 -91.4 116.74 29.09 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.43 -1.041 . . . . 25.539999999999999 110.109 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 360' ' ' TYR . . . . . 0.415 ' HA ' ' HA ' ' S' ' 369' ' ' PRO . 1.3 m-85 -103.54 165.88 10.77 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.344 -0.847 . . . . 40.530000000000001 109.997 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 361' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' S' ' 351' ' ' PHE . . . -140.07 130.02 24.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.427 -0.796 . . . . 18.039999999999999 110.279 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 362' ' ' ILE . . . . . . . . . . . . . 89.2 mt -95.59 83.64 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.379 -0.826 . . . . 15.640000000000001 110.13 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' S' S ' 363' ' ' ASP . . . . . 0.416 ' O ' ' N ' ' S' ' 365' ' ' GLU . 11.9 t0 -75.26 94.52 3.01 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.305 -0.872 . . . . 35.030000000000001 110.149 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 364' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 53.88 -89.4 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.518 -0.739 . . . . 46.719999999999999 110.458 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' S' S ' 365' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' S' ' 363' ' ' ASP . 23.8 mt-10 -122.62 19.14 10.37 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.126 -0.984 . . . . 56.200000000000003 110.24 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 366' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -117.96 125.03 49.64 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.281 -0.887 . . . . 51.020000000000003 110.446 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' S' S ' 367' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -107.06 127.12 53.19 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.349 -0.844 . . . . 37.590000000000003 110.142 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' S' S ' 368' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -165.44 159.55 13.89 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.278 -0.889 . . . . 31.469999999999999 110.39 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' S' S ' 369' ' ' PRO . . . . . 0.415 ' HA ' ' HA ' ' S' ' 360' ' ' TYR . 47.0 Cg_endo -72.9 139.59 30.48 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 O-C-N 123.859 1.452 . . . . 28.850000000000001 110.52 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 370' ' ' TRP . . . . . . . . . . . . . 67.4 t90 -167.2 113.64 0.77 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.387 -0.821 . . . . 26.940000000000001 110.006 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' S' S ' 371' ' ' THR . . . . . . . . . . . . . 59.7 m -74.85 113.06 20.86 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.417 -0.802 . . . . 20.190000000000001 110.0 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' S' S ' 372' ' ' PRO . . . . . 0.565 ' O ' HD11 ' S' ' 334' ' ' LEU . 48.5 Cg_endo -73.55 157.13 49.21 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 O-C-N 123.636 1.335 . . . . 28.68 110.571 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 373' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -90.57 147.16 35.77 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.382 -0.824 . . . . 35.719999999999999 109.873 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' S' S ' 374' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -76.05 -6.37 17.27 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 O-C-N 123.628 1.331 . . . . 30.890000000000001 110.473 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' S' S ' 375' ' ' SER . . . . . . . . . . . . . 69.0 p -104.28 -16.93 15.03 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.277 -0.889 . . . . 29.41 110.477 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' S' S ' 376' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -106.47 43.02 1.19 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.302 -0.874 . . . . 32.890000000000001 110.228 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' S' S ' 377' ' ' VAL . . . . . 0.594 ' O ' HG11 ' S' ' 327' ' ' VAL . 7.3 p -114.62 147.23 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.273 -0.892 . . . . 24.329999999999998 110.274 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 378' ' ' LEU . . . . . . . . . . . . . 52.2 mt -116.03 -57.92 2.16 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.446 -0.784 . . . . 24.370000000000001 109.642 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' S' S ' 379' ' ' VAL . . . . . 0.645 HG22 HG12 ' S' ' 326' ' ' VAL . 60.5 t -120.73 132.32 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.403 -0.811 . . . . 18.02 109.48 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 380' ' ' PHE . . . . . 0.458 ' CE1' ' HB2' ' S' ' 325' ' ' CYS . 14.3 p90 -142.5 173.92 11.1 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.417 -0.802 . . . . 29.350000000000001 110.658 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 381' ' ' VAL . . . . . . . . . . . . . 57.9 t -120.0 107.32 40.02 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.485 -0.759 . . . . 16.34 109.458 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' S' S ' 382' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' S' ' 336' ' ' ASP . 46.0 Cg_endo -71.28 145.63 49.05 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 O-C-N 123.562 1.296 . . . . 20.940000000000001 110.726 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 383' ' ' TYR . . . . . 0.401 ' CZ ' ' HB3' ' S' ' 338' ' ' HIS . 88.2 m-85 -61.16 -53.43 57.06 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.387 -0.82 . . . . 28.93 109.833 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 384' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -107.36 130.69 54.76 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.457 -0.777 . . . . 47.030000000000001 110.426 -177.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' S' S ' 385' ' ' GLN . . . . . 0.455 ' O ' ' C ' ' S' ' 386' ' ' GLU . 0.4 OUTLIER -63.13 -1.8 1.12 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.432 -0.793 . . . . 46.689999999999998 110.163 177.87 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' S' S ' 386' ' ' GLU . . . . . 0.766 ' O ' ' HG3' ' S' ' 321' ' ' PRO . 9.1 pt-20 -40.86 151.62 0.26 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.332 -0.855 . . . . 50.25 109.599 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 387' ' ' PRO . . . . . 0.675 ' O ' ' N ' ' S' ' 389' ' ' ASN . 46.2 Cg_endo -70.23 23.33 0.19 Allowed 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.656 1.345 . . . . 34.390000000000001 110.615 -177.541 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 388' ' ' LEU . . . . . 0.522 ' H ' ' C ' ' S' ' 386' ' ' GLU . 4.2 mt 43.4 -83.65 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.393 -0.817 . . . . 38.009999999999998 110.105 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 389' ' ' ASN . . . . . 0.675 ' N ' ' O ' ' S' ' 387' ' ' PRO . 2.4 m120 -156.04 76.96 0.94 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.442 -0.786 . . . . 45.82 110.083 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 390' ' ' GLY . . . . . . . . . . . . . . . -118.32 92.19 0.54 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.621 -1.392 . . . . 33.460000000000001 109.621 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' S' S ' 391' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -81.29 -33.36 32.7 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.398 -1.06 . . . . 56.579999999999998 110.13 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' S' S ' 392' ' ' TRP . . . . . 0.416 ' CE3' ' HA ' ' S' ' 393' ' ' LYS . 42.8 p-90 -58.23 -18.85 29.27 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.371 -0.83 . . . . 31.43 110.383 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 393' ' ' LYS . . . . . 0.625 ' O ' HG12 ' S' ' 396' ' ' VAL . 0.0 OUTLIER -46.7 -46.73 20.36 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.304 -0.873 . . . . 39.420000000000002 110.334 179.769 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' S' S ' 394' ' ' ALA . . . . . 0.425 ' HA ' ' CG ' ' S' ' 397' ' ' GLN . . . -79.35 -16.57 56.08 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.369 -0.832 . . . . 34.329999999999998 110.092 178.689 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 395' ' ' LYS . . . . . 0.783 ' O ' HD11 ' R' ' 143' ' ' LEU . 20.2 mmtt -77.96 -16.43 58.16 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.372 -0.83 . . . . 60.090000000000003 110.255 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 396' ' ' VAL . . . . . 0.857 ' O ' ' HA ' ' R' ' 99' ' ' PRO . 7.6 p -100.97 -41.49 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.347 -0.846 . . . . 35.5 110.566 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 397' ' ' GLN . . . . . 0.543 ' N ' HG13 ' S' ' 396' ' ' VAL . 1.2 pp0? -77.12 -2.4 34.07 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.152 -0.968 . . . . 49.960000000000001 110.637 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' S' S ' 398' ' ' ARG . . . . . 0.754 ' HB2' ' HA ' ' R' ' 147' ' ' GLU . 0.0 OUTLIER -45.27 157.62 0.08 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.307 -0.871 . . . . 43.420000000000002 110.71 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' S' S ' 399' ' ' LYS . . . . . 0.606 ' CB ' ' HA3' ' R' ' 97' ' ' GLY . 0.8 OUTLIER -142.58 118.16 10.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.299 -0.875 . . . . 55.310000000000002 110.06 179.737 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' S' S ' 400' ' ' LEU . . . . . 0.772 ' O ' HD22 ' S' ' 400' ' ' LEU . 1.0 OUTLIER -35.13 -43.8 0.22 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.305 -0.872 . . . . 41.030000000000001 110.239 -179.939 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' S' S ' 401' ' ' LYS . . . . . 0.633 ' N ' HD13 ' S' ' 400' ' ' LEU . 4.8 tmmt? . . . . . 0 N--CA 1.493 1.683 0 O-C-N 121.23 -0.919 . . . . 61.969999999999999 110.15 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.152 0.501 . . . . 32.140000000000001 110.291 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 30' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -96.27 141.18 29.92 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.382 -0.824 . . . . 43.359999999999999 110.249 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 31' ' ' LEU . . . . . . . . . . . . . 65.3 mt -134.91 140.6 45.89 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.282 -0.886 . . . . 22.93 110.283 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 32' ' ' THR . . . . . . . . . . . . . 70.3 m -87.62 110.49 20.43 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.391 -0.818 . . . . 22.34 109.982 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 33' ' ' LEU . . . . . 0.596 HD22 ' CE2' ' R' ' 62' ' ' TYR . 80.1 mt -62.28 -172.78 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.295 -0.878 . . . . 21.390000000000001 110.221 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 34' ' ' TYR . . . . . . . . . . . . . 37.0 p90 -74.66 -29.36 61.22 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.266 -0.896 . . . . 34.399999999999999 110.414 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 35' ' ' ASN . . . . . . . . . . . . . 48.3 p30 -77.77 -1.92 33.79 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.289 -0.882 . . . . 30.280000000000001 110.633 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.29 -16.56 59.51 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.742 -1.343 . . . . 36.25 109.742 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 37' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -59.02 161.82 4.76 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.285 -1.127 . . . . 53.799999999999997 110.368 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 38' ' ' LYS . . . . . . . . . . . . . 56.8 mttt -117.85 135.73 53.9 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.367 -0.833 . . . . 49.909999999999997 110.132 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 39' ' ' LYS . . . . . 0.406 ' HG2' ' CZ ' ' R' ' 41' ' ' PHE . 8.0 ttmt -138.72 143.68 39.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.375 -0.828 . . . . 35.689999999999998 110.255 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 40' ' ' THR . . . . . . . . . . . . . 23.4 m -102.55 127.95 49.41 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.424 -0.798 . . . . 34.840000000000003 110.198 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 41' ' ' PHE . . . . . 0.406 ' CZ ' ' HG2' ' R' ' 39' ' ' LYS . 96.6 m-85 -113.0 132.69 55.27 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.41 -0.806 . . . . 34.420000000000002 110.179 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 42' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -93.34 140.97 28.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.328 -0.857 . . . . 51.460000000000001 110.229 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 43' ' ' SER . . . . . . . . . . . . . 54.3 m -70.84 141.9 51.28 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.461 -0.774 . . . . 41.840000000000003 110.192 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.77 125.4 29.54 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.367 -0.833 . . . . 33.82 109.957 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 45' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.15 151.05 54.77 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.517 1.272 . . . . 30.27 110.646 -179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 46' ' ' ASN . . . . . 0.4 ' HA ' ' OD1' ' R' ' 50' ' ' ASN . 52.2 t-20 -124.24 109.91 13.99 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.534 -0.728 . . . . 35.100000000000001 109.997 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 47' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -120.32 -34.84 3.56 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.292 -0.88 . . . . 42.810000000000002 110.537 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 48' ' ' HIS . . . . . 0.439 ' NE2' HD11 ' R' ' 80' ' ' LEU . 73.3 m80 -105.86 45.23 0.98 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.346 -0.846 . . . . 49.969999999999999 110.24 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 49' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 50.32 34.62 9.22 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.491 -0.755 . . . . 61.32 110.158 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 50' ' ' ASN . . . . . 0.4 ' OD1' ' HA ' ' R' ' 46' ' ' ASN . 15.0 p-10 -86.15 43.77 1.08 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.388 -0.82 . . . . 51.5 110.747 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 51' ' ' ALA . . . . . 0.483 ' CB ' ' O ' ' S' ' 400' ' ' LEU . . . -66.07 -46.1 78.93 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.243 -0.911 . . . . 38.770000000000003 109.571 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 52' ' ' TRP . . . . . 0.483 ' CD2' ' N ' ' R' ' 53' ' ' LEU . 68.1 p-90 -58.46 -38.34 77.34 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.57 -0.706 . . . . 26.239999999999998 110.048 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 53' ' ' LEU . . . . . 0.483 ' N ' ' CD2' ' R' ' 52' ' ' TRP . 23.2 tp -66.72 -46.68 74.75 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.323 -0.861 . . . . 26.75 110.013 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 54' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -55.25 -41.53 72.29 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.363 -0.836 . . . . 35.020000000000003 110.23 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.16 -46.12 91.83 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.44 -0.788 . . . . 24.469999999999999 110.196 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 56' ' ' ILE . . . . . 0.431 HG12 HD11 ' R' ' 104' ' ' ILE . 76.1 mt -62.12 -42.26 94.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.292 -0.88 . . . . 26.030000000000001 109.927 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 57' ' ' LEU . . . . . . . . . . . . . 22.3 mt -60.35 -45.61 92.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.251 -0.906 . . . . 26.77 109.661 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 58' ' ' GLN . . . . . . . . . . . . . 57.7 mm-40 -63.87 -46.52 84.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.427 -0.796 . . . . 22.32 109.625 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 59' ' ' LEU . . . . . 0.43 ' HA ' ' HE2' ' R' ' 151' ' ' PHE . 24.0 tp -61.33 -37.82 84.67 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.334 -0.854 . . . . 20.550000000000001 109.443 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 60' ' ' PHE . . . . . 0.528 ' CE2' HD21 ' R' ' 111' ' ' LEU . 2.8 m-85 -61.1 -44.7 96.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.567 -0.708 . . . . 20.079999999999998 109.933 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 61' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -63.1 -36.13 82.57 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.441 -0.787 . . . . 18.800000000000001 110.541 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 62' ' ' TYR . . . . . 0.596 ' CE2' HD22 ' R' ' 33' ' ' LEU . 9.2 t80 -63.22 -41.73 99.16 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.233 -0.917 . . . . 26.449999999999999 110.155 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 63' ' ' VAL . . . . . 0.406 ' H ' HG22 ' R' ' 63' ' ' VAL . 30.4 m -93.36 20.34 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.275 -0.891 . . . . 29.75 110.19 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 64' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 52.92 75.63 0.23 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.328 -0.857 . . . . 35.520000000000003 110.559 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 65' ' ' GLU . . . . . 0.443 ' HG2' ' CD2' ' R' ' 60' ' ' PHE . 14.3 tp10 -116.36 104.14 52.15 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.344 -0.847 . . . . 29.890000000000001 109.865 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 66' ' ' PRO . . . . . 0.481 ' HA ' ' HB2' ' R' ' 69' ' ' ASP . 46.7 Cg_endo -73.6 -5.84 17.74 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.806 1.424 . . . . 21.370000000000001 111.064 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 67' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -52.09 -61.52 2.21 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.147 -0.97 . . . . 23.850000000000001 110.375 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 68' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -98.2 36.69 1.55 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.326 -0.859 . . . . 28.07 110.488 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 69' ' ' ASP . . . . . 0.481 ' HB2' ' HA ' ' R' ' 66' ' ' PRO . 11.7 t0 -72.43 -33.17 66.91 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.225 -0.922 . . . . 43.759999999999998 110.175 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 70' ' ' TRP . . . . . 0.476 ' CE2' ' CG2' ' R' ' 71' ' ' VAL . 47.7 p-90 -73.41 -3.98 30.74 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.334 -0.854 . . . . 33.060000000000002 110.71 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 71' ' ' VAL . . . . . 0.557 HG11 ' HB2' ' R' ' 82' ' ' ALA . 40.5 t -109.73 -27.41 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.223 -0.923 . . . . 31.699999999999999 109.756 179.127 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 72' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -86.54 -48.79 8.06 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.407 -0.808 . . . . 33.579999999999998 110.383 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 73' ' ' SER . . . . . . . . . . . . . 70.0 m -89.71 51.06 2.0 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.394 -0.816 . . . . 50.82 110.304 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 74' ' ' SER . . . . . . . . . . . . . 15.9 t -125.96 138.29 31.79 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.238 -0.914 . . . . 34.740000000000002 110.24 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.36 -24.96 15.98 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.742 1.391 . . . . 35.700000000000003 110.343 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 76' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -91.72 153.15 19.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.33 -0.856 . . . . 66.480000000000004 110.355 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 77' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -81.47 95.27 7.03 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.391 -0.818 . . . . 46.719999999999999 110.043 179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 78' ' ' LEU . . . . . . . . . . . . . 96.3 mt -96.49 27.99 3.55 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.389 -0.82 . . . . 37.549999999999997 110.191 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 79' ' ' THR . . . . . . . . . . . . . 29.6 m -56.27 -54.58 43.7 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.225 -0.922 . . . . 37.359999999999999 110.302 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 80' ' ' LEU . . . . . 0.604 ' HA ' HD12 ' R' ' 83' ' ' ILE . 15.9 mt -60.97 -23.16 65.13 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.33 -0.856 . . . . 35.829999999999998 110.511 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 81' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -79.5 -39.11 32.85 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.101 -0.999 . . . . 44.030000000000001 110.356 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 82' ' ' ALA . . . . . 0.557 ' HB2' HG11 ' R' ' 71' ' ' VAL . . . -69.51 -28.64 66.22 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.257 -0.902 . . . . 32.539999999999999 110.169 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 83' ' ' ILE . . . . . 0.604 HD12 ' HA ' ' R' ' 80' ' ' LEU . 77.8 mt -70.08 -46.12 73.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.275 -0.891 . . . . 32.020000000000003 110.352 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 84' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -55.09 -52.17 64.08 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.208 -0.932 . . . . 34.090000000000003 110.56 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 85' ' ' GLN . . . . . 0.533 ' HG2' HD12 ' R' ' 89' ' ' LEU . 31.9 tt0 -54.79 -46.88 74.53 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.209 -0.932 . . . . 25.940000000000001 110.279 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 86' ' ' LEU . . . . . . . . . . . . . 23.7 mt -58.75 -43.76 90.38 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.365 -0.835 . . . . 16.199999999999999 109.853 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 87' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -65.33 -35.25 80.4 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.494 -0.754 . . . . 49.090000000000003 110.317 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 88' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -78.41 -19.05 54.09 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.282 -0.886 . . . . 28.609999999999999 110.529 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 89' ' ' LEU . . . . . 0.533 HD12 ' HG2' ' R' ' 85' ' ' GLN . 32.6 mt -96.21 -29.35 14.09 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.248 -0.907 . . . . 26.16 110.201 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 90' ' ' THR . . . . . . . . . . . . . 60.7 p -105.69 -34.71 7.62 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.255 -0.903 . . . . 33.329999999999998 109.75 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.88 16.15 58.47 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.85 -1.3 . . . . 31.129999999999999 109.85 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 92' ' ' LEU . . . . . . . . . . . . . 97.1 mt -100.18 155.21 17.87 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.213 -1.169 . . . . 42.520000000000003 110.186 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 93' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -86.19 91.59 8.5 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.481 -0.762 . . . . 68.459999999999994 110.038 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 94' ' ' LEU . . . . . 0.458 ' HB3' ' CZ2' ' R' ' 52' ' ' TRP . 48.1 mt -99.37 53.03 0.95 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.204 -0.935 . . . . 44.630000000000003 110.377 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 95' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.57 -38.59 6.38 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.262 -0.898 . . . . 67.159999999999997 110.369 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 96' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -113.93 44.23 1.68 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.364 -0.835 . . . . 67.019999999999996 110.244 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 97' ' ' GLY . . . . . 0.602 ' HA3' ' HA ' ' S' ' 399' ' ' LYS . . . 99.12 150.8 26.05 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.614 -1.395 . . . . 49.479999999999997 109.614 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 98' ' ' GLY . . . . . . . . . . . . . . . -166.27 160.01 33.44 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.265 -1.534 . . . . 36.57 109.265 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 99' ' ' PRO . . . . . 0.997 ' HA ' ' O ' ' S' ' 396' ' ' VAL . 44.5 Cg_endo -72.57 121.12 7.15 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.75 1.395 . . . . 30.41 110.384 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 100' ' ' PRO . . . . . 0.413 ' HA ' HD11 ' R' ' 56' ' ' ILE . 45.4 Cg_endo -72.3 -31.68 11.34 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.619 1.326 . . . . 29.940000000000001 110.493 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 101' ' ' ALA . . . . . 0.475 ' HB2' ' HB3' ' R' ' 178' ' ' LEU . . . -70.01 -38.45 75.96 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.34 -0.85 . . . . 23.640000000000001 110.294 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 102' ' ' LEU . . . . . 0.423 HD23 HD21 ' R' ' 106' ' ' ASN . 0.1 OUTLIER -72.63 -40.77 66.16 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.353 -0.842 . . . . 20.309999999999999 110.382 -179.757 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' R' R ' 103' ' ' VAL . . . . . 0.79 HG23 ' O ' ' R' ' 99' ' ' PRO . 63.1 t -58.01 -40.21 75.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.202 -0.936 . . . . 16.329999999999998 110.023 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 104' ' ' ILE . . . . . 0.431 HD11 HG12 ' R' ' 56' ' ' ILE . 81.7 mt -71.62 -30.6 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.384 -0.823 . . . . 24.77 109.941 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 105' ' ' TRP . . . . . 0.462 ' O ' ' HD3' ' R' ' 108' ' ' LYS . 70.6 t-105 -82.26 0.72 40.08 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.311 -0.868 . . . . 23.280000000000001 110.376 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 106' ' ' ASN . . . . . 0.423 HD21 HD23 ' R' ' 102' ' ' LEU . 6.9 m-80 -104.98 -10.5 17.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.118 -0.989 . . . . 28.260000000000002 110.112 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 107' ' ' ILE . . . . . . . . . . . . . 36.6 pt -126.81 35.0 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.225 -0.922 . . . . 18.77 109.994 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 108' ' ' LYS . . . . . 0.5 ' HG2' ' HB ' ' R' ' 115' ' ' ILE . 9.2 mtpp -61.02 -48.54 81.32 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.499 -0.751 . . . . 42.5 110.011 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 109' ' ' HIS . . . . . 0.447 ' CD2' ' HG ' ' R' ' 110' ' ' LEU . 50.8 p-80 -66.0 -12.84 57.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.518 -0.738 . . . . 20.07 110.64 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 110' ' ' LEU . . . . . 0.447 ' HG ' ' CD2' ' R' ' 109' ' ' HIS . 80.4 mt -94.8 -17.39 22.17 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.116 -0.99 . . . . 15.69 110.156 179.413 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 111' ' ' LEU . . . . . 0.528 HD21 ' CE2' ' R' ' 60' ' ' PHE . 10.4 mt -94.06 144.12 25.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.299 -0.876 . . . . 25.390000000000001 111.046 -179.183 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 112' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -77.66 -17.43 57.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.634 -0.666 . . . . 53.479999999999997 109.854 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 113' ' ' THR . . . . . 0.457 HG22 ' N ' ' R' ' 114' ' ' GLY . 60.0 m -83.63 166.66 17.97 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.379 -0.826 . . . . 14.800000000000001 110.257 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 114' ' ' GLY . . . . . 0.457 ' N ' HG22 ' R' ' 113' ' ' THR . . . -97.97 127.14 9.13 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.041 -1.224 . . . . 16.140000000000001 110.041 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 115' ' ' ILE . . . . . 0.578 HD13 ' HB ' ' R' ' 124' ' ' VAL . 47.7 mm -109.1 139.37 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.457 -1.025 . . . . 13.460000000000001 109.727 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 116' ' ' GLY . . . . . . . . . . . . . . . -152.75 -155.81 7.27 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.876 -1.29 . . . . 23.899999999999999 109.876 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 117' ' ' THR . . . . . 0.53 HG22 ' CG2' ' R' ' 126' ' ' VAL . 18.7 p -135.05 -171.4 2.79 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.432 -1.04 . . . . 27.370000000000001 110.072 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 118' ' ' ALA . . . . . 0.445 ' HB3' ' OD1' ' R' ' 128' ' ' ASP . . . -56.5 -58.12 9.42 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.23 -0.918 . . . . 18.760000000000002 110.031 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 119' ' ' SER . . . . . 0.653 ' O ' ' HB2' ' R' ' 197' ' ' GLN . 1.1 m -56.56 -40.6 75.44 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.259 -0.901 . . . . 32.350000000000001 109.764 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 120' ' ' ARG . . . . . 0.425 ' HG2' ' OE1' ' R' ' 197' ' ' GLN . 10.0 mtm180 -110.05 86.29 4.9 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.47 -0.768 . . . . 27.120000000000001 109.636 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 121' ' ' PRO . . . . . 0.483 ' HA ' ' SG ' ' R' ' 125' ' ' CYS . 44.2 Cg_endo -71.26 166.44 29.25 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 O-C-N 123.819 1.431 . . . . 22.68 111.009 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 122' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' R' ' 121' ' ' PRO . 38.1 t 178.58 -161.65 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.609 -0.682 . . . . 22.989999999999998 109.493 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 123' ' ' GLU . . . . . 0.44 ' HG2' HG23 ' R' ' 113' ' ' THR . 2.3 tp10 -56.45 -39.97 74.01 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.19 -0.944 . . . . 36.18 109.701 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 124' ' ' VAL . . . . . 0.578 ' HB ' HD13 ' R' ' 115' ' ' ILE . 82.6 t -142.5 136.41 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.498 -0.751 . . . . 20.640000000000001 109.393 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 125' ' ' CYS . . . . . 0.483 ' SG ' ' HA ' ' R' ' 121' ' ' PRO . 83.4 m -140.32 168.15 20.49 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.304 -0.873 . . . . 22.800000000000001 111.131 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 126' ' ' VAL . . . . . 0.727 HG12 HG22 ' R' ' 179' ' ' VAL . 35.8 m -122.68 159.7 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.714 -0.616 . . . . 21.239999999999998 109.676 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 127' ' ' VAL . . . . . 0.709 HG11 ' O ' ' R' ' 177' ' ' VAL . 30.6 m -70.81 141.8 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.359 -0.838 . . . . 19.77 110.7 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 128' ' ' ASP . . . . . 0.445 ' OD1' ' HB3' ' R' ' 118' ' ' ALA . 53.9 p-10 -137.63 19.38 2.89 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.333 -0.855 . . . . 29.210000000000001 110.714 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 129' ' ' GLY . . . . . . . . . . . . . . . 113.97 0.08 24.18 Favored Glycine 0 N--CA 1.493 2.458 0 C-N-CA 120.0 -1.095 . . . . 33.859999999999999 110.468 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 130' ' ' THR . . . . . . . . . . . . . 58.1 m -91.82 131.87 36.85 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.171 -1.193 . . . . 26.41 110.072 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -62.58 120.65 11.56 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.312 -0.868 . . . . 33.079999999999998 110.284 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 132' ' ' MET . . . . . 0.433 ' HE1' ' CE2' ' R' ' 180' ' ' PHE . 98.4 mmm -105.16 165.62 10.97 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.543 -0.723 . . . . 30.760000000000002 110.415 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 133' ' ' CYS . . . . . 0.41 ' HA ' ' HB3' ' R' ' 174' ' ' PRO . 32.4 m -141.14 158.13 44.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.511 -0.743 . . . . 27.0 109.912 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 134' ' ' LEU . . . . . 0.563 HD11 ' O ' ' R' ' 172' ' ' PRO . 0.1 OUTLIER -58.48 -19.68 39.12 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.347 -0.846 . . . . 33.899999999999999 110.538 -179.936 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' R' R ' 135' ' ' ALA . . . . . . . . . . . . . . . -92.79 8.22 40.37 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.261 -0.899 . . . . 19.370000000000001 110.801 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 136' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -93.72 -21.87 19.08 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.109 -0.994 . . . . 30.469999999999999 110.195 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 137' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -149.9 165.45 32.56 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.421 -0.8 . . . . 24.27 110.227 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 138' ' ' HIS . . . . . 0.434 ' HA ' HG23 ' R' ' 154' ' ' VAL . 15.1 p80 -117.88 15.09 14.33 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.418 -0.801 . . . . 20.91 110.412 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 139' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' R' ' 152' ' ' ALA . . . -177.19 152.35 0.87 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.187 -0.946 . . . . 15.69 110.171 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 140' ' ' GLY . . . . . 0.428 ' HA3' ' O ' ' R' ' 179' ' ' VAL . . . 161.82 175.18 32.58 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.918 -1.273 . . . . 23.760000000000002 109.918 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 141' ' ' ILE . . . . . . . . . . . . . 83.7 mt -95.54 136.57 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.447 -1.031 . . . . 25.300000000000001 109.702 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 142' ' ' PHE . . . . . 0.577 ' CD2' ' HB2' ' R' ' 172' ' ' PRO . 82.2 m-85 -120.66 -172.58 2.41 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.276 -0.89 . . . . 30.239999999999998 110.566 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 143' ' ' LEU . . . . . 0.742 HD23 ' O ' ' R' ' 148' ' ' HIS . 0.5 OUTLIER -119.84 77.78 1.27 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.455 -0.778 . . . . 32.799999999999997 110.298 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' R' R ' 144' ' ' LYS . . . . . 0.471 ' HG3' ' CZ2' ' R' ' 170' ' ' TRP . 1.0 OUTLIER -69.66 76.84 0.43 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.43 -0.794 . . . . 49.18 109.635 179.651 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' R' R ' 145' ' ' GLY . . . . . 0.458 ' O ' HD22 ' R' ' 143' ' ' LEU . . . 104.57 179.26 24.76 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.168 -1.573 . . . . 53.869999999999997 109.168 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 146' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -88.5 145.79 25.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.388 -1.066 . . . . 68.579999999999998 110.049 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 147' ' ' GLU . . . . . 0.789 ' HA ' ' CB ' ' S' ' 398' ' ' ARG . 10.9 mt-10 58.29 36.51 25.68 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.392 -0.818 . . . . 56.619999999999997 110.655 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 148' ' ' HIS . . . . . 0.742 ' O ' HD23 ' R' ' 143' ' ' LEU . 45.0 t60 -158.68 148.08 19.14 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.205 -0.934 . . . . 44.57 110.377 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 149' ' ' ALA . . . . . 0.658 ' HB2' ' NZ ' ' S' ' 401' ' ' LYS . . . -150.3 146.93 27.06 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.467 -0.771 . . . . 33.539999999999999 110.072 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 150' ' ' VAL . . . . . . . . . . . . . 34.2 m -142.38 161.45 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.273 -0.892 . . . . 27.609999999999999 110.305 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 151' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' R' ' 152' ' ' ALA . 5.9 t80 -86.15 155.58 20.7 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.42 -0.8 . . . . 23.039999999999999 109.867 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 152' ' ' ALA . . . . . 0.537 ' N ' ' CD1' ' R' ' 151' ' ' PHE . . . -157.31 151.59 24.95 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.455 -0.778 . . . . 29.609999999999999 109.565 178.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 153' ' ' CYS . . . . . . . . . . . . . 26.7 p -154.33 173.56 16.02 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.334 -0.854 . . . . 22.75 110.49 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 154' ' ' VAL . . . . . 0.613 HG22 ' CE2' ' R' ' 159' ' ' TRP . 60.4 t -90.6 116.97 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.337 -0.852 . . . . 23.260000000000002 110.083 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 155' ' ' THR . . . . . . . . . . . . . 69.3 p -112.05 -176.65 2.98 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.257 -0.902 . . . . 17.879999999999999 110.102 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 156' ' ' SER . . . . . . . . . . . . . 78.4 p -75.96 -3.69 36.96 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.394 -0.816 . . . . 21.829999999999998 110.721 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 157' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -118.32 10.58 12.84 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.046 -1.034 . . . . 36.539999999999999 110.613 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 158' ' ' GLY . . . . . . . . . . . . . . . 117.98 -162.65 13.04 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.592 -1.403 . . . . 31.739999999999998 109.592 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 159' ' ' TRP . . . . . 0.613 ' CE2' HG22 ' R' ' 154' ' ' VAL . 14.7 m95 -86.55 122.42 30.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.312 -1.111 . . . . 28.25 110.112 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 160' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -108.46 166.94 10.39 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.413 -0.805 . . . . 41.240000000000002 110.19 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 161' ' ' ALA . . . . . . . . . . . . . . . -143.21 123.48 13.79 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.367 -0.833 . . . . 27.399999999999999 110.14 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 162' ' ' ILE . . . . . . . . . . . . . 92.1 mt -87.6 81.14 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.354 -0.841 . . . . 24.27 110.106 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 163' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' R' ' 165' ' ' GLU . 15.3 t0 -72.72 92.33 1.54 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.443 -0.786 . . . . 36.079999999999998 110.332 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 164' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 54.1 -88.93 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.496 -0.752 . . . . 46.079999999999998 110.565 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 165' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' R' ' 163' ' ' ASP . 29.7 mt-10 -124.72 35.96 4.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.017 -1.052 . . . . 50.939999999999998 110.187 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 166' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -135.8 117.34 14.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.339 -0.85 . . . . 47.280000000000001 110.309 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 167' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -101.07 119.92 39.45 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.412 -0.805 . . . . 40.469999999999999 110.127 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 168' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -157.58 158.51 30.6 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.305 -0.872 . . . . 30.210000000000001 110.407 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 169' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.77 133.06 19.54 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 O-C-N 123.868 1.457 . . . . 32.759999999999998 110.474 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 170' ' ' TRP . . . . . 0.471 ' CZ2' ' HG3' ' R' ' 144' ' ' LYS . 67.0 t90 -159.81 119.3 2.88 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.41 -0.806 . . . . 32.789999999999999 109.984 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 171' ' ' THR . . . . . . . . . . . . . 45.7 m -81.08 112.62 34.19 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.444 -0.785 . . . . 36.920000000000002 110.219 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 172' ' ' PRO . . . . . 0.577 ' HB2' ' CD2' ' R' ' 142' ' ' PHE . 46.9 Cg_endo -73.75 158.83 46.45 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.68 1.358 . . . . 33.539999999999999 110.533 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 173' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -88.9 144.96 33.71 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.366 -0.833 . . . . 45.759999999999998 109.843 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 174' ' ' PRO . . . . . 0.41 ' HB3' ' HA ' ' R' ' 133' ' ' CYS . 45.2 Cg_endo -71.71 -10.4 26.46 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 O-C-N 123.553 1.291 . . . . 29.629999999999999 110.438 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 175' ' ' SER . . . . . . . . . . . . . 53.0 p -103.36 -17.69 15.16 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.234 -0.916 . . . . 35.700000000000003 110.404 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 176' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -103.44 43.13 1.1 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.233 -0.917 . . . . 39.649999999999999 110.4 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 177' ' ' VAL . . . . . 0.709 ' O ' HG11 ' R' ' 127' ' ' VAL . 10.4 p -117.69 127.2 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.409 -0.807 . . . . 20.609999999999999 110.021 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 178' ' ' LEU . . . . . 0.475 ' HB3' ' HB2' ' R' ' 101' ' ' ALA . 46.3 mt -91.52 -61.29 1.68 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.35 -0.844 . . . . 15.58 109.376 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 179' ' ' VAL . . . . . 0.727 HG22 HG12 ' R' ' 126' ' ' VAL . 67.1 t -114.62 144.67 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.6 -0.688 . . . . 17.399999999999999 109.444 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 180' ' ' PHE . . . . . 0.433 ' CE2' ' HE1' ' R' ' 132' ' ' MET . 43.7 p90 -152.09 163.37 39.47 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.338 -0.851 . . . . 20.16 110.562 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 181' ' ' VAL . . . . . . . . . . . . . 66.4 t -113.19 111.48 50.22 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.511 -0.743 . . . . 17.690000000000001 109.836 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 182' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.11 149.54 52.44 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.546 1.287 . . . . 17.809999999999999 110.374 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 183' ' ' TYR . . . . . 0.736 ' O ' ' C ' ' R' ' 184' ' ' ASP . 79.2 m-85 -58.99 175.47 0.28 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.464 -0.772 . . . . 28.010000000000002 110.522 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 184' ' ' ASP . . . . . 0.736 ' C ' ' O ' ' R' ' 183' ' ' TYR . 0.0 OUTLIER -13.05 -76.29 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.303 -0.873 . . . . 58.640000000000001 110.221 -178.029 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' R' R ' 185' ' ' GLN . . . . . . . . . . . . . 16.8 tm0? . . . . . 0 N--CA 1.503 2.217 0 CA-C-O 121.265 0.555 . . . . 80.420000000000002 111.773 179.171 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' R' R ' 193' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 120.873 0.368 . . . . 49.5 110.245 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 194' ' ' ALA . . . . . 0.63 ' HB3' ' HA ' ' R' ' 119' ' ' SER . . . -172.7 -142.04 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.162 -0.961 . . . . 40.399999999999999 110.136 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 195' ' ' LYS . . . . . . . . . . . . . 3.1 mtpm? -103.87 -52.07 3.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.316 -0.865 . . . . 34.600000000000001 110.324 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 196' ' ' VAL . . . . . 0.519 ' HB ' ' CB ' ' R' ' 119' ' ' SER . 30.2 t -89.71 56.27 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.254 -0.904 . . . . 33.270000000000003 110.64 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 197' ' ' GLN . . . . . 0.653 ' HB2' ' O ' ' R' ' 119' ' ' SER . 29.1 tp60 -155.98 -33.7 0.09 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.165 -0.959 . . . . 41.579999999999998 110.676 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 198' ' ' ARG . . . . . . . . . . . . . 21.0 mtm180 -62.03 158.88 15.47 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.175 -0.953 . . . . 38.649999999999999 110.219 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' R' R ' 199' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -104.69 68.99 0.87 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.453 -0.779 . . . . 36.770000000000003 109.925 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' R' R ' 200' ' ' LEU . . . . . 0.95 HD12 ' HG2' ' R' ' 201' ' ' LYS . 0.5 OUTLIER -53.52 178.07 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.425 -0.797 . . . . 33.079999999999998 110.176 -179.74 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' R' R ' 201' ' ' LYS . . . . . 0.95 ' HG2' HD12 ' R' ' 200' ' ' LEU . 10.4 mmmm . . . . . 0 N--CA 1.492 1.669 0 O-C-N 121.36 -0.837 . . . . 44.32 110.288 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' S' S ' 229' ' ' MET . . . . . . . . . . . . . 28.8 mtm . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.188 0.518 . . . . 51.829999999999998 110.235 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' S' S ' 230' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -97.34 142.69 28.9 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.409 -0.807 . . . . 54.130000000000003 110.195 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' S' S ' 231' ' ' LEU . . . . . . . . . . . . . 68.0 mt -134.02 141.02 47.06 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.413 -0.805 . . . . 33.039999999999999 110.344 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' S' S ' 232' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' S' ' 355' ' ' THR . 40.2 m -89.27 103.29 15.93 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.432 -0.792 . . . . 26.920000000000002 109.973 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 233' ' ' LEU . . . . . 0.667 HD22 ' CE2' ' S' ' 262' ' ' TYR . 79.7 mt -55.92 179.36 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.471 -0.768 . . . . 13.779999999999999 110.494 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 234' ' ' TYR . . . . . 0.44 ' CG ' ' N ' ' S' ' 235' ' ' ASN . 35.4 p90 -65.13 -35.61 81.67 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.355 -0.841 . . . . 26.079999999999998 110.17 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 235' ' ' ASN . . . . . 0.44 ' N ' ' CG ' ' S' ' 234' ' ' TYR . 50.7 p30 -74.3 -7.5 52.99 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.299 -0.876 . . . . 20.039999999999999 110.504 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 236' ' ' GLY . . . . . . . . . . . . . . . 95.8 -20.02 51.72 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.76 -1.336 . . . . 22.710000000000001 109.76 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' S' S ' 237' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -53.02 145.77 12.41 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.19 -1.182 . . . . 35.439999999999998 110.145 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' S' S ' 238' ' ' LYS . . . . . . . . . . . . . 44.3 mttt -102.18 127.87 48.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.395 -0.815 . . . . 32.560000000000002 110.362 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' S' S ' 239' ' ' LYS . . . . . 0.407 ' HG2' ' CZ ' ' S' ' 241' ' ' PHE . 8.9 ttmt -132.29 144.45 50.59 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.474 -0.766 . . . . 26.68 109.959 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 240' ' ' THR . . . . . . . . . . . . . 52.4 m -101.98 132.22 47.93 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.237 -0.915 . . . . 41.020000000000003 110.375 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' S' S ' 241' ' ' PHE . . . . . 0.407 ' CZ ' ' HG2' ' S' ' 239' ' ' LYS . 96.1 m-85 -117.95 137.75 52.63 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.348 -0.845 . . . . 28.620000000000001 110.203 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 242' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -96.47 161.78 13.76 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.38 -0.825 . . . . 47.890000000000001 110.149 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' S' S ' 243' ' ' SER . . . . . . . . . . . . . 72.1 m -90.59 151.62 21.23 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.31 -0.869 . . . . 45.090000000000003 110.211 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' S' S ' 244' ' ' ARG . . . . . . . . . . . . . 1.4 mtp85 -129.82 126.72 22.66 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.324 -0.86 . . . . 42.490000000000002 110.204 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' S' S ' 245' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.3 160.94 43.97 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 O-C-N 123.635 1.334 . . . . 35.68 110.559 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' S' S ' 246' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -132.82 97.84 4.15 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.327 -0.858 . . . . 51.880000000000003 109.871 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' S' S ' 247' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -110.49 -22.18 11.79 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.376 -0.828 . . . . 53.689999999999998 110.647 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' S' S ' 248' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -117.29 43.66 2.28 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.237 -0.914 . . . . 55.789999999999999 110.717 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' S' S ' 249' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 48.8 38.43 11.89 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.444 -0.785 . . . . 49.450000000000003 110.333 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' S' S ' 250' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -90.69 29.14 1.37 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.53 -0.731 . . . . 36.859999999999999 110.297 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' S' S ' 251' ' ' ALA . . . . . 0.588 ' HB3' ' CE ' ' R' ' 201' ' ' LYS . . . -53.9 -43.18 69.46 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.172 -0.955 . . . . 29.690000000000001 109.564 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 252' ' ' TRP . . . . . 0.428 ' CZ2' ' HB3' ' S' ' 294' ' ' LEU . 68.0 p-90 -61.81 -33.91 74.97 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.491 -0.755 . . . . 41.119999999999997 109.868 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 253' ' ' LEU . . . . . 0.406 ' N ' ' CD2' ' S' ' 252' ' ' TRP . 23.3 tp -70.14 -47.26 62.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.321 -0.862 . . . . 24.890000000000001 109.962 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 254' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -56.12 -42.49 76.94 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.343 -0.848 . . . . 35.649999999999999 109.991 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' S' S ' 255' ' ' ALA . . . . . . . . . . . . . . . -59.56 -48.24 82.44 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.439 -0.788 . . . . 22.73 110.046 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' S' S ' 256' ' ' ILE . . . . . 0.502 HG12 HD11 ' S' ' 304' ' ' ILE . 79.7 mt -62.22 -40.68 88.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.337 -0.852 . . . . 28.850000000000001 109.988 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 257' ' ' LEU . . . . . . . . . . . . . 19.1 mt -61.52 -44.51 96.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.356 -0.84 . . . . 23.07 110.162 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' S' S ' 258' ' ' GLN . . . . . 0.498 ' HB3' ' CD2' ' S' ' 351' ' ' PHE . 53.4 mm-40 -65.07 -45.37 85.55 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.422 -0.799 . . . . 29.780000000000001 109.87 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 259' ' ' LEU . . . . . 0.423 ' O ' HG22 ' S' ' 263' ' ' VAL . 19.9 tp -58.71 -36.34 74.09 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.331 -0.856 . . . . 17.940000000000001 109.452 179.215 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 260' ' ' PHE . . . . . 0.537 ' CE2' HD21 ' S' ' 311' ' ' LEU . 3.1 m-85 -62.84 -45.2 93.7 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.56 -0.713 . . . . 30.57 109.825 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 261' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -62.18 -29.79 70.62 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.475 -0.766 . . . . 41.340000000000003 109.901 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' S' S ' 262' ' ' TYR . . . . . 0.667 ' CE2' HD22 ' S' ' 233' ' ' LEU . 8.6 t80 -71.17 -44.69 65.0 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.435 -0.79 . . . . 26.030000000000001 110.129 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 263' ' ' VAL . . . . . 0.423 HG22 ' O ' ' S' ' 259' ' ' LEU . 33.1 m -92.0 18.29 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.352 -0.843 . . . . 22.800000000000001 110.384 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 264' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 52.72 70.69 0.55 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.206 -0.934 . . . . 44.030000000000001 110.641 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' S' S ' 265' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -111.82 109.24 55.36 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.375 -0.828 . . . . 35.609999999999999 109.649 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' S' S ' 266' ' ' PRO . . . . . 0.476 ' HA ' ' HB2' ' S' ' 269' ' ' ASP . 48.5 Cg_endo -75.33 0.46 9.01 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.631 1.332 . . . . 37.670000000000002 111.772 -179.102 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 267' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -56.56 -67.63 0.29 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.779 -1.201 . . . . 41.490000000000002 110.17 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 268' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -92.94 39.91 1.05 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.193 -0.942 . . . . 50.759999999999998 110.091 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' S' S ' 269' ' ' ASP . . . . . 0.476 ' HB2' ' HA ' ' S' ' 266' ' ' PRO . 0.9 OUTLIER -76.05 -33.1 59.6 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.417 -0.802 . . . . 61.859999999999999 109.816 179.546 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' S' S ' 270' ' ' TRP . . . . . 0.511 ' CE2' HG23 ' S' ' 271' ' ' VAL . 51.0 p-90 -73.98 -4.31 34.49 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.327 -0.858 . . . . 39.850000000000001 110.478 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 271' ' ' VAL . . . . . 0.511 HG23 ' CE2' ' S' ' 270' ' ' TRP . 46.6 t -109.56 -32.69 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.154 -0.966 . . . . 39.18 110.045 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 272' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -78.71 -36.49 43.34 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.365 -0.834 . . . . 40.020000000000003 110.518 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' S' S ' 273' ' ' SER . . . . . . . . . . . . . 71.2 m -103.52 56.17 0.74 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.317 -0.864 . . . . 47.200000000000003 110.345 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' S' S ' 274' ' ' SER . . . . . . . . . . . . . 6.9 t -133.13 141.19 39.9 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.334 -0.854 . . . . 47.609999999999999 110.12 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' S' S ' 275' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.65 -18.9 21.97 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.603 1.317 . . . . 45.280000000000001 110.603 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' S' S ' 276' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -99.94 140.9 33.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.248 -0.908 . . . . 57.270000000000003 110.272 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' S' S ' 277' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -71.71 97.67 1.8 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.48 -0.763 . . . . 37.280000000000001 110.263 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' S' S ' 278' ' ' LEU . . . . . . . . . . . . . 86.4 mt -96.98 33.77 1.85 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.484 -0.76 . . . . 43.880000000000003 110.003 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' S' S ' 279' ' ' THR . . . . . . . . . . . . . 75.3 m -64.05 -60.12 3.62 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.398 -0.814 . . . . 50.049999999999997 110.275 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' S' S ' 280' ' ' LEU . . . . . 0.736 ' HA ' HD12 ' S' ' 283' ' ' ILE . 13.7 mt -51.6 -39.77 58.58 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.301 -0.874 . . . . 54.119999999999997 110.334 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 281' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.49 -49.7 74.34 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.475 -0.766 . . . . 65.280000000000001 110.125 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 282' ' ' ALA . . . . . . . . . . . . . . . -58.89 -34.0 71.16 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.491 -0.756 . . . . 46.509999999999998 110.513 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' S' S ' 283' ' ' ILE . . . . . 0.736 HD12 ' HA ' ' S' ' 280' ' ' LEU . 85.5 mt -66.26 -50.91 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.242 -0.911 . . . . 47.299999999999997 110.149 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 284' ' ' LYS . . . . . . . . . . . . . 33.8 tttp -50.52 -57.52 7.92 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.414 -0.804 . . . . 50.719999999999999 110.476 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' S' S ' 285' ' ' GLN . . . . . 0.52 ' HG2' HD12 ' S' ' 289' ' ' LEU . 34.4 tt0 -51.43 -46.45 62.98 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.469 -0.77 . . . . 68.469999999999999 110.293 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 286' ' ' LEU . . . . . . . . . . . . . 19.2 mt -59.93 -44.49 94.3 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.426 -0.796 . . . . 36.619999999999997 110.26 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' S' S ' 287' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -62.8 -35.25 79.27 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.342 -0.849 . . . . 46.640000000000001 110.067 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' S' S ' 288' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -76.21 -21.04 56.9 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.382 -0.823 . . . . 46.450000000000003 110.329 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' S' S ' 289' ' ' LEU . . . . . 0.52 HD12 ' HG2' ' S' ' 285' ' ' GLN . 30.9 mt -97.24 -21.78 17.07 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.308 -0.87 . . . . 35.090000000000003 110.559 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 290' ' ' THR . . . . . 0.408 HG22 ' HB3' ' S' ' 306' ' ' ASN . 81.3 p -114.82 -28.47 7.06 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.275 -0.89 . . . . 38.609999999999999 110.367 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 291' ' ' GLY . . . . . . . . . . . . . . . 79.35 11.1 85.31 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.829 -1.308 . . . . 36.770000000000003 109.829 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' S' S ' 292' ' ' LEU . . . . . . . . . . . . . 84.6 mt -96.46 145.77 25.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.233 -1.157 . . . . 35.329999999999998 109.815 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' S' S ' 293' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -77.34 102.4 6.75 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.144 -0.973 . . . . 48.700000000000003 110.235 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' S' S ' 294' ' ' LEU . . . . . 0.428 ' HB3' ' CZ2' ' S' ' 252' ' ' TRP . 55.1 mt -106.89 51.73 0.73 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.498 -0.751 . . . . 42.609999999999999 110.128 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 295' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -112.56 -11.11 13.63 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.356 -0.84 . . . . 55.490000000000002 110.518 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 296' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -144.32 48.44 1.36 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.093 -1.004 . . . . 75.680000000000007 110.363 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' S' S ' 297' ' ' GLY . . . . . 0.827 ' HA3' ' C ' ' R' ' 201' ' ' LYS . . . 96.9 145.15 18.66 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.477 -1.449 . . . . 49.439999999999998 109.477 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 298' ' ' GLY . . . . . 0.67 ' N ' ' HB2' ' R' ' 201' ' ' LYS . . . -163.8 156.99 29.09 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.804 -1.318 . . . . 41.109999999999999 109.804 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 299' ' ' PRO . . . . . 0.569 ' HB3' HD21 ' R' ' 200' ' ' LEU . 47.4 Cg_endo -73.82 118.26 5.37 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 124.018 1.536 . . . . 26.199999999999999 110.32 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 300' ' ' PRO . . . . . 0.403 ' CD ' HD11 ' R' ' 200' ' ' LEU . 44.0 Cg_endo -71.26 -15.4 31.63 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.609 1.321 . . . . 21.699999999999999 110.736 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 301' ' ' ALA . . . . . . . . . . . . . . . -80.68 -29.44 36.57 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.237 -0.914 . . . . 31.23 110.129 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' S' S ' 302' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.45 -40.62 19.05 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.404 -0.81 . . . . 38.990000000000002 110.031 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 303' ' ' VAL . . . . . 0.491 HG23 ' O ' ' S' ' 299' ' ' PRO . 57.6 t -60.69 -35.53 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.36 -0.838 . . . . 18.629999999999999 110.135 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 304' ' ' ILE . . . . . 0.523 HD12 HG21 ' S' ' 379' ' ' VAL . 85.9 mt -79.36 -23.72 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.265 -0.897 . . . . 25.460000000000001 110.129 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 305' ' ' TRP . . . . . 0.415 ' CD2' ' HD3' ' S' ' 308' ' ' LYS . 68.7 t-105 -88.55 -14.6 37.29 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.261 -0.899 . . . . 33.399999999999999 110.588 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 306' ' ' ASN . . . . . 0.408 ' HB3' HG22 ' S' ' 290' ' ' THR . 10.4 m-80 -89.64 -13.65 36.63 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.204 -0.935 . . . . 36.969999999999999 110.403 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 307' ' ' ILE . . . . . 0.472 HG12 ' O ' ' S' ' 303' ' ' VAL . 36.8 pt -125.06 45.65 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.198 -0.939 . . . . 30.809999999999999 109.997 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 308' ' ' LYS . . . . . 0.415 ' HD3' ' CD2' ' S' ' 305' ' ' TRP . 1.5 mtmp? -73.52 -37.82 65.53 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.336 -0.852 . . . . 46.520000000000003 110.108 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 309' ' ' HIS . . . . . 0.498 ' CD2' ' HG ' ' S' ' 310' ' ' LEU . 55.5 p-80 -73.21 -8.26 55.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.331 -0.855 . . . . 51.030000000000001 110.078 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 310' ' ' LEU . . . . . 0.498 ' HG ' ' CD2' ' S' ' 309' ' ' HIS . 52.8 mt -99.31 -12.81 20.0 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.245 -0.909 . . . . 36.159999999999997 110.009 179.281 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 311' ' ' LEU . . . . . 0.537 HD21 ' CE2' ' S' ' 260' ' ' PHE . 10.8 mt -97.18 147.87 23.65 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.378 -0.826 . . . . 40.0 110.458 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 312' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -81.65 -16.25 52.0 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.363 -0.836 . . . . 54.18 109.722 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' S' S ' 313' ' ' THR . . . . . 0.82 HG23 ' HG2' ' S' ' 323' ' ' GLU . 92.6 m -87.92 151.65 22.66 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.386 -0.821 . . . . 25.609999999999999 110.119 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 314' ' ' GLY . . . . . . . . . . . . . . . -87.93 126.34 8.02 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.849 -1.3 . . . . 25.18 109.849 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' S' S ' 315' ' ' ILE . . . . . 0.667 HD13 ' HB ' ' S' ' 324' ' ' VAL . 50.7 mm -101.66 150.5 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.409 -1.053 . . . . 23.899999999999999 109.727 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 316' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' S' ' 325' ' ' CYS . . . -157.06 -159.29 9.39 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.928 -1.269 . . . . 23.18 109.928 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 317' ' ' THR . . . . . 0.424 HG22 ' CG2' ' S' ' 326' ' ' VAL . 11.1 p -133.87 -172.99 3.12 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.422 -1.046 . . . . 27.98 110.025 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.54 -56.25 24.33 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.215 -0.928 . . . . 28.100000000000001 109.908 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' S' S ' 319' ' ' SER . . . . . . . . . . . . . 1.2 m -59.91 -41.68 92.25 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.343 -0.848 . . . . 37.0 109.65 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' S' S ' 320' ' ' ARG . . . . . . . . . . . . . 12.2 mtm180 -111.7 79.95 2.67 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.438 -0.789 . . . . 52.07 109.646 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' S' S ' 321' ' ' PRO . . . . . 1.083 ' HG2' ' O ' ' S' ' 386' ' ' GLU . 43.6 Cg_endo -71.5 171.51 16.11 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.772 1.406 . . . . 38.289999999999999 110.867 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 322' ' ' SER . . . . . 0.447 ' HB2' ' O ' ' S' ' 321' ' ' PRO . 41.3 t 178.69 -148.1 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.907 -0.775 . . . . 38.840000000000003 108.907 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 323' ' ' GLU . . . . . 0.82 ' HG2' HG23 ' S' ' 313' ' ' THR . 6.7 tp10 -62.86 -40.26 96.96 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.048 -1.033 . . . . 40.700000000000003 109.707 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 324' ' ' VAL . . . . . 0.667 ' HB ' HD13 ' S' ' 315' ' ' ILE . 72.7 t -141.33 135.01 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.411 -0.806 . . . . 20.34 109.49 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 325' ' ' CYS . . . . . 0.463 ' HB2' ' CE1' ' S' ' 380' ' ' PHE . 11.3 m -125.94 172.22 10.1 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.323 -0.861 . . . . 30.629999999999999 110.84 -179.053 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 326' ' ' VAL . . . . . 0.646 HG12 HG22 ' S' ' 379' ' ' VAL . 34.6 m -135.53 142.26 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 109.186 -0.672 . . . . 23.899999999999999 109.186 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 327' ' ' VAL . . . . . 0.594 HG11 ' O ' ' S' ' 377' ' ' VAL . 34.5 m -56.41 125.01 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.096 -1.002 . . . . 19.48 110.419 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 328' ' ' ASP . . . . . . . . . . . . . 55.5 p-10 -119.43 11.54 12.18 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.461 -0.774 . . . . 26.43 110.445 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' S' S ' 329' ' ' GLY . . . . . . . . . . . . . . . 119.69 2.27 13.05 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.041 -1.223 . . . . 31.239999999999998 110.041 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' S' S ' 330' ' ' THR . . . . . . . . . . . . . 80.1 m -93.04 129.99 38.79 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.117 -1.225 . . . . 30.050000000000001 110.107 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' S' S ' 331' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -56.68 111.47 1.02 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.311 -0.868 . . . . 37.259999999999998 110.011 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' S' S ' 332' ' ' MET . . . . . . . . . . . . . 88.0 mmm -94.1 162.57 13.82 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.234 -0.916 . . . . 26.23 110.356 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' S' S ' 333' ' ' CYS . . . . . . . . . . . . . 25.6 m -137.24 150.01 47.55 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.513 -0.742 . . . . 23.559999999999999 110.015 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' S' S ' 334' ' ' LEU . . . . . 0.563 HD11 ' O ' ' S' ' 372' ' ' PRO . 0.1 OUTLIER -52.57 -24.82 8.96 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.342 -0.849 . . . . 28.93 110.488 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' S' S ' 335' ' ' ALA . . . . . . . . . . . . . . . -89.12 14.52 10.58 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.427 -0.796 . . . . 15.76 110.942 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' S' S ' 336' ' ' ASP . . . . . 0.404 ' O ' ' HA ' ' S' ' 382' ' ' PRO . 70.9 m-20 -100.45 -17.28 17.25 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.164 -0.96 . . . . 34.920000000000002 110.242 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 337' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -152.36 170.88 19.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.329 -0.857 . . . . 19.030000000000001 110.072 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' S' S ' 338' ' ' HIS . . . . . 0.401 ' HB3' ' CZ ' ' S' ' 383' ' ' TYR . 13.5 p80 -120.71 10.47 11.0 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.356 -0.84 . . . . 18.82 110.508 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 339' ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' S' ' 352' ' ' ALA . . . -176.0 155.18 1.56 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.193 -0.942 . . . . 17.18 110.079 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 340' ' ' GLY . . . . . 0.402 ' HA3' ' O ' ' S' ' 379' ' ' VAL . . . 160.82 173.05 28.93 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.089 -1.204 . . . . 18.329999999999998 110.089 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 341' ' ' ILE . . . . . . . . . . . . . 83.9 mt -88.76 138.07 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.493 -1.004 . . . . 18.600000000000001 109.864 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' S' S ' 342' ' ' PHE . . . . . 0.489 ' CE2' ' HB3' ' S' ' 352' ' ' ALA . 70.0 m-85 -120.94 -178.43 3.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.195 -0.941 . . . . 23.440000000000001 110.444 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 343' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.91 93.37 4.17 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.44 -0.787 . . . . 35.590000000000003 110.001 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 344' ' ' LYS . . . . . 0.4 ' O ' ' HB3' ' S' ' 348' ' ' HIS . 0.3 OUTLIER -80.86 125.09 29.67 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.334 -0.854 . . . . 38.340000000000003 109.999 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' S' S ' 345' ' ' GLY . . . . . . . . . . . . . . . 62.71 -130.83 43.26 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 108.928 -1.669 . . . . 53.460000000000001 108.928 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' S' S ' 346' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -132.72 150.9 52.1 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.23 -1.159 . . . . 70.909999999999997 110.018 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' S' S ' 347' ' ' GLU . . . . . 0.543 ' O ' ' HD2' ' R' ' 201' ' ' LYS . 18.0 mt-10 53.26 35.44 20.1 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.319 -0.863 . . . . 47.32 110.442 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 348' ' ' HIS . . . . . 0.4 ' HB3' ' O ' ' S' ' 344' ' ' LYS . 46.9 t60 -150.16 155.83 40.5 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.383 -0.823 . . . . 41.719999999999999 110.36 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 349' ' ' ALA . . . . . 0.458 ' C ' HG13 ' S' ' 350' ' ' VAL . . . -149.79 151.25 33.26 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.427 -0.796 . . . . 22.91 110.481 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 350' ' ' VAL . . . . . 0.458 HG13 ' C ' ' S' ' 349' ' ' ALA . 34.6 m -148.99 169.66 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.534 -0.729 . . . . 21.09 110.072 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 351' ' ' PHE . . . . . 0.498 ' CD2' ' HB3' ' S' ' 258' ' ' GLN . 10.7 t80 -105.44 143.54 33.46 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.246 -0.909 . . . . 25.030000000000001 110.709 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 352' ' ' ALA . . . . . 0.489 ' HB3' ' CE2' ' S' ' 342' ' ' PHE . . . -147.66 151.69 36.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.634 -0.666 . . . . 23.809999999999999 109.766 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 353' ' ' CYS . . . . . . . . . . . . . 26.3 p -153.3 164.9 37.29 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.341 -0.849 . . . . 25.66 110.315 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' S' S ' 354' ' ' VAL . . . . . 0.551 HG22 ' CE2' ' S' ' 359' ' ' TRP . 57.5 t -76.05 118.52 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.359 -0.838 . . . . 34.270000000000003 109.904 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 355' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' S' ' 232' ' ' THR . 51.7 p -117.91 175.15 5.8 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.298 -0.876 . . . . 25.489999999999998 110.283 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 356' ' ' SER . . . . . . . . . . . . . 62.3 p -62.12 -17.75 58.7 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.393 -0.817 . . . . 31.239999999999998 110.731 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' S' S ' 357' ' ' ASN . . . . . . . . . . . . . 46.0 m-20 -106.98 14.16 26.77 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.104 -0.997 . . . . 28.609999999999999 110.559 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' S' S ' 358' ' ' GLY . . . . . . . . . . . . . . . 111.88 -152.9 17.6 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 110.005 -1.238 . . . . 22.010000000000002 110.005 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' S' S ' 359' ' ' TRP . . . . . 0.551 ' CE2' HG22 ' S' ' 354' ' ' VAL . 15.5 m95 -91.22 116.63 28.97 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.446 -1.032 . . . . 25.539999999999999 110.273 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 360' ' ' TYR . . . . . 0.42 ' HA ' ' HA ' ' S' ' 369' ' ' PRO . 1.3 m-85 -103.47 165.81 10.81 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.375 -0.828 . . . . 40.530000000000001 110.104 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 361' ' ' ALA . . . . . 0.426 ' HA ' ' O ' ' S' ' 351' ' ' PHE . . . -140.04 130.07 24.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.379 -0.826 . . . . 18.039999999999999 110.297 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 362' ' ' ILE . . . . . . . . . . . . . 88.7 mt -95.63 83.62 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.415 -0.803 . . . . 15.640000000000001 110.065 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' S' S ' 363' ' ' ASP . . . . . 0.416 ' O ' ' N ' ' S' ' 365' ' ' GLU . 11.8 t0 -75.2 94.43 2.96 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.334 -0.854 . . . . 35.030000000000001 110.216 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 364' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 54.01 -89.34 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.493 -0.754 . . . . 46.719999999999999 110.508 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' S' S ' 365' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' S' ' 363' ' ' ASP . 23.7 mt-10 -122.68 19.09 10.33 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.081 -1.012 . . . . 56.200000000000003 110.202 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 366' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -117.97 125.04 49.64 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.217 -0.927 . . . . 51.020000000000003 110.342 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' S' S ' 367' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -106.99 127.12 53.17 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.392 -0.817 . . . . 37.590000000000003 110.093 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' S' S ' 368' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -165.49 159.58 13.8 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.323 -0.861 . . . . 31.469999999999999 110.423 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' S' S ' 369' ' ' PRO . . . . . 0.42 ' HA ' ' HA ' ' S' ' 360' ' ' TYR . 46.5 Cg_endo -72.92 139.61 30.44 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 O-C-N 123.85 1.447 . . . . 28.850000000000001 110.497 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 370' ' ' TRP . . . . . . . . . . . . . 67.5 t90 -167.19 113.57 0.77 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.408 -0.807 . . . . 26.940000000000001 109.936 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' S' S ' 371' ' ' THR . . . . . . . . . . . . . 59.3 m -74.8 113.04 20.59 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.372 -0.83 . . . . 20.190000000000001 110.02 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' S' S ' 372' ' ' PRO . . . . . 0.563 ' O ' HD11 ' S' ' 334' ' ' LEU . 47.9 Cg_endo -73.49 157.06 49.55 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 O-C-N 123.578 1.304 . . . . 28.68 110.597 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 373' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -90.64 147.18 35.72 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.423 -0.798 . . . . 35.719999999999999 109.87 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' S' S ' 374' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -76.04 -6.25 17.15 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 O-C-N 123.713 1.375 . . . . 30.890000000000001 110.465 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' S' S ' 375' ' ' SER . . . . . . . . . . . . . 68.2 p -104.36 -17.0 14.97 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.297 -0.877 . . . . 29.41 110.46 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' S' S ' 376' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -106.5 43.0 1.19 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.299 -0.876 . . . . 32.890000000000001 110.256 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' S' S ' 377' ' ' VAL . . . . . 0.594 ' O ' HG11 ' S' ' 327' ' ' VAL . 7.4 p -114.62 147.25 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.348 -0.845 . . . . 24.329999999999998 110.26 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 378' ' ' LEU . . . . . . . . . . . . . 53.0 mt -116.05 -57.93 2.16 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.456 -0.778 . . . . 24.370000000000001 109.573 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' S' S ' 379' ' ' VAL . . . . . 0.646 HG22 HG12 ' S' ' 326' ' ' VAL . 61.5 t -120.73 132.39 70.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.454 -0.779 . . . . 18.02 109.409 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 380' ' ' PHE . . . . . 0.463 ' CE1' ' HB2' ' S' ' 325' ' ' CYS . 14.5 p90 -142.59 173.94 11.09 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.38 -0.825 . . . . 29.350000000000001 110.646 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 381' ' ' VAL . . . . . . . . . . . . . 57.8 t -120.02 107.35 39.94 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.486 -0.759 . . . . 16.34 109.412 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' S' S ' 382' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' S' ' 336' ' ' ASP . 45.4 Cg_endo -71.38 145.67 48.61 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 O-C-N 123.636 1.335 . . . . 20.940000000000001 110.762 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 383' ' ' TYR . . . . . 0.401 ' CZ ' ' HB3' ' S' ' 338' ' ' HIS . 88.0 m-85 -61.12 -53.45 56.86 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.344 -0.848 . . . . 28.93 109.825 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 384' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -99.65 125.06 45.42 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.431 -0.793 . . . . 47.030000000000001 110.332 -176.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' S' S ' 385' ' ' GLN . . . . . 0.413 ' O ' ' O ' ' S' ' 386' ' ' GLU . 3.2 pt20 -67.82 2.68 1.83 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.46 -0.775 . . . . 46.689999999999998 110.158 177.413 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 386' ' ' GLU . . . . . 1.083 ' O ' ' HG2' ' S' ' 321' ' ' PRO . 2.9 mt-10 -47.83 171.68 0.08 OUTLIER Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.43 -0.794 . . . . 50.25 109.525 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 387' ' ' PRO . . . . . 0.568 ' O ' ' C ' ' S' ' 388' ' ' LEU . 51.3 Cg_endo -71.55 -10.19 26.35 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 O-C-N 123.66 1.347 . . . . 34.390000000000001 110.621 -177.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 388' ' ' LEU . . . . . 0.616 ' O ' ' HB2' ' S' ' 389' ' ' ASN . 59.5 mt 31.05 85.19 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.393 -0.817 . . . . 38.009999999999998 110.105 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 389' ' ' ASN . . . . . 0.616 ' HB2' ' O ' ' S' ' 388' ' ' LEU . 22.9 m-20 71.26 170.52 0.32 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.375 -0.828 . . . . 45.82 110.131 -179.119 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 390' ' ' GLY . . . . . 0.489 ' O ' ' CB ' ' S' ' 391' ' ' GLU . . . 147.15 -87.28 0.16 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.6 -1.4 . . . . 33.460000000000001 109.6 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 391' ' ' GLU . . . . . 0.489 ' CB ' ' O ' ' S' ' 390' ' ' GLY . 0.9 OUTLIER 68.23 -63.84 0.32 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.322 -1.105 . . . . 56.579999999999998 110.116 179.834 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' S' S ' 392' ' ' TRP . . . . . 0.446 ' N ' ' O ' ' S' ' 390' ' ' GLY . 1.6 m-90 -48.84 -26.1 2.24 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.322 -0.861 . . . . 31.43 110.401 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 393' ' ' LYS . . . . . 0.72 ' O ' HG12 ' S' ' 396' ' ' VAL . 16.6 ttpt -51.96 -60.22 3.43 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.376 -0.828 . . . . 39.420000000000002 110.411 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 394' ' ' ALA . . . . . 0.404 ' O ' ' HG2' ' S' ' 398' ' ' ARG . . . -68.72 -12.23 61.18 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.296 -0.878 . . . . 34.329999999999998 110.135 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 395' ' ' LYS . . . . . 0.561 ' CG ' HD13 ' R' ' 143' ' ' LEU . 0.0 OUTLIER -86.94 -22.62 25.51 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.362 -0.836 . . . . 60.090000000000003 110.29 179.74 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' S' S ' 396' ' ' VAL . . . . . 0.997 ' O ' ' HA ' ' R' ' 99' ' ' PRO . 8.9 p -94.87 -28.64 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.356 -0.84 . . . . 35.5 110.533 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 397' ' ' GLN . . . . . 0.424 ' O ' ' CG ' ' S' ' 397' ' ' GLN . 1.5 pt20 -109.95 96.29 6.14 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.18 -0.95 . . . . 49.960000000000001 110.657 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 398' ' ' ARG . . . . . 0.789 ' CB ' ' HA ' ' R' ' 147' ' ' GLU . 10.2 mmt180 -149.11 170.66 17.91 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.318 -0.864 . . . . 43.420000000000002 110.739 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 399' ' ' LYS . . . . . 0.631 ' C ' ' H ' ' S' ' 401' ' ' LYS . 0.6 OUTLIER -57.58 -86.6 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.36 -0.838 . . . . 55.310000000000002 110.108 -179.207 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' S' S ' 400' ' ' LEU . . . . . 0.588 ' O ' ' HA ' ' R' ' 148' ' ' HIS . 2.6 mt -60.59 15.65 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.352 -0.843 . . . . 41.030000000000001 110.352 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' S' S ' 401' ' ' LYS . . . . . 0.685 ' HE2' ' HA ' ' S' ' 401' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.331 -0.856 . . . . 61.969999999999999 110.216 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.28 0.562 . . . . 32.140000000000001 110.246 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 30' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -96.31 141.18 29.95 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.277 -0.889 . . . . 43.359999999999999 110.262 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 31' ' ' LEU . . . . . . . . . . . . . 65.6 mt -134.91 140.58 45.87 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.312 -0.867 . . . . 22.93 110.268 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 32' ' ' THR . . . . . . . . . . . . . 69.3 m -87.55 110.57 20.45 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.319 -0.863 . . . . 22.34 109.984 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 33' ' ' LEU . . . . . 0.594 HD22 ' CE2' ' R' ' 62' ' ' TYR . 80.1 mt -62.38 -172.76 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.299 -0.876 . . . . 21.390000000000001 110.202 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 34' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -74.6 -29.49 61.33 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.333 -0.855 . . . . 34.399999999999999 110.365 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 35' ' ' ASN . . . . . . . . . . . . . 48.3 p30 -77.72 -1.89 33.46 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.384 -0.822 . . . . 30.280000000000001 110.649 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.28 -16.55 59.53 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.698 -1.361 . . . . 36.25 109.698 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 37' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -59.04 161.77 4.82 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.338 -1.095 . . . . 53.799999999999997 110.368 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 38' ' ' LYS . . . . . . . . . . . . . 57.1 mttt -117.78 135.73 53.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.393 -0.817 . . . . 49.909999999999997 110.181 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 39' ' ' LYS . . . . . 0.405 ' HG2' ' CZ ' ' R' ' 41' ' ' PHE . 8.1 ttmt -138.68 143.74 39.29 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.423 -0.798 . . . . 35.689999999999998 110.198 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 40' ' ' THR . . . . . . . . . . . . . 23.6 m -102.63 128.05 49.47 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.343 -0.848 . . . . 34.840000000000003 110.188 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 41' ' ' PHE . . . . . 0.405 ' CZ ' ' HG2' ' R' ' 39' ' ' LYS . 96.6 m-85 -113.08 132.64 55.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.381 -0.824 . . . . 34.420000000000002 110.14 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 42' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -93.32 140.9 29.04 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.366 -0.834 . . . . 51.460000000000001 110.215 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 43' ' ' SER . . . . . . . . . . . . . 54.6 m -70.76 141.92 51.42 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.397 -0.815 . . . . 41.840000000000003 110.187 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.8 125.34 29.6 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.305 -0.872 . . . . 33.82 109.978 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 45' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.15 151.05 54.79 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.517 1.272 . . . . 30.27 110.649 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 46' ' ' ASN . . . . . 0.4 ' HA ' ' OD1' ' R' ' 50' ' ' ASN . 52.1 t-20 -124.24 109.92 13.99 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.456 -0.777 . . . . 35.100000000000001 109.989 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 47' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -120.27 -34.93 3.54 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.325 -0.859 . . . . 42.810000000000002 110.545 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 48' ' ' HIS . . . . . 0.439 ' NE2' HD11 ' R' ' 80' ' ' LEU . 73.2 m80 -105.74 45.16 0.98 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.181 -0.949 . . . . 49.969999999999999 110.275 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 49' ' ' ASP . . . . . 0.545 ' CB ' ' HA ' ' S' ' 401' ' ' LYS . 37.5 m-20 50.35 34.65 9.32 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.432 -0.793 . . . . 61.32 110.182 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 50' ' ' ASN . . . . . 0.4 ' OD1' ' HA ' ' R' ' 46' ' ' ASN . 15.0 p-10 -86.22 43.81 1.09 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.349 -0.844 . . . . 51.5 110.661 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 51' ' ' ALA . . . . . 0.883 ' HB3' ' CB ' ' S' ' 400' ' ' LEU . . . -66.14 -46.08 78.73 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.225 -0.922 . . . . 38.770000000000003 109.539 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 52' ' ' TRP . . . . . 0.893 ' CA ' HD22 ' S' ' 400' ' ' LEU . 68.2 p-90 -58.37 -38.42 77.21 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.419 -0.801 . . . . 26.239999999999998 110.082 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 53' ' ' LEU . . . . . 0.483 ' N ' ' CD2' ' R' ' 52' ' ' TRP . 23.0 tp -66.71 -46.71 74.65 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.456 -0.777 . . . . 26.75 109.939 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 54' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -55.18 -41.68 72.24 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.321 -0.862 . . . . 35.020000000000003 110.128 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.19 -46.03 92.14 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.4 -0.812 . . . . 24.469999999999999 110.189 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 56' ' ' ILE . . . . . 0.431 HG12 HD11 ' R' ' 104' ' ' ILE . 76.3 mt -62.14 -42.25 94.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.332 -0.855 . . . . 26.030000000000001 109.937 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 57' ' ' LEU . . . . . . . . . . . . . 22.4 mt -60.3 -45.67 92.57 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.299 -0.876 . . . . 26.77 109.661 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 58' ' ' GLN . . . . . . . . . . . . . 57.9 mm-40 -63.92 -46.48 84.59 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.481 -0.762 . . . . 22.32 109.594 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 59' ' ' LEU . . . . . 0.429 ' HA ' ' HE2' ' R' ' 151' ' ' PHE . 23.9 tp -61.43 -37.73 84.6 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.306 -0.871 . . . . 20.550000000000001 109.396 179.295 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 60' ' ' PHE . . . . . 0.528 ' CE2' HD21 ' R' ' 111' ' ' LEU . 2.8 m-85 -61.08 -44.76 96.88 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.664 -0.648 . . . . 20.079999999999998 109.927 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 61' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -63.1 -36.17 82.71 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.479 -0.763 . . . . 18.800000000000001 110.486 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 62' ' ' TYR . . . . . 0.594 ' CE2' HD22 ' R' ' 33' ' ' LEU . 9.1 t80 -63.11 -41.76 99.41 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.266 -0.896 . . . . 26.449999999999999 110.226 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 63' ' ' VAL . . . . . 0.406 ' H ' HG22 ' R' ' 63' ' ' VAL . 30.5 m -93.4 20.45 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.295 -0.878 . . . . 29.75 110.218 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 64' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 52.87 75.58 0.23 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.344 -0.848 . . . . 35.520000000000003 110.58 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 65' ' ' GLU . . . . . 0.443 ' HG2' ' CD2' ' R' ' 60' ' ' PHE . 14.2 tp10 -116.29 104.07 52.33 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.377 -0.827 . . . . 29.890000000000001 109.888 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 66' ' ' PRO . . . . . 0.481 ' HA ' ' HB2' ' R' ' 69' ' ' ASP . 46.9 Cg_endo -73.53 -5.86 17.79 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 123.806 1.424 . . . . 21.370000000000001 111.124 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 67' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -52.09 -61.52 2.21 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.144 -0.973 . . . . 23.850000000000001 110.375 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 68' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -98.11 36.53 1.56 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.326 -0.859 . . . . 28.07 110.475 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 69' ' ' ASP . . . . . 0.481 ' HB2' ' HA ' ' R' ' 66' ' ' PRO . 11.7 t0 -72.3 -33.31 67.31 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.382 -0.824 . . . . 43.759999999999998 110.169 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 70' ' ' TRP . . . . . 0.477 ' CE2' ' CG2' ' R' ' 71' ' ' VAL . 47.9 p-90 -73.34 -3.88 29.9 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.313 -0.867 . . . . 33.060000000000002 110.705 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 71' ' ' VAL . . . . . 0.555 HG11 ' HB2' ' R' ' 82' ' ' ALA . 40.8 t -109.79 -27.48 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.132 -0.98 . . . . 31.699999999999999 109.717 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 72' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -86.56 -48.79 8.05 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.381 -0.824 . . . . 33.579999999999998 110.312 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 73' ' ' SER . . . . . . . . . . . . . 70.1 m -89.78 51.13 2.01 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.292 -0.88 . . . . 50.82 110.284 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 74' ' ' SER . . . . . . . . . . . . . 15.8 t -125.95 138.3 31.8 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.348 -0.845 . . . . 34.740000000000002 110.168 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.36 -25.01 15.92 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 O-C-N 123.669 1.352 . . . . 35.700000000000003 110.319 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 76' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -91.7 153.16 19.85 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.437 -0.789 . . . . 66.480000000000004 110.342 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 77' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -81.51 95.16 7.03 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.374 -0.829 . . . . 46.719999999999999 110.091 179.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 78' ' ' LEU . . . . . . . . . . . . . 96.4 mt -96.41 27.97 3.53 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.464 -0.772 . . . . 37.549999999999997 110.167 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 79' ' ' THR . . . . . . . . . . . . . 29.6 m -56.19 -54.56 43.76 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.27 -0.894 . . . . 37.359999999999999 110.312 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 80' ' ' LEU . . . . . 0.602 ' HA ' HD12 ' R' ' 83' ' ' ILE . 15.8 mt -60.93 -23.23 65.12 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.348 -0.845 . . . . 35.829999999999998 110.46 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 81' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -79.5 -39.18 32.67 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.209 -0.932 . . . . 44.030000000000001 110.298 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 82' ' ' ALA . . . . . 0.555 ' HB2' HG11 ' R' ' 71' ' ' VAL . . . -69.43 -28.68 66.33 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.187 -0.945 . . . . 32.539999999999999 110.159 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 83' ' ' ILE . . . . . 0.602 HD12 ' HA ' ' R' ' 80' ' ' LEU . 78.3 mt -70.16 -45.99 73.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.307 -0.87 . . . . 32.020000000000003 110.3 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 84' ' ' LYS . . . . . . . . . . . . . 36.0 tttm -55.22 -52.08 64.52 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.179 -0.951 . . . . 34.090000000000003 110.596 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 85' ' ' GLN . . . . . 0.533 ' HG2' HD12 ' R' ' 89' ' ' LEU . 31.9 tt0 -54.81 -46.83 74.57 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.224 -0.923 . . . . 25.940000000000001 110.301 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 86' ' ' LEU . . . . . . . . . . . . . 24.0 mt -58.66 -43.88 90.0 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.312 -0.867 . . . . 16.199999999999999 109.878 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 87' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -65.36 -35.21 80.28 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.442 -0.786 . . . . 49.090000000000003 110.28 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 88' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -78.43 -19.04 54.07 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.247 -0.908 . . . . 28.609999999999999 110.493 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 89' ' ' LEU . . . . . 0.533 HD12 ' HG2' ' R' ' 85' ' ' GLN . 32.6 mt -96.21 -29.37 14.07 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.188 -0.945 . . . . 26.16 110.201 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 90' ' ' THR . . . . . . . . . . . . . 59.8 p -105.69 -34.6 7.66 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.211 -0.931 . . . . 33.329999999999998 109.795 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.78 16.06 58.75 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.857 -1.297 . . . . 31.129999999999999 109.857 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 92' ' ' LEU . . . . . . . . . . . . . 97.0 mt -100.07 155.24 17.83 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.141 -1.211 . . . . 42.520000000000003 110.281 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 93' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -86.17 91.54 8.47 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.485 -0.759 . . . . 68.459999999999994 109.99 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 94' ' ' LEU . . . . . 0.458 ' HB3' ' CZ2' ' R' ' 52' ' ' TRP . 47.8 mt -99.46 53.04 0.94 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.162 -0.961 . . . . 44.630000000000003 110.342 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 95' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.48 -38.68 6.38 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.332 -0.855 . . . . 67.159999999999997 110.381 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 96' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -113.96 44.25 1.68 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.392 -0.818 . . . . 67.019999999999996 110.254 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 97' ' ' GLY . . . . . 0.52 ' HA3' ' HA ' ' S' ' 399' ' ' LYS . . . 99.2 150.83 26.02 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.599 -1.401 . . . . 49.479999999999997 109.599 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 98' ' ' GLY . . . . . . . . . . . . . . . -166.23 160.03 33.46 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.253 -1.539 . . . . 36.57 109.253 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 99' ' ' PRO . . . . . 0.792 ' O ' HG23 ' R' ' 103' ' ' VAL . 45.7 Cg_endo -72.54 121.09 7.14 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.641 1.337 . . . . 30.41 110.492 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 100' ' ' PRO . . . . . 0.413 ' HA ' HD11 ' R' ' 56' ' ' ILE . 45.8 Cg_endo -72.33 -31.57 11.38 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.678 1.357 . . . . 29.940000000000001 110.492 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 101' ' ' ALA . . . . . 0.53 ' HB3' HG23 ' S' ' 396' ' ' VAL . . . -70.0 -38.51 75.98 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.357 -0.839 . . . . 23.640000000000001 110.227 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 102' ' ' LEU . . . . . 0.424 HD23 HD21 ' R' ' 106' ' ' ASN . 0.1 OUTLIER -72.67 -40.72 66.09 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.377 -0.827 . . . . 20.309999999999999 110.353 -179.696 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' R' R ' 103' ' ' VAL . . . . . 0.792 HG23 ' O ' ' R' ' 99' ' ' PRO . 63.9 t -58.14 -40.13 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.185 -0.947 . . . . 16.329999999999998 109.986 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 104' ' ' ILE . . . . . 0.431 HD11 HG12 ' R' ' 56' ' ' ILE . 82.1 mt -71.71 -30.54 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.399 -0.813 . . . . 24.77 109.899 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 105' ' ' TRP . . . . . 0.462 ' O ' ' HD3' ' R' ' 108' ' ' LYS . 70.5 t-105 -82.41 0.88 40.02 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.292 -0.88 . . . . 23.280000000000001 110.31 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 106' ' ' ASN . . . . . 0.424 HD21 HD23 ' R' ' 102' ' ' LEU . 6.9 m-80 -105.08 -10.42 17.18 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.152 -0.967 . . . . 28.260000000000002 110.043 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 107' ' ' ILE . . . . . . . . . . . . . 36.7 pt -126.81 34.96 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.225 -0.922 . . . . 18.77 110.047 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 108' ' ' LYS . . . . . 0.501 ' HG2' ' HB ' ' R' ' 115' ' ' ILE . 9.2 mtpp -61.03 -48.43 81.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.565 -0.709 . . . . 42.5 110.055 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 109' ' ' HIS . . . . . 0.445 ' CD2' ' HG ' ' R' ' 110' ' ' LEU . 50.7 p-80 -66.06 -12.84 58.12 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.461 -0.774 . . . . 20.07 110.646 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 110' ' ' LEU . . . . . 0.445 ' HG ' ' CD2' ' R' ' 109' ' ' HIS . 80.6 mt -94.84 -17.21 22.29 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.115 -0.991 . . . . 15.69 110.181 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 111' ' ' LEU . . . . . 0.528 HD21 ' CE2' ' R' ' 60' ' ' PHE . 10.3 mt -94.19 144.16 25.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.376 -0.827 . . . . 25.390000000000001 110.971 -179.151 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 112' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -77.73 -17.33 57.71 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.525 -0.734 . . . . 53.479999999999997 109.811 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 113' ' ' THR . . . . . 0.459 HG22 ' N ' ' R' ' 114' ' ' GLY . 60.3 m -83.76 166.6 17.88 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.355 -0.841 . . . . 14.800000000000001 110.22 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 114' ' ' GLY . . . . . 0.459 ' N ' HG22 ' R' ' 113' ' ' THR . . . -97.94 127.14 9.13 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.995 -1.242 . . . . 16.140000000000001 109.995 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 115' ' ' ILE . . . . . 0.579 HD13 ' HB ' ' R' ' 124' ' ' VAL . 48.0 mm -109.13 139.32 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.54 -0.976 . . . . 13.460000000000001 109.645 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 116' ' ' GLY . . . . . . . . . . . . . . . -152.71 -155.83 7.28 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.955 -1.258 . . . . 23.899999999999999 109.955 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 117' ' ' THR . . . . . 0.529 HG22 ' CG2' ' R' ' 126' ' ' VAL . 18.9 p -134.99 -171.4 2.79 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.467 -1.019 . . . . 27.370000000000001 110.152 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 118' ' ' ALA . . . . . 0.447 ' HB3' ' OD1' ' R' ' 128' ' ' ASP . . . -56.52 -58.07 9.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.338 -0.851 . . . . 18.760000000000002 110.091 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 119' ' ' SER . . . . . 0.476 ' OG ' ' HB ' ' R' ' 196' ' ' VAL . 1.1 m -56.59 -40.51 75.4 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.332 -0.855 . . . . 32.350000000000001 109.784 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 120' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 -110.09 86.2 4.86 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.456 -0.777 . . . . 27.120000000000001 109.708 179.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 121' ' ' PRO . . . . . 0.481 ' HA ' ' SG ' ' R' ' 125' ' ' CYS . 44.6 Cg_endo -71.21 166.4 29.34 Favored 'Trans proline' 0 C--N 1.311 -1.419 0 O-C-N 123.799 1.42 . . . . 22.68 111.086 -179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 122' ' ' SER . . . . . 0.437 ' HB2' ' O ' ' R' ' 121' ' ' PRO . 38.3 t 178.61 -161.69 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.619 -0.675 . . . . 22.989999999999998 109.436 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 123' ' ' GLU . . . . . 0.441 ' HG2' HG23 ' R' ' 113' ' ' THR . 2.3 tp10 -56.38 -40.03 73.92 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.192 -0.943 . . . . 36.18 109.724 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 124' ' ' VAL . . . . . 0.579 ' HB ' HD13 ' R' ' 115' ' ' ILE . 82.6 t -142.51 136.5 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.506 -0.746 . . . . 20.640000000000001 109.39 179.31 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 125' ' ' CYS . . . . . 0.481 ' SG ' ' HA ' ' R' ' 121' ' ' PRO . 83.4 m -140.37 168.17 20.43 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.219 -0.925 . . . . 22.800000000000001 111.131 -179.314 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 126' ' ' VAL . . . . . 0.727 HG12 HG22 ' R' ' 179' ' ' VAL . 35.8 m -122.72 159.77 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.724 -0.61 . . . . 21.239999999999998 109.695 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 127' ' ' VAL . . . . . 0.708 HG11 ' O ' ' R' ' 177' ' ' VAL . 30.5 m -70.81 141.86 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.273 -0.892 . . . . 19.77 110.708 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 128' ' ' ASP . . . . . 0.447 ' OD1' ' HB3' ' R' ' 118' ' ' ALA . 53.9 p-10 -137.73 19.41 2.87 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.336 -0.853 . . . . 29.210000000000001 110.697 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 129' ' ' GLY . . . . . . . . . . . . . . . 114.01 -0.05 24.13 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.963 -1.113 . . . . 33.859999999999999 110.503 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 130' ' ' THR . . . . . . . . . . . . . 58.5 m -91.84 131.81 36.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.12 -1.223 . . . . 26.41 110.117 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -62.52 120.65 11.54 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.372 -0.83 . . . . 33.079999999999998 110.302 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 132' ' ' MET . . . . . 0.433 ' HE1' ' CE2' ' R' ' 180' ' ' PHE . 98.4 mmm -105.12 165.63 10.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.437 -0.79 . . . . 30.760000000000002 110.467 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 133' ' ' CYS . . . . . 0.409 ' HA ' ' HB3' ' R' ' 174' ' ' PRO . 32.4 m -141.12 158.13 44.34 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.511 -0.743 . . . . 27.0 109.988 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 134' ' ' LEU . . . . . 0.563 HD11 ' O ' ' R' ' 172' ' ' PRO . 0.1 OUTLIER -58.45 -19.76 39.41 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.217 -0.927 . . . . 33.899999999999999 110.467 -179.885 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' R' R ' 135' ' ' ALA . . . . . . . . . . . . . . . -92.72 8.16 40.48 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.278 -0.889 . . . . 19.370000000000001 110.749 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 136' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -93.77 -21.78 19.1 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.14 -0.975 . . . . 30.469999999999999 110.186 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 137' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -149.93 165.34 32.93 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.338 -0.851 . . . . 24.27 110.252 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 138' ' ' HIS . . . . . 0.434 ' HA ' HG23 ' R' ' 154' ' ' VAL . 15.2 p80 -117.81 15.03 14.39 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.393 -0.817 . . . . 20.91 110.419 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 139' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' R' ' 152' ' ' ALA . . . -177.15 152.41 0.88 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.163 -0.96 . . . . 15.69 110.181 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 140' ' ' GLY . . . . . 0.428 ' HA3' ' O ' ' R' ' 179' ' ' VAL . . . 161.85 175.18 32.6 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.964 -1.254 . . . . 23.760000000000002 109.964 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 141' ' ' ILE . . . . . . . . . . . . . 83.4 mt -95.49 136.56 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.398 -1.06 . . . . 25.300000000000001 109.681 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 142' ' ' PHE . . . . . 0.575 ' CD2' ' HB2' ' R' ' 172' ' ' PRO . 83.0 m-85 -120.74 -172.58 2.41 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.336 -0.852 . . . . 30.239999999999998 110.552 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 143' ' ' LEU . . . . . 0.742 HD23 ' O ' ' R' ' 148' ' ' HIS . 0.5 OUTLIER -119.8 77.8 1.27 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.437 -0.789 . . . . 32.799999999999997 110.281 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' R' R ' 144' ' ' LYS . . . . . 0.47 ' HG3' ' CZ2' ' R' ' 170' ' ' TRP . 1.0 OUTLIER -69.67 76.82 0.44 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.285 -0.884 . . . . 49.18 109.69 179.56 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' R' R ' 145' ' ' GLY . . . . . 0.458 ' O ' HD22 ' R' ' 143' ' ' LEU . . . 104.57 179.28 24.75 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.168 -1.573 . . . . 53.869999999999997 109.168 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 146' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -88.48 145.82 25.54 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.417 -1.049 . . . . 68.579999999999998 109.989 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 147' ' ' GLU . . . . . 0.882 ' O ' ' HA ' ' S' ' 400' ' ' LEU . 10.8 mt-10 58.25 36.52 25.75 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.405 -0.809 . . . . 56.619999999999997 110.623 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 148' ' ' HIS . . . . . 0.742 ' O ' HD23 ' R' ' 143' ' ' LEU . 45.1 t60 -158.72 148.1 19.09 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.208 -0.933 . . . . 44.57 110.371 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 149' ' ' ALA . . . . . 0.999 ' HB3' ' CD2' ' S' ' 400' ' ' LEU . . . -150.26 146.93 27.1 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.441 -0.787 . . . . 33.539999999999999 110.023 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 150' ' ' VAL . . . . . . . . . . . . . 34.2 m -142.35 161.51 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.273 -0.892 . . . . 27.609999999999999 110.276 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 151' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' R' ' 152' ' ' ALA . 5.9 t80 -86.25 155.61 20.62 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.383 -0.823 . . . . 23.039999999999999 109.926 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 152' ' ' ALA . . . . . 0.537 ' N ' ' CD1' ' R' ' 151' ' ' PHE . . . -157.25 151.56 25.01 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.457 -0.777 . . . . 29.609999999999999 109.623 179.034 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 153' ' ' CYS . . . . . . . . . . . . . 26.7 p -154.31 173.57 16.0 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.335 -0.853 . . . . 22.75 110.507 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 154' ' ' VAL . . . . . 0.613 HG22 ' CE2' ' R' ' 159' ' ' TRP . 60.0 t -90.61 117.02 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.422 -0.799 . . . . 23.260000000000002 110.051 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 155' ' ' THR . . . . . . . . . . . . . 69.7 p -112.1 -176.64 2.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.345 -0.847 . . . . 17.879999999999999 110.118 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 156' ' ' SER . . . . . . . . . . . . . 78.6 p -75.9 -3.77 37.17 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.382 -0.824 . . . . 21.829999999999998 110.674 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 157' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -118.29 10.48 12.83 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.171 -0.955 . . . . 36.539999999999999 110.646 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 158' ' ' GLY . . . . . . . . . . . . . . . 118.0 -162.68 13.04 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.54 -1.424 . . . . 31.739999999999998 109.54 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 159' ' ' TRP . . . . . 0.613 ' CE2' HG22 ' R' ' 154' ' ' VAL . 14.7 m95 -86.58 122.44 30.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.368 -1.078 . . . . 28.25 110.099 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 160' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -108.45 166.95 10.39 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.37 -0.831 . . . . 41.240000000000002 110.22 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 161' ' ' ALA . . . . . . . . . . . . . . . -143.22 123.49 13.79 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.43 -0.794 . . . . 27.399999999999999 110.163 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 162' ' ' ILE . . . . . . . . . . . . . 92.6 mt -87.68 81.23 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.375 -0.828 . . . . 24.27 109.989 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 163' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' R' ' 165' ' ' GLU . 15.4 t0 -72.76 92.32 1.56 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.404 -0.81 . . . . 36.079999999999998 110.278 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 164' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 54.06 -88.92 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.507 -0.745 . . . . 46.079999999999998 110.6 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 165' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' R' ' 163' ' ' ASP . 29.6 mt-10 -124.71 35.88 4.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.13 -0.981 . . . . 50.939999999999998 110.219 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 166' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -135.75 117.3 14.85 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.431 -0.793 . . . . 47.280000000000001 110.255 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 167' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -101.04 120.05 39.63 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.375 -0.828 . . . . 40.469999999999999 110.081 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 168' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -157.62 158.45 30.52 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.223 -0.923 . . . . 30.210000000000001 110.407 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 169' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.67 133.01 19.63 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 O-C-N 123.868 1.457 . . . . 32.759999999999998 110.561 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 170' ' ' TRP . . . . . 0.47 ' CZ2' ' HG3' ' R' ' 144' ' ' LYS . 67.2 t90 -159.77 119.27 2.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.453 -0.779 . . . . 32.789999999999999 109.955 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 171' ' ' THR . . . . . . . . . . . . . 47.4 m -81.06 112.66 34.48 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.488 -0.757 . . . . 36.920000000000002 110.163 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 172' ' ' PRO . . . . . 0.575 ' HB2' ' CD2' ' R' ' 142' ' ' PHE . 45.9 Cg_endo -73.74 158.79 46.5 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 O-C-N 123.681 1.358 . . . . 33.539999999999999 110.525 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 173' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -88.87 144.98 33.8 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.344 -0.848 . . . . 45.759999999999998 109.951 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 174' ' ' PRO . . . . . 0.409 ' HB3' ' HA ' ' R' ' 133' ' ' CYS . 46.2 Cg_endo -71.71 -10.4 26.46 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.596 1.314 . . . . 29.629999999999999 110.445 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 175' ' ' SER . . . . . . . . . . . . . 53.1 p -103.5 -17.55 15.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.281 -0.887 . . . . 35.700000000000003 110.343 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 176' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -103.48 43.16 1.1 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.202 -0.936 . . . . 39.649999999999999 110.4 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 177' ' ' VAL . . . . . 0.708 ' O ' HG11 ' R' ' 127' ' ' VAL . 10.5 p -117.68 127.16 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.336 -0.852 . . . . 20.609999999999999 109.971 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 178' ' ' LEU . . . . . 0.476 ' HB3' ' HB2' ' R' ' 101' ' ' ALA . 46.0 mt -91.45 -61.41 1.65 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.36 -0.837 . . . . 15.58 109.37 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 179' ' ' VAL . . . . . 0.727 HG22 HG12 ' R' ' 126' ' ' VAL . 67.0 t -114.53 144.64 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.625 -0.672 . . . . 17.399999999999999 109.496 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 180' ' ' PHE . . . . . 0.433 ' CE2' ' HE1' ' R' ' 132' ' ' MET . 43.6 p90 -152.13 163.41 39.41 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.282 -0.886 . . . . 20.16 110.537 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 181' ' ' VAL . . . . . . . . . . . . . 66.4 t -113.2 111.48 50.17 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.342 -0.849 . . . . 17.690000000000001 109.842 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 182' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.05 149.47 52.68 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.574 1.302 . . . . 17.809999999999999 110.446 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 183' ' ' TYR . . . . . 0.698 ' O ' ' C ' ' R' ' 184' ' ' ASP . 79.5 m-85 -59.06 175.46 0.29 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.434 -0.791 . . . . 28.010000000000002 110.561 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 184' ' ' ASP . . . . . 0.698 ' C ' ' O ' ' R' ' 183' ' ' TYR . 4.5 m-20 -18.96 -83.16 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.345 -0.847 . . . . 58.640000000000001 110.228 -178.274 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 185' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 . . . . . 0 N--CA 1.503 2.176 0 CA-C-O 121.252 0.549 . . . . 80.420000000000002 111.802 179.526 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' R' R ' 193' ' ' LYS . . . . . . . . . . . . . 66.2 mttt . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 120.856 0.36 . . . . 49.5 110.16 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' R' R ' 194' ' ' ALA . . . . . . . . . . . . . . . -170.98 -159.86 0.18 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.177 -0.952 . . . . 40.399999999999999 110.119 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 195' ' ' LYS . . . . . . . . . . . . . 8.4 ttpt -82.59 -55.38 4.49 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.388 -0.82 . . . . 34.600000000000001 110.338 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' R' R ' 196' ' ' VAL . . . . . 0.558 HG12 ' O ' ' R' ' 196' ' ' VAL . 41.8 t -88.9 48.67 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.233 -0.917 . . . . 33.270000000000003 110.62 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 197' ' ' GLN . . . . . 0.463 ' O ' ' CG ' ' R' ' 197' ' ' GLN . 7.7 tt0 -149.1 14.3 0.9 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.147 -0.971 . . . . 41.579999999999998 110.664 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 198' ' ' ARG . . . . . 0.609 ' HG3' HD23 ' R' ' 200' ' ' LEU . 9.1 ptt180 -106.37 178.4 4.57 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.155 -0.965 . . . . 38.649999999999999 110.215 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 199' ' ' LYS . . . . . 0.496 ' O ' ' HD3' ' S' ' 299' ' ' PRO . 13.2 mtpp -89.9 -52.6 4.89 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.433 -0.792 . . . . 36.770000000000003 109.98 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' R' R ' 200' ' ' LEU . . . . . 0.609 HD23 ' HG3' ' R' ' 198' ' ' ARG . 0.2 OUTLIER 62.04 159.88 0.07 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.371 -0.831 . . . . 33.079999999999998 110.107 179.787 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' R' R ' 201' ' ' LYS . . . . . 0.646 ' C ' ' HA3' ' S' ' 297' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.695 0 O-C-N 121.379 -0.825 . . . . 44.32 110.328 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 229' ' ' MET . . . . . . . . . . . . . 2.6 ptp . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.2 0.524 . . . . 51.829999999999998 110.251 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' S' S ' 230' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -97.3 142.66 28.92 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.39 -0.819 . . . . 54.130000000000003 110.182 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' S' S ' 231' ' ' LEU . . . . . . . . . . . . . 67.8 mt -134.05 141.02 47.04 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.339 -0.851 . . . . 33.039999999999999 110.386 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' S' S ' 232' ' ' THR . . . . . 0.403 ' O ' ' HA ' ' S' ' 355' ' ' THR . 40.4 m -89.24 103.28 15.92 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.354 -0.841 . . . . 26.920000000000002 110.019 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 233' ' ' LEU . . . . . 0.67 HD22 ' CE2' ' S' ' 262' ' ' TYR . 79.8 mt -55.91 179.28 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.538 -0.726 . . . . 13.779999999999999 110.5 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 234' ' ' TYR . . . . . 0.444 ' CG ' ' N ' ' S' ' 235' ' ' ASN . 35.5 p90 -65.05 -35.61 81.7 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.347 -0.846 . . . . 26.079999999999998 110.167 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 235' ' ' ASN . . . . . 0.444 ' N ' ' CG ' ' S' ' 234' ' ' TYR . 50.6 p30 -74.43 -7.28 52.41 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.313 -0.867 . . . . 20.039999999999999 110.581 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 236' ' ' GLY . . . . . . . . . . . . . . . 95.66 -19.9 52.21 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.788 -1.325 . . . . 22.710000000000001 109.788 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' S' S ' 237' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -53.08 145.74 12.67 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.212 -1.17 . . . . 35.439999999999998 110.189 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' S' S ' 238' ' ' LYS . . . . . . . . . . . . . 44.5 mttt -102.17 127.87 48.91 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.38 -0.825 . . . . 32.560000000000002 110.418 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' S' S ' 239' ' ' LYS . . . . . 0.403 ' HG2' ' CZ ' ' S' ' 241' ' ' PHE . 9.0 ttmt -132.32 144.5 50.61 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.407 -0.808 . . . . 26.68 109.958 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 240' ' ' THR . . . . . . . . . . . . . 50.8 m -102.0 132.16 47.99 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.29 -0.881 . . . . 41.020000000000003 110.417 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' S' S ' 241' ' ' PHE . . . . . 0.403 ' CZ ' ' HG2' ' S' ' 239' ' ' LYS . 96.1 m-85 -117.84 137.61 52.65 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.347 -0.846 . . . . 28.620000000000001 110.213 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 242' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -96.39 161.78 13.77 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.396 -0.815 . . . . 47.890000000000001 110.269 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' S' S ' 243' ' ' SER . . . . . . . . . . . . . 72.7 m -90.6 151.58 21.25 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.356 -0.84 . . . . 45.090000000000003 110.211 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' S' S ' 244' ' ' ARG . . . . . . . . . . . . . 1.4 mtp85 -129.76 126.83 22.75 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.374 -0.829 . . . . 42.490000000000002 110.212 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' S' S ' 245' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.39 161.03 43.57 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 O-C-N 123.664 1.35 . . . . 35.68 110.543 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' S' S ' 246' ' ' ASN . . . . . . . . . . . . . 51.3 t-20 -132.93 97.9 4.15 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.477 -0.764 . . . . 51.880000000000003 109.81 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' S' S ' 247' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -110.43 -22.31 11.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.316 -0.865 . . . . 53.689999999999998 110.645 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' S' S ' 248' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -117.24 43.73 2.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.202 -0.936 . . . . 55.789999999999999 110.751 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' S' S ' 249' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 48.83 38.31 11.72 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.429 -0.794 . . . . 49.450000000000003 110.416 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' S' S ' 250' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -90.54 28.95 1.37 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.582 -0.699 . . . . 36.859999999999999 110.363 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' S' S ' 251' ' ' ALA . . . . . 0.431 ' HB3' ' CE ' ' R' ' 201' ' ' LYS . . . -53.8 -43.13 69.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.217 -0.927 . . . . 29.690000000000001 109.585 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 252' ' ' TRP . . . . . 0.427 ' CZ2' ' HB3' ' S' ' 294' ' ' LEU . 67.9 p-90 -61.88 -33.89 75.02 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.622 -0.674 . . . . 41.119999999999997 109.802 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 253' ' ' LEU . . . . . 0.407 ' N ' ' CD2' ' S' ' 252' ' ' TRP . 23.4 tp -70.21 -47.24 62.35 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.386 -0.821 . . . . 24.890000000000001 109.939 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 254' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -56.11 -42.43 76.8 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.507 -0.745 . . . . 35.649999999999999 109.979 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' S' S ' 255' ' ' ALA . . . . . . . . . . . . . . . -59.58 -48.19 82.64 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.459 -0.776 . . . . 22.73 110.038 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' S' S ' 256' ' ' ILE . . . . . 0.505 HG12 HD11 ' S' ' 304' ' ' ILE . 79.9 mt -62.35 -40.69 88.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.261 -0.9 . . . . 28.850000000000001 109.926 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 257' ' ' LEU . . . . . . . . . . . . . 19.4 mt -61.49 -44.47 97.02 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.41 -0.806 . . . . 23.07 110.172 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' S' S ' 258' ' ' GLN . . . . . 0.498 ' HB3' ' CD2' ' S' ' 351' ' ' PHE . 53.3 mm-40 -65.12 -45.36 85.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.458 -0.776 . . . . 29.780000000000001 109.896 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 259' ' ' LEU . . . . . 0.425 ' O ' HG22 ' S' ' 263' ' ' VAL . 19.9 tp -58.64 -36.35 73.98 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.322 -0.861 . . . . 17.940000000000001 109.51 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 260' ' ' PHE . . . . . 0.535 ' CE2' HD21 ' S' ' 311' ' ' LEU . 3.1 m-85 -62.83 -45.27 93.41 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.593 -0.692 . . . . 30.57 109.812 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 261' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -62.03 -29.89 70.59 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.452 -0.78 . . . . 41.340000000000003 110.022 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' S' S ' 262' ' ' TYR . . . . . 0.67 ' CE2' HD22 ' S' ' 233' ' ' LEU . 8.6 t80 -71.15 -44.65 65.12 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.416 -0.803 . . . . 26.030000000000001 110.113 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 263' ' ' VAL . . . . . 0.425 HG22 ' O ' ' S' ' 259' ' ' LEU . 33.0 m -92.03 18.3 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.398 -0.814 . . . . 22.800000000000001 110.395 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 264' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 52.74 70.61 0.56 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.282 -0.886 . . . . 44.030000000000001 110.686 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' S' S ' 265' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -111.75 109.22 55.54 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.373 -0.83 . . . . 35.609999999999999 109.669 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' S' S ' 266' ' ' PRO . . . . . 0.475 ' HA ' ' HB2' ' S' ' 269' ' ' ASP . 49.6 Cg_endo -75.3 0.32 9.17 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.676 1.356 . . . . 37.670000000000002 111.79 -179.141 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 267' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -56.5 -67.63 0.29 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.843 -1.161 . . . . 41.490000000000002 110.212 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 268' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -92.96 39.82 1.05 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.138 -0.976 . . . . 50.759999999999998 110.057 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' S' S ' 269' ' ' ASP . . . . . 0.475 ' HB2' ' HA ' ' S' ' 266' ' ' PRO . 0.9 OUTLIER -75.97 -33.2 59.76 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.424 -0.797 . . . . 61.859999999999999 109.737 179.556 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' S' S ' 270' ' ' TRP . . . . . 0.508 ' CE2' HG23 ' S' ' 271' ' ' VAL . 51.0 p-90 -73.92 -4.3 34.24 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.285 -0.884 . . . . 39.850000000000001 110.47 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 271' ' ' VAL . . . . . 0.508 HG23 ' CE2' ' S' ' 270' ' ' TRP . 46.4 t -109.56 -32.67 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.114 -0.991 . . . . 39.18 110.085 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 272' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -78.74 -36.46 43.16 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.39 -0.819 . . . . 40.020000000000003 110.498 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' S' S ' 273' ' ' SER . . . . . . . . . . . . . 71.0 m -103.58 56.12 0.74 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.346 -0.846 . . . . 47.200000000000003 110.276 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' S' S ' 274' ' ' SER . . . . . . . . . . . . . 6.9 t -133.06 141.25 40.2 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.31 -0.869 . . . . 47.609999999999999 110.137 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' S' S ' 275' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.71 -18.92 21.8 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.719 1.378 . . . . 45.280000000000001 110.541 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' S' S ' 276' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -99.9 140.87 33.49 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.264 -0.897 . . . . 57.270000000000003 110.279 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' S' S ' 277' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -71.73 97.65 1.8 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.466 -0.771 . . . . 37.280000000000001 110.287 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' S' S ' 278' ' ' LEU . . . . . . . . . . . . . 86.8 mt -97.03 33.87 1.84 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.435 -0.79 . . . . 43.880000000000003 109.961 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' S' S ' 279' ' ' THR . . . . . . . . . . . . . 77.8 m -64.1 -60.14 3.59 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.477 -0.764 . . . . 50.049999999999997 110.239 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' S' S ' 280' ' ' LEU . . . . . 0.738 ' HA ' HD12 ' S' ' 283' ' ' ILE . 13.6 mt -51.59 -39.89 58.78 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.441 -0.787 . . . . 54.119999999999997 110.299 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 281' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.31 -49.72 74.5 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.454 -0.779 . . . . 65.280000000000001 110.161 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 282' ' ' ALA . . . . . . . . . . . . . . . -59.03 -33.84 71.21 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.467 -0.771 . . . . 46.509999999999998 110.515 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' S' S ' 283' ' ' ILE . . . . . 0.738 HD12 ' HA ' ' S' ' 280' ' ' LEU . 86.0 mt -66.43 -50.88 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.246 -0.909 . . . . 47.299999999999997 110.028 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 284' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -50.52 -57.65 7.61 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.461 -0.774 . . . . 50.719999999999999 110.361 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' S' S ' 285' ' ' GLN . . . . . 0.518 ' HG2' HD12 ' S' ' 289' ' ' LEU . 34.3 tt0 -51.3 -46.38 62.51 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.494 -0.754 . . . . 68.469999999999999 110.367 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 286' ' ' LEU . . . . . . . . . . . . . 19.0 mt -60.09 -44.41 94.82 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.435 -0.79 . . . . 36.619999999999997 110.242 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' S' S ' 287' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -62.79 -35.29 79.4 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.251 -0.906 . . . . 46.640000000000001 110.05 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' S' S ' 288' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -76.21 -21.04 56.92 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.493 -0.754 . . . . 46.450000000000003 110.311 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' S' S ' 289' ' ' LEU . . . . . 0.518 HD12 ' HG2' ' S' ' 285' ' ' GLN . 30.7 mt -97.33 -21.65 17.1 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.251 -0.906 . . . . 35.090000000000003 110.553 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 290' ' ' THR . . . . . 0.41 HG22 ' HB3' ' S' ' 306' ' ' ASN . 81.4 p -114.84 -28.4 7.08 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.254 -0.904 . . . . 38.609999999999999 110.462 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 291' ' ' GLY . . . . . . . . . . . . . . . 79.41 10.96 85.41 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.793 -1.323 . . . . 36.770000000000003 109.793 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' S' S ' 292' ' ' LEU . . . . . . . . . . . . . 84.7 mt -96.44 145.77 25.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.25 -1.147 . . . . 35.329999999999998 109.779 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' S' S ' 293' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -77.36 102.33 6.74 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.26 -0.9 . . . . 48.700000000000003 110.296 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' S' S ' 294' ' ' LEU . . . . . 0.427 ' HB3' ' CZ2' ' S' ' 252' ' ' TRP . 55.3 mt -106.83 51.71 0.74 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.572 -0.705 . . . . 42.609999999999999 110.136 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 295' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -112.58 -11.14 13.62 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.287 -0.883 . . . . 55.490000000000002 110.539 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 296' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -144.26 48.51 1.37 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.151 -0.968 . . . . 75.680000000000007 110.315 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' S' S ' 297' ' ' GLY . . . . . 0.646 ' HA3' ' C ' ' R' ' 201' ' ' LYS . . . 96.91 145.13 18.63 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.502 -1.439 . . . . 49.439999999999998 109.502 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 298' ' ' GLY . . . . . 0.462 ' N ' ' HB3' ' R' ' 201' ' ' LYS . . . -163.82 156.9 28.96 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.84 -1.304 . . . . 41.109999999999999 109.84 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 299' ' ' PRO . . . . . 0.496 ' HD3' ' O ' ' R' ' 199' ' ' LYS . 47.8 Cg_endo -73.7 118.21 5.36 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 O-C-N 123.932 1.49 . . . . 26.199999999999999 110.341 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 300' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.2 -15.42 31.81 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 O-C-N 123.567 1.299 . . . . 21.699999999999999 110.728 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' S' S ' 301' ' ' ALA . . . . . . . . . . . . . . . -80.75 -29.35 36.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.258 -0.901 . . . . 31.23 110.133 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' S' S ' 302' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.47 -40.65 18.97 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.426 -0.796 . . . . 38.990000000000002 109.943 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 303' ' ' VAL . . . . . 0.494 HG23 ' O ' ' S' ' 299' ' ' PRO . 57.7 t -60.69 -35.53 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.427 -0.795 . . . . 18.629999999999999 110.122 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 304' ' ' ILE . . . . . 0.52 HD12 HG21 ' S' ' 379' ' ' VAL . 86.0 mt -79.3 -23.67 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.341 -0.849 . . . . 25.460000000000001 110.178 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 305' ' ' TRP . . . . . 0.413 ' CD2' ' HD3' ' S' ' 308' ' ' LYS . 68.9 t-105 -88.69 -14.47 37.24 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.252 -0.905 . . . . 33.399999999999999 110.56 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 306' ' ' ASN . . . . . 0.41 ' HB3' HG22 ' S' ' 290' ' ' THR . 10.3 m-80 -89.76 -13.59 36.41 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.215 -0.928 . . . . 36.969999999999999 110.363 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 307' ' ' ILE . . . . . 0.474 HG12 ' O ' ' S' ' 303' ' ' VAL . 36.9 pt -125.06 45.57 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.182 -0.949 . . . . 30.809999999999999 110.04 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 308' ' ' LYS . . . . . 0.413 ' HD3' ' CD2' ' S' ' 305' ' ' TRP . 1.5 mtmp? -73.52 -37.73 65.55 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.357 -0.84 . . . . 46.520000000000003 110.157 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 309' ' ' HIS . . . . . 0.498 ' CD2' ' HG ' ' S' ' 310' ' ' LEU . 55.5 p-80 -73.16 -8.3 55.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.401 -0.812 . . . . 51.030000000000001 110.136 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 310' ' ' LEU . . . . . 0.498 ' HG ' ' CD2' ' S' ' 309' ' ' HIS . 52.9 mt -99.32 -12.83 19.97 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.3 -0.875 . . . . 36.159999999999997 109.958 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 311' ' ' LEU . . . . . 0.535 HD21 ' CE2' ' S' ' 260' ' ' PHE . 10.7 mt -97.24 147.87 23.68 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.373 -0.829 . . . . 40.0 110.441 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 312' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -81.58 -16.26 52.14 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.266 -0.896 . . . . 54.18 109.747 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' S' S ' 313' ' ' THR . . . . . 0.808 HG23 ' HG2' ' S' ' 323' ' ' GLU . 92.6 m -87.95 151.67 22.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.332 -0.855 . . . . 25.609999999999999 110.134 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 314' ' ' GLY . . . . . . . . . . . . . . . -87.94 126.39 8.04 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.776 -1.33 . . . . 25.18 109.776 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' S' S ' 315' ' ' ILE . . . . . 0.665 HD13 ' HB ' ' S' ' 324' ' ' VAL . 50.7 mm -101.63 150.51 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.427 -1.043 . . . . 23.899999999999999 109.757 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 316' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' S' ' 325' ' ' CYS . . . -157.1 -159.21 9.35 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.006 -1.237 . . . . 23.18 110.006 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 317' ' ' THR . . . . . 0.422 HG22 ' CG2' ' S' ' 326' ' ' VAL . 10.9 p -133.95 -173.03 3.13 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.485 -1.009 . . . . 27.98 109.921 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.6 -56.11 26.17 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.176 -0.953 . . . . 28.100000000000001 109.921 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' S' S ' 319' ' ' SER . . . . . . . . . . . . . 1.2 m -60.06 -41.61 92.7 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.331 -0.855 . . . . 37.0 109.593 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' S' S ' 320' ' ' ARG . . . . . . . . . . . . . 12.2 mtm180 -111.71 79.86 2.64 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.525 -0.734 . . . . 52.07 109.719 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' S' S ' 321' ' ' PRO . . . . . 0.833 ' HB3' HD21 ' S' ' 388' ' ' LEU . 44.1 Cg_endo -71.43 171.54 15.99 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.936 1.492 . . . . 38.289999999999999 110.901 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 322' ' ' SER . . . . . 0.446 ' HB2' ' O ' ' S' ' 321' ' ' PRO . 41.2 t 178.64 -148.14 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.905 -0.776 . . . . 38.840000000000003 108.905 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 323' ' ' GLU . . . . . 0.808 ' HG2' HG23 ' S' ' 313' ' ' THR . 6.7 tp10 -62.85 -40.28 96.99 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.971 -1.081 . . . . 40.700000000000003 109.668 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 324' ' ' VAL . . . . . 0.665 ' HB ' HD13 ' S' ' 315' ' ' ILE . 73.0 t -141.3 135.03 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.399 -0.813 . . . . 20.34 109.471 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 325' ' ' CYS . . . . . 0.461 ' HB2' ' CE1' ' S' ' 380' ' ' PHE . 11.4 m -126.03 172.19 10.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.294 -0.878 . . . . 30.629999999999999 110.805 -179.082 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 326' ' ' VAL . . . . . 0.638 HG12 HG22 ' S' ' 379' ' ' VAL . 34.5 m -135.47 142.23 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.641 -0.662 . . . . 23.899999999999999 109.235 179.163 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 327' ' ' VAL . . . . . 0.594 HG11 ' O ' ' S' ' 377' ' ' VAL . 34.5 m -56.37 125.04 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.078 -1.014 . . . . 19.48 110.42 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 328' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -119.38 11.47 12.21 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.442 -0.786 . . . . 26.43 110.411 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' S' S ' 329' ' ' GLY . . . . . . . . . . . . . . . 119.7 2.21 13.06 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.064 -1.214 . . . . 31.239999999999998 110.064 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' S' S ' 330' ' ' THR . . . . . . . . . . . . . 81.9 m -93.02 130.03 38.74 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.067 -1.255 . . . . 30.050000000000001 110.093 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' S' S ' 331' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -56.8 111.57 1.06 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.315 -0.866 . . . . 37.259999999999998 109.948 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' S' S ' 332' ' ' MET . . . . . . . . . . . . . 87.9 mmm -94.16 162.58 13.8 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.268 -0.895 . . . . 26.23 110.322 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' S' S ' 333' ' ' CYS . . . . . . . . . . . . . 26.0 m -137.25 150.05 47.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.456 -0.778 . . . . 23.559999999999999 110.014 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' S' S ' 334' ' ' LEU . . . . . 0.556 HD11 ' O ' ' S' ' 372' ' ' PRO . 0.1 OUTLIER -52.56 -24.93 9.15 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.296 -0.878 . . . . 28.93 110.429 179.905 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' S' S ' 335' ' ' ALA . . . . . . . . . . . . . . . -89.02 14.45 10.6 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.38 -0.825 . . . . 15.76 110.986 -179.343 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' S' S ' 336' ' ' ASP . . . . . 0.403 ' O ' ' HA ' ' S' ' 382' ' ' PRO . 70.3 m-20 -100.53 -17.18 17.23 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.135 -0.978 . . . . 34.920000000000002 110.167 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 337' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -152.37 170.86 19.04 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.369 -0.832 . . . . 19.030000000000001 110.151 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' S' S ' 338' ' ' HIS . . . . . 0.402 ' HB3' ' CZ ' ' S' ' 383' ' ' TYR . 13.4 p80 -120.72 10.42 10.98 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.37 -0.831 . . . . 18.82 110.47 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 339' ' ' ALA . . . . . 0.41 ' HA ' ' O ' ' S' ' 352' ' ' ALA . . . -175.97 155.19 1.57 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.26 -0.9 . . . . 17.18 110.116 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 340' ' ' GLY . . . . . . . . . . . . . . . 160.8 173.08 28.95 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 110.099 -1.201 . . . . 18.329999999999998 110.099 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' S' S ' 341' ' ' ILE . . . . . . . . . . . . . 83.8 mt -88.79 138.07 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.504 -0.998 . . . . 18.600000000000001 109.824 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' S' S ' 342' ' ' PHE . . . . . 0.488 ' CE2' ' HB3' ' S' ' 352' ' ' ALA . 69.9 m-85 -120.92 -178.42 3.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.25 -0.906 . . . . 23.440000000000001 110.419 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 343' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.81 93.32 4.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.505 -0.747 . . . . 35.590000000000003 110.093 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 344' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.83 125.11 29.68 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.34 -0.85 . . . . 38.340000000000003 110.013 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 345' ' ' GLY . . . . . . . . . . . . . . . 62.78 -130.86 43.09 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 108.858 -1.697 . . . . 53.460000000000001 108.858 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' S' S ' 346' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -132.74 150.87 52.11 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.14 -1.212 . . . . 70.909999999999997 110.023 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' S' S ' 347' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 53.3 35.32 19.89 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.294 -0.879 . . . . 47.32 110.452 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' S' S ' 348' ' ' HIS . . . . . . . . . . . . . 46.6 t60 -150.1 155.9 40.67 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.28 -0.888 . . . . 41.719999999999999 110.375 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' S' S ' 349' ' ' ALA . . . . . 0.453 ' C ' HG13 ' S' ' 350' ' ' VAL . . . -149.79 151.25 33.26 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.331 -0.855 . . . . 22.91 110.536 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 350' ' ' VAL . . . . . 0.453 HG13 ' C ' ' S' ' 349' ' ' ALA . 34.6 m -149.01 169.65 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.417 -0.802 . . . . 21.09 110.018 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 351' ' ' PHE . . . . . 0.498 ' CD2' ' HB3' ' S' ' 258' ' ' GLN . 10.7 t80 -105.41 143.62 33.32 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.237 -0.914 . . . . 25.030000000000001 110.689 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 352' ' ' ALA . . . . . 0.488 ' HB3' ' CE2' ' S' ' 342' ' ' PHE . . . -147.74 151.75 36.59 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.674 -0.641 . . . . 23.809999999999999 109.673 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 353' ' ' CYS . . . . . . . . . . . . . 26.3 p -153.36 164.78 37.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.28 -0.888 . . . . 25.66 110.283 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' S' S ' 354' ' ' VAL . . . . . 0.554 HG22 ' CE2' ' S' ' 359' ' ' TRP . 57.0 t -76.02 118.55 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.36 -0.838 . . . . 34.270000000000003 109.959 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 355' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' S' ' 232' ' ' THR . 51.7 p -117.88 175.17 5.79 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.257 -0.902 . . . . 25.489999999999998 110.271 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 356' ' ' SER . . . . . . . . . . . . . 62.1 p -62.22 -17.69 59.0 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.328 -0.858 . . . . 31.239999999999998 110.718 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' S' S ' 357' ' ' ASN . . . . . . . . . . . . . 46.0 m-20 -106.93 14.18 26.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.206 -0.934 . . . . 28.609999999999999 110.637 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' S' S ' 358' ' ' GLY . . . . . . . . . . . . . . . 111.86 -152.88 17.6 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.99 -1.244 . . . . 22.010000000000002 109.99 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' S' S ' 359' ' ' TRP . . . . . 0.554 ' CE2' HG22 ' S' ' 354' ' ' VAL . 15.3 m95 -91.33 116.73 29.07 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.44 -1.035 . . . . 25.539999999999999 110.14 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 360' ' ' TYR . . . . . 0.43 ' HA ' ' HA ' ' S' ' 369' ' ' PRO . 1.3 m-85 -103.53 165.81 10.81 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.29 -0.881 . . . . 40.530000000000001 110.064 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 361' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' S' ' 351' ' ' PHE . . . -140.06 130.1 24.89 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.389 -0.819 . . . . 18.039999999999999 110.295 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 362' ' ' ILE . . . . . . . . . . . . . 88.9 mt -95.66 83.74 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.307 -0.87 . . . . 15.640000000000001 109.959 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' S' S ' 363' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' S' ' 365' ' ' GLU . 11.9 t0 -75.24 94.48 2.99 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.403 -0.81 . . . . 35.030000000000001 110.227 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 364' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 53.93 -89.37 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.535 -0.728 . . . . 46.719999999999999 110.544 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' S' S ' 365' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' S' ' 363' ' ' ASP . 23.8 mt-10 -122.59 19.09 10.4 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.109 -0.994 . . . . 56.200000000000003 110.285 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 366' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -117.96 125.03 49.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.228 -0.92 . . . . 51.020000000000003 110.361 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' S' S ' 367' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -107.0 127.01 53.07 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.406 -0.808 . . . . 37.590000000000003 110.168 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' S' S ' 368' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -165.43 159.58 13.92 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.246 -0.909 . . . . 31.469999999999999 110.445 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' S' S ' 369' ' ' PRO . . . . . 0.43 ' HA ' ' HA ' ' S' ' 360' ' ' TYR . 46.3 Cg_endo -72.88 139.66 30.64 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 O-C-N 123.866 1.456 . . . . 28.850000000000001 110.546 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 370' ' ' TRP . . . . . . . . . . . . . 67.3 t90 -167.24 113.51 0.76 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.44 -0.787 . . . . 26.940000000000001 109.933 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' S' S ' 371' ' ' THR . . . . . . . . . . . . . 59.6 m -74.75 113.08 20.94 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.379 -0.826 . . . . 20.190000000000001 110.034 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' S' S ' 372' ' ' PRO . . . . . 0.556 ' O ' HD11 ' S' ' 334' ' ' LEU . 48.0 Cg_endo -73.57 157.06 49.21 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 O-C-N 123.597 1.314 . . . . 28.68 110.611 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 373' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -90.6 147.11 35.62 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.442 -0.786 . . . . 35.719999999999999 109.947 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' S' S ' 374' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -76.04 -6.15 17.05 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.665 1.35 . . . . 30.890000000000001 110.528 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' S' S ' 375' ' ' SER . . . . . . . . . . . . . 68.8 p -104.4 -16.96 14.96 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.19 -0.944 . . . . 29.41 110.474 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' S' S ' 376' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -106.56 43.08 1.18 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.327 -0.858 . . . . 32.890000000000001 110.24 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' S' S ' 377' ' ' VAL . . . . . 0.594 ' O ' HG11 ' S' ' 327' ' ' VAL . 7.3 p -114.64 147.3 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.34 -0.85 . . . . 24.329999999999998 110.235 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 378' ' ' LEU . . . . . . . . . . . . . 52.3 mt -116.09 -58.01 2.15 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.441 -0.787 . . . . 24.370000000000001 109.582 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' S' S ' 379' ' ' VAL . . . . . 0.638 HG22 HG12 ' S' ' 326' ' ' VAL . 61.1 t -120.67 132.41 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.371 -0.831 . . . . 18.02 109.453 179.23 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 380' ' ' PHE . . . . . 0.461 ' CE1' ' HB2' ' S' ' 325' ' ' CYS . 14.2 p90 -142.62 173.9 11.12 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.347 -0.845 . . . . 29.350000000000001 110.714 -179.341 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 381' ' ' VAL . . . . . . . . . . . . . 58.3 t -120.02 107.32 39.98 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.586 -0.697 . . . . 16.34 109.395 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' S' S ' 382' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' S' ' 336' ' ' ASP . 45.6 Cg_endo -71.26 145.62 49.11 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 O-C-N 123.598 1.315 . . . . 20.940000000000001 110.78 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 383' ' ' TYR . . . . . 0.402 ' CZ ' ' HB3' ' S' ' 338' ' ' HIS . 88.3 m-85 -61.01 -53.49 56.54 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.309 -0.869 . . . . 28.93 109.878 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 384' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -106.38 126.54 52.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.486 -0.759 . . . . 47.030000000000001 110.333 -176.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' S' S ' 385' ' ' GLN . . . . . 0.445 ' O ' ' C ' ' S' ' 386' ' ' GLU . 5.0 pt20 -61.34 -4.86 1.37 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.407 -0.808 . . . . 46.689999999999998 110.294 177.528 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 386' ' ' GLU . . . . . 0.674 ' O ' ' CG ' ' S' ' 321' ' ' PRO . 25.5 mt-10 -40.98 150.67 0.29 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.308 -0.87 . . . . 50.25 109.563 179.327 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 387' ' ' PRO . . . . . 0.773 ' O ' ' O ' ' S' ' 389' ' ' ASN . 50.0 Cg_endo -71.58 24.96 0.24 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.644 1.339 . . . . 34.390000000000001 110.609 -177.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 388' ' ' LEU . . . . . 0.833 HD21 ' HB3' ' S' ' 321' ' ' PRO . 1.2 pp -11.27 100.61 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.487 -0.758 . . . . 38.009999999999998 110.085 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 389' ' ' ASN . . . . . 0.773 ' O ' ' O ' ' S' ' 387' ' ' PRO . 1.4 t-20 76.0 157.58 0.19 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.346 -0.846 . . . . 45.82 110.116 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 390' ' ' GLY . . . . . 0.49 ' O ' ' CB ' ' S' ' 391' ' ' GLU . . . 151.66 -86.42 0.14 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.624 -1.39 . . . . 33.460000000000001 109.624 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 391' ' ' GLU . . . . . 0.49 ' CB ' ' O ' ' S' ' 390' ' ' GLY . 6.1 tt0 67.79 -63.06 0.32 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.351 -1.088 . . . . 56.579999999999998 110.123 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 392' ' ' TRP . . . . . 0.475 ' N ' ' O ' ' S' ' 390' ' ' GLY . 0.9 OUTLIER -51.78 -23.68 4.97 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.348 -0.845 . . . . 31.43 110.41 179.724 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' S' S ' 393' ' ' LYS . . . . . 0.486 ' O ' HG12 ' S' ' 396' ' ' VAL . 0.0 OUTLIER -50.76 -36.1 35.06 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.241 -0.912 . . . . 39.420000000000002 110.368 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' S' S ' 394' ' ' ALA . . . . . 0.46 ' HB2' ' HD2' ' S' ' 393' ' ' LYS . . . -86.91 -15.05 40.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.341 -0.85 . . . . 34.329999999999998 110.109 179.247 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 395' ' ' LYS . . . . . 0.71 ' O ' HD11 ' R' ' 143' ' ' LEU . 21.2 mmmt -80.16 -25.31 39.85 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.467 -0.771 . . . . 60.090000000000003 110.258 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 396' ' ' VAL . . . . . 0.617 ' O ' ' HA ' ' R' ' 99' ' ' PRO . 8.8 p -85.31 -36.32 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.27 -0.894 . . . . 35.5 110.56 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 397' ' ' GLN . . . . . 0.471 ' N ' HG13 ' S' ' 396' ' ' VAL . 22.7 tt0 -123.96 95.46 4.57 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.136 -0.978 . . . . 49.960000000000001 110.653 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 398' ' ' ARG . . . . . 0.713 ' NH2' ' HB2' ' R' ' 149' ' ' ALA . 0.0 OUTLIER -149.26 32.05 0.74 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.232 -0.918 . . . . 43.420000000000002 110.723 -179.57 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' S' S ' 399' ' ' LYS . . . . . 0.581 ' O ' ' HB3' ' R' ' 147' ' ' GLU . 6.0 ttpm? 52.3 106.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.454 -0.779 . . . . 55.310000000000002 110.033 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 400' ' ' LEU . . . . . 0.999 ' CD2' ' HB3' ' R' ' 149' ' ' ALA . 7.5 mp -80.23 -33.42 38.04 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.3 -0.875 . . . . 41.030000000000001 110.272 -178.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' S' S ' 401' ' ' LYS . . . . . 0.545 ' HA ' ' CB ' ' R' ' 49' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.694 0 O-C-N 121.348 -0.845 . . . . 61.969999999999999 110.214 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 29' ' ' MET . . . . . . . . . . . . . 2.0 mpp? . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.136 0.493 . . . . 32.140000000000001 110.314 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' R' R ' 30' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -96.4 141.19 30.01 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.386 -0.821 . . . . 43.359999999999999 110.212 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 31' ' ' LEU . . . . . . . . . . . . . 65.6 mt -134.91 140.58 45.87 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.282 -0.886 . . . . 22.93 110.269 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 32' ' ' THR . . . . . . . . . . . . . 69.6 m -87.54 110.61 20.47 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.439 -0.788 . . . . 22.34 109.971 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 33' ' ' LEU . . . . . 0.595 HD22 ' CE2' ' R' ' 62' ' ' TYR . 80.1 mt -62.5 -172.73 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.408 -0.808 . . . . 21.390000000000001 110.215 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 34' ' ' TYR . . . . . . . . . . . . . 37.0 p90 -74.65 -29.39 61.24 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.352 -0.842 . . . . 34.399999999999999 110.386 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 35' ' ' ASN . . . . . . . . . . . . . 48.3 p30 -77.78 -1.91 33.78 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.332 -0.855 . . . . 30.280000000000001 110.585 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.26 -16.59 59.4 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.754 -1.338 . . . . 36.25 109.754 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 37' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -58.97 161.81 4.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.315 -1.109 . . . . 53.799999999999997 110.383 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 38' ' ' LYS . . . . . . . . . . . . . 56.9 mttt -117.87 135.71 53.92 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.39 -0.818 . . . . 49.909999999999997 110.151 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 39' ' ' LYS . . . . . 0.406 ' HG2' ' CZ ' ' R' ' 41' ' ' PHE . 8.1 ttmt -138.74 143.73 39.16 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.388 -0.82 . . . . 35.689999999999998 110.182 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 40' ' ' THR . . . . . . . . . . . . . 23.7 m -102.57 128.01 49.41 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.305 -0.872 . . . . 34.840000000000003 110.193 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 41' ' ' PHE . . . . . 0.406 ' CZ ' ' HG2' ' R' ' 39' ' ' LYS . 96.6 m-85 -113.12 132.66 55.36 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.381 -0.824 . . . . 34.420000000000002 110.14 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 42' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -93.29 140.86 29.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.331 -0.856 . . . . 51.460000000000001 110.255 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 43' ' ' SER . . . . . . . . . . . . . 53.6 m -70.73 141.89 51.48 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.421 -0.799 . . . . 41.840000000000003 110.186 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.74 125.37 29.59 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.361 -0.837 . . . . 33.82 110.013 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 45' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.11 151.13 55.13 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.596 1.314 . . . . 30.27 110.625 -179.697 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 46' ' ' ASN . . . . . 0.568 ' ND2' HD13 ' S' ' 400' ' ' LEU . 52.2 t-20 -124.3 109.87 13.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.48 -0.762 . . . . 35.100000000000001 110.033 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 47' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -120.29 -34.88 3.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.285 -0.884 . . . . 42.810000000000002 110.55 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 48' ' ' HIS . . . . . 0.439 ' NE2' HD11 ' R' ' 80' ' ' LEU . 73.3 m80 -105.86 45.23 0.98 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.213 -0.929 . . . . 49.969999999999999 110.24 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 49' ' ' ASP . . . . . 0.704 ' HA ' HD22 ' S' ' 400' ' ' LEU . 37.5 m-20 50.29 34.68 9.22 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.447 -0.783 . . . . 61.32 110.149 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 50' ' ' ASN . . . . . 0.4 ' OD1' ' HA ' ' R' ' 46' ' ' ASN . 15.0 p-10 -86.21 43.78 1.08 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.32 -0.862 . . . . 51.5 110.744 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 51' ' ' ALA . . . . . 0.733 ' CB ' ' HB2' ' S' ' 400' ' ' LEU . . . -66.08 -46.14 78.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.193 -0.942 . . . . 38.770000000000003 109.476 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 52' ' ' TRP . . . . . 0.484 ' CD2' ' N ' ' R' ' 53' ' ' LEU . 68.1 p-90 -58.42 -38.43 77.4 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.595 -0.691 . . . . 26.239999999999998 110.036 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 53' ' ' LEU . . . . . 0.484 ' N ' ' CD2' ' R' ' 52' ' ' TRP . 23.2 tp -66.75 -46.66 74.71 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.439 -0.788 . . . . 26.75 109.991 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 54' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -55.11 -41.64 71.91 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.369 -0.832 . . . . 35.020000000000003 110.208 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.19 -46.03 92.16 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.396 -0.815 . . . . 24.469999999999999 110.172 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 56' ' ' ILE . . . . . 0.433 HG12 HD11 ' R' ' 104' ' ' ILE . 76.1 mt -62.26 -42.22 94.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.346 -0.846 . . . . 26.030000000000001 109.857 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 57' ' ' LEU . . . . . . . . . . . . . 22.5 mt -60.24 -45.67 92.45 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.364 -0.835 . . . . 26.77 109.655 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 58' ' ' GLN . . . . . . . . . . . . . 57.7 mm-40 -63.95 -46.53 84.29 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.456 -0.777 . . . . 22.32 109.592 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 59' ' ' LEU . . . . . 0.429 ' HA ' ' HE2' ' R' ' 151' ' ' PHE . 23.9 tp -61.34 -37.81 84.64 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.365 -0.834 . . . . 20.550000000000001 109.427 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 60' ' ' PHE . . . . . 0.528 ' CE2' HD21 ' R' ' 111' ' ' LEU . 2.8 m-85 -61.06 -44.74 96.92 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.67 -0.644 . . . . 20.079999999999998 109.913 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 61' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -63.07 -36.19 82.77 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.45 -0.781 . . . . 18.800000000000001 110.528 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 62' ' ' TYR . . . . . 0.595 ' CE2' HD22 ' R' ' 33' ' ' LEU . 9.3 t80 -63.06 -41.8 99.53 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.158 -0.964 . . . . 26.449999999999999 110.217 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 63' ' ' VAL . . . . . 0.406 ' H ' HG22 ' R' ' 63' ' ' VAL . 30.2 m -93.37 20.43 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.247 -0.908 . . . . 29.75 110.263 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 64' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 52.87 75.53 0.24 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.335 -0.853 . . . . 35.520000000000003 110.582 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 65' ' ' GLU . . . . . 0.443 ' HG2' ' CD2' ' R' ' 60' ' ' PHE . 14.3 tp10 -116.22 104.06 52.45 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.45 -0.782 . . . . 29.890000000000001 109.948 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 66' ' ' PRO . . . . . 0.48 ' HA ' ' HB2' ' R' ' 69' ' ' ASP . 46.1 Cg_endo -73.55 -5.81 17.71 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.864 1.455 . . . . 21.370000000000001 111.089 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 67' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -52.15 -61.47 2.25 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.169 -0.957 . . . . 23.850000000000001 110.39 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 68' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -98.13 36.51 1.57 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.34 -0.85 . . . . 28.07 110.475 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 69' ' ' ASP . . . . . 0.48 ' HB2' ' HA ' ' R' ' 66' ' ' PRO . 11.7 t0 -72.33 -33.23 67.18 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.312 -0.867 . . . . 43.759999999999998 110.18 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 70' ' ' TRP . . . . . 0.476 ' CE2' ' CG2' ' R' ' 71' ' ' VAL . 47.7 p-90 -73.39 -3.9 30.17 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.293 -0.879 . . . . 33.060000000000002 110.739 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 71' ' ' VAL . . . . . 0.556 HG11 ' HB2' ' R' ' 82' ' ' ALA . 40.8 t -109.79 -27.5 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.237 -0.914 . . . . 31.699999999999999 109.679 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 72' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -86.42 -49.0 7.94 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.395 -0.815 . . . . 33.579999999999998 110.299 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 73' ' ' SER . . . . . . . . . . . . . 69.8 m -89.57 50.99 2.0 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.274 -0.892 . . . . 50.82 110.39 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 74' ' ' SER . . . . . . . . . . . . . 15.9 t -125.85 138.28 31.71 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.21 -0.931 . . . . 34.740000000000002 110.262 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.33 -25.02 15.98 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.702 1.369 . . . . 35.700000000000003 110.308 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 76' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -91.7 153.23 19.79 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.364 -0.835 . . . . 66.480000000000004 110.3 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 77' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -81.56 95.29 7.09 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.332 -0.855 . . . . 46.719999999999999 110.064 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 78' ' ' LEU . . . . . . . . . . . . . 96.3 mt -96.45 27.96 3.55 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.443 -0.786 . . . . 37.549999999999997 110.186 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 79' ' ' THR . . . . . . . . . . . . . 29.7 m -56.24 -54.62 43.14 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.337 -0.852 . . . . 37.359999999999999 110.286 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 80' ' ' LEU . . . . . 0.604 ' HA ' HD12 ' R' ' 83' ' ' ILE . 15.9 mt -60.9 -23.26 65.08 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.379 -0.826 . . . . 35.829999999999998 110.514 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 81' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -79.41 -39.15 33.15 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.142 -0.974 . . . . 44.030000000000001 110.37 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 82' ' ' ALA . . . . . 0.556 ' HB2' HG11 ' R' ' 71' ' ' VAL . . . -69.48 -28.54 66.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.288 -0.882 . . . . 32.539999999999999 110.291 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 83' ' ' ILE . . . . . 0.604 HD12 ' HA ' ' R' ' 80' ' ' LEU . 78.2 mt -70.18 -46.06 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.237 -0.915 . . . . 32.020000000000003 110.302 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 84' ' ' LYS . . . . . . . . . . . . . 36.0 tttm -55.29 -52.05 64.69 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.164 -0.96 . . . . 34.090000000000003 110.532 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 85' ' ' GLN . . . . . 0.531 ' HG2' HD12 ' R' ' 89' ' ' LEU . 31.9 tt0 -54.71 -46.98 74.25 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.313 -0.867 . . . . 25.940000000000001 110.308 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 86' ' ' LEU . . . . . . . . . . . . . 24.1 mt -58.62 -43.82 89.78 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.346 -0.846 . . . . 16.199999999999999 109.965 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 87' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -65.3 -35.27 80.48 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.466 -0.771 . . . . 49.090000000000003 110.349 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 88' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -78.5 -18.93 54.08 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.283 -0.886 . . . . 28.609999999999999 110.523 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 89' ' ' LEU . . . . . 0.531 HD12 ' HG2' ' R' ' 85' ' ' GLN . 32.8 mt -96.25 -29.34 14.07 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.26 -0.9 . . . . 26.16 110.238 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 90' ' ' THR . . . . . . . . . . . . . 58.2 p -105.72 -34.57 7.66 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.226 -0.921 . . . . 33.329999999999998 109.806 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.73 16.12 58.75 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.937 -1.265 . . . . 31.129999999999999 109.937 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 92' ' ' LEU . . . . . . . . . . . . . 97.1 mt -100.14 155.2 17.87 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.103 -1.234 . . . . 42.520000000000003 110.237 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 93' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -86.18 91.65 8.51 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.567 -0.708 . . . . 68.459999999999994 109.911 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 94' ' ' LEU . . . . . 0.458 ' HB3' ' CZ2' ' R' ' 52' ' ' TRP . 47.7 mt -99.49 53.11 0.94 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.272 -0.893 . . . . 44.630000000000003 110.319 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 95' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.49 -38.67 6.38 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.331 -0.856 . . . . 67.159999999999997 110.399 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 96' ' ' GLU . . . . . 0.434 ' O ' ' CE ' ' S' ' 399' ' ' LYS . 24.4 mt-10 -113.93 44.23 1.68 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.332 -0.855 . . . . 67.019999999999996 110.255 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 97' ' ' GLY . . . . . 0.829 ' HA3' ' CB ' ' S' ' 399' ' ' LYS . . . 99.15 150.81 26.04 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.674 -1.37 . . . . 49.479999999999997 109.674 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 98' ' ' GLY . . . . . . . . . . . . . . . -166.26 160.03 33.47 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.311 -1.516 . . . . 36.57 109.311 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 99' ' ' PRO . . . . . 0.804 ' CB ' HG22 ' S' ' 396' ' ' VAL . 45.0 Cg_endo -72.59 121.14 7.17 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 123.741 1.39 . . . . 30.41 110.435 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 100' ' ' PRO . . . . . 0.41 ' HA ' HD11 ' R' ' 56' ' ' ILE . 44.8 Cg_endo -72.37 -31.67 11.17 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 O-C-N 123.58 1.305 . . . . 29.940000000000001 110.452 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 101' ' ' ALA . . . . . 0.81 ' HB3' HG21 ' S' ' 396' ' ' VAL . . . -69.9 -38.46 76.32 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.228 -0.92 . . . . 23.640000000000001 110.327 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 102' ' ' LEU . . . . . 0.425 HD23 HD21 ' R' ' 106' ' ' ASN . 0.1 OUTLIER -72.73 -40.72 65.88 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.373 -0.829 . . . . 20.309999999999999 110.323 -179.699 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' R' R ' 103' ' ' VAL . . . . . 0.792 HG23 ' O ' ' R' ' 99' ' ' PRO . 63.3 t -58.13 -40.05 75.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.21 -0.931 . . . . 16.329999999999998 110.065 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 104' ' ' ILE . . . . . 0.433 HD11 HG12 ' R' ' 56' ' ' ILE . 81.9 mt -71.71 -30.51 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.397 -0.814 . . . . 24.77 109.956 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 105' ' ' TRP . . . . . 0.462 ' O ' ' HD3' ' R' ' 108' ' ' LYS . 70.6 t-105 -82.51 0.9 40.35 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.323 -0.861 . . . . 23.280000000000001 110.292 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 106' ' ' ASN . . . . . 0.425 HD21 HD23 ' R' ' 102' ' ' LEU . 6.8 m-80 -105.09 -10.38 17.2 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.144 -0.973 . . . . 28.260000000000002 110.123 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 107' ' ' ILE . . . . . . . . . . . . . 36.7 pt -126.83 35.02 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.181 -0.949 . . . . 18.77 110.033 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 108' ' ' LYS . . . . . 0.502 ' HG2' ' HB ' ' R' ' 115' ' ' ILE . 9.3 mtpp -61.03 -48.48 81.56 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.516 -0.74 . . . . 42.5 110.037 179.494 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 109' ' ' HIS . . . . . 0.444 ' CD2' ' HG ' ' R' ' 110' ' ' LEU . 50.9 p-80 -66.06 -12.83 58.06 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.499 -0.75 . . . . 20.07 110.688 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 110' ' ' LEU . . . . . 0.444 ' HG ' ' CD2' ' R' ' 109' ' ' HIS . 80.3 mt -94.8 -17.3 22.25 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.083 -1.011 . . . . 15.69 110.196 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 111' ' ' LEU . . . . . 0.528 HD21 ' CE2' ' R' ' 60' ' ' PHE . 10.3 mt -94.09 144.15 25.74 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.342 -0.849 . . . . 25.390000000000001 111.008 -179.181 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 112' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -77.67 -17.43 57.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.487 -0.758 . . . . 53.479999999999997 109.823 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 113' ' ' THR . . . . . 0.459 HG22 ' N ' ' R' ' 114' ' ' GLY . 60.5 m -83.67 166.64 17.94 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.308 -0.87 . . . . 14.800000000000001 110.247 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 114' ' ' GLY . . . . . 0.459 ' N ' HG22 ' R' ' 113' ' ' THR . . . -98.0 127.12 9.12 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.042 -1.223 . . . . 16.140000000000001 110.042 -179.637 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 115' ' ' ILE . . . . . 0.579 HD13 ' HB ' ' R' ' 124' ' ' VAL . 47.8 mm -109.02 139.34 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.478 -1.013 . . . . 13.460000000000001 109.741 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 116' ' ' GLY . . . . . . . . . . . . . . . -152.71 -155.8 7.26 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.011 -1.236 . . . . 23.899999999999999 110.011 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 117' ' ' THR . . . . . 0.53 HG22 ' CG2' ' R' ' 126' ' ' VAL . 18.8 p -135.03 -171.33 2.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.514 -0.992 . . . . 27.370000000000001 110.059 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 118' ' ' ALA . . . . . 0.446 ' HB3' ' OD1' ' R' ' 128' ' ' ASP . . . -56.62 -58.06 9.72 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.216 -0.927 . . . . 18.760000000000002 110.083 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 119' ' ' SER . . . . . 0.584 ' HB3' ' HB ' ' R' ' 196' ' ' VAL . 1.1 m -56.55 -40.56 75.36 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.251 -0.905 . . . . 32.350000000000001 109.815 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 120' ' ' ARG . . . . . 0.417 ' NH1' ' NE1' ' S' ' 305' ' ' TRP . 10.0 mtm180 -110.07 86.29 4.91 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.43 -0.794 . . . . 27.120000000000001 109.716 179.337 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 121' ' ' PRO . . . . . 0.482 ' HA ' ' SG ' ' R' ' 125' ' ' CYS . 44.0 Cg_endo -71.32 166.53 28.98 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 O-C-N 123.86 1.453 . . . . 22.68 110.998 -179.394 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 122' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' R' ' 121' ' ' PRO . 38.3 t 178.53 -161.72 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.6 -0.687 . . . . 22.989999999999998 109.461 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 123' ' ' GLU . . . . . 0.442 ' HG2' HG23 ' R' ' 113' ' ' THR . 2.3 tp10 -56.45 -39.98 74.04 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.211 -0.93 . . . . 36.18 109.622 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 124' ' ' VAL . . . . . 0.579 ' HB ' HD13 ' R' ' 115' ' ' ILE . 83.5 t -142.54 136.44 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.597 -0.689 . . . . 20.640000000000001 109.428 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 125' ' ' CYS . . . . . 0.482 ' SG ' ' HA ' ' R' ' 121' ' ' PRO . 83.4 m -140.32 168.16 20.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.145 -0.972 . . . . 22.800000000000001 111.171 -179.276 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 126' ' ' VAL . . . . . 0.727 HG12 HG22 ' R' ' 179' ' ' VAL . 35.8 m -122.72 159.77 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.724 -0.61 . . . . 21.239999999999998 109.695 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 127' ' ' VAL . . . . . 0.709 HG11 ' O ' ' R' ' 177' ' ' VAL . 30.8 m -70.83 141.85 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.293 -0.879 . . . . 19.77 110.681 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 128' ' ' ASP . . . . . 0.446 ' OD1' ' HB3' ' R' ' 118' ' ' ALA . 54.0 p-10 -137.68 19.34 2.88 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.405 -0.809 . . . . 29.210000000000001 110.702 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 129' ' ' GLY . . . . . . . . . . . . . . . 113.99 0.02 24.14 Favored Glycine 0 N--CA 1.493 2.458 0 C-N-CA 119.977 -1.106 . . . . 33.859999999999999 110.472 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 130' ' ' THR . . . . . . . . . . . . . 58.3 m -91.76 131.83 36.85 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.084 -1.244 . . . . 26.41 110.07 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -62.59 120.66 11.59 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.35 -0.844 . . . . 33.079999999999998 110.312 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 132' ' ' MET . . . . . 0.433 ' HE1' ' CE2' ' R' ' 180' ' ' PHE . 98.4 mmm -105.22 165.64 10.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.395 -0.816 . . . . 30.760000000000002 110.377 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 133' ' ' CYS . . . . . 0.411 ' HA ' ' HB3' ' R' ' 174' ' ' PRO . 32.6 m -141.16 158.14 44.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.507 -0.745 . . . . 27.0 109.932 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 134' ' ' LEU . . . . . 0.563 HD11 ' O ' ' R' ' 172' ' ' PRO . 0.1 OUTLIER -58.57 -19.6 39.54 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.388 -0.82 . . . . 33.899999999999999 110.498 -179.862 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' R' R ' 135' ' ' ALA . . . . . . . . . . . . . . . -92.79 8.16 40.62 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.294 -0.879 . . . . 19.370000000000001 110.755 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 136' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -93.74 -21.86 19.07 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.207 -0.933 . . . . 30.469999999999999 110.216 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 137' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -149.94 165.35 32.89 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.351 -0.843 . . . . 24.27 110.231 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 138' ' ' HIS . . . . . 0.433 ' HA ' HG23 ' R' ' 154' ' ' VAL . 15.1 p80 -117.82 15.15 14.38 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.429 -0.794 . . . . 20.91 110.452 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 139' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' R' ' 152' ' ' ALA . . . -177.16 152.49 0.89 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.167 -0.958 . . . . 15.69 110.137 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 140' ' ' GLY . . . . . 0.427 ' HA3' ' O ' ' R' ' 179' ' ' VAL . . . 161.74 175.1 32.41 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 110.007 -1.237 . . . . 23.760000000000002 110.007 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 141' ' ' ILE . . . . . . . . . . . . . 83.6 mt -95.48 136.57 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.447 -1.031 . . . . 25.300000000000001 109.682 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 142' ' ' PHE . . . . . 0.576 ' CD2' ' HB2' ' R' ' 172' ' ' PRO . 82.6 m-85 -120.75 -172.66 2.43 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.33 -0.856 . . . . 30.239999999999998 110.54 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 143' ' ' LEU . . . . . 0.743 HD23 ' O ' ' R' ' 148' ' ' HIS . 0.5 OUTLIER -119.75 77.84 1.27 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.459 -0.776 . . . . 32.799999999999997 110.304 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' R' R ' 144' ' ' LYS . . . . . 0.471 ' HG3' ' CZ2' ' R' ' 170' ' ' TRP . 1.0 OUTLIER -69.67 76.93 0.44 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.381 -0.824 . . . . 49.18 109.653 179.573 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' R' R ' 145' ' ' GLY . . . . . 0.457 ' O ' HD22 ' R' ' 143' ' ' LEU . . . 104.52 179.23 24.81 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.16 -1.576 . . . . 53.869999999999997 109.16 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 146' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -88.44 145.86 25.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.319 -1.107 . . . . 68.579999999999998 109.999 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 147' ' ' GLU . . . . . 0.751 ' HA ' ' CB ' ' S' ' 398' ' ' ARG . 10.9 mt-10 58.19 36.58 25.88 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.294 -0.879 . . . . 56.619999999999997 110.633 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 148' ' ' HIS . . . . . 0.902 ' CE1' HD12 ' S' ' 400' ' ' LEU . 45.1 t60 -158.67 148.11 19.17 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.243 -0.911 . . . . 44.57 110.398 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 149' ' ' ALA . . . . . . . . . . . . . . . -150.25 146.9 27.08 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.451 -0.781 . . . . 33.539999999999999 110.061 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 150' ' ' VAL . . . . . . . . . . . . . 34.2 m -142.38 161.51 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.246 -0.909 . . . . 27.609999999999999 110.322 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 151' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' R' ' 152' ' ' ALA . 5.9 t80 -86.18 155.57 20.68 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.383 -0.823 . . . . 23.039999999999999 109.901 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 152' ' ' ALA . . . . . 0.537 ' N ' ' CD1' ' R' ' 151' ' ' PHE . . . -157.31 151.56 24.92 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.447 -0.783 . . . . 29.609999999999999 109.53 178.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 153' ' ' CYS . . . . . . . . . . . . . 26.7 p -154.28 173.56 15.99 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.28 -0.888 . . . . 22.75 110.539 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 154' ' ' VAL . . . . . 0.614 HG22 ' CE2' ' R' ' 159' ' ' TRP . 59.9 t -90.52 117.04 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.429 -0.794 . . . . 23.260000000000002 110.057 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 155' ' ' THR . . . . . . . . . . . . . 71.0 p -112.18 -176.62 2.96 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.361 -0.837 . . . . 17.879999999999999 110.058 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 156' ' ' SER . . . . . . . . . . . . . 78.4 p -75.96 -3.68 36.89 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.32 -0.863 . . . . 21.829999999999998 110.716 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 157' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -118.33 10.57 12.82 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.096 -1.002 . . . . 36.539999999999999 110.625 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 158' ' ' GLY . . . . . . . . . . . . . . . 117.83 -162.6 13.01 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.55 -1.42 . . . . 31.739999999999998 109.55 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 159' ' ' TRP . . . . . 0.614 ' CE2' HG22 ' R' ' 154' ' ' VAL . 14.6 m95 -86.63 122.54 30.7 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.386 -1.067 . . . . 28.25 110.061 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 160' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -108.48 166.92 10.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.346 -0.846 . . . . 41.240000000000002 110.25 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 161' ' ' ALA . . . . . . . . . . . . . . . -143.25 123.39 13.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.435 -0.791 . . . . 27.399999999999999 110.182 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 162' ' ' ILE . . . . . . . . . . . . . 92.6 mt -87.57 81.24 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.398 -0.814 . . . . 24.27 110.055 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 163' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' R' ' 165' ' ' GLU . 15.3 t0 -72.85 92.37 1.6 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.458 -0.776 . . . . 36.079999999999998 110.237 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 164' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 54.09 -88.97 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.489 -0.757 . . . . 46.079999999999998 110.603 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 165' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' R' ' 163' ' ' ASP . 29.6 mt-10 -124.72 36.0 4.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.109 -0.994 . . . . 50.939999999999998 110.194 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 166' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -135.69 117.3 14.91 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.405 -0.81 . . . . 47.280000000000001 110.361 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 167' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -101.06 119.91 39.43 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.367 -0.833 . . . . 40.469999999999999 110.178 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 168' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -157.51 158.56 30.71 Favored Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 121.235 -0.916 . . . . 30.210000000000001 110.454 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 169' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.77 133.05 19.52 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 O-C-N 123.866 1.456 . . . . 32.759999999999998 110.531 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 170' ' ' TRP . . . . . 0.471 ' CZ2' ' HG3' ' R' ' 144' ' ' LYS . 67.2 t90 -159.78 119.27 2.88 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.444 -0.785 . . . . 32.789999999999999 109.958 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 171' ' ' THR . . . . . . . . . . . . . 45.5 m -81.08 112.58 33.87 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.423 -0.798 . . . . 36.920000000000002 110.219 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 172' ' ' PRO . . . . . 0.576 ' HB2' ' CD2' ' R' ' 142' ' ' PHE . 46.8 Cg_endo -73.77 158.81 46.39 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.634 1.334 . . . . 33.539999999999999 110.556 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 173' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -88.85 144.93 33.77 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.409 -0.807 . . . . 45.759999999999998 109.913 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 174' ' ' PRO . . . . . 0.411 ' HB3' ' HA ' ' R' ' 133' ' ' CYS . 46.0 Cg_endo -71.72 -10.35 26.37 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.649 1.342 . . . . 29.629999999999999 110.505 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 175' ' ' SER . . . . . . . . . . . . . 53.0 p -103.41 -17.63 15.17 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.273 -0.892 . . . . 35.700000000000003 110.367 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 176' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -103.58 43.3 1.09 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.261 -0.899 . . . . 39.649999999999999 110.362 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 177' ' ' VAL . . . . . 0.709 ' O ' HG11 ' R' ' 127' ' ' VAL . 10.5 p -117.78 127.23 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.266 -0.896 . . . . 20.609999999999999 110.006 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 178' ' ' LEU . . . . . 0.556 HD22 ' HB ' ' S' ' 396' ' ' VAL . 46.4 mt -91.6 -61.25 1.68 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.368 -0.832 . . . . 15.58 109.364 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 179' ' ' VAL . . . . . 0.727 HG22 HG12 ' R' ' 126' ' ' VAL . 67.5 t -114.6 144.67 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.66 -0.65 . . . . 17.399999999999999 109.444 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 180' ' ' PHE . . . . . 0.433 ' CE2' ' HE1' ' R' ' 132' ' ' MET . 43.4 p90 -152.13 163.36 39.53 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.33 -0.856 . . . . 20.16 110.517 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 181' ' ' VAL . . . . . . . . . . . . . 65.9 t -113.1 111.5 50.44 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.363 -0.836 . . . . 17.690000000000001 109.848 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 182' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.09 149.57 52.62 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 O-C-N 123.638 1.336 . . . . 17.809999999999999 110.403 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 183' ' ' TYR . . . . . 0.688 ' O ' ' C ' ' R' ' 184' ' ' ASP . 78.9 m-85 -59.13 175.44 0.3 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.401 -0.812 . . . . 28.010000000000002 110.54 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 184' ' ' ASP . . . . . 0.688 ' C ' ' O ' ' R' ' 183' ' ' TYR . 2.3 m-20 -20.0 -84.04 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.315 -0.866 . . . . 58.640000000000001 110.242 -178.31 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 185' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 . . . . . 0 N--CA 1.502 2.173 0 CA-C-O 121.22 0.533 . . . . 80.420000000000002 111.75 179.617 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' R' R ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 120.823 0.344 . . . . 49.5 110.16 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 194' ' ' ALA . . . . . 0.761 ' HB3' ' HG2' ' R' ' 197' ' ' GLN . . . -168.93 -155.21 0.14 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.218 -0.927 . . . . 40.399999999999999 110.144 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 195' ' ' LYS . . . . . . . . . . . . . 17.1 mtmt -89.5 -52.35 5.07 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.386 -0.821 . . . . 34.600000000000001 110.278 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 196' ' ' VAL . . . . . 0.584 ' HB ' ' HB3' ' R' ' 119' ' ' SER . 23.1 t -93.51 59.6 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.254 -0.904 . . . . 33.270000000000003 110.585 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 197' ' ' GLN . . . . . 0.761 ' HG2' ' HB3' ' R' ' 194' ' ' ALA . 3.2 pp0? -164.62 21.21 0.06 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.143 -0.973 . . . . 41.579999999999998 110.717 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 198' ' ' ARG . . . . . . . . . . . . . 9.5 ptt-85 -120.08 165.44 14.72 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.112 -0.993 . . . . 38.649999999999999 110.23 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' R' R ' 199' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.78 81.36 2.28 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.478 -0.764 . . . . 36.770000000000003 109.921 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 200' ' ' LEU . . . . . 0.512 HD21 HD11 ' S' ' 343' ' ' LEU . 3.3 tp -69.07 -159.14 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.443 -0.786 . . . . 33.079999999999998 110.135 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' R' R ' 201' ' ' LYS . . . . . 0.602 ' HA ' ' HA3' ' S' ' 297' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 O-C-N 121.393 -0.817 . . . . 44.32 110.29 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 229' ' ' MET . . . . . . . . . . . . . 5.1 mtm . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.188 0.518 . . . . 51.829999999999998 110.216 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' S' S ' 230' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -97.29 142.71 28.84 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.34 -0.85 . . . . 54.130000000000003 110.199 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' S' S ' 231' ' ' LEU . . . . . . . . . . . . . 67.3 mt -134.07 140.98 47.0 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.388 -0.82 . . . . 33.039999999999999 110.364 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' S' S ' 232' ' ' THR . . . . . 0.418 ' O ' ' HA ' ' S' ' 355' ' ' THR . 40.3 m -89.26 103.28 15.92 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.305 -0.872 . . . . 26.920000000000002 110.032 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 233' ' ' LEU . . . . . 0.671 HD22 ' CE2' ' S' ' 262' ' ' TYR . 79.8 mt -55.88 179.24 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.437 -0.79 . . . . 13.779999999999999 110.463 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 234' ' ' TYR . . . . . 0.448 ' CG ' ' N ' ' S' ' 235' ' ' ASN . 35.5 p90 -65.01 -35.66 81.9 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.384 -0.823 . . . . 26.079999999999998 110.168 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 235' ' ' ASN . . . . . 0.448 ' N ' ' CG ' ' S' ' 234' ' ' TYR . 50.6 p30 -74.38 -7.35 52.6 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.336 -0.852 . . . . 20.039999999999999 110.5 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 236' ' ' GLY . . . . . . . . . . . . . . . 95.69 -19.9 52.18 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.777 -1.329 . . . . 22.710000000000001 109.777 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' S' S ' 237' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -52.94 145.68 12.33 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.2 -1.176 . . . . 35.439999999999998 110.236 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' S' S ' 238' ' ' LYS . . . . . . . . . . . . . 44.5 mttt -102.18 127.92 48.91 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.358 -0.839 . . . . 32.560000000000002 110.41 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' S' S ' 239' ' ' LYS . . . . . 0.408 ' HG2' ' CZ ' ' S' ' 241' ' ' PHE . 9.0 ttmt -132.29 144.55 50.67 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.371 -0.831 . . . . 26.68 109.919 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 240' ' ' THR . . . . . . . . . . . . . 52.1 m -102.07 132.18 48.09 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.304 -0.872 . . . . 41.020000000000003 110.334 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' S' S ' 241' ' ' PHE . . . . . 0.408 ' CZ ' ' HG2' ' S' ' 239' ' ' LYS . 96.0 m-85 -117.94 137.66 52.68 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.335 -0.853 . . . . 28.620000000000001 110.21 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 242' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -96.32 161.78 13.79 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.302 -0.874 . . . . 47.890000000000001 110.198 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' S' S ' 243' ' ' SER . . . . . . . . . . . . . 71.5 m -90.58 151.47 21.3 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.332 -0.855 . . . . 45.090000000000003 110.227 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' S' S ' 244' ' ' ARG . . . . . . . . . . . . . 1.4 mtp85 -129.69 126.77 22.78 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.349 -0.844 . . . . 42.490000000000002 110.247 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' S' S ' 245' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.35 161.0 43.74 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.74 1.389 . . . . 35.68 110.561 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' S' S ' 246' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -132.87 97.87 4.15 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.408 -0.807 . . . . 51.880000000000003 109.867 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' S' S ' 247' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -110.49 -22.22 11.77 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.321 -0.862 . . . . 53.689999999999998 110.655 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' S' S ' 248' ' ' HIS . . . . . . . . . . . . . 76.5 m80 -117.21 43.61 2.28 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.16 -0.963 . . . . 55.789999999999999 110.761 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' S' S ' 249' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 48.77 38.46 11.85 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.417 -0.802 . . . . 49.450000000000003 110.39 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' S' S ' 250' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -90.65 29.02 1.38 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.496 -0.753 . . . . 36.859999999999999 110.364 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' S' S ' 251' ' ' ALA . . . . . . . . . . . . . . . -53.79 -43.23 69.12 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.281 -0.887 . . . . 29.690000000000001 109.563 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' S' S ' 252' ' ' TRP . . . . . 0.426 ' CZ2' ' HB3' ' S' ' 294' ' ' LEU . 67.9 p-90 -61.76 -33.95 74.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.602 -0.686 . . . . 41.119999999999997 109.886 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 253' ' ' LEU . . . . . . . . . . . . . 23.4 tp -70.11 -47.23 62.66 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.446 -0.783 . . . . 24.890000000000001 110.016 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' S' S ' 254' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -56.16 -42.44 77.03 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.299 -0.875 . . . . 35.649999999999999 109.975 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' S' S ' 255' ' ' ALA . . . . . . . . . . . . . . . -59.57 -48.1 82.97 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.447 -0.783 . . . . 22.73 110.141 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' S' S ' 256' ' ' ILE . . . . . 0.507 HG12 HD11 ' S' ' 304' ' ' ILE . 79.7 mt -62.32 -40.7 88.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.273 -0.892 . . . . 28.850000000000001 109.924 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 257' ' ' LEU . . . . . 0.404 ' CD2' ' HB3' ' S' ' 268' ' ' PHE . 19.0 mt -61.54 -44.48 96.98 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.354 -0.841 . . . . 23.07 110.168 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 258' ' ' GLN . . . . . 0.501 ' HB3' ' CD2' ' S' ' 351' ' ' PHE . 53.4 mm-40 -65.09 -45.33 85.66 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.398 -0.814 . . . . 29.780000000000001 109.953 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 259' ' ' LEU . . . . . 0.419 ' O ' HG22 ' S' ' 263' ' ' VAL . 19.9 tp -58.73 -36.27 74.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.285 -0.885 . . . . 17.940000000000001 109.484 179.179 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 260' ' ' PHE . . . . . 0.528 ' CE2' HD21 ' S' ' 311' ' ' LEU . 3.1 m-85 -62.89 -45.24 93.44 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.663 -0.648 . . . . 30.57 109.808 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 261' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -62.08 -29.82 70.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.454 -0.779 . . . . 41.340000000000003 110.015 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' S' S ' 262' ' ' TYR . . . . . 0.671 ' CE2' HD22 ' S' ' 233' ' ' LEU . 8.7 t80 -71.17 -44.6 65.17 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.416 -0.802 . . . . 26.030000000000001 110.137 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 263' ' ' VAL . . . . . 0.419 HG22 ' O ' ' S' ' 259' ' ' LEU . 33.0 m -92.06 18.23 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.385 -0.822 . . . . 22.800000000000001 110.412 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 264' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 52.76 70.67 0.55 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.291 -0.881 . . . . 44.030000000000001 110.568 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' S' S ' 265' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -111.77 109.16 55.53 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.257 -0.902 . . . . 35.609999999999999 109.716 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' S' S ' 266' ' ' PRO . . . . . 0.477 ' HA ' ' HB2' ' S' ' 269' ' ' ASP . 49.0 Cg_endo -75.24 0.37 9.08 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.579 1.305 . . . . 37.670000000000002 111.728 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 267' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -56.53 -67.65 0.29 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.806 -1.184 . . . . 41.490000000000002 110.203 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 268' ' ' PHE . . . . . 0.404 ' HB3' ' CD2' ' S' ' 257' ' ' LEU . 22.4 m-85 -92.91 39.85 1.05 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.164 -0.96 . . . . 50.759999999999998 110.098 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 269' ' ' ASP . . . . . 0.477 ' HB2' ' HA ' ' S' ' 266' ' ' PRO . 0.9 OUTLIER -76.0 -33.16 59.7 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.322 -0.861 . . . . 61.859999999999999 109.83 179.543 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' S' S ' 270' ' ' TRP . . . . . 0.505 ' CE2' HG23 ' S' ' 271' ' ' VAL . 51.0 p-90 -73.97 -4.28 34.28 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.208 -0.932 . . . . 39.850000000000001 110.489 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 271' ' ' VAL . . . . . 0.505 HG23 ' CE2' ' S' ' 270' ' ' TRP . 46.5 t -109.5 -32.77 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.129 -0.982 . . . . 39.18 110.051 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 272' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -78.65 -36.47 43.83 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.384 -0.822 . . . . 40.020000000000003 110.514 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' S' S ' 273' ' ' SER . . . . . . . . . . . . . 70.9 m -103.59 56.08 0.74 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.269 -0.894 . . . . 47.200000000000003 110.291 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' S' S ' 274' ' ' SER . . . . . . . . . . . . . 6.9 t -133.04 141.23 40.17 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.371 -0.83 . . . . 47.609999999999999 110.108 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' S' S ' 275' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.74 -18.92 21.7 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 O-C-N 123.617 1.325 . . . . 45.280000000000001 110.583 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' S' S ' 276' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -99.88 140.88 33.46 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.247 -0.908 . . . . 57.270000000000003 110.288 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' S' S ' 277' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -71.66 97.56 1.75 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.368 -0.832 . . . . 37.280000000000001 110.272 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' S' S ' 278' ' ' LEU . . . . . . . . . . . . . 86.5 mt -96.97 33.87 1.83 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.329 -0.857 . . . . 43.880000000000003 110.023 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' S' S ' 279' ' ' THR . . . . . . . . . . . . . 78.1 m -64.12 -60.08 3.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.505 -0.747 . . . . 50.049999999999997 110.273 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' S' S ' 280' ' ' LEU . . . . . 0.724 ' HA ' HD12 ' S' ' 283' ' ' ILE . 13.7 mt -51.58 -39.92 58.8 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.352 -0.843 . . . . 54.119999999999997 110.255 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 281' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.41 -49.65 74.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.467 -0.77 . . . . 65.280000000000001 110.108 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 282' ' ' ALA . . . . . . . . . . . . . . . -58.95 -33.95 71.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.439 -0.788 . . . . 46.509999999999998 110.512 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' S' S ' 283' ' ' ILE . . . . . 0.724 HD12 ' HA ' ' S' ' 280' ' ' LEU . 86.0 mt -66.39 -50.82 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.358 -0.839 . . . . 47.299999999999997 110.092 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 284' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -50.52 -57.63 7.67 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.444 -0.785 . . . . 50.719999999999999 110.358 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' S' S ' 285' ' ' GLN . . . . . 0.531 ' HG2' HD12 ' S' ' 289' ' ' LEU . 34.4 tt0 -51.41 -46.36 62.89 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.578 -0.701 . . . . 68.469999999999999 110.346 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 286' ' ' LEU . . . . . . . . . . . . . 19.0 mt -59.96 -44.53 94.37 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.448 -0.782 . . . . 36.619999999999997 110.245 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' S' S ' 287' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -62.78 -35.21 79.09 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.288 -0.883 . . . . 46.640000000000001 110.083 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' S' S ' 288' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -76.25 -21.03 56.82 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.361 -0.837 . . . . 46.450000000000003 110.307 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' S' S ' 289' ' ' LEU . . . . . 0.531 HD12 ' HG2' ' S' ' 285' ' ' GLN . 30.7 mt -97.35 -21.73 17.04 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.288 -0.883 . . . . 35.090000000000003 110.524 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 290' ' ' THR . . . . . 0.413 HG22 ' HB3' ' S' ' 306' ' ' ASN . 81.3 p -114.78 -28.35 7.12 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.246 -0.909 . . . . 38.609999999999999 110.455 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 291' ' ' GLY . . . . . . . . . . . . . . . 79.31 10.99 85.45 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.856 -1.298 . . . . 36.770000000000003 109.856 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' S' S ' 292' ' ' LEU . . . . . . . . . . . . . 84.8 mt -96.41 145.81 25.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.304 -1.116 . . . . 35.329999999999998 109.799 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' S' S ' 293' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -77.32 102.4 6.73 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.15 -0.969 . . . . 48.700000000000003 110.302 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' S' S ' 294' ' ' LEU . . . . . 0.426 ' HB3' ' CZ2' ' S' ' 252' ' ' TRP . 55.7 mt -106.93 51.71 0.73 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.521 -0.737 . . . . 42.609999999999999 110.1 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 295' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -112.51 -11.11 13.65 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.365 -0.834 . . . . 55.490000000000002 110.531 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 296' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -144.37 48.55 1.36 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.167 -0.958 . . . . 75.680000000000007 110.261 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' S' S ' 297' ' ' GLY . . . . . 0.602 ' HA3' ' HA ' ' R' ' 201' ' ' LYS . . . 96.84 145.2 18.73 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.467 -1.453 . . . . 49.439999999999998 109.467 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 298' ' ' GLY . . . . . . . . . . . . . . . -163.86 156.99 29.1 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.8 -1.32 . . . . 41.109999999999999 109.8 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' S' S ' 299' ' ' PRO . . . . . 0.484 ' O ' HG23 ' S' ' 303' ' ' VAL . 46.6 Cg_endo -73.86 118.28 5.37 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 124.008 1.531 . . . . 26.199999999999999 110.209 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 300' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.29 -15.49 31.52 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 O-C-N 123.584 1.307 . . . . 21.699999999999999 110.665 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' S' S ' 301' ' ' ALA . . . . . . . . . . . . . . . -80.63 -29.34 36.76 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.295 -0.878 . . . . 31.23 110.13 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' S' S ' 302' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.56 -40.62 18.89 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.391 -0.818 . . . . 38.990000000000002 109.941 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 303' ' ' VAL . . . . . 0.484 HG23 ' O ' ' S' ' 299' ' ' PRO . 58.0 t -60.7 -35.47 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.487 -0.758 . . . . 18.629999999999999 110.167 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 304' ' ' ILE . . . . . 0.522 HD12 HG21 ' S' ' 379' ' ' VAL . 86.1 mt -79.35 -23.61 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.44 -0.787 . . . . 25.460000000000001 110.229 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 305' ' ' TRP . . . . . 0.417 ' NE1' ' NH1' ' R' ' 120' ' ' ARG . 68.8 t-105 -88.64 -14.56 37.17 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.31 -0.869 . . . . 33.399999999999999 110.599 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 306' ' ' ASN . . . . . 0.413 ' HB3' HG22 ' S' ' 290' ' ' THR . 10.4 m-80 -89.67 -13.62 36.59 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.291 -0.88 . . . . 36.969999999999999 110.394 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 307' ' ' ILE . . . . . 0.469 HG12 ' O ' ' S' ' 303' ' ' VAL . 36.9 pt -125.02 45.69 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.255 -0.903 . . . . 30.809999999999999 110.043 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 308' ' ' LYS . . . . . 0.411 ' HD3' ' CD2' ' S' ' 305' ' ' TRP . 1.5 mtmp? -73.63 -37.76 65.26 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.373 -0.83 . . . . 46.520000000000003 110.064 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 309' ' ' HIS . . . . . 0.495 ' CD2' ' HG ' ' S' ' 310' ' ' LEU . 55.6 p-80 -73.15 -8.21 54.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.263 -0.898 . . . . 51.030000000000001 110.187 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 310' ' ' LEU . . . . . 0.495 ' HG ' ' CD2' ' S' ' 309' ' ' HIS . 53.0 mt -99.31 -12.84 19.97 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.317 -0.864 . . . . 36.159999999999997 109.969 179.269 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 311' ' ' LEU . . . . . 0.528 HD21 ' CE2' ' S' ' 260' ' ' PHE . 10.8 mt -97.21 147.9 23.63 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.377 -0.827 . . . . 40.0 110.355 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 312' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -81.67 -16.23 51.97 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.262 -0.899 . . . . 54.18 109.698 179.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' S' S ' 313' ' ' THR . . . . . 0.829 HG23 ' HG2' ' S' ' 323' ' ' GLU . 92.7 m -87.97 151.63 22.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.38 -0.825 . . . . 25.609999999999999 110.149 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 314' ' ' GLY . . . . . . . . . . . . . . . -87.86 126.33 8.0 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.83 -1.308 . . . . 25.18 109.83 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' S' S ' 315' ' ' ILE . . . . . 0.668 HD13 ' HB ' ' S' ' 324' ' ' VAL . 50.6 mm -101.58 150.53 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.416 -1.049 . . . . 23.899999999999999 109.724 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 316' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' S' ' 325' ' ' CYS . . . -157.1 -159.23 9.36 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.026 -1.23 . . . . 23.18 110.026 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 317' ' ' THR . . . . . 0.423 HG22 ' CG2' ' S' ' 326' ' ' VAL . 11.2 p -133.95 -173.04 3.14 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.442 -1.034 . . . . 27.98 109.967 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.58 -56.16 25.44 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.191 -0.943 . . . . 28.100000000000001 109.927 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' S' S ' 319' ' ' SER . . . . . . . . . . . . . 1.2 m -59.9 -41.69 92.2 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.382 -0.824 . . . . 37.0 109.664 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' S' S ' 320' ' ' ARG . . . . . . . . . . . . . 12.1 mtm180 -111.69 79.85 2.63 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.445 -0.784 . . . . 52.07 109.652 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' S' S ' 321' ' ' PRO . . . . . 0.814 ' CG ' ' O ' ' S' ' 386' ' ' GLU . 43.9 Cg_endo -71.44 171.6 15.88 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.83 1.437 . . . . 38.289999999999999 110.937 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 322' ' ' SER . . . . . 0.444 ' HB2' ' O ' ' S' ' 321' ' ' PRO . 41.3 t 178.58 -148.13 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.924 -0.769 . . . . 38.840000000000003 108.924 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 323' ' ' GLU . . . . . 0.829 ' HG2' HG23 ' S' ' 313' ' ' THR . 6.7 tp10 -62.82 -40.33 97.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.946 -1.096 . . . . 40.700000000000003 109.682 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 324' ' ' VAL . . . . . 0.668 ' HB ' HD13 ' S' ' 315' ' ' ILE . 73.5 t -141.28 134.97 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.427 -0.796 . . . . 20.34 109.507 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 325' ' ' CYS . . . . . 0.46 ' HB2' ' CE1' ' S' ' 380' ' ' PHE . 11.3 m -125.98 172.13 10.2 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.385 -0.822 . . . . 30.629999999999999 110.827 -179.049 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 326' ' ' VAL . . . . . 0.644 HG12 HG22 ' S' ' 379' ' ' VAL . 34.5 m -135.41 142.25 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 109.204 -0.665 . . . . 23.899999999999999 109.204 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 327' ' ' VAL . . . . . 0.593 HG11 ' O ' ' S' ' 377' ' ' VAL . 34.5 m -56.34 125.04 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.054 -1.029 . . . . 19.48 110.43 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 328' ' ' ASP . . . . . . . . . . . . . 55.6 p-10 -119.43 11.59 12.2 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.451 -0.781 . . . . 26.43 110.411 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' S' S ' 329' ' ' GLY . . . . . . . . . . . . . . . 119.58 2.26 13.2 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.088 -1.205 . . . . 31.239999999999998 110.088 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' S' S ' 330' ' ' THR . . . . . . . . . . . . . 78.3 m -93.02 129.99 38.76 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.064 -1.256 . . . . 30.050000000000001 110.183 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' S' S ' 331' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -56.8 111.54 1.05 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.217 -0.927 . . . . 37.259999999999998 109.935 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' S' S ' 332' ' ' MET . . . . . . . . . . . . . 87.9 mmm -94.04 162.57 13.83 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.212 -0.93 . . . . 26.23 110.347 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' S' S ' 333' ' ' CYS . . . . . . . . . . . . . 24.9 m -137.3 150.07 47.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.483 -0.761 . . . . 23.559999999999999 109.961 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' S' S ' 334' ' ' LEU . . . . . 0.564 HD11 ' O ' ' S' ' 372' ' ' PRO . 0.1 OUTLIER -52.57 -24.93 9.16 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.334 -0.854 . . . . 28.93 110.457 179.883 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' S' S ' 335' ' ' ALA . . . . . . . . . . . . . . . -88.95 14.39 10.61 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.379 -0.826 . . . . 15.76 110.977 -179.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' S' S ' 336' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -100.51 -17.23 17.23 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.149 -0.969 . . . . 34.920000000000002 110.137 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' S' S ' 337' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -152.37 170.86 19.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.418 -0.801 . . . . 19.030000000000001 110.055 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' S' S ' 338' ' ' HIS . . . . . 0.401 ' HB3' ' CZ ' ' S' ' 383' ' ' TYR . 13.5 p80 -120.7 10.38 10.99 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.318 -0.864 . . . . 18.82 110.465 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 339' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' S' ' 352' ' ' ALA . . . -176.04 155.17 1.54 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.274 -0.891 . . . . 17.18 110.09 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 340' ' ' GLY . . . . . 0.404 ' CA ' ' O ' ' S' ' 379' ' ' VAL . . . 160.87 173.11 29.07 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.013 -1.235 . . . . 18.329999999999998 110.013 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 341' ' ' ILE . . . . . . . . . . . . . 83.9 mt -88.84 138.14 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.498 -1.001 . . . . 18.600000000000001 109.819 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' S' S ' 342' ' ' PHE . . . . . 0.494 ' CE2' ' HB3' ' S' ' 352' ' ' ALA . 70.0 m-85 -120.99 -178.48 3.76 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.299 -0.875 . . . . 23.440000000000001 110.453 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 343' ' ' LEU . . . . . 0.512 HD11 HD21 ' R' ' 200' ' ' LEU . 0.5 OUTLIER -116.8 93.4 4.19 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.408 -0.807 . . . . 35.590000000000003 110.002 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' S' S ' 344' ' ' LYS . . . . . 0.407 ' O ' ' HB3' ' S' ' 348' ' ' HIS . 0.3 OUTLIER -80.85 125.02 29.58 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.26 -0.9 . . . . 38.340000000000003 110.109 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' S' S ' 345' ' ' GLY . . . . . . . . . . . . . . . 62.77 -130.87 43.13 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 108.821 -1.711 . . . . 53.460000000000001 108.821 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' S' S ' 346' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -132.68 150.84 52.1 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.326 -1.102 . . . . 70.909999999999997 110.037 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' S' S ' 347' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 53.27 35.39 19.98 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.353 -0.842 . . . . 47.32 110.433 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' S' S ' 348' ' ' HIS . . . . . 0.407 ' HB3' ' O ' ' S' ' 344' ' ' LYS . 46.5 t60 -150.08 155.94 40.76 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.329 -0.857 . . . . 41.719999999999999 110.303 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 349' ' ' ALA . . . . . 0.459 ' C ' HG13 ' S' ' 350' ' ' VAL . . . -149.88 151.25 33.15 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.326 -0.859 . . . . 22.91 110.441 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 350' ' ' VAL . . . . . 0.459 HG13 ' C ' ' S' ' 349' ' ' ALA . 34.6 m -149.1 169.64 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.514 -0.741 . . . . 21.09 110.023 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 351' ' ' PHE . . . . . 0.501 ' CD2' ' HB3' ' S' ' 258' ' ' GLN . 10.7 t80 -105.39 143.62 33.3 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.155 -0.966 . . . . 25.030000000000001 110.713 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 352' ' ' ALA . . . . . 0.494 ' HB3' ' CE2' ' S' ' 342' ' ' PHE . . . -147.79 151.71 36.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.667 -0.645 . . . . 23.809999999999999 109.715 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 353' ' ' CYS . . . . . . . . . . . . . 26.3 p -153.25 164.91 37.24 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.368 -0.832 . . . . 25.66 110.343 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' S' S ' 354' ' ' VAL . . . . . 0.543 HG22 ' CE2' ' S' ' 359' ' ' TRP . 56.5 t -76.05 118.53 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.361 -0.837 . . . . 34.270000000000003 109.98 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 355' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' S' ' 232' ' ' THR . 52.7 p -117.86 175.14 5.8 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.251 -0.905 . . . . 25.489999999999998 110.332 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 356' ' ' SER . . . . . . . . . . . . . 62.0 p -62.18 -17.72 58.89 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.345 -0.847 . . . . 31.239999999999998 110.71 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' S' S ' 357' ' ' ASN . . . . . . . . . . . . . 45.9 m-20 -107.01 14.22 26.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.201 -0.937 . . . . 28.609999999999999 110.611 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' S' S ' 358' ' ' GLY . . . . . . . . . . . . . . . 111.91 -152.98 17.58 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.984 -1.246 . . . . 22.010000000000002 109.984 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' S' S ' 359' ' ' TRP . . . . . 0.543 ' CE2' HG22 ' S' ' 354' ' ' VAL . 15.4 m95 -91.24 116.68 29.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.371 -1.076 . . . . 25.539999999999999 110.17 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 360' ' ' TYR . . . . . 0.413 ' HA ' ' HA ' ' S' ' 369' ' ' PRO . 1.3 m-85 -103.47 165.79 10.82 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.327 -0.858 . . . . 40.530000000000001 110.107 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 361' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' S' ' 351' ' ' PHE . . . -140.06 130.11 24.9 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.462 -0.774 . . . . 18.039999999999999 110.271 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 362' ' ' ILE . . . . . . . . . . . . . 88.8 mt -95.6 83.67 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.283 -0.885 . . . . 15.640000000000001 110.062 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' S' S ' 363' ' ' ASP . . . . . 0.418 ' O ' ' N ' ' S' ' 365' ' ' GLU . 11.9 t0 -75.25 94.47 3.0 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.298 -0.876 . . . . 35.030000000000001 110.213 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 364' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 53.88 -89.28 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.547 -0.721 . . . . 46.719999999999999 110.621 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' S' S ' 365' ' ' GLU . . . . . 0.418 ' N ' ' O ' ' S' ' 363' ' ' ASP . 23.8 mt-10 -122.7 19.15 10.3 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.091 -1.006 . . . . 56.200000000000003 110.267 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 366' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -117.97 124.99 49.54 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.17 -0.957 . . . . 51.020000000000003 110.421 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' S' S ' 367' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -107.0 127.08 53.13 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.435 -0.791 . . . . 37.590000000000003 110.133 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' S' S ' 368' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -165.47 159.46 13.82 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.229 -0.919 . . . . 31.469999999999999 110.414 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' S' S ' 369' ' ' PRO . . . . . 0.413 ' HA ' ' HA ' ' S' ' 360' ' ' TYR . 46.8 Cg_endo -72.68 139.62 31.19 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 O-C-N 123.903 1.475 . . . . 28.850000000000001 110.505 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 370' ' ' TRP . . . . . . . . . . . . . 67.6 t90 -167.21 113.49 0.76 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.405 -0.81 . . . . 26.940000000000001 110.008 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' S' S ' 371' ' ' THR . . . . . . . . . . . . . 59.8 m -74.78 113.08 20.99 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.317 -0.864 . . . . 20.190000000000001 110.025 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' S' S ' 372' ' ' PRO . . . . . 0.564 ' O ' HD11 ' S' ' 334' ' ' LEU . 48.0 Cg_endo -73.56 157.13 49.17 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.61 1.321 . . . . 28.68 110.609 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 373' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -90.58 147.14 35.73 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.444 -0.785 . . . . 35.719999999999999 109.922 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' S' S ' 374' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -76.0 -6.3 17.23 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 O-C-N 123.632 1.332 . . . . 30.890000000000001 110.502 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' S' S ' 375' ' ' SER . . . . . . . . . . . . . 68.6 p -104.36 -16.94 14.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.207 -0.933 . . . . 29.41 110.436 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' S' S ' 376' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -106.55 43.1 1.18 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.348 -0.845 . . . . 32.890000000000001 110.198 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' S' S ' 377' ' ' VAL . . . . . 0.593 ' O ' HG11 ' S' ' 327' ' ' VAL . 7.3 p -114.68 147.3 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.297 -0.877 . . . . 24.329999999999998 110.207 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 378' ' ' LEU . . . . . . . . . . . . . 52.7 mt -116.02 -58.0 2.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.354 -0.841 . . . . 24.370000000000001 109.626 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' S' S ' 379' ' ' VAL . . . . . 0.644 HG22 HG12 ' S' ' 326' ' ' VAL . 61.2 t -120.66 132.42 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.418 -0.801 . . . . 18.02 109.456 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 380' ' ' PHE . . . . . 0.46 ' CE1' ' HB2' ' S' ' 325' ' ' CYS . 14.4 p90 -142.59 173.89 11.13 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.399 -0.813 . . . . 29.350000000000001 110.614 -179.261 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 381' ' ' VAL . . . . . . . . . . . . . 57.7 t -120.01 107.29 40.06 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.523 -0.735 . . . . 16.34 109.453 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' S' S ' 382' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -71.2 145.62 49.4 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 O-C-N 123.611 1.322 . . . . 20.940000000000001 110.786 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' S' S ' 383' ' ' TYR . . . . . 0.401 ' CZ ' ' HB3' ' S' ' 338' ' ' HIS . 88.4 m-85 -61.1 -53.47 56.72 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.323 -0.861 . . . . 28.93 109.877 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 384' ' ' ASP . . . . . 0.447 ' C ' ' H ' ' S' ' 386' ' ' GLU . 1.5 t70 -107.93 130.93 55.0 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.356 -0.84 . . . . 47.030000000000001 110.357 -176.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 385' ' ' GLN . . . . . 0.433 ' O ' ' C ' ' S' ' 386' ' ' GLU . 6.2 pt20 -66.35 5.5 0.55 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.437 -0.789 . . . . 46.689999999999998 110.281 177.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 386' ' ' GLU . . . . . 0.814 ' O ' ' CG ' ' S' ' 321' ' ' PRO . 14.7 pt-20 -42.37 161.38 0.17 Allowed Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.319 -0.863 . . . . 50.25 109.576 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 387' ' ' PRO . . . . . 0.55 ' O ' ' C ' ' S' ' 388' ' ' LEU . 37.9 Cg_endo -66.45 -12.51 36.01 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 123.725 1.381 . . . . 34.390000000000001 110.576 -177.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 388' ' ' LEU . . . . . 0.56 ' O ' ' CB ' ' S' ' 389' ' ' ASN . 1.9 tt 31.89 78.91 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.443 -0.785 . . . . 38.009999999999998 110.09 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 389' ' ' ASN . . . . . 0.56 ' CB ' ' O ' ' S' ' 388' ' ' LEU . 6.2 t-20 73.75 169.23 0.3 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.343 -0.848 . . . . 45.82 110.079 -179.081 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 390' ' ' GLY . . . . . 0.553 ' O ' ' HB2' ' S' ' 391' ' ' GLU . . . 151.18 -81.18 0.19 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.668 -1.373 . . . . 33.460000000000001 109.668 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 391' ' ' GLU . . . . . 0.553 ' HB2' ' O ' ' S' ' 390' ' ' GLY . 17.4 mt-10 65.53 -64.46 0.19 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.399 -1.06 . . . . 56.579999999999998 110.104 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 392' ' ' TRP . . . . . 0.508 ' N ' ' O ' ' S' ' 390' ' ' GLY . 33.9 p-90 -53.54 -22.25 7.94 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.292 -0.88 . . . . 31.43 110.361 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 393' ' ' LYS . . . . . 0.477 ' O ' HG12 ' S' ' 396' ' ' VAL . 0.1 OUTLIER -46.32 -52.61 12.42 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.271 -0.893 . . . . 39.420000000000002 110.381 -179.989 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' S' S ' 394' ' ' ALA . . . . . 0.558 ' O ' ' CD ' ' S' ' 398' ' ' ARG . . . -76.02 -38.28 57.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.25 -0.906 . . . . 34.329999999999998 110.107 179.075 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 395' ' ' LYS . . . . . 0.609 ' HB3' ' CD1' ' R' ' 143' ' ' LEU . 4.7 mmmm -41.87 -51.33 4.32 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.456 -0.777 . . . . 60.090000000000003 110.26 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 396' ' ' VAL . . . . . 0.81 HG21 ' HB3' ' R' ' 101' ' ' ALA . 7.3 p -69.08 -53.36 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.342 -0.849 . . . . 35.5 110.56 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 397' ' ' GLN . . . . . 0.694 ' N ' HG13 ' S' ' 396' ' ' VAL . 14.2 tt0 -78.16 58.38 2.02 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.142 -0.974 . . . . 49.960000000000001 110.707 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' S' S ' 398' ' ' ARG . . . . . 0.751 ' CB ' ' HA ' ' R' ' 147' ' ' GLU . 0.0 OUTLIER -119.12 -3.86 10.59 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.231 -0.918 . . . . 43.420000000000002 110.679 -178.817 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' S' S ' 399' ' ' LYS . . . . . 0.829 ' CB ' ' HA3' ' R' ' 97' ' ' GLY . 0.3 OUTLIER 41.56 -150.48 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.421 -0.8 . . . . 55.310000000000002 110.127 178.782 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' S' S ' 400' ' ' LEU . . . . . 0.902 HD12 ' CE1' ' R' ' 148' ' ' HIS . 0.0 OUTLIER -120.31 -43.56 2.51 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.399 -0.813 . . . . 41.030000000000001 110.286 179.341 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' S' S ' 401' ' ' LYS . . . . . 0.857 ' N ' HD23 ' S' ' 400' ' ' LEU . 4.3 tttt . . . . . 0 N--CA 1.493 1.677 0 O-C-N 121.352 -0.843 . . . . 61.969999999999999 110.194 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' R' R ' 29' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.193 0.521 . . . . 32.140000000000001 110.255 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' R' R ' 30' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -96.34 141.16 30.0 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.367 -0.833 . . . . 43.359999999999999 110.212 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' R' R ' 31' ' ' LEU . . . . . . . . . . . . . 65.5 mt -134.88 140.63 45.94 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.337 -0.852 . . . . 22.93 110.269 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' R' R ' 32' ' ' THR . . . . . . . . . . . . . 70.6 m -87.61 110.64 20.53 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.33 -0.856 . . . . 22.34 109.9 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' R' R ' 33' ' ' LEU . . . . . 0.595 HD22 ' CE2' ' R' ' 62' ' ' TYR . 80.1 mt -62.45 -172.79 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.307 -0.87 . . . . 21.390000000000001 110.202 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 34' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -74.55 -29.54 61.4 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.355 -0.841 . . . . 34.399999999999999 110.388 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' R' R ' 35' ' ' ASN . . . . . . . . . . . . . 48.3 p30 -77.68 -1.87 33.25 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.348 -0.845 . . . . 30.280000000000001 110.637 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' R' R ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.21 -16.56 59.44 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.733 -1.347 . . . . 36.25 109.733 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' R' R ' 37' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -59.04 161.77 4.83 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.357 -1.084 . . . . 53.799999999999997 110.315 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' R' R ' 38' ' ' LYS . . . . . . . . . . . . . 56.9 mttt -117.78 135.81 53.81 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.426 -0.796 . . . . 49.909999999999997 110.132 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' R' R ' 39' ' ' LYS . . . . . 0.404 ' HG2' ' CZ ' ' R' ' 41' ' ' PHE . 8.1 ttmt -138.76 143.68 39.11 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.468 -0.77 . . . . 35.689999999999998 110.228 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 40' ' ' THR . . . . . . . . . . . . . 23.6 m -102.57 127.98 49.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.41 -0.806 . . . . 34.840000000000003 110.221 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' R' R ' 41' ' ' PHE . . . . . 0.404 ' CZ ' ' HG2' ' R' ' 39' ' ' LYS . 96.6 m-85 -113.02 132.75 55.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.442 -0.786 . . . . 34.420000000000002 110.11 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 42' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -93.3 140.85 29.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.336 -0.852 . . . . 51.460000000000001 110.284 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' R' R ' 43' ' ' SER . . . . . . . . . . . . . 54.3 m -70.82 141.91 51.32 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.412 -0.805 . . . . 41.840000000000003 110.217 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' R' R ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.71 125.4 29.56 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.303 -0.873 . . . . 33.82 110.012 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 45' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -72.12 151.09 55.01 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.59 1.31 . . . . 30.27 110.655 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' R' R ' 46' ' ' ASN . . . . . 0.483 ' ND2' HD22 ' S' ' 400' ' ' LEU . 52.0 t-20 -124.34 109.9 13.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.447 -0.783 . . . . 35.100000000000001 110.054 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 47' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -120.28 -34.88 3.56 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.311 -0.868 . . . . 42.810000000000002 110.54 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' R' R ' 48' ' ' HIS . . . . . 0.441 ' NE2' HD11 ' R' ' 80' ' ' LEU . 73.3 m80 -105.72 45.17 0.98 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.262 -0.899 . . . . 49.969999999999999 110.211 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 49' ' ' ASP . . . . . 0.495 ' OD1' ' CB ' ' S' ' 401' ' ' LYS . 37.7 m-20 50.25 34.69 9.14 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.329 -0.857 . . . . 61.32 110.186 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 50' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -86.28 43.82 1.09 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.333 -0.854 . . . . 51.5 110.623 -179.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' R' R ' 51' ' ' ALA . . . . . 0.528 ' HB2' ' HB2' ' S' ' 400' ' ' LEU . . . -66.14 -46.08 78.75 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.225 -0.922 . . . . 38.770000000000003 109.539 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 52' ' ' TRP . . . . . 0.484 ' CD2' ' N ' ' R' ' 53' ' ' LEU . 68.2 p-90 -58.41 -38.44 77.39 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.413 -0.805 . . . . 26.239999999999998 110.002 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 53' ' ' LEU . . . . . 0.484 ' N ' ' CD2' ' R' ' 52' ' ' TRP . 23.1 tp -66.73 -46.65 74.79 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.351 -0.843 . . . . 26.75 109.984 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 54' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -55.23 -41.65 72.36 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.354 -0.841 . . . . 35.020000000000003 110.113 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' R' R ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.14 -46.1 91.92 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.377 -0.827 . . . . 24.469999999999999 110.163 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' R' R ' 56' ' ' ILE . . . . . 0.432 HG12 HD11 ' R' ' 104' ' ' ILE . 76.1 mt -62.18 -42.23 94.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.332 -0.855 . . . . 26.030000000000001 109.888 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 57' ' ' LEU . . . . . . . . . . . . . 22.5 mt -60.36 -45.56 93.07 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.3 -0.875 . . . . 26.77 109.702 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' R' R ' 58' ' ' GLN . . . . . . . . . . . . . 57.7 mm-40 -63.91 -46.51 84.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.476 -0.765 . . . . 22.32 109.59 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' R' R ' 59' ' ' LEU . . . . . 0.431 ' HA ' ' HE2' ' R' ' 151' ' ' PHE . 24.0 tp -61.45 -37.75 84.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.291 -0.881 . . . . 20.550000000000001 109.396 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 60' ' ' PHE . . . . . 0.528 ' CE2' HD21 ' R' ' 111' ' ' LEU . 2.8 m-85 -61.13 -44.75 96.85 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.628 -0.67 . . . . 20.079999999999998 109.866 179.359 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 61' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -63.11 -36.19 82.78 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.49 -0.756 . . . . 18.800000000000001 110.442 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' R' R ' 62' ' ' TYR . . . . . 0.595 ' CE2' HD22 ' R' ' 33' ' ' LEU . 9.2 t80 -63.04 -41.8 99.58 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.271 -0.893 . . . . 26.449999999999999 110.26 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 63' ' ' VAL . . . . . 0.406 ' H ' HG22 ' R' ' 63' ' ' VAL . 30.0 m -93.34 20.33 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.263 -0.898 . . . . 29.75 110.307 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 64' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 52.96 75.5 0.24 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.328 -0.857 . . . . 35.520000000000003 110.51 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' R' R ' 65' ' ' GLU . . . . . 0.444 ' HG2' ' CD2' ' R' ' 60' ' ' PHE . 14.3 tp10 -116.17 104.09 52.5 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.423 -0.798 . . . . 29.890000000000001 109.944 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 66' ' ' PRO . . . . . 0.479 ' HA ' ' HB2' ' R' ' 69' ' ' ASP . 47.9 Cg_endo -73.46 -5.92 17.92 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.79 1.416 . . . . 21.370000000000001 111.147 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 67' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -52.1 -61.6 2.16 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.038 -1.039 . . . . 23.850000000000001 110.331 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 68' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -98.07 36.57 1.55 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.32 -0.862 . . . . 28.07 110.466 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' R' R ' 69' ' ' ASP . . . . . 0.479 ' HB2' ' HA ' ' R' ' 66' ' ' PRO . 11.7 t0 -72.33 -33.27 67.21 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.342 -0.849 . . . . 43.759999999999998 110.155 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 70' ' ' TRP . . . . . 0.475 ' CE2' ' CG2' ' R' ' 71' ' ' VAL . 47.7 p-90 -73.42 -3.91 30.33 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.334 -0.854 . . . . 33.060000000000002 110.717 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 71' ' ' VAL . . . . . 0.556 HG11 ' HB2' ' R' ' 82' ' ' ALA . 40.8 t -109.8 -27.47 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.112 -0.992 . . . . 31.699999999999999 109.659 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 72' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -86.56 -48.79 8.05 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.407 -0.808 . . . . 33.579999999999998 110.353 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' R' R ' 73' ' ' SER . . . . . . . . . . . . . 69.8 m -89.75 51.06 2.0 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.394 -0.816 . . . . 50.82 110.351 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' R' R ' 74' ' ' SER . . . . . . . . . . . . . 15.9 t -125.95 138.21 31.63 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.278 -0.889 . . . . 34.740000000000002 110.24 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -73.24 -25.01 16.19 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 O-C-N 123.728 1.383 . . . . 35.700000000000003 110.373 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' R' R ' 76' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -91.66 153.12 19.9 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.383 -0.823 . . . . 66.480000000000004 110.428 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' R' R ' 77' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -81.4 95.24 6.98 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.368 -0.832 . . . . 46.719999999999999 110.117 179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' R' R ' 78' ' ' LEU . . . . . . . . . . . . . 96.4 mt -96.45 28.0 3.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.381 -0.825 . . . . 37.549999999999997 110.182 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' R' R ' 79' ' ' THR . . . . . . . . . . . . . 29.6 m -56.2 -54.64 42.82 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.337 -0.852 . . . . 37.359999999999999 110.295 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' R' R ' 80' ' ' LEU . . . . . 0.604 ' HA ' HD12 ' R' ' 83' ' ' ILE . 15.8 mt -60.95 -23.14 65.07 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.348 -0.845 . . . . 35.829999999999998 110.51 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 81' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -79.52 -39.14 32.68 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.133 -0.98 . . . . 44.030000000000001 110.381 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' R' R ' 82' ' ' ALA . . . . . 0.556 ' HB2' HG11 ' R' ' 71' ' ' VAL . . . -69.4 -28.7 66.4 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.26 -0.9 . . . . 32.539999999999999 110.303 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 83' ' ' ILE . . . . . 0.604 HD12 ' HA ' ' R' ' 80' ' ' LEU . 77.7 mt -70.09 -46.06 73.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.253 -0.905 . . . . 32.020000000000003 110.342 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 84' ' ' LYS . . . . . . . . . . . . . 36.0 tttm -55.22 -52.06 64.57 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.179 -0.951 . . . . 34.090000000000003 110.596 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' R' R ' 85' ' ' GLN . . . . . 0.532 ' HG2' HD12 ' R' ' 89' ' ' LEU . 31.9 tt0 -54.8 -46.86 74.54 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.191 -0.943 . . . . 25.940000000000001 110.305 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 86' ' ' LEU . . . . . . . . . . . . . 24.2 mt -58.71 -43.76 90.16 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.267 -0.896 . . . . 16.199999999999999 109.957 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' R' R ' 87' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -65.36 -35.27 80.45 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.393 -0.817 . . . . 49.090000000000003 110.305 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' R' R ' 88' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -78.4 -19.06 54.09 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.284 -0.885 . . . . 28.609999999999999 110.509 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' R' R ' 89' ' ' LEU . . . . . 0.532 HD12 ' HG2' ' R' ' 85' ' ' GLN . 32.4 mt -96.16 -29.43 14.06 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.225 -0.922 . . . . 26.16 110.2 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 90' ' ' THR . . . . . . . . . . . . . 59.9 p -105.77 -34.58 7.64 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.3 -0.875 . . . . 33.329999999999998 109.724 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' R' R ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.85 16.1 58.6 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.821 -1.312 . . . . 31.129999999999999 109.821 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' R' R ' 92' ' ' LEU . . . . . . . . . . . . . 97.1 mt -100.11 155.19 17.87 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.169 -1.195 . . . . 42.520000000000003 110.246 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' R' R ' 93' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -86.15 91.59 8.48 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.471 -0.768 . . . . 68.459999999999994 110.006 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' R' R ' 94' ' ' LEU . . . . . 0.457 ' HB3' ' CZ2' ' R' ' 52' ' ' TRP . 48.2 mt -99.41 53.08 0.95 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.176 -0.952 . . . . 44.630000000000003 110.364 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 95' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.52 -38.7 6.36 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.226 -0.921 . . . . 67.159999999999997 110.376 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 96' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -113.85 44.11 1.69 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.332 -0.855 . . . . 67.019999999999996 110.325 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' R' R ' 97' ' ' GLY . . . . . 0.652 ' HA3' ' CB ' ' S' ' 399' ' ' LYS . . . 99.24 150.83 25.99 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.599 -1.401 . . . . 49.479999999999997 109.599 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 98' ' ' GLY . . . . . . . . . . . . . . . -166.27 160.03 33.46 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.267 -1.533 . . . . 36.57 109.267 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' R' R ' 99' ' ' PRO . . . . . 0.929 ' CB ' HG22 ' S' ' 396' ' ' VAL . 45.5 Cg_endo -72.57 121.11 7.14 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.74 1.39 . . . . 30.41 110.462 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 100' ' ' PRO . . . . . 0.413 ' HA ' HD11 ' R' ' 56' ' ' ILE . 45.7 Cg_endo -72.32 -31.52 11.46 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.637 1.335 . . . . 29.940000000000001 110.545 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 101' ' ' ALA . . . . . 0.475 ' HB2' ' HB3' ' R' ' 178' ' ' LEU . . . -70.07 -38.49 75.77 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.296 -0.878 . . . . 23.640000000000001 110.184 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 102' ' ' LEU . . . . . 0.427 HD23 HD21 ' R' ' 106' ' ' ASN . 0.1 OUTLIER -72.71 -40.66 66.0 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.335 -0.853 . . . . 20.309999999999999 110.411 -179.71 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' R' R ' 103' ' ' VAL . . . . . 0.791 HG23 ' O ' ' R' ' 99' ' ' PRO . 63.3 t -58.15 -40.13 76.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.227 -0.92 . . . . 16.329999999999998 109.986 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 104' ' ' ILE . . . . . 0.432 HD11 HG12 ' R' ' 56' ' ' ILE . 82.0 mt -71.72 -30.47 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.374 -0.829 . . . . 24.77 109.951 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 105' ' ' TRP . . . . . 0.462 ' O ' ' HD3' ' R' ' 108' ' ' LYS . 70.6 t-105 -82.44 0.81 40.5 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.304 -0.873 . . . . 23.280000000000001 110.273 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 106' ' ' ASN . . . . . 0.427 HD21 HD23 ' R' ' 102' ' ' LEU . 6.9 m-80 -105.05 -10.37 17.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.171 -0.956 . . . . 28.260000000000002 110.146 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 107' ' ' ILE . . . . . . . . . . . . . 36.8 pt -126.82 34.9 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.184 -0.947 . . . . 18.77 110.076 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' R' R ' 108' ' ' LYS . . . . . 0.5 ' HG2' ' HB ' ' R' ' 115' ' ' ILE . 9.2 mtpp -60.97 -48.5 81.52 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.516 -0.74 . . . . 42.5 110.06 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 109' ' ' HIS . . . . . 0.446 ' CD2' ' HG ' ' R' ' 110' ' ' LEU . 50.8 p-80 -66.02 -12.87 58.26 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.511 -0.743 . . . . 20.07 110.698 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 110' ' ' LEU . . . . . 0.446 ' HG ' ' CD2' ' R' ' 109' ' ' HIS . 80.5 mt -94.71 -17.38 22.27 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.042 -1.036 . . . . 15.69 110.194 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 111' ' ' LEU . . . . . 0.528 HD21 ' CE2' ' R' ' 60' ' ' PHE . 10.3 mt -94.09 144.17 25.72 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.368 -0.832 . . . . 25.390000000000001 111.016 -179.181 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 112' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -77.71 -17.35 57.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.552 -0.717 . . . . 53.479999999999997 109.835 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' R' R ' 113' ' ' THR . . . . . 0.458 HG22 ' N ' ' R' ' 114' ' ' GLY . 59.6 m -83.71 166.71 17.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.347 -0.846 . . . . 14.800000000000001 110.29 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 114' ' ' GLY . . . . . 0.458 ' N ' HG22 ' R' ' 113' ' ' THR . . . -97.98 127.16 9.13 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.947 -1.261 . . . . 16.140000000000001 109.947 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 115' ' ' ILE . . . . . 0.576 HD13 ' HB ' ' R' ' 124' ' ' VAL . 47.7 mm -109.17 139.36 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.525 -0.985 . . . . 13.460000000000001 109.725 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 116' ' ' GLY . . . . . . . . . . . . . . . -152.72 -155.87 7.29 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.933 -1.267 . . . . 23.899999999999999 109.933 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' R' R ' 117' ' ' THR . . . . . 0.529 HG22 ' CG2' ' R' ' 126' ' ' VAL . 18.9 p -135.03 -171.36 2.78 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.484 -1.01 . . . . 27.370000000000001 110.072 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 118' ' ' ALA . . . . . 0.445 ' HB3' ' OD1' ' R' ' 128' ' ' ASP . . . -56.6 -58.04 9.77 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.297 -0.877 . . . . 18.760000000000002 110.064 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 119' ' ' SER . . . . . 0.609 ' HB3' ' HB ' ' R' ' 196' ' ' VAL . 1.1 m -56.56 -40.56 75.37 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.266 -0.896 . . . . 32.350000000000001 109.787 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 120' ' ' ARG . . . . . 0.419 ' NH1' ' CE2' ' S' ' 305' ' ' TRP . 10.0 mtm180 -110.08 86.23 4.87 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.487 -0.758 . . . . 27.120000000000001 109.673 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 121' ' ' PRO . . . . . 0.483 ' HA ' ' SG ' ' R' ' 125' ' ' CYS . 44.3 Cg_endo -71.24 166.41 29.32 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.874 1.46 . . . . 22.68 111.03 -179.481 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 122' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' R' ' 121' ' ' PRO . 38.5 t 178.61 -161.64 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.61 -0.681 . . . . 22.989999999999998 109.513 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 123' ' ' GLU . . . . . 0.442 ' HG2' HG23 ' R' ' 113' ' ' THR . 2.3 tp10 -56.45 -39.95 74.0 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.211 -0.93 . . . . 36.18 109.762 179.574 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 124' ' ' VAL . . . . . 0.576 ' HB ' HD13 ' R' ' 115' ' ' ILE . 84.6 t -142.55 136.48 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.534 -0.729 . . . . 20.640000000000001 109.43 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 125' ' ' CYS . . . . . 0.483 ' SG ' ' HA ' ' R' ' 121' ' ' PRO . 82.9 m -140.31 168.2 20.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.161 -0.962 . . . . 22.800000000000001 111.136 -179.254 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 126' ' ' VAL . . . . . 0.728 HG12 HG22 ' R' ' 179' ' ' VAL . 35.9 m -122.74 159.8 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.714 -0.616 . . . . 21.239999999999998 109.664 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 127' ' ' VAL . . . . . 0.709 HG11 ' O ' ' R' ' 177' ' ' VAL . 30.7 m -70.86 141.82 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.293 -0.879 . . . . 19.77 110.657 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 128' ' ' ASP . . . . . 0.445 ' OD1' ' HB3' ' R' ' 118' ' ' ALA . 53.9 p-10 -137.73 19.38 2.87 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.327 -0.858 . . . . 29.210000000000001 110.687 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 129' ' ' GLY . . . . . . . . . . . . . . . 114.11 0.0 23.98 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.965 -1.112 . . . . 33.859999999999999 110.469 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' R' R ' 130' ' ' THR . . . . . . . . . . . . . 58.6 m -91.93 131.85 36.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.105 -1.233 . . . . 26.41 110.046 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -62.56 120.65 11.56 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.38 -0.825 . . . . 33.079999999999998 110.302 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' R' R ' 132' ' ' MET . . . . . 0.434 ' HE1' ' CE2' ' R' ' 180' ' ' PHE . 98.4 mmm -105.21 165.66 10.94 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.395 -0.816 . . . . 30.760000000000002 110.435 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 133' ' ' CYS . . . . . 0.411 ' HA ' ' HB3' ' R' ' 174' ' ' PRO . 32.5 m -141.17 158.12 44.33 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.493 -0.754 . . . . 27.0 109.969 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 134' ' ' LEU . . . . . 0.563 HD11 ' O ' ' R' ' 172' ' ' PRO . 0.1 OUTLIER -58.54 -19.68 39.82 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.347 -0.846 . . . . 33.899999999999999 110.444 -179.833 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' R' R ' 135' ' ' ALA . . . . . . . . . . . . . . . -92.72 8.2 40.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.182 -0.949 . . . . 19.370000000000001 110.882 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' R' R ' 136' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -93.76 -21.74 19.13 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.143 -0.973 . . . . 30.469999999999999 110.266 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' R' R ' 137' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -149.98 165.38 32.85 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.341 -0.85 . . . . 24.27 110.204 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' R' R ' 138' ' ' HIS . . . . . 0.434 ' HA ' HG23 ' R' ' 154' ' ' VAL . 15.1 p80 -117.87 15.2 14.33 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.398 -0.814 . . . . 20.91 110.404 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 139' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' R' ' 152' ' ' ALA . . . -177.23 152.35 0.86 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.198 -0.939 . . . . 15.69 110.184 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 140' ' ' GLY . . . . . 0.427 ' HA3' ' O ' ' R' ' 179' ' ' VAL . . . 161.81 175.15 32.53 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.928 -1.269 . . . . 23.760000000000002 109.928 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 141' ' ' ILE . . . . . . . . . . . . . 83.7 mt -95.51 136.56 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.358 -1.084 . . . . 25.300000000000001 109.713 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' R' R ' 142' ' ' PHE . . . . . 0.576 ' CD2' ' HB2' ' R' ' 172' ' ' PRO . 83.0 m-85 -120.73 -172.52 2.4 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.375 -0.828 . . . . 30.239999999999998 110.528 -179.478 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 143' ' ' LEU . . . . . 0.777 HD11 ' O ' ' S' ' 395' ' ' LYS . 0.5 OUTLIER -119.86 77.73 1.26 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.417 -0.802 . . . . 32.799999999999997 110.289 -179.902 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' R' R ' 144' ' ' LYS . . . . . 0.471 ' HG3' ' CZ2' ' R' ' 170' ' ' TRP . 1.0 OUTLIER -69.5 76.82 0.41 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.437 -0.789 . . . . 49.18 109.676 179.575 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' R' R ' 145' ' ' GLY . . . . . 0.457 ' O ' HD22 ' R' ' 143' ' ' LEU . . . 104.48 179.24 24.86 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.203 -1.559 . . . . 53.869999999999997 109.203 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 146' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -88.47 145.85 25.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.358 -1.083 . . . . 68.579999999999998 109.982 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' R' R ' 147' ' ' GLU . . . . . 0.622 ' O ' ' C ' ' S' ' 399' ' ' LYS . 10.9 mt-10 58.21 36.47 25.78 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.26 -0.9 . . . . 56.619999999999997 110.665 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 148' ' ' HIS . . . . . 0.884 ' CE1' HD13 ' S' ' 400' ' ' LEU . 44.6 t60 -158.61 148.17 19.31 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.193 -0.942 . . . . 44.57 110.376 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 149' ' ' ALA . . . . . 0.508 ' HB3' ' NH1' ' S' ' 398' ' ' ARG . . . -150.29 146.92 27.06 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.427 -0.796 . . . . 33.539999999999999 110.078 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 150' ' ' VAL . . . . . . . . . . . . . 34.2 m -142.38 161.47 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.234 -0.916 . . . . 27.609999999999999 110.301 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' R' R ' 151' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' R' ' 152' ' ' ALA . 5.9 t80 -86.18 155.57 20.68 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.402 -0.811 . . . . 23.039999999999999 109.918 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 152' ' ' ALA . . . . . 0.537 ' N ' ' CD1' ' R' ' 151' ' ' PHE . . . -157.28 151.57 24.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.438 -0.789 . . . . 29.609999999999999 109.601 179.011 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 153' ' ' CYS . . . . . . . . . . . . . 26.7 p -154.28 173.61 15.93 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.268 -0.895 . . . . 22.75 110.407 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' R' R ' 154' ' ' VAL . . . . . 0.613 HG22 ' CE2' ' R' ' 159' ' ' TRP . 60.3 t -90.63 117.03 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.383 -0.823 . . . . 23.260000000000002 110.061 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 155' ' ' THR . . . . . . . . . . . . . 70.3 p -112.13 -176.62 2.97 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.356 -0.84 . . . . 17.879999999999999 110.041 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' R' R ' 156' ' ' SER . . . . . . . . . . . . . 78.5 p -75.92 -3.74 37.08 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.33 -0.856 . . . . 21.829999999999998 110.678 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' R' R ' 157' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -118.3 10.51 12.83 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.207 -0.933 . . . . 36.539999999999999 110.652 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' R' R ' 158' ' ' GLY . . . . . . . . . . . . . . . 117.96 -162.58 13.06 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.559 -1.416 . . . . 31.739999999999998 109.559 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' R' R ' 159' ' ' TRP . . . . . 0.613 ' CE2' HG22 ' R' ' 154' ' ' VAL . 14.6 m95 -86.68 122.5 30.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.35 -1.088 . . . . 28.25 110.109 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 160' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -108.46 166.94 10.39 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.345 -0.847 . . . . 41.240000000000002 110.19 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' R' R ' 161' ' ' ALA . . . . . . . . . . . . . . . -143.18 123.5 13.84 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.403 -0.81 . . . . 27.399999999999999 110.151 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' R' R ' 162' ' ' ILE . . . . . . . . . . . . . 92.2 mt -87.63 81.11 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.373 -0.829 . . . . 24.27 110.078 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' R' R ' 163' ' ' ASP . . . . . 0.415 ' O ' ' N ' ' R' ' 165' ' ' GLU . 15.3 t0 -72.74 92.35 1.55 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.389 -0.819 . . . . 36.079999999999998 110.277 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 164' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 54.06 -88.89 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.526 -0.734 . . . . 46.079999999999998 110.556 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' R' R ' 165' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' R' ' 163' ' ' ASP . 29.6 mt-10 -124.72 35.82 4.72 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.151 -0.968 . . . . 50.939999999999998 110.148 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 166' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -135.67 117.36 14.99 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.362 -0.836 . . . . 47.280000000000001 110.353 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' R' R ' 167' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -101.12 119.96 39.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.401 -0.812 . . . . 40.469999999999999 110.083 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' R' R ' 168' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -157.51 158.61 30.74 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.25 -0.906 . . . . 30.210000000000001 110.466 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' R' R ' 169' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.81 133.07 19.48 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.928 1.488 . . . . 32.759999999999998 110.5 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' R' R ' 170' ' ' TRP . . . . . 0.471 ' CZ2' ' HG3' ' R' ' 144' ' ' LYS . 67.1 t90 -159.83 119.35 2.88 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.34 -0.85 . . . . 32.789999999999999 109.965 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 171' ' ' THR . . . . . . . . . . . . . 46.9 m -81.09 112.58 33.91 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.431 -0.793 . . . . 36.920000000000002 110.155 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' R' R ' 172' ' ' PRO . . . . . 0.576 ' HB2' ' CD2' ' R' ' 142' ' ' PHE . 47.0 Cg_endo -73.67 158.76 46.79 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.622 1.328 . . . . 33.539999999999999 110.548 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 173' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -88.91 145.03 33.81 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.324 -0.86 . . . . 45.759999999999998 109.86 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' R' R ' 174' ' ' PRO . . . . . 0.411 ' HB3' ' HA ' ' R' ' 133' ' ' CYS . 45.2 Cg_endo -71.85 -10.28 26.07 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 O-C-N 123.71 1.374 . . . . 29.629999999999999 110.41 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 175' ' ' SER . . . . . . . . . . . . . 53.0 p -103.44 -17.64 15.15 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.348 -0.845 . . . . 35.700000000000003 110.366 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' R' R ' 176' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -103.51 43.29 1.09 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.268 -0.895 . . . . 39.649999999999999 110.418 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' R' R ' 177' ' ' VAL . . . . . 0.709 ' O ' HG11 ' R' ' 127' ' ' VAL . 10.7 p -117.72 127.06 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.3 -0.875 . . . . 20.609999999999999 110.094 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 178' ' ' LEU . . . . . 0.475 ' HB3' ' HB2' ' R' ' 101' ' ' ALA . 46.2 mt -91.42 -61.3 1.68 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.349 -0.845 . . . . 15.58 109.392 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 179' ' ' VAL . . . . . 0.728 HG22 HG12 ' R' ' 126' ' ' VAL . 68.6 t -114.64 144.76 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.561 -0.712 . . . . 17.399999999999999 109.384 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 180' ' ' PHE . . . . . 0.434 ' CE2' ' HE1' ' R' ' 132' ' ' MET . 43.6 p90 -152.15 163.36 39.54 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.197 -0.94 . . . . 20.16 110.63 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 181' ' ' VAL . . . . . . . . . . . . . 66.2 t -113.17 111.44 50.27 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.375 -0.828 . . . . 17.690000000000001 109.836 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' R' R ' 182' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.03 149.49 52.84 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.532 1.28 . . . . 17.809999999999999 110.409 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' R' R ' 183' ' ' TYR . . . . . 0.712 ' O ' ' C ' ' R' ' 184' ' ' ASP . 79.1 m-85 -59.03 175.52 0.28 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.458 -0.776 . . . . 28.010000000000002 110.504 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 184' ' ' ASP . . . . . 0.712 ' C ' ' O ' ' R' ' 183' ' ' TYR . 15.0 t70 -17.26 -81.98 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.353 -0.842 . . . . 58.640000000000001 110.313 -178.083 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 185' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 . . . . . 0 N--CA 1.503 2.2 0 CA-C-O 121.277 0.56 . . . . 80.420000000000002 111.791 179.553 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' R' R ' 193' ' ' LYS . . . . . . . . . . . . . 26.8 tptt . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 120.907 0.384 . . . . 49.5 110.145 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' R' R ' 194' ' ' ALA . . . . . 0.461 ' CB ' ' HA ' ' R' ' 119' ' ' SER . . . -174.45 -155.74 0.06 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.12 -0.988 . . . . 40.399999999999999 110.082 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 195' ' ' LYS . . . . . 0.602 ' CG ' HG23 ' R' ' 196' ' ' VAL . 0.0 OUTLIER -99.29 -27.05 13.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.427 -0.796 . . . . 34.600000000000001 110.266 179.925 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' R' R ' 196' ' ' VAL . . . . . 0.636 HG21 ' HA ' ' S' ' 328' ' ' ASP . 2.0 t -109.8 31.08 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.262 -0.899 . . . . 33.270000000000003 110.637 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 197' ' ' GLN . . . . . 0.469 ' HA ' HD11 ' S' ' 302' ' ' LEU . 0.1 OUTLIER -147.92 38.07 0.9 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.098 -1.001 . . . . 41.579999999999998 110.648 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' R' R ' 198' ' ' ARG . . . . . . . . . . . . . 6.1 ptt-85 -129.85 149.67 51.48 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.135 -0.978 . . . . 38.649999999999999 110.227 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' R' R ' 199' ' ' LYS . . . . . 0.629 ' HA ' ' HD3' ' S' ' 299' ' ' PRO . 28.5 mtpt -84.02 103.98 13.71 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.462 -0.774 . . . . 36.770000000000003 109.992 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 200' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -85.98 -153.26 0.18 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.303 -0.873 . . . . 33.079999999999998 110.195 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' R' R ' 201' ' ' LYS . . . . . 0.458 ' HA ' ' CA ' ' S' ' 297' ' ' GLY . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.675 0 O-C-N 121.348 -0.845 . . . . 44.32 110.304 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 229' ' ' MET . . . . . . . . . . . . . 15.9 mmm . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.231 0.539 . . . . 51.829999999999998 110.228 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' S' S ' 230' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -97.31 142.76 28.8 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.292 -0.88 . . . . 54.130000000000003 110.133 -178.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' S' S ' 231' ' ' LEU . . . . . . . . . . . . . 68.3 mt -134.13 141.05 46.97 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.306 -0.871 . . . . 33.039999999999999 110.372 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' S' S ' 232' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' S' ' 355' ' ' THR . 40.3 m -89.28 103.25 15.89 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.362 -0.836 . . . . 26.920000000000002 110.0 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 233' ' ' LEU . . . . . 0.667 HD22 ' CE2' ' S' ' 262' ' ' TYR . 79.7 mt -55.88 179.3 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.418 -0.801 . . . . 13.779999999999999 110.493 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 234' ' ' TYR . . . . . 0.448 ' CG ' ' N ' ' S' ' 235' ' ' ASN . 35.5 p90 -64.96 -35.73 82.13 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.453 -0.779 . . . . 26.079999999999998 110.213 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 235' ' ' ASN . . . . . 0.448 ' N ' ' CG ' ' S' ' 234' ' ' TYR . 50.7 p30 -74.29 -7.42 52.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.289 -0.882 . . . . 20.039999999999999 110.601 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 236' ' ' GLY . . . . . . . . . . . . . . . 95.74 -19.91 52.21 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.748 -1.341 . . . . 22.710000000000001 109.748 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' S' S ' 237' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -53.08 145.74 12.65 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.243 -1.151 . . . . 35.439999999999998 110.165 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' S' S ' 238' ' ' LYS . . . . . . . . . . . . . 44.5 mttt -102.15 127.97 48.84 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.391 -0.818 . . . . 32.560000000000002 110.337 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' S' S ' 239' ' ' LYS . . . . . 0.414 ' HG2' ' CZ ' ' S' ' 241' ' ' PHE . 9.0 ttmt -132.29 144.49 50.63 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.391 -0.818 . . . . 26.68 109.949 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 240' ' ' THR . . . . . . . . . . . . . 51.3 m -102.06 132.2 48.07 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.329 -0.857 . . . . 41.020000000000003 110.39 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' S' S ' 241' ' ' PHE . . . . . 0.414 ' CZ ' ' HG2' ' S' ' 239' ' ' LYS . 96.1 m-85 -117.88 137.72 52.6 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.364 -0.835 . . . . 28.620000000000001 110.195 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 242' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -96.44 161.83 13.75 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.365 -0.835 . . . . 47.890000000000001 110.163 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' S' S ' 243' ' ' SER . . . . . . . . . . . . . 72.4 m -90.59 151.58 21.25 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.295 -0.878 . . . . 45.090000000000003 110.241 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' S' S ' 244' ' ' ARG . . . . . . . . . . . . . 1.4 mtp85 -129.81 126.75 22.69 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.402 -0.811 . . . . 42.490000000000002 110.162 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' S' S ' 245' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.37 161.05 43.57 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 O-C-N 123.666 1.351 . . . . 35.68 110.503 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' S' S ' 246' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -132.94 97.88 4.14 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.391 -0.818 . . . . 51.880000000000003 109.82 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' S' S ' 247' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -110.5 -22.23 11.77 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.4 -0.813 . . . . 53.689999999999998 110.643 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' S' S ' 248' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -117.21 43.63 2.28 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.178 -0.951 . . . . 55.789999999999999 110.774 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' S' S ' 249' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 48.77 38.43 11.79 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.443 -0.785 . . . . 49.450000000000003 110.381 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' S' S ' 250' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -90.62 29.07 1.36 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.521 -0.737 . . . . 36.859999999999999 110.31 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' S' S ' 251' ' ' ALA . . . . . . . . . . . . . . . -53.9 -43.13 69.42 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.322 -0.861 . . . . 29.690000000000001 109.56 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' S' S ' 252' ' ' TRP . . . . . 0.42 ' CZ2' ' HB3' ' S' ' 294' ' ' LEU . 67.8 p-90 -61.83 -33.97 75.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.556 -0.715 . . . . 41.119999999999997 109.832 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 253' ' ' LEU . . . . . 0.407 ' N ' ' CD2' ' S' ' 252' ' ' TRP . 23.3 tp -70.11 -47.14 63.07 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.335 -0.853 . . . . 24.890000000000001 110.002 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 254' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -56.23 -42.51 77.41 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.326 -0.859 . . . . 35.649999999999999 109.909 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' S' S ' 255' ' ' ALA . . . . . . . . . . . . . . . -59.47 -48.13 82.83 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.402 -0.811 . . . . 22.73 110.115 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' S' S ' 256' ' ' ILE . . . . . 0.505 HG12 HD11 ' S' ' 304' ' ' ILE . 79.9 mt -62.31 -40.72 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.326 -0.858 . . . . 28.850000000000001 109.986 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 257' ' ' LEU . . . . . . . . . . . . . 19.1 mt -61.49 -44.52 96.92 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.405 -0.809 . . . . 23.07 110.186 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' S' S ' 258' ' ' GLN . . . . . 0.502 ' HB3' ' CD2' ' S' ' 351' ' ' PHE . 53.5 mm-40 -65.04 -45.3 85.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.402 -0.811 . . . . 29.780000000000001 109.993 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 259' ' ' LEU . . . . . 0.415 ' O ' HG22 ' S' ' 263' ' ' VAL . 20.0 tp -58.71 -36.41 74.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.236 -0.915 . . . . 17.940000000000001 109.453 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 260' ' ' PHE . . . . . 0.521 ' CE2' HD21 ' S' ' 311' ' ' LEU . 3.1 m-85 -62.77 -45.35 93.07 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.624 -0.673 . . . . 30.57 109.857 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 261' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -62.01 -29.8 70.52 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.432 -0.792 . . . . 41.340000000000003 109.98 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' S' S ' 262' ' ' TYR . . . . . 0.667 ' CE2' HD22 ' S' ' 233' ' ' LEU . 8.7 t80 -71.15 -44.68 65.06 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.415 -0.803 . . . . 26.030000000000001 110.102 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 263' ' ' VAL . . . . . 0.415 HG22 ' O ' ' S' ' 259' ' ' LEU . 33.0 m -91.93 18.19 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.293 -0.88 . . . . 22.800000000000001 110.403 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 264' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 52.75 70.71 0.55 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.26 -0.9 . . . . 44.030000000000001 110.586 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' S' S ' 265' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -111.79 109.17 55.5 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.332 -0.855 . . . . 35.609999999999999 109.716 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' S' S ' 266' ' ' PRO . . . . . 0.479 ' HA ' ' HB2' ' S' ' 269' ' ' ASP . 49.9 Cg_endo -75.33 0.48 8.99 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 O-C-N 123.637 1.335 . . . . 37.670000000000002 111.768 -179.114 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 267' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -56.58 -67.71 0.28 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.797 -1.189 . . . . 41.490000000000002 110.18 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 268' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -92.81 39.83 1.04 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.177 -0.952 . . . . 50.759999999999998 110.124 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' S' S ' 269' ' ' ASP . . . . . 0.479 ' HB2' ' HA ' ' S' ' 266' ' ' PRO . 0.9 OUTLIER -75.99 -33.21 59.72 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.424 -0.798 . . . . 61.859999999999999 109.806 179.559 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' S' S ' 270' ' ' TRP . . . . . 0.514 ' CE2' HG23 ' S' ' 271' ' ' VAL . 50.9 p-90 -73.9 -4.35 34.5 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.279 -0.888 . . . . 39.850000000000001 110.5 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 271' ' ' VAL . . . . . 0.514 HG23 ' CE2' ' S' ' 270' ' ' TRP . 46.5 t -109.49 -32.68 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.15 -0.969 . . . . 39.18 110.088 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 272' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -78.68 -36.53 43.56 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.443 -0.786 . . . . 40.020000000000003 110.489 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' S' S ' 273' ' ' SER . . . . . . . . . . . . . 71.0 m -103.53 56.07 0.74 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.292 -0.88 . . . . 47.200000000000003 110.314 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' S' S ' 274' ' ' SER . . . . . . . . . . . . . 6.9 t -133.01 141.24 40.23 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.317 -0.865 . . . . 47.609999999999999 110.159 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' S' S ' 275' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.72 -18.92 21.78 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 123.678 1.357 . . . . 45.280000000000001 110.526 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' S' S ' 276' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -99.98 140.9 33.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.246 -0.909 . . . . 57.270000000000003 110.299 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' S' S ' 277' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -71.7 97.67 1.79 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.355 -0.841 . . . . 37.280000000000001 110.284 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' S' S ' 278' ' ' LEU . . . . . . . . . . . . . 86.4 mt -96.99 33.8 1.84 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.441 -0.787 . . . . 43.880000000000003 110.014 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' S' S ' 279' ' ' THR . . . . . . . . . . . . . 76.9 m -64.02 -60.23 3.5 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.457 -0.777 . . . . 50.049999999999997 110.203 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' S' S ' 280' ' ' LEU . . . . . 0.743 ' HA ' HD12 ' S' ' 283' ' ' ILE . 13.7 mt -51.53 -39.87 58.55 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.343 -0.848 . . . . 54.119999999999997 110.316 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 281' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.39 -49.71 74.44 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.457 -0.777 . . . . 65.280000000000001 110.178 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 282' ' ' ALA . . . . . . . . . . . . . . . -58.88 -33.98 71.12 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.514 -0.741 . . . . 46.509999999999998 110.557 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' S' S ' 283' ' ' ILE . . . . . 0.743 HD12 ' HA ' ' S' ' 280' ' ' LEU . 85.9 mt -66.37 -50.86 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.328 -0.857 . . . . 47.299999999999997 110.101 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 284' ' ' LYS . . . . . . . . . . . . . 33.6 tttp -50.46 -57.68 7.48 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.422 -0.799 . . . . 50.719999999999999 110.381 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' S' S ' 285' ' ' GLN . . . . . 0.535 ' HG2' HD12 ' S' ' 289' ' ' LEU . 34.3 tt0 -51.31 -46.5 62.58 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.494 -0.754 . . . . 68.469999999999999 110.312 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 286' ' ' LEU . . . . . . . . . . . . . 19.1 mt -59.89 -44.5 94.2 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.379 -0.825 . . . . 36.619999999999997 110.3 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' S' S ' 287' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -62.81 -35.26 79.33 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.319 -0.863 . . . . 46.640000000000001 110.043 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' S' S ' 288' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -76.17 -21.11 56.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.405 -0.809 . . . . 46.450000000000003 110.381 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' S' S ' 289' ' ' LEU . . . . . 0.535 HD12 ' HG2' ' S' ' 285' ' ' GLN . 30.8 mt -97.26 -21.76 17.07 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.244 -0.91 . . . . 35.090000000000003 110.582 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 290' ' ' THR . . . . . 0.413 HG22 ' HB3' ' S' ' 306' ' ' ASN . 81.5 p -114.76 -28.52 7.06 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.25 -0.906 . . . . 38.609999999999999 110.429 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 291' ' ' GLY . . . . . . . . . . . . . . . 79.38 11.11 85.27 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.789 -1.324 . . . . 36.770000000000003 109.789 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' S' S ' 292' ' ' LEU . . . . . . . . . . . . . 84.5 mt -96.48 145.76 25.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.336 -1.096 . . . . 35.329999999999998 109.77 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' S' S ' 293' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -77.3 102.33 6.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.222 -0.923 . . . . 48.700000000000003 110.316 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' S' S ' 294' ' ' LEU . . . . . 0.42 ' HB3' ' CZ2' ' S' ' 252' ' ' TRP . 55.4 mt -106.86 51.7 0.74 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.503 -0.748 . . . . 42.609999999999999 110.136 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 295' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -112.48 -11.2 13.65 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.377 -0.827 . . . . 55.490000000000002 110.498 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 296' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -144.29 48.45 1.37 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.059 -1.025 . . . . 75.680000000000007 110.338 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' S' S ' 297' ' ' GLY . . . . . 0.458 ' CA ' ' HA ' ' R' ' 201' ' ' LYS . . . 96.91 145.12 18.6 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.48 -1.448 . . . . 49.439999999999998 109.48 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 298' ' ' GLY . . . . . . . . . . . . . . . -163.79 156.93 29.01 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.775 -1.33 . . . . 41.109999999999999 109.775 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' S' S ' 299' ' ' PRO . . . . . 0.629 ' HD3' ' HA ' ' R' ' 199' ' ' LYS . 46.6 Cg_endo -73.8 118.3 5.39 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 O-C-N 123.992 1.522 . . . . 26.199999999999999 110.277 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 300' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.21 -15.56 31.76 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 O-C-N 123.616 1.324 . . . . 21.699999999999999 110.692 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' S' S ' 301' ' ' ALA . . . . . . . . . . . . . . . -80.65 -29.36 36.69 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.175 -0.953 . . . . 31.23 110.133 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' S' S ' 302' ' ' LEU . . . . . 0.469 HD11 ' HA ' ' R' ' 197' ' ' GLN . 0.0 OUTLIER -83.43 -40.64 19.05 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.503 -0.748 . . . . 38.990000000000002 109.975 179.807 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' S' S ' 303' ' ' VAL . . . . . 0.488 HG23 ' O ' ' S' ' 299' ' ' PRO . 58.2 t -60.7 -35.46 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.435 -0.791 . . . . 18.629999999999999 110.177 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 304' ' ' ILE . . . . . 0.513 HD12 HG21 ' S' ' 379' ' ' VAL . 86.1 mt -79.43 -23.56 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.423 -0.798 . . . . 25.460000000000001 110.19 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 305' ' ' TRP . . . . . 0.419 ' CE2' ' NH1' ' R' ' 120' ' ' ARG . 68.8 t-105 -88.65 -14.52 37.21 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.224 -0.923 . . . . 33.399999999999999 110.581 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 306' ' ' ASN . . . . . 0.413 ' HB3' HG22 ' S' ' 290' ' ' THR . 10.4 m-80 -89.76 -13.52 36.54 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.142 -0.974 . . . . 36.969999999999999 110.399 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 307' ' ' ILE . . . . . 0.457 HG12 ' O ' ' S' ' 303' ' ' VAL . 36.8 pt -125.05 45.71 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.164 -0.96 . . . . 30.809999999999999 110.071 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 308' ' ' LYS . . . . . 0.419 ' HD3' ' CD2' ' S' ' 305' ' ' TRP . 1.5 mtmp? -73.59 -37.75 65.36 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.378 -0.826 . . . . 46.520000000000003 110.077 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 309' ' ' HIS . . . . . 0.496 ' CD2' ' HG ' ' S' ' 310' ' ' LEU . 55.5 p-80 -73.17 -8.28 55.08 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.35 -0.844 . . . . 51.030000000000001 110.161 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 310' ' ' LEU . . . . . 0.496 ' HG ' ' CD2' ' S' ' 309' ' ' HIS . 53.0 mt -99.32 -12.92 19.89 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.347 -0.845 . . . . 36.159999999999997 109.943 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 311' ' ' LEU . . . . . 0.521 HD21 ' CE2' ' S' ' 260' ' ' PHE . 10.8 mt -97.12 147.85 23.64 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.381 -0.824 . . . . 40.0 110.429 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 312' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -81.59 -16.32 51.97 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.322 -0.861 . . . . 54.18 109.748 179.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' S' S ' 313' ' ' THR . . . . . 0.829 HG23 ' HG2' ' S' ' 323' ' ' GLU . 92.9 m -87.94 151.66 22.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.337 -0.852 . . . . 25.609999999999999 110.115 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 314' ' ' GLY . . . . . . . . . . . . . . . -87.95 126.38 8.04 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.768 -1.333 . . . . 25.18 109.768 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' S' S ' 315' ' ' ILE . . . . . 0.647 HD13 ' HB ' ' S' ' 324' ' ' VAL . 50.7 mm -101.66 150.48 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.441 -1.034 . . . . 23.899999999999999 109.725 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 316' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' S' ' 325' ' ' CYS . . . -157.04 -159.31 9.4 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.931 -1.268 . . . . 23.18 109.931 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 317' ' ' THR . . . . . 0.424 HG22 ' CG2' ' S' ' 326' ' ' VAL . 11.2 p -133.9 -172.98 3.12 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.468 -1.019 . . . . 27.98 110.044 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.59 -56.19 25.06 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.163 -0.961 . . . . 28.100000000000001 109.874 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' S' S ' 319' ' ' SER . . . . . 0.422 ' OG ' ' CZ2' ' S' ' 392' ' ' TRP . 1.2 m -59.93 -41.63 92.19 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.326 -0.859 . . . . 37.0 109.663 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 320' ' ' ARG . . . . . . . . . . . . . 12.1 mtm180 -111.73 79.8 2.64 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.466 -0.771 . . . . 52.07 109.655 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' S' S ' 321' ' ' PRO . . . . . 0.436 ' O ' ' HB2' ' S' ' 322' ' ' SER . 44.4 Cg_endo -71.38 171.51 16.01 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.783 1.412 . . . . 38.289999999999999 110.979 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 322' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' S' ' 321' ' ' PRO . 41.3 t 178.67 -148.15 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.956 -0.757 . . . . 38.840000000000003 108.956 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 323' ' ' GLU . . . . . 0.829 ' HG2' HG23 ' S' ' 313' ' ' THR . 6.7 tp10 -62.87 -40.29 97.05 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.043 -1.036 . . . . 40.700000000000003 109.64 179.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 324' ' ' VAL . . . . . 0.647 ' HB ' HD13 ' S' ' 315' ' ' ILE . 73.6 t -141.27 134.99 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.35 -0.844 . . . . 20.34 109.469 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 325' ' ' CYS . . . . . 0.471 ' HB2' ' CE1' ' S' ' 380' ' ' PHE . 11.1 m -125.99 172.26 10.09 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.312 -0.868 . . . . 30.629999999999999 110.924 -179.173 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 326' ' ' VAL . . . . . 0.646 HG12 HG22 ' S' ' 379' ' ' VAL . 34.5 m -135.56 142.16 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 109.175 -0.676 . . . . 23.899999999999999 109.175 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 327' ' ' VAL . . . . . 0.623 ' O ' HG22 ' R' ' 196' ' ' VAL . 34.6 m -56.37 125.02 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.112 -0.992 . . . . 19.48 110.39 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 328' ' ' ASP . . . . . 0.636 ' HA ' HG21 ' R' ' 196' ' ' VAL . 55.7 p-10 -119.4 11.61 12.23 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.418 -0.801 . . . . 26.43 110.439 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 329' ' ' GLY . . . . . . . . . . . . . . . 119.59 2.3 13.17 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.068 -1.213 . . . . 31.239999999999998 110.068 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' S' S ' 330' ' ' THR . . . . . . . . . . . . . 81.0 m -92.97 129.94 38.71 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.101 -1.235 . . . . 30.050000000000001 110.133 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' S' S ' 331' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -56.77 111.5 1.04 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.302 -0.873 . . . . 37.259999999999998 109.992 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' S' S ' 332' ' ' MET . . . . . . . . . . . . . 87.9 mmm -94.08 162.58 13.82 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.235 -0.915 . . . . 26.23 110.334 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' S' S ' 333' ' ' CYS . . . . . . . . . . . . . 26.4 m -137.15 150.05 47.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.42 -0.8 . . . . 23.559999999999999 110.078 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' S' S ' 334' ' ' LEU . . . . . 0.565 HD11 ' O ' ' S' ' 372' ' ' PRO . 0.1 OUTLIER -52.6 -24.9 9.18 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.228 -0.92 . . . . 28.93 110.508 179.833 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' S' S ' 335' ' ' ALA . . . . . . . . . . . . . . . -89.02 14.45 10.58 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.319 -0.863 . . . . 15.76 110.964 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' S' S ' 336' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -100.49 -17.15 17.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.134 -0.979 . . . . 34.920000000000002 110.214 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' S' S ' 337' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -152.42 170.81 19.21 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.39 -0.819 . . . . 19.030000000000001 110.154 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' S' S ' 338' ' ' HIS . . . . . . . . . . . . . 13.5 p80 -120.73 10.4 10.97 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.394 -0.816 . . . . 18.82 110.411 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' S' S ' 339' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' S' ' 352' ' ' ALA . . . -176.04 155.16 1.54 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.206 -0.934 . . . . 17.18 110.09 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 340' ' ' GLY . . . . . . . . . . . . . . . 160.85 173.05 28.97 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.001 -1.24 . . . . 18.329999999999998 110.001 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' S' S ' 341' ' ' ILE . . . . . . . . . . . . . 83.9 mt -88.8 138.08 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.393 -1.063 . . . . 18.600000000000001 109.839 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' S' S ' 342' ' ' PHE . . . . . 0.488 ' CE2' ' HB3' ' S' ' 352' ' ' ALA . 69.9 m-85 -120.93 -178.49 3.75 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.219 -0.926 . . . . 23.440000000000001 110.412 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 343' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.84 93.4 4.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.397 -0.814 . . . . 35.590000000000003 110.07 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 344' ' ' LYS . . . . . 0.41 ' O ' ' HB3' ' S' ' 348' ' ' HIS . 0.3 OUTLIER -80.82 125.04 29.59 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.236 -0.915 . . . . 38.340000000000003 110.046 -179.934 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' S' S ' 345' ' ' GLY . . . . . . . . . . . . . . . 62.85 -130.85 42.89 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 108.788 -1.725 . . . . 53.460000000000001 108.788 -179.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' S' S ' 346' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -132.7 150.88 52.1 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.173 -1.192 . . . . 70.909999999999997 110.011 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' S' S ' 347' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 53.31 35.36 20.02 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.236 -0.915 . . . . 47.32 110.393 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' S' S ' 348' ' ' HIS . . . . . 0.41 ' HB3' ' O ' ' S' ' 344' ' ' LYS . 46.6 t60 -150.11 155.89 40.66 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.317 -0.865 . . . . 41.719999999999999 110.312 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 349' ' ' ALA . . . . . 0.455 ' C ' HG13 ' S' ' 350' ' ' VAL . . . -149.79 151.3 33.34 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.324 -0.86 . . . . 22.91 110.442 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 350' ' ' VAL . . . . . 0.455 HG13 ' C ' ' S' ' 349' ' ' ALA . 34.6 m -149.14 169.55 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.448 -0.782 . . . . 21.09 109.995 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 351' ' ' PHE . . . . . 0.502 ' CD2' ' HB3' ' S' ' 258' ' ' GLN . 10.7 t80 -105.27 143.58 33.25 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.19 -0.944 . . . . 25.030000000000001 110.716 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 352' ' ' ALA . . . . . 0.488 ' HB3' ' CE2' ' S' ' 342' ' ' PHE . . . -147.7 151.74 36.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.584 -0.698 . . . . 23.809999999999999 109.741 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 353' ' ' CYS . . . . . . . . . . . . . 26.3 p -153.34 164.84 37.43 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.295 -0.878 . . . . 25.66 110.225 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' S' S ' 354' ' ' VAL . . . . . 0.561 HG22 ' CE2' ' S' ' 359' ' ' TRP . 57.2 t -76.04 118.47 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.376 -0.828 . . . . 34.270000000000003 109.943 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 355' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' S' ' 232' ' ' THR . 52.3 p -117.82 175.1 5.82 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.257 -0.902 . . . . 25.489999999999998 110.346 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 356' ' ' SER . . . . . . . . . . . . . 62.2 p -62.2 -17.61 58.65 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.456 -0.778 . . . . 31.239999999999998 110.699 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' S' S ' 357' ' ' ASN . . . . . . . . . . . . . 45.8 m-20 -107.05 14.22 26.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.896 . . . . 28.609999999999999 110.552 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' S' S ' 358' ' ' GLY . . . . . . . . . . . . . . . 111.86 -152.92 17.59 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.013 -1.235 . . . . 22.010000000000002 110.013 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' S' S ' 359' ' ' TRP . . . . . 0.561 ' CE2' HG22 ' S' ' 354' ' ' VAL . 15.3 m95 -91.3 116.65 29.0 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.38 -1.071 . . . . 25.539999999999999 110.23 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 360' ' ' TYR . . . . . 0.422 ' HA ' ' HA ' ' S' ' 369' ' ' PRO . 1.3 m-85 -103.53 165.79 10.82 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.257 -0.902 . . . . 40.530000000000001 110.091 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 361' ' ' ALA . . . . . 0.428 ' HA ' ' O ' ' S' ' 351' ' ' PHE . . . -140.01 129.99 24.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.353 -0.842 . . . . 18.039999999999999 110.295 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 362' ' ' ILE . . . . . . . . . . . . . 88.9 mt -95.54 83.61 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.375 -0.828 . . . . 15.640000000000001 110.081 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' S' S ' 363' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' S' ' 365' ' ' GLU . 11.9 t0 -75.19 94.48 2.96 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.42 -0.8 . . . . 35.030000000000001 110.186 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 364' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 53.92 -89.3 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.53 -0.731 . . . . 46.719999999999999 110.537 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' S' S ' 365' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' S' ' 363' ' ' ASP . 23.7 mt-10 -122.69 19.1 10.32 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.046 -1.033 . . . . 56.200000000000003 110.223 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 366' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -117.91 124.88 49.34 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.21 -0.932 . . . . 51.020000000000003 110.44 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' S' S ' 367' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -106.89 127.05 53.09 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.326 -0.859 . . . . 37.590000000000003 110.18 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' S' S ' 368' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -165.47 159.5 13.83 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.293 -0.879 . . . . 31.469999999999999 110.415 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' S' S ' 369' ' ' PRO . . . . . 0.422 ' HA ' ' HA ' ' S' ' 360' ' ' TYR . 46.9 Cg_endo -72.76 139.59 30.9 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 O-C-N 123.891 1.469 . . . . 28.850000000000001 110.557 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 370' ' ' TRP . . . . . . . . . . . . . 67.4 t90 -167.25 113.52 0.76 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.422 -0.799 . . . . 26.940000000000001 110.001 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' S' S ' 371' ' ' THR . . . . . . . . . . . . . 59.8 m -74.81 113.08 21.02 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.376 -0.828 . . . . 20.190000000000001 110.041 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' S' S ' 372' ' ' PRO . . . . . 0.565 ' O ' HD11 ' S' ' 334' ' ' LEU . 47.0 Cg_endo -73.59 157.11 49.04 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.644 1.339 . . . . 28.68 110.529 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 373' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -90.58 147.15 35.74 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.411 -0.806 . . . . 35.719999999999999 109.934 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' S' S ' 374' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -76.03 -6.27 17.18 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 O-C-N 123.681 1.359 . . . . 30.890000000000001 110.461 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' S' S ' 375' ' ' SER . . . . . . . . . . . . . 70.5 p -104.39 -17.0 14.95 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.227 -0.921 . . . . 29.41 110.428 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' S' S ' 376' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -106.48 43.09 1.18 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.358 -0.839 . . . . 32.890000000000001 110.26 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' S' S ' 377' ' ' VAL . . . . . 0.595 ' O ' HG11 ' S' ' 327' ' ' VAL . 7.3 p -114.71 147.29 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.294 -0.879 . . . . 24.329999999999998 110.223 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 378' ' ' LEU . . . . . . . . . . . . . 52.5 mt -115.99 -57.96 2.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.381 -0.824 . . . . 24.370000000000001 109.611 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' S' S ' 379' ' ' VAL . . . . . 0.646 HG22 HG12 ' S' ' 326' ' ' VAL . 61.0 t -120.76 132.38 70.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.404 -0.81 . . . . 18.02 109.424 179.323 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 380' ' ' PHE . . . . . 0.471 ' CE1' ' HB2' ' S' ' 325' ' ' CYS . 14.6 p90 -142.61 173.96 11.07 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.376 -0.828 . . . . 29.350000000000001 110.704 -179.268 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 381' ' ' VAL . . . . . . . . . . . . . 57.7 t -120.12 107.31 39.79 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.459 -0.776 . . . . 16.34 109.43 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' S' S ' 382' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -71.19 145.6 49.43 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.613 1.322 . . . . 20.940000000000001 110.79 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' S' S ' 383' ' ' TYR . . . . . 0.959 ' O ' ' CB ' ' S' ' 384' ' ' ASP . 88.5 m-85 -61.04 -53.57 55.61 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.317 -0.865 . . . . 28.93 109.826 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 384' ' ' ASP . . . . . 0.959 ' CB ' ' O ' ' S' ' 383' ' ' TYR . 7.0 t70 111.08 -156.87 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.46 -0.775 . . . . 47.030000000000001 110.366 176.502 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 385' ' ' GLN . . . . . 0.405 ' CB ' ' O ' ' S' ' 384' ' ' ASP . 7.7 tm0? 62.27 11.55 4.56 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.435 -0.791 . . . . 46.689999999999998 110.261 -178.336 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 386' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -174.3 129.96 0.48 Allowed Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.316 -0.865 . . . . 50.25 109.56 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' S' S ' 387' ' ' PRO . . . . . 0.553 ' O ' ' N ' ' S' ' 389' ' ' ASN . 55.7 Cg_endo -73.17 0.61 7.67 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.668 1.351 . . . . 34.390000000000001 110.576 -179.02 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 388' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 62.02 -70.3 0.05 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.436 -0.79 . . . . 38.009999999999998 110.132 -179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 389' ' ' ASN . . . . . 0.553 ' N ' ' O ' ' S' ' 387' ' ' PRO . 3.2 m-80 -132.57 -164.81 1.51 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.391 -0.818 . . . . 45.82 110.059 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 390' ' ' GLY . . . . . 0.526 ' O ' ' CD2' ' S' ' 392' ' ' TRP . . . 152.25 -92.73 0.14 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.603 -1.399 . . . . 33.460000000000001 109.603 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 391' ' ' GLU . . . . . 0.481 ' CB ' ' O ' ' S' ' 390' ' ' GLY . 1.5 tp10 66.89 -65.85 0.2 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.331 -1.099 . . . . 56.579999999999998 110.152 -179.286 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 392' ' ' TRP . . . . . 0.574 ' HA ' ' HB2' ' S' ' 395' ' ' LYS . 1.6 p90 -62.2 -17.57 58.56 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.298 -0.876 . . . . 31.43 110.313 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 393' ' ' LYS . . . . . 0.629 ' O ' HG12 ' S' ' 396' ' ' VAL . 3.0 ptmm? -52.17 -36.95 53.19 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.322 -0.861 . . . . 39.420000000000002 110.374 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 394' ' ' ALA . . . . . . . . . . . . . . . -85.99 -20.34 29.04 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.444 -0.785 . . . . 34.329999999999998 110.075 178.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' S' S ' 395' ' ' LYS . . . . . 0.777 ' O ' HD11 ' R' ' 143' ' ' LEU . 18.4 mttp -75.67 -14.56 60.36 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.374 -0.829 . . . . 60.090000000000003 110.308 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 396' ' ' VAL . . . . . 0.929 HG22 ' CB ' ' R' ' 99' ' ' PRO . 8.8 p -95.99 -46.95 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.378 -0.826 . . . . 35.5 110.54 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 397' ' ' GLN . . . . . 0.635 ' N ' HG13 ' S' ' 396' ' ' VAL . 2.4 tt0 -71.17 -7.26 45.54 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.148 -0.97 . . . . 49.960000000000001 110.607 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 398' ' ' ARG . . . . . 0.651 ' O ' ' HD3' ' S' ' 398' ' ' ARG . 0.0 OUTLIER -39.61 157.74 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.222 -0.924 . . . . 43.420000000000002 110.695 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' S' S ' 399' ' ' LYS . . . . . 0.652 ' CB ' ' HA3' ' R' ' 97' ' ' GLY . 0.0 OUTLIER -146.05 120.64 9.77 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.492 -0.755 . . . . 55.310000000000002 110.027 179.852 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' S' S ' 400' ' ' LEU . . . . . 0.884 HD13 ' CE1' ' R' ' 148' ' ' HIS . 19.9 tp -30.93 -48.51 0.11 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.307 -0.871 . . . . 41.030000000000001 110.26 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' S' S ' 401' ' ' LYS . . . . . 0.495 ' CB ' ' OD1' ' R' ' 49' ' ' ASP . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.684 0 O-C-N 121.359 -0.838 . . . . 61.969999999999999 110.174 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 29' ' ' MET . . . . . . . . . . . . . 22.0 ptp . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.14 0.495 . . . . 32.140000000000001 110.303 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' R' R ' 30' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -96.33 141.13 30.03 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.412 -0.805 . . . . 43.359999999999999 110.287 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' R' R ' 31' ' ' LEU . . . . . . . . . . . . . 65.3 mt -134.86 140.61 45.95 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.308 -0.87 . . . . 22.93 110.306 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' R' R ' 32' ' ' THR . . . . . . . . . . . . . 68.4 m -87.59 110.59 20.49 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.408 -0.807 . . . . 22.34 109.971 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' R' R ' 33' ' ' LEU . . . . . 0.596 HD22 ' CE2' ' R' ' 62' ' ' TYR . 80.0 mt -62.38 -172.79 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.314 -0.866 . . . . 21.390000000000001 110.226 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 34' ' ' TYR . . . . . . . . . . . . . 37.0 p90 -74.68 -29.4 61.21 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.333 -0.855 . . . . 34.399999999999999 110.38 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' R' R ' 35' ' ' ASN . . . . . . . . . . . . . 48.3 p30 -77.79 -1.79 33.2 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.356 -0.84 . . . . 30.280000000000001 110.699 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' R' R ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.24 -16.55 59.49 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.691 -1.364 . . . . 36.25 109.691 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' R' R ' 37' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -59.04 161.81 4.79 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.314 -1.11 . . . . 53.799999999999997 110.368 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' R' R ' 38' ' ' LYS . . . . . . . . . . . . . 56.9 mttt -117.86 135.8 53.86 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.445 -0.784 . . . . 49.909999999999997 110.146 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' R' R ' 39' ' ' LYS . . . . . 0.408 ' HG2' ' CZ ' ' R' ' 41' ' ' PHE . 8.1 ttmt -138.75 143.64 39.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.404 -0.81 . . . . 35.689999999999998 110.223 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 40' ' ' THR . . . . . . . . . . . . . 23.5 m -102.54 127.96 49.39 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.302 -0.874 . . . . 34.840000000000003 110.228 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' R' R ' 41' ' ' PHE . . . . . 0.408 ' CZ ' ' HG2' ' R' ' 39' ' ' LYS . 96.6 m-85 -113.04 132.65 55.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.378 -0.826 . . . . 34.420000000000002 110.172 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 42' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -93.36 140.95 28.99 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.331 -0.856 . . . . 51.460000000000001 110.221 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' R' R ' 43' ' ' SER . . . . . . . . . . . . . 54.3 m -70.76 141.93 51.42 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.55 -0.719 . . . . 41.840000000000003 110.205 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' R' R ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.75 125.37 29.59 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.469 -0.769 . . . . 33.82 110.013 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 45' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.11 151.13 55.13 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.59 1.31 . . . . 30.27 110.625 -179.697 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' R' R ' 46' ' ' ASN . . . . . 0.711 HD21 ' HG ' ' S' ' 400' ' ' LEU . 52.2 t-20 -124.28 109.84 13.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.459 -0.776 . . . . 35.100000000000001 110.071 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 47' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -120.27 -34.86 3.56 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.395 -0.816 . . . . 42.810000000000002 110.551 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' R' R ' 48' ' ' HIS . . . . . 0.439 ' NE2' HD11 ' R' ' 80' ' ' LEU . 73.3 m80 -105.73 45.1 0.99 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.187 -0.946 . . . . 49.969999999999999 110.235 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 49' ' ' ASP . . . . . 0.751 ' HB3' ' HB2' ' S' ' 399' ' ' LYS . 37.6 m-20 50.32 34.72 9.38 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.4 -0.813 . . . . 61.32 110.149 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 50' ' ' ASN . . . . . 0.4 ' OD1' ' HA ' ' R' ' 46' ' ' ASN . 15.0 p-10 -86.32 43.87 1.1 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.323 -0.861 . . . . 51.5 110.66 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 51' ' ' ALA . . . . . 0.519 ' HB2' ' CD2' ' S' ' 400' ' ' LEU . . . -66.12 -46.11 78.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.165 -0.959 . . . . 38.770000000000003 109.541 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 52' ' ' TRP . . . . . 0.483 ' CD2' ' N ' ' R' ' 53' ' ' LEU . 68.2 p-90 -58.4 -38.4 77.27 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.482 -0.761 . . . . 26.239999999999998 110.055 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 53' ' ' LEU . . . . . 0.483 ' N ' ' CD2' ' R' ' 52' ' ' TRP . 23.1 tp -66.73 -46.66 74.76 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.456 -0.777 . . . . 26.75 109.946 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 54' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -55.23 -41.54 72.24 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.405 -0.809 . . . . 35.020000000000003 110.132 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' R' R ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.26 -46.11 91.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.352 -0.842 . . . . 24.469999999999999 110.114 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' R' R ' 56' ' ' ILE . . . . . 0.433 HG12 HD11 ' R' ' 104' ' ' ILE . 76.6 mt -62.09 -42.33 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.259 -0.901 . . . . 26.030000000000001 109.906 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 57' ' ' LEU . . . . . . . . . . . . . 22.5 mt -60.26 -45.69 92.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.28 -0.888 . . . . 26.77 109.657 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' R' R ' 58' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -63.87 -46.51 84.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.341 -0.849 . . . . 22.32 109.582 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' R' R ' 59' ' ' LEU . . . . . 0.43 ' HA ' ' HE2' ' R' ' 151' ' ' PHE . 24.0 tp -61.43 -37.73 84.6 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.306 -0.871 . . . . 20.550000000000001 109.396 179.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 60' ' ' PHE . . . . . 0.528 ' CE2' HD21 ' R' ' 111' ' ' LEU . 2.8 m-85 -61.11 -44.72 96.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.617 -0.677 . . . . 20.079999999999998 109.913 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 61' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -63.17 -36.23 82.93 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.498 -0.751 . . . . 18.800000000000001 110.408 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' R' R ' 62' ' ' TYR . . . . . 0.596 ' CE2' HD22 ' R' ' 33' ' ' LEU . 9.2 t80 -63.04 -41.74 99.58 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.226 -0.921 . . . . 26.449999999999999 110.247 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 63' ' ' VAL . . . . . 0.406 ' H ' HG22 ' R' ' 63' ' ' VAL . 30.8 m -93.42 20.32 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.308 -0.87 . . . . 29.75 110.266 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 64' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 53.03 75.44 0.24 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.316 -0.865 . . . . 35.520000000000003 110.561 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' R' R ' 65' ' ' GLU . . . . . 0.443 ' HG2' ' CD2' ' R' ' 60' ' ' PHE . 14.3 tp10 -116.19 104.01 52.55 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.391 -0.818 . . . . 29.890000000000001 109.958 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 66' ' ' PRO . . . . . 0.479 ' HA ' ' HB2' ' R' ' 69' ' ' ASP . 46.6 Cg_endo -73.47 -5.88 17.85 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.708 1.372 . . . . 21.370000000000001 111.068 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 67' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -52.11 -61.58 2.17 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.054 -1.029 . . . . 23.850000000000001 110.341 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 68' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -98.06 36.52 1.56 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.314 -0.866 . . . . 28.07 110.474 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' R' R ' 69' ' ' ASP . . . . . 0.479 ' HB2' ' HA ' ' R' ' 66' ' ' PRO . 11.7 t0 -72.3 -33.25 67.27 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.307 -0.871 . . . . 43.759999999999998 110.205 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 70' ' ' TRP . . . . . 0.476 ' CE2' ' CG2' ' R' ' 71' ' ' VAL . 48.0 p-90 -73.49 -3.85 30.18 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.332 -0.855 . . . . 33.060000000000002 110.686 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 71' ' ' VAL . . . . . 0.557 HG11 ' HB2' ' R' ' 82' ' ' ALA . 40.8 t -109.83 -27.41 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.175 -0.953 . . . . 31.699999999999999 109.674 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 72' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -86.58 -48.88 7.96 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.358 -0.839 . . . . 33.579999999999998 110.278 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' R' R ' 73' ' ' SER . . . . . . . . . . . . . 70.2 m -89.67 51.12 2.02 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.312 -0.868 . . . . 50.82 110.308 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' R' R ' 74' ' ' SER . . . . . . . . . . . . . 15.9 t -125.96 138.33 31.88 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.282 -0.886 . . . . 34.740000000000002 110.189 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.38 -24.99 15.89 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 O-C-N 123.603 1.317 . . . . 35.700000000000003 110.32 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' R' R ' 76' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -91.74 153.24 19.76 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.461 -0.775 . . . . 66.480000000000004 110.356 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' R' R ' 77' ' ' ASN . . . . . . . . . . . . . 37.6 t30 -81.56 95.23 7.07 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.33 -0.856 . . . . 46.719999999999999 110.097 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' R' R ' 78' ' ' LEU . . . . . . . . . . . . . 96.4 mt -96.43 28.01 3.52 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.398 -0.814 . . . . 37.549999999999997 110.187 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' R' R ' 79' ' ' THR . . . . . . . . . . . . . 29.9 m -56.21 -54.62 43.08 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.226 -0.921 . . . . 37.359999999999999 110.301 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' R' R ' 80' ' ' LEU . . . . . 0.602 ' HA ' HD12 ' R' ' 83' ' ' ILE . 15.9 mt -60.88 -23.28 65.07 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.449 -0.782 . . . . 35.829999999999998 110.511 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 81' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -79.44 -39.11 33.07 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.154 -0.966 . . . . 44.030000000000001 110.38 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' R' R ' 82' ' ' ALA . . . . . 0.557 ' HB2' HG11 ' R' ' 71' ' ' VAL . . . -69.45 -28.66 66.3 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.292 -0.88 . . . . 32.539999999999999 110.211 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 83' ' ' ILE . . . . . 0.602 HD12 ' HA ' ' R' ' 80' ' ' LEU . 78.2 mt -70.13 -46.09 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.236 -0.915 . . . . 32.020000000000003 110.265 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 84' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -55.23 -52.09 64.49 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.237 -0.914 . . . . 34.090000000000003 110.521 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' R' R ' 85' ' ' GLN . . . . . 0.531 ' HG2' HD12 ' R' ' 89' ' ' LEU . 31.9 tt0 -54.82 -46.87 74.63 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.238 -0.914 . . . . 25.940000000000001 110.28 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 86' ' ' LEU . . . . . . . . . . . . . 24.0 mt -58.71 -43.73 90.17 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.299 -0.876 . . . . 16.199999999999999 109.923 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' R' R ' 87' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -65.43 -35.11 79.95 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.472 -0.768 . . . . 49.090000000000003 110.33 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' R' R ' 88' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -78.5 -19.06 53.85 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.276 -0.89 . . . . 28.609999999999999 110.479 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' R' R ' 89' ' ' LEU . . . . . 0.531 HD12 ' HG2' ' R' ' 85' ' ' GLN . 32.8 mt -96.18 -29.43 14.05 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.236 -0.915 . . . . 26.16 110.197 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 90' ' ' THR . . . . . . . . . . . . . 59.4 p -105.63 -34.72 7.65 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.259 -0.901 . . . . 33.329999999999998 109.764 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' R' R ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.89 16.08 58.55 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.821 -1.312 . . . . 31.129999999999999 109.821 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' R' R ' 92' ' ' LEU . . . . . . . . . . . . . 97.1 mt -100.06 155.23 17.83 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.147 -1.208 . . . . 42.520000000000003 110.23 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' R' R ' 93' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -86.21 91.62 8.51 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.49 -0.756 . . . . 68.459999999999994 110.017 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' R' R ' 94' ' ' LEU . . . . . 0.459 ' HB3' ' CZ2' ' R' ' 52' ' ' TRP . 48.3 mt -99.48 53.03 0.94 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.222 -0.924 . . . . 44.630000000000003 110.32 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 95' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.43 -38.8 6.35 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.262 -0.899 . . . . 67.159999999999997 110.385 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 96' ' ' GLU . . . . . 0.407 ' O ' ' HG2' ' S' ' 399' ' ' LYS . 24.7 mt-10 -113.83 44.23 1.67 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.251 -0.906 . . . . 67.019999999999996 110.352 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 97' ' ' GLY . . . . . 0.792 ' CA ' ' HB3' ' S' ' 399' ' ' LYS . . . 99.16 150.78 26.0 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.614 -1.395 . . . . 49.479999999999997 109.614 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 98' ' ' GLY . . . . . . . . . . . . . . . -166.26 160.03 33.47 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.286 -1.526 . . . . 36.57 109.286 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' R' R ' 99' ' ' PRO . . . . . 0.792 ' O ' HG23 ' R' ' 103' ' ' VAL . 45.8 Cg_endo -72.49 121.03 7.1 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 O-C-N 123.703 1.37 . . . . 30.41 110.47 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 100' ' ' PRO . . . . . 0.413 ' HA ' HD11 ' R' ' 56' ' ' ILE . 46.1 Cg_endo -72.22 -31.72 11.47 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 O-C-N 123.645 1.339 . . . . 29.940000000000001 110.552 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 101' ' ' ALA . . . . . 0.476 ' HB2' ' HB3' ' R' ' 178' ' ' LEU . . . -69.9 -38.49 76.32 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.228 -0.92 . . . . 23.640000000000001 110.291 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 102' ' ' LEU . . . . . 0.424 HD23 HD21 ' R' ' 106' ' ' ASN . 0.1 OUTLIER -72.64 -40.71 66.19 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.411 -0.805 . . . . 20.309999999999999 110.386 -179.769 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' R' R ' 103' ' ' VAL . . . . . 0.792 HG23 ' O ' ' R' ' 99' ' ' PRO . 64.0 t -58.25 -40.07 76.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.225 -0.922 . . . . 16.329999999999998 109.984 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 104' ' ' ILE . . . . . 0.433 HD11 HG12 ' R' ' 56' ' ' ILE . 81.6 mt -71.63 -30.6 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.388 -0.82 . . . . 24.77 109.939 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 105' ' ' TRP . . . . . 0.462 ' O ' ' HD3' ' R' ' 108' ' ' LYS . 70.5 t-105 -82.35 0.82 40.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.292 -0.88 . . . . 23.280000000000001 110.321 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 106' ' ' ASN . . . . . 0.424 HD21 HD23 ' R' ' 102' ' ' LEU . 6.9 m-80 -105.07 -10.49 17.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.136 -0.977 . . . . 28.260000000000002 110.086 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 107' ' ' ILE . . . . . . . . . . . . . 36.8 pt -126.83 35.06 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.208 -0.933 . . . . 18.77 110.033 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' R' R ' 108' ' ' LYS . . . . . 0.502 ' HG2' ' HB ' ' R' ' 115' ' ' ILE . 9.2 mtpp -61.16 -48.43 81.64 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.528 -0.732 . . . . 42.5 109.987 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 109' ' ' HIS . . . . . 0.446 ' CD2' ' HG ' ' R' ' 110' ' ' LEU . 50.9 p-80 -66.01 -12.88 58.3 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.461 -0.774 . . . . 20.07 110.652 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 110' ' ' LEU . . . . . 0.446 ' HG ' ' CD2' ' R' ' 109' ' ' HIS . 80.6 mt -94.81 -17.26 22.28 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.084 -1.01 . . . . 15.69 110.192 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 111' ' ' LEU . . . . . 0.528 HD21 ' CE2' ' R' ' 60' ' ' PHE . 10.3 mt -94.15 144.11 25.78 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.34 -0.85 . . . . 25.390000000000001 111.002 -179.16 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 112' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -77.7 -17.33 57.75 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.521 -0.737 . . . . 53.479999999999997 109.865 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' R' R ' 113' ' ' THR . . . . . 0.459 HG22 ' N ' ' R' ' 114' ' ' GLY . 60.4 m -83.71 166.68 17.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.311 -0.868 . . . . 14.800000000000001 110.201 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 114' ' ' GLY . . . . . 0.459 ' N ' HG22 ' R' ' 113' ' ' THR . . . -98.01 127.15 9.13 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.962 -1.255 . . . . 16.140000000000001 109.962 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 115' ' ' ILE . . . . . 0.578 HD13 ' HB ' ' R' ' 124' ' ' VAL . 47.9 mm -109.05 139.35 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.424 -1.045 . . . . 13.460000000000001 109.71 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 116' ' ' GLY . . . . . . . . . . . . . . . -152.76 -155.9 7.31 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.856 -1.298 . . . . 23.899999999999999 109.856 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' R' R ' 117' ' ' THR . . . . . 0.529 HG22 ' CG2' ' R' ' 126' ' ' VAL . 18.8 p -135.03 -171.35 2.78 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.53 -0.982 . . . . 27.370000000000001 110.097 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 118' ' ' ALA . . . . . 0.445 ' HB3' ' OD1' ' R' ' 128' ' ' ASP . . . -56.6 -58.04 9.79 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.359 -0.838 . . . . 18.760000000000002 110.064 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 119' ' ' SER . . . . . 0.762 ' HA ' ' HB3' ' R' ' 194' ' ' ALA . 1.1 m -56.55 -40.59 75.39 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.259 -0.901 . . . . 32.350000000000001 109.741 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 120' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 -110.11 86.25 4.92 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.435 -0.791 . . . . 27.120000000000001 109.68 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' R' R ' 121' ' ' PRO . . . . . 0.483 ' HA ' ' SG ' ' R' ' 125' ' ' CYS . 44.3 Cg_endo -71.2 166.47 29.12 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.863 1.454 . . . . 22.68 111.046 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 122' ' ' SER . . . . . 0.434 ' HB2' ' O ' ' R' ' 121' ' ' PRO . 38.4 t 178.56 -161.67 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.649 -0.657 . . . . 22.989999999999998 109.456 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 123' ' ' GLU . . . . . 0.44 ' HG2' HG23 ' R' ' 113' ' ' THR . 2.3 tp10 -56.45 -39.92 73.94 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.211 -0.93 . . . . 36.18 109.701 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 124' ' ' VAL . . . . . 0.578 ' HB ' HD13 ' R' ' 115' ' ' ILE . 84.2 t -142.58 136.41 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.579 -0.701 . . . . 20.640000000000001 109.389 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 125' ' ' CYS . . . . . 0.483 ' SG ' ' HA ' ' R' ' 121' ' ' PRO . 83.3 m -140.26 168.23 20.29 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.252 -0.905 . . . . 22.800000000000001 111.166 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 126' ' ' VAL . . . . . 0.73 HG12 HG22 ' R' ' 179' ' ' VAL . 35.8 m -122.73 159.73 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.671 -0.643 . . . . 21.239999999999998 109.568 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 127' ' ' VAL . . . . . 0.709 HG11 ' O ' ' R' ' 177' ' ' VAL . 30.6 m -70.8 141.91 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.294 -0.879 . . . . 19.77 110.7 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 128' ' ' ASP . . . . . 0.445 ' OD1' ' HB3' ' R' ' 118' ' ' ALA . 53.9 p-10 -137.77 19.4 2.86 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.337 -0.852 . . . . 29.210000000000001 110.642 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 129' ' ' GLY . . . . . . . . . . . . . . . 113.98 0.03 24.16 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.963 -1.113 . . . . 33.859999999999999 110.498 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' R' R ' 130' ' ' THR . . . . . . . . . . . . . 58.1 m -91.86 131.81 36.92 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.14 -1.212 . . . . 26.41 110.082 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -62.52 120.7 11.62 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.36 -0.838 . . . . 33.079999999999998 110.287 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' R' R ' 132' ' ' MET . . . . . 0.433 ' HE1' ' CE2' ' R' ' 180' ' ' PHE . 98.5 mmm -105.26 165.62 10.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.467 -0.771 . . . . 30.760000000000002 110.435 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 133' ' ' CYS . . . . . 0.41 ' HA ' ' HB3' ' R' ' 174' ' ' PRO . 32.8 m -141.09 158.11 44.37 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.511 -0.743 . . . . 27.0 109.973 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 134' ' ' LEU . . . . . 0.564 HD11 ' O ' ' R' ' 172' ' ' PRO . 0.1 OUTLIER -58.45 -19.74 39.11 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.268 -0.895 . . . . 33.899999999999999 110.51 -179.923 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' R' R ' 135' ' ' ALA . . . . . . . . . . . . . . . -92.69 8.07 40.77 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.231 -0.918 . . . . 19.370000000000001 110.779 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' R' R ' 136' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -93.71 -21.76 19.15 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.187 -0.946 . . . . 30.469999999999999 110.272 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' R' R ' 137' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -149.96 165.34 32.94 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.365 -0.835 . . . . 24.27 110.241 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' R' R ' 138' ' ' HIS . . . . . 0.433 ' HA ' HG23 ' R' ' 154' ' ' VAL . 15.1 p80 -117.84 15.11 14.37 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.362 -0.836 . . . . 20.91 110.369 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 139' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' R' ' 152' ' ' ALA . . . -177.16 152.46 0.88 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.158 -0.964 . . . . 15.69 110.12 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 140' ' ' GLY . . . . . 0.428 ' HA3' ' O ' ' R' ' 179' ' ' VAL . . . 161.8 175.2 32.57 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.975 -1.25 . . . . 23.760000000000002 109.975 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 141' ' ' ILE . . . . . . . . . . . . . 83.7 mt -95.55 136.61 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.372 -1.075 . . . . 25.300000000000001 109.673 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' R' R ' 142' ' ' PHE . . . . . 0.578 ' CD2' ' HB2' ' R' ' 172' ' ' PRO . 82.8 m-85 -120.77 -172.63 2.42 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.287 -0.883 . . . . 30.239999999999998 110.545 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 143' ' ' LEU . . . . . 0.742 HD23 ' O ' ' R' ' 148' ' ' HIS . 0.5 OUTLIER -119.75 77.75 1.26 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.444 -0.785 . . . . 32.799999999999997 110.246 -179.84 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' R' R ' 144' ' ' LYS . . . . . 0.469 ' HG3' ' CZ2' ' R' ' 170' ' ' TRP . 1.0 OUTLIER -69.59 76.86 0.42 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.393 -0.817 . . . . 49.18 109.707 179.502 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' R' R ' 145' ' ' GLY . . . . . 0.457 ' O ' HD22 ' R' ' 143' ' ' LEU . . . 104.52 179.32 24.8 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.131 -1.588 . . . . 53.869999999999997 109.131 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 146' ' ' GLN . . . . . 0.422 ' HG2' ' HD3' ' S' ' 395' ' ' LYS . 11.9 mt-30 -88.52 145.81 25.53 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.361 -1.082 . . . . 68.579999999999998 110.023 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 147' ' ' GLU . . . . . 0.869 ' HA ' ' CB ' ' S' ' 398' ' ' ARG . 10.9 mt-10 58.24 36.52 25.77 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.314 -0.866 . . . . 56.619999999999997 110.623 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 148' ' ' HIS . . . . . 0.742 ' O ' HD23 ' R' ' 143' ' ' LEU . 44.5 t60 -158.65 148.17 19.24 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.194 -0.941 . . . . 44.57 110.376 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 149' ' ' ALA . . . . . . . . . . . . . . . -150.29 146.88 27.04 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.427 -0.796 . . . . 33.539999999999999 110.079 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' R' R ' 150' ' ' VAL . . . . . . . . . . . . . 34.2 m -142.32 161.5 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.277 -0.889 . . . . 27.609999999999999 110.356 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' R' R ' 151' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' R' ' 152' ' ' ALA . 5.9 t80 -86.14 155.62 20.69 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.401 -0.812 . . . . 23.039999999999999 109.924 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 152' ' ' ALA . . . . . 0.537 ' N ' ' CD1' ' R' ' 151' ' ' PHE . . . -157.33 151.51 24.81 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.517 -0.739 . . . . 29.609999999999999 109.625 179.02 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 153' ' ' CYS . . . . . . . . . . . . . 26.7 p -154.3 173.61 15.93 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.233 -0.917 . . . . 22.75 110.453 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' R' R ' 154' ' ' VAL . . . . . 0.613 HG22 ' CE2' ' R' ' 159' ' ' TRP . 60.2 t -90.68 117.04 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.37 -0.831 . . . . 23.260000000000002 110.101 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 155' ' ' THR . . . . . . . . . . . . . 69.8 p -112.1 -176.63 2.97 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.302 -0.873 . . . . 17.879999999999999 110.041 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' R' R ' 156' ' ' SER . . . . . . . . . . . . . 78.5 p -75.94 -3.69 36.88 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.329 -0.857 . . . . 21.829999999999998 110.735 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' R' R ' 157' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -118.25 10.38 12.83 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.109 -0.994 . . . . 36.539999999999999 110.635 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' R' R ' 158' ' ' GLY . . . . . . . . . . . . . . . 117.9 -162.7 13.0 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.585 -1.406 . . . . 31.739999999999998 109.585 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' R' R ' 159' ' ' TRP . . . . . 0.613 ' CE2' HG22 ' R' ' 154' ' ' VAL . 14.8 m95 -86.51 122.42 30.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.334 -1.098 . . . . 28.25 110.112 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 160' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -108.42 166.96 10.38 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.384 -0.822 . . . . 41.240000000000002 110.251 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' R' R ' 161' ' ' ALA . . . . . . . . . . . . . . . -143.33 123.51 13.72 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.495 -0.753 . . . . 27.399999999999999 110.117 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' R' R ' 162' ' ' ILE . . . . . . . . . . . . . 92.2 mt -87.54 81.14 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.406 -0.809 . . . . 24.27 110.072 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' R' R ' 163' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' R' ' 165' ' ' GLU . 15.3 t0 -72.81 92.47 1.59 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.422 -0.799 . . . . 36.079999999999998 110.234 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 164' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 54.09 -89.03 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.521 -0.737 . . . . 46.079999999999998 110.574 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' R' R ' 165' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' R' ' 163' ' ' ASP . 29.7 mt-10 -124.68 35.94 4.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.151 -0.968 . . . . 50.939999999999998 110.196 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 166' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -135.72 117.28 14.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.427 -0.796 . . . . 47.280000000000001 110.358 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' R' R ' 167' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -101.02 120.0 39.56 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.396 -0.815 . . . . 40.469999999999999 110.164 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' R' R ' 168' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -157.56 158.48 30.6 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.199 -0.938 . . . . 30.210000000000001 110.436 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' R' R ' 169' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.74 133.01 19.51 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 O-C-N 123.9 1.474 . . . . 32.759999999999998 110.471 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' R' R ' 170' ' ' TRP . . . . . 0.469 ' CZ2' ' HG3' ' R' ' 144' ' ' LYS . 66.9 t90 -159.83 119.42 2.89 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.471 -0.768 . . . . 32.789999999999999 109.925 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 171' ' ' THR . . . . . . . . . . . . . 46.3 m -81.14 112.62 34.41 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.419 -0.801 . . . . 36.920000000000002 110.188 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' R' R ' 172' ' ' PRO . . . . . 0.578 ' HB2' ' CD2' ' R' ' 142' ' ' PHE . 47.5 Cg_endo -73.75 158.82 46.44 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.68 1.358 . . . . 33.539999999999999 110.552 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 173' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -88.88 144.98 33.78 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.429 -0.795 . . . . 45.759999999999998 109.951 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' R' R ' 174' ' ' PRO . . . . . 0.41 ' HB3' ' HA ' ' R' ' 133' ' ' CYS . 45.3 Cg_endo -71.8 -10.32 26.2 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.639 1.336 . . . . 29.629999999999999 110.404 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 175' ' ' SER . . . . . . . . . . . . . 53.1 p -103.47 -17.58 15.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.275 -0.891 . . . . 35.700000000000003 110.34 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' R' R ' 176' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -103.5 43.21 1.1 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.256 -0.903 . . . . 39.649999999999999 110.419 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' R' R ' 177' ' ' VAL . . . . . 0.709 ' O ' HG11 ' R' ' 127' ' ' VAL . 10.4 p -117.77 127.19 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.367 -0.833 . . . . 20.609999999999999 109.961 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 178' ' ' LEU . . . . . 0.581 HD21 ' CG1' ' S' ' 396' ' ' VAL . 46.0 mt -91.53 -61.15 1.71 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.373 -0.829 . . . . 15.58 109.419 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 179' ' ' VAL . . . . . 0.73 HG22 HG12 ' R' ' 126' ' ' VAL . 67.9 t -114.73 144.64 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.602 -0.686 . . . . 17.399999999999999 109.419 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 180' ' ' PHE . . . . . 0.433 ' CE2' ' HE1' ' R' ' 132' ' ' MET . 43.8 p90 -152.12 163.37 39.5 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.271 -0.893 . . . . 20.16 110.551 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 181' ' ' VAL . . . . . . . . . . . . . 66.8 t -113.16 111.52 50.26 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.456 -0.778 . . . . 17.690000000000001 109.833 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' R' R ' 182' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.06 149.48 52.61 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.577 1.304 . . . . 17.809999999999999 110.366 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' R' R ' 183' ' ' TYR . . . . . 0.735 ' O ' ' C ' ' R' ' 184' ' ' ASP . 79.1 m-85 -59.03 175.51 0.28 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.432 -0.792 . . . . 28.010000000000002 110.571 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 184' ' ' ASP . . . . . 0.735 ' C ' ' O ' ' R' ' 183' ' ' TYR . 1.9 m-20 -13.08 -75.98 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.442 -0.786 . . . . 58.640000000000001 110.297 -178.021 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 185' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.503 2.213 0 CA-C-O 121.185 0.517 . . . . 80.420000000000002 111.807 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' R' R ' 193' ' ' LYS . . . . . 0.424 ' HA ' ' NE2' ' R' ' 197' ' ' GLN . 49.1 mmtt . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 120.949 0.404 . . . . 49.5 110.112 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' R' R ' 194' ' ' ALA . . . . . 0.762 ' HB3' ' HA ' ' R' ' 119' ' ' SER . . . -178.03 -149.79 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.117 -0.989 . . . . 40.399999999999999 110.102 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 195' ' ' LYS . . . . . . . . . . . . . 1.2 mmmp? -86.64 -88.29 0.13 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.369 -0.832 . . . . 34.600000000000001 110.304 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' R' R ' 196' ' ' VAL . . . . . 0.621 HG23 ' CB ' ' R' ' 119' ' ' SER . 27.0 m -70.01 69.49 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.239 -0.913 . . . . 33.270000000000003 110.614 -179.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' R' R ' 197' ' ' GLN . . . . . 0.605 ' HG2' ' HB3' ' R' ' 194' ' ' ALA . 0.0 OUTLIER -157.37 -29.74 0.08 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.154 -0.966 . . . . 41.579999999999998 110.72 179.895 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' R' R ' 198' ' ' ARG . . . . . . . . . . . . . 1.6 ttm180 -75.75 165.64 24.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.041 -1.037 . . . . 38.649999999999999 110.17 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' R' R ' 199' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -94.85 73.41 3.55 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.364 -0.835 . . . . 36.770000000000003 109.925 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' R' R ' 200' ' ' LEU . . . . . . . . . . . . . 38.2 mt -60.97 -173.04 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.359 -0.838 . . . . 33.079999999999998 110.15 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' R' R ' 201' ' ' LYS . . . . . 0.5 ' HA ' ' CA ' ' S' ' 297' ' ' GLY . 11.5 tttt . . . . . 0 N--CA 1.492 1.661 0 O-C-N 121.342 -0.849 . . . . 44.32 110.281 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' S' S ' 229' ' ' MET . . . . . . . . . . . . . 2.4 ptt? . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.173 0.511 . . . . 51.829999999999998 110.202 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' S' S ' 230' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -97.32 142.75 28.81 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.369 -0.832 . . . . 54.130000000000003 110.183 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' S' S ' 231' ' ' LEU . . . . . . . . . . . . . 68.2 mt -134.09 141.0 46.99 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.312 -0.868 . . . . 33.039999999999999 110.325 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' S' S ' 232' ' ' THR . . . . . 0.416 ' O ' ' HA ' ' S' ' 355' ' ' THR . 40.0 m -89.22 103.27 15.9 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.438 -0.789 . . . . 26.920000000000002 110.039 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 233' ' ' LEU . . . . . 0.674 HD22 ' CE2' ' S' ' 262' ' ' TYR . 79.9 mt -55.91 179.29 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.471 -0.768 . . . . 13.779999999999999 110.483 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 234' ' ' TYR . . . . . 0.447 ' CG ' ' N ' ' S' ' 235' ' ' ASN . 35.5 p90 -65.02 -35.68 81.95 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.412 -0.805 . . . . 26.079999999999998 110.163 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 235' ' ' ASN . . . . . 0.447 ' N ' ' CG ' ' S' ' 234' ' ' TYR . 50.7 p30 -74.35 -7.38 52.65 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.357 -0.839 . . . . 20.039999999999999 110.511 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 236' ' ' GLY . . . . . . . . . . . . . . . 95.71 -20.0 51.78 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.769 -1.332 . . . . 22.710000000000001 109.769 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' S' S ' 237' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -52.91 145.64 12.29 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.216 -1.167 . . . . 35.439999999999998 110.215 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' S' S ' 238' ' ' LYS . . . . . . . . . . . . . 44.2 mttt -102.17 127.99 48.86 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.438 -0.789 . . . . 32.560000000000002 110.341 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' S' S ' 239' ' ' LYS . . . . . 0.406 ' HG2' ' CZ ' ' S' ' 241' ' ' PHE . 9.0 ttmt -132.35 144.45 50.55 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.371 -0.83 . . . . 26.68 110.002 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 240' ' ' THR . . . . . . . . . . . . . 52.5 m -101.95 132.23 47.89 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.307 -0.871 . . . . 41.020000000000003 110.36 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' S' S ' 241' ' ' PHE . . . . . 0.406 ' CZ ' ' HG2' ' S' ' 239' ' ' LYS . 96.0 m-85 -117.97 137.69 52.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.431 -0.793 . . . . 28.620000000000001 110.188 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 242' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -96.36 161.79 13.78 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.32 -0.862 . . . . 47.890000000000001 110.241 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' S' S ' 243' ' ' SER . . . . . . . . . . . . . 71.5 m -90.58 151.57 21.26 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.376 -0.827 . . . . 45.090000000000003 110.207 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' S' S ' 244' ' ' ARG . . . . . . . . . . . . . 1.4 mtp85 -129.73 126.7 22.72 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.307 -0.871 . . . . 42.490000000000002 110.301 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' S' S ' 245' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.33 161.03 43.71 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 O-C-N 123.651 1.343 . . . . 35.68 110.538 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' S' S ' 246' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -132.9 97.91 4.16 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.381 -0.824 . . . . 51.880000000000003 109.827 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' S' S ' 247' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -110.47 -22.2 11.78 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.364 -0.835 . . . . 53.689999999999998 110.68 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' S' S ' 248' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -117.28 43.65 2.28 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.187 -0.946 . . . . 55.789999999999999 110.719 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' S' S ' 249' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 48.84 38.38 11.9 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.402 -0.811 . . . . 49.450000000000003 110.338 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' S' S ' 250' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -90.6 28.94 1.38 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.544 -0.722 . . . . 36.859999999999999 110.385 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' S' S ' 251' ' ' ALA . . . . . . . . . . . . . . . -53.75 -43.24 68.97 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.271 -0.893 . . . . 29.690000000000001 109.643 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' S' S ' 252' ' ' TRP . . . . . 0.427 ' CZ2' ' HB3' ' S' ' 294' ' ' LEU . 67.9 p-90 -61.74 -33.95 74.97 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.465 -0.772 . . . . 41.119999999999997 109.812 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 253' ' ' LEU . . . . . 0.402 ' N ' ' CD2' ' S' ' 252' ' ' TRP . 23.3 tp -70.14 -47.21 62.68 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.349 -0.845 . . . . 24.890000000000001 109.995 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 254' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -56.16 -42.45 77.04 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.31 -0.869 . . . . 35.649999999999999 109.956 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' S' S ' 255' ' ' ALA . . . . . . . . . . . . . . . -59.58 -48.17 82.7 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.432 -0.793 . . . . 22.73 110.025 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' S' S ' 256' ' ' ILE . . . . . 0.503 HG12 HD11 ' S' ' 304' ' ' ILE . 79.6 mt -62.34 -40.66 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.341 -0.85 . . . . 28.850000000000001 109.957 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 257' ' ' LEU . . . . . 0.4 ' CD2' ' HB3' ' S' ' 268' ' ' PHE . 19.2 mt -61.57 -44.47 96.96 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.359 -0.838 . . . . 23.07 110.17 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 258' ' ' GLN . . . . . 0.5 ' HB3' ' CD2' ' S' ' 351' ' ' PHE . 53.5 mm-40 -65.06 -45.41 85.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.42 -0.8 . . . . 29.780000000000001 109.851 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 259' ' ' LEU . . . . . 0.42 ' O ' HG22 ' S' ' 263' ' ' VAL . 19.8 tp -58.72 -36.33 74.11 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.36 -0.838 . . . . 17.940000000000001 109.433 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 260' ' ' PHE . . . . . 0.531 ' CE2' HD21 ' S' ' 311' ' ' LEU . 3.1 m-85 -62.81 -45.27 93.4 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.619 -0.676 . . . . 30.57 109.833 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 261' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -62.18 -29.67 70.52 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.476 -0.765 . . . . 41.340000000000003 110.006 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' S' S ' 262' ' ' TYR . . . . . 0.674 ' CE2' HD22 ' S' ' 233' ' ' LEU . 8.7 t80 -71.29 -44.61 64.86 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.418 -0.802 . . . . 26.030000000000001 110.067 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 263' ' ' VAL . . . . . 0.42 HG22 ' O ' ' S' ' 259' ' ' LEU . 33.0 m -92.02 18.28 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.366 -0.834 . . . . 22.800000000000001 110.38 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 264' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 52.76 70.63 0.56 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.217 -0.927 . . . . 44.030000000000001 110.678 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' S' S ' 265' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -111.84 109.19 55.34 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.383 -0.823 . . . . 35.609999999999999 109.657 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' S' S ' 266' ' ' PRO . . . . . 0.476 ' HA ' ' HB2' ' S' ' 269' ' ' ASP . 49.3 Cg_endo -75.29 0.37 9.11 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.592 1.312 . . . . 37.670000000000002 111.793 -179.109 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 267' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -56.45 -67.71 0.28 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.74 -1.225 . . . . 41.490000000000002 110.164 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 268' ' ' PHE . . . . . 0.4 ' HB3' ' CD2' ' S' ' 257' ' ' LEU . 22.4 m-85 -92.93 39.87 1.05 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.201 -0.937 . . . . 50.759999999999998 110.071 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 269' ' ' ASP . . . . . 0.476 ' HB2' ' HA ' ' S' ' 266' ' ' PRO . 0.9 OUTLIER -75.95 -33.26 59.8 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.375 -0.828 . . . . 61.859999999999999 109.765 179.567 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' S' S ' 270' ' ' TRP . . . . . 0.506 ' CE2' HG23 ' S' ' 271' ' ' VAL . 51.0 p-90 -73.9 -4.37 34.59 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.312 -0.867 . . . . 39.850000000000001 110.483 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 271' ' ' VAL . . . . . 0.506 HG23 ' CE2' ' S' ' 270' ' ' TRP . 46.4 t -109.49 -32.66 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.151 -0.968 . . . . 39.18 110.073 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 272' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -78.6 -36.53 44.09 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.325 -0.859 . . . . 40.020000000000003 110.523 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' S' S ' 273' ' ' SER . . . . . . . . . . . . . 70.8 m -103.6 56.11 0.74 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.264 -0.898 . . . . 47.200000000000003 110.286 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' S' S ' 274' ' ' SER . . . . . . . . . . . . . 6.9 t -133.03 141.25 40.25 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.35 -0.844 . . . . 47.609999999999999 110.155 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' S' S ' 275' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.7 -18.89 21.85 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 O-C-N 123.629 1.331 . . . . 45.280000000000001 110.594 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' S' S ' 276' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -99.86 140.85 33.47 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.317 -0.864 . . . . 57.270000000000003 110.314 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' S' S ' 277' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -71.68 97.69 1.79 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.476 -0.765 . . . . 37.280000000000001 110.309 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' S' S ' 278' ' ' LEU . . . . . . . . . . . . . 86.7 mt -97.0 33.76 1.85 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.397 -0.815 . . . . 43.880000000000003 109.984 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' S' S ' 279' ' ' THR . . . . . . . . . . . . . 74.8 m -63.98 -60.19 3.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.481 -0.762 . . . . 50.049999999999997 110.24 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' S' S ' 280' ' ' LEU . . . . . 0.729 ' HA ' HD12 ' S' ' 283' ' ' ILE . 13.6 mt -51.58 -39.9 58.77 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.31 -0.869 . . . . 54.119999999999997 110.254 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 281' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.35 -49.71 74.47 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.526 -0.734 . . . . 65.280000000000001 110.143 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 282' ' ' ALA . . . . . . . . . . . . . . . -58.99 -33.86 71.17 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.548 -0.72 . . . . 46.509999999999998 110.506 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' S' S ' 283' ' ' ILE . . . . . 0.729 HD12 ' HA ' ' S' ' 280' ' ' LEU . 85.7 mt -66.35 -50.84 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.287 -0.883 . . . . 47.299999999999997 110.138 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 284' ' ' LYS . . . . . . . . . . . . . 33.6 tttp -50.6 -57.57 7.87 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.487 -0.758 . . . . 50.719999999999999 110.384 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' S' S ' 285' ' ' GLN . . . . . 0.524 ' HG2' HD12 ' S' ' 289' ' ' LEU . 34.4 tt0 -51.35 -46.42 62.68 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.494 -0.754 . . . . 68.469999999999999 110.352 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 286' ' ' LEU . . . . . . . . . . . . . 19.0 mt -59.96 -44.48 94.41 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.417 -0.802 . . . . 36.619999999999997 110.287 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' S' S ' 287' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -62.76 -35.26 79.24 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.326 -0.859 . . . . 46.640000000000001 110.088 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' S' S ' 288' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -76.26 -21.06 56.78 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.437 -0.789 . . . . 46.450000000000003 110.263 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' S' S ' 289' ' ' LEU . . . . . 0.524 HD12 ' HG2' ' S' ' 285' ' ' GLN . 30.7 mt -97.33 -21.69 17.07 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.281 -0.887 . . . . 35.090000000000003 110.54 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 290' ' ' THR . . . . . 0.41 HG22 ' HB3' ' S' ' 306' ' ' ASN . 81.3 p -114.77 -28.49 7.07 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.249 -0.907 . . . . 38.609999999999999 110.435 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 291' ' ' GLY . . . . . . . . . . . . . . . 79.44 11.05 85.3 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.879 -1.288 . . . . 36.770000000000003 109.879 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' S' S ' 292' ' ' LEU . . . . . . . . . . . . . 84.9 mt -96.55 145.82 25.36 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.238 -1.154 . . . . 35.329999999999998 109.754 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' S' S ' 293' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -77.32 102.29 6.68 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.161 -0.962 . . . . 48.700000000000003 110.275 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' S' S ' 294' ' ' LEU . . . . . 0.427 ' HB3' ' CZ2' ' S' ' 252' ' ' TRP . 55.2 mt -106.84 51.75 0.73 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.472 -0.768 . . . . 42.609999999999999 110.117 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 295' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -112.53 -11.2 13.63 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.326 -0.859 . . . . 55.490000000000002 110.485 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 296' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -144.34 48.56 1.36 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.177 -0.952 . . . . 75.680000000000007 110.271 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' S' S ' 297' ' ' GLY . . . . . 0.5 ' CA ' ' HA ' ' R' ' 201' ' ' LYS . . . 96.88 145.19 18.73 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.457 -1.457 . . . . 49.439999999999998 109.457 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 298' ' ' GLY . . . . . . . . . . . . . . . -163.85 156.94 29.02 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.849 -1.3 . . . . 41.109999999999999 109.849 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' S' S ' 299' ' ' PRO . . . . . 0.486 ' O ' HG23 ' S' ' 303' ' ' VAL . 47.5 Cg_endo -73.81 118.27 5.37 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 123.91 1.479 . . . . 26.199999999999999 110.291 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 300' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.18 -15.57 31.86 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.529 1.278 . . . . 21.699999999999999 110.647 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' S' S ' 301' ' ' ALA . . . . . . . . . . . . . . . -80.7 -29.32 36.49 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.256 -0.903 . . . . 31.23 110.117 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' S' S ' 302' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.5 -40.62 18.96 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.406 -0.809 . . . . 38.990000000000002 109.993 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 303' ' ' VAL . . . . . 0.486 HG23 ' O ' ' S' ' 299' ' ' PRO . 57.2 t -60.69 -35.52 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.398 -0.814 . . . . 18.629999999999999 110.147 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 304' ' ' ILE . . . . . 0.523 HD12 HG21 ' S' ' 379' ' ' VAL . 86.0 mt -79.33 -23.65 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.405 -0.809 . . . . 25.460000000000001 110.179 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 305' ' ' TRP . . . . . 0.413 ' CD2' ' HD3' ' S' ' 308' ' ' LYS . 68.9 t-105 -88.63 -14.53 37.24 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.32 -0.863 . . . . 33.399999999999999 110.521 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 306' ' ' ASN . . . . . 0.41 ' HB3' HG22 ' S' ' 290' ' ' THR . 10.3 m-80 -89.72 -13.56 36.59 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.218 -0.926 . . . . 36.969999999999999 110.369 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 307' ' ' ILE . . . . . 0.471 HG12 ' O ' ' S' ' 303' ' ' VAL . 36.9 pt -125.08 45.62 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.21 -0.931 . . . . 30.809999999999999 110.059 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 308' ' ' LYS . . . . . 0.413 ' HD3' ' CD2' ' S' ' 305' ' ' TRP . 1.5 mtmp? -73.5 -37.75 65.58 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.339 -0.851 . . . . 46.520000000000003 110.12 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 309' ' ' HIS . . . . . 0.496 ' CD2' ' HG ' ' S' ' 310' ' ' LEU . 55.5 p-80 -73.22 -8.26 55.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.318 -0.864 . . . . 51.030000000000001 110.065 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 310' ' ' LEU . . . . . 0.496 ' HG ' ' CD2' ' S' ' 309' ' ' HIS . 52.6 mt -99.31 -12.92 19.9 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.312 -0.867 . . . . 36.159999999999997 109.975 179.306 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 311' ' ' LEU . . . . . 0.531 HD21 ' CE2' ' S' ' 260' ' ' PHE . 10.8 mt -97.13 147.83 23.66 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.367 -0.833 . . . . 40.0 110.499 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 312' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -81.6 -16.24 52.15 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.31 -0.869 . . . . 54.18 109.682 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' S' S ' 313' ' ' THR . . . . . 0.829 HG23 ' HG2' ' S' ' 323' ' ' GLU . 92.7 m -87.95 151.66 22.64 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.371 -0.83 . . . . 25.609999999999999 110.098 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 314' ' ' GLY . . . . . . . . . . . . . . . -87.93 126.41 8.05 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.842 -1.303 . . . . 25.18 109.842 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' S' S ' 315' ' ' ILE . . . . . 0.666 HD13 ' HB ' ' S' ' 324' ' ' VAL . 50.8 mm -101.65 150.51 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.411 -1.052 . . . . 23.899999999999999 109.704 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 316' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' S' ' 325' ' ' CYS . . . -157.09 -159.31 9.41 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.932 -1.267 . . . . 23.18 109.932 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 317' ' ' THR . . . . . 0.424 HG22 ' CG2' ' S' ' 326' ' ' VAL . 11.1 p -133.92 -173.01 3.13 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.447 -1.031 . . . . 27.98 109.958 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.58 -56.19 25.08 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.265 -0.897 . . . . 28.100000000000001 109.858 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' S' S ' 319' ' ' SER . . . . . . . . . . . . . 1.2 m -59.93 -41.61 92.16 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.427 -0.796 . . . . 37.0 109.675 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' S' S ' 320' ' ' ARG . . . . . . . . . . . . . 12.1 mtm180 -111.72 79.85 2.65 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.529 -0.732 . . . . 52.07 109.726 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' S' S ' 321' ' ' PRO . . . . . 0.885 ' HG2' ' O ' ' S' ' 386' ' ' GLU . 43.9 Cg_endo -71.44 171.51 16.05 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.883 1.465 . . . . 38.289999999999999 110.927 -179.429 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 322' ' ' SER . . . . . 0.447 ' HB2' ' O ' ' S' ' 321' ' ' PRO . 41.4 t 178.68 -148.15 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.966 -0.753 . . . . 38.840000000000003 108.966 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 323' ' ' GLU . . . . . 0.829 ' HG2' HG23 ' S' ' 313' ' ' THR . 6.7 tp10 -62.85 -40.32 97.1 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.063 -1.023 . . . . 40.700000000000003 109.679 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 324' ' ' VAL . . . . . 0.666 ' HB ' HD13 ' S' ' 315' ' ' ILE . 72.7 t -141.27 135.03 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.396 -0.815 . . . . 20.34 109.46 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 325' ' ' CYS . . . . . 0.462 ' HB2' ' CE1' ' S' ' 380' ' ' PHE . 11.5 m -126.0 172.19 10.16 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.336 -0.853 . . . . 30.629999999999999 110.833 -179.084 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 326' ' ' VAL . . . . . 0.65 HG12 HG22 ' S' ' 379' ' ' VAL . 34.5 m -135.45 142.19 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.58 -0.7 . . . . 23.899999999999999 109.285 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 327' ' ' VAL . . . . . 0.595 HG11 ' O ' ' S' ' 377' ' ' VAL . 34.5 m -56.35 124.93 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.092 -1.005 . . . . 19.48 110.47 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 328' ' ' ASP . . . . . . . . . . . . . 55.6 p-10 -119.28 11.48 12.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.45 -0.781 . . . . 26.43 110.465 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' S' S ' 329' ' ' GLY . . . . . . . . . . . . . . . 119.71 2.23 13.04 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.025 -1.23 . . . . 31.239999999999998 110.025 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' S' S ' 330' ' ' THR . . . . . . . . . . . . . 80.1 m -92.98 130.03 38.69 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.045 -1.268 . . . . 30.050000000000001 110.109 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' S' S ' 331' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -56.81 111.46 1.03 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.261 -0.899 . . . . 37.259999999999998 109.955 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' S' S ' 332' ' ' MET . . . . . . . . . . . . . 88.1 mmm -94.11 162.57 13.82 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.278 -0.889 . . . . 26.23 110.351 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' S' S ' 333' ' ' CYS . . . . . . . . . . . . . 26.2 m -137.19 150.07 47.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.535 -0.728 . . . . 23.559999999999999 110.019 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' S' S ' 334' ' ' LEU . . . . . 0.566 HD11 ' O ' ' S' ' 372' ' ' PRO . 0.1 OUTLIER -52.68 -24.75 9.15 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.339 -0.851 . . . . 28.93 110.522 179.881 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' S' S ' 335' ' ' ALA . . . . . . . . . . . . . . . -89.08 14.42 10.75 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.383 -0.823 . . . . 15.76 110.947 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' S' S ' 336' ' ' ASP . . . . . 0.4 ' O ' ' HA ' ' S' ' 382' ' ' PRO . 70.4 m-20 -100.49 -17.14 17.28 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.1 -1.0 . . . . 34.920000000000002 110.186 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 337' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -152.46 170.85 19.12 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.299 -0.875 . . . . 19.030000000000001 110.017 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' S' S ' 338' ' ' HIS . . . . . 0.402 ' HB3' ' CZ ' ' S' ' 383' ' ' TYR . 13.5 p80 -120.76 10.44 10.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.416 -0.803 . . . . 18.82 110.497 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 339' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' S' ' 352' ' ' ALA . . . -175.97 155.24 1.58 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.293 -0.879 . . . . 17.18 110.103 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 340' ' ' GLY . . . . . 0.401 ' CA ' ' O ' ' S' ' 379' ' ' VAL . . . 160.8 173.09 28.97 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.07 -1.212 . . . . 18.329999999999998 110.07 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 341' ' ' ILE . . . . . . . . . . . . . 84.4 mt -88.88 138.15 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.505 -0.997 . . . . 18.600000000000001 109.757 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' S' S ' 342' ' ' PHE . . . . . 0.493 ' CE2' ' HB3' ' S' ' 352' ' ' ALA . 70.0 m-85 -120.98 -178.41 3.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.26 -0.9 . . . . 23.440000000000001 110.428 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 343' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.85 93.42 4.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.41 -0.806 . . . . 35.590000000000003 109.989 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 344' ' ' LYS . . . . . 0.402 ' O ' ' HB3' ' S' ' 348' ' ' HIS . 0.3 OUTLIER -80.78 125.0 29.52 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.269 -0.894 . . . . 38.340000000000003 110.148 179.948 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' S' S ' 345' ' ' GLY . . . . . . . . . . . . . . . 62.79 -130.81 43.02 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 108.847 -1.701 . . . . 53.460000000000001 108.847 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' S' S ' 346' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -132.79 150.8 52.12 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.199 -1.177 . . . . 70.909999999999997 110.073 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' S' S ' 347' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 53.35 35.36 20.14 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.335 -0.853 . . . . 47.32 110.437 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' S' S ' 348' ' ' HIS . . . . . 0.402 ' HB3' ' O ' ' S' ' 344' ' ' LYS . 46.2 t60 -150.15 155.82 40.49 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.294 -0.879 . . . . 41.719999999999999 110.311 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 349' ' ' ALA . . . . . 0.46 ' C ' HG13 ' S' ' 350' ' ' VAL . . . -149.74 151.32 33.43 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.346 -0.846 . . . . 22.91 110.463 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 350' ' ' VAL . . . . . 0.46 HG13 ' C ' ' S' ' 349' ' ' ALA . 34.6 m -149.11 169.6 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.443 -0.785 . . . . 21.09 110.024 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 351' ' ' PHE . . . . . 0.5 ' CD2' ' HB3' ' S' ' 258' ' ' GLN . 10.7 t80 -105.35 143.54 33.37 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.215 -0.928 . . . . 25.030000000000001 110.706 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 352' ' ' ALA . . . . . 0.493 ' HB3' ' CE2' ' S' ' 342' ' ' PHE . . . -147.66 151.69 36.59 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.646 -0.659 . . . . 23.809999999999999 109.732 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 353' ' ' CYS . . . . . . . . . . . . . 26.3 p -153.34 164.87 37.36 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.291 -0.881 . . . . 25.66 110.246 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' S' S ' 354' ' ' VAL . . . . . 0.547 HG22 ' CE2' ' S' ' 359' ' ' TRP . 56.8 t -75.99 118.5 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.381 -0.824 . . . . 34.270000000000003 109.967 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 355' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' S' ' 232' ' ' THR . 51.5 p -117.81 175.11 5.81 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.282 -0.886 . . . . 25.489999999999998 110.307 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 356' ' ' SER . . . . . . . . . . . . . 62.0 p -62.15 -17.67 58.6 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.455 -0.778 . . . . 31.239999999999998 110.748 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' S' S ' 357' ' ' ASN . . . . . . . . . . . . . 45.8 m-20 -107.03 14.28 26.56 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.145 -0.972 . . . . 28.609999999999999 110.531 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' S' S ' 358' ' ' GLY . . . . . . . . . . . . . . . 111.86 -152.85 17.61 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.045 -1.222 . . . . 22.010000000000002 110.045 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' S' S ' 359' ' ' TRP . . . . . 0.547 ' CE2' HG22 ' S' ' 354' ' ' VAL . 15.4 m95 -91.35 116.73 29.08 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.45 -1.029 . . . . 25.539999999999999 110.176 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 360' ' ' TYR . . . . . 0.413 ' HA ' ' HA ' ' S' ' 369' ' ' PRO . 1.3 m-85 -103.52 165.83 10.8 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.338 -0.851 . . . . 40.530000000000001 110.032 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 361' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' S' ' 351' ' ' PHE . . . -140.1 130.1 24.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.361 -0.837 . . . . 18.039999999999999 110.268 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 362' ' ' ILE . . . . . . . . . . . . . 89.1 mt -95.61 83.64 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.409 -0.807 . . . . 15.640000000000001 110.061 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' S' S ' 363' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' S' ' 365' ' ' GLU . 11.8 t0 -75.25 94.51 3.01 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.422 -0.799 . . . . 35.030000000000001 110.201 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 364' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 53.98 -89.43 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.551 -0.718 . . . . 46.719999999999999 110.511 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' S' S ' 365' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' S' ' 363' ' ' ASP . 23.7 mt-10 -122.7 19.2 10.31 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.075 -1.016 . . . . 56.200000000000003 110.245 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 366' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -117.98 124.96 49.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.169 -0.957 . . . . 51.020000000000003 110.395 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' S' S ' 367' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -107.03 127.05 53.12 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.344 -0.847 . . . . 37.590000000000003 110.137 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' S' S ' 368' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -165.38 159.5 13.99 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.247 -0.908 . . . . 31.469999999999999 110.481 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' S' S ' 369' ' ' PRO . . . . . 0.413 ' HA ' ' HA ' ' S' ' 360' ' ' TYR . 46.8 Cg_endo -72.8 139.61 30.8 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.859 1.452 . . . . 28.850000000000001 110.538 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 370' ' ' TRP . . . . . . . . . . . . . 67.6 t90 -167.2 113.56 0.76 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.347 -0.846 . . . . 26.940000000000001 109.942 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' S' S ' 371' ' ' THR . . . . . . . . . . . . . 59.9 m -74.81 113.02 20.37 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.417 -0.802 . . . . 20.190000000000001 110.01 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' S' S ' 372' ' ' PRO . . . . . 0.566 ' O ' HD11 ' S' ' 334' ' ' LEU . 48.1 Cg_endo -73.52 157.09 49.39 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 O-C-N 123.597 1.314 . . . . 28.68 110.624 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 373' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -90.56 147.15 35.76 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.492 -0.755 . . . . 35.719999999999999 109.896 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' S' S ' 374' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -76.03 -6.27 17.18 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 O-C-N 123.652 1.343 . . . . 30.890000000000001 110.459 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' S' S ' 375' ' ' SER . . . . . . . . . . . . . 68.6 p -104.41 -16.9 14.97 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.22 -0.925 . . . . 29.41 110.451 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' S' S ' 376' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -106.51 43.02 1.19 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.231 -0.918 . . . . 32.890000000000001 110.217 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' S' S ' 377' ' ' VAL . . . . . 0.595 ' O ' HG11 ' S' ' 327' ' ' VAL . 7.3 p -114.65 147.27 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.374 -0.829 . . . . 24.329999999999998 110.216 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 378' ' ' LEU . . . . . . . . . . . . . 52.3 mt -115.99 -58.01 2.15 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.348 -0.845 . . . . 24.370000000000001 109.638 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' S' S ' 379' ' ' VAL . . . . . 0.65 HG22 HG12 ' S' ' 326' ' ' VAL . 61.3 t -120.64 132.4 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.471 -0.768 . . . . 18.02 109.443 179.251 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 380' ' ' PHE . . . . . 0.462 ' CE1' ' HB2' ' S' ' 325' ' ' CYS . 14.4 p90 -142.63 174.0 11.03 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.309 -0.869 . . . . 29.350000000000001 110.634 -179.347 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 381' ' ' VAL . . . . . . . . . . . . . 58.4 t -120.1 107.32 39.81 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.578 -0.701 . . . . 16.34 109.398 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' S' S ' 382' ' ' PRO . . . . . 0.4 ' HA ' ' O ' ' S' ' 336' ' ' ASP . 45.7 Cg_endo -71.26 145.65 49.16 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 O-C-N 123.626 1.329 . . . . 20.940000000000001 110.759 -179.374 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 383' ' ' TYR . . . . . 0.402 ' CZ ' ' HB3' ' S' ' 338' ' ' HIS . 88.3 m-85 -61.08 -53.47 56.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.398 -0.814 . . . . 28.93 109.869 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 384' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -103.65 130.03 51.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.482 -0.761 . . . . 47.030000000000001 110.358 -176.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' S' S ' 385' ' ' GLN . . . . . 0.409 ' O ' ' O ' ' S' ' 386' ' ' GLU . 9.5 tt0 -69.13 3.67 2.01 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.421 -0.799 . . . . 46.689999999999998 110.22 177.199 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 386' ' ' GLU . . . . . 0.885 ' O ' ' HG2' ' S' ' 321' ' ' PRO . 16.0 pt-20 -44.69 165.79 0.14 Allowed Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.348 -0.845 . . . . 50.25 109.572 179.522 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 387' ' ' PRO . . . . . 0.553 ' O ' ' C ' ' S' ' 388' ' ' LEU . 38.7 Cg_endo -67.4 -11.43 32.13 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.752 1.396 . . . . 34.390000000000001 110.61 -177.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 388' ' ' LEU . . . . . 0.574 ' O ' ' CB ' ' S' ' 389' ' ' ASN . 0.2 OUTLIER 32.18 80.99 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.428 -0.795 . . . . 38.009999999999998 110.137 -179.681 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' S' S ' 389' ' ' ASN . . . . . 0.574 ' CB ' ' O ' ' S' ' 388' ' ' LEU . 2.9 t30 75.03 169.14 0.29 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.274 -0.891 . . . . 45.82 110.155 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 390' ' ' GLY . . . . . 0.488 ' O ' ' CB ' ' S' ' 391' ' ' GLU . . . 147.19 -91.51 0.15 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.622 -1.391 . . . . 33.460000000000001 109.622 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 391' ' ' GLU . . . . . 0.488 ' CB ' ' O ' ' S' ' 390' ' ' GLY . 2.5 tt0 68.73 -66.49 0.24 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.377 -1.072 . . . . 56.579999999999998 110.153 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 392' ' ' TRP . . . . . 0.569 ' O ' HG13 ' S' ' 396' ' ' VAL . 41.7 p-90 -50.89 -26.56 6.0 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.385 -0.822 . . . . 31.43 110.342 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 393' ' ' LYS . . . . . 0.441 ' N ' ' CD2' ' S' ' 392' ' ' TRP . 1.9 ptmt -63.91 -22.41 66.91 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.289 -0.882 . . . . 39.420000000000002 110.324 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 394' ' ' ALA . . . . . 0.448 ' O ' ' CG ' ' S' ' 398' ' ' ARG . . . -93.43 -18.02 22.81 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.371 -0.83 . . . . 34.329999999999998 110.068 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 395' ' ' LYS . . . . . 0.573 ' CB ' HD11 ' R' ' 143' ' ' LEU . 10.5 mmtt -94.03 2.4 56.05 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.459 -0.776 . . . . 60.090000000000003 110.231 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 396' ' ' VAL . . . . . 0.581 ' CG1' HD21 ' R' ' 178' ' ' LEU . 32.6 m -113.94 -38.8 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.335 -0.853 . . . . 35.5 110.616 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 397' ' ' GLN . . . . . 0.581 ' HA ' ' N ' ' R' ' 99' ' ' PRO . 1.6 pp0? -84.81 39.97 0.78 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.128 -0.983 . . . . 49.960000000000001 110.641 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' S' S ' 398' ' ' ARG . . . . . 0.869 ' CB ' ' HA ' ' R' ' 147' ' ' GLU . 0.9 OUTLIER -116.0 -144.13 0.38 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.254 -0.904 . . . . 43.420000000000002 110.737 -179.77 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' S' S ' 399' ' ' LYS . . . . . 0.792 ' HB3' ' CA ' ' R' ' 97' ' ' GLY . 0.5 OUTLIER 175.94 177.87 0.21 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.405 -0.809 . . . . 55.310000000000002 110.051 -179.666 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' S' S ' 400' ' ' LEU . . . . . 0.711 ' HG ' HD21 ' R' ' 46' ' ' ASN . 0.8 OUTLIER -42.95 -30.9 0.45 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.329 -0.857 . . . . 41.030000000000001 110.292 178.291 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' S' S ' 401' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.683 0 O-C-N 121.329 -0.857 . . . . 61.969999999999999 110.126 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' R' R ' 29' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.213 0.53 . . . . 32.140000000000001 110.248 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' R' R ' 30' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -96.35 141.15 30.01 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.324 -0.86 . . . . 43.359999999999999 110.247 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' R' R ' 31' ' ' LEU . . . . . . . . . . . . . 65.4 mt -134.86 140.54 45.9 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.293 -0.879 . . . . 22.93 110.332 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' R' R ' 32' ' ' THR . . . . . . . . . . . . . 69.0 m -87.55 110.61 20.48 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.337 -0.852 . . . . 22.34 109.983 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' R' R ' 33' ' ' LEU . . . . . 0.594 HD22 ' CE2' ' R' ' 62' ' ' TYR . 80.2 mt -62.52 -172.74 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.237 -0.915 . . . . 21.390000000000001 110.209 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 34' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -74.59 -29.4 61.31 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.375 -0.828 . . . . 34.399999999999999 110.41 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' R' R ' 35' ' ' ASN . . . . . . . . . . . . . 48.2 p30 -77.84 -1.74 33.11 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.322 -0.861 . . . . 30.280000000000001 110.665 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' R' R ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.1 -16.53 59.4 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.8 -1.32 . . . . 36.25 109.8 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' R' R ' 37' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -59.0 161.81 4.73 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.256 -1.144 . . . . 53.799999999999997 110.383 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' R' R ' 38' ' ' LYS . . . . . . . . . . . . . 57.0 mttt -117.86 135.8 53.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.43 -0.794 . . . . 49.909999999999997 110.175 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' R' R ' 39' ' ' LYS . . . . . 0.404 ' HG2' ' CZ ' ' R' ' 41' ' ' PHE . 8.1 ttmt -138.77 143.65 39.07 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.427 -0.796 . . . . 35.689999999999998 110.241 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 40' ' ' THR . . . . . . . . . . . . . 23.6 m -102.56 127.97 49.41 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.424 -0.798 . . . . 34.840000000000003 110.226 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' R' R ' 41' ' ' PHE . . . . . 0.404 ' CZ ' ' HG2' ' R' ' 39' ' ' LYS . 96.6 m-85 -113.09 132.63 55.35 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.386 -0.821 . . . . 34.420000000000002 110.21 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 42' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -93.21 140.86 29.06 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.348 -0.845 . . . . 51.460000000000001 110.263 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' R' R ' 43' ' ' SER . . . . . . . . . . . . . 54.2 m -70.74 141.83 51.47 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.511 -0.743 . . . . 41.840000000000003 110.196 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' R' R ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.78 125.38 29.56 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.347 -0.845 . . . . 33.82 109.984 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 45' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.11 151.05 55.03 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 123.611 1.321 . . . . 30.27 110.649 -179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' R' R ' 46' ' ' ASN . . . . . 0.677 ' ND2' HD13 ' S' ' 400' ' ' LEU . 52.1 t-20 -124.27 109.95 14.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.456 -0.777 . . . . 35.100000000000001 110.011 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 47' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -120.33 -34.84 3.56 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.339 -0.85 . . . . 42.810000000000002 110.493 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' R' R ' 48' ' ' HIS . . . . . 0.44 ' NE2' HD11 ' R' ' 80' ' ' LEU . 73.3 m80 -105.79 45.23 0.98 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.221 -0.925 . . . . 49.969999999999999 110.216 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 49' ' ' ASP . . . . . 0.764 ' HA ' HD22 ' S' ' 400' ' ' LEU . 37.7 m-20 50.28 34.73 9.26 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.358 -0.839 . . . . 61.32 110.197 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 50' ' ' ASN . . . . . 0.4 ' OD1' ' HA ' ' R' ' 46' ' ' ASN . 15.0 p-10 -86.3 43.78 1.09 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.379 -0.826 . . . . 51.5 110.685 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 51' ' ' ALA . . . . . 0.708 ' CB ' ' HB2' ' S' ' 400' ' ' LEU . . . -66.1 -46.12 78.73 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.199 -0.938 . . . . 38.770000000000003 109.474 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 52' ' ' TRP . . . . . 0.497 ' HB3' ' NH1' ' S' ' 398' ' ' ARG . 68.1 p-90 -58.38 -38.42 77.25 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.455 -0.778 . . . . 26.239999999999998 110.055 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 53' ' ' LEU . . . . . 0.484 ' N ' ' CD2' ' R' ' 52' ' ' TRP . 23.1 tp -66.75 -46.62 74.81 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.424 -0.798 . . . . 26.75 109.984 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 54' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -55.35 -41.52 72.65 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.304 -0.872 . . . . 35.020000000000003 110.111 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' R' R ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.17 -46.08 91.99 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.448 -0.782 . . . . 24.469999999999999 110.157 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' R' R ' 56' ' ' ILE . . . . . 0.431 HG12 HD11 ' R' ' 104' ' ' ILE . 76.0 mt -62.2 -42.28 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.322 -0.861 . . . . 26.030000000000001 109.888 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 57' ' ' LEU . . . . . . . . . . . . . 22.4 mt -60.27 -45.63 92.63 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.28 -0.888 . . . . 26.77 109.68 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' R' R ' 58' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -63.87 -46.59 84.25 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.481 -0.762 . . . . 22.32 109.571 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' R' R ' 59' ' ' LEU . . . . . 0.43 ' HA ' ' HE2' ' R' ' 151' ' ' PHE . 24.0 tp -61.34 -37.84 84.73 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.317 -0.864 . . . . 20.550000000000001 109.389 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 60' ' ' PHE . . . . . 0.528 ' CE2' HD21 ' R' ' 111' ' ' LEU . 2.8 m-85 -61.05 -44.72 96.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.635 -0.666 . . . . 20.079999999999998 109.913 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 61' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -63.18 -36.15 82.66 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.488 -0.758 . . . . 18.800000000000001 110.443 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' R' R ' 62' ' ' TYR . . . . . 0.594 ' CE2' HD22 ' R' ' 33' ' ' LEU . 9.1 t80 -63.09 -41.81 99.48 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.234 -0.916 . . . . 26.449999999999999 110.199 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 63' ' ' VAL . . . . . 0.406 ' H ' HG22 ' R' ' 63' ' ' VAL . 30.5 m -93.38 20.35 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.422 -0.799 . . . . 29.75 110.252 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 64' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 53.03 75.56 0.24 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.316 -0.865 . . . . 35.520000000000003 110.531 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' R' R ' 65' ' ' GLU . . . . . 0.442 ' HG2' ' CD2' ' R' ' 60' ' ' PHE . 14.3 tp10 -116.3 104.06 52.33 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.348 -0.845 . . . . 29.890000000000001 109.901 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 66' ' ' PRO . . . . . 0.48 ' HA ' ' HB2' ' R' ' 69' ' ' ASP . 46.3 Cg_endo -73.57 -5.8 17.69 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.775 1.408 . . . . 21.370000000000001 111.093 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 67' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -52.13 -61.44 2.27 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.116 -0.99 . . . . 23.850000000000001 110.43 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 68' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -98.23 36.58 1.57 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.306 -0.871 . . . . 28.07 110.484 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' R' R ' 69' ' ' ASP . . . . . 0.48 ' HB2' ' HA ' ' R' ' 66' ' ' PRO . 11.7 t0 -72.3 -33.35 67.32 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.23 -0.918 . . . . 43.759999999999998 110.097 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 70' ' ' TRP . . . . . 0.477 ' CE2' ' CG2' ' R' ' 71' ' ' VAL . 47.7 p-90 -73.24 -4.03 30.5 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.313 -0.867 . . . . 33.060000000000002 110.74 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 71' ' ' VAL . . . . . 0.556 HG11 ' HB2' ' R' ' 82' ' ' ALA . 40.8 t -109.78 -27.41 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.078 -1.014 . . . . 31.699999999999999 109.674 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 72' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -86.62 -48.76 8.04 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.347 -0.845 . . . . 33.579999999999998 110.288 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' R' R ' 73' ' ' SER . . . . . . . . . . . . . 69.9 m -89.75 51.12 2.01 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.283 -0.886 . . . . 50.82 110.295 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' R' R ' 74' ' ' SER . . . . . . . . . . . . . 15.7 t -125.99 138.27 31.78 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.335 -0.853 . . . . 34.740000000000002 110.208 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.31 -25.02 16.02 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.737 1.388 . . . . 35.700000000000003 110.341 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' R' R ' 76' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -91.66 153.16 19.87 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.398 -0.814 . . . . 66.480000000000004 110.428 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' R' R ' 77' ' ' ASN . . . . . . . . . . . . . 37.4 t30 -81.5 95.2 7.04 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.364 -0.835 . . . . 46.719999999999999 110.035 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' R' R ' 78' ' ' LEU . . . . . . . . . . . . . 96.3 mt -96.4 27.91 3.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.385 -0.822 . . . . 37.549999999999997 110.22 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' R' R ' 79' ' ' THR . . . . . . . . . . . . . 29.4 m -56.18 -54.64 42.78 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.317 -0.865 . . . . 37.359999999999999 110.295 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' R' R ' 80' ' ' LEU . . . . . 0.603 ' HA ' HD12 ' R' ' 83' ' ' ILE . 15.8 mt -60.97 -23.13 65.1 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.351 -0.843 . . . . 35.829999999999998 110.478 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 81' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -79.55 -39.08 32.7 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.147 -0.971 . . . . 44.030000000000001 110.331 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' R' R ' 82' ' ' ALA . . . . . 0.556 ' HB2' HG11 ' R' ' 71' ' ' VAL . . . -69.5 -28.67 66.25 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.227 -0.921 . . . . 32.539999999999999 110.23 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 83' ' ' ILE . . . . . 0.603 HD12 ' HA ' ' R' ' 80' ' ' LEU . 78.2 mt -70.04 -46.1 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.221 -0.925 . . . . 32.020000000000003 110.342 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 84' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -55.21 -52.02 64.71 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.232 -0.918 . . . . 34.090000000000003 110.607 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' R' R ' 85' ' ' GLN . . . . . 0.533 ' HG2' HD12 ' R' ' 89' ' ' LEU . 31.9 tt0 -54.85 -46.81 74.7 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.203 -0.936 . . . . 25.940000000000001 110.269 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 86' ' ' LEU . . . . . . . . . . . . . 23.9 mt -58.74 -43.77 90.33 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.312 -0.867 . . . . 16.199999999999999 109.905 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' R' R ' 87' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -65.38 -35.16 80.12 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.529 -0.732 . . . . 49.090000000000003 110.251 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' R' R ' 88' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -78.46 -19.03 54.0 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.381 -0.825 . . . . 28.609999999999999 110.51 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' R' R ' 89' ' ' LEU . . . . . 0.533 HD12 ' HG2' ' R' ' 85' ' ' GLN . 32.5 mt -96.24 -29.38 14.05 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.261 -0.899 . . . . 26.16 110.167 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 90' ' ' THR . . . . . . . . . . . . . 59.2 p -105.68 -34.66 7.64 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.327 -0.858 . . . . 33.329999999999998 109.747 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' R' R ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.91 16.06 58.55 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.835 -1.306 . . . . 31.129999999999999 109.835 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' R' R ' 92' ' ' LEU . . . . . . . . . . . . . 97.0 mt -100.07 155.18 17.86 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.112 -1.228 . . . . 42.520000000000003 110.266 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' R' R ' 93' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -86.2 91.66 8.52 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.489 -0.757 . . . . 68.459999999999994 109.948 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' R' R ' 94' ' ' LEU . . . . . 0.457 ' HB3' ' CZ2' ' R' ' 52' ' ' TRP . 48.2 mt -99.51 53.0 0.94 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.147 -0.971 . . . . 44.630000000000003 110.368 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 95' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.54 -38.67 6.37 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.348 -0.845 . . . . 67.159999999999997 110.34 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 96' ' ' GLU . . . . . 0.411 ' O ' ' CD ' ' S' ' 399' ' ' LYS . 24.7 mt-10 -113.83 44.11 1.69 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.316 -0.865 . . . . 67.019999999999996 110.337 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 97' ' ' GLY . . . . . 0.575 ' HA3' ' CB ' ' S' ' 399' ' ' LYS . . . 99.2 150.87 26.06 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.598 -1.401 . . . . 49.479999999999997 109.598 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 98' ' ' GLY . . . . . . . . . . . . . . . -166.28 159.99 33.42 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.245 -1.542 . . . . 36.57 109.245 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' R' R ' 99' ' ' PRO . . . . . 0.79 ' O ' HG23 ' R' ' 103' ' ' VAL . 44.9 Cg_endo -72.56 121.12 7.15 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 O-C-N 123.703 1.37 . . . . 30.41 110.435 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 100' ' ' PRO . . . . . 0.411 ' HA ' HD11 ' R' ' 56' ' ' ILE . 45.8 Cg_endo -72.27 -31.7 11.39 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.567 1.299 . . . . 29.940000000000001 110.506 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 101' ' ' ALA . . . . . 0.476 ' HB2' ' HB3' ' R' ' 178' ' ' LEU . . . -69.97 -38.41 76.06 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.226 -0.921 . . . . 23.640000000000001 110.266 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 102' ' ' LEU . . . . . 0.423 HD23 HD21 ' R' ' 106' ' ' ASN . 0.1 OUTLIER -72.69 -40.82 65.94 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.367 -0.833 . . . . 20.309999999999999 110.324 -179.718 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' R' R ' 103' ' ' VAL . . . . . 0.79 HG23 ' O ' ' R' ' 99' ' ' PRO . 63.9 t -58.08 -40.15 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.281 -0.887 . . . . 16.329999999999998 109.934 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 104' ' ' ILE . . . . . 0.431 HD11 HG12 ' R' ' 56' ' ' ILE . 81.7 mt -71.7 -30.49 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.388 -0.82 . . . . 24.77 109.985 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 105' ' ' TRP . . . . . 0.461 ' O ' ' HD3' ' R' ' 108' ' ' LYS . 70.6 t-105 -82.42 0.81 40.39 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.345 -0.847 . . . . 23.280000000000001 110.33 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 106' ' ' ASN . . . . . 0.423 HD21 HD23 ' R' ' 102' ' ' LEU . 6.9 m-80 -105.05 -10.38 17.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.143 -0.973 . . . . 28.260000000000002 110.146 179.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 107' ' ' ILE . . . . . . . . . . . . . 36.8 pt -126.81 35.0 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.225 -0.922 . . . . 18.77 110.01 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' R' R ' 108' ' ' LYS . . . . . 0.501 ' HG2' ' HB ' ' R' ' 115' ' ' ILE . 9.2 mtpp -61.06 -48.47 81.59 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.528 -0.733 . . . . 42.5 110.031 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 109' ' ' HIS . . . . . 0.445 ' CD2' ' HG ' ' R' ' 110' ' ' LEU . 50.8 p-80 -66.01 -12.86 58.1 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.503 -0.748 . . . . 20.07 110.696 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 110' ' ' LEU . . . . . 0.445 ' HG ' ' CD2' ' R' ' 109' ' ' HIS . 80.8 mt -94.84 -17.31 22.2 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.145 -0.972 . . . . 15.69 110.181 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 111' ' ' LEU . . . . . 0.528 HD21 ' CE2' ' R' ' 60' ' ' PHE . 10.4 mt -94.1 144.14 25.75 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.341 -0.85 . . . . 25.390000000000001 111.004 -179.204 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 112' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -77.71 -17.36 57.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.451 -0.781 . . . . 53.479999999999997 109.846 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' R' R ' 113' ' ' THR . . . . . 0.457 HG22 ' N ' ' R' ' 114' ' ' GLY . 60.5 m -83.72 166.68 17.86 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.251 -0.906 . . . . 14.800000000000001 110.22 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 114' ' ' GLY . . . . . 0.457 ' N ' HG22 ' R' ' 113' ' ' THR . . . -97.96 127.16 9.13 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.994 -1.243 . . . . 16.140000000000001 109.994 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 115' ' ' ILE . . . . . 0.577 HD13 ' HB ' ' R' ' 124' ' ' VAL . 47.8 mm -109.09 139.36 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.475 -1.015 . . . . 13.460000000000001 109.71 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 116' ' ' GLY . . . . . . . . . . . . . . . -152.78 -155.81 7.27 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.964 -1.254 . . . . 23.899999999999999 109.964 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' R' R ' 117' ' ' THR . . . . . 0.528 HG22 ' CG2' ' R' ' 126' ' ' VAL . 18.9 p -135.06 -171.46 2.81 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.467 -1.019 . . . . 27.370000000000001 110.02 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 118' ' ' ALA . . . . . 0.445 ' HB3' ' OD1' ' R' ' 128' ' ' ASP . . . -56.5 -58.09 9.53 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.337 -0.852 . . . . 18.760000000000002 110.064 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 119' ' ' SER . . . . . 0.567 ' HB3' ' HB ' ' R' ' 196' ' ' VAL . 1.1 m -56.54 -40.65 75.46 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.267 -0.896 . . . . 32.350000000000001 109.69 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 120' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 -110.02 86.19 4.77 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.458 -0.776 . . . . 27.120000000000001 109.643 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' R' R ' 121' ' ' PRO . . . . . 0.482 ' HA ' ' SG ' ' R' ' 125' ' ' CYS . 44.3 Cg_endo -71.26 166.55 28.9 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.817 1.43 . . . . 22.68 111.02 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 122' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' R' ' 121' ' ' PRO . 38.6 t 178.55 -161.67 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.643 -0.661 . . . . 22.989999999999998 109.447 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 123' ' ' GLU . . . . . 0.442 ' HG2' HG23 ' R' ' 113' ' ' THR . 2.3 tp10 -56.47 -39.95 74.06 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.211 -0.93 . . . . 36.18 109.673 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 124' ' ' VAL . . . . . 0.577 ' HB ' HD13 ' R' ' 115' ' ' ILE . 84.2 t -142.52 136.43 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.471 -0.768 . . . . 20.640000000000001 109.333 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 125' ' ' CYS . . . . . 0.482 ' SG ' ' HA ' ' R' ' 121' ' ' PRO . 83.4 m -140.32 168.16 20.46 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.245 -0.91 . . . . 22.800000000000001 111.206 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 126' ' ' VAL . . . . . 0.729 HG12 HG22 ' R' ' 179' ' ' VAL . 35.9 m -122.68 159.75 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.713 -0.617 . . . . 21.239999999999998 109.595 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 127' ' ' VAL . . . . . 0.709 HG11 ' O ' ' R' ' 177' ' ' VAL . 30.5 m -70.83 141.83 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.29 -0.881 . . . . 19.77 110.708 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 128' ' ' ASP . . . . . 0.445 ' OD1' ' HB3' ' R' ' 118' ' ' ALA . 53.8 p-10 -137.7 19.42 2.87 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.37 -0.831 . . . . 29.210000000000001 110.664 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 129' ' ' GLY . . . . . . . . . . . . . . . 114.08 0.05 24.02 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.967 -1.111 . . . . 33.859999999999999 110.403 179.274 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' R' R ' 130' ' ' THR . . . . . . . . . . . . . 58.7 m -91.91 131.83 36.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.145 -1.209 . . . . 26.41 110.08 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -62.51 120.66 11.53 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.338 -0.852 . . . . 33.079999999999998 110.224 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' R' R ' 132' ' ' MET . . . . . 0.435 ' HE1' ' CE2' ' R' ' 180' ' ' PHE . 98.3 mmm -105.16 165.67 10.93 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.558 -0.714 . . . . 30.760000000000002 110.472 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 133' ' ' CYS . . . . . 0.411 ' HA ' ' HB3' ' R' ' 174' ' ' PRO . 32.3 m -141.22 158.09 44.36 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.52 -0.737 . . . . 27.0 109.907 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 134' ' ' LEU . . . . . 0.562 HD11 ' O ' ' R' ' 172' ' ' PRO . 0.1 OUTLIER -58.41 -19.76 38.86 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.312 -0.868 . . . . 33.899999999999999 110.453 -179.894 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' R' R ' 135' ' ' ALA . . . . . . . . . . . . . . . -92.77 8.18 40.5 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.257 -0.902 . . . . 19.370000000000001 110.78 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' R' R ' 136' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -93.72 -21.81 19.11 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.198 -0.939 . . . . 30.469999999999999 110.228 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' R' R ' 137' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -149.94 165.28 33.11 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.319 -0.863 . . . . 24.27 110.22 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' R' R ' 138' ' ' HIS . . . . . 0.434 ' HA ' HG23 ' R' ' 154' ' ' VAL . 15.3 p80 -117.73 15.08 14.46 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.429 -0.794 . . . . 20.91 110.459 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 139' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' R' ' 152' ' ' ALA . . . -177.16 152.46 0.88 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.306 -0.871 . . . . 15.69 110.08 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 140' ' ' GLY . . . . . 0.427 ' HA3' ' O ' ' R' ' 179' ' ' VAL . . . 161.74 175.14 32.45 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 110.0 -1.24 . . . . 23.760000000000002 110.0 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 141' ' ' ILE . . . . . . . . . . . . . 83.8 mt -95.48 136.58 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.371 -1.076 . . . . 25.300000000000001 109.674 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' R' R ' 142' ' ' PHE . . . . . 0.578 ' CD2' ' HB2' ' R' ' 172' ' ' PRO . 82.6 m-85 -120.73 -172.59 2.41 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.27 -0.894 . . . . 30.239999999999998 110.512 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 143' ' ' LEU . . . . . 0.743 HD23 ' O ' ' R' ' 148' ' ' HIS . 0.5 OUTLIER -119.81 77.72 1.26 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.43 -0.794 . . . . 32.799999999999997 110.301 -179.924 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' R' R ' 144' ' ' LYS . . . . . 0.47 ' HG3' ' CZ2' ' R' ' 170' ' ' TRP . 1.0 OUTLIER -69.54 76.83 0.41 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.363 -0.835 . . . . 49.18 109.728 179.549 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' R' R ' 145' ' ' GLY . . . . . 0.456 ' O ' HD22 ' R' ' 143' ' ' LEU . . . 104.57 179.32 24.74 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.202 -1.559 . . . . 53.869999999999997 109.202 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 146' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -88.49 145.83 25.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.369 -1.077 . . . . 68.579999999999998 110.006 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' R' R ' 147' ' ' GLU . . . . . 0.649 ' HA ' ' CA ' ' S' ' 398' ' ' ARG . 10.9 mt-10 58.26 36.45 25.68 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.347 -0.845 . . . . 56.619999999999997 110.655 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 148' ' ' HIS . . . . . 0.844 ' CE1' HD12 ' S' ' 400' ' ' LEU . 45.1 t60 -158.67 148.09 19.16 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.267 -0.895 . . . . 44.57 110.359 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 149' ' ' ALA . . . . . 0.891 ' HB3' HH21 ' S' ' 398' ' ' ARG . . . -150.27 146.91 27.07 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.484 -0.76 . . . . 33.539999999999999 110.072 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 150' ' ' VAL . . . . . . . . . . . . . 34.2 m -142.32 161.51 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.263 -0.898 . . . . 27.609999999999999 110.322 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' R' R ' 151' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' R' ' 152' ' ' ALA . 5.9 t80 -86.24 155.63 20.62 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.401 -0.812 . . . . 23.039999999999999 109.881 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 152' ' ' ALA . . . . . 0.537 ' N ' ' CD1' ' R' ' 151' ' ' PHE . . . -157.31 151.51 24.83 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.45 -0.781 . . . . 29.609999999999999 109.589 179.078 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 153' ' ' CYS . . . . . . . . . . . . . 26.7 p -154.27 173.6 15.93 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.347 -0.846 . . . . 22.75 110.444 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' R' R ' 154' ' ' VAL . . . . . 0.615 HG22 ' CE2' ' R' ' 159' ' ' TRP . 59.7 t -90.64 117.03 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.425 -0.797 . . . . 23.260000000000002 110.061 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 155' ' ' THR . . . . . . . . . . . . . 69.9 p -112.11 -176.6 2.96 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.313 -0.867 . . . . 17.879999999999999 110.065 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' R' R ' 156' ' ' SER . . . . . . . . . . . . . 78.5 p -75.98 -3.66 36.86 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.27 -0.894 . . . . 21.829999999999998 110.672 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' R' R ' 157' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -118.36 10.53 12.79 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.138 -0.976 . . . . 36.539999999999999 110.59 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' R' R ' 158' ' ' GLY . . . . . . . . . . . . . . . 117.92 -162.68 13.01 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.567 -1.413 . . . . 31.739999999999998 109.567 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' R' R ' 159' ' ' TRP . . . . . 0.615 ' CE2' HG22 ' R' ' 154' ' ' VAL . 14.7 m95 -86.56 122.45 30.5 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.389 -1.065 . . . . 28.25 110.147 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 160' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -108.45 166.91 10.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.305 -0.872 . . . . 41.240000000000002 110.218 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' R' R ' 161' ' ' ALA . . . . . . . . . . . . . . . -143.21 123.48 13.79 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.403 -0.81 . . . . 27.399999999999999 110.14 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' R' R ' 162' ' ' ILE . . . . . . . . . . . . . 92.3 mt -87.59 81.14 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.324 -0.86 . . . . 24.27 110.015 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' R' R ' 163' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' R' ' 165' ' ' GLU . 15.3 t0 -72.78 92.41 1.57 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.406 -0.809 . . . . 36.079999999999998 110.262 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 164' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 54.07 -88.97 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.564 -0.71 . . . . 46.079999999999998 110.603 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' R' R ' 165' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' R' ' 163' ' ' ASP . 29.8 mt-10 -124.72 36.03 4.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.083 -1.011 . . . . 50.939999999999998 110.194 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 166' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -135.75 117.33 14.88 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.388 -0.82 . . . . 47.280000000000001 110.347 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' R' R ' 167' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -101.1 119.96 39.51 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.427 -0.795 . . . . 40.469999999999999 110.132 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' R' R ' 168' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -157.49 158.59 30.76 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.216 -0.927 . . . . 30.210000000000001 110.423 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' R' R ' 169' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.79 132.98 19.38 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 O-C-N 123.831 1.437 . . . . 32.759999999999998 110.527 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' R' R ' 170' ' ' TRP . . . . . 0.47 ' CZ2' ' HG3' ' R' ' 144' ' ' LYS . 67.0 t90 -159.78 119.37 2.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.384 -0.823 . . . . 32.789999999999999 109.909 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 171' ' ' THR . . . . . . . . . . . . . 47.5 m -81.12 112.62 34.35 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.448 -0.783 . . . . 36.920000000000002 110.141 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' R' R ' 172' ' ' PRO . . . . . 0.578 ' HB2' ' CD2' ' R' ' 142' ' ' PHE . 48.0 Cg_endo -73.7 158.83 46.62 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.596 1.314 . . . . 33.539999999999999 110.545 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 173' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -88.92 144.93 33.64 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.415 -0.803 . . . . 45.759999999999998 109.904 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' R' R ' 174' ' ' PRO . . . . . 0.411 ' HB3' ' HA ' ' R' ' 133' ' ' CYS . 46.0 Cg_endo -71.72 -10.34 26.35 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 O-C-N 123.517 1.272 . . . . 29.629999999999999 110.497 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 175' ' ' SER . . . . . . . . . . . . . 52.9 p -103.42 -17.63 15.16 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.348 -0.845 . . . . 35.700000000000003 110.396 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' R' R ' 176' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -103.48 43.18 1.1 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.213 -0.93 . . . . 39.649999999999999 110.4 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' R' R ' 177' ' ' VAL . . . . . 0.709 ' O ' HG11 ' R' ' 127' ' ' VAL . 10.7 p -117.71 127.17 75.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.368 -0.832 . . . . 20.609999999999999 110.043 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 178' ' ' LEU . . . . . 0.538 HD22 HG12 ' S' ' 396' ' ' VAL . 46.1 mt -91.56 -61.24 1.69 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.362 -0.836 . . . . 15.58 109.378 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 179' ' ' VAL . . . . . 0.729 HG22 HG12 ' R' ' 126' ' ' VAL . 67.8 t -114.67 144.69 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.676 -0.64 . . . . 17.399999999999999 109.391 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 180' ' ' PHE . . . . . 0.435 ' CE2' ' HE1' ' R' ' 132' ' ' MET . 43.6 p90 -152.17 163.41 39.45 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.268 -0.895 . . . . 20.16 110.529 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 181' ' ' VAL . . . . . . . . . . . . . 66.6 t -113.2 111.49 50.19 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.488 -0.758 . . . . 17.690000000000001 109.862 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' R' R ' 182' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.06 149.49 52.61 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 O-C-N 123.606 1.319 . . . . 17.809999999999999 110.456 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' R' R ' 183' ' ' TYR . . . . . 0.709 ' O ' ' C ' ' R' ' 184' ' ' ASP . 79.5 m-85 -58.92 175.45 0.28 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.463 -0.773 . . . . 28.010000000000002 110.535 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 184' ' ' ASP . . . . . 0.709 ' C ' ' O ' ' R' ' 183' ' ' TYR . 6.1 m-20 -17.71 -82.75 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.313 -0.867 . . . . 58.640000000000001 110.271 -178.169 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 185' ' ' GLN . . . . . . . . . . . . . 49.2 mm-40 . . . . . 0 N--CA 1.503 2.183 0 CA-C-O 121.23 0.538 . . . . 80.420000000000002 111.783 179.547 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' R' R ' 193' ' ' LYS . . . . . . . . . . . . . 28.0 mtmt . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 120.888 0.375 . . . . 49.5 110.192 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' R' R ' 194' ' ' ALA . . . . . 0.418 ' CB ' ' HA ' ' R' ' 119' ' ' SER . . . -173.18 -156.94 0.09 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.172 -0.955 . . . . 40.399999999999999 110.127 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 195' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.77 -51.54 5.04 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.397 -0.814 . . . . 34.600000000000001 110.285 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 196' ' ' VAL . . . . . 0.567 ' HB ' ' HB3' ' R' ' 119' ' ' SER . 21.3 t -92.11 48.94 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.186 -0.946 . . . . 33.270000000000003 110.615 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 197' ' ' GLN . . . . . 0.553 ' O ' ' HG3' ' R' ' 197' ' ' GLN . 5.1 tp60 -166.41 61.11 0.1 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.12 -0.988 . . . . 41.579999999999998 110.684 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 198' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -174.45 128.77 0.34 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.064 -1.022 . . . . 38.649999999999999 110.17 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' R' R ' 199' ' ' LYS . . . . . 0.408 ' HA ' ' HD3' ' S' ' 299' ' ' PRO . 19.6 mtmt -46.95 147.68 1.29 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.394 -0.816 . . . . 36.770000000000003 109.937 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 200' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' R' ' 200' ' ' LEU . 14.1 mt -134.27 -95.66 0.28 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.437 -0.79 . . . . 33.079999999999998 110.065 -179.196 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' R' R ' 201' ' ' LYS . . . . . 0.775 ' HE2' ' HB2' ' S' ' 349' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.696 0 O-C-N 121.448 -0.782 . . . . 44.32 110.304 -178.859 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 229' ' ' MET . . . . . 0.469 ' HG3' ' N ' ' S' ' 230' ' ' GLU . 3.3 ptt? . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.181 0.515 . . . . 51.829999999999998 110.233 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' S' S ' 230' ' ' GLU . . . . . 0.469 ' N ' ' HG3' ' S' ' 229' ' ' MET . 33.2 tt0 -97.29 142.75 28.79 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.432 -0.793 . . . . 54.130000000000003 110.196 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 231' ' ' LEU . . . . . . . . . . . . . 68.0 mt -134.12 141.05 46.99 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.352 -0.842 . . . . 33.039999999999999 110.334 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' S' S ' 232' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' S' ' 355' ' ' THR . 40.3 m -89.26 103.24 15.88 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.343 -0.848 . . . . 26.920000000000002 110.041 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 233' ' ' LEU . . . . . 0.672 HD22 ' CE2' ' S' ' 262' ' ' TYR . 79.7 mt -55.87 179.29 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.531 -0.731 . . . . 13.779999999999999 110.543 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 234' ' ' TYR . . . . . 0.448 ' CG ' ' N ' ' S' ' 235' ' ' ASN . 35.5 p90 -65.02 -35.63 81.81 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.426 -0.797 . . . . 26.079999999999998 110.189 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 235' ' ' ASN . . . . . 0.448 ' N ' ' CG ' ' S' ' 234' ' ' TYR . 50.6 p30 -74.36 -7.47 52.96 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.345 -0.847 . . . . 20.039999999999999 110.531 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 236' ' ' GLY . . . . . . . . . . . . . . . 95.79 -19.96 51.97 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.764 -1.334 . . . . 22.710000000000001 109.764 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' S' S ' 237' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -52.95 145.63 12.45 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.258 -1.142 . . . . 35.439999999999998 110.235 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' S' S ' 238' ' ' LYS . . . . . . . . . . . . . 44.4 mttt -102.1 127.85 48.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.349 -0.845 . . . . 32.560000000000002 110.426 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' S' S ' 239' ' ' LYS . . . . . 0.403 ' HG2' ' CZ ' ' S' ' 241' ' ' PHE . 9.0 ttmt -132.29 144.51 50.64 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.41 -0.806 . . . . 26.68 109.992 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 240' ' ' THR . . . . . . . . . . . . . 51.7 m -102.08 132.17 48.12 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.362 -0.836 . . . . 41.020000000000003 110.37 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' S' S ' 241' ' ' PHE . . . . . 0.403 ' CZ ' ' HG2' ' S' ' 239' ' ' LYS . 96.0 m-85 -117.85 137.66 52.63 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.379 -0.826 . . . . 28.620000000000001 110.196 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 242' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -96.29 161.87 13.75 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.288 -0.883 . . . . 47.890000000000001 110.295 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' S' S ' 243' ' ' SER . . . . . . . . . . . . . 71.9 m -90.64 151.52 21.25 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.362 -0.836 . . . . 45.090000000000003 110.309 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' S' S ' 244' ' ' ARG . . . . . . . . . . . . . 1.4 mtp85 -129.85 126.78 22.67 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.415 -0.803 . . . . 42.490000000000002 110.199 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' S' S ' 245' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.37 161.0 43.7 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 O-C-N 123.639 1.336 . . . . 35.68 110.507 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' S' S ' 246' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -132.86 97.87 4.15 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.359 -0.838 . . . . 51.880000000000003 109.822 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' S' S ' 247' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -110.47 -22.21 11.78 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.378 -0.826 . . . . 53.689999999999998 110.664 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' S' S ' 248' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -117.29 43.74 2.26 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.225 -0.922 . . . . 55.789999999999999 110.714 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' S' S ' 249' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 48.77 38.41 11.76 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.447 -0.783 . . . . 49.450000000000003 110.417 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' S' S ' 250' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -90.61 28.99 1.38 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.526 -0.734 . . . . 36.859999999999999 110.358 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' S' S ' 251' ' ' ALA . . . . . . . . . . . . . . . -53.78 -43.18 69.03 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.311 -0.868 . . . . 29.690000000000001 109.575 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' S' S ' 252' ' ' TRP . . . . . 0.425 ' CZ2' ' HB3' ' S' ' 294' ' ' LEU . 67.9 p-90 -61.83 -34.01 75.19 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.451 -0.78 . . . . 41.119999999999997 109.79 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 253' ' ' LEU . . . . . . . . . . . . . 23.3 tp -70.14 -47.23 62.59 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.433 -0.792 . . . . 24.890000000000001 109.906 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' S' S ' 254' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -56.12 -42.41 76.81 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.395 -0.816 . . . . 35.649999999999999 109.956 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' S' S ' 255' ' ' ALA . . . . . . . . . . . . . . . -59.63 -48.09 83.02 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.464 -0.773 . . . . 22.73 110.074 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' S' S ' 256' ' ' ILE . . . . . 0.504 HG12 HD11 ' S' ' 304' ' ' ILE . 79.6 mt -62.37 -40.62 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.315 -0.866 . . . . 28.850000000000001 109.928 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 257' ' ' LEU . . . . . 0.403 ' CD2' ' HB3' ' S' ' 268' ' ' PHE . 19.2 mt -61.56 -44.45 97.01 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.403 -0.81 . . . . 23.07 110.244 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 258' ' ' GLN . . . . . 0.502 ' HB3' ' CD2' ' S' ' 351' ' ' PHE . 53.1 mm-40 -65.05 -45.37 85.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.384 -0.823 . . . . 29.780000000000001 109.918 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 259' ' ' LEU . . . . . 0.419 ' O ' HG22 ' S' ' 263' ' ' VAL . 19.8 tp -58.69 -36.38 74.11 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.291 -0.881 . . . . 17.940000000000001 109.435 179.227 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 260' ' ' PHE . . . . . 0.53 ' CE2' HD21 ' S' ' 311' ' ' LEU . 3.1 m-85 -62.83 -45.27 93.41 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.603 -0.686 . . . . 30.57 109.84 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 261' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -62.12 -29.81 70.59 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.46 -0.775 . . . . 41.340000000000003 109.898 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' S' S ' 262' ' ' TYR . . . . . 0.672 ' CE2' HD22 ' S' ' 233' ' ' LEU . 8.6 t80 -71.22 -44.63 64.99 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.41 -0.806 . . . . 26.030000000000001 110.085 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 263' ' ' VAL . . . . . 0.419 HG22 ' O ' ' S' ' 259' ' ' LEU . 33.1 m -92.06 18.29 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.352 -0.842 . . . . 22.800000000000001 110.373 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 264' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 52.77 70.64 0.55 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.199 -0.938 . . . . 44.030000000000001 110.653 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' S' S ' 265' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -111.81 109.12 55.47 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.303 -0.873 . . . . 35.609999999999999 109.637 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' S' S ' 266' ' ' PRO . . . . . 0.482 ' HA ' ' HB2' ' S' ' 269' ' ' ASP . 49.2 Cg_endo -75.31 0.39 9.08 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 O-C-N 123.578 1.304 . . . . 37.670000000000002 111.753 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 267' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -56.48 -67.73 0.28 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.85 -1.156 . . . . 41.490000000000002 110.173 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 268' ' ' PHE . . . . . 0.403 ' HB3' ' CD2' ' S' ' 257' ' ' LEU . 22.6 m-85 -92.86 39.94 1.05 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.148 -0.97 . . . . 50.759999999999998 110.132 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 269' ' ' ASP . . . . . 0.482 ' HB2' ' HA ' ' S' ' 266' ' ' PRO . 0.9 OUTLIER -76.1 -33.19 59.49 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.307 -0.87 . . . . 61.859999999999999 109.727 179.596 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' S' S ' 270' ' ' TRP . . . . . 0.509 ' CE2' HG23 ' S' ' 271' ' ' VAL . 50.9 p-90 -73.85 -4.41 34.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.322 -0.861 . . . . 39.850000000000001 110.46 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 271' ' ' VAL . . . . . 0.509 HG23 ' CE2' ' S' ' 270' ' ' TRP . 46.6 t -109.49 -32.72 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.117 -0.989 . . . . 39.18 110.156 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 272' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -78.6 -36.6 44.06 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.387 -0.821 . . . . 40.020000000000003 110.486 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' S' S ' 273' ' ' SER . . . . . . . . . . . . . 71.2 m -103.48 56.16 0.74 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.336 -0.853 . . . . 47.200000000000003 110.306 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' S' S ' 274' ' ' SER . . . . . . . . . . . . . 6.9 t -133.06 141.27 40.29 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.336 -0.853 . . . . 47.609999999999999 110.14 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' S' S ' 275' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -73.85 -18.83 21.51 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.684 1.36 . . . . 45.280000000000001 110.485 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' S' S ' 276' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -99.87 140.87 33.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.238 -0.913 . . . . 57.270000000000003 110.317 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' S' S ' 277' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -71.73 97.67 1.8 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.388 -0.82 . . . . 37.280000000000001 110.322 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' S' S ' 278' ' ' LEU . . . . . . . . . . . . . 86.8 mt -97.04 33.84 1.85 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.358 -0.839 . . . . 43.880000000000003 109.987 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' S' S ' 279' ' ' THR . . . . . . . . . . . . . 75.3 m -64.03 -60.09 3.67 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.424 -0.797 . . . . 50.049999999999997 110.347 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' S' S ' 280' ' ' LEU . . . . . 0.728 ' HA ' HD12 ' S' ' 283' ' ' ILE . 13.7 mt -51.59 -39.91 58.84 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.363 -0.836 . . . . 54.119999999999997 110.246 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 281' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.42 -49.68 74.5 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.474 -0.766 . . . . 65.280000000000001 110.141 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 282' ' ' ALA . . . . . . . . . . . . . . . -58.97 -33.86 71.14 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.466 -0.771 . . . . 46.509999999999998 110.555 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' S' S ' 283' ' ' ILE . . . . . 0.728 HD12 ' HA ' ' S' ' 280' ' ' LEU . 85.7 mt -66.37 -50.86 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.273 -0.892 . . . . 47.299999999999997 110.087 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 284' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -50.59 -57.56 7.88 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.43 -0.794 . . . . 50.719999999999999 110.387 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' S' S ' 285' ' ' GLN . . . . . 0.53 ' HG2' HD12 ' S' ' 289' ' ' LEU . 34.4 tt0 -51.46 -46.32 63.02 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.503 -0.748 . . . . 68.469999999999999 110.332 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 286' ' ' LEU . . . . . . . . . . . . . 19.1 mt -59.96 -44.53 94.39 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.42 -0.8 . . . . 36.619999999999997 110.312 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' S' S ' 287' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -62.71 -35.26 79.16 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.372 -0.83 . . . . 46.640000000000001 110.099 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' S' S ' 288' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -76.24 -21.08 56.79 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.37 -0.831 . . . . 46.450000000000003 110.28 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' S' S ' 289' ' ' LEU . . . . . 0.53 HD12 ' HG2' ' S' ' 285' ' ' GLN . 30.8 mt -97.31 -21.75 17.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.286 -0.884 . . . . 35.090000000000003 110.487 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 290' ' ' THR . . . . . 0.409 HG22 ' HB3' ' S' ' 306' ' ' ASN . 81.2 p -114.74 -28.45 7.1 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.221 -0.925 . . . . 38.609999999999999 110.422 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 291' ' ' GLY . . . . . . . . . . . . . . . 79.43 10.93 85.43 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.823 -1.311 . . . . 36.770000000000003 109.823 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' S' S ' 292' ' ' LEU . . . . . . . . . . . . . 84.8 mt -96.44 145.84 25.31 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.226 -1.161 . . . . 35.329999999999998 109.726 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' S' S ' 293' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -77.37 102.41 6.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.196 -0.94 . . . . 48.700000000000003 110.232 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' S' S ' 294' ' ' LEU . . . . . 0.425 ' HB3' ' CZ2' ' S' ' 252' ' ' TRP . 56.2 mt -106.99 51.74 0.73 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.539 -0.726 . . . . 42.609999999999999 110.066 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 295' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -112.51 -11.17 13.65 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.362 -0.836 . . . . 55.490000000000002 110.524 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 296' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -144.36 48.53 1.36 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.127 -0.983 . . . . 75.680000000000007 110.321 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' S' S ' 297' ' ' GLY . . . . . . . . . . . . . . . 96.87 145.22 18.78 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.511 -1.436 . . . . 49.439999999999998 109.511 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' S' S ' 298' ' ' GLY . . . . . 0.624 ' H ' ' C ' ' R' ' 201' ' ' LYS . . . -163.83 156.96 29.05 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.744 -1.342 . . . . 41.109999999999999 109.744 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 299' ' ' PRO . . . . . 0.48 ' O ' HG23 ' S' ' 303' ' ' VAL . 47.4 Cg_endo -73.84 118.26 5.36 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 123.943 1.497 . . . . 26.199999999999999 110.293 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 300' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.33 -15.38 31.4 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 O-C-N 123.647 1.34 . . . . 21.699999999999999 110.675 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' S' S ' 301' ' ' ALA . . . . . . . . . . . . . . . -80.69 -29.31 36.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.238 -0.914 . . . . 31.23 110.182 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' S' S ' 302' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.48 -40.7 18.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.404 -0.81 . . . . 38.990000000000002 109.966 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 303' ' ' VAL . . . . . 0.48 HG23 ' O ' ' S' ' 299' ' ' PRO . 56.9 t -60.61 -35.48 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.399 -0.813 . . . . 18.629999999999999 110.153 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 304' ' ' ILE . . . . . 0.522 HD12 HG21 ' S' ' 379' ' ' VAL . 86.5 mt -79.43 -23.65 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.449 -0.782 . . . . 25.460000000000001 110.124 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 305' ' ' TRP . . . . . 0.41 ' CD2' ' HD3' ' S' ' 308' ' ' LYS . 68.9 t-105 -88.59 -14.69 36.97 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.234 -0.916 . . . . 33.399999999999999 110.501 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 306' ' ' ASN . . . . . 0.409 ' HB3' HG22 ' S' ' 290' ' ' THR . 10.4 m-80 -89.61 -13.52 36.96 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.179 -0.95 . . . . 36.969999999999999 110.438 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 307' ' ' ILE . . . . . 0.471 HG12 ' O ' ' S' ' 303' ' ' VAL . 36.8 pt -125.14 45.66 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.237 -0.915 . . . . 30.809999999999999 110.005 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 308' ' ' LYS . . . . . 0.41 ' HD3' ' CD2' ' S' ' 305' ' ' TRP . 1.5 mtmp? -73.52 -37.71 65.56 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.35 -0.844 . . . . 46.520000000000003 110.169 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 309' ' ' HIS . . . . . 0.492 ' CD2' ' HG ' ' S' ' 310' ' ' LEU . 55.6 p-80 -73.25 -8.26 55.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.407 -0.808 . . . . 51.030000000000001 110.057 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 310' ' ' LEU . . . . . 0.492 ' HG ' ' CD2' ' S' ' 309' ' ' HIS . 52.8 mt -99.25 -12.91 19.96 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.29 -0.881 . . . . 36.159999999999997 109.962 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 311' ' ' LEU . . . . . 0.53 HD21 ' CE2' ' S' ' 260' ' ' PHE . 10.8 mt -97.14 147.77 23.73 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.278 -0.889 . . . . 40.0 110.471 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 312' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -81.58 -16.29 52.08 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.282 -0.886 . . . . 54.18 109.771 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' S' S ' 313' ' ' THR . . . . . 0.825 HG23 ' HG2' ' S' ' 323' ' ' GLU . 92.4 m -87.94 151.64 22.66 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.378 -0.826 . . . . 25.609999999999999 110.151 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 314' ' ' GLY . . . . . . . . . . . . . . . -87.88 126.42 8.04 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.815 -1.314 . . . . 25.18 109.815 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' S' S ' 315' ' ' ILE . . . . . 0.67 HD13 ' HB ' ' S' ' 324' ' ' VAL . 50.6 mm -101.62 150.47 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.346 -1.091 . . . . 23.899999999999999 109.702 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 316' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' S' ' 325' ' ' CYS . . . -157.13 -159.23 9.36 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 110.021 -1.232 . . . . 23.18 110.021 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 317' ' ' THR . . . . . 0.425 HG22 ' CG2' ' S' ' 326' ' ' VAL . 11.0 p -133.96 -173.04 3.14 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.311 -1.111 . . . . 27.98 109.923 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.57 -56.18 25.19 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.2 -0.937 . . . . 28.100000000000001 109.899 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' S' S ' 319' ' ' SER . . . . . . . . . . . . . 1.2 m -59.98 -41.61 92.4 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.321 -0.862 . . . . 37.0 109.621 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' S' S ' 320' ' ' ARG . . . . . . . . . . . . . 12.2 mtm180 -111.67 79.88 2.62 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.481 -0.762 . . . . 52.07 109.657 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' S' S ' 321' ' ' PRO . . . . . 1.07 ' HG2' ' O ' ' S' ' 386' ' ' GLU . 43.9 Cg_endo -71.41 171.54 15.98 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.869 1.457 . . . . 38.289999999999999 110.9 -179.458 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 322' ' ' SER . . . . . 0.443 ' HB2' ' O ' ' S' ' 321' ' ' PRO . 41.2 t 178.62 -148.17 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.89 -0.781 . . . . 38.840000000000003 108.89 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 323' ' ' GLU . . . . . 0.825 ' HG2' HG23 ' S' ' 313' ' ' THR . 6.7 tp10 -62.82 -40.26 96.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.003 -1.061 . . . . 40.700000000000003 109.734 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 324' ' ' VAL . . . . . 0.67 ' HB ' HD13 ' S' ' 315' ' ' ILE . 72.9 t -141.33 134.98 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.427 -0.795 . . . . 20.34 109.5 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 325' ' ' CYS . . . . . 0.462 ' HB2' ' CE1' ' S' ' 380' ' ' PHE . 11.1 m -125.95 172.21 10.11 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.249 -0.907 . . . . 30.629999999999999 110.826 -179.078 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 326' ' ' VAL . . . . . 0.642 HG12 HG22 ' S' ' 379' ' ' VAL . 34.5 m -135.49 142.18 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 109.216 -0.661 . . . . 23.899999999999999 109.216 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 327' ' ' VAL . . . . . 0.594 HG11 ' O ' ' S' ' 377' ' ' VAL . 34.5 m -56.29 124.94 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.133 -0.979 . . . . 19.48 110.432 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 328' ' ' ASP . . . . . . . . . . . . . 55.7 p-10 -119.37 11.54 12.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.432 -0.792 . . . . 26.43 110.422 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' S' S ' 329' ' ' GLY . . . . . . . . . . . . . . . 119.67 2.13 13.14 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.074 -1.21 . . . . 31.239999999999998 110.074 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' S' S ' 330' ' ' THR . . . . . . . . . . . . . 79.4 m -92.9 130.02 38.63 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.082 -1.246 . . . . 30.050000000000001 110.122 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' S' S ' 331' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -56.89 111.53 1.06 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.321 -0.862 . . . . 37.259999999999998 109.991 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' S' S ' 332' ' ' MET . . . . . . . . . . . . . 88.1 mmm -94.1 162.49 13.85 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.267 -0.896 . . . . 26.23 110.344 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' S' S ' 333' ' ' CYS . . . . . . . . . . . . . 25.8 m -137.19 150.11 47.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.475 -0.766 . . . . 23.559999999999999 110.025 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' S' S ' 334' ' ' LEU . . . . . 0.561 HD11 ' O ' ' S' ' 372' ' ' PRO . 0.1 OUTLIER -52.66 -24.76 9.12 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.289 -0.882 . . . . 28.93 110.5 179.902 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' S' S ' 335' ' ' ALA . . . . . . . . . . . . . . . -89.1 14.49 10.64 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.388 -0.82 . . . . 15.76 110.973 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' S' S ' 336' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -100.48 -17.25 17.24 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.133 -0.979 . . . . 34.920000000000002 110.143 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' S' S ' 337' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -152.41 170.83 19.14 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.333 -0.854 . . . . 19.030000000000001 110.077 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' S' S ' 338' ' ' HIS . . . . . 0.401 ' HB3' ' CZ ' ' S' ' 383' ' ' TYR . 13.5 p80 -120.65 10.42 11.03 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.333 -0.854 . . . . 18.82 110.479 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 339' ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' S' ' 352' ' ' ALA . . . -175.98 155.16 1.56 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.204 -0.935 . . . . 17.18 110.146 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 340' ' ' GLY . . . . . 0.405 ' CA ' ' O ' ' S' ' 379' ' ' VAL . . . 160.81 173.06 28.94 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.036 -1.226 . . . . 18.329999999999998 110.036 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 341' ' ' ILE . . . . . . . . . . . . . 84.2 mt -88.78 138.07 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.489 -1.006 . . . . 18.600000000000001 109.787 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' S' S ' 342' ' ' PHE . . . . . 0.493 ' CE2' ' HB3' ' S' ' 352' ' ' ALA . 69.9 m-85 -120.97 -178.43 3.74 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.222 -0.924 . . . . 23.440000000000001 110.407 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 343' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.84 93.41 4.19 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.532 -0.73 . . . . 35.590000000000003 110.024 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 344' ' ' LYS . . . . . 0.406 ' O ' ' HB3' ' S' ' 348' ' ' HIS . 0.3 OUTLIER -80.87 125.04 29.62 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.301 -0.874 . . . . 38.340000000000003 110.067 -179.905 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' S' S ' 345' ' ' GLY . . . . . . . . . . . . . . . 62.75 -130.86 43.17 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 108.874 -1.69 . . . . 53.460000000000001 108.874 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' S' S ' 346' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -132.68 150.89 52.1 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.246 -1.149 . . . . 70.909999999999997 110.043 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' S' S ' 347' ' ' GLU . . . . . 0.498 ' C ' ' HG2' ' R' ' 201' ' ' LYS . 18.0 mt-10 53.19 35.44 19.92 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.321 -0.862 . . . . 47.32 110.45 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 348' ' ' HIS . . . . . 0.435 ' N ' ' HG2' ' R' ' 201' ' ' LYS . 46.4 t60 -150.18 155.87 40.56 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.204 -0.935 . . . . 41.719999999999999 110.311 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 349' ' ' ALA . . . . . 0.775 ' HB2' ' HE2' ' R' ' 201' ' ' LYS . . . -149.82 151.22 33.17 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.314 -0.866 . . . . 22.91 110.527 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 350' ' ' VAL . . . . . 0.458 HG13 ' C ' ' S' ' 349' ' ' ALA . 34.6 m -149.0 169.67 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.463 -0.773 . . . . 21.09 110.058 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 351' ' ' PHE . . . . . 0.502 ' CD2' ' HB3' ' S' ' 258' ' ' GLN . 10.7 t80 -105.43 143.59 33.38 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.178 -0.951 . . . . 25.030000000000001 110.682 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 352' ' ' ALA . . . . . 0.493 ' HB3' ' CE2' ' S' ' 342' ' ' PHE . . . -147.67 151.78 36.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.64 -0.662 . . . . 23.809999999999999 109.704 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 353' ' ' CYS . . . . . . . . . . . . . 26.2 p -153.37 164.85 37.42 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.324 -0.86 . . . . 25.66 110.185 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' S' S ' 354' ' ' VAL . . . . . 0.546 HG22 ' CE2' ' S' ' 359' ' ' TRP . 56.6 t -75.94 118.49 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.351 -0.843 . . . . 34.270000000000003 110.008 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 355' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' S' ' 232' ' ' THR . 52.5 p -117.86 175.1 5.82 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.196 -0.94 . . . . 25.489999999999998 110.327 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 356' ' ' SER . . . . . . . . . . . . . 62.9 p -62.09 -17.75 58.59 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.474 -0.766 . . . . 31.239999999999998 110.749 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' S' S ' 357' ' ' ASN . . . . . . . . . . . . . 46.2 m-20 -106.96 14.21 26.74 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.143 -0.973 . . . . 28.609999999999999 110.564 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' S' S ' 358' ' ' GLY . . . . . . . . . . . . . . . 111.85 -152.93 17.58 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.979 -1.248 . . . . 22.010000000000002 109.979 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' S' S ' 359' ' ' TRP . . . . . 0.546 ' CE2' HG22 ' S' ' 354' ' ' VAL . 15.1 m95 -91.44 116.76 29.11 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.387 -1.067 . . . . 25.539999999999999 110.138 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 360' ' ' TYR . . . . . 0.408 ' HA ' ' HA ' ' S' ' 369' ' ' PRO . 1.3 m-85 -103.49 165.83 10.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.318 -0.864 . . . . 40.530000000000001 110.108 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 361' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' S' ' 351' ' ' PHE . . . -140.07 130.09 24.86 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.39 -0.819 . . . . 18.039999999999999 110.262 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 362' ' ' ILE . . . . . . . . . . . . . 89.0 mt -95.7 83.83 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.307 -0.871 . . . . 15.640000000000001 109.984 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' S' S ' 363' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' S' ' 365' ' ' GLU . 11.9 t0 -75.37 94.51 3.07 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.352 -0.843 . . . . 35.030000000000001 110.16 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 364' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 54.0 -89.44 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.468 -0.77 . . . . 46.719999999999999 110.45 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' S' S ' 365' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' S' ' 363' ' ' ASP . 23.8 mt-10 -122.55 18.99 10.44 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.077 -1.014 . . . . 56.200000000000003 110.218 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 366' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -117.82 124.98 49.7 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.303 -0.873 . . . . 51.020000000000003 110.418 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' S' S ' 367' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -106.98 127.08 53.13 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.361 -0.837 . . . . 37.590000000000003 110.133 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' S' S ' 368' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -165.47 159.61 13.85 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.303 -0.873 . . . . 31.469999999999999 110.437 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' S' S ' 369' ' ' PRO . . . . . 0.408 ' HA ' ' HA ' ' S' ' 360' ' ' TYR . 46.6 Cg_endo -72.83 139.57 30.66 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 O-C-N 123.864 1.455 . . . . 28.850000000000001 110.536 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 370' ' ' TRP . . . . . . . . . . . . . 67.5 t90 -167.23 113.6 0.76 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.376 -0.827 . . . . 26.940000000000001 109.957 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' S' S ' 371' ' ' THR . . . . . . . . . . . . . 59.5 m -74.83 113.04 20.6 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.411 -0.805 . . . . 20.190000000000001 110.059 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' S' S ' 372' ' ' PRO . . . . . 0.561 ' O ' HD11 ' S' ' 334' ' ' LEU . 48.2 Cg_endo -73.46 157.16 49.53 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 O-C-N 123.548 1.288 . . . . 28.68 110.613 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 373' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -90.57 147.12 35.68 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.449 -0.782 . . . . 35.719999999999999 109.896 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' S' S ' 374' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -76.02 -6.38 17.3 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.669 1.352 . . . . 30.890000000000001 110.474 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' S' S ' 375' ' ' SER . . . . . . . . . . . . . 68.5 p -104.32 -16.88 15.02 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.289 -0.882 . . . . 29.41 110.498 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' S' S ' 376' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -106.53 43.09 1.18 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.222 -0.924 . . . . 32.890000000000001 110.227 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' S' S ' 377' ' ' VAL . . . . . 0.594 ' O ' HG11 ' S' ' 327' ' ' VAL . 7.2 p -114.68 147.31 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.343 -0.848 . . . . 24.329999999999998 110.228 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 378' ' ' LEU . . . . . . . . . . . . . 51.7 mt -116.03 -58.0 2.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.401 -0.812 . . . . 24.370000000000001 109.626 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' S' S ' 379' ' ' VAL . . . . . 0.642 HG22 HG12 ' S' ' 326' ' ' VAL . 61.4 t -120.69 132.37 70.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.39 -0.819 . . . . 18.02 109.357 179.316 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 380' ' ' PHE . . . . . 0.462 ' CE1' ' HB2' ' S' ' 325' ' ' CYS . 14.5 p90 -142.54 174.03 11.0 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.367 -0.833 . . . . 29.350000000000001 110.646 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 381' ' ' VAL . . . . . . . . . . . . . 57.8 t -120.09 107.39 39.74 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.51 -0.744 . . . . 16.34 109.394 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' S' S ' 382' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.42 145.65 48.34 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 O-C-N 123.608 1.32 . . . . 20.940000000000001 110.775 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' S' S ' 383' ' ' TYR . . . . . 0.401 ' CZ ' ' HB3' ' S' ' 338' ' ' HIS . 88.1 m-85 -61.05 -53.54 55.86 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.335 -0.853 . . . . 28.93 109.823 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 384' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -99.9 127.92 46.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.361 -0.837 . . . . 47.030000000000001 110.408 -176.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' S' S ' 385' ' ' GLN . . . . . 0.413 ' O ' ' O ' ' S' ' 386' ' ' GLU . 6.5 mm-40 -68.96 3.2 2.13 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.485 -0.759 . . . . 46.689999999999998 110.165 177.22 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 386' ' ' GLU . . . . . 1.07 ' O ' ' HG2' ' S' ' 321' ' ' PRO . 0.4 OUTLIER -47.24 170.7 0.08 OUTLIER Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.355 -0.841 . . . . 50.25 109.557 179.556 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' S' S ' 387' ' ' PRO . . . . . 0.55 ' O ' ' C ' ' S' ' 388' ' ' LEU . 49.1 Cg_endo -70.99 -9.76 26.29 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 O-C-N 123.593 1.312 . . . . 34.390000000000001 110.637 -178.031 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 388' ' ' LEU . . . . . 0.564 ' O ' ' HB2' ' S' ' 389' ' ' ASN . 83.5 mt 31.66 84.32 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.466 -0.771 . . . . 38.009999999999998 110.151 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 389' ' ' ASN . . . . . 0.564 ' HB2' ' O ' ' S' ' 388' ' ' LEU . 24.9 m-20 68.72 171.08 0.29 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.297 -0.877 . . . . 45.82 110.152 -178.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 390' ' ' GLY . . . . . 0.586 ' O ' ' N ' ' S' ' 392' ' ' TRP . . . 149.16 -76.87 0.24 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.636 -1.386 . . . . 33.460000000000001 109.636 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 391' ' ' GLU . . . . . 0.578 ' HB2' ' O ' ' S' ' 390' ' ' GLY . 6.9 mt-10 62.83 -63.19 0.11 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.374 -1.074 . . . . 56.579999999999998 110.176 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 392' ' ' TRP . . . . . 0.586 ' N ' ' O ' ' S' ' 390' ' ' GLY . 0.0 OUTLIER -50.68 -23.86 2.94 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.345 -0.847 . . . . 31.43 110.366 179.709 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' S' S ' 393' ' ' LYS . . . . . 0.424 ' O ' ' CG2' ' S' ' 396' ' ' VAL . 0.1 OUTLIER -51.29 -41.91 60.79 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.299 -0.876 . . . . 39.420000000000002 110.39 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' S' S ' 394' ' ' ALA . . . . . . . . . . . . . . . -79.37 -19.44 50.18 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.288 -0.883 . . . . 34.329999999999998 110.125 178.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' S' S ' 395' ' ' LYS . . . . . 0.7 ' HB3' ' CD1' ' R' ' 143' ' ' LEU . 11.6 mmmt -68.36 -51.21 46.88 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.444 -0.785 . . . . 60.090000000000003 110.285 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 396' ' ' VAL . . . . . 1.002 HG23 ' H ' ' S' ' 397' ' ' GLN . 8.9 m -53.86 -68.17 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.286 -0.884 . . . . 35.5 110.539 179.377 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 397' ' ' GLN . . . . . 1.002 ' H ' HG23 ' S' ' 396' ' ' VAL . 0.8 OUTLIER -70.26 60.77 0.2 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.15 -0.969 . . . . 49.960000000000001 110.596 178.915 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' S' S ' 398' ' ' ARG . . . . . 0.891 HH21 ' HB3' ' R' ' 149' ' ' ALA . 0.0 OUTLIER -78.91 -38.79 36.5 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.325 -0.859 . . . . 43.420000000000002 110.716 -177.964 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' S' S ' 399' ' ' LYS . . . . . 0.711 ' N ' ' HG2' ' S' ' 398' ' ' ARG . 57.2 tttt 59.46 100.65 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.389 -0.819 . . . . 55.310000000000002 110.03 -178.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' S' S ' 400' ' ' LEU . . . . . 0.844 HD12 ' CE1' ' R' ' 148' ' ' HIS . 0.2 OUTLIER -45.11 -40.26 6.75 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.346 -0.846 . . . . 41.030000000000001 110.258 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' S' S ' 401' ' ' LYS . . . . . 0.658 ' N ' HD23 ' S' ' 400' ' ' LEU . 15.0 tttt . . . . . 0 N--CA 1.492 1.666 0 O-C-N 121.382 -0.824 . . . . 61.969999999999999 110.208 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' R' R ' 29' ' ' MET . . . . . 0.471 ' HG3' ' N ' ' R' ' 30' ' ' GLU . 21.8 ptt? . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.174 0.511 . . . . 32.140000000000001 110.259 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' R' R ' 30' ' ' GLU . . . . . 0.471 ' N ' ' HG3' ' R' ' 29' ' ' MET . 41.7 tt0 -96.36 141.15 30.02 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.37 -0.831 . . . . 43.359999999999999 110.202 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' R' R ' 31' ' ' LEU . . . . . . . . . . . . . 65.3 mt -134.9 140.53 45.84 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.312 -0.867 . . . . 22.93 110.318 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' R' R ' 32' ' ' THR . . . . . . . . . . . . . 68.3 m -87.46 110.59 20.41 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.4 -0.812 . . . . 22.34 109.986 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' R' R ' 33' ' ' LEU . . . . . 0.596 HD22 ' CE2' ' R' ' 62' ' ' TYR . 80.2 mt -62.46 -172.76 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.33 -0.856 . . . . 21.390000000000001 110.148 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' R' R ' 34' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -74.68 -29.4 61.21 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.333 -0.855 . . . . 34.399999999999999 110.328 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' R' R ' 35' ' ' ASN . . . . . . . . . . . . . 48.4 p30 -77.7 -1.89 33.41 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.324 -0.86 . . . . 30.280000000000001 110.686 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' R' R ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.2 -16.55 59.46 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.776 -1.329 . . . . 36.25 109.776 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' R' R ' 37' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -59.04 161.81 4.79 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.322 -1.105 . . . . 53.799999999999997 110.368 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' R' R ' 38' ' ' LYS . . . . . . . . . . . . . 56.9 mttt -117.86 135.76 53.88 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.445 -0.784 . . . . 49.909999999999997 110.146 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' R' R ' 39' ' ' LYS . . . . . 0.406 ' HG2' ' CZ ' ' R' ' 41' ' ' PHE . 8.0 ttmt -138.69 143.71 39.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.388 -0.82 . . . . 35.689999999999998 110.27 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' R' R ' 40' ' ' THR . . . . . . . . . . . . . 23.6 m -102.6 127.94 49.48 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.387 -0.82 . . . . 34.840000000000003 110.223 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' R' R ' 41' ' ' PHE . . . . . 0.406 ' CZ ' ' HG2' ' R' ' 39' ' ' LYS . 96.6 m-85 -113.06 132.62 55.33 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.426 -0.796 . . . . 34.420000000000002 110.14 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' R' R ' 42' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -93.28 140.97 28.96 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.335 -0.853 . . . . 51.460000000000001 110.264 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' R' R ' 43' ' ' SER . . . . . . . . . . . . . 54.8 m -70.9 141.92 51.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.445 -0.784 . . . . 41.840000000000003 110.202 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' R' R ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.77 125.46 29.45 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.311 -0.868 . . . . 33.82 109.932 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' R' R ' 45' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.17 151.01 54.59 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 O-C-N 123.616 1.324 . . . . 30.27 110.646 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' R' R ' 46' ' ' ASN . . . . . . . . . . . . . 52.2 t-20 -124.21 109.9 13.98 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.545 -0.722 . . . . 35.100000000000001 110.088 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' R' R ' 47' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -120.25 -34.92 3.55 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.335 -0.853 . . . . 42.810000000000002 110.542 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' R' R ' 48' ' ' HIS . . . . . 0.44 ' NE2' HD11 ' R' ' 80' ' ' LEU . 73.3 m80 -105.74 45.15 0.98 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.322 -0.861 . . . . 49.969999999999999 110.223 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' R' R ' 49' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 50.28 34.71 9.23 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.358 -0.839 . . . . 61.32 110.173 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' R' R ' 50' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -86.26 43.77 1.09 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.402 -0.811 . . . . 51.5 110.685 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' R' R ' 51' ' ' ALA . . . . . 0.763 ' HB3' ' C ' ' S' ' 401' ' ' LYS . . . -66.12 -46.06 78.87 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.131 -0.981 . . . . 38.770000000000003 109.53 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' R' R ' 52' ' ' TRP . . . . . 0.484 ' CD2' ' N ' ' R' ' 53' ' ' LEU . 68.3 p-90 -58.43 -38.37 77.32 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.519 -0.738 . . . . 26.239999999999998 110.098 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' R' R ' 53' ' ' LEU . . . . . 0.484 ' N ' ' CD2' ' R' ' 52' ' ' TRP . 23.0 tp -66.63 -46.75 74.79 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.4 -0.813 . . . . 26.75 110.016 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' R' R ' 54' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -55.27 -41.57 72.4 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.341 -0.85 . . . . 35.020000000000003 110.078 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' R' R ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.19 -46.03 92.14 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.426 -0.796 . . . . 24.469999999999999 110.219 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' R' R ' 56' ' ' ILE . . . . . 0.432 HG12 HD11 ' R' ' 104' ' ' ILE . 76.3 mt -62.15 -42.31 94.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.246 -0.909 . . . . 26.030000000000001 109.907 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' R' R ' 57' ' ' LEU . . . . . . . . . . . . . 22.3 mt -60.27 -45.68 92.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.4 -0.813 . . . . 26.77 109.661 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' R' R ' 58' ' ' GLN . . . . . . . . . . . . . 57.7 mm-40 -63.87 -46.51 84.64 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.525 -0.734 . . . . 22.32 109.622 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' R' R ' 59' ' ' LEU . . . . . 0.428 ' HA ' ' HE2' ' R' ' 151' ' ' PHE . 24.0 tp -61.45 -37.74 84.64 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.334 -0.854 . . . . 20.550000000000001 109.404 179.283 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' R' R ' 60' ' ' PHE . . . . . 0.529 ' CE2' HD21 ' R' ' 111' ' ' LEU . 2.8 m-85 -61.13 -44.75 96.85 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.631 -0.668 . . . . 20.079999999999998 109.866 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' R' R ' 61' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -63.08 -36.19 82.78 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.492 -0.755 . . . . 18.800000000000001 110.511 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' R' R ' 62' ' ' TYR . . . . . 0.596 ' CE2' HD22 ' R' ' 33' ' ' LEU . 9.2 t80 -63.14 -41.7 99.33 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.226 -0.921 . . . . 26.449999999999999 110.218 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' R' R ' 63' ' ' VAL . . . . . 0.407 ' H ' HG22 ' R' ' 63' ' ' VAL . 30.2 m -93.36 20.27 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.289 -0.882 . . . . 29.75 110.232 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' R' R ' 64' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 52.91 75.61 0.23 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.343 -0.848 . . . . 35.520000000000003 110.549 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' R' R ' 65' ' ' GLU . . . . . 0.442 ' HG2' ' CD2' ' R' ' 60' ' ' PHE . 14.2 tp10 -116.3 104.1 52.28 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.44 -0.787 . . . . 29.890000000000001 109.9 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' R' R ' 66' ' ' PRO . . . . . 0.482 ' HA ' ' HB2' ' R' ' 69' ' ' ASP . 47.4 Cg_endo -73.55 -5.83 17.74 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.79 1.416 . . . . 21.370000000000001 111.07 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' R' R ' 67' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -52.11 -61.56 2.19 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.099 -1.0 . . . . 23.850000000000001 110.331 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' R' R ' 68' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -98.12 36.52 1.56 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.275 -0.891 . . . . 28.07 110.442 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' R' R ' 69' ' ' ASP . . . . . 0.482 ' HB2' ' HA ' ' R' ' 66' ' ' PRO . 11.8 t0 -72.3 -33.29 67.3 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.303 -0.873 . . . . 43.759999999999998 110.169 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' R' R ' 70' ' ' TRP . . . . . 0.476 ' CE2' ' CG2' ' R' ' 71' ' ' VAL . 47.9 p-90 -73.32 -3.91 29.99 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.34 -0.85 . . . . 33.060000000000002 110.739 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' R' R ' 71' ' ' VAL . . . . . 0.556 HG11 ' HB2' ' R' ' 82' ' ' ALA . 40.7 t -109.78 -27.49 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.237 -0.914 . . . . 31.699999999999999 109.658 179.202 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' R' R ' 72' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -86.55 -48.87 7.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.407 -0.808 . . . . 33.579999999999998 110.267 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' R' R ' 73' ' ' SER . . . . . . . . . . . . . 70.1 m -89.73 51.01 1.99 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.29 -0.881 . . . . 50.82 110.362 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' R' R ' 74' ' ' SER . . . . . . . . . . . . . 15.8 t -125.89 138.37 31.92 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.303 -0.873 . . . . 34.740000000000002 110.206 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.38 -24.99 15.89 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 O-C-N 123.669 1.352 . . . . 35.700000000000003 110.32 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' R' R ' 76' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -91.7 153.16 19.85 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.422 -0.799 . . . . 66.480000000000004 110.342 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' R' R ' 77' ' ' ASN . . . . . . . . . . . . . 37.5 t30 -81.47 95.23 7.03 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.374 -0.829 . . . . 46.719999999999999 110.061 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' R' R ' 78' ' ' LEU . . . . . . . . . . . . . 96.3 mt -96.46 27.97 3.55 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.473 -0.767 . . . . 37.549999999999997 110.191 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' R' R ' 79' ' ' THR . . . . . . . . . . . . . 29.8 m -56.31 -54.5 44.72 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.26 -0.9 . . . . 37.359999999999999 110.283 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' R' R ' 80' ' ' LEU . . . . . 0.604 ' HA ' HD12 ' R' ' 83' ' ' ILE . 15.9 mt -61.04 -23.09 65.17 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.439 -0.788 . . . . 35.829999999999998 110.513 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' R' R ' 81' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -79.48 -39.21 32.69 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.162 -0.961 . . . . 44.030000000000001 110.349 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' R' R ' 82' ' ' ALA . . . . . 0.556 ' HB2' HG11 ' R' ' 71' ' ' VAL . . . -69.4 -28.64 66.34 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.315 -0.866 . . . . 32.539999999999999 110.278 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' R' R ' 83' ' ' ILE . . . . . 0.604 HD12 ' HA ' ' R' ' 80' ' ' LEU . 78.2 mt -70.11 -46.09 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.307 -0.87 . . . . 32.020000000000003 110.265 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' R' R ' 84' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -55.19 -52.07 64.51 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.222 -0.924 . . . . 34.090000000000003 110.596 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' R' R ' 85' ' ' GLN . . . . . 0.532 ' HG2' HD12 ' R' ' 89' ' ' LEU . 31.9 tt0 -54.81 -46.89 74.59 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.279 -0.888 . . . . 25.940000000000001 110.299 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' R' R ' 86' ' ' LEU . . . . . . . . . . . . . 24.0 mt -58.6 -43.85 89.67 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.339 -0.851 . . . . 16.199999999999999 109.936 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' R' R ' 87' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -65.37 -35.17 80.15 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.435 -0.791 . . . . 49.090000000000003 110.304 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' R' R ' 88' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -78.47 -19.03 53.99 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.257 -0.902 . . . . 28.609999999999999 110.556 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' R' R ' 89' ' ' LEU . . . . . 0.532 HD12 ' HG2' ' R' ' 85' ' ' GLN . 32.5 mt -96.18 -29.41 14.07 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.207 -0.933 . . . . 26.16 110.197 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' R' R ' 90' ' ' THR . . . . . . . . . . . . . 59.0 p -105.7 -34.55 7.67 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.303 -0.873 . . . . 33.329999999999998 109.778 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' R' R ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.78 16.02 58.81 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.857 -1.297 . . . . 31.129999999999999 109.857 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' R' R ' 92' ' ' LEU . . . . . . . . . . . . . 97.0 mt -100.04 155.24 17.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.153 -1.204 . . . . 42.520000000000003 110.229 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' R' R ' 93' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -86.28 91.63 8.54 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.538 -0.726 . . . . 68.459999999999994 109.991 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' R' R ' 94' ' ' LEU . . . . . 0.459 ' HB3' ' CZ2' ' R' ' 52' ' ' TRP . 48.2 mt -99.47 52.99 0.94 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.183 -0.948 . . . . 44.630000000000003 110.282 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' R' R ' 95' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.48 -38.67 6.38 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.263 -0.898 . . . . 67.159999999999997 110.381 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' R' R ' 96' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -113.91 44.25 1.68 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.364 -0.835 . . . . 67.019999999999996 110.278 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' R' R ' 97' ' ' GLY . . . . . . . . . . . . . . . 99.12 150.77 26.02 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.653 -1.379 . . . . 49.479999999999997 109.653 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' R' R ' 98' ' ' GLY . . . . . 0.728 ' O ' ' HD3' ' S' ' 401' ' ' LYS . . . -166.28 159.99 33.42 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.329 -1.508 . . . . 36.57 109.329 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' R' R ' 99' ' ' PRO . . . . . 0.942 ' CB ' HG22 ' S' ' 396' ' ' VAL . 44.6 Cg_endo -72.55 121.11 7.15 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 123.732 1.385 . . . . 30.41 110.413 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' R' R ' 100' ' ' PRO . . . . . 0.48 ' HD3' ' NZ ' ' S' ' 401' ' ' LYS . 45.4 Cg_endo -72.39 -31.5 11.31 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 O-C-N 123.621 1.327 . . . . 29.940000000000001 110.514 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' R' R ' 101' ' ' ALA . . . . . 0.475 ' HB2' ' HB3' ' R' ' 178' ' ' LEU . . . -70.05 -38.45 75.81 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.293 -0.879 . . . . 23.640000000000001 110.294 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' R' R ' 102' ' ' LEU . . . . . 0.425 HD23 HD21 ' R' ' 106' ' ' ASN . 0.1 OUTLIER -72.6 -40.69 66.32 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.353 -0.842 . . . . 20.309999999999999 110.446 -179.801 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' R' R ' 103' ' ' VAL . . . . . 0.79 HG23 ' O ' ' R' ' 99' ' ' PRO . 63.7 t -58.19 -40.08 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.225 -0.922 . . . . 16.329999999999998 109.986 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' R' R ' 104' ' ' ILE . . . . . 0.432 HD11 HG12 ' R' ' 56' ' ' ILE . 81.8 mt -71.71 -30.54 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.427 -0.796 . . . . 24.77 109.968 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' R' R ' 105' ' ' TRP . . . . . 0.462 ' O ' ' HD3' ' R' ' 108' ' ' LYS . 70.5 t-105 -82.43 0.89 40.08 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.277 -0.89 . . . . 23.280000000000001 110.26 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' R' R ' 106' ' ' ASN . . . . . 0.425 HD21 HD23 ' R' ' 102' ' ' LEU . 6.9 m-80 -105.11 -10.45 17.14 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.173 -0.954 . . . . 28.260000000000002 110.03 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' R' R ' 107' ' ' ILE . . . . . . . . . . . . . 36.8 pt -126.85 34.98 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.184 -0.947 . . . . 18.77 110.026 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' R' R ' 108' ' ' LYS . . . . . 0.501 ' HG2' ' HB ' ' R' ' 115' ' ' ILE . 9.3 mtpp -61.02 -48.49 81.57 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.493 -0.755 . . . . 42.5 110.031 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' R' R ' 109' ' ' HIS . . . . . 0.445 ' CD2' ' HG ' ' R' ' 110' ' ' LEU . 50.7 p-80 -66.02 -12.87 58.26 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.511 -0.743 . . . . 20.07 110.698 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' R' R ' 110' ' ' LEU . . . . . 0.445 ' HG ' ' CD2' ' R' ' 109' ' ' HIS . 80.1 mt -94.72 -17.38 22.26 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.071 -1.018 . . . . 15.69 110.183 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' R' R ' 111' ' ' LEU . . . . . 0.529 HD21 ' CE2' ' R' ' 60' ' ' PHE . 10.4 mt -94.05 144.12 25.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.324 -0.86 . . . . 25.390000000000001 111.052 -179.184 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' R' R ' 112' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -77.67 -17.43 57.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.518 -0.739 . . . . 53.479999999999997 109.84 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' R' R ' 113' ' ' THR . . . . . 0.459 HG22 ' N ' ' R' ' 114' ' ' GLY . 60.2 m -83.69 166.62 17.94 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.282 -0.886 . . . . 14.800000000000001 110.186 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' R' R ' 114' ' ' GLY . . . . . 0.459 ' N ' HG22 ' R' ' 113' ' ' THR . . . -97.99 127.12 9.12 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.968 -1.253 . . . . 16.140000000000001 109.968 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' R' R ' 115' ' ' ILE . . . . . 0.578 HD13 ' HB ' ' R' ' 124' ' ' VAL . 47.8 mm -109.07 139.32 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.534 -0.98 . . . . 13.460000000000001 109.71 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' R' R ' 116' ' ' GLY . . . . . . . . . . . . . . . -152.76 -155.78 7.26 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.926 -1.27 . . . . 23.899999999999999 109.926 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' R' R ' 117' ' ' THR . . . . . 0.529 HG22 ' CG2' ' R' ' 126' ' ' VAL . 18.7 p -135.06 -171.4 2.79 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.418 -1.048 . . . . 27.370000000000001 110.095 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' R' R ' 118' ' ' ALA . . . . . 0.444 ' HB3' ' OD1' ' R' ' 128' ' ' ASP . . . -56.59 -58.05 9.73 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.276 -0.89 . . . . 18.760000000000002 110.057 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' R' R ' 119' ' ' SER . . . . . 0.556 ' HA ' ' CB ' ' R' ' 194' ' ' ALA . 1.1 m -56.59 -40.53 75.43 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.332 -0.855 . . . . 32.350000000000001 109.784 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' R' R ' 120' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 -110.12 86.3 4.97 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.435 -0.791 . . . . 27.120000000000001 109.675 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' R' R ' 121' ' ' PRO . . . . . 0.482 ' HA ' ' SG ' ' R' ' 125' ' ' CYS . 44.7 Cg_endo -71.26 166.51 29.03 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.874 1.46 . . . . 22.68 111.035 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' R' R ' 122' ' ' SER . . . . . 0.438 ' HB2' ' O ' ' R' ' 121' ' ' PRO . 38.4 t 178.57 -161.69 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.584 -0.698 . . . . 22.989999999999998 109.436 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' R' R ' 123' ' ' GLU . . . . . 0.44 ' HG2' HG23 ' R' ' 113' ' ' THR . 2.3 tp10 -56.42 -39.94 73.89 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.225 -0.922 . . . . 36.18 109.732 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' R' R ' 124' ' ' VAL . . . . . 0.578 ' HB ' HD13 ' R' ' 115' ' ' ILE . 84.1 t -142.55 136.42 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.484 -0.76 . . . . 20.640000000000001 109.314 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' R' R ' 125' ' ' CYS . . . . . 0.482 ' SG ' ' HA ' ' R' ' 121' ' ' PRO . 83.2 m -140.28 168.19 20.37 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.187 -0.946 . . . . 22.800000000000001 111.193 -179.405 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' R' R ' 126' ' ' VAL . . . . . 0.729 HG12 HG22 ' R' ' 179' ' ' VAL . 35.9 m -122.78 159.83 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.828 -0.545 . . . . 21.239999999999998 109.647 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' R' R ' 127' ' ' VAL . . . . . 0.71 HG11 ' O ' ' R' ' 177' ' ' VAL . 30.5 m -70.86 141.83 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.337 -0.852 . . . . 19.77 110.695 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' R' R ' 128' ' ' ASP . . . . . 0.444 ' OD1' ' HB3' ' R' ' 118' ' ' ALA . 53.9 p-10 -137.7 19.44 2.87 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.319 -0.863 . . . . 29.210000000000001 110.665 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' R' R ' 129' ' ' GLY . . . . . . . . . . . . . . . 113.97 0.06 24.18 Favored Glycine 0 N--CA 1.492 2.399 0 C-N-CA 119.993 -1.098 . . . . 33.859999999999999 110.487 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' R' R ' 130' ' ' THR . . . . . . . . . . . . . 58.9 m -91.9 131.85 36.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.202 -1.176 . . . . 26.41 109.998 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -62.53 120.72 11.66 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.408 -0.808 . . . . 33.079999999999998 110.284 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' R' R ' 132' ' ' MET . . . . . 0.435 ' HE1' ' CE2' ' R' ' 180' ' ' PHE . 98.4 mmm -105.22 165.67 10.94 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.425 -0.797 . . . . 30.760000000000002 110.445 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' R' R ' 133' ' ' CYS . . . . . 0.41 ' HA ' ' HB3' ' R' ' 174' ' ' PRO . 31.7 m -141.17 158.21 44.21 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.493 -0.754 . . . . 27.0 109.912 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' R' R ' 134' ' ' LEU . . . . . 0.564 HD11 ' O ' ' R' ' 172' ' ' PRO . 0.1 OUTLIER -58.48 -19.8 40.09 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.362 -0.836 . . . . 33.899999999999999 110.407 -179.837 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' R' R ' 135' ' ' ALA . . . . . . . . . . . . . . . -92.74 8.14 40.57 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.282 -0.887 . . . . 19.370000000000001 110.78 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' R' R ' 136' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -93.71 -21.72 19.17 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.255 -0.903 . . . . 30.469999999999999 110.272 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' R' R ' 137' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -149.98 165.42 32.74 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.314 -0.866 . . . . 24.27 110.189 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' R' R ' 138' ' ' HIS . . . . . 0.433 ' HA ' HG23 ' R' ' 154' ' ' VAL . 15.2 p80 -117.86 15.11 14.35 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.398 -0.814 . . . . 20.91 110.459 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' R' R ' 139' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' R' ' 152' ' ' ALA . . . -177.14 152.44 0.89 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.278 -0.889 . . . . 15.69 110.098 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' R' R ' 140' ' ' GLY . . . . . 0.427 ' HA3' ' O ' ' R' ' 179' ' ' VAL . . . 161.8 175.15 32.52 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.998 -1.241 . . . . 23.760000000000002 109.998 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' R' R ' 141' ' ' ILE . . . . . . . . . . . . . 83.5 mt -95.49 136.54 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.514 -0.992 . . . . 25.300000000000001 109.718 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' R' R ' 142' ' ' PHE . . . . . 0.576 ' CD2' ' HB2' ' R' ' 172' ' ' PRO . 82.6 m-85 -120.7 -172.58 2.41 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.26 -0.9 . . . . 30.239999999999998 110.511 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' R' R ' 143' ' ' LEU . . . . . 0.743 HD23 ' O ' ' R' ' 148' ' ' HIS . 0.5 OUTLIER -119.79 77.71 1.26 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.437 -0.789 . . . . 32.799999999999997 110.321 -179.908 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' R' R ' 144' ' ' LYS . . . . . 0.47 ' HG3' ' CZ2' ' R' ' 170' ' ' TRP . 1.0 OUTLIER -69.58 76.86 0.42 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.369 -0.832 . . . . 49.18 109.625 179.626 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' R' R ' 145' ' ' GLY . . . . . 0.458 ' O ' HD22 ' R' ' 143' ' ' LEU . . . 104.55 179.31 24.76 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.174 -1.571 . . . . 53.869999999999997 109.174 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' R' R ' 146' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -88.53 145.85 25.5 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.253 -1.145 . . . . 68.579999999999998 110.023 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' R' R ' 147' ' ' GLU . . . . . 0.859 ' HA ' ' CB ' ' S' ' 398' ' ' ARG . 10.9 mt-10 58.17 36.57 25.92 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.288 -0.883 . . . . 56.619999999999997 110.633 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' R' R ' 148' ' ' HIS . . . . . 0.743 ' O ' HD23 ' R' ' 143' ' ' LEU . 45.0 t60 -158.67 148.12 19.17 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.229 -0.92 . . . . 44.57 110.372 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' R' R ' 149' ' ' ALA . . . . . . . . . . . . . . . -150.27 146.89 27.06 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.45 -0.781 . . . . 33.539999999999999 110.091 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' R' R ' 150' ' ' VAL . . . . . . . . . . . . . 34.2 m -142.34 161.5 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.273 -0.892 . . . . 27.609999999999999 110.318 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' R' R ' 151' ' ' PHE . . . . . 0.538 ' CD1' ' N ' ' R' ' 152' ' ' ALA . 5.9 t80 -86.19 155.62 20.66 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.41 -0.806 . . . . 23.039999999999999 109.867 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' R' R ' 152' ' ' ALA . . . . . 0.538 ' N ' ' CD1' ' R' ' 151' ' ' PHE . . . -157.28 151.51 24.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.409 -0.807 . . . . 29.609999999999999 109.612 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' R' R ' 153' ' ' CYS . . . . . . . . . . . . . 26.7 p -154.29 173.62 15.92 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.227 -0.921 . . . . 22.75 110.507 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' R' R ' 154' ' ' VAL . . . . . 0.614 HG22 ' CE2' ' R' ' 159' ' ' TRP . 59.7 t -90.64 117.03 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.322 -0.861 . . . . 23.260000000000002 110.042 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' R' R ' 155' ' ' THR . . . . . . . . . . . . . 70.5 p -112.17 -176.66 2.98 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.361 -0.837 . . . . 17.879999999999999 110.025 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' R' R ' 156' ' ' SER . . . . . . . . . . . . . 78.6 p -75.96 -3.66 36.78 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.32 -0.863 . . . . 21.829999999999998 110.707 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' R' R ' 157' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -118.27 10.38 12.81 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.159 -0.963 . . . . 36.539999999999999 110.635 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' R' R ' 158' ' ' GLY . . . . . . . . . . . . . . . 117.94 -162.68 13.02 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.556 -1.417 . . . . 31.739999999999998 109.556 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' R' R ' 159' ' ' TRP . . . . . 0.614 ' CE2' HG22 ' R' ' 154' ' ' VAL . 14.7 m95 -86.56 122.44 30.49 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.389 -1.065 . . . . 28.25 110.147 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' R' R ' 160' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -108.47 167.03 10.33 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.404 -0.81 . . . . 41.240000000000002 110.175 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' R' R ' 161' ' ' ALA . . . . . . . . . . . . . . . -143.23 123.48 13.77 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.344 -0.847 . . . . 27.399999999999999 110.173 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' R' R ' 162' ' ' ILE . . . . . . . . . . . . . 92.0 mt -87.62 81.13 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.343 -0.848 . . . . 24.27 110.101 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' R' R ' 163' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' R' ' 165' ' ' GLU . 15.3 t0 -72.84 92.42 1.59 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.518 -0.739 . . . . 36.079999999999998 110.254 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' R' R ' 164' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 54.15 -89.0 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.463 -0.773 . . . . 46.079999999999998 110.574 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' R' R ' 165' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' R' ' 163' ' ' ASP . 29.7 mt-10 -124.76 36.03 4.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.088 -1.007 . . . . 50.939999999999998 110.192 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' R' R ' 166' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -135.82 117.23 14.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.4 -0.812 . . . . 47.280000000000001 110.34 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' R' R ' 167' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -100.94 119.96 39.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.457 -0.777 . . . . 40.469999999999999 110.172 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' R' R ' 168' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -157.6 158.54 30.61 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.213 -0.929 . . . . 30.210000000000001 110.399 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' R' R ' 169' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.81 132.99 19.36 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.931 1.49 . . . . 32.759999999999998 110.505 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' R' R ' 170' ' ' TRP . . . . . 0.47 ' CZ2' ' HG3' ' R' ' 144' ' ' LYS . 66.9 t90 -159.78 119.37 2.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.383 -0.823 . . . . 32.789999999999999 109.909 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' R' R ' 171' ' ' THR . . . . . . . . . . . . . 46.9 m -81.1 112.58 33.94 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.471 -0.768 . . . . 36.920000000000002 110.197 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' R' R ' 172' ' ' PRO . . . . . 0.576 ' HB2' ' CD2' ' R' ' 142' ' ' PHE . 46.5 Cg_endo -73.69 158.87 46.6 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.634 1.334 . . . . 33.539999999999999 110.504 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' R' R ' 173' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -88.93 144.97 33.67 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.358 -0.839 . . . . 45.759999999999998 109.882 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' R' R ' 174' ' ' PRO . . . . . 0.41 ' HB3' ' HA ' ' R' ' 133' ' ' CYS . 45.5 Cg_endo -71.71 -10.41 26.47 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.614 1.323 . . . . 29.629999999999999 110.507 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' R' R ' 175' ' ' SER . . . . . . . . . . . . . 53.0 p -103.44 -17.55 15.19 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.293 -0.88 . . . . 35.700000000000003 110.37 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' R' R ' 176' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -103.56 43.32 1.09 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.25 -0.906 . . . . 39.649999999999999 110.379 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' R' R ' 177' ' ' VAL . . . . . 0.71 ' O ' HG11 ' R' ' 127' ' ' VAL . 10.4 p -117.86 127.08 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.324 -0.86 . . . . 20.609999999999999 110.07 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' R' R ' 178' ' ' LEU . . . . . 0.475 ' HB3' ' HB2' ' R' ' 101' ' ' ALA . 45.6 mt -91.45 -61.31 1.68 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.361 -0.837 . . . . 15.58 109.395 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' R' R ' 179' ' ' VAL . . . . . 0.729 HG22 HG12 ' R' ' 126' ' ' VAL . 68.3 t -114.59 144.78 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.621 -0.674 . . . . 17.399999999999999 109.409 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' R' R ' 180' ' ' PHE . . . . . 0.435 ' CE2' ' HE1' ' R' ' 132' ' ' MET . 43.5 p90 -152.21 163.34 39.6 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.328 -0.858 . . . . 20.16 110.474 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' R' R ' 181' ' ' VAL . . . . . . . . . . . . . 66.3 t -113.16 111.48 50.29 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.467 -0.771 . . . . 17.690000000000001 109.833 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' R' R ' 182' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.03 149.52 52.9 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.532 1.28 . . . . 17.809999999999999 110.423 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' R' R ' 183' ' ' TYR . . . . . 0.739 ' O ' ' C ' ' R' ' 184' ' ' ASP . 79.0 m-85 -59.03 175.47 0.28 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.43 -0.794 . . . . 28.010000000000002 110.539 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' R' R ' 184' ' ' ASP . . . . . 0.739 ' C ' ' O ' ' R' ' 183' ' ' TYR . 1.0 OUTLIER -11.78 -75.82 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.452 -0.78 . . . . 58.640000000000001 110.296 -177.936 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' R' R ' 185' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 . . . . . 0 N--CA 1.503 2.177 0 CA-C-O 121.247 0.546 . . . . 80.420000000000002 111.757 179.236 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' R' R ' 193' ' ' LYS . . . . . . . . . . . . . 14.3 ptmt . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 120.895 0.379 . . . . 49.5 110.179 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' R' R ' 194' ' ' ALA . . . . . 0.857 ' HB3' ' HG2' ' R' ' 197' ' ' GLN . . . -174.7 -148.0 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.141 -0.975 . . . . 40.399999999999999 110.079 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' R' R ' 195' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -101.31 -49.95 3.91 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.455 -0.778 . . . . 34.600000000000001 110.241 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' R' R ' 196' ' ' VAL . . . . . 0.552 HG12 ' O ' ' R' ' 196' ' ' VAL . 47.8 t -91.96 54.0 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.288 -0.882 . . . . 33.270000000000003 110.594 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' R' R ' 197' ' ' GLN . . . . . 0.857 ' HG2' ' HB3' ' R' ' 194' ' ' ALA . 0.0 OUTLIER -164.06 26.16 0.07 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.146 -0.971 . . . . 41.579999999999998 110.702 179.842 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' R' R ' 198' ' ' ARG . . . . . . . . . . . . . 4.9 mtm180 -117.41 155.46 29.59 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.063 -1.023 . . . . 38.649999999999999 110.253 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' R' R ' 199' ' ' LYS . . . . . 0.608 ' O ' ' HD3' ' S' ' 299' ' ' PRO . 15.2 tttp -65.25 -66.94 0.48 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.387 -0.821 . . . . 36.770000000000003 109.908 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' R' R ' 200' ' ' LEU . . . . . . . . . . . . . 1.5 tp 61.22 161.67 0.06 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.444 -0.785 . . . . 33.079999999999998 110.117 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' R' R ' 201' ' ' LYS . . . . . 0.777 ' C ' ' N ' ' S' ' 298' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.386 -0.822 . . . . 44.32 110.267 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 229' ' ' MET . . . . . . . . . . . . . 1.5 tpt . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.226 0.536 . . . . 51.829999999999998 110.21 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' S' S ' 230' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -97.27 142.75 28.78 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.372 -0.83 . . . . 54.130000000000003 110.22 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' S' S ' 231' ' ' LEU . . . . . . . . . . . . . 67.9 mt -134.06 141.07 47.05 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.363 -0.836 . . . . 33.039999999999999 110.299 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' S' S ' 232' ' ' THR . . . . . 0.407 ' O ' ' HA ' ' S' ' 355' ' ' THR . 40.0 m -89.27 103.27 15.91 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.345 -0.847 . . . . 26.920000000000002 110.093 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 233' ' ' LEU . . . . . 0.667 HD22 ' CE2' ' S' ' 262' ' ' TYR . 79.8 mt -55.84 179.29 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.476 -0.765 . . . . 13.779999999999999 110.491 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 234' ' ' TYR . . . . . 0.444 ' CG ' ' N ' ' S' ' 235' ' ' ASN . 35.4 p90 -65.12 -35.61 81.67 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.354 -0.841 . . . . 26.079999999999998 110.119 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 235' ' ' ASN . . . . . 0.444 ' N ' ' CG ' ' S' ' 234' ' ' TYR . 50.7 p30 -74.28 -7.5 53.0 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.377 -0.827 . . . . 20.039999999999999 110.506 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 236' ' ' GLY . . . . . . . . . . . . . . . 95.81 -20.01 51.79 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.747 -1.341 . . . . 22.710000000000001 109.747 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' S' S ' 237' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -52.96 145.74 12.26 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.182 -1.187 . . . . 35.439999999999998 110.165 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' S' S ' 238' ' ' LYS . . . . . . . . . . . . . 44.4 mttt -102.17 127.9 48.91 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.397 -0.814 . . . . 32.560000000000002 110.374 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' S' S ' 239' ' ' LYS . . . . . 0.405 ' HG2' ' CZ ' ' S' ' 241' ' ' PHE . 9.0 ttmt -132.27 144.52 50.66 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.373 -0.829 . . . . 26.68 109.959 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 240' ' ' THR . . . . . . . . . . . . . 52.5 m -102.05 132.22 48.04 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.339 -0.851 . . . . 41.020000000000003 110.305 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' S' S ' 241' ' ' PHE . . . . . 0.405 ' CZ ' ' HG2' ' S' ' 239' ' ' LYS . 96.0 m-85 -117.98 137.67 52.7 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.346 -0.846 . . . . 28.620000000000001 110.169 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 242' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -96.36 161.78 13.78 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.451 -0.781 . . . . 47.890000000000001 110.224 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' S' S ' 243' ' ' SER . . . . . . . . . . . . . 72.4 m -90.65 151.52 21.24 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.333 -0.854 . . . . 45.090000000000003 110.225 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' S' S ' 244' ' ' ARG . . . . . . . . . . . . . 1.4 mtp85 -129.76 126.74 22.71 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.335 -0.853 . . . . 42.490000000000002 110.274 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' S' S ' 245' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.31 161.0 43.83 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 123.603 1.317 . . . . 35.68 110.503 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' S' S ' 246' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -132.89 97.88 4.15 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.323 -0.861 . . . . 51.880000000000003 109.821 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' S' S ' 247' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -110.47 -22.21 11.78 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.317 -0.865 . . . . 53.689999999999998 110.636 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' S' S ' 248' ' ' HIS . . . . . . . . . . . . . 76.5 m80 -117.26 43.75 2.26 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.235 -0.916 . . . . 55.789999999999999 110.774 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' S' S ' 249' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 48.8 38.36 11.72 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.459 -0.775 . . . . 49.450000000000003 110.382 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' S' S ' 250' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -90.62 29.05 1.37 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.462 -0.773 . . . . 36.859999999999999 110.277 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' S' S ' 251' ' ' ALA . . . . . . . . . . . . . . . -53.84 -43.21 69.28 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.244 -0.91 . . . . 29.690000000000001 109.577 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' S' S ' 252' ' ' TRP . . . . . 0.607 ' N ' ' HZ1' ' R' ' 201' ' ' LYS . 67.9 p-90 -61.77 -33.86 74.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.508 -0.745 . . . . 41.119999999999997 109.89 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 253' ' ' LEU . . . . . 0.407 ' N ' ' CD2' ' S' ' 252' ' ' TRP . 23.2 tp -70.12 -47.26 62.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.412 -0.805 . . . . 24.890000000000001 110.025 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 254' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -56.1 -42.47 76.82 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.419 -0.801 . . . . 35.649999999999999 110.03 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' S' S ' 255' ' ' ALA . . . . . . . . . . . . . . . -59.49 -48.25 82.37 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.438 -0.789 . . . . 22.73 110.1 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' S' S ' 256' ' ' ILE . . . . . 0.502 HG12 HD11 ' S' ' 304' ' ' ILE . 80.1 mt -62.25 -40.65 88.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.289 -0.882 . . . . 28.850000000000001 110.02 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 257' ' ' LEU . . . . . . . . . . . . . 19.1 mt -61.54 -44.53 96.87 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.365 -0.834 . . . . 23.07 110.144 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' S' S ' 258' ' ' GLN . . . . . 0.498 ' HB3' ' CD2' ' S' ' 351' ' ' PHE . 53.3 mm-40 -65.01 -45.39 85.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.389 -0.82 . . . . 29.780000000000001 109.92 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 259' ' ' LEU . . . . . 0.425 ' O ' HG22 ' S' ' 263' ' ' VAL . 19.8 tp -58.66 -36.42 74.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.43 -0.794 . . . . 17.940000000000001 109.444 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 260' ' ' PHE . . . . . 0.534 ' CE2' HD21 ' S' ' 311' ' ' LEU . 3.1 m-85 -62.79 -45.22 93.64 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.647 -0.658 . . . . 30.57 109.849 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 261' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -62.16 -29.77 70.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.509 -0.744 . . . . 41.340000000000003 109.979 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' S' S ' 262' ' ' TYR . . . . . 0.667 ' CE2' HD22 ' S' ' 233' ' ' LEU . 8.7 t80 -71.19 -44.71 64.92 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.433 -0.792 . . . . 26.030000000000001 110.074 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 263' ' ' VAL . . . . . 0.425 HG22 ' O ' ' S' ' 259' ' ' LEU . 33.1 m -92.02 18.28 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.438 -0.788 . . . . 22.800000000000001 110.355 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 264' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 52.7 70.76 0.54 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.287 -0.883 . . . . 44.030000000000001 110.604 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' S' S ' 265' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -111.84 109.22 55.33 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.295 -0.878 . . . . 35.609999999999999 109.628 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' S' S ' 266' ' ' PRO . . . . . 0.476 ' HA ' ' HB2' ' S' ' 269' ' ' ASP . 48.8 Cg_endo -75.33 0.4 9.08 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 123.55 1.289 . . . . 37.670000000000002 111.807 -179.126 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 267' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -56.48 -67.69 0.28 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.764 -1.21 . . . . 41.490000000000002 110.199 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 268' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -92.9 39.89 1.05 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.159 -0.963 . . . . 50.759999999999998 110.047 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' S' S ' 269' ' ' ASP . . . . . 0.476 ' HB2' ' HA ' ' S' ' 266' ' ' PRO . 0.9 OUTLIER -76.02 -33.29 59.67 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.426 -0.796 . . . . 61.859999999999999 109.762 179.534 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' S' S ' 270' ' ' TRP . . . . . 0.508 ' CE2' HG23 ' S' ' 271' ' ' VAL . 50.9 p-90 -73.83 -4.27 33.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.298 -0.876 . . . . 39.850000000000001 110.527 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 271' ' ' VAL . . . . . 0.508 HG23 ' CE2' ' S' ' 270' ' ' TRP . 46.4 t -109.67 -32.62 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.146 -0.971 . . . . 39.18 110.065 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 272' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -78.71 -36.5 43.33 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.35 -0.844 . . . . 40.020000000000003 110.524 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' S' S ' 273' ' ' SER . . . . . . . . . . . . . 71.2 m -103.49 56.03 0.74 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.295 -0.878 . . . . 47.200000000000003 110.369 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' S' S ' 274' ' ' SER . . . . . . . . . . . . . 6.9 t -133.01 141.26 40.3 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.329 -0.857 . . . . 47.609999999999999 110.113 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' S' S ' 275' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.77 -18.86 21.68 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 O-C-N 123.633 1.333 . . . . 45.280000000000001 110.547 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' S' S ' 276' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -99.96 140.85 33.58 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.327 -0.858 . . . . 57.270000000000003 110.248 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' S' S ' 277' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -71.76 97.69 1.82 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.396 -0.815 . . . . 37.280000000000001 110.251 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' S' S ' 278' ' ' LEU . . . . . . . . . . . . . 86.4 mt -96.93 33.74 1.84 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.39 -0.819 . . . . 43.880000000000003 110.037 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' S' S ' 279' ' ' THR . . . . . . . . . . . . . 76.3 m -64.02 -60.15 3.6 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.436 -0.79 . . . . 50.049999999999997 110.269 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' S' S ' 280' ' ' LEU . . . . . 0.739 ' HA ' HD12 ' S' ' 283' ' ' ILE . 13.6 mt -51.53 -39.98 58.77 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.314 -0.866 . . . . 54.119999999999997 110.241 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 281' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.27 -49.75 74.43 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.494 -0.754 . . . . 65.280000000000001 110.174 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 282' ' ' ALA . . . . . . . . . . . . . . . -58.95 -33.91 71.15 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.44 -0.788 . . . . 46.509999999999998 110.554 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' S' S ' 283' ' ' ILE . . . . . 0.739 HD12 ' HA ' ' S' ' 280' ' ' LEU . 85.6 mt -66.3 -50.88 64.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.319 -0.863 . . . . 47.299999999999997 110.125 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 284' ' ' LYS . . . . . . . . . . . . . 33.8 tttp -50.6 -57.57 7.88 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.318 -0.864 . . . . 50.719999999999999 110.344 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' S' S ' 285' ' ' GLN . . . . . 0.518 ' HG2' HD12 ' S' ' 289' ' ' LEU . 34.4 tt0 -51.47 -46.33 63.07 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.465 -0.772 . . . . 68.469999999999999 110.257 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 286' ' ' LEU . . . . . . . . . . . . . 19.2 mt -60.02 -44.56 94.5 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.372 -0.83 . . . . 36.619999999999997 110.275 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' S' S ' 287' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -62.7 -35.22 79.0 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.289 -0.882 . . . . 46.640000000000001 110.1 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' S' S ' 288' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -76.31 -20.96 56.78 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.4 -0.812 . . . . 46.450000000000003 110.34 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' S' S ' 289' ' ' LEU . . . . . 0.518 HD12 ' HG2' ' S' ' 285' ' ' GLN . 30.7 mt -97.38 -21.69 17.05 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.302 -0.874 . . . . 35.090000000000003 110.494 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 290' ' ' THR . . . . . 0.406 HG22 ' HB3' ' S' ' 306' ' ' ASN . 81.2 p -114.76 -28.49 7.08 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.325 -0.859 . . . . 38.609999999999999 110.406 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 291' ' ' GLY . . . . . . . . . . . . . . . 79.35 11.08 85.33 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.9 -1.28 . . . . 36.770000000000003 109.9 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' S' S ' 292' ' ' LEU . . . . . . . . . . . . . 84.7 mt -96.51 145.82 25.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.286 -1.126 . . . . 35.329999999999998 109.722 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' S' S ' 293' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -77.35 102.34 6.73 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.194 -0.941 . . . . 48.700000000000003 110.273 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' S' S ' 294' ' ' LEU . . . . . 0.428 ' HB3' ' CZ2' ' S' ' 252' ' ' TRP . 56.1 mt -106.96 51.72 0.73 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.51 -0.744 . . . . 42.609999999999999 110.085 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 295' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -112.43 -11.27 13.67 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.274 -0.891 . . . . 55.490000000000002 110.56 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 296' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -144.24 48.55 1.37 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.187 -0.946 . . . . 75.680000000000007 110.319 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' S' S ' 297' ' ' GLY . . . . . . . . . . . . . . . 96.88 145.18 18.72 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.505 -1.438 . . . . 49.439999999999998 109.505 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' S' S ' 298' ' ' GLY . . . . . 0.777 ' N ' ' C ' ' R' ' 201' ' ' LYS . . . -163.85 156.98 29.09 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.823 -1.311 . . . . 41.109999999999999 109.823 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 299' ' ' PRO . . . . . 0.608 ' HD3' ' O ' ' R' ' 199' ' ' LYS . 47.7 Cg_endo -73.73 118.21 5.36 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 O-C-N 123.941 1.495 . . . . 26.199999999999999 110.314 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 300' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.23 -15.42 31.72 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 123.538 1.283 . . . . 21.699999999999999 110.684 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' S' S ' 301' ' ' ALA . . . . . . . . . . . . . . . -80.73 -29.33 36.37 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.259 -0.9 . . . . 31.23 110.091 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' S' S ' 302' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.58 -40.57 18.91 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.512 -0.742 . . . . 38.990000000000002 109.953 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 303' ' ' VAL . . . . . 0.493 HG23 ' O ' ' S' ' 299' ' ' PRO . 58.5 t -60.68 -35.48 64.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.372 -0.83 . . . . 18.629999999999999 110.177 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 304' ' ' ILE . . . . . 0.518 HD12 HG21 ' S' ' 379' ' ' VAL . 86.3 mt -79.39 -23.58 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.418 -0.801 . . . . 25.460000000000001 110.177 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 305' ' ' TRP . . . . . 0.414 ' CD2' ' HD3' ' S' ' 308' ' ' LYS . 68.8 t-105 -88.67 -14.62 36.92 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.194 -0.942 . . . . 33.399999999999999 110.5 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 306' ' ' ASN . . . . . 0.406 ' HB3' HG22 ' S' ' 290' ' ' THR . 10.4 m-80 -89.7 -13.57 36.6 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.237 -0.915 . . . . 36.969999999999999 110.391 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 307' ' ' ILE . . . . . 0.473 HG12 ' O ' ' S' ' 303' ' ' VAL . 36.9 pt -125.03 45.67 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.276 -0.89 . . . . 30.809999999999999 110.036 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 308' ' ' LYS . . . . . 0.414 ' HD3' ' CD2' ' S' ' 305' ' ' TRP . 1.5 mtmp? -73.58 -37.72 65.39 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.366 -0.834 . . . . 46.520000000000003 110.1 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 309' ' ' HIS . . . . . 0.498 ' CD2' ' HG ' ' S' ' 310' ' ' LEU . 55.6 p-80 -73.27 -8.2 54.79 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.333 -0.854 . . . . 51.030000000000001 110.105 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 310' ' ' LEU . . . . . 0.498 ' HG ' ' CD2' ' S' ' 309' ' ' HIS . 53.2 mt -99.32 -12.87 19.94 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.265 -0.897 . . . . 36.159999999999997 109.973 179.269 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 311' ' ' LEU . . . . . 0.534 HD21 ' CE2' ' S' ' 260' ' ' PHE . 10.8 mt -97.14 147.88 23.61 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.421 -0.8 . . . . 40.0 110.431 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 312' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -81.65 -16.28 51.89 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.273 -0.892 . . . . 54.18 109.69 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' S' S ' 313' ' ' THR . . . . . 0.808 HG23 ' HG2' ' S' ' 323' ' ' GLU . 92.8 m -87.92 151.57 22.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.329 -0.857 . . . . 25.609999999999999 110.117 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 314' ' ' GLY . . . . . . . . . . . . . . . -87.81 126.4 8.03 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.861 -1.296 . . . . 25.18 109.861 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' S' S ' 315' ' ' ILE . . . . . 0.666 HD13 ' HB ' ' S' ' 324' ' ' VAL . 50.7 mm -101.69 150.45 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.407 -1.055 . . . . 23.899999999999999 109.703 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 316' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' S' ' 325' ' ' CYS . . . -157.04 -159.25 9.37 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.982 -1.247 . . . . 23.18 109.982 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 317' ' ' THR . . . . . 0.423 HG22 ' CG2' ' S' ' 326' ' ' VAL . 11.0 p -133.94 -173.04 3.14 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.446 -1.032 . . . . 27.98 109.949 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.52 -56.2 24.94 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.142 -0.974 . . . . 28.100000000000001 109.939 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' S' S ' 319' ' ' SER . . . . . . . . . . . . . 1.2 m -59.99 -41.62 92.43 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.405 -0.81 . . . . 37.0 109.673 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' S' S ' 320' ' ' ARG . . . . . . . . . . . . . 12.2 mtm180 -111.68 79.89 2.64 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.592 -0.692 . . . . 52.07 109.666 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' S' S ' 321' ' ' PRO . . . . . 0.731 ' CG ' ' O ' ' S' ' 386' ' ' GLU . 44.1 Cg_endo -71.31 171.52 15.93 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.876 1.461 . . . . 38.289999999999999 110.966 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 322' ' ' SER . . . . . 0.447 ' HB2' ' O ' ' S' ' 321' ' ' PRO . 41.3 t 178.65 -148.13 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.927 -0.768 . . . . 38.840000000000003 108.927 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 323' ' ' GLU . . . . . 0.808 ' HG2' HG23 ' S' ' 313' ' ' THR . 6.7 tp10 -62.84 -40.29 96.96 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.011 -1.055 . . . . 40.700000000000003 109.724 179.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 324' ' ' VAL . . . . . 0.666 ' HB ' HD13 ' S' ' 315' ' ' ILE . 72.9 t -141.28 135.03 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.416 -0.802 . . . . 20.34 109.456 179.358 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 325' ' ' CYS . . . . . 0.462 ' HB2' ' CE1' ' S' ' 380' ' ' PHE . 11.3 m -126.03 172.26 10.12 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.258 -0.901 . . . . 30.629999999999999 110.805 -179.129 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 326' ' ' VAL . . . . . 0.641 HG12 HG22 ' S' ' 379' ' ' VAL . 34.6 m -135.56 142.24 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 109.189 -0.671 . . . . 23.899999999999999 109.189 179.177 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 327' ' ' VAL . . . . . 0.593 HG11 ' O ' ' S' ' 377' ' ' VAL . 34.5 m -56.27 124.93 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.037 -1.04 . . . . 19.48 110.437 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 328' ' ' ASP . . . . . . . . . . . . . 55.6 p-10 -119.36 11.49 12.23 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.467 -0.77 . . . . 26.43 110.403 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' S' S ' 329' ' ' GLY . . . . . . . . . . . . . . . 119.63 2.24 13.14 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.043 -1.223 . . . . 31.239999999999998 110.043 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' S' S ' 330' ' ' THR . . . . . . . . . . . . . 80.9 m -93.02 129.93 38.78 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.044 -1.268 . . . . 30.050000000000001 110.111 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' S' S ' 331' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -56.73 111.49 1.03 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.262 -0.899 . . . . 37.259999999999998 110.02 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' S' S ' 332' ' ' MET . . . . . . . . . . . . . 88.1 mmm -94.11 162.64 13.79 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.285 -0.884 . . . . 26.23 110.345 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' S' S ' 333' ' ' CYS . . . . . . . . . . . . . 25.3 m -137.34 150.07 47.46 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.487 -0.758 . . . . 23.559999999999999 109.96 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' S' S ' 334' ' ' LEU . . . . . 0.558 HD11 ' O ' ' S' ' 372' ' ' PRO . 0.1 OUTLIER -52.58 -24.89 9.1 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.33 -0.856 . . . . 28.93 110.46 179.916 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' S' S ' 335' ' ' ALA . . . . . . . . . . . . . . . -88.99 14.44 10.57 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.302 -0.874 . . . . 15.76 110.957 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' S' S ' 336' ' ' ASP . . . . . 0.403 ' O ' ' HA ' ' S' ' 382' ' ' PRO . 70.7 m-20 -100.48 -17.19 17.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.166 -0.959 . . . . 34.920000000000002 110.206 179.539 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 337' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -152.37 170.84 19.1 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.382 -0.824 . . . . 19.030000000000001 110.095 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' S' S ' 338' ' ' HIS . . . . . 0.401 ' HB3' ' CZ ' ' S' ' 383' ' ' TYR . 13.5 p80 -120.71 10.34 10.97 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.365 -0.834 . . . . 18.82 110.484 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 339' ' ' ALA . . . . . 0.412 ' HA ' ' O ' ' S' ' 352' ' ' ALA . . . -176.01 155.17 1.55 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.289 -0.882 . . . . 17.18 110.131 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 340' ' ' GLY . . . . . 0.401 ' HA3' ' O ' ' S' ' 379' ' ' VAL . . . 160.85 173.07 29.0 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.01 -1.236 . . . . 18.329999999999998 110.01 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 341' ' ' ILE . . . . . . . . . . . . . 83.7 mt -88.77 138.1 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.523 -0.986 . . . . 18.600000000000001 109.862 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' S' S ' 342' ' ' PHE . . . . . 0.488 ' CE2' ' HB3' ' S' ' 352' ' ' ALA . 70.0 m-85 -120.93 -178.48 3.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.184 -0.947 . . . . 23.440000000000001 110.447 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 343' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.9 93.41 4.18 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.428 -0.795 . . . . 35.590000000000003 110.06 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 344' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.93 125.01 29.59 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.268 -0.895 . . . . 38.340000000000003 110.054 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 345' ' ' GLY . . . . . . . . . . . . . . . 62.91 -130.88 42.76 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 108.821 -1.712 . . . . 53.460000000000001 108.821 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' S' S ' 346' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -132.73 150.85 52.11 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.214 -1.168 . . . . 70.909999999999997 110.07 179.405 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' S' S ' 347' ' ' GLU . . . . . 0.536 ' C ' ' HG2' ' R' ' 201' ' ' LYS . 18.0 mt-10 53.28 35.43 20.12 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.307 -0.871 . . . . 47.32 110.374 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 348' ' ' HIS . . . . . 0.615 ' N ' ' HG2' ' R' ' 201' ' ' LYS . 46.6 t60 -150.15 155.83 40.52 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.248 -0.908 . . . . 41.719999999999999 110.346 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 349' ' ' ALA . . . . . 0.567 ' HB3' ' NZ ' ' R' ' 201' ' ' LYS . . . -149.74 151.28 33.36 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.33 -0.856 . . . . 22.91 110.544 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 350' ' ' VAL . . . . . 0.452 HG13 ' C ' ' S' ' 349' ' ' ALA . 34.6 m -149.06 169.64 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.448 -0.782 . . . . 21.09 110.06 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 351' ' ' PHE . . . . . 0.498 ' CD2' ' HB3' ' S' ' 258' ' ' GLN . 10.8 t80 -105.4 143.62 33.32 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.26 -0.9 . . . . 25.030000000000001 110.687 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 352' ' ' ALA . . . . . 0.488 ' HB3' ' CE2' ' S' ' 342' ' ' PHE . . . -147.74 151.72 36.54 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.58 -0.7 . . . . 23.809999999999999 109.75 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 353' ' ' CYS . . . . . . . . . . . . . 26.3 p -153.29 164.97 37.16 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.302 -0.874 . . . . 25.66 110.245 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' S' S ' 354' ' ' VAL . . . . . 0.553 HG22 ' CE2' ' S' ' 359' ' ' TRP . 58.0 t -76.15 118.56 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.4 -0.812 . . . . 34.270000000000003 109.941 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 355' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' S' ' 232' ' ' THR . 51.7 p -117.85 175.09 5.82 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.199 -0.938 . . . . 25.489999999999998 110.29 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 356' ' ' SER . . . . . . . . . . . . . 62.1 p -62.17 -17.65 58.65 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.465 -0.772 . . . . 31.239999999999998 110.743 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' S' S ' 357' ' ' ASN . . . . . . . . . . . . . 46.0 m-20 -107.02 14.2 26.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.154 -0.966 . . . . 28.609999999999999 110.611 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' S' S ' 358' ' ' GLY . . . . . . . . . . . . . . . 111.88 -152.88 17.6 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.997 -1.241 . . . . 22.010000000000002 109.997 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' S' S ' 359' ' ' TRP . . . . . 0.553 ' CE2' HG22 ' S' ' 354' ' ' VAL . 15.5 m95 -91.36 116.64 29.0 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.33 -1.1 . . . . 25.539999999999999 110.205 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 360' ' ' TYR . . . . . 0.426 ' HA ' ' HA ' ' S' ' 369' ' ' PRO . 1.3 m-85 -103.47 165.75 10.85 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.338 -0.852 . . . . 40.530000000000001 110.105 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 361' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' S' ' 351' ' ' PHE . . . -139.97 130.08 25.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.37 -0.831 . . . . 18.039999999999999 110.333 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 362' ' ' ILE . . . . . . . . . . . . . 88.8 mt -95.59 83.65 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.316 -0.865 . . . . 15.640000000000001 110.054 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' S' S ' 363' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' S' ' 365' ' ' GLU . 11.9 t0 -75.25 94.45 2.99 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.334 -0.854 . . . . 35.030000000000001 110.241 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 364' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 54.03 -89.42 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.484 -0.76 . . . . 46.719999999999999 110.547 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' S' S ' 365' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' S' ' 363' ' ' ASP . 23.8 mt-10 -122.6 19.06 10.4 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.048 -1.032 . . . . 56.200000000000003 110.251 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 366' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -118.01 125.0 49.52 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.207 -0.933 . . . . 51.020000000000003 110.308 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' S' S ' 367' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -106.94 127.05 53.09 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.355 -0.841 . . . . 37.590000000000003 110.155 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' S' S ' 368' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -165.4 159.52 13.97 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.253 -0.904 . . . . 31.469999999999999 110.461 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' S' S ' 369' ' ' PRO . . . . . 0.426 ' HA ' ' HA ' ' S' ' 360' ' ' TYR . 45.6 Cg_endo -72.91 139.58 30.42 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.869 1.457 . . . . 28.850000000000001 110.495 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 370' ' ' TRP . . . . . . . . . . . . . 67.6 t90 -167.13 113.63 0.77 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.463 -0.773 . . . . 26.940000000000001 109.973 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' S' S ' 371' ' ' THR . . . . . . . . . . . . . 59.6 m -74.84 113.02 20.41 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.338 -0.851 . . . . 20.190000000000001 109.986 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' S' S ' 372' ' ' PRO . . . . . 0.558 ' O ' HD11 ' S' ' 334' ' ' LEU . 46.5 Cg_endo -73.58 157.08 49.15 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 O-C-N 123.573 1.301 . . . . 28.68 110.546 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 373' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -90.52 147.08 35.65 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.436 -0.79 . . . . 35.719999999999999 109.987 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' S' S ' 374' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -75.95 -6.25 17.21 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.687 1.362 . . . . 30.890000000000001 110.533 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' S' S ' 375' ' ' SER . . . . . . . . . . . . . 68.9 p -104.4 -16.94 14.97 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.288 -0.882 . . . . 29.41 110.484 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' S' S ' 376' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -106.54 43.05 1.19 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.285 -0.884 . . . . 32.890000000000001 110.257 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' S' S ' 377' ' ' VAL . . . . . 0.593 ' O ' HG11 ' S' ' 327' ' ' VAL . 7.3 p -114.72 147.29 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.314 -0.866 . . . . 24.329999999999998 110.17 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 378' ' ' LEU . . . . . . . . . . . . . 52.1 mt -115.97 -58.02 2.15 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.386 -0.821 . . . . 24.370000000000001 109.623 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' S' S ' 379' ' ' VAL . . . . . 0.641 HG22 HG12 ' S' ' 326' ' ' VAL . 62.0 t -120.64 132.4 70.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.452 -0.78 . . . . 18.02 109.44 179.281 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 380' ' ' PHE . . . . . 0.462 ' CE1' ' HB2' ' S' ' 325' ' ' CYS . 14.2 p90 -142.59 173.97 11.06 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.375 -0.828 . . . . 29.350000000000001 110.665 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 381' ' ' VAL . . . . . . . . . . . . . 58.1 t -120.12 107.34 39.76 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.493 -0.755 . . . . 16.34 109.382 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' S' S ' 382' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' S' ' 336' ' ' ASP . 46.0 Cg_endo -71.28 145.6 48.95 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 O-C-N 123.669 1.352 . . . . 20.940000000000001 110.79 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 383' ' ' TYR . . . . . 0.401 ' CZ ' ' HB3' ' S' ' 338' ' ' HIS . 88.3 m-85 -61.05 -53.42 57.36 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.37 -0.831 . . . . 28.93 109.912 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 384' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -103.63 125.91 50.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.362 -0.836 . . . . 47.030000000000001 110.358 -176.558 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' S' S ' 385' ' ' GLN . . . . . 0.425 ' O ' ' C ' ' S' ' 386' ' ' GLU . 49.2 mt-30 -63.42 -4.84 3.0 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.381 -0.825 . . . . 46.689999999999998 110.194 177.363 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 386' ' ' GLU . . . . . 0.731 ' O ' ' CG ' ' S' ' 321' ' ' PRO . 19.7 pt-20 -42.83 156.62 0.25 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.338 -0.851 . . . . 50.25 109.628 179.26 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 387' ' ' PRO . . . . . 0.807 ' O ' ' O ' ' S' ' 389' ' ' ASN . 47.1 Cg_endo -70.52 24.23 0.2 Allowed 'Trans proline' 0 C--N 1.31 -1.488 0 O-C-N 123.572 1.301 . . . . 34.390000000000001 110.621 -177.497 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 388' ' ' LEU . . . . . 0.771 ' C ' ' O ' ' S' ' 387' ' ' PRO . 4.4 tp 0.1 92.26 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.399 -0.813 . . . . 38.009999999999998 110.145 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 389' ' ' ASN . . . . . 0.807 ' O ' ' O ' ' S' ' 387' ' ' PRO . 8.3 t-20 74.73 170.59 0.29 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.302 -0.874 . . . . 45.82 110.108 -179.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 390' ' ' GLY . . . . . 0.504 ' O ' ' CD2' ' S' ' 392' ' ' TRP . . . 149.49 -85.08 0.16 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.687 -1.365 . . . . 33.460000000000001 109.687 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 391' ' ' GLU . . . . . 0.472 ' CB ' ' O ' ' S' ' 390' ' ' GLY . 4.4 tt0 69.04 -67.52 0.21 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.384 -1.068 . . . . 56.579999999999998 110.093 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 392' ' ' TRP . . . . . 0.504 ' CD2' ' O ' ' S' ' 390' ' ' GLY . 0.3 OUTLIER -56.85 -18.04 11.59 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.373 -0.829 . . . . 31.43 110.359 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' S' S ' 393' ' ' LYS . . . . . 0.797 ' HE2' ' HB2' ' S' ' 394' ' ' ALA . 0.0 OUTLIER -51.74 -34.34 38.8 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.253 -0.904 . . . . 39.420000000000002 110.382 179.336 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' S' S ' 394' ' ' ALA . . . . . 0.797 ' HB2' ' HE2' ' S' ' 393' ' ' LYS . . . -89.44 -18.57 26.5 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.307 -0.871 . . . . 34.329999999999998 110.07 178.715 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 395' ' ' LYS . . . . . 0.658 ' HB3' ' CD1' ' R' ' 143' ' ' LEU . 5.3 mmtt -73.86 -10.04 59.26 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.401 -0.812 . . . . 60.090000000000003 110.298 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 396' ' ' VAL . . . . . 0.942 HG22 ' CB ' ' R' ' 99' ' ' PRO . 6.6 p -104.17 -27.99 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.364 -0.835 . . . . 35.5 110.598 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' S' S ' 397' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -117.51 94.71 4.65 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.23 -0.919 . . . . 49.960000000000001 110.578 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' S' S ' 398' ' ' ARG . . . . . 0.859 ' CB ' ' HA ' ' R' ' 147' ' ' GLU . 0.0 OUTLIER -124.78 -122.51 0.26 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.197 -0.939 . . . . 43.420000000000002 110.706 -179.027 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' S' S ' 399' ' ' LYS . . . . . 0.436 ' O ' ' C ' ' S' ' 400' ' ' LEU . 0.1 OUTLIER -150.8 -67.12 0.19 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.424 -0.798 . . . . 55.310000000000002 110.025 -179.62 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' S' S ' 400' ' ' LEU . . . . . 0.629 ' CB ' ' O ' ' R' ' 147' ' ' GLU . 1.0 OUTLIER -41.87 -27.26 0.11 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.322 -0.862 . . . . 41.030000000000001 110.248 -179.723 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' S' S ' 401' ' ' LYS . . . . . 0.763 ' C ' ' HB3' ' R' ' 51' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 O-C-N 121.317 -0.865 . . . . 61.969999999999999 110.231 178.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 29' ' ' MET . . . . . 0.451 ' HG3' ' N ' ' R' ' 30' ' ' GLU . 4.1 ptt? . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.235 0.541 . . . . 32.140000000000001 110.239 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' R' R ' 30' ' ' GLU . . . . . 0.451 ' N ' ' HG3' ' R' ' 29' ' ' MET . 41.7 tt0 -96.36 141.21 29.95 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.354 -0.841 . . . . 43.359999999999999 110.308 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 31' ' ' LEU . . . . . . . . . . . . . 65.5 mt -134.87 140.67 45.98 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.338 -0.851 . . . . 22.93 110.271 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' R' R ' 32' ' ' THR . . . . . . . . . . . . . 71.1 m -87.7 110.61 20.56 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.352 -0.843 . . . . 22.34 109.935 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' R' R ' 33' ' ' LEU . . . . . 0.594 HD22 ' CE2' ' R' ' 62' ' ' TYR . 80.1 mt -62.39 -172.78 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.274 -0.891 . . . . 21.390000000000001 110.209 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 34' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -74.6 -29.52 61.34 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.333 -0.855 . . . . 34.399999999999999 110.365 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' R' R ' 35' ' ' ASN . . . . . . . . . . . . . 48.4 p30 -77.65 -1.95 33.51 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.348 -0.845 . . . . 30.280000000000001 110.689 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' R' R ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.28 -16.55 59.53 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.698 -1.361 . . . . 36.25 109.698 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' R' R ' 37' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -58.95 161.75 4.73 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.314 -1.11 . . . . 53.799999999999997 110.344 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' R' R ' 38' ' ' LYS . . . . . . . . . . . . . 56.9 mttt -117.83 135.76 53.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.315 -0.866 . . . . 49.909999999999997 110.142 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' R' R ' 39' ' ' LYS . . . . . 0.404 ' HG2' ' CZ ' ' R' ' 41' ' ' PHE . 8.1 ttmt -138.69 143.66 39.24 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.388 -0.82 . . . . 35.689999999999998 110.19 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 40' ' ' THR . . . . . . . . . . . . . 23.7 m -102.56 127.98 49.41 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.387 -0.82 . . . . 34.840000000000003 110.193 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' R' R ' 41' ' ' PHE . . . . . 0.404 ' CZ ' ' HG2' ' R' ' 39' ' ' LYS . 96.6 m-85 -113.09 132.71 55.32 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.402 -0.811 . . . . 34.420000000000002 110.11 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 42' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -93.24 140.89 29.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.346 -0.846 . . . . 51.460000000000001 110.247 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' R' R ' 43' ' ' SER . . . . . . . . . . . . . 53.9 m -70.74 141.91 51.47 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.502 -0.749 . . . . 41.840000000000003 110.196 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' R' R ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.75 125.37 29.58 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.263 -0.898 . . . . 33.82 109.986 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 45' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.16 151.05 54.74 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.543 1.286 . . . . 30.27 110.649 -179.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' R' R ' 46' ' ' ASN . . . . . 0.796 ' ND2' HD23 ' S' ' 400' ' ' LEU . 52.1 t-20 -124.28 109.91 13.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.478 -0.764 . . . . 35.100000000000001 110.004 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 47' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -120.32 -34.93 3.54 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.217 -0.927 . . . . 42.810000000000002 110.466 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' R' R ' 48' ' ' HIS . . . . . 0.44 ' NE2' HD11 ' R' ' 80' ' ' LEU . 73.2 m80 -105.7 45.18 0.98 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.239 -0.913 . . . . 49.969999999999999 110.201 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 49' ' ' ASP . . . . . 0.72 ' OD1' ' HA ' ' S' ' 401' ' ' LYS . 37.6 m-20 50.28 34.66 9.17 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.341 -0.849 . . . . 61.32 110.195 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 50' ' ' ASN . . . . . 0.4 ' OD1' ' HA ' ' R' ' 46' ' ' ASN . 15.0 p-10 -86.24 43.83 1.09 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.423 -0.798 . . . . 51.5 110.719 -179.556 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 51' ' ' ALA . . . . . 0.71 ' HB2' ' CB ' ' S' ' 400' ' ' LEU . . . -66.12 -46.11 78.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.276 -0.89 . . . . 38.770000000000003 109.541 179.447 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 52' ' ' TRP . . . . . 0.483 ' CD2' ' N ' ' R' ' 53' ' ' LEU . 68.2 p-90 -58.39 -38.37 77.2 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.525 -0.734 . . . . 26.239999999999998 110.114 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 53' ' ' LEU . . . . . 0.483 ' N ' ' CD2' ' R' ' 52' ' ' TRP . 23.2 tp -66.72 -46.7 74.63 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.373 -0.83 . . . . 26.75 109.958 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 54' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -55.27 -41.55 72.38 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.405 -0.809 . . . . 35.020000000000003 110.142 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' R' R ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.17 -46.11 91.86 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.337 -0.852 . . . . 24.469999999999999 110.145 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' R' R ' 56' ' ' ILE . . . . . 0.433 HG12 HD11 ' R' ' 104' ' ' ILE . 76.4 mt -62.17 -42.24 94.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.332 -0.855 . . . . 26.030000000000001 109.924 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 57' ' ' LEU . . . . . . . . . . . . . 22.5 mt -60.24 -45.71 92.31 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.364 -0.835 . . . . 26.77 109.658 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' R' R ' 58' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -63.9 -46.57 84.25 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.508 -0.745 . . . . 22.32 109.559 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' R' R ' 59' ' ' LEU . . . . . 0.43 ' HA ' ' HE2' ' R' ' 151' ' ' PHE . 23.8 tp -61.43 -37.71 84.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.306 -0.871 . . . . 20.550000000000001 109.424 179.262 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 60' ' ' PHE . . . . . 0.528 ' CE2' HD21 ' R' ' 111' ' ' LEU . 2.8 m-85 -61.08 -44.69 96.98 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.62 -0.675 . . . . 20.079999999999998 109.95 179.285 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 61' ' ' ARG . . . . . . . . . . . . . 5.6 tpt180 -63.22 -36.18 82.81 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.397 -0.814 . . . . 18.800000000000001 110.41 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' R' R ' 62' ' ' TYR . . . . . 0.594 ' CE2' HD22 ' R' ' 33' ' ' LEU . 9.1 t80 -63.03 -41.8 99.62 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.13 -0.981 . . . . 26.449999999999999 110.248 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 63' ' ' VAL . . . . . 0.407 ' H ' HG22 ' R' ' 63' ' ' VAL . 30.7 m -93.35 20.3 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.238 -0.914 . . . . 29.75 110.221 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 64' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 53.02 75.56 0.24 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.322 -0.861 . . . . 35.520000000000003 110.541 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' R' R ' 65' ' ' GLU . . . . . 0.442 ' HG2' ' CD2' ' R' ' 60' ' ' PHE . 14.3 tp10 -116.28 104.01 52.41 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.348 -0.845 . . . . 29.890000000000001 109.893 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 66' ' ' PRO . . . . . 0.482 ' HA ' ' HB2' ' R' ' 69' ' ' ASP . 46.7 Cg_endo -73.58 -5.75 17.6 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.875 1.46 . . . . 21.370000000000001 111.111 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 67' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -52.17 -61.5 2.23 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.054 -1.029 . . . . 23.850000000000001 110.314 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 68' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -98.14 36.48 1.57 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.314 -0.866 . . . . 28.07 110.466 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' R' R ' 69' ' ' ASP . . . . . 0.482 ' HB2' ' HA ' ' R' ' 66' ' ' PRO . 11.7 t0 -72.25 -33.34 67.43 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.387 -0.821 . . . . 43.759999999999998 110.088 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 70' ' ' TRP . . . . . 0.476 ' CE2' ' CG2' ' R' ' 71' ' ' VAL . 47.8 p-90 -73.32 -3.94 30.2 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.34 -0.85 . . . . 33.060000000000002 110.71 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 71' ' ' VAL . . . . . 0.556 HG11 ' HB2' ' R' ' 82' ' ' ALA . 40.8 t -109.81 -27.45 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.241 -0.912 . . . . 31.699999999999999 109.674 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 72' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -86.52 -48.86 8.01 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.407 -0.808 . . . . 33.579999999999998 110.32 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' R' R ' 73' ' ' SER . . . . . . . . . . . . . 70.1 m -89.69 50.99 1.99 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.336 -0.853 . . . . 50.82 110.344 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' R' R ' 74' ' ' SER . . . . . . . . . . . . . 15.8 t -125.88 138.28 31.73 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.362 -0.836 . . . . 34.740000000000002 110.257 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.29 -25.02 16.06 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 O-C-N 123.735 1.387 . . . . 35.700000000000003 110.341 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' R' R ' 76' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -91.59 153.25 19.87 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.398 -0.814 . . . . 66.480000000000004 110.368 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' R' R ' 77' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -81.62 95.29 7.14 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.374 -0.829 . . . . 46.719999999999999 110.046 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' R' R ' 78' ' ' LEU . . . . . . . . . . . . . 96.3 mt -96.46 27.95 3.56 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.467 -0.771 . . . . 37.549999999999997 110.216 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' R' R ' 79' ' ' THR . . . . . . . . . . . . . 29.7 m -56.18 -54.65 42.61 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.325 -0.86 . . . . 37.359999999999999 110.295 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' R' R ' 80' ' ' LEU . . . . . 0.603 ' HA ' HD12 ' R' ' 83' ' ' ILE . 15.9 mt -60.92 -23.16 65.04 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.256 -0.902 . . . . 35.829999999999998 110.513 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 81' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -79.54 -39.08 32.72 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.165 -0.959 . . . . 44.030000000000001 110.331 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' R' R ' 82' ' ' ALA . . . . . 0.556 ' HB2' HG11 ' R' ' 71' ' ' VAL . . . -69.47 -28.66 66.28 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.262 -0.899 . . . . 32.539999999999999 110.245 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 83' ' ' ILE . . . . . 0.603 HD12 ' HA ' ' R' ' 80' ' ' LEU . 78.1 mt -70.11 -46.1 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.307 -0.87 . . . . 32.020000000000003 110.302 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 84' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -55.19 -52.11 64.39 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.177 -0.952 . . . . 34.090000000000003 110.547 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' R' R ' 85' ' ' GLN . . . . . 0.532 ' HG2' HD12 ' R' ' 89' ' ' LEU . 31.9 tt0 -54.74 -46.93 74.35 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.272 -0.893 . . . . 25.940000000000001 110.235 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 86' ' ' LEU . . . . . . . . . . . . . 24.2 mt -58.67 -43.91 90.02 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.318 -0.864 . . . . 16.199999999999999 109.904 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' R' R ' 87' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -65.32 -35.13 80.06 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.471 -0.768 . . . . 49.090000000000003 110.346 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' R' R ' 88' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -78.45 -19.12 53.84 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.308 -0.87 . . . . 28.609999999999999 110.497 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' R' R ' 89' ' ' LEU . . . . . 0.532 HD12 ' HG2' ' R' ' 85' ' ' GLN . 32.8 mt -96.16 -29.45 14.05 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.207 -0.933 . . . . 26.16 110.239 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 90' ' ' THR . . . . . . . . . . . . . 59.6 p -105.64 -34.61 7.68 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.241 -0.912 . . . . 33.329999999999998 109.819 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' R' R ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.79 16.16 58.61 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.862 -1.295 . . . . 31.129999999999999 109.862 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' R' R ' 92' ' ' LEU . . . . . . . . . . . . . 97.0 mt -100.12 155.29 17.81 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.172 -1.193 . . . . 42.520000000000003 110.21 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' R' R ' 93' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -86.26 91.63 8.53 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.432 -0.793 . . . . 68.459999999999994 109.948 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' R' R ' 94' ' ' LEU . . . . . 0.459 ' HB3' ' CZ2' ' R' ' 52' ' ' TRP . 47.7 mt -99.47 53.03 0.94 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.162 -0.961 . . . . 44.630000000000003 110.355 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 95' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.47 -38.66 6.39 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.253 -0.904 . . . . 67.159999999999997 110.399 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 96' ' ' GLU . . . . . 0.416 ' O ' ' CE ' ' S' ' 399' ' ' LYS . 24.6 mt-10 -113.9 44.23 1.68 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -0.922 . . . . 67.019999999999996 110.291 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 97' ' ' GLY . . . . . 0.715 ' HA3' ' HB2' ' S' ' 399' ' ' LYS . . . 99.14 150.79 26.02 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.733 -1.347 . . . . 49.479999999999997 109.733 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 98' ' ' GLY . . . . . . . . . . . . . . . -166.26 160.05 33.49 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.227 -1.549 . . . . 36.57 109.227 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' R' R ' 99' ' ' PRO . . . . . 0.79 ' O ' HG23 ' R' ' 103' ' ' VAL . 45.8 Cg_endo -72.58 121.1 7.13 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.65 1.342 . . . . 30.41 110.435 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 100' ' ' PRO . . . . . 0.47 ' HD2' ' O ' ' S' ' 396' ' ' VAL . 45.8 Cg_endo -72.27 -31.59 11.53 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 O-C-N 123.649 1.342 . . . . 29.940000000000001 110.561 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 101' ' ' ALA . . . . . 0.706 ' HB3' HG21 ' S' ' 396' ' ' VAL . . . -70.01 -38.47 75.95 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.239 -0.913 . . . . 23.640000000000001 110.256 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 102' ' ' LEU . . . . . 0.424 HD23 HD21 ' R' ' 106' ' ' ASN . 0.1 OUTLIER -72.66 -40.74 66.09 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.284 -0.885 . . . . 20.309999999999999 110.358 -179.713 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' R' R ' 103' ' ' VAL . . . . . 0.79 HG23 ' O ' ' R' ' 99' ' ' PRO . 63.6 t -58.19 -40.09 76.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.227 -0.92 . . . . 16.329999999999998 109.996 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 104' ' ' ILE . . . . . 0.433 HD11 HG12 ' R' ' 56' ' ' ILE . 81.9 mt -71.72 -30.39 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.418 -0.801 . . . . 24.77 110.049 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 105' ' ' TRP . . . . . 0.461 ' O ' ' HD3' ' R' ' 108' ' ' LYS . 70.6 t-105 -82.49 0.89 40.35 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.34 -0.85 . . . . 23.280000000000001 110.254 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 106' ' ' ASN . . . . . 0.424 HD21 HD23 ' R' ' 102' ' ' LEU . 6.9 m-80 -105.16 -10.36 17.16 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.108 -0.995 . . . . 28.260000000000002 110.028 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 107' ' ' ILE . . . . . . . . . . . . . 36.8 pt -126.8 34.96 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.268 -0.895 . . . . 18.77 110.008 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' R' R ' 108' ' ' LYS . . . . . 0.5 ' HG2' ' HB ' ' R' ' 115' ' ' ILE . 9.2 mtpp -61.02 -48.5 81.5 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.589 -0.694 . . . . 42.5 110.037 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 109' ' ' HIS . . . . . 0.444 ' CD2' ' HG ' ' R' ' 110' ' ' LEU . 50.7 p-80 -66.02 -12.84 58.0 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.473 -0.767 . . . . 20.07 110.655 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 110' ' ' LEU . . . . . 0.444 ' HG ' ' CD2' ' R' ' 109' ' ' HIS . 80.7 mt -94.78 -17.35 22.22 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.121 -0.987 . . . . 15.69 110.171 179.385 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 111' ' ' LEU . . . . . 0.528 HD21 ' CE2' ' R' ' 60' ' ' PHE . 10.4 mt -94.06 144.14 25.74 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.342 -0.849 . . . . 25.390000000000001 111.05 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 112' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -77.7 -17.35 57.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.51 -0.744 . . . . 53.479999999999997 109.859 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' R' R ' 113' ' ' THR . . . . . 0.458 HG22 ' N ' ' R' ' 114' ' ' GLY . 59.7 m -83.69 166.66 17.9 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.308 -0.87 . . . . 14.800000000000001 110.299 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 114' ' ' GLY . . . . . 0.458 ' N ' HG22 ' R' ' 113' ' ' THR . . . -98.06 127.16 9.14 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.015 -1.234 . . . . 16.140000000000001 110.015 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 115' ' ' ILE . . . . . 0.578 HD13 ' HB ' ' R' ' 124' ' ' VAL . 47.8 mm -109.08 139.44 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.464 -1.021 . . . . 13.460000000000001 109.7 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 116' ' ' GLY . . . . . . . . . . . . . . . -152.74 -155.85 7.29 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.926 -1.27 . . . . 23.899999999999999 109.926 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' R' R ' 117' ' ' THR . . . . . 0.529 HG22 ' CG2' ' R' ' 126' ' ' VAL . 18.6 p -135.02 -171.39 2.79 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.413 -1.051 . . . . 27.370000000000001 110.044 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 118' ' ' ALA . . . . . 0.445 ' HB3' ' OD1' ' R' ' 128' ' ' ASP . . . -56.61 -57.96 10.11 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.251 -0.906 . . . . 18.760000000000002 110.107 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 119' ' ' SER . . . . . 0.799 ' HB3' ' HB ' ' R' ' 196' ' ' VAL . 1.2 m -56.58 -40.61 75.51 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.326 -0.859 . . . . 32.350000000000001 109.791 179.558 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 120' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 -110.04 86.2 4.81 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.442 -0.786 . . . . 27.120000000000001 109.682 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' R' R ' 121' ' ' PRO . . . . . 0.481 ' HA ' ' SG ' ' R' ' 125' ' ' CYS . 44.3 Cg_endo -71.23 166.5 29.06 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.813 1.428 . . . . 22.68 110.981 -179.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 122' ' ' SER . . . . . 0.438 ' HB2' ' O ' ' R' ' 121' ' ' PRO . 38.7 t 178.51 -161.69 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.481 -0.762 . . . . 22.989999999999998 109.492 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 123' ' ' GLU . . . . . 0.441 ' HG2' HG23 ' R' ' 113' ' ' THR . 2.3 tp10 -56.5 -39.97 74.18 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.19 -0.944 . . . . 36.18 109.649 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 124' ' ' VAL . . . . . 0.578 ' HB ' HD13 ' R' ' 115' ' ' ILE . 82.3 t -142.44 136.5 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.584 -0.698 . . . . 20.640000000000001 109.403 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 125' ' ' CYS . . . . . 0.481 ' SG ' ' HA ' ' R' ' 121' ' ' PRO . 83.4 m -140.35 168.21 20.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.219 -0.925 . . . . 22.800000000000001 111.163 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 126' ' ' VAL . . . . . 0.729 HG12 HG22 ' R' ' 179' ' ' VAL . 35.8 m -122.76 159.8 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.747 -0.596 . . . . 21.239999999999998 109.664 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 127' ' ' VAL . . . . . 0.709 HG11 ' O ' ' R' ' 177' ' ' VAL . 30.7 m -70.87 141.86 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.266 -0.896 . . . . 19.77 110.675 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 128' ' ' ASP . . . . . 0.445 ' OD1' ' HB3' ' R' ' 118' ' ' ALA . 53.9 p-10 -137.73 19.4 2.87 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.336 -0.853 . . . . 29.210000000000001 110.669 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 129' ' ' GLY . . . . . . . . . . . . . . . 114.03 0.01 24.1 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.893 -1.146 . . . . 33.859999999999999 110.461 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' R' R ' 130' ' ' THR . . . . . . . . . . . . . 58.1 m -91.77 131.91 36.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.207 -1.172 . . . . 26.41 110.099 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -62.62 120.69 11.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.356 -0.84 . . . . 33.079999999999998 110.274 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' R' R ' 132' ' ' MET . . . . . 0.433 ' HE1' ' CE2' ' R' ' 180' ' ' PHE . 98.4 mmm -105.18 165.58 11.0 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.468 -0.77 . . . . 30.760000000000002 110.409 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 133' ' ' CYS . . . . . 0.411 ' HA ' ' HB3' ' R' ' 174' ' ' PRO . 32.5 m -141.17 158.12 44.33 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.538 -0.726 . . . . 27.0 109.969 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 134' ' ' LEU . . . . . 0.564 HD11 ' O ' ' R' ' 172' ' ' PRO . 0.1 OUTLIER -58.5 -19.65 39.07 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.322 -0.861 . . . . 33.899999999999999 110.544 -179.871 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' R' R ' 135' ' ' ALA . . . . . . . . . . . . . . . -92.74 8.15 40.54 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.31 -0.868 . . . . 19.370000000000001 110.826 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' R' R ' 136' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -93.75 -21.74 19.13 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.174 -0.954 . . . . 30.469999999999999 110.245 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' R' R ' 137' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -149.98 165.35 32.95 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.407 -0.808 . . . . 24.27 110.215 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' R' R ' 138' ' ' HIS . . . . . 0.433 ' HA ' HG23 ' R' ' 154' ' ' VAL . 15.1 p80 -117.81 15.04 14.39 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.4 -0.813 . . . . 20.91 110.494 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 139' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' R' ' 152' ' ' ALA . . . -177.14 152.46 0.89 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.257 -0.902 . . . . 15.69 110.139 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 140' ' ' GLY . . . . . 0.427 ' HA3' ' O ' ' R' ' 179' ' ' VAL . . . 161.78 175.12 32.46 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.889 -1.285 . . . . 23.760000000000002 109.889 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 141' ' ' ILE . . . . . . . . . . . . . 83.8 mt -95.51 136.58 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.473 -1.016 . . . . 25.300000000000001 109.682 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' R' R ' 142' ' ' PHE . . . . . 0.576 ' CD2' ' HB2' ' R' ' 172' ' ' PRO . 82.9 m-85 -120.74 -172.66 2.43 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.287 -0.883 . . . . 30.239999999999998 110.547 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 143' ' ' LEU . . . . . 0.904 HD21 ' HG2' ' S' ' 398' ' ' ARG . 0.5 OUTLIER -119.79 77.75 1.26 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.499 -0.751 . . . . 32.799999999999997 110.292 -179.907 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' R' R ' 144' ' ' LYS . . . . . 0.469 ' HG3' ' CZ2' ' R' ' 170' ' ' TRP . 1.0 OUTLIER -69.54 76.88 0.41 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.448 -0.783 . . . . 49.18 109.653 179.562 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' R' R ' 145' ' ' GLY . . . . . 0.456 ' O ' HD22 ' R' ' 143' ' ' LEU . . . 104.51 179.25 24.82 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.157 -1.577 . . . . 53.869999999999997 109.157 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 146' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -88.52 145.8 25.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.363 -1.081 . . . . 68.579999999999998 109.995 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' R' R ' 147' ' ' GLU . . . . . 0.708 ' N ' ' HG3' ' S' ' 398' ' ' ARG . 10.9 mt-10 58.31 36.51 25.64 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.346 -0.846 . . . . 56.619999999999997 110.607 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 148' ' ' HIS . . . . . 0.96 ' CE1' HD13 ' S' ' 400' ' ' LEU . 44.8 t60 -158.69 148.13 19.16 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.183 -0.948 . . . . 44.57 110.419 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 149' ' ' ALA . . . . . . . . . . . . . . . -150.29 146.83 27.01 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.445 -0.784 . . . . 33.539999999999999 110.057 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' R' R ' 150' ' ' VAL . . . . . . . . . . . . . 34.2 m -142.3 161.55 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.261 -0.9 . . . . 27.609999999999999 110.36 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' R' R ' 151' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' R' ' 152' ' ' ALA . 5.8 t80 -86.22 155.54 20.66 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.392 -0.818 . . . . 23.039999999999999 109.873 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 152' ' ' ALA . . . . . 0.537 ' N ' ' CD1' ' R' ' 151' ' ' PHE . . . -157.26 151.54 24.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.421 -0.799 . . . . 29.609999999999999 109.575 179.02 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 153' ' ' CYS . . . . . . . . . . . . . 26.7 p -154.27 173.61 15.91 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.34 -0.85 . . . . 22.75 110.542 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' R' R ' 154' ' ' VAL . . . . . 0.613 HG22 ' CE2' ' R' ' 159' ' ' TRP . 59.7 t -90.6 117.1 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.453 -0.78 . . . . 23.260000000000002 110.052 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 155' ' ' THR . . . . . . . . . . . . . 69.3 p -112.17 -176.62 2.97 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.359 -0.838 . . . . 17.879999999999999 110.041 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' R' R ' 156' ' ' SER . . . . . . . . . . . . . 78.5 p -75.96 -3.76 37.35 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.32 -0.863 . . . . 21.829999999999998 110.633 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' R' R ' 157' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -118.22 10.46 12.88 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.06 -1.025 . . . . 36.539999999999999 110.612 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' R' R ' 158' ' ' GLY . . . . . . . . . . . . . . . 117.97 -162.63 13.05 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.527 -1.429 . . . . 31.739999999999998 109.527 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' R' R ' 159' ' ' TRP . . . . . 0.613 ' CE2' HG22 ' R' ' 154' ' ' VAL . 14.7 m95 -86.6 122.57 30.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.354 -1.086 . . . . 28.25 110.035 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 160' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -108.48 166.96 10.38 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.42 -0.8 . . . . 41.240000000000002 110.201 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' R' R ' 161' ' ' ALA . . . . . . . . . . . . . . . -143.23 123.47 13.77 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.461 -0.775 . . . . 27.399999999999999 110.163 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' R' R ' 162' ' ' ILE . . . . . . . . . . . . . 92.0 mt -87.59 81.12 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.317 -0.864 . . . . 24.27 110.051 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' R' R ' 163' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' R' ' 165' ' ' GLU . 15.4 t0 -72.74 92.39 1.56 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.422 -0.799 . . . . 36.079999999999998 110.254 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 164' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 54.13 -89.0 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.515 -0.741 . . . . 46.079999999999998 110.574 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' R' R ' 165' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' R' ' 163' ' ' ASP . 29.7 mt-10 -124.76 36.02 4.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.088 -1.007 . . . . 50.939999999999998 110.192 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 166' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -135.81 117.29 14.77 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.416 -0.803 . . . . 47.280000000000001 110.266 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' R' R ' 167' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -101.04 120.02 39.59 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.387 -0.821 . . . . 40.469999999999999 110.155 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' R' R ' 168' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -157.52 158.53 30.68 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.273 -0.892 . . . . 30.210000000000001 110.433 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' R' R ' 169' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.77 132.98 19.42 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 O-C-N 123.863 1.454 . . . . 32.759999999999998 110.471 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' R' R ' 170' ' ' TRP . . . . . 0.469 ' CZ2' ' HG3' ' R' ' 144' ' ' LYS . 67.1 t90 -159.78 119.43 2.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.398 -0.814 . . . . 32.789999999999999 109.946 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 171' ' ' THR . . . . . . . . . . . . . 45.9 m -81.13 112.57 33.91 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.405 -0.809 . . . . 36.920000000000002 110.188 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' R' R ' 172' ' ' PRO . . . . . 0.576 ' HB2' ' CD2' ' R' ' 142' ' ' PHE . 47.2 Cg_endo -73.76 158.78 46.46 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 O-C-N 123.796 1.419 . . . . 33.539999999999999 110.551 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 173' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -88.84 144.96 33.83 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.361 -0.837 . . . . 45.759999999999998 109.951 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' R' R ' 174' ' ' PRO . . . . . 0.411 ' HB3' ' HA ' ' R' ' 133' ' ' CYS . 45.9 Cg_endo -71.74 -10.33 26.3 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 O-C-N 123.621 1.327 . . . . 29.629999999999999 110.497 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 175' ' ' SER . . . . . . . . . . . . . 53.0 p -103.53 -17.47 15.18 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.317 -0.864 . . . . 35.700000000000003 110.306 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' R' R ' 176' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -103.6 43.23 1.1 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.286 -0.884 . . . . 39.649999999999999 110.32 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' R' R ' 177' ' ' VAL . . . . . 0.709 ' O ' HG11 ' R' ' 127' ' ' VAL . 10.6 p -117.74 127.12 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.397 -0.815 . . . . 20.609999999999999 110.095 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 178' ' ' LEU . . . . . 0.53 HD21 ' HG3' ' S' ' 395' ' ' LYS . 46.2 mt -91.47 -61.25 1.69 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.305 -0.872 . . . . 15.58 109.389 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 179' ' ' VAL . . . . . 0.729 HG22 HG12 ' R' ' 126' ' ' VAL . 67.9 t -114.67 144.66 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.643 -0.661 . . . . 17.399999999999999 109.441 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 180' ' ' PHE . . . . . 0.433 ' CE2' ' HE1' ' R' ' 132' ' ' MET . 43.6 p90 -152.17 163.43 39.4 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.239 -0.913 . . . . 20.16 110.519 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 181' ' ' VAL . . . . . . . . . . . . . 66.6 t -113.19 111.47 50.22 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.342 -0.849 . . . . 17.690000000000001 109.756 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' R' R ' 182' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.05 149.56 52.83 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 O-C-N 123.507 1.267 . . . . 17.809999999999999 110.374 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' R' R ' 183' ' ' TYR . . . . . 0.698 ' O ' ' C ' ' R' ' 184' ' ' ASP . 79.5 m-85 -59.05 175.47 0.29 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.4 -0.813 . . . . 28.010000000000002 110.526 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 184' ' ' ASP . . . . . 0.698 ' C ' ' O ' ' R' ' 183' ' ' TYR . 1.1 m-20 -19.01 -82.88 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.425 -0.797 . . . . 58.640000000000001 110.319 -178.344 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 185' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 . . . . . 0 N--CA 1.502 2.16 0 CA-C-O 121.273 0.559 . . . . 80.420000000000002 111.777 179.479 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' R' R ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 120.948 0.404 . . . . 49.5 110.14 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' R' R ' 194' ' ' ALA . . . . . 0.424 ' CB ' ' HA ' ' R' ' 119' ' ' SER . . . -172.22 -155.39 0.09 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.123 -0.986 . . . . 40.399999999999999 110.059 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 195' ' ' LYS . . . . . . . . . . . . . 18.6 mtmt -100.32 -47.52 4.9 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.45 -0.781 . . . . 34.600000000000001 110.25 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' R' R ' 196' ' ' VAL . . . . . 0.799 ' HB ' ' HB3' ' R' ' 119' ' ' SER . 32.9 t -71.27 -39.09 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.194 -0.941 . . . . 33.270000000000003 110.622 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 197' ' ' GLN . . . . . 0.45 ' O ' ' O ' ' R' ' 196' ' ' VAL . 3.7 tt0 -59.94 -134.34 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.149 -0.969 . . . . 41.579999999999998 110.719 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 198' ' ' ARG . . . . . 0.416 ' CB ' ' O ' ' R' ' 197' ' ' GLN . 8.8 ttt180 64.09 173.12 0.18 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.109 -0.994 . . . . 38.649999999999999 110.216 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 199' ' ' LYS . . . . . 0.645 ' O ' ' HD3' ' S' ' 299' ' ' PRO . 0.4 OUTLIER -110.75 -17.19 13.42 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.36 -0.838 . . . . 36.770000000000003 109.936 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' R' R ' 200' ' ' LEU . . . . . 0.464 HD13 ' HA ' ' R' ' 200' ' ' LEU . 1.4 mm? 46.41 -163.46 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.32 -0.862 . . . . 33.079999999999998 110.127 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' R' R ' 201' ' ' LYS . . . . . 0.681 ' HA ' ' HA3' ' S' ' 297' ' ' GLY . 16.4 tttm . . . . . 0 N--CA 1.493 1.698 0 O-C-N 121.384 -0.822 . . . . 44.32 110.297 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' S' S ' 229' ' ' MET . . . . . 0.407 ' HG3' ' N ' ' S' ' 230' ' ' GLU . 24.8 ptp . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.229 0.538 . . . . 51.829999999999998 110.219 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' S' S ' 230' ' ' GLU . . . . . 0.407 ' N ' ' HG3' ' S' ' 229' ' ' MET . 33.1 tt0 -97.24 142.78 28.72 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.336 -0.852 . . . . 54.130000000000003 110.208 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 231' ' ' LEU . . . . . . . . . . . . . 68.0 mt -134.14 141.04 46.96 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.247 -0.908 . . . . 33.039999999999999 110.355 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' S' S ' 232' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' S' ' 355' ' ' THR . 40.0 m -89.22 103.18 15.83 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.414 -0.804 . . . . 26.920000000000002 110.037 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 233' ' ' LEU . . . . . 0.673 HD22 ' CE2' ' S' ' 262' ' ' TYR . 79.7 mt -55.91 179.26 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.467 -0.771 . . . . 13.779999999999999 110.457 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 234' ' ' TYR . . . . . 0.448 ' CG ' ' N ' ' S' ' 235' ' ' ASN . 35.7 p90 -65.02 -35.65 81.85 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.347 -0.845 . . . . 26.079999999999998 110.169 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 235' ' ' ASN . . . . . 0.448 ' N ' ' CG ' ' S' ' 234' ' ' TYR . 50.7 p30 -74.31 -7.46 52.87 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.292 -0.88 . . . . 20.039999999999999 110.524 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 236' ' ' GLY . . . . . . . . . . . . . . . 95.8 -20.03 51.7 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.76 -1.336 . . . . 22.710000000000001 109.76 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' S' S ' 237' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -52.9 145.72 12.13 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.234 -1.157 . . . . 35.439999999999998 110.226 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' S' S ' 238' ' ' LYS . . . . . . . . . . . . . 44.4 mttt -102.2 127.87 48.96 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.389 -0.82 . . . . 32.560000000000002 110.416 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' S' S ' 239' ' ' LYS . . . . . 0.405 ' HG2' ' CZ ' ' S' ' 241' ' ' PHE . 9.1 ttmt -132.25 144.49 50.65 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.377 -0.827 . . . . 26.68 110.036 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 240' ' ' THR . . . . . . . . . . . . . 51.5 m -102.01 132.16 48.01 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.328 -0.858 . . . . 41.020000000000003 110.41 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' S' S ' 241' ' ' PHE . . . . . 0.405 ' CZ ' ' HG2' ' S' ' 239' ' ' LYS . 96.0 m-85 -117.87 137.66 52.64 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.419 -0.801 . . . . 28.620000000000001 110.184 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 242' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -96.39 161.74 13.8 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.371 -0.831 . . . . 47.890000000000001 110.25 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' S' S ' 243' ' ' SER . . . . . . . . . . . . . 71.6 m -90.47 151.49 21.36 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.245 -0.909 . . . . 45.090000000000003 110.298 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' S' S ' 244' ' ' ARG . . . . . . . . . . . . . 1.4 mtp85 -129.76 126.78 22.73 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.371 -0.83 . . . . 42.490000000000002 110.266 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' S' S ' 245' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.37 161.05 43.56 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.652 1.343 . . . . 35.68 110.542 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' S' S ' 246' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -132.86 97.88 4.15 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.443 -0.786 . . . . 51.880000000000003 109.866 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' S' S ' 247' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -110.52 -22.23 11.75 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.395 -0.815 . . . . 53.689999999999998 110.664 -179.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' S' S ' 248' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -117.28 43.77 2.25 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.108 -0.995 . . . . 55.789999999999999 110.804 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' S' S ' 249' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 48.68 38.49 11.63 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.4 -0.813 . . . . 49.450000000000003 110.339 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' S' S ' 250' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -90.65 28.99 1.38 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.521 -0.737 . . . . 36.859999999999999 110.309 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' S' S ' 251' ' ' ALA . . . . . . . . . . . . . . . -53.79 -43.16 69.07 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.271 -0.893 . . . . 29.690000000000001 109.619 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' S' S ' 252' ' ' TRP . . . . . 0.427 ' CZ2' ' HB3' ' S' ' 294' ' ' LEU . 67.8 p-90 -61.81 -33.94 75.04 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.537 -0.727 . . . . 41.119999999999997 109.83 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 253' ' ' LEU . . . . . 0.4 ' N ' ' CD2' ' S' ' 252' ' ' TRP . 23.2 tp -70.16 -47.25 62.43 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.37 -0.831 . . . . 24.890000000000001 109.953 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 254' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -56.1 -42.44 76.8 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.417 -0.802 . . . . 35.649999999999999 109.96 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' S' S ' 255' ' ' ALA . . . . . . . . . . . . . . . -59.63 -48.18 82.69 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.399 -0.813 . . . . 22.73 110.081 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' S' S ' 256' ' ' ILE . . . . . 0.503 HG12 HD11 ' S' ' 304' ' ' ILE . 79.7 mt -62.25 -40.7 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.304 -0.873 . . . . 28.850000000000001 109.979 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 257' ' ' LEU . . . . . 0.404 ' CD2' ' HB3' ' S' ' 268' ' ' PHE . 19.1 mt -61.48 -44.5 96.98 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.257 -0.902 . . . . 23.07 110.154 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 258' ' ' GLN . . . . . 0.502 ' HB3' ' CD2' ' S' ' 351' ' ' PHE . 53.5 mm-40 -65.14 -45.33 85.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.39 -0.818 . . . . 29.780000000000001 109.919 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 259' ' ' LEU . . . . . 0.42 ' O ' HG22 ' S' ' 263' ' ' VAL . 19.7 tp -58.66 -36.35 74.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.337 -0.852 . . . . 17.940000000000001 109.474 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 260' ' ' PHE . . . . . 0.528 ' CE2' HD21 ' S' ' 311' ' ' LEU . 3.1 m-85 -62.9 -45.24 93.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.622 -0.674 . . . . 30.57 109.82 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 261' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -62.08 -29.81 70.56 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.386 -0.821 . . . . 41.340000000000003 109.987 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' S' S ' 262' ' ' TYR . . . . . 0.673 ' CE2' HD22 ' S' ' 233' ' ' LEU . 8.6 t80 -71.16 -44.67 65.05 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.367 -0.833 . . . . 26.030000000000001 110.1 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 263' ' ' VAL . . . . . 0.42 HG22 ' O ' ' S' ' 259' ' ' LEU . 33.1 m -92.02 18.15 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.374 -0.829 . . . . 22.800000000000001 110.334 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 264' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 52.85 70.69 0.55 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.206 -0.934 . . . . 44.030000000000001 110.589 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' S' S ' 265' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -111.86 109.19 55.3 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.397 -0.814 . . . . 35.609999999999999 109.602 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' S' S ' 266' ' ' PRO . . . . . 0.481 ' HA ' ' HB2' ' S' ' 269' ' ' ASP . 49.7 Cg_endo -75.34 0.44 9.04 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.657 1.346 . . . . 37.670000000000002 111.8 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 267' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -56.46 -67.73 0.28 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.781 -1.2 . . . . 41.490000000000002 110.192 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 268' ' ' PHE . . . . . 0.404 ' HB3' ' CD2' ' S' ' 257' ' ' LEU . 22.3 m-85 -92.94 39.95 1.05 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.15 -0.968 . . . . 50.759999999999998 110.063 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 269' ' ' ASP . . . . . 0.481 ' HB2' ' HA ' ' S' ' 266' ' ' PRO . 0.9 OUTLIER -76.04 -33.22 59.6 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.348 -0.845 . . . . 61.859999999999999 109.775 179.519 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' S' S ' 270' ' ' TRP . . . . . 0.511 ' CE2' HG23 ' S' ' 271' ' ' VAL . 50.9 p-90 -73.91 -4.31 34.28 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.33 -0.856 . . . . 39.850000000000001 110.493 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 271' ' ' VAL . . . . . 0.511 HG23 ' CE2' ' S' ' 270' ' ' TRP . 46.6 t -109.59 -32.66 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.187 -0.946 . . . . 39.18 110.058 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 272' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -78.68 -36.52 43.51 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.327 -0.858 . . . . 40.020000000000003 110.519 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' S' S ' 273' ' ' SER . . . . . . . . . . . . . 71.1 m -103.55 56.16 0.74 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.347 -0.846 . . . . 47.200000000000003 110.291 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' S' S ' 274' ' ' SER . . . . . . . . . . . . . 6.8 t -133.09 141.24 40.13 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.382 -0.824 . . . . 47.609999999999999 110.153 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' S' S ' 275' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.76 -18.82 21.75 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 123.639 1.337 . . . . 45.280000000000001 110.544 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' S' S ' 276' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -99.9 140.88 33.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.221 -0.924 . . . . 57.270000000000003 110.327 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' S' S ' 277' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -71.79 97.63 1.83 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.428 -0.795 . . . . 37.280000000000001 110.234 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' S' S ' 278' ' ' LEU . . . . . . . . . . . . . 86.0 mt -96.96 33.85 1.83 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.388 -0.82 . . . . 43.880000000000003 110.087 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' S' S ' 279' ' ' THR . . . . . . . . . . . . . 77.8 m -64.09 -60.19 3.54 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.471 -0.768 . . . . 50.049999999999997 110.194 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' S' S ' 280' ' ' LEU . . . . . 0.729 ' HA ' HD12 ' S' ' 283' ' ' ILE . 13.7 mt -51.51 -39.91 58.57 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.247 -0.908 . . . . 54.119999999999997 110.304 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 281' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.39 -49.69 74.52 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.444 -0.785 . . . . 65.280000000000001 110.132 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 282' ' ' ALA . . . . . . . . . . . . . . . -59.02 -33.89 71.27 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.478 -0.764 . . . . 46.509999999999998 110.488 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' S' S ' 283' ' ' ILE . . . . . 0.729 HD12 ' HA ' ' S' ' 280' ' ' LEU . 85.7 mt -66.34 -50.87 64.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.305 -0.872 . . . . 47.299999999999997 110.072 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 284' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -50.61 -57.56 7.92 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.416 -0.803 . . . . 50.719999999999999 110.359 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' S' S ' 285' ' ' GLN . . . . . 0.529 ' HG2' HD12 ' S' ' 289' ' ' LEU . 34.3 tt0 -51.42 -46.35 62.89 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.523 -0.736 . . . . 68.469999999999999 110.34 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 286' ' ' LEU . . . . . . . . . . . . . 19.1 mt -59.97 -44.47 94.44 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.464 -0.773 . . . . 36.619999999999997 110.309 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' S' S ' 287' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -62.83 -35.25 79.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.279 -0.888 . . . . 46.640000000000001 110.009 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' S' S ' 288' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -76.26 -20.99 56.85 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.42 -0.8 . . . . 46.450000000000003 110.328 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' S' S ' 289' ' ' LEU . . . . . 0.529 HD12 ' HG2' ' S' ' 285' ' ' GLN . 30.7 mt -97.33 -21.73 17.05 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.342 -0.849 . . . . 35.090000000000003 110.52 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 290' ' ' THR . . . . . 0.409 HG22 ' HB3' ' S' ' 306' ' ' ASN . 81.3 p -114.78 -28.5 7.07 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.214 -0.929 . . . . 38.609999999999999 110.373 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 291' ' ' GLY . . . . . . . . . . . . . . . 79.38 11.05 85.34 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.886 -1.286 . . . . 36.770000000000003 109.886 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' S' S ' 292' ' ' LEU . . . . . . . . . . . . . 84.5 mt -96.45 145.77 25.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.222 -1.164 . . . . 35.329999999999998 109.768 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' S' S ' 293' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -77.36 102.37 6.76 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.25 -0.906 . . . . 48.700000000000003 110.272 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' S' S ' 294' ' ' LEU . . . . . 0.427 ' HB3' ' CZ2' ' S' ' 252' ' ' TRP . 55.3 mt -106.86 51.72 0.74 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.55 -0.719 . . . . 42.609999999999999 110.11 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 295' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -112.57 -11.09 13.63 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.325 -0.859 . . . . 55.490000000000002 110.573 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 296' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -144.38 48.53 1.36 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.163 -0.96 . . . . 75.680000000000007 110.292 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' S' S ' 297' ' ' GLY . . . . . 0.681 ' HA3' ' HA ' ' R' ' 201' ' ' LYS . . . 96.84 145.21 18.76 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.509 -1.437 . . . . 49.439999999999998 109.509 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 298' ' ' GLY . . . . . . . . . . . . . . . -163.83 156.93 29.01 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.805 -1.318 . . . . 41.109999999999999 109.805 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' S' S ' 299' ' ' PRO . . . . . 0.645 ' HD3' ' O ' ' R' ' 199' ' ' LYS . 47.4 Cg_endo -73.77 118.25 5.37 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 123.955 1.502 . . . . 26.199999999999999 110.293 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 300' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.24 -15.42 31.68 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 O-C-N 123.577 1.304 . . . . 21.699999999999999 110.734 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' S' S ' 301' ' ' ALA . . . . . . . . . . . . . . . -80.71 -29.34 36.45 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.276 -0.89 . . . . 31.23 110.14 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' S' S ' 302' ' ' LEU . . . . . 0.47 ' CD1' ' O ' ' R' ' 196' ' ' VAL . 0.0 OUTLIER -83.57 -40.57 18.93 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.405 -0.809 . . . . 38.990000000000002 109.926 179.845 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' S' S ' 303' ' ' VAL . . . . . 0.484 HG23 ' O ' ' S' ' 299' ' ' PRO . 58.1 t -60.73 -35.47 64.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.375 -0.828 . . . . 18.629999999999999 110.143 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 304' ' ' ILE . . . . . 0.523 HD12 HG21 ' S' ' 379' ' ' VAL . 86.2 mt -79.45 -23.55 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.463 -0.773 . . . . 25.460000000000001 110.193 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 305' ' ' TRP . . . . . 0.411 ' CD2' ' HD3' ' S' ' 308' ' ' LYS . 68.7 t-105 -88.63 -14.6 37.1 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.253 -0.904 . . . . 33.399999999999999 110.601 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 306' ' ' ASN . . . . . 0.409 ' HB3' HG22 ' S' ' 290' ' ' THR . 10.4 m-80 -89.69 -13.57 36.64 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.227 -0.92 . . . . 36.969999999999999 110.435 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 307' ' ' ILE . . . . . 0.471 HG12 ' O ' ' S' ' 303' ' ' VAL . 36.8 pt -125.09 45.66 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.218 -0.926 . . . . 30.809999999999999 110.066 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 308' ' ' LYS . . . . . 0.411 ' HD3' ' CD2' ' S' ' 305' ' ' TRP . 1.5 mtmp? -73.52 -37.77 65.52 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.355 -0.841 . . . . 46.520000000000003 110.084 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 309' ' ' HIS . . . . . 0.493 ' CD2' ' HG ' ' S' ' 310' ' ' LEU . 55.5 p-80 -73.1 -8.34 55.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.303 -0.873 . . . . 51.030000000000001 110.129 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 310' ' ' LEU . . . . . 0.493 ' HG ' ' CD2' ' S' ' 309' ' ' HIS . 52.6 mt -99.27 -12.94 19.92 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.295 -0.878 . . . . 36.159999999999997 109.971 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 311' ' ' LEU . . . . . 0.528 HD21 ' CE2' ' S' ' 260' ' ' PHE . 10.8 mt -97.11 147.81 23.67 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.314 -0.866 . . . . 40.0 110.452 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 312' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -81.54 -16.33 52.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.345 -0.847 . . . . 54.18 109.763 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' S' S ' 313' ' ' THR . . . . . 0.823 HG23 ' HG2' ' S' ' 323' ' ' GLU . 92.5 m -87.88 151.53 22.76 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.375 -0.828 . . . . 25.609999999999999 110.159 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 314' ' ' GLY . . . . . . . . . . . . . . . -87.83 126.38 8.02 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.836 -1.306 . . . . 25.18 109.836 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' S' S ' 315' ' ' ILE . . . . . 0.671 HD13 ' HB ' ' S' ' 324' ' ' VAL . 50.7 mm -101.64 150.53 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.35 -1.088 . . . . 23.899999999999999 109.71 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 316' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' S' ' 325' ' ' CYS . . . -157.12 -159.32 9.42 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.923 -1.271 . . . . 23.18 109.923 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 317' ' ' THR . . . . . 0.425 HG22 ' CG2' ' S' ' 326' ' ' VAL . 11.2 p -133.88 -173.06 3.14 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.417 -1.049 . . . . 27.98 110.013 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.55 -56.23 24.63 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.199 -0.938 . . . . 28.100000000000001 109.892 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' S' S ' 319' ' ' SER . . . . . . . . . . . . . 1.2 m -59.9 -41.67 92.17 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.405 -0.809 . . . . 37.0 109.632 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' S' S ' 320' ' ' ARG . . . . . . . . . . . . . 12.2 mtm180 -111.69 79.85 2.62 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.471 -0.768 . . . . 52.07 109.679 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' S' S ' 321' ' ' PRO . . . . . 0.921 ' HG2' ' O ' ' S' ' 386' ' ' GLU . 44.1 Cg_endo -71.43 171.46 16.14 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.79 1.416 . . . . 38.289999999999999 110.903 -179.393 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 322' ' ' SER . . . . . 0.445 ' HB2' ' O ' ' S' ' 321' ' ' PRO . 41.3 t 178.7 -148.08 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.928 -0.767 . . . . 38.840000000000003 108.928 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 323' ' ' GLU . . . . . 0.823 ' HG2' HG23 ' S' ' 313' ' ' THR . 6.7 tp10 -62.87 -40.34 97.2 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.944 -1.098 . . . . 40.700000000000003 109.664 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 324' ' ' VAL . . . . . 0.671 ' HB ' HD13 ' S' ' 315' ' ' ILE . 72.7 t -141.24 135.02 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.433 -0.792 . . . . 20.34 109.463 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 325' ' ' CYS . . . . . 0.46 ' HB2' ' CE1' ' S' ' 380' ' ' PHE . 11.1 m -126.02 172.24 10.13 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.246 -0.909 . . . . 30.629999999999999 110.867 -179.144 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 326' ' ' VAL . . . . . 0.643 HG12 HG22 ' S' ' 379' ' ' VAL . 34.5 m -135.51 142.16 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.651 -0.656 . . . . 23.899999999999999 109.248 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 327' ' ' VAL . . . . . 0.595 HG11 ' O ' ' S' ' 377' ' ' VAL . 34.6 m -56.32 125.04 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.015 -1.053 . . . . 19.48 110.388 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 328' ' ' ASP . . . . . . . . . . . . . 55.5 p-10 -119.41 11.46 12.18 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.496 -0.753 . . . . 26.43 110.427 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' S' S ' 329' ' ' GLY . . . . . . . . . . . . . . . 119.75 2.2 12.99 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.973 -1.251 . . . . 31.239999999999998 109.973 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' S' S ' 330' ' ' THR . . . . . . . . . . . . . 78.8 m -92.94 130.02 38.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.093 -1.239 . . . . 30.050000000000001 110.136 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' S' S ' 331' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -56.85 111.48 1.04 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.207 -0.933 . . . . 37.259999999999998 109.927 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' S' S ' 332' ' ' MET . . . . . . . . . . . . . 88.1 mmm -93.99 162.54 13.85 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.275 -0.89 . . . . 26.23 110.42 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' S' S ' 333' ' ' CYS . . . . . . . . . . . . . 25.7 m -137.25 150.0 47.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.398 -0.814 . . . . 23.559999999999999 110.072 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' S' S ' 334' ' ' LEU . . . . . 0.562 HD11 ' O ' ' S' ' 372' ' ' PRO . 0.1 OUTLIER -52.51 -24.93 8.96 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.282 -0.886 . . . . 28.93 110.438 179.921 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' S' S ' 335' ' ' ALA . . . . . . . . . . . . . . . -89.02 14.43 10.66 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.358 -0.839 . . . . 15.76 110.975 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' S' S ' 336' ' ' ASP . . . . . 0.403 ' O ' ' HA ' ' S' ' 382' ' ' PRO . 70.8 m-20 -100.49 -17.21 17.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.092 -1.005 . . . . 34.920000000000002 110.185 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 337' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -152.47 170.84 19.15 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.363 -0.836 . . . . 19.030000000000001 110.084 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' S' S ' 338' ' ' HIS . . . . . . . . . . . . . 13.3 p80 -120.68 10.44 11.01 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.367 -0.833 . . . . 18.82 110.441 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' S' S ' 339' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' S' ' 352' ' ' ALA . . . -175.99 155.18 1.56 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.205 -0.934 . . . . 17.18 110.091 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 340' ' ' GLY . . . . . 0.401 ' CA ' ' O ' ' S' ' 379' ' ' VAL . . . 160.82 173.09 28.99 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 110.088 -1.205 . . . . 18.329999999999998 110.088 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 341' ' ' ILE . . . . . . . . . . . . . 84.2 mt -88.76 138.05 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.434 -1.039 . . . . 18.600000000000001 109.78 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' S' S ' 342' ' ' PHE . . . . . 0.493 ' CE2' ' HB3' ' S' ' 352' ' ' ALA . 70.0 m-85 -120.99 -178.47 3.75 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.187 -0.945 . . . . 23.440000000000001 110.401 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 343' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.81 93.46 4.21 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.431 -0.793 . . . . 35.590000000000003 110.053 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 344' ' ' LYS . . . . . 0.405 ' O ' ' HB3' ' S' ' 348' ' ' HIS . 0.3 OUTLIER -80.89 125.05 29.63 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.268 -0.895 . . . . 38.340000000000003 110.049 -179.884 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' S' S ' 345' ' ' GLY . . . . . . . . . . . . . . . 62.75 -130.73 43.08 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 108.857 -1.697 . . . . 53.460000000000001 108.857 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' S' S ' 346' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -132.76 150.87 52.11 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.252 -1.146 . . . . 70.909999999999997 109.976 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' S' S ' 347' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 53.33 35.38 20.13 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.355 -0.841 . . . . 47.32 110.357 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' S' S ' 348' ' ' HIS . . . . . 0.405 ' HB3' ' O ' ' S' ' 344' ' ' LYS . 46.4 t60 -150.19 155.89 40.59 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.208 -0.932 . . . . 41.719999999999999 110.333 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 349' ' ' ALA . . . . . 0.459 ' C ' HG13 ' S' ' 350' ' ' VAL . . . -149.76 151.23 33.26 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.243 -0.911 . . . . 22.91 110.458 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 350' ' ' VAL . . . . . 0.459 HG13 ' C ' ' S' ' 349' ' ' ALA . 34.6 m -149.06 169.58 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.384 -0.822 . . . . 21.09 110.057 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 351' ' ' PHE . . . . . 0.502 ' CD2' ' HB3' ' S' ' 258' ' ' GLN . 10.8 t80 -105.31 143.58 33.29 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.279 -0.888 . . . . 25.030000000000001 110.748 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 352' ' ' ALA . . . . . 0.493 ' HB3' ' CE2' ' S' ' 342' ' ' PHE . . . -147.74 151.66 36.45 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.566 -0.709 . . . . 23.809999999999999 109.777 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 353' ' ' CYS . . . . . . . . . . . . . 26.3 p -153.25 164.88 37.31 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.348 -0.845 . . . . 25.66 110.274 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' S' S ' 354' ' ' VAL . . . . . 0.549 HG22 ' CE2' ' S' ' 359' ' ' TRP . 57.6 t -76.07 118.44 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.387 -0.82 . . . . 34.270000000000003 109.972 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 355' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' S' ' 232' ' ' THR . 52.3 p -117.81 175.12 5.8 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.236 -0.915 . . . . 25.489999999999998 110.364 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 356' ' ' SER . . . . . . . . . . . . . 62.5 p -62.19 -17.65 58.74 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.462 -0.774 . . . . 31.239999999999998 110.704 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' S' S ' 357' ' ' ASN . . . . . . . . . . . . . 46.3 m-20 -107.0 14.16 26.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.15 -0.969 . . . . 28.609999999999999 110.608 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' S' S ' 358' ' ' GLY . . . . . . . . . . . . . . . 111.83 -152.88 17.59 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.031 -1.227 . . . . 22.010000000000002 110.031 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' S' S ' 359' ' ' TRP . . . . . 0.549 ' CE2' HG22 ' S' ' 354' ' ' VAL . 15.5 m95 -91.32 116.69 29.04 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.396 -1.061 . . . . 25.539999999999999 110.148 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 360' ' ' TYR . . . . . 0.412 ' HA ' ' HA ' ' S' ' 369' ' ' PRO . 1.3 m-85 -103.48 165.8 10.82 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.341 -0.849 . . . . 40.530000000000001 110.069 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 361' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' S' ' 351' ' ' PHE . . . -140.09 130.07 24.81 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.393 -0.817 . . . . 18.039999999999999 110.296 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 362' ' ' ILE . . . . . . . . . . . . . 89.1 mt -95.58 83.8 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.4 -0.813 . . . . 15.640000000000001 109.998 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' S' S ' 363' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' S' ' 365' ' ' GLU . 11.9 t0 -75.27 94.51 3.02 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.337 -0.852 . . . . 35.030000000000001 110.202 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 364' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 53.86 -89.34 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.545 -0.722 . . . . 46.719999999999999 110.575 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' S' S ' 365' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' S' ' 363' ' ' ASP . 23.8 mt-10 -122.67 19.1 10.34 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.082 -1.011 . . . . 56.200000000000003 110.271 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 366' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -117.95 125.05 49.68 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.26 -0.9 . . . . 51.020000000000003 110.406 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' S' S ' 367' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -107.03 127.0 53.07 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.357 -0.84 . . . . 37.590000000000003 110.112 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' S' S ' 368' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -165.39 159.56 13.98 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.303 -0.873 . . . . 31.469999999999999 110.452 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' S' S ' 369' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' S' ' 360' ' ' TYR . 45.7 Cg_endo -72.89 139.63 30.59 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 O-C-N 123.831 1.437 . . . . 28.850000000000001 110.509 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 370' ' ' TRP . . . . . . . . . . . . . 67.4 t90 -167.22 113.53 0.76 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.402 -0.812 . . . . 26.940000000000001 109.987 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' S' S ' 371' ' ' THR . . . . . . . . . . . . . 59.1 m -74.8 113.04 20.62 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.406 -0.808 . . . . 20.190000000000001 110.049 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' S' S ' 372' ' ' PRO . . . . . 0.562 ' O ' HD11 ' S' ' 334' ' ' LEU . 48.0 Cg_endo -73.46 157.16 49.55 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 O-C-N 123.662 1.348 . . . . 28.68 110.625 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 373' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -90.67 147.19 35.69 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.391 -0.818 . . . . 35.719999999999999 109.832 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' S' S ' 374' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -76.02 -6.28 17.2 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.701 1.369 . . . . 30.890000000000001 110.506 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' S' S ' 375' ' ' SER . . . . . . . . . . . . . 70.4 p -104.42 -16.88 14.97 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.235 -0.916 . . . . 29.41 110.43 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' S' S ' 376' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -106.53 43.14 1.18 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.23 -0.919 . . . . 32.890000000000001 110.257 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' S' S ' 377' ' ' VAL . . . . . 0.595 ' O ' HG11 ' S' ' 327' ' ' VAL . 7.3 p -114.7 147.26 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.311 -0.868 . . . . 24.329999999999998 110.163 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 378' ' ' LEU . . . . . . . . . . . . . 52.2 mt -115.96 -58.08 2.15 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.406 -0.809 . . . . 24.370000000000001 109.633 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' S' S ' 379' ' ' VAL . . . . . 0.643 HG22 HG12 ' S' ' 326' ' ' VAL . 61.0 t -120.65 132.33 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.443 -0.786 . . . . 18.02 109.48 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 380' ' ' PHE . . . . . 0.46 ' CE1' ' HB2' ' S' ' 325' ' ' CYS . 14.3 p90 -142.54 173.92 11.1 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.398 -0.814 . . . . 29.350000000000001 110.622 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 381' ' ' VAL . . . . . . . . . . . . . 58.0 t -120.05 107.38 39.85 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.53 -0.731 . . . . 16.34 109.391 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' S' S ' 382' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' S' ' 336' ' ' ASP . 45.4 Cg_endo -71.32 145.58 48.69 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.698 1.367 . . . . 20.940000000000001 110.738 -179.395 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 383' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -61.02 -53.51 56.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.389 -0.819 . . . . 28.93 109.891 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' S' S ' 384' ' ' ASP . . . . . 0.456 ' C ' ' H ' ' S' ' 386' ' ' GLU . 2.1 m-20 -107.01 129.23 54.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.389 -0.82 . . . . 47.030000000000001 110.342 -177.046 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 385' ' ' GLN . . . . . 0.464 ' O ' ' O ' ' S' ' 386' ' ' GLU . 3.2 pt20 -70.22 13.79 0.15 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.403 -0.811 . . . . 46.689999999999998 110.175 177.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 386' ' ' GLU . . . . . 0.921 ' O ' ' HG2' ' S' ' 321' ' ' PRO . 2.6 mt-10 -48.54 176.64 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.388 -0.82 . . . . 50.25 109.602 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 387' ' ' PRO . . . . . 0.543 ' O ' ' C ' ' S' ' 388' ' ' LEU . 44.0 Cg_endo -69.71 -17.12 37.98 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.701 1.369 . . . . 34.390000000000001 110.581 -178.311 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 388' ' ' LEU . . . . . 0.678 HD13 ' OD1' ' S' ' 389' ' ' ASN . 0.1 OUTLIER 33.45 81.79 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.326 -0.859 . . . . 38.009999999999998 110.143 -179.323 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' S' S ' 389' ' ' ASN . . . . . 0.678 ' OD1' HD13 ' S' ' 388' ' ' LEU . 3.5 m120 64.29 168.79 0.17 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.376 -0.828 . . . . 45.82 110.139 -178.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 390' ' ' GLY . . . . . 0.51 ' O ' ' N ' ' S' ' 392' ' ' TRP . . . 151.44 -83.01 0.17 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.557 -1.417 . . . . 33.460000000000001 109.557 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 391' ' ' GLU . . . . . 0.415 ' CB ' ' O ' ' S' ' 390' ' ' GLY . 2.6 tp10 65.54 -62.8 0.22 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.328 -1.101 . . . . 56.579999999999998 110.08 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 392' ' ' TRP . . . . . 0.617 ' O ' ' HG2' ' S' ' 395' ' ' LYS . 0.0 OUTLIER -52.27 -29.34 22.64 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.325 -0.86 . . . . 31.43 110.359 179.622 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' S' S ' 393' ' ' LYS . . . . . 0.462 ' O ' HG12 ' S' ' 396' ' ' VAL . 14.1 mtmt -50.86 -48.55 60.14 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.277 -0.889 . . . . 39.420000000000002 110.418 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 394' ' ' ALA . . . . . 0.566 ' O ' ' HD3' ' S' ' 398' ' ' ARG . . . -78.38 -2.64 39.23 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.391 -0.818 . . . . 34.329999999999998 110.058 179.061 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 395' ' ' LYS . . . . . 0.681 ' O ' HD11 ' R' ' 143' ' ' LEU . 0.1 OUTLIER -90.87 -35.94 14.48 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.416 -0.802 . . . . 60.090000000000003 110.264 179.689 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' S' S ' 396' ' ' VAL . . . . . 0.746 HG22 ' CB ' ' R' ' 99' ' ' PRO . 8.5 p -76.14 -45.94 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.365 -0.835 . . . . 35.5 110.572 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 397' ' ' GLN . . . . . 0.605 ' N ' HG13 ' S' ' 396' ' ' VAL . 0.2 OUTLIER -68.41 40.9 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.159 -0.963 . . . . 49.960000000000001 110.632 179.743 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' S' S ' 398' ' ' ARG . . . . . 0.904 ' HG2' HD21 ' R' ' 143' ' ' LEU . 0.0 OUTLIER -81.4 -166.77 1.25 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.26 -0.9 . . . . 43.420000000000002 110.674 -179.166 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' S' S ' 399' ' ' LYS . . . . . 0.715 ' HB2' ' HA3' ' R' ' 97' ' ' GLY . 0.0 OUTLIER 171.92 124.01 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.355 -0.841 . . . . 55.310000000000002 110.075 179.897 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' S' S ' 400' ' ' LEU . . . . . 0.96 HD13 ' CE1' ' R' ' 148' ' ' HIS . 55.8 tp -61.44 65.31 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.3 -0.875 . . . . 41.030000000000001 110.27 179.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' S' S ' 401' ' ' LYS . . . . . 0.72 ' HA ' ' OD1' ' R' ' 49' ' ' ASP . 19.1 ttmt . . . . . 0 N--CA 1.492 1.671 0 O-C-N 121.349 -0.844 . . . . 61.969999999999999 110.189 -179.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 30' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 121.177 0.513 . . . . 43.36 110.202 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' R' R ' 31' ' ' LEU . . . . . . . . . . . . . 65.3 mt -134.91 140.56 45.85 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.312 -0.867 . . . . 22.93 110.283 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 32' ' ' THR . . . . . . . . . . . . . 69.6 m -87.55 110.57 20.45 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.376 -0.828 . . . . 22.34 109.984 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 33' ' ' LEU . . . . . 0.595 HD22 ' CE2' ' R' ' 62' ' ' TYR . 80.1 mt -62.35 -172.79 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.266 -0.896 . . . . 21.39 110.226 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 34' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -74.65 -29.41 61.25 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.333 -0.855 . . . . 34.4 110.386 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 35' ' ' ASN . . . . . . . . . . . . . 48.3 p30 -77.73 -1.87 33.38 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.324 -0.86 . . . . 30.28 110.633 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.2 -16.56 59.42 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.776 -1.329 . . . . 36.25 109.776 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 37' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -59.02 161.81 4.76 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.285 -1.127 . . . . 53.8 110.383 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 38' ' ' LYS . . . . . . . . . . . . . 56.9 mttt -117.84 135.78 53.86 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.43 -0.794 . . . . 49.91 110.108 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 39' ' ' LYS . . . . . 0.406 ' HG2' ' CZ ' ' R' ' 41' ' ' PHE . 8.1 ttmt -138.75 143.69 39.12 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.432 -0.792 . . . . 35.69 110.223 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 40' ' ' THR . . . . . . . . . . . . . 23.7 m -102.57 127.98 49.42 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.309 -0.87 . . . . 34.84 110.193 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 41' ' ' PHE . . . . . 0.406 ' CZ ' ' HG2' ' R' ' 39' ' ' LYS . 96.6 m-85 -113.09 132.66 55.34 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.402 -0.811 . . . . 34.42 110.147 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 42' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -93.25 140.95 28.98 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.31 -0.869 . . . . 51.46 110.204 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 43' ' ' SER . . . . . . . . . . . . . 54.5 m -70.81 141.89 51.33 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.453 -0.779 . . . . 41.84 110.206 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.74 125.41 29.53 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.296 -0.877 . . . . 33.82 109.934 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 45' ' ' PRO . . . . . 0.424 ' HG2' ' ND2' ' R' ' 77' ' ' ASN . 46.1 Cg_endo -72.16 151.05 54.74 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.59 1.31 . . . . 30.27 110.649 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 46' ' ' ASN . . . . . 0.4 ' HA ' ' OD1' ' R' ' 50' ' ' ASN . 52.1 t-20 -124.23 109.84 13.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.456 -0.777 . . . . 35.1 110.033 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 47' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -120.28 -34.84 3.56 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.298 -0.876 . . . . 42.81 110.503 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 48' ' ' HIS . . . . . 0.439 ' NE2' HD11 ' R' ' 80' ' ' LEU . 73.4 m80 -105.77 45.18 0.98 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.221 -0.925 . . . . 49.97 110.176 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 49' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 50.29 34.72 9.28 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.414 -0.804 . . . . 61.32 110.173 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 50' ' ' ASN . . . . . 0.4 ' OD1' ' HA ' ' R' ' 46' ' ' ASN . 15.0 p-10 -86.25 43.74 1.08 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.333 -0.854 . . . . 51.5 110.703 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.08 -46.11 78.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.184 -0.948 . . . . 38.77 109.558 179.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 52' ' ' TRP . . . . . 0.483 ' CD2' ' N ' ' R' ' 53' ' ' LEU . 68.2 p-90 -58.39 -38.43 77.31 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.419 -0.801 . . . . 26.24 110.055 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 53' ' ' LEU . . . . . 0.483 ' N ' ' CD2' ' R' ' 52' ' ' TRP . 23.2 tp -66.68 -46.68 74.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.4 -0.813 . . . . 26.75 110.013 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 54' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -55.2 -41.61 72.22 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.372 -0.83 . . . . 35.02 110.156 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.17 -46.08 92.0 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.337 -0.852 . . . . 24.47 110.145 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 56' ' ' ILE . . . . . 0.432 HG12 HD11 ' R' ' 104' ' ' ILE . 76.2 mt -62.23 -42.21 94.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.322 -0.861 . . . . 26.03 109.906 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 57' ' ' LEU . . . . . . . . . . . . . 22.4 mt -60.31 -45.6 92.83 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.325 -0.859 . . . . 26.77 109.68 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 58' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -63.97 -46.49 84.4 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.426 -0.796 . . . . 22.32 109.561 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 59' ' ' LEU . . . . . 0.429 ' HA ' ' HE2' ' R' ' 151' ' ' PHE . 23.9 tp -61.43 -37.75 84.65 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.316 -0.865 . . . . 20.55 109.396 179.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 60' ' ' PHE . . . . . 0.528 ' CE2' HD21 ' R' ' 111' ' ' LEU . 2.8 m-85 -61.08 -44.78 96.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.628 -0.67 . . . . 20.08 109.907 179.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 61' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -63.16 -36.15 82.65 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.481 -0.762 . . . . 18.8 110.472 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 62' ' ' TYR . . . . . 0.595 ' CE2' HD22 ' R' ' 33' ' ' LEU . 9.2 t80 -63.04 -41.78 99.58 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.207 -0.933 . . . . 26.45 110.26 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 63' ' ' VAL . . . . . 0.406 ' H ' HG22 ' R' ' 63' ' ' VAL . 30.2 m -93.38 20.38 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.304 -0.872 . . . . 29.75 110.188 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 64' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 52.91 75.6 0.23 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.303 -0.873 . . . . 35.52 110.546 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 65' ' ' GLU . . . . . 0.443 ' HG2' ' CD2' ' R' ' 60' ' ' PHE . 14.3 tp10 -116.29 104.05 52.35 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.457 -0.777 . . . . 29.89 109.901 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 66' ' ' PRO . . . . . 0.48 ' HA ' ' HB2' ' R' ' 69' ' ' ASP . 46.6 Cg_endo -73.55 -5.83 17.74 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.79 1.416 . . . . 21.37 111.094 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 67' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -52.11 -61.56 2.19 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.103 -0.998 . . . . 23.85 110.331 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 68' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -98.12 36.56 1.56 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.25 -0.906 . . . . 28.07 110.438 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 69' ' ' ASP . . . . . 0.48 ' HB2' ' HA ' ' R' ' 66' ' ' PRO . 11.7 t0 -72.36 -33.26 67.13 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.346 -0.846 . . . . 43.76 110.144 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 70' ' ' TRP . . . . . 0.477 ' CE2' ' CG2' ' R' ' 71' ' ' VAL . 47.9 p-90 -73.42 -3.84 29.88 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.275 -0.891 . . . . 33.06 110.716 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 71' ' ' VAL . . . . . 0.556 HG11 ' HB2' ' R' ' 82' ' ' ALA . 40.7 t -109.79 -27.45 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.194 -0.941 . . . . 31.7 109.685 179.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 72' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -86.62 -48.83 7.98 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.358 -0.839 . . . . 33.58 110.282 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 73' ' ' SER . . . . . . . . . . . . . 69.9 m -89.7 51.08 2.01 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.27 -0.893 . . . . 50.82 110.36 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 74' ' ' SER . . . . . . . . . . . . . 15.8 t -125.92 138.3 31.8 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.338 -0.851 . . . . 34.74 110.221 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.38 -24.97 15.93 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 O-C-N 123.641 1.337 . . . . 35.7 110.348 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 76' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -91.68 153.16 19.85 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.37 -0.831 . . . . 66.48 110.379 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 77' ' ' ASN . . . . . 0.424 ' ND2' ' HG2' ' R' ' 45' ' ' PRO . 22.2 t-20 -81.48 95.22 7.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.292 -0.88 . . . . 46.72 110.102 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 78' ' ' LEU . . . . . . . . . . . . . 96.3 mt -96.44 28.0 3.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.331 -0.856 . . . . 37.55 110.182 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 79' ' ' THR . . . . . . . . . . . . . 29.7 m -56.2 -54.67 42.44 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.379 -0.825 . . . . 37.36 110.295 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 80' ' ' LEU . . . . . 0.603 ' HA ' HD12 ' R' ' 83' ' ' ILE . 16.0 mt -60.82 -23.27 64.96 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.347 -0.845 . . . . 35.83 110.543 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 81' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -79.46 -39.12 32.98 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.184 -0.948 . . . . 44.03 110.32 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 82' ' ' ALA . . . . . 0.556 ' HB2' HG11 ' R' ' 71' ' ' VAL . . . -69.5 -28.58 66.17 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.292 -0.88 . . . . 32.54 110.202 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 83' ' ' ILE . . . . . 0.603 HD12 ' HA ' ' R' ' 80' ' ' LEU . 78.1 mt -70.15 -46.06 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.34 -0.85 . . . . 32.02 110.302 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 84' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -55.22 -52.08 64.52 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.164 -0.96 . . . . 34.09 110.596 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 85' ' ' GLN . . . . . 0.532 ' HG2' HD12 ' R' ' 89' ' ' LEU . 31.9 tt0 -54.83 -46.87 74.64 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.235 -0.915 . . . . 25.94 110.28 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 86' ' ' LEU . . . . . . . . . . . . . 24.0 mt -58.63 -43.85 89.81 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.299 -0.876 . . . . 16.2 109.936 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 87' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -65.34 -35.26 80.43 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.466 -0.771 . . . . 49.09 110.286 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 88' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -78.43 -19.04 54.07 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.247 -0.908 . . . . 28.61 110.493 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 89' ' ' LEU . . . . . 0.532 HD12 ' HG2' ' R' ' 85' ' ' GLN . 32.6 mt -96.18 -29.41 14.07 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.207 -0.933 . . . . 26.16 110.197 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 90' ' ' THR . . . . . . . . . . . . . 58.7 p -105.7 -34.59 7.66 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.285 -0.884 . . . . 33.33 109.778 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.85 16.1 58.6 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.821 -1.312 . . . . 31.13 109.821 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 92' ' ' LEU . . . . . . . . . . . . . 97.0 mt -100.1 155.29 17.81 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.169 -1.195 . . . . 42.52 110.21 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 93' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -86.28 91.56 8.51 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.46 -0.775 . . . . 68.46 109.984 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 94' ' ' LEU . . . . . 0.457 ' HB3' ' CZ2' ' R' ' 52' ' ' TRP . 48.1 mt -99.41 53.01 0.95 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.18 -0.95 . . . . 44.63 110.364 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 95' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.44 -38.69 6.39 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.3 -0.875 . . . . 67.16 110.399 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 96' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -113.93 44.29 1.67 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.404 -0.81 . . . . 67.02 110.326 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 97' ' ' GLY . . . . . . . . . . . . . . . 99.12 150.78 26.03 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.614 -1.395 . . . . 49.48 109.614 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 98' ' ' GLY . . . . . . . . . . . . . . . -166.21 160.03 33.46 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.253 -1.539 . . . . 36.57 109.253 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 99' ' ' PRO . . . . . 0.79 ' O ' HG23 ' R' ' 103' ' ' VAL . 45.1 Cg_endo -72.58 121.1 7.13 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.684 1.36 . . . . 30.41 110.435 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 100' ' ' PRO . . . . . 0.412 ' HA ' HD11 ' R' ' 56' ' ' ILE . 45.7 Cg_endo -72.25 -31.65 11.49 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 O-C-N 123.645 1.339 . . . . 29.94 110.54 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 101' ' ' ALA . . . . . 0.476 ' HB2' ' HB3' ' R' ' 178' ' ' LEU . . . -69.96 -38.48 76.13 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.301 -0.875 . . . . 23.64 110.263 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 102' ' ' LEU . . . . . 0.424 HD23 HD21 ' R' ' 106' ' ' ASN . 0.1 OUTLIER -72.62 -40.8 66.17 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.322 -0.861 . . . . 20.31 110.362 -179.713 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' R' R ' 103' ' ' VAL . . . . . 0.79 HG23 ' O ' ' R' ' 99' ' ' PRO . 63.7 t -58.16 -40.06 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.219 -0.925 . . . . 16.33 109.996 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 104' ' ' ILE . . . . . 0.432 HD11 HG12 ' R' ' 56' ' ' ILE . 81.9 mt -71.7 -30.57 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.397 -0.814 . . . . 24.77 109.93 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 105' ' ' TRP . . . . . 0.462 ' O ' ' HD3' ' R' ' 108' ' ' LYS . 70.6 t-105 -82.42 0.84 40.28 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.345 -0.847 . . . . 23.28 110.273 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 106' ' ' ASN . . . . . 0.424 HD21 HD23 ' R' ' 102' ' ' LEU . 6.9 m-80 -105.08 -10.38 17.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.116 -0.99 . . . . 28.26 110.125 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 107' ' ' ILE . . . . . . . . . . . . . 36.8 pt -126.83 34.97 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.211 -0.931 . . . . 18.77 110.05 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 108' ' ' LYS . . . . . 0.502 ' HG2' ' HB ' ' R' ' 115' ' ' ILE . 9.3 mtpp -61.05 -48.44 81.72 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.548 -0.72 . . . . 42.5 110.025 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 109' ' ' HIS . . . . . 0.445 ' CD2' ' HG ' ' R' ' 110' ' ' LEU . 50.8 p-80 -66.02 -12.85 58.07 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.527 -0.733 . . . . 20.07 110.698 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 110' ' ' LEU . . . . . 0.445 ' HG ' ' CD2' ' R' ' 109' ' ' HIS . 80.6 mt -94.79 -17.25 22.31 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.076 -1.015 . . . . 15.69 110.207 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 111' ' ' LEU . . . . . 0.528 HD21 ' CE2' ' R' ' 60' ' ' PHE . 10.3 mt -94.13 144.15 25.75 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.342 -0.849 . . . . 25.39 111.014 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 112' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -77.71 -17.35 57.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.552 -0.717 . . . . 53.48 109.852 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 113' ' ' THR . . . . . 0.459 HG22 ' N ' ' R' ' 114' ' ' GLY . 60.0 m -83.73 166.64 17.88 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.236 -0.915 . . . . 14.8 110.233 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 114' ' ' GLY . . . . . 0.459 ' N ' HG22 ' R' ' 113' ' ' THR . . . -97.96 127.16 9.13 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.994 -1.243 . . . . 16.14 109.994 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 115' ' ' ILE . . . . . 0.577 HD13 ' HB ' ' R' ' 124' ' ' VAL . 47.7 mm -109.11 139.31 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.441 -1.035 . . . . 13.46 109.738 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 116' ' ' GLY . . . . . . . . . . . . . . . -152.74 -155.88 7.3 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.959 -1.257 . . . . 23.9 109.959 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 117' ' ' THR . . . . . 0.528 HG22 ' CG2' ' R' ' 126' ' ' VAL . 18.8 p -134.99 -171.39 2.79 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.453 -1.028 . . . . 27.37 110.044 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 118' ' ' ALA . . . . . 0.445 ' HB3' ' OD1' ' R' ' 128' ' ' ASP . . . -56.6 -58.04 9.79 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.251 -0.906 . . . . 18.76 110.064 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 119' ' ' SER . . . . . . . . . . . . . 1.1 m -56.52 -40.66 75.42 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.259 -0.901 . . . . 32.35 109.721 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 120' ' ' ARG . . . . . 0.409 ' NH1' ' NE1' ' S' ' 305' ' ' TRP . 10.0 mtm180 -110.03 86.26 4.84 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.47 -0.768 . . . . 27.12 109.716 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 121' ' ' PRO . . . . . 0.483 ' HA ' ' SG ' ' R' ' 125' ' ' CYS . 44.7 Cg_endo -71.26 166.44 29.25 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 O-C-N 123.784 1.413 . . . . 22.68 111.009 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 122' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' R' ' 121' ' ' PRO . 38.2 t 178.58 -161.65 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.609 -0.682 . . . . 22.99 109.467 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 123' ' ' GLU . . . . . 0.44 ' HG2' HG23 ' R' ' 113' ' ' THR . 2.3 tp10 -56.5 -39.92 74.08 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.211 -0.93 . . . . 36.18 109.649 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 124' ' ' VAL . . . . . 0.577 ' HB ' HD13 ' R' ' 115' ' ' ILE . 83.8 t -142.57 136.39 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.606 -0.684 . . . . 20.64 109.383 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 125' ' ' CYS . . . . . 0.483 ' SG ' ' HA ' ' R' ' 121' ' ' PRO . 83.7 m -140.3 168.17 20.43 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.17 -0.956 . . . . 22.8 111.131 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 126' ' ' VAL . . . . . 0.728 HG12 HG22 ' R' ' 179' ' ' VAL . 35.9 m -122.68 159.82 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.724 -0.61 . . . . 21.24 109.613 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 127' ' ' VAL . . . . . 0.71 HG11 ' O ' ' R' ' 177' ' ' VAL . 31.1 m -70.89 141.86 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.283 -0.886 . . . . 19.77 110.675 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 128' ' ' ASP . . . . . 0.445 ' OD1' ' HB3' ' R' ' 118' ' ' ALA . 53.9 p-10 -137.73 19.41 2.87 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.327 -0.858 . . . . 29.21 110.697 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 129' ' ' GLY . . . . . . . . . . . . . . . 114.06 -0.02 24.06 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.928 -1.13 . . . . 33.86 110.441 179.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 130' ' ' THR . . . . . . . . . . . . . 58.7 m -91.9 131.88 36.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.11 -1.229 . . . . 26.41 110.046 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -62.57 120.72 11.68 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.369 -0.832 . . . . 33.08 110.258 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 132' ' ' MET . . . . . 0.433 ' HE1' ' CE2' ' R' ' 180' ' ' PHE . 98.4 mmm -105.17 165.63 10.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.467 -0.771 . . . . 30.76 110.467 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 133' ' ' CYS . . . . . 0.41 ' HA ' ' HB3' ' R' ' 174' ' ' PRO . 32.8 m -141.13 158.13 44.34 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.542 -0.724 . . . . 27.0 109.973 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 134' ' ' LEU . . . . . 0.564 HD11 ' O ' ' R' ' 172' ' ' PRO . 0.1 OUTLIER -58.45 -19.71 38.88 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.322 -0.861 . . . . 33.9 110.553 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' R' R ' 135' ' ' ALA . . . . . . . . . . . . . . . -92.8 8.24 40.29 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.31 -0.868 . . . . 19.37 110.802 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 136' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -93.76 -21.84 19.07 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.209 -0.932 . . . . 30.47 110.183 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 137' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -149.95 165.42 32.71 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.321 -0.862 . . . . 24.27 110.189 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 138' ' ' HIS . . . . . 0.433 ' HA ' HG23 ' R' ' 154' ' ' VAL . 15.2 p80 -117.88 15.19 14.33 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.382 -0.824 . . . . 20.91 110.452 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 139' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' R' ' 152' ' ' ALA . . . -177.22 152.4 0.87 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.207 -0.933 . . . . 15.69 110.099 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 140' ' ' GLY . . . . . 0.427 ' HA3' ' O ' ' R' ' 179' ' ' VAL . . . 161.81 175.17 32.55 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.962 -1.255 . . . . 23.76 109.962 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 141' ' ' ILE . . . . . . . . . . . . . 83.7 mt -95.5 136.54 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.473 -1.016 . . . . 25.3 109.718 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 142' ' ' PHE . . . . . 0.576 ' CD2' ' HB2' ' R' ' 172' ' ' PRO . 82.7 m-85 -120.72 -172.61 2.41 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.26 -0.9 . . . . 30.24 110.505 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 143' ' ' LEU . . . . . 0.742 HD23 ' O ' ' R' ' 148' ' ' HIS . 0.5 OUTLIER -119.79 77.74 1.26 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.367 -0.833 . . . . 32.8 110.316 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' R' R ' 144' ' ' LYS . . . . . 0.471 ' HG3' ' CZ2' ' R' ' 170' ' ' TRP . 1.0 OUTLIER -69.62 76.87 0.43 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.43 -0.794 . . . . 49.18 109.679 179.594 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' R' R ' 145' ' ' GLY . . . . . 0.458 ' O ' HD22 ' R' ' 143' ' ' LEU . . . 104.5 179.27 24.83 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.188 -1.565 . . . . 53.87 109.188 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 146' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -88.47 145.83 25.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.388 -1.066 . . . . 68.58 109.999 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 147' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 58.25 36.45 25.69 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.362 -0.837 . . . . 56.62 110.655 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 148' ' ' HIS . . . . . 0.742 ' O ' HD23 ' R' ' 143' ' ' LEU . 44.7 t60 -158.61 148.13 19.28 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.219 -0.926 . . . . 44.57 110.376 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 149' ' ' ALA . . . . . . . . . . . . . . . -150.29 146.9 27.05 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.467 -0.771 . . . . 33.54 110.07 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 150' ' ' VAL . . . . . . . . . . . . . 34.2 m -142.3 161.51 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.261 -0.899 . . . . 27.61 110.36 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 151' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' R' ' 152' ' ' ALA . 5.8 t80 -86.17 155.6 20.67 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.428 -0.795 . . . . 23.04 109.904 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 152' ' ' ALA . . . . . 0.537 ' N ' ' CD1' ' R' ' 151' ' ' PHE . . . -157.29 151.5 24.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.443 -0.786 . . . . 29.61 109.611 179.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 153' ' ' CYS . . . . . . . . . . . . . 26.7 p -154.28 173.57 15.97 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.298 -0.876 . . . . 22.75 110.507 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 154' ' ' VAL . . . . . 0.613 HG22 ' CE2' ' R' ' 159' ' ' TRP . 59.7 t -90.59 117.04 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.392 -0.817 . . . . 23.26 110.076 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 155' ' ' THR . . . . . . . . . . . . . 70.3 p -112.13 -176.63 2.97 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.358 -0.839 . . . . 17.88 110.041 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 156' ' ' SER . . . . . . . . . . . . . 78.6 p -75.92 -3.75 37.16 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.329 -0.857 . . . . 21.83 110.727 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 157' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -118.25 10.43 12.85 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.148 -0.97 . . . . 36.54 110.619 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 158' ' ' GLY . . . . . . . . . . . . . . . 117.97 -162.71 13.02 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.533 -1.427 . . . . 31.74 109.533 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 159' ' ' TRP . . . . . 0.613 ' CE2' HG22 ' R' ' 154' ' ' VAL . 14.7 m95 -86.51 122.42 30.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.334 -1.098 . . . . 28.25 110.112 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 160' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -108.46 166.96 10.38 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.376 -0.827 . . . . 41.24 110.19 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 161' ' ' ALA . . . . . . . . . . . . . . . -143.22 123.42 13.74 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.362 -0.836 . . . . 27.4 110.198 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 162' ' ' ILE . . . . . . . . . . . . . 92.0 mt -87.55 81.15 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.295 -0.878 . . . . 24.27 110.051 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 163' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' R' ' 165' ' ' GLU . 15.3 t0 -72.86 92.42 1.6 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.457 -0.777 . . . . 36.08 110.254 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 164' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 54.09 -88.94 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.489 -0.757 . . . . 46.08 110.603 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 165' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' R' ' 163' ' ' ASP . 29.7 mt-10 -124.72 35.92 4.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.088 -1.007 . . . . 50.94 110.187 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 166' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -135.75 117.3 14.84 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.388 -0.82 . . . . 47.28 110.347 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 167' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -101.04 119.98 39.53 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.434 -0.791 . . . . 40.47 110.164 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 168' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -157.57 158.57 30.65 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.24 -0.913 . . . . 30.21 110.376 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 169' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.8 133.04 19.46 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.931 1.49 . . . . 32.76 110.474 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 170' ' ' TRP . . . . . 0.471 ' CZ2' ' HG3' ' R' ' 144' ' ' LYS . 66.9 t90 -159.81 119.37 2.89 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.461 -0.774 . . . . 32.79 109.909 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 171' ' ' THR . . . . . . . . . . . . . 46.1 m -81.1 112.61 34.16 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.448 -0.783 . . . . 36.92 110.163 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 172' ' ' PRO . . . . . 0.576 ' HB2' ' CD2' ' R' ' 142' ' ' PHE . 47.4 Cg_endo -73.71 158.75 46.68 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.66 1.348 . . . . 33.54 110.592 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 173' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -88.84 144.97 33.86 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.318 -0.864 . . . . 45.76 109.851 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 174' ' ' PRO . . . . . 0.41 ' HB3' ' HA ' ' R' ' 133' ' ' CYS . 46.0 Cg_endo -71.74 -10.34 26.31 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.614 1.323 . . . . 29.63 110.492 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 175' ' ' SER . . . . . . . . . . . . . 53.1 p -103.5 -17.55 15.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.281 -0.887 . . . . 35.7 110.343 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 176' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -103.5 43.26 1.1 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.202 -0.936 . . . . 39.65 110.442 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 177' ' ' VAL . . . . . 0.71 ' O ' HG11 ' R' ' 127' ' ' VAL . 10.5 p -117.79 127.14 75.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.326 -0.859 . . . . 20.61 110.034 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 178' ' ' LEU . . . . . 0.476 ' HB3' ' HB2' ' R' ' 101' ' ' ALA . 46.3 mt -91.47 -61.36 1.66 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.35 -0.844 . . . . 15.58 109.351 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 179' ' ' VAL . . . . . 0.728 HG22 HG12 ' R' ' 126' ' ' VAL . 67.9 t -114.58 144.72 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.621 -0.674 . . . . 17.4 109.413 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 180' ' ' PHE . . . . . 0.433 ' CE2' ' HE1' ' R' ' 132' ' ' MET . 43.7 p90 -152.17 163.32 39.62 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.273 -0.892 . . . . 20.16 110.602 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 181' ' ' VAL . . . . . . . . . . . . . 66.5 t -113.12 111.48 50.4 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.429 -0.795 . . . . 17.69 109.833 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 182' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.03 149.52 52.9 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.545 1.287 . . . . 17.81 110.423 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 183' ' ' TYR . . . . . 0.739 ' O ' ' C ' ' R' ' 184' ' ' ASP . 78.9 m-85 -59.01 175.53 0.28 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.43 -0.794 . . . . 28.01 110.526 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' R' R ' 184' ' ' ASP . . . . . 0.739 ' C ' ' O ' ' R' ' 183' ' ' TYR . 0.0 OUTLIER -12.28 -76.89 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.343 -0.848 . . . . 58.64 110.303 -178.086 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' R' R ' 185' ' ' GLN . . . . . . . . . . . . . 6.7 tm0? . . . . . 0 N--CA 1.503 2.188 0 CA-C-O 121.25 0.548 . . . . 80.42 111.723 179.409 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' R' R ' 193' ' ' LYS . . . . . 0.598 ' O ' ' HB2' ' R' ' 194' ' ' ALA . 20.4 ttpp . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 120.938 0.399 . . . . 49.5 110.166 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' R' R ' 194' ' ' ALA . . . . . 0.598 ' HB2' ' O ' ' R' ' 193' ' ' LYS . . . . . . . . 0 N--CA 1.495 1.8 0 O-C-N 121.125 -0.984 . . . . 40.4 110.099 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 229' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.171 0.51 . . . . 51.83 110.208 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 230' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -97.28 142.76 28.78 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.4 -0.813 . . . . 54.13 110.222 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 231' ' ' LEU . . . . . . . . . . . . . 67.8 mt -134.11 140.99 46.97 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.343 -0.848 . . . . 33.04 110.337 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 232' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' S' ' 355' ' ' THR . 40.0 m -89.25 103.23 15.87 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.319 -0.863 . . . . 26.92 110.068 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' S' S ' 233' ' ' LEU . . . . . 0.666 HD22 ' CE2' ' S' ' 262' ' ' TYR . 79.9 mt -55.92 179.28 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.437 -0.79 . . . . 13.78 110.498 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' S' S ' 234' ' ' TYR . . . . . 0.442 ' CG ' ' N ' ' S' ' 235' ' ' ASN . 35.6 p90 -65.01 -35.65 81.89 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.393 -0.817 . . . . 26.08 110.198 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' S' S ' 235' ' ' ASN . . . . . 0.442 ' N ' ' CG ' ' S' ' 234' ' ' TYR . 50.7 p30 -74.33 -7.4 52.69 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.373 -0.829 . . . . 20.04 110.567 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' S' S ' 236' ' ' GLY . . . . . . . . . . . . . . . 95.69 -19.9 52.22 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.782 -1.327 . . . . 22.71 109.782 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 237' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -53.03 145.73 12.49 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.189 -1.183 . . . . 35.44 110.183 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 238' ' ' LYS . . . . . . . . . . . . . 44.3 mttt -102.17 127.91 48.89 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.38 -0.825 . . . . 32.56 110.361 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 239' ' ' LYS . . . . . 0.412 ' HG2' ' CZ ' ' S' ' 241' ' ' PHE . 9.0 ttmt -132.31 144.52 50.63 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.357 -0.839 . . . . 26.68 109.955 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' S' S ' 240' ' ' THR . . . . . . . . . . . . . 51.8 m -102.0 132.22 47.97 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.34 -0.85 . . . . 41.02 110.348 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 241' ' ' PHE . . . . . 0.412 ' CZ ' ' HG2' ' S' ' 239' ' ' LYS . 96.0 m-85 -117.96 137.7 52.67 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.418 -0.801 . . . . 28.62 110.186 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' S' S ' 242' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -96.42 161.78 13.77 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.392 -0.818 . . . . 47.89 110.257 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 243' ' ' SER . . . . . . . . . . . . . 72.0 m -90.5 151.52 21.33 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.372 -0.83 . . . . 45.09 110.282 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 244' ' ' ARG . . . . . . . . . . . . . 1.4 mtp85 -129.72 126.73 22.74 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.375 -0.828 . . . . 42.49 110.282 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 245' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.31 161.02 43.78 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.674 1.355 . . . . 35.68 110.544 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 246' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -132.89 97.85 4.14 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.353 -0.842 . . . . 51.88 109.853 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 247' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -110.47 -22.25 11.76 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.398 -0.813 . . . . 53.69 110.658 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 248' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -117.24 43.65 2.27 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.223 -0.923 . . . . 55.79 110.704 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 249' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 48.84 38.37 11.9 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.405 -0.809 . . . . 49.45 110.386 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 250' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -90.67 29.09 1.37 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.489 -0.757 . . . . 36.86 110.327 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 251' ' ' ALA . . . . . . . . . . . . . . . -53.91 -43.12 69.44 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.229 -0.919 . . . . 29.69 109.612 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 252' ' ' TRP . . . . . 0.417 ' CZ2' ' HB3' ' S' ' 294' ' ' LEU . 67.9 p-90 -61.81 -33.94 75.03 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.523 -0.736 . . . . 41.12 109.829 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' S' S ' 253' ' ' LEU . . . . . 0.408 ' N ' ' CD2' ' S' ' 252' ' ' TRP . 23.4 tp -70.17 -47.17 62.77 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.378 -0.826 . . . . 24.89 110.001 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' S' S ' 254' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -56.13 -42.47 76.96 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.445 -0.784 . . . . 35.65 109.966 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 255' ' ' ALA . . . . . . . . . . . . . . . -59.53 -48.25 82.39 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.463 -0.773 . . . . 22.73 110.071 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 256' ' ' ILE . . . . . 0.509 HG12 HD11 ' S' ' 304' ' ' ILE . 79.7 mt -62.24 -40.68 88.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.321 -0.862 . . . . 28.85 109.983 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' S' S ' 257' ' ' LEU . . . . . . . . . . . . . 19.0 mt -61.54 -44.45 97.03 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.352 -0.843 . . . . 23.07 110.183 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 258' ' ' GLN . . . . . 0.499 ' HB3' ' CD2' ' S' ' 351' ' ' PHE . 53.4 mm-40 -65.12 -45.33 85.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.371 -0.831 . . . . 29.78 109.882 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' S' S ' 259' ' ' LEU . . . . . 0.416 ' O ' HG22 ' S' ' 263' ' ' VAL . 19.9 tp -58.67 -36.41 74.13 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.344 -0.848 . . . . 17.94 109.462 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' S' S ' 260' ' ' PHE . . . . . 0.523 ' CE2' HD21 ' S' ' 311' ' ' LEU . 3.1 m-85 -62.83 -45.29 93.3 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.655 -0.653 . . . . 30.57 109.834 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' S' S ' 261' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -62.01 -29.8 70.52 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.525 -0.734 . . . . 41.34 110.033 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 262' ' ' TYR . . . . . 0.666 ' CE2' HD22 ' S' ' 233' ' ' LEU . 8.7 t80 -71.24 -44.62 64.94 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.443 -0.786 . . . . 26.03 110.093 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' S' S ' 263' ' ' VAL . . . . . 0.416 HG22 ' O ' ' S' ' 259' ' ' LEU . 33.0 m -91.99 18.24 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.336 -0.852 . . . . 22.8 110.411 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' S' S ' 264' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 52.79 70.65 0.55 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.223 -0.923 . . . . 44.03 110.611 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 265' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -111.78 109.25 55.46 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.394 -0.817 . . . . 35.61 109.654 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 266' ' ' PRO . . . . . 0.475 ' HA ' ' HB2' ' S' ' 269' ' ' ASP . 48.6 Cg_endo -75.39 0.45 9.05 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 O-C-N 123.605 1.318 . . . . 37.67 111.742 -179.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' S' S ' 267' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -56.54 -67.7 0.28 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.802 -1.186 . . . . 41.49 110.165 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' S' S ' 268' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -92.91 39.89 1.05 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.148 -0.97 . . . . 50.76 110.048 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 269' ' ' ASP . . . . . 0.475 ' HB2' ' HA ' ' S' ' 266' ' ' PRO . 0.9 OUTLIER -76.01 -33.19 59.67 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.381 -0.825 . . . . 61.86 109.765 179.55 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' S' S ' 270' ' ' TRP . . . . . 0.512 ' CE2' HG23 ' S' ' 271' ' ' VAL . 51.0 p-90 -73.94 -4.28 34.2 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.268 -0.895 . . . . 39.85 110.466 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' S' S ' 271' ' ' VAL . . . . . 0.512 HG23 ' CE2' ' S' ' 270' ' ' TRP . 46.6 t -109.58 -32.66 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.157 -0.964 . . . . 39.18 110.07 179.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' S' S ' 272' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -78.67 -36.53 43.63 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.42 -0.8 . . . . 40.02 110.47 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 273' ' ' SER . . . . . . . . . . . . . 70.9 m -103.57 56.16 0.74 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.278 -0.889 . . . . 47.2 110.294 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 274' ' ' SER . . . . . . . . . . . . . 6.9 t -133.03 141.22 40.15 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.385 -0.822 . . . . 47.61 110.158 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 275' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.76 -18.85 21.71 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.66 1.347 . . . . 45.28 110.556 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 276' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -99.89 140.87 33.47 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.3 -0.875 . . . . 57.27 110.31 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 277' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -71.73 97.66 1.81 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.398 -0.814 . . . . 37.28 110.279 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 278' ' ' LEU . . . . . . . . . . . . . 86.3 mt -97.02 33.82 1.84 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.394 -0.816 . . . . 43.88 110.047 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 279' ' ' THR . . . . . . . . . . . . . 74.7 m -64.03 -60.1 3.65 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.484 -0.76 . . . . 50.05 110.303 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 280' ' ' LEU . . . . . 0.75 ' HA ' HD12 ' S' ' 283' ' ' ILE . 13.7 mt -51.61 -39.87 58.79 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.334 -0.854 . . . . 54.12 110.287 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' S' S ' 281' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.42 -49.67 74.57 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.499 -0.751 . . . . 65.28 110.177 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' S' S ' 282' ' ' ALA . . . . . . . . . . . . . . . -58.93 -33.9 71.12 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.456 -0.778 . . . . 46.51 110.571 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 283' ' ' ILE . . . . . 0.75 HD12 ' HA ' ' S' ' 280' ' ' LEU . 85.9 mt -66.39 -50.84 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.306 -0.871 . . . . 47.3 110.083 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' S' S ' 284' ' ' LYS . . . . . . . . . . . . . 33.8 tttp -50.52 -57.63 7.65 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.411 -0.806 . . . . 50.72 110.381 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 285' ' ' GLN . . . . . 0.538 ' HG2' HD12 ' S' ' 289' ' ' LEU . 34.4 tt0 -51.4 -46.4 62.84 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.487 -0.758 . . . . 68.47 110.283 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' S' S ' 286' ' ' LEU . . . . . . . . . . . . . 19.1 mt -59.95 -44.49 94.35 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.429 -0.794 . . . . 36.62 110.284 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 287' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -62.74 -35.29 79.3 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.33 -0.856 . . . . 46.64 110.077 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 288' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -76.23 -21.04 56.87 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.442 -0.787 . . . . 46.45 110.34 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 289' ' ' LEU . . . . . 0.538 HD12 ' HG2' ' S' ' 285' ' ' GLN . 30.8 mt -97.35 -21.75 17.03 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.256 -0.902 . . . . 35.09 110.485 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' S' S ' 290' ' ' THR . . . . . 0.416 HG22 ' HB3' ' S' ' 306' ' ' ASN . 81.3 p -114.8 -28.44 7.08 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.281 -0.887 . . . . 38.61 110.419 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' S' S ' 291' ' ' GLY . . . . . . . . . . . . . . . 79.4 10.97 85.41 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.833 -1.307 . . . . 36.77 109.833 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 292' ' ' LEU . . . . . . . . . . . . . 84.7 mt -96.42 145.83 25.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.247 -1.149 . . . . 35.33 109.77 179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 293' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -77.37 102.32 6.74 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.222 -0.924 . . . . 48.7 110.262 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 294' ' ' LEU . . . . . 0.417 ' HB3' ' CZ2' ' S' ' 252' ' ' TRP . 55.8 mt -106.86 51.73 0.74 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.575 -0.703 . . . . 42.61 110.123 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' S' S ' 295' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -112.56 -11.11 13.63 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.296 -0.878 . . . . 55.49 110.505 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' S' S ' 296' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -144.34 48.52 1.36 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.178 -0.951 . . . . 75.68 110.308 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 297' ' ' GLY . . . . . . . . . . . . . . . 96.9 145.18 18.7 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.524 -1.43 . . . . 49.44 109.524 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 298' ' ' GLY . . . . . . . . . . . . . . . -163.8 156.93 29.0 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.807 -1.317 . . . . 41.11 109.807 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 299' ' ' PRO . . . . . 0.489 ' O ' HG23 ' S' ' 303' ' ' VAL . 47.9 Cg_endo -73.8 118.33 5.4 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.916 1.482 . . . . 26.2 110.278 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' S' S ' 300' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.25 -15.48 31.64 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.587 1.309 . . . . 21.7 110.725 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 301' ' ' ALA . . . . . . . . . . . . . . . -80.73 -29.35 36.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.271 -0.893 . . . . 31.23 110.099 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 302' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.49 -40.61 18.99 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.4 -0.812 . . . . 38.99 109.982 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' S' S ' 303' ' ' VAL . . . . . 0.489 HG23 ' O ' ' S' ' 299' ' ' PRO . 58.1 t -60.74 -35.43 64.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.436 -0.79 . . . . 18.63 110.14 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' S' S ' 304' ' ' ILE . . . . . 0.509 HD11 HG12 ' S' ' 256' ' ' ILE . 86.0 mt -79.39 -23.65 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.37 -0.831 . . . . 25.46 110.178 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' S' S ' 305' ' ' TRP . . . . . 0.419 ' CD2' ' HD3' ' S' ' 308' ' ' LYS . 68.9 t-105 -88.61 -14.54 37.27 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.295 -0.878 . . . . 33.4 110.569 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' S' S ' 306' ' ' ASN . . . . . 0.416 ' HB3' HG22 ' S' ' 290' ' ' THR . 10.4 m-80 -89.67 -13.65 36.52 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.191 -0.943 . . . . 36.97 110.388 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' S' S ' 307' ' ' ILE . . . . . 0.462 HG12 ' O ' ' S' ' 303' ' ' VAL . 36.9 pt -125.01 45.66 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.237 -0.915 . . . . 30.81 110.004 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' S' S ' 308' ' ' LYS . . . . . 0.419 ' HD3' ' CD2' ' S' ' 305' ' ' TRP . 1.5 mtmp? -73.64 -37.63 65.26 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.371 -0.831 . . . . 46.52 110.097 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' S' S ' 309' ' ' HIS . . . . . 0.494 ' CD2' ' HG ' ' S' ' 310' ' ' LEU . 55.6 p-80 -73.26 -8.28 55.16 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.321 -0.862 . . . . 51.03 110.062 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' S' S ' 310' ' ' LEU . . . . . 0.494 ' HG ' ' CD2' ' S' ' 309' ' ' HIS . 53.0 mt -99.28 -12.87 19.97 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.353 -0.842 . . . . 36.16 109.986 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' S' S ' 311' ' ' LEU . . . . . 0.523 HD21 ' CE2' ' S' ' 260' ' ' PHE . 10.7 mt -97.19 147.88 23.64 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.339 -0.85 . . . . 40.0 110.399 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' S' S ' 312' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -81.6 -16.3 51.98 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.275 -0.891 . . . . 54.18 109.69 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 313' ' ' THR . . . . . 0.818 HG23 ' HG2' ' S' ' 323' ' ' GLU . 92.7 m -87.97 151.65 22.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.336 -0.853 . . . . 25.61 110.098 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' S' S ' 314' ' ' GLY . . . . . . . . . . . . . . . -87.95 126.43 8.06 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.783 -1.327 . . . . 25.18 109.783 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 315' ' ' ILE . . . . . 0.643 HD13 ' HB ' ' S' ' 324' ' ' VAL . 50.7 mm -101.6 150.49 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.356 -1.085 . . . . 23.9 109.72 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' S' S ' 316' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' S' ' 325' ' ' CYS . . . -157.08 -159.25 9.37 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.957 -1.257 . . . . 23.18 109.957 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' S' S ' 317' ' ' THR . . . . . 0.421 HG22 ' CG2' ' S' ' 326' ' ' VAL . 11.2 p -133.94 -173.06 3.14 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.418 -1.048 . . . . 27.98 110.023 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' S' S ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.51 -56.19 25.15 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.175 -0.953 . . . . 28.1 109.926 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 319' ' ' SER . . . . . . . . . . . . . 1.2 m -59.94 -41.7 92.42 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.36 -0.838 . . . . 37.0 109.656 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 320' ' ' ARG . . . . . . . . . . . . . 12.1 mtm180 -111.67 79.91 2.64 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.529 -0.732 . . . . 52.07 109.718 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 321' ' ' PRO . . . . . 0.432 ' O ' ' HB2' ' S' ' 322' ' ' SER . 43.9 Cg_endo -71.45 171.48 16.13 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.865 1.455 . . . . 38.29 110.92 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' S' S ' 322' ' ' SER . . . . . 0.432 ' HB2' ' O ' ' S' ' 321' ' ' PRO . 41.3 t 178.68 -148.12 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.934 -0.765 . . . . 38.84 108.934 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' S' S ' 323' ' ' GLU . . . . . 0.818 ' HG2' HG23 ' S' ' 313' ' ' THR . 6.7 tp10 -62.89 -40.31 97.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.017 -1.052 . . . . 40.7 109.635 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' S' S ' 324' ' ' VAL . . . . . 0.643 ' HB ' HD13 ' S' ' 315' ' ' ILE . 72.8 t -141.25 135.01 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.402 -0.811 . . . . 20.34 109.506 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' S' S ' 325' ' ' CYS . . . . . 0.472 ' HB2' ' CE1' ' S' ' 380' ' ' PHE . 11.2 m -126.02 172.26 10.11 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.267 -0.895 . . . . 30.63 110.854 -179.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' S' S ' 326' ' ' VAL . . . . . 0.643 HG12 HG22 ' S' ' 379' ' ' VAL . 34.6 m -135.57 142.2 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.611 -0.681 . . . . 23.9 109.191 179.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' S' S ' 327' ' ' VAL . . . . . 0.601 HG11 ' O ' ' S' ' 377' ' ' VAL . 34.5 m -56.32 124.99 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.111 -0.993 . . . . 19.48 110.456 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' S' S ' 328' ' ' ASP . . . . . . . . . . . . . 55.5 p-10 -119.37 11.53 12.22 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.412 -0.805 . . . . 26.43 110.417 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 329' ' ' GLY . . . . . . . . . . . . . . . 119.65 2.24 13.12 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.052 -1.219 . . . . 31.24 110.052 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 330' ' ' THR . . . . . . . . . . . . . 80.7 m -93.04 130.06 38.77 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.116 -1.226 . . . . 30.05 110.109 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 331' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -56.86 111.52 1.05 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.244 -0.91 . . . . 37.26 109.916 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 332' ' ' MET . . . . . . . . . . . . . 88.0 mmm -94.09 162.53 13.83 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.234 -0.916 . . . . 26.23 110.332 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 333' ' ' CYS . . . . . . . . . . . . . 25.8 m -137.2 150.07 47.64 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.47 -0.769 . . . . 23.56 110.058 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 334' ' ' LEU . . . . . 0.562 HD11 ' O ' ' S' ' 372' ' ' PRO . 0.1 OUTLIER -52.62 -24.83 9.15 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.371 -0.83 . . . . 28.93 110.428 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' S' S ' 335' ' ' ALA . . . . . . . . . . . . . . . -89.06 14.44 10.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.396 -0.815 . . . . 15.76 110.954 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 336' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -100.45 -17.25 17.26 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.124 -0.985 . . . . 34.92 110.191 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 337' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -152.4 170.85 19.08 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.412 -0.805 . . . . 19.03 110.054 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 338' ' ' HIS . . . . . . . . . . . . . 13.4 p80 -120.71 10.37 10.98 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.363 -0.835 . . . . 18.82 110.449 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 339' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' S' ' 352' ' ' ALA . . . -175.95 155.18 1.58 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.221 -0.924 . . . . 17.18 110.054 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' S' S ' 340' ' ' GLY . . . . . . . . . . . . . . . 160.84 173.08 29.0 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.056 -1.218 . . . . 18.33 110.056 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 341' ' ' ILE . . . . . . . . . . . . . 83.9 mt -88.82 138.1 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.508 -0.995 . . . . 18.6 109.786 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 342' ' ' PHE . . . . . 0.485 ' CE2' ' HB3' ' S' ' 352' ' ' ALA . 70.0 m-85 -120.97 -178.46 3.75 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.256 -0.903 . . . . 23.44 110.396 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' S' S ' 343' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.82 93.33 4.16 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.412 -0.805 . . . . 35.59 110.008 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' S' S ' 344' ' ' LYS . . . . . 0.41 ' O ' ' HB3' ' S' ' 348' ' ' HIS . 0.3 OUTLIER -80.8 124.98 29.52 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.219 -0.926 . . . . 38.34 110.102 -179.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' S' S ' 345' ' ' GLY . . . . . . . . . . . . . . . 62.77 -130.83 43.09 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 108.887 -1.685 . . . . 53.46 108.887 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 346' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -132.68 150.83 52.11 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.244 -1.151 . . . . 70.91 110.066 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 347' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 53.35 35.38 20.18 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.339 -0.85 . . . . 47.32 110.352 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 348' ' ' HIS . . . . . 0.41 ' HB3' ' O ' ' S' ' 344' ' ' LYS . 46.7 t60 -150.17 155.86 40.56 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.265 -0.897 . . . . 41.72 110.317 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' S' S ' 349' ' ' ALA . . . . . 0.452 ' C ' HG13 ' S' ' 350' ' ' VAL . . . -149.75 151.26 33.33 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.306 -0.871 . . . . 22.91 110.487 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' S' S ' 350' ' ' VAL . . . . . 0.452 HG13 ' C ' ' S' ' 349' ' ' ALA . 34.6 m -149.08 169.66 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.465 -0.772 . . . . 21.09 110.014 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' S' S ' 351' ' ' PHE . . . . . 0.499 ' CD2' ' HB3' ' S' ' 258' ' ' GLN . 10.7 t80 -105.42 143.66 33.28 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.284 -0.885 . . . . 25.03 110.67 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' S' S ' 352' ' ' ALA . . . . . 0.485 ' HB3' ' CE2' ' S' ' 342' ' ' PHE . . . -147.73 151.71 36.53 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.617 -0.677 . . . . 23.81 109.742 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' S' S ' 353' ' ' CYS . . . . . . . . . . . . . 26.3 p -153.35 164.85 37.42 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.346 -0.846 . . . . 25.66 110.27 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 354' ' ' VAL . . . . . 0.562 HG22 ' CE2' ' S' ' 359' ' ' TRP . 56.4 t -75.97 118.47 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.378 -0.826 . . . . 34.27 110.025 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' S' S ' 355' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' S' ' 232' ' ' THR . 51.9 p -117.83 175.11 5.81 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.243 -0.911 . . . . 25.49 110.314 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' S' S ' 356' ' ' SER . . . . . . . . . . . . . 62.3 p -62.15 -17.72 58.77 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.395 -0.815 . . . . 31.24 110.716 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 357' ' ' ASN . . . . . . . . . . . . . 46.1 m-20 -106.97 14.18 26.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.149 -0.969 . . . . 28.61 110.604 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 358' ' ' GLY . . . . . . . . . . . . . . . 111.82 -152.83 17.6 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.031 -1.228 . . . . 22.01 110.031 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 359' ' ' TRP . . . . . 0.562 ' CE2' HG22 ' S' ' 354' ' ' VAL . 15.4 m95 -91.37 116.73 29.08 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.442 -1.034 . . . . 25.54 110.155 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' S' S ' 360' ' ' TYR . . . . . 0.421 ' HA ' ' HA ' ' S' ' 369' ' ' PRO . 1.3 m-85 -103.48 165.79 10.82 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.276 -0.89 . . . . 40.53 110.094 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' S' S ' 361' ' ' ALA . . . . . 0.433 ' HA ' ' O ' ' S' ' 351' ' ' PHE . . . -140.09 130.08 24.83 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.376 -0.828 . . . . 18.04 110.272 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' S' S ' 362' ' ' ILE . . . . . . . . . . . . . 88.9 mt -95.6 83.63 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.353 -0.842 . . . . 15.64 110.023 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 363' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' S' ' 365' ' ' GLU . 11.8 t0 -75.18 94.46 2.96 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.364 -0.835 . . . . 35.03 110.208 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' S' S ' 364' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 53.95 -89.39 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.543 -0.723 . . . . 46.72 110.524 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 365' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' S' ' 363' ' ' ASP . 23.8 mt-10 -122.64 19.11 10.36 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.058 -1.026 . . . . 56.2 110.233 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' S' S ' 366' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -118.01 125.06 49.63 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.231 -0.918 . . . . 51.02 110.368 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 367' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -107.06 127.08 53.15 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.321 -0.862 . . . . 37.59 110.101 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 368' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -165.44 159.55 13.88 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.3 -0.875 . . . . 31.47 110.427 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 369' ' ' PRO . . . . . 0.421 ' HA ' ' HA ' ' S' ' 360' ' ' TYR . 46.3 Cg_endo -72.83 139.63 30.75 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 O-C-N 123.872 1.459 . . . . 28.85 110.535 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' S' S ' 370' ' ' TRP . . . . . . . . . . . . . 67.4 t90 -167.24 113.5 0.76 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.362 -0.836 . . . . 26.94 110.007 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 371' ' ' THR . . . . . . . . . . . . . 59.4 m -74.74 113.03 20.4 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.433 -0.792 . . . . 20.19 110.057 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 372' ' ' PRO . . . . . 0.562 ' O ' HD11 ' S' ' 334' ' ' LEU . 47.7 Cg_endo -73.55 157.09 49.25 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 O-C-N 123.609 1.32 . . . . 28.68 110.583 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' S' S ' 373' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -90.57 147.13 35.72 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.415 -0.803 . . . . 35.72 109.93 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 374' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -76.03 -6.23 17.13 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.676 1.356 . . . . 30.89 110.534 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 375' ' ' SER . . . . . . . . . . . . . 69.4 p -104.39 -17.01 14.95 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.209 -0.932 . . . . 29.41 110.414 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 376' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -106.45 42.98 1.19 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.348 -0.845 . . . . 32.89 110.24 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 377' ' ' VAL . . . . . 0.601 ' O ' HG11 ' S' ' 327' ' ' VAL . 7.3 p -114.63 147.31 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.253 -0.905 . . . . 24.33 110.2 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' S' S ' 378' ' ' LEU . . . . . . . . . . . . . 52.2 mt -116.01 -58.02 2.15 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.426 -0.796 . . . . 24.37 109.626 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 379' ' ' VAL . . . . . 0.643 HG22 HG12 ' S' ' 326' ' ' VAL . 61.5 t -120.7 132.42 70.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.437 -0.789 . . . . 18.02 109.385 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' S' S ' 380' ' ' PHE . . . . . 0.472 ' CE1' ' HB2' ' S' ' 325' ' ' CYS . 14.5 p90 -142.59 173.92 11.11 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.427 -0.796 . . . . 29.35 110.675 -179.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' S' S ' 381' ' ' VAL . . . . . . . . . . . . . 58.1 t -120.03 107.36 39.92 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.512 -0.743 . . . . 16.34 109.413 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 382' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -71.31 145.63 48.9 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.68 1.358 . . . . 20.94 110.803 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' S' S ' 383' ' ' TYR . . . . . 0.978 ' O ' ' CB ' ' S' ' 384' ' ' ASP . 88.3 m-85 -61.11 -53.43 57.12 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.405 -0.809 . . . . 28.93 109.838 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' S' S ' 384' ' ' ASP . . . . . 0.978 ' CB ' ' O ' ' S' ' 383' ' ' TYR . 13.3 t70 . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.433 -0.792 . . . . 47.03 110.36 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 30' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 121.203 0.525 . . . . 43.36 110.212 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' R' R ' 31' ' ' LEU . . . . . . . . . . . . . 65.7 mt -134.86 140.65 45.98 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.286 -0.884 . . . . 22.93 110.306 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 32' ' ' THR . . . . . . . . . . . . . 69.1 m -87.61 110.51 20.43 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.433 -0.792 . . . . 22.34 109.962 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 33' ' ' LEU . . . . . 0.595 HD22 ' CE2' ' R' ' 62' ' ' TYR . 80.1 mt -62.35 -172.79 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.316 -0.865 . . . . 21.39 110.226 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 34' ' ' TYR . . . . . . . . . . . . . 37.0 p90 -74.65 -29.41 61.25 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.333 -0.855 . . . . 34.4 110.386 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 35' ' ' ASN . . . . . . . . . . . . . 48.3 p30 -77.79 -1.83 33.39 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.314 -0.866 . . . . 30.28 110.643 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.25 -16.56 59.48 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.784 -1.326 . . . . 36.25 109.784 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 37' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -59.04 161.79 4.82 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.373 -1.075 . . . . 53.8 110.405 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 38' ' ' LYS . . . . . . . . . . . . . 57.2 mttt -117.8 135.7 53.9 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.405 -0.809 . . . . 49.91 110.19 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 39' ' ' LYS . . . . . 0.405 ' HG2' ' CZ ' ' R' ' 41' ' ' PHE . 8.1 ttmt -138.73 143.66 39.17 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.319 -0.863 . . . . 35.69 110.235 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 40' ' ' THR . . . . . . . . . . . . . 23.4 m -102.56 127.91 49.43 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.287 -0.883 . . . . 34.84 110.308 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 41' ' ' PHE . . . . . 0.405 ' CZ ' ' HG2' ' R' ' 39' ' ' LYS . 96.6 m-85 -113.04 132.6 55.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.413 -0.804 . . . . 34.42 110.179 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 42' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -93.24 140.95 28.98 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.348 -0.845 . . . . 51.46 110.204 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 43' ' ' SER . . . . . . . . . . . . . 54.2 m -70.81 141.9 51.33 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.453 -0.779 . . . . 41.84 110.206 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.76 125.39 29.55 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.308 -0.87 . . . . 33.82 109.962 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 45' ' ' PRO . . . . . 0.424 ' HG2' ' ND2' ' R' ' 77' ' ' ASN . 45.6 Cg_endo -72.15 151.06 54.8 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.563 1.297 . . . . 30.27 110.66 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 46' ' ' ASN . . . . . 0.4 ' HA ' ' OD1' ' R' ' 50' ' ' ASN . 52.1 t-20 -124.28 109.92 13.97 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.415 -0.803 . . . . 35.1 109.999 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 47' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -120.34 -34.88 3.54 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.367 -0.833 . . . . 42.81 110.489 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 48' ' ' HIS . . . . . 0.44 ' NE2' HD11 ' R' ' 80' ' ' LEU . 73.3 m80 -105.76 45.23 0.98 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.328 -0.857 . . . . 49.97 110.263 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 49' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 50.27 34.68 9.16 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.345 -0.847 . . . . 61.32 110.199 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 50' ' ' ASN . . . . . 0.4 ' OD1' ' HA ' ' R' ' 46' ' ' ASN . 15.0 p-10 -86.29 43.8 1.09 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.426 -0.796 . . . . 51.5 110.706 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.11 -46.14 78.65 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.325 -0.86 . . . . 38.77 109.502 179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 52' ' ' TRP . . . . . 0.483 ' CD2' ' N ' ' R' ' 53' ' ' LEU . 68.2 p-90 -58.35 -38.43 77.18 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.504 -0.747 . . . . 26.24 110.055 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 53' ' ' LEU . . . . . 0.483 ' N ' ' CD2' ' R' ' 52' ' ' TRP . 23.1 tp -66.68 -46.72 74.72 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.362 -0.836 . . . . 26.75 109.958 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 54' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -55.15 -41.66 72.11 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.341 -0.85 . . . . 35.02 110.14 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.24 -46.04 92.03 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.369 -0.832 . . . . 24.47 110.141 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 56' ' ' ILE . . . . . 0.432 HG12 HD11 ' R' ' 104' ' ' ILE . 76.1 mt -62.1 -42.32 94.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.213 -0.93 . . . . 26.03 109.92 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 57' ' ' LEU . . . . . . . . . . . . . 22.4 mt -60.31 -45.63 92.71 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.336 -0.853 . . . . 26.77 109.68 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 58' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -63.92 -46.48 84.59 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.521 -0.737 . . . . 22.32 109.594 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 59' ' ' LEU . . . . . 0.429 ' HA ' ' HE2' ' R' ' 151' ' ' PHE . 23.9 tp -61.45 -37.74 84.65 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.337 -0.852 . . . . 20.55 109.373 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 60' ' ' PHE . . . . . 0.528 ' CE2' HD21 ' R' ' 111' ' ' LEU . 2.8 m-85 -61.04 -44.84 96.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.628 -0.67 . . . . 20.08 109.921 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 61' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -63.0 -36.22 82.83 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.504 -0.747 . . . . 18.8 110.532 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 62' ' ' TYR . . . . . 0.595 ' CE2' HD22 ' R' ' 33' ' ' LEU . 9.2 t80 -63.16 -41.73 99.31 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.157 -0.964 . . . . 26.45 110.213 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 63' ' ' VAL . . . . . 0.406 ' H ' HG22 ' R' ' 63' ' ' VAL . 30.4 m -93.34 20.3 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.199 -0.938 . . . . 29.75 110.185 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 64' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 52.94 75.56 0.24 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.369 -0.832 . . . . 35.52 110.556 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 65' ' ' GLU . . . . . 0.442 ' HG2' ' CD2' ' R' ' 60' ' ' PHE . 14.3 tp10 -116.29 104.02 52.38 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.424 -0.797 . . . . 29.89 109.866 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 66' ' ' PRO . . . . . 0.481 ' HA ' ' HB2' ' R' ' 69' ' ' ASP . 46.8 Cg_endo -73.48 -5.89 17.86 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.708 1.372 . . . . 21.37 111.109 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 67' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -52.09 -61.52 2.21 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.144 -0.973 . . . . 23.85 110.375 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 68' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -98.11 36.51 1.56 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.312 -0.867 . . . . 28.07 110.512 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 69' ' ' ASP . . . . . 0.481 ' HB2' ' HA ' ' R' ' 66' ' ' PRO . 11.8 t0 -72.33 -33.23 67.18 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.296 -0.878 . . . . 43.76 110.18 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 70' ' ' TRP . . . . . 0.475 ' CE2' ' CG2' ' R' ' 71' ' ' VAL . 47.9 p-90 -73.4 -3.94 30.46 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.29 -0.881 . . . . 33.06 110.7 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 71' ' ' VAL . . . . . 0.557 HG11 ' HB2' ' R' ' 82' ' ' ALA . 40.9 t -109.75 -27.45 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.23 -0.919 . . . . 31.7 109.647 179.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 72' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -86.58 -48.84 7.99 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.407 -0.808 . . . . 33.58 110.294 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 73' ' ' SER . . . . . . . . . . . . . 69.9 m -89.63 50.96 1.99 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.338 -0.851 . . . . 50.82 110.379 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 74' ' ' SER . . . . . . . . . . . . . 16.0 t -125.82 138.32 31.77 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.226 -0.921 . . . . 34.74 110.265 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.33 -24.98 16.01 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.672 1.354 . . . . 35.7 110.336 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 76' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -91.71 153.2 19.8 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.476 -0.765 . . . . 66.48 110.343 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 77' ' ' ASN . . . . . 0.424 ' ND2' ' HG2' ' R' ' 45' ' ' PRO . 22.2 t-20 -81.47 95.26 7.03 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.298 -0.876 . . . . 46.72 110.114 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 78' ' ' LEU . . . . . . . . . . . . . 96.3 mt -96.43 27.93 3.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.338 -0.851 . . . . 37.55 110.191 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 79' ' ' THR . . . . . . . . . . . . . 29.5 m -56.2 -54.65 42.65 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.329 -0.857 . . . . 37.36 110.295 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 80' ' ' LEU . . . . . 0.603 ' HA ' HD12 ' R' ' 83' ' ' ILE . 15.9 mt -60.81 -23.29 64.95 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.337 -0.852 . . . . 35.83 110.549 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 81' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -79.5 -39.12 32.82 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.229 -0.919 . . . . 44.03 110.321 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 82' ' ' ALA . . . . . 0.557 ' HB2' HG11 ' R' ' 71' ' ' VAL . . . -69.49 -28.6 66.2 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.224 -0.923 . . . . 32.54 110.256 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 83' ' ' ILE . . . . . 0.603 HD12 ' HA ' ' R' ' 80' ' ' LEU . 78.2 mt -70.16 -46.12 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.308 -0.87 . . . . 32.02 110.302 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 84' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -55.15 -52.08 64.42 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.193 -0.942 . . . . 34.09 110.611 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 85' ' ' GLN . . . . . 0.533 ' HG2' HD12 ' R' ' 89' ' ' LEU . 31.9 tt0 -54.83 -46.85 74.64 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.206 -0.934 . . . . 25.94 110.249 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 86' ' ' LEU . . . . . . . . . . . . . 24.0 mt -58.7 -43.81 90.17 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.332 -0.855 . . . . 16.2 109.91 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 87' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -65.38 -35.17 80.16 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.391 -0.818 . . . . 49.09 110.251 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 88' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -78.48 -19.08 53.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.345 -0.847 . . . . 28.61 110.522 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 89' ' ' LEU . . . . . 0.533 HD12 ' HG2' ' R' ' 85' ' ' GLN . 32.7 mt -96.15 -29.4 14.09 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.304 -0.872 . . . . 26.16 110.22 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 90' ' ' THR . . . . . . . . . . . . . 60.4 p -105.7 -34.55 7.67 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.284 -0.885 . . . . 33.33 109.763 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.77 16.18 58.6 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.862 -1.295 . . . . 31.13 109.862 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 92' ' ' LEU . . . . . . . . . . . . . 97.1 mt -100.18 155.19 17.89 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.213 -1.169 . . . . 42.52 110.229 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 93' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -86.17 91.64 8.51 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.567 -0.708 . . . . 68.46 110.038 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 94' ' ' LEU . . . . . 0.458 ' HB3' ' CZ2' ' R' ' 52' ' ' TRP . 48.3 mt -99.46 53.0 0.94 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.289 -0.882 . . . . 44.63 110.33 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 95' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.44 -38.71 6.38 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.3 -0.875 . . . . 67.16 110.395 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 96' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -113.9 44.32 1.66 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.364 -0.835 . . . . 67.02 110.238 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 97' ' ' GLY . . . . . . . . . . . . . . . 99.12 150.78 26.03 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.634 -1.387 . . . . 49.48 109.634 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 98' ' ' GLY . . . . . . . . . . . . . . . -166.22 160.07 33.5 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.294 -1.522 . . . . 36.57 109.294 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 99' ' ' PRO . . . . . 0.79 ' O ' HG23 ' R' ' 103' ' ' VAL . 45.7 Cg_endo -72.59 121.07 7.1 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.645 1.34 . . . . 30.41 110.413 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 100' ' ' PRO . . . . . 0.412 ' HA ' HD11 ' R' ' 56' ' ' ILE . 45.8 Cg_endo -72.25 -31.67 11.48 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 O-C-N 123.645 1.339 . . . . 29.94 110.53 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 101' ' ' ALA . . . . . 0.476 ' HB2' ' HB3' ' R' ' 178' ' ' LEU . . . -70.02 -38.4 75.91 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.226 -0.921 . . . . 23.64 110.233 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 102' ' ' LEU . . . . . 0.424 HD23 HD21 ' R' ' 106' ' ' ASN . 0.1 OUTLIER -72.67 -40.71 66.07 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.358 -0.839 . . . . 20.31 110.386 -179.78 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' R' R ' 103' ' ' VAL . . . . . 0.79 HG23 ' O ' ' R' ' 99' ' ' PRO . 64.3 t -58.25 -40.02 76.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.195 -0.941 . . . . 16.33 109.984 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 104' ' ' ILE . . . . . 0.432 HD11 HG12 ' R' ' 56' ' ' ILE . 81.6 mt -71.68 -30.6 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.397 -0.814 . . . . 24.77 109.966 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 105' ' ' TRP . . . . . 0.463 ' O ' ' HD3' ' R' ' 108' ' ' LYS . 70.5 t-105 -82.41 0.85 40.15 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.292 -0.88 . . . . 23.28 110.31 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 106' ' ' ASN . . . . . 0.424 HD21 HD23 ' R' ' 102' ' ' LEU . 6.9 m-80 -105.07 -10.35 17.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.171 -0.956 . . . . 28.26 110.118 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 107' ' ' ILE . . . . . . . . . . . . . 36.7 pt -126.88 35.08 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.254 -0.904 . . . . 18.77 109.966 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 108' ' ' LYS . . . . . 0.502 ' HG2' ' HB ' ' R' ' 115' ' ' ILE . 9.2 mtpp -61.12 -48.41 81.78 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.56 -0.713 . . . . 42.5 110.049 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 109' ' ' HIS . . . . . 0.444 ' CD2' ' HG ' ' R' ' 110' ' ' LEU . 50.8 p-80 -66.02 -12.85 58.07 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.456 -0.777 . . . . 20.07 110.698 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 110' ' ' LEU . . . . . 0.444 ' HG ' ' CD2' ' R' ' 109' ' ' HIS . 80.3 mt -94.79 -17.25 22.31 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.076 -1.015 . . . . 15.69 110.207 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 111' ' ' LEU . . . . . 0.528 HD21 ' CE2' ' R' ' 60' ' ' PHE . 10.3 mt -94.13 144.16 25.74 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.342 -0.849 . . . . 25.39 111.014 -179.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 112' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -77.71 -17.36 57.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.51 -0.744 . . . . 53.48 109.846 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 113' ' ' THR . . . . . 0.459 HG22 ' N ' ' R' ' 114' ' ' GLY . 59.8 m -83.76 166.67 17.83 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.273 -0.892 . . . . 14.8 110.193 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 114' ' ' GLY . . . . . 0.459 ' N ' HG22 ' R' ' 113' ' ' THR . . . -97.99 127.1 9.11 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.042 -1.223 . . . . 16.14 110.042 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 115' ' ' ILE . . . . . 0.577 HD13 ' HB ' ' R' ' 124' ' ' VAL . 47.7 mm -109.01 139.46 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.503 -0.998 . . . . 13.46 109.674 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 116' ' ' GLY . . . . . . . . . . . . . . . -152.84 -155.89 7.31 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.932 -1.267 . . . . 23.9 109.932 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 117' ' ' THR . . . . . 0.53 HG22 ' CG2' ' R' ' 126' ' ' VAL . 18.5 p -135.03 -171.39 2.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.451 -1.029 . . . . 27.37 110.079 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 118' ' ' ALA . . . . . 0.445 ' HB3' ' OD1' ' R' ' 128' ' ' ASP . . . -56.52 -58.14 9.32 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.246 -0.909 . . . . 18.76 110.074 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 119' ' ' SER . . . . . . . . . . . . . 1.2 m -56.51 -40.48 75.09 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.351 -0.843 . . . . 32.35 109.838 179.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 120' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 -110.12 86.21 4.9 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.411 -0.806 . . . . 27.12 109.69 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 121' ' ' PRO . . . . . 0.483 ' HA ' ' SG ' ' R' ' 125' ' ' CYS . 44.0 Cg_endo -71.26 166.49 29.09 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 O-C-N 123.903 1.475 . . . . 22.68 111.035 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 122' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' R' ' 121' ' ' PRO . 38.6 t 178.55 -161.7 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.609 -0.682 . . . . 22.99 109.455 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 123' ' ' GLU . . . . . 0.442 ' HG2' HG23 ' R' ' 113' ' ' THR . 2.3 tp10 -56.44 -40.01 74.06 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.216 -0.928 . . . . 36.18 109.63 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 124' ' ' VAL . . . . . 0.577 ' HB ' HD13 ' R' ' 115' ' ' ILE . 82.2 t -142.5 136.4 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.62 -0.675 . . . . 20.64 109.457 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 125' ' ' CYS . . . . . 0.483 ' SG ' ' HA ' ' R' ' 121' ' ' PRO . 83.0 m -140.23 168.21 20.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.193 -0.942 . . . . 22.8 111.206 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 126' ' ' VAL . . . . . 0.73 HG12 HG22 ' R' ' 179' ' ' VAL . 35.9 m -122.78 159.72 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.733 -0.604 . . . . 21.24 109.574 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 127' ' ' VAL . . . . . 0.709 HG11 ' O ' ' R' ' 177' ' ' VAL . 30.4 m -70.76 141.82 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.305 -0.872 . . . . 19.77 110.734 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 128' ' ' ASP . . . . . 0.445 ' OD1' ' HB3' ' R' ' 118' ' ' ALA . 53.8 p-10 -137.74 19.41 2.87 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.417 -0.802 . . . . 29.21 110.66 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 129' ' ' GLY . . . . . . . . . . . . . . . 114.0 0.04 24.14 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.939 -1.124 . . . . 33.86 110.527 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 130' ' ' THR . . . . . . . . . . . . . 58.4 m -91.94 131.81 36.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.135 -1.215 . . . . 26.41 110.046 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -62.43 120.64 11.46 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.317 -0.865 . . . . 33.08 110.336 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 132' ' ' MET . . . . . 0.433 ' HE1' ' CE2' ' R' ' 180' ' ' PHE . 98.5 mmm -105.24 165.64 10.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.482 -0.761 . . . . 30.76 110.409 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 133' ' ' CYS . . . . . 0.411 ' HA ' ' HB3' ' R' ' 174' ' ' PRO . 32.2 m -141.12 158.23 44.2 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.451 -0.78 . . . . 27.0 109.956 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 134' ' ' LEU . . . . . 0.565 HD11 ' O ' ' R' ' 172' ' ' PRO . 0.1 OUTLIER -58.53 -19.74 40.24 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.232 -0.918 . . . . 33.9 110.515 -179.86 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' R' R ' 135' ' ' ALA . . . . . . . . . . . . . . . -92.66 8.11 40.55 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.344 -0.848 . . . . 19.37 110.833 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 136' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -93.7 -21.88 19.08 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.165 -0.96 . . . . 30.47 110.178 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 137' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -149.91 165.3 33.01 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.351 -0.843 . . . . 24.27 110.241 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 138' ' ' HIS . . . . . 0.434 ' HA ' HG23 ' R' ' 154' ' ' VAL . 15.1 p80 -117.79 15.18 14.41 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.422 -0.798 . . . . 20.91 110.417 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 139' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' R' ' 152' ' ' ALA . . . -177.23 152.4 0.87 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.187 -0.946 . . . . 15.69 110.157 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 140' ' ' GLY . . . . . 0.428 ' HA3' ' O ' ' R' ' 179' ' ' VAL . . . 161.83 175.09 32.49 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.881 -1.288 . . . . 23.76 109.881 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 141' ' ' ILE . . . . . . . . . . . . . 83.7 mt -95.5 136.63 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.435 -1.038 . . . . 25.3 109.691 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 142' ' ' PHE . . . . . 0.578 ' CD2' ' HB2' ' R' ' 172' ' ' PRO . 82.9 m-85 -120.77 -172.66 2.43 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.27 -0.894 . . . . 30.24 110.524 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 143' ' ' LEU . . . . . 0.742 HD23 ' O ' ' R' ' 148' ' ' HIS . 0.5 OUTLIER -119.78 77.73 1.26 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.426 -0.796 . . . . 32.8 110.295 -179.879 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' R' R ' 144' ' ' LYS . . . . . 0.471 ' HG3' ' CZ2' ' R' ' 170' ' ' TRP . 1.0 OUTLIER -69.55 76.78 0.42 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.437 -0.789 . . . . 49.18 109.68 179.541 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' R' R ' 145' ' ' GLY . . . . . 0.458 ' O ' HD22 ' R' ' 143' ' ' LEU . . . 104.62 179.24 24.71 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.139 -1.584 . . . . 53.87 109.139 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 146' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -88.46 145.83 25.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.388 -1.066 . . . . 68.58 110.053 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 147' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 58.27 36.46 25.66 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.256 -0.902 . . . . 56.62 110.611 179.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 148' ' ' HIS . . . . . 0.742 ' O ' HD23 ' R' ' 143' ' ' LEU . 44.6 t60 -158.58 148.14 19.33 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.205 -0.934 . . . . 44.57 110.422 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 149' ' ' ALA . . . . . . . . . . . . . . . -150.27 146.83 27.02 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.467 -0.771 . . . . 33.54 110.082 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 150' ' ' VAL . . . . . . . . . . . . . 34.2 m -142.28 161.54 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.231 -0.918 . . . . 27.61 110.309 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 151' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' R' ' 152' ' ' ALA . 5.8 t80 -86.21 155.53 20.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.4 -0.812 . . . . 23.04 109.907 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 152' ' ' ALA . . . . . 0.537 ' N ' ' CD1' ' R' ' 151' ' ' PHE . . . -157.22 151.53 25.05 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.499 -0.75 . . . . 29.61 109.565 179.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 153' ' ' CYS . . . . . . . . . . . . . 26.7 p -154.33 173.54 16.04 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.234 -0.916 . . . . 22.75 110.556 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 154' ' ' VAL . . . . . 0.614 HG22 ' CE2' ' R' ' 159' ' ' TRP . 60.0 t -90.56 116.97 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.443 -0.785 . . . . 23.26 110.078 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 155' ' ' THR . . . . . . . . . . . . . 70.7 p -112.08 -176.65 2.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.347 -0.846 . . . . 17.88 110.034 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 156' ' ' SER . . . . . . . . . . . . . 78.5 p -75.98 -3.64 36.72 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.329 -0.857 . . . . 21.83 110.697 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 157' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -118.32 10.48 12.8 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.159 -0.963 . . . . 36.54 110.603 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 158' ' ' GLY . . . . . . . . . . . . . . . 117.99 -162.62 13.05 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.547 -1.421 . . . . 31.74 109.547 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 159' ' ' TRP . . . . . 0.614 ' CE2' HG22 ' R' ' 154' ' ' VAL . 14.8 m95 -86.6 122.4 30.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.285 -1.127 . . . . 28.25 110.092 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 160' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -108.4 167.01 10.34 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.448 -0.783 . . . . 41.24 110.212 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 161' ' ' ALA . . . . . . . . . . . . . . . -143.24 123.43 13.72 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.355 -0.841 . . . . 27.4 110.208 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 162' ' ' ILE . . . . . . . . . . . . . 92.1 mt -87.6 81.17 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.362 -0.837 . . . . 24.27 110.078 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 163' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' R' ' 165' ' ' GLU . 15.4 t0 -72.92 92.36 1.62 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.438 -0.789 . . . . 36.08 110.246 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 164' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 54.13 -88.94 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.542 -0.724 . . . . 46.08 110.565 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 165' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' R' ' 163' ' ' ASP . 29.6 mt-10 -124.75 36.01 4.68 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.052 -1.03 . . . . 50.94 110.199 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 166' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -135.8 117.32 14.82 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.397 -0.814 . . . . 47.28 110.324 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 167' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -100.98 119.95 39.48 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.434 -0.791 . . . . 40.47 110.134 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 168' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -157.6 158.54 30.6 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.29 -0.881 . . . . 30.21 110.399 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 169' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.8 133.04 19.46 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.931 1.49 . . . . 32.76 110.474 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 170' ' ' TRP . . . . . 0.471 ' CZ2' ' HG3' ' R' ' 144' ' ' LYS . 67.0 t90 -159.78 119.3 2.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.416 -0.802 . . . . 32.79 109.928 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 171' ' ' THR . . . . . . . . . . . . . 46.6 m -81.06 112.6 33.95 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.437 -0.789 . . . . 36.92 110.184 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 172' ' ' PRO . . . . . 0.578 ' HB2' ' CD2' ' R' ' 142' ' ' PHE . 47.2 Cg_endo -73.74 158.83 46.48 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.66 1.348 . . . . 33.54 110.519 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 173' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -88.84 144.97 33.85 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.362 -0.836 . . . . 45.76 109.911 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 174' ' ' PRO . . . . . 0.411 ' HB3' ' HA ' ' R' ' 133' ' ' CYS . 45.9 Cg_endo -71.73 -10.41 26.44 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 O-C-N 123.675 1.355 . . . . 29.63 110.499 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 175' ' ' SER . . . . . . . . . . . . . 53.1 p -103.48 -17.47 15.2 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.299 -0.876 . . . . 35.7 110.369 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 176' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -103.5 43.19 1.1 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.24 -0.913 . . . . 39.65 110.423 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 177' ' ' VAL . . . . . 0.709 ' O ' HG11 ' R' ' 127' ' ' VAL . 10.5 p -117.72 127.17 75.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.368 -0.832 . . . . 20.61 110.041 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 178' ' ' LEU . . . . . 0.476 ' HB3' ' HB2' ' R' ' 101' ' ' ALA . 45.9 mt -91.5 -61.23 1.69 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.424 -0.798 . . . . 15.58 109.464 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 179' ' ' VAL . . . . . 0.73 HG22 HG12 ' R' ' 126' ' ' VAL . 67.4 t -114.6 144.7 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.579 -0.7 . . . . 17.4 109.443 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 180' ' ' PHE . . . . . 0.433 ' CE2' ' HE1' ' R' ' 132' ' ' MET . 43.4 p90 -152.11 163.37 39.48 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.273 -0.892 . . . . 20.16 110.562 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 181' ' ' VAL . . . . . . . . . . . . . 66.9 t -113.2 111.49 50.17 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.468 -0.77 . . . . 17.69 109.795 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 182' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.03 149.51 52.86 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.577 1.304 . . . . 17.81 110.423 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' R' R ' 183' ' ' TYR . . . . . 0.706 ' O ' ' C ' ' R' ' 184' ' ' ASP . 79.0 m-85 -59.01 175.54 0.28 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.459 -0.775 . . . . 28.01 110.549 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 184' ' ' ASP . . . . . 0.706 ' C ' ' O ' ' R' ' 183' ' ' TYR . 6.0 t70 -18.36 -82.2 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.3 -0.875 . . . . 58.64 110.232 -178.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' R' R ' 185' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 . . . . . 0 N--CA 1.504 2.232 0 CA-C-O 121.272 0.558 . . . . 80.42 111.721 179.566 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' R' R ' 193' ' ' LYS . . . . . . . . . . . . . 15.0 pttt . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 120.898 0.38 . . . . 49.5 110.157 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' R' R ' 194' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.835 0 O-C-N 121.144 -0.973 . . . . 40.4 110.156 179.92 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' S' S ' 229' ' ' MET . . . . . . . . . . . . . 5.8 mtm . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 121.176 0.513 . . . . 51.83 110.191 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' S' S ' 230' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -97.27 142.73 28.8 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.318 -0.864 . . . . 54.13 110.161 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' S' S ' 231' ' ' LEU . . . . . . . . . . . . . 67.9 mt -134.12 141.04 46.98 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.391 -0.818 . . . . 33.04 110.343 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' S' S ' 232' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' S' ' 355' ' ' THR . 40.7 m -89.26 103.26 15.9 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.381 -0.824 . . . . 26.92 110.04 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' S' S ' 233' ' ' LEU . . . . . 0.67 HD22 ' CE2' ' S' ' 262' ' ' TYR . 79.9 mt -56.0 179.31 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.43 -0.794 . . . . 13.78 110.463 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' S' S ' 234' ' ' TYR . . . . . 0.446 ' CG ' ' N ' ' S' ' 235' ' ' ASN . 35.6 p90 -65.02 -35.69 81.99 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.361 -0.837 . . . . 26.08 110.148 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' S' S ' 235' ' ' ASN . . . . . 0.446 ' N ' ' CG ' ' S' ' 234' ' ' TYR . 50.7 p30 -74.3 -7.44 52.78 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.428 -0.795 . . . . 20.04 110.596 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' S' S ' 236' ' ' GLY . . . . . . . . . . . . . . . 95.76 -19.92 52.15 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.781 -1.328 . . . . 22.71 109.781 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' S' S ' 237' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -52.98 145.65 12.48 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.18 -1.188 . . . . 35.44 110.276 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' S' S ' 238' ' ' LYS . . . . . . . . . . . . . 44.4 mttt -102.18 127.91 48.91 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.396 -0.815 . . . . 32.56 110.434 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' S' S ' 239' ' ' LYS . . . . . 0.409 ' HG2' ' CZ ' ' S' ' 241' ' ' PHE . 9.0 ttmt -132.26 144.54 50.68 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.391 -0.818 . . . . 26.68 110.004 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' S' S ' 240' ' ' THR . . . . . . . . . . . . . 51.9 m -102.02 132.2 48.01 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.307 -0.871 . . . . 41.02 110.355 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' S' S ' 241' ' ' PHE . . . . . 0.409 ' CZ ' ' HG2' ' S' ' 239' ' ' LYS . 96.1 m-85 -117.91 137.62 52.69 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.379 -0.826 . . . . 28.62 110.253 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' S' S ' 242' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -96.35 161.83 13.76 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.34 -0.85 . . . . 47.89 110.188 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' S' S ' 243' ' ' SER . . . . . . . . . . . . . 72.1 m -90.57 151.56 21.27 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.29 -0.881 . . . . 45.09 110.29 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' S' S ' 244' ' ' ARG . . . . . . . . . . . . . 1.4 mtp85 -129.77 126.73 22.7 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.416 -0.802 . . . . 42.49 110.263 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' S' S ' 245' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.35 160.98 43.77 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.617 1.325 . . . . 35.68 110.551 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' S' S ' 246' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -132.84 97.77 4.13 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.325 -0.859 . . . . 51.88 109.873 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' S' S ' 247' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -110.45 -22.24 11.77 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.32 -0.863 . . . . 53.69 110.649 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' S' S ' 248' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -117.26 43.67 2.27 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.182 -0.949 . . . . 55.79 110.708 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' S' S ' 249' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 48.78 38.46 11.88 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.485 -0.759 . . . . 49.45 110.363 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' S' S ' 250' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -90.57 28.95 1.38 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.552 -0.717 . . . . 36.86 110.325 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' S' S ' 251' ' ' ALA . . . . . . . . . . . . . . . -53.79 -43.19 69.08 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.286 -0.884 . . . . 29.69 109.621 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' S' S ' 252' ' ' TRP . . . . . 0.428 ' CZ2' ' HB3' ' S' ' 294' ' ' LEU . 67.8 p-90 -61.82 -33.9 74.98 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.51 -0.744 . . . . 41.12 109.802 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' S' S ' 253' ' ' LEU . . . . . 0.402 ' N ' ' CD2' ' S' ' 252' ' ' TRP . 23.4 tp -70.15 -47.3 62.27 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.422 -0.799 . . . . 24.89 109.955 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' S' S ' 254' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -56.06 -42.43 76.61 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.308 -0.87 . . . . 35.65 110.031 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' S' S ' 255' ' ' ALA . . . . . . . . . . . . . . . -59.61 -48.19 82.63 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.427 -0.795 . . . . 22.73 110.042 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' S' S ' 256' ' ' ILE . . . . . 0.504 HG12 HD11 ' S' ' 304' ' ' ILE . 79.7 mt -62.35 -40.6 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.308 -0.87 . . . . 28.85 110.014 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' S' S ' 257' ' ' LEU . . . . . 0.402 ' CD2' ' HB3' ' S' ' 268' ' ' PHE . 19.4 mt -61.52 -44.49 96.97 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.286 -0.884 . . . . 23.07 110.216 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' S' S ' 258' ' ' GLN . . . . . 0.501 ' HB3' ' CD2' ' S' ' 351' ' ' PHE . 53.4 mm-40 -65.05 -45.35 85.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.382 -0.824 . . . . 29.78 109.947 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' S' S ' 259' ' ' LEU . . . . . 0.421 ' O ' HG22 ' S' ' 263' ' ' VAL . 19.8 tp -58.66 -36.41 74.11 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.299 -0.876 . . . . 17.94 109.405 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' S' S ' 260' ' ' PHE . . . . . 0.533 ' CE2' HD21 ' S' ' 311' ' ' LEU . 3.1 m-85 -62.86 -45.22 93.57 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.593 -0.692 . . . . 30.57 109.872 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' S' S ' 261' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -62.06 -29.81 70.55 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.383 -0.823 . . . . 41.34 109.995 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' S' S ' 262' ' ' TYR . . . . . 0.67 ' CE2' HD22 ' S' ' 233' ' ' LEU . 8.6 t80 -71.24 -44.59 65.02 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.37 -0.831 . . . . 26.03 110.086 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' S' S ' 263' ' ' VAL . . . . . 0.421 HG22 ' O ' ' S' ' 259' ' ' LEU . 33.2 m -92.1 18.34 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.417 -0.802 . . . . 22.8 110.35 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' S' S ' 264' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 52.78 70.67 0.55 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.292 -0.88 . . . . 44.03 110.59 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' S' S ' 265' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -111.8 109.18 55.45 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.375 -0.828 . . . . 35.61 109.622 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' S' S ' 266' ' ' PRO . . . . . 0.478 ' HA ' ' HB2' ' S' ' 269' ' ' ASP . 49.8 Cg_endo -75.25 0.39 9.06 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 123.65 1.342 . . . . 37.67 111.826 -179.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' S' S ' 267' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -56.52 -67.71 0.28 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.76 -1.213 . . . . 41.49 110.17 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' S' S ' 268' ' ' PHE . . . . . 0.402 ' HB3' ' CD2' ' S' ' 257' ' ' LEU . 22.3 m-85 -92.92 39.92 1.05 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.197 -0.939 . . . . 50.76 110.095 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' S' S ' 269' ' ' ASP . . . . . 0.478 ' HB2' ' HA ' ' S' ' 266' ' ' PRO . 0.9 OUTLIER -76.01 -33.17 59.67 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.428 -0.795 . . . . 61.86 109.795 179.533 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' S' S ' 270' ' ' TRP . . . . . 0.51 ' CE2' HG23 ' S' ' 271' ' ' VAL . 50.9 p-90 -73.96 -4.26 34.1 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.28 -0.888 . . . . 39.85 110.501 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' S' S ' 271' ' ' VAL . . . . . 0.51 HG23 ' CE2' ' S' ' 270' ' ' TRP . 46.4 t -109.48 -32.82 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.121 -0.987 . . . . 39.18 110.058 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' S' S ' 272' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -78.59 -36.57 44.14 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.327 -0.858 . . . . 40.02 110.538 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' S' S ' 273' ' ' SER . . . . . . . . . . . . . 71.2 m -103.51 56.11 0.74 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.267 -0.896 . . . . 47.2 110.388 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' S' S ' 274' ' ' SER . . . . . . . . . . . . . 6.9 t -133.04 141.25 40.24 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.298 -0.876 . . . . 47.61 110.129 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' S' S ' 275' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.7 -18.88 21.84 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 O-C-N 123.72 1.379 . . . . 45.28 110.533 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' S' S ' 276' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -99.94 140.89 33.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.294 -0.879 . . . . 57.27 110.314 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' S' S ' 277' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -71.75 97.7 1.82 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.387 -0.821 . . . . 37.28 110.254 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' S' S ' 278' ' ' LEU . . . . . . . . . . . . . 86.3 mt -97.03 33.84 1.84 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.382 -0.824 . . . . 43.88 110.001 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' S' S ' 279' ' ' THR . . . . . . . . . . . . . 76.4 m -63.99 -60.17 3.58 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.416 -0.802 . . . . 50.05 110.282 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' S' S ' 280' ' ' LEU . . . . . 0.73 ' HA ' HD12 ' S' ' 283' ' ' ILE . 13.7 mt -51.51 -39.99 58.7 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.32 -0.862 . . . . 54.12 110.283 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' S' S ' 281' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.38 -49.64 74.74 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.435 -0.79 . . . . 65.28 110.161 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' S' S ' 282' ' ' ALA . . . . . . . . . . . . . . . -59.04 -33.9 71.3 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.438 -0.789 . . . . 46.51 110.499 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' S' S ' 283' ' ' ILE . . . . . 0.73 HD12 ' HA ' ' S' ' 280' ' ' LEU . 85.6 mt -66.25 -50.93 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.288 -0.883 . . . . 47.3 110.118 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' S' S ' 284' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -50.56 -57.56 7.85 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.388 -0.82 . . . . 50.72 110.405 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' S' S ' 285' ' ' GLN . . . . . 0.527 ' HG2' HD12 ' S' ' 289' ' ' LEU . 34.4 tt0 -51.41 -46.43 62.91 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.471 -0.768 . . . . 68.47 110.252 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' S' S ' 286' ' ' LEU . . . . . . . . . . . . . 19.1 mt -60.02 -44.49 94.57 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.403 -0.811 . . . . 36.62 110.202 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' S' S ' 287' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -62.71 -35.33 79.39 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.387 -0.82 . . . . 46.64 110.076 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' S' S ' 288' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -76.22 -21.04 56.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.353 -0.842 . . . . 46.45 110.292 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' S' S ' 289' ' ' LEU . . . . . 0.527 HD12 ' HG2' ' S' ' 285' ' ' GLN . 31.0 mt -97.29 -21.78 17.05 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.254 -0.904 . . . . 35.09 110.568 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' S' S ' 290' ' ' THR . . . . . 0.41 HG22 ' HB3' ' S' ' 306' ' ' ASN . 81.3 p -114.76 -28.44 7.09 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.252 -0.905 . . . . 38.61 110.403 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' S' S ' 291' ' ' GLY . . . . . . . . . . . . . . . 79.37 10.96 85.44 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.847 -1.301 . . . . 36.77 109.847 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' S' S ' 292' ' ' LEU . . . . . . . . . . . . . 84.7 mt -96.43 145.82 25.32 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.271 -1.135 . . . . 35.33 109.803 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' S' S ' 293' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -77.36 102.39 6.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.163 -0.96 . . . . 48.7 110.257 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' S' S ' 294' ' ' LEU . . . . . 0.428 ' HB3' ' CZ2' ' S' ' 252' ' ' TRP . 56.2 mt -107.03 51.8 0.73 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.526 -0.734 . . . . 42.61 110.074 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' S' S ' 295' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -112.51 -11.21 13.64 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.343 -0.848 . . . . 55.49 110.523 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' S' S ' 296' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -144.33 48.62 1.36 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.123 -0.986 . . . . 75.68 110.291 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' S' S ' 297' ' ' GLY . . . . . . . . . . . . . . . 96.85 145.09 18.53 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.555 -1.418 . . . . 49.44 109.555 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' S' S ' 298' ' ' GLY . . . . . . . . . . . . . . . -163.77 157.03 29.14 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.77 -1.332 . . . . 41.11 109.77 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' S' S ' 299' ' ' PRO . . . . . 0.486 ' O ' HG23 ' S' ' 303' ' ' VAL . 47.3 Cg_endo -73.91 118.31 5.38 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 123.917 1.483 . . . . 26.2 110.304 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' S' S ' 300' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.26 -15.43 31.63 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 O-C-N 123.616 1.324 . . . . 21.7 110.693 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' S' S ' 301' ' ' ALA . . . . . . . . . . . . . . . -80.75 -29.37 36.28 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.192 -0.942 . . . . 31.23 110.073 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' S' S ' 302' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.45 -40.72 18.93 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.409 -0.807 . . . . 38.99 109.969 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' S' S ' 303' ' ' VAL . . . . . 0.486 HG23 ' O ' ' S' ' 299' ' ' PRO . 58.0 t -60.67 -35.5 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.364 -0.835 . . . . 18.63 110.095 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' S' S ' 304' ' ' ILE . . . . . 0.524 HD12 HG21 ' S' ' 379' ' ' VAL . 86.1 mt -79.42 -23.58 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.431 -0.793 . . . . 25.46 110.153 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' S' S ' 305' ' ' TRP . . . . . 0.412 ' CD2' ' HD3' ' S' ' 308' ' ' LYS . 68.8 t-105 -88.69 -14.53 37.1 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.32 -0.862 . . . . 33.4 110.503 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' S' S ' 306' ' ' ASN . . . . . 0.41 ' HB3' HG22 ' S' ' 290' ' ' THR . 10.4 m-80 -89.68 -13.62 36.56 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.168 -0.957 . . . . 36.97 110.378 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' S' S ' 307' ' ' ILE . . . . . 0.473 HG12 ' O ' ' S' ' 303' ' ' VAL . 36.9 pt -125.1 45.59 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.266 -0.896 . . . . 30.81 110.045 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' S' S ' 308' ' ' LYS . . . . . 0.412 ' HD3' ' CD2' ' S' ' 305' ' ' TRP . 1.5 mtmp? -73.5 -37.79 65.56 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.366 -0.834 . . . . 46.52 110.086 -179.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' S' S ' 309' ' ' HIS . . . . . 0.496 ' CD2' ' HG ' ' S' ' 310' ' ' LEU . 55.5 p-80 -73.14 -8.38 55.51 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.284 -0.885 . . . . 51.03 110.097 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' S' S ' 310' ' ' LEU . . . . . 0.496 ' HG ' ' CD2' ' S' ' 309' ' ' HIS . 52.9 mt -99.25 -12.91 19.96 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.311 -0.868 . . . . 36.16 109.944 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' S' S ' 311' ' ' LEU . . . . . 0.533 HD21 ' CE2' ' S' ' 260' ' ' PHE . 10.8 mt -97.12 147.88 23.61 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.282 -0.886 . . . . 40.0 110.406 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' S' S ' 312' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -81.66 -16.3 51.79 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.28 -0.888 . . . . 54.18 109.68 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' S' S ' 313' ' ' THR . . . . . 0.824 HG23 ' HG2' ' S' ' 323' ' ' GLU . 92.6 m -87.9 151.63 22.68 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.322 -0.861 . . . . 25.61 110.125 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' S' S ' 314' ' ' GLY . . . . . . . . . . . . . . . -87.93 126.42 8.05 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.791 -1.324 . . . . 25.18 109.791 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' S' S ' 315' ' ' ILE . . . . . 0.669 HD13 ' HB ' ' S' ' 324' ' ' VAL . 50.7 mm -101.62 150.48 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.377 -1.072 . . . . 23.9 109.722 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' S' S ' 316' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' S' ' 325' ' ' CYS . . . -157.1 -159.26 9.38 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.006 -1.237 . . . . 23.18 110.006 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' S' S ' 317' ' ' THR . . . . . 0.423 HG22 ' CG2' ' S' ' 326' ' ' VAL . 11.1 p -133.89 -173.0 3.12 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.367 -1.078 . . . . 27.98 110.044 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' S' S ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.51 -56.26 24.12 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.239 -0.913 . . . . 28.1 109.885 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' S' S ' 319' ' ' SER . . . . . . . . . . . . . 1.2 m -59.93 -41.69 92.34 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.372 -0.83 . . . . 37.0 109.604 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' S' S ' 320' ' ' ARG . . . . . . . . . . . . . 12.1 mtm180 -111.71 79.84 2.64 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.483 -0.761 . . . . 52.07 109.717 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' S' S ' 321' ' ' PRO . . . . . 0.445 ' O ' ' HB2' ' S' ' 322' ' ' SER . 44.1 Cg_endo -71.44 171.47 16.13 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.853 1.449 . . . . 38.29 110.928 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' S' S ' 322' ' ' SER . . . . . 0.445 ' HB2' ' O ' ' S' ' 321' ' ' PRO . 41.5 t 178.73 -148.14 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.021 -0.733 . . . . 38.84 109.021 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' S' S ' 323' ' ' GLU . . . . . 0.824 ' HG2' HG23 ' S' ' 313' ' ' THR . 6.7 tp10 -62.86 -40.26 96.93 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.947 -1.096 . . . . 40.7 109.733 179.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' S' S ' 324' ' ' VAL . . . . . 0.669 ' HB ' HD13 ' S' ' 315' ' ' ILE . 73.2 t -141.26 135.0 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.502 -0.749 . . . . 20.34 109.462 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' S' S ' 325' ' ' CYS . . . . . 0.458 ' HB2' ' CE1' ' S' ' 380' ' ' PHE . 11.2 m -125.99 172.14 10.19 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.275 -0.891 . . . . 30.63 110.886 -179.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' S' S ' 326' ' ' VAL . . . . . 0.645 HG12 HG22 ' S' ' 379' ' ' VAL . 34.6 m -135.41 142.21 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.62 -0.675 . . . . 23.9 109.237 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' S' S ' 327' ' ' VAL . . . . . 0.594 HG11 ' O ' ' S' ' 377' ' ' VAL . 34.5 m -56.32 125.03 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.104 -0.998 . . . . 19.48 110.4 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' S' S ' 328' ' ' ASP . . . . . . . . . . . . . 55.6 p-10 -119.4 11.47 12.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.494 -0.754 . . . . 26.43 110.461 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' S' S ' 329' ' ' GLY . . . . . . . . . . . . . . . 119.68 2.31 13.04 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.027 -1.229 . . . . 31.24 110.027 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' S' S ' 330' ' ' THR . . . . . . . . . . . . . 77.4 m -92.98 130.01 38.7 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.104 -1.233 . . . . 30.05 110.132 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' S' S ' 331' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -56.81 111.54 1.05 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.321 -0.862 . . . . 37.26 110.005 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' S' S ' 332' ' ' MET . . . . . . . . . . . . . 88.1 mmm -94.09 162.56 13.83 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.336 -0.852 . . . . 26.23 110.347 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' S' S ' 333' ' ' CYS . . . . . . . . . . . . . 26.1 m -137.26 149.95 47.48 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.419 -0.801 . . . . 23.56 110.07 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' S' S ' 334' ' ' LEU . . . . . 0.565 HD11 ' O ' ' S' ' 372' ' ' PRO . 0.1 OUTLIER -52.54 -24.85 8.93 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.23 -0.919 . . . . 28.93 110.435 179.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' S' S ' 335' ' ' ALA . . . . . . . . . . . . . . . -89.05 14.4 10.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.32 -0.863 . . . . 15.76 110.896 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' S' S ' 336' ' ' ASP . . . . . 0.402 ' O ' ' HA ' ' S' ' 382' ' ' PRO . 70.4 m-20 -100.49 -17.19 17.26 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.191 -0.943 . . . . 34.92 110.13 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' S' S ' 337' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -152.33 170.86 19.03 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.295 -0.878 . . . . 19.03 110.068 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' S' S ' 338' ' ' HIS . . . . . 0.401 ' HB3' ' CZ ' ' S' ' 383' ' ' TYR . 13.4 p80 -120.71 10.33 10.96 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.354 -0.841 . . . . 18.82 110.432 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' S' S ' 339' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' S' ' 352' ' ' ALA . . . -175.96 155.17 1.57 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.291 -0.88 . . . . 17.18 110.065 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' S' S ' 340' ' ' GLY . . . . . 0.401 ' CA ' ' O ' ' S' ' 379' ' ' VAL . . . 160.87 173.09 29.05 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 110.067 -1.213 . . . . 18.33 110.067 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' S' S ' 341' ' ' ILE . . . . . . . . . . . . . 84.2 mt -88.85 138.14 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.444 -1.033 . . . . 18.6 109.766 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' S' S ' 342' ' ' PHE . . . . . 0.493 ' CE2' ' HB3' ' S' ' 352' ' ' ALA . 70.0 m-85 -120.99 -178.48 3.76 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.214 -0.929 . . . . 23.44 110.375 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' S' S ' 343' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.83 93.38 4.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.484 -0.76 . . . . 35.59 109.973 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' S' S ' 344' ' ' LYS . . . . . 0.403 ' O ' ' HB3' ' S' ' 348' ' ' HIS . 0.3 OUTLIER -80.82 125.01 29.56 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.229 -0.919 . . . . 38.34 110.107 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' S' S ' 345' ' ' GLY . . . . . . . . . . . . . . . 62.72 -130.86 43.27 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 108.87 -1.692 . . . . 53.46 108.87 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' S' S ' 346' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -132.66 150.9 52.09 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.212 -1.17 . . . . 70.91 110.065 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' S' S ' 347' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 53.25 35.4 19.97 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.34 -0.85 . . . . 47.32 110.395 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' S' S ' 348' ' ' HIS . . . . . 0.403 ' HB3' ' O ' ' S' ' 344' ' ' LYS . 46.6 t60 -150.11 155.85 40.58 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.279 -0.888 . . . . 41.72 110.369 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' S' S ' 349' ' ' ALA . . . . . 0.458 ' C ' HG13 ' S' ' 350' ' ' VAL . . . -149.8 151.24 33.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.281 -0.887 . . . . 22.91 110.543 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' S' S ' 350' ' ' VAL . . . . . 0.458 HG13 ' C ' ' S' ' 349' ' ' ALA . 34.6 m -149.05 169.61 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.421 -0.8 . . . . 21.09 110.017 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' S' S ' 351' ' ' PHE . . . . . 0.501 ' CD2' ' HB3' ' S' ' 258' ' ' GLN . 10.7 t80 -105.36 143.67 33.19 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.249 -0.907 . . . . 25.03 110.693 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' S' S ' 352' ' ' ALA . . . . . 0.493 ' HB3' ' CE2' ' S' ' 342' ' ' PHE . . . -147.74 151.72 36.55 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.52 -0.738 . . . . 23.81 109.807 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' S' S ' 353' ' ' CYS . . . . . . . . . . . . . 26.2 p -153.4 164.86 37.42 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.271 -0.893 . . . . 25.66 110.175 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' S' S ' 354' ' ' VAL . . . . . 0.55 HG22 ' CE2' ' S' ' 359' ' ' TRP . 57.3 t -76.0 118.56 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.39 -0.819 . . . . 34.27 109.994 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' S' S ' 355' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' S' ' 232' ' ' THR . 52.3 p -117.86 175.07 5.83 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.294 -0.879 . . . . 25.49 110.306 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' S' S ' 356' ' ' SER . . . . . . . . . . . . . 62.3 p -62.1 -17.78 58.73 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.41 -0.806 . . . . 31.24 110.698 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' S' S ' 357' ' ' ASN . . . . . . . . . . . . . 45.8 m-20 -106.96 14.17 26.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.158 -0.964 . . . . 28.61 110.564 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' S' S ' 358' ' ' GLY . . . . . . . . . . . . . . . 111.87 -152.88 17.6 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.043 -1.223 . . . . 22.01 110.043 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' S' S ' 359' ' ' TRP . . . . . 0.55 ' CE2' HG22 ' S' ' 354' ' ' VAL . 15.3 m95 -91.4 116.74 29.09 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.43 -1.041 . . . . 25.54 110.109 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' S' S ' 360' ' ' TYR . . . . . 0.415 ' HA ' ' HA ' ' S' ' 369' ' ' PRO . 1.3 m-85 -103.54 165.88 10.77 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.344 -0.847 . . . . 40.53 109.997 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' S' S ' 361' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' S' ' 351' ' ' PHE . . . -140.07 130.02 24.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.427 -0.796 . . . . 18.04 110.279 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' S' S ' 362' ' ' ILE . . . . . . . . . . . . . 89.2 mt -95.59 83.64 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.379 -0.826 . . . . 15.64 110.13 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' S' S ' 363' ' ' ASP . . . . . 0.416 ' O ' ' N ' ' S' ' 365' ' ' GLU . 11.9 t0 -75.26 94.52 3.01 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.305 -0.872 . . . . 35.03 110.149 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' S' S ' 364' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 53.88 -89.4 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.518 -0.739 . . . . 46.72 110.458 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' S' S ' 365' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' S' ' 363' ' ' ASP . 23.8 mt-10 -122.62 19.14 10.37 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.126 -0.984 . . . . 56.2 110.24 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' S' S ' 366' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -117.96 125.03 49.64 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.281 -0.887 . . . . 51.02 110.446 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' S' S ' 367' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -107.06 127.12 53.19 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.349 -0.844 . . . . 37.59 110.142 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' S' S ' 368' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -165.44 159.55 13.89 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.278 -0.889 . . . . 31.47 110.39 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' S' S ' 369' ' ' PRO . . . . . 0.415 ' HA ' ' HA ' ' S' ' 360' ' ' TYR . 47.0 Cg_endo -72.9 139.59 30.48 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 O-C-N 123.859 1.452 . . . . 28.85 110.52 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' S' S ' 370' ' ' TRP . . . . . . . . . . . . . 67.4 t90 -167.2 113.64 0.77 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.387 -0.821 . . . . 26.94 110.006 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' S' S ' 371' ' ' THR . . . . . . . . . . . . . 59.7 m -74.85 113.06 20.86 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.417 -0.802 . . . . 20.19 110.0 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' S' S ' 372' ' ' PRO . . . . . 0.565 ' O ' HD11 ' S' ' 334' ' ' LEU . 48.5 Cg_endo -73.55 157.13 49.21 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 O-C-N 123.636 1.335 . . . . 28.68 110.571 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' S' S ' 373' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -90.57 147.16 35.77 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.382 -0.824 . . . . 35.72 109.873 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' S' S ' 374' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -76.05 -6.37 17.27 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 O-C-N 123.628 1.331 . . . . 30.89 110.473 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' S' S ' 375' ' ' SER . . . . . . . . . . . . . 69.0 p -104.28 -16.93 15.03 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.277 -0.889 . . . . 29.41 110.477 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' S' S ' 376' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -106.47 43.02 1.19 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.302 -0.874 . . . . 32.89 110.228 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' S' S ' 377' ' ' VAL . . . . . 0.594 ' O ' HG11 ' S' ' 327' ' ' VAL . 7.3 p -114.62 147.23 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.273 -0.892 . . . . 24.33 110.274 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' S' S ' 378' ' ' LEU . . . . . . . . . . . . . 52.2 mt -116.03 -57.92 2.16 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.446 -0.784 . . . . 24.37 109.642 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' S' S ' 379' ' ' VAL . . . . . 0.645 HG22 HG12 ' S' ' 326' ' ' VAL . 60.5 t -120.73 132.32 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.403 -0.811 . . . . 18.02 109.48 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' S' S ' 380' ' ' PHE . . . . . 0.458 ' CE1' ' HB2' ' S' ' 325' ' ' CYS . 14.3 p90 -142.5 173.92 11.1 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.417 -0.802 . . . . 29.35 110.658 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' S' S ' 381' ' ' VAL . . . . . . . . . . . . . 57.9 t -120.0 107.32 40.02 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.485 -0.759 . . . . 16.34 109.458 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' S' S ' 382' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' S' ' 336' ' ' ASP . 46.0 Cg_endo -71.28 145.63 49.05 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 O-C-N 123.562 1.296 . . . . 20.94 110.726 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' S' S ' 383' ' ' TYR . . . . . 0.401 ' CZ ' ' HB3' ' S' ' 338' ' ' HIS . 88.2 m-85 -61.16 -53.43 57.06 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.387 -0.82 . . . . 28.93 109.833 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' S' S ' 384' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.457 -0.777 . . . . 47.03 110.426 -177.04 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' R' R ' 30' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 . . . . . 0 N--CA 1.493 1.719 0 CA-C-O 121.207 0.527 . . . . 43.36 110.249 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' R' R ' 31' ' ' LEU . . . . . . . . . . . . . 65.3 mt -134.91 140.6 45.89 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.282 -0.886 . . . . 22.93 110.283 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 32' ' ' THR . . . . . . . . . . . . . 70.3 m -87.62 110.49 20.43 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.391 -0.818 . . . . 22.34 109.982 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 33' ' ' LEU . . . . . 0.596 HD22 ' CE2' ' R' ' 62' ' ' TYR . 80.1 mt -62.28 -172.78 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.295 -0.878 . . . . 21.39 110.221 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 34' ' ' TYR . . . . . . . . . . . . . 37.0 p90 -74.66 -29.36 61.22 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.266 -0.896 . . . . 34.4 110.414 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 35' ' ' ASN . . . . . . . . . . . . . 48.3 p30 -77.77 -1.92 33.79 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.289 -0.882 . . . . 30.28 110.633 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.29 -16.56 59.51 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.742 -1.343 . . . . 36.25 109.742 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 37' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -59.02 161.82 4.76 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.285 -1.127 . . . . 53.8 110.368 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 38' ' ' LYS . . . . . . . . . . . . . 56.8 mttt -117.85 135.73 53.9 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.367 -0.833 . . . . 49.91 110.132 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 39' ' ' LYS . . . . . 0.406 ' HG2' ' CZ ' ' R' ' 41' ' ' PHE . 8.0 ttmt -138.72 143.68 39.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.375 -0.828 . . . . 35.69 110.255 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 40' ' ' THR . . . . . . . . . . . . . 23.4 m -102.55 127.95 49.41 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.424 -0.798 . . . . 34.84 110.198 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 41' ' ' PHE . . . . . 0.406 ' CZ ' ' HG2' ' R' ' 39' ' ' LYS . 96.6 m-85 -113.0 132.69 55.27 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.41 -0.806 . . . . 34.42 110.179 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 42' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -93.34 140.97 28.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.328 -0.857 . . . . 51.46 110.229 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 43' ' ' SER . . . . . . . . . . . . . 54.3 m -70.84 141.9 51.28 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.461 -0.774 . . . . 41.84 110.192 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.77 125.4 29.54 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.367 -0.833 . . . . 33.82 109.957 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 45' ' ' PRO . . . . . 0.424 ' HG2' ' ND2' ' R' ' 77' ' ' ASN . 45.6 Cg_endo -72.15 151.05 54.77 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.517 1.272 . . . . 30.27 110.646 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 46' ' ' ASN . . . . . 0.4 ' HA ' ' OD1' ' R' ' 50' ' ' ASN . 52.2 t-20 -124.24 109.91 13.99 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.534 -0.728 . . . . 35.1 109.997 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 47' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -120.32 -34.84 3.56 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.292 -0.88 . . . . 42.81 110.537 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 48' ' ' HIS . . . . . 0.439 ' NE2' HD11 ' R' ' 80' ' ' LEU . 73.3 m80 -105.86 45.23 0.98 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.346 -0.846 . . . . 49.97 110.24 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 49' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 50.32 34.62 9.22 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.491 -0.755 . . . . 61.32 110.158 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 50' ' ' ASN . . . . . 0.4 ' OD1' ' HA ' ' R' ' 46' ' ' ASN . 15.0 p-10 -86.15 43.77 1.08 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.388 -0.82 . . . . 51.5 110.747 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.07 -46.1 78.93 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.243 -0.911 . . . . 38.77 109.571 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 52' ' ' TRP . . . . . 0.483 ' CD2' ' N ' ' R' ' 53' ' ' LEU . 68.1 p-90 -58.46 -38.34 77.34 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.57 -0.706 . . . . 26.24 110.048 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 53' ' ' LEU . . . . . 0.483 ' N ' ' CD2' ' R' ' 52' ' ' TRP . 23.2 tp -66.72 -46.68 74.75 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.323 -0.861 . . . . 26.75 110.013 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 54' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -55.25 -41.53 72.29 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.363 -0.836 . . . . 35.02 110.23 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.16 -46.12 91.83 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.44 -0.788 . . . . 24.47 110.196 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 56' ' ' ILE . . . . . 0.431 HG12 HD11 ' R' ' 104' ' ' ILE . 76.1 mt -62.12 -42.26 94.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.292 -0.88 . . . . 26.03 109.927 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 57' ' ' LEU . . . . . . . . . . . . . 22.3 mt -60.35 -45.61 92.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.251 -0.906 . . . . 26.77 109.661 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 58' ' ' GLN . . . . . . . . . . . . . 57.7 mm-40 -63.87 -46.52 84.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.427 -0.796 . . . . 22.32 109.625 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 59' ' ' LEU . . . . . 0.43 ' HA ' ' HE2' ' R' ' 151' ' ' PHE . 24.0 tp -61.33 -37.82 84.67 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.334 -0.854 . . . . 20.55 109.443 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 60' ' ' PHE . . . . . 0.528 ' CE2' HD21 ' R' ' 111' ' ' LEU . 2.8 m-85 -61.1 -44.7 96.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.567 -0.708 . . . . 20.08 109.933 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 61' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -63.1 -36.13 82.57 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.441 -0.787 . . . . 18.8 110.541 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 62' ' ' TYR . . . . . 0.596 ' CE2' HD22 ' R' ' 33' ' ' LEU . 9.2 t80 -63.22 -41.73 99.16 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.233 -0.917 . . . . 26.45 110.155 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 63' ' ' VAL . . . . . 0.406 ' H ' HG22 ' R' ' 63' ' ' VAL . 30.4 m -93.36 20.34 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.275 -0.891 . . . . 29.75 110.19 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 64' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 52.92 75.63 0.23 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.328 -0.857 . . . . 35.52 110.559 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 65' ' ' GLU . . . . . 0.443 ' HG2' ' CD2' ' R' ' 60' ' ' PHE . 14.3 tp10 -116.36 104.14 52.15 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.344 -0.847 . . . . 29.89 109.865 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 66' ' ' PRO . . . . . 0.481 ' HA ' ' HB2' ' R' ' 69' ' ' ASP . 46.7 Cg_endo -73.6 -5.84 17.74 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.806 1.424 . . . . 21.37 111.064 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 67' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -52.09 -61.52 2.21 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.147 -0.97 . . . . 23.85 110.375 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 68' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -98.2 36.69 1.55 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.326 -0.859 . . . . 28.07 110.488 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 69' ' ' ASP . . . . . 0.481 ' HB2' ' HA ' ' R' ' 66' ' ' PRO . 11.7 t0 -72.43 -33.17 66.91 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.225 -0.922 . . . . 43.76 110.175 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 70' ' ' TRP . . . . . 0.476 ' CE2' ' CG2' ' R' ' 71' ' ' VAL . 47.7 p-90 -73.41 -3.98 30.74 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.334 -0.854 . . . . 33.06 110.71 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 71' ' ' VAL . . . . . 0.557 HG11 ' HB2' ' R' ' 82' ' ' ALA . 40.5 t -109.73 -27.41 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.223 -0.923 . . . . 31.7 109.756 179.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 72' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -86.54 -48.79 8.06 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.407 -0.808 . . . . 33.58 110.383 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 73' ' ' SER . . . . . . . . . . . . . 70.0 m -89.71 51.06 2.0 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.394 -0.816 . . . . 50.82 110.304 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 74' ' ' SER . . . . . . . . . . . . . 15.9 t -125.96 138.29 31.79 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.238 -0.914 . . . . 34.74 110.24 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.36 -24.96 15.98 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.742 1.391 . . . . 35.7 110.343 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 76' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -91.72 153.15 19.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.33 -0.856 . . . . 66.48 110.355 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 77' ' ' ASN . . . . . 0.424 ' ND2' ' HG2' ' R' ' 45' ' ' PRO . 22.3 t-20 -81.47 95.27 7.03 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.391 -0.818 . . . . 46.72 110.043 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 78' ' ' LEU . . . . . . . . . . . . . 96.3 mt -96.49 27.99 3.55 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.389 -0.82 . . . . 37.55 110.191 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 79' ' ' THR . . . . . . . . . . . . . 29.6 m -56.27 -54.58 43.7 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.225 -0.922 . . . . 37.36 110.302 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 80' ' ' LEU . . . . . 0.604 ' HA ' HD12 ' R' ' 83' ' ' ILE . 15.9 mt -60.97 -23.16 65.13 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.33 -0.856 . . . . 35.83 110.511 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 81' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -79.5 -39.11 32.85 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.101 -0.999 . . . . 44.03 110.356 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 82' ' ' ALA . . . . . 0.557 ' HB2' HG11 ' R' ' 71' ' ' VAL . . . -69.51 -28.64 66.22 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.257 -0.902 . . . . 32.54 110.169 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 83' ' ' ILE . . . . . 0.604 HD12 ' HA ' ' R' ' 80' ' ' LEU . 77.8 mt -70.08 -46.12 73.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.275 -0.891 . . . . 32.02 110.352 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 84' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -55.09 -52.17 64.08 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.208 -0.932 . . . . 34.09 110.56 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 85' ' ' GLN . . . . . 0.533 ' HG2' HD12 ' R' ' 89' ' ' LEU . 31.9 tt0 -54.79 -46.88 74.53 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.209 -0.932 . . . . 25.94 110.279 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 86' ' ' LEU . . . . . . . . . . . . . 23.7 mt -58.75 -43.76 90.38 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.365 -0.835 . . . . 16.2 109.853 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 87' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -65.33 -35.25 80.4 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.494 -0.754 . . . . 49.09 110.317 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 88' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -78.41 -19.05 54.09 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.282 -0.886 . . . . 28.61 110.529 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 89' ' ' LEU . . . . . 0.533 HD12 ' HG2' ' R' ' 85' ' ' GLN . 32.6 mt -96.21 -29.35 14.09 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.248 -0.907 . . . . 26.16 110.201 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 90' ' ' THR . . . . . . . . . . . . . 60.7 p -105.69 -34.71 7.62 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.255 -0.903 . . . . 33.33 109.75 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.88 16.15 58.47 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.85 -1.3 . . . . 31.13 109.85 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 92' ' ' LEU . . . . . . . . . . . . . 97.1 mt -100.18 155.21 17.87 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.213 -1.169 . . . . 42.52 110.186 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 93' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -86.19 91.59 8.5 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.481 -0.762 . . . . 68.46 110.038 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 94' ' ' LEU . . . . . 0.458 ' HB3' ' CZ2' ' R' ' 52' ' ' TRP . 48.1 mt -99.37 53.03 0.95 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.204 -0.935 . . . . 44.63 110.377 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 95' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.57 -38.59 6.38 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.262 -0.898 . . . . 67.16 110.369 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 96' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -113.93 44.23 1.68 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.364 -0.835 . . . . 67.02 110.244 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 97' ' ' GLY . . . . . . . . . . . . . . . 99.12 150.8 26.05 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.614 -1.395 . . . . 49.48 109.614 179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 98' ' ' GLY . . . . . . . . . . . . . . . -166.27 160.01 33.44 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.265 -1.534 . . . . 36.57 109.265 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 99' ' ' PRO . . . . . 0.79 ' O ' HG23 ' R' ' 103' ' ' VAL . 44.5 Cg_endo -72.57 121.12 7.15 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.75 1.395 . . . . 30.41 110.384 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 100' ' ' PRO . . . . . 0.413 ' HA ' HD11 ' R' ' 56' ' ' ILE . 45.4 Cg_endo -72.3 -31.68 11.34 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.619 1.326 . . . . 29.94 110.493 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 101' ' ' ALA . . . . . 0.475 ' HB2' ' HB3' ' R' ' 178' ' ' LEU . . . -70.01 -38.45 75.96 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.34 -0.85 . . . . 23.64 110.294 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 102' ' ' LEU . . . . . 0.423 HD23 HD21 ' R' ' 106' ' ' ASN . 0.1 OUTLIER -72.63 -40.77 66.16 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.353 -0.842 . . . . 20.31 110.382 -179.757 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' R' R ' 103' ' ' VAL . . . . . 0.79 HG23 ' O ' ' R' ' 99' ' ' PRO . 63.1 t -58.01 -40.21 75.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.202 -0.936 . . . . 16.33 110.023 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 104' ' ' ILE . . . . . 0.431 HD11 HG12 ' R' ' 56' ' ' ILE . 81.7 mt -71.62 -30.6 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.384 -0.823 . . . . 24.77 109.941 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 105' ' ' TRP . . . . . 0.462 ' O ' ' HD3' ' R' ' 108' ' ' LYS . 70.6 t-105 -82.26 0.72 40.08 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.311 -0.868 . . . . 23.28 110.376 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 106' ' ' ASN . . . . . 0.423 HD21 HD23 ' R' ' 102' ' ' LEU . 6.9 m-80 -104.98 -10.5 17.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.118 -0.989 . . . . 28.26 110.112 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 107' ' ' ILE . . . . . . . . . . . . . 36.6 pt -126.81 35.0 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.225 -0.922 . . . . 18.77 109.994 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 108' ' ' LYS . . . . . 0.5 ' HG2' ' HB ' ' R' ' 115' ' ' ILE . 9.2 mtpp -61.02 -48.54 81.32 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.499 -0.751 . . . . 42.5 110.011 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 109' ' ' HIS . . . . . 0.447 ' CD2' ' HG ' ' R' ' 110' ' ' LEU . 50.8 p-80 -66.0 -12.84 57.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.518 -0.738 . . . . 20.07 110.64 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 110' ' ' LEU . . . . . 0.447 ' HG ' ' CD2' ' R' ' 109' ' ' HIS . 80.4 mt -94.8 -17.39 22.17 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.116 -0.99 . . . . 15.69 110.156 179.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 111' ' ' LEU . . . . . 0.528 HD21 ' CE2' ' R' ' 60' ' ' PHE . 10.4 mt -94.06 144.12 25.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.299 -0.876 . . . . 25.39 111.046 -179.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 112' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -77.66 -17.43 57.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.634 -0.666 . . . . 53.48 109.854 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 113' ' ' THR . . . . . 0.457 HG22 ' N ' ' R' ' 114' ' ' GLY . 60.0 m -83.63 166.66 17.97 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.379 -0.826 . . . . 14.8 110.257 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 114' ' ' GLY . . . . . 0.457 ' N ' HG22 ' R' ' 113' ' ' THR . . . -97.97 127.14 9.13 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.041 -1.224 . . . . 16.14 110.041 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 115' ' ' ILE . . . . . 0.578 HD13 ' HB ' ' R' ' 124' ' ' VAL . 47.7 mm -109.1 139.37 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.457 -1.025 . . . . 13.46 109.727 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 116' ' ' GLY . . . . . . . . . . . . . . . -152.75 -155.81 7.27 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.876 -1.29 . . . . 23.9 109.876 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 117' ' ' THR . . . . . 0.53 HG22 ' CG2' ' R' ' 126' ' ' VAL . 18.7 p -135.05 -171.4 2.79 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.432 -1.04 . . . . 27.37 110.072 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 118' ' ' ALA . . . . . 0.445 ' HB3' ' OD1' ' R' ' 128' ' ' ASP . . . -56.5 -58.12 9.42 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.23 -0.918 . . . . 18.76 110.031 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 119' ' ' SER . . . . . 0.63 ' HA ' ' HB3' ' R' ' 194' ' ' ALA . 1.1 m -56.56 -40.6 75.44 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.259 -0.901 . . . . 32.35 109.764 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 120' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 -110.05 86.29 4.9 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.47 -0.768 . . . . 27.12 109.636 179.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 121' ' ' PRO . . . . . 0.483 ' HA ' ' SG ' ' R' ' 125' ' ' CYS . 44.2 Cg_endo -71.26 166.44 29.25 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 O-C-N 123.819 1.431 . . . . 22.68 111.009 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 122' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' R' ' 121' ' ' PRO . 38.1 t 178.58 -161.65 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.609 -0.682 . . . . 22.99 109.493 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 123' ' ' GLU . . . . . 0.44 ' HG2' HG23 ' R' ' 113' ' ' THR . 2.3 tp10 -56.45 -39.97 74.01 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.19 -0.944 . . . . 36.18 109.701 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 124' ' ' VAL . . . . . 0.578 ' HB ' HD13 ' R' ' 115' ' ' ILE . 82.6 t -142.5 136.41 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.498 -0.751 . . . . 20.64 109.393 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 125' ' ' CYS . . . . . 0.483 ' SG ' ' HA ' ' R' ' 121' ' ' PRO . 83.4 m -140.32 168.15 20.49 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.304 -0.873 . . . . 22.8 111.131 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 126' ' ' VAL . . . . . 0.727 HG12 HG22 ' R' ' 179' ' ' VAL . 35.8 m -122.68 159.7 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.714 -0.616 . . . . 21.24 109.676 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 127' ' ' VAL . . . . . 0.709 HG11 ' O ' ' R' ' 177' ' ' VAL . 30.6 m -70.81 141.8 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.359 -0.838 . . . . 19.77 110.7 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 128' ' ' ASP . . . . . 0.445 ' OD1' ' HB3' ' R' ' 118' ' ' ALA . 53.9 p-10 -137.63 19.38 2.89 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.333 -0.855 . . . . 29.21 110.714 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 129' ' ' GLY . . . . . . . . . . . . . . . 113.97 0.08 24.18 Favored Glycine 0 N--CA 1.493 2.458 0 C-N-CA 120.0 -1.095 . . . . 33.86 110.468 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 130' ' ' THR . . . . . . . . . . . . . 58.1 m -91.82 131.87 36.85 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.171 -1.193 . . . . 26.41 110.072 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -62.58 120.65 11.56 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.312 -0.868 . . . . 33.08 110.284 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 132' ' ' MET . . . . . 0.433 ' HE1' ' CE2' ' R' ' 180' ' ' PHE . 98.4 mmm -105.16 165.62 10.97 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.543 -0.723 . . . . 30.76 110.415 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 133' ' ' CYS . . . . . 0.41 ' HA ' ' HB3' ' R' ' 174' ' ' PRO . 32.4 m -141.14 158.13 44.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.511 -0.743 . . . . 27.0 109.912 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 134' ' ' LEU . . . . . 0.563 HD11 ' O ' ' R' ' 172' ' ' PRO . 0.1 OUTLIER -58.48 -19.68 39.12 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.347 -0.846 . . . . 33.9 110.538 -179.936 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' R' R ' 135' ' ' ALA . . . . . . . . . . . . . . . -92.79 8.22 40.37 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.261 -0.899 . . . . 19.37 110.801 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 136' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -93.72 -21.87 19.08 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.109 -0.994 . . . . 30.47 110.195 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 137' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -149.9 165.45 32.56 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.421 -0.8 . . . . 24.27 110.227 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 138' ' ' HIS . . . . . 0.434 ' HA ' HG23 ' R' ' 154' ' ' VAL . 15.1 p80 -117.88 15.09 14.33 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.418 -0.801 . . . . 20.91 110.412 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 139' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' R' ' 152' ' ' ALA . . . -177.19 152.35 0.87 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.187 -0.946 . . . . 15.69 110.171 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 140' ' ' GLY . . . . . 0.428 ' HA3' ' O ' ' R' ' 179' ' ' VAL . . . 161.82 175.18 32.58 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.918 -1.273 . . . . 23.76 109.918 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 141' ' ' ILE . . . . . . . . . . . . . 83.7 mt -95.54 136.57 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.447 -1.031 . . . . 25.3 109.702 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 142' ' ' PHE . . . . . 0.577 ' CD2' ' HB2' ' R' ' 172' ' ' PRO . 82.2 m-85 -120.66 -172.58 2.41 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.276 -0.89 . . . . 30.24 110.566 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 143' ' ' LEU . . . . . 0.742 HD23 ' O ' ' R' ' 148' ' ' HIS . 0.5 OUTLIER -119.84 77.78 1.27 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.455 -0.778 . . . . 32.8 110.298 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' R' R ' 144' ' ' LYS . . . . . 0.471 ' HG3' ' CZ2' ' R' ' 170' ' ' TRP . 1.0 OUTLIER -69.66 76.84 0.43 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.43 -0.794 . . . . 49.18 109.635 179.651 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' R' R ' 145' ' ' GLY . . . . . 0.458 ' O ' HD22 ' R' ' 143' ' ' LEU . . . 104.57 179.26 24.76 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.168 -1.573 . . . . 53.87 109.168 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 146' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -88.5 145.79 25.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.388 -1.066 . . . . 68.58 110.049 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 147' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 58.29 36.51 25.68 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.392 -0.818 . . . . 56.62 110.655 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 148' ' ' HIS . . . . . 0.742 ' O ' HD23 ' R' ' 143' ' ' LEU . 45.0 t60 -158.68 148.08 19.14 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.205 -0.934 . . . . 44.57 110.377 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 149' ' ' ALA . . . . . . . . . . . . . . . -150.3 146.93 27.06 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.467 -0.771 . . . . 33.54 110.072 179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 150' ' ' VAL . . . . . . . . . . . . . 34.2 m -142.38 161.45 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.273 -0.892 . . . . 27.61 110.305 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 151' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' R' ' 152' ' ' ALA . 5.9 t80 -86.15 155.58 20.7 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.42 -0.8 . . . . 23.04 109.867 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 152' ' ' ALA . . . . . 0.537 ' N ' ' CD1' ' R' ' 151' ' ' PHE . . . -157.31 151.59 24.95 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.455 -0.778 . . . . 29.61 109.565 178.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 153' ' ' CYS . . . . . . . . . . . . . 26.7 p -154.33 173.56 16.02 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.334 -0.854 . . . . 22.75 110.49 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 154' ' ' VAL . . . . . 0.613 HG22 ' CE2' ' R' ' 159' ' ' TRP . 60.4 t -90.6 116.97 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.337 -0.852 . . . . 23.26 110.083 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 155' ' ' THR . . . . . . . . . . . . . 69.3 p -112.05 -176.65 2.98 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.257 -0.902 . . . . 17.88 110.102 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 156' ' ' SER . . . . . . . . . . . . . 78.4 p -75.96 -3.69 36.96 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.394 -0.816 . . . . 21.83 110.721 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 157' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -118.32 10.58 12.84 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.046 -1.034 . . . . 36.54 110.613 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 158' ' ' GLY . . . . . . . . . . . . . . . 117.98 -162.65 13.04 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.592 -1.403 . . . . 31.74 109.592 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 159' ' ' TRP . . . . . 0.613 ' CE2' HG22 ' R' ' 154' ' ' VAL . 14.7 m95 -86.55 122.42 30.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.312 -1.111 . . . . 28.25 110.112 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 160' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -108.46 166.94 10.39 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.413 -0.805 . . . . 41.24 110.19 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 161' ' ' ALA . . . . . . . . . . . . . . . -143.21 123.48 13.79 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.367 -0.833 . . . . 27.4 110.14 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 162' ' ' ILE . . . . . . . . . . . . . 92.1 mt -87.6 81.14 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.354 -0.841 . . . . 24.27 110.106 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 163' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' R' ' 165' ' ' GLU . 15.3 t0 -72.72 92.33 1.54 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.443 -0.786 . . . . 36.08 110.332 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 164' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 54.1 -88.93 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.496 -0.752 . . . . 46.08 110.565 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 165' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' R' ' 163' ' ' ASP . 29.7 mt-10 -124.72 35.96 4.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.017 -1.052 . . . . 50.94 110.187 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 166' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -135.8 117.34 14.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.339 -0.85 . . . . 47.28 110.309 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 167' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -101.07 119.92 39.45 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.412 -0.805 . . . . 40.47 110.127 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 168' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -157.58 158.51 30.6 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.305 -0.872 . . . . 30.21 110.407 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 169' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.77 133.06 19.54 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 O-C-N 123.868 1.457 . . . . 32.76 110.474 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 170' ' ' TRP . . . . . 0.471 ' CZ2' ' HG3' ' R' ' 144' ' ' LYS . 67.0 t90 -159.81 119.3 2.88 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.41 -0.806 . . . . 32.79 109.984 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 171' ' ' THR . . . . . . . . . . . . . 45.7 m -81.08 112.62 34.19 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.444 -0.785 . . . . 36.92 110.219 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 172' ' ' PRO . . . . . 0.577 ' HB2' ' CD2' ' R' ' 142' ' ' PHE . 46.9 Cg_endo -73.75 158.83 46.45 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.68 1.358 . . . . 33.54 110.533 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 173' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -88.9 144.96 33.71 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.366 -0.833 . . . . 45.76 109.843 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 174' ' ' PRO . . . . . 0.41 ' HB3' ' HA ' ' R' ' 133' ' ' CYS . 45.2 Cg_endo -71.71 -10.4 26.46 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 O-C-N 123.553 1.291 . . . . 29.63 110.438 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 175' ' ' SER . . . . . . . . . . . . . 53.0 p -103.36 -17.69 15.16 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.234 -0.916 . . . . 35.7 110.404 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 176' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -103.44 43.13 1.1 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.233 -0.917 . . . . 39.65 110.4 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 177' ' ' VAL . . . . . 0.709 ' O ' HG11 ' R' ' 127' ' ' VAL . 10.4 p -117.69 127.2 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.409 -0.807 . . . . 20.61 110.021 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 178' ' ' LEU . . . . . 0.475 ' HB3' ' HB2' ' R' ' 101' ' ' ALA . 46.3 mt -91.52 -61.29 1.68 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.35 -0.844 . . . . 15.58 109.376 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 179' ' ' VAL . . . . . 0.727 HG22 HG12 ' R' ' 126' ' ' VAL . 67.1 t -114.62 144.67 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.6 -0.688 . . . . 17.4 109.444 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 180' ' ' PHE . . . . . 0.433 ' CE2' ' HE1' ' R' ' 132' ' ' MET . 43.7 p90 -152.09 163.37 39.47 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.338 -0.851 . . . . 20.16 110.562 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 181' ' ' VAL . . . . . . . . . . . . . 66.4 t -113.19 111.48 50.22 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.511 -0.743 . . . . 17.69 109.836 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 182' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.11 149.54 52.44 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.546 1.287 . . . . 17.81 110.374 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 183' ' ' TYR . . . . . 0.736 ' O ' ' C ' ' R' ' 184' ' ' ASP . 79.2 m-85 -58.99 175.47 0.28 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.464 -0.772 . . . . 28.01 110.522 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' R' R ' 184' ' ' ASP . . . . . 0.736 ' C ' ' O ' ' R' ' 183' ' ' TYR . 0.0 OUTLIER -13.05 -76.29 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.303 -0.873 . . . . 58.64 110.221 -178.029 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' R' R ' 185' ' ' GLN . . . . . . . . . . . . . 16.8 tm0? . . . . . 0 N--CA 1.503 2.217 0 CA-C-O 121.265 0.555 . . . . 80.42 111.773 179.171 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' R' R ' 193' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 120.873 0.368 . . . . 49.5 110.245 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' R' R ' 194' ' ' ALA . . . . . 0.63 ' HB3' ' HA ' ' R' ' 119' ' ' SER . . . . . . . . 0 N--CA 1.495 1.777 0 O-C-N 121.162 -0.961 . . . . 40.4 110.136 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' S' S ' 229' ' ' MET . . . . . . . . . . . . . 28.8 mtm . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.188 0.518 . . . . 51.83 110.235 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' S' S ' 230' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -97.34 142.69 28.9 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.409 -0.807 . . . . 54.13 110.195 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' S' S ' 231' ' ' LEU . . . . . . . . . . . . . 68.0 mt -134.02 141.02 47.06 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.413 -0.805 . . . . 33.04 110.344 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' S' S ' 232' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' S' ' 355' ' ' THR . 40.2 m -89.27 103.29 15.93 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.432 -0.792 . . . . 26.92 109.973 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' S' S ' 233' ' ' LEU . . . . . 0.667 HD22 ' CE2' ' S' ' 262' ' ' TYR . 79.7 mt -55.92 179.36 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.471 -0.768 . . . . 13.78 110.494 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' S' S ' 234' ' ' TYR . . . . . 0.44 ' CG ' ' N ' ' S' ' 235' ' ' ASN . 35.4 p90 -65.13 -35.61 81.67 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.355 -0.841 . . . . 26.08 110.17 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' S' S ' 235' ' ' ASN . . . . . 0.44 ' N ' ' CG ' ' S' ' 234' ' ' TYR . 50.7 p30 -74.3 -7.5 52.99 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.299 -0.876 . . . . 20.04 110.504 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' S' S ' 236' ' ' GLY . . . . . . . . . . . . . . . 95.8 -20.02 51.72 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.76 -1.336 . . . . 22.71 109.76 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' S' S ' 237' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -53.02 145.77 12.41 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.19 -1.182 . . . . 35.44 110.145 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' S' S ' 238' ' ' LYS . . . . . . . . . . . . . 44.3 mttt -102.18 127.87 48.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.395 -0.815 . . . . 32.56 110.362 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' S' S ' 239' ' ' LYS . . . . . 0.407 ' HG2' ' CZ ' ' S' ' 241' ' ' PHE . 8.9 ttmt -132.29 144.45 50.59 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.474 -0.766 . . . . 26.68 109.959 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' S' S ' 240' ' ' THR . . . . . . . . . . . . . 52.4 m -101.98 132.22 47.93 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.237 -0.915 . . . . 41.02 110.375 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' S' S ' 241' ' ' PHE . . . . . 0.407 ' CZ ' ' HG2' ' S' ' 239' ' ' LYS . 96.1 m-85 -117.95 137.75 52.63 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.348 -0.845 . . . . 28.62 110.203 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' S' S ' 242' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -96.47 161.78 13.76 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.38 -0.825 . . . . 47.89 110.149 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' S' S ' 243' ' ' SER . . . . . . . . . . . . . 72.1 m -90.59 151.62 21.23 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.31 -0.869 . . . . 45.09 110.211 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' S' S ' 244' ' ' ARG . . . . . . . . . . . . . 1.4 mtp85 -129.82 126.72 22.66 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.324 -0.86 . . . . 42.49 110.204 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' S' S ' 245' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.3 160.94 43.97 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 O-C-N 123.635 1.334 . . . . 35.68 110.559 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' S' S ' 246' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -132.82 97.84 4.15 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.327 -0.858 . . . . 51.88 109.871 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' S' S ' 247' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -110.49 -22.18 11.79 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.376 -0.828 . . . . 53.69 110.647 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' S' S ' 248' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -117.29 43.66 2.28 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.237 -0.914 . . . . 55.79 110.717 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' S' S ' 249' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 48.8 38.43 11.89 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.444 -0.785 . . . . 49.45 110.333 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' S' S ' 250' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -90.69 29.14 1.37 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.53 -0.731 . . . . 36.86 110.297 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' S' S ' 251' ' ' ALA . . . . . . . . . . . . . . . -53.9 -43.18 69.46 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.172 -0.955 . . . . 29.69 109.564 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' S' S ' 252' ' ' TRP . . . . . 0.428 ' CZ2' ' HB3' ' S' ' 294' ' ' LEU . 68.0 p-90 -61.81 -33.91 74.97 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.491 -0.755 . . . . 41.12 109.868 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' S' S ' 253' ' ' LEU . . . . . 0.406 ' N ' ' CD2' ' S' ' 252' ' ' TRP . 23.3 tp -70.14 -47.26 62.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.321 -0.862 . . . . 24.89 109.962 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' S' S ' 254' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -56.12 -42.49 76.94 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.343 -0.848 . . . . 35.65 109.991 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' S' S ' 255' ' ' ALA . . . . . . . . . . . . . . . -59.56 -48.24 82.44 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.439 -0.788 . . . . 22.73 110.046 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' S' S ' 256' ' ' ILE . . . . . 0.502 HG12 HD11 ' S' ' 304' ' ' ILE . 79.7 mt -62.22 -40.68 88.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.337 -0.852 . . . . 28.85 109.988 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' S' S ' 257' ' ' LEU . . . . . . . . . . . . . 19.1 mt -61.52 -44.51 96.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.356 -0.84 . . . . 23.07 110.162 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' S' S ' 258' ' ' GLN . . . . . 0.498 ' HB3' ' CD2' ' S' ' 351' ' ' PHE . 53.4 mm-40 -65.07 -45.37 85.55 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.422 -0.799 . . . . 29.78 109.87 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' S' S ' 259' ' ' LEU . . . . . 0.423 ' O ' HG22 ' S' ' 263' ' ' VAL . 19.9 tp -58.71 -36.34 74.09 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.331 -0.856 . . . . 17.94 109.452 179.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' S' S ' 260' ' ' PHE . . . . . 0.537 ' CE2' HD21 ' S' ' 311' ' ' LEU . 3.1 m-85 -62.84 -45.2 93.7 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.56 -0.713 . . . . 30.57 109.825 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' S' S ' 261' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -62.18 -29.79 70.62 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.475 -0.766 . . . . 41.34 109.901 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' S' S ' 262' ' ' TYR . . . . . 0.667 ' CE2' HD22 ' S' ' 233' ' ' LEU . 8.6 t80 -71.17 -44.69 65.0 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.435 -0.79 . . . . 26.03 110.129 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' S' S ' 263' ' ' VAL . . . . . 0.423 HG22 ' O ' ' S' ' 259' ' ' LEU . 33.1 m -92.0 18.29 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.352 -0.843 . . . . 22.8 110.384 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' S' S ' 264' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 52.72 70.69 0.55 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.206 -0.934 . . . . 44.03 110.641 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' S' S ' 265' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -111.82 109.24 55.36 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.375 -0.828 . . . . 35.61 109.649 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' S' S ' 266' ' ' PRO . . . . . 0.476 ' HA ' ' HB2' ' S' ' 269' ' ' ASP . 48.5 Cg_endo -75.33 0.46 9.01 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.631 1.332 . . . . 37.67 111.772 -179.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' S' S ' 267' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -56.56 -67.63 0.29 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.779 -1.201 . . . . 41.49 110.17 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' S' S ' 268' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -92.94 39.91 1.05 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.193 -0.942 . . . . 50.76 110.091 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' S' S ' 269' ' ' ASP . . . . . 0.476 ' HB2' ' HA ' ' S' ' 266' ' ' PRO . 0.9 OUTLIER -76.05 -33.1 59.6 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.417 -0.802 . . . . 61.86 109.816 179.546 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' S' S ' 270' ' ' TRP . . . . . 0.511 ' CE2' HG23 ' S' ' 271' ' ' VAL . 51.0 p-90 -73.98 -4.31 34.49 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.327 -0.858 . . . . 39.85 110.478 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' S' S ' 271' ' ' VAL . . . . . 0.511 HG23 ' CE2' ' S' ' 270' ' ' TRP . 46.6 t -109.56 -32.69 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.154 -0.966 . . . . 39.18 110.045 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' S' S ' 272' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -78.71 -36.49 43.34 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.365 -0.834 . . . . 40.02 110.518 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' S' S ' 273' ' ' SER . . . . . . . . . . . . . 71.2 m -103.52 56.17 0.74 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.317 -0.864 . . . . 47.2 110.345 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' S' S ' 274' ' ' SER . . . . . . . . . . . . . 6.9 t -133.13 141.19 39.9 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.334 -0.854 . . . . 47.61 110.12 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' S' S ' 275' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.65 -18.9 21.97 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.603 1.317 . . . . 45.28 110.603 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' S' S ' 276' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -99.94 140.9 33.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.248 -0.908 . . . . 57.27 110.272 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' S' S ' 277' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -71.71 97.67 1.8 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.48 -0.763 . . . . 37.28 110.263 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' S' S ' 278' ' ' LEU . . . . . . . . . . . . . 86.4 mt -96.98 33.77 1.85 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.484 -0.76 . . . . 43.88 110.003 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' S' S ' 279' ' ' THR . . . . . . . . . . . . . 75.3 m -64.05 -60.12 3.62 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.398 -0.814 . . . . 50.05 110.275 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' S' S ' 280' ' ' LEU . . . . . 0.736 ' HA ' HD12 ' S' ' 283' ' ' ILE . 13.7 mt -51.6 -39.77 58.58 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.301 -0.874 . . . . 54.12 110.334 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' S' S ' 281' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.49 -49.7 74.34 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.475 -0.766 . . . . 65.28 110.125 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' S' S ' 282' ' ' ALA . . . . . . . . . . . . . . . -58.89 -34.0 71.16 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.491 -0.756 . . . . 46.51 110.513 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' S' S ' 283' ' ' ILE . . . . . 0.736 HD12 ' HA ' ' S' ' 280' ' ' LEU . 85.5 mt -66.26 -50.91 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.242 -0.911 . . . . 47.3 110.149 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' S' S ' 284' ' ' LYS . . . . . . . . . . . . . 33.8 tttp -50.52 -57.52 7.92 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.414 -0.804 . . . . 50.72 110.476 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' S' S ' 285' ' ' GLN . . . . . 0.52 ' HG2' HD12 ' S' ' 289' ' ' LEU . 34.4 tt0 -51.43 -46.45 62.98 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.469 -0.77 . . . . 68.47 110.293 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' S' S ' 286' ' ' LEU . . . . . . . . . . . . . 19.2 mt -59.93 -44.49 94.3 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.426 -0.796 . . . . 36.62 110.26 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' S' S ' 287' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -62.8 -35.25 79.27 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.342 -0.849 . . . . 46.64 110.067 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' S' S ' 288' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -76.21 -21.04 56.9 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.382 -0.823 . . . . 46.45 110.329 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' S' S ' 289' ' ' LEU . . . . . 0.52 HD12 ' HG2' ' S' ' 285' ' ' GLN . 30.9 mt -97.24 -21.78 17.07 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.308 -0.87 . . . . 35.09 110.559 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' S' S ' 290' ' ' THR . . . . . 0.408 HG22 ' HB3' ' S' ' 306' ' ' ASN . 81.3 p -114.82 -28.47 7.06 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.275 -0.89 . . . . 38.61 110.367 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' S' S ' 291' ' ' GLY . . . . . . . . . . . . . . . 79.35 11.1 85.31 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.829 -1.308 . . . . 36.77 109.829 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' S' S ' 292' ' ' LEU . . . . . . . . . . . . . 84.6 mt -96.46 145.77 25.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.233 -1.157 . . . . 35.33 109.815 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' S' S ' 293' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -77.34 102.4 6.75 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.144 -0.973 . . . . 48.7 110.235 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' S' S ' 294' ' ' LEU . . . . . 0.428 ' HB3' ' CZ2' ' S' ' 252' ' ' TRP . 55.1 mt -106.89 51.73 0.73 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.498 -0.751 . . . . 42.61 110.128 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' S' S ' 295' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -112.56 -11.11 13.63 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.356 -0.84 . . . . 55.49 110.518 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' S' S ' 296' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -144.32 48.44 1.36 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.093 -1.004 . . . . 75.68 110.363 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' S' S ' 297' ' ' GLY . . . . . . . . . . . . . . . 96.9 145.15 18.66 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.477 -1.449 . . . . 49.44 109.477 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' S' S ' 298' ' ' GLY . . . . . . . . . . . . . . . -163.8 156.99 29.09 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.804 -1.318 . . . . 41.11 109.804 -179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' S' S ' 299' ' ' PRO . . . . . 0.491 ' O ' HG23 ' S' ' 303' ' ' VAL . 47.4 Cg_endo -73.82 118.26 5.37 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 124.018 1.536 . . . . 26.2 110.32 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' S' S ' 300' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.26 -15.4 31.63 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.609 1.321 . . . . 21.7 110.736 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' S' S ' 301' ' ' ALA . . . . . . . . . . . . . . . -80.68 -29.44 36.57 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.237 -0.914 . . . . 31.23 110.129 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' S' S ' 302' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.45 -40.62 19.05 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.404 -0.81 . . . . 38.99 110.031 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' S' S ' 303' ' ' VAL . . . . . 0.491 HG23 ' O ' ' S' ' 299' ' ' PRO . 57.6 t -60.69 -35.53 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.36 -0.838 . . . . 18.63 110.135 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' S' S ' 304' ' ' ILE . . . . . 0.523 HD12 HG21 ' S' ' 379' ' ' VAL . 85.9 mt -79.36 -23.72 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.265 -0.897 . . . . 25.46 110.129 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' S' S ' 305' ' ' TRP . . . . . 0.415 ' CD2' ' HD3' ' S' ' 308' ' ' LYS . 68.7 t-105 -88.55 -14.6 37.29 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.261 -0.899 . . . . 33.4 110.588 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' S' S ' 306' ' ' ASN . . . . . 0.408 ' HB3' HG22 ' S' ' 290' ' ' THR . 10.4 m-80 -89.64 -13.65 36.63 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.204 -0.935 . . . . 36.97 110.403 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' S' S ' 307' ' ' ILE . . . . . 0.472 HG12 ' O ' ' S' ' 303' ' ' VAL . 36.8 pt -125.06 45.65 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.198 -0.939 . . . . 30.81 109.997 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' S' S ' 308' ' ' LYS . . . . . 0.415 ' HD3' ' CD2' ' S' ' 305' ' ' TRP . 1.5 mtmp? -73.52 -37.82 65.53 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.336 -0.852 . . . . 46.52 110.108 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' S' S ' 309' ' ' HIS . . . . . 0.498 ' CD2' ' HG ' ' S' ' 310' ' ' LEU . 55.5 p-80 -73.21 -8.26 55.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.331 -0.855 . . . . 51.03 110.078 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' S' S ' 310' ' ' LEU . . . . . 0.498 ' HG ' ' CD2' ' S' ' 309' ' ' HIS . 52.8 mt -99.31 -12.81 20.0 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.245 -0.909 . . . . 36.16 110.009 179.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' S' S ' 311' ' ' LEU . . . . . 0.537 HD21 ' CE2' ' S' ' 260' ' ' PHE . 10.8 mt -97.18 147.87 23.65 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.378 -0.826 . . . . 40.0 110.458 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' S' S ' 312' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -81.65 -16.25 52.0 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.363 -0.836 . . . . 54.18 109.722 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' S' S ' 313' ' ' THR . . . . . 0.82 HG23 ' HG2' ' S' ' 323' ' ' GLU . 92.6 m -87.92 151.65 22.66 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.386 -0.821 . . . . 25.61 110.119 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' S' S ' 314' ' ' GLY . . . . . . . . . . . . . . . -87.93 126.34 8.02 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.849 -1.3 . . . . 25.18 109.849 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' S' S ' 315' ' ' ILE . . . . . 0.667 HD13 ' HB ' ' S' ' 324' ' ' VAL . 50.7 mm -101.66 150.5 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.409 -1.053 . . . . 23.9 109.727 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' S' S ' 316' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' S' ' 325' ' ' CYS . . . -157.06 -159.29 9.39 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.928 -1.269 . . . . 23.18 109.928 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' S' S ' 317' ' ' THR . . . . . 0.424 HG22 ' CG2' ' S' ' 326' ' ' VAL . 11.1 p -133.87 -172.99 3.12 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.422 -1.046 . . . . 27.98 110.025 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' S' S ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.54 -56.25 24.33 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.215 -0.928 . . . . 28.1 109.908 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' S' S ' 319' ' ' SER . . . . . . . . . . . . . 1.2 m -59.91 -41.68 92.25 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.343 -0.848 . . . . 37.0 109.65 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' S' S ' 320' ' ' ARG . . . . . . . . . . . . . 12.2 mtm180 -111.7 79.95 2.67 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.438 -0.789 . . . . 52.07 109.646 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' S' S ' 321' ' ' PRO . . . . . 0.447 ' O ' ' HB2' ' S' ' 322' ' ' SER . 43.6 Cg_endo -71.5 171.51 16.11 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.772 1.406 . . . . 38.29 110.867 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' S' S ' 322' ' ' SER . . . . . 0.447 ' HB2' ' O ' ' S' ' 321' ' ' PRO . 41.3 t 178.69 -148.1 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.907 -0.775 . . . . 38.84 108.907 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' S' S ' 323' ' ' GLU . . . . . 0.82 ' HG2' HG23 ' S' ' 313' ' ' THR . 6.7 tp10 -62.86 -40.26 96.96 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.048 -1.033 . . . . 40.7 109.707 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' S' S ' 324' ' ' VAL . . . . . 0.667 ' HB ' HD13 ' S' ' 315' ' ' ILE . 72.7 t -141.33 135.01 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.411 -0.806 . . . . 20.34 109.49 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' S' S ' 325' ' ' CYS . . . . . 0.463 ' HB2' ' CE1' ' S' ' 380' ' ' PHE . 11.3 m -125.94 172.22 10.1 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.323 -0.861 . . . . 30.63 110.84 -179.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' S' S ' 326' ' ' VAL . . . . . 0.646 HG12 HG22 ' S' ' 379' ' ' VAL . 34.6 m -135.53 142.26 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 109.186 -0.672 . . . . 23.9 109.186 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' S' S ' 327' ' ' VAL . . . . . 0.594 HG11 ' O ' ' S' ' 377' ' ' VAL . 34.5 m -56.41 125.01 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.096 -1.002 . . . . 19.48 110.419 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' S' S ' 328' ' ' ASP . . . . . . . . . . . . . 55.5 p-10 -119.43 11.54 12.18 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.461 -0.774 . . . . 26.43 110.445 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' S' S ' 329' ' ' GLY . . . . . . . . . . . . . . . 119.69 2.27 13.05 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.041 -1.223 . . . . 31.24 110.041 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' S' S ' 330' ' ' THR . . . . . . . . . . . . . 80.1 m -93.04 129.99 38.79 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.117 -1.225 . . . . 30.05 110.107 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' S' S ' 331' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -56.68 111.47 1.02 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.311 -0.868 . . . . 37.26 110.011 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' S' S ' 332' ' ' MET . . . . . . . . . . . . . 88.0 mmm -94.1 162.57 13.82 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.234 -0.916 . . . . 26.23 110.356 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' S' S ' 333' ' ' CYS . . . . . . . . . . . . . 25.6 m -137.24 150.01 47.55 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.513 -0.742 . . . . 23.56 110.015 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' S' S ' 334' ' ' LEU . . . . . 0.563 HD11 ' O ' ' S' ' 372' ' ' PRO . 0.1 OUTLIER -52.57 -24.82 8.96 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.342 -0.849 . . . . 28.93 110.488 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' S' S ' 335' ' ' ALA . . . . . . . . . . . . . . . -89.12 14.52 10.58 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.427 -0.796 . . . . 15.76 110.942 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' S' S ' 336' ' ' ASP . . . . . 0.404 ' O ' ' HA ' ' S' ' 382' ' ' PRO . 70.9 m-20 -100.45 -17.28 17.25 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.164 -0.96 . . . . 34.92 110.242 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' S' S ' 337' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -152.36 170.88 19.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.329 -0.857 . . . . 19.03 110.072 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' S' S ' 338' ' ' HIS . . . . . 0.401 ' HB3' ' CZ ' ' S' ' 383' ' ' TYR . 13.5 p80 -120.71 10.47 11.0 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.356 -0.84 . . . . 18.82 110.508 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' S' S ' 339' ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' S' ' 352' ' ' ALA . . . -176.0 155.18 1.56 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.193 -0.942 . . . . 17.18 110.079 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' S' S ' 340' ' ' GLY . . . . . 0.402 ' HA3' ' O ' ' S' ' 379' ' ' VAL . . . 160.82 173.05 28.93 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.089 -1.204 . . . . 18.33 110.089 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' S' S ' 341' ' ' ILE . . . . . . . . . . . . . 83.9 mt -88.76 138.07 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.493 -1.004 . . . . 18.6 109.864 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' S' S ' 342' ' ' PHE . . . . . 0.489 ' CE2' ' HB3' ' S' ' 352' ' ' ALA . 70.0 m-85 -120.94 -178.43 3.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.195 -0.941 . . . . 23.44 110.444 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' S' S ' 343' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.91 93.37 4.17 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.44 -0.787 . . . . 35.59 110.001 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' S' S ' 344' ' ' LYS . . . . . 0.4 ' O ' ' HB3' ' S' ' 348' ' ' HIS . 0.3 OUTLIER -80.86 125.09 29.67 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.334 -0.854 . . . . 38.34 109.999 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' S' S ' 345' ' ' GLY . . . . . . . . . . . . . . . 62.71 -130.83 43.26 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 108.928 -1.669 . . . . 53.46 108.928 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' S' S ' 346' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -132.72 150.9 52.1 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.23 -1.159 . . . . 70.91 110.018 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' S' S ' 347' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 53.26 35.44 20.1 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.319 -0.863 . . . . 47.32 110.442 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' S' S ' 348' ' ' HIS . . . . . 0.4 ' HB3' ' O ' ' S' ' 344' ' ' LYS . 46.9 t60 -150.16 155.83 40.5 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.383 -0.823 . . . . 41.72 110.36 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' S' S ' 349' ' ' ALA . . . . . 0.458 ' C ' HG13 ' S' ' 350' ' ' VAL . . . -149.79 151.25 33.26 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.427 -0.796 . . . . 22.91 110.481 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' S' S ' 350' ' ' VAL . . . . . 0.458 HG13 ' C ' ' S' ' 349' ' ' ALA . 34.6 m -148.99 169.66 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.534 -0.729 . . . . 21.09 110.072 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' S' S ' 351' ' ' PHE . . . . . 0.498 ' CD2' ' HB3' ' S' ' 258' ' ' GLN . 10.7 t80 -105.44 143.54 33.46 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.246 -0.909 . . . . 25.03 110.709 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' S' S ' 352' ' ' ALA . . . . . 0.489 ' HB3' ' CE2' ' S' ' 342' ' ' PHE . . . -147.66 151.69 36.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.634 -0.666 . . . . 23.81 109.766 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' S' S ' 353' ' ' CYS . . . . . . . . . . . . . 26.3 p -153.3 164.9 37.29 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.341 -0.849 . . . . 25.66 110.315 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' S' S ' 354' ' ' VAL . . . . . 0.551 HG22 ' CE2' ' S' ' 359' ' ' TRP . 57.5 t -76.05 118.52 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.359 -0.838 . . . . 34.27 109.904 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' S' S ' 355' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' S' ' 232' ' ' THR . 51.7 p -117.91 175.15 5.8 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.298 -0.876 . . . . 25.49 110.283 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' S' S ' 356' ' ' SER . . . . . . . . . . . . . 62.3 p -62.12 -17.75 58.7 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.393 -0.817 . . . . 31.24 110.731 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' S' S ' 357' ' ' ASN . . . . . . . . . . . . . 46.0 m-20 -106.98 14.16 26.77 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.104 -0.997 . . . . 28.61 110.559 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' S' S ' 358' ' ' GLY . . . . . . . . . . . . . . . 111.88 -152.9 17.6 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 110.005 -1.238 . . . . 22.01 110.005 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' S' S ' 359' ' ' TRP . . . . . 0.551 ' CE2' HG22 ' S' ' 354' ' ' VAL . 15.5 m95 -91.22 116.63 28.97 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.446 -1.032 . . . . 25.54 110.273 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' S' S ' 360' ' ' TYR . . . . . 0.42 ' HA ' ' HA ' ' S' ' 369' ' ' PRO . 1.3 m-85 -103.47 165.81 10.81 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.375 -0.828 . . . . 40.53 110.104 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' S' S ' 361' ' ' ALA . . . . . 0.426 ' HA ' ' O ' ' S' ' 351' ' ' PHE . . . -140.04 130.07 24.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.379 -0.826 . . . . 18.04 110.297 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' S' S ' 362' ' ' ILE . . . . . . . . . . . . . 88.7 mt -95.63 83.62 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.415 -0.803 . . . . 15.64 110.065 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' S' S ' 363' ' ' ASP . . . . . 0.416 ' O ' ' N ' ' S' ' 365' ' ' GLU . 11.8 t0 -75.2 94.43 2.96 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.334 -0.854 . . . . 35.03 110.216 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' S' S ' 364' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 54.01 -89.34 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.493 -0.754 . . . . 46.72 110.508 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' S' S ' 365' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' S' ' 363' ' ' ASP . 23.7 mt-10 -122.68 19.09 10.33 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.081 -1.012 . . . . 56.2 110.202 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' S' S ' 366' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -117.97 125.04 49.64 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.217 -0.927 . . . . 51.02 110.342 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' S' S ' 367' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -106.99 127.12 53.17 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.392 -0.817 . . . . 37.59 110.093 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' S' S ' 368' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -165.49 159.58 13.8 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.323 -0.861 . . . . 31.47 110.423 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' S' S ' 369' ' ' PRO . . . . . 0.42 ' HA ' ' HA ' ' S' ' 360' ' ' TYR . 46.5 Cg_endo -72.92 139.61 30.44 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 O-C-N 123.85 1.447 . . . . 28.85 110.497 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' S' S ' 370' ' ' TRP . . . . . . . . . . . . . 67.5 t90 -167.19 113.57 0.77 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.408 -0.807 . . . . 26.94 109.936 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' S' S ' 371' ' ' THR . . . . . . . . . . . . . 59.3 m -74.8 113.04 20.59 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.372 -0.83 . . . . 20.19 110.02 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' S' S ' 372' ' ' PRO . . . . . 0.563 ' O ' HD11 ' S' ' 334' ' ' LEU . 47.9 Cg_endo -73.49 157.06 49.55 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 O-C-N 123.578 1.304 . . . . 28.68 110.597 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' S' S ' 373' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -90.64 147.18 35.72 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.423 -0.798 . . . . 35.72 109.87 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' S' S ' 374' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -76.04 -6.25 17.15 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 O-C-N 123.713 1.375 . . . . 30.89 110.465 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' S' S ' 375' ' ' SER . . . . . . . . . . . . . 68.2 p -104.36 -17.0 14.97 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.297 -0.877 . . . . 29.41 110.46 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' S' S ' 376' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -106.5 43.0 1.19 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.299 -0.876 . . . . 32.89 110.256 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' S' S ' 377' ' ' VAL . . . . . 0.594 ' O ' HG11 ' S' ' 327' ' ' VAL . 7.4 p -114.62 147.25 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.348 -0.845 . . . . 24.33 110.26 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' S' S ' 378' ' ' LEU . . . . . . . . . . . . . 53.0 mt -116.05 -57.93 2.16 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.456 -0.778 . . . . 24.37 109.573 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' S' S ' 379' ' ' VAL . . . . . 0.646 HG22 HG12 ' S' ' 326' ' ' VAL . 61.5 t -120.73 132.39 70.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.454 -0.779 . . . . 18.02 109.409 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' S' S ' 380' ' ' PHE . . . . . 0.463 ' CE1' ' HB2' ' S' ' 325' ' ' CYS . 14.5 p90 -142.59 173.94 11.09 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.38 -0.825 . . . . 29.35 110.646 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' S' S ' 381' ' ' VAL . . . . . . . . . . . . . 57.8 t -120.02 107.35 39.94 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.486 -0.759 . . . . 16.34 109.412 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' S' S ' 382' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' S' ' 336' ' ' ASP . 45.4 Cg_endo -71.38 145.67 48.61 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 O-C-N 123.636 1.335 . . . . 20.94 110.762 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' S' S ' 383' ' ' TYR . . . . . 0.401 ' CZ ' ' HB3' ' S' ' 338' ' ' HIS . 88.0 m-85 -61.12 -53.45 56.86 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.344 -0.848 . . . . 28.93 109.825 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' S' S ' 384' ' ' ASP . . . . . . . . . . . . . 3.9 p30 . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.431 -0.793 . . . . 47.03 110.332 -176.496 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' R' R ' 30' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 . . . . . 0 N--CA 1.493 1.719 0 CA-C-O 121.161 0.505 . . . . 43.36 110.262 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' R' R ' 31' ' ' LEU . . . . . . . . . . . . . 65.6 mt -134.91 140.58 45.87 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.312 -0.867 . . . . 22.93 110.268 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 32' ' ' THR . . . . . . . . . . . . . 69.3 m -87.55 110.57 20.45 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.319 -0.863 . . . . 22.34 109.984 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 33' ' ' LEU . . . . . 0.594 HD22 ' CE2' ' R' ' 62' ' ' TYR . 80.1 mt -62.38 -172.76 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.299 -0.876 . . . . 21.39 110.202 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 34' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -74.6 -29.49 61.33 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.333 -0.855 . . . . 34.4 110.365 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 35' ' ' ASN . . . . . . . . . . . . . 48.3 p30 -77.72 -1.89 33.46 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.384 -0.822 . . . . 30.28 110.649 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.28 -16.55 59.53 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.698 -1.361 . . . . 36.25 109.698 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 37' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -59.04 161.77 4.82 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.338 -1.095 . . . . 53.8 110.368 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 38' ' ' LYS . . . . . . . . . . . . . 57.1 mttt -117.78 135.73 53.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.393 -0.817 . . . . 49.91 110.181 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 39' ' ' LYS . . . . . 0.405 ' HG2' ' CZ ' ' R' ' 41' ' ' PHE . 8.1 ttmt -138.68 143.74 39.29 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.423 -0.798 . . . . 35.69 110.198 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 40' ' ' THR . . . . . . . . . . . . . 23.6 m -102.63 128.05 49.47 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.343 -0.848 . . . . 34.84 110.188 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 41' ' ' PHE . . . . . 0.405 ' CZ ' ' HG2' ' R' ' 39' ' ' LYS . 96.6 m-85 -113.08 132.64 55.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.381 -0.824 . . . . 34.42 110.14 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 42' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -93.32 140.9 29.04 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.366 -0.834 . . . . 51.46 110.215 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 43' ' ' SER . . . . . . . . . . . . . 54.6 m -70.76 141.92 51.42 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.397 -0.815 . . . . 41.84 110.187 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.8 125.34 29.6 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.305 -0.872 . . . . 33.82 109.978 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 45' ' ' PRO . . . . . 0.425 ' HG2' ' ND2' ' R' ' 77' ' ' ASN . 45.8 Cg_endo -72.15 151.05 54.79 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.517 1.272 . . . . 30.27 110.649 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 46' ' ' ASN . . . . . 0.4 ' HA ' ' OD1' ' R' ' 50' ' ' ASN . 52.1 t-20 -124.24 109.92 13.99 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.456 -0.777 . . . . 35.1 109.989 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 47' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -120.27 -34.93 3.54 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.325 -0.859 . . . . 42.81 110.545 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 48' ' ' HIS . . . . . 0.439 ' NE2' HD11 ' R' ' 80' ' ' LEU . 73.2 m80 -105.74 45.16 0.98 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.181 -0.949 . . . . 49.97 110.275 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 49' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 50.35 34.65 9.32 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.432 -0.793 . . . . 61.32 110.182 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 50' ' ' ASN . . . . . 0.4 ' OD1' ' HA ' ' R' ' 46' ' ' ASN . 15.0 p-10 -86.22 43.81 1.09 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.349 -0.844 . . . . 51.5 110.661 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.14 -46.08 78.73 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.225 -0.922 . . . . 38.77 109.539 179.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 52' ' ' TRP . . . . . 0.483 ' CD2' ' N ' ' R' ' 53' ' ' LEU . 68.2 p-90 -58.37 -38.42 77.21 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.419 -0.801 . . . . 26.24 110.082 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 53' ' ' LEU . . . . . 0.483 ' N ' ' CD2' ' R' ' 52' ' ' TRP . 23.0 tp -66.71 -46.71 74.65 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.456 -0.777 . . . . 26.75 109.939 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 54' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -55.18 -41.68 72.24 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.321 -0.862 . . . . 35.02 110.128 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.19 -46.03 92.14 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.4 -0.812 . . . . 24.47 110.189 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 56' ' ' ILE . . . . . 0.431 HG12 HD11 ' R' ' 104' ' ' ILE . 76.3 mt -62.14 -42.25 94.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.332 -0.855 . . . . 26.03 109.937 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 57' ' ' LEU . . . . . . . . . . . . . 22.4 mt -60.3 -45.67 92.57 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.299 -0.876 . . . . 26.77 109.661 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 58' ' ' GLN . . . . . . . . . . . . . 57.9 mm-40 -63.92 -46.48 84.59 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.481 -0.762 . . . . 22.32 109.594 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 59' ' ' LEU . . . . . 0.429 ' HA ' ' HE2' ' R' ' 151' ' ' PHE . 23.9 tp -61.43 -37.73 84.6 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.306 -0.871 . . . . 20.55 109.396 179.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 60' ' ' PHE . . . . . 0.528 ' CE2' HD21 ' R' ' 111' ' ' LEU . 2.8 m-85 -61.08 -44.76 96.88 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.664 -0.648 . . . . 20.08 109.927 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 61' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -63.1 -36.17 82.71 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.479 -0.763 . . . . 18.8 110.486 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 62' ' ' TYR . . . . . 0.594 ' CE2' HD22 ' R' ' 33' ' ' LEU . 9.1 t80 -63.11 -41.76 99.41 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.266 -0.896 . . . . 26.45 110.226 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 63' ' ' VAL . . . . . 0.406 ' H ' HG22 ' R' ' 63' ' ' VAL . 30.5 m -93.4 20.45 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.295 -0.878 . . . . 29.75 110.218 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 64' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 52.87 75.58 0.23 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.344 -0.848 . . . . 35.52 110.58 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 65' ' ' GLU . . . . . 0.443 ' HG2' ' CD2' ' R' ' 60' ' ' PHE . 14.2 tp10 -116.29 104.07 52.33 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.377 -0.827 . . . . 29.89 109.888 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 66' ' ' PRO . . . . . 0.481 ' HA ' ' HB2' ' R' ' 69' ' ' ASP . 46.9 Cg_endo -73.53 -5.86 17.79 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 123.806 1.424 . . . . 21.37 111.124 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 67' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -52.09 -61.52 2.21 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.144 -0.973 . . . . 23.85 110.375 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 68' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -98.11 36.53 1.56 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.326 -0.859 . . . . 28.07 110.475 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 69' ' ' ASP . . . . . 0.481 ' HB2' ' HA ' ' R' ' 66' ' ' PRO . 11.7 t0 -72.3 -33.31 67.31 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.382 -0.824 . . . . 43.76 110.169 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 70' ' ' TRP . . . . . 0.477 ' CE2' ' CG2' ' R' ' 71' ' ' VAL . 47.9 p-90 -73.34 -3.88 29.9 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.313 -0.867 . . . . 33.06 110.705 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 71' ' ' VAL . . . . . 0.555 HG11 ' HB2' ' R' ' 82' ' ' ALA . 40.8 t -109.79 -27.48 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.132 -0.98 . . . . 31.7 109.717 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 72' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -86.56 -48.79 8.05 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.381 -0.824 . . . . 33.58 110.312 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 73' ' ' SER . . . . . . . . . . . . . 70.1 m -89.78 51.13 2.01 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.292 -0.88 . . . . 50.82 110.284 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 74' ' ' SER . . . . . . . . . . . . . 15.8 t -125.95 138.3 31.8 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.348 -0.845 . . . . 34.74 110.168 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.36 -25.01 15.92 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 O-C-N 123.669 1.352 . . . . 35.7 110.319 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 76' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -91.7 153.16 19.85 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.437 -0.789 . . . . 66.48 110.342 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 77' ' ' ASN . . . . . 0.425 ' ND2' ' HG2' ' R' ' 45' ' ' PRO . 22.3 t-20 -81.51 95.16 7.03 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.374 -0.829 . . . . 46.72 110.091 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 78' ' ' LEU . . . . . . . . . . . . . 96.4 mt -96.41 27.97 3.53 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.464 -0.772 . . . . 37.55 110.167 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 79' ' ' THR . . . . . . . . . . . . . 29.6 m -56.19 -54.56 43.76 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.27 -0.894 . . . . 37.36 110.312 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 80' ' ' LEU . . . . . 0.602 ' HA ' HD12 ' R' ' 83' ' ' ILE . 15.8 mt -60.93 -23.23 65.12 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.348 -0.845 . . . . 35.83 110.46 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 81' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -79.5 -39.18 32.67 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.209 -0.932 . . . . 44.03 110.298 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 82' ' ' ALA . . . . . 0.555 ' HB2' HG11 ' R' ' 71' ' ' VAL . . . -69.43 -28.68 66.33 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.187 -0.945 . . . . 32.54 110.159 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 83' ' ' ILE . . . . . 0.602 HD12 ' HA ' ' R' ' 80' ' ' LEU . 78.3 mt -70.16 -45.99 73.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.307 -0.87 . . . . 32.02 110.3 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 84' ' ' LYS . . . . . . . . . . . . . 36.0 tttm -55.22 -52.08 64.52 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.179 -0.951 . . . . 34.09 110.596 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 85' ' ' GLN . . . . . 0.533 ' HG2' HD12 ' R' ' 89' ' ' LEU . 31.9 tt0 -54.81 -46.83 74.57 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.224 -0.923 . . . . 25.94 110.301 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 86' ' ' LEU . . . . . . . . . . . . . 24.0 mt -58.66 -43.88 90.0 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.312 -0.867 . . . . 16.2 109.878 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 87' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -65.36 -35.21 80.28 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.442 -0.786 . . . . 49.09 110.28 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 88' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -78.43 -19.04 54.07 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.247 -0.908 . . . . 28.61 110.493 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 89' ' ' LEU . . . . . 0.533 HD12 ' HG2' ' R' ' 85' ' ' GLN . 32.6 mt -96.21 -29.37 14.07 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.188 -0.945 . . . . 26.16 110.201 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 90' ' ' THR . . . . . . . . . . . . . 59.8 p -105.69 -34.6 7.66 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.211 -0.931 . . . . 33.33 109.795 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.78 16.06 58.75 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.857 -1.297 . . . . 31.13 109.857 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 92' ' ' LEU . . . . . . . . . . . . . 97.0 mt -100.07 155.24 17.83 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.141 -1.211 . . . . 42.52 110.281 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 93' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -86.17 91.54 8.47 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.485 -0.759 . . . . 68.46 109.99 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 94' ' ' LEU . . . . . 0.458 ' HB3' ' CZ2' ' R' ' 52' ' ' TRP . 47.8 mt -99.46 53.04 0.94 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.162 -0.961 . . . . 44.63 110.342 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 95' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.48 -38.68 6.38 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.332 -0.855 . . . . 67.16 110.381 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 96' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -113.96 44.25 1.68 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.392 -0.818 . . . . 67.02 110.254 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 97' ' ' GLY . . . . . . . . . . . . . . . 99.2 150.83 26.02 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.599 -1.401 . . . . 49.48 109.599 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 98' ' ' GLY . . . . . . . . . . . . . . . -166.23 160.03 33.46 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.253 -1.539 . . . . 36.57 109.253 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 99' ' ' PRO . . . . . 0.792 ' O ' HG23 ' R' ' 103' ' ' VAL . 45.7 Cg_endo -72.54 121.09 7.14 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.641 1.337 . . . . 30.41 110.492 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 100' ' ' PRO . . . . . 0.413 ' HA ' HD11 ' R' ' 56' ' ' ILE . 45.8 Cg_endo -72.33 -31.57 11.38 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.678 1.357 . . . . 29.94 110.492 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 101' ' ' ALA . . . . . 0.476 ' HB2' ' HB3' ' R' ' 178' ' ' LEU . . . -70.0 -38.51 75.98 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.357 -0.839 . . . . 23.64 110.227 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 102' ' ' LEU . . . . . 0.424 HD23 HD21 ' R' ' 106' ' ' ASN . 0.1 OUTLIER -72.67 -40.72 66.09 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.377 -0.827 . . . . 20.31 110.353 -179.696 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' R' R ' 103' ' ' VAL . . . . . 0.792 HG23 ' O ' ' R' ' 99' ' ' PRO . 63.9 t -58.14 -40.13 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.185 -0.947 . . . . 16.33 109.986 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 104' ' ' ILE . . . . . 0.431 HD11 HG12 ' R' ' 56' ' ' ILE . 82.1 mt -71.71 -30.54 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.399 -0.813 . . . . 24.77 109.899 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 105' ' ' TRP . . . . . 0.462 ' O ' ' HD3' ' R' ' 108' ' ' LYS . 70.5 t-105 -82.41 0.88 40.02 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.292 -0.88 . . . . 23.28 110.31 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 106' ' ' ASN . . . . . 0.424 HD21 HD23 ' R' ' 102' ' ' LEU . 6.9 m-80 -105.08 -10.42 17.18 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.152 -0.967 . . . . 28.26 110.043 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 107' ' ' ILE . . . . . . . . . . . . . 36.7 pt -126.81 34.96 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.225 -0.922 . . . . 18.77 110.047 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 108' ' ' LYS . . . . . 0.501 ' HG2' ' HB ' ' R' ' 115' ' ' ILE . 9.2 mtpp -61.03 -48.43 81.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.565 -0.709 . . . . 42.5 110.055 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 109' ' ' HIS . . . . . 0.445 ' CD2' ' HG ' ' R' ' 110' ' ' LEU . 50.7 p-80 -66.06 -12.84 58.12 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.461 -0.774 . . . . 20.07 110.646 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 110' ' ' LEU . . . . . 0.445 ' HG ' ' CD2' ' R' ' 109' ' ' HIS . 80.6 mt -94.84 -17.21 22.29 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.115 -0.991 . . . . 15.69 110.181 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 111' ' ' LEU . . . . . 0.528 HD21 ' CE2' ' R' ' 60' ' ' PHE . 10.3 mt -94.19 144.16 25.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.376 -0.827 . . . . 25.39 110.971 -179.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 112' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -77.73 -17.33 57.71 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.525 -0.734 . . . . 53.48 109.811 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 113' ' ' THR . . . . . 0.459 HG22 ' N ' ' R' ' 114' ' ' GLY . 60.3 m -83.76 166.6 17.88 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.355 -0.841 . . . . 14.8 110.22 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 114' ' ' GLY . . . . . 0.459 ' N ' HG22 ' R' ' 113' ' ' THR . . . -97.94 127.14 9.13 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.995 -1.242 . . . . 16.14 109.995 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 115' ' ' ILE . . . . . 0.579 HD13 ' HB ' ' R' ' 124' ' ' VAL . 48.0 mm -109.13 139.32 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.54 -0.976 . . . . 13.46 109.645 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 116' ' ' GLY . . . . . . . . . . . . . . . -152.71 -155.83 7.28 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.955 -1.258 . . . . 23.9 109.955 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 117' ' ' THR . . . . . 0.529 HG22 ' CG2' ' R' ' 126' ' ' VAL . 18.9 p -134.99 -171.4 2.79 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.467 -1.019 . . . . 27.37 110.152 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 118' ' ' ALA . . . . . 0.447 ' HB3' ' OD1' ' R' ' 128' ' ' ASP . . . -56.52 -58.07 9.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.338 -0.851 . . . . 18.76 110.091 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 119' ' ' SER . . . . . . . . . . . . . 1.1 m -56.59 -40.51 75.4 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.332 -0.855 . . . . 32.35 109.784 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 120' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 -110.09 86.2 4.86 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.456 -0.777 . . . . 27.12 109.708 179.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 121' ' ' PRO . . . . . 0.481 ' HA ' ' SG ' ' R' ' 125' ' ' CYS . 44.6 Cg_endo -71.21 166.4 29.34 Favored 'Trans proline' 0 C--N 1.311 -1.419 0 O-C-N 123.799 1.42 . . . . 22.68 111.086 -179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 122' ' ' SER . . . . . 0.437 ' HB2' ' O ' ' R' ' 121' ' ' PRO . 38.3 t 178.61 -161.69 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.619 -0.675 . . . . 22.99 109.436 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 123' ' ' GLU . . . . . 0.441 ' HG2' HG23 ' R' ' 113' ' ' THR . 2.3 tp10 -56.38 -40.03 73.92 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.192 -0.943 . . . . 36.18 109.724 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 124' ' ' VAL . . . . . 0.579 ' HB ' HD13 ' R' ' 115' ' ' ILE . 82.6 t -142.51 136.5 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.506 -0.746 . . . . 20.64 109.39 179.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 125' ' ' CYS . . . . . 0.481 ' SG ' ' HA ' ' R' ' 121' ' ' PRO . 83.4 m -140.37 168.17 20.43 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.219 -0.925 . . . . 22.8 111.131 -179.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 126' ' ' VAL . . . . . 0.727 HG12 HG22 ' R' ' 179' ' ' VAL . 35.8 m -122.72 159.77 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.724 -0.61 . . . . 21.24 109.695 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 127' ' ' VAL . . . . . 0.708 HG11 ' O ' ' R' ' 177' ' ' VAL . 30.5 m -70.81 141.86 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.273 -0.892 . . . . 19.77 110.708 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 128' ' ' ASP . . . . . 0.447 ' OD1' ' HB3' ' R' ' 118' ' ' ALA . 53.9 p-10 -137.73 19.41 2.87 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.336 -0.853 . . . . 29.21 110.697 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 129' ' ' GLY . . . . . . . . . . . . . . . 114.01 -0.05 24.13 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.963 -1.113 . . . . 33.86 110.503 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 130' ' ' THR . . . . . . . . . . . . . 58.5 m -91.84 131.81 36.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.12 -1.223 . . . . 26.41 110.117 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -62.52 120.65 11.54 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.372 -0.83 . . . . 33.08 110.302 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 132' ' ' MET . . . . . 0.433 ' HE1' ' CE2' ' R' ' 180' ' ' PHE . 98.4 mmm -105.12 165.63 10.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.437 -0.79 . . . . 30.76 110.467 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 133' ' ' CYS . . . . . 0.409 ' HA ' ' HB3' ' R' ' 174' ' ' PRO . 32.4 m -141.12 158.13 44.34 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.511 -0.743 . . . . 27.0 109.988 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 134' ' ' LEU . . . . . 0.563 HD11 ' O ' ' R' ' 172' ' ' PRO . 0.1 OUTLIER -58.45 -19.76 39.41 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.217 -0.927 . . . . 33.9 110.467 -179.885 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' R' R ' 135' ' ' ALA . . . . . . . . . . . . . . . -92.72 8.16 40.48 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.278 -0.889 . . . . 19.37 110.749 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 136' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -93.77 -21.78 19.1 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.14 -0.975 . . . . 30.47 110.186 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 137' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -149.93 165.34 32.93 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.338 -0.851 . . . . 24.27 110.252 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 138' ' ' HIS . . . . . 0.434 ' HA ' HG23 ' R' ' 154' ' ' VAL . 15.2 p80 -117.81 15.03 14.39 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.393 -0.817 . . . . 20.91 110.419 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 139' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' R' ' 152' ' ' ALA . . . -177.15 152.41 0.88 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.163 -0.96 . . . . 15.69 110.181 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 140' ' ' GLY . . . . . 0.428 ' HA3' ' O ' ' R' ' 179' ' ' VAL . . . 161.85 175.18 32.6 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.964 -1.254 . . . . 23.76 109.964 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 141' ' ' ILE . . . . . . . . . . . . . 83.4 mt -95.49 136.56 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.398 -1.06 . . . . 25.3 109.681 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 142' ' ' PHE . . . . . 0.575 ' CD2' ' HB2' ' R' ' 172' ' ' PRO . 83.0 m-85 -120.74 -172.58 2.41 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.336 -0.852 . . . . 30.24 110.552 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 143' ' ' LEU . . . . . 0.742 HD23 ' O ' ' R' ' 148' ' ' HIS . 0.5 OUTLIER -119.8 77.8 1.27 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.437 -0.789 . . . . 32.8 110.281 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' R' R ' 144' ' ' LYS . . . . . 0.47 ' HG3' ' CZ2' ' R' ' 170' ' ' TRP . 1.0 OUTLIER -69.67 76.82 0.44 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.285 -0.884 . . . . 49.18 109.69 179.56 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' R' R ' 145' ' ' GLY . . . . . 0.458 ' O ' HD22 ' R' ' 143' ' ' LEU . . . 104.57 179.28 24.75 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.168 -1.573 . . . . 53.87 109.168 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 146' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -88.48 145.82 25.54 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.417 -1.049 . . . . 68.58 109.989 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 147' ' ' GLU . . . . . . . . . . . . . 10.8 mt-10 58.25 36.52 25.75 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.405 -0.809 . . . . 56.62 110.623 179.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 148' ' ' HIS . . . . . 0.742 ' O ' HD23 ' R' ' 143' ' ' LEU . 45.1 t60 -158.72 148.1 19.09 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.208 -0.933 . . . . 44.57 110.371 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 149' ' ' ALA . . . . . . . . . . . . . . . -150.26 146.93 27.1 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.441 -0.787 . . . . 33.54 110.023 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 150' ' ' VAL . . . . . . . . . . . . . 34.2 m -142.35 161.51 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.273 -0.892 . . . . 27.61 110.276 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 151' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' R' ' 152' ' ' ALA . 5.9 t80 -86.25 155.61 20.62 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.383 -0.823 . . . . 23.04 109.926 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 152' ' ' ALA . . . . . 0.537 ' N ' ' CD1' ' R' ' 151' ' ' PHE . . . -157.25 151.56 25.01 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.457 -0.777 . . . . 29.61 109.623 179.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 153' ' ' CYS . . . . . . . . . . . . . 26.7 p -154.31 173.57 16.0 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.335 -0.853 . . . . 22.75 110.507 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 154' ' ' VAL . . . . . 0.613 HG22 ' CE2' ' R' ' 159' ' ' TRP . 60.0 t -90.61 117.02 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.422 -0.799 . . . . 23.26 110.051 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 155' ' ' THR . . . . . . . . . . . . . 69.7 p -112.1 -176.64 2.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.345 -0.847 . . . . 17.88 110.118 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 156' ' ' SER . . . . . . . . . . . . . 78.6 p -75.9 -3.77 37.17 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.382 -0.824 . . . . 21.83 110.674 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 157' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -118.29 10.48 12.83 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.171 -0.955 . . . . 36.54 110.646 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 158' ' ' GLY . . . . . . . . . . . . . . . 118.0 -162.68 13.04 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.54 -1.424 . . . . 31.74 109.54 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 159' ' ' TRP . . . . . 0.613 ' CE2' HG22 ' R' ' 154' ' ' VAL . 14.7 m95 -86.58 122.44 30.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.368 -1.078 . . . . 28.25 110.099 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 160' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -108.45 166.95 10.39 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.37 -0.831 . . . . 41.24 110.22 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 161' ' ' ALA . . . . . . . . . . . . . . . -143.22 123.49 13.79 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.43 -0.794 . . . . 27.4 110.163 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 162' ' ' ILE . . . . . . . . . . . . . 92.6 mt -87.68 81.23 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.375 -0.828 . . . . 24.27 109.989 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 163' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' R' ' 165' ' ' GLU . 15.4 t0 -72.76 92.32 1.56 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.404 -0.81 . . . . 36.08 110.278 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 164' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 54.06 -88.92 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.507 -0.745 . . . . 46.08 110.6 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 165' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' R' ' 163' ' ' ASP . 29.6 mt-10 -124.71 35.88 4.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.13 -0.981 . . . . 50.94 110.219 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 166' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -135.75 117.3 14.85 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.431 -0.793 . . . . 47.28 110.255 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 167' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -101.04 120.05 39.63 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.375 -0.828 . . . . 40.47 110.081 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 168' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -157.62 158.45 30.52 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.223 -0.923 . . . . 30.21 110.407 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 169' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.67 133.01 19.63 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 O-C-N 123.868 1.457 . . . . 32.76 110.561 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 170' ' ' TRP . . . . . 0.47 ' CZ2' ' HG3' ' R' ' 144' ' ' LYS . 67.2 t90 -159.77 119.27 2.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.453 -0.779 . . . . 32.79 109.955 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 171' ' ' THR . . . . . . . . . . . . . 47.4 m -81.06 112.66 34.48 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.488 -0.757 . . . . 36.92 110.163 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 172' ' ' PRO . . . . . 0.575 ' HB2' ' CD2' ' R' ' 142' ' ' PHE . 45.9 Cg_endo -73.74 158.79 46.5 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 O-C-N 123.681 1.358 . . . . 33.54 110.525 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 173' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -88.87 144.98 33.8 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.344 -0.848 . . . . 45.76 109.951 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 174' ' ' PRO . . . . . 0.409 ' HB3' ' HA ' ' R' ' 133' ' ' CYS . 46.2 Cg_endo -71.71 -10.4 26.46 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.596 1.314 . . . . 29.63 110.445 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 175' ' ' SER . . . . . . . . . . . . . 53.1 p -103.5 -17.55 15.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.281 -0.887 . . . . 35.7 110.343 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 176' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -103.48 43.16 1.1 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.202 -0.936 . . . . 39.65 110.4 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 177' ' ' VAL . . . . . 0.708 ' O ' HG11 ' R' ' 127' ' ' VAL . 10.5 p -117.68 127.16 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.336 -0.852 . . . . 20.61 109.971 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 178' ' ' LEU . . . . . 0.476 ' HB3' ' HB2' ' R' ' 101' ' ' ALA . 46.0 mt -91.45 -61.41 1.65 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.36 -0.837 . . . . 15.58 109.37 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 179' ' ' VAL . . . . . 0.727 HG22 HG12 ' R' ' 126' ' ' VAL . 67.0 t -114.53 144.64 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.625 -0.672 . . . . 17.4 109.496 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 180' ' ' PHE . . . . . 0.433 ' CE2' ' HE1' ' R' ' 132' ' ' MET . 43.6 p90 -152.13 163.41 39.41 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.282 -0.886 . . . . 20.16 110.537 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 181' ' ' VAL . . . . . . . . . . . . . 66.4 t -113.2 111.48 50.17 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.342 -0.849 . . . . 17.69 109.842 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 182' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.05 149.47 52.68 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.574 1.302 . . . . 17.81 110.446 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' R' R ' 183' ' ' TYR . . . . . 0.698 ' O ' ' C ' ' R' ' 184' ' ' ASP . 79.5 m-85 -59.06 175.46 0.29 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.434 -0.791 . . . . 28.01 110.561 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 184' ' ' ASP . . . . . 0.698 ' C ' ' O ' ' R' ' 183' ' ' TYR . 4.5 m-20 -18.96 -83.16 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.345 -0.847 . . . . 58.64 110.228 -178.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' R' R ' 185' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 . . . . . 0 N--CA 1.503 2.176 0 CA-C-O 121.252 0.549 . . . . 80.42 111.802 179.526 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' R' R ' 193' ' ' LYS . . . . . . . . . . . . . 66.2 mttt . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 120.856 0.36 . . . . 49.5 110.16 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' R' R ' 194' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.8 0 O-C-N 121.177 -0.952 . . . . 40.4 110.119 179.973 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' S' S ' 229' ' ' MET . . . . . . . . . . . . . 2.6 ptp . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.2 0.524 . . . . 51.83 110.251 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' S' S ' 230' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -97.3 142.66 28.92 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.39 -0.819 . . . . 54.13 110.182 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' S' S ' 231' ' ' LEU . . . . . . . . . . . . . 67.8 mt -134.05 141.02 47.04 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.339 -0.851 . . . . 33.04 110.386 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' S' S ' 232' ' ' THR . . . . . 0.403 ' O ' ' HA ' ' S' ' 355' ' ' THR . 40.4 m -89.24 103.28 15.92 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.354 -0.841 . . . . 26.92 110.019 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' S' S ' 233' ' ' LEU . . . . . 0.67 HD22 ' CE2' ' S' ' 262' ' ' TYR . 79.8 mt -55.91 179.28 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.538 -0.726 . . . . 13.78 110.5 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' S' S ' 234' ' ' TYR . . . . . 0.444 ' CG ' ' N ' ' S' ' 235' ' ' ASN . 35.5 p90 -65.05 -35.61 81.7 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.347 -0.846 . . . . 26.08 110.167 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' S' S ' 235' ' ' ASN . . . . . 0.444 ' N ' ' CG ' ' S' ' 234' ' ' TYR . 50.6 p30 -74.43 -7.28 52.41 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.313 -0.867 . . . . 20.04 110.581 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' S' S ' 236' ' ' GLY . . . . . . . . . . . . . . . 95.66 -19.9 52.21 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.788 -1.325 . . . . 22.71 109.788 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' S' S ' 237' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -53.08 145.74 12.67 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.212 -1.17 . . . . 35.44 110.189 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' S' S ' 238' ' ' LYS . . . . . . . . . . . . . 44.5 mttt -102.17 127.87 48.91 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.38 -0.825 . . . . 32.56 110.418 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' S' S ' 239' ' ' LYS . . . . . 0.403 ' HG2' ' CZ ' ' S' ' 241' ' ' PHE . 9.0 ttmt -132.32 144.5 50.61 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.407 -0.808 . . . . 26.68 109.958 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' S' S ' 240' ' ' THR . . . . . . . . . . . . . 50.8 m -102.0 132.16 47.99 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.29 -0.881 . . . . 41.02 110.417 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' S' S ' 241' ' ' PHE . . . . . 0.403 ' CZ ' ' HG2' ' S' ' 239' ' ' LYS . 96.1 m-85 -117.84 137.61 52.65 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.347 -0.846 . . . . 28.62 110.213 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' S' S ' 242' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -96.39 161.78 13.77 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.396 -0.815 . . . . 47.89 110.269 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' S' S ' 243' ' ' SER . . . . . . . . . . . . . 72.7 m -90.6 151.58 21.25 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.356 -0.84 . . . . 45.09 110.211 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' S' S ' 244' ' ' ARG . . . . . . . . . . . . . 1.4 mtp85 -129.76 126.83 22.75 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.374 -0.829 . . . . 42.49 110.212 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' S' S ' 245' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.39 161.03 43.57 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 O-C-N 123.664 1.35 . . . . 35.68 110.543 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' S' S ' 246' ' ' ASN . . . . . . . . . . . . . 51.3 t-20 -132.93 97.9 4.15 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.477 -0.764 . . . . 51.88 109.81 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' S' S ' 247' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -110.43 -22.31 11.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.316 -0.865 . . . . 53.69 110.645 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' S' S ' 248' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -117.24 43.73 2.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.202 -0.936 . . . . 55.79 110.751 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' S' S ' 249' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 48.83 38.31 11.72 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.429 -0.794 . . . . 49.45 110.416 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' S' S ' 250' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -90.54 28.95 1.37 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.582 -0.699 . . . . 36.86 110.363 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' S' S ' 251' ' ' ALA . . . . . . . . . . . . . . . -53.8 -43.13 69.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.217 -0.927 . . . . 29.69 109.585 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' S' S ' 252' ' ' TRP . . . . . 0.427 ' CZ2' ' HB3' ' S' ' 294' ' ' LEU . 67.9 p-90 -61.88 -33.89 75.02 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.622 -0.674 . . . . 41.12 109.802 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' S' S ' 253' ' ' LEU . . . . . 0.407 ' N ' ' CD2' ' S' ' 252' ' ' TRP . 23.4 tp -70.21 -47.24 62.35 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.386 -0.821 . . . . 24.89 109.939 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' S' S ' 254' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -56.11 -42.43 76.8 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.507 -0.745 . . . . 35.65 109.979 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' S' S ' 255' ' ' ALA . . . . . . . . . . . . . . . -59.58 -48.19 82.64 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.459 -0.776 . . . . 22.73 110.038 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' S' S ' 256' ' ' ILE . . . . . 0.505 HG12 HD11 ' S' ' 304' ' ' ILE . 79.9 mt -62.35 -40.69 88.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.261 -0.9 . . . . 28.85 109.926 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' S' S ' 257' ' ' LEU . . . . . . . . . . . . . 19.4 mt -61.49 -44.47 97.02 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.41 -0.806 . . . . 23.07 110.172 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' S' S ' 258' ' ' GLN . . . . . 0.498 ' HB3' ' CD2' ' S' ' 351' ' ' PHE . 53.3 mm-40 -65.12 -45.36 85.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.458 -0.776 . . . . 29.78 109.896 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' S' S ' 259' ' ' LEU . . . . . 0.425 ' O ' HG22 ' S' ' 263' ' ' VAL . 19.9 tp -58.64 -36.35 73.98 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.322 -0.861 . . . . 17.94 109.51 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' S' S ' 260' ' ' PHE . . . . . 0.535 ' CE2' HD21 ' S' ' 311' ' ' LEU . 3.1 m-85 -62.83 -45.27 93.41 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.593 -0.692 . . . . 30.57 109.812 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' S' S ' 261' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -62.03 -29.89 70.59 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.452 -0.78 . . . . 41.34 110.022 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' S' S ' 262' ' ' TYR . . . . . 0.67 ' CE2' HD22 ' S' ' 233' ' ' LEU . 8.6 t80 -71.15 -44.65 65.12 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.416 -0.803 . . . . 26.03 110.113 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' S' S ' 263' ' ' VAL . . . . . 0.425 HG22 ' O ' ' S' ' 259' ' ' LEU . 33.0 m -92.03 18.3 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.398 -0.814 . . . . 22.8 110.395 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' S' S ' 264' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 52.74 70.61 0.56 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.282 -0.886 . . . . 44.03 110.686 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' S' S ' 265' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -111.75 109.22 55.54 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.373 -0.83 . . . . 35.61 109.669 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' S' S ' 266' ' ' PRO . . . . . 0.475 ' HA ' ' HB2' ' S' ' 269' ' ' ASP . 49.6 Cg_endo -75.3 0.32 9.17 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.676 1.356 . . . . 37.67 111.79 -179.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' S' S ' 267' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -56.5 -67.63 0.29 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.843 -1.161 . . . . 41.49 110.212 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' S' S ' 268' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -92.96 39.82 1.05 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.138 -0.976 . . . . 50.76 110.057 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' S' S ' 269' ' ' ASP . . . . . 0.475 ' HB2' ' HA ' ' S' ' 266' ' ' PRO . 0.9 OUTLIER -75.97 -33.2 59.76 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.424 -0.797 . . . . 61.86 109.737 179.556 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' S' S ' 270' ' ' TRP . . . . . 0.508 ' CE2' HG23 ' S' ' 271' ' ' VAL . 51.0 p-90 -73.92 -4.3 34.24 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.285 -0.884 . . . . 39.85 110.47 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' S' S ' 271' ' ' VAL . . . . . 0.508 HG23 ' CE2' ' S' ' 270' ' ' TRP . 46.4 t -109.56 -32.67 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.114 -0.991 . . . . 39.18 110.085 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' S' S ' 272' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -78.74 -36.46 43.16 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.39 -0.819 . . . . 40.02 110.498 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' S' S ' 273' ' ' SER . . . . . . . . . . . . . 71.0 m -103.58 56.12 0.74 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.346 -0.846 . . . . 47.2 110.276 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' S' S ' 274' ' ' SER . . . . . . . . . . . . . 6.9 t -133.06 141.25 40.2 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.31 -0.869 . . . . 47.61 110.137 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' S' S ' 275' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.71 -18.92 21.8 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.719 1.378 . . . . 45.28 110.541 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' S' S ' 276' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -99.9 140.87 33.49 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.264 -0.897 . . . . 57.27 110.279 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' S' S ' 277' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -71.73 97.65 1.8 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.466 -0.771 . . . . 37.28 110.287 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' S' S ' 278' ' ' LEU . . . . . . . . . . . . . 86.8 mt -97.03 33.87 1.84 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.435 -0.79 . . . . 43.88 109.961 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' S' S ' 279' ' ' THR . . . . . . . . . . . . . 77.8 m -64.1 -60.14 3.59 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.477 -0.764 . . . . 50.05 110.239 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' S' S ' 280' ' ' LEU . . . . . 0.738 ' HA ' HD12 ' S' ' 283' ' ' ILE . 13.6 mt -51.59 -39.89 58.78 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.441 -0.787 . . . . 54.12 110.299 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' S' S ' 281' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.31 -49.72 74.5 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.454 -0.779 . . . . 65.28 110.161 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' S' S ' 282' ' ' ALA . . . . . . . . . . . . . . . -59.03 -33.84 71.21 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.467 -0.771 . . . . 46.51 110.515 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' S' S ' 283' ' ' ILE . . . . . 0.738 HD12 ' HA ' ' S' ' 280' ' ' LEU . 86.0 mt -66.43 -50.88 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.246 -0.909 . . . . 47.3 110.028 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' S' S ' 284' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -50.52 -57.65 7.61 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.461 -0.774 . . . . 50.72 110.361 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' S' S ' 285' ' ' GLN . . . . . 0.518 ' HG2' HD12 ' S' ' 289' ' ' LEU . 34.3 tt0 -51.3 -46.38 62.51 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.494 -0.754 . . . . 68.47 110.367 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' S' S ' 286' ' ' LEU . . . . . . . . . . . . . 19.0 mt -60.09 -44.41 94.82 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.435 -0.79 . . . . 36.62 110.242 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' S' S ' 287' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -62.79 -35.29 79.4 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.251 -0.906 . . . . 46.64 110.05 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' S' S ' 288' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -76.21 -21.04 56.92 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.493 -0.754 . . . . 46.45 110.311 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' S' S ' 289' ' ' LEU . . . . . 0.518 HD12 ' HG2' ' S' ' 285' ' ' GLN . 30.7 mt -97.33 -21.65 17.1 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.251 -0.906 . . . . 35.09 110.553 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' S' S ' 290' ' ' THR . . . . . 0.41 HG22 ' HB3' ' S' ' 306' ' ' ASN . 81.4 p -114.84 -28.4 7.08 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.254 -0.904 . . . . 38.61 110.462 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' S' S ' 291' ' ' GLY . . . . . . . . . . . . . . . 79.41 10.96 85.41 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.793 -1.323 . . . . 36.77 109.793 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' S' S ' 292' ' ' LEU . . . . . . . . . . . . . 84.7 mt -96.44 145.77 25.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.25 -1.147 . . . . 35.33 109.779 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' S' S ' 293' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -77.36 102.33 6.74 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.26 -0.9 . . . . 48.7 110.296 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' S' S ' 294' ' ' LEU . . . . . 0.427 ' HB3' ' CZ2' ' S' ' 252' ' ' TRP . 55.3 mt -106.83 51.71 0.74 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.572 -0.705 . . . . 42.61 110.136 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' S' S ' 295' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -112.58 -11.14 13.62 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.287 -0.883 . . . . 55.49 110.539 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' S' S ' 296' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -144.26 48.51 1.37 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.151 -0.968 . . . . 75.68 110.315 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' S' S ' 297' ' ' GLY . . . . . . . . . . . . . . . 96.91 145.13 18.63 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.502 -1.439 . . . . 49.44 109.502 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' S' S ' 298' ' ' GLY . . . . . . . . . . . . . . . -163.82 156.9 28.96 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.84 -1.304 . . . . 41.11 109.84 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' S' S ' 299' ' ' PRO . . . . . 0.494 ' O ' HG23 ' S' ' 303' ' ' VAL . 47.8 Cg_endo -73.7 118.21 5.36 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 O-C-N 123.932 1.49 . . . . 26.2 110.341 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' S' S ' 300' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.2 -15.42 31.81 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 O-C-N 123.567 1.299 . . . . 21.7 110.728 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' S' S ' 301' ' ' ALA . . . . . . . . . . . . . . . -80.75 -29.35 36.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.258 -0.901 . . . . 31.23 110.133 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' S' S ' 302' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.47 -40.65 18.97 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.426 -0.796 . . . . 38.99 109.943 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' S' S ' 303' ' ' VAL . . . . . 0.494 HG23 ' O ' ' S' ' 299' ' ' PRO . 57.7 t -60.69 -35.53 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.427 -0.795 . . . . 18.63 110.122 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' S' S ' 304' ' ' ILE . . . . . 0.52 HD12 HG21 ' S' ' 379' ' ' VAL . 86.0 mt -79.3 -23.67 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.341 -0.849 . . . . 25.46 110.178 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' S' S ' 305' ' ' TRP . . . . . 0.413 ' CD2' ' HD3' ' S' ' 308' ' ' LYS . 68.9 t-105 -88.69 -14.47 37.24 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.252 -0.905 . . . . 33.4 110.56 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' S' S ' 306' ' ' ASN . . . . . 0.41 ' HB3' HG22 ' S' ' 290' ' ' THR . 10.3 m-80 -89.76 -13.59 36.41 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.215 -0.928 . . . . 36.97 110.363 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' S' S ' 307' ' ' ILE . . . . . 0.474 HG12 ' O ' ' S' ' 303' ' ' VAL . 36.9 pt -125.06 45.57 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.182 -0.949 . . . . 30.81 110.04 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' S' S ' 308' ' ' LYS . . . . . 0.413 ' HD3' ' CD2' ' S' ' 305' ' ' TRP . 1.5 mtmp? -73.52 -37.73 65.55 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.357 -0.84 . . . . 46.52 110.157 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' S' S ' 309' ' ' HIS . . . . . 0.498 ' CD2' ' HG ' ' S' ' 310' ' ' LEU . 55.5 p-80 -73.16 -8.3 55.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.401 -0.812 . . . . 51.03 110.136 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' S' S ' 310' ' ' LEU . . . . . 0.498 ' HG ' ' CD2' ' S' ' 309' ' ' HIS . 52.9 mt -99.32 -12.83 19.97 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.3 -0.875 . . . . 36.16 109.958 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' S' S ' 311' ' ' LEU . . . . . 0.535 HD21 ' CE2' ' S' ' 260' ' ' PHE . 10.7 mt -97.24 147.87 23.68 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.373 -0.829 . . . . 40.0 110.441 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' S' S ' 312' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -81.58 -16.26 52.14 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.266 -0.896 . . . . 54.18 109.747 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' S' S ' 313' ' ' THR . . . . . 0.808 HG23 ' HG2' ' S' ' 323' ' ' GLU . 92.6 m -87.95 151.67 22.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.332 -0.855 . . . . 25.61 110.134 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' S' S ' 314' ' ' GLY . . . . . . . . . . . . . . . -87.94 126.39 8.04 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.776 -1.33 . . . . 25.18 109.776 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' S' S ' 315' ' ' ILE . . . . . 0.665 HD13 ' HB ' ' S' ' 324' ' ' VAL . 50.7 mm -101.63 150.51 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.427 -1.043 . . . . 23.9 109.757 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' S' S ' 316' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' S' ' 325' ' ' CYS . . . -157.1 -159.21 9.35 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.006 -1.237 . . . . 23.18 110.006 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' S' S ' 317' ' ' THR . . . . . 0.422 HG22 ' CG2' ' S' ' 326' ' ' VAL . 10.9 p -133.95 -173.03 3.13 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.485 -1.009 . . . . 27.98 109.921 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' S' S ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.6 -56.11 26.17 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.176 -0.953 . . . . 28.1 109.921 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' S' S ' 319' ' ' SER . . . . . . . . . . . . . 1.2 m -60.06 -41.61 92.7 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.331 -0.855 . . . . 37.0 109.593 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' S' S ' 320' ' ' ARG . . . . . . . . . . . . . 12.2 mtm180 -111.71 79.86 2.64 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.525 -0.734 . . . . 52.07 109.719 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' S' S ' 321' ' ' PRO . . . . . 0.446 ' O ' ' HB2' ' S' ' 322' ' ' SER . 44.1 Cg_endo -71.43 171.54 15.99 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.936 1.492 . . . . 38.29 110.901 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' S' S ' 322' ' ' SER . . . . . 0.446 ' HB2' ' O ' ' S' ' 321' ' ' PRO . 41.2 t 178.64 -148.14 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.905 -0.776 . . . . 38.84 108.905 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' S' S ' 323' ' ' GLU . . . . . 0.808 ' HG2' HG23 ' S' ' 313' ' ' THR . 6.7 tp10 -62.85 -40.28 96.99 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.971 -1.081 . . . . 40.7 109.668 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' S' S ' 324' ' ' VAL . . . . . 0.665 ' HB ' HD13 ' S' ' 315' ' ' ILE . 73.0 t -141.3 135.03 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.399 -0.813 . . . . 20.34 109.471 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' S' S ' 325' ' ' CYS . . . . . 0.461 ' HB2' ' CE1' ' S' ' 380' ' ' PHE . 11.4 m -126.03 172.19 10.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.294 -0.878 . . . . 30.63 110.805 -179.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' S' S ' 326' ' ' VAL . . . . . 0.638 HG12 HG22 ' S' ' 379' ' ' VAL . 34.5 m -135.47 142.23 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.641 -0.662 . . . . 23.9 109.235 179.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' S' S ' 327' ' ' VAL . . . . . 0.594 HG11 ' O ' ' S' ' 377' ' ' VAL . 34.5 m -56.37 125.04 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.078 -1.014 . . . . 19.48 110.42 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' S' S ' 328' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -119.38 11.47 12.21 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.442 -0.786 . . . . 26.43 110.411 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' S' S ' 329' ' ' GLY . . . . . . . . . . . . . . . 119.7 2.21 13.06 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.064 -1.214 . . . . 31.24 110.064 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' S' S ' 330' ' ' THR . . . . . . . . . . . . . 81.9 m -93.02 130.03 38.74 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.067 -1.255 . . . . 30.05 110.093 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' S' S ' 331' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -56.8 111.57 1.06 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.315 -0.866 . . . . 37.26 109.948 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' S' S ' 332' ' ' MET . . . . . . . . . . . . . 87.9 mmm -94.16 162.58 13.8 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.268 -0.895 . . . . 26.23 110.322 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' S' S ' 333' ' ' CYS . . . . . . . . . . . . . 26.0 m -137.25 150.05 47.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.456 -0.778 . . . . 23.56 110.014 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' S' S ' 334' ' ' LEU . . . . . 0.556 HD11 ' O ' ' S' ' 372' ' ' PRO . 0.1 OUTLIER -52.56 -24.93 9.15 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.296 -0.878 . . . . 28.93 110.429 179.905 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' S' S ' 335' ' ' ALA . . . . . . . . . . . . . . . -89.02 14.45 10.6 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.38 -0.825 . . . . 15.76 110.986 -179.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' S' S ' 336' ' ' ASP . . . . . 0.403 ' O ' ' HA ' ' S' ' 382' ' ' PRO . 70.3 m-20 -100.53 -17.18 17.23 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.135 -0.978 . . . . 34.92 110.167 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' S' S ' 337' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -152.37 170.86 19.04 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.369 -0.832 . . . . 19.03 110.151 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' S' S ' 338' ' ' HIS . . . . . 0.402 ' HB3' ' CZ ' ' S' ' 383' ' ' TYR . 13.4 p80 -120.72 10.42 10.98 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.37 -0.831 . . . . 18.82 110.47 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' S' S ' 339' ' ' ALA . . . . . 0.41 ' HA ' ' O ' ' S' ' 352' ' ' ALA . . . -175.97 155.19 1.57 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.26 -0.9 . . . . 17.18 110.116 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' S' S ' 340' ' ' GLY . . . . . . . . . . . . . . . 160.8 173.08 28.95 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 110.099 -1.201 . . . . 18.33 110.099 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' S' S ' 341' ' ' ILE . . . . . . . . . . . . . 83.8 mt -88.79 138.07 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.504 -0.998 . . . . 18.6 109.824 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' S' S ' 342' ' ' PHE . . . . . 0.488 ' CE2' ' HB3' ' S' ' 352' ' ' ALA . 69.9 m-85 -120.92 -178.42 3.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.25 -0.906 . . . . 23.44 110.419 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' S' S ' 343' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.81 93.32 4.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.505 -0.747 . . . . 35.59 110.093 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' S' S ' 344' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.83 125.11 29.68 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.34 -0.85 . . . . 38.34 110.013 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' S' S ' 345' ' ' GLY . . . . . . . . . . . . . . . 62.78 -130.86 43.09 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 108.858 -1.697 . . . . 53.46 108.858 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' S' S ' 346' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -132.74 150.87 52.11 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.14 -1.212 . . . . 70.91 110.023 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' S' S ' 347' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 53.3 35.32 19.89 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.294 -0.879 . . . . 47.32 110.452 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' S' S ' 348' ' ' HIS . . . . . . . . . . . . . 46.6 t60 -150.1 155.9 40.67 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.28 -0.888 . . . . 41.72 110.375 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' S' S ' 349' ' ' ALA . . . . . 0.453 ' C ' HG13 ' S' ' 350' ' ' VAL . . . -149.79 151.25 33.26 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.331 -0.855 . . . . 22.91 110.536 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' S' S ' 350' ' ' VAL . . . . . 0.453 HG13 ' C ' ' S' ' 349' ' ' ALA . 34.6 m -149.01 169.65 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.417 -0.802 . . . . 21.09 110.018 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' S' S ' 351' ' ' PHE . . . . . 0.498 ' CD2' ' HB3' ' S' ' 258' ' ' GLN . 10.7 t80 -105.41 143.62 33.32 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.237 -0.914 . . . . 25.03 110.689 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' S' S ' 352' ' ' ALA . . . . . 0.488 ' HB3' ' CE2' ' S' ' 342' ' ' PHE . . . -147.74 151.75 36.59 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.674 -0.641 . . . . 23.81 109.673 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' S' S ' 353' ' ' CYS . . . . . . . . . . . . . 26.3 p -153.36 164.78 37.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.28 -0.888 . . . . 25.66 110.283 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' S' S ' 354' ' ' VAL . . . . . 0.554 HG22 ' CE2' ' S' ' 359' ' ' TRP . 57.0 t -76.02 118.55 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.36 -0.838 . . . . 34.27 109.959 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' S' S ' 355' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' S' ' 232' ' ' THR . 51.7 p -117.88 175.17 5.79 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.257 -0.902 . . . . 25.49 110.271 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' S' S ' 356' ' ' SER . . . . . . . . . . . . . 62.1 p -62.22 -17.69 59.0 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.328 -0.858 . . . . 31.24 110.718 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' S' S ' 357' ' ' ASN . . . . . . . . . . . . . 46.0 m-20 -106.93 14.18 26.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.206 -0.934 . . . . 28.61 110.637 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' S' S ' 358' ' ' GLY . . . . . . . . . . . . . . . 111.86 -152.88 17.6 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.99 -1.244 . . . . 22.01 109.99 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' S' S ' 359' ' ' TRP . . . . . 0.554 ' CE2' HG22 ' S' ' 354' ' ' VAL . 15.3 m95 -91.33 116.73 29.07 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.44 -1.035 . . . . 25.54 110.14 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' S' S ' 360' ' ' TYR . . . . . 0.43 ' HA ' ' HA ' ' S' ' 369' ' ' PRO . 1.3 m-85 -103.53 165.81 10.81 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.29 -0.881 . . . . 40.53 110.064 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' S' S ' 361' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' S' ' 351' ' ' PHE . . . -140.06 130.1 24.89 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.389 -0.819 . . . . 18.04 110.295 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' S' S ' 362' ' ' ILE . . . . . . . . . . . . . 88.9 mt -95.66 83.74 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.307 -0.87 . . . . 15.64 109.959 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' S' S ' 363' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' S' ' 365' ' ' GLU . 11.9 t0 -75.24 94.48 2.99 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.403 -0.81 . . . . 35.03 110.227 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' S' S ' 364' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 53.93 -89.37 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.535 -0.728 . . . . 46.72 110.544 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' S' S ' 365' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' S' ' 363' ' ' ASP . 23.8 mt-10 -122.59 19.09 10.4 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.109 -0.994 . . . . 56.2 110.285 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' S' S ' 366' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -117.96 125.03 49.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.228 -0.92 . . . . 51.02 110.361 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' S' S ' 367' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -107.0 127.01 53.07 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.406 -0.808 . . . . 37.59 110.168 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' S' S ' 368' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -165.43 159.58 13.92 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.246 -0.909 . . . . 31.47 110.445 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' S' S ' 369' ' ' PRO . . . . . 0.43 ' HA ' ' HA ' ' S' ' 360' ' ' TYR . 46.3 Cg_endo -72.88 139.66 30.64 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 O-C-N 123.866 1.456 . . . . 28.85 110.546 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' S' S ' 370' ' ' TRP . . . . . . . . . . . . . 67.3 t90 -167.24 113.51 0.76 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.44 -0.787 . . . . 26.94 109.933 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' S' S ' 371' ' ' THR . . . . . . . . . . . . . 59.6 m -74.75 113.08 20.94 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.379 -0.826 . . . . 20.19 110.034 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' S' S ' 372' ' ' PRO . . . . . 0.556 ' O ' HD11 ' S' ' 334' ' ' LEU . 48.0 Cg_endo -73.57 157.06 49.21 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 O-C-N 123.597 1.314 . . . . 28.68 110.611 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' S' S ' 373' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -90.6 147.11 35.62 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.442 -0.786 . . . . 35.72 109.947 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' S' S ' 374' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -76.04 -6.15 17.05 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.665 1.35 . . . . 30.89 110.528 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' S' S ' 375' ' ' SER . . . . . . . . . . . . . 68.8 p -104.4 -16.96 14.96 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.19 -0.944 . . . . 29.41 110.474 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' S' S ' 376' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -106.56 43.08 1.18 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.327 -0.858 . . . . 32.89 110.24 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' S' S ' 377' ' ' VAL . . . . . 0.594 ' O ' HG11 ' S' ' 327' ' ' VAL . 7.3 p -114.64 147.3 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.34 -0.85 . . . . 24.33 110.235 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' S' S ' 378' ' ' LEU . . . . . . . . . . . . . 52.3 mt -116.09 -58.01 2.15 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.441 -0.787 . . . . 24.37 109.582 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' S' S ' 379' ' ' VAL . . . . . 0.638 HG22 HG12 ' S' ' 326' ' ' VAL . 61.1 t -120.67 132.41 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.371 -0.831 . . . . 18.02 109.453 179.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' S' S ' 380' ' ' PHE . . . . . 0.461 ' CE1' ' HB2' ' S' ' 325' ' ' CYS . 14.2 p90 -142.62 173.9 11.12 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.347 -0.845 . . . . 29.35 110.714 -179.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' S' S ' 381' ' ' VAL . . . . . . . . . . . . . 58.3 t -120.02 107.32 39.98 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.586 -0.697 . . . . 16.34 109.395 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' S' S ' 382' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' S' ' 336' ' ' ASP . 45.6 Cg_endo -71.26 145.62 49.11 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 O-C-N 123.598 1.315 . . . . 20.94 110.78 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' S' S ' 383' ' ' TYR . . . . . 0.402 ' CZ ' ' HB3' ' S' ' 338' ' ' HIS . 88.3 m-85 -61.01 -53.49 56.54 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.309 -0.869 . . . . 28.93 109.878 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' S' S ' 384' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.486 -0.759 . . . . 47.03 110.333 -176.922 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' R' R ' 30' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 121.23 0.538 . . . . 43.36 110.212 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' R' R ' 31' ' ' LEU . . . . . . . . . . . . . 65.6 mt -134.91 140.58 45.87 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.282 -0.886 . . . . 22.93 110.269 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 32' ' ' THR . . . . . . . . . . . . . 69.6 m -87.54 110.61 20.47 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.439 -0.788 . . . . 22.34 109.971 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 33' ' ' LEU . . . . . 0.595 HD22 ' CE2' ' R' ' 62' ' ' TYR . 80.1 mt -62.5 -172.73 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.408 -0.808 . . . . 21.39 110.215 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 34' ' ' TYR . . . . . . . . . . . . . 37.0 p90 -74.65 -29.39 61.24 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.352 -0.842 . . . . 34.4 110.386 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 35' ' ' ASN . . . . . . . . . . . . . 48.3 p30 -77.78 -1.91 33.78 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.332 -0.855 . . . . 30.28 110.585 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.26 -16.59 59.4 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.754 -1.338 . . . . 36.25 109.754 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 37' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -58.97 161.81 4.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.315 -1.109 . . . . 53.8 110.383 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 38' ' ' LYS . . . . . . . . . . . . . 56.9 mttt -117.87 135.71 53.92 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.39 -0.818 . . . . 49.91 110.151 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 39' ' ' LYS . . . . . 0.406 ' HG2' ' CZ ' ' R' ' 41' ' ' PHE . 8.1 ttmt -138.74 143.73 39.16 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.388 -0.82 . . . . 35.69 110.182 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 40' ' ' THR . . . . . . . . . . . . . 23.7 m -102.57 128.01 49.41 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.305 -0.872 . . . . 34.84 110.193 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 41' ' ' PHE . . . . . 0.406 ' CZ ' ' HG2' ' R' ' 39' ' ' LYS . 96.6 m-85 -113.12 132.66 55.36 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.381 -0.824 . . . . 34.42 110.14 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 42' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -93.29 140.86 29.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.331 -0.856 . . . . 51.46 110.255 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 43' ' ' SER . . . . . . . . . . . . . 53.6 m -70.73 141.89 51.48 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.421 -0.799 . . . . 41.84 110.186 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.74 125.37 29.59 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.361 -0.837 . . . . 33.82 110.013 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 45' ' ' PRO . . . . . 0.423 ' HG2' ' ND2' ' R' ' 77' ' ' ASN . 46.2 Cg_endo -72.11 151.13 55.13 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.596 1.314 . . . . 30.27 110.625 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 46' ' ' ASN . . . . . 0.4 ' HA ' ' OD1' ' R' ' 50' ' ' ASN . 52.2 t-20 -124.3 109.87 13.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.48 -0.762 . . . . 35.1 110.033 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 47' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -120.29 -34.88 3.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.285 -0.884 . . . . 42.81 110.55 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 48' ' ' HIS . . . . . 0.439 ' NE2' HD11 ' R' ' 80' ' ' LEU . 73.3 m80 -105.86 45.23 0.98 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.213 -0.929 . . . . 49.97 110.24 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 49' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 50.29 34.68 9.22 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.447 -0.783 . . . . 61.32 110.149 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 50' ' ' ASN . . . . . 0.4 ' OD1' ' HA ' ' R' ' 46' ' ' ASN . 15.0 p-10 -86.21 43.78 1.08 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.32 -0.862 . . . . 51.5 110.744 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.08 -46.14 78.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.193 -0.942 . . . . 38.77 109.476 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 52' ' ' TRP . . . . . 0.484 ' CD2' ' N ' ' R' ' 53' ' ' LEU . 68.1 p-90 -58.42 -38.43 77.4 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.595 -0.691 . . . . 26.24 110.036 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 53' ' ' LEU . . . . . 0.484 ' N ' ' CD2' ' R' ' 52' ' ' TRP . 23.2 tp -66.75 -46.66 74.71 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.439 -0.788 . . . . 26.75 109.991 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 54' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -55.11 -41.64 71.91 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.369 -0.832 . . . . 35.02 110.208 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.19 -46.03 92.16 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.396 -0.815 . . . . 24.47 110.172 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 56' ' ' ILE . . . . . 0.433 HG12 HD11 ' R' ' 104' ' ' ILE . 76.1 mt -62.26 -42.22 94.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.346 -0.846 . . . . 26.03 109.857 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 57' ' ' LEU . . . . . . . . . . . . . 22.5 mt -60.24 -45.67 92.45 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.364 -0.835 . . . . 26.77 109.655 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 58' ' ' GLN . . . . . . . . . . . . . 57.7 mm-40 -63.95 -46.53 84.29 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.456 -0.777 . . . . 22.32 109.592 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 59' ' ' LEU . . . . . 0.429 ' HA ' ' HE2' ' R' ' 151' ' ' PHE . 23.9 tp -61.34 -37.81 84.64 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.365 -0.834 . . . . 20.55 109.427 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 60' ' ' PHE . . . . . 0.528 ' CE2' HD21 ' R' ' 111' ' ' LEU . 2.8 m-85 -61.06 -44.74 96.92 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.67 -0.644 . . . . 20.08 109.913 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 61' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -63.07 -36.19 82.77 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.45 -0.781 . . . . 18.8 110.528 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 62' ' ' TYR . . . . . 0.595 ' CE2' HD22 ' R' ' 33' ' ' LEU . 9.3 t80 -63.06 -41.8 99.53 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.158 -0.964 . . . . 26.45 110.217 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 63' ' ' VAL . . . . . 0.406 ' H ' HG22 ' R' ' 63' ' ' VAL . 30.2 m -93.37 20.43 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.247 -0.908 . . . . 29.75 110.263 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 64' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 52.87 75.53 0.24 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.335 -0.853 . . . . 35.52 110.582 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 65' ' ' GLU . . . . . 0.443 ' HG2' ' CD2' ' R' ' 60' ' ' PHE . 14.3 tp10 -116.22 104.06 52.45 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.45 -0.782 . . . . 29.89 109.948 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 66' ' ' PRO . . . . . 0.48 ' HA ' ' HB2' ' R' ' 69' ' ' ASP . 46.1 Cg_endo -73.55 -5.81 17.71 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.864 1.455 . . . . 21.37 111.089 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 67' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -52.15 -61.47 2.25 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.169 -0.957 . . . . 23.85 110.39 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 68' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -98.13 36.51 1.57 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.34 -0.85 . . . . 28.07 110.475 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 69' ' ' ASP . . . . . 0.48 ' HB2' ' HA ' ' R' ' 66' ' ' PRO . 11.7 t0 -72.33 -33.23 67.18 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.312 -0.867 . . . . 43.76 110.18 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 70' ' ' TRP . . . . . 0.476 ' CE2' ' CG2' ' R' ' 71' ' ' VAL . 47.7 p-90 -73.39 -3.9 30.17 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.293 -0.879 . . . . 33.06 110.739 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 71' ' ' VAL . . . . . 0.556 HG11 ' HB2' ' R' ' 82' ' ' ALA . 40.8 t -109.79 -27.5 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.237 -0.914 . . . . 31.7 109.679 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 72' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -86.42 -49.0 7.94 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.395 -0.815 . . . . 33.58 110.299 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 73' ' ' SER . . . . . . . . . . . . . 69.8 m -89.57 50.99 2.0 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.274 -0.892 . . . . 50.82 110.39 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 74' ' ' SER . . . . . . . . . . . . . 15.9 t -125.85 138.28 31.71 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.21 -0.931 . . . . 34.74 110.262 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.33 -25.02 15.98 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.702 1.369 . . . . 35.7 110.308 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 76' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -91.7 153.23 19.79 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.364 -0.835 . . . . 66.48 110.3 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 77' ' ' ASN . . . . . 0.423 ' ND2' ' HG2' ' R' ' 45' ' ' PRO . 22.3 t-20 -81.56 95.29 7.09 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.332 -0.855 . . . . 46.72 110.064 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 78' ' ' LEU . . . . . . . . . . . . . 96.3 mt -96.45 27.96 3.55 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.443 -0.786 . . . . 37.55 110.186 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 79' ' ' THR . . . . . . . . . . . . . 29.7 m -56.24 -54.62 43.14 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.337 -0.852 . . . . 37.36 110.286 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 80' ' ' LEU . . . . . 0.604 ' HA ' HD12 ' R' ' 83' ' ' ILE . 15.9 mt -60.9 -23.26 65.08 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.379 -0.826 . . . . 35.83 110.514 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 81' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -79.41 -39.15 33.15 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.142 -0.974 . . . . 44.03 110.37 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 82' ' ' ALA . . . . . 0.556 ' HB2' HG11 ' R' ' 71' ' ' VAL . . . -69.48 -28.54 66.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.288 -0.882 . . . . 32.54 110.291 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 83' ' ' ILE . . . . . 0.604 HD12 ' HA ' ' R' ' 80' ' ' LEU . 78.2 mt -70.18 -46.06 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.237 -0.915 . . . . 32.02 110.302 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 84' ' ' LYS . . . . . . . . . . . . . 36.0 tttm -55.29 -52.05 64.69 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.164 -0.96 . . . . 34.09 110.532 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 85' ' ' GLN . . . . . 0.531 ' HG2' HD12 ' R' ' 89' ' ' LEU . 31.9 tt0 -54.71 -46.98 74.25 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.313 -0.867 . . . . 25.94 110.308 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 86' ' ' LEU . . . . . . . . . . . . . 24.1 mt -58.62 -43.82 89.78 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.346 -0.846 . . . . 16.2 109.965 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 87' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -65.3 -35.27 80.48 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.466 -0.771 . . . . 49.09 110.349 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 88' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -78.5 -18.93 54.08 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.283 -0.886 . . . . 28.61 110.523 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 89' ' ' LEU . . . . . 0.531 HD12 ' HG2' ' R' ' 85' ' ' GLN . 32.8 mt -96.25 -29.34 14.07 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.26 -0.9 . . . . 26.16 110.238 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 90' ' ' THR . . . . . . . . . . . . . 58.2 p -105.72 -34.57 7.66 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.226 -0.921 . . . . 33.33 109.806 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.73 16.12 58.75 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.937 -1.265 . . . . 31.13 109.937 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 92' ' ' LEU . . . . . . . . . . . . . 97.1 mt -100.14 155.2 17.87 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.103 -1.234 . . . . 42.52 110.237 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 93' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -86.18 91.65 8.51 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.567 -0.708 . . . . 68.46 109.911 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 94' ' ' LEU . . . . . 0.458 ' HB3' ' CZ2' ' R' ' 52' ' ' TRP . 47.7 mt -99.49 53.11 0.94 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.272 -0.893 . . . . 44.63 110.319 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 95' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.49 -38.67 6.38 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.331 -0.856 . . . . 67.16 110.399 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 96' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -113.93 44.23 1.68 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.332 -0.855 . . . . 67.02 110.255 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 97' ' ' GLY . . . . . . . . . . . . . . . 99.15 150.81 26.04 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.674 -1.37 . . . . 49.48 109.674 179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 98' ' ' GLY . . . . . . . . . . . . . . . -166.26 160.03 33.47 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.311 -1.516 . . . . 36.57 109.311 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 99' ' ' PRO . . . . . 0.792 ' O ' HG23 ' R' ' 103' ' ' VAL . 45.0 Cg_endo -72.59 121.14 7.17 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 123.741 1.39 . . . . 30.41 110.435 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 100' ' ' PRO . . . . . 0.41 ' HA ' HD11 ' R' ' 56' ' ' ILE . 44.8 Cg_endo -72.37 -31.67 11.17 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 O-C-N 123.58 1.305 . . . . 29.94 110.452 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 101' ' ' ALA . . . . . 0.475 ' HB2' ' HB3' ' R' ' 178' ' ' LEU . . . -69.9 -38.46 76.32 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.228 -0.92 . . . . 23.64 110.327 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 102' ' ' LEU . . . . . 0.425 HD23 HD21 ' R' ' 106' ' ' ASN . 0.1 OUTLIER -72.73 -40.72 65.88 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.373 -0.829 . . . . 20.31 110.323 -179.699 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' R' R ' 103' ' ' VAL . . . . . 0.792 HG23 ' O ' ' R' ' 99' ' ' PRO . 63.3 t -58.13 -40.05 75.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.21 -0.931 . . . . 16.33 110.065 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 104' ' ' ILE . . . . . 0.433 HD11 HG12 ' R' ' 56' ' ' ILE . 81.9 mt -71.71 -30.51 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.397 -0.814 . . . . 24.77 109.956 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 105' ' ' TRP . . . . . 0.462 ' O ' ' HD3' ' R' ' 108' ' ' LYS . 70.6 t-105 -82.51 0.9 40.35 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.323 -0.861 . . . . 23.28 110.292 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 106' ' ' ASN . . . . . 0.425 HD21 HD23 ' R' ' 102' ' ' LEU . 6.8 m-80 -105.09 -10.38 17.2 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.144 -0.973 . . . . 28.26 110.123 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 107' ' ' ILE . . . . . . . . . . . . . 36.7 pt -126.83 35.02 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.181 -0.949 . . . . 18.77 110.033 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 108' ' ' LYS . . . . . 0.502 ' HG2' ' HB ' ' R' ' 115' ' ' ILE . 9.3 mtpp -61.03 -48.48 81.56 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.516 -0.74 . . . . 42.5 110.037 179.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 109' ' ' HIS . . . . . 0.444 ' CD2' ' HG ' ' R' ' 110' ' ' LEU . 50.9 p-80 -66.06 -12.83 58.06 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.499 -0.75 . . . . 20.07 110.688 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 110' ' ' LEU . . . . . 0.444 ' HG ' ' CD2' ' R' ' 109' ' ' HIS . 80.3 mt -94.8 -17.3 22.25 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.083 -1.011 . . . . 15.69 110.196 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 111' ' ' LEU . . . . . 0.528 HD21 ' CE2' ' R' ' 60' ' ' PHE . 10.3 mt -94.09 144.15 25.74 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.342 -0.849 . . . . 25.39 111.008 -179.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 112' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -77.67 -17.43 57.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.487 -0.758 . . . . 53.48 109.823 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 113' ' ' THR . . . . . 0.459 HG22 ' N ' ' R' ' 114' ' ' GLY . 60.5 m -83.67 166.64 17.94 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.308 -0.87 . . . . 14.8 110.247 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 114' ' ' GLY . . . . . 0.459 ' N ' HG22 ' R' ' 113' ' ' THR . . . -98.0 127.12 9.12 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.042 -1.223 . . . . 16.14 110.042 -179.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 115' ' ' ILE . . . . . 0.579 HD13 ' HB ' ' R' ' 124' ' ' VAL . 47.8 mm -109.02 139.34 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.478 -1.013 . . . . 13.46 109.741 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 116' ' ' GLY . . . . . . . . . . . . . . . -152.71 -155.8 7.26 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.011 -1.236 . . . . 23.9 110.011 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 117' ' ' THR . . . . . 0.53 HG22 ' CG2' ' R' ' 126' ' ' VAL . 18.8 p -135.03 -171.33 2.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.514 -0.992 . . . . 27.37 110.059 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 118' ' ' ALA . . . . . 0.446 ' HB3' ' OD1' ' R' ' 128' ' ' ASP . . . -56.62 -58.06 9.72 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.216 -0.927 . . . . 18.76 110.083 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 119' ' ' SER . . . . . . . . . . . . . 1.1 m -56.55 -40.56 75.36 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.251 -0.905 . . . . 32.35 109.815 179.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 120' ' ' ARG . . . . . 0.417 ' NH1' ' NE1' ' S' ' 305' ' ' TRP . 10.0 mtm180 -110.07 86.29 4.91 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.43 -0.794 . . . . 27.12 109.716 179.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 121' ' ' PRO . . . . . 0.482 ' HA ' ' SG ' ' R' ' 125' ' ' CYS . 44.0 Cg_endo -71.32 166.53 28.98 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 O-C-N 123.86 1.453 . . . . 22.68 110.998 -179.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 122' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' R' ' 121' ' ' PRO . 38.3 t 178.53 -161.72 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.6 -0.687 . . . . 22.99 109.461 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 123' ' ' GLU . . . . . 0.442 ' HG2' HG23 ' R' ' 113' ' ' THR . 2.3 tp10 -56.45 -39.98 74.04 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.211 -0.93 . . . . 36.18 109.622 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 124' ' ' VAL . . . . . 0.579 ' HB ' HD13 ' R' ' 115' ' ' ILE . 83.5 t -142.54 136.44 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.597 -0.689 . . . . 20.64 109.428 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 125' ' ' CYS . . . . . 0.482 ' SG ' ' HA ' ' R' ' 121' ' ' PRO . 83.4 m -140.32 168.16 20.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.145 -0.972 . . . . 22.8 111.171 -179.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 126' ' ' VAL . . . . . 0.727 HG12 HG22 ' R' ' 179' ' ' VAL . 35.8 m -122.72 159.77 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.724 -0.61 . . . . 21.24 109.695 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 127' ' ' VAL . . . . . 0.709 HG11 ' O ' ' R' ' 177' ' ' VAL . 30.8 m -70.83 141.85 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.293 -0.879 . . . . 19.77 110.681 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 128' ' ' ASP . . . . . 0.446 ' OD1' ' HB3' ' R' ' 118' ' ' ALA . 54.0 p-10 -137.68 19.34 2.88 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.405 -0.809 . . . . 29.21 110.702 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 129' ' ' GLY . . . . . . . . . . . . . . . 113.99 0.02 24.14 Favored Glycine 0 N--CA 1.493 2.458 0 C-N-CA 119.977 -1.106 . . . . 33.86 110.472 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 130' ' ' THR . . . . . . . . . . . . . 58.3 m -91.76 131.83 36.85 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.084 -1.244 . . . . 26.41 110.07 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -62.59 120.66 11.59 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.35 -0.844 . . . . 33.08 110.312 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 132' ' ' MET . . . . . 0.433 ' HE1' ' CE2' ' R' ' 180' ' ' PHE . 98.4 mmm -105.22 165.64 10.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.395 -0.816 . . . . 30.76 110.377 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 133' ' ' CYS . . . . . 0.411 ' HA ' ' HB3' ' R' ' 174' ' ' PRO . 32.6 m -141.16 158.14 44.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.507 -0.745 . . . . 27.0 109.932 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 134' ' ' LEU . . . . . 0.563 HD11 ' O ' ' R' ' 172' ' ' PRO . 0.1 OUTLIER -58.57 -19.6 39.54 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.388 -0.82 . . . . 33.9 110.498 -179.862 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' R' R ' 135' ' ' ALA . . . . . . . . . . . . . . . -92.79 8.16 40.62 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.294 -0.879 . . . . 19.37 110.755 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 136' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -93.74 -21.86 19.07 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.207 -0.933 . . . . 30.47 110.216 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 137' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -149.94 165.35 32.89 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.351 -0.843 . . . . 24.27 110.231 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 138' ' ' HIS . . . . . 0.433 ' HA ' HG23 ' R' ' 154' ' ' VAL . 15.1 p80 -117.82 15.15 14.38 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.429 -0.794 . . . . 20.91 110.452 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 139' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' R' ' 152' ' ' ALA . . . -177.16 152.49 0.89 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.167 -0.958 . . . . 15.69 110.137 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 140' ' ' GLY . . . . . 0.427 ' HA3' ' O ' ' R' ' 179' ' ' VAL . . . 161.74 175.1 32.41 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 110.007 -1.237 . . . . 23.76 110.007 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 141' ' ' ILE . . . . . . . . . . . . . 83.6 mt -95.48 136.57 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.447 -1.031 . . . . 25.3 109.682 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 142' ' ' PHE . . . . . 0.576 ' CD2' ' HB2' ' R' ' 172' ' ' PRO . 82.6 m-85 -120.75 -172.66 2.43 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.33 -0.856 . . . . 30.24 110.54 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 143' ' ' LEU . . . . . 0.743 HD23 ' O ' ' R' ' 148' ' ' HIS . 0.5 OUTLIER -119.75 77.84 1.27 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.459 -0.776 . . . . 32.8 110.304 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' R' R ' 144' ' ' LYS . . . . . 0.471 ' HG3' ' CZ2' ' R' ' 170' ' ' TRP . 1.0 OUTLIER -69.67 76.93 0.44 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.381 -0.824 . . . . 49.18 109.653 179.573 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' R' R ' 145' ' ' GLY . . . . . 0.457 ' O ' HD22 ' R' ' 143' ' ' LEU . . . 104.52 179.23 24.81 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.16 -1.576 . . . . 53.87 109.16 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 146' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -88.44 145.86 25.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.319 -1.107 . . . . 68.58 109.999 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 147' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 58.19 36.58 25.88 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.294 -0.879 . . . . 56.62 110.633 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 148' ' ' HIS . . . . . 0.743 ' O ' HD23 ' R' ' 143' ' ' LEU . 45.1 t60 -158.67 148.11 19.17 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.243 -0.911 . . . . 44.57 110.398 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 149' ' ' ALA . . . . . . . . . . . . . . . -150.25 146.9 27.08 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.451 -0.781 . . . . 33.54 110.061 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 150' ' ' VAL . . . . . . . . . . . . . 34.2 m -142.38 161.51 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.246 -0.909 . . . . 27.61 110.322 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 151' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' R' ' 152' ' ' ALA . 5.9 t80 -86.18 155.57 20.68 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.383 -0.823 . . . . 23.04 109.901 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 152' ' ' ALA . . . . . 0.537 ' N ' ' CD1' ' R' ' 151' ' ' PHE . . . -157.31 151.56 24.92 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.447 -0.783 . . . . 29.61 109.53 178.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 153' ' ' CYS . . . . . . . . . . . . . 26.7 p -154.28 173.56 15.99 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.28 -0.888 . . . . 22.75 110.539 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 154' ' ' VAL . . . . . 0.614 HG22 ' CE2' ' R' ' 159' ' ' TRP . 59.9 t -90.52 117.04 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.429 -0.794 . . . . 23.26 110.057 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 155' ' ' THR . . . . . . . . . . . . . 71.0 p -112.18 -176.62 2.96 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.361 -0.837 . . . . 17.88 110.058 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 156' ' ' SER . . . . . . . . . . . . . 78.4 p -75.96 -3.68 36.89 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.32 -0.863 . . . . 21.83 110.716 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 157' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -118.33 10.57 12.82 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.096 -1.002 . . . . 36.54 110.625 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 158' ' ' GLY . . . . . . . . . . . . . . . 117.83 -162.6 13.01 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.55 -1.42 . . . . 31.74 109.55 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 159' ' ' TRP . . . . . 0.614 ' CE2' HG22 ' R' ' 154' ' ' VAL . 14.6 m95 -86.63 122.54 30.7 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.386 -1.067 . . . . 28.25 110.061 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 160' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -108.48 166.92 10.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.346 -0.846 . . . . 41.24 110.25 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 161' ' ' ALA . . . . . . . . . . . . . . . -143.25 123.39 13.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.435 -0.791 . . . . 27.4 110.182 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 162' ' ' ILE . . . . . . . . . . . . . 92.6 mt -87.57 81.24 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.398 -0.814 . . . . 24.27 110.055 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 163' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' R' ' 165' ' ' GLU . 15.3 t0 -72.85 92.37 1.6 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.458 -0.776 . . . . 36.08 110.237 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 164' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 54.09 -88.97 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.489 -0.757 . . . . 46.08 110.603 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 165' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' R' ' 163' ' ' ASP . 29.6 mt-10 -124.72 36.0 4.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.109 -0.994 . . . . 50.94 110.194 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 166' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -135.69 117.3 14.91 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.405 -0.81 . . . . 47.28 110.361 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 167' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -101.06 119.91 39.43 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.367 -0.833 . . . . 40.47 110.178 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 168' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -157.51 158.56 30.71 Favored Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 121.235 -0.916 . . . . 30.21 110.454 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 169' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.77 133.05 19.52 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 O-C-N 123.866 1.456 . . . . 32.76 110.531 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 170' ' ' TRP . . . . . 0.471 ' CZ2' ' HG3' ' R' ' 144' ' ' LYS . 67.2 t90 -159.78 119.27 2.88 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.444 -0.785 . . . . 32.79 109.958 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 171' ' ' THR . . . . . . . . . . . . . 45.5 m -81.08 112.58 33.87 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.423 -0.798 . . . . 36.92 110.219 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 172' ' ' PRO . . . . . 0.576 ' HB2' ' CD2' ' R' ' 142' ' ' PHE . 46.8 Cg_endo -73.77 158.81 46.39 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.634 1.334 . . . . 33.54 110.556 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 173' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -88.85 144.93 33.77 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.409 -0.807 . . . . 45.76 109.913 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 174' ' ' PRO . . . . . 0.411 ' HB3' ' HA ' ' R' ' 133' ' ' CYS . 46.0 Cg_endo -71.72 -10.35 26.37 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.649 1.342 . . . . 29.63 110.505 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 175' ' ' SER . . . . . . . . . . . . . 53.0 p -103.41 -17.63 15.17 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.273 -0.892 . . . . 35.7 110.367 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 176' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -103.58 43.3 1.09 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.261 -0.899 . . . . 39.65 110.362 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 177' ' ' VAL . . . . . 0.709 ' O ' HG11 ' R' ' 127' ' ' VAL . 10.5 p -117.78 127.23 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.266 -0.896 . . . . 20.61 110.006 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 178' ' ' LEU . . . . . 0.475 ' HB3' ' HB2' ' R' ' 101' ' ' ALA . 46.4 mt -91.6 -61.25 1.68 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.368 -0.832 . . . . 15.58 109.364 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 179' ' ' VAL . . . . . 0.727 HG22 HG12 ' R' ' 126' ' ' VAL . 67.5 t -114.6 144.67 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.66 -0.65 . . . . 17.4 109.444 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 180' ' ' PHE . . . . . 0.433 ' CE2' ' HE1' ' R' ' 132' ' ' MET . 43.4 p90 -152.13 163.36 39.53 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.33 -0.856 . . . . 20.16 110.517 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 181' ' ' VAL . . . . . . . . . . . . . 65.9 t -113.1 111.5 50.44 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.363 -0.836 . . . . 17.69 109.848 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 182' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.09 149.57 52.62 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 O-C-N 123.638 1.336 . . . . 17.81 110.403 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 183' ' ' TYR . . . . . 0.688 ' O ' ' C ' ' R' ' 184' ' ' ASP . 78.9 m-85 -59.13 175.44 0.3 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.401 -0.812 . . . . 28.01 110.54 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 184' ' ' ASP . . . . . 0.688 ' C ' ' O ' ' R' ' 183' ' ' TYR . 2.3 m-20 -20.0 -84.04 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.315 -0.866 . . . . 58.64 110.242 -178.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' R' R ' 185' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 . . . . . 0 N--CA 1.502 2.173 0 CA-C-O 121.22 0.533 . . . . 80.42 111.75 179.617 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' R' R ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 120.823 0.344 . . . . 49.5 110.16 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' R' R ' 194' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.862 0 O-C-N 121.218 -0.927 . . . . 40.4 110.144 179.906 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' S' S ' 229' ' ' MET . . . . . . . . . . . . . 5.1 mtm . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.188 0.518 . . . . 51.83 110.216 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' S' S ' 230' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -97.29 142.71 28.84 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.34 -0.85 . . . . 54.13 110.199 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' S' S ' 231' ' ' LEU . . . . . . . . . . . . . 67.3 mt -134.07 140.98 47.0 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.388 -0.82 . . . . 33.04 110.364 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' S' S ' 232' ' ' THR . . . . . 0.418 ' O ' ' HA ' ' S' ' 355' ' ' THR . 40.3 m -89.26 103.28 15.92 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.305 -0.872 . . . . 26.92 110.032 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' S' S ' 233' ' ' LEU . . . . . 0.671 HD22 ' CE2' ' S' ' 262' ' ' TYR . 79.8 mt -55.88 179.24 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.437 -0.79 . . . . 13.78 110.463 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' S' S ' 234' ' ' TYR . . . . . 0.448 ' CG ' ' N ' ' S' ' 235' ' ' ASN . 35.5 p90 -65.01 -35.66 81.9 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.384 -0.823 . . . . 26.08 110.168 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' S' S ' 235' ' ' ASN . . . . . 0.448 ' N ' ' CG ' ' S' ' 234' ' ' TYR . 50.6 p30 -74.38 -7.35 52.6 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.336 -0.852 . . . . 20.04 110.5 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' S' S ' 236' ' ' GLY . . . . . . . . . . . . . . . 95.69 -19.9 52.18 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.777 -1.329 . . . . 22.71 109.777 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' S' S ' 237' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -52.94 145.68 12.33 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.2 -1.176 . . . . 35.44 110.236 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' S' S ' 238' ' ' LYS . . . . . . . . . . . . . 44.5 mttt -102.18 127.92 48.91 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.358 -0.839 . . . . 32.56 110.41 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' S' S ' 239' ' ' LYS . . . . . 0.408 ' HG2' ' CZ ' ' S' ' 241' ' ' PHE . 9.0 ttmt -132.29 144.55 50.67 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.371 -0.831 . . . . 26.68 109.919 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' S' S ' 240' ' ' THR . . . . . . . . . . . . . 52.1 m -102.07 132.18 48.09 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.304 -0.872 . . . . 41.02 110.334 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' S' S ' 241' ' ' PHE . . . . . 0.408 ' CZ ' ' HG2' ' S' ' 239' ' ' LYS . 96.0 m-85 -117.94 137.66 52.68 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.335 -0.853 . . . . 28.62 110.21 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' S' S ' 242' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -96.32 161.78 13.79 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.302 -0.874 . . . . 47.89 110.198 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' S' S ' 243' ' ' SER . . . . . . . . . . . . . 71.5 m -90.58 151.47 21.3 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.332 -0.855 . . . . 45.09 110.227 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' S' S ' 244' ' ' ARG . . . . . . . . . . . . . 1.4 mtp85 -129.69 126.77 22.78 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.349 -0.844 . . . . 42.49 110.247 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' S' S ' 245' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.35 161.0 43.74 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.74 1.389 . . . . 35.68 110.561 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' S' S ' 246' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -132.87 97.87 4.15 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.408 -0.807 . . . . 51.88 109.867 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' S' S ' 247' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -110.49 -22.22 11.77 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.321 -0.862 . . . . 53.69 110.655 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' S' S ' 248' ' ' HIS . . . . . . . . . . . . . 76.5 m80 -117.21 43.61 2.28 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.16 -0.963 . . . . 55.79 110.761 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' S' S ' 249' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 48.77 38.46 11.85 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.417 -0.802 . . . . 49.45 110.39 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' S' S ' 250' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -90.65 29.02 1.38 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.496 -0.753 . . . . 36.86 110.364 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' S' S ' 251' ' ' ALA . . . . . . . . . . . . . . . -53.79 -43.23 69.12 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.281 -0.887 . . . . 29.69 109.563 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' S' S ' 252' ' ' TRP . . . . . 0.426 ' CZ2' ' HB3' ' S' ' 294' ' ' LEU . 67.9 p-90 -61.76 -33.95 74.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.602 -0.686 . . . . 41.12 109.886 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' S' S ' 253' ' ' LEU . . . . . . . . . . . . . 23.4 tp -70.11 -47.23 62.66 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.446 -0.783 . . . . 24.89 110.016 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' S' S ' 254' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -56.16 -42.44 77.03 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.299 -0.875 . . . . 35.65 109.975 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' S' S ' 255' ' ' ALA . . . . . . . . . . . . . . . -59.57 -48.1 82.97 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.447 -0.783 . . . . 22.73 110.141 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' S' S ' 256' ' ' ILE . . . . . 0.507 HG12 HD11 ' S' ' 304' ' ' ILE . 79.7 mt -62.32 -40.7 88.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.273 -0.892 . . . . 28.85 109.924 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' S' S ' 257' ' ' LEU . . . . . 0.404 ' CD2' ' HB3' ' S' ' 268' ' ' PHE . 19.0 mt -61.54 -44.48 96.98 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.354 -0.841 . . . . 23.07 110.168 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' S' S ' 258' ' ' GLN . . . . . 0.501 ' HB3' ' CD2' ' S' ' 351' ' ' PHE . 53.4 mm-40 -65.09 -45.33 85.66 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.398 -0.814 . . . . 29.78 109.953 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' S' S ' 259' ' ' LEU . . . . . 0.419 ' O ' HG22 ' S' ' 263' ' ' VAL . 19.9 tp -58.73 -36.27 74.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.285 -0.885 . . . . 17.94 109.484 179.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' S' S ' 260' ' ' PHE . . . . . 0.528 ' CE2' HD21 ' S' ' 311' ' ' LEU . 3.1 m-85 -62.89 -45.24 93.44 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.663 -0.648 . . . . 30.57 109.808 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' S' S ' 261' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -62.08 -29.82 70.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.454 -0.779 . . . . 41.34 110.015 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' S' S ' 262' ' ' TYR . . . . . 0.671 ' CE2' HD22 ' S' ' 233' ' ' LEU . 8.7 t80 -71.17 -44.6 65.17 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.416 -0.802 . . . . 26.03 110.137 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' S' S ' 263' ' ' VAL . . . . . 0.419 HG22 ' O ' ' S' ' 259' ' ' LEU . 33.0 m -92.06 18.23 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.385 -0.822 . . . . 22.8 110.412 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' S' S ' 264' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 52.76 70.67 0.55 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.291 -0.881 . . . . 44.03 110.568 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' S' S ' 265' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -111.77 109.16 55.53 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.257 -0.902 . . . . 35.61 109.716 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' S' S ' 266' ' ' PRO . . . . . 0.477 ' HA ' ' HB2' ' S' ' 269' ' ' ASP . 49.0 Cg_endo -75.24 0.37 9.08 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.579 1.305 . . . . 37.67 111.728 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' S' S ' 267' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -56.53 -67.65 0.29 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.806 -1.184 . . . . 41.49 110.203 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' S' S ' 268' ' ' PHE . . . . . 0.404 ' HB3' ' CD2' ' S' ' 257' ' ' LEU . 22.4 m-85 -92.91 39.85 1.05 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.164 -0.96 . . . . 50.76 110.098 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' S' S ' 269' ' ' ASP . . . . . 0.477 ' HB2' ' HA ' ' S' ' 266' ' ' PRO . 0.9 OUTLIER -76.0 -33.16 59.7 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.322 -0.861 . . . . 61.86 109.83 179.543 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' S' S ' 270' ' ' TRP . . . . . 0.505 ' CE2' HG23 ' S' ' 271' ' ' VAL . 51.0 p-90 -73.97 -4.28 34.28 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.208 -0.932 . . . . 39.85 110.489 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' S' S ' 271' ' ' VAL . . . . . 0.505 HG23 ' CE2' ' S' ' 270' ' ' TRP . 46.5 t -109.5 -32.77 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.129 -0.982 . . . . 39.18 110.051 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' S' S ' 272' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -78.65 -36.47 43.83 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.384 -0.822 . . . . 40.02 110.514 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' S' S ' 273' ' ' SER . . . . . . . . . . . . . 70.9 m -103.59 56.08 0.74 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.269 -0.894 . . . . 47.2 110.291 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' S' S ' 274' ' ' SER . . . . . . . . . . . . . 6.9 t -133.04 141.23 40.17 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.371 -0.83 . . . . 47.61 110.108 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' S' S ' 275' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.74 -18.92 21.7 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 O-C-N 123.617 1.325 . . . . 45.28 110.583 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' S' S ' 276' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -99.88 140.88 33.46 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.247 -0.908 . . . . 57.27 110.288 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' S' S ' 277' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -71.66 97.56 1.75 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.368 -0.832 . . . . 37.28 110.272 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' S' S ' 278' ' ' LEU . . . . . . . . . . . . . 86.5 mt -96.97 33.87 1.83 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.329 -0.857 . . . . 43.88 110.023 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' S' S ' 279' ' ' THR . . . . . . . . . . . . . 78.1 m -64.12 -60.08 3.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.505 -0.747 . . . . 50.05 110.273 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' S' S ' 280' ' ' LEU . . . . . 0.724 ' HA ' HD12 ' S' ' 283' ' ' ILE . 13.7 mt -51.58 -39.92 58.8 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.352 -0.843 . . . . 54.12 110.255 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' S' S ' 281' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.41 -49.65 74.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.467 -0.77 . . . . 65.28 110.108 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' S' S ' 282' ' ' ALA . . . . . . . . . . . . . . . -58.95 -33.95 71.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.439 -0.788 . . . . 46.51 110.512 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' S' S ' 283' ' ' ILE . . . . . 0.724 HD12 ' HA ' ' S' ' 280' ' ' LEU . 86.0 mt -66.39 -50.82 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.358 -0.839 . . . . 47.3 110.092 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' S' S ' 284' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -50.52 -57.63 7.67 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.444 -0.785 . . . . 50.72 110.358 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' S' S ' 285' ' ' GLN . . . . . 0.531 ' HG2' HD12 ' S' ' 289' ' ' LEU . 34.4 tt0 -51.41 -46.36 62.89 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.578 -0.701 . . . . 68.47 110.346 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' S' S ' 286' ' ' LEU . . . . . . . . . . . . . 19.0 mt -59.96 -44.53 94.37 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.448 -0.782 . . . . 36.62 110.245 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' S' S ' 287' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -62.78 -35.21 79.09 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.288 -0.883 . . . . 46.64 110.083 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' S' S ' 288' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -76.25 -21.03 56.82 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.361 -0.837 . . . . 46.45 110.307 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' S' S ' 289' ' ' LEU . . . . . 0.531 HD12 ' HG2' ' S' ' 285' ' ' GLN . 30.7 mt -97.35 -21.73 17.04 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.288 -0.883 . . . . 35.09 110.524 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' S' S ' 290' ' ' THR . . . . . 0.413 HG22 ' HB3' ' S' ' 306' ' ' ASN . 81.3 p -114.78 -28.35 7.12 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.246 -0.909 . . . . 38.61 110.455 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' S' S ' 291' ' ' GLY . . . . . . . . . . . . . . . 79.31 10.99 85.45 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.856 -1.298 . . . . 36.77 109.856 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' S' S ' 292' ' ' LEU . . . . . . . . . . . . . 84.8 mt -96.41 145.81 25.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.304 -1.116 . . . . 35.33 109.799 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' S' S ' 293' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -77.32 102.4 6.73 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.15 -0.969 . . . . 48.7 110.302 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' S' S ' 294' ' ' LEU . . . . . 0.426 ' HB3' ' CZ2' ' S' ' 252' ' ' TRP . 55.7 mt -106.93 51.71 0.73 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.521 -0.737 . . . . 42.61 110.1 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' S' S ' 295' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -112.51 -11.11 13.65 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.365 -0.834 . . . . 55.49 110.531 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' S' S ' 296' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -144.37 48.55 1.36 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.167 -0.958 . . . . 75.68 110.261 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' S' S ' 297' ' ' GLY . . . . . . . . . . . . . . . 96.84 145.2 18.73 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.467 -1.453 . . . . 49.44 109.467 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' S' S ' 298' ' ' GLY . . . . . . . . . . . . . . . -163.86 156.99 29.1 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.8 -1.32 . . . . 41.11 109.8 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' S' S ' 299' ' ' PRO . . . . . 0.484 ' O ' HG23 ' S' ' 303' ' ' VAL . 46.6 Cg_endo -73.86 118.28 5.37 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 124.008 1.531 . . . . 26.2 110.209 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' S' S ' 300' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.29 -15.49 31.52 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 O-C-N 123.584 1.307 . . . . 21.7 110.665 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' S' S ' 301' ' ' ALA . . . . . . . . . . . . . . . -80.63 -29.34 36.76 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.295 -0.878 . . . . 31.23 110.13 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' S' S ' 302' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.56 -40.62 18.89 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.391 -0.818 . . . . 38.99 109.941 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' S' S ' 303' ' ' VAL . . . . . 0.484 HG23 ' O ' ' S' ' 299' ' ' PRO . 58.0 t -60.7 -35.47 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.487 -0.758 . . . . 18.63 110.167 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' S' S ' 304' ' ' ILE . . . . . 0.522 HD12 HG21 ' S' ' 379' ' ' VAL . 86.1 mt -79.35 -23.61 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.44 -0.787 . . . . 25.46 110.229 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' S' S ' 305' ' ' TRP . . . . . 0.417 ' NE1' ' NH1' ' R' ' 120' ' ' ARG . 68.8 t-105 -88.64 -14.56 37.17 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.31 -0.869 . . . . 33.4 110.599 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' S' S ' 306' ' ' ASN . . . . . 0.413 ' HB3' HG22 ' S' ' 290' ' ' THR . 10.4 m-80 -89.67 -13.62 36.59 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.291 -0.88 . . . . 36.97 110.394 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' S' S ' 307' ' ' ILE . . . . . 0.469 HG12 ' O ' ' S' ' 303' ' ' VAL . 36.9 pt -125.02 45.69 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.255 -0.903 . . . . 30.81 110.043 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' S' S ' 308' ' ' LYS . . . . . 0.411 ' HD3' ' CD2' ' S' ' 305' ' ' TRP . 1.5 mtmp? -73.63 -37.76 65.26 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.373 -0.83 . . . . 46.52 110.064 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' S' S ' 309' ' ' HIS . . . . . 0.495 ' CD2' ' HG ' ' S' ' 310' ' ' LEU . 55.6 p-80 -73.15 -8.21 54.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.263 -0.898 . . . . 51.03 110.187 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' S' S ' 310' ' ' LEU . . . . . 0.495 ' HG ' ' CD2' ' S' ' 309' ' ' HIS . 53.0 mt -99.31 -12.84 19.97 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.317 -0.864 . . . . 36.16 109.969 179.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' S' S ' 311' ' ' LEU . . . . . 0.528 HD21 ' CE2' ' S' ' 260' ' ' PHE . 10.8 mt -97.21 147.9 23.63 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.377 -0.827 . . . . 40.0 110.355 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' S' S ' 312' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -81.67 -16.23 51.97 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.262 -0.899 . . . . 54.18 109.698 179.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' S' S ' 313' ' ' THR . . . . . 0.829 HG23 ' HG2' ' S' ' 323' ' ' GLU . 92.7 m -87.97 151.63 22.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.38 -0.825 . . . . 25.61 110.149 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' S' S ' 314' ' ' GLY . . . . . . . . . . . . . . . -87.86 126.33 8.0 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.83 -1.308 . . . . 25.18 109.83 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' S' S ' 315' ' ' ILE . . . . . 0.668 HD13 ' HB ' ' S' ' 324' ' ' VAL . 50.6 mm -101.58 150.53 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.416 -1.049 . . . . 23.9 109.724 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' S' S ' 316' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' S' ' 325' ' ' CYS . . . -157.1 -159.23 9.36 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.026 -1.23 . . . . 23.18 110.026 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' S' S ' 317' ' ' THR . . . . . 0.423 HG22 ' CG2' ' S' ' 326' ' ' VAL . 11.2 p -133.95 -173.04 3.14 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.442 -1.034 . . . . 27.98 109.967 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' S' S ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.58 -56.16 25.44 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.191 -0.943 . . . . 28.1 109.927 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' S' S ' 319' ' ' SER . . . . . . . . . . . . . 1.2 m -59.9 -41.69 92.2 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.382 -0.824 . . . . 37.0 109.664 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' S' S ' 320' ' ' ARG . . . . . . . . . . . . . 12.1 mtm180 -111.69 79.85 2.63 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.445 -0.784 . . . . 52.07 109.652 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' S' S ' 321' ' ' PRO . . . . . 0.444 ' O ' ' HB2' ' S' ' 322' ' ' SER . 43.9 Cg_endo -71.44 171.6 15.88 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.83 1.437 . . . . 38.29 110.937 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' S' S ' 322' ' ' SER . . . . . 0.444 ' HB2' ' O ' ' S' ' 321' ' ' PRO . 41.3 t 178.58 -148.13 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.924 -0.769 . . . . 38.84 108.924 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' S' S ' 323' ' ' GLU . . . . . 0.829 ' HG2' HG23 ' S' ' 313' ' ' THR . 6.7 tp10 -62.82 -40.33 97.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.946 -1.096 . . . . 40.7 109.682 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' S' S ' 324' ' ' VAL . . . . . 0.668 ' HB ' HD13 ' S' ' 315' ' ' ILE . 73.5 t -141.28 134.97 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.427 -0.796 . . . . 20.34 109.507 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' S' S ' 325' ' ' CYS . . . . . 0.46 ' HB2' ' CE1' ' S' ' 380' ' ' PHE . 11.3 m -125.98 172.13 10.2 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.385 -0.822 . . . . 30.63 110.827 -179.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' S' S ' 326' ' ' VAL . . . . . 0.644 HG12 HG22 ' S' ' 379' ' ' VAL . 34.5 m -135.41 142.25 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 109.204 -0.665 . . . . 23.9 109.204 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' S' S ' 327' ' ' VAL . . . . . 0.593 HG11 ' O ' ' S' ' 377' ' ' VAL . 34.5 m -56.34 125.04 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.054 -1.029 . . . . 19.48 110.43 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' S' S ' 328' ' ' ASP . . . . . . . . . . . . . 55.6 p-10 -119.43 11.59 12.2 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.451 -0.781 . . . . 26.43 110.411 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' S' S ' 329' ' ' GLY . . . . . . . . . . . . . . . 119.58 2.26 13.2 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.088 -1.205 . . . . 31.24 110.088 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' S' S ' 330' ' ' THR . . . . . . . . . . . . . 78.3 m -93.02 129.99 38.76 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.064 -1.256 . . . . 30.05 110.183 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' S' S ' 331' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -56.8 111.54 1.05 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.217 -0.927 . . . . 37.26 109.935 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' S' S ' 332' ' ' MET . . . . . . . . . . . . . 87.9 mmm -94.04 162.57 13.83 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.212 -0.93 . . . . 26.23 110.347 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' S' S ' 333' ' ' CYS . . . . . . . . . . . . . 24.9 m -137.3 150.07 47.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.483 -0.761 . . . . 23.56 109.961 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' S' S ' 334' ' ' LEU . . . . . 0.564 HD11 ' O ' ' S' ' 372' ' ' PRO . 0.1 OUTLIER -52.57 -24.93 9.16 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.334 -0.854 . . . . 28.93 110.457 179.883 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' S' S ' 335' ' ' ALA . . . . . . . . . . . . . . . -88.95 14.39 10.61 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.379 -0.826 . . . . 15.76 110.977 -179.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' S' S ' 336' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -100.51 -17.23 17.23 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.149 -0.969 . . . . 34.92 110.137 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' S' S ' 337' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -152.37 170.86 19.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.418 -0.801 . . . . 19.03 110.055 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' S' S ' 338' ' ' HIS . . . . . 0.401 ' HB3' ' CZ ' ' S' ' 383' ' ' TYR . 13.5 p80 -120.7 10.38 10.99 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.318 -0.864 . . . . 18.82 110.465 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' S' S ' 339' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' S' ' 352' ' ' ALA . . . -176.04 155.17 1.54 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.274 -0.891 . . . . 17.18 110.09 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' S' S ' 340' ' ' GLY . . . . . 0.404 ' CA ' ' O ' ' S' ' 379' ' ' VAL . . . 160.87 173.11 29.07 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.013 -1.235 . . . . 18.33 110.013 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' S' S ' 341' ' ' ILE . . . . . . . . . . . . . 83.9 mt -88.84 138.14 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.498 -1.001 . . . . 18.6 109.819 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' S' S ' 342' ' ' PHE . . . . . 0.494 ' CE2' ' HB3' ' S' ' 352' ' ' ALA . 70.0 m-85 -120.99 -178.48 3.76 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.299 -0.875 . . . . 23.44 110.453 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' S' S ' 343' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.8 93.4 4.19 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.408 -0.807 . . . . 35.59 110.002 179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' S' S ' 344' ' ' LYS . . . . . 0.407 ' O ' ' HB3' ' S' ' 348' ' ' HIS . 0.3 OUTLIER -80.85 125.02 29.58 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.26 -0.9 . . . . 38.34 110.109 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' S' S ' 345' ' ' GLY . . . . . . . . . . . . . . . 62.77 -130.87 43.13 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 108.821 -1.711 . . . . 53.46 108.821 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' S' S ' 346' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -132.68 150.84 52.1 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.326 -1.102 . . . . 70.91 110.037 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' S' S ' 347' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 53.27 35.39 19.98 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.353 -0.842 . . . . 47.32 110.433 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' S' S ' 348' ' ' HIS . . . . . 0.407 ' HB3' ' O ' ' S' ' 344' ' ' LYS . 46.5 t60 -150.08 155.94 40.76 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.329 -0.857 . . . . 41.72 110.303 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' S' S ' 349' ' ' ALA . . . . . 0.459 ' C ' HG13 ' S' ' 350' ' ' VAL . . . -149.88 151.25 33.15 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.326 -0.859 . . . . 22.91 110.441 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' S' S ' 350' ' ' VAL . . . . . 0.459 HG13 ' C ' ' S' ' 349' ' ' ALA . 34.6 m -149.1 169.64 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.514 -0.741 . . . . 21.09 110.023 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' S' S ' 351' ' ' PHE . . . . . 0.501 ' CD2' ' HB3' ' S' ' 258' ' ' GLN . 10.7 t80 -105.39 143.62 33.3 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.155 -0.966 . . . . 25.03 110.713 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' S' S ' 352' ' ' ALA . . . . . 0.494 ' HB3' ' CE2' ' S' ' 342' ' ' PHE . . . -147.79 151.71 36.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.667 -0.645 . . . . 23.81 109.715 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' S' S ' 353' ' ' CYS . . . . . . . . . . . . . 26.3 p -153.25 164.91 37.24 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.368 -0.832 . . . . 25.66 110.343 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' S' S ' 354' ' ' VAL . . . . . 0.543 HG22 ' CE2' ' S' ' 359' ' ' TRP . 56.5 t -76.05 118.53 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.361 -0.837 . . . . 34.27 109.98 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' S' S ' 355' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' S' ' 232' ' ' THR . 52.7 p -117.86 175.14 5.8 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.251 -0.905 . . . . 25.49 110.332 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' S' S ' 356' ' ' SER . . . . . . . . . . . . . 62.0 p -62.18 -17.72 58.89 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.345 -0.847 . . . . 31.24 110.71 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' S' S ' 357' ' ' ASN . . . . . . . . . . . . . 45.9 m-20 -107.01 14.22 26.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.201 -0.937 . . . . 28.61 110.611 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' S' S ' 358' ' ' GLY . . . . . . . . . . . . . . . 111.91 -152.98 17.58 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.984 -1.246 . . . . 22.01 109.984 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' S' S ' 359' ' ' TRP . . . . . 0.543 ' CE2' HG22 ' S' ' 354' ' ' VAL . 15.4 m95 -91.24 116.68 29.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.371 -1.076 . . . . 25.54 110.17 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' S' S ' 360' ' ' TYR . . . . . 0.413 ' HA ' ' HA ' ' S' ' 369' ' ' PRO . 1.3 m-85 -103.47 165.79 10.82 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.327 -0.858 . . . . 40.53 110.107 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' S' S ' 361' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' S' ' 351' ' ' PHE . . . -140.06 130.11 24.9 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.462 -0.774 . . . . 18.04 110.271 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' S' S ' 362' ' ' ILE . . . . . . . . . . . . . 88.8 mt -95.6 83.67 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.283 -0.885 . . . . 15.64 110.062 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' S' S ' 363' ' ' ASP . . . . . 0.418 ' O ' ' N ' ' S' ' 365' ' ' GLU . 11.9 t0 -75.25 94.47 3.0 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.298 -0.876 . . . . 35.03 110.213 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' S' S ' 364' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 53.88 -89.28 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.547 -0.721 . . . . 46.72 110.621 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' S' S ' 365' ' ' GLU . . . . . 0.418 ' N ' ' O ' ' S' ' 363' ' ' ASP . 23.8 mt-10 -122.7 19.15 10.3 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.091 -1.006 . . . . 56.2 110.267 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' S' S ' 366' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -117.97 124.99 49.54 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.17 -0.957 . . . . 51.02 110.421 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' S' S ' 367' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -107.0 127.08 53.13 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.435 -0.791 . . . . 37.59 110.133 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' S' S ' 368' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -165.47 159.46 13.82 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.229 -0.919 . . . . 31.47 110.414 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' S' S ' 369' ' ' PRO . . . . . 0.413 ' HA ' ' HA ' ' S' ' 360' ' ' TYR . 46.8 Cg_endo -72.68 139.62 31.19 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 O-C-N 123.903 1.475 . . . . 28.85 110.505 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' S' S ' 370' ' ' TRP . . . . . . . . . . . . . 67.6 t90 -167.21 113.49 0.76 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.405 -0.81 . . . . 26.94 110.008 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' S' S ' 371' ' ' THR . . . . . . . . . . . . . 59.8 m -74.78 113.08 20.99 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.317 -0.864 . . . . 20.19 110.025 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' S' S ' 372' ' ' PRO . . . . . 0.564 ' O ' HD11 ' S' ' 334' ' ' LEU . 48.0 Cg_endo -73.56 157.13 49.17 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.61 1.321 . . . . 28.68 110.609 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' S' S ' 373' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -90.58 147.14 35.73 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.444 -0.785 . . . . 35.72 109.922 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' S' S ' 374' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -76.0 -6.3 17.23 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 O-C-N 123.632 1.332 . . . . 30.89 110.502 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' S' S ' 375' ' ' SER . . . . . . . . . . . . . 68.6 p -104.36 -16.94 14.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.207 -0.933 . . . . 29.41 110.436 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' S' S ' 376' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -106.55 43.1 1.18 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.348 -0.845 . . . . 32.89 110.198 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' S' S ' 377' ' ' VAL . . . . . 0.593 ' O ' HG11 ' S' ' 327' ' ' VAL . 7.3 p -114.68 147.3 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.297 -0.877 . . . . 24.33 110.207 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' S' S ' 378' ' ' LEU . . . . . . . . . . . . . 52.7 mt -116.02 -58.0 2.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.354 -0.841 . . . . 24.37 109.626 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' S' S ' 379' ' ' VAL . . . . . 0.644 HG22 HG12 ' S' ' 326' ' ' VAL . 61.2 t -120.66 132.42 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.418 -0.801 . . . . 18.02 109.456 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' S' S ' 380' ' ' PHE . . . . . 0.46 ' CE1' ' HB2' ' S' ' 325' ' ' CYS . 14.4 p90 -142.59 173.89 11.13 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.399 -0.813 . . . . 29.35 110.614 -179.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' S' S ' 381' ' ' VAL . . . . . . . . . . . . . 57.7 t -120.01 107.29 40.06 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.523 -0.735 . . . . 16.34 109.453 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' S' S ' 382' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -71.2 145.62 49.4 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 O-C-N 123.611 1.322 . . . . 20.94 110.786 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' S' S ' 383' ' ' TYR . . . . . 0.401 ' CZ ' ' HB3' ' S' ' 338' ' ' HIS . 88.4 m-85 -61.1 -53.47 56.72 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.323 -0.861 . . . . 28.93 109.877 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' S' S ' 384' ' ' ASP . . . . . . . . . . . . . 1.5 t70 . . . . . 0 N--CA 1.49 1.557 0 O-C-N 121.356 -0.84 . . . . 47.03 110.357 -176.784 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' R' R ' 30' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 121.152 0.501 . . . . 43.36 110.212 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' R' R ' 31' ' ' LEU . . . . . . . . . . . . . 65.5 mt -134.88 140.63 45.94 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.337 -0.852 . . . . 22.93 110.269 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' R' R ' 32' ' ' THR . . . . . . . . . . . . . 70.6 m -87.61 110.64 20.53 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.33 -0.856 . . . . 22.34 109.9 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' R' R ' 33' ' ' LEU . . . . . 0.595 HD22 ' CE2' ' R' ' 62' ' ' TYR . 80.1 mt -62.45 -172.79 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.307 -0.87 . . . . 21.39 110.202 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' R' R ' 34' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -74.55 -29.54 61.4 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.355 -0.841 . . . . 34.4 110.388 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' R' R ' 35' ' ' ASN . . . . . . . . . . . . . 48.3 p30 -77.68 -1.87 33.25 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.348 -0.845 . . . . 30.28 110.637 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' R' R ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.21 -16.56 59.44 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.733 -1.347 . . . . 36.25 109.733 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' R' R ' 37' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -59.04 161.77 4.83 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.357 -1.084 . . . . 53.8 110.315 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' R' R ' 38' ' ' LYS . . . . . . . . . . . . . 56.9 mttt -117.78 135.81 53.81 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.426 -0.796 . . . . 49.91 110.132 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' R' R ' 39' ' ' LYS . . . . . 0.404 ' HG2' ' CZ ' ' R' ' 41' ' ' PHE . 8.1 ttmt -138.76 143.68 39.11 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.468 -0.77 . . . . 35.69 110.228 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' R' R ' 40' ' ' THR . . . . . . . . . . . . . 23.6 m -102.57 127.98 49.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.41 -0.806 . . . . 34.84 110.221 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' R' R ' 41' ' ' PHE . . . . . 0.404 ' CZ ' ' HG2' ' R' ' 39' ' ' LYS . 96.6 m-85 -113.02 132.75 55.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.442 -0.786 . . . . 34.42 110.11 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' R' R ' 42' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -93.3 140.85 29.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.336 -0.852 . . . . 51.46 110.284 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' R' R ' 43' ' ' SER . . . . . . . . . . . . . 54.3 m -70.82 141.91 51.32 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.412 -0.805 . . . . 41.84 110.217 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' R' R ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.71 125.4 29.56 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.303 -0.873 . . . . 33.82 110.012 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' R' R ' 45' ' ' PRO . . . . . 0.423 ' HG2' ' ND2' ' R' ' 77' ' ' ASN . 46.7 Cg_endo -72.12 151.09 55.01 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.59 1.31 . . . . 30.27 110.655 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' R' R ' 46' ' ' ASN . . . . . . . . . . . . . 52.0 t-20 -124.34 109.9 13.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.447 -0.783 . . . . 35.1 110.054 179.804 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' R' R ' 47' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -120.28 -34.88 3.56 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.311 -0.868 . . . . 42.81 110.54 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' R' R ' 48' ' ' HIS . . . . . 0.441 ' NE2' HD11 ' R' ' 80' ' ' LEU . 73.3 m80 -105.72 45.17 0.98 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.262 -0.899 . . . . 49.97 110.211 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' R' R ' 49' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 50.25 34.69 9.14 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.329 -0.857 . . . . 61.32 110.186 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' R' R ' 50' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -86.28 43.82 1.09 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.333 -0.854 . . . . 51.5 110.623 -179.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' R' R ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.14 -46.08 78.75 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.225 -0.922 . . . . 38.77 109.539 179.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' R' R ' 52' ' ' TRP . . . . . 0.484 ' CD2' ' N ' ' R' ' 53' ' ' LEU . 68.2 p-90 -58.41 -38.44 77.39 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.413 -0.805 . . . . 26.24 110.002 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' R' R ' 53' ' ' LEU . . . . . 0.484 ' N ' ' CD2' ' R' ' 52' ' ' TRP . 23.1 tp -66.73 -46.65 74.79 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.351 -0.843 . . . . 26.75 109.984 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' R' R ' 54' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -55.23 -41.65 72.36 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.354 -0.841 . . . . 35.02 110.113 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' R' R ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.14 -46.1 91.92 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.377 -0.827 . . . . 24.47 110.163 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' R' R ' 56' ' ' ILE . . . . . 0.432 HG12 HD11 ' R' ' 104' ' ' ILE . 76.1 mt -62.18 -42.23 94.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.332 -0.855 . . . . 26.03 109.888 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' R' R ' 57' ' ' LEU . . . . . . . . . . . . . 22.5 mt -60.36 -45.56 93.07 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.3 -0.875 . . . . 26.77 109.702 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' R' R ' 58' ' ' GLN . . . . . . . . . . . . . 57.7 mm-40 -63.91 -46.51 84.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.476 -0.765 . . . . 22.32 109.59 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' R' R ' 59' ' ' LEU . . . . . 0.431 ' HA ' ' HE2' ' R' ' 151' ' ' PHE . 24.0 tp -61.45 -37.75 84.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.291 -0.881 . . . . 20.55 109.396 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' R' R ' 60' ' ' PHE . . . . . 0.528 ' CE2' HD21 ' R' ' 111' ' ' LEU . 2.8 m-85 -61.13 -44.75 96.85 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.628 -0.67 . . . . 20.08 109.866 179.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' R' R ' 61' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -63.11 -36.19 82.78 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.49 -0.756 . . . . 18.8 110.442 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' R' R ' 62' ' ' TYR . . . . . 0.595 ' CE2' HD22 ' R' ' 33' ' ' LEU . 9.2 t80 -63.04 -41.8 99.58 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.271 -0.893 . . . . 26.45 110.26 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' R' R ' 63' ' ' VAL . . . . . 0.406 ' H ' HG22 ' R' ' 63' ' ' VAL . 30.0 m -93.34 20.33 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.263 -0.898 . . . . 29.75 110.307 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' R' R ' 64' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 52.96 75.5 0.24 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.328 -0.857 . . . . 35.52 110.51 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' R' R ' 65' ' ' GLU . . . . . 0.444 ' HG2' ' CD2' ' R' ' 60' ' ' PHE . 14.3 tp10 -116.17 104.09 52.5 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.423 -0.798 . . . . 29.89 109.944 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' R' R ' 66' ' ' PRO . . . . . 0.479 ' HA ' ' HB2' ' R' ' 69' ' ' ASP . 47.9 Cg_endo -73.46 -5.92 17.92 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.79 1.416 . . . . 21.37 111.147 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' R' R ' 67' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -52.1 -61.6 2.16 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.038 -1.039 . . . . 23.85 110.331 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' R' R ' 68' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -98.07 36.57 1.55 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.32 -0.862 . . . . 28.07 110.466 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' R' R ' 69' ' ' ASP . . . . . 0.479 ' HB2' ' HA ' ' R' ' 66' ' ' PRO . 11.7 t0 -72.33 -33.27 67.21 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.342 -0.849 . . . . 43.76 110.155 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' R' R ' 70' ' ' TRP . . . . . 0.475 ' CE2' ' CG2' ' R' ' 71' ' ' VAL . 47.7 p-90 -73.42 -3.91 30.33 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.334 -0.854 . . . . 33.06 110.717 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' R' R ' 71' ' ' VAL . . . . . 0.556 HG11 ' HB2' ' R' ' 82' ' ' ALA . 40.8 t -109.8 -27.47 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.112 -0.992 . . . . 31.7 109.659 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' R' R ' 72' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -86.56 -48.79 8.05 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.407 -0.808 . . . . 33.58 110.353 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' R' R ' 73' ' ' SER . . . . . . . . . . . . . 69.8 m -89.75 51.06 2.0 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.394 -0.816 . . . . 50.82 110.351 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' R' R ' 74' ' ' SER . . . . . . . . . . . . . 15.9 t -125.95 138.21 31.63 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.278 -0.889 . . . . 34.74 110.24 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -73.24 -25.01 16.19 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 O-C-N 123.728 1.383 . . . . 35.7 110.373 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' R' R ' 76' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -91.66 153.12 19.9 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.383 -0.823 . . . . 66.48 110.428 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' R' R ' 77' ' ' ASN . . . . . 0.423 ' ND2' ' HG2' ' R' ' 45' ' ' PRO . 22.3 t-20 -81.4 95.24 6.98 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.368 -0.832 . . . . 46.72 110.117 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' R' R ' 78' ' ' LEU . . . . . . . . . . . . . 96.4 mt -96.45 28.0 3.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.381 -0.825 . . . . 37.55 110.182 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' R' R ' 79' ' ' THR . . . . . . . . . . . . . 29.6 m -56.2 -54.64 42.82 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.337 -0.852 . . . . 37.36 110.295 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' R' R ' 80' ' ' LEU . . . . . 0.604 ' HA ' HD12 ' R' ' 83' ' ' ILE . 15.8 mt -60.95 -23.14 65.07 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.348 -0.845 . . . . 35.83 110.51 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' R' R ' 81' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -79.52 -39.14 32.68 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.133 -0.98 . . . . 44.03 110.381 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' R' R ' 82' ' ' ALA . . . . . 0.556 ' HB2' HG11 ' R' ' 71' ' ' VAL . . . -69.4 -28.7 66.4 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.26 -0.9 . . . . 32.54 110.303 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' R' R ' 83' ' ' ILE . . . . . 0.604 HD12 ' HA ' ' R' ' 80' ' ' LEU . 77.7 mt -70.09 -46.06 73.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.253 -0.905 . . . . 32.02 110.342 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' R' R ' 84' ' ' LYS . . . . . . . . . . . . . 36.0 tttm -55.22 -52.06 64.57 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.179 -0.951 . . . . 34.09 110.596 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' R' R ' 85' ' ' GLN . . . . . 0.532 ' HG2' HD12 ' R' ' 89' ' ' LEU . 31.9 tt0 -54.8 -46.86 74.54 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.191 -0.943 . . . . 25.94 110.305 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' R' R ' 86' ' ' LEU . . . . . . . . . . . . . 24.2 mt -58.71 -43.76 90.16 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.267 -0.896 . . . . 16.2 109.957 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' R' R ' 87' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -65.36 -35.27 80.45 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.393 -0.817 . . . . 49.09 110.305 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' R' R ' 88' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -78.4 -19.06 54.09 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.284 -0.885 . . . . 28.61 110.509 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' R' R ' 89' ' ' LEU . . . . . 0.532 HD12 ' HG2' ' R' ' 85' ' ' GLN . 32.4 mt -96.16 -29.43 14.06 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.225 -0.922 . . . . 26.16 110.2 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' R' R ' 90' ' ' THR . . . . . . . . . . . . . 59.9 p -105.77 -34.58 7.64 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.3 -0.875 . . . . 33.33 109.724 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' R' R ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.85 16.1 58.6 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.821 -1.312 . . . . 31.13 109.821 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' R' R ' 92' ' ' LEU . . . . . . . . . . . . . 97.1 mt -100.11 155.19 17.87 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.169 -1.195 . . . . 42.52 110.246 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' R' R ' 93' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -86.15 91.59 8.48 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.471 -0.768 . . . . 68.46 110.006 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' R' R ' 94' ' ' LEU . . . . . 0.457 ' HB3' ' CZ2' ' R' ' 52' ' ' TRP . 48.2 mt -99.41 53.08 0.95 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.176 -0.952 . . . . 44.63 110.364 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' R' R ' 95' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.52 -38.7 6.36 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.226 -0.921 . . . . 67.16 110.376 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' R' R ' 96' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -113.85 44.11 1.69 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.332 -0.855 . . . . 67.02 110.325 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' R' R ' 97' ' ' GLY . . . . . . . . . . . . . . . 99.24 150.83 25.99 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.599 -1.401 . . . . 49.48 109.599 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' R' R ' 98' ' ' GLY . . . . . . . . . . . . . . . -166.27 160.03 33.46 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.267 -1.533 . . . . 36.57 109.267 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' R' R ' 99' ' ' PRO . . . . . 0.791 ' O ' HG23 ' R' ' 103' ' ' VAL . 45.5 Cg_endo -72.57 121.11 7.14 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.74 1.39 . . . . 30.41 110.462 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' R' R ' 100' ' ' PRO . . . . . 0.413 ' HA ' HD11 ' R' ' 56' ' ' ILE . 45.7 Cg_endo -72.32 -31.52 11.46 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.637 1.335 . . . . 29.94 110.545 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' R' R ' 101' ' ' ALA . . . . . 0.475 ' HB2' ' HB3' ' R' ' 178' ' ' LEU . . . -70.07 -38.49 75.77 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.296 -0.878 . . . . 23.64 110.184 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' R' R ' 102' ' ' LEU . . . . . 0.427 HD23 HD21 ' R' ' 106' ' ' ASN . 0.1 OUTLIER -72.71 -40.66 66.0 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.335 -0.853 . . . . 20.31 110.411 -179.71 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' R' R ' 103' ' ' VAL . . . . . 0.791 HG23 ' O ' ' R' ' 99' ' ' PRO . 63.3 t -58.15 -40.13 76.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.227 -0.92 . . . . 16.33 109.986 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' R' R ' 104' ' ' ILE . . . . . 0.432 HD11 HG12 ' R' ' 56' ' ' ILE . 82.0 mt -71.72 -30.47 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.374 -0.829 . . . . 24.77 109.951 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' R' R ' 105' ' ' TRP . . . . . 0.462 ' O ' ' HD3' ' R' ' 108' ' ' LYS . 70.6 t-105 -82.44 0.81 40.5 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.304 -0.873 . . . . 23.28 110.273 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' R' R ' 106' ' ' ASN . . . . . 0.427 HD21 HD23 ' R' ' 102' ' ' LEU . 6.9 m-80 -105.05 -10.37 17.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.171 -0.956 . . . . 28.26 110.146 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' R' R ' 107' ' ' ILE . . . . . . . . . . . . . 36.8 pt -126.82 34.9 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.184 -0.947 . . . . 18.77 110.076 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' R' R ' 108' ' ' LYS . . . . . 0.5 ' HG2' ' HB ' ' R' ' 115' ' ' ILE . 9.2 mtpp -60.97 -48.5 81.52 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.516 -0.74 . . . . 42.5 110.06 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' R' R ' 109' ' ' HIS . . . . . 0.446 ' CD2' ' HG ' ' R' ' 110' ' ' LEU . 50.8 p-80 -66.02 -12.87 58.26 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.511 -0.743 . . . . 20.07 110.698 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' R' R ' 110' ' ' LEU . . . . . 0.446 ' HG ' ' CD2' ' R' ' 109' ' ' HIS . 80.5 mt -94.71 -17.38 22.27 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.042 -1.036 . . . . 15.69 110.194 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' R' R ' 111' ' ' LEU . . . . . 0.528 HD21 ' CE2' ' R' ' 60' ' ' PHE . 10.3 mt -94.09 144.17 25.72 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.368 -0.832 . . . . 25.39 111.016 -179.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' R' R ' 112' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -77.71 -17.35 57.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.552 -0.717 . . . . 53.48 109.835 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' R' R ' 113' ' ' THR . . . . . 0.458 HG22 ' N ' ' R' ' 114' ' ' GLY . 59.6 m -83.71 166.71 17.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.347 -0.846 . . . . 14.8 110.29 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' R' R ' 114' ' ' GLY . . . . . 0.458 ' N ' HG22 ' R' ' 113' ' ' THR . . . -97.98 127.16 9.13 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.947 -1.261 . . . . 16.14 109.947 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' R' R ' 115' ' ' ILE . . . . . 0.576 HD13 ' HB ' ' R' ' 124' ' ' VAL . 47.7 mm -109.17 139.36 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.525 -0.985 . . . . 13.46 109.725 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' R' R ' 116' ' ' GLY . . . . . . . . . . . . . . . -152.72 -155.87 7.29 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.933 -1.267 . . . . 23.9 109.933 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' R' R ' 117' ' ' THR . . . . . 0.529 HG22 ' CG2' ' R' ' 126' ' ' VAL . 18.9 p -135.03 -171.36 2.78 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.484 -1.01 . . . . 27.37 110.072 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' R' R ' 118' ' ' ALA . . . . . 0.445 ' HB3' ' OD1' ' R' ' 128' ' ' ASP . . . -56.6 -58.04 9.77 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.297 -0.877 . . . . 18.76 110.064 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' R' R ' 119' ' ' SER . . . . . 0.461 ' HA ' ' CB ' ' R' ' 194' ' ' ALA . 1.1 m -56.56 -40.56 75.37 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.266 -0.896 . . . . 32.35 109.787 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' R' R ' 120' ' ' ARG . . . . . 0.419 ' NH1' ' CE2' ' S' ' 305' ' ' TRP . 10.0 mtm180 -110.08 86.23 4.87 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.487 -0.758 . . . . 27.12 109.673 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' R' R ' 121' ' ' PRO . . . . . 0.483 ' HA ' ' SG ' ' R' ' 125' ' ' CYS . 44.3 Cg_endo -71.24 166.41 29.32 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.874 1.46 . . . . 22.68 111.03 -179.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' R' R ' 122' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' R' ' 121' ' ' PRO . 38.5 t 178.61 -161.64 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.61 -0.681 . . . . 22.99 109.513 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' R' R ' 123' ' ' GLU . . . . . 0.442 ' HG2' HG23 ' R' ' 113' ' ' THR . 2.3 tp10 -56.45 -39.95 74.0 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.211 -0.93 . . . . 36.18 109.762 179.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' R' R ' 124' ' ' VAL . . . . . 0.576 ' HB ' HD13 ' R' ' 115' ' ' ILE . 84.6 t -142.55 136.48 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.534 -0.729 . . . . 20.64 109.43 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' R' R ' 125' ' ' CYS . . . . . 0.483 ' SG ' ' HA ' ' R' ' 121' ' ' PRO . 82.9 m -140.31 168.2 20.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.161 -0.962 . . . . 22.8 111.136 -179.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' R' R ' 126' ' ' VAL . . . . . 0.728 HG12 HG22 ' R' ' 179' ' ' VAL . 35.9 m -122.74 159.8 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.714 -0.616 . . . . 21.24 109.664 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' R' R ' 127' ' ' VAL . . . . . 0.709 HG11 ' O ' ' R' ' 177' ' ' VAL . 30.7 m -70.86 141.82 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.293 -0.879 . . . . 19.77 110.657 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' R' R ' 128' ' ' ASP . . . . . 0.445 ' OD1' ' HB3' ' R' ' 118' ' ' ALA . 53.9 p-10 -137.73 19.38 2.87 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.327 -0.858 . . . . 29.21 110.687 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' R' R ' 129' ' ' GLY . . . . . . . . . . . . . . . 114.11 0.0 23.98 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.965 -1.112 . . . . 33.86 110.469 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' R' R ' 130' ' ' THR . . . . . . . . . . . . . 58.6 m -91.93 131.85 36.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.105 -1.233 . . . . 26.41 110.046 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -62.56 120.65 11.56 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.38 -0.825 . . . . 33.08 110.302 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' R' R ' 132' ' ' MET . . . . . 0.434 ' HE1' ' CE2' ' R' ' 180' ' ' PHE . 98.4 mmm -105.21 165.66 10.94 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.395 -0.816 . . . . 30.76 110.435 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' R' R ' 133' ' ' CYS . . . . . 0.411 ' HA ' ' HB3' ' R' ' 174' ' ' PRO . 32.5 m -141.17 158.12 44.33 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.493 -0.754 . . . . 27.0 109.969 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' R' R ' 134' ' ' LEU . . . . . 0.563 HD11 ' O ' ' R' ' 172' ' ' PRO . 0.1 OUTLIER -58.54 -19.68 39.82 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.347 -0.846 . . . . 33.9 110.444 -179.833 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' R' R ' 135' ' ' ALA . . . . . . . . . . . . . . . -92.72 8.2 40.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.182 -0.949 . . . . 19.37 110.882 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' R' R ' 136' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -93.76 -21.74 19.13 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.143 -0.973 . . . . 30.47 110.266 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' R' R ' 137' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -149.98 165.38 32.85 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.341 -0.85 . . . . 24.27 110.204 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' R' R ' 138' ' ' HIS . . . . . 0.434 ' HA ' HG23 ' R' ' 154' ' ' VAL . 15.1 p80 -117.87 15.2 14.33 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.398 -0.814 . . . . 20.91 110.404 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' R' R ' 139' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' R' ' 152' ' ' ALA . . . -177.23 152.35 0.86 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.198 -0.939 . . . . 15.69 110.184 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' R' R ' 140' ' ' GLY . . . . . 0.427 ' HA3' ' O ' ' R' ' 179' ' ' VAL . . . 161.81 175.15 32.53 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.928 -1.269 . . . . 23.76 109.928 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' R' R ' 141' ' ' ILE . . . . . . . . . . . . . 83.7 mt -95.51 136.56 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.358 -1.084 . . . . 25.3 109.713 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' R' R ' 142' ' ' PHE . . . . . 0.576 ' CD2' ' HB2' ' R' ' 172' ' ' PRO . 83.0 m-85 -120.73 -172.52 2.4 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.375 -0.828 . . . . 30.24 110.528 -179.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' R' R ' 143' ' ' LEU . . . . . 0.741 HD23 ' O ' ' R' ' 148' ' ' HIS . 0.5 OUTLIER -119.86 77.73 1.26 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.417 -0.802 . . . . 32.8 110.289 -179.902 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' R' R ' 144' ' ' LYS . . . . . 0.471 ' HG3' ' CZ2' ' R' ' 170' ' ' TRP . 1.0 OUTLIER -69.5 76.82 0.41 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.437 -0.789 . . . . 49.18 109.676 179.575 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' R' R ' 145' ' ' GLY . . . . . 0.457 ' O ' HD22 ' R' ' 143' ' ' LEU . . . 104.48 179.24 24.86 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.203 -1.559 . . . . 53.87 109.203 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' R' R ' 146' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -88.47 145.85 25.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.358 -1.083 . . . . 68.58 109.982 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' R' R ' 147' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 58.21 36.47 25.78 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.26 -0.9 . . . . 56.62 110.665 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' R' R ' 148' ' ' HIS . . . . . 0.741 ' O ' HD23 ' R' ' 143' ' ' LEU . 44.6 t60 -158.61 148.17 19.31 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.193 -0.942 . . . . 44.57 110.376 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' R' R ' 149' ' ' ALA . . . . . . . . . . . . . . . -150.29 146.92 27.06 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.427 -0.796 . . . . 33.54 110.078 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' R' R ' 150' ' ' VAL . . . . . . . . . . . . . 34.2 m -142.38 161.47 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.234 -0.916 . . . . 27.61 110.301 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' R' R ' 151' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' R' ' 152' ' ' ALA . 5.9 t80 -86.18 155.57 20.68 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.402 -0.811 . . . . 23.04 109.918 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' R' R ' 152' ' ' ALA . . . . . 0.537 ' N ' ' CD1' ' R' ' 151' ' ' PHE . . . -157.28 151.57 24.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.438 -0.789 . . . . 29.61 109.601 179.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' R' R ' 153' ' ' CYS . . . . . . . . . . . . . 26.7 p -154.28 173.61 15.93 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.268 -0.895 . . . . 22.75 110.407 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' R' R ' 154' ' ' VAL . . . . . 0.613 HG22 ' CE2' ' R' ' 159' ' ' TRP . 60.3 t -90.63 117.03 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.383 -0.823 . . . . 23.26 110.061 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' R' R ' 155' ' ' THR . . . . . . . . . . . . . 70.3 p -112.13 -176.62 2.97 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.356 -0.84 . . . . 17.88 110.041 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' R' R ' 156' ' ' SER . . . . . . . . . . . . . 78.5 p -75.92 -3.74 37.08 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.33 -0.856 . . . . 21.83 110.678 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' R' R ' 157' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -118.3 10.51 12.83 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.207 -0.933 . . . . 36.54 110.652 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' R' R ' 158' ' ' GLY . . . . . . . . . . . . . . . 117.96 -162.58 13.06 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.559 -1.416 . . . . 31.74 109.559 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' R' R ' 159' ' ' TRP . . . . . 0.613 ' CE2' HG22 ' R' ' 154' ' ' VAL . 14.6 m95 -86.68 122.5 30.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.35 -1.088 . . . . 28.25 110.109 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' R' R ' 160' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -108.46 166.94 10.39 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.345 -0.847 . . . . 41.24 110.19 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' R' R ' 161' ' ' ALA . . . . . . . . . . . . . . . -143.18 123.5 13.84 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.403 -0.81 . . . . 27.4 110.151 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' R' R ' 162' ' ' ILE . . . . . . . . . . . . . 92.2 mt -87.63 81.11 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.373 -0.829 . . . . 24.27 110.078 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' R' R ' 163' ' ' ASP . . . . . 0.415 ' O ' ' N ' ' R' ' 165' ' ' GLU . 15.3 t0 -72.74 92.35 1.55 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.389 -0.819 . . . . 36.08 110.277 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' R' R ' 164' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 54.06 -88.89 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.526 -0.734 . . . . 46.08 110.556 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' R' R ' 165' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' R' ' 163' ' ' ASP . 29.6 mt-10 -124.72 35.82 4.72 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.151 -0.968 . . . . 50.94 110.148 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' R' R ' 166' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -135.67 117.36 14.99 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.362 -0.836 . . . . 47.28 110.353 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' R' R ' 167' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -101.12 119.96 39.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.401 -0.812 . . . . 40.47 110.083 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' R' R ' 168' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -157.51 158.61 30.74 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.25 -0.906 . . . . 30.21 110.466 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' R' R ' 169' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.81 133.07 19.48 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.928 1.488 . . . . 32.76 110.5 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' R' R ' 170' ' ' TRP . . . . . 0.471 ' CZ2' ' HG3' ' R' ' 144' ' ' LYS . 67.1 t90 -159.83 119.35 2.88 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.34 -0.85 . . . . 32.79 109.965 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' R' R ' 171' ' ' THR . . . . . . . . . . . . . 46.9 m -81.09 112.58 33.91 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.431 -0.793 . . . . 36.92 110.155 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' R' R ' 172' ' ' PRO . . . . . 0.576 ' HB2' ' CD2' ' R' ' 142' ' ' PHE . 47.0 Cg_endo -73.67 158.76 46.79 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.622 1.328 . . . . 33.54 110.548 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' R' R ' 173' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -88.91 145.03 33.81 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.324 -0.86 . . . . 45.76 109.86 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' R' R ' 174' ' ' PRO . . . . . 0.411 ' HB3' ' HA ' ' R' ' 133' ' ' CYS . 45.2 Cg_endo -71.85 -10.28 26.07 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 O-C-N 123.71 1.374 . . . . 29.63 110.41 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' R' R ' 175' ' ' SER . . . . . . . . . . . . . 53.0 p -103.44 -17.64 15.15 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.348 -0.845 . . . . 35.7 110.366 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' R' R ' 176' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -103.51 43.29 1.09 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.268 -0.895 . . . . 39.65 110.418 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' R' R ' 177' ' ' VAL . . . . . 0.709 ' O ' HG11 ' R' ' 127' ' ' VAL . 10.7 p -117.72 127.06 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.3 -0.875 . . . . 20.61 110.094 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' R' R ' 178' ' ' LEU . . . . . 0.475 ' HB3' ' HB2' ' R' ' 101' ' ' ALA . 46.2 mt -91.42 -61.3 1.68 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.349 -0.845 . . . . 15.58 109.392 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' R' R ' 179' ' ' VAL . . . . . 0.728 HG22 HG12 ' R' ' 126' ' ' VAL . 68.6 t -114.64 144.76 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.561 -0.712 . . . . 17.4 109.384 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' R' R ' 180' ' ' PHE . . . . . 0.434 ' CE2' ' HE1' ' R' ' 132' ' ' MET . 43.6 p90 -152.15 163.36 39.54 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.197 -0.94 . . . . 20.16 110.63 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' R' R ' 181' ' ' VAL . . . . . . . . . . . . . 66.2 t -113.17 111.44 50.27 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.375 -0.828 . . . . 17.69 109.836 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' R' R ' 182' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.03 149.49 52.84 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.532 1.28 . . . . 17.81 110.409 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' R' R ' 183' ' ' TYR . . . . . 0.712 ' O ' ' C ' ' R' ' 184' ' ' ASP . 79.1 m-85 -59.03 175.52 0.28 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.458 -0.776 . . . . 28.01 110.504 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' R' R ' 184' ' ' ASP . . . . . 0.712 ' C ' ' O ' ' R' ' 183' ' ' TYR . 15.0 t70 -17.26 -81.98 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.353 -0.842 . . . . 58.64 110.313 -178.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' R' R ' 185' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 . . . . . 0 N--CA 1.503 2.2 0 CA-C-O 121.277 0.56 . . . . 80.42 111.791 179.553 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' R' R ' 193' ' ' LYS . . . . . . . . . . . . . 26.8 tptt . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 120.907 0.384 . . . . 49.5 110.145 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' R' R ' 194' ' ' ALA . . . . . 0.461 ' CB ' ' HA ' ' R' ' 119' ' ' SER . . . . . . . . 0 N--CA 1.496 1.835 0 O-C-N 121.12 -0.988 . . . . 40.4 110.082 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 229' ' ' MET . . . . . . . . . . . . . 15.9 mmm . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.231 0.539 . . . . 51.83 110.228 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' S' S ' 230' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -97.31 142.76 28.8 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.292 -0.88 . . . . 54.13 110.133 -178.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 231' ' ' LEU . . . . . . . . . . . . . 68.3 mt -134.13 141.05 46.97 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.306 -0.871 . . . . 33.04 110.372 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 232' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' S' ' 355' ' ' THR . 40.3 m -89.28 103.25 15.89 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.362 -0.836 . . . . 26.92 110.0 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' S' S ' 233' ' ' LEU . . . . . 0.667 HD22 ' CE2' ' S' ' 262' ' ' TYR . 79.7 mt -55.88 179.3 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.418 -0.801 . . . . 13.78 110.493 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' S' S ' 234' ' ' TYR . . . . . 0.448 ' CG ' ' N ' ' S' ' 235' ' ' ASN . 35.5 p90 -64.96 -35.73 82.13 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.453 -0.779 . . . . 26.08 110.213 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' S' S ' 235' ' ' ASN . . . . . 0.448 ' N ' ' CG ' ' S' ' 234' ' ' TYR . 50.7 p30 -74.29 -7.42 52.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.289 -0.882 . . . . 20.04 110.601 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' S' S ' 236' ' ' GLY . . . . . . . . . . . . . . . 95.74 -19.91 52.21 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.748 -1.341 . . . . 22.71 109.748 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 237' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -53.08 145.74 12.65 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.243 -1.151 . . . . 35.44 110.165 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 238' ' ' LYS . . . . . . . . . . . . . 44.5 mttt -102.15 127.97 48.84 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.391 -0.818 . . . . 32.56 110.337 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 239' ' ' LYS . . . . . 0.414 ' HG2' ' CZ ' ' S' ' 241' ' ' PHE . 9.0 ttmt -132.29 144.49 50.63 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.391 -0.818 . . . . 26.68 109.949 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' S' S ' 240' ' ' THR . . . . . . . . . . . . . 51.3 m -102.06 132.2 48.07 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.329 -0.857 . . . . 41.02 110.39 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 241' ' ' PHE . . . . . 0.414 ' CZ ' ' HG2' ' S' ' 239' ' ' LYS . 96.1 m-85 -117.88 137.72 52.6 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.364 -0.835 . . . . 28.62 110.195 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' S' S ' 242' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -96.44 161.83 13.75 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.365 -0.835 . . . . 47.89 110.163 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 243' ' ' SER . . . . . . . . . . . . . 72.4 m -90.59 151.58 21.25 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.295 -0.878 . . . . 45.09 110.241 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 244' ' ' ARG . . . . . . . . . . . . . 1.4 mtp85 -129.81 126.75 22.69 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.402 -0.811 . . . . 42.49 110.162 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 245' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.37 161.05 43.57 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 O-C-N 123.666 1.351 . . . . 35.68 110.503 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 246' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -132.94 97.88 4.14 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.391 -0.818 . . . . 51.88 109.82 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 247' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -110.5 -22.23 11.77 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.4 -0.813 . . . . 53.69 110.643 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 248' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -117.21 43.63 2.28 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.178 -0.951 . . . . 55.79 110.774 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 249' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 48.77 38.43 11.79 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.443 -0.785 . . . . 49.45 110.381 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 250' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -90.62 29.07 1.36 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.521 -0.737 . . . . 36.86 110.31 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 251' ' ' ALA . . . . . . . . . . . . . . . -53.9 -43.13 69.42 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.322 -0.861 . . . . 29.69 109.56 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 252' ' ' TRP . . . . . 0.42 ' CZ2' ' HB3' ' S' ' 294' ' ' LEU . 67.8 p-90 -61.83 -33.97 75.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.556 -0.715 . . . . 41.12 109.832 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' S' S ' 253' ' ' LEU . . . . . 0.407 ' N ' ' CD2' ' S' ' 252' ' ' TRP . 23.3 tp -70.11 -47.14 63.07 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.335 -0.853 . . . . 24.89 110.002 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' S' S ' 254' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -56.23 -42.51 77.41 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.326 -0.859 . . . . 35.65 109.909 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 255' ' ' ALA . . . . . . . . . . . . . . . -59.47 -48.13 82.83 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.402 -0.811 . . . . 22.73 110.115 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 256' ' ' ILE . . . . . 0.505 HG12 HD11 ' S' ' 304' ' ' ILE . 79.9 mt -62.31 -40.72 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.326 -0.858 . . . . 28.85 109.986 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' S' S ' 257' ' ' LEU . . . . . . . . . . . . . 19.1 mt -61.49 -44.52 96.92 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.405 -0.809 . . . . 23.07 110.186 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 258' ' ' GLN . . . . . 0.502 ' HB3' ' CD2' ' S' ' 351' ' ' PHE . 53.5 mm-40 -65.04 -45.3 85.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.402 -0.811 . . . . 29.78 109.993 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' S' S ' 259' ' ' LEU . . . . . 0.415 ' O ' HG22 ' S' ' 263' ' ' VAL . 20.0 tp -58.71 -36.41 74.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.236 -0.915 . . . . 17.94 109.453 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' S' S ' 260' ' ' PHE . . . . . 0.521 ' CE2' HD21 ' S' ' 311' ' ' LEU . 3.1 m-85 -62.77 -45.35 93.07 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.624 -0.673 . . . . 30.57 109.857 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' S' S ' 261' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -62.01 -29.8 70.52 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.432 -0.792 . . . . 41.34 109.98 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 262' ' ' TYR . . . . . 0.667 ' CE2' HD22 ' S' ' 233' ' ' LEU . 8.7 t80 -71.15 -44.68 65.06 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.415 -0.803 . . . . 26.03 110.102 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' S' S ' 263' ' ' VAL . . . . . 0.415 HG22 ' O ' ' S' ' 259' ' ' LEU . 33.0 m -91.93 18.19 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.293 -0.88 . . . . 22.8 110.403 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' S' S ' 264' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 52.75 70.71 0.55 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.26 -0.9 . . . . 44.03 110.586 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 265' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -111.79 109.17 55.5 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.332 -0.855 . . . . 35.61 109.716 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 266' ' ' PRO . . . . . 0.479 ' HA ' ' HB2' ' S' ' 269' ' ' ASP . 49.9 Cg_endo -75.33 0.48 8.99 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 O-C-N 123.637 1.335 . . . . 37.67 111.768 -179.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' S' S ' 267' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -56.58 -67.71 0.28 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.797 -1.189 . . . . 41.49 110.18 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' S' S ' 268' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -92.81 39.83 1.04 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.177 -0.952 . . . . 50.76 110.124 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 269' ' ' ASP . . . . . 0.479 ' HB2' ' HA ' ' S' ' 266' ' ' PRO . 0.9 OUTLIER -75.99 -33.21 59.72 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.424 -0.798 . . . . 61.86 109.806 179.559 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' S' S ' 270' ' ' TRP . . . . . 0.514 ' CE2' HG23 ' S' ' 271' ' ' VAL . 50.9 p-90 -73.9 -4.35 34.5 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.279 -0.888 . . . . 39.85 110.5 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' S' S ' 271' ' ' VAL . . . . . 0.514 HG23 ' CE2' ' S' ' 270' ' ' TRP . 46.5 t -109.49 -32.68 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.15 -0.969 . . . . 39.18 110.088 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' S' S ' 272' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -78.68 -36.53 43.56 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.443 -0.786 . . . . 40.02 110.489 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 273' ' ' SER . . . . . . . . . . . . . 71.0 m -103.53 56.07 0.74 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.292 -0.88 . . . . 47.2 110.314 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 274' ' ' SER . . . . . . . . . . . . . 6.9 t -133.01 141.24 40.23 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.317 -0.865 . . . . 47.61 110.159 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 275' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.72 -18.92 21.78 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 123.678 1.357 . . . . 45.28 110.526 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 276' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -99.98 140.9 33.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.246 -0.909 . . . . 57.27 110.299 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 277' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -71.7 97.67 1.79 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.355 -0.841 . . . . 37.28 110.284 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 278' ' ' LEU . . . . . . . . . . . . . 86.4 mt -96.99 33.8 1.84 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.441 -0.787 . . . . 43.88 110.014 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 279' ' ' THR . . . . . . . . . . . . . 76.9 m -64.02 -60.23 3.5 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.457 -0.777 . . . . 50.05 110.203 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 280' ' ' LEU . . . . . 0.743 ' HA ' HD12 ' S' ' 283' ' ' ILE . 13.7 mt -51.53 -39.87 58.55 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.343 -0.848 . . . . 54.12 110.316 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' S' S ' 281' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.39 -49.71 74.44 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.457 -0.777 . . . . 65.28 110.178 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' S' S ' 282' ' ' ALA . . . . . . . . . . . . . . . -58.88 -33.98 71.12 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.514 -0.741 . . . . 46.51 110.557 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 283' ' ' ILE . . . . . 0.743 HD12 ' HA ' ' S' ' 280' ' ' LEU . 85.9 mt -66.37 -50.86 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.328 -0.857 . . . . 47.3 110.101 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' S' S ' 284' ' ' LYS . . . . . . . . . . . . . 33.6 tttp -50.46 -57.68 7.48 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.422 -0.799 . . . . 50.72 110.381 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 285' ' ' GLN . . . . . 0.535 ' HG2' HD12 ' S' ' 289' ' ' LEU . 34.3 tt0 -51.31 -46.5 62.58 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.494 -0.754 . . . . 68.47 110.312 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' S' S ' 286' ' ' LEU . . . . . . . . . . . . . 19.1 mt -59.89 -44.5 94.2 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.379 -0.825 . . . . 36.62 110.3 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 287' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -62.81 -35.26 79.33 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.319 -0.863 . . . . 46.64 110.043 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 288' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -76.17 -21.11 56.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.405 -0.809 . . . . 46.45 110.381 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 289' ' ' LEU . . . . . 0.535 HD12 ' HG2' ' S' ' 285' ' ' GLN . 30.8 mt -97.26 -21.76 17.07 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.244 -0.91 . . . . 35.09 110.582 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' S' S ' 290' ' ' THR . . . . . 0.413 HG22 ' HB3' ' S' ' 306' ' ' ASN . 81.5 p -114.76 -28.52 7.06 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.25 -0.906 . . . . 38.61 110.429 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' S' S ' 291' ' ' GLY . . . . . . . . . . . . . . . 79.38 11.11 85.27 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.789 -1.324 . . . . 36.77 109.789 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 292' ' ' LEU . . . . . . . . . . . . . 84.5 mt -96.48 145.76 25.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.336 -1.096 . . . . 35.33 109.77 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 293' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -77.3 102.33 6.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.222 -0.923 . . . . 48.7 110.316 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 294' ' ' LEU . . . . . 0.42 ' HB3' ' CZ2' ' S' ' 252' ' ' TRP . 55.4 mt -106.86 51.7 0.74 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.503 -0.748 . . . . 42.61 110.136 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' S' S ' 295' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -112.48 -11.2 13.65 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.377 -0.827 . . . . 55.49 110.498 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' S' S ' 296' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -144.29 48.45 1.37 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.059 -1.025 . . . . 75.68 110.338 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 297' ' ' GLY . . . . . . . . . . . . . . . 96.91 145.12 18.6 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.48 -1.448 . . . . 49.44 109.48 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 298' ' ' GLY . . . . . . . . . . . . . . . -163.79 156.93 29.01 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.775 -1.33 . . . . 41.11 109.775 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 299' ' ' PRO . . . . . 0.488 ' O ' HG23 ' S' ' 303' ' ' VAL . 46.6 Cg_endo -73.8 118.3 5.39 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 O-C-N 123.992 1.522 . . . . 26.2 110.277 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' S' S ' 300' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.21 -15.56 31.76 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 O-C-N 123.616 1.324 . . . . 21.7 110.692 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 301' ' ' ALA . . . . . . . . . . . . . . . -80.65 -29.36 36.69 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.175 -0.953 . . . . 31.23 110.133 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 302' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.43 -40.64 19.05 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.503 -0.748 . . . . 38.99 109.975 179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' S' S ' 303' ' ' VAL . . . . . 0.488 HG23 ' O ' ' S' ' 299' ' ' PRO . 58.2 t -60.7 -35.46 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.435 -0.791 . . . . 18.63 110.177 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' S' S ' 304' ' ' ILE . . . . . 0.513 HD12 HG21 ' S' ' 379' ' ' VAL . 86.1 mt -79.43 -23.56 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.423 -0.798 . . . . 25.46 110.19 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' S' S ' 305' ' ' TRP . . . . . 0.419 ' CD2' ' HD3' ' S' ' 308' ' ' LYS . 68.8 t-105 -88.65 -14.52 37.21 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.224 -0.923 . . . . 33.4 110.581 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' S' S ' 306' ' ' ASN . . . . . 0.413 ' HB3' HG22 ' S' ' 290' ' ' THR . 10.4 m-80 -89.76 -13.52 36.54 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.142 -0.974 . . . . 36.97 110.399 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' S' S ' 307' ' ' ILE . . . . . 0.457 HG12 ' O ' ' S' ' 303' ' ' VAL . 36.8 pt -125.05 45.71 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.164 -0.96 . . . . 30.81 110.071 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' S' S ' 308' ' ' LYS . . . . . 0.419 ' HD3' ' CD2' ' S' ' 305' ' ' TRP . 1.5 mtmp? -73.59 -37.75 65.36 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.378 -0.826 . . . . 46.52 110.077 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' S' S ' 309' ' ' HIS . . . . . 0.496 ' CD2' ' HG ' ' S' ' 310' ' ' LEU . 55.5 p-80 -73.17 -8.28 55.08 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.35 -0.844 . . . . 51.03 110.161 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' S' S ' 310' ' ' LEU . . . . . 0.496 ' HG ' ' CD2' ' S' ' 309' ' ' HIS . 53.0 mt -99.32 -12.92 19.89 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.347 -0.845 . . . . 36.16 109.943 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' S' S ' 311' ' ' LEU . . . . . 0.521 HD21 ' CE2' ' S' ' 260' ' ' PHE . 10.8 mt -97.12 147.85 23.64 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.381 -0.824 . . . . 40.0 110.429 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' S' S ' 312' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -81.59 -16.32 51.97 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.322 -0.861 . . . . 54.18 109.748 179.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 313' ' ' THR . . . . . 0.829 HG23 ' HG2' ' S' ' 323' ' ' GLU . 92.9 m -87.94 151.66 22.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.337 -0.852 . . . . 25.61 110.115 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' S' S ' 314' ' ' GLY . . . . . . . . . . . . . . . -87.95 126.38 8.04 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.768 -1.333 . . . . 25.18 109.768 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 315' ' ' ILE . . . . . 0.647 HD13 ' HB ' ' S' ' 324' ' ' VAL . 50.7 mm -101.66 150.48 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.441 -1.034 . . . . 23.9 109.725 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' S' S ' 316' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' S' ' 325' ' ' CYS . . . -157.04 -159.31 9.4 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.931 -1.268 . . . . 23.18 109.931 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' S' S ' 317' ' ' THR . . . . . 0.424 HG22 ' CG2' ' S' ' 326' ' ' VAL . 11.2 p -133.9 -172.98 3.12 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.468 -1.019 . . . . 27.98 110.044 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' S' S ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.59 -56.19 25.06 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.163 -0.961 . . . . 28.1 109.874 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 319' ' ' SER . . . . . . . . . . . . . 1.2 m -59.93 -41.63 92.19 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.326 -0.859 . . . . 37.0 109.663 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 320' ' ' ARG . . . . . . . . . . . . . 12.1 mtm180 -111.73 79.8 2.64 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.466 -0.771 . . . . 52.07 109.655 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 321' ' ' PRO . . . . . 0.436 ' O ' ' HB2' ' S' ' 322' ' ' SER . 44.4 Cg_endo -71.38 171.51 16.01 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.783 1.412 . . . . 38.29 110.979 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' S' S ' 322' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' S' ' 321' ' ' PRO . 41.3 t 178.67 -148.15 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.956 -0.757 . . . . 38.84 108.956 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' S' S ' 323' ' ' GLU . . . . . 0.829 ' HG2' HG23 ' S' ' 313' ' ' THR . 6.7 tp10 -62.87 -40.29 97.05 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.043 -1.036 . . . . 40.7 109.64 179.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' S' S ' 324' ' ' VAL . . . . . 0.647 ' HB ' HD13 ' S' ' 315' ' ' ILE . 73.6 t -141.27 134.99 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.35 -0.844 . . . . 20.34 109.469 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' S' S ' 325' ' ' CYS . . . . . 0.471 ' HB2' ' CE1' ' S' ' 380' ' ' PHE . 11.1 m -125.99 172.26 10.09 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.312 -0.868 . . . . 30.63 110.924 -179.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' S' S ' 326' ' ' VAL . . . . . 0.646 HG12 HG22 ' S' ' 379' ' ' VAL . 34.5 m -135.56 142.16 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 109.175 -0.676 . . . . 23.9 109.175 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' S' S ' 327' ' ' VAL . . . . . 0.595 HG11 ' O ' ' S' ' 377' ' ' VAL . 34.6 m -56.37 125.02 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.112 -0.992 . . . . 19.48 110.39 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' S' S ' 328' ' ' ASP . . . . . . . . . . . . . 55.7 p-10 -119.4 11.61 12.23 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.418 -0.801 . . . . 26.43 110.439 179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 329' ' ' GLY . . . . . . . . . . . . . . . 119.59 2.3 13.17 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.068 -1.213 . . . . 31.24 110.068 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 330' ' ' THR . . . . . . . . . . . . . 81.0 m -92.97 129.94 38.71 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.101 -1.235 . . . . 30.05 110.133 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 331' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -56.77 111.5 1.04 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.302 -0.873 . . . . 37.26 109.992 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 332' ' ' MET . . . . . . . . . . . . . 87.9 mmm -94.08 162.58 13.82 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.235 -0.915 . . . . 26.23 110.334 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 333' ' ' CYS . . . . . . . . . . . . . 26.4 m -137.15 150.05 47.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.42 -0.8 . . . . 23.56 110.078 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 334' ' ' LEU . . . . . 0.565 HD11 ' O ' ' S' ' 372' ' ' PRO . 0.1 OUTLIER -52.6 -24.9 9.18 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.228 -0.92 . . . . 28.93 110.508 179.833 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' S' S ' 335' ' ' ALA . . . . . . . . . . . . . . . -89.02 14.45 10.58 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.319 -0.863 . . . . 15.76 110.964 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 336' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -100.49 -17.15 17.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.134 -0.979 . . . . 34.92 110.214 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 337' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -152.42 170.81 19.21 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.39 -0.819 . . . . 19.03 110.154 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 338' ' ' HIS . . . . . . . . . . . . . 13.5 p80 -120.73 10.4 10.97 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.394 -0.816 . . . . 18.82 110.411 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 339' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' S' ' 352' ' ' ALA . . . -176.04 155.16 1.54 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.206 -0.934 . . . . 17.18 110.09 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' S' S ' 340' ' ' GLY . . . . . . . . . . . . . . . 160.85 173.05 28.97 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.001 -1.24 . . . . 18.33 110.001 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 341' ' ' ILE . . . . . . . . . . . . . 83.9 mt -88.8 138.08 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.393 -1.063 . . . . 18.6 109.839 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 342' ' ' PHE . . . . . 0.488 ' CE2' ' HB3' ' S' ' 352' ' ' ALA . 69.9 m-85 -120.93 -178.49 3.75 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.219 -0.926 . . . . 23.44 110.412 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' S' S ' 343' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.84 93.4 4.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.397 -0.814 . . . . 35.59 110.07 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' S' S ' 344' ' ' LYS . . . . . 0.41 ' O ' ' HB3' ' S' ' 348' ' ' HIS . 0.3 OUTLIER -80.82 125.04 29.59 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.236 -0.915 . . . . 38.34 110.046 -179.934 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' S' S ' 345' ' ' GLY . . . . . . . . . . . . . . . 62.85 -130.85 42.89 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 108.788 -1.725 . . . . 53.46 108.788 -179.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 346' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -132.7 150.88 52.1 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.173 -1.192 . . . . 70.91 110.011 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 347' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 53.31 35.36 20.02 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.236 -0.915 . . . . 47.32 110.393 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 348' ' ' HIS . . . . . 0.41 ' HB3' ' O ' ' S' ' 344' ' ' LYS . 46.6 t60 -150.11 155.89 40.66 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.317 -0.865 . . . . 41.72 110.312 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' S' S ' 349' ' ' ALA . . . . . 0.455 ' C ' HG13 ' S' ' 350' ' ' VAL . . . -149.79 151.3 33.34 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.324 -0.86 . . . . 22.91 110.442 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' S' S ' 350' ' ' VAL . . . . . 0.455 HG13 ' C ' ' S' ' 349' ' ' ALA . 34.6 m -149.14 169.55 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.448 -0.782 . . . . 21.09 109.995 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' S' S ' 351' ' ' PHE . . . . . 0.502 ' CD2' ' HB3' ' S' ' 258' ' ' GLN . 10.7 t80 -105.27 143.58 33.25 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.19 -0.944 . . . . 25.03 110.716 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' S' S ' 352' ' ' ALA . . . . . 0.488 ' HB3' ' CE2' ' S' ' 342' ' ' PHE . . . -147.7 151.74 36.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.584 -0.698 . . . . 23.81 109.741 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' S' S ' 353' ' ' CYS . . . . . . . . . . . . . 26.3 p -153.34 164.84 37.43 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.295 -0.878 . . . . 25.66 110.225 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 354' ' ' VAL . . . . . 0.561 HG22 ' CE2' ' S' ' 359' ' ' TRP . 57.2 t -76.04 118.47 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.376 -0.828 . . . . 34.27 109.943 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' S' S ' 355' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' S' ' 232' ' ' THR . 52.3 p -117.82 175.1 5.82 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.257 -0.902 . . . . 25.49 110.346 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' S' S ' 356' ' ' SER . . . . . . . . . . . . . 62.2 p -62.2 -17.61 58.65 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.456 -0.778 . . . . 31.24 110.699 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 357' ' ' ASN . . . . . . . . . . . . . 45.8 m-20 -107.05 14.22 26.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.896 . . . . 28.61 110.552 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 358' ' ' GLY . . . . . . . . . . . . . . . 111.86 -152.92 17.59 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.013 -1.235 . . . . 22.01 110.013 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 359' ' ' TRP . . . . . 0.561 ' CE2' HG22 ' S' ' 354' ' ' VAL . 15.3 m95 -91.3 116.65 29.0 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.38 -1.071 . . . . 25.54 110.23 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' S' S ' 360' ' ' TYR . . . . . 0.422 ' HA ' ' HA ' ' S' ' 369' ' ' PRO . 1.3 m-85 -103.53 165.79 10.82 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.257 -0.902 . . . . 40.53 110.091 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' S' S ' 361' ' ' ALA . . . . . 0.428 ' HA ' ' O ' ' S' ' 351' ' ' PHE . . . -140.01 129.99 24.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.353 -0.842 . . . . 18.04 110.295 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' S' S ' 362' ' ' ILE . . . . . . . . . . . . . 88.9 mt -95.54 83.61 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.375 -0.828 . . . . 15.64 110.081 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 363' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' S' ' 365' ' ' GLU . 11.9 t0 -75.19 94.48 2.96 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.42 -0.8 . . . . 35.03 110.186 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' S' S ' 364' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 53.92 -89.3 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.53 -0.731 . . . . 46.72 110.537 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 365' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' S' ' 363' ' ' ASP . 23.7 mt-10 -122.69 19.1 10.32 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.046 -1.033 . . . . 56.2 110.223 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' S' S ' 366' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -117.91 124.88 49.34 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.21 -0.932 . . . . 51.02 110.44 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 367' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -106.89 127.05 53.09 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.326 -0.859 . . . . 37.59 110.18 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 368' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -165.47 159.5 13.83 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.293 -0.879 . . . . 31.47 110.415 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 369' ' ' PRO . . . . . 0.422 ' HA ' ' HA ' ' S' ' 360' ' ' TYR . 46.9 Cg_endo -72.76 139.59 30.9 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 O-C-N 123.891 1.469 . . . . 28.85 110.557 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' S' S ' 370' ' ' TRP . . . . . . . . . . . . . 67.4 t90 -167.25 113.52 0.76 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.422 -0.799 . . . . 26.94 110.001 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 371' ' ' THR . . . . . . . . . . . . . 59.8 m -74.81 113.08 21.02 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.376 -0.828 . . . . 20.19 110.041 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 372' ' ' PRO . . . . . 0.565 ' O ' HD11 ' S' ' 334' ' ' LEU . 47.0 Cg_endo -73.59 157.11 49.04 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.644 1.339 . . . . 28.68 110.529 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' S' S ' 373' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -90.58 147.15 35.74 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.411 -0.806 . . . . 35.72 109.934 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 374' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -76.03 -6.27 17.18 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 O-C-N 123.681 1.359 . . . . 30.89 110.461 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 375' ' ' SER . . . . . . . . . . . . . 70.5 p -104.39 -17.0 14.95 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.227 -0.921 . . . . 29.41 110.428 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 376' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -106.48 43.09 1.18 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.358 -0.839 . . . . 32.89 110.26 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 377' ' ' VAL . . . . . 0.595 ' O ' HG11 ' S' ' 327' ' ' VAL . 7.3 p -114.71 147.29 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.294 -0.879 . . . . 24.33 110.223 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' S' S ' 378' ' ' LEU . . . . . . . . . . . . . 52.5 mt -115.99 -57.96 2.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.381 -0.824 . . . . 24.37 109.611 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 379' ' ' VAL . . . . . 0.646 HG22 HG12 ' S' ' 326' ' ' VAL . 61.0 t -120.76 132.38 70.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.404 -0.81 . . . . 18.02 109.424 179.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' S' S ' 380' ' ' PHE . . . . . 0.471 ' CE1' ' HB2' ' S' ' 325' ' ' CYS . 14.6 p90 -142.61 173.96 11.07 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.376 -0.828 . . . . 29.35 110.704 -179.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' S' S ' 381' ' ' VAL . . . . . . . . . . . . . 57.7 t -120.12 107.31 39.79 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.459 -0.776 . . . . 16.34 109.43 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 382' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -71.19 145.6 49.43 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.613 1.322 . . . . 20.94 110.79 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' S' S ' 383' ' ' TYR . . . . . 0.959 ' O ' ' CB ' ' S' ' 384' ' ' ASP . 88.5 m-85 -61.04 -53.57 55.61 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.317 -0.865 . . . . 28.93 109.826 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' S' S ' 384' ' ' ASP . . . . . 0.959 ' CB ' ' O ' ' S' ' 383' ' ' TYR . 7.0 t70 . . . . . 0 N--CA 1.491 1.588 0 O-C-N 121.46 -0.775 . . . . 47.03 110.366 176.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' R' R ' 30' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 121.14 0.495 . . . . 43.36 110.287 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' R' R ' 31' ' ' LEU . . . . . . . . . . . . . 65.3 mt -134.86 140.61 45.95 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.308 -0.87 . . . . 22.93 110.306 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' R' R ' 32' ' ' THR . . . . . . . . . . . . . 68.4 m -87.59 110.59 20.49 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.408 -0.807 . . . . 22.34 109.971 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' R' R ' 33' ' ' LEU . . . . . 0.596 HD22 ' CE2' ' R' ' 62' ' ' TYR . 80.0 mt -62.38 -172.79 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.314 -0.866 . . . . 21.39 110.226 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' R' R ' 34' ' ' TYR . . . . . . . . . . . . . 37.0 p90 -74.68 -29.4 61.21 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.333 -0.855 . . . . 34.4 110.38 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' R' R ' 35' ' ' ASN . . . . . . . . . . . . . 48.3 p30 -77.79 -1.79 33.2 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.356 -0.84 . . . . 30.28 110.699 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' R' R ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.24 -16.55 59.49 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.691 -1.364 . . . . 36.25 109.691 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' R' R ' 37' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -59.04 161.81 4.79 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.314 -1.11 . . . . 53.8 110.368 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' R' R ' 38' ' ' LYS . . . . . . . . . . . . . 56.9 mttt -117.86 135.8 53.86 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.445 -0.784 . . . . 49.91 110.146 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' R' R ' 39' ' ' LYS . . . . . 0.408 ' HG2' ' CZ ' ' R' ' 41' ' ' PHE . 8.1 ttmt -138.75 143.64 39.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.404 -0.81 . . . . 35.69 110.223 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' R' R ' 40' ' ' THR . . . . . . . . . . . . . 23.5 m -102.54 127.96 49.39 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.302 -0.874 . . . . 34.84 110.228 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' R' R ' 41' ' ' PHE . . . . . 0.408 ' CZ ' ' HG2' ' R' ' 39' ' ' LYS . 96.6 m-85 -113.04 132.65 55.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.378 -0.826 . . . . 34.42 110.172 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' R' R ' 42' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -93.36 140.95 28.99 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.331 -0.856 . . . . 51.46 110.221 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' R' R ' 43' ' ' SER . . . . . . . . . . . . . 54.3 m -70.76 141.93 51.42 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.55 -0.719 . . . . 41.84 110.205 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' R' R ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.75 125.37 29.59 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.469 -0.769 . . . . 33.82 110.013 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' R' R ' 45' ' ' PRO . . . . . 0.423 ' HG2' ' ND2' ' R' ' 77' ' ' ASN . 45.5 Cg_endo -72.11 151.13 55.13 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.59 1.31 . . . . 30.27 110.625 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' R' R ' 46' ' ' ASN . . . . . 0.4 ' HA ' ' OD1' ' R' ' 50' ' ' ASN . 52.2 t-20 -124.28 109.84 13.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.459 -0.776 . . . . 35.1 110.071 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' R' R ' 47' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -120.27 -34.86 3.56 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.395 -0.816 . . . . 42.81 110.551 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' R' R ' 48' ' ' HIS . . . . . 0.439 ' NE2' HD11 ' R' ' 80' ' ' LEU . 73.3 m80 -105.73 45.1 0.99 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.187 -0.946 . . . . 49.97 110.235 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' R' R ' 49' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 50.32 34.72 9.38 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.4 -0.813 . . . . 61.32 110.149 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' R' R ' 50' ' ' ASN . . . . . 0.4 ' OD1' ' HA ' ' R' ' 46' ' ' ASN . 15.0 p-10 -86.32 43.87 1.1 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.323 -0.861 . . . . 51.5 110.66 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' R' R ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.12 -46.11 78.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.165 -0.959 . . . . 38.77 109.541 179.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' R' R ' 52' ' ' TRP . . . . . 0.483 ' CD2' ' N ' ' R' ' 53' ' ' LEU . 68.2 p-90 -58.4 -38.4 77.27 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.482 -0.761 . . . . 26.24 110.055 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' R' R ' 53' ' ' LEU . . . . . 0.483 ' N ' ' CD2' ' R' ' 52' ' ' TRP . 23.1 tp -66.73 -46.66 74.76 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.456 -0.777 . . . . 26.75 109.946 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' R' R ' 54' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -55.23 -41.54 72.24 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.405 -0.809 . . . . 35.02 110.132 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' R' R ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.26 -46.11 91.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.352 -0.842 . . . . 24.47 110.114 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' R' R ' 56' ' ' ILE . . . . . 0.433 HG12 HD11 ' R' ' 104' ' ' ILE . 76.6 mt -62.09 -42.33 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.259 -0.901 . . . . 26.03 109.906 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' R' R ' 57' ' ' LEU . . . . . . . . . . . . . 22.5 mt -60.26 -45.69 92.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.28 -0.888 . . . . 26.77 109.657 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' R' R ' 58' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -63.87 -46.51 84.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.341 -0.849 . . . . 22.32 109.582 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' R' R ' 59' ' ' LEU . . . . . 0.43 ' HA ' ' HE2' ' R' ' 151' ' ' PHE . 24.0 tp -61.43 -37.73 84.6 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.306 -0.871 . . . . 20.55 109.396 179.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' R' R ' 60' ' ' PHE . . . . . 0.528 ' CE2' HD21 ' R' ' 111' ' ' LEU . 2.8 m-85 -61.11 -44.72 96.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.617 -0.677 . . . . 20.08 109.913 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' R' R ' 61' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -63.17 -36.23 82.93 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.498 -0.751 . . . . 18.8 110.408 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' R' R ' 62' ' ' TYR . . . . . 0.596 ' CE2' HD22 ' R' ' 33' ' ' LEU . 9.2 t80 -63.04 -41.74 99.58 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.226 -0.921 . . . . 26.45 110.247 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' R' R ' 63' ' ' VAL . . . . . 0.406 ' H ' HG22 ' R' ' 63' ' ' VAL . 30.8 m -93.42 20.32 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.308 -0.87 . . . . 29.75 110.266 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' R' R ' 64' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 53.03 75.44 0.24 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.316 -0.865 . . . . 35.52 110.561 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' R' R ' 65' ' ' GLU . . . . . 0.443 ' HG2' ' CD2' ' R' ' 60' ' ' PHE . 14.3 tp10 -116.19 104.01 52.55 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.391 -0.818 . . . . 29.89 109.958 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' R' R ' 66' ' ' PRO . . . . . 0.479 ' HA ' ' HB2' ' R' ' 69' ' ' ASP . 46.6 Cg_endo -73.47 -5.88 17.85 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.708 1.372 . . . . 21.37 111.068 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' R' R ' 67' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -52.11 -61.58 2.17 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.054 -1.029 . . . . 23.85 110.341 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' R' R ' 68' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -98.06 36.52 1.56 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.314 -0.866 . . . . 28.07 110.474 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' R' R ' 69' ' ' ASP . . . . . 0.479 ' HB2' ' HA ' ' R' ' 66' ' ' PRO . 11.7 t0 -72.3 -33.25 67.27 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.307 -0.871 . . . . 43.76 110.205 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' R' R ' 70' ' ' TRP . . . . . 0.476 ' CE2' ' CG2' ' R' ' 71' ' ' VAL . 48.0 p-90 -73.49 -3.85 30.18 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.332 -0.855 . . . . 33.06 110.686 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' R' R ' 71' ' ' VAL . . . . . 0.557 HG11 ' HB2' ' R' ' 82' ' ' ALA . 40.8 t -109.83 -27.41 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.175 -0.953 . . . . 31.7 109.674 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' R' R ' 72' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -86.58 -48.88 7.96 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.358 -0.839 . . . . 33.58 110.278 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' R' R ' 73' ' ' SER . . . . . . . . . . . . . 70.2 m -89.67 51.12 2.02 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.312 -0.868 . . . . 50.82 110.308 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' R' R ' 74' ' ' SER . . . . . . . . . . . . . 15.9 t -125.96 138.33 31.88 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.282 -0.886 . . . . 34.74 110.189 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.38 -24.99 15.89 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 O-C-N 123.603 1.317 . . . . 35.7 110.32 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' R' R ' 76' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -91.74 153.24 19.76 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.461 -0.775 . . . . 66.48 110.356 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' R' R ' 77' ' ' ASN . . . . . 0.423 ' ND2' ' HG2' ' R' ' 45' ' ' PRO . 22.3 t-20 -81.56 95.23 7.07 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.33 -0.856 . . . . 46.72 110.097 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' R' R ' 78' ' ' LEU . . . . . . . . . . . . . 96.4 mt -96.43 28.01 3.52 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.398 -0.814 . . . . 37.55 110.187 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' R' R ' 79' ' ' THR . . . . . . . . . . . . . 29.9 m -56.21 -54.62 43.08 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.226 -0.921 . . . . 37.36 110.301 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' R' R ' 80' ' ' LEU . . . . . 0.602 ' HA ' HD12 ' R' ' 83' ' ' ILE . 15.9 mt -60.88 -23.28 65.07 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.449 -0.782 . . . . 35.83 110.511 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' R' R ' 81' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -79.44 -39.11 33.07 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.154 -0.966 . . . . 44.03 110.38 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' R' R ' 82' ' ' ALA . . . . . 0.557 ' HB2' HG11 ' R' ' 71' ' ' VAL . . . -69.45 -28.66 66.3 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.292 -0.88 . . . . 32.54 110.211 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' R' R ' 83' ' ' ILE . . . . . 0.602 HD12 ' HA ' ' R' ' 80' ' ' LEU . 78.2 mt -70.13 -46.09 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.236 -0.915 . . . . 32.02 110.265 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' R' R ' 84' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -55.23 -52.09 64.49 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.237 -0.914 . . . . 34.09 110.521 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' R' R ' 85' ' ' GLN . . . . . 0.531 ' HG2' HD12 ' R' ' 89' ' ' LEU . 31.9 tt0 -54.82 -46.87 74.63 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.238 -0.914 . . . . 25.94 110.28 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' R' R ' 86' ' ' LEU . . . . . . . . . . . . . 24.0 mt -58.71 -43.73 90.17 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.299 -0.876 . . . . 16.2 109.923 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' R' R ' 87' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -65.43 -35.11 79.95 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.472 -0.768 . . . . 49.09 110.33 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' R' R ' 88' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -78.5 -19.06 53.85 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.276 -0.89 . . . . 28.61 110.479 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' R' R ' 89' ' ' LEU . . . . . 0.531 HD12 ' HG2' ' R' ' 85' ' ' GLN . 32.8 mt -96.18 -29.43 14.05 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.236 -0.915 . . . . 26.16 110.197 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' R' R ' 90' ' ' THR . . . . . . . . . . . . . 59.4 p -105.63 -34.72 7.65 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.259 -0.901 . . . . 33.33 109.764 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' R' R ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.89 16.08 58.55 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.821 -1.312 . . . . 31.13 109.821 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' R' R ' 92' ' ' LEU . . . . . . . . . . . . . 97.1 mt -100.06 155.23 17.83 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.147 -1.208 . . . . 42.52 110.23 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' R' R ' 93' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -86.21 91.62 8.51 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.49 -0.756 . . . . 68.46 110.017 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' R' R ' 94' ' ' LEU . . . . . 0.459 ' HB3' ' CZ2' ' R' ' 52' ' ' TRP . 48.3 mt -99.48 53.03 0.94 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.222 -0.924 . . . . 44.63 110.32 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' R' R ' 95' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.43 -38.8 6.35 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.262 -0.899 . . . . 67.16 110.385 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' R' R ' 96' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -113.83 44.23 1.67 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.251 -0.906 . . . . 67.02 110.352 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' R' R ' 97' ' ' GLY . . . . . . . . . . . . . . . 99.16 150.78 26.0 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.614 -1.395 . . . . 49.48 109.614 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' R' R ' 98' ' ' GLY . . . . . . . . . . . . . . . -166.26 160.03 33.47 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.286 -1.526 . . . . 36.57 109.286 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' R' R ' 99' ' ' PRO . . . . . 0.792 ' O ' HG23 ' R' ' 103' ' ' VAL . 45.8 Cg_endo -72.49 121.03 7.1 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 O-C-N 123.703 1.37 . . . . 30.41 110.47 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' R' R ' 100' ' ' PRO . . . . . 0.413 ' HA ' HD11 ' R' ' 56' ' ' ILE . 46.1 Cg_endo -72.22 -31.72 11.47 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 O-C-N 123.645 1.339 . . . . 29.94 110.552 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' R' R ' 101' ' ' ALA . . . . . 0.476 ' HB2' ' HB3' ' R' ' 178' ' ' LEU . . . -69.9 -38.49 76.32 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.228 -0.92 . . . . 23.64 110.291 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' R' R ' 102' ' ' LEU . . . . . 0.424 HD23 HD21 ' R' ' 106' ' ' ASN . 0.1 OUTLIER -72.64 -40.71 66.19 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.411 -0.805 . . . . 20.31 110.386 -179.769 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' R' R ' 103' ' ' VAL . . . . . 0.792 HG23 ' O ' ' R' ' 99' ' ' PRO . 64.0 t -58.25 -40.07 76.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.225 -0.922 . . . . 16.33 109.984 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' R' R ' 104' ' ' ILE . . . . . 0.433 HD11 HG12 ' R' ' 56' ' ' ILE . 81.6 mt -71.63 -30.6 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.388 -0.82 . . . . 24.77 109.939 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' R' R ' 105' ' ' TRP . . . . . 0.462 ' O ' ' HD3' ' R' ' 108' ' ' LYS . 70.5 t-105 -82.35 0.82 40.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.292 -0.88 . . . . 23.28 110.321 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' R' R ' 106' ' ' ASN . . . . . 0.424 HD21 HD23 ' R' ' 102' ' ' LEU . 6.9 m-80 -105.07 -10.49 17.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.136 -0.977 . . . . 28.26 110.086 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' R' R ' 107' ' ' ILE . . . . . . . . . . . . . 36.8 pt -126.83 35.06 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.208 -0.933 . . . . 18.77 110.033 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' R' R ' 108' ' ' LYS . . . . . 0.502 ' HG2' ' HB ' ' R' ' 115' ' ' ILE . 9.2 mtpp -61.16 -48.43 81.64 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.528 -0.732 . . . . 42.5 109.987 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' R' R ' 109' ' ' HIS . . . . . 0.446 ' CD2' ' HG ' ' R' ' 110' ' ' LEU . 50.9 p-80 -66.01 -12.88 58.3 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.461 -0.774 . . . . 20.07 110.652 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' R' R ' 110' ' ' LEU . . . . . 0.446 ' HG ' ' CD2' ' R' ' 109' ' ' HIS . 80.6 mt -94.81 -17.26 22.28 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.084 -1.01 . . . . 15.69 110.192 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' R' R ' 111' ' ' LEU . . . . . 0.528 HD21 ' CE2' ' R' ' 60' ' ' PHE . 10.3 mt -94.15 144.11 25.78 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.34 -0.85 . . . . 25.39 111.002 -179.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' R' R ' 112' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -77.7 -17.33 57.75 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.521 -0.737 . . . . 53.48 109.865 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' R' R ' 113' ' ' THR . . . . . 0.459 HG22 ' N ' ' R' ' 114' ' ' GLY . 60.4 m -83.71 166.68 17.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.311 -0.868 . . . . 14.8 110.201 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' R' R ' 114' ' ' GLY . . . . . 0.459 ' N ' HG22 ' R' ' 113' ' ' THR . . . -98.01 127.15 9.13 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.962 -1.255 . . . . 16.14 109.962 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' R' R ' 115' ' ' ILE . . . . . 0.578 HD13 ' HB ' ' R' ' 124' ' ' VAL . 47.9 mm -109.05 139.35 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.424 -1.045 . . . . 13.46 109.71 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' R' R ' 116' ' ' GLY . . . . . . . . . . . . . . . -152.76 -155.9 7.31 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.856 -1.298 . . . . 23.9 109.856 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' R' R ' 117' ' ' THR . . . . . 0.529 HG22 ' CG2' ' R' ' 126' ' ' VAL . 18.8 p -135.03 -171.35 2.78 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.53 -0.982 . . . . 27.37 110.097 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' R' R ' 118' ' ' ALA . . . . . 0.445 ' HB3' ' OD1' ' R' ' 128' ' ' ASP . . . -56.6 -58.04 9.79 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.359 -0.838 . . . . 18.76 110.064 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' R' R ' 119' ' ' SER . . . . . 0.762 ' HA ' ' HB3' ' R' ' 194' ' ' ALA . 1.1 m -56.55 -40.59 75.39 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.259 -0.901 . . . . 32.35 109.741 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' R' R ' 120' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 -110.11 86.25 4.92 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.435 -0.791 . . . . 27.12 109.68 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' R' R ' 121' ' ' PRO . . . . . 0.483 ' HA ' ' SG ' ' R' ' 125' ' ' CYS . 44.3 Cg_endo -71.2 166.47 29.12 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.863 1.454 . . . . 22.68 111.046 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' R' R ' 122' ' ' SER . . . . . 0.434 ' HB2' ' O ' ' R' ' 121' ' ' PRO . 38.4 t 178.56 -161.67 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.649 -0.657 . . . . 22.99 109.456 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' R' R ' 123' ' ' GLU . . . . . 0.44 ' HG2' HG23 ' R' ' 113' ' ' THR . 2.3 tp10 -56.45 -39.92 73.94 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.211 -0.93 . . . . 36.18 109.701 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' R' R ' 124' ' ' VAL . . . . . 0.578 ' HB ' HD13 ' R' ' 115' ' ' ILE . 84.2 t -142.58 136.41 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.579 -0.701 . . . . 20.64 109.389 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' R' R ' 125' ' ' CYS . . . . . 0.483 ' SG ' ' HA ' ' R' ' 121' ' ' PRO . 83.3 m -140.26 168.23 20.29 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.252 -0.905 . . . . 22.8 111.166 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' R' R ' 126' ' ' VAL . . . . . 0.73 HG12 HG22 ' R' ' 179' ' ' VAL . 35.8 m -122.73 159.73 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.671 -0.643 . . . . 21.24 109.568 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' R' R ' 127' ' ' VAL . . . . . 0.709 HG11 ' O ' ' R' ' 177' ' ' VAL . 30.6 m -70.8 141.91 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.294 -0.879 . . . . 19.77 110.7 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' R' R ' 128' ' ' ASP . . . . . 0.445 ' OD1' ' HB3' ' R' ' 118' ' ' ALA . 53.9 p-10 -137.77 19.4 2.86 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.337 -0.852 . . . . 29.21 110.642 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' R' R ' 129' ' ' GLY . . . . . . . . . . . . . . . 113.98 0.03 24.16 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.963 -1.113 . . . . 33.86 110.498 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' R' R ' 130' ' ' THR . . . . . . . . . . . . . 58.1 m -91.86 131.81 36.92 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.14 -1.212 . . . . 26.41 110.082 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -62.52 120.7 11.62 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.36 -0.838 . . . . 33.08 110.287 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' R' R ' 132' ' ' MET . . . . . 0.433 ' HE1' ' CE2' ' R' ' 180' ' ' PHE . 98.5 mmm -105.26 165.62 10.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.467 -0.771 . . . . 30.76 110.435 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' R' R ' 133' ' ' CYS . . . . . 0.41 ' HA ' ' HB3' ' R' ' 174' ' ' PRO . 32.8 m -141.09 158.11 44.37 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.511 -0.743 . . . . 27.0 109.973 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' R' R ' 134' ' ' LEU . . . . . 0.564 HD11 ' O ' ' R' ' 172' ' ' PRO . 0.1 OUTLIER -58.45 -19.74 39.11 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.268 -0.895 . . . . 33.9 110.51 -179.923 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' R' R ' 135' ' ' ALA . . . . . . . . . . . . . . . -92.69 8.07 40.77 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.231 -0.918 . . . . 19.37 110.779 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' R' R ' 136' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -93.71 -21.76 19.15 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.187 -0.946 . . . . 30.47 110.272 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' R' R ' 137' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -149.96 165.34 32.94 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.365 -0.835 . . . . 24.27 110.241 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' R' R ' 138' ' ' HIS . . . . . 0.433 ' HA ' HG23 ' R' ' 154' ' ' VAL . 15.1 p80 -117.84 15.11 14.37 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.362 -0.836 . . . . 20.91 110.369 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' R' R ' 139' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' R' ' 152' ' ' ALA . . . -177.16 152.46 0.88 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.158 -0.964 . . . . 15.69 110.12 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' R' R ' 140' ' ' GLY . . . . . 0.428 ' HA3' ' O ' ' R' ' 179' ' ' VAL . . . 161.8 175.2 32.57 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.975 -1.25 . . . . 23.76 109.975 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' R' R ' 141' ' ' ILE . . . . . . . . . . . . . 83.7 mt -95.55 136.61 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.372 -1.075 . . . . 25.3 109.673 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' R' R ' 142' ' ' PHE . . . . . 0.578 ' CD2' ' HB2' ' R' ' 172' ' ' PRO . 82.8 m-85 -120.77 -172.63 2.42 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.287 -0.883 . . . . 30.24 110.545 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' R' R ' 143' ' ' LEU . . . . . 0.742 HD23 ' O ' ' R' ' 148' ' ' HIS . 0.5 OUTLIER -119.75 77.75 1.26 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.444 -0.785 . . . . 32.8 110.246 -179.84 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' R' R ' 144' ' ' LYS . . . . . 0.469 ' HG3' ' CZ2' ' R' ' 170' ' ' TRP . 1.0 OUTLIER -69.59 76.86 0.42 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.393 -0.817 . . . . 49.18 109.707 179.502 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' R' R ' 145' ' ' GLY . . . . . 0.457 ' O ' HD22 ' R' ' 143' ' ' LEU . . . 104.52 179.32 24.8 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.131 -1.588 . . . . 53.87 109.131 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' R' R ' 146' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -88.52 145.81 25.53 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.361 -1.082 . . . . 68.58 110.023 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' R' R ' 147' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 58.24 36.52 25.77 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.314 -0.866 . . . . 56.62 110.623 179.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' R' R ' 148' ' ' HIS . . . . . 0.742 ' O ' HD23 ' R' ' 143' ' ' LEU . 44.5 t60 -158.65 148.17 19.24 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.194 -0.941 . . . . 44.57 110.376 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' R' R ' 149' ' ' ALA . . . . . . . . . . . . . . . -150.29 146.88 27.04 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.427 -0.796 . . . . 33.54 110.079 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' R' R ' 150' ' ' VAL . . . . . . . . . . . . . 34.2 m -142.32 161.5 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.277 -0.889 . . . . 27.61 110.356 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' R' R ' 151' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' R' ' 152' ' ' ALA . 5.9 t80 -86.14 155.62 20.69 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.401 -0.812 . . . . 23.04 109.924 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' R' R ' 152' ' ' ALA . . . . . 0.537 ' N ' ' CD1' ' R' ' 151' ' ' PHE . . . -157.33 151.51 24.81 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.517 -0.739 . . . . 29.61 109.625 179.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' R' R ' 153' ' ' CYS . . . . . . . . . . . . . 26.7 p -154.3 173.61 15.93 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.233 -0.917 . . . . 22.75 110.453 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' R' R ' 154' ' ' VAL . . . . . 0.613 HG22 ' CE2' ' R' ' 159' ' ' TRP . 60.2 t -90.68 117.04 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.37 -0.831 . . . . 23.26 110.101 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' R' R ' 155' ' ' THR . . . . . . . . . . . . . 69.8 p -112.1 -176.63 2.97 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.302 -0.873 . . . . 17.88 110.041 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' R' R ' 156' ' ' SER . . . . . . . . . . . . . 78.5 p -75.94 -3.69 36.88 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.329 -0.857 . . . . 21.83 110.735 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' R' R ' 157' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -118.25 10.38 12.83 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.109 -0.994 . . . . 36.54 110.635 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' R' R ' 158' ' ' GLY . . . . . . . . . . . . . . . 117.9 -162.7 13.0 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.585 -1.406 . . . . 31.74 109.585 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' R' R ' 159' ' ' TRP . . . . . 0.613 ' CE2' HG22 ' R' ' 154' ' ' VAL . 14.8 m95 -86.51 122.42 30.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.334 -1.098 . . . . 28.25 110.112 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' R' R ' 160' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -108.42 166.96 10.38 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.384 -0.822 . . . . 41.24 110.251 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' R' R ' 161' ' ' ALA . . . . . . . . . . . . . . . -143.33 123.51 13.72 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.495 -0.753 . . . . 27.4 110.117 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' R' R ' 162' ' ' ILE . . . . . . . . . . . . . 92.2 mt -87.54 81.14 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.406 -0.809 . . . . 24.27 110.072 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' R' R ' 163' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' R' ' 165' ' ' GLU . 15.3 t0 -72.81 92.47 1.59 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.422 -0.799 . . . . 36.08 110.234 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' R' R ' 164' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 54.09 -89.03 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.521 -0.737 . . . . 46.08 110.574 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' R' R ' 165' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' R' ' 163' ' ' ASP . 29.7 mt-10 -124.68 35.94 4.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.151 -0.968 . . . . 50.94 110.196 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' R' R ' 166' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -135.72 117.28 14.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.427 -0.796 . . . . 47.28 110.358 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' R' R ' 167' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -101.02 120.0 39.56 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.396 -0.815 . . . . 40.47 110.164 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' R' R ' 168' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -157.56 158.48 30.6 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.199 -0.938 . . . . 30.21 110.436 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' R' R ' 169' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.74 133.01 19.51 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 O-C-N 123.9 1.474 . . . . 32.76 110.471 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' R' R ' 170' ' ' TRP . . . . . 0.469 ' CZ2' ' HG3' ' R' ' 144' ' ' LYS . 66.9 t90 -159.83 119.42 2.89 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.471 -0.768 . . . . 32.79 109.925 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' R' R ' 171' ' ' THR . . . . . . . . . . . . . 46.3 m -81.14 112.62 34.41 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.419 -0.801 . . . . 36.92 110.188 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' R' R ' 172' ' ' PRO . . . . . 0.578 ' HB2' ' CD2' ' R' ' 142' ' ' PHE . 47.5 Cg_endo -73.75 158.82 46.44 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.68 1.358 . . . . 33.54 110.552 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' R' R ' 173' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -88.88 144.98 33.78 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.429 -0.795 . . . . 45.76 109.951 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' R' R ' 174' ' ' PRO . . . . . 0.41 ' HB3' ' HA ' ' R' ' 133' ' ' CYS . 45.3 Cg_endo -71.8 -10.32 26.2 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.639 1.336 . . . . 29.63 110.404 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' R' R ' 175' ' ' SER . . . . . . . . . . . . . 53.1 p -103.47 -17.58 15.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.275 -0.891 . . . . 35.7 110.34 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' R' R ' 176' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -103.5 43.21 1.1 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.256 -0.903 . . . . 39.65 110.419 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' R' R ' 177' ' ' VAL . . . . . 0.709 ' O ' HG11 ' R' ' 127' ' ' VAL . 10.4 p -117.77 127.19 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.367 -0.833 . . . . 20.61 109.961 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' R' R ' 178' ' ' LEU . . . . . 0.476 ' HB3' ' HB2' ' R' ' 101' ' ' ALA . 46.0 mt -91.53 -61.15 1.71 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.373 -0.829 . . . . 15.58 109.419 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' R' R ' 179' ' ' VAL . . . . . 0.73 HG22 HG12 ' R' ' 126' ' ' VAL . 67.9 t -114.73 144.64 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.602 -0.686 . . . . 17.4 109.419 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' R' R ' 180' ' ' PHE . . . . . 0.433 ' CE2' ' HE1' ' R' ' 132' ' ' MET . 43.8 p90 -152.12 163.37 39.5 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.271 -0.893 . . . . 20.16 110.551 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' R' R ' 181' ' ' VAL . . . . . . . . . . . . . 66.8 t -113.16 111.52 50.26 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.456 -0.778 . . . . 17.69 109.833 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' R' R ' 182' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.06 149.48 52.61 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.577 1.304 . . . . 17.81 110.366 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' R' R ' 183' ' ' TYR . . . . . 0.735 ' O ' ' C ' ' R' ' 184' ' ' ASP . 79.1 m-85 -59.03 175.51 0.28 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.432 -0.792 . . . . 28.01 110.571 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' R' R ' 184' ' ' ASP . . . . . 0.735 ' C ' ' O ' ' R' ' 183' ' ' TYR . 1.9 m-20 -13.08 -75.98 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.442 -0.786 . . . . 58.64 110.297 -178.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' R' R ' 185' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.503 2.213 0 CA-C-O 121.185 0.517 . . . . 80.42 111.807 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' R' R ' 193' ' ' LYS . . . . . 0.416 ' O ' ' HB2' ' R' ' 194' ' ' ALA . 49.1 mmtt . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 120.949 0.404 . . . . 49.5 110.112 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' R' R ' 194' ' ' ALA . . . . . 0.762 ' HB3' ' HA ' ' R' ' 119' ' ' SER . . . . . . . . 0 N--CA 1.495 1.796 0 O-C-N 121.117 -0.989 . . . . 40.4 110.102 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' S' S ' 229' ' ' MET . . . . . . . . . . . . . 2.4 ptt? . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.173 0.511 . . . . 51.83 110.202 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' S' S ' 230' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -97.32 142.75 28.81 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.369 -0.832 . . . . 54.13 110.183 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' S' S ' 231' ' ' LEU . . . . . . . . . . . . . 68.2 mt -134.09 141.0 46.99 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.312 -0.868 . . . . 33.04 110.325 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' S' S ' 232' ' ' THR . . . . . 0.416 ' O ' ' HA ' ' S' ' 355' ' ' THR . 40.0 m -89.22 103.27 15.9 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.438 -0.789 . . . . 26.92 110.039 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' S' S ' 233' ' ' LEU . . . . . 0.674 HD22 ' CE2' ' S' ' 262' ' ' TYR . 79.9 mt -55.91 179.29 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.471 -0.768 . . . . 13.78 110.483 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' S' S ' 234' ' ' TYR . . . . . 0.447 ' CG ' ' N ' ' S' ' 235' ' ' ASN . 35.5 p90 -65.02 -35.68 81.95 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.412 -0.805 . . . . 26.08 110.163 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' S' S ' 235' ' ' ASN . . . . . 0.447 ' N ' ' CG ' ' S' ' 234' ' ' TYR . 50.7 p30 -74.35 -7.38 52.65 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.357 -0.839 . . . . 20.04 110.511 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' S' S ' 236' ' ' GLY . . . . . . . . . . . . . . . 95.71 -20.0 51.78 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.769 -1.332 . . . . 22.71 109.769 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' S' S ' 237' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -52.91 145.64 12.29 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.216 -1.167 . . . . 35.44 110.215 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' S' S ' 238' ' ' LYS . . . . . . . . . . . . . 44.2 mttt -102.17 127.99 48.86 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.438 -0.789 . . . . 32.56 110.341 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' S' S ' 239' ' ' LYS . . . . . 0.406 ' HG2' ' CZ ' ' S' ' 241' ' ' PHE . 9.0 ttmt -132.35 144.45 50.55 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.371 -0.83 . . . . 26.68 110.002 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' S' S ' 240' ' ' THR . . . . . . . . . . . . . 52.5 m -101.95 132.23 47.89 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.307 -0.871 . . . . 41.02 110.36 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' S' S ' 241' ' ' PHE . . . . . 0.406 ' CZ ' ' HG2' ' S' ' 239' ' ' LYS . 96.0 m-85 -117.97 137.69 52.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.431 -0.793 . . . . 28.62 110.188 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' S' S ' 242' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -96.36 161.79 13.78 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.32 -0.862 . . . . 47.89 110.241 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' S' S ' 243' ' ' SER . . . . . . . . . . . . . 71.5 m -90.58 151.57 21.26 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.376 -0.827 . . . . 45.09 110.207 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' S' S ' 244' ' ' ARG . . . . . . . . . . . . . 1.4 mtp85 -129.73 126.7 22.72 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.307 -0.871 . . . . 42.49 110.301 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' S' S ' 245' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.33 161.03 43.71 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 O-C-N 123.651 1.343 . . . . 35.68 110.538 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' S' S ' 246' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -132.9 97.91 4.16 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.381 -0.824 . . . . 51.88 109.827 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' S' S ' 247' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -110.47 -22.2 11.78 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.364 -0.835 . . . . 53.69 110.68 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' S' S ' 248' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -117.28 43.65 2.28 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.187 -0.946 . . . . 55.79 110.719 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' S' S ' 249' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 48.84 38.38 11.9 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.402 -0.811 . . . . 49.45 110.338 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' S' S ' 250' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -90.6 28.94 1.38 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.544 -0.722 . . . . 36.86 110.385 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' S' S ' 251' ' ' ALA . . . . . . . . . . . . . . . -53.75 -43.24 68.97 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.271 -0.893 . . . . 29.69 109.643 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' S' S ' 252' ' ' TRP . . . . . 0.427 ' CZ2' ' HB3' ' S' ' 294' ' ' LEU . 67.9 p-90 -61.74 -33.95 74.97 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.465 -0.772 . . . . 41.12 109.812 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' S' S ' 253' ' ' LEU . . . . . 0.402 ' N ' ' CD2' ' S' ' 252' ' ' TRP . 23.3 tp -70.14 -47.21 62.68 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.349 -0.845 . . . . 24.89 109.995 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' S' S ' 254' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -56.16 -42.45 77.04 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.31 -0.869 . . . . 35.65 109.956 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' S' S ' 255' ' ' ALA . . . . . . . . . . . . . . . -59.58 -48.17 82.7 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.432 -0.793 . . . . 22.73 110.025 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' S' S ' 256' ' ' ILE . . . . . 0.503 HG12 HD11 ' S' ' 304' ' ' ILE . 79.6 mt -62.34 -40.66 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.341 -0.85 . . . . 28.85 109.957 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' S' S ' 257' ' ' LEU . . . . . 0.4 ' CD2' ' HB3' ' S' ' 268' ' ' PHE . 19.2 mt -61.57 -44.47 96.96 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.359 -0.838 . . . . 23.07 110.17 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' S' S ' 258' ' ' GLN . . . . . 0.5 ' HB3' ' CD2' ' S' ' 351' ' ' PHE . 53.5 mm-40 -65.06 -45.41 85.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.42 -0.8 . . . . 29.78 109.851 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' S' S ' 259' ' ' LEU . . . . . 0.42 ' O ' HG22 ' S' ' 263' ' ' VAL . 19.8 tp -58.72 -36.33 74.11 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.36 -0.838 . . . . 17.94 109.433 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' S' S ' 260' ' ' PHE . . . . . 0.531 ' CE2' HD21 ' S' ' 311' ' ' LEU . 3.1 m-85 -62.81 -45.27 93.4 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.619 -0.676 . . . . 30.57 109.833 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' S' S ' 261' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -62.18 -29.67 70.52 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.476 -0.765 . . . . 41.34 110.006 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' S' S ' 262' ' ' TYR . . . . . 0.674 ' CE2' HD22 ' S' ' 233' ' ' LEU . 8.7 t80 -71.29 -44.61 64.86 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.418 -0.802 . . . . 26.03 110.067 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' S' S ' 263' ' ' VAL . . . . . 0.42 HG22 ' O ' ' S' ' 259' ' ' LEU . 33.0 m -92.02 18.28 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.366 -0.834 . . . . 22.8 110.38 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' S' S ' 264' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 52.76 70.63 0.56 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.217 -0.927 . . . . 44.03 110.678 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' S' S ' 265' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -111.84 109.19 55.34 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.383 -0.823 . . . . 35.61 109.657 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' S' S ' 266' ' ' PRO . . . . . 0.476 ' HA ' ' HB2' ' S' ' 269' ' ' ASP . 49.3 Cg_endo -75.29 0.37 9.11 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.592 1.312 . . . . 37.67 111.793 -179.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' S' S ' 267' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -56.45 -67.71 0.28 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.74 -1.225 . . . . 41.49 110.164 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' S' S ' 268' ' ' PHE . . . . . 0.4 ' HB3' ' CD2' ' S' ' 257' ' ' LEU . 22.4 m-85 -92.93 39.87 1.05 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.201 -0.937 . . . . 50.76 110.071 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' S' S ' 269' ' ' ASP . . . . . 0.476 ' HB2' ' HA ' ' S' ' 266' ' ' PRO . 0.9 OUTLIER -75.95 -33.26 59.8 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.375 -0.828 . . . . 61.86 109.765 179.567 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' S' S ' 270' ' ' TRP . . . . . 0.506 ' CE2' HG23 ' S' ' 271' ' ' VAL . 51.0 p-90 -73.9 -4.37 34.59 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.312 -0.867 . . . . 39.85 110.483 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' S' S ' 271' ' ' VAL . . . . . 0.506 HG23 ' CE2' ' S' ' 270' ' ' TRP . 46.4 t -109.49 -32.66 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.151 -0.968 . . . . 39.18 110.073 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' S' S ' 272' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -78.6 -36.53 44.09 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.325 -0.859 . . . . 40.02 110.523 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' S' S ' 273' ' ' SER . . . . . . . . . . . . . 70.8 m -103.6 56.11 0.74 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.264 -0.898 . . . . 47.2 110.286 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' S' S ' 274' ' ' SER . . . . . . . . . . . . . 6.9 t -133.03 141.25 40.25 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.35 -0.844 . . . . 47.61 110.155 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' S' S ' 275' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.7 -18.89 21.85 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 O-C-N 123.629 1.331 . . . . 45.28 110.594 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' S' S ' 276' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -99.86 140.85 33.47 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.317 -0.864 . . . . 57.27 110.314 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' S' S ' 277' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -71.68 97.69 1.79 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.476 -0.765 . . . . 37.28 110.309 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' S' S ' 278' ' ' LEU . . . . . . . . . . . . . 86.7 mt -97.0 33.76 1.85 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.397 -0.815 . . . . 43.88 109.984 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' S' S ' 279' ' ' THR . . . . . . . . . . . . . 74.8 m -63.98 -60.19 3.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.481 -0.762 . . . . 50.05 110.24 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' S' S ' 280' ' ' LEU . . . . . 0.729 ' HA ' HD12 ' S' ' 283' ' ' ILE . 13.6 mt -51.58 -39.9 58.77 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.31 -0.869 . . . . 54.12 110.254 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' S' S ' 281' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.35 -49.71 74.47 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.526 -0.734 . . . . 65.28 110.143 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' S' S ' 282' ' ' ALA . . . . . . . . . . . . . . . -58.99 -33.86 71.17 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.548 -0.72 . . . . 46.51 110.506 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' S' S ' 283' ' ' ILE . . . . . 0.729 HD12 ' HA ' ' S' ' 280' ' ' LEU . 85.7 mt -66.35 -50.84 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.287 -0.883 . . . . 47.3 110.138 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' S' S ' 284' ' ' LYS . . . . . . . . . . . . . 33.6 tttp -50.6 -57.57 7.87 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.487 -0.758 . . . . 50.72 110.384 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' S' S ' 285' ' ' GLN . . . . . 0.524 ' HG2' HD12 ' S' ' 289' ' ' LEU . 34.4 tt0 -51.35 -46.42 62.68 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.494 -0.754 . . . . 68.47 110.352 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' S' S ' 286' ' ' LEU . . . . . . . . . . . . . 19.0 mt -59.96 -44.48 94.41 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.417 -0.802 . . . . 36.62 110.287 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' S' S ' 287' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -62.76 -35.26 79.24 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.326 -0.859 . . . . 46.64 110.088 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' S' S ' 288' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -76.26 -21.06 56.78 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.437 -0.789 . . . . 46.45 110.263 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' S' S ' 289' ' ' LEU . . . . . 0.524 HD12 ' HG2' ' S' ' 285' ' ' GLN . 30.7 mt -97.33 -21.69 17.07 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.281 -0.887 . . . . 35.09 110.54 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' S' S ' 290' ' ' THR . . . . . 0.41 HG22 ' HB3' ' S' ' 306' ' ' ASN . 81.3 p -114.77 -28.49 7.07 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.249 -0.907 . . . . 38.61 110.435 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' S' S ' 291' ' ' GLY . . . . . . . . . . . . . . . 79.44 11.05 85.3 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.879 -1.288 . . . . 36.77 109.879 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' S' S ' 292' ' ' LEU . . . . . . . . . . . . . 84.9 mt -96.55 145.82 25.36 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.238 -1.154 . . . . 35.33 109.754 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' S' S ' 293' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -77.32 102.29 6.68 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.161 -0.962 . . . . 48.7 110.275 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' S' S ' 294' ' ' LEU . . . . . 0.427 ' HB3' ' CZ2' ' S' ' 252' ' ' TRP . 55.2 mt -106.84 51.75 0.73 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.472 -0.768 . . . . 42.61 110.117 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' S' S ' 295' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -112.53 -11.2 13.63 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.326 -0.859 . . . . 55.49 110.485 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' S' S ' 296' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -144.34 48.56 1.36 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.177 -0.952 . . . . 75.68 110.271 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' S' S ' 297' ' ' GLY . . . . . . . . . . . . . . . 96.88 145.19 18.73 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.457 -1.457 . . . . 49.44 109.457 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' S' S ' 298' ' ' GLY . . . . . . . . . . . . . . . -163.85 156.94 29.02 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.849 -1.3 . . . . 41.11 109.849 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' S' S ' 299' ' ' PRO . . . . . 0.486 ' O ' HG23 ' S' ' 303' ' ' VAL . 47.5 Cg_endo -73.81 118.27 5.37 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 123.91 1.479 . . . . 26.2 110.291 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' S' S ' 300' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.18 -15.57 31.86 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.529 1.278 . . . . 21.7 110.647 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' S' S ' 301' ' ' ALA . . . . . . . . . . . . . . . -80.7 -29.32 36.49 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.256 -0.903 . . . . 31.23 110.117 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' S' S ' 302' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.5 -40.62 18.96 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.406 -0.809 . . . . 38.99 109.993 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' S' S ' 303' ' ' VAL . . . . . 0.486 HG23 ' O ' ' S' ' 299' ' ' PRO . 57.2 t -60.69 -35.52 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.398 -0.814 . . . . 18.63 110.147 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' S' S ' 304' ' ' ILE . . . . . 0.523 HD12 HG21 ' S' ' 379' ' ' VAL . 86.0 mt -79.33 -23.65 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.405 -0.809 . . . . 25.46 110.179 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' S' S ' 305' ' ' TRP . . . . . 0.413 ' CD2' ' HD3' ' S' ' 308' ' ' LYS . 68.9 t-105 -88.63 -14.53 37.24 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.32 -0.863 . . . . 33.4 110.521 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' S' S ' 306' ' ' ASN . . . . . 0.41 ' HB3' HG22 ' S' ' 290' ' ' THR . 10.3 m-80 -89.72 -13.56 36.59 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.218 -0.926 . . . . 36.97 110.369 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' S' S ' 307' ' ' ILE . . . . . 0.471 HG12 ' O ' ' S' ' 303' ' ' VAL . 36.9 pt -125.08 45.62 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.21 -0.931 . . . . 30.81 110.059 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' S' S ' 308' ' ' LYS . . . . . 0.413 ' HD3' ' CD2' ' S' ' 305' ' ' TRP . 1.5 mtmp? -73.5 -37.75 65.58 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.339 -0.851 . . . . 46.52 110.12 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' S' S ' 309' ' ' HIS . . . . . 0.496 ' CD2' ' HG ' ' S' ' 310' ' ' LEU . 55.5 p-80 -73.22 -8.26 55.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.318 -0.864 . . . . 51.03 110.065 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' S' S ' 310' ' ' LEU . . . . . 0.496 ' HG ' ' CD2' ' S' ' 309' ' ' HIS . 52.6 mt -99.31 -12.92 19.9 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.312 -0.867 . . . . 36.16 109.975 179.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' S' S ' 311' ' ' LEU . . . . . 0.531 HD21 ' CE2' ' S' ' 260' ' ' PHE . 10.8 mt -97.13 147.83 23.66 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.367 -0.833 . . . . 40.0 110.499 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' S' S ' 312' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -81.6 -16.24 52.15 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.31 -0.869 . . . . 54.18 109.682 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' S' S ' 313' ' ' THR . . . . . 0.829 HG23 ' HG2' ' S' ' 323' ' ' GLU . 92.7 m -87.95 151.66 22.64 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.371 -0.83 . . . . 25.61 110.098 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' S' S ' 314' ' ' GLY . . . . . . . . . . . . . . . -87.93 126.41 8.05 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.842 -1.303 . . . . 25.18 109.842 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' S' S ' 315' ' ' ILE . . . . . 0.666 HD13 ' HB ' ' S' ' 324' ' ' VAL . 50.8 mm -101.65 150.51 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.411 -1.052 . . . . 23.9 109.704 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' S' S ' 316' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' S' ' 325' ' ' CYS . . . -157.09 -159.31 9.41 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.932 -1.267 . . . . 23.18 109.932 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' S' S ' 317' ' ' THR . . . . . 0.424 HG22 ' CG2' ' S' ' 326' ' ' VAL . 11.1 p -133.92 -173.01 3.13 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.447 -1.031 . . . . 27.98 109.958 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' S' S ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.58 -56.19 25.08 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.265 -0.897 . . . . 28.1 109.858 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' S' S ' 319' ' ' SER . . . . . . . . . . . . . 1.2 m -59.93 -41.61 92.16 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.427 -0.796 . . . . 37.0 109.675 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' S' S ' 320' ' ' ARG . . . . . . . . . . . . . 12.1 mtm180 -111.72 79.85 2.65 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.529 -0.732 . . . . 52.07 109.726 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' S' S ' 321' ' ' PRO . . . . . 0.447 ' O ' ' HB2' ' S' ' 322' ' ' SER . 43.9 Cg_endo -71.44 171.51 16.05 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.883 1.465 . . . . 38.29 110.927 -179.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' S' S ' 322' ' ' SER . . . . . 0.447 ' HB2' ' O ' ' S' ' 321' ' ' PRO . 41.4 t 178.68 -148.15 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.966 -0.753 . . . . 38.84 108.966 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' S' S ' 323' ' ' GLU . . . . . 0.829 ' HG2' HG23 ' S' ' 313' ' ' THR . 6.7 tp10 -62.85 -40.32 97.1 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.063 -1.023 . . . . 40.7 109.679 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' S' S ' 324' ' ' VAL . . . . . 0.666 ' HB ' HD13 ' S' ' 315' ' ' ILE . 72.7 t -141.27 135.03 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.396 -0.815 . . . . 20.34 109.46 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' S' S ' 325' ' ' CYS . . . . . 0.462 ' HB2' ' CE1' ' S' ' 380' ' ' PHE . 11.5 m -126.0 172.19 10.16 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.336 -0.853 . . . . 30.63 110.833 -179.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' S' S ' 326' ' ' VAL . . . . . 0.65 HG12 HG22 ' S' ' 379' ' ' VAL . 34.5 m -135.45 142.19 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.58 -0.7 . . . . 23.9 109.285 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' S' S ' 327' ' ' VAL . . . . . 0.595 HG11 ' O ' ' S' ' 377' ' ' VAL . 34.5 m -56.35 124.93 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.092 -1.005 . . . . 19.48 110.47 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' S' S ' 328' ' ' ASP . . . . . . . . . . . . . 55.6 p-10 -119.28 11.48 12.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.45 -0.781 . . . . 26.43 110.465 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' S' S ' 329' ' ' GLY . . . . . . . . . . . . . . . 119.71 2.23 13.04 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.025 -1.23 . . . . 31.24 110.025 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' S' S ' 330' ' ' THR . . . . . . . . . . . . . 80.1 m -92.98 130.03 38.69 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.045 -1.268 . . . . 30.05 110.109 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' S' S ' 331' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -56.81 111.46 1.03 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.261 -0.899 . . . . 37.26 109.955 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' S' S ' 332' ' ' MET . . . . . . . . . . . . . 88.1 mmm -94.11 162.57 13.82 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.278 -0.889 . . . . 26.23 110.351 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' S' S ' 333' ' ' CYS . . . . . . . . . . . . . 26.2 m -137.19 150.07 47.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.535 -0.728 . . . . 23.56 110.019 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' S' S ' 334' ' ' LEU . . . . . 0.566 HD11 ' O ' ' S' ' 372' ' ' PRO . 0.1 OUTLIER -52.68 -24.75 9.15 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.339 -0.851 . . . . 28.93 110.522 179.881 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' S' S ' 335' ' ' ALA . . . . . . . . . . . . . . . -89.08 14.42 10.75 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.383 -0.823 . . . . 15.76 110.947 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' S' S ' 336' ' ' ASP . . . . . 0.4 ' O ' ' HA ' ' S' ' 382' ' ' PRO . 70.4 m-20 -100.49 -17.14 17.28 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.1 -1.0 . . . . 34.92 110.186 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' S' S ' 337' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -152.46 170.85 19.12 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.299 -0.875 . . . . 19.03 110.017 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' S' S ' 338' ' ' HIS . . . . . 0.402 ' HB3' ' CZ ' ' S' ' 383' ' ' TYR . 13.5 p80 -120.76 10.44 10.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.416 -0.803 . . . . 18.82 110.497 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' S' S ' 339' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' S' ' 352' ' ' ALA . . . -175.97 155.24 1.58 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.293 -0.879 . . . . 17.18 110.103 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' S' S ' 340' ' ' GLY . . . . . 0.401 ' CA ' ' O ' ' S' ' 379' ' ' VAL . . . 160.8 173.09 28.97 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.07 -1.212 . . . . 18.33 110.07 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' S' S ' 341' ' ' ILE . . . . . . . . . . . . . 84.4 mt -88.88 138.15 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.505 -0.997 . . . . 18.6 109.757 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' S' S ' 342' ' ' PHE . . . . . 0.493 ' CE2' ' HB3' ' S' ' 352' ' ' ALA . 70.0 m-85 -120.98 -178.41 3.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.26 -0.9 . . . . 23.44 110.428 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' S' S ' 343' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.85 93.42 4.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.41 -0.806 . . . . 35.59 109.989 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' S' S ' 344' ' ' LYS . . . . . 0.402 ' O ' ' HB3' ' S' ' 348' ' ' HIS . 0.3 OUTLIER -80.78 125.0 29.52 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.269 -0.894 . . . . 38.34 110.148 179.948 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' S' S ' 345' ' ' GLY . . . . . . . . . . . . . . . 62.79 -130.81 43.02 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 108.847 -1.701 . . . . 53.46 108.847 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' S' S ' 346' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -132.79 150.8 52.12 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.199 -1.177 . . . . 70.91 110.073 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' S' S ' 347' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 53.35 35.36 20.14 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.335 -0.853 . . . . 47.32 110.437 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' S' S ' 348' ' ' HIS . . . . . 0.402 ' HB3' ' O ' ' S' ' 344' ' ' LYS . 46.2 t60 -150.15 155.82 40.49 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.294 -0.879 . . . . 41.72 110.311 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' S' S ' 349' ' ' ALA . . . . . 0.46 ' C ' HG13 ' S' ' 350' ' ' VAL . . . -149.74 151.32 33.43 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.346 -0.846 . . . . 22.91 110.463 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' S' S ' 350' ' ' VAL . . . . . 0.46 HG13 ' C ' ' S' ' 349' ' ' ALA . 34.6 m -149.11 169.6 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.443 -0.785 . . . . 21.09 110.024 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' S' S ' 351' ' ' PHE . . . . . 0.5 ' CD2' ' HB3' ' S' ' 258' ' ' GLN . 10.7 t80 -105.35 143.54 33.37 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.215 -0.928 . . . . 25.03 110.706 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' S' S ' 352' ' ' ALA . . . . . 0.493 ' HB3' ' CE2' ' S' ' 342' ' ' PHE . . . -147.66 151.69 36.59 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.646 -0.659 . . . . 23.81 109.732 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' S' S ' 353' ' ' CYS . . . . . . . . . . . . . 26.3 p -153.34 164.87 37.36 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.291 -0.881 . . . . 25.66 110.246 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' S' S ' 354' ' ' VAL . . . . . 0.547 HG22 ' CE2' ' S' ' 359' ' ' TRP . 56.8 t -75.99 118.5 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.381 -0.824 . . . . 34.27 109.967 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' S' S ' 355' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' S' ' 232' ' ' THR . 51.5 p -117.81 175.11 5.81 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.282 -0.886 . . . . 25.49 110.307 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' S' S ' 356' ' ' SER . . . . . . . . . . . . . 62.0 p -62.15 -17.67 58.6 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.455 -0.778 . . . . 31.24 110.748 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' S' S ' 357' ' ' ASN . . . . . . . . . . . . . 45.8 m-20 -107.03 14.28 26.56 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.145 -0.972 . . . . 28.61 110.531 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' S' S ' 358' ' ' GLY . . . . . . . . . . . . . . . 111.86 -152.85 17.61 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.045 -1.222 . . . . 22.01 110.045 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' S' S ' 359' ' ' TRP . . . . . 0.547 ' CE2' HG22 ' S' ' 354' ' ' VAL . 15.4 m95 -91.35 116.73 29.08 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.45 -1.029 . . . . 25.54 110.176 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' S' S ' 360' ' ' TYR . . . . . 0.413 ' HA ' ' HA ' ' S' ' 369' ' ' PRO . 1.3 m-85 -103.52 165.83 10.8 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.338 -0.851 . . . . 40.53 110.032 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' S' S ' 361' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' S' ' 351' ' ' PHE . . . -140.1 130.1 24.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.361 -0.837 . . . . 18.04 110.268 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' S' S ' 362' ' ' ILE . . . . . . . . . . . . . 89.1 mt -95.61 83.64 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.409 -0.807 . . . . 15.64 110.061 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' S' S ' 363' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' S' ' 365' ' ' GLU . 11.8 t0 -75.25 94.51 3.01 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.422 -0.799 . . . . 35.03 110.201 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' S' S ' 364' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 53.98 -89.43 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.551 -0.718 . . . . 46.72 110.511 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' S' S ' 365' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' S' ' 363' ' ' ASP . 23.7 mt-10 -122.7 19.2 10.31 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.075 -1.016 . . . . 56.2 110.245 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' S' S ' 366' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -117.98 124.96 49.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.169 -0.957 . . . . 51.02 110.395 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' S' S ' 367' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -107.03 127.05 53.12 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.344 -0.847 . . . . 37.59 110.137 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' S' S ' 368' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -165.38 159.5 13.99 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.247 -0.908 . . . . 31.47 110.481 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' S' S ' 369' ' ' PRO . . . . . 0.413 ' HA ' ' HA ' ' S' ' 360' ' ' TYR . 46.8 Cg_endo -72.8 139.61 30.8 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.859 1.452 . . . . 28.85 110.538 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' S' S ' 370' ' ' TRP . . . . . . . . . . . . . 67.6 t90 -167.2 113.56 0.76 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.347 -0.846 . . . . 26.94 109.942 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' S' S ' 371' ' ' THR . . . . . . . . . . . . . 59.9 m -74.81 113.02 20.37 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.417 -0.802 . . . . 20.19 110.01 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' S' S ' 372' ' ' PRO . . . . . 0.566 ' O ' HD11 ' S' ' 334' ' ' LEU . 48.1 Cg_endo -73.52 157.09 49.39 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 O-C-N 123.597 1.314 . . . . 28.68 110.624 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' S' S ' 373' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -90.56 147.15 35.76 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.492 -0.755 . . . . 35.72 109.896 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' S' S ' 374' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -76.03 -6.27 17.18 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 O-C-N 123.652 1.343 . . . . 30.89 110.459 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' S' S ' 375' ' ' SER . . . . . . . . . . . . . 68.6 p -104.41 -16.9 14.97 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.22 -0.925 . . . . 29.41 110.451 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' S' S ' 376' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -106.51 43.02 1.19 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.231 -0.918 . . . . 32.89 110.217 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' S' S ' 377' ' ' VAL . . . . . 0.595 ' O ' HG11 ' S' ' 327' ' ' VAL . 7.3 p -114.65 147.27 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.374 -0.829 . . . . 24.33 110.216 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' S' S ' 378' ' ' LEU . . . . . . . . . . . . . 52.3 mt -115.99 -58.01 2.15 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.348 -0.845 . . . . 24.37 109.638 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' S' S ' 379' ' ' VAL . . . . . 0.65 HG22 HG12 ' S' ' 326' ' ' VAL . 61.3 t -120.64 132.4 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.471 -0.768 . . . . 18.02 109.443 179.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' S' S ' 380' ' ' PHE . . . . . 0.462 ' CE1' ' HB2' ' S' ' 325' ' ' CYS . 14.4 p90 -142.63 174.0 11.03 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.309 -0.869 . . . . 29.35 110.634 -179.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' S' S ' 381' ' ' VAL . . . . . . . . . . . . . 58.4 t -120.1 107.32 39.81 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.578 -0.701 . . . . 16.34 109.398 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' S' S ' 382' ' ' PRO . . . . . 0.4 ' HA ' ' O ' ' S' ' 336' ' ' ASP . 45.7 Cg_endo -71.26 145.65 49.16 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 O-C-N 123.626 1.329 . . . . 20.94 110.759 -179.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' S' S ' 383' ' ' TYR . . . . . 0.402 ' CZ ' ' HB3' ' S' ' 338' ' ' HIS . 88.3 m-85 -61.08 -53.47 56.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.398 -0.814 . . . . 28.93 109.869 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' S' S ' 384' ' ' ASP . . . . . . . . . . . . . 9.7 t0 . . . . . 0 N--CA 1.49 1.566 0 O-C-N 121.482 -0.761 . . . . 47.03 110.358 -176.083 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' R' R ' 30' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 . . . . . 0 N--CA 1.492 1.67 0 CA-C-O 121.127 0.489 . . . . 43.36 110.247 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' R' R ' 31' ' ' LEU . . . . . . . . . . . . . 65.4 mt -134.86 140.54 45.9 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.293 -0.879 . . . . 22.93 110.332 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' R' R ' 32' ' ' THR . . . . . . . . . . . . . 69.0 m -87.55 110.61 20.48 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.337 -0.852 . . . . 22.34 109.983 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' R' R ' 33' ' ' LEU . . . . . 0.594 HD22 ' CE2' ' R' ' 62' ' ' TYR . 80.2 mt -62.52 -172.74 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.237 -0.915 . . . . 21.39 110.209 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' R' R ' 34' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -74.59 -29.4 61.31 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.375 -0.828 . . . . 34.4 110.41 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' R' R ' 35' ' ' ASN . . . . . . . . . . . . . 48.2 p30 -77.84 -1.74 33.11 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.322 -0.861 . . . . 30.28 110.665 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' R' R ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.1 -16.53 59.4 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.8 -1.32 . . . . 36.25 109.8 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' R' R ' 37' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -59.0 161.81 4.73 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.256 -1.144 . . . . 53.8 110.383 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' R' R ' 38' ' ' LYS . . . . . . . . . . . . . 57.0 mttt -117.86 135.8 53.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.43 -0.794 . . . . 49.91 110.175 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' R' R ' 39' ' ' LYS . . . . . 0.404 ' HG2' ' CZ ' ' R' ' 41' ' ' PHE . 8.1 ttmt -138.77 143.65 39.07 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.427 -0.796 . . . . 35.69 110.241 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' R' R ' 40' ' ' THR . . . . . . . . . . . . . 23.6 m -102.56 127.97 49.41 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.424 -0.798 . . . . 34.84 110.226 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' R' R ' 41' ' ' PHE . . . . . 0.404 ' CZ ' ' HG2' ' R' ' 39' ' ' LYS . 96.6 m-85 -113.09 132.63 55.35 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.386 -0.821 . . . . 34.42 110.21 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' R' R ' 42' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -93.21 140.86 29.06 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.348 -0.845 . . . . 51.46 110.263 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' R' R ' 43' ' ' SER . . . . . . . . . . . . . 54.2 m -70.74 141.83 51.47 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.511 -0.743 . . . . 41.84 110.196 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' R' R ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.78 125.38 29.56 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.347 -0.845 . . . . 33.82 109.984 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' R' R ' 45' ' ' PRO . . . . . 0.425 ' HG2' ' ND2' ' R' ' 77' ' ' ASN . 45.6 Cg_endo -72.11 151.05 55.03 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 123.611 1.321 . . . . 30.27 110.649 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' R' R ' 46' ' ' ASN . . . . . 0.4 ' HA ' ' OD1' ' R' ' 50' ' ' ASN . 52.1 t-20 -124.27 109.95 14.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.456 -0.777 . . . . 35.1 110.011 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' R' R ' 47' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -120.33 -34.84 3.56 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.339 -0.85 . . . . 42.81 110.493 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' R' R ' 48' ' ' HIS . . . . . 0.44 ' NE2' HD11 ' R' ' 80' ' ' LEU . 73.3 m80 -105.79 45.23 0.98 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.221 -0.925 . . . . 49.97 110.216 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' R' R ' 49' ' ' ASP . . . . . . . . . . . . . 37.7 m-20 50.28 34.73 9.26 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.358 -0.839 . . . . 61.32 110.197 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' R' R ' 50' ' ' ASN . . . . . 0.4 ' OD1' ' HA ' ' R' ' 46' ' ' ASN . 15.0 p-10 -86.3 43.78 1.09 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.379 -0.826 . . . . 51.5 110.685 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' R' R ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.1 -46.12 78.73 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.199 -0.938 . . . . 38.77 109.474 179.461 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' R' R ' 52' ' ' TRP . . . . . 0.484 ' CD2' ' N ' ' R' ' 53' ' ' LEU . 68.1 p-90 -58.38 -38.42 77.25 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.455 -0.778 . . . . 26.24 110.055 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' R' R ' 53' ' ' LEU . . . . . 0.484 ' N ' ' CD2' ' R' ' 52' ' ' TRP . 23.1 tp -66.75 -46.62 74.81 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.424 -0.798 . . . . 26.75 109.984 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' R' R ' 54' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -55.35 -41.52 72.65 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.304 -0.872 . . . . 35.02 110.111 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' R' R ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.17 -46.08 91.99 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.448 -0.782 . . . . 24.47 110.157 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' R' R ' 56' ' ' ILE . . . . . 0.431 HG12 HD11 ' R' ' 104' ' ' ILE . 76.0 mt -62.2 -42.28 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.322 -0.861 . . . . 26.03 109.888 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' R' R ' 57' ' ' LEU . . . . . . . . . . . . . 22.4 mt -60.27 -45.63 92.63 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.28 -0.888 . . . . 26.77 109.68 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' R' R ' 58' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -63.87 -46.59 84.25 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.481 -0.762 . . . . 22.32 109.571 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' R' R ' 59' ' ' LEU . . . . . 0.43 ' HA ' ' HE2' ' R' ' 151' ' ' PHE . 24.0 tp -61.34 -37.84 84.73 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.317 -0.864 . . . . 20.55 109.389 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' R' R ' 60' ' ' PHE . . . . . 0.528 ' CE2' HD21 ' R' ' 111' ' ' LEU . 2.8 m-85 -61.05 -44.72 96.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.635 -0.666 . . . . 20.08 109.913 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' R' R ' 61' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -63.18 -36.15 82.66 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.488 -0.758 . . . . 18.8 110.443 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' R' R ' 62' ' ' TYR . . . . . 0.594 ' CE2' HD22 ' R' ' 33' ' ' LEU . 9.1 t80 -63.09 -41.81 99.48 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.234 -0.916 . . . . 26.45 110.199 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' R' R ' 63' ' ' VAL . . . . . 0.406 ' H ' HG22 ' R' ' 63' ' ' VAL . 30.5 m -93.38 20.35 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.422 -0.799 . . . . 29.75 110.252 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' R' R ' 64' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 53.03 75.56 0.24 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.316 -0.865 . . . . 35.52 110.531 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' R' R ' 65' ' ' GLU . . . . . 0.442 ' HG2' ' CD2' ' R' ' 60' ' ' PHE . 14.3 tp10 -116.3 104.06 52.33 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.348 -0.845 . . . . 29.89 109.901 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' R' R ' 66' ' ' PRO . . . . . 0.48 ' HA ' ' HB2' ' R' ' 69' ' ' ASP . 46.3 Cg_endo -73.57 -5.8 17.69 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.775 1.408 . . . . 21.37 111.093 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' R' R ' 67' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -52.13 -61.44 2.27 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.116 -0.99 . . . . 23.85 110.43 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' R' R ' 68' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -98.23 36.58 1.57 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.306 -0.871 . . . . 28.07 110.484 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' R' R ' 69' ' ' ASP . . . . . 0.48 ' HB2' ' HA ' ' R' ' 66' ' ' PRO . 11.7 t0 -72.3 -33.35 67.32 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.23 -0.918 . . . . 43.76 110.097 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' R' R ' 70' ' ' TRP . . . . . 0.477 ' CE2' ' CG2' ' R' ' 71' ' ' VAL . 47.7 p-90 -73.24 -4.03 30.5 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.313 -0.867 . . . . 33.06 110.74 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' R' R ' 71' ' ' VAL . . . . . 0.556 HG11 ' HB2' ' R' ' 82' ' ' ALA . 40.8 t -109.78 -27.41 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.078 -1.014 . . . . 31.7 109.674 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' R' R ' 72' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -86.62 -48.76 8.04 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.347 -0.845 . . . . 33.58 110.288 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' R' R ' 73' ' ' SER . . . . . . . . . . . . . 69.9 m -89.75 51.12 2.01 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.283 -0.886 . . . . 50.82 110.295 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' R' R ' 74' ' ' SER . . . . . . . . . . . . . 15.7 t -125.99 138.27 31.78 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.335 -0.853 . . . . 34.74 110.208 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.31 -25.02 16.02 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.737 1.388 . . . . 35.7 110.341 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' R' R ' 76' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -91.66 153.16 19.87 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.398 -0.814 . . . . 66.48 110.428 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' R' R ' 77' ' ' ASN . . . . . 0.425 ' ND2' ' HG2' ' R' ' 45' ' ' PRO . 22.2 t-20 -81.5 95.2 7.04 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.364 -0.835 . . . . 46.72 110.035 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' R' R ' 78' ' ' LEU . . . . . . . . . . . . . 96.3 mt -96.4 27.91 3.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.385 -0.822 . . . . 37.55 110.22 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' R' R ' 79' ' ' THR . . . . . . . . . . . . . 29.4 m -56.18 -54.64 42.78 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.317 -0.865 . . . . 37.36 110.295 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' R' R ' 80' ' ' LEU . . . . . 0.603 ' HA ' HD12 ' R' ' 83' ' ' ILE . 15.8 mt -60.97 -23.13 65.1 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.351 -0.843 . . . . 35.83 110.478 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' R' R ' 81' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -79.55 -39.08 32.7 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.147 -0.971 . . . . 44.03 110.331 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' R' R ' 82' ' ' ALA . . . . . 0.556 ' HB2' HG11 ' R' ' 71' ' ' VAL . . . -69.5 -28.67 66.25 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.227 -0.921 . . . . 32.54 110.23 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' R' R ' 83' ' ' ILE . . . . . 0.603 HD12 ' HA ' ' R' ' 80' ' ' LEU . 78.2 mt -70.04 -46.1 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.221 -0.925 . . . . 32.02 110.342 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' R' R ' 84' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -55.21 -52.02 64.71 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.232 -0.918 . . . . 34.09 110.607 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' R' R ' 85' ' ' GLN . . . . . 0.533 ' HG2' HD12 ' R' ' 89' ' ' LEU . 31.9 tt0 -54.85 -46.81 74.7 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.203 -0.936 . . . . 25.94 110.269 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' R' R ' 86' ' ' LEU . . . . . . . . . . . . . 23.9 mt -58.74 -43.77 90.33 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.312 -0.867 . . . . 16.2 109.905 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' R' R ' 87' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -65.38 -35.16 80.12 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.529 -0.732 . . . . 49.09 110.251 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' R' R ' 88' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -78.46 -19.03 54.0 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.381 -0.825 . . . . 28.61 110.51 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' R' R ' 89' ' ' LEU . . . . . 0.533 HD12 ' HG2' ' R' ' 85' ' ' GLN . 32.5 mt -96.24 -29.38 14.05 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.261 -0.899 . . . . 26.16 110.167 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' R' R ' 90' ' ' THR . . . . . . . . . . . . . 59.2 p -105.68 -34.66 7.64 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.327 -0.858 . . . . 33.33 109.747 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' R' R ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.91 16.06 58.55 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.835 -1.306 . . . . 31.13 109.835 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' R' R ' 92' ' ' LEU . . . . . . . . . . . . . 97.0 mt -100.07 155.18 17.86 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.112 -1.228 . . . . 42.52 110.266 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' R' R ' 93' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -86.2 91.66 8.52 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.489 -0.757 . . . . 68.46 109.948 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' R' R ' 94' ' ' LEU . . . . . 0.457 ' HB3' ' CZ2' ' R' ' 52' ' ' TRP . 48.2 mt -99.51 53.0 0.94 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.147 -0.971 . . . . 44.63 110.368 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' R' R ' 95' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.54 -38.67 6.37 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.348 -0.845 . . . . 67.16 110.34 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' R' R ' 96' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -113.83 44.11 1.69 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.316 -0.865 . . . . 67.02 110.337 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' R' R ' 97' ' ' GLY . . . . . . . . . . . . . . . 99.2 150.87 26.06 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.598 -1.401 . . . . 49.48 109.598 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' R' R ' 98' ' ' GLY . . . . . . . . . . . . . . . -166.28 159.99 33.42 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.245 -1.542 . . . . 36.57 109.245 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' R' R ' 99' ' ' PRO . . . . . 0.79 ' O ' HG23 ' R' ' 103' ' ' VAL . 44.9 Cg_endo -72.56 121.12 7.15 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 O-C-N 123.703 1.37 . . . . 30.41 110.435 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' R' R ' 100' ' ' PRO . . . . . 0.411 ' HA ' HD11 ' R' ' 56' ' ' ILE . 45.8 Cg_endo -72.27 -31.7 11.39 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.567 1.299 . . . . 29.94 110.506 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' R' R ' 101' ' ' ALA . . . . . 0.476 ' HB2' ' HB3' ' R' ' 178' ' ' LEU . . . -69.97 -38.41 76.06 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.226 -0.921 . . . . 23.64 110.266 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' R' R ' 102' ' ' LEU . . . . . 0.423 HD23 HD21 ' R' ' 106' ' ' ASN . 0.1 OUTLIER -72.69 -40.82 65.94 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.367 -0.833 . . . . 20.31 110.324 -179.718 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' R' R ' 103' ' ' VAL . . . . . 0.79 HG23 ' O ' ' R' ' 99' ' ' PRO . 63.9 t -58.08 -40.15 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.281 -0.887 . . . . 16.33 109.934 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' R' R ' 104' ' ' ILE . . . . . 0.431 HD11 HG12 ' R' ' 56' ' ' ILE . 81.7 mt -71.7 -30.49 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.388 -0.82 . . . . 24.77 109.985 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' R' R ' 105' ' ' TRP . . . . . 0.461 ' O ' ' HD3' ' R' ' 108' ' ' LYS . 70.6 t-105 -82.42 0.81 40.39 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.345 -0.847 . . . . 23.28 110.33 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' R' R ' 106' ' ' ASN . . . . . 0.423 HD21 HD23 ' R' ' 102' ' ' LEU . 6.9 m-80 -105.05 -10.38 17.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.143 -0.973 . . . . 28.26 110.146 179.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' R' R ' 107' ' ' ILE . . . . . . . . . . . . . 36.8 pt -126.81 35.0 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.225 -0.922 . . . . 18.77 110.01 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' R' R ' 108' ' ' LYS . . . . . 0.501 ' HG2' ' HB ' ' R' ' 115' ' ' ILE . 9.2 mtpp -61.06 -48.47 81.59 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.528 -0.733 . . . . 42.5 110.031 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' R' R ' 109' ' ' HIS . . . . . 0.445 ' CD2' ' HG ' ' R' ' 110' ' ' LEU . 50.8 p-80 -66.01 -12.86 58.1 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.503 -0.748 . . . . 20.07 110.696 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' R' R ' 110' ' ' LEU . . . . . 0.445 ' HG ' ' CD2' ' R' ' 109' ' ' HIS . 80.8 mt -94.84 -17.31 22.2 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.145 -0.972 . . . . 15.69 110.181 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' R' R ' 111' ' ' LEU . . . . . 0.528 HD21 ' CE2' ' R' ' 60' ' ' PHE . 10.4 mt -94.1 144.14 25.75 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.341 -0.85 . . . . 25.39 111.004 -179.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' R' R ' 112' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -77.71 -17.36 57.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.451 -0.781 . . . . 53.48 109.846 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' R' R ' 113' ' ' THR . . . . . 0.457 HG22 ' N ' ' R' ' 114' ' ' GLY . 60.5 m -83.72 166.68 17.86 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.251 -0.906 . . . . 14.8 110.22 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' R' R ' 114' ' ' GLY . . . . . 0.457 ' N ' HG22 ' R' ' 113' ' ' THR . . . -97.96 127.16 9.13 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.994 -1.243 . . . . 16.14 109.994 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' R' R ' 115' ' ' ILE . . . . . 0.577 HD13 ' HB ' ' R' ' 124' ' ' VAL . 47.8 mm -109.09 139.36 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.475 -1.015 . . . . 13.46 109.71 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' R' R ' 116' ' ' GLY . . . . . . . . . . . . . . . -152.78 -155.81 7.27 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.964 -1.254 . . . . 23.9 109.964 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' R' R ' 117' ' ' THR . . . . . 0.528 HG22 ' CG2' ' R' ' 126' ' ' VAL . 18.9 p -135.06 -171.46 2.81 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.467 -1.019 . . . . 27.37 110.02 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' R' R ' 118' ' ' ALA . . . . . 0.445 ' HB3' ' OD1' ' R' ' 128' ' ' ASP . . . -56.5 -58.09 9.53 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.337 -0.852 . . . . 18.76 110.064 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' R' R ' 119' ' ' SER . . . . . 0.418 ' HA ' ' CB ' ' R' ' 194' ' ' ALA . 1.1 m -56.54 -40.65 75.46 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.267 -0.896 . . . . 32.35 109.69 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' R' R ' 120' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 -110.02 86.19 4.77 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.458 -0.776 . . . . 27.12 109.643 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' R' R ' 121' ' ' PRO . . . . . 0.482 ' HA ' ' SG ' ' R' ' 125' ' ' CYS . 44.3 Cg_endo -71.26 166.55 28.9 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.817 1.43 . . . . 22.68 111.02 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' R' R ' 122' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' R' ' 121' ' ' PRO . 38.6 t 178.55 -161.67 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.643 -0.661 . . . . 22.99 109.447 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' R' R ' 123' ' ' GLU . . . . . 0.442 ' HG2' HG23 ' R' ' 113' ' ' THR . 2.3 tp10 -56.47 -39.95 74.06 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.211 -0.93 . . . . 36.18 109.673 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' R' R ' 124' ' ' VAL . . . . . 0.577 ' HB ' HD13 ' R' ' 115' ' ' ILE . 84.2 t -142.52 136.43 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.471 -0.768 . . . . 20.64 109.333 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' R' R ' 125' ' ' CYS . . . . . 0.482 ' SG ' ' HA ' ' R' ' 121' ' ' PRO . 83.4 m -140.32 168.16 20.46 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.245 -0.91 . . . . 22.8 111.206 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' R' R ' 126' ' ' VAL . . . . . 0.729 HG12 HG22 ' R' ' 179' ' ' VAL . 35.9 m -122.68 159.75 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.713 -0.617 . . . . 21.24 109.595 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' R' R ' 127' ' ' VAL . . . . . 0.709 HG11 ' O ' ' R' ' 177' ' ' VAL . 30.5 m -70.83 141.83 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.29 -0.881 . . . . 19.77 110.708 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' R' R ' 128' ' ' ASP . . . . . 0.445 ' OD1' ' HB3' ' R' ' 118' ' ' ALA . 53.8 p-10 -137.7 19.42 2.87 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.37 -0.831 . . . . 29.21 110.664 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' R' R ' 129' ' ' GLY . . . . . . . . . . . . . . . 114.08 0.05 24.02 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.967 -1.111 . . . . 33.86 110.403 179.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' R' R ' 130' ' ' THR . . . . . . . . . . . . . 58.7 m -91.91 131.83 36.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.145 -1.209 . . . . 26.41 110.08 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -62.51 120.66 11.53 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.338 -0.852 . . . . 33.08 110.224 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' R' R ' 132' ' ' MET . . . . . 0.435 ' HE1' ' CE2' ' R' ' 180' ' ' PHE . 98.3 mmm -105.16 165.67 10.93 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.558 -0.714 . . . . 30.76 110.472 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' R' R ' 133' ' ' CYS . . . . . 0.411 ' HA ' ' HB3' ' R' ' 174' ' ' PRO . 32.3 m -141.22 158.09 44.36 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.52 -0.737 . . . . 27.0 109.907 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' R' R ' 134' ' ' LEU . . . . . 0.562 HD11 ' O ' ' R' ' 172' ' ' PRO . 0.1 OUTLIER -58.41 -19.76 38.86 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.312 -0.868 . . . . 33.9 110.453 -179.894 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' R' R ' 135' ' ' ALA . . . . . . . . . . . . . . . -92.77 8.18 40.5 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.257 -0.902 . . . . 19.37 110.78 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' R' R ' 136' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -93.72 -21.81 19.11 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.198 -0.939 . . . . 30.47 110.228 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' R' R ' 137' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -149.94 165.28 33.11 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.319 -0.863 . . . . 24.27 110.22 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' R' R ' 138' ' ' HIS . . . . . 0.434 ' HA ' HG23 ' R' ' 154' ' ' VAL . 15.3 p80 -117.73 15.08 14.46 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.429 -0.794 . . . . 20.91 110.459 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' R' R ' 139' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' R' ' 152' ' ' ALA . . . -177.16 152.46 0.88 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.306 -0.871 . . . . 15.69 110.08 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' R' R ' 140' ' ' GLY . . . . . 0.427 ' HA3' ' O ' ' R' ' 179' ' ' VAL . . . 161.74 175.14 32.45 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 110.0 -1.24 . . . . 23.76 110.0 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' R' R ' 141' ' ' ILE . . . . . . . . . . . . . 83.8 mt -95.48 136.58 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.371 -1.076 . . . . 25.3 109.674 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' R' R ' 142' ' ' PHE . . . . . 0.578 ' CD2' ' HB2' ' R' ' 172' ' ' PRO . 82.6 m-85 -120.73 -172.59 2.41 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.27 -0.894 . . . . 30.24 110.512 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' R' R ' 143' ' ' LEU . . . . . 0.743 HD23 ' O ' ' R' ' 148' ' ' HIS . 0.5 OUTLIER -119.81 77.72 1.26 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.43 -0.794 . . . . 32.8 110.301 -179.924 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' R' R ' 144' ' ' LYS . . . . . 0.47 ' HG3' ' CZ2' ' R' ' 170' ' ' TRP . 1.0 OUTLIER -69.54 76.83 0.41 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.363 -0.835 . . . . 49.18 109.728 179.549 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' R' R ' 145' ' ' GLY . . . . . 0.456 ' O ' HD22 ' R' ' 143' ' ' LEU . . . 104.57 179.32 24.74 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.202 -1.559 . . . . 53.87 109.202 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' R' R ' 146' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -88.49 145.83 25.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.369 -1.077 . . . . 68.58 110.006 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' R' R ' 147' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 58.26 36.45 25.68 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.347 -0.845 . . . . 56.62 110.655 179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' R' R ' 148' ' ' HIS . . . . . 0.743 ' O ' HD23 ' R' ' 143' ' ' LEU . 45.1 t60 -158.67 148.09 19.16 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.267 -0.895 . . . . 44.57 110.359 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' R' R ' 149' ' ' ALA . . . . . . . . . . . . . . . -150.27 146.91 27.07 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.484 -0.76 . . . . 33.54 110.072 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' R' R ' 150' ' ' VAL . . . . . . . . . . . . . 34.2 m -142.32 161.51 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.263 -0.898 . . . . 27.61 110.322 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' R' R ' 151' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' R' ' 152' ' ' ALA . 5.9 t80 -86.24 155.63 20.62 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.401 -0.812 . . . . 23.04 109.881 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' R' R ' 152' ' ' ALA . . . . . 0.537 ' N ' ' CD1' ' R' ' 151' ' ' PHE . . . -157.31 151.51 24.83 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.45 -0.781 . . . . 29.61 109.589 179.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' R' R ' 153' ' ' CYS . . . . . . . . . . . . . 26.7 p -154.27 173.6 15.93 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.347 -0.846 . . . . 22.75 110.444 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' R' R ' 154' ' ' VAL . . . . . 0.615 HG22 ' CE2' ' R' ' 159' ' ' TRP . 59.7 t -90.64 117.03 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.425 -0.797 . . . . 23.26 110.061 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' R' R ' 155' ' ' THR . . . . . . . . . . . . . 69.9 p -112.11 -176.6 2.96 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.313 -0.867 . . . . 17.88 110.065 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' R' R ' 156' ' ' SER . . . . . . . . . . . . . 78.5 p -75.98 -3.66 36.86 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.27 -0.894 . . . . 21.83 110.672 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' R' R ' 157' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -118.36 10.53 12.79 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.138 -0.976 . . . . 36.54 110.59 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' R' R ' 158' ' ' GLY . . . . . . . . . . . . . . . 117.92 -162.68 13.01 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.567 -1.413 . . . . 31.74 109.567 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' R' R ' 159' ' ' TRP . . . . . 0.615 ' CE2' HG22 ' R' ' 154' ' ' VAL . 14.7 m95 -86.56 122.45 30.5 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.389 -1.065 . . . . 28.25 110.147 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' R' R ' 160' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -108.45 166.91 10.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.305 -0.872 . . . . 41.24 110.218 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' R' R ' 161' ' ' ALA . . . . . . . . . . . . . . . -143.21 123.48 13.79 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.403 -0.81 . . . . 27.4 110.14 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' R' R ' 162' ' ' ILE . . . . . . . . . . . . . 92.3 mt -87.59 81.14 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.324 -0.86 . . . . 24.27 110.015 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' R' R ' 163' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' R' ' 165' ' ' GLU . 15.3 t0 -72.78 92.41 1.57 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.406 -0.809 . . . . 36.08 110.262 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' R' R ' 164' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 54.07 -88.97 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.564 -0.71 . . . . 46.08 110.603 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' R' R ' 165' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' R' ' 163' ' ' ASP . 29.8 mt-10 -124.72 36.03 4.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.083 -1.011 . . . . 50.94 110.194 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' R' R ' 166' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -135.75 117.33 14.88 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.388 -0.82 . . . . 47.28 110.347 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' R' R ' 167' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -101.1 119.96 39.51 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.427 -0.795 . . . . 40.47 110.132 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' R' R ' 168' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -157.49 158.59 30.76 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.216 -0.927 . . . . 30.21 110.423 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' R' R ' 169' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.79 132.98 19.38 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 O-C-N 123.831 1.437 . . . . 32.76 110.527 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' R' R ' 170' ' ' TRP . . . . . 0.47 ' CZ2' ' HG3' ' R' ' 144' ' ' LYS . 67.0 t90 -159.78 119.37 2.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.384 -0.823 . . . . 32.79 109.909 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' R' R ' 171' ' ' THR . . . . . . . . . . . . . 47.5 m -81.12 112.62 34.35 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.448 -0.783 . . . . 36.92 110.141 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' R' R ' 172' ' ' PRO . . . . . 0.578 ' HB2' ' CD2' ' R' ' 142' ' ' PHE . 48.0 Cg_endo -73.7 158.83 46.62 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.596 1.314 . . . . 33.54 110.545 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' R' R ' 173' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -88.92 144.93 33.64 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.415 -0.803 . . . . 45.76 109.904 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' R' R ' 174' ' ' PRO . . . . . 0.411 ' HB3' ' HA ' ' R' ' 133' ' ' CYS . 46.0 Cg_endo -71.72 -10.34 26.35 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 O-C-N 123.517 1.272 . . . . 29.63 110.497 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' R' R ' 175' ' ' SER . . . . . . . . . . . . . 52.9 p -103.42 -17.63 15.16 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.348 -0.845 . . . . 35.7 110.396 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' R' R ' 176' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -103.48 43.18 1.1 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.213 -0.93 . . . . 39.65 110.4 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' R' R ' 177' ' ' VAL . . . . . 0.709 ' O ' HG11 ' R' ' 127' ' ' VAL . 10.7 p -117.71 127.17 75.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.368 -0.832 . . . . 20.61 110.043 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' R' R ' 178' ' ' LEU . . . . . 0.476 ' HB3' ' HB2' ' R' ' 101' ' ' ALA . 46.1 mt -91.56 -61.24 1.69 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.362 -0.836 . . . . 15.58 109.378 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' R' R ' 179' ' ' VAL . . . . . 0.729 HG22 HG12 ' R' ' 126' ' ' VAL . 67.8 t -114.67 144.69 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.676 -0.64 . . . . 17.4 109.391 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' R' R ' 180' ' ' PHE . . . . . 0.435 ' CE2' ' HE1' ' R' ' 132' ' ' MET . 43.6 p90 -152.17 163.41 39.45 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.268 -0.895 . . . . 20.16 110.529 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' R' R ' 181' ' ' VAL . . . . . . . . . . . . . 66.6 t -113.2 111.49 50.19 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.488 -0.758 . . . . 17.69 109.862 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' R' R ' 182' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.06 149.49 52.61 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 O-C-N 123.606 1.319 . . . . 17.81 110.456 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' R' R ' 183' ' ' TYR . . . . . 0.709 ' O ' ' C ' ' R' ' 184' ' ' ASP . 79.5 m-85 -58.92 175.45 0.28 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.463 -0.773 . . . . 28.01 110.535 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' R' R ' 184' ' ' ASP . . . . . 0.709 ' C ' ' O ' ' R' ' 183' ' ' TYR . 6.1 m-20 -17.71 -82.75 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.313 -0.867 . . . . 58.64 110.271 -178.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' R' R ' 185' ' ' GLN . . . . . . . . . . . . . 49.2 mm-40 . . . . . 0 N--CA 1.503 2.183 0 CA-C-O 121.23 0.538 . . . . 80.42 111.783 179.547 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' R' R ' 193' ' ' LYS . . . . . . . . . . . . . 28.0 mtmt . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 120.888 0.375 . . . . 49.5 110.192 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' R' R ' 194' ' ' ALA . . . . . 0.418 ' CB ' ' HA ' ' R' ' 119' ' ' SER . . . . . . . . 0 N--CA 1.494 1.76 0 O-C-N 121.172 -0.955 . . . . 40.4 110.127 179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' S' S ' 229' ' ' MET . . . . . 0.469 ' HG3' ' N ' ' S' ' 230' ' ' GLU . 3.3 ptt? . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.181 0.515 . . . . 51.83 110.233 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' S' S ' 230' ' ' GLU . . . . . 0.469 ' N ' ' HG3' ' S' ' 229' ' ' MET . 33.2 tt0 -97.29 142.75 28.79 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.432 -0.793 . . . . 54.13 110.196 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' S' S ' 231' ' ' LEU . . . . . . . . . . . . . 68.0 mt -134.12 141.05 46.99 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.352 -0.842 . . . . 33.04 110.334 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' S' S ' 232' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' S' ' 355' ' ' THR . 40.3 m -89.26 103.24 15.88 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.343 -0.848 . . . . 26.92 110.041 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' S' S ' 233' ' ' LEU . . . . . 0.672 HD22 ' CE2' ' S' ' 262' ' ' TYR . 79.7 mt -55.87 179.29 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.531 -0.731 . . . . 13.78 110.543 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' S' S ' 234' ' ' TYR . . . . . 0.448 ' CG ' ' N ' ' S' ' 235' ' ' ASN . 35.5 p90 -65.02 -35.63 81.81 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.426 -0.797 . . . . 26.08 110.189 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' S' S ' 235' ' ' ASN . . . . . 0.448 ' N ' ' CG ' ' S' ' 234' ' ' TYR . 50.6 p30 -74.36 -7.47 52.96 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.345 -0.847 . . . . 20.04 110.531 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' S' S ' 236' ' ' GLY . . . . . . . . . . . . . . . 95.79 -19.96 51.97 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.764 -1.334 . . . . 22.71 109.764 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' S' S ' 237' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -52.95 145.63 12.45 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.258 -1.142 . . . . 35.44 110.235 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' S' S ' 238' ' ' LYS . . . . . . . . . . . . . 44.4 mttt -102.1 127.85 48.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.349 -0.845 . . . . 32.56 110.426 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' S' S ' 239' ' ' LYS . . . . . 0.403 ' HG2' ' CZ ' ' S' ' 241' ' ' PHE . 9.0 ttmt -132.29 144.51 50.64 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.41 -0.806 . . . . 26.68 109.992 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' S' S ' 240' ' ' THR . . . . . . . . . . . . . 51.7 m -102.08 132.17 48.12 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.362 -0.836 . . . . 41.02 110.37 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' S' S ' 241' ' ' PHE . . . . . 0.403 ' CZ ' ' HG2' ' S' ' 239' ' ' LYS . 96.0 m-85 -117.85 137.66 52.63 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.379 -0.826 . . . . 28.62 110.196 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' S' S ' 242' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -96.29 161.87 13.75 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.288 -0.883 . . . . 47.89 110.295 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' S' S ' 243' ' ' SER . . . . . . . . . . . . . 71.9 m -90.64 151.52 21.25 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.362 -0.836 . . . . 45.09 110.309 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' S' S ' 244' ' ' ARG . . . . . . . . . . . . . 1.4 mtp85 -129.85 126.78 22.67 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.415 -0.803 . . . . 42.49 110.199 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' S' S ' 245' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.37 161.0 43.7 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 O-C-N 123.639 1.336 . . . . 35.68 110.507 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' S' S ' 246' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -132.86 97.87 4.15 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.359 -0.838 . . . . 51.88 109.822 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' S' S ' 247' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -110.47 -22.21 11.78 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.378 -0.826 . . . . 53.69 110.664 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' S' S ' 248' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -117.29 43.74 2.26 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.225 -0.922 . . . . 55.79 110.714 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' S' S ' 249' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 48.77 38.41 11.76 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.447 -0.783 . . . . 49.45 110.417 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' S' S ' 250' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -90.61 28.99 1.38 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.526 -0.734 . . . . 36.86 110.358 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' S' S ' 251' ' ' ALA . . . . . . . . . . . . . . . -53.78 -43.18 69.03 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.311 -0.868 . . . . 29.69 109.575 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' S' S ' 252' ' ' TRP . . . . . 0.425 ' CZ2' ' HB3' ' S' ' 294' ' ' LEU . 67.9 p-90 -61.83 -34.01 75.19 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.451 -0.78 . . . . 41.12 109.79 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' S' S ' 253' ' ' LEU . . . . . . . . . . . . . 23.3 tp -70.14 -47.23 62.59 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.433 -0.792 . . . . 24.89 109.906 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' S' S ' 254' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -56.12 -42.41 76.81 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.395 -0.816 . . . . 35.65 109.956 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' S' S ' 255' ' ' ALA . . . . . . . . . . . . . . . -59.63 -48.09 83.02 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.464 -0.773 . . . . 22.73 110.074 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' S' S ' 256' ' ' ILE . . . . . 0.504 HG12 HD11 ' S' ' 304' ' ' ILE . 79.6 mt -62.37 -40.62 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.315 -0.866 . . . . 28.85 109.928 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' S' S ' 257' ' ' LEU . . . . . 0.403 ' CD2' ' HB3' ' S' ' 268' ' ' PHE . 19.2 mt -61.56 -44.45 97.01 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.403 -0.81 . . . . 23.07 110.244 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' S' S ' 258' ' ' GLN . . . . . 0.502 ' HB3' ' CD2' ' S' ' 351' ' ' PHE . 53.1 mm-40 -65.05 -45.37 85.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.384 -0.823 . . . . 29.78 109.918 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' S' S ' 259' ' ' LEU . . . . . 0.419 ' O ' HG22 ' S' ' 263' ' ' VAL . 19.8 tp -58.69 -36.38 74.11 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.291 -0.881 . . . . 17.94 109.435 179.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' S' S ' 260' ' ' PHE . . . . . 0.53 ' CE2' HD21 ' S' ' 311' ' ' LEU . 3.1 m-85 -62.83 -45.27 93.41 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.603 -0.686 . . . . 30.57 109.84 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' S' S ' 261' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -62.12 -29.81 70.59 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.46 -0.775 . . . . 41.34 109.898 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' S' S ' 262' ' ' TYR . . . . . 0.672 ' CE2' HD22 ' S' ' 233' ' ' LEU . 8.6 t80 -71.22 -44.63 64.99 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.41 -0.806 . . . . 26.03 110.085 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' S' S ' 263' ' ' VAL . . . . . 0.419 HG22 ' O ' ' S' ' 259' ' ' LEU . 33.1 m -92.06 18.29 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.352 -0.842 . . . . 22.8 110.373 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' S' S ' 264' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 52.77 70.64 0.55 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.199 -0.938 . . . . 44.03 110.653 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' S' S ' 265' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -111.81 109.12 55.47 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.303 -0.873 . . . . 35.61 109.637 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' S' S ' 266' ' ' PRO . . . . . 0.482 ' HA ' ' HB2' ' S' ' 269' ' ' ASP . 49.2 Cg_endo -75.31 0.39 9.08 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 O-C-N 123.578 1.304 . . . . 37.67 111.753 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' S' S ' 267' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -56.48 -67.73 0.28 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.85 -1.156 . . . . 41.49 110.173 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' S' S ' 268' ' ' PHE . . . . . 0.403 ' HB3' ' CD2' ' S' ' 257' ' ' LEU . 22.6 m-85 -92.86 39.94 1.05 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.148 -0.97 . . . . 50.76 110.132 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' S' S ' 269' ' ' ASP . . . . . 0.482 ' HB2' ' HA ' ' S' ' 266' ' ' PRO . 0.9 OUTLIER -76.1 -33.19 59.49 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.307 -0.87 . . . . 61.86 109.727 179.596 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' S' S ' 270' ' ' TRP . . . . . 0.509 ' CE2' HG23 ' S' ' 271' ' ' VAL . 50.9 p-90 -73.85 -4.41 34.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.322 -0.861 . . . . 39.85 110.46 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' S' S ' 271' ' ' VAL . . . . . 0.509 HG23 ' CE2' ' S' ' 270' ' ' TRP . 46.6 t -109.49 -32.72 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.117 -0.989 . . . . 39.18 110.156 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' S' S ' 272' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -78.6 -36.6 44.06 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.387 -0.821 . . . . 40.02 110.486 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' S' S ' 273' ' ' SER . . . . . . . . . . . . . 71.2 m -103.48 56.16 0.74 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.336 -0.853 . . . . 47.2 110.306 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' S' S ' 274' ' ' SER . . . . . . . . . . . . . 6.9 t -133.06 141.27 40.29 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.336 -0.853 . . . . 47.61 110.14 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' S' S ' 275' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -73.85 -18.83 21.51 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.684 1.36 . . . . 45.28 110.485 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' S' S ' 276' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -99.87 140.87 33.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.238 -0.913 . . . . 57.27 110.317 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' S' S ' 277' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -71.73 97.67 1.8 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.388 -0.82 . . . . 37.28 110.322 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' S' S ' 278' ' ' LEU . . . . . . . . . . . . . 86.8 mt -97.04 33.84 1.85 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.358 -0.839 . . . . 43.88 109.987 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' S' S ' 279' ' ' THR . . . . . . . . . . . . . 75.3 m -64.03 -60.09 3.67 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.424 -0.797 . . . . 50.05 110.347 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' S' S ' 280' ' ' LEU . . . . . 0.728 ' HA ' HD12 ' S' ' 283' ' ' ILE . 13.7 mt -51.59 -39.91 58.84 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.363 -0.836 . . . . 54.12 110.246 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' S' S ' 281' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.42 -49.68 74.5 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.474 -0.766 . . . . 65.28 110.141 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' S' S ' 282' ' ' ALA . . . . . . . . . . . . . . . -58.97 -33.86 71.14 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.466 -0.771 . . . . 46.51 110.555 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' S' S ' 283' ' ' ILE . . . . . 0.728 HD12 ' HA ' ' S' ' 280' ' ' LEU . 85.7 mt -66.37 -50.86 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.273 -0.892 . . . . 47.3 110.087 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' S' S ' 284' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -50.59 -57.56 7.88 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.43 -0.794 . . . . 50.72 110.387 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' S' S ' 285' ' ' GLN . . . . . 0.53 ' HG2' HD12 ' S' ' 289' ' ' LEU . 34.4 tt0 -51.46 -46.32 63.02 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.503 -0.748 . . . . 68.47 110.332 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' S' S ' 286' ' ' LEU . . . . . . . . . . . . . 19.1 mt -59.96 -44.53 94.39 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.42 -0.8 . . . . 36.62 110.312 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' S' S ' 287' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -62.71 -35.26 79.16 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.372 -0.83 . . . . 46.64 110.099 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' S' S ' 288' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -76.24 -21.08 56.79 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.37 -0.831 . . . . 46.45 110.28 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' S' S ' 289' ' ' LEU . . . . . 0.53 HD12 ' HG2' ' S' ' 285' ' ' GLN . 30.8 mt -97.31 -21.75 17.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.286 -0.884 . . . . 35.09 110.487 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' S' S ' 290' ' ' THR . . . . . 0.409 HG22 ' HB3' ' S' ' 306' ' ' ASN . 81.2 p -114.74 -28.45 7.1 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.221 -0.925 . . . . 38.61 110.422 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' S' S ' 291' ' ' GLY . . . . . . . . . . . . . . . 79.43 10.93 85.43 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.823 -1.311 . . . . 36.77 109.823 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' S' S ' 292' ' ' LEU . . . . . . . . . . . . . 84.8 mt -96.44 145.84 25.31 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.226 -1.161 . . . . 35.33 109.726 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' S' S ' 293' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -77.37 102.41 6.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.196 -0.94 . . . . 48.7 110.232 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' S' S ' 294' ' ' LEU . . . . . 0.425 ' HB3' ' CZ2' ' S' ' 252' ' ' TRP . 56.2 mt -106.99 51.74 0.73 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.539 -0.726 . . . . 42.61 110.066 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' S' S ' 295' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -112.51 -11.17 13.65 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.362 -0.836 . . . . 55.49 110.524 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' S' S ' 296' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -144.36 48.53 1.36 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.127 -0.983 . . . . 75.68 110.321 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' S' S ' 297' ' ' GLY . . . . . . . . . . . . . . . 96.87 145.22 18.78 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.511 -1.436 . . . . 49.44 109.511 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' S' S ' 298' ' ' GLY . . . . . . . . . . . . . . . -163.83 156.96 29.05 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.744 -1.342 . . . . 41.11 109.744 -179.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' S' S ' 299' ' ' PRO . . . . . 0.48 ' O ' HG23 ' S' ' 303' ' ' VAL . 47.4 Cg_endo -73.84 118.26 5.36 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 123.943 1.497 . . . . 26.2 110.293 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' S' S ' 300' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.33 -15.38 31.4 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 O-C-N 123.647 1.34 . . . . 21.7 110.675 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' S' S ' 301' ' ' ALA . . . . . . . . . . . . . . . -80.69 -29.31 36.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.238 -0.914 . . . . 31.23 110.182 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' S' S ' 302' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.48 -40.7 18.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.404 -0.81 . . . . 38.99 109.966 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' S' S ' 303' ' ' VAL . . . . . 0.48 HG23 ' O ' ' S' ' 299' ' ' PRO . 56.9 t -60.61 -35.48 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.399 -0.813 . . . . 18.63 110.153 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' S' S ' 304' ' ' ILE . . . . . 0.522 HD12 HG21 ' S' ' 379' ' ' VAL . 86.5 mt -79.43 -23.65 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.449 -0.782 . . . . 25.46 110.124 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' S' S ' 305' ' ' TRP . . . . . 0.41 ' CD2' ' HD3' ' S' ' 308' ' ' LYS . 68.9 t-105 -88.59 -14.69 36.97 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.234 -0.916 . . . . 33.4 110.501 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' S' S ' 306' ' ' ASN . . . . . 0.409 ' HB3' HG22 ' S' ' 290' ' ' THR . 10.4 m-80 -89.61 -13.52 36.96 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.179 -0.95 . . . . 36.97 110.438 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' S' S ' 307' ' ' ILE . . . . . 0.471 HG12 ' O ' ' S' ' 303' ' ' VAL . 36.8 pt -125.14 45.66 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.237 -0.915 . . . . 30.81 110.005 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' S' S ' 308' ' ' LYS . . . . . 0.41 ' HD3' ' CD2' ' S' ' 305' ' ' TRP . 1.5 mtmp? -73.52 -37.71 65.56 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.35 -0.844 . . . . 46.52 110.169 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' S' S ' 309' ' ' HIS . . . . . 0.492 ' CD2' ' HG ' ' S' ' 310' ' ' LEU . 55.6 p-80 -73.25 -8.26 55.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.407 -0.808 . . . . 51.03 110.057 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' S' S ' 310' ' ' LEU . . . . . 0.492 ' HG ' ' CD2' ' S' ' 309' ' ' HIS . 52.8 mt -99.25 -12.91 19.96 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.29 -0.881 . . . . 36.16 109.962 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' S' S ' 311' ' ' LEU . . . . . 0.53 HD21 ' CE2' ' S' ' 260' ' ' PHE . 10.8 mt -97.14 147.77 23.73 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.278 -0.889 . . . . 40.0 110.471 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' S' S ' 312' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -81.58 -16.29 52.08 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.282 -0.886 . . . . 54.18 109.771 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' S' S ' 313' ' ' THR . . . . . 0.825 HG23 ' HG2' ' S' ' 323' ' ' GLU . 92.4 m -87.94 151.64 22.66 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.378 -0.826 . . . . 25.61 110.151 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' S' S ' 314' ' ' GLY . . . . . . . . . . . . . . . -87.88 126.42 8.04 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.815 -1.314 . . . . 25.18 109.815 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' S' S ' 315' ' ' ILE . . . . . 0.67 HD13 ' HB ' ' S' ' 324' ' ' VAL . 50.6 mm -101.62 150.47 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.346 -1.091 . . . . 23.9 109.702 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' S' S ' 316' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' S' ' 325' ' ' CYS . . . -157.13 -159.23 9.36 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 110.021 -1.232 . . . . 23.18 110.021 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' S' S ' 317' ' ' THR . . . . . 0.425 HG22 ' CG2' ' S' ' 326' ' ' VAL . 11.0 p -133.96 -173.04 3.14 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.311 -1.111 . . . . 27.98 109.923 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' S' S ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.57 -56.18 25.19 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.2 -0.937 . . . . 28.1 109.899 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' S' S ' 319' ' ' SER . . . . . . . . . . . . . 1.2 m -59.98 -41.61 92.4 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.321 -0.862 . . . . 37.0 109.621 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' S' S ' 320' ' ' ARG . . . . . . . . . . . . . 12.2 mtm180 -111.67 79.88 2.62 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.481 -0.762 . . . . 52.07 109.657 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' S' S ' 321' ' ' PRO . . . . . 0.443 ' O ' ' HB2' ' S' ' 322' ' ' SER . 43.9 Cg_endo -71.41 171.54 15.98 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.869 1.457 . . . . 38.29 110.9 -179.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' S' S ' 322' ' ' SER . . . . . 0.443 ' HB2' ' O ' ' S' ' 321' ' ' PRO . 41.2 t 178.62 -148.17 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.89 -0.781 . . . . 38.84 108.89 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' S' S ' 323' ' ' GLU . . . . . 0.825 ' HG2' HG23 ' S' ' 313' ' ' THR . 6.7 tp10 -62.82 -40.26 96.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.003 -1.061 . . . . 40.7 109.734 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' S' S ' 324' ' ' VAL . . . . . 0.67 ' HB ' HD13 ' S' ' 315' ' ' ILE . 72.9 t -141.33 134.98 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.427 -0.795 . . . . 20.34 109.5 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' S' S ' 325' ' ' CYS . . . . . 0.462 ' HB2' ' CE1' ' S' ' 380' ' ' PHE . 11.1 m -125.95 172.21 10.11 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.249 -0.907 . . . . 30.63 110.826 -179.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' S' S ' 326' ' ' VAL . . . . . 0.642 HG12 HG22 ' S' ' 379' ' ' VAL . 34.5 m -135.49 142.18 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 109.216 -0.661 . . . . 23.9 109.216 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' S' S ' 327' ' ' VAL . . . . . 0.594 HG11 ' O ' ' S' ' 377' ' ' VAL . 34.5 m -56.29 124.94 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.133 -0.979 . . . . 19.48 110.432 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' S' S ' 328' ' ' ASP . . . . . . . . . . . . . 55.7 p-10 -119.37 11.54 12.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.432 -0.792 . . . . 26.43 110.422 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' S' S ' 329' ' ' GLY . . . . . . . . . . . . . . . 119.67 2.13 13.14 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.074 -1.21 . . . . 31.24 110.074 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' S' S ' 330' ' ' THR . . . . . . . . . . . . . 79.4 m -92.9 130.02 38.63 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.082 -1.246 . . . . 30.05 110.122 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' S' S ' 331' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -56.89 111.53 1.06 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.321 -0.862 . . . . 37.26 109.991 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' S' S ' 332' ' ' MET . . . . . . . . . . . . . 88.1 mmm -94.1 162.49 13.85 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.267 -0.896 . . . . 26.23 110.344 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' S' S ' 333' ' ' CYS . . . . . . . . . . . . . 25.8 m -137.19 150.11 47.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.475 -0.766 . . . . 23.56 110.025 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' S' S ' 334' ' ' LEU . . . . . 0.561 HD11 ' O ' ' S' ' 372' ' ' PRO . 0.1 OUTLIER -52.66 -24.76 9.12 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.289 -0.882 . . . . 28.93 110.5 179.902 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' S' S ' 335' ' ' ALA . . . . . . . . . . . . . . . -89.1 14.49 10.64 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.388 -0.82 . . . . 15.76 110.973 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' S' S ' 336' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -100.48 -17.25 17.24 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.133 -0.979 . . . . 34.92 110.143 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' S' S ' 337' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -152.41 170.83 19.14 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.333 -0.854 . . . . 19.03 110.077 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' S' S ' 338' ' ' HIS . . . . . 0.401 ' HB3' ' CZ ' ' S' ' 383' ' ' TYR . 13.5 p80 -120.65 10.42 11.03 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.333 -0.854 . . . . 18.82 110.479 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' S' S ' 339' ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' S' ' 352' ' ' ALA . . . -175.98 155.16 1.56 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.204 -0.935 . . . . 17.18 110.146 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' S' S ' 340' ' ' GLY . . . . . 0.405 ' CA ' ' O ' ' S' ' 379' ' ' VAL . . . 160.81 173.06 28.94 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.036 -1.226 . . . . 18.33 110.036 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' S' S ' 341' ' ' ILE . . . . . . . . . . . . . 84.2 mt -88.78 138.07 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.489 -1.006 . . . . 18.6 109.787 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' S' S ' 342' ' ' PHE . . . . . 0.493 ' CE2' ' HB3' ' S' ' 352' ' ' ALA . 69.9 m-85 -120.97 -178.43 3.74 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.222 -0.924 . . . . 23.44 110.407 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' S' S ' 343' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.84 93.41 4.19 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.532 -0.73 . . . . 35.59 110.024 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' S' S ' 344' ' ' LYS . . . . . 0.406 ' O ' ' HB3' ' S' ' 348' ' ' HIS . 0.3 OUTLIER -80.87 125.04 29.62 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.301 -0.874 . . . . 38.34 110.067 -179.905 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' S' S ' 345' ' ' GLY . . . . . . . . . . . . . . . 62.75 -130.86 43.17 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 108.874 -1.69 . . . . 53.46 108.874 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' S' S ' 346' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -132.68 150.89 52.1 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.246 -1.149 . . . . 70.91 110.043 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' S' S ' 347' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 53.19 35.44 19.92 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.321 -0.862 . . . . 47.32 110.45 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' S' S ' 348' ' ' HIS . . . . . 0.406 ' HB3' ' O ' ' S' ' 344' ' ' LYS . 46.4 t60 -150.18 155.87 40.56 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.204 -0.935 . . . . 41.72 110.311 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' S' S ' 349' ' ' ALA . . . . . 0.458 ' C ' HG13 ' S' ' 350' ' ' VAL . . . -149.82 151.22 33.17 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.314 -0.866 . . . . 22.91 110.527 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' S' S ' 350' ' ' VAL . . . . . 0.458 HG13 ' C ' ' S' ' 349' ' ' ALA . 34.6 m -149.0 169.67 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.463 -0.773 . . . . 21.09 110.058 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' S' S ' 351' ' ' PHE . . . . . 0.502 ' CD2' ' HB3' ' S' ' 258' ' ' GLN . 10.7 t80 -105.43 143.59 33.38 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.178 -0.951 . . . . 25.03 110.682 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' S' S ' 352' ' ' ALA . . . . . 0.493 ' HB3' ' CE2' ' S' ' 342' ' ' PHE . . . -147.67 151.78 36.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.64 -0.662 . . . . 23.81 109.704 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' S' S ' 353' ' ' CYS . . . . . . . . . . . . . 26.2 p -153.37 164.85 37.42 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.324 -0.86 . . . . 25.66 110.185 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' S' S ' 354' ' ' VAL . . . . . 0.546 HG22 ' CE2' ' S' ' 359' ' ' TRP . 56.6 t -75.94 118.49 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.351 -0.843 . . . . 34.27 110.008 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' S' S ' 355' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' S' ' 232' ' ' THR . 52.5 p -117.86 175.1 5.82 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.196 -0.94 . . . . 25.49 110.327 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' S' S ' 356' ' ' SER . . . . . . . . . . . . . 62.9 p -62.09 -17.75 58.59 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.474 -0.766 . . . . 31.24 110.749 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' S' S ' 357' ' ' ASN . . . . . . . . . . . . . 46.2 m-20 -106.96 14.21 26.74 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.143 -0.973 . . . . 28.61 110.564 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' S' S ' 358' ' ' GLY . . . . . . . . . . . . . . . 111.85 -152.93 17.58 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.979 -1.248 . . . . 22.01 109.979 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' S' S ' 359' ' ' TRP . . . . . 0.546 ' CE2' HG22 ' S' ' 354' ' ' VAL . 15.1 m95 -91.44 116.76 29.11 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.387 -1.067 . . . . 25.54 110.138 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' S' S ' 360' ' ' TYR . . . . . 0.408 ' HA ' ' HA ' ' S' ' 369' ' ' PRO . 1.3 m-85 -103.49 165.83 10.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.318 -0.864 . . . . 40.53 110.108 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' S' S ' 361' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' S' ' 351' ' ' PHE . . . -140.07 130.09 24.86 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.39 -0.819 . . . . 18.04 110.262 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' S' S ' 362' ' ' ILE . . . . . . . . . . . . . 89.0 mt -95.7 83.83 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.307 -0.871 . . . . 15.64 109.984 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' S' S ' 363' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' S' ' 365' ' ' GLU . 11.9 t0 -75.37 94.51 3.07 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.352 -0.843 . . . . 35.03 110.16 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' S' S ' 364' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 54.0 -89.44 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.468 -0.77 . . . . 46.72 110.45 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' S' S ' 365' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' S' ' 363' ' ' ASP . 23.8 mt-10 -122.55 18.99 10.44 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.077 -1.014 . . . . 56.2 110.218 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' S' S ' 366' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -117.82 124.98 49.7 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.303 -0.873 . . . . 51.02 110.418 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' S' S ' 367' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -106.98 127.08 53.13 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.361 -0.837 . . . . 37.59 110.133 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' S' S ' 368' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -165.47 159.61 13.85 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.303 -0.873 . . . . 31.47 110.437 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' S' S ' 369' ' ' PRO . . . . . 0.408 ' HA ' ' HA ' ' S' ' 360' ' ' TYR . 46.6 Cg_endo -72.83 139.57 30.66 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 O-C-N 123.864 1.455 . . . . 28.85 110.536 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' S' S ' 370' ' ' TRP . . . . . . . . . . . . . 67.5 t90 -167.23 113.6 0.76 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.376 -0.827 . . . . 26.94 109.957 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' S' S ' 371' ' ' THR . . . . . . . . . . . . . 59.5 m -74.83 113.04 20.6 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.411 -0.805 . . . . 20.19 110.059 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' S' S ' 372' ' ' PRO . . . . . 0.561 ' O ' HD11 ' S' ' 334' ' ' LEU . 48.2 Cg_endo -73.46 157.16 49.53 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 O-C-N 123.548 1.288 . . . . 28.68 110.613 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' S' S ' 373' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -90.57 147.12 35.68 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.449 -0.782 . . . . 35.72 109.896 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' S' S ' 374' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -76.02 -6.38 17.3 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.669 1.352 . . . . 30.89 110.474 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' S' S ' 375' ' ' SER . . . . . . . . . . . . . 68.5 p -104.32 -16.88 15.02 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.289 -0.882 . . . . 29.41 110.498 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' S' S ' 376' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -106.53 43.09 1.18 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.222 -0.924 . . . . 32.89 110.227 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' S' S ' 377' ' ' VAL . . . . . 0.594 ' O ' HG11 ' S' ' 327' ' ' VAL . 7.2 p -114.68 147.31 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.343 -0.848 . . . . 24.33 110.228 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' S' S ' 378' ' ' LEU . . . . . . . . . . . . . 51.7 mt -116.03 -58.0 2.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.401 -0.812 . . . . 24.37 109.626 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' S' S ' 379' ' ' VAL . . . . . 0.642 HG22 HG12 ' S' ' 326' ' ' VAL . 61.4 t -120.69 132.37 70.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.39 -0.819 . . . . 18.02 109.357 179.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' S' S ' 380' ' ' PHE . . . . . 0.462 ' CE1' ' HB2' ' S' ' 325' ' ' CYS . 14.5 p90 -142.54 174.03 11.0 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.367 -0.833 . . . . 29.35 110.646 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' S' S ' 381' ' ' VAL . . . . . . . . . . . . . 57.8 t -120.09 107.39 39.74 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.51 -0.744 . . . . 16.34 109.394 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' S' S ' 382' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.42 145.65 48.34 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 O-C-N 123.608 1.32 . . . . 20.94 110.775 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' S' S ' 383' ' ' TYR . . . . . 0.401 ' CZ ' ' HB3' ' S' ' 338' ' ' HIS . 88.1 m-85 -61.05 -53.54 55.86 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.335 -0.853 . . . . 28.93 109.823 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' S' S ' 384' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 . . . . . 0 N--CA 1.49 1.547 0 O-C-N 121.361 -0.837 . . . . 47.03 110.408 -176.226 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' R' R ' 30' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 121.177 0.513 . . . . 43.36 110.202 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' R' R ' 31' ' ' LEU . . . . . . . . . . . . . 65.3 mt -134.9 140.53 45.84 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.312 -0.867 . . . . 22.93 110.318 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' R' R ' 32' ' ' THR . . . . . . . . . . . . . 68.3 m -87.46 110.59 20.41 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.4 -0.812 . . . . 22.34 109.986 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' R' R ' 33' ' ' LEU . . . . . 0.596 HD22 ' CE2' ' R' ' 62' ' ' TYR . 80.2 mt -62.46 -172.76 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.33 -0.856 . . . . 21.39 110.148 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' R' R ' 34' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -74.68 -29.4 61.21 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.333 -0.855 . . . . 34.4 110.328 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' R' R ' 35' ' ' ASN . . . . . . . . . . . . . 48.4 p30 -77.7 -1.89 33.41 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.324 -0.86 . . . . 30.28 110.686 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' R' R ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.2 -16.55 59.46 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.776 -1.329 . . . . 36.25 109.776 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' R' R ' 37' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -59.04 161.81 4.79 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.322 -1.105 . . . . 53.8 110.368 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' R' R ' 38' ' ' LYS . . . . . . . . . . . . . 56.9 mttt -117.86 135.76 53.88 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.445 -0.784 . . . . 49.91 110.146 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' R' R ' 39' ' ' LYS . . . . . 0.406 ' HG2' ' CZ ' ' R' ' 41' ' ' PHE . 8.0 ttmt -138.69 143.71 39.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.388 -0.82 . . . . 35.69 110.27 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' R' R ' 40' ' ' THR . . . . . . . . . . . . . 23.6 m -102.6 127.94 49.48 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.387 -0.82 . . . . 34.84 110.223 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' R' R ' 41' ' ' PHE . . . . . 0.406 ' CZ ' ' HG2' ' R' ' 39' ' ' LYS . 96.6 m-85 -113.06 132.62 55.33 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.426 -0.796 . . . . 34.42 110.14 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' R' R ' 42' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -93.28 140.97 28.96 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.335 -0.853 . . . . 51.46 110.264 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' R' R ' 43' ' ' SER . . . . . . . . . . . . . 54.8 m -70.9 141.92 51.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.445 -0.784 . . . . 41.84 110.202 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' R' R ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.77 125.46 29.45 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.311 -0.868 . . . . 33.82 109.932 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' R' R ' 45' ' ' PRO . . . . . 0.423 ' HG2' ' ND2' ' R' ' 77' ' ' ASN . 46.4 Cg_endo -72.17 151.01 54.59 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 O-C-N 123.616 1.324 . . . . 30.27 110.646 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' R' R ' 46' ' ' ASN . . . . . . . . . . . . . 52.2 t-20 -124.21 109.9 13.98 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.545 -0.722 . . . . 35.1 110.088 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' R' R ' 47' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -120.25 -34.92 3.55 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.335 -0.853 . . . . 42.81 110.542 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' R' R ' 48' ' ' HIS . . . . . 0.44 ' NE2' HD11 ' R' ' 80' ' ' LEU . 73.3 m80 -105.74 45.15 0.98 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.322 -0.861 . . . . 49.97 110.223 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' R' R ' 49' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 50.28 34.71 9.23 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.358 -0.839 . . . . 61.32 110.173 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' R' R ' 50' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -86.26 43.77 1.09 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.402 -0.811 . . . . 51.5 110.685 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' R' R ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.12 -46.06 78.87 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.131 -0.981 . . . . 38.77 109.53 179.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' R' R ' 52' ' ' TRP . . . . . 0.484 ' CD2' ' N ' ' R' ' 53' ' ' LEU . 68.3 p-90 -58.43 -38.37 77.32 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.519 -0.738 . . . . 26.24 110.098 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' R' R ' 53' ' ' LEU . . . . . 0.484 ' N ' ' CD2' ' R' ' 52' ' ' TRP . 23.0 tp -66.63 -46.75 74.79 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.4 -0.813 . . . . 26.75 110.016 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' R' R ' 54' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -55.27 -41.57 72.4 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.341 -0.85 . . . . 35.02 110.078 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' R' R ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.19 -46.03 92.14 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.426 -0.796 . . . . 24.47 110.219 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' R' R ' 56' ' ' ILE . . . . . 0.432 HG12 HD11 ' R' ' 104' ' ' ILE . 76.3 mt -62.15 -42.31 94.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.246 -0.909 . . . . 26.03 109.907 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' R' R ' 57' ' ' LEU . . . . . . . . . . . . . 22.3 mt -60.27 -45.68 92.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.4 -0.813 . . . . 26.77 109.661 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' R' R ' 58' ' ' GLN . . . . . . . . . . . . . 57.7 mm-40 -63.87 -46.51 84.64 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.525 -0.734 . . . . 22.32 109.622 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' R' R ' 59' ' ' LEU . . . . . 0.428 ' HA ' ' HE2' ' R' ' 151' ' ' PHE . 24.0 tp -61.45 -37.74 84.64 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.334 -0.854 . . . . 20.55 109.404 179.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' R' R ' 60' ' ' PHE . . . . . 0.529 ' CE2' HD21 ' R' ' 111' ' ' LEU . 2.8 m-85 -61.13 -44.75 96.85 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.631 -0.668 . . . . 20.08 109.866 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' R' R ' 61' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -63.08 -36.19 82.78 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.492 -0.755 . . . . 18.8 110.511 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' R' R ' 62' ' ' TYR . . . . . 0.596 ' CE2' HD22 ' R' ' 33' ' ' LEU . 9.2 t80 -63.14 -41.7 99.33 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.226 -0.921 . . . . 26.45 110.218 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' R' R ' 63' ' ' VAL . . . . . 0.407 ' H ' HG22 ' R' ' 63' ' ' VAL . 30.2 m -93.36 20.27 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.289 -0.882 . . . . 29.75 110.232 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' R' R ' 64' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 52.91 75.61 0.23 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.343 -0.848 . . . . 35.52 110.549 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' R' R ' 65' ' ' GLU . . . . . 0.442 ' HG2' ' CD2' ' R' ' 60' ' ' PHE . 14.2 tp10 -116.3 104.1 52.28 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.44 -0.787 . . . . 29.89 109.9 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' R' R ' 66' ' ' PRO . . . . . 0.482 ' HA ' ' HB2' ' R' ' 69' ' ' ASP . 47.4 Cg_endo -73.55 -5.83 17.74 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.79 1.416 . . . . 21.37 111.07 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' R' R ' 67' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -52.11 -61.56 2.19 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.099 -1.0 . . . . 23.85 110.331 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' R' R ' 68' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -98.12 36.52 1.56 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.275 -0.891 . . . . 28.07 110.442 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' R' R ' 69' ' ' ASP . . . . . 0.482 ' HB2' ' HA ' ' R' ' 66' ' ' PRO . 11.8 t0 -72.3 -33.29 67.3 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.303 -0.873 . . . . 43.76 110.169 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' R' R ' 70' ' ' TRP . . . . . 0.476 ' CE2' ' CG2' ' R' ' 71' ' ' VAL . 47.9 p-90 -73.32 -3.91 29.99 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.34 -0.85 . . . . 33.06 110.739 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' R' R ' 71' ' ' VAL . . . . . 0.556 HG11 ' HB2' ' R' ' 82' ' ' ALA . 40.7 t -109.78 -27.49 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.237 -0.914 . . . . 31.7 109.658 179.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' R' R ' 72' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -86.55 -48.87 7.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.407 -0.808 . . . . 33.58 110.267 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' R' R ' 73' ' ' SER . . . . . . . . . . . . . 70.1 m -89.73 51.01 1.99 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.29 -0.881 . . . . 50.82 110.362 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' R' R ' 74' ' ' SER . . . . . . . . . . . . . 15.8 t -125.89 138.37 31.92 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.303 -0.873 . . . . 34.74 110.206 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.38 -24.99 15.89 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 O-C-N 123.669 1.352 . . . . 35.7 110.32 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' R' R ' 76' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -91.7 153.16 19.85 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.422 -0.799 . . . . 66.48 110.342 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' R' R ' 77' ' ' ASN . . . . . 0.423 ' ND2' ' HG2' ' R' ' 45' ' ' PRO . 22.2 t-20 -81.47 95.23 7.03 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.374 -0.829 . . . . 46.72 110.061 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' R' R ' 78' ' ' LEU . . . . . . . . . . . . . 96.3 mt -96.46 27.97 3.55 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.473 -0.767 . . . . 37.55 110.191 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' R' R ' 79' ' ' THR . . . . . . . . . . . . . 29.8 m -56.31 -54.5 44.72 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.26 -0.9 . . . . 37.36 110.283 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' R' R ' 80' ' ' LEU . . . . . 0.604 ' HA ' HD12 ' R' ' 83' ' ' ILE . 15.9 mt -61.04 -23.09 65.17 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.439 -0.788 . . . . 35.83 110.513 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' R' R ' 81' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -79.48 -39.21 32.69 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.162 -0.961 . . . . 44.03 110.349 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' R' R ' 82' ' ' ALA . . . . . 0.556 ' HB2' HG11 ' R' ' 71' ' ' VAL . . . -69.4 -28.64 66.34 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.315 -0.866 . . . . 32.54 110.278 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' R' R ' 83' ' ' ILE . . . . . 0.604 HD12 ' HA ' ' R' ' 80' ' ' LEU . 78.2 mt -70.11 -46.09 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.307 -0.87 . . . . 32.02 110.265 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' R' R ' 84' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -55.19 -52.07 64.51 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.222 -0.924 . . . . 34.09 110.596 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' R' R ' 85' ' ' GLN . . . . . 0.532 ' HG2' HD12 ' R' ' 89' ' ' LEU . 31.9 tt0 -54.81 -46.89 74.59 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.279 -0.888 . . . . 25.94 110.299 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' R' R ' 86' ' ' LEU . . . . . . . . . . . . . 24.0 mt -58.6 -43.85 89.67 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.339 -0.851 . . . . 16.2 109.936 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' R' R ' 87' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -65.37 -35.17 80.15 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.435 -0.791 . . . . 49.09 110.304 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' R' R ' 88' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -78.47 -19.03 53.99 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.257 -0.902 . . . . 28.61 110.556 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' R' R ' 89' ' ' LEU . . . . . 0.532 HD12 ' HG2' ' R' ' 85' ' ' GLN . 32.5 mt -96.18 -29.41 14.07 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.207 -0.933 . . . . 26.16 110.197 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' R' R ' 90' ' ' THR . . . . . . . . . . . . . 59.0 p -105.7 -34.55 7.67 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.303 -0.873 . . . . 33.33 109.778 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' R' R ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.78 16.02 58.81 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.857 -1.297 . . . . 31.13 109.857 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' R' R ' 92' ' ' LEU . . . . . . . . . . . . . 97.0 mt -100.04 155.24 17.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.153 -1.204 . . . . 42.52 110.229 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' R' R ' 93' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -86.28 91.63 8.54 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.538 -0.726 . . . . 68.46 109.991 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' R' R ' 94' ' ' LEU . . . . . 0.459 ' HB3' ' CZ2' ' R' ' 52' ' ' TRP . 48.2 mt -99.47 52.99 0.94 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.183 -0.948 . . . . 44.63 110.282 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' R' R ' 95' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.48 -38.67 6.38 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.263 -0.898 . . . . 67.16 110.381 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' R' R ' 96' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -113.91 44.25 1.68 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.364 -0.835 . . . . 67.02 110.278 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' R' R ' 97' ' ' GLY . . . . . . . . . . . . . . . 99.12 150.77 26.02 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.653 -1.379 . . . . 49.48 109.653 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' R' R ' 98' ' ' GLY . . . . . . . . . . . . . . . -166.28 159.99 33.42 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.329 -1.508 . . . . 36.57 109.329 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' R' R ' 99' ' ' PRO . . . . . 0.79 ' O ' HG23 ' R' ' 103' ' ' VAL . 44.6 Cg_endo -72.55 121.11 7.15 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 123.732 1.385 . . . . 30.41 110.413 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' R' R ' 100' ' ' PRO . . . . . 0.411 ' HA ' HD11 ' R' ' 56' ' ' ILE . 45.4 Cg_endo -72.39 -31.5 11.31 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 O-C-N 123.621 1.327 . . . . 29.94 110.514 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' R' R ' 101' ' ' ALA . . . . . 0.475 ' HB2' ' HB3' ' R' ' 178' ' ' LEU . . . -70.05 -38.45 75.81 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.293 -0.879 . . . . 23.64 110.294 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' R' R ' 102' ' ' LEU . . . . . 0.425 HD23 HD21 ' R' ' 106' ' ' ASN . 0.1 OUTLIER -72.6 -40.69 66.32 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.353 -0.842 . . . . 20.31 110.446 -179.801 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' R' R ' 103' ' ' VAL . . . . . 0.79 HG23 ' O ' ' R' ' 99' ' ' PRO . 63.7 t -58.19 -40.08 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.225 -0.922 . . . . 16.33 109.986 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' R' R ' 104' ' ' ILE . . . . . 0.432 HD11 HG12 ' R' ' 56' ' ' ILE . 81.8 mt -71.71 -30.54 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.427 -0.796 . . . . 24.77 109.968 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' R' R ' 105' ' ' TRP . . . . . 0.462 ' O ' ' HD3' ' R' ' 108' ' ' LYS . 70.5 t-105 -82.43 0.89 40.08 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.277 -0.89 . . . . 23.28 110.26 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' R' R ' 106' ' ' ASN . . . . . 0.425 HD21 HD23 ' R' ' 102' ' ' LEU . 6.9 m-80 -105.11 -10.45 17.14 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.173 -0.954 . . . . 28.26 110.03 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' R' R ' 107' ' ' ILE . . . . . . . . . . . . . 36.8 pt -126.85 34.98 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.184 -0.947 . . . . 18.77 110.026 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' R' R ' 108' ' ' LYS . . . . . 0.501 ' HG2' ' HB ' ' R' ' 115' ' ' ILE . 9.3 mtpp -61.02 -48.49 81.57 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.493 -0.755 . . . . 42.5 110.031 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' R' R ' 109' ' ' HIS . . . . . 0.445 ' CD2' ' HG ' ' R' ' 110' ' ' LEU . 50.7 p-80 -66.02 -12.87 58.26 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.511 -0.743 . . . . 20.07 110.698 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' R' R ' 110' ' ' LEU . . . . . 0.445 ' HG ' ' CD2' ' R' ' 109' ' ' HIS . 80.1 mt -94.72 -17.38 22.26 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.071 -1.018 . . . . 15.69 110.183 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' R' R ' 111' ' ' LEU . . . . . 0.529 HD21 ' CE2' ' R' ' 60' ' ' PHE . 10.4 mt -94.05 144.12 25.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.324 -0.86 . . . . 25.39 111.052 -179.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' R' R ' 112' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -77.67 -17.43 57.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.518 -0.739 . . . . 53.48 109.84 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' R' R ' 113' ' ' THR . . . . . 0.459 HG22 ' N ' ' R' ' 114' ' ' GLY . 60.2 m -83.69 166.62 17.94 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.282 -0.886 . . . . 14.8 110.186 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' R' R ' 114' ' ' GLY . . . . . 0.459 ' N ' HG22 ' R' ' 113' ' ' THR . . . -97.99 127.12 9.12 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.968 -1.253 . . . . 16.14 109.968 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' R' R ' 115' ' ' ILE . . . . . 0.578 HD13 ' HB ' ' R' ' 124' ' ' VAL . 47.8 mm -109.07 139.32 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.534 -0.98 . . . . 13.46 109.71 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' R' R ' 116' ' ' GLY . . . . . . . . . . . . . . . -152.76 -155.78 7.26 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.926 -1.27 . . . . 23.9 109.926 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' R' R ' 117' ' ' THR . . . . . 0.529 HG22 ' CG2' ' R' ' 126' ' ' VAL . 18.7 p -135.06 -171.4 2.79 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.418 -1.048 . . . . 27.37 110.095 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' R' R ' 118' ' ' ALA . . . . . 0.444 ' HB3' ' OD1' ' R' ' 128' ' ' ASP . . . -56.59 -58.05 9.73 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.276 -0.89 . . . . 18.76 110.057 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' R' R ' 119' ' ' SER . . . . . 0.556 ' HA ' ' CB ' ' R' ' 194' ' ' ALA . 1.1 m -56.59 -40.53 75.43 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.332 -0.855 . . . . 32.35 109.784 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' R' R ' 120' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 -110.12 86.3 4.97 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.435 -0.791 . . . . 27.12 109.675 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' R' R ' 121' ' ' PRO . . . . . 0.482 ' HA ' ' SG ' ' R' ' 125' ' ' CYS . 44.7 Cg_endo -71.26 166.51 29.03 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.874 1.46 . . . . 22.68 111.035 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' R' R ' 122' ' ' SER . . . . . 0.438 ' HB2' ' O ' ' R' ' 121' ' ' PRO . 38.4 t 178.57 -161.69 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.584 -0.698 . . . . 22.99 109.436 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' R' R ' 123' ' ' GLU . . . . . 0.44 ' HG2' HG23 ' R' ' 113' ' ' THR . 2.3 tp10 -56.42 -39.94 73.89 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.225 -0.922 . . . . 36.18 109.732 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' R' R ' 124' ' ' VAL . . . . . 0.578 ' HB ' HD13 ' R' ' 115' ' ' ILE . 84.1 t -142.55 136.42 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.484 -0.76 . . . . 20.64 109.314 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' R' R ' 125' ' ' CYS . . . . . 0.482 ' SG ' ' HA ' ' R' ' 121' ' ' PRO . 83.2 m -140.28 168.19 20.37 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.187 -0.946 . . . . 22.8 111.193 -179.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' R' R ' 126' ' ' VAL . . . . . 0.729 HG12 HG22 ' R' ' 179' ' ' VAL . 35.9 m -122.78 159.83 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.828 -0.545 . . . . 21.24 109.647 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' R' R ' 127' ' ' VAL . . . . . 0.71 HG11 ' O ' ' R' ' 177' ' ' VAL . 30.5 m -70.86 141.83 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.337 -0.852 . . . . 19.77 110.695 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' R' R ' 128' ' ' ASP . . . . . 0.444 ' OD1' ' HB3' ' R' ' 118' ' ' ALA . 53.9 p-10 -137.7 19.44 2.87 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.319 -0.863 . . . . 29.21 110.665 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' R' R ' 129' ' ' GLY . . . . . . . . . . . . . . . 113.97 0.06 24.18 Favored Glycine 0 N--CA 1.492 2.399 0 C-N-CA 119.993 -1.098 . . . . 33.86 110.487 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' R' R ' 130' ' ' THR . . . . . . . . . . . . . 58.9 m -91.9 131.85 36.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.202 -1.176 . . . . 26.41 109.998 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -62.53 120.72 11.66 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.408 -0.808 . . . . 33.08 110.284 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' R' R ' 132' ' ' MET . . . . . 0.435 ' HE1' ' CE2' ' R' ' 180' ' ' PHE . 98.4 mmm -105.22 165.67 10.94 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.425 -0.797 . . . . 30.76 110.445 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' R' R ' 133' ' ' CYS . . . . . 0.41 ' HA ' ' HB3' ' R' ' 174' ' ' PRO . 31.7 m -141.17 158.21 44.21 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.493 -0.754 . . . . 27.0 109.912 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' R' R ' 134' ' ' LEU . . . . . 0.564 HD11 ' O ' ' R' ' 172' ' ' PRO . 0.1 OUTLIER -58.48 -19.8 40.09 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.362 -0.836 . . . . 33.9 110.407 -179.837 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' R' R ' 135' ' ' ALA . . . . . . . . . . . . . . . -92.74 8.14 40.57 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.282 -0.887 . . . . 19.37 110.78 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' R' R ' 136' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -93.71 -21.72 19.17 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.255 -0.903 . . . . 30.47 110.272 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' R' R ' 137' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -149.98 165.42 32.74 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.314 -0.866 . . . . 24.27 110.189 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' R' R ' 138' ' ' HIS . . . . . 0.433 ' HA ' HG23 ' R' ' 154' ' ' VAL . 15.2 p80 -117.86 15.11 14.35 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.398 -0.814 . . . . 20.91 110.459 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' R' R ' 139' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' R' ' 152' ' ' ALA . . . -177.14 152.44 0.89 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.278 -0.889 . . . . 15.69 110.098 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' R' R ' 140' ' ' GLY . . . . . 0.427 ' HA3' ' O ' ' R' ' 179' ' ' VAL . . . 161.8 175.15 32.52 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.998 -1.241 . . . . 23.76 109.998 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' R' R ' 141' ' ' ILE . . . . . . . . . . . . . 83.5 mt -95.49 136.54 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.514 -0.992 . . . . 25.3 109.718 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' R' R ' 142' ' ' PHE . . . . . 0.576 ' CD2' ' HB2' ' R' ' 172' ' ' PRO . 82.6 m-85 -120.7 -172.58 2.41 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.26 -0.9 . . . . 30.24 110.511 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' R' R ' 143' ' ' LEU . . . . . 0.743 HD23 ' O ' ' R' ' 148' ' ' HIS . 0.5 OUTLIER -119.79 77.71 1.26 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.437 -0.789 . . . . 32.8 110.321 -179.908 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' R' R ' 144' ' ' LYS . . . . . 0.47 ' HG3' ' CZ2' ' R' ' 170' ' ' TRP . 1.0 OUTLIER -69.58 76.86 0.42 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.369 -0.832 . . . . 49.18 109.625 179.626 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' R' R ' 145' ' ' GLY . . . . . 0.458 ' O ' HD22 ' R' ' 143' ' ' LEU . . . 104.55 179.31 24.76 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.174 -1.571 . . . . 53.87 109.174 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' R' R ' 146' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -88.53 145.85 25.5 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.253 -1.145 . . . . 68.58 110.023 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' R' R ' 147' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 58.17 36.57 25.92 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.288 -0.883 . . . . 56.62 110.633 179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' R' R ' 148' ' ' HIS . . . . . 0.743 ' O ' HD23 ' R' ' 143' ' ' LEU . 45.0 t60 -158.67 148.12 19.17 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.229 -0.92 . . . . 44.57 110.372 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' R' R ' 149' ' ' ALA . . . . . . . . . . . . . . . -150.27 146.89 27.06 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.45 -0.781 . . . . 33.54 110.091 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' R' R ' 150' ' ' VAL . . . . . . . . . . . . . 34.2 m -142.34 161.5 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.273 -0.892 . . . . 27.61 110.318 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' R' R ' 151' ' ' PHE . . . . . 0.538 ' CD1' ' N ' ' R' ' 152' ' ' ALA . 5.9 t80 -86.19 155.62 20.66 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.41 -0.806 . . . . 23.04 109.867 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' R' R ' 152' ' ' ALA . . . . . 0.538 ' N ' ' CD1' ' R' ' 151' ' ' PHE . . . -157.28 151.51 24.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.409 -0.807 . . . . 29.61 109.612 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' R' R ' 153' ' ' CYS . . . . . . . . . . . . . 26.7 p -154.29 173.62 15.92 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.227 -0.921 . . . . 22.75 110.507 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' R' R ' 154' ' ' VAL . . . . . 0.614 HG22 ' CE2' ' R' ' 159' ' ' TRP . 59.7 t -90.64 117.03 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.322 -0.861 . . . . 23.26 110.042 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' R' R ' 155' ' ' THR . . . . . . . . . . . . . 70.5 p -112.17 -176.66 2.98 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.361 -0.837 . . . . 17.88 110.025 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' R' R ' 156' ' ' SER . . . . . . . . . . . . . 78.6 p -75.96 -3.66 36.78 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.32 -0.863 . . . . 21.83 110.707 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' R' R ' 157' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -118.27 10.38 12.81 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.159 -0.963 . . . . 36.54 110.635 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' R' R ' 158' ' ' GLY . . . . . . . . . . . . . . . 117.94 -162.68 13.02 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.556 -1.417 . . . . 31.74 109.556 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' R' R ' 159' ' ' TRP . . . . . 0.614 ' CE2' HG22 ' R' ' 154' ' ' VAL . 14.7 m95 -86.56 122.44 30.49 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.389 -1.065 . . . . 28.25 110.147 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' R' R ' 160' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -108.47 167.03 10.33 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.404 -0.81 . . . . 41.24 110.175 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' R' R ' 161' ' ' ALA . . . . . . . . . . . . . . . -143.23 123.48 13.77 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.344 -0.847 . . . . 27.4 110.173 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' R' R ' 162' ' ' ILE . . . . . . . . . . . . . 92.0 mt -87.62 81.13 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.343 -0.848 . . . . 24.27 110.101 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' R' R ' 163' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' R' ' 165' ' ' GLU . 15.3 t0 -72.84 92.42 1.59 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.518 -0.739 . . . . 36.08 110.254 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' R' R ' 164' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 54.15 -89.0 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.463 -0.773 . . . . 46.08 110.574 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' R' R ' 165' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' R' ' 163' ' ' ASP . 29.7 mt-10 -124.76 36.03 4.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.088 -1.007 . . . . 50.94 110.192 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' R' R ' 166' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -135.82 117.23 14.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.4 -0.812 . . . . 47.28 110.34 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' R' R ' 167' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -100.94 119.96 39.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.457 -0.777 . . . . 40.47 110.172 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' R' R ' 168' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -157.6 158.54 30.61 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.213 -0.929 . . . . 30.21 110.399 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' R' R ' 169' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.81 132.99 19.36 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.931 1.49 . . . . 32.76 110.505 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' R' R ' 170' ' ' TRP . . . . . 0.47 ' CZ2' ' HG3' ' R' ' 144' ' ' LYS . 66.9 t90 -159.78 119.37 2.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.383 -0.823 . . . . 32.79 109.909 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' R' R ' 171' ' ' THR . . . . . . . . . . . . . 46.9 m -81.1 112.58 33.94 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.471 -0.768 . . . . 36.92 110.197 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' R' R ' 172' ' ' PRO . . . . . 0.576 ' HB2' ' CD2' ' R' ' 142' ' ' PHE . 46.5 Cg_endo -73.69 158.87 46.6 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.634 1.334 . . . . 33.54 110.504 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' R' R ' 173' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -88.93 144.97 33.67 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.358 -0.839 . . . . 45.76 109.882 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' R' R ' 174' ' ' PRO . . . . . 0.41 ' HB3' ' HA ' ' R' ' 133' ' ' CYS . 45.5 Cg_endo -71.71 -10.41 26.47 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.614 1.323 . . . . 29.63 110.507 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' R' R ' 175' ' ' SER . . . . . . . . . . . . . 53.0 p -103.44 -17.55 15.19 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.293 -0.88 . . . . 35.7 110.37 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' R' R ' 176' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -103.56 43.32 1.09 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.25 -0.906 . . . . 39.65 110.379 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' R' R ' 177' ' ' VAL . . . . . 0.71 ' O ' HG11 ' R' ' 127' ' ' VAL . 10.4 p -117.86 127.08 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.324 -0.86 . . . . 20.61 110.07 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' R' R ' 178' ' ' LEU . . . . . 0.475 ' HB3' ' HB2' ' R' ' 101' ' ' ALA . 45.6 mt -91.45 -61.31 1.68 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.361 -0.837 . . . . 15.58 109.395 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' R' R ' 179' ' ' VAL . . . . . 0.729 HG22 HG12 ' R' ' 126' ' ' VAL . 68.3 t -114.59 144.78 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.621 -0.674 . . . . 17.4 109.409 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' R' R ' 180' ' ' PHE . . . . . 0.435 ' CE2' ' HE1' ' R' ' 132' ' ' MET . 43.5 p90 -152.21 163.34 39.6 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.328 -0.858 . . . . 20.16 110.474 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' R' R ' 181' ' ' VAL . . . . . . . . . . . . . 66.3 t -113.16 111.48 50.29 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.467 -0.771 . . . . 17.69 109.833 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' R' R ' 182' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.03 149.52 52.9 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.532 1.28 . . . . 17.81 110.423 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' R' R ' 183' ' ' TYR . . . . . 0.739 ' O ' ' C ' ' R' ' 184' ' ' ASP . 79.0 m-85 -59.03 175.47 0.28 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.43 -0.794 . . . . 28.01 110.539 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' R' R ' 184' ' ' ASP . . . . . 0.739 ' C ' ' O ' ' R' ' 183' ' ' TYR . 1.0 OUTLIER -11.78 -75.82 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.452 -0.78 . . . . 58.64 110.296 -177.936 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' R' R ' 185' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 . . . . . 0 N--CA 1.503 2.177 0 CA-C-O 121.247 0.546 . . . . 80.42 111.757 179.236 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' R' R ' 193' ' ' LYS . . . . . . . . . . . . . 14.3 ptmt . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 120.895 0.379 . . . . 49.5 110.179 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' R' R ' 194' ' ' ALA . . . . . 0.556 ' CB ' ' HA ' ' R' ' 119' ' ' SER . . . . . . . . 0 N--CA 1.496 1.869 0 O-C-N 121.141 -0.975 . . . . 40.4 110.079 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' S' S ' 229' ' ' MET . . . . . . . . . . . . . 1.5 tpt . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.226 0.536 . . . . 51.83 110.21 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' S' S ' 230' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -97.27 142.75 28.78 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.372 -0.83 . . . . 54.13 110.22 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' S' S ' 231' ' ' LEU . . . . . . . . . . . . . 67.9 mt -134.06 141.07 47.05 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.363 -0.836 . . . . 33.04 110.299 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' S' S ' 232' ' ' THR . . . . . 0.407 ' O ' ' HA ' ' S' ' 355' ' ' THR . 40.0 m -89.27 103.27 15.91 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.345 -0.847 . . . . 26.92 110.093 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' S' S ' 233' ' ' LEU . . . . . 0.667 HD22 ' CE2' ' S' ' 262' ' ' TYR . 79.8 mt -55.84 179.29 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.476 -0.765 . . . . 13.78 110.491 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' S' S ' 234' ' ' TYR . . . . . 0.444 ' CG ' ' N ' ' S' ' 235' ' ' ASN . 35.4 p90 -65.12 -35.61 81.67 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.354 -0.841 . . . . 26.08 110.119 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' S' S ' 235' ' ' ASN . . . . . 0.444 ' N ' ' CG ' ' S' ' 234' ' ' TYR . 50.7 p30 -74.28 -7.5 53.0 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.377 -0.827 . . . . 20.04 110.506 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' S' S ' 236' ' ' GLY . . . . . . . . . . . . . . . 95.81 -20.01 51.79 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.747 -1.341 . . . . 22.71 109.747 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' S' S ' 237' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -52.96 145.74 12.26 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.182 -1.187 . . . . 35.44 110.165 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' S' S ' 238' ' ' LYS . . . . . . . . . . . . . 44.4 mttt -102.17 127.9 48.91 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.397 -0.814 . . . . 32.56 110.374 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' S' S ' 239' ' ' LYS . . . . . 0.405 ' HG2' ' CZ ' ' S' ' 241' ' ' PHE . 9.0 ttmt -132.27 144.52 50.66 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.373 -0.829 . . . . 26.68 109.959 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' S' S ' 240' ' ' THR . . . . . . . . . . . . . 52.5 m -102.05 132.22 48.04 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.339 -0.851 . . . . 41.02 110.305 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' S' S ' 241' ' ' PHE . . . . . 0.405 ' CZ ' ' HG2' ' S' ' 239' ' ' LYS . 96.0 m-85 -117.98 137.67 52.7 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.346 -0.846 . . . . 28.62 110.169 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' S' S ' 242' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -96.36 161.78 13.78 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.451 -0.781 . . . . 47.89 110.224 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' S' S ' 243' ' ' SER . . . . . . . . . . . . . 72.4 m -90.65 151.52 21.24 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.333 -0.854 . . . . 45.09 110.225 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' S' S ' 244' ' ' ARG . . . . . . . . . . . . . 1.4 mtp85 -129.76 126.74 22.71 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.335 -0.853 . . . . 42.49 110.274 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' S' S ' 245' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.31 161.0 43.83 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 123.603 1.317 . . . . 35.68 110.503 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' S' S ' 246' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -132.89 97.88 4.15 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.323 -0.861 . . . . 51.88 109.821 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' S' S ' 247' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -110.47 -22.21 11.78 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.317 -0.865 . . . . 53.69 110.636 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' S' S ' 248' ' ' HIS . . . . . . . . . . . . . 76.5 m80 -117.26 43.75 2.26 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.235 -0.916 . . . . 55.79 110.774 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' S' S ' 249' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 48.8 38.36 11.72 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.459 -0.775 . . . . 49.45 110.382 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' S' S ' 250' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -90.62 29.05 1.37 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.462 -0.773 . . . . 36.86 110.277 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' S' S ' 251' ' ' ALA . . . . . . . . . . . . . . . -53.84 -43.21 69.28 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.244 -0.91 . . . . 29.69 109.577 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' S' S ' 252' ' ' TRP . . . . . 0.428 ' CZ2' ' HB3' ' S' ' 294' ' ' LEU . 67.9 p-90 -61.77 -33.86 74.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.508 -0.745 . . . . 41.12 109.89 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' S' S ' 253' ' ' LEU . . . . . 0.407 ' N ' ' CD2' ' S' ' 252' ' ' TRP . 23.2 tp -70.12 -47.26 62.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.412 -0.805 . . . . 24.89 110.025 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' S' S ' 254' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -56.1 -42.47 76.82 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.419 -0.801 . . . . 35.65 110.03 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' S' S ' 255' ' ' ALA . . . . . . . . . . . . . . . -59.49 -48.25 82.37 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.438 -0.789 . . . . 22.73 110.1 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' S' S ' 256' ' ' ILE . . . . . 0.502 HG12 HD11 ' S' ' 304' ' ' ILE . 80.1 mt -62.25 -40.65 88.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.289 -0.882 . . . . 28.85 110.02 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' S' S ' 257' ' ' LEU . . . . . . . . . . . . . 19.1 mt -61.54 -44.53 96.87 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.365 -0.834 . . . . 23.07 110.144 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' S' S ' 258' ' ' GLN . . . . . 0.498 ' HB3' ' CD2' ' S' ' 351' ' ' PHE . 53.3 mm-40 -65.01 -45.39 85.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.389 -0.82 . . . . 29.78 109.92 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' S' S ' 259' ' ' LEU . . . . . 0.425 ' O ' HG22 ' S' ' 263' ' ' VAL . 19.8 tp -58.66 -36.42 74.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.43 -0.794 . . . . 17.94 109.444 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' S' S ' 260' ' ' PHE . . . . . 0.534 ' CE2' HD21 ' S' ' 311' ' ' LEU . 3.1 m-85 -62.79 -45.22 93.64 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.647 -0.658 . . . . 30.57 109.849 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' S' S ' 261' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -62.16 -29.77 70.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.509 -0.744 . . . . 41.34 109.979 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' S' S ' 262' ' ' TYR . . . . . 0.667 ' CE2' HD22 ' S' ' 233' ' ' LEU . 8.7 t80 -71.19 -44.71 64.92 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.433 -0.792 . . . . 26.03 110.074 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' S' S ' 263' ' ' VAL . . . . . 0.425 HG22 ' O ' ' S' ' 259' ' ' LEU . 33.1 m -92.02 18.28 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.438 -0.788 . . . . 22.8 110.355 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' S' S ' 264' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 52.7 70.76 0.54 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.287 -0.883 . . . . 44.03 110.604 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' S' S ' 265' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -111.84 109.22 55.33 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.295 -0.878 . . . . 35.61 109.628 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' S' S ' 266' ' ' PRO . . . . . 0.476 ' HA ' ' HB2' ' S' ' 269' ' ' ASP . 48.8 Cg_endo -75.33 0.4 9.08 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 123.55 1.289 . . . . 37.67 111.807 -179.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' S' S ' 267' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -56.48 -67.69 0.28 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.764 -1.21 . . . . 41.49 110.199 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' S' S ' 268' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -92.9 39.89 1.05 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.159 -0.963 . . . . 50.76 110.047 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' S' S ' 269' ' ' ASP . . . . . 0.476 ' HB2' ' HA ' ' S' ' 266' ' ' PRO . 0.9 OUTLIER -76.02 -33.29 59.67 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.426 -0.796 . . . . 61.86 109.762 179.534 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' S' S ' 270' ' ' TRP . . . . . 0.508 ' CE2' HG23 ' S' ' 271' ' ' VAL . 50.9 p-90 -73.83 -4.27 33.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.298 -0.876 . . . . 39.85 110.527 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' S' S ' 271' ' ' VAL . . . . . 0.508 HG23 ' CE2' ' S' ' 270' ' ' TRP . 46.4 t -109.67 -32.62 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.146 -0.971 . . . . 39.18 110.065 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' S' S ' 272' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -78.71 -36.5 43.33 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.35 -0.844 . . . . 40.02 110.524 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' S' S ' 273' ' ' SER . . . . . . . . . . . . . 71.2 m -103.49 56.03 0.74 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.295 -0.878 . . . . 47.2 110.369 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' S' S ' 274' ' ' SER . . . . . . . . . . . . . 6.9 t -133.01 141.26 40.3 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.329 -0.857 . . . . 47.61 110.113 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' S' S ' 275' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.77 -18.86 21.68 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 O-C-N 123.633 1.333 . . . . 45.28 110.547 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' S' S ' 276' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -99.96 140.85 33.58 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.327 -0.858 . . . . 57.27 110.248 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' S' S ' 277' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -71.76 97.69 1.82 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.396 -0.815 . . . . 37.28 110.251 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' S' S ' 278' ' ' LEU . . . . . . . . . . . . . 86.4 mt -96.93 33.74 1.84 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.39 -0.819 . . . . 43.88 110.037 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' S' S ' 279' ' ' THR . . . . . . . . . . . . . 76.3 m -64.02 -60.15 3.6 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.436 -0.79 . . . . 50.05 110.269 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' S' S ' 280' ' ' LEU . . . . . 0.739 ' HA ' HD12 ' S' ' 283' ' ' ILE . 13.6 mt -51.53 -39.98 58.77 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.314 -0.866 . . . . 54.12 110.241 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' S' S ' 281' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.27 -49.75 74.43 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.494 -0.754 . . . . 65.28 110.174 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' S' S ' 282' ' ' ALA . . . . . . . . . . . . . . . -58.95 -33.91 71.15 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.44 -0.788 . . . . 46.51 110.554 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' S' S ' 283' ' ' ILE . . . . . 0.739 HD12 ' HA ' ' S' ' 280' ' ' LEU . 85.6 mt -66.3 -50.88 64.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.319 -0.863 . . . . 47.3 110.125 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' S' S ' 284' ' ' LYS . . . . . . . . . . . . . 33.8 tttp -50.6 -57.57 7.88 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.318 -0.864 . . . . 50.72 110.344 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' S' S ' 285' ' ' GLN . . . . . 0.518 ' HG2' HD12 ' S' ' 289' ' ' LEU . 34.4 tt0 -51.47 -46.33 63.07 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.465 -0.772 . . . . 68.47 110.257 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' S' S ' 286' ' ' LEU . . . . . . . . . . . . . 19.2 mt -60.02 -44.56 94.5 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.372 -0.83 . . . . 36.62 110.275 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' S' S ' 287' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -62.7 -35.22 79.0 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.289 -0.882 . . . . 46.64 110.1 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' S' S ' 288' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -76.31 -20.96 56.78 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.4 -0.812 . . . . 46.45 110.34 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' S' S ' 289' ' ' LEU . . . . . 0.518 HD12 ' HG2' ' S' ' 285' ' ' GLN . 30.7 mt -97.38 -21.69 17.05 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.302 -0.874 . . . . 35.09 110.494 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' S' S ' 290' ' ' THR . . . . . 0.406 HG22 ' HB3' ' S' ' 306' ' ' ASN . 81.2 p -114.76 -28.49 7.08 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.325 -0.859 . . . . 38.61 110.406 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' S' S ' 291' ' ' GLY . . . . . . . . . . . . . . . 79.35 11.08 85.33 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.9 -1.28 . . . . 36.77 109.9 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' S' S ' 292' ' ' LEU . . . . . . . . . . . . . 84.7 mt -96.51 145.82 25.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.286 -1.126 . . . . 35.33 109.722 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' S' S ' 293' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -77.35 102.34 6.73 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.194 -0.941 . . . . 48.7 110.273 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' S' S ' 294' ' ' LEU . . . . . 0.428 ' HB3' ' CZ2' ' S' ' 252' ' ' TRP . 56.1 mt -106.96 51.72 0.73 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.51 -0.744 . . . . 42.61 110.085 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' S' S ' 295' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -112.43 -11.27 13.67 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.274 -0.891 . . . . 55.49 110.56 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' S' S ' 296' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -144.24 48.55 1.37 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.187 -0.946 . . . . 75.68 110.319 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' S' S ' 297' ' ' GLY . . . . . . . . . . . . . . . 96.88 145.18 18.72 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.505 -1.438 . . . . 49.44 109.505 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' S' S ' 298' ' ' GLY . . . . . . . . . . . . . . . -163.85 156.98 29.09 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.823 -1.311 . . . . 41.11 109.823 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' S' S ' 299' ' ' PRO . . . . . 0.493 ' O ' HG23 ' S' ' 303' ' ' VAL . 47.7 Cg_endo -73.73 118.21 5.36 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 O-C-N 123.941 1.495 . . . . 26.2 110.314 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' S' S ' 300' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.23 -15.42 31.72 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 123.538 1.283 . . . . 21.7 110.684 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' S' S ' 301' ' ' ALA . . . . . . . . . . . . . . . -80.73 -29.33 36.37 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.259 -0.9 . . . . 31.23 110.091 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' S' S ' 302' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.58 -40.57 18.91 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.512 -0.742 . . . . 38.99 109.953 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' S' S ' 303' ' ' VAL . . . . . 0.493 HG23 ' O ' ' S' ' 299' ' ' PRO . 58.5 t -60.68 -35.48 64.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.372 -0.83 . . . . 18.63 110.177 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' S' S ' 304' ' ' ILE . . . . . 0.518 HD12 HG21 ' S' ' 379' ' ' VAL . 86.3 mt -79.39 -23.58 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.418 -0.801 . . . . 25.46 110.177 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' S' S ' 305' ' ' TRP . . . . . 0.414 ' CD2' ' HD3' ' S' ' 308' ' ' LYS . 68.8 t-105 -88.67 -14.62 36.92 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.194 -0.942 . . . . 33.4 110.5 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' S' S ' 306' ' ' ASN . . . . . 0.406 ' HB3' HG22 ' S' ' 290' ' ' THR . 10.4 m-80 -89.7 -13.57 36.6 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.237 -0.915 . . . . 36.97 110.391 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' S' S ' 307' ' ' ILE . . . . . 0.473 HG12 ' O ' ' S' ' 303' ' ' VAL . 36.9 pt -125.03 45.67 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.276 -0.89 . . . . 30.81 110.036 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' S' S ' 308' ' ' LYS . . . . . 0.414 ' HD3' ' CD2' ' S' ' 305' ' ' TRP . 1.5 mtmp? -73.58 -37.72 65.39 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.366 -0.834 . . . . 46.52 110.1 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' S' S ' 309' ' ' HIS . . . . . 0.498 ' CD2' ' HG ' ' S' ' 310' ' ' LEU . 55.6 p-80 -73.27 -8.2 54.79 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.333 -0.854 . . . . 51.03 110.105 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' S' S ' 310' ' ' LEU . . . . . 0.498 ' HG ' ' CD2' ' S' ' 309' ' ' HIS . 53.2 mt -99.32 -12.87 19.94 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.265 -0.897 . . . . 36.16 109.973 179.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' S' S ' 311' ' ' LEU . . . . . 0.534 HD21 ' CE2' ' S' ' 260' ' ' PHE . 10.8 mt -97.14 147.88 23.61 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.421 -0.8 . . . . 40.0 110.431 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' S' S ' 312' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -81.65 -16.28 51.89 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.273 -0.892 . . . . 54.18 109.69 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' S' S ' 313' ' ' THR . . . . . 0.808 HG23 ' HG2' ' S' ' 323' ' ' GLU . 92.8 m -87.92 151.57 22.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.329 -0.857 . . . . 25.61 110.117 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' S' S ' 314' ' ' GLY . . . . . . . . . . . . . . . -87.81 126.4 8.03 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.861 -1.296 . . . . 25.18 109.861 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' S' S ' 315' ' ' ILE . . . . . 0.666 HD13 ' HB ' ' S' ' 324' ' ' VAL . 50.7 mm -101.69 150.45 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.407 -1.055 . . . . 23.9 109.703 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' S' S ' 316' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' S' ' 325' ' ' CYS . . . -157.04 -159.25 9.37 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.982 -1.247 . . . . 23.18 109.982 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' S' S ' 317' ' ' THR . . . . . 0.423 HG22 ' CG2' ' S' ' 326' ' ' VAL . 11.0 p -133.94 -173.04 3.14 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.446 -1.032 . . . . 27.98 109.949 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' S' S ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.52 -56.2 24.94 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.142 -0.974 . . . . 28.1 109.939 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' S' S ' 319' ' ' SER . . . . . . . . . . . . . 1.2 m -59.99 -41.62 92.43 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.405 -0.81 . . . . 37.0 109.673 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' S' S ' 320' ' ' ARG . . . . . . . . . . . . . 12.2 mtm180 -111.68 79.89 2.64 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.592 -0.692 . . . . 52.07 109.666 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' S' S ' 321' ' ' PRO . . . . . 0.447 ' O ' ' HB2' ' S' ' 322' ' ' SER . 44.1 Cg_endo -71.31 171.52 15.93 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.876 1.461 . . . . 38.29 110.966 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' S' S ' 322' ' ' SER . . . . . 0.447 ' HB2' ' O ' ' S' ' 321' ' ' PRO . 41.3 t 178.65 -148.13 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.927 -0.768 . . . . 38.84 108.927 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' S' S ' 323' ' ' GLU . . . . . 0.808 ' HG2' HG23 ' S' ' 313' ' ' THR . 6.7 tp10 -62.84 -40.29 96.96 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.011 -1.055 . . . . 40.7 109.724 179.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' S' S ' 324' ' ' VAL . . . . . 0.666 ' HB ' HD13 ' S' ' 315' ' ' ILE . 72.9 t -141.28 135.03 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.416 -0.802 . . . . 20.34 109.456 179.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' S' S ' 325' ' ' CYS . . . . . 0.462 ' HB2' ' CE1' ' S' ' 380' ' ' PHE . 11.3 m -126.03 172.26 10.12 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.258 -0.901 . . . . 30.63 110.805 -179.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' S' S ' 326' ' ' VAL . . . . . 0.641 HG12 HG22 ' S' ' 379' ' ' VAL . 34.6 m -135.56 142.24 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 109.189 -0.671 . . . . 23.9 109.189 179.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' S' S ' 327' ' ' VAL . . . . . 0.593 HG11 ' O ' ' S' ' 377' ' ' VAL . 34.5 m -56.27 124.93 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.037 -1.04 . . . . 19.48 110.437 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' S' S ' 328' ' ' ASP . . . . . . . . . . . . . 55.6 p-10 -119.36 11.49 12.23 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.467 -0.77 . . . . 26.43 110.403 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' S' S ' 329' ' ' GLY . . . . . . . . . . . . . . . 119.63 2.24 13.14 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.043 -1.223 . . . . 31.24 110.043 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' S' S ' 330' ' ' THR . . . . . . . . . . . . . 80.9 m -93.02 129.93 38.78 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.044 -1.268 . . . . 30.05 110.111 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' S' S ' 331' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -56.73 111.49 1.03 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.262 -0.899 . . . . 37.26 110.02 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' S' S ' 332' ' ' MET . . . . . . . . . . . . . 88.1 mmm -94.11 162.64 13.79 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.285 -0.884 . . . . 26.23 110.345 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' S' S ' 333' ' ' CYS . . . . . . . . . . . . . 25.3 m -137.34 150.07 47.46 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.487 -0.758 . . . . 23.56 109.96 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' S' S ' 334' ' ' LEU . . . . . 0.558 HD11 ' O ' ' S' ' 372' ' ' PRO . 0.1 OUTLIER -52.58 -24.89 9.1 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.33 -0.856 . . . . 28.93 110.46 179.916 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' S' S ' 335' ' ' ALA . . . . . . . . . . . . . . . -88.99 14.44 10.57 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.302 -0.874 . . . . 15.76 110.957 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' S' S ' 336' ' ' ASP . . . . . 0.403 ' O ' ' HA ' ' S' ' 382' ' ' PRO . 70.7 m-20 -100.48 -17.19 17.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.166 -0.959 . . . . 34.92 110.206 179.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' S' S ' 337' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -152.37 170.84 19.1 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.382 -0.824 . . . . 19.03 110.095 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' S' S ' 338' ' ' HIS . . . . . 0.401 ' HB3' ' CZ ' ' S' ' 383' ' ' TYR . 13.5 p80 -120.71 10.34 10.97 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.365 -0.834 . . . . 18.82 110.484 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' S' S ' 339' ' ' ALA . . . . . 0.412 ' HA ' ' O ' ' S' ' 352' ' ' ALA . . . -176.01 155.17 1.55 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.289 -0.882 . . . . 17.18 110.131 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' S' S ' 340' ' ' GLY . . . . . 0.401 ' HA3' ' O ' ' S' ' 379' ' ' VAL . . . 160.85 173.07 29.0 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.01 -1.236 . . . . 18.33 110.01 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' S' S ' 341' ' ' ILE . . . . . . . . . . . . . 83.7 mt -88.77 138.1 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.523 -0.986 . . . . 18.6 109.862 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' S' S ' 342' ' ' PHE . . . . . 0.488 ' CE2' ' HB3' ' S' ' 352' ' ' ALA . 70.0 m-85 -120.93 -178.48 3.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.184 -0.947 . . . . 23.44 110.447 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' S' S ' 343' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.9 93.41 4.18 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.428 -0.795 . . . . 35.59 110.06 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' S' S ' 344' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.93 125.01 29.59 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.268 -0.895 . . . . 38.34 110.054 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' S' S ' 345' ' ' GLY . . . . . . . . . . . . . . . 62.91 -130.88 42.76 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 108.821 -1.712 . . . . 53.46 108.821 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' S' S ' 346' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -132.73 150.85 52.11 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.214 -1.168 . . . . 70.91 110.07 179.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' S' S ' 347' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 53.28 35.43 20.12 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.307 -0.871 . . . . 47.32 110.374 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' S' S ' 348' ' ' HIS . . . . . . . . . . . . . 46.6 t60 -150.15 155.83 40.52 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.248 -0.908 . . . . 41.72 110.346 179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' S' S ' 349' ' ' ALA . . . . . 0.452 ' C ' HG13 ' S' ' 350' ' ' VAL . . . -149.74 151.28 33.36 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.33 -0.856 . . . . 22.91 110.544 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' S' S ' 350' ' ' VAL . . . . . 0.452 HG13 ' C ' ' S' ' 349' ' ' ALA . 34.6 m -149.06 169.64 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.448 -0.782 . . . . 21.09 110.06 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' S' S ' 351' ' ' PHE . . . . . 0.498 ' CD2' ' HB3' ' S' ' 258' ' ' GLN . 10.8 t80 -105.4 143.62 33.32 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.26 -0.9 . . . . 25.03 110.687 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' S' S ' 352' ' ' ALA . . . . . 0.488 ' HB3' ' CE2' ' S' ' 342' ' ' PHE . . . -147.74 151.72 36.54 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.58 -0.7 . . . . 23.81 109.75 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' S' S ' 353' ' ' CYS . . . . . . . . . . . . . 26.3 p -153.29 164.97 37.16 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.302 -0.874 . . . . 25.66 110.245 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' S' S ' 354' ' ' VAL . . . . . 0.553 HG22 ' CE2' ' S' ' 359' ' ' TRP . 58.0 t -76.15 118.56 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.4 -0.812 . . . . 34.27 109.941 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' S' S ' 355' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' S' ' 232' ' ' THR . 51.7 p -117.85 175.09 5.82 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.199 -0.938 . . . . 25.49 110.29 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' S' S ' 356' ' ' SER . . . . . . . . . . . . . 62.1 p -62.17 -17.65 58.65 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.465 -0.772 . . . . 31.24 110.743 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' S' S ' 357' ' ' ASN . . . . . . . . . . . . . 46.0 m-20 -107.02 14.2 26.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.154 -0.966 . . . . 28.61 110.611 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' S' S ' 358' ' ' GLY . . . . . . . . . . . . . . . 111.88 -152.88 17.6 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.997 -1.241 . . . . 22.01 109.997 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' S' S ' 359' ' ' TRP . . . . . 0.553 ' CE2' HG22 ' S' ' 354' ' ' VAL . 15.5 m95 -91.36 116.64 29.0 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.33 -1.1 . . . . 25.54 110.205 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' S' S ' 360' ' ' TYR . . . . . 0.426 ' HA ' ' HA ' ' S' ' 369' ' ' PRO . 1.3 m-85 -103.47 165.75 10.85 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.338 -0.852 . . . . 40.53 110.105 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' S' S ' 361' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' S' ' 351' ' ' PHE . . . -139.97 130.08 25.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.37 -0.831 . . . . 18.04 110.333 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' S' S ' 362' ' ' ILE . . . . . . . . . . . . . 88.8 mt -95.59 83.65 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.316 -0.865 . . . . 15.64 110.054 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' S' S ' 363' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' S' ' 365' ' ' GLU . 11.9 t0 -75.25 94.45 2.99 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.334 -0.854 . . . . 35.03 110.241 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' S' S ' 364' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 54.03 -89.42 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.484 -0.76 . . . . 46.72 110.547 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' S' S ' 365' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' S' ' 363' ' ' ASP . 23.8 mt-10 -122.6 19.06 10.4 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.048 -1.032 . . . . 56.2 110.251 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' S' S ' 366' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -118.01 125.0 49.52 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.207 -0.933 . . . . 51.02 110.308 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' S' S ' 367' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -106.94 127.05 53.09 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.355 -0.841 . . . . 37.59 110.155 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' S' S ' 368' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -165.4 159.52 13.97 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.253 -0.904 . . . . 31.47 110.461 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' S' S ' 369' ' ' PRO . . . . . 0.426 ' HA ' ' HA ' ' S' ' 360' ' ' TYR . 45.6 Cg_endo -72.91 139.58 30.42 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.869 1.457 . . . . 28.85 110.495 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' S' S ' 370' ' ' TRP . . . . . . . . . . . . . 67.6 t90 -167.13 113.63 0.77 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.463 -0.773 . . . . 26.94 109.973 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' S' S ' 371' ' ' THR . . . . . . . . . . . . . 59.6 m -74.84 113.02 20.41 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.338 -0.851 . . . . 20.19 109.986 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' S' S ' 372' ' ' PRO . . . . . 0.558 ' O ' HD11 ' S' ' 334' ' ' LEU . 46.5 Cg_endo -73.58 157.08 49.15 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 O-C-N 123.573 1.301 . . . . 28.68 110.546 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' S' S ' 373' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -90.52 147.08 35.65 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.436 -0.79 . . . . 35.72 109.987 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' S' S ' 374' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -75.95 -6.25 17.21 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.687 1.362 . . . . 30.89 110.533 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' S' S ' 375' ' ' SER . . . . . . . . . . . . . 68.9 p -104.4 -16.94 14.97 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.288 -0.882 . . . . 29.41 110.484 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' S' S ' 376' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -106.54 43.05 1.19 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.285 -0.884 . . . . 32.89 110.257 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' S' S ' 377' ' ' VAL . . . . . 0.593 ' O ' HG11 ' S' ' 327' ' ' VAL . 7.3 p -114.72 147.29 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.314 -0.866 . . . . 24.33 110.17 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' S' S ' 378' ' ' LEU . . . . . . . . . . . . . 52.1 mt -115.97 -58.02 2.15 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.386 -0.821 . . . . 24.37 109.623 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' S' S ' 379' ' ' VAL . . . . . 0.641 HG22 HG12 ' S' ' 326' ' ' VAL . 62.0 t -120.64 132.4 70.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.452 -0.78 . . . . 18.02 109.44 179.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' S' S ' 380' ' ' PHE . . . . . 0.462 ' CE1' ' HB2' ' S' ' 325' ' ' CYS . 14.2 p90 -142.59 173.97 11.06 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.375 -0.828 . . . . 29.35 110.665 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' S' S ' 381' ' ' VAL . . . . . . . . . . . . . 58.1 t -120.12 107.34 39.76 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.493 -0.755 . . . . 16.34 109.382 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' S' S ' 382' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' S' ' 336' ' ' ASP . 46.0 Cg_endo -71.28 145.6 48.95 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 O-C-N 123.669 1.352 . . . . 20.94 110.79 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' S' S ' 383' ' ' TYR . . . . . 0.401 ' CZ ' ' HB3' ' S' ' 338' ' ' HIS . 88.3 m-85 -61.05 -53.42 57.36 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.37 -0.831 . . . . 28.93 109.912 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' S' S ' 384' ' ' ASP . . . . . . . . . . . . . 27.4 t0 . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.362 -0.836 . . . . 47.03 110.358 -176.558 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' R' R ' 30' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.133 0.492 . . . . 43.36 110.308 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' R' R ' 31' ' ' LEU . . . . . . . . . . . . . 65.5 mt -134.87 140.67 45.98 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.338 -0.851 . . . . 22.93 110.271 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' R' R ' 32' ' ' THR . . . . . . . . . . . . . 71.1 m -87.7 110.61 20.56 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.352 -0.843 . . . . 22.34 109.935 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' R' R ' 33' ' ' LEU . . . . . 0.594 HD22 ' CE2' ' R' ' 62' ' ' TYR . 80.1 mt -62.39 -172.78 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.274 -0.891 . . . . 21.39 110.209 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' R' R ' 34' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -74.6 -29.52 61.34 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.333 -0.855 . . . . 34.4 110.365 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' R' R ' 35' ' ' ASN . . . . . . . . . . . . . 48.4 p30 -77.65 -1.95 33.51 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.348 -0.845 . . . . 30.28 110.689 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' R' R ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.28 -16.55 59.53 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.698 -1.361 . . . . 36.25 109.698 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' R' R ' 37' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -58.95 161.75 4.73 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.314 -1.11 . . . . 53.8 110.344 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' R' R ' 38' ' ' LYS . . . . . . . . . . . . . 56.9 mttt -117.83 135.76 53.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.315 -0.866 . . . . 49.91 110.142 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' R' R ' 39' ' ' LYS . . . . . 0.404 ' HG2' ' CZ ' ' R' ' 41' ' ' PHE . 8.1 ttmt -138.69 143.66 39.24 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.388 -0.82 . . . . 35.69 110.19 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' R' R ' 40' ' ' THR . . . . . . . . . . . . . 23.7 m -102.56 127.98 49.41 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.387 -0.82 . . . . 34.84 110.193 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' R' R ' 41' ' ' PHE . . . . . 0.404 ' CZ ' ' HG2' ' R' ' 39' ' ' LYS . 96.6 m-85 -113.09 132.71 55.32 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.402 -0.811 . . . . 34.42 110.11 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' R' R ' 42' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -93.24 140.89 29.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.346 -0.846 . . . . 51.46 110.247 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' R' R ' 43' ' ' SER . . . . . . . . . . . . . 53.9 m -70.74 141.91 51.47 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.502 -0.749 . . . . 41.84 110.196 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' R' R ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.75 125.37 29.58 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.263 -0.898 . . . . 33.82 109.986 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' R' R ' 45' ' ' PRO . . . . . 0.425 ' HG2' ' ND2' ' R' ' 77' ' ' ASN . 45.5 Cg_endo -72.16 151.05 54.74 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.543 1.286 . . . . 30.27 110.649 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' R' R ' 46' ' ' ASN . . . . . 0.4 ' HA ' ' OD1' ' R' ' 50' ' ' ASN . 52.1 t-20 -124.28 109.91 13.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.478 -0.764 . . . . 35.1 110.004 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' R' R ' 47' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -120.32 -34.93 3.54 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.217 -0.927 . . . . 42.81 110.466 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' R' R ' 48' ' ' HIS . . . . . 0.44 ' NE2' HD11 ' R' ' 80' ' ' LEU . 73.2 m80 -105.7 45.18 0.98 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.239 -0.913 . . . . 49.97 110.201 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' R' R ' 49' ' ' ASP . . . . . . . . . . . . . 37.6 m-20 50.28 34.66 9.17 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.341 -0.849 . . . . 61.32 110.195 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' R' R ' 50' ' ' ASN . . . . . 0.4 ' OD1' ' HA ' ' R' ' 46' ' ' ASN . 15.0 p-10 -86.24 43.83 1.09 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.423 -0.798 . . . . 51.5 110.719 -179.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' R' R ' 51' ' ' ALA . . . . . . . . . . . . . . . -66.12 -46.11 78.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.276 -0.89 . . . . 38.77 109.541 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' R' R ' 52' ' ' TRP . . . . . 0.483 ' CD2' ' N ' ' R' ' 53' ' ' LEU . 68.2 p-90 -58.39 -38.37 77.2 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.525 -0.734 . . . . 26.24 110.114 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' R' R ' 53' ' ' LEU . . . . . 0.483 ' N ' ' CD2' ' R' ' 52' ' ' TRP . 23.2 tp -66.72 -46.7 74.63 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.373 -0.83 . . . . 26.75 109.958 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' R' R ' 54' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -55.27 -41.55 72.38 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.405 -0.809 . . . . 35.02 110.142 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' R' R ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.17 -46.11 91.86 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.337 -0.852 . . . . 24.47 110.145 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' R' R ' 56' ' ' ILE . . . . . 0.433 HG12 HD11 ' R' ' 104' ' ' ILE . 76.4 mt -62.17 -42.24 94.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.332 -0.855 . . . . 26.03 109.924 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' R' R ' 57' ' ' LEU . . . . . . . . . . . . . 22.5 mt -60.24 -45.71 92.31 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.364 -0.835 . . . . 26.77 109.658 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' R' R ' 58' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -63.9 -46.57 84.25 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.508 -0.745 . . . . 22.32 109.559 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' R' R ' 59' ' ' LEU . . . . . 0.43 ' HA ' ' HE2' ' R' ' 151' ' ' PHE . 23.8 tp -61.43 -37.71 84.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.306 -0.871 . . . . 20.55 109.424 179.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' R' R ' 60' ' ' PHE . . . . . 0.528 ' CE2' HD21 ' R' ' 111' ' ' LEU . 2.8 m-85 -61.08 -44.69 96.98 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.62 -0.675 . . . . 20.08 109.95 179.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' R' R ' 61' ' ' ARG . . . . . . . . . . . . . 5.6 tpt180 -63.22 -36.18 82.81 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.397 -0.814 . . . . 18.8 110.41 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' R' R ' 62' ' ' TYR . . . . . 0.594 ' CE2' HD22 ' R' ' 33' ' ' LEU . 9.1 t80 -63.03 -41.8 99.62 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.13 -0.981 . . . . 26.45 110.248 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' R' R ' 63' ' ' VAL . . . . . 0.407 ' H ' HG22 ' R' ' 63' ' ' VAL . 30.7 m -93.35 20.3 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.238 -0.914 . . . . 29.75 110.221 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' R' R ' 64' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 53.02 75.56 0.24 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.322 -0.861 . . . . 35.52 110.541 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' R' R ' 65' ' ' GLU . . . . . 0.442 ' HG2' ' CD2' ' R' ' 60' ' ' PHE . 14.3 tp10 -116.28 104.01 52.41 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.348 -0.845 . . . . 29.89 109.893 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' R' R ' 66' ' ' PRO . . . . . 0.482 ' HA ' ' HB2' ' R' ' 69' ' ' ASP . 46.7 Cg_endo -73.58 -5.75 17.6 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.875 1.46 . . . . 21.37 111.111 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' R' R ' 67' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -52.17 -61.5 2.23 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.054 -1.029 . . . . 23.85 110.314 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' R' R ' 68' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -98.14 36.48 1.57 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.314 -0.866 . . . . 28.07 110.466 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' R' R ' 69' ' ' ASP . . . . . 0.482 ' HB2' ' HA ' ' R' ' 66' ' ' PRO . 11.7 t0 -72.25 -33.34 67.43 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.387 -0.821 . . . . 43.76 110.088 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' R' R ' 70' ' ' TRP . . . . . 0.476 ' CE2' ' CG2' ' R' ' 71' ' ' VAL . 47.8 p-90 -73.32 -3.94 30.2 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.34 -0.85 . . . . 33.06 110.71 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' R' R ' 71' ' ' VAL . . . . . 0.556 HG11 ' HB2' ' R' ' 82' ' ' ALA . 40.8 t -109.81 -27.45 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.241 -0.912 . . . . 31.7 109.674 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' R' R ' 72' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -86.52 -48.86 8.01 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.407 -0.808 . . . . 33.58 110.32 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' R' R ' 73' ' ' SER . . . . . . . . . . . . . 70.1 m -89.69 50.99 1.99 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.336 -0.853 . . . . 50.82 110.344 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' R' R ' 74' ' ' SER . . . . . . . . . . . . . 15.8 t -125.88 138.28 31.73 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.362 -0.836 . . . . 34.74 110.257 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.29 -25.02 16.06 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 O-C-N 123.735 1.387 . . . . 35.7 110.341 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' R' R ' 76' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -91.59 153.25 19.87 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.398 -0.814 . . . . 66.48 110.368 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' R' R ' 77' ' ' ASN . . . . . 0.425 ' ND2' ' HG2' ' R' ' 45' ' ' PRO . 22.3 t-20 -81.62 95.29 7.14 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.374 -0.829 . . . . 46.72 110.046 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' R' R ' 78' ' ' LEU . . . . . . . . . . . . . 96.3 mt -96.46 27.95 3.56 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.467 -0.771 . . . . 37.55 110.216 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' R' R ' 79' ' ' THR . . . . . . . . . . . . . 29.7 m -56.18 -54.65 42.61 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.325 -0.86 . . . . 37.36 110.295 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' R' R ' 80' ' ' LEU . . . . . 0.603 ' HA ' HD12 ' R' ' 83' ' ' ILE . 15.9 mt -60.92 -23.16 65.04 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.256 -0.902 . . . . 35.83 110.513 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' R' R ' 81' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -79.54 -39.08 32.72 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.165 -0.959 . . . . 44.03 110.331 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' R' R ' 82' ' ' ALA . . . . . 0.556 ' HB2' HG11 ' R' ' 71' ' ' VAL . . . -69.47 -28.66 66.28 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.262 -0.899 . . . . 32.54 110.245 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' R' R ' 83' ' ' ILE . . . . . 0.603 HD12 ' HA ' ' R' ' 80' ' ' LEU . 78.1 mt -70.11 -46.1 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.307 -0.87 . . . . 32.02 110.302 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' R' R ' 84' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -55.19 -52.11 64.39 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.177 -0.952 . . . . 34.09 110.547 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' R' R ' 85' ' ' GLN . . . . . 0.532 ' HG2' HD12 ' R' ' 89' ' ' LEU . 31.9 tt0 -54.74 -46.93 74.35 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.272 -0.893 . . . . 25.94 110.235 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' R' R ' 86' ' ' LEU . . . . . . . . . . . . . 24.2 mt -58.67 -43.91 90.02 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.318 -0.864 . . . . 16.2 109.904 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' R' R ' 87' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -65.32 -35.13 80.06 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.471 -0.768 . . . . 49.09 110.346 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' R' R ' 88' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -78.45 -19.12 53.84 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.308 -0.87 . . . . 28.61 110.497 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' R' R ' 89' ' ' LEU . . . . . 0.532 HD12 ' HG2' ' R' ' 85' ' ' GLN . 32.8 mt -96.16 -29.45 14.05 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.207 -0.933 . . . . 26.16 110.239 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' R' R ' 90' ' ' THR . . . . . . . . . . . . . 59.6 p -105.64 -34.61 7.68 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.241 -0.912 . . . . 33.33 109.819 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' R' R ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.79 16.16 58.61 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.862 -1.295 . . . . 31.13 109.862 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' R' R ' 92' ' ' LEU . . . . . . . . . . . . . 97.0 mt -100.12 155.29 17.81 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.172 -1.193 . . . . 42.52 110.21 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' R' R ' 93' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -86.26 91.63 8.53 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.432 -0.793 . . . . 68.46 109.948 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' R' R ' 94' ' ' LEU . . . . . 0.459 ' HB3' ' CZ2' ' R' ' 52' ' ' TRP . 47.7 mt -99.47 53.03 0.94 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.162 -0.961 . . . . 44.63 110.355 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' R' R ' 95' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.47 -38.66 6.39 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.253 -0.904 . . . . 67.16 110.399 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' R' R ' 96' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -113.9 44.23 1.68 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -0.922 . . . . 67.02 110.291 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' R' R ' 97' ' ' GLY . . . . . . . . . . . . . . . 99.14 150.79 26.02 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.733 -1.347 . . . . 49.48 109.733 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' R' R ' 98' ' ' GLY . . . . . . . . . . . . . . . -166.26 160.05 33.49 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.227 -1.549 . . . . 36.57 109.227 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' R' R ' 99' ' ' PRO . . . . . 0.79 ' O ' HG23 ' R' ' 103' ' ' VAL . 45.8 Cg_endo -72.58 121.1 7.13 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.65 1.342 . . . . 30.41 110.435 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' R' R ' 100' ' ' PRO . . . . . 0.413 ' HA ' HD11 ' R' ' 56' ' ' ILE . 45.8 Cg_endo -72.27 -31.59 11.53 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 O-C-N 123.649 1.342 . . . . 29.94 110.561 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' R' R ' 101' ' ' ALA . . . . . 0.476 ' HB2' ' HB3' ' R' ' 178' ' ' LEU . . . -70.01 -38.47 75.95 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.239 -0.913 . . . . 23.64 110.256 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' R' R ' 102' ' ' LEU . . . . . 0.424 HD23 HD21 ' R' ' 106' ' ' ASN . 0.1 OUTLIER -72.66 -40.74 66.09 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.284 -0.885 . . . . 20.31 110.358 -179.713 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' R' R ' 103' ' ' VAL . . . . . 0.79 HG23 ' O ' ' R' ' 99' ' ' PRO . 63.6 t -58.19 -40.09 76.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.227 -0.92 . . . . 16.33 109.996 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' R' R ' 104' ' ' ILE . . . . . 0.433 HD11 HG12 ' R' ' 56' ' ' ILE . 81.9 mt -71.72 -30.39 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.418 -0.801 . . . . 24.77 110.049 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' R' R ' 105' ' ' TRP . . . . . 0.461 ' O ' ' HD3' ' R' ' 108' ' ' LYS . 70.6 t-105 -82.49 0.89 40.35 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.34 -0.85 . . . . 23.28 110.254 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' R' R ' 106' ' ' ASN . . . . . 0.424 HD21 HD23 ' R' ' 102' ' ' LEU . 6.9 m-80 -105.16 -10.36 17.16 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.108 -0.995 . . . . 28.26 110.028 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' R' R ' 107' ' ' ILE . . . . . . . . . . . . . 36.8 pt -126.8 34.96 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.268 -0.895 . . . . 18.77 110.008 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' R' R ' 108' ' ' LYS . . . . . 0.5 ' HG2' ' HB ' ' R' ' 115' ' ' ILE . 9.2 mtpp -61.02 -48.5 81.5 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.589 -0.694 . . . . 42.5 110.037 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' R' R ' 109' ' ' HIS . . . . . 0.444 ' CD2' ' HG ' ' R' ' 110' ' ' LEU . 50.7 p-80 -66.02 -12.84 58.0 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.473 -0.767 . . . . 20.07 110.655 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' R' R ' 110' ' ' LEU . . . . . 0.444 ' HG ' ' CD2' ' R' ' 109' ' ' HIS . 80.7 mt -94.78 -17.35 22.22 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.121 -0.987 . . . . 15.69 110.171 179.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' R' R ' 111' ' ' LEU . . . . . 0.528 HD21 ' CE2' ' R' ' 60' ' ' PHE . 10.4 mt -94.06 144.14 25.74 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.342 -0.849 . . . . 25.39 111.05 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' R' R ' 112' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -77.7 -17.35 57.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.51 -0.744 . . . . 53.48 109.859 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' R' R ' 113' ' ' THR . . . . . 0.458 HG22 ' N ' ' R' ' 114' ' ' GLY . 59.7 m -83.69 166.66 17.9 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.308 -0.87 . . . . 14.8 110.299 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' R' R ' 114' ' ' GLY . . . . . 0.458 ' N ' HG22 ' R' ' 113' ' ' THR . . . -98.06 127.16 9.14 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.015 -1.234 . . . . 16.14 110.015 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' R' R ' 115' ' ' ILE . . . . . 0.578 HD13 ' HB ' ' R' ' 124' ' ' VAL . 47.8 mm -109.08 139.44 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.464 -1.021 . . . . 13.46 109.7 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' R' R ' 116' ' ' GLY . . . . . . . . . . . . . . . -152.74 -155.85 7.29 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.926 -1.27 . . . . 23.9 109.926 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' R' R ' 117' ' ' THR . . . . . 0.529 HG22 ' CG2' ' R' ' 126' ' ' VAL . 18.6 p -135.02 -171.39 2.79 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.413 -1.051 . . . . 27.37 110.044 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' R' R ' 118' ' ' ALA . . . . . 0.445 ' HB3' ' OD1' ' R' ' 128' ' ' ASP . . . -56.61 -57.96 10.11 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.251 -0.906 . . . . 18.76 110.107 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' R' R ' 119' ' ' SER . . . . . 0.424 ' HA ' ' CB ' ' R' ' 194' ' ' ALA . 1.2 m -56.58 -40.61 75.51 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.326 -0.859 . . . . 32.35 109.791 179.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' R' R ' 120' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 -110.04 86.2 4.81 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.442 -0.786 . . . . 27.12 109.682 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' R' R ' 121' ' ' PRO . . . . . 0.481 ' HA ' ' SG ' ' R' ' 125' ' ' CYS . 44.3 Cg_endo -71.23 166.5 29.06 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.813 1.428 . . . . 22.68 110.981 -179.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' R' R ' 122' ' ' SER . . . . . 0.438 ' HB2' ' O ' ' R' ' 121' ' ' PRO . 38.7 t 178.51 -161.69 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.481 -0.762 . . . . 22.99 109.492 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' R' R ' 123' ' ' GLU . . . . . 0.441 ' HG2' HG23 ' R' ' 113' ' ' THR . 2.3 tp10 -56.5 -39.97 74.18 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.19 -0.944 . . . . 36.18 109.649 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' R' R ' 124' ' ' VAL . . . . . 0.578 ' HB ' HD13 ' R' ' 115' ' ' ILE . 82.3 t -142.44 136.5 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.584 -0.698 . . . . 20.64 109.403 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' R' R ' 125' ' ' CYS . . . . . 0.481 ' SG ' ' HA ' ' R' ' 121' ' ' PRO . 83.4 m -140.35 168.21 20.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.219 -0.925 . . . . 22.8 111.163 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' R' R ' 126' ' ' VAL . . . . . 0.729 HG12 HG22 ' R' ' 179' ' ' VAL . 35.8 m -122.76 159.8 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.747 -0.596 . . . . 21.24 109.664 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' R' R ' 127' ' ' VAL . . . . . 0.709 HG11 ' O ' ' R' ' 177' ' ' VAL . 30.7 m -70.87 141.86 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.266 -0.896 . . . . 19.77 110.675 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' R' R ' 128' ' ' ASP . . . . . 0.445 ' OD1' ' HB3' ' R' ' 118' ' ' ALA . 53.9 p-10 -137.73 19.4 2.87 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.336 -0.853 . . . . 29.21 110.669 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' R' R ' 129' ' ' GLY . . . . . . . . . . . . . . . 114.03 0.01 24.1 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.893 -1.146 . . . . 33.86 110.461 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' R' R ' 130' ' ' THR . . . . . . . . . . . . . 58.1 m -91.77 131.91 36.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.207 -1.172 . . . . 26.41 110.099 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -62.62 120.69 11.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.356 -0.84 . . . . 33.08 110.274 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' R' R ' 132' ' ' MET . . . . . 0.433 ' HE1' ' CE2' ' R' ' 180' ' ' PHE . 98.4 mmm -105.18 165.58 11.0 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.468 -0.77 . . . . 30.76 110.409 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' R' R ' 133' ' ' CYS . . . . . 0.411 ' HA ' ' HB3' ' R' ' 174' ' ' PRO . 32.5 m -141.17 158.12 44.33 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.538 -0.726 . . . . 27.0 109.969 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' R' R ' 134' ' ' LEU . . . . . 0.564 HD11 ' O ' ' R' ' 172' ' ' PRO . 0.1 OUTLIER -58.5 -19.65 39.07 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.322 -0.861 . . . . 33.9 110.544 -179.871 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' R' R ' 135' ' ' ALA . . . . . . . . . . . . . . . -92.74 8.15 40.54 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.31 -0.868 . . . . 19.37 110.826 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' R' R ' 136' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -93.75 -21.74 19.13 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.174 -0.954 . . . . 30.47 110.245 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' R' R ' 137' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -149.98 165.35 32.95 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.407 -0.808 . . . . 24.27 110.215 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' R' R ' 138' ' ' HIS . . . . . 0.433 ' HA ' HG23 ' R' ' 154' ' ' VAL . 15.1 p80 -117.81 15.04 14.39 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.4 -0.813 . . . . 20.91 110.494 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' R' R ' 139' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' R' ' 152' ' ' ALA . . . -177.14 152.46 0.89 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.257 -0.902 . . . . 15.69 110.139 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' R' R ' 140' ' ' GLY . . . . . 0.427 ' HA3' ' O ' ' R' ' 179' ' ' VAL . . . 161.78 175.12 32.46 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.889 -1.285 . . . . 23.76 109.889 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' R' R ' 141' ' ' ILE . . . . . . . . . . . . . 83.8 mt -95.51 136.58 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.473 -1.016 . . . . 25.3 109.682 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' R' R ' 142' ' ' PHE . . . . . 0.576 ' CD2' ' HB2' ' R' ' 172' ' ' PRO . 82.9 m-85 -120.74 -172.66 2.43 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.287 -0.883 . . . . 30.24 110.547 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' R' R ' 143' ' ' LEU . . . . . 0.741 HD23 ' O ' ' R' ' 148' ' ' HIS . 0.5 OUTLIER -119.79 77.75 1.26 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.499 -0.751 . . . . 32.8 110.292 -179.907 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' R' R ' 144' ' ' LYS . . . . . 0.469 ' HG3' ' CZ2' ' R' ' 170' ' ' TRP . 1.0 OUTLIER -69.54 76.88 0.41 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.448 -0.783 . . . . 49.18 109.653 179.562 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' R' R ' 145' ' ' GLY . . . . . 0.456 ' O ' HD22 ' R' ' 143' ' ' LEU . . . 104.51 179.25 24.82 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.157 -1.577 . . . . 53.87 109.157 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' R' R ' 146' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -88.52 145.8 25.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.363 -1.081 . . . . 68.58 109.995 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' R' R ' 147' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 58.31 36.51 25.64 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.346 -0.846 . . . . 56.62 110.607 179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' R' R ' 148' ' ' HIS . . . . . 0.741 ' O ' HD23 ' R' ' 143' ' ' LEU . 44.8 t60 -158.69 148.13 19.16 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.183 -0.948 . . . . 44.57 110.419 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' R' R ' 149' ' ' ALA . . . . . . . . . . . . . . . -150.29 146.83 27.01 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.445 -0.784 . . . . 33.54 110.057 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' R' R ' 150' ' ' VAL . . . . . . . . . . . . . 34.2 m -142.3 161.55 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.261 -0.9 . . . . 27.61 110.36 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' R' R ' 151' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' R' ' 152' ' ' ALA . 5.8 t80 -86.22 155.54 20.66 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.392 -0.818 . . . . 23.04 109.873 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' R' R ' 152' ' ' ALA . . . . . 0.537 ' N ' ' CD1' ' R' ' 151' ' ' PHE . . . -157.26 151.54 24.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.421 -0.799 . . . . 29.61 109.575 179.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' R' R ' 153' ' ' CYS . . . . . . . . . . . . . 26.7 p -154.27 173.61 15.91 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.34 -0.85 . . . . 22.75 110.542 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' R' R ' 154' ' ' VAL . . . . . 0.613 HG22 ' CE2' ' R' ' 159' ' ' TRP . 59.7 t -90.6 117.1 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.453 -0.78 . . . . 23.26 110.052 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' R' R ' 155' ' ' THR . . . . . . . . . . . . . 69.3 p -112.17 -176.62 2.97 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.359 -0.838 . . . . 17.88 110.041 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' R' R ' 156' ' ' SER . . . . . . . . . . . . . 78.5 p -75.96 -3.76 37.35 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.32 -0.863 . . . . 21.83 110.633 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' R' R ' 157' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -118.22 10.46 12.88 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.06 -1.025 . . . . 36.54 110.612 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' R' R ' 158' ' ' GLY . . . . . . . . . . . . . . . 117.97 -162.63 13.05 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.527 -1.429 . . . . 31.74 109.527 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' R' R ' 159' ' ' TRP . . . . . 0.613 ' CE2' HG22 ' R' ' 154' ' ' VAL . 14.7 m95 -86.6 122.57 30.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.354 -1.086 . . . . 28.25 110.035 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' R' R ' 160' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -108.48 166.96 10.38 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.42 -0.8 . . . . 41.24 110.201 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' R' R ' 161' ' ' ALA . . . . . . . . . . . . . . . -143.23 123.47 13.77 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.461 -0.775 . . . . 27.4 110.163 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' R' R ' 162' ' ' ILE . . . . . . . . . . . . . 92.0 mt -87.59 81.12 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.317 -0.864 . . . . 24.27 110.051 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' R' R ' 163' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' R' ' 165' ' ' GLU . 15.4 t0 -72.74 92.39 1.56 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.422 -0.799 . . . . 36.08 110.254 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' R' R ' 164' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 54.13 -89.0 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.515 -0.741 . . . . 46.08 110.574 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' R' R ' 165' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' R' ' 163' ' ' ASP . 29.7 mt-10 -124.76 36.02 4.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.088 -1.007 . . . . 50.94 110.192 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' R' R ' 166' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -135.81 117.29 14.77 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.416 -0.803 . . . . 47.28 110.266 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' R' R ' 167' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -101.04 120.02 39.59 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.387 -0.821 . . . . 40.47 110.155 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' R' R ' 168' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -157.52 158.53 30.68 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.273 -0.892 . . . . 30.21 110.433 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' R' R ' 169' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.77 132.98 19.42 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 O-C-N 123.863 1.454 . . . . 32.76 110.471 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' R' R ' 170' ' ' TRP . . . . . 0.469 ' CZ2' ' HG3' ' R' ' 144' ' ' LYS . 67.1 t90 -159.78 119.43 2.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.398 -0.814 . . . . 32.79 109.946 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' R' R ' 171' ' ' THR . . . . . . . . . . . . . 45.9 m -81.13 112.57 33.91 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.405 -0.809 . . . . 36.92 110.188 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' R' R ' 172' ' ' PRO . . . . . 0.576 ' HB2' ' CD2' ' R' ' 142' ' ' PHE . 47.2 Cg_endo -73.76 158.78 46.46 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 O-C-N 123.796 1.419 . . . . 33.54 110.551 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' R' R ' 173' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -88.84 144.96 33.83 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.361 -0.837 . . . . 45.76 109.951 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' R' R ' 174' ' ' PRO . . . . . 0.411 ' HB3' ' HA ' ' R' ' 133' ' ' CYS . 45.9 Cg_endo -71.74 -10.33 26.3 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 O-C-N 123.621 1.327 . . . . 29.63 110.497 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' R' R ' 175' ' ' SER . . . . . . . . . . . . . 53.0 p -103.53 -17.47 15.18 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.317 -0.864 . . . . 35.7 110.306 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' R' R ' 176' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -103.6 43.23 1.1 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.286 -0.884 . . . . 39.65 110.32 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' R' R ' 177' ' ' VAL . . . . . 0.709 ' O ' HG11 ' R' ' 127' ' ' VAL . 10.6 p -117.74 127.12 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.397 -0.815 . . . . 20.61 110.095 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' R' R ' 178' ' ' LEU . . . . . 0.476 ' HB3' ' HB2' ' R' ' 101' ' ' ALA . 46.2 mt -91.47 -61.25 1.69 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.305 -0.872 . . . . 15.58 109.389 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' R' R ' 179' ' ' VAL . . . . . 0.729 HG22 HG12 ' R' ' 126' ' ' VAL . 67.9 t -114.67 144.66 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.643 -0.661 . . . . 17.4 109.441 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' R' R ' 180' ' ' PHE . . . . . 0.433 ' CE2' ' HE1' ' R' ' 132' ' ' MET . 43.6 p90 -152.17 163.43 39.4 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.239 -0.913 . . . . 20.16 110.519 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' R' R ' 181' ' ' VAL . . . . . . . . . . . . . 66.6 t -113.19 111.47 50.22 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.342 -0.849 . . . . 17.69 109.756 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' R' R ' 182' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.05 149.56 52.83 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 O-C-N 123.507 1.267 . . . . 17.81 110.374 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' R' R ' 183' ' ' TYR . . . . . 0.698 ' O ' ' C ' ' R' ' 184' ' ' ASP . 79.5 m-85 -59.05 175.47 0.29 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.4 -0.813 . . . . 28.01 110.526 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' R' R ' 184' ' ' ASP . . . . . 0.698 ' C ' ' O ' ' R' ' 183' ' ' TYR . 1.1 m-20 -19.01 -82.88 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.425 -0.797 . . . . 58.64 110.319 -178.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' R' R ' 185' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 . . . . . 0 N--CA 1.502 2.16 0 CA-C-O 121.273 0.559 . . . . 80.42 111.777 179.479 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' R' R ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 120.948 0.404 . . . . 49.5 110.14 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' R' R ' 194' ' ' ALA . . . . . 0.424 ' CB ' ' HA ' ' R' ' 119' ' ' SER . . . . . . . . 0 N--CA 1.496 1.826 0 O-C-N 121.123 -0.986 . . . . 40.4 110.059 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' S' S ' 229' ' ' MET . . . . . 0.407 ' HG3' ' N ' ' S' ' 230' ' ' GLU . 24.8 ptp . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.229 0.538 . . . . 51.83 110.219 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' S' S ' 230' ' ' GLU . . . . . 0.407 ' N ' ' HG3' ' S' ' 229' ' ' MET . 33.1 tt0 -97.24 142.78 28.72 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.336 -0.852 . . . . 54.13 110.208 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' S' S ' 231' ' ' LEU . . . . . . . . . . . . . 68.0 mt -134.14 141.04 46.96 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.247 -0.908 . . . . 33.04 110.355 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' S' S ' 232' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' S' ' 355' ' ' THR . 40.0 m -89.22 103.18 15.83 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.414 -0.804 . . . . 26.92 110.037 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' S' S ' 233' ' ' LEU . . . . . 0.673 HD22 ' CE2' ' S' ' 262' ' ' TYR . 79.7 mt -55.91 179.26 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.467 -0.771 . . . . 13.78 110.457 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' S' S ' 234' ' ' TYR . . . . . 0.448 ' CG ' ' N ' ' S' ' 235' ' ' ASN . 35.7 p90 -65.02 -35.65 81.85 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.347 -0.845 . . . . 26.08 110.169 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' S' S ' 235' ' ' ASN . . . . . 0.448 ' N ' ' CG ' ' S' ' 234' ' ' TYR . 50.7 p30 -74.31 -7.46 52.87 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.292 -0.88 . . . . 20.04 110.524 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' S' S ' 236' ' ' GLY . . . . . . . . . . . . . . . 95.8 -20.03 51.7 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.76 -1.336 . . . . 22.71 109.76 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' S' S ' 237' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -52.9 145.72 12.13 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.234 -1.157 . . . . 35.44 110.226 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' S' S ' 238' ' ' LYS . . . . . . . . . . . . . 44.4 mttt -102.2 127.87 48.96 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.389 -0.82 . . . . 32.56 110.416 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' S' S ' 239' ' ' LYS . . . . . 0.405 ' HG2' ' CZ ' ' S' ' 241' ' ' PHE . 9.1 ttmt -132.25 144.49 50.65 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.377 -0.827 . . . . 26.68 110.036 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' S' S ' 240' ' ' THR . . . . . . . . . . . . . 51.5 m -102.01 132.16 48.01 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.328 -0.858 . . . . 41.02 110.41 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' S' S ' 241' ' ' PHE . . . . . 0.405 ' CZ ' ' HG2' ' S' ' 239' ' ' LYS . 96.0 m-85 -117.87 137.66 52.64 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.419 -0.801 . . . . 28.62 110.184 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' S' S ' 242' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -96.39 161.74 13.8 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.371 -0.831 . . . . 47.89 110.25 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' S' S ' 243' ' ' SER . . . . . . . . . . . . . 71.6 m -90.47 151.49 21.36 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.245 -0.909 . . . . 45.09 110.298 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' S' S ' 244' ' ' ARG . . . . . . . . . . . . . 1.4 mtp85 -129.76 126.78 22.73 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.371 -0.83 . . . . 42.49 110.266 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' S' S ' 245' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.37 161.05 43.56 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.652 1.343 . . . . 35.68 110.542 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' S' S ' 246' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -132.86 97.88 4.15 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.443 -0.786 . . . . 51.88 109.866 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' S' S ' 247' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -110.52 -22.23 11.75 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.395 -0.815 . . . . 53.69 110.664 -179.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' S' S ' 248' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -117.28 43.77 2.25 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.108 -0.995 . . . . 55.79 110.804 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' S' S ' 249' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 48.68 38.49 11.63 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.4 -0.813 . . . . 49.45 110.339 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' S' S ' 250' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -90.65 28.99 1.38 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.521 -0.737 . . . . 36.86 110.309 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' S' S ' 251' ' ' ALA . . . . . . . . . . . . . . . -53.79 -43.16 69.07 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.271 -0.893 . . . . 29.69 109.619 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' S' S ' 252' ' ' TRP . . . . . 0.427 ' CZ2' ' HB3' ' S' ' 294' ' ' LEU . 67.8 p-90 -61.81 -33.94 75.04 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.537 -0.727 . . . . 41.12 109.83 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' S' S ' 253' ' ' LEU . . . . . 0.4 ' N ' ' CD2' ' S' ' 252' ' ' TRP . 23.2 tp -70.16 -47.25 62.43 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.37 -0.831 . . . . 24.89 109.953 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' S' S ' 254' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -56.1 -42.44 76.8 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.417 -0.802 . . . . 35.65 109.96 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' S' S ' 255' ' ' ALA . . . . . . . . . . . . . . . -59.63 -48.18 82.69 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.399 -0.813 . . . . 22.73 110.081 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' S' S ' 256' ' ' ILE . . . . . 0.503 HG12 HD11 ' S' ' 304' ' ' ILE . 79.7 mt -62.25 -40.7 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.304 -0.873 . . . . 28.85 109.979 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' S' S ' 257' ' ' LEU . . . . . 0.404 ' CD2' ' HB3' ' S' ' 268' ' ' PHE . 19.1 mt -61.48 -44.5 96.98 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.257 -0.902 . . . . 23.07 110.154 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' S' S ' 258' ' ' GLN . . . . . 0.502 ' HB3' ' CD2' ' S' ' 351' ' ' PHE . 53.5 mm-40 -65.14 -45.33 85.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.39 -0.818 . . . . 29.78 109.919 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' S' S ' 259' ' ' LEU . . . . . 0.42 ' O ' HG22 ' S' ' 263' ' ' VAL . 19.7 tp -58.66 -36.35 74.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.337 -0.852 . . . . 17.94 109.474 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' S' S ' 260' ' ' PHE . . . . . 0.528 ' CE2' HD21 ' S' ' 311' ' ' LEU . 3.1 m-85 -62.9 -45.24 93.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.622 -0.674 . . . . 30.57 109.82 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' S' S ' 261' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -62.08 -29.81 70.56 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.386 -0.821 . . . . 41.34 109.987 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' S' S ' 262' ' ' TYR . . . . . 0.673 ' CE2' HD22 ' S' ' 233' ' ' LEU . 8.6 t80 -71.16 -44.67 65.05 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.367 -0.833 . . . . 26.03 110.1 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' S' S ' 263' ' ' VAL . . . . . 0.42 HG22 ' O ' ' S' ' 259' ' ' LEU . 33.1 m -92.02 18.15 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.374 -0.829 . . . . 22.8 110.334 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' S' S ' 264' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 52.85 70.69 0.55 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.206 -0.934 . . . . 44.03 110.589 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' S' S ' 265' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -111.86 109.19 55.3 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.397 -0.814 . . . . 35.61 109.602 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' S' S ' 266' ' ' PRO . . . . . 0.481 ' HA ' ' HB2' ' S' ' 269' ' ' ASP . 49.7 Cg_endo -75.34 0.44 9.04 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.657 1.346 . . . . 37.67 111.8 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' S' S ' 267' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -56.46 -67.73 0.28 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.781 -1.2 . . . . 41.49 110.192 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' S' S ' 268' ' ' PHE . . . . . 0.404 ' HB3' ' CD2' ' S' ' 257' ' ' LEU . 22.3 m-85 -92.94 39.95 1.05 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.15 -0.968 . . . . 50.76 110.063 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' S' S ' 269' ' ' ASP . . . . . 0.481 ' HB2' ' HA ' ' S' ' 266' ' ' PRO . 0.9 OUTLIER -76.04 -33.22 59.6 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.348 -0.845 . . . . 61.86 109.775 179.519 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' S' S ' 270' ' ' TRP . . . . . 0.511 ' CE2' HG23 ' S' ' 271' ' ' VAL . 50.9 p-90 -73.91 -4.31 34.28 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.33 -0.856 . . . . 39.85 110.493 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' S' S ' 271' ' ' VAL . . . . . 0.511 HG23 ' CE2' ' S' ' 270' ' ' TRP . 46.6 t -109.59 -32.66 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.187 -0.946 . . . . 39.18 110.058 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' S' S ' 272' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -78.68 -36.52 43.51 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.327 -0.858 . . . . 40.02 110.519 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' S' S ' 273' ' ' SER . . . . . . . . . . . . . 71.1 m -103.55 56.16 0.74 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.347 -0.846 . . . . 47.2 110.291 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' S' S ' 274' ' ' SER . . . . . . . . . . . . . 6.8 t -133.09 141.24 40.13 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.382 -0.824 . . . . 47.61 110.153 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' S' S ' 275' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.76 -18.82 21.75 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 123.639 1.337 . . . . 45.28 110.544 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' S' S ' 276' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -99.9 140.88 33.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.221 -0.924 . . . . 57.27 110.327 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' S' S ' 277' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -71.79 97.63 1.83 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.428 -0.795 . . . . 37.28 110.234 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' S' S ' 278' ' ' LEU . . . . . . . . . . . . . 86.0 mt -96.96 33.85 1.83 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.388 -0.82 . . . . 43.88 110.087 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' S' S ' 279' ' ' THR . . . . . . . . . . . . . 77.8 m -64.09 -60.19 3.54 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.471 -0.768 . . . . 50.05 110.194 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' S' S ' 280' ' ' LEU . . . . . 0.729 ' HA ' HD12 ' S' ' 283' ' ' ILE . 13.7 mt -51.51 -39.91 58.57 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.247 -0.908 . . . . 54.12 110.304 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' S' S ' 281' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.39 -49.69 74.52 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.444 -0.785 . . . . 65.28 110.132 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' S' S ' 282' ' ' ALA . . . . . . . . . . . . . . . -59.02 -33.89 71.27 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.478 -0.764 . . . . 46.51 110.488 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' S' S ' 283' ' ' ILE . . . . . 0.729 HD12 ' HA ' ' S' ' 280' ' ' LEU . 85.7 mt -66.34 -50.87 64.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.305 -0.872 . . . . 47.3 110.072 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' S' S ' 284' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -50.61 -57.56 7.92 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.416 -0.803 . . . . 50.72 110.359 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' S' S ' 285' ' ' GLN . . . . . 0.529 ' HG2' HD12 ' S' ' 289' ' ' LEU . 34.3 tt0 -51.42 -46.35 62.89 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.523 -0.736 . . . . 68.47 110.34 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' S' S ' 286' ' ' LEU . . . . . . . . . . . . . 19.1 mt -59.97 -44.47 94.44 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.464 -0.773 . . . . 36.62 110.309 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' S' S ' 287' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -62.83 -35.25 79.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.279 -0.888 . . . . 46.64 110.009 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' S' S ' 288' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -76.26 -20.99 56.85 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.42 -0.8 . . . . 46.45 110.328 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' S' S ' 289' ' ' LEU . . . . . 0.529 HD12 ' HG2' ' S' ' 285' ' ' GLN . 30.7 mt -97.33 -21.73 17.05 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.342 -0.849 . . . . 35.09 110.52 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' S' S ' 290' ' ' THR . . . . . 0.409 HG22 ' HB3' ' S' ' 306' ' ' ASN . 81.3 p -114.78 -28.5 7.07 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.214 -0.929 . . . . 38.61 110.373 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' S' S ' 291' ' ' GLY . . . . . . . . . . . . . . . 79.38 11.05 85.34 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.886 -1.286 . . . . 36.77 109.886 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' S' S ' 292' ' ' LEU . . . . . . . . . . . . . 84.5 mt -96.45 145.77 25.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.222 -1.164 . . . . 35.33 109.768 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' S' S ' 293' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -77.36 102.37 6.76 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.25 -0.906 . . . . 48.7 110.272 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' S' S ' 294' ' ' LEU . . . . . 0.427 ' HB3' ' CZ2' ' S' ' 252' ' ' TRP . 55.3 mt -106.86 51.72 0.74 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.55 -0.719 . . . . 42.61 110.11 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' S' S ' 295' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -112.57 -11.09 13.63 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.325 -0.859 . . . . 55.49 110.573 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' S' S ' 296' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -144.38 48.53 1.36 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.163 -0.96 . . . . 75.68 110.292 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' S' S ' 297' ' ' GLY . . . . . . . . . . . . . . . 96.84 145.21 18.76 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.509 -1.437 . . . . 49.44 109.509 179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' S' S ' 298' ' ' GLY . . . . . . . . . . . . . . . -163.83 156.93 29.01 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.805 -1.318 . . . . 41.11 109.805 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' S' S ' 299' ' ' PRO . . . . . 0.484 ' O ' HG23 ' S' ' 303' ' ' VAL . 47.4 Cg_endo -73.77 118.25 5.37 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 123.955 1.502 . . . . 26.2 110.293 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' S' S ' 300' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.24 -15.42 31.68 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 O-C-N 123.577 1.304 . . . . 21.7 110.734 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' S' S ' 301' ' ' ALA . . . . . . . . . . . . . . . -80.71 -29.34 36.45 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.276 -0.89 . . . . 31.23 110.14 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' S' S ' 302' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.57 -40.57 18.93 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.405 -0.809 . . . . 38.99 109.926 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' S' S ' 303' ' ' VAL . . . . . 0.484 HG23 ' O ' ' S' ' 299' ' ' PRO . 58.1 t -60.73 -35.47 64.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.375 -0.828 . . . . 18.63 110.143 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' S' S ' 304' ' ' ILE . . . . . 0.523 HD12 HG21 ' S' ' 379' ' ' VAL . 86.2 mt -79.45 -23.55 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.463 -0.773 . . . . 25.46 110.193 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' S' S ' 305' ' ' TRP . . . . . 0.411 ' CD2' ' HD3' ' S' ' 308' ' ' LYS . 68.7 t-105 -88.63 -14.6 37.1 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.253 -0.904 . . . . 33.4 110.601 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' S' S ' 306' ' ' ASN . . . . . 0.409 ' HB3' HG22 ' S' ' 290' ' ' THR . 10.4 m-80 -89.69 -13.57 36.64 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.227 -0.92 . . . . 36.97 110.435 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' S' S ' 307' ' ' ILE . . . . . 0.471 HG12 ' O ' ' S' ' 303' ' ' VAL . 36.8 pt -125.09 45.66 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.218 -0.926 . . . . 30.81 110.066 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' S' S ' 308' ' ' LYS . . . . . 0.411 ' HD3' ' CD2' ' S' ' 305' ' ' TRP . 1.5 mtmp? -73.52 -37.77 65.52 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.355 -0.841 . . . . 46.52 110.084 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' S' S ' 309' ' ' HIS . . . . . 0.493 ' CD2' ' HG ' ' S' ' 310' ' ' LEU . 55.5 p-80 -73.1 -8.34 55.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.303 -0.873 . . . . 51.03 110.129 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' S' S ' 310' ' ' LEU . . . . . 0.493 ' HG ' ' CD2' ' S' ' 309' ' ' HIS . 52.6 mt -99.27 -12.94 19.92 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.295 -0.878 . . . . 36.16 109.971 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' S' S ' 311' ' ' LEU . . . . . 0.528 HD21 ' CE2' ' S' ' 260' ' ' PHE . 10.8 mt -97.11 147.81 23.67 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.314 -0.866 . . . . 40.0 110.452 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' S' S ' 312' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -81.54 -16.33 52.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.345 -0.847 . . . . 54.18 109.763 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' S' S ' 313' ' ' THR . . . . . 0.823 HG23 ' HG2' ' S' ' 323' ' ' GLU . 92.5 m -87.88 151.53 22.76 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.375 -0.828 . . . . 25.61 110.159 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' S' S ' 314' ' ' GLY . . . . . . . . . . . . . . . -87.83 126.38 8.02 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.836 -1.306 . . . . 25.18 109.836 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' S' S ' 315' ' ' ILE . . . . . 0.671 HD13 ' HB ' ' S' ' 324' ' ' VAL . 50.7 mm -101.64 150.53 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.35 -1.088 . . . . 23.9 109.71 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' S' S ' 316' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' S' ' 325' ' ' CYS . . . -157.12 -159.32 9.42 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.923 -1.271 . . . . 23.18 109.923 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' S' S ' 317' ' ' THR . . . . . 0.425 HG22 ' CG2' ' S' ' 326' ' ' VAL . 11.2 p -133.88 -173.06 3.14 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.417 -1.049 . . . . 27.98 110.013 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' S' S ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.55 -56.23 24.63 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.199 -0.938 . . . . 28.1 109.892 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' S' S ' 319' ' ' SER . . . . . . . . . . . . . 1.2 m -59.9 -41.67 92.17 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.405 -0.809 . . . . 37.0 109.632 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' S' S ' 320' ' ' ARG . . . . . . . . . . . . . 12.2 mtm180 -111.69 79.85 2.62 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.471 -0.768 . . . . 52.07 109.679 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' S' S ' 321' ' ' PRO . . . . . 0.445 ' O ' ' HB2' ' S' ' 322' ' ' SER . 44.1 Cg_endo -71.43 171.46 16.14 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.79 1.416 . . . . 38.29 110.903 -179.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' S' S ' 322' ' ' SER . . . . . 0.445 ' HB2' ' O ' ' S' ' 321' ' ' PRO . 41.3 t 178.7 -148.08 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.928 -0.767 . . . . 38.84 108.928 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' S' S ' 323' ' ' GLU . . . . . 0.823 ' HG2' HG23 ' S' ' 313' ' ' THR . 6.7 tp10 -62.87 -40.34 97.2 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.944 -1.098 . . . . 40.7 109.664 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' S' S ' 324' ' ' VAL . . . . . 0.671 ' HB ' HD13 ' S' ' 315' ' ' ILE . 72.7 t -141.24 135.02 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.433 -0.792 . . . . 20.34 109.463 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' S' S ' 325' ' ' CYS . . . . . 0.46 ' HB2' ' CE1' ' S' ' 380' ' ' PHE . 11.1 m -126.02 172.24 10.13 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.246 -0.909 . . . . 30.63 110.867 -179.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' S' S ' 326' ' ' VAL . . . . . 0.643 HG12 HG22 ' S' ' 379' ' ' VAL . 34.5 m -135.51 142.16 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.651 -0.656 . . . . 23.9 109.248 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' S' S ' 327' ' ' VAL . . . . . 0.595 HG11 ' O ' ' S' ' 377' ' ' VAL . 34.6 m -56.32 125.04 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.015 -1.053 . . . . 19.48 110.388 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' S' S ' 328' ' ' ASP . . . . . . . . . . . . . 55.5 p-10 -119.41 11.46 12.18 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.496 -0.753 . . . . 26.43 110.427 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' S' S ' 329' ' ' GLY . . . . . . . . . . . . . . . 119.75 2.2 12.99 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.973 -1.251 . . . . 31.24 109.973 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' S' S ' 330' ' ' THR . . . . . . . . . . . . . 78.8 m -92.94 130.02 38.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.093 -1.239 . . . . 30.05 110.136 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' S' S ' 331' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -56.85 111.48 1.04 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.207 -0.933 . . . . 37.26 109.927 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' S' S ' 332' ' ' MET . . . . . . . . . . . . . 88.1 mmm -93.99 162.54 13.85 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.275 -0.89 . . . . 26.23 110.42 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' S' S ' 333' ' ' CYS . . . . . . . . . . . . . 25.7 m -137.25 150.0 47.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.398 -0.814 . . . . 23.56 110.072 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' S' S ' 334' ' ' LEU . . . . . 0.562 HD11 ' O ' ' S' ' 372' ' ' PRO . 0.1 OUTLIER -52.51 -24.93 8.96 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.282 -0.886 . . . . 28.93 110.438 179.921 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' S' S ' 335' ' ' ALA . . . . . . . . . . . . . . . -89.02 14.43 10.66 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.358 -0.839 . . . . 15.76 110.975 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' S' S ' 336' ' ' ASP . . . . . 0.403 ' O ' ' HA ' ' S' ' 382' ' ' PRO . 70.8 m-20 -100.49 -17.21 17.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.092 -1.005 . . . . 34.92 110.185 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' S' S ' 337' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -152.47 170.84 19.15 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.363 -0.836 . . . . 19.03 110.084 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' S' S ' 338' ' ' HIS . . . . . . . . . . . . . 13.3 p80 -120.68 10.44 11.01 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.367 -0.833 . . . . 18.82 110.441 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' S' S ' 339' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' S' ' 352' ' ' ALA . . . -175.99 155.18 1.56 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.205 -0.934 . . . . 17.18 110.091 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' S' S ' 340' ' ' GLY . . . . . 0.401 ' CA ' ' O ' ' S' ' 379' ' ' VAL . . . 160.82 173.09 28.99 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 110.088 -1.205 . . . . 18.33 110.088 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' S' S ' 341' ' ' ILE . . . . . . . . . . . . . 84.2 mt -88.76 138.05 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.434 -1.039 . . . . 18.6 109.78 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' S' S ' 342' ' ' PHE . . . . . 0.493 ' CE2' ' HB3' ' S' ' 352' ' ' ALA . 70.0 m-85 -120.99 -178.47 3.75 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.187 -0.945 . . . . 23.44 110.401 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' S' S ' 343' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.81 93.46 4.21 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.431 -0.793 . . . . 35.59 110.053 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' S' S ' 344' ' ' LYS . . . . . 0.405 ' O ' ' HB3' ' S' ' 348' ' ' HIS . 0.3 OUTLIER -80.89 125.05 29.63 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.268 -0.895 . . . . 38.34 110.049 -179.884 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' S' S ' 345' ' ' GLY . . . . . . . . . . . . . . . 62.75 -130.73 43.08 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 108.857 -1.697 . . . . 53.46 108.857 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' S' S ' 346' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -132.76 150.87 52.11 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.252 -1.146 . . . . 70.91 109.976 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' S' S ' 347' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 53.33 35.38 20.13 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.355 -0.841 . . . . 47.32 110.357 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' S' S ' 348' ' ' HIS . . . . . 0.405 ' HB3' ' O ' ' S' ' 344' ' ' LYS . 46.4 t60 -150.19 155.89 40.59 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.208 -0.932 . . . . 41.72 110.333 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' S' S ' 349' ' ' ALA . . . . . 0.459 ' C ' HG13 ' S' ' 350' ' ' VAL . . . -149.76 151.23 33.26 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.243 -0.911 . . . . 22.91 110.458 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' S' S ' 350' ' ' VAL . . . . . 0.459 HG13 ' C ' ' S' ' 349' ' ' ALA . 34.6 m -149.06 169.58 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.384 -0.822 . . . . 21.09 110.057 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' S' S ' 351' ' ' PHE . . . . . 0.502 ' CD2' ' HB3' ' S' ' 258' ' ' GLN . 10.8 t80 -105.31 143.58 33.29 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.279 -0.888 . . . . 25.03 110.748 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' S' S ' 352' ' ' ALA . . . . . 0.493 ' HB3' ' CE2' ' S' ' 342' ' ' PHE . . . -147.74 151.66 36.45 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.566 -0.709 . . . . 23.81 109.777 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' S' S ' 353' ' ' CYS . . . . . . . . . . . . . 26.3 p -153.25 164.88 37.31 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.348 -0.845 . . . . 25.66 110.274 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' S' S ' 354' ' ' VAL . . . . . 0.549 HG22 ' CE2' ' S' ' 359' ' ' TRP . 57.6 t -76.07 118.44 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.387 -0.82 . . . . 34.27 109.972 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' S' S ' 355' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' S' ' 232' ' ' THR . 52.3 p -117.81 175.12 5.8 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.236 -0.915 . . . . 25.49 110.364 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' S' S ' 356' ' ' SER . . . . . . . . . . . . . 62.5 p -62.19 -17.65 58.74 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.462 -0.774 . . . . 31.24 110.704 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' S' S ' 357' ' ' ASN . . . . . . . . . . . . . 46.3 m-20 -107.0 14.16 26.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.15 -0.969 . . . . 28.61 110.608 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' S' S ' 358' ' ' GLY . . . . . . . . . . . . . . . 111.83 -152.88 17.59 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.031 -1.227 . . . . 22.01 110.031 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' S' S ' 359' ' ' TRP . . . . . 0.549 ' CE2' HG22 ' S' ' 354' ' ' VAL . 15.5 m95 -91.32 116.69 29.04 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.396 -1.061 . . . . 25.54 110.148 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' S' S ' 360' ' ' TYR . . . . . 0.412 ' HA ' ' HA ' ' S' ' 369' ' ' PRO . 1.3 m-85 -103.48 165.8 10.82 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.341 -0.849 . . . . 40.53 110.069 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' S' S ' 361' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' S' ' 351' ' ' PHE . . . -140.09 130.07 24.81 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.393 -0.817 . . . . 18.04 110.296 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' S' S ' 362' ' ' ILE . . . . . . . . . . . . . 89.1 mt -95.58 83.8 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.4 -0.813 . . . . 15.64 109.998 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' S' S ' 363' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' S' ' 365' ' ' GLU . 11.9 t0 -75.27 94.51 3.02 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.337 -0.852 . . . . 35.03 110.202 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' S' S ' 364' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 53.86 -89.34 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.545 -0.722 . . . . 46.72 110.575 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' S' S ' 365' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' S' ' 363' ' ' ASP . 23.8 mt-10 -122.67 19.1 10.34 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.082 -1.011 . . . . 56.2 110.271 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' S' S ' 366' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -117.95 125.05 49.68 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.26 -0.9 . . . . 51.02 110.406 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' S' S ' 367' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -107.03 127.0 53.07 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.357 -0.84 . . . . 37.59 110.112 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' S' S ' 368' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -165.39 159.56 13.98 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.303 -0.873 . . . . 31.47 110.452 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' S' S ' 369' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' S' ' 360' ' ' TYR . 45.7 Cg_endo -72.89 139.63 30.59 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 O-C-N 123.831 1.437 . . . . 28.85 110.509 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' S' S ' 370' ' ' TRP . . . . . . . . . . . . . 67.4 t90 -167.22 113.53 0.76 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.402 -0.812 . . . . 26.94 109.987 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' S' S ' 371' ' ' THR . . . . . . . . . . . . . 59.1 m -74.8 113.04 20.62 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.406 -0.808 . . . . 20.19 110.049 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' S' S ' 372' ' ' PRO . . . . . 0.562 ' O ' HD11 ' S' ' 334' ' ' LEU . 48.0 Cg_endo -73.46 157.16 49.55 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 O-C-N 123.662 1.348 . . . . 28.68 110.625 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' S' S ' 373' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -90.67 147.19 35.69 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.391 -0.818 . . . . 35.72 109.832 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' S' S ' 374' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -76.02 -6.28 17.2 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.701 1.369 . . . . 30.89 110.506 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' S' S ' 375' ' ' SER . . . . . . . . . . . . . 70.4 p -104.42 -16.88 14.97 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.235 -0.916 . . . . 29.41 110.43 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' S' S ' 376' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -106.53 43.14 1.18 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.23 -0.919 . . . . 32.89 110.257 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' S' S ' 377' ' ' VAL . . . . . 0.595 ' O ' HG11 ' S' ' 327' ' ' VAL . 7.3 p -114.7 147.26 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.311 -0.868 . . . . 24.33 110.163 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' S' S ' 378' ' ' LEU . . . . . . . . . . . . . 52.2 mt -115.96 -58.08 2.15 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.406 -0.809 . . . . 24.37 109.633 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' S' S ' 379' ' ' VAL . . . . . 0.643 HG22 HG12 ' S' ' 326' ' ' VAL . 61.0 t -120.65 132.33 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.443 -0.786 . . . . 18.02 109.48 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' S' S ' 380' ' ' PHE . . . . . 0.46 ' CE1' ' HB2' ' S' ' 325' ' ' CYS . 14.3 p90 -142.54 173.92 11.1 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.398 -0.814 . . . . 29.35 110.622 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' S' S ' 381' ' ' VAL . . . . . . . . . . . . . 58.0 t -120.05 107.38 39.85 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.53 -0.731 . . . . 16.34 109.391 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' S' S ' 382' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' S' ' 336' ' ' ASP . 45.4 Cg_endo -71.32 145.58 48.69 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.698 1.367 . . . . 20.94 110.738 -179.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' S' S ' 383' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -61.02 -53.51 56.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.389 -0.819 . . . . 28.93 109.891 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' S' S ' 384' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.389 -0.82 . . . . 47.03 110.342 -177.046 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' R' R ' 29' ' ' MET . . . . . . . . . . . . . 15.6 mtt . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.164 0.507 . . . . 32.14 110.224 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' R' R ' 30' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -96.36 141.15 30.02 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.382 -0.824 . . . . 43.36 110.202 -179.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 31' ' ' LEU . . . . . . . . . . . . . 65.3 mt -134.91 140.56 45.85 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.312 -0.867 . . . . 22.93 110.283 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 32' ' ' THR . . . . . . . . . . . . . 69.6 m -87.55 110.57 20.45 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.376 -0.828 . . . . 22.34 109.984 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 33' ' ' LEU . . . . . 0.595 HD22 ' CE2' ' R' ' 62' ' ' TYR . 80.1 mt -62.35 -172.79 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.266 -0.896 . . . . 21.39 110.226 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 34' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -74.65 -29.41 61.25 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.333 -0.855 . . . . 34.4 110.386 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 35' ' ' ASN . . . . . . . . . . . . . 48.3 p30 -77.73 -1.87 33.38 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.324 -0.86 . . . . 30.28 110.633 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.2 -16.56 59.42 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.776 -1.329 . . . . 36.25 109.776 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 37' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -59.02 161.81 4.76 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.285 -1.127 . . . . 53.8 110.383 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 38' ' ' LYS . . . . . . . . . . . . . 56.9 mttt -117.84 135.78 53.86 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.43 -0.794 . . . . 49.91 110.108 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 39' ' ' LYS . . . . . 0.406 ' HG2' ' CZ ' ' R' ' 41' ' ' PHE . 8.1 ttmt -138.75 143.69 39.12 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.432 -0.792 . . . . 35.69 110.223 -179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 40' ' ' THR . . . . . . . . . . . . . 23.7 m -102.57 127.98 49.42 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.309 -0.87 . . . . 34.84 110.193 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 41' ' ' PHE . . . . . 0.406 ' CZ ' ' HG2' ' R' ' 39' ' ' LYS . 96.6 m-85 -113.09 132.66 55.34 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.402 -0.811 . . . . 34.42 110.147 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 42' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -93.25 140.95 28.98 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.31 -0.869 . . . . 51.46 110.204 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 43' ' ' SER . . . . . . . . . . . . . 54.5 m -70.81 141.89 51.33 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.453 -0.779 . . . . 41.84 110.206 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.74 125.41 29.53 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.296 -0.877 . . . . 33.82 109.934 179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 45' ' ' PRO . . . . . 0.424 ' HG2' ' ND2' ' R' ' 77' ' ' ASN . 46.1 Cg_endo -72.16 151.05 54.74 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.59 1.31 . . . . 30.27 110.649 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 46' ' ' ASN . . . . . 0.4 ' HA ' ' OD1' ' R' ' 50' ' ' ASN . 52.1 t-20 -124.23 109.84 13.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.456 -0.777 . . . . 35.1 110.033 179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 47' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -120.28 -34.84 3.56 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.298 -0.876 . . . . 42.81 110.503 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 48' ' ' HIS . . . . . 0.439 ' NE2' HD11 ' R' ' 80' ' ' LEU . 73.4 m80 -105.77 45.18 0.98 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.221 -0.925 . . . . 49.97 110.176 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 49' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 50.29 34.72 9.28 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.414 -0.804 . . . . 61.32 110.173 -179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 50' ' ' ASN . . . . . 0.4 ' OD1' ' HA ' ' R' ' 46' ' ' ASN . 15.0 p-10 -86.25 43.74 1.08 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.333 -0.854 . . . . 51.5 110.703 -179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 51' ' ' ALA . . . . . 0.455 ' HB3' ' C ' ' S' ' 401' ' ' LYS . . . -66.08 -46.11 78.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.184 -0.948 . . . . 38.77 109.558 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 52' ' ' TRP . . . . . 0.483 ' CD2' ' N ' ' R' ' 53' ' ' LEU . 68.2 p-90 -58.39 -38.43 77.31 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.419 -0.801 . . . . 26.24 110.055 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 53' ' ' LEU . . . . . 0.483 ' N ' ' CD2' ' R' ' 52' ' ' TRP . 23.2 tp -66.68 -46.68 74.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.4 -0.813 . . . . 26.75 110.013 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 54' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -55.2 -41.61 72.22 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.372 -0.83 . . . . 35.02 110.156 179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.17 -46.08 92.0 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.337 -0.852 . . . . 24.47 110.145 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 56' ' ' ILE . . . . . 0.432 HG12 HD11 ' R' ' 104' ' ' ILE . 76.2 mt -62.23 -42.21 94.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.322 -0.861 . . . . 26.03 109.906 179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 57' ' ' LEU . . . . . . . . . . . . . 22.4 mt -60.31 -45.6 92.83 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.325 -0.859 . . . . 26.77 109.68 179.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 58' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -63.97 -46.49 84.4 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.426 -0.796 . . . . 22.32 109.561 179.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 59' ' ' LEU . . . . . 0.429 ' HA ' ' HE2' ' R' ' 151' ' ' PHE . 23.9 tp -61.43 -37.75 84.65 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.316 -0.865 . . . . 20.55 109.396 179.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 60' ' ' PHE . . . . . 0.528 ' CE2' HD21 ' R' ' 111' ' ' LEU . 2.8 m-85 -61.08 -44.78 96.85 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.628 -0.67 . . . . 20.08 109.907 179.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 61' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -63.16 -36.15 82.65 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.481 -0.762 . . . . 18.8 110.472 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 62' ' ' TYR . . . . . 0.595 ' CE2' HD22 ' R' ' 33' ' ' LEU . 9.2 t80 -63.04 -41.78 99.58 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.207 -0.933 . . . . 26.45 110.26 -179.792 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 63' ' ' VAL . . . . . 0.406 ' H ' HG22 ' R' ' 63' ' ' VAL . 30.2 m -93.38 20.38 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.304 -0.872 . . . . 29.75 110.188 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 64' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 52.91 75.6 0.23 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.303 -0.873 . . . . 35.52 110.546 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 65' ' ' GLU . . . . . 0.443 ' HG2' ' CD2' ' R' ' 60' ' ' PHE . 14.3 tp10 -116.29 104.05 52.35 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.457 -0.777 . . . . 29.89 109.901 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 66' ' ' PRO . . . . . 0.48 ' HA ' ' HB2' ' R' ' 69' ' ' ASP . 46.6 Cg_endo -73.55 -5.83 17.74 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.79 1.416 . . . . 21.37 111.094 -179.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 67' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -52.11 -61.56 2.19 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.103 -0.998 . . . . 23.85 110.331 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 68' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -98.12 36.56 1.56 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.25 -0.906 . . . . 28.07 110.438 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 69' ' ' ASP . . . . . 0.48 ' HB2' ' HA ' ' R' ' 66' ' ' PRO . 11.7 t0 -72.36 -33.26 67.13 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.346 -0.846 . . . . 43.76 110.144 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 70' ' ' TRP . . . . . 0.477 ' CE2' ' CG2' ' R' ' 71' ' ' VAL . 47.9 p-90 -73.42 -3.84 29.88 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.275 -0.891 . . . . 33.06 110.716 -179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 71' ' ' VAL . . . . . 0.556 HG11 ' HB2' ' R' ' 82' ' ' ALA . 40.7 t -109.79 -27.45 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.194 -0.941 . . . . 31.7 109.685 179.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 72' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -86.62 -48.83 7.98 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.358 -0.839 . . . . 33.58 110.282 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 73' ' ' SER . . . . . . . . . . . . . 69.9 m -89.7 51.08 2.01 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.27 -0.893 . . . . 50.82 110.36 -179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 74' ' ' SER . . . . . . . . . . . . . 15.8 t -125.92 138.3 31.8 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.338 -0.851 . . . . 34.74 110.221 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.38 -24.97 15.93 Favored 'Trans proline' 0 C--N 1.312 -1.389 0 O-C-N 123.641 1.337 . . . . 35.7 110.348 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 76' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -91.68 153.16 19.85 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.37 -0.831 . . . . 66.48 110.379 -179.804 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 77' ' ' ASN . . . . . 0.424 ' ND2' ' HG2' ' R' ' 45' ' ' PRO . 22.2 t-20 -81.48 95.22 7.03 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.292 -0.88 . . . . 46.72 110.102 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 78' ' ' LEU . . . . . . . . . . . . . 96.3 mt -96.44 28.0 3.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.331 -0.856 . . . . 37.55 110.182 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 79' ' ' THR . . . . . . . . . . . . . 29.7 m -56.2 -54.67 42.44 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.379 -0.825 . . . . 37.36 110.295 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 80' ' ' LEU . . . . . 0.603 ' HA ' HD12 ' R' ' 83' ' ' ILE . 16.0 mt -60.82 -23.27 64.96 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.347 -0.845 . . . . 35.83 110.543 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 81' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -79.46 -39.12 32.98 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.184 -0.948 . . . . 44.03 110.32 -179.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 82' ' ' ALA . . . . . 0.556 ' HB2' HG11 ' R' ' 71' ' ' VAL . . . -69.5 -28.58 66.17 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.292 -0.88 . . . . 32.54 110.202 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 83' ' ' ILE . . . . . 0.603 HD12 ' HA ' ' R' ' 80' ' ' LEU . 78.1 mt -70.15 -46.06 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.34 -0.85 . . . . 32.02 110.302 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 84' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -55.22 -52.08 64.52 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.164 -0.96 . . . . 34.09 110.596 -179.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 85' ' ' GLN . . . . . 0.532 ' HG2' HD12 ' R' ' 89' ' ' LEU . 31.9 tt0 -54.83 -46.87 74.64 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.235 -0.915 . . . . 25.94 110.28 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 86' ' ' LEU . . . . . . . . . . . . . 24.0 mt -58.63 -43.85 89.81 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.299 -0.876 . . . . 16.2 109.936 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 87' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -65.34 -35.26 80.43 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.466 -0.771 . . . . 49.09 110.286 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 88' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -78.43 -19.04 54.07 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.247 -0.908 . . . . 28.61 110.493 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 89' ' ' LEU . . . . . 0.532 HD12 ' HG2' ' R' ' 85' ' ' GLN . 32.6 mt -96.18 -29.41 14.07 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.207 -0.933 . . . . 26.16 110.197 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 90' ' ' THR . . . . . . . . . . . . . 58.7 p -105.7 -34.59 7.66 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.285 -0.884 . . . . 33.33 109.778 179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.85 16.1 58.6 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.821 -1.312 . . . . 31.13 109.821 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 92' ' ' LEU . . . . . . . . . . . . . 97.0 mt -100.1 155.29 17.81 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.169 -1.195 . . . . 42.52 110.21 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 93' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -86.28 91.56 8.51 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.46 -0.775 . . . . 68.46 109.984 179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 94' ' ' LEU . . . . . 0.457 ' HB3' ' CZ2' ' R' ' 52' ' ' TRP . 48.1 mt -99.41 53.01 0.95 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.18 -0.95 . . . . 44.63 110.364 -179.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 95' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.44 -38.69 6.39 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.3 -0.875 . . . . 67.16 110.399 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 96' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -113.93 44.29 1.67 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.404 -0.81 . . . . 67.02 110.326 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 97' ' ' GLY . . . . . . . . . . . . . . . 99.12 150.78 26.03 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.614 -1.395 . . . . 49.48 109.614 179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 98' ' ' GLY . . . . . . . . . . . . . . . -166.21 160.03 33.46 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.253 -1.539 . . . . 36.57 109.253 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 99' ' ' PRO . . . . . 0.95 ' HB3' HG12 ' S' ' 396' ' ' VAL . 45.1 Cg_endo -72.58 121.1 7.13 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.684 1.36 . . . . 30.41 110.435 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 100' ' ' PRO . . . . . 0.642 ' HD3' ' HD3' ' S' ' 401' ' ' LYS . 45.7 Cg_endo -72.25 -31.65 11.49 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 O-C-N 123.645 1.339 . . . . 29.94 110.54 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 101' ' ' ALA . . . . . 0.476 ' HB2' ' HB3' ' R' ' 178' ' ' LEU . . . -69.96 -38.48 76.13 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.301 -0.875 . . . . 23.64 110.263 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 102' ' ' LEU . . . . . 0.424 HD23 HD21 ' R' ' 106' ' ' ASN . 0.1 OUTLIER -72.62 -40.8 66.17 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.322 -0.861 . . . . 20.31 110.362 -179.713 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' R' R ' 103' ' ' VAL . . . . . 0.79 HG23 ' O ' ' R' ' 99' ' ' PRO . 63.7 t -58.16 -40.06 75.71 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.219 -0.925 . . . . 16.33 109.996 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 104' ' ' ILE . . . . . 0.432 HD11 HG12 ' R' ' 56' ' ' ILE . 81.9 mt -71.7 -30.57 38.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.397 -0.814 . . . . 24.77 109.93 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 105' ' ' TRP . . . . . 0.462 ' O ' ' HD3' ' R' ' 108' ' ' LYS . 70.6 t-105 -82.42 0.84 40.28 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.345 -0.847 . . . . 23.28 110.273 179.643 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 106' ' ' ASN . . . . . 0.424 HD21 HD23 ' R' ' 102' ' ' LEU . 6.9 m-80 -105.08 -10.38 17.21 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.116 -0.99 . . . . 28.26 110.125 179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 107' ' ' ILE . . . . . . . . . . . . . 36.8 pt -126.83 34.97 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.211 -0.931 . . . . 18.77 110.05 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 108' ' ' LYS . . . . . 0.502 ' HG2' ' HB ' ' R' ' 115' ' ' ILE . 9.3 mtpp -61.05 -48.44 81.72 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.548 -0.72 . . . . 42.5 110.025 179.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 109' ' ' HIS . . . . . 0.445 ' CD2' ' HG ' ' R' ' 110' ' ' LEU . 50.8 p-80 -66.02 -12.85 58.07 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.527 -0.733 . . . . 20.07 110.698 -179.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 110' ' ' LEU . . . . . 0.445 ' HG ' ' CD2' ' R' ' 109' ' ' HIS . 80.6 mt -94.79 -17.25 22.31 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.076 -1.015 . . . . 15.69 110.207 179.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 111' ' ' LEU . . . . . 0.528 HD21 ' CE2' ' R' ' 60' ' ' PHE . 10.3 mt -94.13 144.15 25.75 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.342 -0.849 . . . . 25.39 111.014 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 112' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -77.71 -17.35 57.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.552 -0.717 . . . . 53.48 109.852 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 113' ' ' THR . . . . . 0.459 HG22 ' N ' ' R' ' 114' ' ' GLY . 60.0 m -83.73 166.64 17.88 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.236 -0.915 . . . . 14.8 110.233 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 114' ' ' GLY . . . . . 0.459 ' N ' HG22 ' R' ' 113' ' ' THR . . . -97.96 127.16 9.13 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.994 -1.243 . . . . 16.14 109.994 -179.597 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 115' ' ' ILE . . . . . 0.577 HD13 ' HB ' ' R' ' 124' ' ' VAL . 47.7 mm -109.11 139.31 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.441 -1.035 . . . . 13.46 109.738 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 116' ' ' GLY . . . . . . . . . . . . . . . -152.74 -155.88 7.3 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.959 -1.257 . . . . 23.9 109.959 -179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 117' ' ' THR . . . . . 0.528 HG22 ' CG2' ' R' ' 126' ' ' VAL . 18.8 p -134.99 -171.39 2.79 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.453 -1.028 . . . . 27.37 110.044 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 118' ' ' ALA . . . . . 0.445 ' HB3' ' OD1' ' R' ' 128' ' ' ASP . . . -56.6 -58.04 9.79 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.251 -0.906 . . . . 18.76 110.064 179.741 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 119' ' ' SER . . . . . 0.491 ' CB ' ' HB ' ' R' ' 196' ' ' VAL . 1.1 m -56.52 -40.66 75.42 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.259 -0.901 . . . . 32.35 109.721 179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 120' ' ' ARG . . . . . 0.409 ' NH1' ' NE1' ' S' ' 305' ' ' TRP . 10.0 mtm180 -110.03 86.26 4.84 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.47 -0.768 . . . . 27.12 109.716 179.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 121' ' ' PRO . . . . . 0.483 ' HA ' ' SG ' ' R' ' 125' ' ' CYS . 44.7 Cg_endo -71.26 166.44 29.25 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 O-C-N 123.784 1.413 . . . . 22.68 111.009 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 122' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' R' ' 121' ' ' PRO . 38.2 t 178.58 -161.65 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.609 -0.682 . . . . 22.99 109.467 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 123' ' ' GLU . . . . . 0.44 ' HG2' HG23 ' R' ' 113' ' ' THR . 2.3 tp10 -56.5 -39.92 74.08 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.211 -0.93 . . . . 36.18 109.649 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 124' ' ' VAL . . . . . 0.577 ' HB ' HD13 ' R' ' 115' ' ' ILE . 83.8 t -142.57 136.39 27.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.606 -0.684 . . . . 20.64 109.383 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 125' ' ' CYS . . . . . 0.483 ' SG ' ' HA ' ' R' ' 121' ' ' PRO . 83.7 m -140.3 168.17 20.43 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.17 -0.956 . . . . 22.8 111.131 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 126' ' ' VAL . . . . . 0.728 HG12 HG22 ' R' ' 179' ' ' VAL . 35.9 m -122.68 159.82 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.724 -0.61 . . . . 21.24 109.613 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 127' ' ' VAL . . . . . 0.71 HG11 ' O ' ' R' ' 177' ' ' VAL . 31.1 m -70.89 141.86 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.283 -0.886 . . . . 19.77 110.675 -179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 128' ' ' ASP . . . . . 0.445 ' OD1' ' HB3' ' R' ' 118' ' ' ALA . 53.9 p-10 -137.73 19.41 2.87 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.327 -0.858 . . . . 29.21 110.697 179.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 129' ' ' GLY . . . . . . . . . . . . . . . 114.06 -0.02 24.06 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.928 -1.13 . . . . 33.86 110.441 179.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 130' ' ' THR . . . . . . . . . . . . . 58.7 m -91.9 131.88 36.9 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.11 -1.229 . . . . 26.41 110.046 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -62.57 120.72 11.68 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.369 -0.832 . . . . 33.08 110.258 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 132' ' ' MET . . . . . 0.433 ' HE1' ' CE2' ' R' ' 180' ' ' PHE . 98.4 mmm -105.17 165.63 10.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.467 -0.771 . . . . 30.76 110.467 -179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 133' ' ' CYS . . . . . 0.41 ' HA ' ' HB3' ' R' ' 174' ' ' PRO . 32.8 m -141.13 158.13 44.34 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.542 -0.724 . . . . 27.0 109.973 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 134' ' ' LEU . . . . . 0.564 HD11 ' O ' ' R' ' 172' ' ' PRO . 0.1 OUTLIER -58.45 -19.71 38.88 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.322 -0.861 . . . . 33.9 110.553 -179.922 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' R' R ' 135' ' ' ALA . . . . . . . . . . . . . . . -92.8 8.24 40.29 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.31 -0.868 . . . . 19.37 110.802 -179.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 136' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -93.76 -21.84 19.07 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.209 -0.932 . . . . 30.47 110.183 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 137' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -149.95 165.42 32.71 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.321 -0.862 . . . . 24.27 110.189 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 138' ' ' HIS . . . . . 0.433 ' HA ' HG23 ' R' ' 154' ' ' VAL . 15.2 p80 -117.88 15.19 14.33 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.382 -0.824 . . . . 20.91 110.452 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 139' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' R' ' 152' ' ' ALA . . . -177.22 152.4 0.87 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.207 -0.933 . . . . 15.69 110.099 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 140' ' ' GLY . . . . . 0.427 ' HA3' ' O ' ' R' ' 179' ' ' VAL . . . 161.81 175.17 32.55 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.962 -1.255 . . . . 23.76 109.962 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 141' ' ' ILE . . . . . . . . . . . . . 83.7 mt -95.5 136.54 26.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.473 -1.016 . . . . 25.3 109.718 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 142' ' ' PHE . . . . . 0.576 ' CD2' ' HB2' ' R' ' 172' ' ' PRO . 82.7 m-85 -120.72 -172.61 2.41 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.26 -0.9 . . . . 30.24 110.505 -179.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 143' ' ' LEU . . . . . 0.742 HD23 ' O ' ' R' ' 148' ' ' HIS . 0.5 OUTLIER -119.79 77.74 1.26 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.367 -0.833 . . . . 32.8 110.316 -179.887 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' R' R ' 144' ' ' LYS . . . . . 0.471 ' HG3' ' CZ2' ' R' ' 170' ' ' TRP . 1.0 OUTLIER -69.62 76.87 0.43 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.43 -0.794 . . . . 49.18 109.679 179.594 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' R' R ' 145' ' ' GLY . . . . . 0.458 ' O ' HD22 ' R' ' 143' ' ' LEU . . . 104.5 179.27 24.83 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.188 -1.565 . . . . 53.87 109.188 -179.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 146' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -88.47 145.83 25.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.388 -1.066 . . . . 68.58 109.999 179.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 147' ' ' GLU . . . . . 0.68 ' HA ' ' CB ' ' S' ' 398' ' ' ARG . 10.9 mt-10 58.25 36.45 25.69 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.362 -0.837 . . . . 56.62 110.655 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 148' ' ' HIS . . . . . 0.742 ' O ' HD23 ' R' ' 143' ' ' LEU . 44.7 t60 -158.61 148.13 19.28 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.219 -0.926 . . . . 44.57 110.376 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 149' ' ' ALA . . . . . 0.587 ' HB2' ' NZ ' ' S' ' 401' ' ' LYS . . . -150.29 146.9 27.05 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.467 -0.771 . . . . 33.54 110.07 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 150' ' ' VAL . . . . . . . . . . . . . 34.2 m -142.3 161.51 19.51 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.261 -0.899 . . . . 27.61 110.36 179.697 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 151' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' R' ' 152' ' ' ALA . 5.8 t80 -86.17 155.6 20.67 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.428 -0.795 . . . . 23.04 109.904 179.66 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 152' ' ' ALA . . . . . 0.537 ' N ' ' CD1' ' R' ' 151' ' ' PHE . . . -157.29 151.5 24.87 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.443 -0.786 . . . . 29.61 109.611 179.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 153' ' ' CYS . . . . . . . . . . . . . 26.7 p -154.28 173.57 15.97 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.298 -0.876 . . . . 22.75 110.507 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 154' ' ' VAL . . . . . 0.613 HG22 ' CE2' ' R' ' 159' ' ' TRP . 59.7 t -90.59 117.04 33.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.392 -0.817 . . . . 23.26 110.076 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 155' ' ' THR . . . . . . . . . . . . . 70.3 p -112.13 -176.63 2.97 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.358 -0.839 . . . . 17.88 110.041 179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 156' ' ' SER . . . . . . . . . . . . . 78.6 p -75.92 -3.75 37.16 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.329 -0.857 . . . . 21.83 110.727 -179.9 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 157' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -118.25 10.43 12.85 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.148 -0.97 . . . . 36.54 110.619 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 158' ' ' GLY . . . . . . . . . . . . . . . 117.97 -162.71 13.02 Favored Glycine 0 N--CA 1.492 2.404 0 N-CA-C 109.533 -1.427 . . . . 31.74 109.533 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 159' ' ' TRP . . . . . 0.613 ' CE2' HG22 ' R' ' 154' ' ' VAL . 14.7 m95 -86.51 122.42 30.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.334 -1.098 . . . . 28.25 110.112 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 160' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -108.46 166.96 10.38 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.376 -0.827 . . . . 41.24 110.19 -179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 161' ' ' ALA . . . . . . . . . . . . . . . -143.22 123.42 13.74 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.362 -0.836 . . . . 27.4 110.198 -179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 162' ' ' ILE . . . . . . . . . . . . . 92.0 mt -87.55 81.15 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.295 -0.878 . . . . 24.27 110.051 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 163' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' R' ' 165' ' ' GLU . 15.3 t0 -72.86 92.42 1.6 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.457 -0.777 . . . . 36.08 110.254 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 164' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 54.09 -88.94 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.489 -0.757 . . . . 46.08 110.603 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 165' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' R' ' 163' ' ' ASP . 29.7 mt-10 -124.72 35.92 4.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.088 -1.007 . . . . 50.94 110.187 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 166' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -135.75 117.3 14.84 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.388 -0.82 . . . . 47.28 110.347 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 167' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -101.04 119.98 39.53 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.434 -0.791 . . . . 40.47 110.164 179.873 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 168' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -157.57 158.57 30.65 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.24 -0.913 . . . . 30.21 110.376 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 169' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.8 133.04 19.46 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.931 1.49 . . . . 32.76 110.474 -179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 170' ' ' TRP . . . . . 0.471 ' CZ2' ' HG3' ' R' ' 144' ' ' LYS . 66.9 t90 -159.81 119.37 2.89 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.461 -0.774 . . . . 32.79 109.909 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 171' ' ' THR . . . . . . . . . . . . . 46.1 m -81.1 112.61 34.16 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.448 -0.783 . . . . 36.92 110.163 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 172' ' ' PRO . . . . . 0.576 ' HB2' ' CD2' ' R' ' 142' ' ' PHE . 47.4 Cg_endo -73.71 158.75 46.68 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.66 1.348 . . . . 33.54 110.592 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 173' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -88.84 144.97 33.86 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.318 -0.864 . . . . 45.76 109.851 179.701 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 174' ' ' PRO . . . . . 0.41 ' HB3' ' HA ' ' R' ' 133' ' ' CYS . 46.0 Cg_endo -71.74 -10.34 26.31 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.614 1.323 . . . . 29.63 110.492 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 175' ' ' SER . . . . . . . . . . . . . 53.1 p -103.5 -17.55 15.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.281 -0.887 . . . . 35.7 110.343 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 176' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -103.5 43.26 1.1 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.202 -0.936 . . . . 39.65 110.442 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 177' ' ' VAL . . . . . 0.71 ' O ' HG11 ' R' ' 127' ' ' VAL . 10.5 p -117.79 127.14 75.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.326 -0.859 . . . . 20.61 110.034 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 178' ' ' LEU . . . . . 0.476 ' HB3' ' HB2' ' R' ' 101' ' ' ALA . 46.3 mt -91.47 -61.36 1.66 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.35 -0.844 . . . . 15.58 109.351 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 179' ' ' VAL . . . . . 0.728 HG22 HG12 ' R' ' 126' ' ' VAL . 67.9 t -114.58 144.72 21.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.621 -0.674 . . . . 17.4 109.413 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 180' ' ' PHE . . . . . 0.433 ' CE2' ' HE1' ' R' ' 132' ' ' MET . 43.7 p90 -152.17 163.32 39.62 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.273 -0.892 . . . . 20.16 110.602 -179.818 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 181' ' ' VAL . . . . . . . . . . . . . 66.5 t -113.12 111.48 50.4 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.429 -0.795 . . . . 17.69 109.833 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 182' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.03 149.52 52.9 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.545 1.287 . . . . 17.81 110.423 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 183' ' ' TYR . . . . . 0.739 ' O ' ' C ' ' R' ' 184' ' ' ASP . 78.9 m-85 -59.01 175.53 0.28 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.43 -0.794 . . . . 28.01 110.526 -179.731 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 184' ' ' ASP . . . . . 0.739 ' C ' ' O ' ' R' ' 183' ' ' TYR . 0.0 OUTLIER -12.28 -76.89 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.343 -0.848 . . . . 58.64 110.303 -178.086 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' R' R ' 185' ' ' GLN . . . . . . . . . . . . . 6.7 tm0? . . . . . 0 N--CA 1.503 2.188 0 CA-C-O 121.25 0.548 . . . . 80.42 111.723 179.409 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' R' R ' 193' ' ' LYS . . . . . 0.598 ' O ' ' HB2' ' R' ' 194' ' ' ALA . 20.4 ttpp . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 120.938 0.399 . . . . 49.5 110.166 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' R' R ' 194' ' ' ALA . . . . . 0.598 ' HB2' ' O ' ' R' ' 193' ' ' LYS . . . 174.32 -165.57 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.125 -0.984 . . . . 40.4 110.099 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 195' ' ' LYS . . . . . 0.427 ' O ' ' OG ' ' R' ' 119' ' ' SER . 24.8 mmtt -79.5 174.5 11.52 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.441 -0.787 . . . . 34.6 110.31 179.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 196' ' ' VAL . . . . . 0.594 HG21 ' HA ' ' S' ' 328' ' ' ASP . 2.5 t 51.56 25.31 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.249 -0.907 . . . . 33.27 110.629 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 197' ' ' GLN . . . . . 0.641 ' HA ' HD11 ' S' ' 302' ' ' LEU . 0.0 OUTLIER -162.48 27.62 0.11 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.124 -0.985 . . . . 41.58 110.709 179.778 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' R' R ' 198' ' ' ARG . . . . . 0.678 ' NH1' HD13 ' R' ' 200' ' ' LEU . 0.0 OUTLIER -124.98 149.99 47.13 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.199 -0.938 . . . . 38.65 110.203 179.998 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' R' R ' 199' ' ' LYS . . . . . 0.68 ' HA ' ' HD3' ' S' ' 299' ' ' PRO . 27.9 mmtm -82.22 99.24 9.17 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.372 -0.83 . . . . 36.77 109.954 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' R' R ' 200' ' ' LEU . . . . . 0.678 HD13 ' NH1' ' R' ' 198' ' ' ARG . 0.4 OUTLIER -81.59 -153.29 0.1 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.433 -0.792 . . . . 33.08 110.095 179.697 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' R' R ' 201' ' ' LYS . . . . . 0.491 ' HA ' ' CA ' ' S' ' 297' ' ' GLY . 63.2 mttt . . . . . 0 N--CA 1.492 1.673 0 O-C-N 121.364 -0.835 . . . . 44.32 110.234 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' S' S ' 229' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.171 0.51 . . . . 51.83 110.208 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' S' S ' 230' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -97.28 142.76 28.78 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.4 -0.813 . . . . 54.13 110.222 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' S' S ' 231' ' ' LEU . . . . . . . . . . . . . 67.8 mt -134.11 140.99 46.97 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.343 -0.848 . . . . 33.04 110.337 -179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' S' S ' 232' ' ' THR . . . . . 0.411 ' O ' ' HA ' ' S' ' 355' ' ' THR . 40.0 m -89.25 103.23 15.87 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.319 -0.863 . . . . 26.92 110.068 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 233' ' ' LEU . . . . . 0.666 HD22 ' CE2' ' S' ' 262' ' ' TYR . 79.9 mt -55.92 179.28 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.437 -0.79 . . . . 13.78 110.498 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 234' ' ' TYR . . . . . 0.442 ' CG ' ' N ' ' S' ' 235' ' ' ASN . 35.6 p90 -65.01 -35.65 81.89 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.393 -0.817 . . . . 26.08 110.198 179.944 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 235' ' ' ASN . . . . . 0.442 ' N ' ' CG ' ' S' ' 234' ' ' TYR . 50.7 p30 -74.33 -7.4 52.69 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.373 -0.829 . . . . 20.04 110.567 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 236' ' ' GLY . . . . . . . . . . . . . . . 95.69 -19.9 52.22 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.782 -1.327 . . . . 22.71 109.782 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' S' S ' 237' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -53.03 145.73 12.49 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.189 -1.183 . . . . 35.44 110.183 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' S' S ' 238' ' ' LYS . . . . . . . . . . . . . 44.3 mttt -102.17 127.91 48.89 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.38 -0.825 . . . . 32.56 110.361 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' S' S ' 239' ' ' LYS . . . . . 0.412 ' HG2' ' CZ ' ' S' ' 241' ' ' PHE . 9.0 ttmt -132.31 144.52 50.63 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.357 -0.839 . . . . 26.68 109.955 179.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 240' ' ' THR . . . . . . . . . . . . . 51.8 m -102.0 132.22 47.97 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.34 -0.85 . . . . 41.02 110.348 -179.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' S' S ' 241' ' ' PHE . . . . . 0.412 ' CZ ' ' HG2' ' S' ' 239' ' ' LYS . 96.0 m-85 -117.96 137.7 52.67 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.418 -0.801 . . . . 28.62 110.186 179.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 242' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -96.42 161.78 13.77 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.392 -0.818 . . . . 47.89 110.257 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' S' S ' 243' ' ' SER . . . . . . . . . . . . . 72.0 m -90.5 151.52 21.33 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.372 -0.83 . . . . 45.09 110.282 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' S' S ' 244' ' ' ARG . . . . . . . . . . . . . 1.4 mtp85 -129.72 126.73 22.74 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.375 -0.828 . . . . 42.49 110.282 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' S' S ' 245' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.31 161.02 43.78 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.674 1.355 . . . . 35.68 110.544 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' S' S ' 246' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -132.89 97.85 4.14 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.353 -0.842 . . . . 51.88 109.853 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' S' S ' 247' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -110.47 -22.25 11.76 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.398 -0.813 . . . . 53.69 110.658 -179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' S' S ' 248' ' ' HIS . . . . . . . . . . . . . 76.7 m80 -117.24 43.65 2.27 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.223 -0.923 . . . . 55.79 110.704 -179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' S' S ' 249' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 48.84 38.37 11.9 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.405 -0.809 . . . . 49.45 110.386 179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' S' S ' 250' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -90.67 29.09 1.37 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.489 -0.757 . . . . 36.86 110.327 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' S' S ' 251' ' ' ALA . . . . . . . . . . . . . . . -53.91 -43.12 69.44 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.229 -0.919 . . . . 29.69 109.612 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' S' S ' 252' ' ' TRP . . . . . 0.417 ' CZ2' ' HB3' ' S' ' 294' ' ' LEU . 67.9 p-90 -61.81 -33.94 75.03 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.523 -0.736 . . . . 41.12 109.829 179.377 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 253' ' ' LEU . . . . . 0.408 ' N ' ' CD2' ' S' ' 252' ' ' TRP . 23.4 tp -70.17 -47.17 62.77 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.378 -0.826 . . . . 24.89 110.001 179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 254' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -56.13 -42.47 76.96 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.445 -0.784 . . . . 35.65 109.966 179.681 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' S' S ' 255' ' ' ALA . . . . . . . . . . . . . . . -59.53 -48.25 82.39 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.463 -0.773 . . . . 22.73 110.071 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' S' S ' 256' ' ' ILE . . . . . 0.509 HG12 HD11 ' S' ' 304' ' ' ILE . 79.7 mt -62.24 -40.68 88.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.321 -0.862 . . . . 28.85 109.983 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 257' ' ' LEU . . . . . . . . . . . . . 19.0 mt -61.54 -44.45 97.03 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.352 -0.843 . . . . 23.07 110.183 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' S' S ' 258' ' ' GLN . . . . . 0.499 ' HB3' ' CD2' ' S' ' 351' ' ' PHE . 53.4 mm-40 -65.12 -45.33 85.52 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.371 -0.831 . . . . 29.78 109.882 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 259' ' ' LEU . . . . . 0.416 ' O ' HG22 ' S' ' 263' ' ' VAL . 19.9 tp -58.67 -36.41 74.13 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.344 -0.848 . . . . 17.94 109.462 179.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 260' ' ' PHE . . . . . 0.523 ' CE2' HD21 ' S' ' 311' ' ' LEU . 3.1 m-85 -62.83 -45.29 93.3 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.655 -0.653 . . . . 30.57 109.834 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 261' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -62.01 -29.8 70.52 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.525 -0.734 . . . . 41.34 110.033 179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' S' S ' 262' ' ' TYR . . . . . 0.666 ' CE2' HD22 ' S' ' 233' ' ' LEU . 8.7 t80 -71.24 -44.62 64.94 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.443 -0.786 . . . . 26.03 110.093 179.697 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 263' ' ' VAL . . . . . 0.416 HG22 ' O ' ' S' ' 259' ' ' LEU . 33.0 m -91.99 18.24 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.336 -0.852 . . . . 22.8 110.411 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 264' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 52.79 70.65 0.55 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.223 -0.923 . . . . 44.03 110.611 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' S' S ' 265' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -111.78 109.25 55.46 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.394 -0.817 . . . . 35.61 109.654 179.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' S' S ' 266' ' ' PRO . . . . . 0.475 ' HA ' ' HB2' ' S' ' 269' ' ' ASP . 48.6 Cg_endo -75.39 0.45 9.05 Favored 'Trans proline' 0 C--N 1.311 -1.447 0 O-C-N 123.605 1.318 . . . . 37.67 111.742 -179.111 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 267' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -56.54 -67.7 0.28 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.802 -1.186 . . . . 41.49 110.165 -179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 268' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -92.91 39.89 1.05 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.148 -0.97 . . . . 50.76 110.048 179.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' S' S ' 269' ' ' ASP . . . . . 0.475 ' HB2' ' HA ' ' S' ' 266' ' ' PRO . 0.9 OUTLIER -76.01 -33.19 59.67 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.381 -0.825 . . . . 61.86 109.765 179.55 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' S' S ' 270' ' ' TRP . . . . . 0.512 ' CE2' HG23 ' S' ' 271' ' ' VAL . 51.0 p-90 -73.94 -4.28 34.2 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.268 -0.895 . . . . 39.85 110.466 179.852 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 271' ' ' VAL . . . . . 0.512 HG23 ' CE2' ' S' ' 270' ' ' TRP . 46.6 t -109.58 -32.66 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.157 -0.964 . . . . 39.18 110.07 179.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 272' ' ' TYR . . . . . . . . . . . . . 39.4 t80 -78.67 -36.53 43.63 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.42 -0.8 . . . . 40.02 110.47 -179.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' S' S ' 273' ' ' SER . . . . . . . . . . . . . 70.9 m -103.57 56.16 0.74 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.278 -0.889 . . . . 47.2 110.294 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' S' S ' 274' ' ' SER . . . . . . . . . . . . . 6.9 t -133.03 141.22 40.15 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.385 -0.822 . . . . 47.61 110.158 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' S' S ' 275' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.76 -18.85 21.71 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.66 1.347 . . . . 45.28 110.556 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' S' S ' 276' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -99.89 140.87 33.47 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.3 -0.875 . . . . 57.27 110.31 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' S' S ' 277' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -71.73 97.66 1.81 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.398 -0.814 . . . . 37.28 110.279 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' S' S ' 278' ' ' LEU . . . . . . . . . . . . . 86.3 mt -97.02 33.82 1.84 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.394 -0.816 . . . . 43.88 110.047 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' S' S ' 279' ' ' THR . . . . . . . . . . . . . 74.7 m -64.03 -60.1 3.65 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.484 -0.76 . . . . 50.05 110.303 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' S' S ' 280' ' ' LEU . . . . . 0.75 ' HA ' HD12 ' S' ' 283' ' ' ILE . 13.7 mt -51.61 -39.87 58.79 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.334 -0.854 . . . . 54.12 110.287 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 281' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.42 -49.67 74.57 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.499 -0.751 . . . . 65.28 110.177 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 282' ' ' ALA . . . . . . . . . . . . . . . -58.93 -33.9 71.12 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.456 -0.778 . . . . 46.51 110.571 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' S' S ' 283' ' ' ILE . . . . . 0.75 HD12 ' HA ' ' S' ' 280' ' ' LEU . 85.9 mt -66.39 -50.84 64.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.306 -0.871 . . . . 47.3 110.083 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 284' ' ' LYS . . . . . . . . . . . . . 33.8 tttp -50.52 -57.63 7.65 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.411 -0.806 . . . . 50.72 110.381 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' S' S ' 285' ' ' GLN . . . . . 0.538 ' HG2' HD12 ' S' ' 289' ' ' LEU . 34.4 tt0 -51.4 -46.4 62.84 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.487 -0.758 . . . . 68.47 110.283 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 286' ' ' LEU . . . . . . . . . . . . . 19.1 mt -59.95 -44.49 94.35 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.429 -0.794 . . . . 36.62 110.284 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' S' S ' 287' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -62.74 -35.29 79.3 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.33 -0.856 . . . . 46.64 110.077 179.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' S' S ' 288' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -76.23 -21.04 56.87 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.442 -0.787 . . . . 46.45 110.34 179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' S' S ' 289' ' ' LEU . . . . . 0.538 HD12 ' HG2' ' S' ' 285' ' ' GLN . 30.8 mt -97.35 -21.75 17.03 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.256 -0.902 . . . . 35.09 110.485 -179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 290' ' ' THR . . . . . 0.416 HG22 ' HB3' ' S' ' 306' ' ' ASN . 81.3 p -114.8 -28.44 7.08 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.281 -0.887 . . . . 38.61 110.419 -179.669 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 291' ' ' GLY . . . . . . . . . . . . . . . 79.4 10.97 85.41 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.833 -1.307 . . . . 36.77 109.833 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' S' S ' 292' ' ' LEU . . . . . 0.48 HD22 ' NZ ' ' R' ' 199' ' ' LYS . 84.7 mt -96.42 145.83 25.3 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.247 -1.149 . . . . 35.33 109.77 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 293' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -77.37 102.32 6.74 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.222 -0.924 . . . . 48.7 110.262 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' S' S ' 294' ' ' LEU . . . . . 0.417 ' HB3' ' CZ2' ' S' ' 252' ' ' TRP . 55.8 mt -106.86 51.73 0.74 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.575 -0.703 . . . . 42.61 110.123 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 295' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -112.56 -11.11 13.63 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.296 -0.878 . . . . 55.49 110.505 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 296' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -144.34 48.52 1.36 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.178 -0.951 . . . . 75.68 110.308 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' S' S ' 297' ' ' GLY . . . . . 0.491 ' CA ' ' HA ' ' R' ' 201' ' ' LYS . . . 96.9 145.18 18.7 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.524 -1.43 . . . . 49.44 109.524 179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 298' ' ' GLY . . . . . . . . . . . . . . . -163.8 156.93 29.0 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.807 -1.317 . . . . 41.11 109.807 -179.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' S' S ' 299' ' ' PRO . . . . . 0.68 ' HD3' ' HA ' ' R' ' 199' ' ' LYS . 47.9 Cg_endo -73.8 118.33 5.4 Favored 'Trans proline' 0 C--N 1.309 -1.515 0 O-C-N 123.916 1.482 . . . . 26.2 110.278 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 300' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.25 -15.48 31.64 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.587 1.309 . . . . 21.7 110.725 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' S' S ' 301' ' ' ALA . . . . . . . . . . . . . . . -80.73 -29.35 36.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.271 -0.893 . . . . 31.23 110.099 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' S' S ' 302' ' ' LEU . . . . . 0.641 HD11 ' HA ' ' R' ' 197' ' ' GLN . 0.0 OUTLIER -83.49 -40.61 18.99 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.4 -0.812 . . . . 38.99 109.982 179.802 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' S' S ' 303' ' ' VAL . . . . . 0.489 HG23 ' O ' ' S' ' 299' ' ' PRO . 58.1 t -60.74 -35.43 64.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.436 -0.79 . . . . 18.63 110.14 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 304' ' ' ILE . . . . . 0.509 HD11 HG12 ' S' ' 256' ' ' ILE . 86.0 mt -79.39 -23.65 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.37 -0.831 . . . . 25.46 110.178 179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 305' ' ' TRP . . . . . 0.419 ' CD2' ' HD3' ' S' ' 308' ' ' LYS . 68.9 t-105 -88.61 -14.54 37.27 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.295 -0.878 . . . . 33.4 110.569 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 306' ' ' ASN . . . . . 0.416 ' HB3' HG22 ' S' ' 290' ' ' THR . 10.4 m-80 -89.67 -13.65 36.52 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.191 -0.943 . . . . 36.97 110.388 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 307' ' ' ILE . . . . . 0.462 HG12 ' O ' ' S' ' 303' ' ' VAL . 36.9 pt -125.01 45.66 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.237 -0.915 . . . . 30.81 110.004 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 308' ' ' LYS . . . . . 0.419 ' HD3' ' CD2' ' S' ' 305' ' ' TRP . 1.5 mtmp? -73.64 -37.63 65.26 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.371 -0.831 . . . . 46.52 110.097 -179.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 309' ' ' HIS . . . . . 0.494 ' CD2' ' HG ' ' S' ' 310' ' ' LEU . 55.6 p-80 -73.26 -8.28 55.16 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.321 -0.862 . . . . 51.03 110.062 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 310' ' ' LEU . . . . . 0.494 ' HG ' ' CD2' ' S' ' 309' ' ' HIS . 53.0 mt -99.28 -12.87 19.97 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.353 -0.842 . . . . 36.16 109.986 179.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 311' ' ' LEU . . . . . 0.523 HD21 ' CE2' ' S' ' 260' ' ' PHE . 10.7 mt -97.19 147.88 23.64 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.339 -0.85 . . . . 40.0 110.399 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 312' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -81.6 -16.3 51.98 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.275 -0.891 . . . . 54.18 109.69 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' S' S ' 313' ' ' THR . . . . . 0.818 HG23 ' HG2' ' S' ' 323' ' ' GLU . 92.7 m -87.97 151.65 22.64 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.336 -0.853 . . . . 25.61 110.098 179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 314' ' ' GLY . . . . . . . . . . . . . . . -87.95 126.43 8.06 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 109.783 -1.327 . . . . 25.18 109.783 -179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' S' S ' 315' ' ' ILE . . . . . 0.643 HD13 ' HB ' ' S' ' 324' ' ' VAL . 50.7 mm -101.6 150.49 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 121.356 -1.085 . . . . 23.9 109.72 179.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 316' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' S' ' 325' ' ' CYS . . . -157.08 -159.25 9.37 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.957 -1.257 . . . . 23.18 109.957 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 317' ' ' THR . . . . . 0.421 HG22 ' CG2' ' S' ' 326' ' ' VAL . 11.2 p -133.94 -173.06 3.14 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.418 -1.048 . . . . 27.98 110.023 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.51 -56.19 25.15 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.175 -0.953 . . . . 28.1 109.926 179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' S' S ' 319' ' ' SER . . . . . . . . . . . . . 1.2 m -59.94 -41.7 92.42 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.36 -0.838 . . . . 37.0 109.656 179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' S' S ' 320' ' ' ARG . . . . . . . . . . . . . 12.1 mtm180 -111.67 79.91 2.64 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.529 -0.732 . . . . 52.07 109.718 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' S' S ' 321' ' ' PRO . . . . . 0.432 ' O ' ' HB2' ' S' ' 322' ' ' SER . 43.9 Cg_endo -71.45 171.48 16.13 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.865 1.455 . . . . 38.29 110.92 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 322' ' ' SER . . . . . 0.432 ' HB2' ' O ' ' S' ' 321' ' ' PRO . 41.3 t 178.68 -148.12 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 108.934 -0.765 . . . . 38.84 108.934 -179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 323' ' ' GLU . . . . . 0.818 ' HG2' HG23 ' S' ' 313' ' ' THR . 6.7 tp10 -62.89 -40.31 97.14 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.017 -1.052 . . . . 40.7 109.635 179.351 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 324' ' ' VAL . . . . . 0.643 ' HB ' HD13 ' S' ' 315' ' ' ILE . 72.8 t -141.25 135.01 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.402 -0.811 . . . . 20.34 109.506 179.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 325' ' ' CYS . . . . . 0.472 ' HB2' ' CE1' ' S' ' 380' ' ' PHE . 11.2 m -126.02 172.26 10.11 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.267 -0.895 . . . . 30.63 110.854 -179.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 326' ' ' VAL . . . . . 0.643 HG12 HG22 ' S' ' 379' ' ' VAL . 34.6 m -135.57 142.2 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.611 -0.681 . . . . 23.9 109.191 179.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 327' ' ' VAL . . . . . 0.601 HG11 ' O ' ' S' ' 377' ' ' VAL . 34.5 m -56.32 124.99 11.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.111 -0.993 . . . . 19.48 110.456 -179.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 328' ' ' ASP . . . . . 0.594 ' HA ' HG21 ' R' ' 196' ' ' VAL . 55.5 p-10 -119.37 11.53 12.22 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.412 -0.805 . . . . 26.43 110.417 179.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 329' ' ' GLY . . . . . . . . . . . . . . . 119.65 2.24 13.12 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 110.052 -1.219 . . . . 31.24 110.052 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' S' S ' 330' ' ' THR . . . . . . . . . . . . . 80.7 m -93.04 130.06 38.77 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.116 -1.226 . . . . 30.05 110.109 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' S' S ' 331' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -56.86 111.52 1.05 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.244 -0.91 . . . . 37.26 109.916 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' S' S ' 332' ' ' MET . . . . . . . . . . . . . 88.0 mmm -94.09 162.53 13.83 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.234 -0.916 . . . . 26.23 110.332 -179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' S' S ' 333' ' ' CYS . . . . . . . . . . . . . 25.8 m -137.2 150.07 47.64 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.47 -0.769 . . . . 23.56 110.058 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' S' S ' 334' ' ' LEU . . . . . 0.562 HD11 ' O ' ' S' ' 372' ' ' PRO . 0.1 OUTLIER -52.62 -24.83 9.15 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.371 -0.83 . . . . 28.93 110.428 179.933 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' S' S ' 335' ' ' ALA . . . . . . . . . . . . . . . -89.06 14.44 10.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.396 -0.815 . . . . 15.76 110.954 -179.351 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' S' S ' 336' ' ' ASP . . . . . . . . . . . . . 70.7 m-20 -100.45 -17.25 17.26 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.124 -0.985 . . . . 34.92 110.191 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' S' S ' 337' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -152.4 170.85 19.08 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.412 -0.805 . . . . 19.03 110.054 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' S' S ' 338' ' ' HIS . . . . . . . . . . . . . 13.4 p80 -120.71 10.37 10.98 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.363 -0.835 . . . . 18.82 110.449 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' S' S ' 339' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' S' ' 352' ' ' ALA . . . -175.95 155.18 1.58 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.221 -0.924 . . . . 17.18 110.054 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 340' ' ' GLY . . . . . . . . . . . . . . . 160.84 173.08 29.0 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.056 -1.218 . . . . 18.33 110.056 179.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' S' S ' 341' ' ' ILE . . . . . . . . . . . . . 83.9 mt -88.82 138.1 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.508 -0.995 . . . . 18.6 109.786 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' S' S ' 342' ' ' PHE . . . . . 0.485 ' CE2' ' HB3' ' S' ' 352' ' ' ALA . 70.0 m-85 -120.97 -178.46 3.75 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.256 -0.903 . . . . 23.44 110.396 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 343' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.82 93.33 4.16 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.412 -0.805 . . . . 35.59 110.008 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 344' ' ' LYS . . . . . 0.41 ' O ' ' HB3' ' S' ' 348' ' ' HIS . 0.3 OUTLIER -80.8 124.98 29.52 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.219 -0.926 . . . . 38.34 110.102 -179.987 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' S' S ' 345' ' ' GLY . . . . . . . . . . . . . . . 62.77 -130.83 43.09 Favored Glycine 0 N--CA 1.492 2.385 0 N-CA-C 108.887 -1.685 . . . . 53.46 108.887 -179.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' S' S ' 346' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -132.68 150.83 52.11 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.244 -1.151 . . . . 70.91 110.066 179.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' S' S ' 347' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 53.35 35.38 20.18 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.339 -0.85 . . . . 47.32 110.352 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' S' S ' 348' ' ' HIS . . . . . 0.41 ' HB3' ' O ' ' S' ' 344' ' ' LYS . 46.7 t60 -150.17 155.86 40.56 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.265 -0.897 . . . . 41.72 110.317 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 349' ' ' ALA . . . . . 0.452 ' C ' HG13 ' S' ' 350' ' ' VAL . . . -149.75 151.26 33.33 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.306 -0.871 . . . . 22.91 110.487 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 350' ' ' VAL . . . . . 0.452 HG13 ' C ' ' S' ' 349' ' ' ALA . 34.6 m -149.08 169.66 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.465 -0.772 . . . . 21.09 110.014 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 351' ' ' PHE . . . . . 0.499 ' CD2' ' HB3' ' S' ' 258' ' ' GLN . 10.7 t80 -105.42 143.66 33.28 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.284 -0.885 . . . . 25.03 110.67 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 352' ' ' ALA . . . . . 0.485 ' HB3' ' CE2' ' S' ' 342' ' ' PHE . . . -147.73 151.71 36.53 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.617 -0.677 . . . . 23.81 109.742 179.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 353' ' ' CYS . . . . . . . . . . . . . 26.3 p -153.35 164.85 37.42 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.346 -0.846 . . . . 25.66 110.27 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' S' S ' 354' ' ' VAL . . . . . 0.562 HG22 ' CE2' ' S' ' 359' ' ' TRP . 56.4 t -75.97 118.47 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.378 -0.826 . . . . 34.27 110.025 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 355' ' ' THR . . . . . 0.411 ' HA ' ' O ' ' S' ' 232' ' ' THR . 51.9 p -117.83 175.11 5.81 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.243 -0.911 . . . . 25.49 110.314 179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 356' ' ' SER . . . . . . . . . . . . . 62.3 p -62.15 -17.72 58.77 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.395 -0.815 . . . . 31.24 110.716 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' S' S ' 357' ' ' ASN . . . . . . . . . . . . . 46.1 m-20 -106.97 14.18 26.76 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.149 -0.969 . . . . 28.61 110.604 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' S' S ' 358' ' ' GLY . . . . . . . . . . . . . . . 111.82 -152.83 17.6 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 110.031 -1.228 . . . . 22.01 110.031 179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' S' S ' 359' ' ' TRP . . . . . 0.562 ' CE2' HG22 ' S' ' 354' ' ' VAL . 15.4 m95 -91.37 116.73 29.08 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.442 -1.034 . . . . 25.54 110.155 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 360' ' ' TYR . . . . . 0.421 ' HA ' ' HA ' ' S' ' 369' ' ' PRO . 1.3 m-85 -103.48 165.79 10.82 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.276 -0.89 . . . . 40.53 110.094 179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 361' ' ' ALA . . . . . 0.433 ' HA ' ' O ' ' S' ' 351' ' ' PHE . . . -140.09 130.08 24.83 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.376 -0.828 . . . . 18.04 110.272 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 362' ' ' ILE . . . . . . . . . . . . . 88.9 mt -95.6 83.63 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.353 -0.842 . . . . 15.64 110.023 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' S' S ' 363' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' S' ' 365' ' ' GLU . 11.8 t0 -75.18 94.46 2.96 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.364 -0.835 . . . . 35.03 110.208 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 364' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 53.95 -89.39 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.543 -0.723 . . . . 46.72 110.524 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' S' S ' 365' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' S' ' 363' ' ' ASP . 23.8 mt-10 -122.64 19.11 10.36 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.058 -1.026 . . . . 56.2 110.233 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 366' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -118.01 125.06 49.63 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.231 -0.918 . . . . 51.02 110.368 -179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' S' S ' 367' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -107.06 127.08 53.15 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.321 -0.862 . . . . 37.59 110.101 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' S' S ' 368' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -165.44 159.55 13.88 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.3 -0.875 . . . . 31.47 110.427 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' S' S ' 369' ' ' PRO . . . . . 0.421 ' HA ' ' HA ' ' S' ' 360' ' ' TYR . 46.3 Cg_endo -72.83 139.63 30.75 Favored 'Trans proline' 0 C--N 1.31 -1.49 0 O-C-N 123.872 1.459 . . . . 28.85 110.535 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 370' ' ' TRP . . . . . . . . . . . . . 67.4 t90 -167.24 113.5 0.76 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.362 -0.836 . . . . 26.94 110.007 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' S' S ' 371' ' ' THR . . . . . . . . . . . . . 59.4 m -74.74 113.03 20.4 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.433 -0.792 . . . . 20.19 110.057 179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' S' S ' 372' ' ' PRO . . . . . 0.562 ' O ' HD11 ' S' ' 334' ' ' LEU . 47.7 Cg_endo -73.55 157.09 49.25 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 O-C-N 123.609 1.32 . . . . 28.68 110.583 -179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 373' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -90.57 147.13 35.72 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.415 -0.803 . . . . 35.72 109.93 179.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' S' S ' 374' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -76.03 -6.23 17.13 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.676 1.356 . . . . 30.89 110.534 179.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' S' S ' 375' ' ' SER . . . . . . . . . . . . . 69.4 p -104.39 -17.01 14.95 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.209 -0.932 . . . . 29.41 110.414 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' S' S ' 376' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -106.45 42.98 1.19 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.348 -0.845 . . . . 32.89 110.24 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' S' S ' 377' ' ' VAL . . . . . 0.601 ' O ' HG11 ' S' ' 327' ' ' VAL . 7.3 p -114.63 147.31 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.253 -0.905 . . . . 24.33 110.2 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 378' ' ' LEU . . . . . . . . . . . . . 52.2 mt -116.01 -58.02 2.15 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.426 -0.796 . . . . 24.37 109.626 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' S' S ' 379' ' ' VAL . . . . . 0.643 HG22 HG12 ' S' ' 326' ' ' VAL . 61.5 t -120.7 132.42 70.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.437 -0.789 . . . . 18.02 109.385 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 380' ' ' PHE . . . . . 0.472 ' CE1' ' HB2' ' S' ' 325' ' ' CYS . 14.5 p90 -142.59 173.92 11.11 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.427 -0.796 . . . . 29.35 110.675 -179.3 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 381' ' ' VAL . . . . . . . . . . . . . 58.1 t -120.03 107.36 39.92 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.512 -0.743 . . . . 16.34 109.413 179.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' S' S ' 382' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -71.31 145.63 48.9 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.68 1.358 . . . . 20.94 110.803 -179.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' S' S ' 383' ' ' TYR . . . . . 0.978 ' O ' ' CB ' ' S' ' 384' ' ' ASP . 88.3 m-85 -61.11 -53.43 57.12 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.405 -0.809 . . . . 28.93 109.838 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 384' ' ' ASP . . . . . 0.978 ' CB ' ' O ' ' S' ' 383' ' ' TYR . 13.3 t70 112.65 111.0 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.433 -0.792 . . . . 47.03 110.36 178.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 385' ' ' GLN . . . . . 0.531 ' HB2' ' O ' ' S' ' 384' ' ' ASP . 17.6 tt0 176.62 -33.21 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.462 -0.774 . . . . 46.69 110.197 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 386' ' ' GLU . . . . . 0.476 ' C ' ' H ' ' S' ' 388' ' ' LEU . 2.4 mt-10 -142.4 135.81 14.26 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.337 -0.852 . . . . 50.25 109.595 179.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 387' ' ' PRO . . . . . 0.627 ' O ' ' C ' ' S' ' 388' ' ' LEU . 52.1 Cg_endo -71.71 33.45 0.26 Allowed 'Trans proline' 0 C--N 1.309 -1.523 0 O-C-N 123.67 1.352 . . . . 34.39 110.582 -178.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 388' ' ' LEU . . . . . 0.627 ' C ' ' O ' ' S' ' 387' ' ' PRO . 16.3 mt 24.16 95.83 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.489 -0.757 . . . . 38.01 110.099 -179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 389' ' ' ASN . . . . . 0.619 ' CG ' ' O ' ' S' ' 388' ' ' LEU . 8.1 p30 46.76 -167.99 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.4 -0.812 . . . . 45.82 110.157 -179.573 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 390' ' ' GLY . . . . . 0.603 ' HA2' ' CE2' ' S' ' 392' ' ' TRP . . . 122.48 46.41 0.29 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 109.597 -1.401 . . . . 33.46 109.597 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 391' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.3 -42.16 99.13 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.352 -1.087 . . . . 56.58 110.166 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 392' ' ' TRP . . . . . 0.737 ' O ' HG23 ' S' ' 396' ' ' VAL . 1.8 p90 -51.97 -24.41 6.46 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.354 -0.841 . . . . 31.43 110.346 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 393' ' ' LYS . . . . . 0.433 ' N ' ' CD1' ' S' ' 392' ' ' TRP . 16.8 tttt -43.76 -50.69 7.63 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.289 -0.882 . . . . 39.42 110.375 179.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 394' ' ' ALA . . . . . 0.442 ' O ' ' HD3' ' S' ' 398' ' ' ARG . . . -70.43 -29.06 65.56 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.272 -0.892 . . . . 34.33 110.081 178.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 395' ' ' LYS . . . . . 0.693 ' C ' ' NH1' ' S' ' 398' ' ' ARG . 0.2 OUTLIER -73.04 4.41 4.33 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.429 -0.795 . . . . 60.09 110.214 179.193 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' S' S ' 396' ' ' VAL . . . . . 0.95 HG12 ' HB3' ' R' ' 99' ' ' PRO . 34.4 t -111.14 -47.82 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.325 -0.859 . . . . 35.5 110.553 179.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 397' ' ' GLN . . . . . 0.497 ' C ' ' HG3' ' S' ' 398' ' ' ARG . 21.5 tt0 -109.66 117.51 34.12 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.182 -0.949 . . . . 49.96 110.623 179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 398' ' ' ARG . . . . . 0.693 ' NH1' ' C ' ' S' ' 395' ' ' LYS . 76.2 mtm-85 -151.13 -149.67 0.31 Allowed 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.266 -0.896 . . . . 43.42 110.73 -179.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 399' ' ' LYS . . . . . 0.611 ' C ' ' H ' ' S' ' 401' ' ' LYS . 11.3 mtpp -94.87 -88.63 0.25 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.381 -0.824 . . . . 55.31 110.058 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 400' ' ' LEU . . . . . 0.637 ' O ' ' HA ' ' R' ' 148' ' ' HIS . 8.4 mt -64.92 28.15 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.344 -0.848 . . . . 41.03 110.32 -179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' S' S ' 401' ' ' LYS . . . . . 0.642 ' HD3' ' HD3' ' R' ' 100' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.652 0 O-C-N 121.315 -0.865 . . . . 61.97 110.212 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 29' ' ' MET . . . . . . . . . . . . . 21.6 mtm . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.202 0.525 . . . . 32.14 110.252 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' R' R ' 30' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -96.34 141.19 29.96 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.358 -0.838 . . . . 43.36 110.212 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 31' ' ' LEU . . . . . . . . . . . . . 65.7 mt -134.86 140.65 45.98 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.286 -0.884 . . . . 22.93 110.306 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 32' ' ' THR . . . . . . . . . . . . . 69.1 m -87.61 110.51 20.43 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.433 -0.792 . . . . 22.34 109.962 179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 33' ' ' LEU . . . . . 0.595 HD22 ' CE2' ' R' ' 62' ' ' TYR . 80.1 mt -62.35 -172.79 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.316 -0.865 . . . . 21.39 110.226 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 34' ' ' TYR . . . . . . . . . . . . . 37.0 p90 -74.65 -29.41 61.25 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.333 -0.855 . . . . 34.4 110.386 -179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 35' ' ' ASN . . . . . . . . . . . . . 48.3 p30 -77.79 -1.83 33.39 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.314 -0.866 . . . . 30.28 110.643 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.25 -16.56 59.48 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.784 -1.326 . . . . 36.25 109.784 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 37' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -59.04 161.79 4.82 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.373 -1.075 . . . . 53.8 110.405 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 38' ' ' LYS . . . . . . . . . . . . . 57.2 mttt -117.8 135.7 53.9 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.405 -0.809 . . . . 49.91 110.19 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 39' ' ' LYS . . . . . 0.405 ' HG2' ' CZ ' ' R' ' 41' ' ' PHE . 8.1 ttmt -138.73 143.66 39.17 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.319 -0.863 . . . . 35.69 110.235 -179.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 40' ' ' THR . . . . . . . . . . . . . 23.4 m -102.56 127.91 49.43 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.287 -0.883 . . . . 34.84 110.308 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 41' ' ' PHE . . . . . 0.405 ' CZ ' ' HG2' ' R' ' 39' ' ' LYS . 96.6 m-85 -113.04 132.6 55.33 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.413 -0.804 . . . . 34.42 110.179 -179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 42' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -93.24 140.95 28.98 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.348 -0.845 . . . . 51.46 110.204 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 43' ' ' SER . . . . . . . . . . . . . 54.2 m -70.81 141.9 51.33 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.453 -0.779 . . . . 41.84 110.206 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.76 125.39 29.55 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.308 -0.87 . . . . 33.82 109.962 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 45' ' ' PRO . . . . . 0.424 ' HG2' ' ND2' ' R' ' 77' ' ' ASN . 45.6 Cg_endo -72.15 151.06 54.8 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.563 1.297 . . . . 30.27 110.66 -179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 46' ' ' ASN . . . . . 0.4 ' HA ' ' OD1' ' R' ' 50' ' ' ASN . 52.1 t-20 -124.28 109.92 13.97 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.415 -0.803 . . . . 35.1 109.999 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 47' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -120.34 -34.88 3.54 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.367 -0.833 . . . . 42.81 110.489 -179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 48' ' ' HIS . . . . . 0.44 ' NE2' HD11 ' R' ' 80' ' ' LEU . 73.3 m80 -105.76 45.23 0.98 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.328 -0.857 . . . . 49.97 110.263 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 49' ' ' ASP . . . . . 0.477 ' OD1' ' CA ' ' S' ' 401' ' ' LYS . 37.6 m-20 50.27 34.68 9.16 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.345 -0.847 . . . . 61.32 110.199 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 50' ' ' ASN . . . . . 0.4 ' OD1' ' HA ' ' R' ' 46' ' ' ASN . 15.0 p-10 -86.29 43.8 1.09 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.426 -0.796 . . . . 51.5 110.706 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 51' ' ' ALA . . . . . 0.673 ' CB ' ' HB2' ' S' ' 400' ' ' LEU . . . -66.11 -46.14 78.65 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.325 -0.86 . . . . 38.77 109.502 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 52' ' ' TRP . . . . . 0.483 ' CD2' ' N ' ' R' ' 53' ' ' LEU . 68.2 p-90 -58.35 -38.43 77.18 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.504 -0.747 . . . . 26.24 110.055 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 53' ' ' LEU . . . . . 0.483 ' N ' ' CD2' ' R' ' 52' ' ' TRP . 23.1 tp -66.68 -46.72 74.72 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.362 -0.836 . . . . 26.75 109.958 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 54' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -55.15 -41.66 72.11 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.341 -0.85 . . . . 35.02 110.14 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.24 -46.04 92.03 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.369 -0.832 . . . . 24.47 110.141 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 56' ' ' ILE . . . . . 0.432 HG12 HD11 ' R' ' 104' ' ' ILE . 76.1 mt -62.1 -42.32 94.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.213 -0.93 . . . . 26.03 109.92 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 57' ' ' LEU . . . . . . . . . . . . . 22.4 mt -60.31 -45.63 92.71 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.336 -0.853 . . . . 26.77 109.68 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 58' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -63.92 -46.48 84.59 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.521 -0.737 . . . . 22.32 109.594 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 59' ' ' LEU . . . . . 0.429 ' HA ' ' HE2' ' R' ' 151' ' ' PHE . 23.9 tp -61.45 -37.74 84.65 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.337 -0.852 . . . . 20.55 109.373 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 60' ' ' PHE . . . . . 0.528 ' CE2' HD21 ' R' ' 111' ' ' LEU . 2.8 m-85 -61.04 -44.84 96.79 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.628 -0.67 . . . . 20.08 109.921 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 61' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -63.0 -36.22 82.83 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.504 -0.747 . . . . 18.8 110.532 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 62' ' ' TYR . . . . . 0.595 ' CE2' HD22 ' R' ' 33' ' ' LEU . 9.2 t80 -63.16 -41.73 99.31 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.157 -0.964 . . . . 26.45 110.213 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 63' ' ' VAL . . . . . 0.406 ' H ' HG22 ' R' ' 63' ' ' VAL . 30.4 m -93.34 20.3 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.199 -0.938 . . . . 29.75 110.185 179.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 64' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 52.94 75.56 0.24 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.369 -0.832 . . . . 35.52 110.556 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 65' ' ' GLU . . . . . 0.442 ' HG2' ' CD2' ' R' ' 60' ' ' PHE . 14.3 tp10 -116.29 104.02 52.38 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.424 -0.797 . . . . 29.89 109.866 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 66' ' ' PRO . . . . . 0.481 ' HA ' ' HB2' ' R' ' 69' ' ' ASP . 46.8 Cg_endo -73.48 -5.89 17.86 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.708 1.372 . . . . 21.37 111.109 -179.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 67' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -52.09 -61.52 2.21 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.144 -0.973 . . . . 23.85 110.375 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 68' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -98.11 36.51 1.56 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.312 -0.867 . . . . 28.07 110.512 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 69' ' ' ASP . . . . . 0.481 ' HB2' ' HA ' ' R' ' 66' ' ' PRO . 11.8 t0 -72.33 -33.23 67.18 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.296 -0.878 . . . . 43.76 110.18 -179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 70' ' ' TRP . . . . . 0.475 ' CE2' ' CG2' ' R' ' 71' ' ' VAL . 47.9 p-90 -73.4 -3.94 30.46 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.29 -0.881 . . . . 33.06 110.7 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 71' ' ' VAL . . . . . 0.557 HG11 ' HB2' ' R' ' 82' ' ' ALA . 40.9 t -109.75 -27.45 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.23 -0.919 . . . . 31.7 109.647 179.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 72' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -86.58 -48.84 7.99 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.407 -0.808 . . . . 33.58 110.294 179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 73' ' ' SER . . . . . . . . . . . . . 69.9 m -89.63 50.96 1.99 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.338 -0.851 . . . . 50.82 110.379 -179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 74' ' ' SER . . . . . . . . . . . . . 16.0 t -125.82 138.32 31.77 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.226 -0.921 . . . . 34.74 110.265 179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.33 -24.98 16.01 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.672 1.354 . . . . 35.7 110.336 179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 76' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -91.71 153.2 19.8 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.476 -0.765 . . . . 66.48 110.343 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 77' ' ' ASN . . . . . 0.424 ' ND2' ' HG2' ' R' ' 45' ' ' PRO . 22.2 t-20 -81.47 95.26 7.03 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.298 -0.876 . . . . 46.72 110.114 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 78' ' ' LEU . . . . . . . . . . . . . 96.3 mt -96.43 27.93 3.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.338 -0.851 . . . . 37.55 110.191 179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 79' ' ' THR . . . . . . . . . . . . . 29.5 m -56.2 -54.65 42.65 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.329 -0.857 . . . . 37.36 110.295 -179.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 80' ' ' LEU . . . . . 0.603 ' HA ' HD12 ' R' ' 83' ' ' ILE . 15.9 mt -60.81 -23.29 64.95 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.337 -0.852 . . . . 35.83 110.549 -179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 81' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -79.5 -39.12 32.82 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.229 -0.919 . . . . 44.03 110.321 -179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 82' ' ' ALA . . . . . 0.557 ' HB2' HG11 ' R' ' 71' ' ' VAL . . . -69.49 -28.6 66.2 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.224 -0.923 . . . . 32.54 110.256 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 83' ' ' ILE . . . . . 0.603 HD12 ' HA ' ' R' ' 80' ' ' LEU . 78.2 mt -70.16 -46.12 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.308 -0.87 . . . . 32.02 110.302 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 84' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -55.15 -52.08 64.42 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.193 -0.942 . . . . 34.09 110.611 -179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 85' ' ' GLN . . . . . 0.533 ' HG2' HD12 ' R' ' 89' ' ' LEU . 31.9 tt0 -54.83 -46.85 74.64 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.206 -0.934 . . . . 25.94 110.249 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 86' ' ' LEU . . . . . . . . . . . . . 24.0 mt -58.7 -43.81 90.17 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.332 -0.855 . . . . 16.2 109.91 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 87' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -65.38 -35.17 80.16 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.391 -0.818 . . . . 49.09 110.251 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 88' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 -78.48 -19.08 53.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.345 -0.847 . . . . 28.61 110.522 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 89' ' ' LEU . . . . . 0.533 HD12 ' HG2' ' R' ' 85' ' ' GLN . 32.7 mt -96.15 -29.4 14.09 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.304 -0.872 . . . . 26.16 110.22 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 90' ' ' THR . . . . . . . . . . . . . 60.4 p -105.7 -34.55 7.67 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.284 -0.885 . . . . 33.33 109.763 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.77 16.18 58.6 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.862 -1.295 . . . . 31.13 109.862 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 92' ' ' LEU . . . . . . . . . . . . . 97.1 mt -100.18 155.19 17.89 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.213 -1.169 . . . . 42.52 110.229 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 93' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -86.17 91.64 8.51 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.567 -0.708 . . . . 68.46 110.038 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 94' ' ' LEU . . . . . 0.458 ' HB3' ' CZ2' ' R' ' 52' ' ' TRP . 48.3 mt -99.46 53.0 0.94 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.289 -0.882 . . . . 44.63 110.33 -179.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 95' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.44 -38.71 6.38 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.3 -0.875 . . . . 67.16 110.395 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 96' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -113.9 44.32 1.66 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.364 -0.835 . . . . 67.02 110.238 -179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 97' ' ' GLY . . . . . 0.606 ' HA3' ' CB ' ' S' ' 399' ' ' LYS . . . 99.12 150.78 26.03 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.634 -1.387 . . . . 49.48 109.634 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 98' ' ' GLY . . . . . . . . . . . . . . . -166.22 160.07 33.5 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.294 -1.522 . . . . 36.57 109.294 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 99' ' ' PRO . . . . . 0.857 ' HA ' ' O ' ' S' ' 396' ' ' VAL . 45.7 Cg_endo -72.59 121.07 7.1 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.645 1.34 . . . . 30.41 110.413 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 100' ' ' PRO . . . . . 0.452 ' HD3' ' NH1' ' S' ' 398' ' ' ARG . 45.8 Cg_endo -72.25 -31.67 11.48 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 O-C-N 123.645 1.339 . . . . 29.94 110.53 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 101' ' ' ALA . . . . . 0.481 ' HB3' HG23 ' S' ' 396' ' ' VAL . . . -70.02 -38.4 75.91 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.226 -0.921 . . . . 23.64 110.233 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 102' ' ' LEU . . . . . 0.424 HD23 HD21 ' R' ' 106' ' ' ASN . 0.1 OUTLIER -72.67 -40.71 66.07 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.358 -0.839 . . . . 20.31 110.386 -179.78 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' R' R ' 103' ' ' VAL . . . . . 0.79 HG23 ' O ' ' R' ' 99' ' ' PRO . 64.3 t -58.25 -40.02 76.04 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.195 -0.941 . . . . 16.33 109.984 179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 104' ' ' ILE . . . . . 0.432 HD11 HG12 ' R' ' 56' ' ' ILE . 81.6 mt -71.68 -30.6 38.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.397 -0.814 . . . . 24.77 109.966 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 105' ' ' TRP . . . . . 0.463 ' O ' ' HD3' ' R' ' 108' ' ' LYS . 70.5 t-105 -82.41 0.85 40.15 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.292 -0.88 . . . . 23.28 110.31 179.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 106' ' ' ASN . . . . . 0.424 HD21 HD23 ' R' ' 102' ' ' LEU . 6.9 m-80 -105.07 -10.35 17.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.171 -0.956 . . . . 28.26 110.118 179.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 107' ' ' ILE . . . . . . . . . . . . . 36.7 pt -126.88 35.08 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.254 -0.904 . . . . 18.77 109.966 179.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 108' ' ' LYS . . . . . 0.502 ' HG2' ' HB ' ' R' ' 115' ' ' ILE . 9.2 mtpp -61.12 -48.41 81.78 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.56 -0.713 . . . . 42.5 110.049 179.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 109' ' ' HIS . . . . . 0.444 ' CD2' ' HG ' ' R' ' 110' ' ' LEU . 50.8 p-80 -66.02 -12.85 58.07 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.456 -0.777 . . . . 20.07 110.698 -179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 110' ' ' LEU . . . . . 0.444 ' HG ' ' CD2' ' R' ' 109' ' ' HIS . 80.3 mt -94.79 -17.25 22.31 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.076 -1.015 . . . . 15.69 110.207 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 111' ' ' LEU . . . . . 0.528 HD21 ' CE2' ' R' ' 60' ' ' PHE . 10.3 mt -94.13 144.16 25.74 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.342 -0.849 . . . . 25.39 111.014 -179.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 112' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -77.71 -17.36 57.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.51 -0.744 . . . . 53.48 109.846 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 113' ' ' THR . . . . . 0.459 HG22 ' N ' ' R' ' 114' ' ' GLY . 59.8 m -83.76 166.67 17.83 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.273 -0.892 . . . . 14.8 110.193 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 114' ' ' GLY . . . . . 0.459 ' N ' HG22 ' R' ' 113' ' ' THR . . . -97.99 127.1 9.11 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.042 -1.223 . . . . 16.14 110.042 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 115' ' ' ILE . . . . . 0.577 HD13 ' HB ' ' R' ' 124' ' ' VAL . 47.7 mm -109.01 139.46 31.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.503 -0.998 . . . . 13.46 109.674 179.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 116' ' ' GLY . . . . . . . . . . . . . . . -152.84 -155.89 7.31 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.932 -1.267 . . . . 23.9 109.932 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 117' ' ' THR . . . . . 0.53 HG22 ' CG2' ' R' ' 126' ' ' VAL . 18.5 p -135.03 -171.39 2.79 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.451 -1.029 . . . . 27.37 110.079 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 118' ' ' ALA . . . . . 0.445 ' HB3' ' OD1' ' R' ' 128' ' ' ASP . . . -56.52 -58.14 9.32 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.246 -0.909 . . . . 18.76 110.074 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 119' ' ' SER . . . . . 0.511 ' CB ' ' HB ' ' R' ' 196' ' ' VAL . 1.2 m -56.51 -40.48 75.09 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.351 -0.843 . . . . 32.35 109.838 179.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 120' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 -110.12 86.21 4.9 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.411 -0.806 . . . . 27.12 109.69 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 121' ' ' PRO . . . . . 0.483 ' HA ' ' SG ' ' R' ' 125' ' ' CYS . 44.0 Cg_endo -71.26 166.49 29.09 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 O-C-N 123.903 1.475 . . . . 22.68 111.035 -179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 122' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' R' ' 121' ' ' PRO . 38.6 t 178.55 -161.7 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.609 -0.682 . . . . 22.99 109.455 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 123' ' ' GLU . . . . . 0.442 ' HG2' HG23 ' R' ' 113' ' ' THR . 2.3 tp10 -56.44 -40.01 74.06 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.216 -0.928 . . . . 36.18 109.63 179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 124' ' ' VAL . . . . . 0.577 ' HB ' HD13 ' R' ' 115' ' ' ILE . 82.2 t -142.5 136.4 27.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.62 -0.675 . . . . 20.64 109.457 179.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 125' ' ' CYS . . . . . 0.483 ' SG ' ' HA ' ' R' ' 121' ' ' PRO . 83.0 m -140.23 168.21 20.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.193 -0.942 . . . . 22.8 111.206 -179.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 126' ' ' VAL . . . . . 0.73 HG12 HG22 ' R' ' 179' ' ' VAL . 35.9 m -122.78 159.72 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.733 -0.604 . . . . 21.24 109.574 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 127' ' ' VAL . . . . . 0.709 HG11 ' O ' ' R' ' 177' ' ' VAL . 30.4 m -70.76 141.82 16.44 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.305 -0.872 . . . . 19.77 110.734 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 128' ' ' ASP . . . . . 0.445 ' OD1' ' HB3' ' R' ' 118' ' ' ALA . 53.8 p-10 -137.74 19.41 2.87 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.417 -0.802 . . . . 29.21 110.66 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 129' ' ' GLY . . . . . . . . . . . . . . . 114.0 0.04 24.14 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.939 -1.124 . . . . 33.86 110.527 179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 130' ' ' THR . . . . . . . . . . . . . 58.4 m -91.94 131.81 36.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.135 -1.215 . . . . 26.41 110.046 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -62.43 120.64 11.46 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.317 -0.865 . . . . 33.08 110.336 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 132' ' ' MET . . . . . 0.433 ' HE1' ' CE2' ' R' ' 180' ' ' PHE . 98.5 mmm -105.24 165.64 10.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.482 -0.761 . . . . 30.76 110.409 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 133' ' ' CYS . . . . . 0.411 ' HA ' ' HB3' ' R' ' 174' ' ' PRO . 32.2 m -141.12 158.23 44.2 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.451 -0.78 . . . . 27.0 109.956 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 134' ' ' LEU . . . . . 0.565 HD11 ' O ' ' R' ' 172' ' ' PRO . 0.1 OUTLIER -58.53 -19.74 40.24 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.232 -0.918 . . . . 33.9 110.515 -179.86 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' R' R ' 135' ' ' ALA . . . . . . . . . . . . . . . -92.66 8.11 40.55 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.344 -0.848 . . . . 19.37 110.833 -179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 136' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -93.7 -21.88 19.08 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.165 -0.96 . . . . 30.47 110.178 179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 137' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -149.91 165.3 33.01 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.351 -0.843 . . . . 24.27 110.241 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 138' ' ' HIS . . . . . 0.434 ' HA ' HG23 ' R' ' 154' ' ' VAL . 15.1 p80 -117.79 15.18 14.41 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.422 -0.798 . . . . 20.91 110.417 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 139' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' R' ' 152' ' ' ALA . . . -177.23 152.4 0.87 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.187 -0.946 . . . . 15.69 110.157 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 140' ' ' GLY . . . . . 0.428 ' HA3' ' O ' ' R' ' 179' ' ' VAL . . . 161.83 175.09 32.49 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.881 -1.288 . . . . 23.76 109.881 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 141' ' ' ILE . . . . . . . . . . . . . 83.7 mt -95.5 136.63 25.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.435 -1.038 . . . . 25.3 109.691 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 142' ' ' PHE . . . . . 0.578 ' CD2' ' HB2' ' R' ' 172' ' ' PRO . 82.9 m-85 -120.77 -172.66 2.43 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.27 -0.894 . . . . 30.24 110.524 -179.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 143' ' ' LEU . . . . . 0.783 HD11 ' O ' ' S' ' 395' ' ' LYS . 0.5 OUTLIER -119.78 77.73 1.26 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.426 -0.796 . . . . 32.8 110.295 -179.879 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' R' R ' 144' ' ' LYS . . . . . 0.471 ' HG3' ' CZ2' ' R' ' 170' ' ' TRP . 1.0 OUTLIER -69.55 76.78 0.42 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.437 -0.789 . . . . 49.18 109.68 179.541 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' R' R ' 145' ' ' GLY . . . . . 0.458 ' O ' HD22 ' R' ' 143' ' ' LEU . . . 104.62 179.24 24.71 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.139 -1.584 . . . . 53.87 109.139 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 146' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -88.46 145.83 25.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.388 -1.066 . . . . 68.58 110.053 179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 147' ' ' GLU . . . . . 0.754 ' HA ' ' HB2' ' S' ' 398' ' ' ARG . 10.9 mt-10 58.27 36.46 25.66 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.256 -0.902 . . . . 56.62 110.611 179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 148' ' ' HIS . . . . . 0.756 ' ND1' HD23 ' S' ' 400' ' ' LEU . 44.6 t60 -158.58 148.14 19.33 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.205 -0.934 . . . . 44.57 110.422 179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 149' ' ' ALA . . . . . 0.735 ' HB2' ' HD3' ' S' ' 398' ' ' ARG . . . -150.27 146.83 27.02 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.467 -0.771 . . . . 33.54 110.082 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 150' ' ' VAL . . . . . . . . . . . . . 34.2 m -142.28 161.54 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.231 -0.918 . . . . 27.61 110.309 179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 151' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' R' ' 152' ' ' ALA . 5.8 t80 -86.21 155.53 20.68 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.4 -0.812 . . . . 23.04 109.907 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 152' ' ' ALA . . . . . 0.537 ' N ' ' CD1' ' R' ' 151' ' ' PHE . . . -157.22 151.53 25.05 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.499 -0.75 . . . . 29.61 109.565 179.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 153' ' ' CYS . . . . . . . . . . . . . 26.7 p -154.33 173.54 16.04 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.234 -0.916 . . . . 22.75 110.556 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 154' ' ' VAL . . . . . 0.614 HG22 ' CE2' ' R' ' 159' ' ' TRP . 60.0 t -90.56 116.97 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.443 -0.785 . . . . 23.26 110.078 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 155' ' ' THR . . . . . . . . . . . . . 70.7 p -112.08 -176.65 2.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.347 -0.846 . . . . 17.88 110.034 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 156' ' ' SER . . . . . . . . . . . . . 78.5 p -75.98 -3.64 36.72 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.329 -0.857 . . . . 21.83 110.697 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 157' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -118.32 10.48 12.8 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.159 -0.963 . . . . 36.54 110.603 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 158' ' ' GLY . . . . . . . . . . . . . . . 117.99 -162.62 13.05 Favored Glycine 0 N--CA 1.493 2.463 0 N-CA-C 109.547 -1.421 . . . . 31.74 109.547 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 159' ' ' TRP . . . . . 0.614 ' CE2' HG22 ' R' ' 154' ' ' VAL . 14.8 m95 -86.6 122.4 30.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.285 -1.127 . . . . 28.25 110.092 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 160' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -108.4 167.01 10.34 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.448 -0.783 . . . . 41.24 110.212 -179.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 161' ' ' ALA . . . . . . . . . . . . . . . -143.24 123.43 13.72 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.355 -0.841 . . . . 27.4 110.208 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 162' ' ' ILE . . . . . . . . . . . . . 92.1 mt -87.6 81.17 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.362 -0.837 . . . . 24.27 110.078 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 163' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' R' ' 165' ' ' GLU . 15.4 t0 -72.92 92.36 1.62 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.438 -0.789 . . . . 36.08 110.246 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 164' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 54.13 -88.94 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.542 -0.724 . . . . 46.08 110.565 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 165' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' R' ' 163' ' ' ASP . 29.6 mt-10 -124.75 36.01 4.68 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.052 -1.03 . . . . 50.94 110.199 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 166' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -135.8 117.32 14.82 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.397 -0.814 . . . . 47.28 110.324 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 167' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -100.98 119.95 39.48 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.434 -0.791 . . . . 40.47 110.134 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 168' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -157.6 158.54 30.6 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.29 -0.881 . . . . 30.21 110.399 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 169' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.8 133.04 19.46 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.931 1.49 . . . . 32.76 110.474 -179.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 170' ' ' TRP . . . . . 0.471 ' CZ2' ' HG3' ' R' ' 144' ' ' LYS . 67.0 t90 -159.78 119.3 2.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.416 -0.802 . . . . 32.79 109.928 179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 171' ' ' THR . . . . . . . . . . . . . 46.6 m -81.06 112.6 33.95 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.437 -0.789 . . . . 36.92 110.184 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 172' ' ' PRO . . . . . 0.578 ' HB2' ' CD2' ' R' ' 142' ' ' PHE . 47.2 Cg_endo -73.74 158.83 46.48 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.66 1.348 . . . . 33.54 110.519 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 173' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -88.84 144.97 33.85 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.362 -0.836 . . . . 45.76 109.911 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 174' ' ' PRO . . . . . 0.411 ' HB3' ' HA ' ' R' ' 133' ' ' CYS . 45.9 Cg_endo -71.73 -10.41 26.44 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 O-C-N 123.675 1.355 . . . . 29.63 110.499 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 175' ' ' SER . . . . . . . . . . . . . 53.1 p -103.48 -17.47 15.2 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.299 -0.876 . . . . 35.7 110.369 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 176' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -103.5 43.19 1.1 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.24 -0.913 . . . . 39.65 110.423 -179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 177' ' ' VAL . . . . . 0.709 ' O ' HG11 ' R' ' 127' ' ' VAL . 10.5 p -117.72 127.17 75.1 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.368 -0.832 . . . . 20.61 110.041 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 178' ' ' LEU . . . . . 0.476 ' HB3' ' HB2' ' R' ' 101' ' ' ALA . 45.9 mt -91.5 -61.23 1.69 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.424 -0.798 . . . . 15.58 109.464 179.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 179' ' ' VAL . . . . . 0.73 HG22 HG12 ' R' ' 126' ' ' VAL . 67.4 t -114.6 144.7 21.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.579 -0.7 . . . . 17.4 109.443 179.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 180' ' ' PHE . . . . . 0.433 ' CE2' ' HE1' ' R' ' 132' ' ' MET . 43.4 p90 -152.11 163.37 39.48 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.273 -0.892 . . . . 20.16 110.562 -179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 181' ' ' VAL . . . . . . . . . . . . . 66.9 t -113.2 111.49 50.17 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 121.468 -0.77 . . . . 17.69 109.795 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 182' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.03 149.51 52.86 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.577 1.304 . . . . 17.81 110.423 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 183' ' ' TYR . . . . . 0.706 ' O ' ' C ' ' R' ' 184' ' ' ASP . 79.0 m-85 -59.01 175.54 0.28 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.459 -0.775 . . . . 28.01 110.549 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 184' ' ' ASP . . . . . 0.706 ' C ' ' O ' ' R' ' 183' ' ' TYR . 6.0 t70 -18.36 -82.2 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.3 -0.875 . . . . 58.64 110.232 -178.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 185' ' ' GLN . . . . . . . . . . . . . 2.8 pt20 . . . . . 0 N--CA 1.504 2.232 0 CA-C-O 121.272 0.558 . . . . 80.42 111.721 179.566 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' R' R ' 193' ' ' LYS . . . . . . . . . . . . . 15.0 pttt . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 120.898 0.38 . . . . 49.5 110.157 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' R' R ' 194' ' ' ALA . . . . . . . . . . . . . . . -169.84 -163.95 0.4 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.144 -0.973 . . . . 40.4 110.156 179.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 195' ' ' LYS . . . . . . . . . . . . . 20.4 mtpp -74.88 -66.33 0.76 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.416 -0.802 . . . . 34.6 110.304 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 196' ' ' VAL . . . . . 0.511 ' HB ' ' CB ' ' R' ' 119' ' ' SER . 35.0 t -81.37 63.16 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.279 -0.888 . . . . 33.27 110.601 179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 197' ' ' GLN . . . . . 0.516 ' HG3' ' O ' ' R' ' 197' ' ' GLN . 11.5 tp60 -168.24 25.19 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.147 -0.971 . . . . 41.58 110.725 179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 198' ' ' ARG . . . . . . . . . . . . . 20.2 mtp180 -123.89 164.99 18.15 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.073 -1.017 . . . . 38.65 110.22 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 199' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.34 70.94 1.53 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.391 -0.818 . . . . 36.77 109.909 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' R' R ' 200' ' ' LEU . . . . . . . . . . . . . 4.3 mp -64.55 -168.84 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.387 -0.82 . . . . 33.08 110.132 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' R' R ' 201' ' ' LYS . . . . . 0.546 ' HA ' ' CA ' ' S' ' 297' ' ' GLY . 26.3 mmtt . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.309 -0.869 . . . . 44.32 110.305 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' S' S ' 229' ' ' MET . . . . . . . . . . . . . 5.8 mtm . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 121.176 0.513 . . . . 51.83 110.191 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' S' S ' 230' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -97.27 142.73 28.8 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.318 -0.864 . . . . 54.13 110.161 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' S' S ' 231' ' ' LEU . . . . . . . . . . . . . 67.9 mt -134.12 141.04 46.98 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.391 -0.818 . . . . 33.04 110.343 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' S' S ' 232' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' S' ' 355' ' ' THR . 40.7 m -89.26 103.26 15.9 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.381 -0.824 . . . . 26.92 110.04 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 233' ' ' LEU . . . . . 0.67 HD22 ' CE2' ' S' ' 262' ' ' TYR . 79.9 mt -56.0 179.31 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.43 -0.794 . . . . 13.78 110.463 -179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 234' ' ' TYR . . . . . 0.446 ' CG ' ' N ' ' S' ' 235' ' ' ASN . 35.6 p90 -65.02 -35.69 81.99 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.361 -0.837 . . . . 26.08 110.148 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 235' ' ' ASN . . . . . 0.446 ' N ' ' CG ' ' S' ' 234' ' ' TYR . 50.7 p30 -74.3 -7.44 52.78 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.428 -0.795 . . . . 20.04 110.596 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 236' ' ' GLY . . . . . . . . . . . . . . . 95.76 -19.92 52.15 Favored Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.781 -1.328 . . . . 22.71 109.781 179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' S' S ' 237' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -52.98 145.65 12.48 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.18 -1.188 . . . . 35.44 110.276 -179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' S' S ' 238' ' ' LYS . . . . . . . . . . . . . 44.4 mttt -102.18 127.91 48.91 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.396 -0.815 . . . . 32.56 110.434 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' S' S ' 239' ' ' LYS . . . . . 0.409 ' HG2' ' CZ ' ' S' ' 241' ' ' PHE . 9.0 ttmt -132.26 144.54 50.68 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.391 -0.818 . . . . 26.68 110.004 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 240' ' ' THR . . . . . . . . . . . . . 51.9 m -102.02 132.2 48.01 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.307 -0.871 . . . . 41.02 110.355 -179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' S' S ' 241' ' ' PHE . . . . . 0.409 ' CZ ' ' HG2' ' S' ' 239' ' ' LYS . 96.1 m-85 -117.91 137.62 52.69 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.379 -0.826 . . . . 28.62 110.253 179.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 242' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -96.35 161.83 13.76 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.34 -0.85 . . . . 47.89 110.188 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' S' S ' 243' ' ' SER . . . . . . . . . . . . . 72.1 m -90.57 151.56 21.27 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.29 -0.881 . . . . 45.09 110.29 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' S' S ' 244' ' ' ARG . . . . . . . . . . . . . 1.4 mtp85 -129.77 126.73 22.7 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.416 -0.802 . . . . 42.49 110.263 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' S' S ' 245' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.35 160.98 43.77 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.617 1.325 . . . . 35.68 110.551 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' S' S ' 246' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -132.84 97.77 4.13 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.325 -0.859 . . . . 51.88 109.873 179.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' S' S ' 247' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -110.45 -22.24 11.77 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.32 -0.863 . . . . 53.69 110.649 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' S' S ' 248' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -117.26 43.67 2.27 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.182 -0.949 . . . . 55.79 110.708 -179.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' S' S ' 249' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 48.78 38.46 11.88 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.485 -0.759 . . . . 49.45 110.363 179.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' S' S ' 250' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -90.57 28.95 1.38 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.552 -0.717 . . . . 36.86 110.325 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' S' S ' 251' ' ' ALA . . . . . . . . . . . . . . . -53.79 -43.19 69.08 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.286 -0.884 . . . . 29.69 109.621 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' S' S ' 252' ' ' TRP . . . . . 0.428 ' CZ2' ' HB3' ' S' ' 294' ' ' LEU . 67.8 p-90 -61.82 -33.9 74.98 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.51 -0.744 . . . . 41.12 109.802 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 253' ' ' LEU . . . . . 0.402 ' N ' ' CD2' ' S' ' 252' ' ' TRP . 23.4 tp -70.15 -47.3 62.27 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.422 -0.799 . . . . 24.89 109.955 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 254' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -56.06 -42.43 76.61 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.308 -0.87 . . . . 35.65 110.031 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' S' S ' 255' ' ' ALA . . . . . . . . . . . . . . . -59.61 -48.19 82.63 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.427 -0.795 . . . . 22.73 110.042 179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' S' S ' 256' ' ' ILE . . . . . 0.504 HG12 HD11 ' S' ' 304' ' ' ILE . 79.7 mt -62.35 -40.6 88.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.308 -0.87 . . . . 28.85 110.014 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 257' ' ' LEU . . . . . 0.402 ' CD2' ' HB3' ' S' ' 268' ' ' PHE . 19.4 mt -61.52 -44.49 96.97 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.286 -0.884 . . . . 23.07 110.216 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 258' ' ' GLN . . . . . 0.501 ' HB3' ' CD2' ' S' ' 351' ' ' PHE . 53.4 mm-40 -65.05 -45.35 85.73 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.382 -0.824 . . . . 29.78 109.947 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 259' ' ' LEU . . . . . 0.421 ' O ' HG22 ' S' ' 263' ' ' VAL . 19.8 tp -58.66 -36.41 74.11 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.299 -0.876 . . . . 17.94 109.405 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 260' ' ' PHE . . . . . 0.533 ' CE2' HD21 ' S' ' 311' ' ' LEU . 3.1 m-85 -62.86 -45.22 93.57 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.593 -0.692 . . . . 30.57 109.872 179.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 261' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -62.06 -29.81 70.55 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.383 -0.823 . . . . 41.34 109.995 179.764 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' S' S ' 262' ' ' TYR . . . . . 0.67 ' CE2' HD22 ' S' ' 233' ' ' LEU . 8.6 t80 -71.24 -44.59 65.02 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.37 -0.831 . . . . 26.03 110.086 179.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 263' ' ' VAL . . . . . 0.421 HG22 ' O ' ' S' ' 259' ' ' LEU . 33.2 m -92.1 18.34 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.417 -0.802 . . . . 22.8 110.35 179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 264' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 52.78 70.67 0.55 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.292 -0.88 . . . . 44.03 110.59 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' S' S ' 265' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -111.8 109.18 55.45 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.375 -0.828 . . . . 35.61 109.622 179.694 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' S' S ' 266' ' ' PRO . . . . . 0.478 ' HA ' ' HB2' ' S' ' 269' ' ' ASP . 49.8 Cg_endo -75.25 0.39 9.06 Favored 'Trans proline' 0 C--N 1.309 -1.511 0 O-C-N 123.65 1.342 . . . . 37.67 111.826 -179.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 267' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -56.52 -67.71 0.28 Allowed 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.76 -1.213 . . . . 41.49 110.17 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 268' ' ' PHE . . . . . 0.402 ' HB3' ' CD2' ' S' ' 257' ' ' LEU . 22.3 m-85 -92.92 39.92 1.05 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.197 -0.939 . . . . 50.76 110.095 179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 269' ' ' ASP . . . . . 0.478 ' HB2' ' HA ' ' S' ' 266' ' ' PRO . 0.9 OUTLIER -76.01 -33.17 59.67 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.428 -0.795 . . . . 61.86 109.795 179.533 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' S' S ' 270' ' ' TRP . . . . . 0.51 ' CE2' HG23 ' S' ' 271' ' ' VAL . 50.9 p-90 -73.96 -4.26 34.1 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.28 -0.888 . . . . 39.85 110.501 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 271' ' ' VAL . . . . . 0.51 HG23 ' CE2' ' S' ' 270' ' ' TRP . 46.4 t -109.48 -32.82 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.121 -0.987 . . . . 39.18 110.058 179.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 272' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -78.59 -36.57 44.14 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.327 -0.858 . . . . 40.02 110.538 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' S' S ' 273' ' ' SER . . . . . . . . . . . . . 71.2 m -103.51 56.11 0.74 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.267 -0.896 . . . . 47.2 110.388 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' S' S ' 274' ' ' SER . . . . . . . . . . . . . 6.9 t -133.04 141.25 40.24 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.298 -0.876 . . . . 47.61 110.129 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' S' S ' 275' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.7 -18.88 21.84 Favored 'Trans proline' 0 C--N 1.31 -1.48 0 O-C-N 123.72 1.379 . . . . 45.28 110.533 179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' S' S ' 276' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -99.94 140.89 33.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.294 -0.879 . . . . 57.27 110.314 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' S' S ' 277' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -71.75 97.7 1.82 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.387 -0.821 . . . . 37.28 110.254 -179.786 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' S' S ' 278' ' ' LEU . . . . . . . . . . . . . 86.3 mt -97.03 33.84 1.84 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.382 -0.824 . . . . 43.88 110.001 -179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' S' S ' 279' ' ' THR . . . . . . . . . . . . . 76.4 m -63.99 -60.17 3.58 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.416 -0.802 . . . . 50.05 110.282 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' S' S ' 280' ' ' LEU . . . . . 0.73 ' HA ' HD12 ' S' ' 283' ' ' ILE . 13.7 mt -51.51 -39.99 58.7 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.32 -0.862 . . . . 54.12 110.283 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 281' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.38 -49.64 74.74 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.435 -0.79 . . . . 65.28 110.161 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 282' ' ' ALA . . . . . . . . . . . . . . . -59.04 -33.9 71.3 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.438 -0.789 . . . . 46.51 110.499 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' S' S ' 283' ' ' ILE . . . . . 0.73 HD12 ' HA ' ' S' ' 280' ' ' LEU . 85.6 mt -66.25 -50.93 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.288 -0.883 . . . . 47.3 110.118 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 284' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -50.56 -57.56 7.85 Favored 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.388 -0.82 . . . . 50.72 110.405 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' S' S ' 285' ' ' GLN . . . . . 0.527 ' HG2' HD12 ' S' ' 289' ' ' LEU . 34.4 tt0 -51.41 -46.43 62.91 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.471 -0.768 . . . . 68.47 110.252 179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 286' ' ' LEU . . . . . . . . . . . . . 19.1 mt -60.02 -44.49 94.57 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.403 -0.811 . . . . 36.62 110.202 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' S' S ' 287' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -62.71 -35.33 79.39 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.387 -0.82 . . . . 46.64 110.076 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' S' S ' 288' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -76.22 -21.04 56.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.353 -0.842 . . . . 46.45 110.292 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' S' S ' 289' ' ' LEU . . . . . 0.527 HD12 ' HG2' ' S' ' 285' ' ' GLN . 31.0 mt -97.29 -21.78 17.05 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.254 -0.904 . . . . 35.09 110.568 -179.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 290' ' ' THR . . . . . 0.41 HG22 ' HB3' ' S' ' 306' ' ' ASN . 81.3 p -114.76 -28.44 7.09 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.252 -0.905 . . . . 38.61 110.403 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 291' ' ' GLY . . . . . . . . . . . . . . . 79.37 10.96 85.44 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.847 -1.301 . . . . 36.77 109.847 179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' S' S ' 292' ' ' LEU . . . . . . . . . . . . . 84.7 mt -96.43 145.82 25.32 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.271 -1.135 . . . . 35.33 109.803 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' S' S ' 293' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -77.36 102.39 6.76 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.163 -0.96 . . . . 48.7 110.257 -179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' S' S ' 294' ' ' LEU . . . . . 0.428 ' HB3' ' CZ2' ' S' ' 252' ' ' TRP . 56.2 mt -107.03 51.8 0.73 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.526 -0.734 . . . . 42.61 110.074 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 295' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -112.51 -11.21 13.64 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.343 -0.848 . . . . 55.49 110.523 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 296' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -144.33 48.62 1.36 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.123 -0.986 . . . . 75.68 110.291 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' S' S ' 297' ' ' GLY . . . . . 0.546 ' CA ' ' HA ' ' R' ' 201' ' ' LYS . . . 96.85 145.09 18.53 Favored Glycine 0 N--CA 1.493 2.436 0 N-CA-C 109.555 -1.418 . . . . 49.44 109.555 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 298' ' ' GLY . . . . . . . . . . . . . . . -163.77 157.03 29.14 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.77 -1.332 . . . . 41.11 109.77 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' S' S ' 299' ' ' PRO . . . . . 0.486 ' O ' HG23 ' S' ' 303' ' ' VAL . 47.3 Cg_endo -73.91 118.31 5.38 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 123.917 1.483 . . . . 26.2 110.304 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 300' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.26 -15.43 31.63 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 O-C-N 123.616 1.324 . . . . 21.7 110.693 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' S' S ' 301' ' ' ALA . . . . . . . . . . . . . . . -80.75 -29.37 36.28 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.192 -0.942 . . . . 31.23 110.073 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' S' S ' 302' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.45 -40.72 18.93 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.409 -0.807 . . . . 38.99 109.969 179.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 303' ' ' VAL . . . . . 0.486 HG23 ' O ' ' S' ' 299' ' ' PRO . 58.0 t -60.67 -35.5 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.364 -0.835 . . . . 18.63 110.095 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 304' ' ' ILE . . . . . 0.524 HD12 HG21 ' S' ' 379' ' ' VAL . 86.1 mt -79.42 -23.58 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.431 -0.793 . . . . 25.46 110.153 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 305' ' ' TRP . . . . . 0.412 ' CD2' ' HD3' ' S' ' 308' ' ' LYS . 68.8 t-105 -88.69 -14.53 37.1 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.32 -0.862 . . . . 33.4 110.503 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 306' ' ' ASN . . . . . 0.41 ' HB3' HG22 ' S' ' 290' ' ' THR . 10.4 m-80 -89.68 -13.62 36.56 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.168 -0.957 . . . . 36.97 110.378 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 307' ' ' ILE . . . . . 0.473 HG12 ' O ' ' S' ' 303' ' ' VAL . 36.9 pt -125.1 45.59 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.266 -0.896 . . . . 30.81 110.045 -179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 308' ' ' LYS . . . . . 0.412 ' HD3' ' CD2' ' S' ' 305' ' ' TRP . 1.5 mtmp? -73.5 -37.79 65.56 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.366 -0.834 . . . . 46.52 110.086 -179.537 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 309' ' ' HIS . . . . . 0.496 ' CD2' ' HG ' ' S' ' 310' ' ' LEU . 55.5 p-80 -73.14 -8.38 55.51 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.284 -0.885 . . . . 51.03 110.097 179.652 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 310' ' ' LEU . . . . . 0.496 ' HG ' ' CD2' ' S' ' 309' ' ' HIS . 52.9 mt -99.25 -12.91 19.96 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.311 -0.868 . . . . 36.16 109.944 179.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 311' ' ' LEU . . . . . 0.533 HD21 ' CE2' ' S' ' 260' ' ' PHE . 10.8 mt -97.12 147.88 23.61 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.282 -0.886 . . . . 40.0 110.406 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 312' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -81.66 -16.3 51.79 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.28 -0.888 . . . . 54.18 109.68 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' S' S ' 313' ' ' THR . . . . . 0.824 HG23 ' HG2' ' S' ' 323' ' ' GLU . 92.6 m -87.9 151.63 22.68 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.322 -0.861 . . . . 25.61 110.125 179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 314' ' ' GLY . . . . . . . . . . . . . . . -87.93 126.42 8.05 Favored Glycine 0 N--CA 1.493 2.484 0 N-CA-C 109.791 -1.324 . . . . 25.18 109.791 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' S' S ' 315' ' ' ILE . . . . . 0.669 HD13 ' HB ' ' S' ' 324' ' ' VAL . 50.7 mm -101.62 150.48 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.377 -1.072 . . . . 23.9 109.722 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 316' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' S' ' 325' ' ' CYS . . . -157.1 -159.26 9.38 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.006 -1.237 . . . . 23.18 110.006 179.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 317' ' ' THR . . . . . 0.423 HG22 ' CG2' ' S' ' 326' ' ' VAL . 11.1 p -133.89 -173.0 3.12 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.367 -1.078 . . . . 27.98 110.044 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.51 -56.26 24.12 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.239 -0.913 . . . . 28.1 109.885 179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' S' S ' 319' ' ' SER . . . . . . . . . . . . . 1.2 m -59.93 -41.69 92.34 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.372 -0.83 . . . . 37.0 109.604 179.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' S' S ' 320' ' ' ARG . . . . . . . . . . . . . 12.1 mtm180 -111.71 79.84 2.64 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.483 -0.761 . . . . 52.07 109.717 179.596 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' S' S ' 321' ' ' PRO . . . . . 0.766 ' HG3' ' O ' ' S' ' 386' ' ' GLU . 44.1 Cg_endo -71.44 171.47 16.13 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.853 1.449 . . . . 38.29 110.928 -179.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 322' ' ' SER . . . . . 0.445 ' HB2' ' O ' ' S' ' 321' ' ' PRO . 41.5 t 178.73 -148.14 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 109.021 -0.733 . . . . 38.84 109.021 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 323' ' ' GLU . . . . . 0.824 ' HG2' HG23 ' S' ' 313' ' ' THR . 6.7 tp10 -62.86 -40.26 96.93 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.947 -1.096 . . . . 40.7 109.733 179.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 324' ' ' VAL . . . . . 0.669 ' HB ' HD13 ' S' ' 315' ' ' ILE . 73.2 t -141.26 135.0 31.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.502 -0.749 . . . . 20.34 109.462 179.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 325' ' ' CYS . . . . . 0.458 ' HB2' ' CE1' ' S' ' 380' ' ' PHE . 11.2 m -125.99 172.14 10.19 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.275 -0.891 . . . . 30.63 110.886 -179.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 326' ' ' VAL . . . . . 0.645 HG12 HG22 ' S' ' 379' ' ' VAL . 34.6 m -135.41 142.21 40.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.62 -0.675 . . . . 23.9 109.237 179.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 327' ' ' VAL . . . . . 0.594 HG11 ' O ' ' S' ' 377' ' ' VAL . 34.5 m -56.32 125.03 11.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 O-C-N 121.104 -0.998 . . . . 19.48 110.4 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 328' ' ' ASP . . . . . . . . . . . . . 55.6 p-10 -119.4 11.47 12.19 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.494 -0.754 . . . . 26.43 110.461 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' S' S ' 329' ' ' GLY . . . . . . . . . . . . . . . 119.68 2.31 13.04 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.027 -1.229 . . . . 31.24 110.027 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' S' S ' 330' ' ' THR . . . . . . . . . . . . . 77.4 m -92.98 130.01 38.7 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.104 -1.233 . . . . 30.05 110.132 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' S' S ' 331' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -56.81 111.54 1.05 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.321 -0.862 . . . . 37.26 110.005 179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' S' S ' 332' ' ' MET . . . . . . . . . . . . . 88.1 mmm -94.09 162.56 13.83 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.336 -0.852 . . . . 26.23 110.347 -179.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' S' S ' 333' ' ' CYS . . . . . . . . . . . . . 26.1 m -137.26 149.95 47.48 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.419 -0.801 . . . . 23.56 110.07 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' S' S ' 334' ' ' LEU . . . . . 0.565 HD11 ' O ' ' S' ' 372' ' ' PRO . 0.1 OUTLIER -52.54 -24.85 8.93 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.23 -0.919 . . . . 28.93 110.435 179.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' S' S ' 335' ' ' ALA . . . . . . . . . . . . . . . -89.05 14.4 10.75 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.32 -0.863 . . . . 15.76 110.896 -179.35 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' S' S ' 336' ' ' ASP . . . . . 0.402 ' O ' ' HA ' ' S' ' 382' ' ' PRO . 70.4 m-20 -100.49 -17.19 17.26 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.191 -0.943 . . . . 34.92 110.13 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 337' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -152.33 170.86 19.03 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.295 -0.878 . . . . 19.03 110.068 179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' S' S ' 338' ' ' HIS . . . . . 0.401 ' HB3' ' CZ ' ' S' ' 383' ' ' TYR . 13.4 p80 -120.71 10.33 10.96 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.354 -0.841 . . . . 18.82 110.432 179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 339' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' S' ' 352' ' ' ALA . . . -175.96 155.17 1.57 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.291 -0.88 . . . . 17.18 110.065 -179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 340' ' ' GLY . . . . . 0.401 ' CA ' ' O ' ' S' ' 379' ' ' VAL . . . 160.87 173.09 29.05 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 110.067 -1.213 . . . . 18.33 110.067 179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 341' ' ' ILE . . . . . . . . . . . . . 84.2 mt -88.85 138.14 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.444 -1.033 . . . . 18.6 109.766 179.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' S' S ' 342' ' ' PHE . . . . . 0.493 ' CE2' ' HB3' ' S' ' 352' ' ' ALA . 70.0 m-85 -120.99 -178.48 3.76 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.214 -0.929 . . . . 23.44 110.375 -179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 343' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.83 93.38 4.18 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.484 -0.76 . . . . 35.59 109.973 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 344' ' ' LYS . . . . . 0.403 ' O ' ' HB3' ' S' ' 348' ' ' HIS . 0.3 OUTLIER -80.82 125.01 29.56 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.229 -0.919 . . . . 38.34 110.107 179.991 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' S' S ' 345' ' ' GLY . . . . . . . . . . . . . . . 62.72 -130.86 43.27 Favored Glycine 0 N--CA 1.492 2.424 0 N-CA-C 108.87 -1.692 . . . . 53.46 108.87 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' S' S ' 346' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -132.66 150.9 52.09 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.212 -1.17 . . . . 70.91 110.065 179.404 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' S' S ' 347' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 53.25 35.4 19.97 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.34 -0.85 . . . . 47.32 110.395 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' S' S ' 348' ' ' HIS . . . . . 0.403 ' HB3' ' O ' ' S' ' 344' ' ' LYS . 46.6 t60 -150.11 155.85 40.58 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.279 -0.888 . . . . 41.72 110.369 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 349' ' ' ALA . . . . . 0.458 ' C ' HG13 ' S' ' 350' ' ' VAL . . . -149.8 151.24 33.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.281 -0.887 . . . . 22.91 110.543 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 350' ' ' VAL . . . . . 0.458 HG13 ' C ' ' S' ' 349' ' ' ALA . 34.6 m -149.05 169.61 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.421 -0.8 . . . . 21.09 110.017 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 351' ' ' PHE . . . . . 0.501 ' CD2' ' HB3' ' S' ' 258' ' ' GLN . 10.7 t80 -105.36 143.67 33.19 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.249 -0.907 . . . . 25.03 110.693 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 352' ' ' ALA . . . . . 0.493 ' HB3' ' CE2' ' S' ' 342' ' ' PHE . . . -147.74 151.72 36.55 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.52 -0.738 . . . . 23.81 109.807 179.586 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 353' ' ' CYS . . . . . . . . . . . . . 26.2 p -153.4 164.86 37.42 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.271 -0.893 . . . . 25.66 110.175 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' S' S ' 354' ' ' VAL . . . . . 0.55 HG22 ' CE2' ' S' ' 359' ' ' TRP . 57.3 t -76.0 118.56 22.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.39 -0.819 . . . . 34.27 109.994 179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 355' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' S' ' 232' ' ' THR . 52.3 p -117.86 175.07 5.83 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.294 -0.879 . . . . 25.49 110.306 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 356' ' ' SER . . . . . . . . . . . . . 62.3 p -62.1 -17.78 58.73 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.41 -0.806 . . . . 31.24 110.698 -179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' S' S ' 357' ' ' ASN . . . . . . . . . . . . . 45.8 m-20 -106.96 14.17 26.79 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.158 -0.964 . . . . 28.61 110.564 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' S' S ' 358' ' ' GLY . . . . . . . . . . . . . . . 111.87 -152.88 17.6 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 110.043 -1.223 . . . . 22.01 110.043 179.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' S' S ' 359' ' ' TRP . . . . . 0.55 ' CE2' HG22 ' S' ' 354' ' ' VAL . 15.3 m95 -91.4 116.74 29.09 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.43 -1.041 . . . . 25.54 110.109 -179.877 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 360' ' ' TYR . . . . . 0.415 ' HA ' ' HA ' ' S' ' 369' ' ' PRO . 1.3 m-85 -103.54 165.88 10.77 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.344 -0.847 . . . . 40.53 109.997 179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 361' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' S' ' 351' ' ' PHE . . . -140.07 130.02 24.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.427 -0.796 . . . . 18.04 110.279 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 362' ' ' ILE . . . . . . . . . . . . . 89.2 mt -95.59 83.64 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.379 -0.826 . . . . 15.64 110.13 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' S' S ' 363' ' ' ASP . . . . . 0.416 ' O ' ' N ' ' S' ' 365' ' ' GLU . 11.9 t0 -75.26 94.52 3.01 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.305 -0.872 . . . . 35.03 110.149 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 364' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 53.88 -89.4 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.518 -0.739 . . . . 46.72 110.458 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' S' S ' 365' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' S' ' 363' ' ' ASP . 23.8 mt-10 -122.62 19.14 10.37 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.126 -0.984 . . . . 56.2 110.24 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 366' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -117.96 125.03 49.64 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.281 -0.887 . . . . 51.02 110.446 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' S' S ' 367' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -107.06 127.12 53.19 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.349 -0.844 . . . . 37.59 110.142 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' S' S ' 368' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -165.44 159.55 13.89 Favored Pre-proline 0 N--CA 1.493 1.706 0 O-C-N 121.278 -0.889 . . . . 31.47 110.39 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' S' S ' 369' ' ' PRO . . . . . 0.415 ' HA ' ' HA ' ' S' ' 360' ' ' TYR . 47.0 Cg_endo -72.9 139.59 30.48 Favored 'Trans proline' 0 C--N 1.309 -1.504 0 O-C-N 123.859 1.452 . . . . 28.85 110.52 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 370' ' ' TRP . . . . . . . . . . . . . 67.4 t90 -167.2 113.64 0.77 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.387 -0.821 . . . . 26.94 110.006 179.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' S' S ' 371' ' ' THR . . . . . . . . . . . . . 59.7 m -74.85 113.06 20.86 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.417 -0.802 . . . . 20.19 110.0 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' S' S ' 372' ' ' PRO . . . . . 0.565 ' O ' HD11 ' S' ' 334' ' ' LEU . 48.5 Cg_endo -73.55 157.13 49.21 Favored 'Trans proline' 0 C--N 1.312 -1.349 0 O-C-N 123.636 1.335 . . . . 28.68 110.571 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 373' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -90.57 147.16 35.77 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.382 -0.824 . . . . 35.72 109.873 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' S' S ' 374' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -76.05 -6.37 17.27 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 O-C-N 123.628 1.331 . . . . 30.89 110.473 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' S' S ' 375' ' ' SER . . . . . . . . . . . . . 69.0 p -104.28 -16.93 15.03 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.277 -0.889 . . . . 29.41 110.477 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' S' S ' 376' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -106.47 43.02 1.19 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.302 -0.874 . . . . 32.89 110.228 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' S' S ' 377' ' ' VAL . . . . . 0.594 ' O ' HG11 ' S' ' 327' ' ' VAL . 7.3 p -114.62 147.23 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.273 -0.892 . . . . 24.33 110.274 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 378' ' ' LEU . . . . . . . . . . . . . 52.2 mt -116.03 -57.92 2.16 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.446 -0.784 . . . . 24.37 109.642 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' S' S ' 379' ' ' VAL . . . . . 0.645 HG22 HG12 ' S' ' 326' ' ' VAL . 60.5 t -120.73 132.32 70.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.403 -0.811 . . . . 18.02 109.48 179.207 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 380' ' ' PHE . . . . . 0.458 ' CE1' ' HB2' ' S' ' 325' ' ' CYS . 14.3 p90 -142.5 173.92 11.1 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.417 -0.802 . . . . 29.35 110.658 -179.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 381' ' ' VAL . . . . . . . . . . . . . 57.9 t -120.0 107.32 40.02 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.485 -0.759 . . . . 16.34 109.458 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' S' S ' 382' ' ' PRO . . . . . 0.402 ' HA ' ' O ' ' S' ' 336' ' ' ASP . 46.0 Cg_endo -71.28 145.63 49.05 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 O-C-N 123.562 1.296 . . . . 20.94 110.726 -179.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 383' ' ' TYR . . . . . 0.401 ' CZ ' ' HB3' ' S' ' 338' ' ' HIS . 88.2 m-85 -61.16 -53.43 57.06 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.387 -0.82 . . . . 28.93 109.833 179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 384' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -107.36 130.69 54.76 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.457 -0.777 . . . . 47.03 110.426 -177.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' S' S ' 385' ' ' GLN . . . . . 0.455 ' O ' ' C ' ' S' ' 386' ' ' GLU . 0.4 OUTLIER -63.13 -1.8 1.12 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.432 -0.793 . . . . 46.69 110.163 177.87 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' S' S ' 386' ' ' GLU . . . . . 0.766 ' O ' ' HG3' ' S' ' 321' ' ' PRO . 9.1 pt-20 -40.86 151.62 0.26 Allowed Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.332 -0.855 . . . . 50.25 109.599 179.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 387' ' ' PRO . . . . . 0.675 ' O ' ' N ' ' S' ' 389' ' ' ASN . 46.2 Cg_endo -70.23 23.33 0.19 Allowed 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.656 1.345 . . . . 34.39 110.615 -177.541 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 388' ' ' LEU . . . . . 0.522 ' H ' ' C ' ' S' ' 386' ' ' GLU . 4.2 mt 43.4 -83.65 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.393 -0.817 . . . . 38.01 110.105 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 389' ' ' ASN . . . . . 0.675 ' N ' ' O ' ' S' ' 387' ' ' PRO . 2.4 m120 -156.04 76.96 0.94 Allowed 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.442 -0.786 . . . . 45.82 110.083 179.763 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 390' ' ' GLY . . . . . . . . . . . . . . . -118.32 92.19 0.54 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.621 -1.392 . . . . 33.46 109.621 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' S' S ' 391' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -81.29 -33.36 32.7 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.398 -1.06 . . . . 56.58 110.13 179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' S' S ' 392' ' ' TRP . . . . . 0.416 ' CE3' ' HA ' ' S' ' 393' ' ' LYS . 42.8 p-90 -58.23 -18.85 29.27 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.371 -0.83 . . . . 31.43 110.383 179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 393' ' ' LYS . . . . . 0.625 ' O ' HG12 ' S' ' 396' ' ' VAL . 0.0 OUTLIER -46.7 -46.73 20.36 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.304 -0.873 . . . . 39.42 110.334 179.769 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' S' S ' 394' ' ' ALA . . . . . 0.425 ' HA ' ' CG ' ' S' ' 397' ' ' GLN . . . -79.35 -16.57 56.08 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.369 -0.832 . . . . 34.33 110.092 178.689 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 395' ' ' LYS . . . . . 0.783 ' O ' HD11 ' R' ' 143' ' ' LEU . 20.2 mmtt -77.96 -16.43 58.16 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.372 -0.83 . . . . 60.09 110.255 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 396' ' ' VAL . . . . . 0.857 ' O ' ' HA ' ' R' ' 99' ' ' PRO . 7.6 p -100.97 -41.49 8.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.347 -0.846 . . . . 35.5 110.566 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 397' ' ' GLN . . . . . 0.543 ' N ' HG13 ' S' ' 396' ' ' VAL . 1.2 pp0? -77.12 -2.4 34.07 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.152 -0.968 . . . . 49.96 110.637 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' S' S ' 398' ' ' ARG . . . . . 0.754 ' HB2' ' HA ' ' R' ' 147' ' ' GLU . 0.0 OUTLIER -45.27 157.62 0.08 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.307 -0.871 . . . . 43.42 110.71 -179.994 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' S' S ' 399' ' ' LYS . . . . . 0.606 ' CB ' ' HA3' ' R' ' 97' ' ' GLY . 0.8 OUTLIER -142.58 118.16 10.37 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.299 -0.875 . . . . 55.31 110.06 179.737 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' S' S ' 400' ' ' LEU . . . . . 0.772 ' O ' HD22 ' S' ' 400' ' ' LEU . 1.0 OUTLIER -35.13 -43.8 0.22 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.305 -0.872 . . . . 41.03 110.239 -179.939 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' S' S ' 401' ' ' LYS . . . . . 0.633 ' N ' HD13 ' S' ' 400' ' ' LEU . 4.8 tmmt? . . . . . 0 N--CA 1.493 1.683 0 O-C-N 121.23 -0.919 . . . . 61.97 110.15 179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.152 0.501 . . . . 32.14 110.291 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 30' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -96.27 141.18 29.92 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.382 -0.824 . . . . 43.36 110.249 -179.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 31' ' ' LEU . . . . . . . . . . . . . 65.3 mt -134.91 140.6 45.89 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.282 -0.886 . . . . 22.93 110.283 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 32' ' ' THR . . . . . . . . . . . . . 70.3 m -87.62 110.49 20.43 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.391 -0.818 . . . . 22.34 109.982 179.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 33' ' ' LEU . . . . . 0.596 HD22 ' CE2' ' R' ' 62' ' ' TYR . 80.1 mt -62.28 -172.78 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.295 -0.878 . . . . 21.39 110.221 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 34' ' ' TYR . . . . . . . . . . . . . 37.0 p90 -74.66 -29.36 61.22 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.266 -0.896 . . . . 34.4 110.414 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 35' ' ' ASN . . . . . . . . . . . . . 48.3 p30 -77.77 -1.92 33.79 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.289 -0.882 . . . . 30.28 110.633 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.29 -16.56 59.51 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.742 -1.343 . . . . 36.25 109.742 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 37' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -59.02 161.82 4.76 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.285 -1.127 . . . . 53.8 110.368 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 38' ' ' LYS . . . . . . . . . . . . . 56.8 mttt -117.85 135.73 53.9 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.367 -0.833 . . . . 49.91 110.132 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 39' ' ' LYS . . . . . 0.406 ' HG2' ' CZ ' ' R' ' 41' ' ' PHE . 8.0 ttmt -138.72 143.68 39.19 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.375 -0.828 . . . . 35.69 110.255 -179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 40' ' ' THR . . . . . . . . . . . . . 23.4 m -102.55 127.95 49.41 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.424 -0.798 . . . . 34.84 110.198 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 41' ' ' PHE . . . . . 0.406 ' CZ ' ' HG2' ' R' ' 39' ' ' LYS . 96.6 m-85 -113.0 132.69 55.27 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.41 -0.806 . . . . 34.42 110.179 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 42' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -93.34 140.97 28.96 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.328 -0.857 . . . . 51.46 110.229 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 43' ' ' SER . . . . . . . . . . . . . 54.3 m -70.84 141.9 51.28 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.461 -0.774 . . . . 41.84 110.192 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.77 125.4 29.54 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.367 -0.833 . . . . 33.82 109.957 179.668 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 45' ' ' PRO . . . . . 0.424 ' HG2' ' ND2' ' R' ' 77' ' ' ASN . 45.6 Cg_endo -72.15 151.05 54.77 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.517 1.272 . . . . 30.27 110.646 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 46' ' ' ASN . . . . . 0.4 ' HA ' ' OD1' ' R' ' 50' ' ' ASN . 52.2 t-20 -124.24 109.91 13.99 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.534 -0.728 . . . . 35.1 109.997 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 47' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -120.32 -34.84 3.56 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.292 -0.88 . . . . 42.81 110.537 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 48' ' ' HIS . . . . . 0.439 ' NE2' HD11 ' R' ' 80' ' ' LEU . 73.3 m80 -105.86 45.23 0.98 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.346 -0.846 . . . . 49.97 110.24 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 49' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 50.32 34.62 9.22 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.491 -0.755 . . . . 61.32 110.158 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 50' ' ' ASN . . . . . 0.4 ' OD1' ' HA ' ' R' ' 46' ' ' ASN . 15.0 p-10 -86.15 43.77 1.08 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.388 -0.82 . . . . 51.5 110.747 -179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 51' ' ' ALA . . . . . 0.483 ' CB ' ' O ' ' S' ' 400' ' ' LEU . . . -66.07 -46.1 78.93 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.243 -0.911 . . . . 38.77 109.571 179.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 52' ' ' TRP . . . . . 0.483 ' CD2' ' N ' ' R' ' 53' ' ' LEU . 68.1 p-90 -58.46 -38.34 77.34 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.57 -0.706 . . . . 26.24 110.048 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 53' ' ' LEU . . . . . 0.483 ' N ' ' CD2' ' R' ' 52' ' ' TRP . 23.2 tp -66.72 -46.68 74.75 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.323 -0.861 . . . . 26.75 110.013 179.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 54' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -55.25 -41.53 72.29 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.363 -0.836 . . . . 35.02 110.23 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.16 -46.12 91.83 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.44 -0.788 . . . . 24.47 110.196 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 56' ' ' ILE . . . . . 0.431 HG12 HD11 ' R' ' 104' ' ' ILE . 76.1 mt -62.12 -42.26 94.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.292 -0.88 . . . . 26.03 109.927 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 57' ' ' LEU . . . . . . . . . . . . . 22.3 mt -60.35 -45.61 92.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.251 -0.906 . . . . 26.77 109.661 179.473 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 58' ' ' GLN . . . . . . . . . . . . . 57.7 mm-40 -63.87 -46.52 84.58 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.427 -0.796 . . . . 22.32 109.625 179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 59' ' ' LEU . . . . . 0.43 ' HA ' ' HE2' ' R' ' 151' ' ' PHE . 24.0 tp -61.33 -37.82 84.67 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.334 -0.854 . . . . 20.55 109.443 179.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 60' ' ' PHE . . . . . 0.528 ' CE2' HD21 ' R' ' 111' ' ' LEU . 2.8 m-85 -61.1 -44.7 96.95 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.567 -0.708 . . . . 20.08 109.933 179.351 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 61' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -63.1 -36.13 82.57 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.441 -0.787 . . . . 18.8 110.541 -179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 62' ' ' TYR . . . . . 0.596 ' CE2' HD22 ' R' ' 33' ' ' LEU . 9.2 t80 -63.22 -41.73 99.16 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.233 -0.917 . . . . 26.45 110.155 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 63' ' ' VAL . . . . . 0.406 ' H ' HG22 ' R' ' 63' ' ' VAL . 30.4 m -93.36 20.34 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.275 -0.891 . . . . 29.75 110.19 179.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 64' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 52.92 75.63 0.23 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.328 -0.857 . . . . 35.52 110.559 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 65' ' ' GLU . . . . . 0.443 ' HG2' ' CD2' ' R' ' 60' ' ' PHE . 14.3 tp10 -116.36 104.14 52.15 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.344 -0.847 . . . . 29.89 109.865 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 66' ' ' PRO . . . . . 0.481 ' HA ' ' HB2' ' R' ' 69' ' ' ASP . 46.7 Cg_endo -73.6 -5.84 17.74 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.806 1.424 . . . . 21.37 111.064 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 67' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -52.09 -61.52 2.21 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.147 -0.97 . . . . 23.85 110.375 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 68' ' ' PHE . . . . . . . . . . . . . 11.0 m-85 -98.2 36.69 1.55 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.326 -0.859 . . . . 28.07 110.488 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 69' ' ' ASP . . . . . 0.481 ' HB2' ' HA ' ' R' ' 66' ' ' PRO . 11.7 t0 -72.43 -33.17 66.91 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.225 -0.922 . . . . 43.76 110.175 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 70' ' ' TRP . . . . . 0.476 ' CE2' ' CG2' ' R' ' 71' ' ' VAL . 47.7 p-90 -73.41 -3.98 30.74 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.334 -0.854 . . . . 33.06 110.71 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 71' ' ' VAL . . . . . 0.557 HG11 ' HB2' ' R' ' 82' ' ' ALA . 40.5 t -109.73 -27.41 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.223 -0.923 . . . . 31.7 109.756 179.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 72' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -86.54 -48.79 8.06 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.407 -0.808 . . . . 33.58 110.383 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 73' ' ' SER . . . . . . . . . . . . . 70.0 m -89.71 51.06 2.0 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.394 -0.816 . . . . 50.82 110.304 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 74' ' ' SER . . . . . . . . . . . . . 15.9 t -125.96 138.29 31.79 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.238 -0.914 . . . . 34.74 110.24 179.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.36 -24.96 15.98 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.742 1.391 . . . . 35.7 110.343 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 76' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -91.72 153.15 19.83 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.33 -0.856 . . . . 66.48 110.355 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 77' ' ' ASN . . . . . 0.424 ' ND2' ' HG2' ' R' ' 45' ' ' PRO . 22.3 t-20 -81.47 95.27 7.03 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.391 -0.818 . . . . 46.72 110.043 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 78' ' ' LEU . . . . . . . . . . . . . 96.3 mt -96.49 27.99 3.55 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.389 -0.82 . . . . 37.55 110.191 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 79' ' ' THR . . . . . . . . . . . . . 29.6 m -56.27 -54.58 43.7 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.225 -0.922 . . . . 37.36 110.302 -179.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 80' ' ' LEU . . . . . 0.604 ' HA ' HD12 ' R' ' 83' ' ' ILE . 15.9 mt -60.97 -23.16 65.13 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.33 -0.856 . . . . 35.83 110.511 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 81' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -79.5 -39.11 32.85 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.101 -0.999 . . . . 44.03 110.356 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 82' ' ' ALA . . . . . 0.557 ' HB2' HG11 ' R' ' 71' ' ' VAL . . . -69.51 -28.64 66.22 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.257 -0.902 . . . . 32.54 110.169 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 83' ' ' ILE . . . . . 0.604 HD12 ' HA ' ' R' ' 80' ' ' LEU . 77.8 mt -70.08 -46.12 73.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.275 -0.891 . . . . 32.02 110.352 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 84' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -55.09 -52.17 64.08 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.208 -0.932 . . . . 34.09 110.56 -179.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 85' ' ' GLN . . . . . 0.533 ' HG2' HD12 ' R' ' 89' ' ' LEU . 31.9 tt0 -54.79 -46.88 74.53 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.209 -0.932 . . . . 25.94 110.279 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 86' ' ' LEU . . . . . . . . . . . . . 23.7 mt -58.75 -43.76 90.38 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.365 -0.835 . . . . 16.2 109.853 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 87' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -65.33 -35.25 80.4 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.494 -0.754 . . . . 49.09 110.317 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 88' ' ' ASP . . . . . . . . . . . . . 31.5 m-20 -78.41 -19.05 54.09 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.282 -0.886 . . . . 28.61 110.529 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 89' ' ' LEU . . . . . 0.533 HD12 ' HG2' ' R' ' 85' ' ' GLN . 32.6 mt -96.21 -29.35 14.09 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.248 -0.907 . . . . 26.16 110.201 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 90' ' ' THR . . . . . . . . . . . . . 60.7 p -105.69 -34.71 7.62 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.255 -0.903 . . . . 33.33 109.75 179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.88 16.15 58.47 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.85 -1.3 . . . . 31.13 109.85 -179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 92' ' ' LEU . . . . . . . . . . . . . 97.1 mt -100.18 155.21 17.87 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.213 -1.169 . . . . 42.52 110.186 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 93' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -86.19 91.59 8.5 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.481 -0.762 . . . . 68.46 110.038 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 94' ' ' LEU . . . . . 0.458 ' HB3' ' CZ2' ' R' ' 52' ' ' TRP . 48.1 mt -99.37 53.03 0.95 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.204 -0.935 . . . . 44.63 110.377 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 95' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.57 -38.59 6.38 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.262 -0.898 . . . . 67.16 110.369 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 96' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -113.93 44.23 1.68 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.364 -0.835 . . . . 67.02 110.244 -179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 97' ' ' GLY . . . . . 0.602 ' HA3' ' HA ' ' S' ' 399' ' ' LYS . . . 99.12 150.8 26.05 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.614 -1.395 . . . . 49.48 109.614 179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 98' ' ' GLY . . . . . . . . . . . . . . . -166.27 160.01 33.44 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.265 -1.534 . . . . 36.57 109.265 179.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 99' ' ' PRO . . . . . 0.997 ' HA ' ' O ' ' S' ' 396' ' ' VAL . 44.5 Cg_endo -72.57 121.12 7.15 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.75 1.395 . . . . 30.41 110.384 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 100' ' ' PRO . . . . . 0.413 ' HA ' HD11 ' R' ' 56' ' ' ILE . 45.4 Cg_endo -72.3 -31.68 11.34 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 123.619 1.326 . . . . 29.94 110.493 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 101' ' ' ALA . . . . . 0.475 ' HB2' ' HB3' ' R' ' 178' ' ' LEU . . . -70.01 -38.45 75.96 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.34 -0.85 . . . . 23.64 110.294 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 102' ' ' LEU . . . . . 0.423 HD23 HD21 ' R' ' 106' ' ' ASN . 0.1 OUTLIER -72.63 -40.77 66.16 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.353 -0.842 . . . . 20.31 110.382 -179.757 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' R' R ' 103' ' ' VAL . . . . . 0.79 HG23 ' O ' ' R' ' 99' ' ' PRO . 63.1 t -58.01 -40.21 75.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 O-C-N 121.202 -0.936 . . . . 16.33 110.023 179.81 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 104' ' ' ILE . . . . . 0.431 HD11 HG12 ' R' ' 56' ' ' ILE . 81.7 mt -71.62 -30.6 39.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.384 -0.823 . . . . 24.77 109.941 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 105' ' ' TRP . . . . . 0.462 ' O ' ' HD3' ' R' ' 108' ' ' LYS . 70.6 t-105 -82.26 0.72 40.08 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.311 -0.868 . . . . 23.28 110.376 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 106' ' ' ASN . . . . . 0.423 HD21 HD23 ' R' ' 102' ' ' LEU . 6.9 m-80 -104.98 -10.5 17.2 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.118 -0.989 . . . . 28.26 110.112 179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 107' ' ' ILE . . . . . . . . . . . . . 36.6 pt -126.81 35.0 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.225 -0.922 . . . . 18.77 109.994 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 108' ' ' LYS . . . . . 0.5 ' HG2' ' HB ' ' R' ' 115' ' ' ILE . 9.2 mtpp -61.02 -48.54 81.32 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.499 -0.751 . . . . 42.5 110.011 179.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 109' ' ' HIS . . . . . 0.447 ' CD2' ' HG ' ' R' ' 110' ' ' LEU . 50.8 p-80 -66.0 -12.84 57.93 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.518 -0.738 . . . . 20.07 110.64 -179.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 110' ' ' LEU . . . . . 0.447 ' HG ' ' CD2' ' R' ' 109' ' ' HIS . 80.4 mt -94.8 -17.39 22.17 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.116 -0.99 . . . . 15.69 110.156 179.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 111' ' ' LEU . . . . . 0.528 HD21 ' CE2' ' R' ' 60' ' ' PHE . 10.4 mt -94.06 144.12 25.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.299 -0.876 . . . . 25.39 111.046 -179.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 112' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -77.66 -17.43 57.72 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.634 -0.666 . . . . 53.48 109.854 179.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 113' ' ' THR . . . . . 0.457 HG22 ' N ' ' R' ' 114' ' ' GLY . 60.0 m -83.63 166.66 17.97 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.379 -0.826 . . . . 14.8 110.257 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 114' ' ' GLY . . . . . 0.457 ' N ' HG22 ' R' ' 113' ' ' THR . . . -97.97 127.14 9.13 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 110.041 -1.224 . . . . 16.14 110.041 -179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 115' ' ' ILE . . . . . 0.578 HD13 ' HB ' ' R' ' 124' ' ' VAL . 47.7 mm -109.1 139.37 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.457 -1.025 . . . . 13.46 109.727 179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 116' ' ' GLY . . . . . . . . . . . . . . . -152.75 -155.81 7.27 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.876 -1.29 . . . . 23.9 109.876 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 117' ' ' THR . . . . . 0.53 HG22 ' CG2' ' R' ' 126' ' ' VAL . 18.7 p -135.05 -171.4 2.79 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.432 -1.04 . . . . 27.37 110.072 -179.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 118' ' ' ALA . . . . . 0.445 ' HB3' ' OD1' ' R' ' 128' ' ' ASP . . . -56.5 -58.12 9.42 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.23 -0.918 . . . . 18.76 110.031 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 119' ' ' SER . . . . . 0.653 ' O ' ' HB2' ' R' ' 197' ' ' GLN . 1.1 m -56.56 -40.6 75.44 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.259 -0.901 . . . . 32.35 109.764 179.692 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 120' ' ' ARG . . . . . 0.425 ' HG2' ' OE1' ' R' ' 197' ' ' GLN . 10.0 mtm180 -110.05 86.29 4.9 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.47 -0.768 . . . . 27.12 109.636 179.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 121' ' ' PRO . . . . . 0.483 ' HA ' ' SG ' ' R' ' 125' ' ' CYS . 44.2 Cg_endo -71.26 166.44 29.25 Favored 'Trans proline' 0 C--N 1.311 -1.445 0 O-C-N 123.819 1.431 . . . . 22.68 111.009 -179.48 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 122' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' R' ' 121' ' ' PRO . 38.1 t 178.58 -161.65 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.609 -0.682 . . . . 22.99 109.493 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 123' ' ' GLU . . . . . 0.44 ' HG2' HG23 ' R' ' 113' ' ' THR . 2.3 tp10 -56.45 -39.97 74.01 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.19 -0.944 . . . . 36.18 109.701 179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 124' ' ' VAL . . . . . 0.578 ' HB ' HD13 ' R' ' 115' ' ' ILE . 82.6 t -142.5 136.41 27.93 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.498 -0.751 . . . . 20.64 109.393 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 125' ' ' CYS . . . . . 0.483 ' SG ' ' HA ' ' R' ' 121' ' ' PRO . 83.4 m -140.32 168.15 20.49 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.304 -0.873 . . . . 22.8 111.131 -179.328 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 126' ' ' VAL . . . . . 0.727 HG12 HG22 ' R' ' 179' ' ' VAL . 35.8 m -122.68 159.7 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 121.714 -0.616 . . . . 21.24 109.676 179.653 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 127' ' ' VAL . . . . . 0.709 HG11 ' O ' ' R' ' 177' ' ' VAL . 30.6 m -70.81 141.8 16.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.359 -0.838 . . . . 19.77 110.7 -179.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 128' ' ' ASP . . . . . 0.445 ' OD1' ' HB3' ' R' ' 118' ' ' ALA . 53.9 p-10 -137.63 19.38 2.89 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.333 -0.855 . . . . 29.21 110.714 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 129' ' ' GLY . . . . . . . . . . . . . . . 113.97 0.08 24.18 Favored Glycine 0 N--CA 1.493 2.458 0 C-N-CA 120.0 -1.095 . . . . 33.86 110.468 179.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 130' ' ' THR . . . . . . . . . . . . . 58.1 m -91.82 131.87 36.85 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.171 -1.193 . . . . 26.41 110.072 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -62.58 120.65 11.56 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.312 -0.868 . . . . 33.08 110.284 -179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 132' ' ' MET . . . . . 0.433 ' HE1' ' CE2' ' R' ' 180' ' ' PHE . 98.4 mmm -105.16 165.62 10.97 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.543 -0.723 . . . . 30.76 110.415 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 133' ' ' CYS . . . . . 0.41 ' HA ' ' HB3' ' R' ' 174' ' ' PRO . 32.4 m -141.14 158.13 44.33 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.511 -0.743 . . . . 27.0 109.912 179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 134' ' ' LEU . . . . . 0.563 HD11 ' O ' ' R' ' 172' ' ' PRO . 0.1 OUTLIER -58.48 -19.68 39.12 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.347 -0.846 . . . . 33.9 110.538 -179.936 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' R' R ' 135' ' ' ALA . . . . . . . . . . . . . . . -92.79 8.22 40.37 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.261 -0.899 . . . . 19.37 110.801 -179.86 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 136' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -93.72 -21.87 19.08 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.109 -0.994 . . . . 30.47 110.195 179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 137' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -149.9 165.45 32.56 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.421 -0.8 . . . . 24.27 110.227 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 138' ' ' HIS . . . . . 0.434 ' HA ' HG23 ' R' ' 154' ' ' VAL . 15.1 p80 -117.88 15.09 14.33 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.418 -0.801 . . . . 20.91 110.412 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 139' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' R' ' 152' ' ' ALA . . . -177.19 152.35 0.87 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.187 -0.946 . . . . 15.69 110.171 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 140' ' ' GLY . . . . . 0.428 ' HA3' ' O ' ' R' ' 179' ' ' VAL . . . 161.82 175.18 32.58 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.918 -1.273 . . . . 23.76 109.918 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 141' ' ' ILE . . . . . . . . . . . . . 83.7 mt -95.54 136.57 26.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.447 -1.031 . . . . 25.3 109.702 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 142' ' ' PHE . . . . . 0.577 ' CD2' ' HB2' ' R' ' 172' ' ' PRO . 82.2 m-85 -120.66 -172.58 2.41 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.276 -0.89 . . . . 30.24 110.566 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 143' ' ' LEU . . . . . 0.742 HD23 ' O ' ' R' ' 148' ' ' HIS . 0.5 OUTLIER -119.84 77.78 1.27 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.455 -0.778 . . . . 32.8 110.298 -179.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' R' R ' 144' ' ' LYS . . . . . 0.471 ' HG3' ' CZ2' ' R' ' 170' ' ' TRP . 1.0 OUTLIER -69.66 76.84 0.43 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.43 -0.794 . . . . 49.18 109.635 179.651 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' R' R ' 145' ' ' GLY . . . . . 0.458 ' O ' HD22 ' R' ' 143' ' ' LEU . . . 104.57 179.26 24.76 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.168 -1.573 . . . . 53.87 109.168 -179.558 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 146' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -88.5 145.79 25.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.388 -1.066 . . . . 68.58 110.049 179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 147' ' ' GLU . . . . . 0.789 ' HA ' ' CB ' ' S' ' 398' ' ' ARG . 10.9 mt-10 58.29 36.51 25.68 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.392 -0.818 . . . . 56.62 110.655 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 148' ' ' HIS . . . . . 0.742 ' O ' HD23 ' R' ' 143' ' ' LEU . 45.0 t60 -158.68 148.08 19.14 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.205 -0.934 . . . . 44.57 110.377 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 149' ' ' ALA . . . . . 0.658 ' HB2' ' NZ ' ' S' ' 401' ' ' LYS . . . -150.3 146.93 27.06 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.467 -0.771 . . . . 33.54 110.072 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 150' ' ' VAL . . . . . . . . . . . . . 34.2 m -142.38 161.45 19.31 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.273 -0.892 . . . . 27.61 110.305 179.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 151' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' R' ' 152' ' ' ALA . 5.9 t80 -86.15 155.58 20.7 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.42 -0.8 . . . . 23.04 109.867 179.694 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 152' ' ' ALA . . . . . 0.537 ' N ' ' CD1' ' R' ' 151' ' ' PHE . . . -157.31 151.59 24.95 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.455 -0.778 . . . . 29.61 109.565 178.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 153' ' ' CYS . . . . . . . . . . . . . 26.7 p -154.33 173.56 16.02 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.334 -0.854 . . . . 22.75 110.49 -179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 154' ' ' VAL . . . . . 0.613 HG22 ' CE2' ' R' ' 159' ' ' TRP . 60.4 t -90.6 116.97 32.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.337 -0.852 . . . . 23.26 110.083 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 155' ' ' THR . . . . . . . . . . . . . 69.3 p -112.05 -176.65 2.98 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.257 -0.902 . . . . 17.88 110.102 179.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 156' ' ' SER . . . . . . . . . . . . . 78.4 p -75.96 -3.69 36.96 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.394 -0.816 . . . . 21.83 110.721 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 157' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -118.32 10.58 12.84 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.046 -1.034 . . . . 36.54 110.613 -179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 158' ' ' GLY . . . . . . . . . . . . . . . 117.98 -162.65 13.04 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.592 -1.403 . . . . 31.74 109.592 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 159' ' ' TRP . . . . . 0.613 ' CE2' HG22 ' R' ' 154' ' ' VAL . 14.7 m95 -86.55 122.42 30.47 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.312 -1.111 . . . . 28.25 110.112 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 160' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -108.46 166.94 10.39 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.413 -0.805 . . . . 41.24 110.19 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 161' ' ' ALA . . . . . . . . . . . . . . . -143.21 123.48 13.79 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.367 -0.833 . . . . 27.4 110.14 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 162' ' ' ILE . . . . . . . . . . . . . 92.1 mt -87.6 81.14 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.354 -0.841 . . . . 24.27 110.106 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 163' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' R' ' 165' ' ' GLU . 15.3 t0 -72.72 92.33 1.54 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.443 -0.786 . . . . 36.08 110.332 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 164' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 54.1 -88.93 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.496 -0.752 . . . . 46.08 110.565 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 165' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' R' ' 163' ' ' ASP . 29.7 mt-10 -124.72 35.96 4.7 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.017 -1.052 . . . . 50.94 110.187 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 166' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -135.8 117.34 14.84 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.339 -0.85 . . . . 47.28 110.309 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 167' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -101.07 119.92 39.45 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.412 -0.805 . . . . 40.47 110.127 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 168' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -157.58 158.51 30.6 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.305 -0.872 . . . . 30.21 110.407 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 169' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.77 133.06 19.54 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 O-C-N 123.868 1.457 . . . . 32.76 110.474 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 170' ' ' TRP . . . . . 0.471 ' CZ2' ' HG3' ' R' ' 144' ' ' LYS . 67.0 t90 -159.81 119.3 2.88 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.41 -0.806 . . . . 32.79 109.984 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 171' ' ' THR . . . . . . . . . . . . . 45.7 m -81.08 112.62 34.19 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.444 -0.785 . . . . 36.92 110.219 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 172' ' ' PRO . . . . . 0.577 ' HB2' ' CD2' ' R' ' 142' ' ' PHE . 46.9 Cg_endo -73.75 158.83 46.45 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.68 1.358 . . . . 33.54 110.533 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 173' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -88.9 144.96 33.71 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.366 -0.833 . . . . 45.76 109.843 179.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 174' ' ' PRO . . . . . 0.41 ' HB3' ' HA ' ' R' ' 133' ' ' CYS . 45.2 Cg_endo -71.71 -10.4 26.46 Favored 'Trans proline' 0 C--N 1.311 -1.415 0 O-C-N 123.553 1.291 . . . . 29.63 110.438 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 175' ' ' SER . . . . . . . . . . . . . 53.0 p -103.36 -17.69 15.16 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.234 -0.916 . . . . 35.7 110.404 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 176' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -103.44 43.13 1.1 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.233 -0.917 . . . . 39.65 110.4 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 177' ' ' VAL . . . . . 0.709 ' O ' HG11 ' R' ' 127' ' ' VAL . 10.4 p -117.69 127.2 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.409 -0.807 . . . . 20.61 110.021 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 178' ' ' LEU . . . . . 0.475 ' HB3' ' HB2' ' R' ' 101' ' ' ALA . 46.3 mt -91.52 -61.29 1.68 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.35 -0.844 . . . . 15.58 109.376 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 179' ' ' VAL . . . . . 0.727 HG22 HG12 ' R' ' 126' ' ' VAL . 67.1 t -114.62 144.67 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.6 -0.688 . . . . 17.4 109.444 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 180' ' ' PHE . . . . . 0.433 ' CE2' ' HE1' ' R' ' 132' ' ' MET . 43.7 p90 -152.09 163.37 39.47 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.338 -0.851 . . . . 20.16 110.562 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 181' ' ' VAL . . . . . . . . . . . . . 66.4 t -113.19 111.48 50.22 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.511 -0.743 . . . . 17.69 109.836 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 182' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.11 149.54 52.44 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.546 1.287 . . . . 17.81 110.374 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 183' ' ' TYR . . . . . 0.736 ' O ' ' C ' ' R' ' 184' ' ' ASP . 79.2 m-85 -58.99 175.47 0.28 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.464 -0.772 . . . . 28.01 110.522 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 184' ' ' ASP . . . . . 0.736 ' C ' ' O ' ' R' ' 183' ' ' TYR . 0.0 OUTLIER -13.05 -76.29 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.303 -0.873 . . . . 58.64 110.221 -178.029 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' R' R ' 185' ' ' GLN . . . . . . . . . . . . . 16.8 tm0? . . . . . 0 N--CA 1.503 2.217 0 CA-C-O 121.265 0.555 . . . . 80.42 111.773 179.171 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' R' R ' 193' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 120.873 0.368 . . . . 49.5 110.245 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 194' ' ' ALA . . . . . 0.63 ' HB3' ' HA ' ' R' ' 119' ' ' SER . . . -172.7 -142.04 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.162 -0.961 . . . . 40.4 110.136 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 195' ' ' LYS . . . . . . . . . . . . . 3.1 mtpm? -103.87 -52.07 3.04 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.316 -0.865 . . . . 34.6 110.324 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 196' ' ' VAL . . . . . 0.519 ' HB ' ' CB ' ' R' ' 119' ' ' SER . 30.2 t -89.71 56.27 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.254 -0.904 . . . . 33.27 110.64 -179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 197' ' ' GLN . . . . . 0.653 ' HB2' ' O ' ' R' ' 119' ' ' SER . 29.1 tp60 -155.98 -33.7 0.09 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.165 -0.959 . . . . 41.58 110.676 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 198' ' ' ARG . . . . . . . . . . . . . 21.0 mtm180 -62.03 158.88 15.47 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.175 -0.953 . . . . 38.65 110.219 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' R' R ' 199' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -104.69 68.99 0.87 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.453 -0.779 . . . . 36.77 109.925 179.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' R' R ' 200' ' ' LEU . . . . . 0.95 HD12 ' HG2' ' R' ' 201' ' ' LYS . 0.5 OUTLIER -53.52 178.07 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.425 -0.797 . . . . 33.08 110.176 -179.74 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' R' R ' 201' ' ' LYS . . . . . 0.95 ' HG2' HD12 ' R' ' 200' ' ' LEU . 10.4 mmmm . . . . . 0 N--CA 1.492 1.669 0 O-C-N 121.36 -0.837 . . . . 44.32 110.288 -179.839 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' S' S ' 229' ' ' MET . . . . . . . . . . . . . 28.8 mtm . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.188 0.518 . . . . 51.83 110.235 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' S' S ' 230' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -97.34 142.69 28.9 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.409 -0.807 . . . . 54.13 110.195 179.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' S' S ' 231' ' ' LEU . . . . . . . . . . . . . 68.0 mt -134.02 141.02 47.06 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.413 -0.805 . . . . 33.04 110.344 -179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' S' S ' 232' ' ' THR . . . . . 0.412 ' O ' ' HA ' ' S' ' 355' ' ' THR . 40.2 m -89.27 103.29 15.93 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.432 -0.792 . . . . 26.92 109.973 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 233' ' ' LEU . . . . . 0.667 HD22 ' CE2' ' S' ' 262' ' ' TYR . 79.7 mt -55.92 179.36 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.471 -0.768 . . . . 13.78 110.494 -179.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 234' ' ' TYR . . . . . 0.44 ' CG ' ' N ' ' S' ' 235' ' ' ASN . 35.4 p90 -65.13 -35.61 81.67 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.355 -0.841 . . . . 26.08 110.17 179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 235' ' ' ASN . . . . . 0.44 ' N ' ' CG ' ' S' ' 234' ' ' TYR . 50.7 p30 -74.3 -7.5 52.99 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.299 -0.876 . . . . 20.04 110.504 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 236' ' ' GLY . . . . . . . . . . . . . . . 95.8 -20.02 51.72 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.76 -1.336 . . . . 22.71 109.76 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' S' S ' 237' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -53.02 145.77 12.41 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.19 -1.182 . . . . 35.44 110.145 -179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' S' S ' 238' ' ' LYS . . . . . . . . . . . . . 44.3 mttt -102.18 127.87 48.93 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.395 -0.815 . . . . 32.56 110.362 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' S' S ' 239' ' ' LYS . . . . . 0.407 ' HG2' ' CZ ' ' S' ' 241' ' ' PHE . 8.9 ttmt -132.29 144.45 50.59 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.474 -0.766 . . . . 26.68 109.959 179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 240' ' ' THR . . . . . . . . . . . . . 52.4 m -101.98 132.22 47.93 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.237 -0.915 . . . . 41.02 110.375 -179.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' S' S ' 241' ' ' PHE . . . . . 0.407 ' CZ ' ' HG2' ' S' ' 239' ' ' LYS . 96.1 m-85 -117.95 137.75 52.63 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.348 -0.845 . . . . 28.62 110.203 179.829 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 242' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -96.47 161.78 13.76 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.38 -0.825 . . . . 47.89 110.149 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' S' S ' 243' ' ' SER . . . . . . . . . . . . . 72.1 m -90.59 151.62 21.23 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.31 -0.869 . . . . 45.09 110.211 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' S' S ' 244' ' ' ARG . . . . . . . . . . . . . 1.4 mtp85 -129.82 126.72 22.66 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.324 -0.86 . . . . 42.49 110.204 -179.818 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' S' S ' 245' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.3 160.94 43.97 Favored 'Trans proline' 0 C--N 1.311 -1.412 0 O-C-N 123.635 1.334 . . . . 35.68 110.559 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' S' S ' 246' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -132.82 97.84 4.15 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.327 -0.858 . . . . 51.88 109.871 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' S' S ' 247' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -110.49 -22.18 11.79 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.376 -0.828 . . . . 53.69 110.647 -179.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' S' S ' 248' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -117.29 43.66 2.28 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.237 -0.914 . . . . 55.79 110.717 -179.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' S' S ' 249' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 48.8 38.43 11.89 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.444 -0.785 . . . . 49.45 110.333 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' S' S ' 250' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -90.69 29.14 1.37 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.53 -0.731 . . . . 36.86 110.297 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' S' S ' 251' ' ' ALA . . . . . 0.588 ' HB3' ' CE ' ' R' ' 201' ' ' LYS . . . -53.9 -43.18 69.46 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.172 -0.955 . . . . 29.69 109.564 179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 252' ' ' TRP . . . . . 0.428 ' CZ2' ' HB3' ' S' ' 294' ' ' LEU . 68.0 p-90 -61.81 -33.91 74.97 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.491 -0.755 . . . . 41.12 109.868 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 253' ' ' LEU . . . . . 0.406 ' N ' ' CD2' ' S' ' 252' ' ' TRP . 23.3 tp -70.14 -47.26 62.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.321 -0.862 . . . . 24.89 109.962 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 254' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -56.12 -42.49 76.94 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.343 -0.848 . . . . 35.65 109.991 179.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' S' S ' 255' ' ' ALA . . . . . . . . . . . . . . . -59.56 -48.24 82.44 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.439 -0.788 . . . . 22.73 110.046 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' S' S ' 256' ' ' ILE . . . . . 0.502 HG12 HD11 ' S' ' 304' ' ' ILE . 79.7 mt -62.22 -40.68 88.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.337 -0.852 . . . . 28.85 109.988 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 257' ' ' LEU . . . . . . . . . . . . . 19.1 mt -61.52 -44.51 96.93 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.356 -0.84 . . . . 23.07 110.162 179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' S' S ' 258' ' ' GLN . . . . . 0.498 ' HB3' ' CD2' ' S' ' 351' ' ' PHE . 53.4 mm-40 -65.07 -45.37 85.55 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.422 -0.799 . . . . 29.78 109.87 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 259' ' ' LEU . . . . . 0.423 ' O ' HG22 ' S' ' 263' ' ' VAL . 19.9 tp -58.71 -36.34 74.09 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.331 -0.856 . . . . 17.94 109.452 179.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 260' ' ' PHE . . . . . 0.537 ' CE2' HD21 ' S' ' 311' ' ' LEU . 3.1 m-85 -62.84 -45.2 93.7 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.56 -0.713 . . . . 30.57 109.825 179.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 261' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -62.18 -29.79 70.62 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.475 -0.766 . . . . 41.34 109.901 179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' S' S ' 262' ' ' TYR . . . . . 0.667 ' CE2' HD22 ' S' ' 233' ' ' LEU . 8.6 t80 -71.17 -44.69 65.0 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.435 -0.79 . . . . 26.03 110.129 179.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 263' ' ' VAL . . . . . 0.423 HG22 ' O ' ' S' ' 259' ' ' LEU . 33.1 m -92.0 18.29 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.352 -0.843 . . . . 22.8 110.384 179.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 264' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 52.72 70.69 0.55 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.206 -0.934 . . . . 44.03 110.641 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' S' S ' 265' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -111.82 109.24 55.36 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.375 -0.828 . . . . 35.61 109.649 179.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' S' S ' 266' ' ' PRO . . . . . 0.476 ' HA ' ' HB2' ' S' ' 269' ' ' ASP . 48.5 Cg_endo -75.33 0.46 9.01 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.631 1.332 . . . . 37.67 111.772 -179.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 267' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -56.56 -67.63 0.29 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 120.779 -1.201 . . . . 41.49 110.17 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 268' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -92.94 39.91 1.05 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.193 -0.942 . . . . 50.76 110.091 179.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' S' S ' 269' ' ' ASP . . . . . 0.476 ' HB2' ' HA ' ' S' ' 266' ' ' PRO . 0.9 OUTLIER -76.05 -33.1 59.6 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.417 -0.802 . . . . 61.86 109.816 179.546 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' S' S ' 270' ' ' TRP . . . . . 0.511 ' CE2' HG23 ' S' ' 271' ' ' VAL . 51.0 p-90 -73.98 -4.31 34.49 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.327 -0.858 . . . . 39.85 110.478 179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 271' ' ' VAL . . . . . 0.511 HG23 ' CE2' ' S' ' 270' ' ' TRP . 46.6 t -109.56 -32.69 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.154 -0.966 . . . . 39.18 110.045 179.53 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 272' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -78.71 -36.49 43.34 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.365 -0.834 . . . . 40.02 110.518 -179.572 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' S' S ' 273' ' ' SER . . . . . . . . . . . . . 71.2 m -103.52 56.17 0.74 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.317 -0.864 . . . . 47.2 110.345 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' S' S ' 274' ' ' SER . . . . . . . . . . . . . 6.9 t -133.13 141.19 39.9 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.334 -0.854 . . . . 47.61 110.12 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' S' S ' 275' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -73.65 -18.9 21.97 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.603 1.317 . . . . 45.28 110.603 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' S' S ' 276' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -99.94 140.9 33.49 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.248 -0.908 . . . . 57.27 110.272 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' S' S ' 277' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -71.71 97.67 1.8 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.48 -0.763 . . . . 37.28 110.263 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' S' S ' 278' ' ' LEU . . . . . . . . . . . . . 86.4 mt -96.98 33.77 1.85 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.484 -0.76 . . . . 43.88 110.003 -179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' S' S ' 279' ' ' THR . . . . . . . . . . . . . 75.3 m -64.05 -60.12 3.62 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.398 -0.814 . . . . 50.05 110.275 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' S' S ' 280' ' ' LEU . . . . . 0.736 ' HA ' HD12 ' S' ' 283' ' ' ILE . 13.7 mt -51.6 -39.77 58.58 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.301 -0.874 . . . . 54.12 110.334 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 281' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.49 -49.7 74.34 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.475 -0.766 . . . . 65.28 110.125 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 282' ' ' ALA . . . . . . . . . . . . . . . -58.89 -34.0 71.16 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.491 -0.756 . . . . 46.51 110.513 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' S' S ' 283' ' ' ILE . . . . . 0.736 HD12 ' HA ' ' S' ' 280' ' ' LEU . 85.5 mt -66.26 -50.91 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.242 -0.911 . . . . 47.3 110.149 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 284' ' ' LYS . . . . . . . . . . . . . 33.8 tttp -50.52 -57.52 7.92 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.414 -0.804 . . . . 50.72 110.476 179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' S' S ' 285' ' ' GLN . . . . . 0.52 ' HG2' HD12 ' S' ' 289' ' ' LEU . 34.4 tt0 -51.43 -46.45 62.98 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.469 -0.77 . . . . 68.47 110.293 179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 286' ' ' LEU . . . . . . . . . . . . . 19.2 mt -59.93 -44.49 94.3 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.426 -0.796 . . . . 36.62 110.26 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' S' S ' 287' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -62.8 -35.25 79.27 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.342 -0.849 . . . . 46.64 110.067 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' S' S ' 288' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -76.21 -21.04 56.9 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.382 -0.823 . . . . 46.45 110.329 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' S' S ' 289' ' ' LEU . . . . . 0.52 HD12 ' HG2' ' S' ' 285' ' ' GLN . 30.9 mt -97.24 -21.78 17.07 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.308 -0.87 . . . . 35.09 110.559 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 290' ' ' THR . . . . . 0.408 HG22 ' HB3' ' S' ' 306' ' ' ASN . 81.3 p -114.82 -28.47 7.06 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.275 -0.89 . . . . 38.61 110.367 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 291' ' ' GLY . . . . . . . . . . . . . . . 79.35 11.1 85.31 Favored Glycine 0 N--CA 1.492 2.37 0 N-CA-C 109.829 -1.308 . . . . 36.77 109.829 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' S' S ' 292' ' ' LEU . . . . . . . . . . . . . 84.6 mt -96.46 145.77 25.37 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.233 -1.157 . . . . 35.33 109.815 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' S' S ' 293' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -77.34 102.4 6.75 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.144 -0.973 . . . . 48.7 110.235 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' S' S ' 294' ' ' LEU . . . . . 0.428 ' HB3' ' CZ2' ' S' ' 252' ' ' TRP . 55.1 mt -106.89 51.73 0.73 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.498 -0.751 . . . . 42.61 110.128 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 295' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -112.56 -11.11 13.63 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.356 -0.84 . . . . 55.49 110.518 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 296' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -144.32 48.44 1.36 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.093 -1.004 . . . . 75.68 110.363 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' S' S ' 297' ' ' GLY . . . . . 0.827 ' HA3' ' C ' ' R' ' 201' ' ' LYS . . . 96.9 145.15 18.66 Favored Glycine 0 N--CA 1.493 2.465 0 N-CA-C 109.477 -1.449 . . . . 49.44 109.477 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 298' ' ' GLY . . . . . 0.67 ' N ' ' HB2' ' R' ' 201' ' ' LYS . . . -163.8 156.99 29.09 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.804 -1.318 . . . . 41.11 109.804 -179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 299' ' ' PRO . . . . . 0.569 ' HB3' HD21 ' R' ' 200' ' ' LEU . 47.4 Cg_endo -73.82 118.26 5.37 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 124.018 1.536 . . . . 26.2 110.32 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 300' ' ' PRO . . . . . 0.403 ' CD ' HD11 ' R' ' 200' ' ' LEU . 44.0 Cg_endo -71.26 -15.4 31.63 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.609 1.321 . . . . 21.7 110.736 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 301' ' ' ALA . . . . . . . . . . . . . . . -80.68 -29.44 36.57 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.237 -0.914 . . . . 31.23 110.129 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' S' S ' 302' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.45 -40.62 19.05 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.404 -0.81 . . . . 38.99 110.031 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 303' ' ' VAL . . . . . 0.491 HG23 ' O ' ' S' ' 299' ' ' PRO . 57.6 t -60.69 -35.53 64.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.36 -0.838 . . . . 18.63 110.135 180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 304' ' ' ILE . . . . . 0.523 HD12 HG21 ' S' ' 379' ' ' VAL . 85.9 mt -79.36 -23.72 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.265 -0.897 . . . . 25.46 110.129 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 305' ' ' TRP . . . . . 0.415 ' CD2' ' HD3' ' S' ' 308' ' ' LYS . 68.7 t-105 -88.55 -14.6 37.29 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.261 -0.899 . . . . 33.4 110.588 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 306' ' ' ASN . . . . . 0.408 ' HB3' HG22 ' S' ' 290' ' ' THR . 10.4 m-80 -89.64 -13.65 36.63 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.204 -0.935 . . . . 36.97 110.403 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 307' ' ' ILE . . . . . 0.472 HG12 ' O ' ' S' ' 303' ' ' VAL . 36.8 pt -125.06 45.65 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 O-C-N 121.198 -0.939 . . . . 30.81 109.997 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 308' ' ' LYS . . . . . 0.415 ' HD3' ' CD2' ' S' ' 305' ' ' TRP . 1.5 mtmp? -73.52 -37.82 65.53 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.336 -0.852 . . . . 46.52 110.108 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 309' ' ' HIS . . . . . 0.498 ' CD2' ' HG ' ' S' ' 310' ' ' LEU . 55.5 p-80 -73.21 -8.26 55.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.331 -0.855 . . . . 51.03 110.078 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 310' ' ' LEU . . . . . 0.498 ' HG ' ' CD2' ' S' ' 309' ' ' HIS . 52.8 mt -99.31 -12.81 20.0 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.245 -0.909 . . . . 36.16 110.009 179.281 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 311' ' ' LEU . . . . . 0.537 HD21 ' CE2' ' S' ' 260' ' ' PHE . 10.8 mt -97.18 147.87 23.65 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.378 -0.826 . . . . 40.0 110.458 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 312' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -81.65 -16.25 52.0 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.363 -0.836 . . . . 54.18 109.722 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' S' S ' 313' ' ' THR . . . . . 0.82 HG23 ' HG2' ' S' ' 323' ' ' GLU . 92.6 m -87.92 151.65 22.66 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.386 -0.821 . . . . 25.61 110.119 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 314' ' ' GLY . . . . . . . . . . . . . . . -87.93 126.34 8.02 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.849 -1.3 . . . . 25.18 109.849 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' S' S ' 315' ' ' ILE . . . . . 0.667 HD13 ' HB ' ' S' ' 324' ' ' VAL . 50.7 mm -101.66 150.5 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.409 -1.053 . . . . 23.9 109.727 179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 316' ' ' GLY . . . . . 0.406 ' O ' ' HA ' ' S' ' 325' ' ' CYS . . . -157.06 -159.29 9.39 Favored Glycine 0 N--CA 1.493 2.464 0 N-CA-C 109.928 -1.269 . . . . 23.18 109.928 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 317' ' ' THR . . . . . 0.424 HG22 ' CG2' ' S' ' 326' ' ' VAL . 11.1 p -133.87 -172.99 3.12 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.422 -1.046 . . . . 27.98 110.025 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.54 -56.25 24.33 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.215 -0.928 . . . . 28.1 109.908 179.743 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' S' S ' 319' ' ' SER . . . . . . . . . . . . . 1.2 m -59.91 -41.68 92.25 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.343 -0.848 . . . . 37.0 109.65 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' S' S ' 320' ' ' ARG . . . . . . . . . . . . . 12.2 mtm180 -111.7 79.95 2.67 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.438 -0.789 . . . . 52.07 109.646 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' S' S ' 321' ' ' PRO . . . . . 1.083 ' HG2' ' O ' ' S' ' 386' ' ' GLU . 43.6 Cg_endo -71.5 171.51 16.11 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.772 1.406 . . . . 38.29 110.867 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 322' ' ' SER . . . . . 0.447 ' HB2' ' O ' ' S' ' 321' ' ' PRO . 41.3 t 178.69 -148.1 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.907 -0.775 . . . . 38.84 108.907 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 323' ' ' GLU . . . . . 0.82 ' HG2' HG23 ' S' ' 313' ' ' THR . 6.7 tp10 -62.86 -40.26 96.96 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.048 -1.033 . . . . 40.7 109.707 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 324' ' ' VAL . . . . . 0.667 ' HB ' HD13 ' S' ' 315' ' ' ILE . 72.7 t -141.33 135.01 31.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.411 -0.806 . . . . 20.34 109.49 179.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 325' ' ' CYS . . . . . 0.463 ' HB2' ' CE1' ' S' ' 380' ' ' PHE . 11.3 m -125.94 172.22 10.1 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.323 -0.861 . . . . 30.63 110.84 -179.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 326' ' ' VAL . . . . . 0.646 HG12 HG22 ' S' ' 379' ' ' VAL . 34.6 m -135.53 142.26 39.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 109.186 -0.672 . . . . 23.9 109.186 179.159 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 327' ' ' VAL . . . . . 0.594 HG11 ' O ' ' S' ' 377' ' ' VAL . 34.5 m -56.41 125.01 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 121.096 -1.002 . . . . 19.48 110.419 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 328' ' ' ASP . . . . . . . . . . . . . 55.5 p-10 -119.43 11.54 12.18 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.461 -0.774 . . . . 26.43 110.445 179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' S' S ' 329' ' ' GLY . . . . . . . . . . . . . . . 119.69 2.27 13.05 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 110.041 -1.223 . . . . 31.24 110.041 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' S' S ' 330' ' ' THR . . . . . . . . . . . . . 80.1 m -93.04 129.99 38.79 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.117 -1.225 . . . . 30.05 110.107 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' S' S ' 331' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -56.68 111.47 1.02 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.311 -0.868 . . . . 37.26 110.011 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' S' S ' 332' ' ' MET . . . . . . . . . . . . . 88.0 mmm -94.1 162.57 13.82 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.234 -0.916 . . . . 26.23 110.356 -179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' S' S ' 333' ' ' CYS . . . . . . . . . . . . . 25.6 m -137.24 150.01 47.55 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.513 -0.742 . . . . 23.56 110.015 179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' S' S ' 334' ' ' LEU . . . . . 0.563 HD11 ' O ' ' S' ' 372' ' ' PRO . 0.1 OUTLIER -52.57 -24.82 8.96 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.342 -0.849 . . . . 28.93 110.488 179.889 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' S' S ' 335' ' ' ALA . . . . . . . . . . . . . . . -89.12 14.52 10.58 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.427 -0.796 . . . . 15.76 110.942 -179.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' S' S ' 336' ' ' ASP . . . . . 0.404 ' O ' ' HA ' ' S' ' 382' ' ' PRO . 70.9 m-20 -100.45 -17.28 17.25 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.164 -0.96 . . . . 34.92 110.242 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 337' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -152.36 170.88 19.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.329 -0.857 . . . . 19.03 110.072 179.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' S' S ' 338' ' ' HIS . . . . . 0.401 ' HB3' ' CZ ' ' S' ' 383' ' ' TYR . 13.5 p80 -120.71 10.47 11.0 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.356 -0.84 . . . . 18.82 110.508 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 339' ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' S' ' 352' ' ' ALA . . . -176.0 155.18 1.56 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.193 -0.942 . . . . 17.18 110.079 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 340' ' ' GLY . . . . . 0.402 ' HA3' ' O ' ' S' ' 379' ' ' VAL . . . 160.82 173.05 28.93 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 110.089 -1.204 . . . . 18.33 110.089 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 341' ' ' ILE . . . . . . . . . . . . . 83.9 mt -88.76 138.07 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.493 -1.004 . . . . 18.6 109.864 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' S' S ' 342' ' ' PHE . . . . . 0.489 ' CE2' ' HB3' ' S' ' 352' ' ' ALA . 70.0 m-85 -120.94 -178.43 3.74 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.195 -0.941 . . . . 23.44 110.444 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 343' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.91 93.37 4.17 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.44 -0.787 . . . . 35.59 110.001 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 344' ' ' LYS . . . . . 0.4 ' O ' ' HB3' ' S' ' 348' ' ' HIS . 0.3 OUTLIER -80.86 125.09 29.67 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.334 -0.854 . . . . 38.34 109.999 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' S' S ' 345' ' ' GLY . . . . . . . . . . . . . . . 62.71 -130.83 43.26 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 108.928 -1.669 . . . . 53.46 108.928 -179.446 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' S' S ' 346' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -132.72 150.9 52.1 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.23 -1.159 . . . . 70.91 110.018 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' S' S ' 347' ' ' GLU . . . . . 0.543 ' O ' ' HD2' ' R' ' 201' ' ' LYS . 18.0 mt-10 53.26 35.44 20.1 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.319 -0.863 . . . . 47.32 110.442 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 348' ' ' HIS . . . . . 0.4 ' HB3' ' O ' ' S' ' 344' ' ' LYS . 46.9 t60 -150.16 155.83 40.5 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.383 -0.823 . . . . 41.72 110.36 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 349' ' ' ALA . . . . . 0.458 ' C ' HG13 ' S' ' 350' ' ' VAL . . . -149.79 151.25 33.26 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.427 -0.796 . . . . 22.91 110.481 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 350' ' ' VAL . . . . . 0.458 HG13 ' C ' ' S' ' 349' ' ' ALA . 34.6 m -148.99 169.66 2.55 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.534 -0.729 . . . . 21.09 110.072 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 351' ' ' PHE . . . . . 0.498 ' CD2' ' HB3' ' S' ' 258' ' ' GLN . 10.7 t80 -105.44 143.54 33.46 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.246 -0.909 . . . . 25.03 110.709 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 352' ' ' ALA . . . . . 0.489 ' HB3' ' CE2' ' S' ' 342' ' ' PHE . . . -147.66 151.69 36.59 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.634 -0.666 . . . . 23.81 109.766 179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 353' ' ' CYS . . . . . . . . . . . . . 26.3 p -153.3 164.9 37.29 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.341 -0.849 . . . . 25.66 110.315 -179.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' S' S ' 354' ' ' VAL . . . . . 0.551 HG22 ' CE2' ' S' ' 359' ' ' TRP . 57.5 t -76.05 118.52 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.359 -0.838 . . . . 34.27 109.904 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 355' ' ' THR . . . . . 0.412 ' HA ' ' O ' ' S' ' 232' ' ' THR . 51.7 p -117.91 175.15 5.8 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.298 -0.876 . . . . 25.49 110.283 179.801 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 356' ' ' SER . . . . . . . . . . . . . 62.3 p -62.12 -17.75 58.7 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.393 -0.817 . . . . 31.24 110.731 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' S' S ' 357' ' ' ASN . . . . . . . . . . . . . 46.0 m-20 -106.98 14.16 26.77 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.104 -0.997 . . . . 28.61 110.559 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' S' S ' 358' ' ' GLY . . . . . . . . . . . . . . . 111.88 -152.9 17.6 Favored Glycine 0 N--CA 1.492 2.421 0 N-CA-C 110.005 -1.238 . . . . 22.01 110.005 179.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' S' S ' 359' ' ' TRP . . . . . 0.551 ' CE2' HG22 ' S' ' 354' ' ' VAL . 15.5 m95 -91.22 116.63 28.97 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.446 -1.032 . . . . 25.54 110.273 -179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 360' ' ' TYR . . . . . 0.42 ' HA ' ' HA ' ' S' ' 369' ' ' PRO . 1.3 m-85 -103.47 165.81 10.81 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.375 -0.828 . . . . 40.53 110.104 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 361' ' ' ALA . . . . . 0.426 ' HA ' ' O ' ' S' ' 351' ' ' PHE . . . -140.04 130.07 24.88 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.379 -0.826 . . . . 18.04 110.297 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 362' ' ' ILE . . . . . . . . . . . . . 88.7 mt -95.63 83.62 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.415 -0.803 . . . . 15.64 110.065 179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' S' S ' 363' ' ' ASP . . . . . 0.416 ' O ' ' N ' ' S' ' 365' ' ' GLU . 11.8 t0 -75.2 94.43 2.96 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.334 -0.854 . . . . 35.03 110.216 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 364' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 54.01 -89.34 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.493 -0.754 . . . . 46.72 110.508 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' S' S ' 365' ' ' GLU . . . . . 0.416 ' N ' ' O ' ' S' ' 363' ' ' ASP . 23.7 mt-10 -122.68 19.09 10.33 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.081 -1.012 . . . . 56.2 110.202 179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 366' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -117.97 125.04 49.64 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.217 -0.927 . . . . 51.02 110.342 -179.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' S' S ' 367' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -106.99 127.12 53.17 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.392 -0.817 . . . . 37.59 110.093 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' S' S ' 368' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -165.49 159.58 13.8 Favored Pre-proline 0 N--CA 1.493 1.695 0 O-C-N 121.323 -0.861 . . . . 31.47 110.423 179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' S' S ' 369' ' ' PRO . . . . . 0.42 ' HA ' ' HA ' ' S' ' 360' ' ' TYR . 46.5 Cg_endo -72.92 139.61 30.44 Favored 'Trans proline' 0 C--N 1.311 -1.434 0 O-C-N 123.85 1.447 . . . . 28.85 110.497 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 370' ' ' TRP . . . . . . . . . . . . . 67.5 t90 -167.19 113.57 0.77 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.408 -0.807 . . . . 26.94 109.936 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' S' S ' 371' ' ' THR . . . . . . . . . . . . . 59.3 m -74.8 113.04 20.59 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.372 -0.83 . . . . 20.19 110.02 179.892 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' S' S ' 372' ' ' PRO . . . . . 0.563 ' O ' HD11 ' S' ' 334' ' ' LEU . 47.9 Cg_endo -73.49 157.06 49.55 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 O-C-N 123.578 1.304 . . . . 28.68 110.597 -179.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 373' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -90.64 147.18 35.72 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.423 -0.798 . . . . 35.72 109.87 179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' S' S ' 374' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -76.04 -6.25 17.15 Favored 'Trans proline' 0 C--N 1.31 -1.489 0 O-C-N 123.713 1.375 . . . . 30.89 110.465 179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' S' S ' 375' ' ' SER . . . . . . . . . . . . . 68.2 p -104.36 -17.0 14.97 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.297 -0.877 . . . . 29.41 110.46 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' S' S ' 376' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -106.5 43.0 1.19 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.299 -0.876 . . . . 32.89 110.256 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' S' S ' 377' ' ' VAL . . . . . 0.594 ' O ' HG11 ' S' ' 327' ' ' VAL . 7.4 p -114.62 147.25 18.2 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.348 -0.845 . . . . 24.33 110.26 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 378' ' ' LEU . . . . . . . . . . . . . 53.0 mt -116.05 -57.93 2.16 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.456 -0.778 . . . . 24.37 109.573 179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' S' S ' 379' ' ' VAL . . . . . 0.646 HG22 HG12 ' S' ' 326' ' ' VAL . 61.5 t -120.73 132.39 70.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.454 -0.779 . . . . 18.02 109.409 179.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 380' ' ' PHE . . . . . 0.463 ' CE1' ' HB2' ' S' ' 325' ' ' CYS . 14.5 p90 -142.59 173.94 11.09 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.38 -0.825 . . . . 29.35 110.646 -179.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 381' ' ' VAL . . . . . . . . . . . . . 57.8 t -120.02 107.35 39.94 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.486 -0.759 . . . . 16.34 109.412 179.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' S' S ' 382' ' ' PRO . . . . . 0.404 ' HA ' ' O ' ' S' ' 336' ' ' ASP . 45.4 Cg_endo -71.38 145.67 48.61 Favored 'Trans proline' 0 C--N 1.31 -1.468 0 O-C-N 123.636 1.335 . . . . 20.94 110.762 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 383' ' ' TYR . . . . . 0.401 ' CZ ' ' HB3' ' S' ' 338' ' ' HIS . 88.0 m-85 -61.12 -53.45 56.86 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.344 -0.848 . . . . 28.93 109.825 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 384' ' ' ASP . . . . . . . . . . . . . 3.9 p30 -99.65 125.06 45.42 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.431 -0.793 . . . . 47.03 110.332 -176.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' S' S ' 385' ' ' GLN . . . . . 0.413 ' O ' ' O ' ' S' ' 386' ' ' GLU . 3.2 pt20 -67.82 2.68 1.83 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.46 -0.775 . . . . 46.69 110.158 177.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 386' ' ' GLU . . . . . 1.083 ' O ' ' HG2' ' S' ' 321' ' ' PRO . 2.9 mt-10 -47.83 171.68 0.08 OUTLIER Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.43 -0.794 . . . . 50.25 109.525 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 387' ' ' PRO . . . . . 0.568 ' O ' ' C ' ' S' ' 388' ' ' LEU . 51.3 Cg_endo -71.55 -10.19 26.35 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 O-C-N 123.66 1.347 . . . . 34.39 110.621 -177.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 388' ' ' LEU . . . . . 0.616 ' O ' ' HB2' ' S' ' 389' ' ' ASN . 59.5 mt 31.05 85.19 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.393 -0.817 . . . . 38.01 110.105 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 389' ' ' ASN . . . . . 0.616 ' HB2' ' O ' ' S' ' 388' ' ' LEU . 22.9 m-20 71.26 170.52 0.32 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.375 -0.828 . . . . 45.82 110.131 -179.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 390' ' ' GLY . . . . . 0.489 ' O ' ' CB ' ' S' ' 391' ' ' GLU . . . 147.15 -87.28 0.16 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.6 -1.4 . . . . 33.46 109.6 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 391' ' ' GLU . . . . . 0.489 ' CB ' ' O ' ' S' ' 390' ' ' GLY . 0.9 OUTLIER 68.23 -63.84 0.32 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.322 -1.105 . . . . 56.58 110.116 179.834 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' S' S ' 392' ' ' TRP . . . . . 0.446 ' N ' ' O ' ' S' ' 390' ' ' GLY . 1.6 m-90 -48.84 -26.1 2.24 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.322 -0.861 . . . . 31.43 110.401 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 393' ' ' LYS . . . . . 0.72 ' O ' HG12 ' S' ' 396' ' ' VAL . 16.6 ttpt -51.96 -60.22 3.43 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.376 -0.828 . . . . 39.42 110.411 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 394' ' ' ALA . . . . . 0.404 ' O ' ' HG2' ' S' ' 398' ' ' ARG . . . -68.72 -12.23 61.18 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.296 -0.878 . . . . 34.33 110.135 179.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 395' ' ' LYS . . . . . 0.561 ' CG ' HD13 ' R' ' 143' ' ' LEU . 0.0 OUTLIER -86.94 -22.62 25.51 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.362 -0.836 . . . . 60.09 110.29 179.74 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' S' S ' 396' ' ' VAL . . . . . 0.997 ' O ' ' HA ' ' R' ' 99' ' ' PRO . 8.9 p -94.87 -28.64 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.356 -0.84 . . . . 35.5 110.533 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 397' ' ' GLN . . . . . 0.424 ' O ' ' CG ' ' S' ' 397' ' ' GLN . 1.5 pt20 -109.95 96.29 6.14 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.18 -0.95 . . . . 49.96 110.657 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 398' ' ' ARG . . . . . 0.789 ' CB ' ' HA ' ' R' ' 147' ' ' GLU . 10.2 mmt180 -149.11 170.66 17.91 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.318 -0.864 . . . . 43.42 110.739 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 399' ' ' LYS . . . . . 0.631 ' C ' ' H ' ' S' ' 401' ' ' LYS . 0.6 OUTLIER -57.58 -86.6 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.36 -0.838 . . . . 55.31 110.108 -179.207 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' S' S ' 400' ' ' LEU . . . . . 0.588 ' O ' ' HA ' ' R' ' 148' ' ' HIS . 2.6 mt -60.59 15.65 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.352 -0.843 . . . . 41.03 110.352 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' S' S ' 401' ' ' LYS . . . . . 0.685 ' HE2' ' HA ' ' S' ' 401' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.66 0 O-C-N 121.331 -0.856 . . . . 61.97 110.216 179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 29' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 121.28 0.562 . . . . 32.14 110.246 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 30' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -96.31 141.18 29.95 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.277 -0.889 . . . . 43.36 110.262 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 31' ' ' LEU . . . . . . . . . . . . . 65.6 mt -134.91 140.58 45.87 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.312 -0.867 . . . . 22.93 110.268 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 32' ' ' THR . . . . . . . . . . . . . 69.3 m -87.55 110.57 20.45 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.319 -0.863 . . . . 22.34 109.984 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 33' ' ' LEU . . . . . 0.594 HD22 ' CE2' ' R' ' 62' ' ' TYR . 80.1 mt -62.38 -172.76 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.299 -0.876 . . . . 21.39 110.202 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 34' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -74.6 -29.49 61.33 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.333 -0.855 . . . . 34.4 110.365 -179.729 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 35' ' ' ASN . . . . . . . . . . . . . 48.3 p30 -77.72 -1.89 33.46 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.384 -0.822 . . . . 30.28 110.649 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.28 -16.55 59.53 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.698 -1.361 . . . . 36.25 109.698 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 37' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -59.04 161.77 4.82 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.338 -1.095 . . . . 53.8 110.368 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 38' ' ' LYS . . . . . . . . . . . . . 57.1 mttt -117.78 135.73 53.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.393 -0.817 . . . . 49.91 110.181 179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 39' ' ' LYS . . . . . 0.405 ' HG2' ' CZ ' ' R' ' 41' ' ' PHE . 8.1 ttmt -138.68 143.74 39.29 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.423 -0.798 . . . . 35.69 110.198 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 40' ' ' THR . . . . . . . . . . . . . 23.6 m -102.63 128.05 49.47 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.343 -0.848 . . . . 34.84 110.188 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 41' ' ' PHE . . . . . 0.405 ' CZ ' ' HG2' ' R' ' 39' ' ' LYS . 96.6 m-85 -113.08 132.64 55.34 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.381 -0.824 . . . . 34.42 110.14 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 42' ' ' TYR . . . . . . . . . . . . . 38.3 m-85 -93.32 140.9 29.04 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.366 -0.834 . . . . 51.46 110.215 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 43' ' ' SER . . . . . . . . . . . . . 54.6 m -70.76 141.92 51.42 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.397 -0.815 . . . . 41.84 110.187 -179.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.8 125.34 29.6 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.305 -0.872 . . . . 33.82 109.978 179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 45' ' ' PRO . . . . . 0.425 ' HG2' ' ND2' ' R' ' 77' ' ' ASN . 45.8 Cg_endo -72.15 151.05 54.79 Favored 'Trans proline' 0 C--N 1.312 -1.383 0 O-C-N 123.517 1.272 . . . . 30.27 110.649 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 46' ' ' ASN . . . . . 0.4 ' HA ' ' OD1' ' R' ' 50' ' ' ASN . 52.1 t-20 -124.24 109.92 13.99 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.456 -0.777 . . . . 35.1 109.989 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 47' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -120.27 -34.93 3.54 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.325 -0.859 . . . . 42.81 110.545 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 48' ' ' HIS . . . . . 0.439 ' NE2' HD11 ' R' ' 80' ' ' LEU . 73.2 m80 -105.74 45.16 0.98 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.181 -0.949 . . . . 49.97 110.275 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 49' ' ' ASP . . . . . 0.545 ' CB ' ' HA ' ' S' ' 401' ' ' LYS . 37.5 m-20 50.35 34.65 9.32 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.432 -0.793 . . . . 61.32 110.182 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 50' ' ' ASN . . . . . 0.4 ' OD1' ' HA ' ' R' ' 46' ' ' ASN . 15.0 p-10 -86.22 43.81 1.09 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.349 -0.844 . . . . 51.5 110.661 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 51' ' ' ALA . . . . . 0.883 ' HB3' ' CB ' ' S' ' 400' ' ' LEU . . . -66.14 -46.08 78.73 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.225 -0.922 . . . . 38.77 109.539 179.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 52' ' ' TRP . . . . . 0.893 ' CA ' HD22 ' S' ' 400' ' ' LEU . 68.2 p-90 -58.37 -38.42 77.21 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.419 -0.801 . . . . 26.24 110.082 179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 53' ' ' LEU . . . . . 0.483 ' N ' ' CD2' ' R' ' 52' ' ' TRP . 23.0 tp -66.71 -46.71 74.65 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.456 -0.777 . . . . 26.75 109.939 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 54' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -55.18 -41.68 72.24 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.321 -0.862 . . . . 35.02 110.128 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.19 -46.03 92.14 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.4 -0.812 . . . . 24.47 110.189 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 56' ' ' ILE . . . . . 0.431 HG12 HD11 ' R' ' 104' ' ' ILE . 76.3 mt -62.14 -42.25 94.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.332 -0.855 . . . . 26.03 109.937 179.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 57' ' ' LEU . . . . . . . . . . . . . 22.4 mt -60.3 -45.67 92.57 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.299 -0.876 . . . . 26.77 109.661 179.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 58' ' ' GLN . . . . . . . . . . . . . 57.9 mm-40 -63.92 -46.48 84.59 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.481 -0.762 . . . . 22.32 109.594 179.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 59' ' ' LEU . . . . . 0.429 ' HA ' ' HE2' ' R' ' 151' ' ' PHE . 23.9 tp -61.43 -37.73 84.6 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.306 -0.871 . . . . 20.55 109.396 179.295 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 60' ' ' PHE . . . . . 0.528 ' CE2' HD21 ' R' ' 111' ' ' LEU . 2.8 m-85 -61.08 -44.76 96.88 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.664 -0.648 . . . . 20.08 109.927 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 61' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -63.1 -36.17 82.71 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.479 -0.763 . . . . 18.8 110.486 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 62' ' ' TYR . . . . . 0.594 ' CE2' HD22 ' R' ' 33' ' ' LEU . 9.1 t80 -63.11 -41.76 99.41 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.266 -0.896 . . . . 26.45 110.226 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 63' ' ' VAL . . . . . 0.406 ' H ' HG22 ' R' ' 63' ' ' VAL . 30.5 m -93.4 20.45 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.295 -0.878 . . . . 29.75 110.218 179.7 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 64' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 52.87 75.58 0.23 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.344 -0.848 . . . . 35.52 110.58 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 65' ' ' GLU . . . . . 0.443 ' HG2' ' CD2' ' R' ' 60' ' ' PHE . 14.2 tp10 -116.29 104.07 52.33 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.377 -0.827 . . . . 29.89 109.888 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 66' ' ' PRO . . . . . 0.481 ' HA ' ' HB2' ' R' ' 69' ' ' ASP . 46.9 Cg_endo -73.53 -5.86 17.79 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 123.806 1.424 . . . . 21.37 111.124 -179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 67' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -52.09 -61.52 2.21 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.144 -0.973 . . . . 23.85 110.375 -179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 68' ' ' PHE . . . . . . . . . . . . . 11.2 m-85 -98.11 36.53 1.56 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.326 -0.859 . . . . 28.07 110.475 -179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 69' ' ' ASP . . . . . 0.481 ' HB2' ' HA ' ' R' ' 66' ' ' PRO . 11.7 t0 -72.3 -33.31 67.31 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.382 -0.824 . . . . 43.76 110.169 179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 70' ' ' TRP . . . . . 0.477 ' CE2' ' CG2' ' R' ' 71' ' ' VAL . 47.9 p-90 -73.34 -3.88 29.9 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.313 -0.867 . . . . 33.06 110.705 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 71' ' ' VAL . . . . . 0.555 HG11 ' HB2' ' R' ' 82' ' ' ALA . 40.8 t -109.79 -27.48 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.132 -0.98 . . . . 31.7 109.717 179.172 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 72' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -86.56 -48.79 8.05 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.381 -0.824 . . . . 33.58 110.312 179.819 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 73' ' ' SER . . . . . . . . . . . . . 70.1 m -89.78 51.13 2.01 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.292 -0.88 . . . . 50.82 110.284 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 74' ' ' SER . . . . . . . . . . . . . 15.8 t -125.95 138.3 31.8 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.348 -0.845 . . . . 34.74 110.168 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.36 -25.01 15.92 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 O-C-N 123.669 1.352 . . . . 35.7 110.319 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 76' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -91.7 153.16 19.85 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.437 -0.789 . . . . 66.48 110.342 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 77' ' ' ASN . . . . . 0.425 ' ND2' ' HG2' ' R' ' 45' ' ' PRO . 22.3 t-20 -81.51 95.16 7.03 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.374 -0.829 . . . . 46.72 110.091 179.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 78' ' ' LEU . . . . . . . . . . . . . 96.4 mt -96.41 27.97 3.53 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.464 -0.772 . . . . 37.55 110.167 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 79' ' ' THR . . . . . . . . . . . . . 29.6 m -56.19 -54.56 43.76 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.27 -0.894 . . . . 37.36 110.312 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 80' ' ' LEU . . . . . 0.602 ' HA ' HD12 ' R' ' 83' ' ' ILE . 15.8 mt -60.93 -23.23 65.12 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.348 -0.845 . . . . 35.83 110.46 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 81' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -79.5 -39.18 32.67 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.209 -0.932 . . . . 44.03 110.298 -179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 82' ' ' ALA . . . . . 0.555 ' HB2' HG11 ' R' ' 71' ' ' VAL . . . -69.43 -28.68 66.33 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.187 -0.945 . . . . 32.54 110.159 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 83' ' ' ILE . . . . . 0.602 HD12 ' HA ' ' R' ' 80' ' ' LEU . 78.3 mt -70.16 -45.99 73.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.307 -0.87 . . . . 32.02 110.3 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 84' ' ' LYS . . . . . . . . . . . . . 36.0 tttm -55.22 -52.08 64.52 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.179 -0.951 . . . . 34.09 110.596 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 85' ' ' GLN . . . . . 0.533 ' HG2' HD12 ' R' ' 89' ' ' LEU . 31.9 tt0 -54.81 -46.83 74.57 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.224 -0.923 . . . . 25.94 110.301 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 86' ' ' LEU . . . . . . . . . . . . . 24.0 mt -58.66 -43.88 90.0 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.312 -0.867 . . . . 16.2 109.878 179.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 87' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -65.36 -35.21 80.28 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.442 -0.786 . . . . 49.09 110.28 -179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 88' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -78.43 -19.04 54.07 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.247 -0.908 . . . . 28.61 110.493 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 89' ' ' LEU . . . . . 0.533 HD12 ' HG2' ' R' ' 85' ' ' GLN . 32.6 mt -96.21 -29.37 14.07 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.188 -0.945 . . . . 26.16 110.201 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 90' ' ' THR . . . . . . . . . . . . . 59.8 p -105.69 -34.6 7.66 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.211 -0.931 . . . . 33.33 109.795 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.78 16.06 58.75 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.857 -1.297 . . . . 31.13 109.857 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 92' ' ' LEU . . . . . . . . . . . . . 97.0 mt -100.07 155.24 17.83 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.141 -1.211 . . . . 42.52 110.281 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 93' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -86.17 91.54 8.47 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.485 -0.759 . . . . 68.46 109.99 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 94' ' ' LEU . . . . . 0.458 ' HB3' ' CZ2' ' R' ' 52' ' ' TRP . 47.8 mt -99.46 53.04 0.94 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.162 -0.961 . . . . 44.63 110.342 -179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 95' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.48 -38.68 6.38 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.332 -0.855 . . . . 67.16 110.381 -179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 96' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -113.96 44.25 1.68 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.392 -0.818 . . . . 67.02 110.254 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 97' ' ' GLY . . . . . 0.52 ' HA3' ' HA ' ' S' ' 399' ' ' LYS . . . 99.2 150.83 26.02 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.599 -1.401 . . . . 49.48 109.599 179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 98' ' ' GLY . . . . . . . . . . . . . . . -166.23 160.03 33.46 Favored Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.253 -1.539 . . . . 36.57 109.253 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 99' ' ' PRO . . . . . 0.792 ' O ' HG23 ' R' ' 103' ' ' VAL . 45.7 Cg_endo -72.54 121.09 7.14 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.641 1.337 . . . . 30.41 110.492 -179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 100' ' ' PRO . . . . . 0.413 ' HA ' HD11 ' R' ' 56' ' ' ILE . 45.8 Cg_endo -72.33 -31.57 11.38 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.678 1.357 . . . . 29.94 110.492 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 101' ' ' ALA . . . . . 0.53 ' HB3' HG23 ' S' ' 396' ' ' VAL . . . -70.0 -38.51 75.98 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.357 -0.839 . . . . 23.64 110.227 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 102' ' ' LEU . . . . . 0.424 HD23 HD21 ' R' ' 106' ' ' ASN . 0.1 OUTLIER -72.67 -40.72 66.09 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.377 -0.827 . . . . 20.31 110.353 -179.696 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' R' R ' 103' ' ' VAL . . . . . 0.792 HG23 ' O ' ' R' ' 99' ' ' PRO . 63.9 t -58.14 -40.13 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.185 -0.947 . . . . 16.33 109.986 179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 104' ' ' ILE . . . . . 0.431 HD11 HG12 ' R' ' 56' ' ' ILE . 82.1 mt -71.71 -30.54 38.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.399 -0.813 . . . . 24.77 109.899 179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 105' ' ' TRP . . . . . 0.462 ' O ' ' HD3' ' R' ' 108' ' ' LYS . 70.5 t-105 -82.41 0.88 40.02 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.292 -0.88 . . . . 23.28 110.31 179.602 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 106' ' ' ASN . . . . . 0.424 HD21 HD23 ' R' ' 102' ' ' LEU . 6.9 m-80 -105.08 -10.42 17.18 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.152 -0.967 . . . . 28.26 110.043 179.64 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 107' ' ' ILE . . . . . . . . . . . . . 36.7 pt -126.81 34.96 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.225 -0.922 . . . . 18.77 110.047 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 108' ' ' LYS . . . . . 0.501 ' HG2' ' HB ' ' R' ' 115' ' ' ILE . 9.2 mtpp -61.03 -48.43 81.8 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.565 -0.709 . . . . 42.5 110.055 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 109' ' ' HIS . . . . . 0.445 ' CD2' ' HG ' ' R' ' 110' ' ' LEU . 50.7 p-80 -66.06 -12.84 58.12 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.461 -0.774 . . . . 20.07 110.646 -179.604 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 110' ' ' LEU . . . . . 0.445 ' HG ' ' CD2' ' R' ' 109' ' ' HIS . 80.6 mt -94.84 -17.21 22.29 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.115 -0.991 . . . . 15.69 110.181 179.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 111' ' ' LEU . . . . . 0.528 HD21 ' CE2' ' R' ' 60' ' ' PHE . 10.3 mt -94.19 144.16 25.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.376 -0.827 . . . . 25.39 110.971 -179.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 112' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -77.73 -17.33 57.71 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.525 -0.734 . . . . 53.48 109.811 179.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 113' ' ' THR . . . . . 0.459 HG22 ' N ' ' R' ' 114' ' ' GLY . 60.3 m -83.76 166.6 17.88 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.355 -0.841 . . . . 14.8 110.22 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 114' ' ' GLY . . . . . 0.459 ' N ' HG22 ' R' ' 113' ' ' THR . . . -97.94 127.14 9.13 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.995 -1.242 . . . . 16.14 109.995 -179.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 115' ' ' ILE . . . . . 0.579 HD13 ' HB ' ' R' ' 124' ' ' VAL . 48.0 mm -109.13 139.32 32.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.54 -0.976 . . . . 13.46 109.645 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 116' ' ' GLY . . . . . . . . . . . . . . . -152.71 -155.83 7.28 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.955 -1.258 . . . . 23.9 109.955 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 117' ' ' THR . . . . . 0.529 HG22 ' CG2' ' R' ' 126' ' ' VAL . 18.9 p -134.99 -171.4 2.79 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.467 -1.019 . . . . 27.37 110.152 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 118' ' ' ALA . . . . . 0.447 ' HB3' ' OD1' ' R' ' 128' ' ' ASP . . . -56.52 -58.07 9.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.338 -0.851 . . . . 18.76 110.091 179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 119' ' ' SER . . . . . 0.476 ' OG ' ' HB ' ' R' ' 196' ' ' VAL . 1.1 m -56.59 -40.51 75.4 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.332 -0.855 . . . . 32.35 109.784 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 120' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 -110.09 86.2 4.86 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.456 -0.777 . . . . 27.12 109.708 179.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 121' ' ' PRO . . . . . 0.481 ' HA ' ' SG ' ' R' ' 125' ' ' CYS . 44.6 Cg_endo -71.21 166.4 29.34 Favored 'Trans proline' 0 C--N 1.311 -1.419 0 O-C-N 123.799 1.42 . . . . 22.68 111.086 -179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 122' ' ' SER . . . . . 0.437 ' HB2' ' O ' ' R' ' 121' ' ' PRO . 38.3 t 178.61 -161.69 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.619 -0.675 . . . . 22.99 109.436 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 123' ' ' GLU . . . . . 0.441 ' HG2' HG23 ' R' ' 113' ' ' THR . 2.3 tp10 -56.38 -40.03 73.92 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.192 -0.943 . . . . 36.18 109.724 179.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 124' ' ' VAL . . . . . 0.579 ' HB ' HD13 ' R' ' 115' ' ' ILE . 82.6 t -142.51 136.5 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.506 -0.746 . . . . 20.64 109.39 179.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 125' ' ' CYS . . . . . 0.481 ' SG ' ' HA ' ' R' ' 121' ' ' PRO . 83.4 m -140.37 168.17 20.43 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.219 -0.925 . . . . 22.8 111.131 -179.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 126' ' ' VAL . . . . . 0.727 HG12 HG22 ' R' ' 179' ' ' VAL . 35.8 m -122.72 159.77 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.724 -0.61 . . . . 21.24 109.695 179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 127' ' ' VAL . . . . . 0.708 HG11 ' O ' ' R' ' 177' ' ' VAL . 30.5 m -70.81 141.86 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.273 -0.892 . . . . 19.77 110.708 -179.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 128' ' ' ASP . . . . . 0.447 ' OD1' ' HB3' ' R' ' 118' ' ' ALA . 53.9 p-10 -137.73 19.41 2.87 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.336 -0.853 . . . . 29.21 110.697 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 129' ' ' GLY . . . . . . . . . . . . . . . 114.01 -0.05 24.13 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.963 -1.113 . . . . 33.86 110.503 179.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 130' ' ' THR . . . . . . . . . . . . . 58.5 m -91.84 131.81 36.91 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.12 -1.223 . . . . 26.41 110.117 179.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 59.2 m-20 -62.52 120.65 11.54 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.372 -0.83 . . . . 33.08 110.302 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 132' ' ' MET . . . . . 0.433 ' HE1' ' CE2' ' R' ' 180' ' ' PHE . 98.4 mmm -105.12 165.63 10.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.437 -0.79 . . . . 30.76 110.467 -179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 133' ' ' CYS . . . . . 0.409 ' HA ' ' HB3' ' R' ' 174' ' ' PRO . 32.4 m -141.12 158.13 44.34 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.511 -0.743 . . . . 27.0 109.988 179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 134' ' ' LEU . . . . . 0.563 HD11 ' O ' ' R' ' 172' ' ' PRO . 0.1 OUTLIER -58.45 -19.76 39.41 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.217 -0.927 . . . . 33.9 110.467 -179.885 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' R' R ' 135' ' ' ALA . . . . . . . . . . . . . . . -92.72 8.16 40.48 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.278 -0.889 . . . . 19.37 110.749 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 136' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -93.77 -21.78 19.1 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.14 -0.975 . . . . 30.47 110.186 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 137' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -149.93 165.34 32.93 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.338 -0.851 . . . . 24.27 110.252 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 138' ' ' HIS . . . . . 0.434 ' HA ' HG23 ' R' ' 154' ' ' VAL . 15.2 p80 -117.81 15.03 14.39 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.393 -0.817 . . . . 20.91 110.419 179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 139' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' R' ' 152' ' ' ALA . . . -177.15 152.41 0.88 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.163 -0.96 . . . . 15.69 110.181 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 140' ' ' GLY . . . . . 0.428 ' HA3' ' O ' ' R' ' 179' ' ' VAL . . . 161.85 175.18 32.6 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.964 -1.254 . . . . 23.76 109.964 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 141' ' ' ILE . . . . . . . . . . . . . 83.4 mt -95.49 136.56 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.398 -1.06 . . . . 25.3 109.681 179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 142' ' ' PHE . . . . . 0.575 ' CD2' ' HB2' ' R' ' 172' ' ' PRO . 83.0 m-85 -120.74 -172.58 2.41 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.336 -0.852 . . . . 30.24 110.552 -179.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 143' ' ' LEU . . . . . 0.742 HD23 ' O ' ' R' ' 148' ' ' HIS . 0.5 OUTLIER -119.8 77.8 1.27 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.437 -0.789 . . . . 32.8 110.281 -179.946 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' R' R ' 144' ' ' LYS . . . . . 0.47 ' HG3' ' CZ2' ' R' ' 170' ' ' TRP . 1.0 OUTLIER -69.67 76.82 0.44 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.285 -0.884 . . . . 49.18 109.69 179.56 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' R' R ' 145' ' ' GLY . . . . . 0.458 ' O ' HD22 ' R' ' 143' ' ' LEU . . . 104.57 179.28 24.75 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.168 -1.573 . . . . 53.87 109.168 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 146' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -88.48 145.82 25.54 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.417 -1.049 . . . . 68.58 109.989 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 147' ' ' GLU . . . . . 0.882 ' O ' ' HA ' ' S' ' 400' ' ' LEU . 10.8 mt-10 58.25 36.52 25.75 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.405 -0.809 . . . . 56.62 110.623 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 148' ' ' HIS . . . . . 0.742 ' O ' HD23 ' R' ' 143' ' ' LEU . 45.1 t60 -158.72 148.1 19.09 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.208 -0.933 . . . . 44.57 110.371 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 149' ' ' ALA . . . . . 0.999 ' HB3' ' CD2' ' S' ' 400' ' ' LEU . . . -150.26 146.93 27.1 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.441 -0.787 . . . . 33.54 110.023 -179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 150' ' ' VAL . . . . . . . . . . . . . 34.2 m -142.35 161.51 19.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.273 -0.892 . . . . 27.61 110.276 179.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 151' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' R' ' 152' ' ' ALA . 5.9 t80 -86.25 155.61 20.62 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.383 -0.823 . . . . 23.04 109.926 179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 152' ' ' ALA . . . . . 0.537 ' N ' ' CD1' ' R' ' 151' ' ' PHE . . . -157.25 151.56 25.01 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.457 -0.777 . . . . 29.61 109.623 179.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 153' ' ' CYS . . . . . . . . . . . . . 26.7 p -154.31 173.57 16.0 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.335 -0.853 . . . . 22.75 110.507 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 154' ' ' VAL . . . . . 0.613 HG22 ' CE2' ' R' ' 159' ' ' TRP . 60.0 t -90.61 117.02 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.676 0 O-C-N 121.422 -0.799 . . . . 23.26 110.051 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 155' ' ' THR . . . . . . . . . . . . . 69.7 p -112.1 -176.64 2.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.345 -0.847 . . . . 17.88 110.118 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 156' ' ' SER . . . . . . . . . . . . . 78.6 p -75.9 -3.77 37.17 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.382 -0.824 . . . . 21.83 110.674 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 157' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -118.29 10.48 12.83 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.171 -0.955 . . . . 36.54 110.646 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 158' ' ' GLY . . . . . . . . . . . . . . . 118.0 -162.68 13.04 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.54 -1.424 . . . . 31.74 109.54 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 159' ' ' TRP . . . . . 0.613 ' CE2' HG22 ' R' ' 154' ' ' VAL . 14.7 m95 -86.58 122.44 30.51 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.368 -1.078 . . . . 28.25 110.099 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 160' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -108.45 166.95 10.39 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.37 -0.831 . . . . 41.24 110.22 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 161' ' ' ALA . . . . . . . . . . . . . . . -143.22 123.49 13.79 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.43 -0.794 . . . . 27.4 110.163 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 162' ' ' ILE . . . . . . . . . . . . . 92.6 mt -87.68 81.23 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.375 -0.828 . . . . 24.27 109.989 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 163' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' R' ' 165' ' ' GLU . 15.4 t0 -72.76 92.32 1.56 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.404 -0.81 . . . . 36.08 110.278 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 164' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 54.06 -88.92 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.507 -0.745 . . . . 46.08 110.6 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 165' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' R' ' 163' ' ' ASP . 29.6 mt-10 -124.71 35.88 4.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.13 -0.981 . . . . 50.94 110.219 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 166' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -135.75 117.3 14.85 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.431 -0.793 . . . . 47.28 110.255 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 167' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -101.04 120.05 39.63 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.375 -0.828 . . . . 40.47 110.081 179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 168' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -157.62 158.45 30.52 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.223 -0.923 . . . . 30.21 110.407 179.876 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 169' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.67 133.01 19.63 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 O-C-N 123.868 1.457 . . . . 32.76 110.561 -179.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 170' ' ' TRP . . . . . 0.47 ' CZ2' ' HG3' ' R' ' 144' ' ' LYS . 67.2 t90 -159.77 119.27 2.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.453 -0.779 . . . . 32.79 109.955 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 171' ' ' THR . . . . . . . . . . . . . 47.4 m -81.06 112.66 34.48 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.488 -0.757 . . . . 36.92 110.163 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 172' ' ' PRO . . . . . 0.575 ' HB2' ' CD2' ' R' ' 142' ' ' PHE . 45.9 Cg_endo -73.74 158.79 46.5 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 O-C-N 123.681 1.358 . . . . 33.54 110.525 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 173' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -88.87 144.98 33.8 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.344 -0.848 . . . . 45.76 109.951 179.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 174' ' ' PRO . . . . . 0.409 ' HB3' ' HA ' ' R' ' 133' ' ' CYS . 46.2 Cg_endo -71.71 -10.4 26.46 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.596 1.314 . . . . 29.63 110.445 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 175' ' ' SER . . . . . . . . . . . . . 53.1 p -103.5 -17.55 15.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.281 -0.887 . . . . 35.7 110.343 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 176' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -103.48 43.16 1.1 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.202 -0.936 . . . . 39.65 110.4 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 177' ' ' VAL . . . . . 0.708 ' O ' HG11 ' R' ' 127' ' ' VAL . 10.5 p -117.68 127.16 75.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.336 -0.852 . . . . 20.61 109.971 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 178' ' ' LEU . . . . . 0.476 ' HB3' ' HB2' ' R' ' 101' ' ' ALA . 46.0 mt -91.45 -61.41 1.65 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.36 -0.837 . . . . 15.58 109.37 179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 179' ' ' VAL . . . . . 0.727 HG22 HG12 ' R' ' 126' ' ' VAL . 67.0 t -114.53 144.64 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.625 -0.672 . . . . 17.4 109.496 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 180' ' ' PHE . . . . . 0.433 ' CE2' ' HE1' ' R' ' 132' ' ' MET . 43.6 p90 -152.13 163.41 39.41 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.282 -0.886 . . . . 20.16 110.537 -179.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 181' ' ' VAL . . . . . . . . . . . . . 66.4 t -113.2 111.48 50.17 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.342 -0.849 . . . . 17.69 109.842 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 182' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.05 149.47 52.68 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.574 1.302 . . . . 17.81 110.446 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 183' ' ' TYR . . . . . 0.698 ' O ' ' C ' ' R' ' 184' ' ' ASP . 79.5 m-85 -59.06 175.46 0.29 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.434 -0.791 . . . . 28.01 110.561 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 184' ' ' ASP . . . . . 0.698 ' C ' ' O ' ' R' ' 183' ' ' TYR . 4.5 m-20 -18.96 -83.16 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.345 -0.847 . . . . 58.64 110.228 -178.274 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 185' ' ' GLN . . . . . . . . . . . . . 13.6 pt20 . . . . . 0 N--CA 1.503 2.176 0 CA-C-O 121.252 0.549 . . . . 80.42 111.802 179.526 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' R' R ' 193' ' ' LYS . . . . . . . . . . . . . 66.2 mttt . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 120.856 0.36 . . . . 49.5 110.16 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' R' R ' 194' ' ' ALA . . . . . . . . . . . . . . . -170.98 -159.86 0.18 Allowed 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.177 -0.952 . . . . 40.4 110.119 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 195' ' ' LYS . . . . . . . . . . . . . 8.4 ttpt -82.59 -55.38 4.49 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.388 -0.82 . . . . 34.6 110.338 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' R' R ' 196' ' ' VAL . . . . . 0.558 ' O ' HG12 ' R' ' 196' ' ' VAL . 41.8 t -88.9 48.67 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.233 -0.917 . . . . 33.27 110.62 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 197' ' ' GLN . . . . . 0.463 ' CG ' ' O ' ' R' ' 197' ' ' GLN . 7.7 tt0 -149.1 14.3 0.9 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.147 -0.971 . . . . 41.58 110.664 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 198' ' ' ARG . . . . . 0.609 ' HG3' HD23 ' R' ' 200' ' ' LEU . 9.1 ptt180 -106.37 178.4 4.57 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.155 -0.965 . . . . 38.65 110.215 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 199' ' ' LYS . . . . . 0.496 ' O ' ' HD3' ' S' ' 299' ' ' PRO . 13.2 mtpp -89.9 -52.6 4.89 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.433 -0.792 . . . . 36.77 109.98 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' R' R ' 200' ' ' LEU . . . . . 0.609 HD23 ' HG3' ' R' ' 198' ' ' ARG . 0.2 OUTLIER 62.04 159.88 0.07 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.371 -0.831 . . . . 33.08 110.107 179.787 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' R' R ' 201' ' ' LYS . . . . . 0.646 ' C ' ' HA3' ' S' ' 297' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.695 0 O-C-N 121.379 -0.825 . . . . 44.32 110.328 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 229' ' ' MET . . . . . . . . . . . . . 2.6 ptp . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.2 0.524 . . . . 51.83 110.251 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' S' S ' 230' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -97.3 142.66 28.92 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.39 -0.819 . . . . 54.13 110.182 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' S' S ' 231' ' ' LEU . . . . . . . . . . . . . 67.8 mt -134.05 141.02 47.04 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.339 -0.851 . . . . 33.04 110.386 -179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' S' S ' 232' ' ' THR . . . . . 0.403 ' O ' ' HA ' ' S' ' 355' ' ' THR . 40.4 m -89.24 103.28 15.92 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.354 -0.841 . . . . 26.92 110.019 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 233' ' ' LEU . . . . . 0.67 HD22 ' CE2' ' S' ' 262' ' ' TYR . 79.8 mt -55.91 179.28 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.538 -0.726 . . . . 13.78 110.5 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 234' ' ' TYR . . . . . 0.444 ' CG ' ' N ' ' S' ' 235' ' ' ASN . 35.5 p90 -65.05 -35.61 81.7 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.347 -0.846 . . . . 26.08 110.167 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 235' ' ' ASN . . . . . 0.444 ' N ' ' CG ' ' S' ' 234' ' ' TYR . 50.6 p30 -74.43 -7.28 52.41 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.313 -0.867 . . . . 20.04 110.581 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 236' ' ' GLY . . . . . . . . . . . . . . . 95.66 -19.9 52.21 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.788 -1.325 . . . . 22.71 109.788 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' S' S ' 237' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -53.08 145.74 12.67 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.212 -1.17 . . . . 35.44 110.189 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' S' S ' 238' ' ' LYS . . . . . . . . . . . . . 44.5 mttt -102.17 127.87 48.91 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.38 -0.825 . . . . 32.56 110.418 -179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' S' S ' 239' ' ' LYS . . . . . 0.403 ' HG2' ' CZ ' ' S' ' 241' ' ' PHE . 9.0 ttmt -132.32 144.5 50.61 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.407 -0.808 . . . . 26.68 109.958 179.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 240' ' ' THR . . . . . . . . . . . . . 50.8 m -102.0 132.16 47.99 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.29 -0.881 . . . . 41.02 110.417 -179.925 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' S' S ' 241' ' ' PHE . . . . . 0.403 ' CZ ' ' HG2' ' S' ' 239' ' ' LYS . 96.1 m-85 -117.84 137.61 52.65 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.347 -0.846 . . . . 28.62 110.213 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 242' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -96.39 161.78 13.77 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.396 -0.815 . . . . 47.89 110.269 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' S' S ' 243' ' ' SER . . . . . . . . . . . . . 72.7 m -90.6 151.58 21.25 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.356 -0.84 . . . . 45.09 110.211 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' S' S ' 244' ' ' ARG . . . . . . . . . . . . . 1.4 mtp85 -129.76 126.83 22.75 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.374 -0.829 . . . . 42.49 110.212 -179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' S' S ' 245' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.39 161.03 43.57 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 O-C-N 123.664 1.35 . . . . 35.68 110.543 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' S' S ' 246' ' ' ASN . . . . . . . . . . . . . 51.3 t-20 -132.93 97.9 4.15 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.477 -0.764 . . . . 51.88 109.81 179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' S' S ' 247' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -110.43 -22.31 11.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.316 -0.865 . . . . 53.69 110.645 -179.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' S' S ' 248' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -117.24 43.73 2.26 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.202 -0.936 . . . . 55.79 110.751 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' S' S ' 249' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 48.83 38.31 11.72 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.429 -0.794 . . . . 49.45 110.416 179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' S' S ' 250' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -90.54 28.95 1.37 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.582 -0.699 . . . . 36.86 110.363 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' S' S ' 251' ' ' ALA . . . . . 0.431 ' HB3' ' CE ' ' R' ' 201' ' ' LYS . . . -53.8 -43.13 69.09 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.217 -0.927 . . . . 29.69 109.585 179.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 252' ' ' TRP . . . . . 0.427 ' CZ2' ' HB3' ' S' ' 294' ' ' LEU . 67.9 p-90 -61.88 -33.89 75.02 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.622 -0.674 . . . . 41.12 109.802 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 253' ' ' LEU . . . . . 0.407 ' N ' ' CD2' ' S' ' 252' ' ' TRP . 23.4 tp -70.21 -47.24 62.35 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.386 -0.821 . . . . 24.89 109.939 179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 254' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -56.11 -42.43 76.8 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.507 -0.745 . . . . 35.65 109.979 179.676 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' S' S ' 255' ' ' ALA . . . . . . . . . . . . . . . -59.58 -48.19 82.64 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.459 -0.776 . . . . 22.73 110.038 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' S' S ' 256' ' ' ILE . . . . . 0.505 HG12 HD11 ' S' ' 304' ' ' ILE . 79.9 mt -62.35 -40.69 88.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.261 -0.9 . . . . 28.85 109.926 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 257' ' ' LEU . . . . . . . . . . . . . 19.4 mt -61.49 -44.47 97.02 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.41 -0.806 . . . . 23.07 110.172 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' S' S ' 258' ' ' GLN . . . . . 0.498 ' HB3' ' CD2' ' S' ' 351' ' ' PHE . 53.3 mm-40 -65.12 -45.36 85.43 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.458 -0.776 . . . . 29.78 109.896 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 259' ' ' LEU . . . . . 0.425 ' O ' HG22 ' S' ' 263' ' ' VAL . 19.9 tp -58.64 -36.35 73.98 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.322 -0.861 . . . . 17.94 109.51 179.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 260' ' ' PHE . . . . . 0.535 ' CE2' HD21 ' S' ' 311' ' ' LEU . 3.1 m-85 -62.83 -45.27 93.41 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.593 -0.692 . . . . 30.57 109.812 179.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 261' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -62.03 -29.89 70.59 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.452 -0.78 . . . . 41.34 110.022 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' S' S ' 262' ' ' TYR . . . . . 0.67 ' CE2' HD22 ' S' ' 233' ' ' LEU . 8.6 t80 -71.15 -44.65 65.12 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.416 -0.803 . . . . 26.03 110.113 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 263' ' ' VAL . . . . . 0.425 HG22 ' O ' ' S' ' 259' ' ' LEU . 33.0 m -92.03 18.3 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.398 -0.814 . . . . 22.8 110.395 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 264' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 52.74 70.61 0.56 Allowed 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.282 -0.886 . . . . 44.03 110.686 -179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' S' S ' 265' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -111.75 109.22 55.54 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.373 -0.83 . . . . 35.61 109.669 179.687 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' S' S ' 266' ' ' PRO . . . . . 0.475 ' HA ' ' HB2' ' S' ' 269' ' ' ASP . 49.6 Cg_endo -75.3 0.32 9.17 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.676 1.356 . . . . 37.67 111.79 -179.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 267' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -56.5 -67.63 0.29 Allowed 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.843 -1.161 . . . . 41.49 110.212 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 268' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -92.96 39.82 1.05 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.138 -0.976 . . . . 50.76 110.057 179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' S' S ' 269' ' ' ASP . . . . . 0.475 ' HB2' ' HA ' ' S' ' 266' ' ' PRO . 0.9 OUTLIER -75.97 -33.2 59.76 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.424 -0.797 . . . . 61.86 109.737 179.556 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' S' S ' 270' ' ' TRP . . . . . 0.508 ' CE2' HG23 ' S' ' 271' ' ' VAL . 51.0 p-90 -73.92 -4.3 34.24 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.285 -0.884 . . . . 39.85 110.47 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 271' ' ' VAL . . . . . 0.508 HG23 ' CE2' ' S' ' 270' ' ' TRP . 46.4 t -109.56 -32.67 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.114 -0.991 . . . . 39.18 110.085 179.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 272' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -78.74 -36.46 43.16 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.39 -0.819 . . . . 40.02 110.498 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' S' S ' 273' ' ' SER . . . . . . . . . . . . . 71.0 m -103.58 56.12 0.74 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.346 -0.846 . . . . 47.2 110.276 -179.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' S' S ' 274' ' ' SER . . . . . . . . . . . . . 6.9 t -133.06 141.25 40.2 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.31 -0.869 . . . . 47.61 110.137 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' S' S ' 275' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.71 -18.92 21.8 Favored 'Trans proline' 0 C--N 1.31 -1.462 0 O-C-N 123.719 1.378 . . . . 45.28 110.541 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' S' S ' 276' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -99.9 140.87 33.49 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.264 -0.897 . . . . 57.27 110.279 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' S' S ' 277' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -71.73 97.65 1.8 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.466 -0.771 . . . . 37.28 110.287 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' S' S ' 278' ' ' LEU . . . . . . . . . . . . . 86.8 mt -97.03 33.87 1.84 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.435 -0.79 . . . . 43.88 109.961 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' S' S ' 279' ' ' THR . . . . . . . . . . . . . 77.8 m -64.1 -60.14 3.59 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.477 -0.764 . . . . 50.05 110.239 179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' S' S ' 280' ' ' LEU . . . . . 0.738 ' HA ' HD12 ' S' ' 283' ' ' ILE . 13.6 mt -51.59 -39.89 58.78 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.441 -0.787 . . . . 54.12 110.299 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 281' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.31 -49.72 74.5 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.454 -0.779 . . . . 65.28 110.161 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 282' ' ' ALA . . . . . . . . . . . . . . . -59.03 -33.84 71.21 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.467 -0.771 . . . . 46.51 110.515 -179.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' S' S ' 283' ' ' ILE . . . . . 0.738 HD12 ' HA ' ' S' ' 280' ' ' LEU . 86.0 mt -66.43 -50.88 63.77 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.246 -0.909 . . . . 47.3 110.028 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 284' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -50.52 -57.65 7.61 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.461 -0.774 . . . . 50.72 110.361 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' S' S ' 285' ' ' GLN . . . . . 0.518 ' HG2' HD12 ' S' ' 289' ' ' LEU . 34.3 tt0 -51.3 -46.38 62.51 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.494 -0.754 . . . . 68.47 110.367 179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 286' ' ' LEU . . . . . . . . . . . . . 19.0 mt -60.09 -44.41 94.82 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.435 -0.79 . . . . 36.62 110.242 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' S' S ' 287' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -62.79 -35.29 79.4 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.251 -0.906 . . . . 46.64 110.05 179.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' S' S ' 288' ' ' ASP . . . . . . . . . . . . . 54.8 m-20 -76.21 -21.04 56.92 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.493 -0.754 . . . . 46.45 110.311 179.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' S' S ' 289' ' ' LEU . . . . . 0.518 HD12 ' HG2' ' S' ' 285' ' ' GLN . 30.7 mt -97.33 -21.65 17.1 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.251 -0.906 . . . . 35.09 110.553 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 290' ' ' THR . . . . . 0.41 HG22 ' HB3' ' S' ' 306' ' ' ASN . 81.4 p -114.84 -28.4 7.08 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.254 -0.904 . . . . 38.61 110.462 -179.726 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 291' ' ' GLY . . . . . . . . . . . . . . . 79.41 10.96 85.41 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 109.793 -1.323 . . . . 36.77 109.793 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' S' S ' 292' ' ' LEU . . . . . . . . . . . . . 84.7 mt -96.44 145.77 25.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.25 -1.147 . . . . 35.33 109.779 179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' S' S ' 293' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -77.36 102.33 6.74 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.26 -0.9 . . . . 48.7 110.296 -179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' S' S ' 294' ' ' LEU . . . . . 0.427 ' HB3' ' CZ2' ' S' ' 252' ' ' TRP . 55.3 mt -106.83 51.71 0.74 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.572 -0.705 . . . . 42.61 110.136 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 295' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -112.58 -11.14 13.62 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.287 -0.883 . . . . 55.49 110.539 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 296' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -144.26 48.51 1.37 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.151 -0.968 . . . . 75.68 110.315 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' S' S ' 297' ' ' GLY . . . . . 0.646 ' HA3' ' C ' ' R' ' 201' ' ' LYS . . . 96.91 145.13 18.63 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.502 -1.439 . . . . 49.44 109.502 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 298' ' ' GLY . . . . . 0.462 ' N ' ' HB3' ' R' ' 201' ' ' LYS . . . -163.82 156.9 28.96 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.84 -1.304 . . . . 41.11 109.84 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 299' ' ' PRO . . . . . 0.496 ' HD3' ' O ' ' R' ' 199' ' ' LYS . 47.8 Cg_endo -73.7 118.21 5.36 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 O-C-N 123.932 1.49 . . . . 26.2 110.341 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 300' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.2 -15.42 31.81 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 O-C-N 123.567 1.299 . . . . 21.7 110.728 179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' S' S ' 301' ' ' ALA . . . . . . . . . . . . . . . -80.75 -29.35 36.28 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.258 -0.901 . . . . 31.23 110.133 179.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' S' S ' 302' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.47 -40.65 18.97 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.426 -0.796 . . . . 38.99 109.943 179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 303' ' ' VAL . . . . . 0.494 HG23 ' O ' ' S' ' 299' ' ' PRO . 57.7 t -60.69 -35.53 64.63 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.427 -0.795 . . . . 18.63 110.122 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 304' ' ' ILE . . . . . 0.52 HD12 HG21 ' S' ' 379' ' ' VAL . 86.0 mt -79.3 -23.67 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.341 -0.849 . . . . 25.46 110.178 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 305' ' ' TRP . . . . . 0.413 ' CD2' ' HD3' ' S' ' 308' ' ' LYS . 68.9 t-105 -88.69 -14.47 37.24 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.252 -0.905 . . . . 33.4 110.56 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 306' ' ' ASN . . . . . 0.41 ' HB3' HG22 ' S' ' 290' ' ' THR . 10.3 m-80 -89.76 -13.59 36.41 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.215 -0.928 . . . . 36.97 110.363 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 307' ' ' ILE . . . . . 0.474 HG12 ' O ' ' S' ' 303' ' ' VAL . 36.9 pt -125.06 45.57 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.182 -0.949 . . . . 30.81 110.04 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 308' ' ' LYS . . . . . 0.413 ' HD3' ' CD2' ' S' ' 305' ' ' TRP . 1.5 mtmp? -73.52 -37.73 65.55 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.357 -0.84 . . . . 46.52 110.157 -179.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 309' ' ' HIS . . . . . 0.498 ' CD2' ' HG ' ' S' ' 310' ' ' LEU . 55.5 p-80 -73.16 -8.3 55.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.401 -0.812 . . . . 51.03 110.136 179.559 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 310' ' ' LEU . . . . . 0.498 ' HG ' ' CD2' ' S' ' 309' ' ' HIS . 52.9 mt -99.32 -12.83 19.97 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.3 -0.875 . . . . 36.16 109.958 179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 311' ' ' LEU . . . . . 0.535 HD21 ' CE2' ' S' ' 260' ' ' PHE . 10.7 mt -97.24 147.87 23.68 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.373 -0.829 . . . . 40.0 110.441 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 312' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -81.58 -16.26 52.14 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.266 -0.896 . . . . 54.18 109.747 179.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' S' S ' 313' ' ' THR . . . . . 0.808 HG23 ' HG2' ' S' ' 323' ' ' GLU . 92.6 m -87.95 151.67 22.63 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.332 -0.855 . . . . 25.61 110.134 179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 314' ' ' GLY . . . . . . . . . . . . . . . -87.94 126.39 8.04 Favored Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.776 -1.33 . . . . 25.18 109.776 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' S' S ' 315' ' ' ILE . . . . . 0.665 HD13 ' HB ' ' S' ' 324' ' ' VAL . 50.7 mm -101.63 150.51 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.427 -1.043 . . . . 23.9 109.757 179.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 316' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' S' ' 325' ' ' CYS . . . -157.1 -159.21 9.35 Favored Glycine 0 N--CA 1.492 2.373 0 N-CA-C 110.006 -1.237 . . . . 23.18 110.006 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 317' ' ' THR . . . . . 0.422 HG22 ' CG2' ' S' ' 326' ' ' VAL . 10.9 p -133.95 -173.03 3.13 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.485 -1.009 . . . . 27.98 109.921 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.6 -56.11 26.17 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.176 -0.953 . . . . 28.1 109.921 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' S' S ' 319' ' ' SER . . . . . . . . . . . . . 1.2 m -60.06 -41.61 92.7 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.331 -0.855 . . . . 37.0 109.593 179.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' S' S ' 320' ' ' ARG . . . . . . . . . . . . . 12.2 mtm180 -111.71 79.86 2.64 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.525 -0.734 . . . . 52.07 109.719 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' S' S ' 321' ' ' PRO . . . . . 0.833 ' HB3' HD21 ' S' ' 388' ' ' LEU . 44.1 Cg_endo -71.43 171.54 15.99 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.936 1.492 . . . . 38.29 110.901 -179.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 322' ' ' SER . . . . . 0.446 ' HB2' ' O ' ' S' ' 321' ' ' PRO . 41.2 t 178.64 -148.14 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.905 -0.776 . . . . 38.84 108.905 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 323' ' ' GLU . . . . . 0.808 ' HG2' HG23 ' S' ' 313' ' ' THR . 6.7 tp10 -62.85 -40.28 96.99 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.971 -1.081 . . . . 40.7 109.668 179.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 324' ' ' VAL . . . . . 0.665 ' HB ' HD13 ' S' ' 315' ' ' ILE . 73.0 t -141.3 135.03 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.399 -0.813 . . . . 20.34 109.471 179.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 325' ' ' CYS . . . . . 0.461 ' HB2' ' CE1' ' S' ' 380' ' ' PHE . 11.4 m -126.03 172.19 10.17 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.294 -0.878 . . . . 30.63 110.805 -179.082 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 326' ' ' VAL . . . . . 0.638 HG12 HG22 ' S' ' 379' ' ' VAL . 34.5 m -135.47 142.23 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.641 -0.662 . . . . 23.9 109.235 179.163 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 327' ' ' VAL . . . . . 0.594 HG11 ' O ' ' S' ' 377' ' ' VAL . 34.5 m -56.37 125.04 11.3 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.078 -1.014 . . . . 19.48 110.42 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 328' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -119.38 11.47 12.21 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.442 -0.786 . . . . 26.43 110.411 179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' S' S ' 329' ' ' GLY . . . . . . . . . . . . . . . 119.7 2.21 13.06 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.064 -1.214 . . . . 31.24 110.064 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' S' S ' 330' ' ' THR . . . . . . . . . . . . . 81.9 m -93.02 130.03 38.74 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.067 -1.255 . . . . 30.05 110.093 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' S' S ' 331' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -56.8 111.57 1.06 Allowed 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.315 -0.866 . . . . 37.26 109.948 179.752 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' S' S ' 332' ' ' MET . . . . . . . . . . . . . 87.9 mmm -94.16 162.58 13.8 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.268 -0.895 . . . . 26.23 110.322 -179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' S' S ' 333' ' ' CYS . . . . . . . . . . . . . 26.0 m -137.25 150.05 47.56 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.456 -0.778 . . . . 23.56 110.014 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' S' S ' 334' ' ' LEU . . . . . 0.556 HD11 ' O ' ' S' ' 372' ' ' PRO . 0.1 OUTLIER -52.56 -24.93 9.15 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.296 -0.878 . . . . 28.93 110.429 179.905 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' S' S ' 335' ' ' ALA . . . . . . . . . . . . . . . -89.02 14.45 10.6 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.38 -0.825 . . . . 15.76 110.986 -179.343 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' S' S ' 336' ' ' ASP . . . . . 0.403 ' O ' ' HA ' ' S' ' 382' ' ' PRO . 70.3 m-20 -100.53 -17.18 17.23 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.135 -0.978 . . . . 34.92 110.167 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 337' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -152.37 170.86 19.04 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.369 -0.832 . . . . 19.03 110.151 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' S' S ' 338' ' ' HIS . . . . . 0.402 ' HB3' ' CZ ' ' S' ' 383' ' ' TYR . 13.4 p80 -120.72 10.42 10.98 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.37 -0.831 . . . . 18.82 110.47 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 339' ' ' ALA . . . . . 0.41 ' HA ' ' O ' ' S' ' 352' ' ' ALA . . . -175.97 155.19 1.57 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.26 -0.9 . . . . 17.18 110.116 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 340' ' ' GLY . . . . . . . . . . . . . . . 160.8 173.08 28.95 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 110.099 -1.201 . . . . 18.33 110.099 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' S' S ' 341' ' ' ILE . . . . . . . . . . . . . 83.8 mt -88.79 138.07 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.504 -0.998 . . . . 18.6 109.824 179.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' S' S ' 342' ' ' PHE . . . . . 0.488 ' CE2' ' HB3' ' S' ' 352' ' ' ALA . 69.9 m-85 -120.92 -178.42 3.74 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.25 -0.906 . . . . 23.44 110.419 -179.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 343' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.81 93.32 4.15 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.505 -0.747 . . . . 35.59 110.093 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 344' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.83 125.11 29.68 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.34 -0.85 . . . . 38.34 110.013 -179.87 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 345' ' ' GLY . . . . . . . . . . . . . . . 62.78 -130.86 43.09 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 108.858 -1.697 . . . . 53.46 108.858 -179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' S' S ' 346' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -132.74 150.87 52.11 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.14 -1.212 . . . . 70.91 110.023 179.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' S' S ' 347' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 53.3 35.32 19.89 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.294 -0.879 . . . . 47.32 110.452 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' S' S ' 348' ' ' HIS . . . . . . . . . . . . . 46.6 t60 -150.1 155.9 40.67 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.28 -0.888 . . . . 41.72 110.375 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' S' S ' 349' ' ' ALA . . . . . 0.453 ' C ' HG13 ' S' ' 350' ' ' VAL . . . -149.79 151.25 33.26 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.331 -0.855 . . . . 22.91 110.536 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 350' ' ' VAL . . . . . 0.453 HG13 ' C ' ' S' ' 349' ' ' ALA . 34.6 m -149.01 169.65 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.703 0 O-C-N 121.417 -0.802 . . . . 21.09 110.018 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 351' ' ' PHE . . . . . 0.498 ' CD2' ' HB3' ' S' ' 258' ' ' GLN . 10.7 t80 -105.41 143.62 33.32 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.237 -0.914 . . . . 25.03 110.689 -179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 352' ' ' ALA . . . . . 0.488 ' HB3' ' CE2' ' S' ' 342' ' ' PHE . . . -147.74 151.75 36.59 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.674 -0.641 . . . . 23.81 109.673 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 353' ' ' CYS . . . . . . . . . . . . . 26.3 p -153.36 164.78 37.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.28 -0.888 . . . . 25.66 110.283 -179.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' S' S ' 354' ' ' VAL . . . . . 0.554 HG22 ' CE2' ' S' ' 359' ' ' TRP . 57.0 t -76.02 118.55 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 O-C-N 121.36 -0.838 . . . . 34.27 109.959 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 355' ' ' THR . . . . . 0.403 ' HA ' ' O ' ' S' ' 232' ' ' THR . 51.7 p -117.88 175.17 5.79 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.257 -0.902 . . . . 25.49 110.271 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 356' ' ' SER . . . . . . . . . . . . . 62.1 p -62.22 -17.69 59.0 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.328 -0.858 . . . . 31.24 110.718 -179.601 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' S' S ' 357' ' ' ASN . . . . . . . . . . . . . 46.0 m-20 -106.93 14.18 26.82 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.206 -0.934 . . . . 28.61 110.637 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' S' S ' 358' ' ' GLY . . . . . . . . . . . . . . . 111.86 -152.88 17.6 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.99 -1.244 . . . . 22.01 109.99 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' S' S ' 359' ' ' TRP . . . . . 0.554 ' CE2' HG22 ' S' ' 354' ' ' VAL . 15.3 m95 -91.33 116.73 29.07 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.44 -1.035 . . . . 25.54 110.14 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 360' ' ' TYR . . . . . 0.43 ' HA ' ' HA ' ' S' ' 369' ' ' PRO . 1.3 m-85 -103.53 165.81 10.81 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.29 -0.881 . . . . 40.53 110.064 179.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 361' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' S' ' 351' ' ' PHE . . . -140.06 130.1 24.89 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.389 -0.819 . . . . 18.04 110.295 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 362' ' ' ILE . . . . . . . . . . . . . 88.9 mt -95.66 83.74 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.307 -0.87 . . . . 15.64 109.959 179.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' S' S ' 363' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' S' ' 365' ' ' GLU . 11.9 t0 -75.24 94.48 2.99 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.403 -0.81 . . . . 35.03 110.227 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 364' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 53.93 -89.37 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.535 -0.728 . . . . 46.72 110.544 -179.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' S' S ' 365' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' S' ' 363' ' ' ASP . 23.8 mt-10 -122.59 19.09 10.4 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.109 -0.994 . . . . 56.2 110.285 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 366' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -117.96 125.03 49.64 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.228 -0.92 . . . . 51.02 110.361 -179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' S' S ' 367' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -107.0 127.01 53.07 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.406 -0.808 . . . . 37.59 110.168 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' S' S ' 368' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -165.43 159.58 13.92 Favored Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 121.246 -0.909 . . . . 31.47 110.445 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' S' S ' 369' ' ' PRO . . . . . 0.43 ' HA ' ' HA ' ' S' ' 360' ' ' TYR . 46.3 Cg_endo -72.88 139.66 30.64 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 O-C-N 123.866 1.456 . . . . 28.85 110.546 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 370' ' ' TRP . . . . . . . . . . . . . 67.3 t90 -167.24 113.51 0.76 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.44 -0.787 . . . . 26.94 109.933 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' S' S ' 371' ' ' THR . . . . . . . . . . . . . 59.6 m -74.75 113.08 20.94 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.379 -0.826 . . . . 20.19 110.034 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' S' S ' 372' ' ' PRO . . . . . 0.556 ' O ' HD11 ' S' ' 334' ' ' LEU . 48.0 Cg_endo -73.57 157.06 49.21 Favored 'Trans proline' 0 C--N 1.312 -1.361 0 O-C-N 123.597 1.314 . . . . 28.68 110.611 -179.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 373' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -90.6 147.11 35.62 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.442 -0.786 . . . . 35.72 109.947 179.805 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' S' S ' 374' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -76.04 -6.15 17.05 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.665 1.35 . . . . 30.89 110.528 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' S' S ' 375' ' ' SER . . . . . . . . . . . . . 68.8 p -104.4 -16.96 14.96 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.19 -0.944 . . . . 29.41 110.474 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' S' S ' 376' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -106.56 43.08 1.18 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.327 -0.858 . . . . 32.89 110.24 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' S' S ' 377' ' ' VAL . . . . . 0.594 ' O ' HG11 ' S' ' 327' ' ' VAL . 7.3 p -114.64 147.3 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.34 -0.85 . . . . 24.33 110.235 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 378' ' ' LEU . . . . . . . . . . . . . 52.3 mt -116.09 -58.01 2.15 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.441 -0.787 . . . . 24.37 109.582 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' S' S ' 379' ' ' VAL . . . . . 0.638 HG22 HG12 ' S' ' 326' ' ' VAL . 61.1 t -120.67 132.41 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.371 -0.831 . . . . 18.02 109.453 179.23 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 380' ' ' PHE . . . . . 0.461 ' CE1' ' HB2' ' S' ' 325' ' ' CYS . 14.2 p90 -142.62 173.9 11.12 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.347 -0.845 . . . . 29.35 110.714 -179.341 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 381' ' ' VAL . . . . . . . . . . . . . 58.3 t -120.02 107.32 39.98 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.586 -0.697 . . . . 16.34 109.395 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' S' S ' 382' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' S' ' 336' ' ' ASP . 45.6 Cg_endo -71.26 145.62 49.11 Favored 'Trans proline' 0 C--N 1.311 -1.439 0 O-C-N 123.598 1.315 . . . . 20.94 110.78 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 383' ' ' TYR . . . . . 0.402 ' CZ ' ' HB3' ' S' ' 338' ' ' HIS . 88.3 m-85 -61.01 -53.49 56.54 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.309 -0.869 . . . . 28.93 109.878 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 384' ' ' ASP . . . . . . . . . . . . . 29.1 m-20 -106.38 126.54 52.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.486 -0.759 . . . . 47.03 110.333 -176.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' S' S ' 385' ' ' GLN . . . . . 0.445 ' O ' ' C ' ' S' ' 386' ' ' GLU . 5.0 pt20 -61.34 -4.86 1.37 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.407 -0.808 . . . . 46.69 110.294 177.528 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 386' ' ' GLU . . . . . 0.674 ' O ' ' CG ' ' S' ' 321' ' ' PRO . 25.5 mt-10 -40.98 150.67 0.29 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.308 -0.87 . . . . 50.25 109.563 179.327 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 387' ' ' PRO . . . . . 0.773 ' O ' ' O ' ' S' ' 389' ' ' ASN . 50.0 Cg_endo -71.58 24.96 0.24 Allowed 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.644 1.339 . . . . 34.39 110.609 -177.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 388' ' ' LEU . . . . . 0.833 HD21 ' HB3' ' S' ' 321' ' ' PRO . 1.2 pp -11.27 100.61 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.487 -0.758 . . . . 38.01 110.085 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 389' ' ' ASN . . . . . 0.773 ' O ' ' O ' ' S' ' 387' ' ' PRO . 1.4 t-20 76.0 157.58 0.19 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.346 -0.846 . . . . 45.82 110.116 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 390' ' ' GLY . . . . . 0.49 ' O ' ' CB ' ' S' ' 391' ' ' GLU . . . 151.66 -86.42 0.14 Allowed Glycine 0 N--CA 1.491 2.338 0 N-CA-C 109.624 -1.39 . . . . 33.46 109.624 -179.554 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 391' ' ' GLU . . . . . 0.49 ' CB ' ' O ' ' S' ' 390' ' ' GLY . 6.1 tt0 67.79 -63.06 0.32 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.351 -1.088 . . . . 56.58 110.123 -179.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 392' ' ' TRP . . . . . 0.475 ' N ' ' O ' ' S' ' 390' ' ' GLY . 0.9 OUTLIER -51.78 -23.68 4.97 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.348 -0.845 . . . . 31.43 110.41 179.724 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' S' S ' 393' ' ' LYS . . . . . 0.486 ' O ' HG12 ' S' ' 396' ' ' VAL . 0.0 OUTLIER -50.76 -36.1 35.06 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.241 -0.912 . . . . 39.42 110.368 179.933 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' S' S ' 394' ' ' ALA . . . . . 0.46 ' HB2' ' HD2' ' S' ' 393' ' ' LYS . . . -86.91 -15.05 40.13 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.341 -0.85 . . . . 34.33 110.109 179.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 395' ' ' LYS . . . . . 0.71 ' O ' HD11 ' R' ' 143' ' ' LEU . 21.2 mmmt -80.16 -25.31 39.85 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.467 -0.771 . . . . 60.09 110.258 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 396' ' ' VAL . . . . . 0.617 ' O ' ' HA ' ' R' ' 99' ' ' PRO . 8.8 p -85.31 -36.32 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.27 -0.894 . . . . 35.5 110.56 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 397' ' ' GLN . . . . . 0.471 ' N ' HG13 ' S' ' 396' ' ' VAL . 22.7 tt0 -123.96 95.46 4.57 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.136 -0.978 . . . . 49.96 110.653 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 398' ' ' ARG . . . . . 0.713 ' NH2' ' HB2' ' R' ' 149' ' ' ALA . 0.0 OUTLIER -149.26 32.05 0.74 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.232 -0.918 . . . . 43.42 110.723 -179.57 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' S' S ' 399' ' ' LYS . . . . . 0.581 ' O ' ' HB3' ' R' ' 147' ' ' GLU . 6.0 ttpm? 52.3 106.9 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.454 -0.779 . . . . 55.31 110.033 -179.753 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 400' ' ' LEU . . . . . 0.999 ' CD2' ' HB3' ' R' ' 149' ' ' ALA . 7.5 mp -80.23 -33.42 38.04 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.3 -0.875 . . . . 41.03 110.272 -178.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' S' S ' 401' ' ' LYS . . . . . 0.545 ' HA ' ' CB ' ' R' ' 49' ' ' ASP . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.694 0 O-C-N 121.348 -0.845 . . . . 61.97 110.214 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 29' ' ' MET . . . . . . . . . . . . . 2.0 mpp? . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.136 0.493 . . . . 32.14 110.314 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' R' R ' 30' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -96.4 141.19 30.01 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.386 -0.821 . . . . 43.36 110.212 179.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 31' ' ' LEU . . . . . . . . . . . . . 65.6 mt -134.91 140.58 45.87 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.282 -0.886 . . . . 22.93 110.269 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 32' ' ' THR . . . . . . . . . . . . . 69.6 m -87.54 110.61 20.47 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.439 -0.788 . . . . 22.34 109.971 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 33' ' ' LEU . . . . . 0.595 HD22 ' CE2' ' R' ' 62' ' ' TYR . 80.1 mt -62.5 -172.73 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.408 -0.808 . . . . 21.39 110.215 -179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 34' ' ' TYR . . . . . . . . . . . . . 37.0 p90 -74.65 -29.39 61.24 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.352 -0.842 . . . . 34.4 110.386 -179.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 35' ' ' ASN . . . . . . . . . . . . . 48.3 p30 -77.78 -1.91 33.78 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.332 -0.855 . . . . 30.28 110.585 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.26 -16.59 59.4 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.754 -1.338 . . . . 36.25 109.754 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 37' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -58.97 161.81 4.71 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.315 -1.109 . . . . 53.8 110.383 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 38' ' ' LYS . . . . . . . . . . . . . 56.9 mttt -117.87 135.71 53.92 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.39 -0.818 . . . . 49.91 110.151 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 39' ' ' LYS . . . . . 0.406 ' HG2' ' CZ ' ' R' ' 41' ' ' PHE . 8.1 ttmt -138.74 143.73 39.16 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.388 -0.82 . . . . 35.69 110.182 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 40' ' ' THR . . . . . . . . . . . . . 23.7 m -102.57 128.01 49.41 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.305 -0.872 . . . . 34.84 110.193 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 41' ' ' PHE . . . . . 0.406 ' CZ ' ' HG2' ' R' ' 39' ' ' LYS . 96.6 m-85 -113.12 132.66 55.36 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.381 -0.824 . . . . 34.42 110.14 -179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 42' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -93.29 140.86 29.08 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.331 -0.856 . . . . 51.46 110.255 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 43' ' ' SER . . . . . . . . . . . . . 53.6 m -70.73 141.89 51.48 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.421 -0.799 . . . . 41.84 110.186 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.74 125.37 29.59 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.361 -0.837 . . . . 33.82 110.013 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 45' ' ' PRO . . . . . 0.423 ' HG2' ' ND2' ' R' ' 77' ' ' ASN . 46.2 Cg_endo -72.11 151.13 55.13 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.596 1.314 . . . . 30.27 110.625 -179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 46' ' ' ASN . . . . . 0.568 ' ND2' HD13 ' S' ' 400' ' ' LEU . 52.2 t-20 -124.3 109.87 13.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.48 -0.762 . . . . 35.1 110.033 179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 47' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -120.29 -34.88 3.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.285 -0.884 . . . . 42.81 110.55 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 48' ' ' HIS . . . . . 0.439 ' NE2' HD11 ' R' ' 80' ' ' LEU . 73.3 m80 -105.86 45.23 0.98 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.213 -0.929 . . . . 49.97 110.24 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 49' ' ' ASP . . . . . 0.704 ' HA ' HD22 ' S' ' 400' ' ' LEU . 37.5 m-20 50.29 34.68 9.22 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.447 -0.783 . . . . 61.32 110.149 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 50' ' ' ASN . . . . . 0.4 ' OD1' ' HA ' ' R' ' 46' ' ' ASN . 15.0 p-10 -86.21 43.78 1.08 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.32 -0.862 . . . . 51.5 110.744 -179.633 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 51' ' ' ALA . . . . . 0.733 ' CB ' ' HB2' ' S' ' 400' ' ' LEU . . . -66.08 -46.14 78.76 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.193 -0.942 . . . . 38.77 109.476 179.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 52' ' ' TRP . . . . . 0.484 ' CD2' ' N ' ' R' ' 53' ' ' LEU . 68.1 p-90 -58.42 -38.43 77.4 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.595 -0.691 . . . . 26.24 110.036 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 53' ' ' LEU . . . . . 0.484 ' N ' ' CD2' ' R' ' 52' ' ' TRP . 23.2 tp -66.75 -46.66 74.71 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.439 -0.788 . . . . 26.75 109.991 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 54' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -55.11 -41.64 71.91 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.369 -0.832 . . . . 35.02 110.208 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.19 -46.03 92.16 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.396 -0.815 . . . . 24.47 110.172 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 56' ' ' ILE . . . . . 0.433 HG12 HD11 ' R' ' 104' ' ' ILE . 76.1 mt -62.26 -42.22 94.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.346 -0.846 . . . . 26.03 109.857 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 57' ' ' LEU . . . . . . . . . . . . . 22.5 mt -60.24 -45.67 92.45 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.364 -0.835 . . . . 26.77 109.655 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 58' ' ' GLN . . . . . . . . . . . . . 57.7 mm-40 -63.95 -46.53 84.29 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.456 -0.777 . . . . 22.32 109.592 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 59' ' ' LEU . . . . . 0.429 ' HA ' ' HE2' ' R' ' 151' ' ' PHE . 23.9 tp -61.34 -37.81 84.64 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.365 -0.834 . . . . 20.55 109.427 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 60' ' ' PHE . . . . . 0.528 ' CE2' HD21 ' R' ' 111' ' ' LEU . 2.8 m-85 -61.06 -44.74 96.92 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.67 -0.644 . . . . 20.08 109.913 179.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 61' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -63.07 -36.19 82.77 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.45 -0.781 . . . . 18.8 110.528 -179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 62' ' ' TYR . . . . . 0.595 ' CE2' HD22 ' R' ' 33' ' ' LEU . 9.3 t80 -63.06 -41.8 99.53 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.158 -0.964 . . . . 26.45 110.217 -179.736 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 63' ' ' VAL . . . . . 0.406 ' H ' HG22 ' R' ' 63' ' ' VAL . 30.2 m -93.37 20.43 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.247 -0.908 . . . . 29.75 110.263 179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 64' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 52.87 75.53 0.24 Allowed 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.335 -0.853 . . . . 35.52 110.582 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 65' ' ' GLU . . . . . 0.443 ' HG2' ' CD2' ' R' ' 60' ' ' PHE . 14.3 tp10 -116.22 104.06 52.45 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.45 -0.782 . . . . 29.89 109.948 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 66' ' ' PRO . . . . . 0.48 ' HA ' ' HB2' ' R' ' 69' ' ' ASP . 46.1 Cg_endo -73.55 -5.81 17.71 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.864 1.455 . . . . 21.37 111.089 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 67' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -52.15 -61.47 2.25 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.169 -0.957 . . . . 23.85 110.39 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 68' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -98.13 36.51 1.57 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.34 -0.85 . . . . 28.07 110.475 -179.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 69' ' ' ASP . . . . . 0.48 ' HB2' ' HA ' ' R' ' 66' ' ' PRO . 11.7 t0 -72.33 -33.23 67.18 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.312 -0.867 . . . . 43.76 110.18 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 70' ' ' TRP . . . . . 0.476 ' CE2' ' CG2' ' R' ' 71' ' ' VAL . 47.7 p-90 -73.39 -3.9 30.17 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.293 -0.879 . . . . 33.06 110.739 -179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 71' ' ' VAL . . . . . 0.556 HG11 ' HB2' ' R' ' 82' ' ' ALA . 40.8 t -109.79 -27.5 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.237 -0.914 . . . . 31.7 109.679 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 72' ' ' TYR . . . . . . . . . . . . . 43.0 t80 -86.42 -49.0 7.94 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.395 -0.815 . . . . 33.58 110.299 179.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 73' ' ' SER . . . . . . . . . . . . . 69.8 m -89.57 50.99 2.0 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.274 -0.892 . . . . 50.82 110.39 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 74' ' ' SER . . . . . . . . . . . . . 15.9 t -125.85 138.28 31.71 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.21 -0.931 . . . . 34.74 110.262 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.33 -25.02 15.98 Favored 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 123.702 1.369 . . . . 35.7 110.308 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 76' ' ' GLU . . . . . . . . . . . . . 35.5 mm-40 -91.7 153.23 19.79 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.364 -0.835 . . . . 66.48 110.3 -179.636 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 77' ' ' ASN . . . . . 0.423 ' ND2' ' HG2' ' R' ' 45' ' ' PRO . 22.3 t-20 -81.56 95.29 7.09 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.332 -0.855 . . . . 46.72 110.064 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 78' ' ' LEU . . . . . . . . . . . . . 96.3 mt -96.45 27.96 3.55 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.443 -0.786 . . . . 37.55 110.186 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 79' ' ' THR . . . . . . . . . . . . . 29.7 m -56.24 -54.62 43.14 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.337 -0.852 . . . . 37.36 110.286 -179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 80' ' ' LEU . . . . . 0.604 ' HA ' HD12 ' R' ' 83' ' ' ILE . 15.9 mt -60.9 -23.26 65.08 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.379 -0.826 . . . . 35.83 110.514 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 81' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -79.41 -39.15 33.15 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.142 -0.974 . . . . 44.03 110.37 -179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 82' ' ' ALA . . . . . 0.556 ' HB2' HG11 ' R' ' 71' ' ' VAL . . . -69.48 -28.54 66.16 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.288 -0.882 . . . . 32.54 110.291 179.858 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 83' ' ' ILE . . . . . 0.604 HD12 ' HA ' ' R' ' 80' ' ' LEU . 78.2 mt -70.18 -46.06 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.237 -0.915 . . . . 32.02 110.302 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 84' ' ' LYS . . . . . . . . . . . . . 36.0 tttm -55.29 -52.05 64.69 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.164 -0.96 . . . . 34.09 110.532 -179.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 85' ' ' GLN . . . . . 0.531 ' HG2' HD12 ' R' ' 89' ' ' LEU . 31.9 tt0 -54.71 -46.98 74.25 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.313 -0.867 . . . . 25.94 110.308 -179.969 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 86' ' ' LEU . . . . . . . . . . . . . 24.1 mt -58.62 -43.82 89.78 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.346 -0.846 . . . . 16.2 109.965 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 87' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -65.3 -35.27 80.48 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.466 -0.771 . . . . 49.09 110.349 179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 88' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -78.5 -18.93 54.08 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.283 -0.886 . . . . 28.61 110.523 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 89' ' ' LEU . . . . . 0.531 HD12 ' HG2' ' R' ' 85' ' ' GLN . 32.8 mt -96.25 -29.34 14.07 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.26 -0.9 . . . . 26.16 110.238 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 90' ' ' THR . . . . . . . . . . . . . 58.2 p -105.72 -34.57 7.66 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.226 -0.921 . . . . 33.33 109.806 179.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.73 16.12 58.75 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.937 -1.265 . . . . 31.13 109.937 -179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 92' ' ' LEU . . . . . . . . . . . . . 97.1 mt -100.14 155.2 17.87 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.103 -1.234 . . . . 42.52 110.237 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 93' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -86.18 91.65 8.51 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.567 -0.708 . . . . 68.46 109.911 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 94' ' ' LEU . . . . . 0.458 ' HB3' ' CZ2' ' R' ' 52' ' ' TRP . 47.7 mt -99.49 53.11 0.94 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.272 -0.893 . . . . 44.63 110.319 -179.862 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 95' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.49 -38.67 6.38 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.331 -0.856 . . . . 67.16 110.399 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 96' ' ' GLU . . . . . 0.434 ' O ' ' CE ' ' S' ' 399' ' ' LYS . 24.4 mt-10 -113.93 44.23 1.68 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.332 -0.855 . . . . 67.02 110.255 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 97' ' ' GLY . . . . . 0.829 ' HA3' ' CB ' ' S' ' 399' ' ' LYS . . . 99.15 150.81 26.04 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.674 -1.37 . . . . 49.48 109.674 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 98' ' ' GLY . . . . . . . . . . . . . . . -166.26 160.03 33.47 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.311 -1.516 . . . . 36.57 109.311 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 99' ' ' PRO . . . . . 0.804 ' CB ' HG22 ' S' ' 396' ' ' VAL . 45.0 Cg_endo -72.59 121.14 7.17 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 123.741 1.39 . . . . 30.41 110.435 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 100' ' ' PRO . . . . . 0.41 ' HA ' HD11 ' R' ' 56' ' ' ILE . 44.8 Cg_endo -72.37 -31.67 11.17 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 O-C-N 123.58 1.305 . . . . 29.94 110.452 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 101' ' ' ALA . . . . . 0.81 ' HB3' HG21 ' S' ' 396' ' ' VAL . . . -69.9 -38.46 76.32 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.228 -0.92 . . . . 23.64 110.327 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 102' ' ' LEU . . . . . 0.425 HD23 HD21 ' R' ' 106' ' ' ASN . 0.1 OUTLIER -72.73 -40.72 65.88 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.373 -0.829 . . . . 20.31 110.323 -179.699 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' R' R ' 103' ' ' VAL . . . . . 0.792 HG23 ' O ' ' R' ' 99' ' ' PRO . 63.3 t -58.13 -40.05 75.54 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.21 -0.931 . . . . 16.33 110.065 179.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 104' ' ' ILE . . . . . 0.433 HD11 HG12 ' R' ' 56' ' ' ILE . 81.9 mt -71.71 -30.51 38.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.397 -0.814 . . . . 24.77 109.956 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 105' ' ' TRP . . . . . 0.462 ' O ' ' HD3' ' R' ' 108' ' ' LYS . 70.6 t-105 -82.51 0.9 40.35 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.323 -0.861 . . . . 23.28 110.292 179.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 106' ' ' ASN . . . . . 0.425 HD21 HD23 ' R' ' 102' ' ' LEU . 6.8 m-80 -105.09 -10.38 17.2 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.144 -0.973 . . . . 28.26 110.123 179.614 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 107' ' ' ILE . . . . . . . . . . . . . 36.7 pt -126.83 35.02 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.181 -0.949 . . . . 18.77 110.033 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 108' ' ' LYS . . . . . 0.502 ' HG2' ' HB ' ' R' ' 115' ' ' ILE . 9.3 mtpp -61.03 -48.48 81.56 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.516 -0.74 . . . . 42.5 110.037 179.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 109' ' ' HIS . . . . . 0.444 ' CD2' ' HG ' ' R' ' 110' ' ' LEU . 50.9 p-80 -66.06 -12.83 58.06 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.499 -0.75 . . . . 20.07 110.688 -179.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 110' ' ' LEU . . . . . 0.444 ' HG ' ' CD2' ' R' ' 109' ' ' HIS . 80.3 mt -94.8 -17.3 22.25 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.083 -1.011 . . . . 15.69 110.196 179.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 111' ' ' LEU . . . . . 0.528 HD21 ' CE2' ' R' ' 60' ' ' PHE . 10.3 mt -94.09 144.15 25.74 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.342 -0.849 . . . . 25.39 111.008 -179.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 112' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -77.67 -17.43 57.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.487 -0.758 . . . . 53.48 109.823 179.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 113' ' ' THR . . . . . 0.459 HG22 ' N ' ' R' ' 114' ' ' GLY . 60.5 m -83.67 166.64 17.94 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.308 -0.87 . . . . 14.8 110.247 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 114' ' ' GLY . . . . . 0.459 ' N ' HG22 ' R' ' 113' ' ' THR . . . -98.0 127.12 9.12 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.042 -1.223 . . . . 16.14 110.042 -179.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 115' ' ' ILE . . . . . 0.579 HD13 ' HB ' ' R' ' 124' ' ' VAL . 47.8 mm -109.02 139.34 32.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.478 -1.013 . . . . 13.46 109.741 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 116' ' ' GLY . . . . . . . . . . . . . . . -152.71 -155.8 7.26 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 110.011 -1.236 . . . . 23.9 110.011 -179.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 117' ' ' THR . . . . . 0.53 HG22 ' CG2' ' R' ' 126' ' ' VAL . 18.8 p -135.03 -171.33 2.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.514 -0.992 . . . . 27.37 110.059 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 118' ' ' ALA . . . . . 0.446 ' HB3' ' OD1' ' R' ' 128' ' ' ASP . . . -56.62 -58.06 9.72 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.216 -0.927 . . . . 18.76 110.083 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 119' ' ' SER . . . . . 0.584 ' HB3' ' HB ' ' R' ' 196' ' ' VAL . 1.1 m -56.55 -40.56 75.36 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.251 -0.905 . . . . 32.35 109.815 179.565 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 120' ' ' ARG . . . . . 0.417 ' NH1' ' NE1' ' S' ' 305' ' ' TRP . 10.0 mtm180 -110.07 86.29 4.91 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.43 -0.794 . . . . 27.12 109.716 179.337 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 121' ' ' PRO . . . . . 0.482 ' HA ' ' SG ' ' R' ' 125' ' ' CYS . 44.0 Cg_endo -71.32 166.53 28.98 Favored 'Trans proline' 0 C--N 1.311 -1.42 0 O-C-N 123.86 1.453 . . . . 22.68 110.998 -179.394 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 122' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' R' ' 121' ' ' PRO . 38.3 t 178.53 -161.72 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.6 -0.687 . . . . 22.99 109.461 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 123' ' ' GLU . . . . . 0.442 ' HG2' HG23 ' R' ' 113' ' ' THR . 2.3 tp10 -56.45 -39.98 74.04 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.211 -0.93 . . . . 36.18 109.622 179.605 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 124' ' ' VAL . . . . . 0.579 ' HB ' HD13 ' R' ' 115' ' ' ILE . 83.5 t -142.54 136.44 27.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.597 -0.689 . . . . 20.64 109.428 179.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 125' ' ' CYS . . . . . 0.482 ' SG ' ' HA ' ' R' ' 121' ' ' PRO . 83.4 m -140.32 168.16 20.47 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.145 -0.972 . . . . 22.8 111.171 -179.276 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 126' ' ' VAL . . . . . 0.727 HG12 HG22 ' R' ' 179' ' ' VAL . 35.8 m -122.72 159.77 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 O-C-N 121.724 -0.61 . . . . 21.24 109.695 179.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 127' ' ' VAL . . . . . 0.709 HG11 ' O ' ' R' ' 177' ' ' VAL . 30.8 m -70.83 141.85 16.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.293 -0.879 . . . . 19.77 110.681 -179.472 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 128' ' ' ASP . . . . . 0.446 ' OD1' ' HB3' ' R' ' 118' ' ' ALA . 54.0 p-10 -137.68 19.34 2.88 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.405 -0.809 . . . . 29.21 110.702 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 129' ' ' GLY . . . . . . . . . . . . . . . 113.99 0.02 24.14 Favored Glycine 0 N--CA 1.493 2.458 0 C-N-CA 119.977 -1.106 . . . . 33.86 110.472 179.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 130' ' ' THR . . . . . . . . . . . . . 58.3 m -91.76 131.83 36.85 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.084 -1.244 . . . . 26.41 110.07 179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -62.59 120.66 11.59 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.35 -0.844 . . . . 33.08 110.312 -179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 132' ' ' MET . . . . . 0.433 ' HE1' ' CE2' ' R' ' 180' ' ' PHE . 98.4 mmm -105.22 165.64 10.96 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.395 -0.816 . . . . 30.76 110.377 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 133' ' ' CYS . . . . . 0.411 ' HA ' ' HB3' ' R' ' 174' ' ' PRO . 32.6 m -141.16 158.14 44.31 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.507 -0.745 . . . . 27.0 109.932 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 134' ' ' LEU . . . . . 0.563 HD11 ' O ' ' R' ' 172' ' ' PRO . 0.1 OUTLIER -58.57 -19.6 39.54 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.388 -0.82 . . . . 33.9 110.498 -179.862 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' R' R ' 135' ' ' ALA . . . . . . . . . . . . . . . -92.79 8.16 40.62 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.294 -0.879 . . . . 19.37 110.755 -179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 136' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -93.74 -21.86 19.07 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.207 -0.933 . . . . 30.47 110.216 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 137' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -149.94 165.35 32.89 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.351 -0.843 . . . . 24.27 110.231 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 138' ' ' HIS . . . . . 0.433 ' HA ' HG23 ' R' ' 154' ' ' VAL . 15.1 p80 -117.82 15.15 14.38 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.429 -0.794 . . . . 20.91 110.452 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 139' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' R' ' 152' ' ' ALA . . . -177.16 152.49 0.89 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.167 -0.958 . . . . 15.69 110.137 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 140' ' ' GLY . . . . . 0.427 ' HA3' ' O ' ' R' ' 179' ' ' VAL . . . 161.74 175.1 32.41 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 110.007 -1.237 . . . . 23.76 110.007 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 141' ' ' ILE . . . . . . . . . . . . . 83.6 mt -95.48 136.57 26.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.447 -1.031 . . . . 25.3 109.682 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 142' ' ' PHE . . . . . 0.576 ' CD2' ' HB2' ' R' ' 172' ' ' PRO . 82.6 m-85 -120.75 -172.66 2.43 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.33 -0.856 . . . . 30.24 110.54 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 143' ' ' LEU . . . . . 0.743 HD23 ' O ' ' R' ' 148' ' ' HIS . 0.5 OUTLIER -119.75 77.84 1.27 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.459 -0.776 . . . . 32.8 110.304 -179.942 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' R' R ' 144' ' ' LYS . . . . . 0.471 ' HG3' ' CZ2' ' R' ' 170' ' ' TRP . 1.0 OUTLIER -69.67 76.93 0.44 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.381 -0.824 . . . . 49.18 109.653 179.573 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' R' R ' 145' ' ' GLY . . . . . 0.457 ' O ' HD22 ' R' ' 143' ' ' LEU . . . 104.52 179.23 24.81 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.16 -1.576 . . . . 53.87 109.16 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 146' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -88.44 145.86 25.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.319 -1.107 . . . . 68.58 109.999 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 147' ' ' GLU . . . . . 0.751 ' HA ' ' CB ' ' S' ' 398' ' ' ARG . 10.9 mt-10 58.19 36.58 25.88 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.294 -0.879 . . . . 56.62 110.633 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 148' ' ' HIS . . . . . 0.902 ' CE1' HD12 ' S' ' 400' ' ' LEU . 45.1 t60 -158.67 148.11 19.17 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.243 -0.911 . . . . 44.57 110.398 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 149' ' ' ALA . . . . . . . . . . . . . . . -150.25 146.9 27.08 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.451 -0.781 . . . . 33.54 110.061 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 150' ' ' VAL . . . . . . . . . . . . . 34.2 m -142.38 161.51 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.246 -0.909 . . . . 27.61 110.322 179.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 151' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' R' ' 152' ' ' ALA . 5.9 t80 -86.18 155.57 20.68 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.383 -0.823 . . . . 23.04 109.901 179.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 152' ' ' ALA . . . . . 0.537 ' N ' ' CD1' ' R' ' 151' ' ' PHE . . . -157.31 151.56 24.92 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.447 -0.783 . . . . 29.61 109.53 178.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 153' ' ' CYS . . . . . . . . . . . . . 26.7 p -154.28 173.56 15.99 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.28 -0.888 . . . . 22.75 110.539 -179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 154' ' ' VAL . . . . . 0.614 HG22 ' CE2' ' R' ' 159' ' ' TRP . 59.9 t -90.52 117.04 32.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.429 -0.794 . . . . 23.26 110.057 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 155' ' ' THR . . . . . . . . . . . . . 71.0 p -112.18 -176.62 2.96 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.361 -0.837 . . . . 17.88 110.058 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 156' ' ' SER . . . . . . . . . . . . . 78.4 p -75.96 -3.68 36.89 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.32 -0.863 . . . . 21.83 110.716 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 157' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -118.33 10.57 12.82 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.096 -1.002 . . . . 36.54 110.625 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 158' ' ' GLY . . . . . . . . . . . . . . . 117.83 -162.6 13.01 Favored Glycine 0 N--CA 1.492 2.425 0 N-CA-C 109.55 -1.42 . . . . 31.74 109.55 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 159' ' ' TRP . . . . . 0.614 ' CE2' HG22 ' R' ' 154' ' ' VAL . 14.6 m95 -86.63 122.54 30.7 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.386 -1.067 . . . . 28.25 110.061 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 160' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -108.48 166.92 10.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.346 -0.846 . . . . 41.24 110.25 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 161' ' ' ALA . . . . . . . . . . . . . . . -143.25 123.39 13.69 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.435 -0.791 . . . . 27.4 110.182 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 162' ' ' ILE . . . . . . . . . . . . . 92.6 mt -87.57 81.24 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.398 -0.814 . . . . 24.27 110.055 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 163' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' R' ' 165' ' ' GLU . 15.3 t0 -72.85 92.37 1.6 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.458 -0.776 . . . . 36.08 110.237 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 164' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 54.09 -88.97 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.489 -0.757 . . . . 46.08 110.603 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 165' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' R' ' 163' ' ' ASP . 29.6 mt-10 -124.72 36.0 4.69 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.109 -0.994 . . . . 50.94 110.194 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 166' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -135.69 117.3 14.91 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.405 -0.81 . . . . 47.28 110.361 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 167' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -101.06 119.91 39.43 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.367 -0.833 . . . . 40.47 110.178 179.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 168' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -157.51 158.56 30.71 Favored Pre-proline 0 N--CA 1.493 1.675 0 O-C-N 121.235 -0.916 . . . . 30.21 110.454 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 169' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.77 133.05 19.52 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 O-C-N 123.866 1.456 . . . . 32.76 110.531 -179.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 170' ' ' TRP . . . . . 0.471 ' CZ2' ' HG3' ' R' ' 144' ' ' LYS . 67.2 t90 -159.78 119.27 2.88 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.444 -0.785 . . . . 32.79 109.958 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 171' ' ' THR . . . . . . . . . . . . . 45.5 m -81.08 112.58 33.87 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.423 -0.798 . . . . 36.92 110.219 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 172' ' ' PRO . . . . . 0.576 ' HB2' ' CD2' ' R' ' 142' ' ' PHE . 46.8 Cg_endo -73.77 158.81 46.39 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.634 1.334 . . . . 33.54 110.556 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 173' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -88.85 144.93 33.77 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.409 -0.807 . . . . 45.76 109.913 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 174' ' ' PRO . . . . . 0.411 ' HB3' ' HA ' ' R' ' 133' ' ' CYS . 46.0 Cg_endo -71.72 -10.35 26.37 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.649 1.342 . . . . 29.63 110.505 179.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 175' ' ' SER . . . . . . . . . . . . . 53.0 p -103.41 -17.63 15.17 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.273 -0.892 . . . . 35.7 110.367 179.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 176' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -103.58 43.3 1.09 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.261 -0.899 . . . . 39.65 110.362 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 177' ' ' VAL . . . . . 0.709 ' O ' HG11 ' R' ' 127' ' ' VAL . 10.5 p -117.78 127.23 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.266 -0.896 . . . . 20.61 110.006 179.766 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 178' ' ' LEU . . . . . 0.556 HD22 ' HB ' ' S' ' 396' ' ' VAL . 46.4 mt -91.6 -61.25 1.68 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.368 -0.832 . . . . 15.58 109.364 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 179' ' ' VAL . . . . . 0.727 HG22 HG12 ' R' ' 126' ' ' VAL . 67.5 t -114.6 144.67 21.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.66 -0.65 . . . . 17.4 109.444 179.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 180' ' ' PHE . . . . . 0.433 ' CE2' ' HE1' ' R' ' 132' ' ' MET . 43.4 p90 -152.13 163.36 39.53 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.33 -0.856 . . . . 20.16 110.517 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 181' ' ' VAL . . . . . . . . . . . . . 65.9 t -113.1 111.5 50.44 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.363 -0.836 . . . . 17.69 109.848 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 182' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.09 149.57 52.62 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 O-C-N 123.638 1.336 . . . . 17.81 110.403 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 183' ' ' TYR . . . . . 0.688 ' O ' ' C ' ' R' ' 184' ' ' ASP . 78.9 m-85 -59.13 175.44 0.3 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.401 -0.812 . . . . 28.01 110.54 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 184' ' ' ASP . . . . . 0.688 ' C ' ' O ' ' R' ' 183' ' ' TYR . 2.3 m-20 -20.0 -84.04 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.315 -0.866 . . . . 58.64 110.242 -178.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 185' ' ' GLN . . . . . . . . . . . . . 3.6 tt0 . . . . . 0 N--CA 1.502 2.173 0 CA-C-O 121.22 0.533 . . . . 80.42 111.75 179.617 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' R' R ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 120.823 0.344 . . . . 49.5 110.16 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 194' ' ' ALA . . . . . 0.761 ' HB3' ' HG2' ' R' ' 197' ' ' GLN . . . -168.93 -155.21 0.14 Allowed 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.218 -0.927 . . . . 40.4 110.144 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 195' ' ' LYS . . . . . . . . . . . . . 17.1 mtmt -89.5 -52.35 5.07 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.386 -0.821 . . . . 34.6 110.278 179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 196' ' ' VAL . . . . . 0.584 ' HB ' ' HB3' ' R' ' 119' ' ' SER . 23.1 t -93.51 59.6 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.254 -0.904 . . . . 33.27 110.585 -179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 197' ' ' GLN . . . . . 0.761 ' HG2' ' HB3' ' R' ' 194' ' ' ALA . 3.2 pp0? -164.62 21.21 0.06 Allowed 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.143 -0.973 . . . . 41.58 110.717 179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 198' ' ' ARG . . . . . . . . . . . . . 9.5 ptt-85 -120.08 165.44 14.72 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.112 -0.993 . . . . 38.65 110.23 -179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' R' R ' 199' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.78 81.36 2.28 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.478 -0.764 . . . . 36.77 109.921 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 200' ' ' LEU . . . . . 0.512 HD21 HD11 ' S' ' 343' ' ' LEU . 3.3 tp -69.07 -159.14 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.443 -0.786 . . . . 33.08 110.135 -179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' R' R ' 201' ' ' LYS . . . . . 0.602 ' HA ' ' HA3' ' S' ' 297' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 O-C-N 121.393 -0.817 . . . . 44.32 110.29 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 229' ' ' MET . . . . . . . . . . . . . 5.1 mtm . . . . . 0 N--CA 1.493 1.683 0 CA-C-O 121.188 0.518 . . . . 51.83 110.216 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' S' S ' 230' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -97.29 142.71 28.84 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.34 -0.85 . . . . 54.13 110.199 -179.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' S' S ' 231' ' ' LEU . . . . . . . . . . . . . 67.3 mt -134.07 140.98 47.0 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.388 -0.82 . . . . 33.04 110.364 -179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' S' S ' 232' ' ' THR . . . . . 0.418 ' O ' ' HA ' ' S' ' 355' ' ' THR . 40.3 m -89.26 103.28 15.92 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.305 -0.872 . . . . 26.92 110.032 179.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 233' ' ' LEU . . . . . 0.671 HD22 ' CE2' ' S' ' 262' ' ' TYR . 79.8 mt -55.88 179.24 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.437 -0.79 . . . . 13.78 110.463 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 234' ' ' TYR . . . . . 0.448 ' CG ' ' N ' ' S' ' 235' ' ' ASN . 35.5 p90 -65.01 -35.66 81.9 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.384 -0.823 . . . . 26.08 110.168 179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 235' ' ' ASN . . . . . 0.448 ' N ' ' CG ' ' S' ' 234' ' ' TYR . 50.6 p30 -74.38 -7.35 52.6 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.336 -0.852 . . . . 20.04 110.5 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 236' ' ' GLY . . . . . . . . . . . . . . . 95.69 -19.9 52.18 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.777 -1.329 . . . . 22.71 109.777 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' S' S ' 237' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -52.94 145.68 12.33 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.2 -1.176 . . . . 35.44 110.236 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' S' S ' 238' ' ' LYS . . . . . . . . . . . . . 44.5 mttt -102.18 127.92 48.91 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.358 -0.839 . . . . 32.56 110.41 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' S' S ' 239' ' ' LYS . . . . . 0.408 ' HG2' ' CZ ' ' S' ' 241' ' ' PHE . 9.0 ttmt -132.29 144.55 50.67 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.371 -0.831 . . . . 26.68 109.919 179.74 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 240' ' ' THR . . . . . . . . . . . . . 52.1 m -102.07 132.18 48.09 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.304 -0.872 . . . . 41.02 110.334 -179.901 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' S' S ' 241' ' ' PHE . . . . . 0.408 ' CZ ' ' HG2' ' S' ' 239' ' ' LYS . 96.0 m-85 -117.94 137.66 52.68 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.335 -0.853 . . . . 28.62 110.21 179.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 242' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -96.32 161.78 13.79 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.302 -0.874 . . . . 47.89 110.198 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' S' S ' 243' ' ' SER . . . . . . . . . . . . . 71.5 m -90.58 151.47 21.3 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.332 -0.855 . . . . 45.09 110.227 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' S' S ' 244' ' ' ARG . . . . . . . . . . . . . 1.4 mtp85 -129.69 126.77 22.78 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.349 -0.844 . . . . 42.49 110.247 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' S' S ' 245' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.35 161.0 43.74 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.74 1.389 . . . . 35.68 110.561 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' S' S ' 246' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -132.87 97.87 4.15 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.408 -0.807 . . . . 51.88 109.867 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' S' S ' 247' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -110.49 -22.22 11.77 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.321 -0.862 . . . . 53.69 110.655 -179.462 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' S' S ' 248' ' ' HIS . . . . . . . . . . . . . 76.5 m80 -117.21 43.61 2.28 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.16 -0.963 . . . . 55.79 110.761 -179.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' S' S ' 249' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 48.77 38.46 11.85 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.417 -0.802 . . . . 49.45 110.39 179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' S' S ' 250' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -90.65 29.02 1.38 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.496 -0.753 . . . . 36.86 110.364 179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' S' S ' 251' ' ' ALA . . . . . . . . . . . . . . . -53.79 -43.23 69.12 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.281 -0.887 . . . . 29.69 109.563 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' S' S ' 252' ' ' TRP . . . . . 0.426 ' CZ2' ' HB3' ' S' ' 294' ' ' LEU . 67.9 p-90 -61.76 -33.95 74.98 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.602 -0.686 . . . . 41.12 109.886 179.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 253' ' ' LEU . . . . . . . . . . . . . 23.4 tp -70.11 -47.23 62.66 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.446 -0.783 . . . . 24.89 110.016 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' S' S ' 254' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -56.16 -42.44 77.03 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.299 -0.875 . . . . 35.65 109.975 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' S' S ' 255' ' ' ALA . . . . . . . . . . . . . . . -59.57 -48.1 82.97 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.447 -0.783 . . . . 22.73 110.141 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' S' S ' 256' ' ' ILE . . . . . 0.507 HG12 HD11 ' S' ' 304' ' ' ILE . 79.7 mt -62.32 -40.7 88.83 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.273 -0.892 . . . . 28.85 109.924 179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 257' ' ' LEU . . . . . 0.404 ' CD2' ' HB3' ' S' ' 268' ' ' PHE . 19.0 mt -61.54 -44.48 96.98 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.354 -0.841 . . . . 23.07 110.168 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 258' ' ' GLN . . . . . 0.501 ' HB3' ' CD2' ' S' ' 351' ' ' PHE . 53.4 mm-40 -65.09 -45.33 85.66 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.398 -0.814 . . . . 29.78 109.953 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 259' ' ' LEU . . . . . 0.419 ' O ' HG22 ' S' ' 263' ' ' VAL . 19.9 tp -58.73 -36.27 74.04 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.285 -0.885 . . . . 17.94 109.484 179.179 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 260' ' ' PHE . . . . . 0.528 ' CE2' HD21 ' S' ' 311' ' ' LEU . 3.1 m-85 -62.89 -45.24 93.44 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.663 -0.648 . . . . 30.57 109.808 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 261' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -62.08 -29.82 70.57 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.454 -0.779 . . . . 41.34 110.015 179.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' S' S ' 262' ' ' TYR . . . . . 0.671 ' CE2' HD22 ' S' ' 233' ' ' LEU . 8.7 t80 -71.17 -44.6 65.17 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.416 -0.802 . . . . 26.03 110.137 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 263' ' ' VAL . . . . . 0.419 HG22 ' O ' ' S' ' 259' ' ' LEU . 33.0 m -92.06 18.23 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.385 -0.822 . . . . 22.8 110.412 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 264' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 52.76 70.67 0.55 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.291 -0.881 . . . . 44.03 110.568 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' S' S ' 265' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -111.77 109.16 55.53 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.257 -0.902 . . . . 35.61 109.716 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' S' S ' 266' ' ' PRO . . . . . 0.477 ' HA ' ' HB2' ' S' ' 269' ' ' ASP . 49.0 Cg_endo -75.24 0.37 9.08 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.579 1.305 . . . . 37.67 111.728 -179.108 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 267' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -56.53 -67.65 0.29 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.806 -1.184 . . . . 41.49 110.203 -179.914 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 268' ' ' PHE . . . . . 0.404 ' HB3' ' CD2' ' S' ' 257' ' ' LEU . 22.4 m-85 -92.91 39.85 1.05 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.164 -0.96 . . . . 50.76 110.098 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 269' ' ' ASP . . . . . 0.477 ' HB2' ' HA ' ' S' ' 266' ' ' PRO . 0.9 OUTLIER -76.0 -33.16 59.7 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.322 -0.861 . . . . 61.86 109.83 179.543 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' S' S ' 270' ' ' TRP . . . . . 0.505 ' CE2' HG23 ' S' ' 271' ' ' VAL . 51.0 p-90 -73.97 -4.28 34.28 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.208 -0.932 . . . . 39.85 110.489 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 271' ' ' VAL . . . . . 0.505 HG23 ' CE2' ' S' ' 270' ' ' TRP . 46.5 t -109.5 -32.77 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.129 -0.982 . . . . 39.18 110.051 179.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 272' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -78.65 -36.47 43.83 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.384 -0.822 . . . . 40.02 110.514 -179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' S' S ' 273' ' ' SER . . . . . . . . . . . . . 70.9 m -103.59 56.08 0.74 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.269 -0.894 . . . . 47.2 110.291 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' S' S ' 274' ' ' SER . . . . . . . . . . . . . 6.9 t -133.04 141.23 40.17 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.371 -0.83 . . . . 47.61 110.108 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' S' S ' 275' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.74 -18.92 21.7 Favored 'Trans proline' 0 C--N 1.31 -1.453 0 O-C-N 123.617 1.325 . . . . 45.28 110.583 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' S' S ' 276' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -99.88 140.88 33.46 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.247 -0.908 . . . . 57.27 110.288 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' S' S ' 277' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -71.66 97.56 1.75 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.368 -0.832 . . . . 37.28 110.272 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' S' S ' 278' ' ' LEU . . . . . . . . . . . . . 86.5 mt -96.97 33.87 1.83 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.329 -0.857 . . . . 43.88 110.023 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' S' S ' 279' ' ' THR . . . . . . . . . . . . . 78.1 m -64.12 -60.08 3.66 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.505 -0.747 . . . . 50.05 110.273 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' S' S ' 280' ' ' LEU . . . . . 0.724 ' HA ' HD12 ' S' ' 283' ' ' ILE . 13.7 mt -51.58 -39.92 58.8 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.352 -0.843 . . . . 54.12 110.255 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 281' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.41 -49.65 74.64 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.467 -0.77 . . . . 65.28 110.108 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 282' ' ' ALA . . . . . . . . . . . . . . . -58.95 -33.95 71.21 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.439 -0.788 . . . . 46.51 110.512 -179.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' S' S ' 283' ' ' ILE . . . . . 0.724 HD12 ' HA ' ' S' ' 280' ' ' LEU . 86.0 mt -66.39 -50.82 64.48 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.358 -0.839 . . . . 47.3 110.092 -179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 284' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -50.52 -57.63 7.67 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.444 -0.785 . . . . 50.72 110.358 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' S' S ' 285' ' ' GLN . . . . . 0.531 ' HG2' HD12 ' S' ' 289' ' ' LEU . 34.4 tt0 -51.41 -46.36 62.89 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.578 -0.701 . . . . 68.47 110.346 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 286' ' ' LEU . . . . . . . . . . . . . 19.0 mt -59.96 -44.53 94.37 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.448 -0.782 . . . . 36.62 110.245 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' S' S ' 287' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -62.78 -35.21 79.09 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.288 -0.883 . . . . 46.64 110.083 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' S' S ' 288' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -76.25 -21.03 56.82 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.361 -0.837 . . . . 46.45 110.307 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' S' S ' 289' ' ' LEU . . . . . 0.531 HD12 ' HG2' ' S' ' 285' ' ' GLN . 30.7 mt -97.35 -21.73 17.04 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.288 -0.883 . . . . 35.09 110.524 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 290' ' ' THR . . . . . 0.413 HG22 ' HB3' ' S' ' 306' ' ' ASN . 81.3 p -114.78 -28.35 7.12 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.246 -0.909 . . . . 38.61 110.455 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 291' ' ' GLY . . . . . . . . . . . . . . . 79.31 10.99 85.45 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.856 -1.298 . . . . 36.77 109.856 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' S' S ' 292' ' ' LEU . . . . . . . . . . . . . 84.8 mt -96.41 145.81 25.32 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.304 -1.116 . . . . 35.33 109.799 179.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' S' S ' 293' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -77.32 102.4 6.73 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.15 -0.969 . . . . 48.7 110.302 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' S' S ' 294' ' ' LEU . . . . . 0.426 ' HB3' ' CZ2' ' S' ' 252' ' ' TRP . 55.7 mt -106.93 51.71 0.73 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.521 -0.737 . . . . 42.61 110.1 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 295' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -112.51 -11.11 13.65 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.365 -0.834 . . . . 55.49 110.531 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 296' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -144.37 48.55 1.36 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.167 -0.958 . . . . 75.68 110.261 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' S' S ' 297' ' ' GLY . . . . . 0.602 ' HA3' ' HA ' ' R' ' 201' ' ' LYS . . . 96.84 145.2 18.73 Favored Glycine 0 N--CA 1.492 2.419 0 N-CA-C 109.467 -1.453 . . . . 49.44 109.467 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 298' ' ' GLY . . . . . . . . . . . . . . . -163.86 156.99 29.1 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.8 -1.32 . . . . 41.11 109.8 -179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' S' S ' 299' ' ' PRO . . . . . 0.484 ' O ' HG23 ' S' ' 303' ' ' VAL . 46.6 Cg_endo -73.86 118.28 5.37 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 124.008 1.531 . . . . 26.2 110.209 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 300' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_endo -71.29 -15.49 31.52 Favored 'Trans proline' 0 C--N 1.311 -1.429 0 O-C-N 123.584 1.307 . . . . 21.7 110.665 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' S' S ' 301' ' ' ALA . . . . . . . . . . . . . . . -80.63 -29.34 36.76 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.295 -0.878 . . . . 31.23 110.13 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' S' S ' 302' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.56 -40.62 18.89 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.391 -0.818 . . . . 38.99 109.941 179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 303' ' ' VAL . . . . . 0.484 HG23 ' O ' ' S' ' 299' ' ' PRO . 58.0 t -60.7 -35.47 64.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.487 -0.758 . . . . 18.63 110.167 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 304' ' ' ILE . . . . . 0.522 HD12 HG21 ' S' ' 379' ' ' VAL . 86.1 mt -79.35 -23.61 12.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.44 -0.787 . . . . 25.46 110.229 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 305' ' ' TRP . . . . . 0.417 ' NE1' ' NH1' ' R' ' 120' ' ' ARG . 68.8 t-105 -88.64 -14.56 37.17 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.31 -0.869 . . . . 33.4 110.599 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 306' ' ' ASN . . . . . 0.413 ' HB3' HG22 ' S' ' 290' ' ' THR . 10.4 m-80 -89.67 -13.62 36.59 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.291 -0.88 . . . . 36.97 110.394 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 307' ' ' ILE . . . . . 0.469 HG12 ' O ' ' S' ' 303' ' ' VAL . 36.9 pt -125.02 45.69 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.777 0 O-C-N 121.255 -0.903 . . . . 30.81 110.043 179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 308' ' ' LYS . . . . . 0.411 ' HD3' ' CD2' ' S' ' 305' ' ' TRP . 1.5 mtmp? -73.63 -37.76 65.26 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.373 -0.83 . . . . 46.52 110.064 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 309' ' ' HIS . . . . . 0.495 ' CD2' ' HG ' ' S' ' 310' ' ' LEU . 55.6 p-80 -73.15 -8.21 54.79 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.263 -0.898 . . . . 51.03 110.187 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 310' ' ' LEU . . . . . 0.495 ' HG ' ' CD2' ' S' ' 309' ' ' HIS . 53.0 mt -99.31 -12.84 19.97 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.317 -0.864 . . . . 36.16 109.969 179.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 311' ' ' LEU . . . . . 0.528 HD21 ' CE2' ' S' ' 260' ' ' PHE . 10.8 mt -97.21 147.9 23.63 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.377 -0.827 . . . . 40.0 110.355 -179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 312' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -81.67 -16.23 51.97 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.262 -0.899 . . . . 54.18 109.698 179.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' S' S ' 313' ' ' THR . . . . . 0.829 HG23 ' HG2' ' S' ' 323' ' ' GLU . 92.7 m -87.97 151.63 22.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.38 -0.825 . . . . 25.61 110.149 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 314' ' ' GLY . . . . . . . . . . . . . . . -87.86 126.33 8.0 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.83 -1.308 . . . . 25.18 109.83 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' S' S ' 315' ' ' ILE . . . . . 0.668 HD13 ' HB ' ' S' ' 324' ' ' VAL . 50.6 mm -101.58 150.53 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.416 -1.049 . . . . 23.9 109.724 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 316' ' ' GLY . . . . . 0.401 ' O ' ' HA ' ' S' ' 325' ' ' CYS . . . -157.1 -159.23 9.36 Favored Glycine 0 N--CA 1.493 2.498 0 N-CA-C 110.026 -1.23 . . . . 23.18 110.026 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 317' ' ' THR . . . . . 0.423 HG22 ' CG2' ' S' ' 326' ' ' VAL . 11.2 p -133.95 -173.04 3.14 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.442 -1.034 . . . . 27.98 109.967 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.58 -56.16 25.44 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.191 -0.943 . . . . 28.1 109.927 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' S' S ' 319' ' ' SER . . . . . . . . . . . . . 1.2 m -59.9 -41.69 92.2 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.382 -0.824 . . . . 37.0 109.664 179.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' S' S ' 320' ' ' ARG . . . . . . . . . . . . . 12.1 mtm180 -111.69 79.85 2.63 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.445 -0.784 . . . . 52.07 109.652 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' S' S ' 321' ' ' PRO . . . . . 0.814 ' CG ' ' O ' ' S' ' 386' ' ' GLU . 43.9 Cg_endo -71.44 171.6 15.88 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.83 1.437 . . . . 38.29 110.937 -179.47 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 322' ' ' SER . . . . . 0.444 ' HB2' ' O ' ' S' ' 321' ' ' PRO . 41.3 t 178.58 -148.13 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 108.924 -0.769 . . . . 38.84 108.924 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 323' ' ' GLU . . . . . 0.829 ' HG2' HG23 ' S' ' 313' ' ' THR . 6.7 tp10 -62.82 -40.33 97.05 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.946 -1.096 . . . . 40.7 109.682 179.325 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 324' ' ' VAL . . . . . 0.668 ' HB ' HD13 ' S' ' 315' ' ' ILE . 73.5 t -141.28 134.97 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.427 -0.796 . . . . 20.34 109.507 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 325' ' ' CYS . . . . . 0.46 ' HB2' ' CE1' ' S' ' 380' ' ' PHE . 11.3 m -125.98 172.13 10.2 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.385 -0.822 . . . . 30.63 110.827 -179.049 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 326' ' ' VAL . . . . . 0.644 HG12 HG22 ' S' ' 379' ' ' VAL . 34.5 m -135.41 142.25 40.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 109.204 -0.665 . . . . 23.9 109.204 179.139 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 327' ' ' VAL . . . . . 0.593 HG11 ' O ' ' S' ' 377' ' ' VAL . 34.5 m -56.34 125.04 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.054 -1.029 . . . . 19.48 110.43 -179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 328' ' ' ASP . . . . . . . . . . . . . 55.6 p-10 -119.43 11.59 12.2 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.451 -0.781 . . . . 26.43 110.411 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' S' S ' 329' ' ' GLY . . . . . . . . . . . . . . . 119.58 2.26 13.2 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 110.088 -1.205 . . . . 31.24 110.088 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' S' S ' 330' ' ' THR . . . . . . . . . . . . . 78.3 m -93.02 129.99 38.76 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.064 -1.256 . . . . 30.05 110.183 179.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' S' S ' 331' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -56.8 111.54 1.05 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.217 -0.927 . . . . 37.26 109.935 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' S' S ' 332' ' ' MET . . . . . . . . . . . . . 87.9 mmm -94.04 162.57 13.83 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.212 -0.93 . . . . 26.23 110.347 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' S' S ' 333' ' ' CYS . . . . . . . . . . . . . 24.9 m -137.3 150.07 47.52 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.483 -0.761 . . . . 23.56 109.961 179.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' S' S ' 334' ' ' LEU . . . . . 0.564 HD11 ' O ' ' S' ' 372' ' ' PRO . 0.1 OUTLIER -52.57 -24.93 9.16 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.334 -0.854 . . . . 28.93 110.457 179.883 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' S' S ' 335' ' ' ALA . . . . . . . . . . . . . . . -88.95 14.39 10.61 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.379 -0.826 . . . . 15.76 110.977 -179.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' S' S ' 336' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -100.51 -17.23 17.23 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.149 -0.969 . . . . 34.92 110.137 179.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' S' S ' 337' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -152.37 170.86 19.04 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.418 -0.801 . . . . 19.03 110.055 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' S' S ' 338' ' ' HIS . . . . . 0.401 ' HB3' ' CZ ' ' S' ' 383' ' ' TYR . 13.5 p80 -120.7 10.38 10.99 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.318 -0.864 . . . . 18.82 110.465 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 339' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' S' ' 352' ' ' ALA . . . -176.04 155.17 1.54 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.274 -0.891 . . . . 17.18 110.09 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 340' ' ' GLY . . . . . 0.404 ' CA ' ' O ' ' S' ' 379' ' ' VAL . . . 160.87 173.11 29.07 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 110.013 -1.235 . . . . 18.33 110.013 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 341' ' ' ILE . . . . . . . . . . . . . 83.9 mt -88.84 138.14 19.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.498 -1.001 . . . . 18.6 109.819 179.621 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' S' S ' 342' ' ' PHE . . . . . 0.494 ' CE2' ' HB3' ' S' ' 352' ' ' ALA . 70.0 m-85 -120.99 -178.48 3.76 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.299 -0.875 . . . . 23.44 110.453 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 343' ' ' LEU . . . . . 0.512 HD11 HD21 ' R' ' 200' ' ' LEU . 0.5 OUTLIER -116.8 93.4 4.19 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.408 -0.807 . . . . 35.59 110.002 179.955 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' S' S ' 344' ' ' LYS . . . . . 0.407 ' O ' ' HB3' ' S' ' 348' ' ' HIS . 0.3 OUTLIER -80.85 125.02 29.58 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.26 -0.9 . . . . 38.34 110.109 179.993 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' S' S ' 345' ' ' GLY . . . . . . . . . . . . . . . 62.77 -130.87 43.13 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 108.821 -1.711 . . . . 53.46 108.821 -179.446 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' S' S ' 346' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -132.68 150.84 52.1 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.326 -1.102 . . . . 70.91 110.037 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' S' S ' 347' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 53.27 35.39 19.98 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.353 -0.842 . . . . 47.32 110.433 179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' S' S ' 348' ' ' HIS . . . . . 0.407 ' HB3' ' O ' ' S' ' 344' ' ' LYS . 46.5 t60 -150.08 155.94 40.76 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.329 -0.857 . . . . 41.72 110.303 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 349' ' ' ALA . . . . . 0.459 ' C ' HG13 ' S' ' 350' ' ' VAL . . . -149.88 151.25 33.15 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.326 -0.859 . . . . 22.91 110.441 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 350' ' ' VAL . . . . . 0.459 HG13 ' C ' ' S' ' 349' ' ' ALA . 34.6 m -149.1 169.64 2.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.514 -0.741 . . . . 21.09 110.023 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 351' ' ' PHE . . . . . 0.501 ' CD2' ' HB3' ' S' ' 258' ' ' GLN . 10.7 t80 -105.39 143.62 33.3 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.155 -0.966 . . . . 25.03 110.713 -179.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 352' ' ' ALA . . . . . 0.494 ' HB3' ' CE2' ' S' ' 342' ' ' PHE . . . -147.79 151.71 36.47 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.667 -0.645 . . . . 23.81 109.715 179.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 353' ' ' CYS . . . . . . . . . . . . . 26.3 p -153.25 164.91 37.24 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.368 -0.832 . . . . 25.66 110.343 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' S' S ' 354' ' ' VAL . . . . . 0.543 HG22 ' CE2' ' S' ' 359' ' ' TRP . 56.5 t -76.05 118.53 22.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.361 -0.837 . . . . 34.27 109.98 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 355' ' ' THR . . . . . 0.418 ' HA ' ' O ' ' S' ' 232' ' ' THR . 52.7 p -117.86 175.14 5.8 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.251 -0.905 . . . . 25.49 110.332 179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 356' ' ' SER . . . . . . . . . . . . . 62.0 p -62.18 -17.72 58.89 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.345 -0.847 . . . . 31.24 110.71 -179.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' S' S ' 357' ' ' ASN . . . . . . . . . . . . . 45.9 m-20 -107.01 14.22 26.66 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.201 -0.937 . . . . 28.61 110.611 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' S' S ' 358' ' ' GLY . . . . . . . . . . . . . . . 111.91 -152.98 17.58 Favored Glycine 0 N--CA 1.492 2.41 0 N-CA-C 109.984 -1.246 . . . . 22.01 109.984 179.421 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' S' S ' 359' ' ' TRP . . . . . 0.543 ' CE2' HG22 ' S' ' 354' ' ' VAL . 15.4 m95 -91.24 116.68 29.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.371 -1.076 . . . . 25.54 110.17 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 360' ' ' TYR . . . . . 0.413 ' HA ' ' HA ' ' S' ' 369' ' ' PRO . 1.3 m-85 -103.47 165.79 10.82 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.327 -0.858 . . . . 40.53 110.107 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 361' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' S' ' 351' ' ' PHE . . . -140.06 130.11 24.9 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.462 -0.774 . . . . 18.04 110.271 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 362' ' ' ILE . . . . . . . . . . . . . 88.8 mt -95.6 83.67 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.283 -0.885 . . . . 15.64 110.062 179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' S' S ' 363' ' ' ASP . . . . . 0.418 ' O ' ' N ' ' S' ' 365' ' ' GLU . 11.9 t0 -75.25 94.47 3.0 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.298 -0.876 . . . . 35.03 110.213 -179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 364' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 53.88 -89.28 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.547 -0.721 . . . . 46.72 110.621 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' S' S ' 365' ' ' GLU . . . . . 0.418 ' N ' ' O ' ' S' ' 363' ' ' ASP . 23.8 mt-10 -122.7 19.15 10.3 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.091 -1.006 . . . . 56.2 110.267 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 366' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -117.97 124.99 49.54 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.17 -0.957 . . . . 51.02 110.421 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' S' S ' 367' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -107.0 127.08 53.13 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.435 -0.791 . . . . 37.59 110.133 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' S' S ' 368' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -165.47 159.46 13.82 Favored Pre-proline 0 N--CA 1.493 1.72 0 O-C-N 121.229 -0.919 . . . . 31.47 110.414 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' S' S ' 369' ' ' PRO . . . . . 0.413 ' HA ' ' HA ' ' S' ' 360' ' ' TYR . 46.8 Cg_endo -72.68 139.62 31.19 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 O-C-N 123.903 1.475 . . . . 28.85 110.505 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 370' ' ' TRP . . . . . . . . . . . . . 67.6 t90 -167.21 113.49 0.76 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.405 -0.81 . . . . 26.94 110.008 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' S' S ' 371' ' ' THR . . . . . . . . . . . . . 59.8 m -74.78 113.08 20.99 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.317 -0.864 . . . . 20.19 110.025 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' S' S ' 372' ' ' PRO . . . . . 0.564 ' O ' HD11 ' S' ' 334' ' ' LEU . 48.0 Cg_endo -73.56 157.13 49.17 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.61 1.321 . . . . 28.68 110.609 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 373' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -90.58 147.14 35.73 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.444 -0.785 . . . . 35.72 109.922 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' S' S ' 374' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -76.0 -6.3 17.23 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 O-C-N 123.632 1.332 . . . . 30.89 110.502 179.883 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' S' S ' 375' ' ' SER . . . . . . . . . . . . . 68.6 p -104.36 -16.94 14.99 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.207 -0.933 . . . . 29.41 110.436 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' S' S ' 376' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -106.55 43.1 1.18 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.348 -0.845 . . . . 32.89 110.198 -179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' S' S ' 377' ' ' VAL . . . . . 0.593 ' O ' HG11 ' S' ' 327' ' ' VAL . 7.3 p -114.68 147.3 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.297 -0.877 . . . . 24.33 110.207 -179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 378' ' ' LEU . . . . . . . . . . . . . 52.7 mt -116.02 -58.0 2.15 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.354 -0.841 . . . . 24.37 109.626 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' S' S ' 379' ' ' VAL . . . . . 0.644 HG22 HG12 ' S' ' 326' ' ' VAL . 61.2 t -120.66 132.42 70.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.418 -0.801 . . . . 18.02 109.456 179.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 380' ' ' PHE . . . . . 0.46 ' CE1' ' HB2' ' S' ' 325' ' ' CYS . 14.4 p90 -142.59 173.89 11.13 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.399 -0.813 . . . . 29.35 110.614 -179.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 381' ' ' VAL . . . . . . . . . . . . . 57.7 t -120.01 107.29 40.06 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.523 -0.735 . . . . 16.34 109.453 179.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' S' S ' 382' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -71.2 145.62 49.4 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 O-C-N 123.611 1.322 . . . . 20.94 110.786 -179.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' S' S ' 383' ' ' TYR . . . . . 0.401 ' CZ ' ' HB3' ' S' ' 338' ' ' HIS . 88.4 m-85 -61.1 -53.47 56.72 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.323 -0.861 . . . . 28.93 109.877 179.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 384' ' ' ASP . . . . . 0.447 ' C ' ' H ' ' S' ' 386' ' ' GLU . 1.5 t70 -107.93 130.93 55.0 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.356 -0.84 . . . . 47.03 110.357 -176.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 385' ' ' GLN . . . . . 0.433 ' O ' ' C ' ' S' ' 386' ' ' GLU . 6.2 pt20 -66.35 5.5 0.55 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.437 -0.789 . . . . 46.69 110.281 177.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 386' ' ' GLU . . . . . 0.814 ' O ' ' CG ' ' S' ' 321' ' ' PRO . 14.7 pt-20 -42.37 161.38 0.17 Allowed Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.319 -0.863 . . . . 50.25 109.576 179.447 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 387' ' ' PRO . . . . . 0.55 ' O ' ' C ' ' S' ' 388' ' ' LEU . 37.9 Cg_endo -66.45 -12.51 36.01 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 123.725 1.381 . . . . 34.39 110.576 -177.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 388' ' ' LEU . . . . . 0.56 ' O ' ' CB ' ' S' ' 389' ' ' ASN . 1.9 tt 31.89 78.91 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.443 -0.785 . . . . 38.01 110.09 -179.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 389' ' ' ASN . . . . . 0.56 ' CB ' ' O ' ' S' ' 388' ' ' LEU . 6.2 t-20 73.75 169.23 0.3 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.343 -0.848 . . . . 45.82 110.079 -179.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 390' ' ' GLY . . . . . 0.553 ' O ' ' HB2' ' S' ' 391' ' ' GLU . . . 151.18 -81.18 0.19 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.668 -1.373 . . . . 33.46 109.668 -179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 391' ' ' GLU . . . . . 0.553 ' HB2' ' O ' ' S' ' 390' ' ' GLY . 17.4 mt-10 65.53 -64.46 0.19 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.399 -1.06 . . . . 56.58 110.104 -179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 392' ' ' TRP . . . . . 0.508 ' N ' ' O ' ' S' ' 390' ' ' GLY . 33.9 p-90 -53.54 -22.25 7.94 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.292 -0.88 . . . . 31.43 110.361 179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 393' ' ' LYS . . . . . 0.477 ' O ' HG12 ' S' ' 396' ' ' VAL . 0.1 OUTLIER -46.32 -52.61 12.42 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.271 -0.893 . . . . 39.42 110.381 -179.989 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' S' S ' 394' ' ' ALA . . . . . 0.558 ' O ' ' CD ' ' S' ' 398' ' ' ARG . . . -76.02 -38.28 57.43 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.25 -0.906 . . . . 34.33 110.107 179.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 395' ' ' LYS . . . . . 0.609 ' HB3' ' CD1' ' R' ' 143' ' ' LEU . 4.7 mmmm -41.87 -51.33 4.32 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.456 -0.777 . . . . 60.09 110.26 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 396' ' ' VAL . . . . . 0.81 HG21 ' HB3' ' R' ' 101' ' ' ALA . 7.3 p -69.08 -53.36 26.19 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.342 -0.849 . . . . 35.5 110.56 179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 397' ' ' GLN . . . . . 0.694 ' N ' HG13 ' S' ' 396' ' ' VAL . 14.2 tt0 -78.16 58.38 2.02 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.142 -0.974 . . . . 49.96 110.707 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' S' S ' 398' ' ' ARG . . . . . 0.751 ' CB ' ' HA ' ' R' ' 147' ' ' GLU . 0.0 OUTLIER -119.12 -3.86 10.59 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.231 -0.918 . . . . 43.42 110.679 -178.817 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' S' S ' 399' ' ' LYS . . . . . 0.829 ' CB ' ' HA3' ' R' ' 97' ' ' GLY . 0.3 OUTLIER 41.56 -150.48 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.421 -0.8 . . . . 55.31 110.127 178.782 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' S' S ' 400' ' ' LEU . . . . . 0.902 HD12 ' CE1' ' R' ' 148' ' ' HIS . 0.0 OUTLIER -120.31 -43.56 2.51 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.399 -0.813 . . . . 41.03 110.286 179.341 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' S' S ' 401' ' ' LYS . . . . . 0.857 ' N ' HD23 ' S' ' 400' ' ' LEU . 4.3 tttt . . . . . 0 N--CA 1.493 1.677 0 O-C-N 121.352 -0.843 . . . . 61.97 110.194 -179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' R' R ' 29' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.193 0.521 . . . . 32.14 110.255 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' R' R ' 30' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -96.34 141.16 30.0 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.367 -0.833 . . . . 43.36 110.212 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' R' R ' 31' ' ' LEU . . . . . . . . . . . . . 65.5 mt -134.88 140.63 45.94 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.337 -0.852 . . . . 22.93 110.269 179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' R' R ' 32' ' ' THR . . . . . . . . . . . . . 70.6 m -87.61 110.64 20.53 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.33 -0.856 . . . . 22.34 109.9 179.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' R' R ' 33' ' ' LEU . . . . . 0.595 HD22 ' CE2' ' R' ' 62' ' ' TYR . 80.1 mt -62.45 -172.79 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.307 -0.87 . . . . 21.39 110.202 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 34' ' ' TYR . . . . . . . . . . . . . 36.7 p90 -74.55 -29.54 61.4 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.355 -0.841 . . . . 34.4 110.388 -179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' R' R ' 35' ' ' ASN . . . . . . . . . . . . . 48.3 p30 -77.68 -1.87 33.25 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.348 -0.845 . . . . 30.28 110.637 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' R' R ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.21 -16.56 59.44 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.733 -1.347 . . . . 36.25 109.733 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' R' R ' 37' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -59.04 161.77 4.83 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.357 -1.084 . . . . 53.8 110.315 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' R' R ' 38' ' ' LYS . . . . . . . . . . . . . 56.9 mttt -117.78 135.81 53.81 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.426 -0.796 . . . . 49.91 110.132 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' R' R ' 39' ' ' LYS . . . . . 0.404 ' HG2' ' CZ ' ' R' ' 41' ' ' PHE . 8.1 ttmt -138.76 143.68 39.11 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.468 -0.77 . . . . 35.69 110.228 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 40' ' ' THR . . . . . . . . . . . . . 23.6 m -102.57 127.98 49.42 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.41 -0.806 . . . . 34.84 110.221 -179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' R' R ' 41' ' ' PHE . . . . . 0.404 ' CZ ' ' HG2' ' R' ' 39' ' ' LYS . 96.6 m-85 -113.02 132.75 55.26 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.442 -0.786 . . . . 34.42 110.11 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 42' ' ' TYR . . . . . . . . . . . . . 38.7 m-85 -93.3 140.85 29.09 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.336 -0.852 . . . . 51.46 110.284 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' R' R ' 43' ' ' SER . . . . . . . . . . . . . 54.3 m -70.82 141.91 51.32 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.412 -0.805 . . . . 41.84 110.217 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' R' R ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.71 125.4 29.56 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.303 -0.873 . . . . 33.82 110.012 179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 45' ' ' PRO . . . . . 0.423 ' HG2' ' ND2' ' R' ' 77' ' ' ASN . 46.7 Cg_endo -72.12 151.09 55.01 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.59 1.31 . . . . 30.27 110.655 -179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 46' ' ' ASN . . . . . 0.483 ' ND2' HD22 ' S' ' 400' ' ' LEU . 52.0 t-20 -124.34 109.9 13.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.447 -0.783 . . . . 35.1 110.054 179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 47' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -120.28 -34.88 3.56 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.311 -0.868 . . . . 42.81 110.54 -179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' R' R ' 48' ' ' HIS . . . . . 0.441 ' NE2' HD11 ' R' ' 80' ' ' LEU . 73.3 m80 -105.72 45.17 0.98 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.262 -0.899 . . . . 49.97 110.211 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 49' ' ' ASP . . . . . 0.495 ' OD1' ' CB ' ' S' ' 401' ' ' LYS . 37.7 m-20 50.25 34.69 9.14 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.329 -0.857 . . . . 61.32 110.186 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 50' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -86.28 43.82 1.09 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.333 -0.854 . . . . 51.5 110.623 -179.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' R' R ' 51' ' ' ALA . . . . . 0.528 ' HB2' ' HB2' ' S' ' 400' ' ' LEU . . . -66.14 -46.08 78.75 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.225 -0.922 . . . . 38.77 109.539 179.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 52' ' ' TRP . . . . . 0.484 ' CD2' ' N ' ' R' ' 53' ' ' LEU . 68.2 p-90 -58.41 -38.44 77.39 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.413 -0.805 . . . . 26.24 110.002 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 53' ' ' LEU . . . . . 0.484 ' N ' ' CD2' ' R' ' 52' ' ' TRP . 23.1 tp -66.73 -46.65 74.79 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.351 -0.843 . . . . 26.75 109.984 179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 54' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -55.23 -41.65 72.36 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.354 -0.841 . . . . 35.02 110.113 179.884 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' R' R ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.14 -46.1 91.92 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.377 -0.827 . . . . 24.47 110.163 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' R' R ' 56' ' ' ILE . . . . . 0.432 HG12 HD11 ' R' ' 104' ' ' ILE . 76.1 mt -62.18 -42.23 94.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.332 -0.855 . . . . 26.03 109.888 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 57' ' ' LEU . . . . . . . . . . . . . 22.5 mt -60.36 -45.56 93.07 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.3 -0.875 . . . . 26.77 109.702 179.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' R' R ' 58' ' ' GLN . . . . . . . . . . . . . 57.7 mm-40 -63.91 -46.51 84.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.476 -0.765 . . . . 22.32 109.59 179.47 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' R' R ' 59' ' ' LEU . . . . . 0.431 ' HA ' ' HE2' ' R' ' 151' ' ' PHE . 24.0 tp -61.45 -37.75 84.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.291 -0.881 . . . . 20.55 109.396 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 60' ' ' PHE . . . . . 0.528 ' CE2' HD21 ' R' ' 111' ' ' LEU . 2.8 m-85 -61.13 -44.75 96.85 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.628 -0.67 . . . . 20.08 109.866 179.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 61' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -63.11 -36.19 82.78 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.49 -0.756 . . . . 18.8 110.442 -179.783 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' R' R ' 62' ' ' TYR . . . . . 0.595 ' CE2' HD22 ' R' ' 33' ' ' LEU . 9.2 t80 -63.04 -41.8 99.58 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.271 -0.893 . . . . 26.45 110.26 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 63' ' ' VAL . . . . . 0.406 ' H ' HG22 ' R' ' 63' ' ' VAL . 30.0 m -93.34 20.33 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.263 -0.898 . . . . 29.75 110.307 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 64' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 52.96 75.5 0.24 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.328 -0.857 . . . . 35.52 110.51 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' R' R ' 65' ' ' GLU . . . . . 0.444 ' HG2' ' CD2' ' R' ' 60' ' ' PHE . 14.3 tp10 -116.17 104.09 52.5 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.423 -0.798 . . . . 29.89 109.944 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 66' ' ' PRO . . . . . 0.479 ' HA ' ' HB2' ' R' ' 69' ' ' ASP . 47.9 Cg_endo -73.46 -5.92 17.92 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.79 1.416 . . . . 21.37 111.147 -179.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 67' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -52.1 -61.6 2.16 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.038 -1.039 . . . . 23.85 110.331 -179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 68' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -98.07 36.57 1.55 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.32 -0.862 . . . . 28.07 110.466 -179.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' R' R ' 69' ' ' ASP . . . . . 0.479 ' HB2' ' HA ' ' R' ' 66' ' ' PRO . 11.7 t0 -72.33 -33.27 67.21 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.342 -0.849 . . . . 43.76 110.155 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 70' ' ' TRP . . . . . 0.475 ' CE2' ' CG2' ' R' ' 71' ' ' VAL . 47.7 p-90 -73.42 -3.91 30.33 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.334 -0.854 . . . . 33.06 110.717 -179.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 71' ' ' VAL . . . . . 0.556 HG11 ' HB2' ' R' ' 82' ' ' ALA . 40.8 t -109.8 -27.47 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.112 -0.992 . . . . 31.7 109.659 179.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 72' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -86.56 -48.79 8.05 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.407 -0.808 . . . . 33.58 110.353 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' R' R ' 73' ' ' SER . . . . . . . . . . . . . 69.8 m -89.75 51.06 2.0 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.394 -0.816 . . . . 50.82 110.351 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' R' R ' 74' ' ' SER . . . . . . . . . . . . . 15.9 t -125.95 138.21 31.63 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.278 -0.889 . . . . 34.74 110.24 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -73.24 -25.01 16.19 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 O-C-N 123.728 1.383 . . . . 35.7 110.373 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' R' R ' 76' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -91.66 153.12 19.9 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.383 -0.823 . . . . 66.48 110.428 -179.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' R' R ' 77' ' ' ASN . . . . . 0.423 ' ND2' ' HG2' ' R' ' 45' ' ' PRO . 22.3 t-20 -81.4 95.24 6.98 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.368 -0.832 . . . . 46.72 110.117 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 78' ' ' LEU . . . . . . . . . . . . . 96.4 mt -96.45 28.0 3.53 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.381 -0.825 . . . . 37.55 110.182 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' R' R ' 79' ' ' THR . . . . . . . . . . . . . 29.6 m -56.2 -54.64 42.82 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.337 -0.852 . . . . 37.36 110.295 -179.814 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' R' R ' 80' ' ' LEU . . . . . 0.604 ' HA ' HD12 ' R' ' 83' ' ' ILE . 15.8 mt -60.95 -23.14 65.07 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.348 -0.845 . . . . 35.83 110.51 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 81' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -79.52 -39.14 32.68 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.133 -0.98 . . . . 44.03 110.381 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' R' R ' 82' ' ' ALA . . . . . 0.556 ' HB2' HG11 ' R' ' 71' ' ' VAL . . . -69.4 -28.7 66.4 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.26 -0.9 . . . . 32.54 110.303 179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 83' ' ' ILE . . . . . 0.604 HD12 ' HA ' ' R' ' 80' ' ' LEU . 77.7 mt -70.09 -46.06 73.99 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.253 -0.905 . . . . 32.02 110.342 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 84' ' ' LYS . . . . . . . . . . . . . 36.0 tttm -55.22 -52.06 64.57 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.179 -0.951 . . . . 34.09 110.596 -179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' R' R ' 85' ' ' GLN . . . . . 0.532 ' HG2' HD12 ' R' ' 89' ' ' LEU . 31.9 tt0 -54.8 -46.86 74.54 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.191 -0.943 . . . . 25.94 110.305 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 86' ' ' LEU . . . . . . . . . . . . . 24.2 mt -58.71 -43.76 90.16 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.267 -0.896 . . . . 16.2 109.957 179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' R' R ' 87' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -65.36 -35.27 80.45 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.393 -0.817 . . . . 49.09 110.305 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' R' R ' 88' ' ' ASP . . . . . . . . . . . . . 31.1 m-20 -78.4 -19.06 54.09 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.284 -0.885 . . . . 28.61 110.509 -179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' R' R ' 89' ' ' LEU . . . . . 0.532 HD12 ' HG2' ' R' ' 85' ' ' GLN . 32.4 mt -96.16 -29.43 14.06 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.225 -0.922 . . . . 26.16 110.2 179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 90' ' ' THR . . . . . . . . . . . . . 59.9 p -105.77 -34.58 7.64 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.3 -0.875 . . . . 33.33 109.724 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' R' R ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.85 16.1 58.6 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.821 -1.312 . . . . 31.13 109.821 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' R' R ' 92' ' ' LEU . . . . . . . . . . . . . 97.1 mt -100.11 155.19 17.87 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.169 -1.195 . . . . 42.52 110.246 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' R' R ' 93' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -86.15 91.59 8.48 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.471 -0.768 . . . . 68.46 110.006 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' R' R ' 94' ' ' LEU . . . . . 0.457 ' HB3' ' CZ2' ' R' ' 52' ' ' TRP . 48.2 mt -99.41 53.08 0.95 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.176 -0.952 . . . . 44.63 110.364 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 95' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.52 -38.7 6.36 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.226 -0.921 . . . . 67.16 110.376 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 96' ' ' GLU . . . . . . . . . . . . . 24.6 mt-10 -113.85 44.11 1.69 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.332 -0.855 . . . . 67.02 110.325 -179.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' R' R ' 97' ' ' GLY . . . . . 0.652 ' HA3' ' CB ' ' S' ' 399' ' ' LYS . . . 99.24 150.83 25.99 Favored Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.599 -1.401 . . . . 49.48 109.599 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 98' ' ' GLY . . . . . . . . . . . . . . . -166.27 160.03 33.46 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.267 -1.533 . . . . 36.57 109.267 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' R' R ' 99' ' ' PRO . . . . . 0.929 ' CB ' HG22 ' S' ' 396' ' ' VAL . 45.5 Cg_endo -72.57 121.11 7.14 Favored 'Trans proline' 0 C--N 1.309 -1.513 0 O-C-N 123.74 1.39 . . . . 30.41 110.462 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 100' ' ' PRO . . . . . 0.413 ' HA ' HD11 ' R' ' 56' ' ' ILE . 45.7 Cg_endo -72.32 -31.52 11.46 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 O-C-N 123.637 1.335 . . . . 29.94 110.545 179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 101' ' ' ALA . . . . . 0.475 ' HB2' ' HB3' ' R' ' 178' ' ' LEU . . . -70.07 -38.49 75.77 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.296 -0.878 . . . . 23.64 110.184 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 102' ' ' LEU . . . . . 0.427 HD23 HD21 ' R' ' 106' ' ' ASN . 0.1 OUTLIER -72.71 -40.66 66.0 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.335 -0.853 . . . . 20.31 110.411 -179.71 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' R' R ' 103' ' ' VAL . . . . . 0.791 HG23 ' O ' ' R' ' 99' ' ' PRO . 63.3 t -58.15 -40.13 76.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.227 -0.92 . . . . 16.33 109.986 179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 104' ' ' ILE . . . . . 0.432 HD11 HG12 ' R' ' 56' ' ' ILE . 82.0 mt -71.72 -30.47 38.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.374 -0.829 . . . . 24.77 109.951 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 105' ' ' TRP . . . . . 0.462 ' O ' ' HD3' ' R' ' 108' ' ' LYS . 70.6 t-105 -82.44 0.81 40.5 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.304 -0.873 . . . . 23.28 110.273 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 106' ' ' ASN . . . . . 0.427 HD21 HD23 ' R' ' 102' ' ' LEU . 6.9 m-80 -105.05 -10.37 17.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.171 -0.956 . . . . 28.26 110.146 179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 107' ' ' ILE . . . . . . . . . . . . . 36.8 pt -126.82 34.9 1.33 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.184 -0.947 . . . . 18.77 110.076 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' R' R ' 108' ' ' LYS . . . . . 0.5 ' HG2' ' HB ' ' R' ' 115' ' ' ILE . 9.2 mtpp -60.97 -48.5 81.52 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.516 -0.74 . . . . 42.5 110.06 179.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 109' ' ' HIS . . . . . 0.446 ' CD2' ' HG ' ' R' ' 110' ' ' LEU . 50.8 p-80 -66.02 -12.87 58.26 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.511 -0.743 . . . . 20.07 110.698 -179.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 110' ' ' LEU . . . . . 0.446 ' HG ' ' CD2' ' R' ' 109' ' ' HIS . 80.5 mt -94.71 -17.38 22.27 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.042 -1.036 . . . . 15.69 110.194 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 111' ' ' LEU . . . . . 0.528 HD21 ' CE2' ' R' ' 60' ' ' PHE . 10.3 mt -94.09 144.17 25.72 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.368 -0.832 . . . . 25.39 111.016 -179.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 112' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -77.71 -17.35 57.71 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.552 -0.717 . . . . 53.48 109.835 179.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' R' R ' 113' ' ' THR . . . . . 0.458 HG22 ' N ' ' R' ' 114' ' ' GLY . 59.6 m -83.71 166.71 17.85 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.347 -0.846 . . . . 14.8 110.29 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 114' ' ' GLY . . . . . 0.458 ' N ' HG22 ' R' ' 113' ' ' THR . . . -97.98 127.16 9.13 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.947 -1.261 . . . . 16.14 109.947 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 115' ' ' ILE . . . . . 0.576 HD13 ' HB ' ' R' ' 124' ' ' VAL . 47.7 mm -109.17 139.36 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.525 -0.985 . . . . 13.46 109.725 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 116' ' ' GLY . . . . . . . . . . . . . . . -152.72 -155.87 7.29 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.933 -1.267 . . . . 23.9 109.933 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' R' R ' 117' ' ' THR . . . . . 0.529 HG22 ' CG2' ' R' ' 126' ' ' VAL . 18.9 p -135.03 -171.36 2.78 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.484 -1.01 . . . . 27.37 110.072 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 118' ' ' ALA . . . . . 0.445 ' HB3' ' OD1' ' R' ' 128' ' ' ASP . . . -56.6 -58.04 9.77 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.297 -0.877 . . . . 18.76 110.064 179.776 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 119' ' ' SER . . . . . 0.609 ' HB3' ' HB ' ' R' ' 196' ' ' VAL . 1.1 m -56.56 -40.56 75.37 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.266 -0.896 . . . . 32.35 109.787 179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 120' ' ' ARG . . . . . 0.419 ' NH1' ' CE2' ' S' ' 305' ' ' TRP . 10.0 mtm180 -110.08 86.23 4.87 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.487 -0.758 . . . . 27.12 109.673 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 121' ' ' PRO . . . . . 0.483 ' HA ' ' SG ' ' R' ' 125' ' ' CYS . 44.3 Cg_endo -71.24 166.41 29.32 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.874 1.46 . . . . 22.68 111.03 -179.481 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 122' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' R' ' 121' ' ' PRO . 38.5 t 178.61 -161.64 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.61 -0.681 . . . . 22.99 109.513 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 123' ' ' GLU . . . . . 0.442 ' HG2' HG23 ' R' ' 113' ' ' THR . 2.3 tp10 -56.45 -39.95 74.0 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.211 -0.93 . . . . 36.18 109.762 179.574 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 124' ' ' VAL . . . . . 0.576 ' HB ' HD13 ' R' ' 115' ' ' ILE . 84.6 t -142.55 136.48 27.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.534 -0.729 . . . . 20.64 109.43 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 125' ' ' CYS . . . . . 0.483 ' SG ' ' HA ' ' R' ' 121' ' ' PRO . 82.9 m -140.31 168.2 20.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.161 -0.962 . . . . 22.8 111.136 -179.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 126' ' ' VAL . . . . . 0.728 HG12 HG22 ' R' ' 179' ' ' VAL . 35.9 m -122.74 159.8 25.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.714 -0.616 . . . . 21.24 109.664 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 127' ' ' VAL . . . . . 0.709 HG11 ' O ' ' R' ' 177' ' ' VAL . 30.7 m -70.86 141.82 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.293 -0.879 . . . . 19.77 110.657 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 128' ' ' ASP . . . . . 0.445 ' OD1' ' HB3' ' R' ' 118' ' ' ALA . 53.9 p-10 -137.73 19.38 2.87 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.327 -0.858 . . . . 29.21 110.687 179.893 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 129' ' ' GLY . . . . . . . . . . . . . . . 114.11 0.0 23.98 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.965 -1.112 . . . . 33.86 110.469 179.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' R' R ' 130' ' ' THR . . . . . . . . . . . . . 58.6 m -91.93 131.85 36.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.105 -1.233 . . . . 26.41 110.046 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -62.56 120.65 11.56 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.38 -0.825 . . . . 33.08 110.302 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' R' R ' 132' ' ' MET . . . . . 0.434 ' HE1' ' CE2' ' R' ' 180' ' ' PHE . 98.4 mmm -105.21 165.66 10.94 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.395 -0.816 . . . . 30.76 110.435 -179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 133' ' ' CYS . . . . . 0.411 ' HA ' ' HB3' ' R' ' 174' ' ' PRO . 32.5 m -141.17 158.12 44.33 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.493 -0.754 . . . . 27.0 109.969 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 134' ' ' LEU . . . . . 0.563 HD11 ' O ' ' R' ' 172' ' ' PRO . 0.1 OUTLIER -58.54 -19.68 39.82 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.347 -0.846 . . . . 33.9 110.444 -179.833 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' R' R ' 135' ' ' ALA . . . . . . . . . . . . . . . -92.72 8.2 40.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.182 -0.949 . . . . 19.37 110.882 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' R' R ' 136' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -93.76 -21.74 19.13 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.143 -0.973 . . . . 30.47 110.266 179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' R' R ' 137' ' ' PHE . . . . . . . . . . . . . 10.3 p90 -149.98 165.38 32.85 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.341 -0.85 . . . . 24.27 110.204 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' R' R ' 138' ' ' HIS . . . . . 0.434 ' HA ' HG23 ' R' ' 154' ' ' VAL . 15.1 p80 -117.87 15.2 14.33 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.398 -0.814 . . . . 20.91 110.404 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 139' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' R' ' 152' ' ' ALA . . . -177.23 152.35 0.86 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.198 -0.939 . . . . 15.69 110.184 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 140' ' ' GLY . . . . . 0.427 ' HA3' ' O ' ' R' ' 179' ' ' VAL . . . 161.81 175.15 32.53 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.928 -1.269 . . . . 23.76 109.928 179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 141' ' ' ILE . . . . . . . . . . . . . 83.7 mt -95.51 136.56 26.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.358 -1.084 . . . . 25.3 109.713 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' R' R ' 142' ' ' PHE . . . . . 0.576 ' CD2' ' HB2' ' R' ' 172' ' ' PRO . 83.0 m-85 -120.73 -172.52 2.4 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.375 -0.828 . . . . 30.24 110.528 -179.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 143' ' ' LEU . . . . . 0.777 HD11 ' O ' ' S' ' 395' ' ' LYS . 0.5 OUTLIER -119.86 77.73 1.26 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.417 -0.802 . . . . 32.8 110.289 -179.902 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' R' R ' 144' ' ' LYS . . . . . 0.471 ' HG3' ' CZ2' ' R' ' 170' ' ' TRP . 1.0 OUTLIER -69.5 76.82 0.41 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.437 -0.789 . . . . 49.18 109.676 179.575 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' R' R ' 145' ' ' GLY . . . . . 0.457 ' O ' HD22 ' R' ' 143' ' ' LEU . . . 104.48 179.24 24.86 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.203 -1.559 . . . . 53.87 109.203 -179.495 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 146' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -88.47 145.85 25.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.358 -1.083 . . . . 68.58 109.982 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' R' R ' 147' ' ' GLU . . . . . 0.622 ' O ' ' C ' ' S' ' 399' ' ' LYS . 10.9 mt-10 58.21 36.47 25.78 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.26 -0.9 . . . . 56.62 110.665 179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 148' ' ' HIS . . . . . 0.884 ' CE1' HD13 ' S' ' 400' ' ' LEU . 44.6 t60 -158.61 148.17 19.31 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.193 -0.942 . . . . 44.57 110.376 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 149' ' ' ALA . . . . . 0.508 ' HB3' ' NH1' ' S' ' 398' ' ' ARG . . . -150.29 146.92 27.06 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.427 -0.796 . . . . 33.54 110.078 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 150' ' ' VAL . . . . . . . . . . . . . 34.2 m -142.38 161.47 19.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.234 -0.916 . . . . 27.61 110.301 179.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' R' R ' 151' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' R' ' 152' ' ' ALA . 5.9 t80 -86.18 155.57 20.68 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.402 -0.811 . . . . 23.04 109.918 179.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 152' ' ' ALA . . . . . 0.537 ' N ' ' CD1' ' R' ' 151' ' ' PHE . . . -157.28 151.57 24.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.438 -0.789 . . . . 29.61 109.601 179.011 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 153' ' ' CYS . . . . . . . . . . . . . 26.7 p -154.28 173.61 15.93 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.268 -0.895 . . . . 22.75 110.407 -179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' R' R ' 154' ' ' VAL . . . . . 0.613 HG22 ' CE2' ' R' ' 159' ' ' TRP . 60.3 t -90.63 117.03 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.383 -0.823 . . . . 23.26 110.061 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 155' ' ' THR . . . . . . . . . . . . . 70.3 p -112.13 -176.62 2.97 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.356 -0.84 . . . . 17.88 110.041 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' R' R ' 156' ' ' SER . . . . . . . . . . . . . 78.5 p -75.92 -3.74 37.08 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.33 -0.856 . . . . 21.83 110.678 -179.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' R' R ' 157' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -118.3 10.51 12.83 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.207 -0.933 . . . . 36.54 110.652 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' R' R ' 158' ' ' GLY . . . . . . . . . . . . . . . 117.96 -162.58 13.06 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.559 -1.416 . . . . 31.74 109.559 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' R' R ' 159' ' ' TRP . . . . . 0.613 ' CE2' HG22 ' R' ' 154' ' ' VAL . 14.6 m95 -86.68 122.5 30.67 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.35 -1.088 . . . . 28.25 110.109 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 160' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -108.46 166.94 10.39 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.345 -0.847 . . . . 41.24 110.19 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' R' R ' 161' ' ' ALA . . . . . . . . . . . . . . . -143.18 123.5 13.84 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.403 -0.81 . . . . 27.4 110.151 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' R' R ' 162' ' ' ILE . . . . . . . . . . . . . 92.2 mt -87.63 81.11 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.373 -0.829 . . . . 24.27 110.078 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' R' R ' 163' ' ' ASP . . . . . 0.415 ' O ' ' N ' ' R' ' 165' ' ' GLU . 15.3 t0 -72.74 92.35 1.55 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.389 -0.819 . . . . 36.08 110.277 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 164' ' ' ASP . . . . . . . . . . . . . 73.0 m-20 54.06 -88.89 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.526 -0.734 . . . . 46.08 110.556 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' R' R ' 165' ' ' GLU . . . . . 0.415 ' N ' ' O ' ' R' ' 163' ' ' ASP . 29.6 mt-10 -124.72 35.82 4.72 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.151 -0.968 . . . . 50.94 110.148 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 166' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -135.67 117.36 14.99 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.362 -0.836 . . . . 47.28 110.353 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' R' R ' 167' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -101.12 119.96 39.51 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.401 -0.812 . . . . 40.47 110.083 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' R' R ' 168' ' ' TYR . . . . . . . . . . . . . 25.5 p90 -157.51 158.61 30.74 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.25 -0.906 . . . . 30.21 110.466 179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' R' R ' 169' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.81 133.07 19.48 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.928 1.488 . . . . 32.76 110.5 -179.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' R' R ' 170' ' ' TRP . . . . . 0.471 ' CZ2' ' HG3' ' R' ' 144' ' ' LYS . 67.1 t90 -159.83 119.35 2.88 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.34 -0.85 . . . . 32.79 109.965 179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 171' ' ' THR . . . . . . . . . . . . . 46.9 m -81.09 112.58 33.91 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.431 -0.793 . . . . 36.92 110.155 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' R' R ' 172' ' ' PRO . . . . . 0.576 ' HB2' ' CD2' ' R' ' 142' ' ' PHE . 47.0 Cg_endo -73.67 158.76 46.79 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.622 1.328 . . . . 33.54 110.548 -179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 173' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -88.91 145.03 33.81 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.324 -0.86 . . . . 45.76 109.86 179.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' R' R ' 174' ' ' PRO . . . . . 0.411 ' HB3' ' HA ' ' R' ' 133' ' ' CYS . 45.2 Cg_endo -71.85 -10.28 26.07 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 O-C-N 123.71 1.374 . . . . 29.63 110.41 179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 175' ' ' SER . . . . . . . . . . . . . 53.0 p -103.44 -17.64 15.15 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.348 -0.845 . . . . 35.7 110.366 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' R' R ' 176' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -103.51 43.29 1.09 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.268 -0.895 . . . . 39.65 110.418 -179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' R' R ' 177' ' ' VAL . . . . . 0.709 ' O ' HG11 ' R' ' 127' ' ' VAL . 10.7 p -117.72 127.06 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.3 -0.875 . . . . 20.61 110.094 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 178' ' ' LEU . . . . . 0.475 ' HB3' ' HB2' ' R' ' 101' ' ' ALA . 46.2 mt -91.42 -61.3 1.68 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.349 -0.845 . . . . 15.58 109.392 179.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 179' ' ' VAL . . . . . 0.728 HG22 HG12 ' R' ' 126' ' ' VAL . 68.6 t -114.64 144.76 21.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.561 -0.712 . . . . 17.4 109.384 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 180' ' ' PHE . . . . . 0.434 ' CE2' ' HE1' ' R' ' 132' ' ' MET . 43.6 p90 -152.15 163.36 39.54 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.197 -0.94 . . . . 20.16 110.63 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 181' ' ' VAL . . . . . . . . . . . . . 66.2 t -113.17 111.44 50.27 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.375 -0.828 . . . . 17.69 109.836 179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' R' R ' 182' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.03 149.49 52.84 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.532 1.28 . . . . 17.81 110.409 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' R' R ' 183' ' ' TYR . . . . . 0.712 ' O ' ' C ' ' R' ' 184' ' ' ASP . 79.1 m-85 -59.03 175.52 0.28 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.458 -0.776 . . . . 28.01 110.504 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 184' ' ' ASP . . . . . 0.712 ' C ' ' O ' ' R' ' 183' ' ' TYR . 15.0 t70 -17.26 -81.98 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.353 -0.842 . . . . 58.64 110.313 -178.083 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 185' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 . . . . . 0 N--CA 1.503 2.2 0 CA-C-O 121.277 0.56 . . . . 80.42 111.791 179.553 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' R' R ' 193' ' ' LYS . . . . . . . . . . . . . 26.8 tptt . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 120.907 0.384 . . . . 49.5 110.145 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' R' R ' 194' ' ' ALA . . . . . 0.461 ' CB ' ' HA ' ' R' ' 119' ' ' SER . . . -174.45 -155.74 0.06 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.12 -0.988 . . . . 40.4 110.082 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 195' ' ' LYS . . . . . 0.602 ' CG ' HG23 ' R' ' 196' ' ' VAL . 0.0 OUTLIER -99.29 -27.05 13.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.427 -0.796 . . . . 34.6 110.266 179.925 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' R' R ' 196' ' ' VAL . . . . . 0.636 HG21 ' HA ' ' S' ' 328' ' ' ASP . 2.0 t -109.8 31.08 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.262 -0.899 . . . . 33.27 110.637 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 197' ' ' GLN . . . . . 0.469 ' HA ' HD11 ' S' ' 302' ' ' LEU . 0.1 OUTLIER -147.92 38.07 0.9 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.098 -1.001 . . . . 41.58 110.648 -179.949 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' R' R ' 198' ' ' ARG . . . . . . . . . . . . . 6.1 ptt-85 -129.85 149.67 51.48 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.135 -0.978 . . . . 38.65 110.227 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' R' R ' 199' ' ' LYS . . . . . 0.629 ' HA ' ' HD3' ' S' ' 299' ' ' PRO . 28.5 mtpt -84.02 103.98 13.71 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.462 -0.774 . . . . 36.77 109.992 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 200' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -85.98 -153.26 0.18 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.303 -0.873 . . . . 33.08 110.195 179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' R' R ' 201' ' ' LYS . . . . . 0.458 ' HA ' ' CA ' ' S' ' 297' ' ' GLY . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.675 0 O-C-N 121.348 -0.845 . . . . 44.32 110.304 -179.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 229' ' ' MET . . . . . . . . . . . . . 15.9 mmm . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.231 0.539 . . . . 51.83 110.228 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' S' S ' 230' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -97.31 142.76 28.8 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.292 -0.88 . . . . 54.13 110.133 -178.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' S' S ' 231' ' ' LEU . . . . . . . . . . . . . 68.3 mt -134.13 141.05 46.97 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.306 -0.871 . . . . 33.04 110.372 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' S' S ' 232' ' ' THR . . . . . 0.413 ' O ' ' HA ' ' S' ' 355' ' ' THR . 40.3 m -89.28 103.25 15.89 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.362 -0.836 . . . . 26.92 110.0 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 233' ' ' LEU . . . . . 0.667 HD22 ' CE2' ' S' ' 262' ' ' TYR . 79.7 mt -55.88 179.3 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.418 -0.801 . . . . 13.78 110.493 -179.794 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 234' ' ' TYR . . . . . 0.448 ' CG ' ' N ' ' S' ' 235' ' ' ASN . 35.5 p90 -64.96 -35.73 82.13 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.453 -0.779 . . . . 26.08 110.213 179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 235' ' ' ASN . . . . . 0.448 ' N ' ' CG ' ' S' ' 234' ' ' TYR . 50.7 p30 -74.29 -7.42 52.71 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.289 -0.882 . . . . 20.04 110.601 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 236' ' ' GLY . . . . . . . . . . . . . . . 95.74 -19.91 52.21 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.748 -1.341 . . . . 22.71 109.748 179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' S' S ' 237' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -53.08 145.74 12.65 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.243 -1.151 . . . . 35.44 110.165 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' S' S ' 238' ' ' LYS . . . . . . . . . . . . . 44.5 mttt -102.15 127.97 48.84 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.391 -0.818 . . . . 32.56 110.337 -179.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' S' S ' 239' ' ' LYS . . . . . 0.414 ' HG2' ' CZ ' ' S' ' 241' ' ' PHE . 9.0 ttmt -132.29 144.49 50.63 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.391 -0.818 . . . . 26.68 109.949 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 240' ' ' THR . . . . . . . . . . . . . 51.3 m -102.06 132.2 48.07 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.329 -0.857 . . . . 41.02 110.39 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' S' S ' 241' ' ' PHE . . . . . 0.414 ' CZ ' ' HG2' ' S' ' 239' ' ' LYS . 96.1 m-85 -117.88 137.72 52.6 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.364 -0.835 . . . . 28.62 110.195 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 242' ' ' TYR . . . . . . . . . . . . . 37.1 m-85 -96.44 161.83 13.75 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.365 -0.835 . . . . 47.89 110.163 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' S' S ' 243' ' ' SER . . . . . . . . . . . . . 72.4 m -90.59 151.58 21.25 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.295 -0.878 . . . . 45.09 110.241 179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' S' S ' 244' ' ' ARG . . . . . . . . . . . . . 1.4 mtp85 -129.81 126.75 22.69 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.402 -0.811 . . . . 42.49 110.162 -179.785 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' S' S ' 245' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.37 161.05 43.57 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 O-C-N 123.666 1.351 . . . . 35.68 110.503 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' S' S ' 246' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -132.94 97.88 4.14 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.391 -0.818 . . . . 51.88 109.82 179.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' S' S ' 247' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -110.5 -22.23 11.77 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.4 -0.813 . . . . 53.69 110.643 -179.471 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' S' S ' 248' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -117.21 43.63 2.28 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.178 -0.951 . . . . 55.79 110.774 -179.438 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' S' S ' 249' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 48.77 38.43 11.79 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.443 -0.785 . . . . 49.45 110.381 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' S' S ' 250' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -90.62 29.07 1.36 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.521 -0.737 . . . . 36.86 110.31 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' S' S ' 251' ' ' ALA . . . . . . . . . . . . . . . -53.9 -43.13 69.42 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.322 -0.861 . . . . 29.69 109.56 179.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' S' S ' 252' ' ' TRP . . . . . 0.42 ' CZ2' ' HB3' ' S' ' 294' ' ' LEU . 67.8 p-90 -61.83 -33.97 75.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.556 -0.715 . . . . 41.12 109.832 179.412 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 253' ' ' LEU . . . . . 0.407 ' N ' ' CD2' ' S' ' 252' ' ' TRP . 23.3 tp -70.11 -47.14 63.07 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.335 -0.853 . . . . 24.89 110.002 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 254' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -56.23 -42.51 77.41 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.326 -0.859 . . . . 35.65 109.909 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' S' S ' 255' ' ' ALA . . . . . . . . . . . . . . . -59.47 -48.13 82.83 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.402 -0.811 . . . . 22.73 110.115 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' S' S ' 256' ' ' ILE . . . . . 0.505 HG12 HD11 ' S' ' 304' ' ' ILE . 79.9 mt -62.31 -40.72 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.326 -0.858 . . . . 28.85 109.986 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 257' ' ' LEU . . . . . . . . . . . . . 19.1 mt -61.49 -44.52 96.92 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.405 -0.809 . . . . 23.07 110.186 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' S' S ' 258' ' ' GLN . . . . . 0.502 ' HB3' ' CD2' ' S' ' 351' ' ' PHE . 53.5 mm-40 -65.04 -45.3 85.99 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.402 -0.811 . . . . 29.78 109.993 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 259' ' ' LEU . . . . . 0.415 ' O ' HG22 ' S' ' 263' ' ' VAL . 20.0 tp -58.71 -36.41 74.22 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.236 -0.915 . . . . 17.94 109.453 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 260' ' ' PHE . . . . . 0.521 ' CE2' HD21 ' S' ' 311' ' ' LEU . 3.1 m-85 -62.77 -45.35 93.07 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.624 -0.673 . . . . 30.57 109.857 179.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 261' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -62.01 -29.8 70.52 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.432 -0.792 . . . . 41.34 109.98 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' S' S ' 262' ' ' TYR . . . . . 0.667 ' CE2' HD22 ' S' ' 233' ' ' LEU . 8.7 t80 -71.15 -44.68 65.06 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.415 -0.803 . . . . 26.03 110.102 179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 263' ' ' VAL . . . . . 0.415 HG22 ' O ' ' S' ' 259' ' ' LEU . 33.0 m -91.93 18.19 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.293 -0.88 . . . . 22.8 110.403 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 264' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 52.75 70.71 0.55 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.26 -0.9 . . . . 44.03 110.586 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' S' S ' 265' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -111.79 109.17 55.5 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.332 -0.855 . . . . 35.61 109.716 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' S' S ' 266' ' ' PRO . . . . . 0.479 ' HA ' ' HB2' ' S' ' 269' ' ' ASP . 49.9 Cg_endo -75.33 0.48 8.99 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 O-C-N 123.637 1.335 . . . . 37.67 111.768 -179.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 267' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -56.58 -67.71 0.28 Allowed 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.797 -1.189 . . . . 41.49 110.18 -179.937 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 268' ' ' PHE . . . . . . . . . . . . . 22.5 m-85 -92.81 39.83 1.04 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.177 -0.952 . . . . 50.76 110.124 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' S' S ' 269' ' ' ASP . . . . . 0.479 ' HB2' ' HA ' ' S' ' 266' ' ' PRO . 0.9 OUTLIER -75.99 -33.21 59.72 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.424 -0.798 . . . . 61.86 109.806 179.559 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' S' S ' 270' ' ' TRP . . . . . 0.514 ' CE2' HG23 ' S' ' 271' ' ' VAL . 50.9 p-90 -73.9 -4.35 34.5 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.279 -0.888 . . . . 39.85 110.5 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 271' ' ' VAL . . . . . 0.514 HG23 ' CE2' ' S' ' 270' ' ' TRP . 46.5 t -109.49 -32.68 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.15 -0.969 . . . . 39.18 110.088 179.509 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 272' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -78.68 -36.53 43.56 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.443 -0.786 . . . . 40.02 110.489 -179.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' S' S ' 273' ' ' SER . . . . . . . . . . . . . 71.0 m -103.53 56.07 0.74 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.292 -0.88 . . . . 47.2 110.314 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' S' S ' 274' ' ' SER . . . . . . . . . . . . . 6.9 t -133.01 141.24 40.23 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.317 -0.865 . . . . 47.61 110.159 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' S' S ' 275' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.72 -18.92 21.78 Favored 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 123.678 1.357 . . . . 45.28 110.526 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' S' S ' 276' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -99.98 140.9 33.53 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.246 -0.909 . . . . 57.27 110.299 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' S' S ' 277' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -71.7 97.67 1.79 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.355 -0.841 . . . . 37.28 110.284 -179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' S' S ' 278' ' ' LEU . . . . . . . . . . . . . 86.4 mt -96.99 33.8 1.84 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.441 -0.787 . . . . 43.88 110.014 -179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' S' S ' 279' ' ' THR . . . . . . . . . . . . . 76.9 m -64.02 -60.23 3.5 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.457 -0.777 . . . . 50.05 110.203 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' S' S ' 280' ' ' LEU . . . . . 0.743 ' HA ' HD12 ' S' ' 283' ' ' ILE . 13.7 mt -51.53 -39.87 58.55 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.343 -0.848 . . . . 54.12 110.316 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 281' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.39 -49.71 74.44 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.457 -0.777 . . . . 65.28 110.178 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 282' ' ' ALA . . . . . . . . . . . . . . . -58.88 -33.98 71.12 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.514 -0.741 . . . . 46.51 110.557 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' S' S ' 283' ' ' ILE . . . . . 0.743 HD12 ' HA ' ' S' ' 280' ' ' LEU . 85.9 mt -66.37 -50.86 64.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.328 -0.857 . . . . 47.3 110.101 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 284' ' ' LYS . . . . . . . . . . . . . 33.6 tttp -50.46 -57.68 7.48 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.422 -0.799 . . . . 50.72 110.381 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' S' S ' 285' ' ' GLN . . . . . 0.535 ' HG2' HD12 ' S' ' 289' ' ' LEU . 34.3 tt0 -51.31 -46.5 62.58 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.494 -0.754 . . . . 68.47 110.312 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 286' ' ' LEU . . . . . . . . . . . . . 19.1 mt -59.89 -44.5 94.2 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.379 -0.825 . . . . 36.62 110.3 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' S' S ' 287' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -62.81 -35.26 79.33 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.319 -0.863 . . . . 46.64 110.043 179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' S' S ' 288' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -76.17 -21.11 56.9 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.405 -0.809 . . . . 46.45 110.381 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' S' S ' 289' ' ' LEU . . . . . 0.535 HD12 ' HG2' ' S' ' 285' ' ' GLN . 30.8 mt -97.26 -21.76 17.07 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.244 -0.91 . . . . 35.09 110.582 -179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 290' ' ' THR . . . . . 0.413 HG22 ' HB3' ' S' ' 306' ' ' ASN . 81.5 p -114.76 -28.52 7.06 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.25 -0.906 . . . . 38.61 110.429 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 291' ' ' GLY . . . . . . . . . . . . . . . 79.38 11.11 85.27 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.789 -1.324 . . . . 36.77 109.789 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' S' S ' 292' ' ' LEU . . . . . . . . . . . . . 84.5 mt -96.48 145.76 25.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.336 -1.096 . . . . 35.33 109.77 179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' S' S ' 293' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -77.3 102.33 6.68 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.222 -0.923 . . . . 48.7 110.316 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' S' S ' 294' ' ' LEU . . . . . 0.42 ' HB3' ' CZ2' ' S' ' 252' ' ' TRP . 55.4 mt -106.86 51.7 0.74 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.503 -0.748 . . . . 42.61 110.136 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 295' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -112.48 -11.2 13.65 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.377 -0.827 . . . . 55.49 110.498 -179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 296' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -144.29 48.45 1.37 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.059 -1.025 . . . . 75.68 110.338 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' S' S ' 297' ' ' GLY . . . . . 0.458 ' CA ' ' HA ' ' R' ' 201' ' ' LYS . . . 96.91 145.12 18.6 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.48 -1.448 . . . . 49.44 109.48 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 298' ' ' GLY . . . . . . . . . . . . . . . -163.79 156.93 29.01 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.775 -1.33 . . . . 41.11 109.775 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' S' S ' 299' ' ' PRO . . . . . 0.629 ' HD3' ' HA ' ' R' ' 199' ' ' LYS . 46.6 Cg_endo -73.8 118.3 5.39 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 O-C-N 123.992 1.522 . . . . 26.2 110.277 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 300' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.21 -15.56 31.76 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 O-C-N 123.616 1.324 . . . . 21.7 110.692 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' S' S ' 301' ' ' ALA . . . . . . . . . . . . . . . -80.65 -29.36 36.69 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.175 -0.953 . . . . 31.23 110.133 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' S' S ' 302' ' ' LEU . . . . . 0.469 HD11 ' HA ' ' R' ' 197' ' ' GLN . 0.0 OUTLIER -83.43 -40.64 19.05 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.503 -0.748 . . . . 38.99 109.975 179.807 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' S' S ' 303' ' ' VAL . . . . . 0.488 HG23 ' O ' ' S' ' 299' ' ' PRO . 58.2 t -60.7 -35.46 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.435 -0.791 . . . . 18.63 110.177 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 304' ' ' ILE . . . . . 0.513 HD12 HG21 ' S' ' 379' ' ' VAL . 86.1 mt -79.43 -23.56 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.423 -0.798 . . . . 25.46 110.19 179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 305' ' ' TRP . . . . . 0.419 ' CD2' ' HD3' ' S' ' 308' ' ' LYS . 68.8 t-105 -88.65 -14.52 37.21 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.224 -0.923 . . . . 33.4 110.581 179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 306' ' ' ASN . . . . . 0.413 ' HB3' HG22 ' S' ' 290' ' ' THR . 10.4 m-80 -89.76 -13.52 36.54 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.142 -0.974 . . . . 36.97 110.399 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 307' ' ' ILE . . . . . 0.457 HG12 ' O ' ' S' ' 303' ' ' VAL . 36.8 pt -125.05 45.71 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.164 -0.96 . . . . 30.81 110.071 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 308' ' ' LYS . . . . . 0.419 ' HD3' ' CD2' ' S' ' 305' ' ' TRP . 1.5 mtmp? -73.59 -37.75 65.36 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.378 -0.826 . . . . 46.52 110.077 -179.533 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 309' ' ' HIS . . . . . 0.496 ' CD2' ' HG ' ' S' ' 310' ' ' LEU . 55.5 p-80 -73.17 -8.28 55.08 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.35 -0.844 . . . . 51.03 110.161 179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 310' ' ' LEU . . . . . 0.496 ' HG ' ' CD2' ' S' ' 309' ' ' HIS . 53.0 mt -99.32 -12.92 19.89 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.347 -0.845 . . . . 36.16 109.943 179.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 311' ' ' LEU . . . . . 0.521 HD21 ' CE2' ' S' ' 260' ' ' PHE . 10.8 mt -97.12 147.85 23.64 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.381 -0.824 . . . . 40.0 110.429 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 312' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -81.59 -16.32 51.97 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.322 -0.861 . . . . 54.18 109.748 179.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' S' S ' 313' ' ' THR . . . . . 0.829 HG23 ' HG2' ' S' ' 323' ' ' GLU . 92.9 m -87.94 151.66 22.64 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.337 -0.852 . . . . 25.61 110.115 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 314' ' ' GLY . . . . . . . . . . . . . . . -87.95 126.38 8.04 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.768 -1.333 . . . . 25.18 109.768 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' S' S ' 315' ' ' ILE . . . . . 0.647 HD13 ' HB ' ' S' ' 324' ' ' VAL . 50.7 mm -101.66 150.48 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.441 -1.034 . . . . 23.9 109.725 179.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 316' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' S' ' 325' ' ' CYS . . . -157.04 -159.31 9.4 Favored Glycine 0 N--CA 1.493 2.492 0 N-CA-C 109.931 -1.268 . . . . 23.18 109.931 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 317' ' ' THR . . . . . 0.424 HG22 ' CG2' ' S' ' 326' ' ' VAL . 11.2 p -133.9 -172.98 3.12 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.468 -1.019 . . . . 27.98 110.044 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.59 -56.19 25.06 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.163 -0.961 . . . . 28.1 109.874 179.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' S' S ' 319' ' ' SER . . . . . 0.422 ' OG ' ' CZ2' ' S' ' 392' ' ' TRP . 1.2 m -59.93 -41.63 92.19 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.326 -0.859 . . . . 37.0 109.663 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 320' ' ' ARG . . . . . . . . . . . . . 12.1 mtm180 -111.73 79.8 2.64 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.466 -0.771 . . . . 52.07 109.655 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' S' S ' 321' ' ' PRO . . . . . 0.436 ' O ' ' HB2' ' S' ' 322' ' ' SER . 44.4 Cg_endo -71.38 171.51 16.01 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.783 1.412 . . . . 38.29 110.979 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 322' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' S' ' 321' ' ' PRO . 41.3 t 178.67 -148.15 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 108.956 -0.757 . . . . 38.84 108.956 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 323' ' ' GLU . . . . . 0.829 ' HG2' HG23 ' S' ' 313' ' ' THR . 6.7 tp10 -62.87 -40.29 97.05 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.043 -1.036 . . . . 40.7 109.64 179.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 324' ' ' VAL . . . . . 0.647 ' HB ' HD13 ' S' ' 315' ' ' ILE . 73.6 t -141.27 134.99 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.35 -0.844 . . . . 20.34 109.469 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 325' ' ' CYS . . . . . 0.471 ' HB2' ' CE1' ' S' ' 380' ' ' PHE . 11.1 m -125.99 172.26 10.09 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.312 -0.868 . . . . 30.63 110.924 -179.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 326' ' ' VAL . . . . . 0.646 HG12 HG22 ' S' ' 379' ' ' VAL . 34.5 m -135.56 142.16 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 N-CA-C 109.175 -0.676 . . . . 23.9 109.175 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 327' ' ' VAL . . . . . 0.623 ' O ' HG22 ' R' ' 196' ' ' VAL . 34.6 m -56.37 125.02 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 121.112 -0.992 . . . . 19.48 110.39 -179.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 328' ' ' ASP . . . . . 0.636 ' HA ' HG21 ' R' ' 196' ' ' VAL . 55.7 p-10 -119.4 11.61 12.23 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.418 -0.801 . . . . 26.43 110.439 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 329' ' ' GLY . . . . . . . . . . . . . . . 119.59 2.3 13.17 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.068 -1.213 . . . . 31.24 110.068 -179.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' S' S ' 330' ' ' THR . . . . . . . . . . . . . 81.0 m -92.97 129.94 38.71 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.101 -1.235 . . . . 30.05 110.133 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' S' S ' 331' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -56.77 111.5 1.04 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.302 -0.873 . . . . 37.26 109.992 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' S' S ' 332' ' ' MET . . . . . . . . . . . . . 87.9 mmm -94.08 162.58 13.82 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.235 -0.915 . . . . 26.23 110.334 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' S' S ' 333' ' ' CYS . . . . . . . . . . . . . 26.4 m -137.15 150.05 47.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.42 -0.8 . . . . 23.56 110.078 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' S' S ' 334' ' ' LEU . . . . . 0.565 HD11 ' O ' ' S' ' 372' ' ' PRO . 0.1 OUTLIER -52.6 -24.9 9.18 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.228 -0.92 . . . . 28.93 110.508 179.833 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' S' S ' 335' ' ' ALA . . . . . . . . . . . . . . . -89.02 14.45 10.58 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.319 -0.863 . . . . 15.76 110.964 -179.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' S' S ' 336' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -100.49 -17.15 17.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.134 -0.979 . . . . 34.92 110.214 179.495 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' S' S ' 337' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -152.42 170.81 19.21 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.39 -0.819 . . . . 19.03 110.154 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' S' S ' 338' ' ' HIS . . . . . . . . . . . . . 13.5 p80 -120.73 10.4 10.97 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.394 -0.816 . . . . 18.82 110.411 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' S' S ' 339' ' ' ALA . . . . . 0.417 ' HA ' ' O ' ' S' ' 352' ' ' ALA . . . -176.04 155.16 1.54 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.206 -0.934 . . . . 17.18 110.09 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 340' ' ' GLY . . . . . . . . . . . . . . . 160.85 173.05 28.97 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 110.001 -1.24 . . . . 18.33 110.001 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' S' S ' 341' ' ' ILE . . . . . . . . . . . . . 83.9 mt -88.8 138.08 19.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.393 -1.063 . . . . 18.6 109.839 179.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' S' S ' 342' ' ' PHE . . . . . 0.488 ' CE2' ' HB3' ' S' ' 352' ' ' ALA . 69.9 m-85 -120.93 -178.49 3.75 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.219 -0.926 . . . . 23.44 110.412 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 343' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.84 93.4 4.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.397 -0.814 . . . . 35.59 110.07 179.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 344' ' ' LYS . . . . . 0.41 ' O ' ' HB3' ' S' ' 348' ' ' HIS . 0.3 OUTLIER -80.82 125.04 29.59 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.236 -0.915 . . . . 38.34 110.046 -179.934 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' S' S ' 345' ' ' GLY . . . . . . . . . . . . . . . 62.85 -130.85 42.89 Favored Glycine 0 N--CA 1.492 2.417 0 N-CA-C 108.788 -1.725 . . . . 53.46 108.788 -179.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' S' S ' 346' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -132.7 150.88 52.1 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.173 -1.192 . . . . 70.91 110.011 179.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' S' S ' 347' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 53.31 35.36 20.02 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.236 -0.915 . . . . 47.32 110.393 179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' S' S ' 348' ' ' HIS . . . . . 0.41 ' HB3' ' O ' ' S' ' 344' ' ' LYS . 46.6 t60 -150.11 155.89 40.66 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.317 -0.865 . . . . 41.72 110.312 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 349' ' ' ALA . . . . . 0.455 ' C ' HG13 ' S' ' 350' ' ' VAL . . . -149.79 151.3 33.34 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.324 -0.86 . . . . 22.91 110.442 -179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 350' ' ' VAL . . . . . 0.455 HG13 ' C ' ' S' ' 349' ' ' ALA . 34.6 m -149.14 169.55 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 O-C-N 121.448 -0.782 . . . . 21.09 109.995 179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 351' ' ' PHE . . . . . 0.502 ' CD2' ' HB3' ' S' ' 258' ' ' GLN . 10.7 t80 -105.27 143.58 33.25 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.19 -0.944 . . . . 25.03 110.716 -179.764 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 352' ' ' ALA . . . . . 0.488 ' HB3' ' CE2' ' S' ' 342' ' ' PHE . . . -147.7 151.74 36.62 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.584 -0.698 . . . . 23.81 109.741 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 353' ' ' CYS . . . . . . . . . . . . . 26.3 p -153.34 164.84 37.43 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.295 -0.878 . . . . 25.66 110.225 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' S' S ' 354' ' ' VAL . . . . . 0.561 HG22 ' CE2' ' S' ' 359' ' ' TRP . 57.2 t -76.04 118.47 22.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.376 -0.828 . . . . 34.27 109.943 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 355' ' ' THR . . . . . 0.413 ' HA ' ' O ' ' S' ' 232' ' ' THR . 52.3 p -117.82 175.1 5.82 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.257 -0.902 . . . . 25.49 110.346 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 356' ' ' SER . . . . . . . . . . . . . 62.2 p -62.2 -17.61 58.65 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.456 -0.778 . . . . 31.24 110.699 -179.504 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' S' S ' 357' ' ' ASN . . . . . . . . . . . . . 45.8 m-20 -107.05 14.22 26.6 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.896 . . . . 28.61 110.552 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' S' S ' 358' ' ' GLY . . . . . . . . . . . . . . . 111.86 -152.92 17.59 Favored Glycine 0 N--CA 1.492 2.432 0 N-CA-C 110.013 -1.235 . . . . 22.01 110.013 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' S' S ' 359' ' ' TRP . . . . . 0.561 ' CE2' HG22 ' S' ' 354' ' ' VAL . 15.3 m95 -91.3 116.65 29.0 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.38 -1.071 . . . . 25.54 110.23 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 360' ' ' TYR . . . . . 0.422 ' HA ' ' HA ' ' S' ' 369' ' ' PRO . 1.3 m-85 -103.53 165.79 10.82 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.257 -0.902 . . . . 40.53 110.091 179.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 361' ' ' ALA . . . . . 0.428 ' HA ' ' O ' ' S' ' 351' ' ' PHE . . . -140.01 129.99 24.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.353 -0.842 . . . . 18.04 110.295 -179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 362' ' ' ILE . . . . . . . . . . . . . 88.9 mt -95.54 83.61 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.375 -0.828 . . . . 15.64 110.081 179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' S' S ' 363' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' S' ' 365' ' ' GLU . 11.9 t0 -75.19 94.48 2.96 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.42 -0.8 . . . . 35.03 110.186 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 364' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 53.92 -89.3 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.53 -0.731 . . . . 46.72 110.537 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' S' S ' 365' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' S' ' 363' ' ' ASP . 23.7 mt-10 -122.69 19.1 10.32 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.046 -1.033 . . . . 56.2 110.223 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 366' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -117.91 124.88 49.34 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.21 -0.932 . . . . 51.02 110.44 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' S' S ' 367' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -106.89 127.05 53.09 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.326 -0.859 . . . . 37.59 110.18 179.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' S' S ' 368' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -165.47 159.5 13.83 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.293 -0.879 . . . . 31.47 110.415 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' S' S ' 369' ' ' PRO . . . . . 0.422 ' HA ' ' HA ' ' S' ' 360' ' ' TYR . 46.9 Cg_endo -72.76 139.59 30.9 Favored 'Trans proline' 0 C--N 1.31 -1.481 0 O-C-N 123.891 1.469 . . . . 28.85 110.557 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 370' ' ' TRP . . . . . . . . . . . . . 67.4 t90 -167.25 113.52 0.76 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.422 -0.799 . . . . 26.94 110.001 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' S' S ' 371' ' ' THR . . . . . . . . . . . . . 59.8 m -74.81 113.08 21.02 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.376 -0.828 . . . . 20.19 110.041 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' S' S ' 372' ' ' PRO . . . . . 0.565 ' O ' HD11 ' S' ' 334' ' ' LEU . 47.0 Cg_endo -73.59 157.11 49.04 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.644 1.339 . . . . 28.68 110.529 -179.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 373' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -90.58 147.15 35.74 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.411 -0.806 . . . . 35.72 109.934 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' S' S ' 374' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -76.03 -6.27 17.18 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 O-C-N 123.681 1.359 . . . . 30.89 110.461 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' S' S ' 375' ' ' SER . . . . . . . . . . . . . 70.5 p -104.39 -17.0 14.95 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.227 -0.921 . . . . 29.41 110.428 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' S' S ' 376' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -106.48 43.09 1.18 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.358 -0.839 . . . . 32.89 110.26 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' S' S ' 377' ' ' VAL . . . . . 0.595 ' O ' HG11 ' S' ' 327' ' ' VAL . 7.3 p -114.71 147.29 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.294 -0.879 . . . . 24.33 110.223 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 378' ' ' LEU . . . . . . . . . . . . . 52.5 mt -115.99 -57.96 2.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.381 -0.824 . . . . 24.37 109.611 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' S' S ' 379' ' ' VAL . . . . . 0.646 HG22 HG12 ' S' ' 326' ' ' VAL . 61.0 t -120.76 132.38 70.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.404 -0.81 . . . . 18.02 109.424 179.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 380' ' ' PHE . . . . . 0.471 ' CE1' ' HB2' ' S' ' 325' ' ' CYS . 14.6 p90 -142.61 173.96 11.07 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.376 -0.828 . . . . 29.35 110.704 -179.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 381' ' ' VAL . . . . . . . . . . . . . 57.7 t -120.12 107.31 39.79 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.459 -0.776 . . . . 16.34 109.43 179.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' S' S ' 382' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -71.19 145.6 49.43 Favored 'Trans proline' 0 C--N 1.31 -1.449 0 O-C-N 123.613 1.322 . . . . 20.94 110.79 -179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' S' S ' 383' ' ' TYR . . . . . 0.959 ' O ' ' CB ' ' S' ' 384' ' ' ASP . 88.5 m-85 -61.04 -53.57 55.61 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.317 -0.865 . . . . 28.93 109.826 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 384' ' ' ASP . . . . . 0.959 ' CB ' ' O ' ' S' ' 383' ' ' TYR . 7.0 t70 111.08 -156.87 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.46 -0.775 . . . . 47.03 110.366 176.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 385' ' ' GLN . . . . . 0.405 ' CB ' ' O ' ' S' ' 384' ' ' ASP . 7.7 tm0? 62.27 11.55 4.56 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.435 -0.791 . . . . 46.69 110.261 -178.336 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 386' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -174.3 129.96 0.48 Allowed Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.316 -0.865 . . . . 50.25 109.56 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' S' S ' 387' ' ' PRO . . . . . 0.553 ' O ' ' N ' ' S' ' 389' ' ' ASN . 55.7 Cg_endo -73.17 0.61 7.67 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.668 1.351 . . . . 34.39 110.576 -179.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 388' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 62.02 -70.3 0.05 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.436 -0.79 . . . . 38.01 110.132 -179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 389' ' ' ASN . . . . . 0.553 ' N ' ' O ' ' S' ' 387' ' ' PRO . 3.2 m-80 -132.57 -164.81 1.51 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.391 -0.818 . . . . 45.82 110.059 179.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 390' ' ' GLY . . . . . 0.526 ' O ' ' CD2' ' S' ' 392' ' ' TRP . . . 152.25 -92.73 0.14 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.603 -1.399 . . . . 33.46 109.603 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 391' ' ' GLU . . . . . 0.481 ' CB ' ' O ' ' S' ' 390' ' ' GLY . 1.5 tp10 66.89 -65.85 0.2 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.331 -1.099 . . . . 56.58 110.152 -179.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 392' ' ' TRP . . . . . 0.574 ' HA ' ' HB2' ' S' ' 395' ' ' LYS . 1.6 p90 -62.2 -17.57 58.56 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.298 -0.876 . . . . 31.43 110.313 179.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 393' ' ' LYS . . . . . 0.629 ' O ' HG12 ' S' ' 396' ' ' VAL . 3.0 ptmm? -52.17 -36.95 53.19 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.322 -0.861 . . . . 39.42 110.374 179.746 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 394' ' ' ALA . . . . . . . . . . . . . . . -85.99 -20.34 29.04 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.444 -0.785 . . . . 34.33 110.075 178.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' S' S ' 395' ' ' LYS . . . . . 0.777 ' O ' HD11 ' R' ' 143' ' ' LEU . 18.4 mttp -75.67 -14.56 60.36 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.374 -0.829 . . . . 60.09 110.308 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 396' ' ' VAL . . . . . 0.929 HG22 ' CB ' ' R' ' 99' ' ' PRO . 8.8 p -95.99 -46.95 13.07 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.378 -0.826 . . . . 35.5 110.54 179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 397' ' ' GLN . . . . . 0.635 ' N ' HG13 ' S' ' 396' ' ' VAL . 2.4 tt0 -71.17 -7.26 45.54 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.148 -0.97 . . . . 49.96 110.607 -179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 398' ' ' ARG . . . . . 0.651 ' HD3' ' O ' ' S' ' 398' ' ' ARG . 0.0 OUTLIER -39.61 157.74 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.222 -0.924 . . . . 43.42 110.695 179.985 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' S' S ' 399' ' ' LYS . . . . . 0.652 ' CB ' ' HA3' ' R' ' 97' ' ' GLY . 0.0 OUTLIER -146.05 120.64 9.77 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.492 -0.755 . . . . 55.31 110.027 179.852 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' S' S ' 400' ' ' LEU . . . . . 0.884 HD13 ' CE1' ' R' ' 148' ' ' HIS . 19.9 tp -30.93 -48.51 0.11 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.307 -0.871 . . . . 41.03 110.26 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' S' S ' 401' ' ' LYS . . . . . 0.495 ' CB ' ' OD1' ' R' ' 49' ' ' ASP . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.684 0 O-C-N 121.359 -0.838 . . . . 61.97 110.174 179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 29' ' ' MET . . . . . . . . . . . . . 22.0 ptp . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.14 0.495 . . . . 32.14 110.303 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' R' R ' 30' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -96.33 141.13 30.03 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.412 -0.805 . . . . 43.36 110.287 179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' R' R ' 31' ' ' LEU . . . . . . . . . . . . . 65.3 mt -134.86 140.61 45.95 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.308 -0.87 . . . . 22.93 110.306 179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' R' R ' 32' ' ' THR . . . . . . . . . . . . . 68.4 m -87.59 110.59 20.49 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.408 -0.807 . . . . 22.34 109.971 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' R' R ' 33' ' ' LEU . . . . . 0.596 HD22 ' CE2' ' R' ' 62' ' ' TYR . 80.0 mt -62.38 -172.79 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.314 -0.866 . . . . 21.39 110.226 -179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 34' ' ' TYR . . . . . . . . . . . . . 37.0 p90 -74.68 -29.4 61.21 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.333 -0.855 . . . . 34.4 110.38 -179.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' R' R ' 35' ' ' ASN . . . . . . . . . . . . . 48.3 p30 -77.79 -1.79 33.2 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.356 -0.84 . . . . 30.28 110.699 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' R' R ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.24 -16.55 59.49 Favored Glycine 0 N--CA 1.493 2.437 0 N-CA-C 109.691 -1.364 . . . . 36.25 109.691 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' R' R ' 37' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -59.04 161.81 4.79 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.314 -1.11 . . . . 53.8 110.368 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' R' R ' 38' ' ' LYS . . . . . . . . . . . . . 56.9 mttt -117.86 135.8 53.86 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.445 -0.784 . . . . 49.91 110.146 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' R' R ' 39' ' ' LYS . . . . . 0.408 ' HG2' ' CZ ' ' R' ' 41' ' ' PHE . 8.1 ttmt -138.75 143.64 39.1 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.404 -0.81 . . . . 35.69 110.223 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 40' ' ' THR . . . . . . . . . . . . . 23.5 m -102.54 127.96 49.39 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.302 -0.874 . . . . 34.84 110.228 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' R' R ' 41' ' ' PHE . . . . . 0.408 ' CZ ' ' HG2' ' R' ' 39' ' ' LYS . 96.6 m-85 -113.04 132.65 55.31 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.378 -0.826 . . . . 34.42 110.172 -179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 42' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -93.36 140.95 28.99 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.331 -0.856 . . . . 51.46 110.221 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' R' R ' 43' ' ' SER . . . . . . . . . . . . . 54.3 m -70.76 141.93 51.42 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.55 -0.719 . . . . 41.84 110.205 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' R' R ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.75 125.37 29.59 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.469 -0.769 . . . . 33.82 110.013 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 45' ' ' PRO . . . . . 0.423 ' HG2' ' ND2' ' R' ' 77' ' ' ASN . 45.5 Cg_endo -72.11 151.13 55.13 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.59 1.31 . . . . 30.27 110.625 -179.697 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 46' ' ' ASN . . . . . 0.711 HD21 ' HG ' ' S' ' 400' ' ' LEU . 52.2 t-20 -124.28 109.84 13.88 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.459 -0.776 . . . . 35.1 110.071 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 47' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -120.27 -34.86 3.56 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.395 -0.816 . . . . 42.81 110.551 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' R' R ' 48' ' ' HIS . . . . . 0.439 ' NE2' HD11 ' R' ' 80' ' ' LEU . 73.3 m80 -105.73 45.1 0.99 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.187 -0.946 . . . . 49.97 110.235 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 49' ' ' ASP . . . . . 0.751 ' HB3' ' HB2' ' S' ' 399' ' ' LYS . 37.6 m-20 50.32 34.72 9.38 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.4 -0.813 . . . . 61.32 110.149 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 50' ' ' ASN . . . . . 0.4 ' OD1' ' HA ' ' R' ' 46' ' ' ASN . 15.0 p-10 -86.32 43.87 1.1 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.323 -0.861 . . . . 51.5 110.66 -179.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 51' ' ' ALA . . . . . 0.519 ' HB2' ' CD2' ' S' ' 400' ' ' LEU . . . -66.12 -46.11 78.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.165 -0.959 . . . . 38.77 109.541 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 52' ' ' TRP . . . . . 0.483 ' CD2' ' N ' ' R' ' 53' ' ' LEU . 68.2 p-90 -58.4 -38.4 77.27 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.482 -0.761 . . . . 26.24 110.055 179.605 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 53' ' ' LEU . . . . . 0.483 ' N ' ' CD2' ' R' ' 52' ' ' TRP . 23.1 tp -66.73 -46.66 74.76 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.456 -0.777 . . . . 26.75 109.946 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 54' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -55.23 -41.54 72.24 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.405 -0.809 . . . . 35.02 110.132 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' R' R ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.26 -46.11 91.71 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.352 -0.842 . . . . 24.47 110.114 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' R' R ' 56' ' ' ILE . . . . . 0.433 HG12 HD11 ' R' ' 104' ' ' ILE . 76.6 mt -62.09 -42.33 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.259 -0.901 . . . . 26.03 109.906 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 57' ' ' LEU . . . . . . . . . . . . . 22.5 mt -60.26 -45.69 92.42 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.28 -0.888 . . . . 26.77 109.657 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' R' R ' 58' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -63.87 -46.51 84.6 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.341 -0.849 . . . . 22.32 109.582 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' R' R ' 59' ' ' LEU . . . . . 0.43 ' HA ' ' HE2' ' R' ' 151' ' ' PHE . 24.0 tp -61.43 -37.73 84.6 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.306 -0.871 . . . . 20.55 109.396 179.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 60' ' ' PHE . . . . . 0.528 ' CE2' HD21 ' R' ' 111' ' ' LEU . 2.8 m-85 -61.11 -44.72 96.91 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.617 -0.677 . . . . 20.08 109.913 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 61' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -63.17 -36.23 82.93 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.498 -0.751 . . . . 18.8 110.408 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' R' R ' 62' ' ' TYR . . . . . 0.596 ' CE2' HD22 ' R' ' 33' ' ' LEU . 9.2 t80 -63.04 -41.74 99.58 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.226 -0.921 . . . . 26.45 110.247 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 63' ' ' VAL . . . . . 0.406 ' H ' HG22 ' R' ' 63' ' ' VAL . 30.8 m -93.42 20.32 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.308 -0.87 . . . . 29.75 110.266 179.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 64' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 53.03 75.44 0.24 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.316 -0.865 . . . . 35.52 110.561 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' R' R ' 65' ' ' GLU . . . . . 0.443 ' HG2' ' CD2' ' R' ' 60' ' ' PHE . 14.3 tp10 -116.19 104.01 52.55 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.391 -0.818 . . . . 29.89 109.958 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 66' ' ' PRO . . . . . 0.479 ' HA ' ' HB2' ' R' ' 69' ' ' ASP . 46.6 Cg_endo -73.47 -5.88 17.85 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.708 1.372 . . . . 21.37 111.068 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 67' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -52.11 -61.58 2.17 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.054 -1.029 . . . . 23.85 110.341 -179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 68' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -98.06 36.52 1.56 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.314 -0.866 . . . . 28.07 110.474 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' R' R ' 69' ' ' ASP . . . . . 0.479 ' HB2' ' HA ' ' R' ' 66' ' ' PRO . 11.7 t0 -72.3 -33.25 67.27 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.307 -0.871 . . . . 43.76 110.205 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 70' ' ' TRP . . . . . 0.476 ' CE2' ' CG2' ' R' ' 71' ' ' VAL . 48.0 p-90 -73.49 -3.85 30.18 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.332 -0.855 . . . . 33.06 110.686 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 71' ' ' VAL . . . . . 0.557 HG11 ' HB2' ' R' ' 82' ' ' ALA . 40.8 t -109.83 -27.41 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.175 -0.953 . . . . 31.7 109.674 179.173 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 72' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -86.58 -48.88 7.96 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.358 -0.839 . . . . 33.58 110.278 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' R' R ' 73' ' ' SER . . . . . . . . . . . . . 70.2 m -89.67 51.12 2.02 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.312 -0.868 . . . . 50.82 110.308 -179.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' R' R ' 74' ' ' SER . . . . . . . . . . . . . 15.9 t -125.96 138.33 31.88 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.282 -0.886 . . . . 34.74 110.189 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -73.38 -24.99 15.89 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 O-C-N 123.603 1.317 . . . . 35.7 110.32 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' R' R ' 76' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -91.74 153.24 19.76 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.461 -0.775 . . . . 66.48 110.356 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' R' R ' 77' ' ' ASN . . . . . 0.423 ' ND2' ' HG2' ' R' ' 45' ' ' PRO . 22.3 t-20 -81.56 95.23 7.07 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.33 -0.856 . . . . 46.72 110.097 179.727 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 78' ' ' LEU . . . . . . . . . . . . . 96.4 mt -96.43 28.01 3.52 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.398 -0.814 . . . . 37.55 110.187 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' R' R ' 79' ' ' THR . . . . . . . . . . . . . 29.9 m -56.21 -54.62 43.08 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.226 -0.921 . . . . 37.36 110.301 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' R' R ' 80' ' ' LEU . . . . . 0.602 ' HA ' HD12 ' R' ' 83' ' ' ILE . 15.9 mt -60.88 -23.28 65.07 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.449 -0.782 . . . . 35.83 110.511 -179.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 81' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -79.44 -39.11 33.07 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.154 -0.966 . . . . 44.03 110.38 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' R' R ' 82' ' ' ALA . . . . . 0.557 ' HB2' HG11 ' R' ' 71' ' ' VAL . . . -69.45 -28.66 66.3 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.292 -0.88 . . . . 32.54 110.211 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 83' ' ' ILE . . . . . 0.602 HD12 ' HA ' ' R' ' 80' ' ' LEU . 78.2 mt -70.13 -46.09 73.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.236 -0.915 . . . . 32.02 110.265 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 84' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -55.23 -52.09 64.49 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.237 -0.914 . . . . 34.09 110.521 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' R' R ' 85' ' ' GLN . . . . . 0.531 ' HG2' HD12 ' R' ' 89' ' ' LEU . 31.9 tt0 -54.82 -46.87 74.63 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.238 -0.914 . . . . 25.94 110.28 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 86' ' ' LEU . . . . . . . . . . . . . 24.0 mt -58.71 -43.73 90.17 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.299 -0.876 . . . . 16.2 109.923 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' R' R ' 87' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -65.43 -35.11 79.95 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.472 -0.768 . . . . 49.09 110.33 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' R' R ' 88' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -78.5 -19.06 53.85 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.276 -0.89 . . . . 28.61 110.479 -179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' R' R ' 89' ' ' LEU . . . . . 0.531 HD12 ' HG2' ' R' ' 85' ' ' GLN . 32.8 mt -96.18 -29.43 14.05 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.236 -0.915 . . . . 26.16 110.197 179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 90' ' ' THR . . . . . . . . . . . . . 59.4 p -105.63 -34.72 7.65 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.259 -0.901 . . . . 33.33 109.764 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' R' R ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.89 16.08 58.55 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.821 -1.312 . . . . 31.13 109.821 -179.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' R' R ' 92' ' ' LEU . . . . . . . . . . . . . 97.1 mt -100.06 155.23 17.83 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.147 -1.208 . . . . 42.52 110.23 -179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' R' R ' 93' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -86.21 91.62 8.51 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.49 -0.756 . . . . 68.46 110.017 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' R' R ' 94' ' ' LEU . . . . . 0.459 ' HB3' ' CZ2' ' R' ' 52' ' ' TRP . 48.3 mt -99.48 53.03 0.94 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.222 -0.924 . . . . 44.63 110.32 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 95' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.43 -38.8 6.35 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.262 -0.899 . . . . 67.16 110.385 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 96' ' ' GLU . . . . . 0.407 ' O ' ' HG2' ' S' ' 399' ' ' LYS . 24.7 mt-10 -113.83 44.23 1.67 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.251 -0.906 . . . . 67.02 110.352 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 97' ' ' GLY . . . . . 0.792 ' CA ' ' HB3' ' S' ' 399' ' ' LYS . . . 99.16 150.78 26.0 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.614 -1.395 . . . . 49.48 109.614 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 98' ' ' GLY . . . . . . . . . . . . . . . -166.26 160.03 33.47 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.286 -1.526 . . . . 36.57 109.286 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' R' R ' 99' ' ' PRO . . . . . 0.792 ' O ' HG23 ' R' ' 103' ' ' VAL . 45.8 Cg_endo -72.49 121.03 7.1 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 O-C-N 123.703 1.37 . . . . 30.41 110.47 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 100' ' ' PRO . . . . . 0.413 ' HA ' HD11 ' R' ' 56' ' ' ILE . 46.1 Cg_endo -72.22 -31.72 11.47 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 O-C-N 123.645 1.339 . . . . 29.94 110.552 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 101' ' ' ALA . . . . . 0.476 ' HB2' ' HB3' ' R' ' 178' ' ' LEU . . . -69.9 -38.49 76.32 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.228 -0.92 . . . . 23.64 110.291 179.987 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 102' ' ' LEU . . . . . 0.424 HD23 HD21 ' R' ' 106' ' ' ASN . 0.1 OUTLIER -72.64 -40.71 66.19 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.411 -0.805 . . . . 20.31 110.386 -179.769 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' R' R ' 103' ' ' VAL . . . . . 0.792 HG23 ' O ' ' R' ' 99' ' ' PRO . 64.0 t -58.25 -40.07 76.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.225 -0.922 . . . . 16.33 109.984 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 104' ' ' ILE . . . . . 0.433 HD11 HG12 ' R' ' 56' ' ' ILE . 81.6 mt -71.63 -30.6 39.08 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.388 -0.82 . . . . 24.77 109.939 179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 105' ' ' TRP . . . . . 0.462 ' O ' ' HD3' ' R' ' 108' ' ' LYS . 70.5 t-105 -82.35 0.82 40.02 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.292 -0.88 . . . . 23.28 110.321 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 106' ' ' ASN . . . . . 0.424 HD21 HD23 ' R' ' 102' ' ' LEU . 6.9 m-80 -105.07 -10.49 17.14 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.136 -0.977 . . . . 28.26 110.086 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 107' ' ' ILE . . . . . . . . . . . . . 36.8 pt -126.83 35.06 1.31 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.208 -0.933 . . . . 18.77 110.033 179.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' R' R ' 108' ' ' LYS . . . . . 0.502 ' HG2' ' HB ' ' R' ' 115' ' ' ILE . 9.2 mtpp -61.16 -48.43 81.64 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.528 -0.732 . . . . 42.5 109.987 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 109' ' ' HIS . . . . . 0.446 ' CD2' ' HG ' ' R' ' 110' ' ' LEU . 50.9 p-80 -66.01 -12.88 58.3 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.461 -0.774 . . . . 20.07 110.652 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 110' ' ' LEU . . . . . 0.446 ' HG ' ' CD2' ' R' ' 109' ' ' HIS . 80.6 mt -94.81 -17.26 22.28 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.084 -1.01 . . . . 15.69 110.192 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 111' ' ' LEU . . . . . 0.528 HD21 ' CE2' ' R' ' 60' ' ' PHE . 10.3 mt -94.15 144.11 25.78 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.34 -0.85 . . . . 25.39 111.002 -179.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 112' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -77.7 -17.33 57.75 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.521 -0.737 . . . . 53.48 109.865 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' R' R ' 113' ' ' THR . . . . . 0.459 HG22 ' N ' ' R' ' 114' ' ' GLY . 60.4 m -83.71 166.68 17.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.311 -0.868 . . . . 14.8 110.201 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 114' ' ' GLY . . . . . 0.459 ' N ' HG22 ' R' ' 113' ' ' THR . . . -98.01 127.15 9.13 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.962 -1.255 . . . . 16.14 109.962 -179.624 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 115' ' ' ILE . . . . . 0.578 HD13 ' HB ' ' R' ' 124' ' ' VAL . 47.9 mm -109.05 139.35 32.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.424 -1.045 . . . . 13.46 109.71 179.646 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 116' ' ' GLY . . . . . . . . . . . . . . . -152.76 -155.9 7.31 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.856 -1.298 . . . . 23.9 109.856 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' R' R ' 117' ' ' THR . . . . . 0.529 HG22 ' CG2' ' R' ' 126' ' ' VAL . 18.8 p -135.03 -171.35 2.78 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.53 -0.982 . . . . 27.37 110.097 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 118' ' ' ALA . . . . . 0.445 ' HB3' ' OD1' ' R' ' 128' ' ' ASP . . . -56.6 -58.04 9.79 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.359 -0.838 . . . . 18.76 110.064 179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 119' ' ' SER . . . . . 0.762 ' HA ' ' HB3' ' R' ' 194' ' ' ALA . 1.1 m -56.55 -40.59 75.39 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.259 -0.901 . . . . 32.35 109.741 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 120' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 -110.11 86.25 4.92 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.435 -0.791 . . . . 27.12 109.68 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' R' R ' 121' ' ' PRO . . . . . 0.483 ' HA ' ' SG ' ' R' ' 125' ' ' CYS . 44.3 Cg_endo -71.2 166.47 29.12 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.863 1.454 . . . . 22.68 111.046 -179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 122' ' ' SER . . . . . 0.434 ' HB2' ' O ' ' R' ' 121' ' ' PRO . 38.4 t 178.56 -161.67 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.649 -0.657 . . . . 22.99 109.456 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 123' ' ' GLU . . . . . 0.44 ' HG2' HG23 ' R' ' 113' ' ' THR . 2.3 tp10 -56.45 -39.92 73.94 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.211 -0.93 . . . . 36.18 109.701 179.596 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 124' ' ' VAL . . . . . 0.578 ' HB ' HD13 ' R' ' 115' ' ' ILE . 84.2 t -142.58 136.41 27.59 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.579 -0.701 . . . . 20.64 109.389 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 125' ' ' CYS . . . . . 0.483 ' SG ' ' HA ' ' R' ' 121' ' ' PRO . 83.3 m -140.26 168.23 20.29 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.252 -0.905 . . . . 22.8 111.166 -179.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 126' ' ' VAL . . . . . 0.73 HG12 HG22 ' R' ' 179' ' ' VAL . 35.8 m -122.73 159.73 25.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.671 -0.643 . . . . 21.24 109.568 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 127' ' ' VAL . . . . . 0.709 HG11 ' O ' ' R' ' 177' ' ' VAL . 30.6 m -70.8 141.91 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.294 -0.879 . . . . 19.77 110.7 -179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 128' ' ' ASP . . . . . 0.445 ' OD1' ' HB3' ' R' ' 118' ' ' ALA . 53.9 p-10 -137.77 19.4 2.86 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.337 -0.852 . . . . 29.21 110.642 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 129' ' ' GLY . . . . . . . . . . . . . . . 113.98 0.03 24.16 Favored Glycine 0 N--CA 1.493 2.468 0 C-N-CA 119.963 -1.113 . . . . 33.86 110.498 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' R' R ' 130' ' ' THR . . . . . . . . . . . . . 58.1 m -91.86 131.81 36.92 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.14 -1.212 . . . . 26.41 110.082 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -62.52 120.7 11.62 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.36 -0.838 . . . . 33.08 110.287 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' R' R ' 132' ' ' MET . . . . . 0.433 ' HE1' ' CE2' ' R' ' 180' ' ' PHE . 98.5 mmm -105.26 165.62 10.98 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.467 -0.771 . . . . 30.76 110.435 -179.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 133' ' ' CYS . . . . . 0.41 ' HA ' ' HB3' ' R' ' 174' ' ' PRO . 32.8 m -141.09 158.11 44.37 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.511 -0.743 . . . . 27.0 109.973 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 134' ' ' LEU . . . . . 0.564 HD11 ' O ' ' R' ' 172' ' ' PRO . 0.1 OUTLIER -58.45 -19.74 39.11 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.268 -0.895 . . . . 33.9 110.51 -179.923 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' R' R ' 135' ' ' ALA . . . . . . . . . . . . . . . -92.69 8.07 40.77 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.231 -0.918 . . . . 19.37 110.779 -179.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' R' R ' 136' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -93.71 -21.76 19.15 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.187 -0.946 . . . . 30.47 110.272 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' R' R ' 137' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -149.96 165.34 32.94 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.365 -0.835 . . . . 24.27 110.241 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' R' R ' 138' ' ' HIS . . . . . 0.433 ' HA ' HG23 ' R' ' 154' ' ' VAL . 15.1 p80 -117.84 15.11 14.37 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.362 -0.836 . . . . 20.91 110.369 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 139' ' ' ALA . . . . . 0.473 ' HA ' ' O ' ' R' ' 152' ' ' ALA . . . -177.16 152.46 0.88 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.158 -0.964 . . . . 15.69 110.12 179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 140' ' ' GLY . . . . . 0.428 ' HA3' ' O ' ' R' ' 179' ' ' VAL . . . 161.8 175.2 32.57 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.975 -1.25 . . . . 23.76 109.975 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 141' ' ' ILE . . . . . . . . . . . . . 83.7 mt -95.55 136.61 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.372 -1.075 . . . . 25.3 109.673 179.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' R' R ' 142' ' ' PHE . . . . . 0.578 ' CD2' ' HB2' ' R' ' 172' ' ' PRO . 82.8 m-85 -120.77 -172.63 2.42 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.287 -0.883 . . . . 30.24 110.545 -179.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 143' ' ' LEU . . . . . 0.742 HD23 ' O ' ' R' ' 148' ' ' HIS . 0.5 OUTLIER -119.75 77.75 1.26 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.444 -0.785 . . . . 32.8 110.246 -179.84 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' R' R ' 144' ' ' LYS . . . . . 0.469 ' HG3' ' CZ2' ' R' ' 170' ' ' TRP . 1.0 OUTLIER -69.59 76.86 0.42 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.393 -0.817 . . . . 49.18 109.707 179.502 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' R' R ' 145' ' ' GLY . . . . . 0.457 ' O ' HD22 ' R' ' 143' ' ' LEU . . . 104.52 179.32 24.8 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.131 -1.588 . . . . 53.87 109.131 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 146' ' ' GLN . . . . . 0.422 ' HG2' ' HD3' ' S' ' 395' ' ' LYS . 11.9 mt-30 -88.52 145.81 25.53 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.361 -1.082 . . . . 68.58 110.023 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 147' ' ' GLU . . . . . 0.869 ' HA ' ' CB ' ' S' ' 398' ' ' ARG . 10.9 mt-10 58.24 36.52 25.77 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.314 -0.866 . . . . 56.62 110.623 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 148' ' ' HIS . . . . . 0.742 ' O ' HD23 ' R' ' 143' ' ' LEU . 44.5 t60 -158.65 148.17 19.24 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.194 -0.941 . . . . 44.57 110.376 179.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 149' ' ' ALA . . . . . . . . . . . . . . . -150.29 146.88 27.04 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.427 -0.796 . . . . 33.54 110.079 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' R' R ' 150' ' ' VAL . . . . . . . . . . . . . 34.2 m -142.32 161.5 19.45 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.768 0 O-C-N 121.277 -0.889 . . . . 27.61 110.356 179.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' R' R ' 151' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' R' ' 152' ' ' ALA . 5.9 t80 -86.14 155.62 20.69 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.401 -0.812 . . . . 23.04 109.924 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 152' ' ' ALA . . . . . 0.537 ' N ' ' CD1' ' R' ' 151' ' ' PHE . . . -157.33 151.51 24.81 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.517 -0.739 . . . . 29.61 109.625 179.02 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 153' ' ' CYS . . . . . . . . . . . . . 26.7 p -154.3 173.61 15.93 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.233 -0.917 . . . . 22.75 110.453 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' R' R ' 154' ' ' VAL . . . . . 0.613 HG22 ' CE2' ' R' ' 159' ' ' TRP . 60.2 t -90.68 117.04 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.37 -0.831 . . . . 23.26 110.101 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 155' ' ' THR . . . . . . . . . . . . . 69.8 p -112.1 -176.63 2.97 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.302 -0.873 . . . . 17.88 110.041 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' R' R ' 156' ' ' SER . . . . . . . . . . . . . 78.5 p -75.94 -3.69 36.88 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.329 -0.857 . . . . 21.83 110.735 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' R' R ' 157' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -118.25 10.38 12.83 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.109 -0.994 . . . . 36.54 110.635 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' R' R ' 158' ' ' GLY . . . . . . . . . . . . . . . 117.9 -162.7 13.0 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.585 -1.406 . . . . 31.74 109.585 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' R' R ' 159' ' ' TRP . . . . . 0.613 ' CE2' HG22 ' R' ' 154' ' ' VAL . 14.8 m95 -86.51 122.42 30.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.334 -1.098 . . . . 28.25 110.112 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 160' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -108.42 166.96 10.38 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.384 -0.822 . . . . 41.24 110.251 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' R' R ' 161' ' ' ALA . . . . . . . . . . . . . . . -143.33 123.51 13.72 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.495 -0.753 . . . . 27.4 110.117 -179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' R' R ' 162' ' ' ILE . . . . . . . . . . . . . 92.2 mt -87.54 81.14 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.406 -0.809 . . . . 24.27 110.072 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' R' R ' 163' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' R' ' 165' ' ' GLU . 15.3 t0 -72.81 92.47 1.59 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.422 -0.799 . . . . 36.08 110.234 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 164' ' ' ASP . . . . . . . . . . . . . 73.2 m-20 54.09 -89.03 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.521 -0.737 . . . . 46.08 110.574 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' R' R ' 165' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' R' ' 163' ' ' ASP . 29.7 mt-10 -124.68 35.94 4.7 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.151 -0.968 . . . . 50.94 110.196 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 166' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -135.72 117.28 14.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.427 -0.796 . . . . 47.28 110.358 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' R' R ' 167' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -101.02 120.0 39.56 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.396 -0.815 . . . . 40.47 110.164 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' R' R ' 168' ' ' TYR . . . . . . . . . . . . . 25.2 p90 -157.56 158.48 30.6 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.199 -0.938 . . . . 30.21 110.436 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' R' R ' 169' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.74 133.01 19.51 Favored 'Trans proline' 0 C--N 1.31 -1.5 0 O-C-N 123.9 1.474 . . . . 32.76 110.471 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' R' R ' 170' ' ' TRP . . . . . 0.469 ' CZ2' ' HG3' ' R' ' 144' ' ' LYS . 66.9 t90 -159.83 119.42 2.89 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.471 -0.768 . . . . 32.79 109.925 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 171' ' ' THR . . . . . . . . . . . . . 46.3 m -81.14 112.62 34.41 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.419 -0.801 . . . . 36.92 110.188 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' R' R ' 172' ' ' PRO . . . . . 0.578 ' HB2' ' CD2' ' R' ' 142' ' ' PHE . 47.5 Cg_endo -73.75 158.82 46.44 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.68 1.358 . . . . 33.54 110.552 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 173' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -88.88 144.98 33.78 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.429 -0.795 . . . . 45.76 109.951 179.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' R' R ' 174' ' ' PRO . . . . . 0.41 ' HB3' ' HA ' ' R' ' 133' ' ' CYS . 45.3 Cg_endo -71.8 -10.32 26.2 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 123.639 1.336 . . . . 29.63 110.404 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 175' ' ' SER . . . . . . . . . . . . . 53.1 p -103.47 -17.58 15.16 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.275 -0.891 . . . . 35.7 110.34 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' R' R ' 176' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -103.5 43.21 1.1 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.256 -0.903 . . . . 39.65 110.419 -179.74 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' R' R ' 177' ' ' VAL . . . . . 0.709 ' O ' HG11 ' R' ' 127' ' ' VAL . 10.4 p -117.77 127.19 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.367 -0.833 . . . . 20.61 109.961 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 178' ' ' LEU . . . . . 0.581 HD21 ' CG1' ' S' ' 396' ' ' VAL . 46.0 mt -91.53 -61.15 1.71 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.373 -0.829 . . . . 15.58 109.419 179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 179' ' ' VAL . . . . . 0.73 HG22 HG12 ' R' ' 126' ' ' VAL . 67.9 t -114.73 144.64 21.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.602 -0.686 . . . . 17.4 109.419 179.488 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 180' ' ' PHE . . . . . 0.433 ' CE2' ' HE1' ' R' ' 132' ' ' MET . 43.8 p90 -152.12 163.37 39.5 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.271 -0.893 . . . . 20.16 110.551 -179.763 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 181' ' ' VAL . . . . . . . . . . . . . 66.8 t -113.16 111.52 50.26 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.456 -0.778 . . . . 17.69 109.833 179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' R' R ' 182' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.06 149.48 52.61 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.577 1.304 . . . . 17.81 110.366 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' R' R ' 183' ' ' TYR . . . . . 0.735 ' O ' ' C ' ' R' ' 184' ' ' ASP . 79.1 m-85 -59.03 175.51 0.28 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.432 -0.792 . . . . 28.01 110.571 -179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 184' ' ' ASP . . . . . 0.735 ' C ' ' O ' ' R' ' 183' ' ' TYR . 1.9 m-20 -13.08 -75.98 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.442 -0.786 . . . . 58.64 110.297 -178.021 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 185' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.503 2.213 0 CA-C-O 121.185 0.517 . . . . 80.42 111.807 179.073 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' R' R ' 193' ' ' LYS . . . . . 0.424 ' HA ' ' NE2' ' R' ' 197' ' ' GLN . 49.1 mmtt . . . . . 0 N--CA 1.491 1.596 0 CA-C-O 120.949 0.404 . . . . 49.5 110.112 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' R' R ' 194' ' ' ALA . . . . . 0.762 ' HB3' ' HA ' ' R' ' 119' ' ' SER . . . -178.03 -149.79 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.117 -0.989 . . . . 40.4 110.102 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 195' ' ' LYS . . . . . . . . . . . . . 1.2 mmmp? -86.64 -88.29 0.13 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.369 -0.832 . . . . 34.6 110.304 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' R' R ' 196' ' ' VAL . . . . . 0.621 HG23 ' CB ' ' R' ' 119' ' ' SER . 27.0 m -70.01 69.49 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.239 -0.913 . . . . 33.27 110.614 -179.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' R' R ' 197' ' ' GLN . . . . . 0.605 ' HG2' ' HB3' ' R' ' 194' ' ' ALA . 0.0 OUTLIER -157.37 -29.74 0.08 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.154 -0.966 . . . . 41.58 110.72 179.895 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' R' R ' 198' ' ' ARG . . . . . . . . . . . . . 1.6 ttm180 -75.75 165.64 24.73 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.041 -1.037 . . . . 38.65 110.17 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' R' R ' 199' ' ' LYS . . . . . . . . . . . . . 1.6 mppt? -94.85 73.41 3.55 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.364 -0.835 . . . . 36.77 109.925 179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' R' R ' 200' ' ' LEU . . . . . . . . . . . . . 38.2 mt -60.97 -173.04 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.359 -0.838 . . . . 33.08 110.15 -179.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' R' R ' 201' ' ' LYS . . . . . 0.5 ' HA ' ' CA ' ' S' ' 297' ' ' GLY . 11.5 tttt . . . . . 0 N--CA 1.492 1.661 0 O-C-N 121.342 -0.849 . . . . 44.32 110.281 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' S' S ' 229' ' ' MET . . . . . . . . . . . . . 2.4 ptt? . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 121.173 0.511 . . . . 51.83 110.202 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' S' S ' 230' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -97.32 142.75 28.81 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.369 -0.832 . . . . 54.13 110.183 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' S' S ' 231' ' ' LEU . . . . . . . . . . . . . 68.2 mt -134.09 141.0 46.99 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.312 -0.868 . . . . 33.04 110.325 -179.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' S' S ' 232' ' ' THR . . . . . 0.416 ' O ' ' HA ' ' S' ' 355' ' ' THR . 40.0 m -89.22 103.27 15.9 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.438 -0.789 . . . . 26.92 110.039 179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 233' ' ' LEU . . . . . 0.674 HD22 ' CE2' ' S' ' 262' ' ' TYR . 79.9 mt -55.91 179.29 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.471 -0.768 . . . . 13.78 110.483 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 234' ' ' TYR . . . . . 0.447 ' CG ' ' N ' ' S' ' 235' ' ' ASN . 35.5 p90 -65.02 -35.68 81.95 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.412 -0.805 . . . . 26.08 110.163 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 235' ' ' ASN . . . . . 0.447 ' N ' ' CG ' ' S' ' 234' ' ' TYR . 50.7 p30 -74.35 -7.38 52.65 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.357 -0.839 . . . . 20.04 110.511 -179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 236' ' ' GLY . . . . . . . . . . . . . . . 95.71 -20.0 51.78 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.769 -1.332 . . . . 22.71 109.769 179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' S' S ' 237' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -52.91 145.64 12.29 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.216 -1.167 . . . . 35.44 110.215 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' S' S ' 238' ' ' LYS . . . . . . . . . . . . . 44.2 mttt -102.17 127.99 48.86 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.438 -0.789 . . . . 32.56 110.341 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' S' S ' 239' ' ' LYS . . . . . 0.406 ' HG2' ' CZ ' ' S' ' 241' ' ' PHE . 9.0 ttmt -132.35 144.45 50.55 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.371 -0.83 . . . . 26.68 110.002 179.648 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 240' ' ' THR . . . . . . . . . . . . . 52.5 m -101.95 132.23 47.89 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.307 -0.871 . . . . 41.02 110.36 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' S' S ' 241' ' ' PHE . . . . . 0.406 ' CZ ' ' HG2' ' S' ' 239' ' ' LYS . 96.0 m-85 -117.97 137.69 52.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.431 -0.793 . . . . 28.62 110.188 179.809 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 242' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -96.36 161.79 13.78 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.32 -0.862 . . . . 47.89 110.241 -179.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' S' S ' 243' ' ' SER . . . . . . . . . . . . . 71.5 m -90.58 151.57 21.26 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.376 -0.827 . . . . 45.09 110.207 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' S' S ' 244' ' ' ARG . . . . . . . . . . . . . 1.4 mtp85 -129.73 126.7 22.72 Favored Pre-proline 0 N--CA 1.493 1.715 0 O-C-N 121.307 -0.871 . . . . 42.49 110.301 -179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' S' S ' 245' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.33 161.03 43.71 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 O-C-N 123.651 1.343 . . . . 35.68 110.538 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' S' S ' 246' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -132.9 97.91 4.16 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.381 -0.824 . . . . 51.88 109.827 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' S' S ' 247' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -110.47 -22.2 11.78 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.364 -0.835 . . . . 53.69 110.68 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' S' S ' 248' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -117.28 43.65 2.28 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.187 -0.946 . . . . 55.79 110.719 -179.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' S' S ' 249' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 48.84 38.38 11.9 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.402 -0.811 . . . . 49.45 110.338 179.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' S' S ' 250' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -90.6 28.94 1.38 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.544 -0.722 . . . . 36.86 110.385 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' S' S ' 251' ' ' ALA . . . . . . . . . . . . . . . -53.75 -43.24 68.97 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.271 -0.893 . . . . 29.69 109.643 179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' S' S ' 252' ' ' TRP . . . . . 0.427 ' CZ2' ' HB3' ' S' ' 294' ' ' LEU . 67.9 p-90 -61.74 -33.95 74.97 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.465 -0.772 . . . . 41.12 109.812 179.402 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 253' ' ' LEU . . . . . 0.402 ' N ' ' CD2' ' S' ' 252' ' ' TRP . 23.3 tp -70.14 -47.21 62.68 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.349 -0.845 . . . . 24.89 109.995 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 254' ' ' ASN . . . . . . . . . . . . . 98.9 m-20 -56.16 -42.45 77.04 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.31 -0.869 . . . . 35.65 109.956 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' S' S ' 255' ' ' ALA . . . . . . . . . . . . . . . -59.58 -48.17 82.7 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.432 -0.793 . . . . 22.73 110.025 179.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' S' S ' 256' ' ' ILE . . . . . 0.503 HG12 HD11 ' S' ' 304' ' ' ILE . 79.6 mt -62.34 -40.66 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 O-C-N 121.341 -0.85 . . . . 28.85 109.957 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 257' ' ' LEU . . . . . 0.4 ' CD2' ' HB3' ' S' ' 268' ' ' PHE . 19.2 mt -61.57 -44.47 96.96 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.359 -0.838 . . . . 23.07 110.17 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 258' ' ' GLN . . . . . 0.5 ' HB3' ' CD2' ' S' ' 351' ' ' PHE . 53.5 mm-40 -65.06 -45.41 85.47 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.42 -0.8 . . . . 29.78 109.851 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 259' ' ' LEU . . . . . 0.42 ' O ' HG22 ' S' ' 263' ' ' VAL . 19.8 tp -58.72 -36.33 74.11 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.36 -0.838 . . . . 17.94 109.433 179.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 260' ' ' PHE . . . . . 0.531 ' CE2' HD21 ' S' ' 311' ' ' LEU . 3.1 m-85 -62.81 -45.27 93.4 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.619 -0.676 . . . . 30.57 109.833 179.466 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 261' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -62.18 -29.67 70.52 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.476 -0.765 . . . . 41.34 110.006 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' S' S ' 262' ' ' TYR . . . . . 0.674 ' CE2' HD22 ' S' ' 233' ' ' LEU . 8.7 t80 -71.29 -44.61 64.86 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.418 -0.802 . . . . 26.03 110.067 179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 263' ' ' VAL . . . . . 0.42 HG22 ' O ' ' S' ' 259' ' ' LEU . 33.0 m -92.02 18.28 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.366 -0.834 . . . . 22.8 110.38 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 264' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 52.76 70.63 0.56 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.217 -0.927 . . . . 44.03 110.678 -179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' S' S ' 265' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -111.84 109.19 55.34 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.383 -0.823 . . . . 35.61 109.657 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' S' S ' 266' ' ' PRO . . . . . 0.476 ' HA ' ' HB2' ' S' ' 269' ' ' ASP . 49.3 Cg_endo -75.29 0.37 9.11 Favored 'Trans proline' 0 C--N 1.311 -1.403 0 O-C-N 123.592 1.312 . . . . 37.67 111.793 -179.109 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 267' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -56.45 -67.71 0.28 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.74 -1.225 . . . . 41.49 110.164 -179.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 268' ' ' PHE . . . . . 0.4 ' HB3' ' CD2' ' S' ' 257' ' ' LEU . 22.4 m-85 -92.93 39.87 1.05 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.201 -0.937 . . . . 50.76 110.071 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 269' ' ' ASP . . . . . 0.476 ' HB2' ' HA ' ' S' ' 266' ' ' PRO . 0.9 OUTLIER -75.95 -33.26 59.8 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.375 -0.828 . . . . 61.86 109.765 179.567 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' S' S ' 270' ' ' TRP . . . . . 0.506 ' CE2' HG23 ' S' ' 271' ' ' VAL . 51.0 p-90 -73.9 -4.37 34.59 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.312 -0.867 . . . . 39.85 110.483 179.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 271' ' ' VAL . . . . . 0.506 HG23 ' CE2' ' S' ' 270' ' ' TRP . 46.4 t -109.49 -32.66 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.151 -0.968 . . . . 39.18 110.073 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 272' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -78.6 -36.53 44.09 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.325 -0.859 . . . . 40.02 110.523 -179.613 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' S' S ' 273' ' ' SER . . . . . . . . . . . . . 70.8 m -103.6 56.11 0.74 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.264 -0.898 . . . . 47.2 110.286 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' S' S ' 274' ' ' SER . . . . . . . . . . . . . 6.9 t -133.03 141.25 40.25 Favored Pre-proline 0 N--CA 1.492 1.672 0 O-C-N 121.35 -0.844 . . . . 47.61 110.155 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' S' S ' 275' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.7 -18.89 21.85 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 O-C-N 123.629 1.331 . . . . 45.28 110.594 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' S' S ' 276' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -99.86 140.85 33.47 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.317 -0.864 . . . . 57.27 110.314 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' S' S ' 277' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -71.68 97.69 1.79 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.476 -0.765 . . . . 37.28 110.309 -179.873 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' S' S ' 278' ' ' LEU . . . . . . . . . . . . . 86.7 mt -97.0 33.76 1.85 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.397 -0.815 . . . . 43.88 109.984 -179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' S' S ' 279' ' ' THR . . . . . . . . . . . . . 74.8 m -63.98 -60.19 3.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.481 -0.762 . . . . 50.05 110.24 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' S' S ' 280' ' ' LEU . . . . . 0.729 ' HA ' HD12 ' S' ' 283' ' ' ILE . 13.6 mt -51.58 -39.9 58.77 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.31 -0.869 . . . . 54.12 110.254 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 281' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.35 -49.71 74.47 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.526 -0.734 . . . . 65.28 110.143 179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 282' ' ' ALA . . . . . . . . . . . . . . . -58.99 -33.86 71.17 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.548 -0.72 . . . . 46.51 110.506 -179.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' S' S ' 283' ' ' ILE . . . . . 0.729 HD12 ' HA ' ' S' ' 280' ' ' LEU . 85.7 mt -66.35 -50.84 64.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.287 -0.883 . . . . 47.3 110.138 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 284' ' ' LYS . . . . . . . . . . . . . 33.6 tttp -50.6 -57.57 7.87 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.487 -0.758 . . . . 50.72 110.384 179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' S' S ' 285' ' ' GLN . . . . . 0.524 ' HG2' HD12 ' S' ' 289' ' ' LEU . 34.4 tt0 -51.35 -46.42 62.68 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.494 -0.754 . . . . 68.47 110.352 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 286' ' ' LEU . . . . . . . . . . . . . 19.0 mt -59.96 -44.48 94.41 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.417 -0.802 . . . . 36.62 110.287 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' S' S ' 287' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -62.76 -35.26 79.24 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.326 -0.859 . . . . 46.64 110.088 179.758 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' S' S ' 288' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -76.26 -21.06 56.78 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.437 -0.789 . . . . 46.45 110.263 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' S' S ' 289' ' ' LEU . . . . . 0.524 HD12 ' HG2' ' S' ' 285' ' ' GLN . 30.7 mt -97.33 -21.69 17.07 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.281 -0.887 . . . . 35.09 110.54 -179.647 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 290' ' ' THR . . . . . 0.41 HG22 ' HB3' ' S' ' 306' ' ' ASN . 81.3 p -114.77 -28.49 7.07 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.249 -0.907 . . . . 38.61 110.435 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 291' ' ' GLY . . . . . . . . . . . . . . . 79.44 11.05 85.3 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.879 -1.288 . . . . 36.77 109.879 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' S' S ' 292' ' ' LEU . . . . . . . . . . . . . 84.9 mt -96.55 145.82 25.36 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.238 -1.154 . . . . 35.33 109.754 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' S' S ' 293' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -77.32 102.29 6.68 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.161 -0.962 . . . . 48.7 110.275 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' S' S ' 294' ' ' LEU . . . . . 0.427 ' HB3' ' CZ2' ' S' ' 252' ' ' TRP . 55.2 mt -106.84 51.75 0.73 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.472 -0.768 . . . . 42.61 110.117 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 295' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -112.53 -11.2 13.63 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.326 -0.859 . . . . 55.49 110.485 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 296' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -144.34 48.56 1.36 Allowed 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.177 -0.952 . . . . 75.68 110.271 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' S' S ' 297' ' ' GLY . . . . . 0.5 ' CA ' ' HA ' ' R' ' 201' ' ' LYS . . . 96.88 145.19 18.73 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.457 -1.457 . . . . 49.44 109.457 179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 298' ' ' GLY . . . . . . . . . . . . . . . -163.85 156.94 29.02 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.849 -1.3 . . . . 41.11 109.849 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' S' S ' 299' ' ' PRO . . . . . 0.486 ' O ' HG23 ' S' ' 303' ' ' VAL . 47.5 Cg_endo -73.81 118.27 5.37 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 123.91 1.479 . . . . 26.2 110.291 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 300' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.18 -15.57 31.86 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.529 1.278 . . . . 21.7 110.647 179.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' S' S ' 301' ' ' ALA . . . . . . . . . . . . . . . -80.7 -29.32 36.49 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.256 -0.903 . . . . 31.23 110.117 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' S' S ' 302' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.5 -40.62 18.96 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.406 -0.809 . . . . 38.99 109.993 179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 303' ' ' VAL . . . . . 0.486 HG23 ' O ' ' S' ' 299' ' ' PRO . 57.2 t -60.69 -35.52 64.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.398 -0.814 . . . . 18.63 110.147 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 304' ' ' ILE . . . . . 0.523 HD12 HG21 ' S' ' 379' ' ' VAL . 86.0 mt -79.33 -23.65 12.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.405 -0.809 . . . . 25.46 110.179 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 305' ' ' TRP . . . . . 0.413 ' CD2' ' HD3' ' S' ' 308' ' ' LYS . 68.9 t-105 -88.63 -14.53 37.24 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.32 -0.863 . . . . 33.4 110.521 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 306' ' ' ASN . . . . . 0.41 ' HB3' HG22 ' S' ' 290' ' ' THR . 10.3 m-80 -89.72 -13.56 36.59 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.218 -0.926 . . . . 36.97 110.369 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 307' ' ' ILE . . . . . 0.471 HG12 ' O ' ' S' ' 303' ' ' VAL . 36.9 pt -125.08 45.62 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.21 -0.931 . . . . 30.81 110.059 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 308' ' ' LYS . . . . . 0.413 ' HD3' ' CD2' ' S' ' 305' ' ' TRP . 1.5 mtmp? -73.5 -37.75 65.58 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.339 -0.851 . . . . 46.52 110.12 -179.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 309' ' ' HIS . . . . . 0.496 ' CD2' ' HG ' ' S' ' 310' ' ' LEU . 55.5 p-80 -73.22 -8.26 55.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.318 -0.864 . . . . 51.03 110.065 179.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 310' ' ' LEU . . . . . 0.496 ' HG ' ' CD2' ' S' ' 309' ' ' HIS . 52.6 mt -99.31 -12.92 19.9 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.312 -0.867 . . . . 36.16 109.975 179.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 311' ' ' LEU . . . . . 0.531 HD21 ' CE2' ' S' ' 260' ' ' PHE . 10.8 mt -97.13 147.83 23.66 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.367 -0.833 . . . . 40.0 110.499 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 312' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -81.6 -16.24 52.15 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.31 -0.869 . . . . 54.18 109.682 179.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' S' S ' 313' ' ' THR . . . . . 0.829 HG23 ' HG2' ' S' ' 323' ' ' GLU . 92.7 m -87.95 151.66 22.64 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.371 -0.83 . . . . 25.61 110.098 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 314' ' ' GLY . . . . . . . . . . . . . . . -87.93 126.41 8.05 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.842 -1.303 . . . . 25.18 109.842 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' S' S ' 315' ' ' ILE . . . . . 0.666 HD13 ' HB ' ' S' ' 324' ' ' VAL . 50.8 mm -101.65 150.51 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.411 -1.052 . . . . 23.9 109.704 179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 316' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' S' ' 325' ' ' CYS . . . -157.09 -159.31 9.41 Favored Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.932 -1.267 . . . . 23.18 109.932 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 317' ' ' THR . . . . . 0.424 HG22 ' CG2' ' S' ' 326' ' ' VAL . 11.1 p -133.92 -173.01 3.13 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.447 -1.031 . . . . 27.98 109.958 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.58 -56.19 25.08 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.265 -0.897 . . . . 28.1 109.858 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' S' S ' 319' ' ' SER . . . . . . . . . . . . . 1.2 m -59.93 -41.61 92.16 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.427 -0.796 . . . . 37.0 109.675 179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' S' S ' 320' ' ' ARG . . . . . . . . . . . . . 12.1 mtm180 -111.72 79.85 2.65 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.529 -0.732 . . . . 52.07 109.726 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' S' S ' 321' ' ' PRO . . . . . 0.885 ' HG2' ' O ' ' S' ' 386' ' ' GLU . 43.9 Cg_endo -71.44 171.51 16.05 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.883 1.465 . . . . 38.29 110.927 -179.429 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 322' ' ' SER . . . . . 0.447 ' HB2' ' O ' ' S' ' 321' ' ' PRO . 41.4 t 178.68 -148.15 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.783 0 N-CA-C 108.966 -0.753 . . . . 38.84 108.966 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 323' ' ' GLU . . . . . 0.829 ' HG2' HG23 ' S' ' 313' ' ' THR . 6.7 tp10 -62.85 -40.32 97.1 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.063 -1.023 . . . . 40.7 109.679 179.296 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 324' ' ' VAL . . . . . 0.666 ' HB ' HD13 ' S' ' 315' ' ' ILE . 72.7 t -141.27 135.03 31.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.396 -0.815 . . . . 20.34 109.46 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 325' ' ' CYS . . . . . 0.462 ' HB2' ' CE1' ' S' ' 380' ' ' PHE . 11.5 m -126.0 172.19 10.16 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.336 -0.853 . . . . 30.63 110.833 -179.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 326' ' ' VAL . . . . . 0.65 HG12 HG22 ' S' ' 379' ' ' VAL . 34.5 m -135.45 142.19 40.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.58 -0.7 . . . . 23.9 109.285 179.187 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 327' ' ' VAL . . . . . 0.595 HG11 ' O ' ' S' ' 377' ' ' VAL . 34.5 m -56.35 124.93 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.092 -1.005 . . . . 19.48 110.47 -179.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 328' ' ' ASP . . . . . . . . . . . . . 55.6 p-10 -119.28 11.48 12.28 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.45 -0.781 . . . . 26.43 110.465 179.751 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' S' S ' 329' ' ' GLY . . . . . . . . . . . . . . . 119.71 2.23 13.04 Favored Glycine 0 N--CA 1.492 2.387 0 N-CA-C 110.025 -1.23 . . . . 31.24 110.025 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' S' S ' 330' ' ' THR . . . . . . . . . . . . . 80.1 m -92.98 130.03 38.69 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.045 -1.268 . . . . 30.05 110.109 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' S' S ' 331' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -56.81 111.46 1.03 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.261 -0.899 . . . . 37.26 109.955 179.719 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' S' S ' 332' ' ' MET . . . . . . . . . . . . . 88.1 mmm -94.11 162.57 13.82 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.278 -0.889 . . . . 26.23 110.351 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' S' S ' 333' ' ' CYS . . . . . . . . . . . . . 26.2 m -137.19 150.07 47.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.535 -0.728 . . . . 23.56 110.019 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' S' S ' 334' ' ' LEU . . . . . 0.566 HD11 ' O ' ' S' ' 372' ' ' PRO . 0.1 OUTLIER -52.68 -24.75 9.15 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.339 -0.851 . . . . 28.93 110.522 179.881 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' S' S ' 335' ' ' ALA . . . . . . . . . . . . . . . -89.08 14.42 10.75 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.383 -0.823 . . . . 15.76 110.947 -179.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' S' S ' 336' ' ' ASP . . . . . 0.4 ' O ' ' HA ' ' S' ' 382' ' ' PRO . 70.4 m-20 -100.49 -17.14 17.28 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.1 -1.0 . . . . 34.92 110.186 179.546 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 337' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -152.46 170.85 19.12 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.299 -0.875 . . . . 19.03 110.017 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' S' S ' 338' ' ' HIS . . . . . 0.402 ' HB3' ' CZ ' ' S' ' 383' ' ' TYR . 13.5 p80 -120.76 10.44 10.96 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.416 -0.803 . . . . 18.82 110.497 179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 339' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' S' ' 352' ' ' ALA . . . -175.97 155.24 1.58 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.293 -0.879 . . . . 17.18 110.103 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 340' ' ' GLY . . . . . 0.401 ' CA ' ' O ' ' S' ' 379' ' ' VAL . . . 160.8 173.09 28.97 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.07 -1.212 . . . . 18.33 110.07 179.906 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 341' ' ' ILE . . . . . . . . . . . . . 84.4 mt -88.88 138.15 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.505 -0.997 . . . . 18.6 109.757 179.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' S' S ' 342' ' ' PHE . . . . . 0.493 ' CE2' ' HB3' ' S' ' 352' ' ' ALA . 70.0 m-85 -120.98 -178.41 3.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.26 -0.9 . . . . 23.44 110.428 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 343' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.85 93.42 4.19 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.41 -0.806 . . . . 35.59 109.989 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 344' ' ' LYS . . . . . 0.402 ' O ' ' HB3' ' S' ' 348' ' ' HIS . 0.3 OUTLIER -80.78 125.0 29.52 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.269 -0.894 . . . . 38.34 110.148 179.948 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' S' S ' 345' ' ' GLY . . . . . . . . . . . . . . . 62.79 -130.81 43.02 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 108.847 -1.701 . . . . 53.46 108.847 -179.439 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' S' S ' 346' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -132.79 150.8 52.12 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.199 -1.177 . . . . 70.91 110.073 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' S' S ' 347' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 53.35 35.36 20.14 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.335 -0.853 . . . . 47.32 110.437 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' S' S ' 348' ' ' HIS . . . . . 0.402 ' HB3' ' O ' ' S' ' 344' ' ' LYS . 46.2 t60 -150.15 155.82 40.49 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.294 -0.879 . . . . 41.72 110.311 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 349' ' ' ALA . . . . . 0.46 ' C ' HG13 ' S' ' 350' ' ' VAL . . . -149.74 151.32 33.43 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.346 -0.846 . . . . 22.91 110.463 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 350' ' ' VAL . . . . . 0.46 HG13 ' C ' ' S' ' 349' ' ' ALA . 34.6 m -149.11 169.6 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 O-C-N 121.443 -0.785 . . . . 21.09 110.024 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 351' ' ' PHE . . . . . 0.5 ' CD2' ' HB3' ' S' ' 258' ' ' GLN . 10.7 t80 -105.35 143.54 33.37 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.215 -0.928 . . . . 25.03 110.706 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 352' ' ' ALA . . . . . 0.493 ' HB3' ' CE2' ' S' ' 342' ' ' PHE . . . -147.66 151.69 36.59 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.646 -0.659 . . . . 23.81 109.732 179.63 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 353' ' ' CYS . . . . . . . . . . . . . 26.3 p -153.34 164.87 37.36 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.291 -0.881 . . . . 25.66 110.246 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' S' S ' 354' ' ' VAL . . . . . 0.547 HG22 ' CE2' ' S' ' 359' ' ' TRP . 56.8 t -75.99 118.5 22.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.381 -0.824 . . . . 34.27 109.967 179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 355' ' ' THR . . . . . 0.416 ' HA ' ' O ' ' S' ' 232' ' ' THR . 51.5 p -117.81 175.11 5.81 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.282 -0.886 . . . . 25.49 110.307 179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 356' ' ' SER . . . . . . . . . . . . . 62.0 p -62.15 -17.67 58.6 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.455 -0.778 . . . . 31.24 110.748 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' S' S ' 357' ' ' ASN . . . . . . . . . . . . . 45.8 m-20 -107.03 14.28 26.56 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.145 -0.972 . . . . 28.61 110.531 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' S' S ' 358' ' ' GLY . . . . . . . . . . . . . . . 111.86 -152.85 17.61 Favored Glycine 0 N--CA 1.492 2.406 0 N-CA-C 110.045 -1.222 . . . . 22.01 110.045 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' S' S ' 359' ' ' TRP . . . . . 0.547 ' CE2' HG22 ' S' ' 354' ' ' VAL . 15.4 m95 -91.35 116.73 29.08 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.45 -1.029 . . . . 25.54 110.176 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 360' ' ' TYR . . . . . 0.413 ' HA ' ' HA ' ' S' ' 369' ' ' PRO . 1.3 m-85 -103.52 165.83 10.8 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.338 -0.851 . . . . 40.53 110.032 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 361' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' S' ' 351' ' ' PHE . . . -140.1 130.1 24.84 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.361 -0.837 . . . . 18.04 110.268 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 362' ' ' ILE . . . . . . . . . . . . . 89.1 mt -95.61 83.64 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.409 -0.807 . . . . 15.64 110.061 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' S' S ' 363' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' S' ' 365' ' ' GLU . 11.8 t0 -75.25 94.51 3.01 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.422 -0.799 . . . . 35.03 110.201 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 364' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 53.98 -89.43 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.551 -0.718 . . . . 46.72 110.511 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' S' S ' 365' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' S' ' 363' ' ' ASP . 23.7 mt-10 -122.7 19.2 10.31 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.075 -1.016 . . . . 56.2 110.245 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 366' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -117.98 124.96 49.46 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.169 -0.957 . . . . 51.02 110.395 -179.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' S' S ' 367' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -107.03 127.05 53.12 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.344 -0.847 . . . . 37.59 110.137 179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' S' S ' 368' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -165.38 159.5 13.99 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.247 -0.908 . . . . 31.47 110.481 179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' S' S ' 369' ' ' PRO . . . . . 0.413 ' HA ' ' HA ' ' S' ' 360' ' ' TYR . 46.8 Cg_endo -72.8 139.61 30.8 Favored 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.859 1.452 . . . . 28.85 110.538 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 370' ' ' TRP . . . . . . . . . . . . . 67.6 t90 -167.2 113.56 0.76 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.347 -0.846 . . . . 26.94 109.942 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' S' S ' 371' ' ' THR . . . . . . . . . . . . . 59.9 m -74.81 113.02 20.37 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.417 -0.802 . . . . 20.19 110.01 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' S' S ' 372' ' ' PRO . . . . . 0.566 ' O ' HD11 ' S' ' 334' ' ' LEU . 48.1 Cg_endo -73.52 157.09 49.39 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 O-C-N 123.597 1.314 . . . . 28.68 110.624 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 373' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -90.56 147.15 35.76 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.492 -0.755 . . . . 35.72 109.896 179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' S' S ' 374' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -76.03 -6.27 17.18 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 O-C-N 123.652 1.343 . . . . 30.89 110.459 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' S' S ' 375' ' ' SER . . . . . . . . . . . . . 68.6 p -104.41 -16.9 14.97 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.22 -0.925 . . . . 29.41 110.451 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' S' S ' 376' ' ' ASP . . . . . . . . . . . . . 75.8 m-20 -106.51 43.02 1.19 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.231 -0.918 . . . . 32.89 110.217 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' S' S ' 377' ' ' VAL . . . . . 0.595 ' O ' HG11 ' S' ' 327' ' ' VAL . 7.3 p -114.65 147.27 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.374 -0.829 . . . . 24.33 110.216 -179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 378' ' ' LEU . . . . . . . . . . . . . 52.3 mt -115.99 -58.01 2.15 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.348 -0.845 . . . . 24.37 109.638 179.586 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' S' S ' 379' ' ' VAL . . . . . 0.65 HG22 HG12 ' S' ' 326' ' ' VAL . 61.3 t -120.64 132.4 70.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.471 -0.768 . . . . 18.02 109.443 179.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 380' ' ' PHE . . . . . 0.462 ' CE1' ' HB2' ' S' ' 325' ' ' CYS . 14.4 p90 -142.63 174.0 11.03 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.309 -0.869 . . . . 29.35 110.634 -179.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 381' ' ' VAL . . . . . . . . . . . . . 58.4 t -120.1 107.32 39.81 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.578 -0.701 . . . . 16.34 109.398 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' S' S ' 382' ' ' PRO . . . . . 0.4 ' HA ' ' O ' ' S' ' 336' ' ' ASP . 45.7 Cg_endo -71.26 145.65 49.16 Favored 'Trans proline' 0 C--N 1.31 -1.461 0 O-C-N 123.626 1.329 . . . . 20.94 110.759 -179.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 383' ' ' TYR . . . . . 0.402 ' CZ ' ' HB3' ' S' ' 338' ' ' HIS . 88.3 m-85 -61.08 -53.47 56.67 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.398 -0.814 . . . . 28.93 109.869 179.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 384' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -103.65 130.03 51.05 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.482 -0.761 . . . . 47.03 110.358 -176.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' S' S ' 385' ' ' GLN . . . . . 0.409 ' O ' ' O ' ' S' ' 386' ' ' GLU . 2.6 tt0 -69.13 3.67 2.01 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.421 -0.799 . . . . 46.69 110.22 177.199 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 386' ' ' GLU . . . . . 0.885 ' O ' ' HG2' ' S' ' 321' ' ' PRO . 16.0 pt-20 -44.69 165.79 0.14 Allowed Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.348 -0.845 . . . . 50.25 109.572 179.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 387' ' ' PRO . . . . . 0.553 ' O ' ' C ' ' S' ' 388' ' ' LEU . 38.7 Cg_endo -67.4 -11.43 32.13 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 O-C-N 123.752 1.396 . . . . 34.39 110.61 -177.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 388' ' ' LEU . . . . . 0.574 ' O ' ' CB ' ' S' ' 389' ' ' ASN . 0.2 OUTLIER 32.18 80.99 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.428 -0.795 . . . . 38.01 110.137 -179.681 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' S' S ' 389' ' ' ASN . . . . . 0.574 ' CB ' ' O ' ' S' ' 388' ' ' LEU . 2.9 t30 75.03 169.14 0.29 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.274 -0.891 . . . . 45.82 110.155 -179.531 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 390' ' ' GLY . . . . . 0.488 ' O ' ' CB ' ' S' ' 391' ' ' GLU . . . 147.19 -91.51 0.15 Allowed Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.622 -1.391 . . . . 33.46 109.622 -179.765 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 391' ' ' GLU . . . . . 0.488 ' CB ' ' O ' ' S' ' 390' ' ' GLY . 2.5 tt0 68.73 -66.49 0.24 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.377 -1.072 . . . . 56.58 110.153 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 392' ' ' TRP . . . . . 0.569 ' O ' HG13 ' S' ' 396' ' ' VAL . 41.7 p-90 -50.89 -26.56 6.0 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.385 -0.822 . . . . 31.43 110.342 -179.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 393' ' ' LYS . . . . . 0.441 ' N ' ' CD2' ' S' ' 392' ' ' TRP . 1.9 ptmt -63.91 -22.41 66.91 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.289 -0.882 . . . . 39.42 110.324 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 394' ' ' ALA . . . . . 0.448 ' O ' ' CG ' ' S' ' 398' ' ' ARG . . . -93.43 -18.02 22.81 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.371 -0.83 . . . . 34.33 110.068 -179.836 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 395' ' ' LYS . . . . . 0.573 ' CB ' HD11 ' R' ' 143' ' ' LEU . 10.5 mmtt -94.03 2.4 56.05 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.459 -0.776 . . . . 60.09 110.231 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 396' ' ' VAL . . . . . 0.581 ' CG1' HD21 ' R' ' 178' ' ' LEU . 32.6 m -113.94 -38.8 2.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.335 -0.853 . . . . 35.5 110.616 179.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 397' ' ' GLN . . . . . 0.581 ' HA ' ' N ' ' R' ' 99' ' ' PRO . 1.6 pp0? -84.81 39.97 0.78 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.128 -0.983 . . . . 49.96 110.641 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' S' S ' 398' ' ' ARG . . . . . 0.869 ' CB ' ' HA ' ' R' ' 147' ' ' GLU . 0.9 OUTLIER -116.0 -144.13 0.38 Allowed 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.254 -0.904 . . . . 43.42 110.737 -179.77 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' S' S ' 399' ' ' LYS . . . . . 0.792 ' HB3' ' CA ' ' R' ' 97' ' ' GLY . 0.5 OUTLIER 175.94 177.87 0.21 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.405 -0.809 . . . . 55.31 110.051 -179.666 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' S' S ' 400' ' ' LEU . . . . . 0.711 ' HG ' HD21 ' R' ' 46' ' ' ASN . 0.8 OUTLIER -42.95 -30.9 0.45 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.329 -0.857 . . . . 41.03 110.292 178.291 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' S' S ' 401' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.683 0 O-C-N 121.329 -0.857 . . . . 61.97 110.126 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' R' R ' 29' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 121.213 0.53 . . . . 32.14 110.248 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' R' R ' 30' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -96.35 141.15 30.01 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.324 -0.86 . . . . 43.36 110.247 179.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' R' R ' 31' ' ' LEU . . . . . . . . . . . . . 65.4 mt -134.86 140.54 45.9 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.293 -0.879 . . . . 22.93 110.332 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' R' R ' 32' ' ' THR . . . . . . . . . . . . . 69.0 m -87.55 110.61 20.48 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.337 -0.852 . . . . 22.34 109.983 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' R' R ' 33' ' ' LEU . . . . . 0.594 HD22 ' CE2' ' R' ' 62' ' ' TYR . 80.2 mt -62.52 -172.74 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.237 -0.915 . . . . 21.39 110.209 -179.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 34' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -74.59 -29.4 61.31 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.375 -0.828 . . . . 34.4 110.41 -179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' R' R ' 35' ' ' ASN . . . . . . . . . . . . . 48.2 p30 -77.84 -1.74 33.11 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.322 -0.861 . . . . 30.28 110.665 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' R' R ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.1 -16.53 59.4 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 109.8 -1.32 . . . . 36.25 109.8 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' R' R ' 37' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -59.0 161.81 4.73 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.256 -1.144 . . . . 53.8 110.383 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' R' R ' 38' ' ' LYS . . . . . . . . . . . . . 57.0 mttt -117.86 135.8 53.86 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.43 -0.794 . . . . 49.91 110.175 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' R' R ' 39' ' ' LYS . . . . . 0.404 ' HG2' ' CZ ' ' R' ' 41' ' ' PHE . 8.1 ttmt -138.77 143.65 39.07 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.427 -0.796 . . . . 35.69 110.241 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 40' ' ' THR . . . . . . . . . . . . . 23.6 m -102.56 127.97 49.41 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.424 -0.798 . . . . 34.84 110.226 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' R' R ' 41' ' ' PHE . . . . . 0.404 ' CZ ' ' HG2' ' R' ' 39' ' ' LYS . 96.6 m-85 -113.09 132.63 55.35 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.386 -0.821 . . . . 34.42 110.21 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 42' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -93.21 140.86 29.06 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.348 -0.845 . . . . 51.46 110.263 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' R' R ' 43' ' ' SER . . . . . . . . . . . . . 54.2 m -70.74 141.83 51.47 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.511 -0.743 . . . . 41.84 110.196 -179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' R' R ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.78 125.38 29.56 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.347 -0.845 . . . . 33.82 109.984 179.646 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 45' ' ' PRO . . . . . 0.425 ' HG2' ' ND2' ' R' ' 77' ' ' ASN . 45.6 Cg_endo -72.11 151.05 55.03 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 123.611 1.321 . . . . 30.27 110.649 -179.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 46' ' ' ASN . . . . . 0.677 ' ND2' HD13 ' S' ' 400' ' ' LEU . 52.1 t-20 -124.27 109.95 14.02 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.456 -0.777 . . . . 35.1 110.011 179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 47' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -120.33 -34.84 3.56 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.339 -0.85 . . . . 42.81 110.493 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' R' R ' 48' ' ' HIS . . . . . 0.44 ' NE2' HD11 ' R' ' 80' ' ' LEU . 73.3 m80 -105.79 45.23 0.98 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.221 -0.925 . . . . 49.97 110.216 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 49' ' ' ASP . . . . . 0.764 ' HA ' HD22 ' S' ' 400' ' ' LEU . 37.7 m-20 50.28 34.73 9.26 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.358 -0.839 . . . . 61.32 110.197 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 50' ' ' ASN . . . . . 0.4 ' OD1' ' HA ' ' R' ' 46' ' ' ASN . 15.0 p-10 -86.3 43.78 1.09 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.379 -0.826 . . . . 51.5 110.685 -179.594 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 51' ' ' ALA . . . . . 0.708 ' CB ' ' HB2' ' S' ' 400' ' ' LEU . . . -66.1 -46.12 78.73 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.199 -0.938 . . . . 38.77 109.474 179.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 52' ' ' TRP . . . . . 0.497 ' HB3' ' NH1' ' S' ' 398' ' ' ARG . 68.1 p-90 -58.38 -38.42 77.25 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.455 -0.778 . . . . 26.24 110.055 179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 53' ' ' LEU . . . . . 0.484 ' N ' ' CD2' ' R' ' 52' ' ' TRP . 23.1 tp -66.75 -46.62 74.81 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.424 -0.798 . . . . 26.75 109.984 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 54' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -55.35 -41.52 72.65 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.304 -0.872 . . . . 35.02 110.111 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' R' R ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.17 -46.08 91.99 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.448 -0.782 . . . . 24.47 110.157 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' R' R ' 56' ' ' ILE . . . . . 0.431 HG12 HD11 ' R' ' 104' ' ' ILE . 76.0 mt -62.2 -42.28 94.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.322 -0.861 . . . . 26.03 109.888 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 57' ' ' LEU . . . . . . . . . . . . . 22.4 mt -60.27 -45.63 92.63 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.28 -0.888 . . . . 26.77 109.68 179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' R' R ' 58' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -63.87 -46.59 84.25 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.481 -0.762 . . . . 22.32 109.571 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' R' R ' 59' ' ' LEU . . . . . 0.43 ' HA ' ' HE2' ' R' ' 151' ' ' PHE . 24.0 tp -61.34 -37.84 84.73 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.317 -0.864 . . . . 20.55 109.389 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 60' ' ' PHE . . . . . 0.528 ' CE2' HD21 ' R' ' 111' ' ' LEU . 2.8 m-85 -61.05 -44.72 96.96 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.635 -0.666 . . . . 20.08 109.913 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 61' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -63.18 -36.15 82.66 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.488 -0.758 . . . . 18.8 110.443 -179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' R' R ' 62' ' ' TYR . . . . . 0.594 ' CE2' HD22 ' R' ' 33' ' ' LEU . 9.1 t80 -63.09 -41.81 99.48 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.234 -0.916 . . . . 26.45 110.199 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 63' ' ' VAL . . . . . 0.406 ' H ' HG22 ' R' ' 63' ' ' VAL . 30.5 m -93.38 20.35 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.422 -0.799 . . . . 29.75 110.252 179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 64' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 53.03 75.56 0.24 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.316 -0.865 . . . . 35.52 110.531 179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' R' R ' 65' ' ' GLU . . . . . 0.442 ' HG2' ' CD2' ' R' ' 60' ' ' PHE . 14.3 tp10 -116.3 104.06 52.33 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.348 -0.845 . . . . 29.89 109.901 179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 66' ' ' PRO . . . . . 0.48 ' HA ' ' HB2' ' R' ' 69' ' ' ASP . 46.3 Cg_endo -73.57 -5.8 17.69 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.775 1.408 . . . . 21.37 111.093 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 67' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -52.13 -61.44 2.27 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.116 -0.99 . . . . 23.85 110.43 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 68' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -98.23 36.58 1.57 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.306 -0.871 . . . . 28.07 110.484 -179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' R' R ' 69' ' ' ASP . . . . . 0.48 ' HB2' ' HA ' ' R' ' 66' ' ' PRO . 11.7 t0 -72.3 -33.35 67.32 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.23 -0.918 . . . . 43.76 110.097 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 70' ' ' TRP . . . . . 0.477 ' CE2' ' CG2' ' R' ' 71' ' ' VAL . 47.7 p-90 -73.24 -4.03 30.5 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.313 -0.867 . . . . 33.06 110.74 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 71' ' ' VAL . . . . . 0.556 HG11 ' HB2' ' R' ' 82' ' ' ALA . 40.8 t -109.78 -27.41 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.078 -1.014 . . . . 31.7 109.674 179.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 72' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -86.62 -48.76 8.04 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.347 -0.845 . . . . 33.58 110.288 179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' R' R ' 73' ' ' SER . . . . . . . . . . . . . 69.9 m -89.75 51.12 2.01 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.283 -0.886 . . . . 50.82 110.295 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' R' R ' 74' ' ' SER . . . . . . . . . . . . . 15.7 t -125.99 138.27 31.78 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.335 -0.853 . . . . 34.74 110.208 179.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.31 -25.02 16.02 Favored 'Trans proline' 0 C--N 1.311 -1.409 0 O-C-N 123.737 1.388 . . . . 35.7 110.341 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' R' R ' 76' ' ' GLU . . . . . . . . . . . . . 35.6 mm-40 -91.66 153.16 19.87 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.398 -0.814 . . . . 66.48 110.428 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' R' R ' 77' ' ' ASN . . . . . 0.425 ' ND2' ' HG2' ' R' ' 45' ' ' PRO . 22.2 t-20 -81.5 95.2 7.04 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.364 -0.835 . . . . 46.72 110.035 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 78' ' ' LEU . . . . . . . . . . . . . 96.3 mt -96.4 27.91 3.56 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.385 -0.822 . . . . 37.55 110.22 179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' R' R ' 79' ' ' THR . . . . . . . . . . . . . 29.4 m -56.18 -54.64 42.78 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.317 -0.865 . . . . 37.36 110.295 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' R' R ' 80' ' ' LEU . . . . . 0.603 ' HA ' HD12 ' R' ' 83' ' ' ILE . 15.8 mt -60.97 -23.13 65.1 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.351 -0.843 . . . . 35.83 110.478 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 81' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -79.55 -39.08 32.7 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.147 -0.971 . . . . 44.03 110.331 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' R' R ' 82' ' ' ALA . . . . . 0.556 ' HB2' HG11 ' R' ' 71' ' ' VAL . . . -69.5 -28.67 66.25 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.227 -0.921 . . . . 32.54 110.23 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 83' ' ' ILE . . . . . 0.603 HD12 ' HA ' ' R' ' 80' ' ' LEU . 78.2 mt -70.04 -46.1 74.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.221 -0.925 . . . . 32.02 110.342 -179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 84' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -55.21 -52.02 64.71 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.232 -0.918 . . . . 34.09 110.607 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' R' R ' 85' ' ' GLN . . . . . 0.533 ' HG2' HD12 ' R' ' 89' ' ' LEU . 31.9 tt0 -54.85 -46.81 74.7 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.203 -0.936 . . . . 25.94 110.269 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 86' ' ' LEU . . . . . . . . . . . . . 23.9 mt -58.74 -43.77 90.33 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.312 -0.867 . . . . 16.2 109.905 179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' R' R ' 87' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -65.38 -35.16 80.12 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.529 -0.732 . . . . 49.09 110.251 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' R' R ' 88' ' ' ASP . . . . . . . . . . . . . 31.3 m-20 -78.46 -19.03 54.0 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.381 -0.825 . . . . 28.61 110.51 -179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' R' R ' 89' ' ' LEU . . . . . 0.533 HD12 ' HG2' ' R' ' 85' ' ' GLN . 32.5 mt -96.24 -29.38 14.05 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.261 -0.899 . . . . 26.16 110.167 179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 90' ' ' THR . . . . . . . . . . . . . 59.2 p -105.68 -34.66 7.64 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.327 -0.858 . . . . 33.33 109.747 179.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' R' R ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.91 16.06 58.55 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.835 -1.306 . . . . 31.13 109.835 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' R' R ' 92' ' ' LEU . . . . . . . . . . . . . 97.0 mt -100.07 155.18 17.86 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.112 -1.228 . . . . 42.52 110.266 -179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' R' R ' 93' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -86.2 91.66 8.52 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.489 -0.757 . . . . 68.46 109.948 179.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' R' R ' 94' ' ' LEU . . . . . 0.457 ' HB3' ' CZ2' ' R' ' 52' ' ' TRP . 48.2 mt -99.51 53.0 0.94 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.147 -0.971 . . . . 44.63 110.368 -179.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 95' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.54 -38.67 6.37 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.348 -0.845 . . . . 67.16 110.34 -179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 96' ' ' GLU . . . . . 0.411 ' O ' ' CD ' ' S' ' 399' ' ' LYS . 24.7 mt-10 -113.83 44.11 1.69 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.316 -0.865 . . . . 67.02 110.337 -179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 97' ' ' GLY . . . . . 0.575 ' HA3' ' CB ' ' S' ' 399' ' ' LYS . . . 99.2 150.87 26.06 Favored Glycine 0 N--CA 1.491 2.35 0 N-CA-C 109.598 -1.401 . . . . 49.48 109.598 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 98' ' ' GLY . . . . . . . . . . . . . . . -166.28 159.99 33.42 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.245 -1.542 . . . . 36.57 109.245 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' R' R ' 99' ' ' PRO . . . . . 0.79 ' O ' HG23 ' R' ' 103' ' ' VAL . 44.9 Cg_endo -72.56 121.12 7.15 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 O-C-N 123.703 1.37 . . . . 30.41 110.435 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 100' ' ' PRO . . . . . 0.411 ' HA ' HD11 ' R' ' 56' ' ' ILE . 45.8 Cg_endo -72.27 -31.7 11.39 Favored 'Trans proline' 0 C--N 1.313 -1.32 0 O-C-N 123.567 1.299 . . . . 29.94 110.506 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 101' ' ' ALA . . . . . 0.476 ' HB2' ' HB3' ' R' ' 178' ' ' LEU . . . -69.97 -38.41 76.06 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.226 -0.921 . . . . 23.64 110.266 -179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 102' ' ' LEU . . . . . 0.423 HD23 HD21 ' R' ' 106' ' ' ASN . 0.1 OUTLIER -72.69 -40.82 65.94 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.367 -0.833 . . . . 20.31 110.324 -179.718 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' R' R ' 103' ' ' VAL . . . . . 0.79 HG23 ' O ' ' R' ' 99' ' ' PRO . 63.9 t -58.08 -40.15 75.79 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 O-C-N 121.281 -0.887 . . . . 16.33 109.934 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 104' ' ' ILE . . . . . 0.431 HD11 HG12 ' R' ' 56' ' ' ILE . 81.7 mt -71.7 -30.49 38.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.388 -0.82 . . . . 24.77 109.985 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 105' ' ' TRP . . . . . 0.461 ' O ' ' HD3' ' R' ' 108' ' ' LYS . 70.6 t-105 -82.42 0.81 40.39 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.345 -0.847 . . . . 23.28 110.33 179.589 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 106' ' ' ASN . . . . . 0.423 HD21 HD23 ' R' ' 102' ' ' LEU . 6.9 m-80 -105.05 -10.38 17.23 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.143 -0.973 . . . . 28.26 110.146 179.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 107' ' ' ILE . . . . . . . . . . . . . 36.8 pt -126.81 35.0 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.225 -0.922 . . . . 18.77 110.01 179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' R' R ' 108' ' ' LYS . . . . . 0.501 ' HG2' ' HB ' ' R' ' 115' ' ' ILE . 9.2 mtpp -61.06 -48.47 81.59 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.528 -0.733 . . . . 42.5 110.031 179.526 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 109' ' ' HIS . . . . . 0.445 ' CD2' ' HG ' ' R' ' 110' ' ' LEU . 50.8 p-80 -66.01 -12.86 58.1 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.503 -0.748 . . . . 20.07 110.696 -179.606 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 110' ' ' LEU . . . . . 0.445 ' HG ' ' CD2' ' R' ' 109' ' ' HIS . 80.8 mt -94.84 -17.31 22.2 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.145 -0.972 . . . . 15.69 110.181 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 111' ' ' LEU . . . . . 0.528 HD21 ' CE2' ' R' ' 60' ' ' PHE . 10.4 mt -94.1 144.14 25.75 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.341 -0.85 . . . . 25.39 111.004 -179.204 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 112' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -77.71 -17.36 57.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.451 -0.781 . . . . 53.48 109.846 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' R' R ' 113' ' ' THR . . . . . 0.457 HG22 ' N ' ' R' ' 114' ' ' GLY . 60.5 m -83.72 166.68 17.86 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.251 -0.906 . . . . 14.8 110.22 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 114' ' ' GLY . . . . . 0.457 ' N ' HG22 ' R' ' 113' ' ' THR . . . -97.96 127.16 9.13 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.994 -1.243 . . . . 16.14 109.994 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 115' ' ' ILE . . . . . 0.577 HD13 ' HB ' ' R' ' 124' ' ' VAL . 47.8 mm -109.09 139.36 32.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.475 -1.015 . . . . 13.46 109.71 179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 116' ' ' GLY . . . . . . . . . . . . . . . -152.78 -155.81 7.27 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.964 -1.254 . . . . 23.9 109.964 -179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' R' R ' 117' ' ' THR . . . . . 0.528 HG22 ' CG2' ' R' ' 126' ' ' VAL . 18.9 p -135.06 -171.46 2.81 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.467 -1.019 . . . . 27.37 110.02 -179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 118' ' ' ALA . . . . . 0.445 ' HB3' ' OD1' ' R' ' 128' ' ' ASP . . . -56.5 -58.09 9.53 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.337 -0.852 . . . . 18.76 110.064 179.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 119' ' ' SER . . . . . 0.567 ' HB3' ' HB ' ' R' ' 196' ' ' VAL . 1.1 m -56.54 -40.65 75.46 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.267 -0.896 . . . . 32.35 109.69 179.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 120' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 -110.02 86.19 4.77 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.458 -0.776 . . . . 27.12 109.643 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' R' R ' 121' ' ' PRO . . . . . 0.482 ' HA ' ' SG ' ' R' ' 125' ' ' CYS . 44.3 Cg_endo -71.26 166.55 28.9 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.817 1.43 . . . . 22.68 111.02 -179.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 122' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' R' ' 121' ' ' PRO . 38.6 t 178.55 -161.67 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.643 -0.661 . . . . 22.99 109.447 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 123' ' ' GLU . . . . . 0.442 ' HG2' HG23 ' R' ' 113' ' ' THR . 2.3 tp10 -56.47 -39.95 74.06 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.211 -0.93 . . . . 36.18 109.673 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 124' ' ' VAL . . . . . 0.577 ' HB ' HD13 ' R' ' 115' ' ' ILE . 84.2 t -142.52 136.43 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.471 -0.768 . . . . 20.64 109.333 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 125' ' ' CYS . . . . . 0.482 ' SG ' ' HA ' ' R' ' 121' ' ' PRO . 83.4 m -140.32 168.16 20.46 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.245 -0.91 . . . . 22.8 111.206 -179.342 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 126' ' ' VAL . . . . . 0.729 HG12 HG22 ' R' ' 179' ' ' VAL . 35.9 m -122.68 159.75 25.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.713 -0.617 . . . . 21.24 109.595 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 127' ' ' VAL . . . . . 0.709 HG11 ' O ' ' R' ' 177' ' ' VAL . 30.5 m -70.83 141.83 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.29 -0.881 . . . . 19.77 110.708 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 128' ' ' ASP . . . . . 0.445 ' OD1' ' HB3' ' R' ' 118' ' ' ALA . 53.8 p-10 -137.7 19.42 2.87 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.37 -0.831 . . . . 29.21 110.664 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 129' ' ' GLY . . . . . . . . . . . . . . . 114.08 0.05 24.02 Favored Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.967 -1.111 . . . . 33.86 110.403 179.274 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' R' R ' 130' ' ' THR . . . . . . . . . . . . . 58.7 m -91.91 131.83 36.94 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.145 -1.209 . . . . 26.41 110.08 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -62.51 120.66 11.53 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.338 -0.852 . . . . 33.08 110.224 -179.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' R' R ' 132' ' ' MET . . . . . 0.435 ' HE1' ' CE2' ' R' ' 180' ' ' PHE . 98.3 mmm -105.16 165.67 10.93 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.558 -0.714 . . . . 30.76 110.472 -179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 133' ' ' CYS . . . . . 0.411 ' HA ' ' HB3' ' R' ' 174' ' ' PRO . 32.3 m -141.22 158.09 44.36 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.52 -0.737 . . . . 27.0 109.907 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 134' ' ' LEU . . . . . 0.562 HD11 ' O ' ' R' ' 172' ' ' PRO . 0.1 OUTLIER -58.41 -19.76 38.86 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.312 -0.868 . . . . 33.9 110.453 -179.894 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' R' R ' 135' ' ' ALA . . . . . . . . . . . . . . . -92.77 8.18 40.5 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.257 -0.902 . . . . 19.37 110.78 -179.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' R' R ' 136' ' ' ASP . . . . . . . . . . . . . 45.3 m-20 -93.72 -21.81 19.11 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.198 -0.939 . . . . 30.47 110.228 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' R' R ' 137' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -149.94 165.28 33.11 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.319 -0.863 . . . . 24.27 110.22 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' R' R ' 138' ' ' HIS . . . . . 0.434 ' HA ' HG23 ' R' ' 154' ' ' VAL . 15.3 p80 -117.73 15.08 14.46 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.429 -0.794 . . . . 20.91 110.459 179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 139' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' R' ' 152' ' ' ALA . . . -177.16 152.46 0.88 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.306 -0.871 . . . . 15.69 110.08 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 140' ' ' GLY . . . . . 0.427 ' HA3' ' O ' ' R' ' 179' ' ' VAL . . . 161.74 175.14 32.45 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 110.0 -1.24 . . . . 23.76 110.0 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 141' ' ' ILE . . . . . . . . . . . . . 83.8 mt -95.48 136.58 26.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.371 -1.076 . . . . 25.3 109.674 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' R' R ' 142' ' ' PHE . . . . . 0.578 ' CD2' ' HB2' ' R' ' 172' ' ' PRO . 82.6 m-85 -120.73 -172.59 2.41 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.27 -0.894 . . . . 30.24 110.512 -179.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 143' ' ' LEU . . . . . 0.743 HD23 ' O ' ' R' ' 148' ' ' HIS . 0.5 OUTLIER -119.81 77.72 1.26 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.43 -0.794 . . . . 32.8 110.301 -179.924 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' R' R ' 144' ' ' LYS . . . . . 0.47 ' HG3' ' CZ2' ' R' ' 170' ' ' TRP . 1.0 OUTLIER -69.54 76.83 0.41 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.363 -0.835 . . . . 49.18 109.728 179.549 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' R' R ' 145' ' ' GLY . . . . . 0.456 ' O ' HD22 ' R' ' 143' ' ' LEU . . . 104.57 179.32 24.74 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.202 -1.559 . . . . 53.87 109.202 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 146' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -88.49 145.83 25.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.369 -1.077 . . . . 68.58 110.006 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' R' R ' 147' ' ' GLU . . . . . 0.649 ' HA ' ' CA ' ' S' ' 398' ' ' ARG . 10.9 mt-10 58.26 36.45 25.68 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.347 -0.845 . . . . 56.62 110.655 179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 148' ' ' HIS . . . . . 0.844 ' CE1' HD12 ' S' ' 400' ' ' LEU . 45.1 t60 -158.67 148.09 19.16 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.267 -0.895 . . . . 44.57 110.359 179.658 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 149' ' ' ALA . . . . . 0.891 ' HB3' HH21 ' S' ' 398' ' ' ARG . . . -150.27 146.91 27.07 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.484 -0.76 . . . . 33.54 110.072 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 150' ' ' VAL . . . . . . . . . . . . . 34.2 m -142.32 161.51 19.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.263 -0.898 . . . . 27.61 110.322 179.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' R' R ' 151' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' R' ' 152' ' ' ALA . 5.9 t80 -86.24 155.63 20.62 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.401 -0.812 . . . . 23.04 109.881 179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 152' ' ' ALA . . . . . 0.537 ' N ' ' CD1' ' R' ' 151' ' ' PHE . . . -157.31 151.51 24.83 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.45 -0.781 . . . . 29.61 109.589 179.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 153' ' ' CYS . . . . . . . . . . . . . 26.7 p -154.27 173.6 15.93 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.347 -0.846 . . . . 22.75 110.444 -179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' R' R ' 154' ' ' VAL . . . . . 0.615 HG22 ' CE2' ' R' ' 159' ' ' TRP . 59.7 t -90.64 117.03 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.425 -0.797 . . . . 23.26 110.061 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 155' ' ' THR . . . . . . . . . . . . . 69.9 p -112.11 -176.6 2.96 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.313 -0.867 . . . . 17.88 110.065 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' R' R ' 156' ' ' SER . . . . . . . . . . . . . 78.5 p -75.98 -3.66 36.86 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.27 -0.894 . . . . 21.83 110.672 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' R' R ' 157' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -118.36 10.53 12.79 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.138 -0.976 . . . . 36.54 110.59 -179.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' R' R ' 158' ' ' GLY . . . . . . . . . . . . . . . 117.92 -162.68 13.01 Favored Glycine 0 N--CA 1.492 2.375 0 N-CA-C 109.567 -1.413 . . . . 31.74 109.567 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' R' R ' 159' ' ' TRP . . . . . 0.615 ' CE2' HG22 ' R' ' 154' ' ' VAL . 14.7 m95 -86.56 122.45 30.5 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.389 -1.065 . . . . 28.25 110.147 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 160' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -108.45 166.91 10.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.305 -0.872 . . . . 41.24 110.218 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' R' R ' 161' ' ' ALA . . . . . . . . . . . . . . . -143.21 123.48 13.79 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.403 -0.81 . . . . 27.4 110.14 -179.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' R' R ' 162' ' ' ILE . . . . . . . . . . . . . 92.3 mt -87.59 81.14 1.9 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.324 -0.86 . . . . 24.27 110.015 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' R' R ' 163' ' ' ASP . . . . . 0.413 ' O ' ' N ' ' R' ' 165' ' ' GLU . 15.3 t0 -72.78 92.41 1.57 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.406 -0.809 . . . . 36.08 110.262 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 164' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 54.07 -88.97 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.564 -0.71 . . . . 46.08 110.603 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' R' R ' 165' ' ' GLU . . . . . 0.413 ' N ' ' O ' ' R' ' 163' ' ' ASP . 29.8 mt-10 -124.72 36.03 4.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.083 -1.011 . . . . 50.94 110.194 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 166' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -135.75 117.33 14.88 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.388 -0.82 . . . . 47.28 110.347 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' R' R ' 167' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -101.1 119.96 39.51 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.427 -0.795 . . . . 40.47 110.132 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' R' R ' 168' ' ' TYR . . . . . . . . . . . . . 25.3 p90 -157.49 158.59 30.76 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.216 -0.927 . . . . 30.21 110.423 179.856 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' R' R ' 169' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.79 132.98 19.38 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 O-C-N 123.831 1.437 . . . . 32.76 110.527 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' R' R ' 170' ' ' TRP . . . . . 0.47 ' CZ2' ' HG3' ' R' ' 144' ' ' LYS . 67.0 t90 -159.78 119.37 2.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.384 -0.823 . . . . 32.79 109.909 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 171' ' ' THR . . . . . . . . . . . . . 47.5 m -81.12 112.62 34.35 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.448 -0.783 . . . . 36.92 110.141 -179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' R' R ' 172' ' ' PRO . . . . . 0.578 ' HB2' ' CD2' ' R' ' 142' ' ' PHE . 48.0 Cg_endo -73.7 158.83 46.62 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.596 1.314 . . . . 33.54 110.545 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 173' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -88.92 144.93 33.64 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.415 -0.803 . . . . 45.76 109.904 179.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' R' R ' 174' ' ' PRO . . . . . 0.411 ' HB3' ' HA ' ' R' ' 133' ' ' CYS . 46.0 Cg_endo -71.72 -10.34 26.35 Favored 'Trans proline' 0 C--N 1.311 -1.443 0 O-C-N 123.517 1.272 . . . . 29.63 110.497 179.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 175' ' ' SER . . . . . . . . . . . . . 52.9 p -103.42 -17.63 15.16 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.348 -0.845 . . . . 35.7 110.396 179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' R' R ' 176' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -103.48 43.18 1.1 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.213 -0.93 . . . . 39.65 110.4 -179.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' R' R ' 177' ' ' VAL . . . . . 0.709 ' O ' HG11 ' R' ' 127' ' ' VAL . 10.7 p -117.71 127.17 75.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.368 -0.832 . . . . 20.61 110.043 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 178' ' ' LEU . . . . . 0.538 HD22 HG12 ' S' ' 396' ' ' VAL . 46.1 mt -91.56 -61.24 1.69 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.362 -0.836 . . . . 15.58 109.378 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 179' ' ' VAL . . . . . 0.729 HG22 HG12 ' R' ' 126' ' ' VAL . 67.8 t -114.67 144.69 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.676 -0.64 . . . . 17.4 109.391 179.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 180' ' ' PHE . . . . . 0.435 ' CE2' ' HE1' ' R' ' 132' ' ' MET . 43.6 p90 -152.17 163.41 39.45 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.268 -0.895 . . . . 20.16 110.529 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 181' ' ' VAL . . . . . . . . . . . . . 66.6 t -113.2 111.49 50.19 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.488 -0.758 . . . . 17.69 109.862 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' R' R ' 182' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.06 149.49 52.61 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 O-C-N 123.606 1.319 . . . . 17.81 110.456 -180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' R' R ' 183' ' ' TYR . . . . . 0.709 ' O ' ' C ' ' R' ' 184' ' ' ASP . 79.5 m-85 -58.92 175.45 0.28 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.463 -0.773 . . . . 28.01 110.535 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 184' ' ' ASP . . . . . 0.709 ' C ' ' O ' ' R' ' 183' ' ' TYR . 6.1 m-20 -17.71 -82.75 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.313 -0.867 . . . . 58.64 110.271 -178.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 185' ' ' GLN . . . . . . . . . . . . . 49.2 mm-40 . . . . . 0 N--CA 1.503 2.183 0 CA-C-O 121.23 0.538 . . . . 80.42 111.783 179.547 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' R' R ' 193' ' ' LYS . . . . . . . . . . . . . 28.0 mtmt . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 120.888 0.375 . . . . 49.5 110.192 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' R' R ' 194' ' ' ALA . . . . . 0.418 ' CB ' ' HA ' ' R' ' 119' ' ' SER . . . -173.18 -156.94 0.09 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.172 -0.955 . . . . 40.4 110.127 179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 195' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.77 -51.54 5.04 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.397 -0.814 . . . . 34.6 110.285 179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 196' ' ' VAL . . . . . 0.567 ' HB ' ' HB3' ' R' ' 119' ' ' SER . 21.3 t -92.11 48.94 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.186 -0.946 . . . . 33.27 110.615 -179.87 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 197' ' ' GLN . . . . . 0.553 ' HG3' ' O ' ' R' ' 197' ' ' GLN . 5.1 tp60 -166.41 61.11 0.1 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.12 -0.988 . . . . 41.58 110.684 179.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 198' ' ' ARG . . . . . . . . . . . . . 6.2 ptm180 -174.45 128.77 0.34 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.064 -1.022 . . . . 38.65 110.17 -179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' R' R ' 199' ' ' LYS . . . . . 0.408 ' HA ' ' HD3' ' S' ' 299' ' ' PRO . 19.6 mtmt -46.95 147.68 1.29 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.394 -0.816 . . . . 36.77 109.937 179.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 200' ' ' LEU . . . . . 0.432 HD23 ' HA ' ' R' ' 200' ' ' LEU . 14.1 mt -134.27 -95.66 0.28 Allowed 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.437 -0.79 . . . . 33.08 110.065 -179.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' R' R ' 201' ' ' LYS . . . . . 0.775 ' HE2' ' HB2' ' S' ' 349' ' ' ALA . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.696 0 O-C-N 121.448 -0.782 . . . . 44.32 110.304 -178.859 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 229' ' ' MET . . . . . 0.469 ' HG3' ' N ' ' S' ' 230' ' ' GLU . 3.3 ptt? . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.181 0.515 . . . . 51.83 110.233 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' S' S ' 230' ' ' GLU . . . . . 0.469 ' N ' ' HG3' ' S' ' 229' ' ' MET . 33.2 tt0 -97.29 142.75 28.79 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.432 -0.793 . . . . 54.13 110.196 -179.494 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 231' ' ' LEU . . . . . . . . . . . . . 68.0 mt -134.12 141.05 46.99 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.352 -0.842 . . . . 33.04 110.334 -179.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' S' S ' 232' ' ' THR . . . . . 0.417 ' O ' ' HA ' ' S' ' 355' ' ' THR . 40.3 m -89.26 103.24 15.88 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.343 -0.848 . . . . 26.92 110.041 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 233' ' ' LEU . . . . . 0.672 HD22 ' CE2' ' S' ' 262' ' ' TYR . 79.7 mt -55.87 179.29 0.03 OUTLIER 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.531 -0.731 . . . . 13.78 110.543 -179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 234' ' ' TYR . . . . . 0.448 ' CG ' ' N ' ' S' ' 235' ' ' ASN . 35.5 p90 -65.02 -35.63 81.81 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.426 -0.797 . . . . 26.08 110.189 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 235' ' ' ASN . . . . . 0.448 ' N ' ' CG ' ' S' ' 234' ' ' TYR . 50.6 p30 -74.36 -7.47 52.96 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.345 -0.847 . . . . 20.04 110.531 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 236' ' ' GLY . . . . . . . . . . . . . . . 95.79 -19.96 51.97 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.764 -1.334 . . . . 22.71 109.764 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' S' S ' 237' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -52.95 145.63 12.45 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.258 -1.142 . . . . 35.44 110.235 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' S' S ' 238' ' ' LYS . . . . . . . . . . . . . 44.4 mttt -102.1 127.85 48.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.349 -0.845 . . . . 32.56 110.426 -179.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' S' S ' 239' ' ' LYS . . . . . 0.403 ' HG2' ' CZ ' ' S' ' 241' ' ' PHE . 9.0 ttmt -132.29 144.51 50.64 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.41 -0.806 . . . . 26.68 109.992 179.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 240' ' ' THR . . . . . . . . . . . . . 51.7 m -102.08 132.17 48.12 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.362 -0.836 . . . . 41.02 110.37 -179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' S' S ' 241' ' ' PHE . . . . . 0.403 ' CZ ' ' HG2' ' S' ' 239' ' ' LYS . 96.0 m-85 -117.85 137.66 52.63 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.379 -0.826 . . . . 28.62 110.196 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 242' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -96.29 161.87 13.75 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.288 -0.883 . . . . 47.89 110.295 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' S' S ' 243' ' ' SER . . . . . . . . . . . . . 71.9 m -90.64 151.52 21.25 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.362 -0.836 . . . . 45.09 110.309 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' S' S ' 244' ' ' ARG . . . . . . . . . . . . . 1.4 mtp85 -129.85 126.78 22.67 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.415 -0.803 . . . . 42.49 110.199 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' S' S ' 245' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.37 161.0 43.7 Favored 'Trans proline' 0 C--N 1.311 -1.396 0 O-C-N 123.639 1.336 . . . . 35.68 110.507 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' S' S ' 246' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -132.86 97.87 4.15 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.359 -0.838 . . . . 51.88 109.822 179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' S' S ' 247' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -110.47 -22.21 11.78 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.378 -0.826 . . . . 53.69 110.664 -179.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' S' S ' 248' ' ' HIS . . . . . . . . . . . . . 76.8 m80 -117.29 43.74 2.26 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.225 -0.922 . . . . 55.79 110.714 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' S' S ' 249' ' ' ASP . . . . . . . . . . . . . 40.7 m-20 48.77 38.41 11.76 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.447 -0.783 . . . . 49.45 110.417 179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' S' S ' 250' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -90.61 28.99 1.38 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.526 -0.734 . . . . 36.86 110.358 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' S' S ' 251' ' ' ALA . . . . . . . . . . . . . . . -53.78 -43.18 69.03 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.311 -0.868 . . . . 29.69 109.575 179.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' S' S ' 252' ' ' TRP . . . . . 0.425 ' CZ2' ' HB3' ' S' ' 294' ' ' LEU . 67.9 p-90 -61.83 -34.01 75.19 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.451 -0.78 . . . . 41.12 109.79 179.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 253' ' ' LEU . . . . . . . . . . . . . 23.3 tp -70.14 -47.23 62.59 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.433 -0.792 . . . . 24.89 109.906 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' S' S ' 254' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -56.12 -42.41 76.81 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.395 -0.816 . . . . 35.65 109.956 179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' S' S ' 255' ' ' ALA . . . . . . . . . . . . . . . -59.63 -48.09 83.02 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.464 -0.773 . . . . 22.73 110.074 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' S' S ' 256' ' ' ILE . . . . . 0.504 HG12 HD11 ' S' ' 304' ' ' ILE . 79.6 mt -62.37 -40.62 88.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.315 -0.866 . . . . 28.85 109.928 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 257' ' ' LEU . . . . . 0.403 ' CD2' ' HB3' ' S' ' 268' ' ' PHE . 19.2 mt -61.56 -44.45 97.01 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.403 -0.81 . . . . 23.07 110.244 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 258' ' ' GLN . . . . . 0.502 ' HB3' ' CD2' ' S' ' 351' ' ' PHE . 53.1 mm-40 -65.05 -45.37 85.66 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.384 -0.823 . . . . 29.78 109.918 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 259' ' ' LEU . . . . . 0.419 ' O ' HG22 ' S' ' 263' ' ' VAL . 19.8 tp -58.69 -36.38 74.11 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.291 -0.881 . . . . 17.94 109.435 179.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 260' ' ' PHE . . . . . 0.53 ' CE2' HD21 ' S' ' 311' ' ' LEU . 3.1 m-85 -62.83 -45.27 93.41 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.603 -0.686 . . . . 30.57 109.84 179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 261' ' ' ARG . . . . . . . . . . . . . 6.2 tpt180 -62.12 -29.81 70.59 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.46 -0.775 . . . . 41.34 109.898 179.864 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' S' S ' 262' ' ' TYR . . . . . 0.672 ' CE2' HD22 ' S' ' 233' ' ' LEU . 8.6 t80 -71.22 -44.63 64.99 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.41 -0.806 . . . . 26.03 110.085 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 263' ' ' VAL . . . . . 0.419 HG22 ' O ' ' S' ' 259' ' ' LEU . 33.1 m -92.06 18.29 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.352 -0.842 . . . . 22.8 110.373 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 264' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 52.77 70.64 0.55 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.199 -0.938 . . . . 44.03 110.653 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' S' S ' 265' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -111.81 109.12 55.47 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.303 -0.873 . . . . 35.61 109.637 179.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' S' S ' 266' ' ' PRO . . . . . 0.482 ' HA ' ' HB2' ' S' ' 269' ' ' ASP . 49.2 Cg_endo -75.31 0.39 9.08 Favored 'Trans proline' 0 C--N 1.311 -1.4 0 O-C-N 123.578 1.304 . . . . 37.67 111.753 -179.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 267' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -56.48 -67.73 0.28 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.85 -1.156 . . . . 41.49 110.173 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 268' ' ' PHE . . . . . 0.403 ' HB3' ' CD2' ' S' ' 257' ' ' LEU . 22.6 m-85 -92.86 39.94 1.05 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.148 -0.97 . . . . 50.76 110.132 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 269' ' ' ASP . . . . . 0.482 ' HB2' ' HA ' ' S' ' 266' ' ' PRO . 0.9 OUTLIER -76.1 -33.19 59.49 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.307 -0.87 . . . . 61.86 109.727 179.596 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' S' S ' 270' ' ' TRP . . . . . 0.509 ' CE2' HG23 ' S' ' 271' ' ' VAL . 50.9 p-90 -73.85 -4.41 34.72 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.322 -0.861 . . . . 39.85 110.46 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 271' ' ' VAL . . . . . 0.509 HG23 ' CE2' ' S' ' 270' ' ' TRP . 46.6 t -109.49 -32.72 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.117 -0.989 . . . . 39.18 110.156 179.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 272' ' ' TYR . . . . . . . . . . . . . 39.2 t80 -78.6 -36.6 44.06 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.387 -0.821 . . . . 40.02 110.486 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' S' S ' 273' ' ' SER . . . . . . . . . . . . . 71.2 m -103.48 56.16 0.74 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.336 -0.853 . . . . 47.2 110.306 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' S' S ' 274' ' ' SER . . . . . . . . . . . . . 6.9 t -133.06 141.27 40.29 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.336 -0.853 . . . . 47.61 110.14 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' S' S ' 275' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -73.85 -18.83 21.51 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.684 1.36 . . . . 45.28 110.485 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' S' S ' 276' ' ' GLU . . . . . . . . . . . . . 62.9 mm-40 -99.87 140.87 33.46 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.238 -0.913 . . . . 57.27 110.317 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' S' S ' 277' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -71.73 97.67 1.8 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.388 -0.82 . . . . 37.28 110.322 -179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' S' S ' 278' ' ' LEU . . . . . . . . . . . . . 86.8 mt -97.04 33.84 1.85 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.358 -0.839 . . . . 43.88 109.987 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' S' S ' 279' ' ' THR . . . . . . . . . . . . . 75.3 m -64.03 -60.09 3.67 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.424 -0.797 . . . . 50.05 110.347 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' S' S ' 280' ' ' LEU . . . . . 0.728 ' HA ' HD12 ' S' ' 283' ' ' ILE . 13.7 mt -51.59 -39.91 58.84 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.363 -0.836 . . . . 54.12 110.246 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 281' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.42 -49.68 74.5 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.474 -0.766 . . . . 65.28 110.141 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 282' ' ' ALA . . . . . . . . . . . . . . . -58.97 -33.86 71.14 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.466 -0.771 . . . . 46.51 110.555 -179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' S' S ' 283' ' ' ILE . . . . . 0.728 HD12 ' HA ' ' S' ' 280' ' ' LEU . 85.7 mt -66.37 -50.86 64.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.273 -0.892 . . . . 47.3 110.087 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 284' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -50.59 -57.56 7.88 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.43 -0.794 . . . . 50.72 110.387 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' S' S ' 285' ' ' GLN . . . . . 0.53 ' HG2' HD12 ' S' ' 289' ' ' LEU . 34.4 tt0 -51.46 -46.32 63.02 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.503 -0.748 . . . . 68.47 110.332 179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 286' ' ' LEU . . . . . . . . . . . . . 19.1 mt -59.96 -44.53 94.39 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.42 -0.8 . . . . 36.62 110.312 -179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' S' S ' 287' ' ' GLU . . . . . . . . . . . . . 52.4 mt-10 -62.71 -35.26 79.16 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.372 -0.83 . . . . 46.64 110.099 179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' S' S ' 288' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -76.24 -21.08 56.79 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.37 -0.831 . . . . 46.45 110.28 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' S' S ' 289' ' ' LEU . . . . . 0.53 HD12 ' HG2' ' S' ' 285' ' ' GLN . 30.8 mt -97.31 -21.75 17.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.286 -0.884 . . . . 35.09 110.487 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 290' ' ' THR . . . . . 0.409 HG22 ' HB3' ' S' ' 306' ' ' ASN . 81.2 p -114.74 -28.45 7.1 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.221 -0.925 . . . . 38.61 110.422 -179.7 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 291' ' ' GLY . . . . . . . . . . . . . . . 79.43 10.93 85.43 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.823 -1.311 . . . . 36.77 109.823 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' S' S ' 292' ' ' LEU . . . . . . . . . . . . . 84.8 mt -96.44 145.84 25.31 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.226 -1.161 . . . . 35.33 109.726 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' S' S ' 293' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -77.37 102.41 6.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.196 -0.94 . . . . 48.7 110.232 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' S' S ' 294' ' ' LEU . . . . . 0.425 ' HB3' ' CZ2' ' S' ' 252' ' ' TRP . 56.2 mt -106.99 51.74 0.73 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.539 -0.726 . . . . 42.61 110.066 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 295' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -112.51 -11.17 13.65 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.362 -0.836 . . . . 55.49 110.524 -179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 296' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -144.36 48.53 1.36 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.127 -0.983 . . . . 75.68 110.321 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' S' S ' 297' ' ' GLY . . . . . . . . . . . . . . . 96.87 145.22 18.78 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.511 -1.436 . . . . 49.44 109.511 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' S' S ' 298' ' ' GLY . . . . . 0.624 ' H ' ' C ' ' R' ' 201' ' ' LYS . . . -163.83 156.96 29.05 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.744 -1.342 . . . . 41.11 109.744 -179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 299' ' ' PRO . . . . . 0.48 ' O ' HG23 ' S' ' 303' ' ' VAL . 47.4 Cg_endo -73.84 118.26 5.36 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 123.943 1.497 . . . . 26.2 110.293 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 300' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.33 -15.38 31.4 Favored 'Trans proline' 0 C--N 1.311 -1.431 0 O-C-N 123.647 1.34 . . . . 21.7 110.675 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' S' S ' 301' ' ' ALA . . . . . . . . . . . . . . . -80.69 -29.31 36.53 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.238 -0.914 . . . . 31.23 110.182 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' S' S ' 302' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.48 -40.7 18.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.404 -0.81 . . . . 38.99 109.966 179.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 303' ' ' VAL . . . . . 0.48 HG23 ' O ' ' S' ' 299' ' ' PRO . 56.9 t -60.61 -35.48 63.87 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.7 0 O-C-N 121.399 -0.813 . . . . 18.63 110.153 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 304' ' ' ILE . . . . . 0.522 HD12 HG21 ' S' ' 379' ' ' VAL . 86.5 mt -79.43 -23.65 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.449 -0.782 . . . . 25.46 110.124 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 305' ' ' TRP . . . . . 0.41 ' CD2' ' HD3' ' S' ' 308' ' ' LYS . 68.9 t-105 -88.59 -14.69 36.97 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.234 -0.916 . . . . 33.4 110.501 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 306' ' ' ASN . . . . . 0.409 ' HB3' HG22 ' S' ' 290' ' ' THR . 10.4 m-80 -89.61 -13.52 36.96 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.179 -0.95 . . . . 36.97 110.438 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 307' ' ' ILE . . . . . 0.471 HG12 ' O ' ' S' ' 303' ' ' VAL . 36.8 pt -125.14 45.66 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.806 0 O-C-N 121.237 -0.915 . . . . 30.81 110.005 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 308' ' ' LYS . . . . . 0.41 ' HD3' ' CD2' ' S' ' 305' ' ' TRP . 1.5 mtmp? -73.52 -37.71 65.56 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.35 -0.844 . . . . 46.52 110.169 -179.625 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 309' ' ' HIS . . . . . 0.492 ' CD2' ' HG ' ' S' ' 310' ' ' LEU . 55.6 p-80 -73.25 -8.26 55.03 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.407 -0.808 . . . . 51.03 110.057 179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 310' ' ' LEU . . . . . 0.492 ' HG ' ' CD2' ' S' ' 309' ' ' HIS . 52.8 mt -99.25 -12.91 19.96 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.29 -0.881 . . . . 36.16 109.962 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 311' ' ' LEU . . . . . 0.53 HD21 ' CE2' ' S' ' 260' ' ' PHE . 10.8 mt -97.14 147.77 23.73 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.278 -0.889 . . . . 40.0 110.471 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 312' ' ' HIS . . . . . . . . . . . . . 82.2 t60 -81.58 -16.29 52.08 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.282 -0.886 . . . . 54.18 109.771 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' S' S ' 313' ' ' THR . . . . . 0.825 HG23 ' HG2' ' S' ' 323' ' ' GLU . 92.4 m -87.94 151.64 22.66 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.378 -0.826 . . . . 25.61 110.151 179.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 314' ' ' GLY . . . . . . . . . . . . . . . -87.88 126.42 8.04 Favored Glycine 0 N--CA 1.492 2.427 0 N-CA-C 109.815 -1.314 . . . . 25.18 109.815 -179.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' S' S ' 315' ' ' ILE . . . . . 0.67 HD13 ' HB ' ' S' ' 324' ' ' VAL . 50.6 mm -101.62 150.47 6.02 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.346 -1.091 . . . . 23.9 109.702 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 316' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' S' ' 325' ' ' CYS . . . -157.13 -159.23 9.36 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 110.021 -1.232 . . . . 23.18 110.021 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 317' ' ' THR . . . . . 0.425 HG22 ' CG2' ' S' ' 326' ' ' VAL . 11.0 p -133.96 -173.04 3.14 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.311 -1.111 . . . . 27.98 109.923 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.57 -56.18 25.19 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.2 -0.937 . . . . 28.1 109.899 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' S' S ' 319' ' ' SER . . . . . . . . . . . . . 1.2 m -59.98 -41.61 92.4 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.321 -0.862 . . . . 37.0 109.621 179.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' S' S ' 320' ' ' ARG . . . . . . . . . . . . . 12.2 mtm180 -111.67 79.88 2.62 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.481 -0.762 . . . . 52.07 109.657 179.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' S' S ' 321' ' ' PRO . . . . . 1.07 ' HG2' ' O ' ' S' ' 386' ' ' GLU . 43.9 Cg_endo -71.41 171.54 15.98 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.869 1.457 . . . . 38.29 110.9 -179.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 322' ' ' SER . . . . . 0.443 ' HB2' ' O ' ' S' ' 321' ' ' PRO . 41.2 t 178.62 -148.17 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.787 0 N-CA-C 108.89 -0.781 . . . . 38.84 108.89 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 323' ' ' GLU . . . . . 0.825 ' HG2' HG23 ' S' ' 313' ' ' THR . 6.7 tp10 -62.82 -40.26 96.83 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.003 -1.061 . . . . 40.7 109.734 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 324' ' ' VAL . . . . . 0.67 ' HB ' HD13 ' S' ' 315' ' ' ILE . 72.9 t -141.33 134.98 31.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.427 -0.795 . . . . 20.34 109.5 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 325' ' ' CYS . . . . . 0.462 ' HB2' ' CE1' ' S' ' 380' ' ' PHE . 11.1 m -125.95 172.21 10.11 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.249 -0.907 . . . . 30.63 110.826 -179.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 326' ' ' VAL . . . . . 0.642 HG12 HG22 ' S' ' 379' ' ' VAL . 34.5 m -135.49 142.18 40.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 N-CA-C 109.216 -0.661 . . . . 23.9 109.216 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 327' ' ' VAL . . . . . 0.594 HG11 ' O ' ' S' ' 377' ' ' VAL . 34.5 m -56.29 124.94 10.97 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.133 -0.979 . . . . 19.48 110.432 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 328' ' ' ASP . . . . . . . . . . . . . 55.7 p-10 -119.37 11.54 12.23 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.432 -0.792 . . . . 26.43 110.422 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' S' S ' 329' ' ' GLY . . . . . . . . . . . . . . . 119.67 2.13 13.14 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.074 -1.21 . . . . 31.24 110.074 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' S' S ' 330' ' ' THR . . . . . . . . . . . . . 79.4 m -92.9 130.02 38.63 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.082 -1.246 . . . . 30.05 110.122 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' S' S ' 331' ' ' ASP . . . . . . . . . . . . . 63.3 m-20 -56.89 111.53 1.06 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.321 -0.862 . . . . 37.26 109.991 179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' S' S ' 332' ' ' MET . . . . . . . . . . . . . 88.1 mmm -94.1 162.49 13.85 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.267 -0.896 . . . . 26.23 110.344 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' S' S ' 333' ' ' CYS . . . . . . . . . . . . . 25.8 m -137.19 150.11 47.68 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.475 -0.766 . . . . 23.56 110.025 179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' S' S ' 334' ' ' LEU . . . . . 0.561 HD11 ' O ' ' S' ' 372' ' ' PRO . 0.1 OUTLIER -52.66 -24.76 9.12 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.289 -0.882 . . . . 28.93 110.5 179.902 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' S' S ' 335' ' ' ALA . . . . . . . . . . . . . . . -89.1 14.49 10.64 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.388 -0.82 . . . . 15.76 110.973 -179.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' S' S ' 336' ' ' ASP . . . . . . . . . . . . . 70.6 m-20 -100.48 -17.25 17.24 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.133 -0.979 . . . . 34.92 110.143 179.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' S' S ' 337' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -152.41 170.83 19.14 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.333 -0.854 . . . . 19.03 110.077 179.925 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' S' S ' 338' ' ' HIS . . . . . 0.401 ' HB3' ' CZ ' ' S' ' 383' ' ' TYR . 13.5 p80 -120.65 10.42 11.03 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.333 -0.854 . . . . 18.82 110.479 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 339' ' ' ALA . . . . . 0.413 ' HA ' ' O ' ' S' ' 352' ' ' ALA . . . -175.98 155.16 1.56 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.204 -0.935 . . . . 17.18 110.146 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 340' ' ' GLY . . . . . 0.405 ' CA ' ' O ' ' S' ' 379' ' ' VAL . . . 160.81 173.06 28.94 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.036 -1.226 . . . . 18.33 110.036 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 341' ' ' ILE . . . . . . . . . . . . . 84.2 mt -88.78 138.07 19.93 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.678 0 O-C-N 121.489 -1.006 . . . . 18.6 109.787 179.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' S' S ' 342' ' ' PHE . . . . . 0.493 ' CE2' ' HB3' ' S' ' 352' ' ' ALA . 69.9 m-85 -120.97 -178.43 3.74 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.222 -0.924 . . . . 23.44 110.407 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 343' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.84 93.41 4.19 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.532 -0.73 . . . . 35.59 110.024 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 344' ' ' LYS . . . . . 0.406 ' O ' ' HB3' ' S' ' 348' ' ' HIS . 0.3 OUTLIER -80.87 125.04 29.62 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.301 -0.874 . . . . 38.34 110.067 -179.905 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' S' S ' 345' ' ' GLY . . . . . . . . . . . . . . . 62.75 -130.86 43.17 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 108.874 -1.69 . . . . 53.46 108.874 -179.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' S' S ' 346' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -132.68 150.89 52.1 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.246 -1.149 . . . . 70.91 110.043 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' S' S ' 347' ' ' GLU . . . . . 0.498 ' C ' ' HG2' ' R' ' 201' ' ' LYS . 18.0 mt-10 53.19 35.44 19.92 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.321 -0.862 . . . . 47.32 110.45 179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 348' ' ' HIS . . . . . 0.435 ' N ' ' HG2' ' R' ' 201' ' ' LYS . 46.4 t60 -150.18 155.87 40.56 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.204 -0.935 . . . . 41.72 110.311 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 349' ' ' ALA . . . . . 0.775 ' HB2' ' HE2' ' R' ' 201' ' ' LYS . . . -149.82 151.22 33.17 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.314 -0.866 . . . . 22.91 110.527 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 350' ' ' VAL . . . . . 0.458 HG13 ' C ' ' S' ' 349' ' ' ALA . 34.6 m -149.0 169.67 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.463 -0.773 . . . . 21.09 110.058 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 351' ' ' PHE . . . . . 0.502 ' CD2' ' HB3' ' S' ' 258' ' ' GLN . 10.7 t80 -105.43 143.59 33.38 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.178 -0.951 . . . . 25.03 110.682 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 352' ' ' ALA . . . . . 0.493 ' HB3' ' CE2' ' S' ' 342' ' ' PHE . . . -147.67 151.78 36.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.64 -0.662 . . . . 23.81 109.704 179.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 353' ' ' CYS . . . . . . . . . . . . . 26.2 p -153.37 164.85 37.42 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.324 -0.86 . . . . 25.66 110.185 -179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' S' S ' 354' ' ' VAL . . . . . 0.546 HG22 ' CE2' ' S' ' 359' ' ' TRP . 56.6 t -75.94 118.49 22.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.351 -0.843 . . . . 34.27 110.008 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 355' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' S' ' 232' ' ' THR . 52.5 p -117.86 175.1 5.82 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.196 -0.94 . . . . 25.49 110.327 179.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 356' ' ' SER . . . . . . . . . . . . . 62.9 p -62.09 -17.75 58.59 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.474 -0.766 . . . . 31.24 110.749 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' S' S ' 357' ' ' ASN . . . . . . . . . . . . . 46.2 m-20 -106.96 14.21 26.74 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.143 -0.973 . . . . 28.61 110.564 -179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' S' S ' 358' ' ' GLY . . . . . . . . . . . . . . . 111.85 -152.93 17.58 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.979 -1.248 . . . . 22.01 109.979 179.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' S' S ' 359' ' ' TRP . . . . . 0.546 ' CE2' HG22 ' S' ' 354' ' ' VAL . 15.1 m95 -91.44 116.76 29.11 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.387 -1.067 . . . . 25.54 110.138 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 360' ' ' TYR . . . . . 0.408 ' HA ' ' HA ' ' S' ' 369' ' ' PRO . 1.3 m-85 -103.49 165.83 10.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.318 -0.864 . . . . 40.53 110.108 179.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 361' ' ' ALA . . . . . 0.419 ' HA ' ' O ' ' S' ' 351' ' ' PHE . . . -140.07 130.09 24.86 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.39 -0.819 . . . . 18.04 110.262 -179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 362' ' ' ILE . . . . . . . . . . . . . 89.0 mt -95.7 83.83 1.48 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.307 -0.871 . . . . 15.64 109.984 179.907 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' S' S ' 363' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' S' ' 365' ' ' GLU . 11.9 t0 -75.37 94.51 3.07 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.352 -0.843 . . . . 35.03 110.16 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 364' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 54.0 -89.44 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.468 -0.77 . . . . 46.72 110.45 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' S' S ' 365' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' S' ' 363' ' ' ASP . 23.8 mt-10 -122.55 18.99 10.44 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.077 -1.014 . . . . 56.2 110.218 179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 366' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -117.82 124.98 49.7 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.303 -0.873 . . . . 51.02 110.418 -179.677 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' S' S ' 367' ' ' PHE . . . . . . . . . . . . . 26.9 m-85 -106.98 127.08 53.13 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.361 -0.837 . . . . 37.59 110.133 179.865 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' S' S ' 368' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -165.47 159.61 13.85 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.303 -0.873 . . . . 31.47 110.437 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' S' S ' 369' ' ' PRO . . . . . 0.408 ' HA ' ' HA ' ' S' ' 360' ' ' TYR . 46.6 Cg_endo -72.83 139.57 30.66 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 O-C-N 123.864 1.455 . . . . 28.85 110.536 -179.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 370' ' ' TRP . . . . . . . . . . . . . 67.5 t90 -167.23 113.6 0.76 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.376 -0.827 . . . . 26.94 109.957 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' S' S ' 371' ' ' THR . . . . . . . . . . . . . 59.5 m -74.83 113.04 20.6 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.411 -0.805 . . . . 20.19 110.059 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' S' S ' 372' ' ' PRO . . . . . 0.561 ' O ' HD11 ' S' ' 334' ' ' LEU . 48.2 Cg_endo -73.46 157.16 49.53 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 O-C-N 123.548 1.288 . . . . 28.68 110.613 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 373' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -90.57 147.12 35.68 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.449 -0.782 . . . . 35.72 109.896 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' S' S ' 374' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -76.02 -6.38 17.3 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 O-C-N 123.669 1.352 . . . . 30.89 110.474 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' S' S ' 375' ' ' SER . . . . . . . . . . . . . 68.5 p -104.32 -16.88 15.02 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.289 -0.882 . . . . 29.41 110.498 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' S' S ' 376' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -106.53 43.09 1.18 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.222 -0.924 . . . . 32.89 110.227 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' S' S ' 377' ' ' VAL . . . . . 0.594 ' O ' HG11 ' S' ' 327' ' ' VAL . 7.2 p -114.68 147.31 18.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 121.343 -0.848 . . . . 24.33 110.228 -179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 378' ' ' LEU . . . . . . . . . . . . . 51.7 mt -116.03 -58.0 2.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.401 -0.812 . . . . 24.37 109.626 179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' S' S ' 379' ' ' VAL . . . . . 0.642 HG22 HG12 ' S' ' 326' ' ' VAL . 61.4 t -120.69 132.37 70.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.39 -0.819 . . . . 18.02 109.357 179.316 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 380' ' ' PHE . . . . . 0.462 ' CE1' ' HB2' ' S' ' 325' ' ' CYS . 14.5 p90 -142.54 174.03 11.0 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.367 -0.833 . . . . 29.35 110.646 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 381' ' ' VAL . . . . . . . . . . . . . 57.8 t -120.09 107.39 39.74 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.51 -0.744 . . . . 16.34 109.394 179.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' S' S ' 382' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.42 145.65 48.34 Favored 'Trans proline' 0 C--N 1.311 -1.432 0 O-C-N 123.608 1.32 . . . . 20.94 110.775 -179.373 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' S' S ' 383' ' ' TYR . . . . . 0.401 ' CZ ' ' HB3' ' S' ' 338' ' ' HIS . 88.1 m-85 -61.05 -53.54 55.86 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.335 -0.853 . . . . 28.93 109.823 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 384' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -99.9 127.92 46.03 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.361 -0.837 . . . . 47.03 110.408 -176.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' S' S ' 385' ' ' GLN . . . . . 0.413 ' O ' ' O ' ' S' ' 386' ' ' GLU . 6.5 mm-40 -68.96 3.2 2.13 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.485 -0.759 . . . . 46.69 110.165 177.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 386' ' ' GLU . . . . . 1.07 ' O ' ' HG2' ' S' ' 321' ' ' PRO . 0.4 OUTLIER -47.24 170.7 0.08 OUTLIER Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.355 -0.841 . . . . 50.25 109.557 179.556 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' S' S ' 387' ' ' PRO . . . . . 0.55 ' O ' ' C ' ' S' ' 388' ' ' LEU . 49.1 Cg_endo -70.99 -9.76 26.29 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 O-C-N 123.593 1.312 . . . . 34.39 110.637 -178.031 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 388' ' ' LEU . . . . . 0.564 ' O ' ' HB2' ' S' ' 389' ' ' ASN . 83.5 mt 31.66 84.32 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.466 -0.771 . . . . 38.01 110.151 -179.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 389' ' ' ASN . . . . . 0.564 ' HB2' ' O ' ' S' ' 388' ' ' LEU . 24.9 m-20 68.72 171.08 0.29 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.297 -0.877 . . . . 45.82 110.152 -178.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 390' ' ' GLY . . . . . 0.586 ' O ' ' N ' ' S' ' 392' ' ' TRP . . . 149.16 -76.87 0.24 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.636 -1.386 . . . . 33.46 109.636 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 391' ' ' GLU . . . . . 0.578 ' HB2' ' O ' ' S' ' 390' ' ' GLY . 6.9 mt-10 62.83 -63.19 0.11 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.374 -1.074 . . . . 56.58 110.176 -179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 392' ' ' TRP . . . . . 0.586 ' N ' ' O ' ' S' ' 390' ' ' GLY . 0.0 OUTLIER -50.68 -23.86 2.94 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.345 -0.847 . . . . 31.43 110.366 179.709 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' S' S ' 393' ' ' LYS . . . . . 0.424 ' O ' ' CG2' ' S' ' 396' ' ' VAL . 0.1 OUTLIER -51.29 -41.91 60.79 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.299 -0.876 . . . . 39.42 110.39 179.914 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' S' S ' 394' ' ' ALA . . . . . . . . . . . . . . . -79.37 -19.44 50.18 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.288 -0.883 . . . . 34.33 110.125 178.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' S' S ' 395' ' ' LYS . . . . . 0.7 ' HB3' ' CD1' ' R' ' 143' ' ' LEU . 11.6 mmmt -68.36 -51.21 46.88 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.444 -0.785 . . . . 60.09 110.285 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 396' ' ' VAL . . . . . 1.002 HG23 ' H ' ' S' ' 397' ' ' GLN . 8.9 m -53.86 -68.17 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.286 -0.884 . . . . 35.5 110.539 179.377 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 397' ' ' GLN . . . . . 1.002 ' H ' HG23 ' S' ' 396' ' ' VAL . 0.8 OUTLIER -70.26 60.77 0.2 Allowed 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.15 -0.969 . . . . 49.96 110.596 178.915 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' S' S ' 398' ' ' ARG . . . . . 0.891 HH21 ' HB3' ' R' ' 149' ' ' ALA . 0.0 OUTLIER -78.91 -38.79 36.5 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.325 -0.859 . . . . 43.42 110.716 -177.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' S' S ' 399' ' ' LYS . . . . . 0.711 ' N ' ' HG2' ' S' ' 398' ' ' ARG . 57.2 tttt 59.46 100.65 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.389 -0.819 . . . . 55.31 110.03 -178.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' S' S ' 400' ' ' LEU . . . . . 0.844 HD12 ' CE1' ' R' ' 148' ' ' HIS . 0.2 OUTLIER -45.11 -40.26 6.75 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.346 -0.846 . . . . 41.03 110.258 179.97 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' S' S ' 401' ' ' LYS . . . . . 0.658 ' N ' HD23 ' S' ' 400' ' ' LEU . 15.0 tttt . . . . . 0 N--CA 1.492 1.666 0 O-C-N 121.382 -0.824 . . . . 61.97 110.208 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' R' R ' 29' ' ' MET . . . . . 0.471 ' HG3' ' N ' ' R' ' 30' ' ' GLU . 21.8 ptt? . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 121.174 0.511 . . . . 32.14 110.259 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' R' R ' 30' ' ' GLU . . . . . 0.471 ' N ' ' HG3' ' R' ' 29' ' ' MET . 41.7 tt0 -96.36 141.15 30.02 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.37 -0.831 . . . . 43.36 110.202 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 31' ' ' LEU . . . . . . . . . . . . . 65.3 mt -134.9 140.53 45.84 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.312 -0.867 . . . . 22.93 110.318 179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' R' R ' 32' ' ' THR . . . . . . . . . . . . . 68.3 m -87.46 110.59 20.41 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.4 -0.812 . . . . 22.34 109.986 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' R' R ' 33' ' ' LEU . . . . . 0.596 HD22 ' CE2' ' R' ' 62' ' ' TYR . 80.2 mt -62.46 -172.76 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.33 -0.856 . . . . 21.39 110.148 -179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 34' ' ' TYR . . . . . . . . . . . . . 37.1 p90 -74.68 -29.4 61.21 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.333 -0.855 . . . . 34.4 110.328 -179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' R' R ' 35' ' ' ASN . . . . . . . . . . . . . 48.4 p30 -77.7 -1.89 33.41 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.324 -0.86 . . . . 30.28 110.686 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' R' R ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.2 -16.55 59.46 Favored Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.776 -1.329 . . . . 36.25 109.776 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' R' R ' 37' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -59.04 161.81 4.79 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.322 -1.105 . . . . 53.8 110.368 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' R' R ' 38' ' ' LYS . . . . . . . . . . . . . 56.9 mttt -117.86 135.76 53.88 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.445 -0.784 . . . . 49.91 110.146 179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' R' R ' 39' ' ' LYS . . . . . 0.406 ' HG2' ' CZ ' ' R' ' 41' ' ' PHE . 8.0 ttmt -138.69 143.71 39.26 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.388 -0.82 . . . . 35.69 110.27 -179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 40' ' ' THR . . . . . . . . . . . . . 23.6 m -102.6 127.94 49.48 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.387 -0.82 . . . . 34.84 110.223 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' R' R ' 41' ' ' PHE . . . . . 0.406 ' CZ ' ' HG2' ' R' ' 39' ' ' LYS . 96.6 m-85 -113.06 132.62 55.33 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.426 -0.796 . . . . 34.42 110.14 -179.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 42' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -93.28 140.97 28.96 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.335 -0.853 . . . . 51.46 110.264 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' R' R ' 43' ' ' SER . . . . . . . . . . . . . 54.8 m -70.9 141.92 51.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.445 -0.784 . . . . 41.84 110.202 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' R' R ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.77 125.46 29.45 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.311 -0.868 . . . . 33.82 109.932 179.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 45' ' ' PRO . . . . . 0.423 ' HG2' ' ND2' ' R' ' 77' ' ' ASN . 46.4 Cg_endo -72.17 151.01 54.59 Favored 'Trans proline' 0 C--N 1.312 -1.391 0 O-C-N 123.616 1.324 . . . . 30.27 110.646 -179.721 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 46' ' ' ASN . . . . . . . . . . . . . 52.2 t-20 -124.21 109.9 13.98 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.545 -0.722 . . . . 35.1 110.088 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' R' R ' 47' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -120.25 -34.92 3.55 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.335 -0.853 . . . . 42.81 110.542 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' R' R ' 48' ' ' HIS . . . . . 0.44 ' NE2' HD11 ' R' ' 80' ' ' LEU . 73.3 m80 -105.74 45.15 0.98 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.322 -0.861 . . . . 49.97 110.223 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 49' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 50.28 34.71 9.23 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.358 -0.839 . . . . 61.32 110.173 -179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' R' R ' 50' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -86.26 43.77 1.09 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.402 -0.811 . . . . 51.5 110.685 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' R' R ' 51' ' ' ALA . . . . . 0.763 ' HB3' ' C ' ' S' ' 401' ' ' LYS . . . -66.12 -46.06 78.87 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.131 -0.981 . . . . 38.77 109.53 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 52' ' ' TRP . . . . . 0.484 ' CD2' ' N ' ' R' ' 53' ' ' LEU . 68.3 p-90 -58.43 -38.37 77.32 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.519 -0.738 . . . . 26.24 110.098 179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 53' ' ' LEU . . . . . 0.484 ' N ' ' CD2' ' R' ' 52' ' ' TRP . 23.0 tp -66.63 -46.75 74.79 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.4 -0.813 . . . . 26.75 110.016 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 54' ' ' ASN . . . . . . . . . . . . . 91.7 m-20 -55.27 -41.57 72.4 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.341 -0.85 . . . . 35.02 110.078 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' R' R ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.19 -46.03 92.14 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.426 -0.796 . . . . 24.47 110.219 179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' R' R ' 56' ' ' ILE . . . . . 0.432 HG12 HD11 ' R' ' 104' ' ' ILE . 76.3 mt -62.15 -42.31 94.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.246 -0.909 . . . . 26.03 109.907 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 57' ' ' LEU . . . . . . . . . . . . . 22.3 mt -60.27 -45.68 92.46 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.4 -0.813 . . . . 26.77 109.661 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' R' R ' 58' ' ' GLN . . . . . . . . . . . . . 57.7 mm-40 -63.87 -46.51 84.64 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.525 -0.734 . . . . 22.32 109.622 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' R' R ' 59' ' ' LEU . . . . . 0.428 ' HA ' ' HE2' ' R' ' 151' ' ' PHE . 24.0 tp -61.45 -37.74 84.64 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.334 -0.854 . . . . 20.55 109.404 179.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 60' ' ' PHE . . . . . 0.529 ' CE2' HD21 ' R' ' 111' ' ' LEU . 2.8 m-85 -61.13 -44.75 96.85 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.631 -0.668 . . . . 20.08 109.866 179.359 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 61' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -63.08 -36.19 82.78 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.492 -0.755 . . . . 18.8 110.511 -179.84 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' R' R ' 62' ' ' TYR . . . . . 0.596 ' CE2' HD22 ' R' ' 33' ' ' LEU . 9.2 t80 -63.14 -41.7 99.33 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.226 -0.921 . . . . 26.45 110.218 -179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 63' ' ' VAL . . . . . 0.407 ' H ' HG22 ' R' ' 63' ' ' VAL . 30.2 m -93.36 20.27 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.289 -0.882 . . . . 29.75 110.232 179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 64' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 52.91 75.61 0.23 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.343 -0.848 . . . . 35.52 110.549 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' R' R ' 65' ' ' GLU . . . . . 0.442 ' HG2' ' CD2' ' R' ' 60' ' ' PHE . 14.2 tp10 -116.3 104.1 52.28 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.44 -0.787 . . . . 29.89 109.9 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 66' ' ' PRO . . . . . 0.482 ' HA ' ' HB2' ' R' ' 69' ' ' ASP . 47.4 Cg_endo -73.55 -5.83 17.74 Favored 'Trans proline' 0 C--N 1.31 -1.457 0 O-C-N 123.79 1.416 . . . . 21.37 111.07 -179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 67' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -52.11 -61.56 2.19 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.099 -1.0 . . . . 23.85 110.331 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 68' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -98.12 36.52 1.56 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.275 -0.891 . . . . 28.07 110.442 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' R' R ' 69' ' ' ASP . . . . . 0.482 ' HB2' ' HA ' ' R' ' 66' ' ' PRO . 11.8 t0 -72.3 -33.29 67.3 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.303 -0.873 . . . . 43.76 110.169 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 70' ' ' TRP . . . . . 0.476 ' CE2' ' CG2' ' R' ' 71' ' ' VAL . 47.9 p-90 -73.32 -3.91 29.99 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.34 -0.85 . . . . 33.06 110.739 -179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 71' ' ' VAL . . . . . 0.556 HG11 ' HB2' ' R' ' 82' ' ' ALA . 40.7 t -109.78 -27.49 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.237 -0.914 . . . . 31.7 109.658 179.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 72' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -86.55 -48.87 7.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.407 -0.808 . . . . 33.58 110.267 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' R' R ' 73' ' ' SER . . . . . . . . . . . . . 70.1 m -89.73 51.01 1.99 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.29 -0.881 . . . . 50.82 110.362 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' R' R ' 74' ' ' SER . . . . . . . . . . . . . 15.8 t -125.89 138.37 31.92 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.303 -0.873 . . . . 34.74 110.206 179.863 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.38 -24.99 15.89 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 O-C-N 123.669 1.352 . . . . 35.7 110.32 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' R' R ' 76' ' ' GLU . . . . . . . . . . . . . 35.7 mm-40 -91.7 153.16 19.85 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.422 -0.799 . . . . 66.48 110.342 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' R' R ' 77' ' ' ASN . . . . . 0.423 ' ND2' ' HG2' ' R' ' 45' ' ' PRO . 22.2 t-20 -81.47 95.23 7.03 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.374 -0.829 . . . . 46.72 110.061 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 78' ' ' LEU . . . . . . . . . . . . . 96.3 mt -96.46 27.97 3.55 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.473 -0.767 . . . . 37.55 110.191 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' R' R ' 79' ' ' THR . . . . . . . . . . . . . 29.8 m -56.31 -54.5 44.72 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.26 -0.9 . . . . 37.36 110.283 -179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' R' R ' 80' ' ' LEU . . . . . 0.604 ' HA ' HD12 ' R' ' 83' ' ' ILE . 15.9 mt -61.04 -23.09 65.17 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.439 -0.788 . . . . 35.83 110.513 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 81' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -79.48 -39.21 32.69 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.162 -0.961 . . . . 44.03 110.349 -179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' R' R ' 82' ' ' ALA . . . . . 0.556 ' HB2' HG11 ' R' ' 71' ' ' VAL . . . -69.4 -28.64 66.34 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.315 -0.866 . . . . 32.54 110.278 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 83' ' ' ILE . . . . . 0.604 HD12 ' HA ' ' R' ' 80' ' ' LEU . 78.2 mt -70.11 -46.09 73.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.307 -0.87 . . . . 32.02 110.265 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 84' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -55.19 -52.07 64.51 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.222 -0.924 . . . . 34.09 110.596 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' R' R ' 85' ' ' GLN . . . . . 0.532 ' HG2' HD12 ' R' ' 89' ' ' LEU . 31.9 tt0 -54.81 -46.89 74.59 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.279 -0.888 . . . . 25.94 110.299 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 86' ' ' LEU . . . . . . . . . . . . . 24.0 mt -58.6 -43.85 89.67 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.339 -0.851 . . . . 16.2 109.936 179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' R' R ' 87' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -65.37 -35.17 80.15 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.435 -0.791 . . . . 49.09 110.304 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' R' R ' 88' ' ' ASP . . . . . . . . . . . . . 31.7 m-20 -78.47 -19.03 53.99 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.257 -0.902 . . . . 28.61 110.556 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' R' R ' 89' ' ' LEU . . . . . 0.532 HD12 ' HG2' ' R' ' 85' ' ' GLN . 32.5 mt -96.18 -29.41 14.07 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.207 -0.933 . . . . 26.16 110.197 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 90' ' ' THR . . . . . . . . . . . . . 59.0 p -105.7 -34.55 7.67 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.303 -0.873 . . . . 33.33 109.778 179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' R' R ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.78 16.02 58.81 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.857 -1.297 . . . . 31.13 109.857 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' R' R ' 92' ' ' LEU . . . . . . . . . . . . . 97.0 mt -100.04 155.24 17.82 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.153 -1.204 . . . . 42.52 110.229 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' R' R ' 93' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -86.28 91.63 8.54 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.538 -0.726 . . . . 68.46 109.991 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' R' R ' 94' ' ' LEU . . . . . 0.459 ' HB3' ' CZ2' ' R' ' 52' ' ' TRP . 48.2 mt -99.47 52.99 0.94 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.183 -0.948 . . . . 44.63 110.282 -179.708 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 95' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.48 -38.67 6.38 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.263 -0.898 . . . . 67.16 110.381 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 96' ' ' GLU . . . . . . . . . . . . . 24.7 mt-10 -113.91 44.25 1.68 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.364 -0.835 . . . . 67.02 110.278 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' R' R ' 97' ' ' GLY . . . . . . . . . . . . . . . 99.12 150.77 26.02 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.653 -1.379 . . . . 49.48 109.653 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' R' R ' 98' ' ' GLY . . . . . 0.728 ' O ' ' HD3' ' S' ' 401' ' ' LYS . . . -166.28 159.99 33.42 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.329 -1.508 . . . . 36.57 109.329 179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 99' ' ' PRO . . . . . 0.942 ' CB ' HG22 ' S' ' 396' ' ' VAL . 44.6 Cg_endo -72.55 121.11 7.15 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 O-C-N 123.732 1.385 . . . . 30.41 110.413 -179.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 100' ' ' PRO . . . . . 0.48 ' HD3' ' NZ ' ' S' ' 401' ' ' LYS . 45.4 Cg_endo -72.39 -31.5 11.31 Favored 'Trans proline' 0 C--N 1.313 -1.298 0 O-C-N 123.621 1.327 . . . . 29.94 110.514 -179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 101' ' ' ALA . . . . . 0.475 ' HB2' ' HB3' ' R' ' 178' ' ' LEU . . . -70.05 -38.45 75.81 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.293 -0.879 . . . . 23.64 110.294 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 102' ' ' LEU . . . . . 0.425 HD23 HD21 ' R' ' 106' ' ' ASN . 0.1 OUTLIER -72.6 -40.69 66.32 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.353 -0.842 . . . . 20.31 110.446 -179.801 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' R' R ' 103' ' ' VAL . . . . . 0.79 HG23 ' O ' ' R' ' 99' ' ' PRO . 63.7 t -58.19 -40.08 75.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.225 -0.922 . . . . 16.33 109.986 179.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 104' ' ' ILE . . . . . 0.432 HD11 HG12 ' R' ' 56' ' ' ILE . 81.8 mt -71.71 -30.54 38.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.427 -0.796 . . . . 24.77 109.968 179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 105' ' ' TRP . . . . . 0.462 ' O ' ' HD3' ' R' ' 108' ' ' LYS . 70.5 t-105 -82.43 0.89 40.08 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.277 -0.89 . . . . 23.28 110.26 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 106' ' ' ASN . . . . . 0.425 HD21 HD23 ' R' ' 102' ' ' LEU . 6.9 m-80 -105.11 -10.45 17.14 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.173 -0.954 . . . . 28.26 110.03 179.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 107' ' ' ILE . . . . . . . . . . . . . 36.8 pt -126.85 34.98 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.184 -0.947 . . . . 18.77 110.026 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' R' R ' 108' ' ' LYS . . . . . 0.501 ' HG2' ' HB ' ' R' ' 115' ' ' ILE . 9.3 mtpp -61.02 -48.49 81.57 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.493 -0.755 . . . . 42.5 110.031 179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 109' ' ' HIS . . . . . 0.445 ' CD2' ' HG ' ' R' ' 110' ' ' LEU . 50.7 p-80 -66.02 -12.87 58.26 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.511 -0.743 . . . . 20.07 110.698 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 110' ' ' LEU . . . . . 0.445 ' HG ' ' CD2' ' R' ' 109' ' ' HIS . 80.1 mt -94.72 -17.38 22.26 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.071 -1.018 . . . . 15.69 110.183 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 111' ' ' LEU . . . . . 0.529 HD21 ' CE2' ' R' ' 60' ' ' PHE . 10.4 mt -94.05 144.12 25.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.324 -0.86 . . . . 25.39 111.052 -179.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 112' ' ' HIS . . . . . . . . . . . . . 84.4 t60 -77.67 -17.43 57.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.518 -0.739 . . . . 53.48 109.84 179.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' R' R ' 113' ' ' THR . . . . . 0.459 HG22 ' N ' ' R' ' 114' ' ' GLY . 60.2 m -83.69 166.62 17.94 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.282 -0.886 . . . . 14.8 110.186 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 114' ' ' GLY . . . . . 0.459 ' N ' HG22 ' R' ' 113' ' ' THR . . . -97.99 127.12 9.12 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.968 -1.253 . . . . 16.14 109.968 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 115' ' ' ILE . . . . . 0.578 HD13 ' HB ' ' R' ' 124' ' ' VAL . 47.8 mm -109.07 139.32 32.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.534 -0.98 . . . . 13.46 109.71 179.683 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 116' ' ' GLY . . . . . . . . . . . . . . . -152.76 -155.78 7.26 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.926 -1.27 . . . . 23.9 109.926 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' R' R ' 117' ' ' THR . . . . . 0.529 HG22 ' CG2' ' R' ' 126' ' ' VAL . 18.7 p -135.06 -171.4 2.79 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.418 -1.048 . . . . 27.37 110.095 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 118' ' ' ALA . . . . . 0.444 ' HB3' ' OD1' ' R' ' 128' ' ' ASP . . . -56.59 -58.05 9.73 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.276 -0.89 . . . . 18.76 110.057 179.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 119' ' ' SER . . . . . 0.556 ' HA ' ' CB ' ' R' ' 194' ' ' ALA . 1.1 m -56.59 -40.53 75.43 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.332 -0.855 . . . . 32.35 109.784 179.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 120' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 -110.12 86.3 4.97 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.435 -0.791 . . . . 27.12 109.675 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' R' R ' 121' ' ' PRO . . . . . 0.482 ' HA ' ' SG ' ' R' ' 125' ' ' CYS . 44.7 Cg_endo -71.26 166.51 29.03 Favored 'Trans proline' 0 C--N 1.312 -1.394 0 O-C-N 123.874 1.46 . . . . 22.68 111.035 -179.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 122' ' ' SER . . . . . 0.438 ' HB2' ' O ' ' R' ' 121' ' ' PRO . 38.4 t 178.57 -161.69 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.584 -0.698 . . . . 22.99 109.436 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 123' ' ' GLU . . . . . 0.44 ' HG2' HG23 ' R' ' 113' ' ' THR . 2.3 tp10 -56.42 -39.94 73.89 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.225 -0.922 . . . . 36.18 109.732 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 124' ' ' VAL . . . . . 0.578 ' HB ' HD13 ' R' ' 115' ' ' ILE . 84.1 t -142.55 136.42 27.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.484 -0.76 . . . . 20.64 109.314 179.353 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 125' ' ' CYS . . . . . 0.482 ' SG ' ' HA ' ' R' ' 121' ' ' PRO . 83.2 m -140.28 168.19 20.37 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.187 -0.946 . . . . 22.8 111.193 -179.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 126' ' ' VAL . . . . . 0.729 HG12 HG22 ' R' ' 179' ' ' VAL . 35.9 m -122.78 159.83 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.828 -0.545 . . . . 21.24 109.647 179.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 127' ' ' VAL . . . . . 0.71 HG11 ' O ' ' R' ' 177' ' ' VAL . 30.5 m -70.86 141.83 16.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.773 0 O-C-N 121.337 -0.852 . . . . 19.77 110.695 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 128' ' ' ASP . . . . . 0.444 ' OD1' ' HB3' ' R' ' 118' ' ' ALA . 53.9 p-10 -137.7 19.44 2.87 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.319 -0.863 . . . . 29.21 110.665 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 129' ' ' GLY . . . . . . . . . . . . . . . 113.97 0.06 24.18 Favored Glycine 0 N--CA 1.492 2.399 0 C-N-CA 119.993 -1.098 . . . . 33.86 110.487 179.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' R' R ' 130' ' ' THR . . . . . . . . . . . . . 58.9 m -91.9 131.85 36.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.202 -1.176 . . . . 26.41 109.998 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 59.5 m-20 -62.53 120.72 11.66 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.408 -0.808 . . . . 33.08 110.284 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' R' R ' 132' ' ' MET . . . . . 0.435 ' HE1' ' CE2' ' R' ' 180' ' ' PHE . 98.4 mmm -105.22 165.67 10.94 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.425 -0.797 . . . . 30.76 110.445 -179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 133' ' ' CYS . . . . . 0.41 ' HA ' ' HB3' ' R' ' 174' ' ' PRO . 31.7 m -141.17 158.21 44.21 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.493 -0.754 . . . . 27.0 109.912 179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 134' ' ' LEU . . . . . 0.564 HD11 ' O ' ' R' ' 172' ' ' PRO . 0.1 OUTLIER -58.48 -19.8 40.09 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.362 -0.836 . . . . 33.9 110.407 -179.837 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' R' R ' 135' ' ' ALA . . . . . . . . . . . . . . . -92.74 8.14 40.57 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.282 -0.887 . . . . 19.37 110.78 -179.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' R' R ' 136' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -93.71 -21.72 19.17 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.255 -0.903 . . . . 30.47 110.272 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' R' R ' 137' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -149.98 165.42 32.74 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.314 -0.866 . . . . 24.27 110.189 179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' R' R ' 138' ' ' HIS . . . . . 0.433 ' HA ' HG23 ' R' ' 154' ' ' VAL . 15.2 p80 -117.86 15.11 14.35 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.398 -0.814 . . . . 20.91 110.459 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 139' ' ' ALA . . . . . 0.472 ' HA ' ' O ' ' R' ' 152' ' ' ALA . . . -177.14 152.44 0.89 Allowed 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.278 -0.889 . . . . 15.69 110.098 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 140' ' ' GLY . . . . . 0.427 ' HA3' ' O ' ' R' ' 179' ' ' VAL . . . 161.8 175.15 32.52 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.998 -1.241 . . . . 23.76 109.998 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 141' ' ' ILE . . . . . . . . . . . . . 83.5 mt -95.49 136.54 26.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.514 -0.992 . . . . 25.3 109.718 179.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' R' R ' 142' ' ' PHE . . . . . 0.576 ' CD2' ' HB2' ' R' ' 172' ' ' PRO . 82.6 m-85 -120.7 -172.58 2.41 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.26 -0.9 . . . . 30.24 110.511 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 143' ' ' LEU . . . . . 0.743 HD23 ' O ' ' R' ' 148' ' ' HIS . 0.5 OUTLIER -119.79 77.71 1.26 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.437 -0.789 . . . . 32.8 110.321 -179.908 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' R' R ' 144' ' ' LYS . . . . . 0.47 ' HG3' ' CZ2' ' R' ' 170' ' ' TRP . 1.0 OUTLIER -69.58 76.86 0.42 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.369 -0.832 . . . . 49.18 109.625 179.626 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' R' R ' 145' ' ' GLY . . . . . 0.458 ' O ' HD22 ' R' ' 143' ' ' LEU . . . 104.55 179.31 24.76 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.174 -1.571 . . . . 53.87 109.174 -179.589 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 146' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -88.53 145.85 25.5 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.253 -1.145 . . . . 68.58 110.023 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' R' R ' 147' ' ' GLU . . . . . 0.859 ' HA ' ' CB ' ' S' ' 398' ' ' ARG . 10.9 mt-10 58.17 36.57 25.92 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.288 -0.883 . . . . 56.62 110.633 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 148' ' ' HIS . . . . . 0.743 ' O ' HD23 ' R' ' 143' ' ' LEU . 45.0 t60 -158.67 148.12 19.17 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.229 -0.92 . . . . 44.57 110.372 179.625 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 149' ' ' ALA . . . . . . . . . . . . . . . -150.27 146.89 27.06 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.45 -0.781 . . . . 33.54 110.091 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' R' R ' 150' ' ' VAL . . . . . . . . . . . . . 34.2 m -142.34 161.5 19.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.273 -0.892 . . . . 27.61 110.318 179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' R' R ' 151' ' ' PHE . . . . . 0.538 ' CD1' ' N ' ' R' ' 152' ' ' ALA . 5.9 t80 -86.19 155.62 20.66 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.41 -0.806 . . . . 23.04 109.867 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 152' ' ' ALA . . . . . 0.538 ' N ' ' CD1' ' R' ' 151' ' ' PHE . . . -157.28 151.51 24.9 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.409 -0.807 . . . . 29.61 109.612 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 153' ' ' CYS . . . . . . . . . . . . . 26.7 p -154.29 173.62 15.92 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.227 -0.921 . . . . 22.75 110.507 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' R' R ' 154' ' ' VAL . . . . . 0.614 HG22 ' CE2' ' R' ' 159' ' ' TRP . 59.7 t -90.64 117.03 33.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.322 -0.861 . . . . 23.26 110.042 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 155' ' ' THR . . . . . . . . . . . . . 70.5 p -112.17 -176.66 2.98 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.361 -0.837 . . . . 17.88 110.025 179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' R' R ' 156' ' ' SER . . . . . . . . . . . . . 78.6 p -75.96 -3.66 36.78 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.32 -0.863 . . . . 21.83 110.707 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' R' R ' 157' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -118.27 10.38 12.81 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.159 -0.963 . . . . 36.54 110.635 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' R' R ' 158' ' ' GLY . . . . . . . . . . . . . . . 117.94 -162.68 13.02 Favored Glycine 0 N--CA 1.493 2.434 0 N-CA-C 109.556 -1.417 . . . . 31.74 109.556 -179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' R' R ' 159' ' ' TRP . . . . . 0.614 ' CE2' HG22 ' R' ' 154' ' ' VAL . 14.7 m95 -86.56 122.44 30.49 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.389 -1.065 . . . . 28.25 110.147 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 160' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -108.47 167.03 10.33 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.404 -0.81 . . . . 41.24 110.175 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' R' R ' 161' ' ' ALA . . . . . . . . . . . . . . . -143.23 123.48 13.77 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.344 -0.847 . . . . 27.4 110.173 -179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' R' R ' 162' ' ' ILE . . . . . . . . . . . . . 92.0 mt -87.62 81.13 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.343 -0.848 . . . . 24.27 110.101 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' R' R ' 163' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' R' ' 165' ' ' GLU . 15.3 t0 -72.84 92.42 1.59 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.518 -0.739 . . . . 36.08 110.254 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 164' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 54.15 -89.0 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.463 -0.773 . . . . 46.08 110.574 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' R' R ' 165' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' R' ' 163' ' ' ASP . 29.7 mt-10 -124.76 36.03 4.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.088 -1.007 . . . . 50.94 110.192 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 166' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -135.82 117.23 14.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.4 -0.812 . . . . 47.28 110.34 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' R' R ' 167' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -100.94 119.96 39.47 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.457 -0.777 . . . . 40.47 110.172 179.909 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' R' R ' 168' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -157.6 158.54 30.61 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.213 -0.929 . . . . 30.21 110.399 179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' R' R ' 169' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -72.81 132.99 19.36 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.931 1.49 . . . . 32.76 110.505 -179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' R' R ' 170' ' ' TRP . . . . . 0.47 ' CZ2' ' HG3' ' R' ' 144' ' ' LYS . 66.9 t90 -159.78 119.37 2.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.383 -0.823 . . . . 32.79 109.909 179.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 171' ' ' THR . . . . . . . . . . . . . 46.9 m -81.1 112.58 33.94 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.471 -0.768 . . . . 36.92 110.197 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' R' R ' 172' ' ' PRO . . . . . 0.576 ' HB2' ' CD2' ' R' ' 142' ' ' PHE . 46.5 Cg_endo -73.69 158.87 46.6 Favored 'Trans proline' 0 C--N 1.31 -1.485 0 O-C-N 123.634 1.334 . . . . 33.54 110.504 -179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 173' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -88.93 144.97 33.67 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.358 -0.839 . . . . 45.76 109.882 179.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' R' R ' 174' ' ' PRO . . . . . 0.41 ' HB3' ' HA ' ' R' ' 133' ' ' CYS . 45.5 Cg_endo -71.71 -10.41 26.47 Favored 'Trans proline' 0 C--N 1.31 -1.459 0 O-C-N 123.614 1.323 . . . . 29.63 110.507 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 175' ' ' SER . . . . . . . . . . . . . 53.0 p -103.44 -17.55 15.19 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.293 -0.88 . . . . 35.7 110.37 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' R' R ' 176' ' ' ASP . . . . . . . . . . . . . 74.1 m-20 -103.56 43.32 1.09 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.25 -0.906 . . . . 39.65 110.379 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' R' R ' 177' ' ' VAL . . . . . 0.71 ' O ' HG11 ' R' ' 127' ' ' VAL . 10.4 p -117.86 127.08 75.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.324 -0.86 . . . . 20.61 110.07 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 178' ' ' LEU . . . . . 0.475 ' HB3' ' HB2' ' R' ' 101' ' ' ALA . 45.6 mt -91.45 -61.31 1.68 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.361 -0.837 . . . . 15.58 109.395 179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 179' ' ' VAL . . . . . 0.729 HG22 HG12 ' R' ' 126' ' ' VAL . 68.3 t -114.59 144.78 21.41 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.621 -0.674 . . . . 17.4 109.409 179.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 180' ' ' PHE . . . . . 0.435 ' CE2' ' HE1' ' R' ' 132' ' ' MET . 43.5 p90 -152.21 163.34 39.6 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.328 -0.858 . . . . 20.16 110.474 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 181' ' ' VAL . . . . . . . . . . . . . 66.3 t -113.16 111.48 50.29 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.467 -0.771 . . . . 17.69 109.833 179.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' R' R ' 182' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -72.03 149.52 52.9 Favored 'Trans proline' 0 C--N 1.311 -1.41 0 O-C-N 123.532 1.28 . . . . 17.81 110.423 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' R' R ' 183' ' ' TYR . . . . . 0.739 ' O ' ' C ' ' R' ' 184' ' ' ASP . 79.0 m-85 -59.03 175.47 0.28 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.43 -0.794 . . . . 28.01 110.539 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 184' ' ' ASP . . . . . 0.739 ' C ' ' O ' ' R' ' 183' ' ' TYR . 1.0 OUTLIER -11.78 -75.82 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.452 -0.78 . . . . 58.64 110.296 -177.936 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' R' R ' 185' ' ' GLN . . . . . . . . . . . . . 14.0 tt0 . . . . . 0 N--CA 1.503 2.177 0 CA-C-O 121.247 0.546 . . . . 80.42 111.757 179.236 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' R' R ' 193' ' ' LYS . . . . . . . . . . . . . 14.3 ptmt . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 120.895 0.379 . . . . 49.5 110.179 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' R' R ' 194' ' ' ALA . . . . . 0.857 ' HB3' ' HG2' ' R' ' 197' ' ' GLN . . . -174.7 -148.0 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.141 -0.975 . . . . 40.4 110.079 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 195' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -101.31 -49.95 3.91 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.455 -0.778 . . . . 34.6 110.241 -179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 196' ' ' VAL . . . . . 0.552 ' O ' HG12 ' R' ' 196' ' ' VAL . 47.8 t -91.96 54.0 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.288 -0.882 . . . . 33.27 110.594 -179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 197' ' ' GLN . . . . . 0.857 ' HG2' ' HB3' ' R' ' 194' ' ' ALA . 0.0 OUTLIER -164.06 26.16 0.07 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.146 -0.971 . . . . 41.58 110.702 179.842 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' R' R ' 198' ' ' ARG . . . . . . . . . . . . . 4.9 mtm180 -117.41 155.46 29.59 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.063 -1.023 . . . . 38.65 110.253 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' R' R ' 199' ' ' LYS . . . . . 0.608 ' O ' ' HD3' ' S' ' 299' ' ' PRO . 15.2 tttp -65.25 -66.94 0.48 Allowed 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.387 -0.821 . . . . 36.77 109.908 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' R' R ' 200' ' ' LEU . . . . . . . . . . . . . 1.5 tp 61.22 161.67 0.06 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.444 -0.785 . . . . 33.08 110.117 -179.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' R' R ' 201' ' ' LYS . . . . . 0.777 ' C ' ' N ' ' S' ' 298' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.386 -0.822 . . . . 44.32 110.267 179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 229' ' ' MET . . . . . . . . . . . . . 1.5 tpt . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.226 0.536 . . . . 51.83 110.21 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' S' S ' 230' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -97.27 142.75 28.78 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.372 -0.83 . . . . 54.13 110.22 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' S' S ' 231' ' ' LEU . . . . . . . . . . . . . 67.9 mt -134.06 141.07 47.05 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.363 -0.836 . . . . 33.04 110.299 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' S' S ' 232' ' ' THR . . . . . 0.407 ' O ' ' HA ' ' S' ' 355' ' ' THR . 40.0 m -89.27 103.27 15.91 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.345 -0.847 . . . . 26.92 110.093 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 233' ' ' LEU . . . . . 0.667 HD22 ' CE2' ' S' ' 262' ' ' TYR . 79.8 mt -55.84 179.29 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.476 -0.765 . . . . 13.78 110.491 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 234' ' ' TYR . . . . . 0.444 ' CG ' ' N ' ' S' ' 235' ' ' ASN . 35.4 p90 -65.12 -35.61 81.67 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.354 -0.841 . . . . 26.08 110.119 179.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 235' ' ' ASN . . . . . 0.444 ' N ' ' CG ' ' S' ' 234' ' ' TYR . 50.7 p30 -74.28 -7.5 53.0 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.377 -0.827 . . . . 20.04 110.506 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 236' ' ' GLY . . . . . . . . . . . . . . . 95.81 -20.01 51.79 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.747 -1.341 . . . . 22.71 109.747 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' S' S ' 237' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -52.96 145.74 12.26 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.182 -1.187 . . . . 35.44 110.165 -179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' S' S ' 238' ' ' LYS . . . . . . . . . . . . . 44.4 mttt -102.17 127.9 48.91 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.397 -0.814 . . . . 32.56 110.374 -179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' S' S ' 239' ' ' LYS . . . . . 0.405 ' HG2' ' CZ ' ' S' ' 241' ' ' PHE . 9.0 ttmt -132.27 144.52 50.66 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.373 -0.829 . . . . 26.68 109.959 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 240' ' ' THR . . . . . . . . . . . . . 52.5 m -102.05 132.22 48.04 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.339 -0.851 . . . . 41.02 110.305 -179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' S' S ' 241' ' ' PHE . . . . . 0.405 ' CZ ' ' HG2' ' S' ' 239' ' ' LYS . 96.0 m-85 -117.98 137.67 52.7 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.346 -0.846 . . . . 28.62 110.169 179.811 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 242' ' ' TYR . . . . . . . . . . . . . 36.9 m-85 -96.36 161.78 13.78 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.451 -0.781 . . . . 47.89 110.224 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' S' S ' 243' ' ' SER . . . . . . . . . . . . . 72.4 m -90.65 151.52 21.24 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.333 -0.854 . . . . 45.09 110.225 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' S' S ' 244' ' ' ARG . . . . . . . . . . . . . 1.4 mtp85 -129.76 126.74 22.71 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.335 -0.853 . . . . 42.49 110.274 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' S' S ' 245' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.31 161.0 43.83 Favored 'Trans proline' 0 C--N 1.311 -1.426 0 O-C-N 123.603 1.317 . . . . 35.68 110.503 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' S' S ' 246' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -132.89 97.88 4.15 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.323 -0.861 . . . . 51.88 109.821 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' S' S ' 247' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -110.47 -22.21 11.78 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.317 -0.865 . . . . 53.69 110.636 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' S' S ' 248' ' ' HIS . . . . . . . . . . . . . 76.5 m80 -117.26 43.75 2.26 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.235 -0.916 . . . . 55.79 110.774 -179.476 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' S' S ' 249' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 48.8 38.36 11.72 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.459 -0.775 . . . . 49.45 110.382 179.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' S' S ' 250' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -90.62 29.05 1.37 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.462 -0.773 . . . . 36.86 110.277 179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' S' S ' 251' ' ' ALA . . . . . . . . . . . . . . . -53.84 -43.21 69.28 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.244 -0.91 . . . . 29.69 109.577 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' S' S ' 252' ' ' TRP . . . . . 0.607 ' N ' ' HZ1' ' R' ' 201' ' ' LYS . 67.9 p-90 -61.77 -33.86 74.83 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.508 -0.745 . . . . 41.12 109.89 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 253' ' ' LEU . . . . . 0.407 ' N ' ' CD2' ' S' ' 252' ' ' TRP . 23.2 tp -70.12 -47.26 62.51 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.412 -0.805 . . . . 24.89 110.025 179.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 254' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -56.1 -42.47 76.82 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.419 -0.801 . . . . 35.65 110.03 179.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' S' S ' 255' ' ' ALA . . . . . . . . . . . . . . . -59.49 -48.25 82.37 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.438 -0.789 . . . . 22.73 110.1 179.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' S' S ' 256' ' ' ILE . . . . . 0.502 HG12 HD11 ' S' ' 304' ' ' ILE . 80.1 mt -62.25 -40.65 88.51 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.289 -0.882 . . . . 28.85 110.02 179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 257' ' ' LEU . . . . . . . . . . . . . 19.1 mt -61.54 -44.53 96.87 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.365 -0.834 . . . . 23.07 110.144 179.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' S' S ' 258' ' ' GLN . . . . . 0.498 ' HB3' ' CD2' ' S' ' 351' ' ' PHE . 53.3 mm-40 -65.01 -45.39 85.73 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.389 -0.82 . . . . 29.78 109.92 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 259' ' ' LEU . . . . . 0.425 ' O ' HG22 ' S' ' 263' ' ' VAL . 19.8 tp -58.66 -36.42 74.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.43 -0.794 . . . . 17.94 109.444 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 260' ' ' PHE . . . . . 0.534 ' CE2' HD21 ' S' ' 311' ' ' LEU . 3.1 m-85 -62.79 -45.22 93.64 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.647 -0.658 . . . . 30.57 109.849 179.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 261' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -62.16 -29.77 70.59 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.509 -0.744 . . . . 41.34 109.979 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' S' S ' 262' ' ' TYR . . . . . 0.667 ' CE2' HD22 ' S' ' 233' ' ' LEU . 8.7 t80 -71.19 -44.71 64.92 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.433 -0.792 . . . . 26.03 110.074 179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 263' ' ' VAL . . . . . 0.425 HG22 ' O ' ' S' ' 259' ' ' LEU . 33.1 m -92.02 18.28 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 121.438 -0.788 . . . . 22.8 110.355 179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 264' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 52.7 70.76 0.54 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.287 -0.883 . . . . 44.03 110.604 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' S' S ' 265' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -111.84 109.22 55.33 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.295 -0.878 . . . . 35.61 109.628 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' S' S ' 266' ' ' PRO . . . . . 0.476 ' HA ' ' HB2' ' S' ' 269' ' ' ASP . 48.8 Cg_endo -75.33 0.4 9.08 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 123.55 1.289 . . . . 37.67 111.807 -179.126 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 267' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -56.48 -67.69 0.28 Allowed 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.764 -1.21 . . . . 41.49 110.199 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 268' ' ' PHE . . . . . . . . . . . . . 22.4 m-85 -92.9 39.89 1.05 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.159 -0.963 . . . . 50.76 110.047 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' S' S ' 269' ' ' ASP . . . . . 0.476 ' HB2' ' HA ' ' S' ' 266' ' ' PRO . 0.9 OUTLIER -76.02 -33.29 59.67 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.426 -0.796 . . . . 61.86 109.762 179.534 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' S' S ' 270' ' ' TRP . . . . . 0.508 ' CE2' HG23 ' S' ' 271' ' ' VAL . 50.9 p-90 -73.83 -4.27 33.79 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.298 -0.876 . . . . 39.85 110.527 179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 271' ' ' VAL . . . . . 0.508 HG23 ' CE2' ' S' ' 270' ' ' TRP . 46.4 t -109.67 -32.62 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.732 0 O-C-N 121.146 -0.971 . . . . 39.18 110.065 179.55 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 272' ' ' TYR . . . . . . . . . . . . . 39.3 t80 -78.71 -36.5 43.33 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.35 -0.844 . . . . 40.02 110.524 -179.646 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' S' S ' 273' ' ' SER . . . . . . . . . . . . . 71.2 m -103.49 56.03 0.74 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.295 -0.878 . . . . 47.2 110.369 -179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' S' S ' 274' ' ' SER . . . . . . . . . . . . . 6.9 t -133.01 141.26 40.3 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.329 -0.857 . . . . 47.61 110.113 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' S' S ' 275' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.77 -18.86 21.68 Favored 'Trans proline' 0 C--N 1.311 -1.442 0 O-C-N 123.633 1.333 . . . . 45.28 110.547 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' S' S ' 276' ' ' GLU . . . . . . . . . . . . . 63.1 mm-40 -99.96 140.85 33.58 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.327 -0.858 . . . . 57.27 110.248 179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' S' S ' 277' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -71.76 97.69 1.82 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.396 -0.815 . . . . 37.28 110.251 -179.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' S' S ' 278' ' ' LEU . . . . . . . . . . . . . 86.4 mt -96.93 33.74 1.84 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.39 -0.819 . . . . 43.88 110.037 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' S' S ' 279' ' ' THR . . . . . . . . . . . . . 76.3 m -64.02 -60.15 3.6 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.436 -0.79 . . . . 50.05 110.269 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' S' S ' 280' ' ' LEU . . . . . 0.739 ' HA ' HD12 ' S' ' 283' ' ' ILE . 13.6 mt -51.53 -39.98 58.77 Favored 'General case' 0 N--CA 1.497 1.894 0 O-C-N 121.314 -0.866 . . . . 54.12 110.241 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 281' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.27 -49.75 74.43 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.494 -0.754 . . . . 65.28 110.174 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 282' ' ' ALA . . . . . . . . . . . . . . . -58.95 -33.91 71.15 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.44 -0.788 . . . . 46.51 110.554 -179.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' S' S ' 283' ' ' ILE . . . . . 0.739 HD12 ' HA ' ' S' ' 280' ' ' LEU . 85.6 mt -66.3 -50.88 64.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.319 -0.863 . . . . 47.3 110.125 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 284' ' ' LYS . . . . . . . . . . . . . 33.8 tttp -50.6 -57.57 7.88 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.318 -0.864 . . . . 50.72 110.344 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' S' S ' 285' ' ' GLN . . . . . 0.518 ' HG2' HD12 ' S' ' 289' ' ' LEU . 34.4 tt0 -51.47 -46.33 63.07 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.465 -0.772 . . . . 68.47 110.257 179.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 286' ' ' LEU . . . . . . . . . . . . . 19.2 mt -60.02 -44.56 94.5 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.372 -0.83 . . . . 36.62 110.275 -179.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' S' S ' 287' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -62.7 -35.22 79.0 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.289 -0.882 . . . . 46.64 110.1 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' S' S ' 288' ' ' ASP . . . . . . . . . . . . . 54.4 m-20 -76.31 -20.96 56.78 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.4 -0.812 . . . . 46.45 110.34 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' S' S ' 289' ' ' LEU . . . . . 0.518 HD12 ' HG2' ' S' ' 285' ' ' GLN . 30.7 mt -97.38 -21.69 17.05 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.302 -0.874 . . . . 35.09 110.494 -179.662 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 290' ' ' THR . . . . . 0.406 HG22 ' HB3' ' S' ' 306' ' ' ASN . 81.2 p -114.76 -28.49 7.08 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.325 -0.859 . . . . 38.61 110.406 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 291' ' ' GLY . . . . . . . . . . . . . . . 79.35 11.08 85.33 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.9 -1.28 . . . . 36.77 109.9 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' S' S ' 292' ' ' LEU . . . . . . . . . . . . . 84.7 mt -96.51 145.82 25.35 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.286 -1.126 . . . . 35.33 109.722 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' S' S ' 293' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -77.35 102.34 6.73 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.194 -0.941 . . . . 48.7 110.273 -179.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' S' S ' 294' ' ' LEU . . . . . 0.428 ' HB3' ' CZ2' ' S' ' 252' ' ' TRP . 56.1 mt -106.96 51.72 0.73 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.51 -0.744 . . . . 42.61 110.085 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 295' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -112.43 -11.27 13.67 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.274 -0.891 . . . . 55.49 110.56 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 296' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -144.24 48.55 1.37 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.187 -0.946 . . . . 75.68 110.319 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' S' S ' 297' ' ' GLY . . . . . . . . . . . . . . . 96.88 145.18 18.72 Favored Glycine 0 N--CA 1.493 2.488 0 N-CA-C 109.505 -1.438 . . . . 49.44 109.505 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' S' S ' 298' ' ' GLY . . . . . 0.777 ' N ' ' C ' ' R' ' 201' ' ' LYS . . . -163.85 156.98 29.09 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.823 -1.311 . . . . 41.11 109.823 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 299' ' ' PRO . . . . . 0.608 ' HD3' ' O ' ' R' ' 199' ' ' LYS . 47.7 Cg_endo -73.73 118.21 5.36 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 O-C-N 123.941 1.495 . . . . 26.2 110.314 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 300' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.23 -15.42 31.72 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 123.538 1.283 . . . . 21.7 110.684 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' S' S ' 301' ' ' ALA . . . . . . . . . . . . . . . -80.73 -29.33 36.37 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.259 -0.9 . . . . 31.23 110.091 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' S' S ' 302' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -83.58 -40.57 18.91 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.512 -0.742 . . . . 38.99 109.953 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 303' ' ' VAL . . . . . 0.493 HG23 ' O ' ' S' ' 299' ' ' PRO . 58.5 t -60.68 -35.48 64.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.372 -0.83 . . . . 18.63 110.177 179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 304' ' ' ILE . . . . . 0.518 HD12 HG21 ' S' ' 379' ' ' VAL . 86.3 mt -79.39 -23.58 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.418 -0.801 . . . . 25.46 110.177 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 305' ' ' TRP . . . . . 0.414 ' CD2' ' HD3' ' S' ' 308' ' ' LYS . 68.8 t-105 -88.67 -14.62 36.92 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.194 -0.942 . . . . 33.4 110.5 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 306' ' ' ASN . . . . . 0.406 ' HB3' HG22 ' S' ' 290' ' ' THR . 10.4 m-80 -89.7 -13.57 36.6 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.237 -0.915 . . . . 36.97 110.391 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 307' ' ' ILE . . . . . 0.473 HG12 ' O ' ' S' ' 303' ' ' VAL . 36.9 pt -125.03 45.67 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 121.276 -0.89 . . . . 30.81 110.036 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 308' ' ' LYS . . . . . 0.414 ' HD3' ' CD2' ' S' ' 305' ' ' TRP . 1.5 mtmp? -73.58 -37.72 65.39 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.366 -0.834 . . . . 46.52 110.1 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 309' ' ' HIS . . . . . 0.498 ' CD2' ' HG ' ' S' ' 310' ' ' LEU . 55.6 p-80 -73.27 -8.2 54.79 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.333 -0.854 . . . . 51.03 110.105 179.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 310' ' ' LEU . . . . . 0.498 ' HG ' ' CD2' ' S' ' 309' ' ' HIS . 53.2 mt -99.32 -12.87 19.94 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.265 -0.897 . . . . 36.16 109.973 179.269 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 311' ' ' LEU . . . . . 0.534 HD21 ' CE2' ' S' ' 260' ' ' PHE . 10.8 mt -97.14 147.88 23.61 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.421 -0.8 . . . . 40.0 110.431 -179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 312' ' ' HIS . . . . . . . . . . . . . 82.0 t60 -81.65 -16.28 51.89 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.273 -0.892 . . . . 54.18 109.69 179.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' S' S ' 313' ' ' THR . . . . . 0.808 HG23 ' HG2' ' S' ' 323' ' ' GLU . 92.8 m -87.92 151.57 22.71 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.329 -0.857 . . . . 25.61 110.117 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 314' ' ' GLY . . . . . . . . . . . . . . . -87.81 126.4 8.03 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.861 -1.296 . . . . 25.18 109.861 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' S' S ' 315' ' ' ILE . . . . . 0.666 HD13 ' HB ' ' S' ' 324' ' ' VAL . 50.7 mm -101.69 150.45 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.779 0 O-C-N 121.407 -1.055 . . . . 23.9 109.703 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 316' ' ' GLY . . . . . 0.405 ' O ' ' HA ' ' S' ' 325' ' ' CYS . . . -157.04 -159.25 9.37 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.982 -1.247 . . . . 23.18 109.982 179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 317' ' ' THR . . . . . 0.423 HG22 ' CG2' ' S' ' 326' ' ' VAL . 11.0 p -133.94 -173.04 3.14 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.446 -1.032 . . . . 27.98 109.949 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.52 -56.2 24.94 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.142 -0.974 . . . . 28.1 109.939 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' S' S ' 319' ' ' SER . . . . . . . . . . . . . 1.2 m -59.99 -41.62 92.43 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.405 -0.81 . . . . 37.0 109.673 179.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' S' S ' 320' ' ' ARG . . . . . . . . . . . . . 12.2 mtm180 -111.68 79.89 2.64 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.592 -0.692 . . . . 52.07 109.666 179.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' S' S ' 321' ' ' PRO . . . . . 0.731 ' CG ' ' O ' ' S' ' 386' ' ' GLU . 44.1 Cg_endo -71.31 171.52 15.93 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.876 1.461 . . . . 38.29 110.966 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 322' ' ' SER . . . . . 0.447 ' HB2' ' O ' ' S' ' 321' ' ' PRO . 41.3 t 178.65 -148.13 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 108.927 -0.768 . . . . 38.84 108.927 -179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 323' ' ' GLU . . . . . 0.808 ' HG2' HG23 ' S' ' 313' ' ' THR . 6.7 tp10 -62.84 -40.29 96.96 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.011 -1.055 . . . . 40.7 109.724 179.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 324' ' ' VAL . . . . . 0.666 ' HB ' HD13 ' S' ' 315' ' ' ILE . 72.9 t -141.28 135.03 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.416 -0.802 . . . . 20.34 109.456 179.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 325' ' ' CYS . . . . . 0.462 ' HB2' ' CE1' ' S' ' 380' ' ' PHE . 11.3 m -126.03 172.26 10.12 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.258 -0.901 . . . . 30.63 110.805 -179.129 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 326' ' ' VAL . . . . . 0.641 HG12 HG22 ' S' ' 379' ' ' VAL . 34.6 m -135.56 142.24 40.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 109.189 -0.671 . . . . 23.9 109.189 179.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 327' ' ' VAL . . . . . 0.593 HG11 ' O ' ' S' ' 377' ' ' VAL . 34.5 m -56.27 124.93 10.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.037 -1.04 . . . . 19.48 110.437 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 328' ' ' ASP . . . . . . . . . . . . . 55.6 p-10 -119.36 11.49 12.23 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.467 -0.77 . . . . 26.43 110.403 179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' S' S ' 329' ' ' GLY . . . . . . . . . . . . . . . 119.63 2.24 13.14 Favored Glycine 0 N--CA 1.492 2.39 0 N-CA-C 110.043 -1.223 . . . . 31.24 110.043 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' S' S ' 330' ' ' THR . . . . . . . . . . . . . 80.9 m -93.02 129.93 38.78 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.044 -1.268 . . . . 30.05 110.111 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' S' S ' 331' ' ' ASP . . . . . . . . . . . . . 63.4 m-20 -56.73 111.49 1.03 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.262 -0.899 . . . . 37.26 110.02 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' S' S ' 332' ' ' MET . . . . . . . . . . . . . 88.1 mmm -94.11 162.64 13.79 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.285 -0.884 . . . . 26.23 110.345 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' S' S ' 333' ' ' CYS . . . . . . . . . . . . . 25.3 m -137.34 150.07 47.46 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.487 -0.758 . . . . 23.56 109.96 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' S' S ' 334' ' ' LEU . . . . . 0.558 HD11 ' O ' ' S' ' 372' ' ' PRO . 0.1 OUTLIER -52.58 -24.89 9.1 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.33 -0.856 . . . . 28.93 110.46 179.916 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' S' S ' 335' ' ' ALA . . . . . . . . . . . . . . . -88.99 14.44 10.57 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.302 -0.874 . . . . 15.76 110.957 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' S' S ' 336' ' ' ASP . . . . . 0.403 ' O ' ' HA ' ' S' ' 382' ' ' PRO . 70.7 m-20 -100.48 -17.19 17.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.166 -0.959 . . . . 34.92 110.206 179.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 337' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -152.37 170.84 19.1 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.382 -0.824 . . . . 19.03 110.095 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' S' S ' 338' ' ' HIS . . . . . 0.401 ' HB3' ' CZ ' ' S' ' 383' ' ' TYR . 13.5 p80 -120.71 10.34 10.97 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.365 -0.834 . . . . 18.82 110.484 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 339' ' ' ALA . . . . . 0.412 ' HA ' ' O ' ' S' ' 352' ' ' ALA . . . -176.01 155.17 1.55 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.289 -0.882 . . . . 17.18 110.131 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 340' ' ' GLY . . . . . 0.401 ' HA3' ' O ' ' S' ' 379' ' ' VAL . . . 160.85 173.07 29.0 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.01 -1.236 . . . . 18.33 110.01 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 341' ' ' ILE . . . . . . . . . . . . . 83.7 mt -88.77 138.1 19.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.675 0 O-C-N 121.523 -0.986 . . . . 18.6 109.862 179.601 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' S' S ' 342' ' ' PHE . . . . . 0.488 ' CE2' ' HB3' ' S' ' 352' ' ' ALA . 70.0 m-85 -120.93 -178.48 3.75 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.184 -0.947 . . . . 23.44 110.447 -179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 343' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.9 93.41 4.18 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.428 -0.795 . . . . 35.59 110.06 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 344' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -80.93 125.01 29.59 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.268 -0.895 . . . . 38.34 110.054 -179.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 345' ' ' GLY . . . . . . . . . . . . . . . 62.91 -130.88 42.76 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 108.821 -1.712 . . . . 53.46 108.821 -179.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' S' S ' 346' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -132.73 150.85 52.11 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.214 -1.168 . . . . 70.91 110.07 179.405 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' S' S ' 347' ' ' GLU . . . . . 0.536 ' C ' ' HG2' ' R' ' 201' ' ' LYS . 18.0 mt-10 53.28 35.43 20.12 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.307 -0.871 . . . . 47.32 110.374 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 348' ' ' HIS . . . . . 0.615 ' N ' ' HG2' ' R' ' 201' ' ' LYS . 46.6 t60 -150.15 155.83 40.52 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.248 -0.908 . . . . 41.72 110.346 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 349' ' ' ALA . . . . . 0.567 ' HB3' ' NZ ' ' R' ' 201' ' ' LYS . . . -149.74 151.28 33.36 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.33 -0.856 . . . . 22.91 110.544 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 350' ' ' VAL . . . . . 0.452 HG13 ' C ' ' S' ' 349' ' ' ALA . 34.6 m -149.06 169.64 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 O-C-N 121.448 -0.782 . . . . 21.09 110.06 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 351' ' ' PHE . . . . . 0.498 ' CD2' ' HB3' ' S' ' 258' ' ' GLN . 10.8 t80 -105.4 143.62 33.32 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.26 -0.9 . . . . 25.03 110.687 -179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 352' ' ' ALA . . . . . 0.488 ' HB3' ' CE2' ' S' ' 342' ' ' PHE . . . -147.74 151.72 36.54 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.58 -0.7 . . . . 23.81 109.75 179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 353' ' ' CYS . . . . . . . . . . . . . 26.3 p -153.29 164.97 37.16 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.302 -0.874 . . . . 25.66 110.245 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' S' S ' 354' ' ' VAL . . . . . 0.553 HG22 ' CE2' ' S' ' 359' ' ' TRP . 58.0 t -76.15 118.56 22.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.4 -0.812 . . . . 34.27 109.941 179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 355' ' ' THR . . . . . 0.407 ' HA ' ' O ' ' S' ' 232' ' ' THR . 51.7 p -117.85 175.09 5.82 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.199 -0.938 . . . . 25.49 110.29 179.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 356' ' ' SER . . . . . . . . . . . . . 62.1 p -62.17 -17.65 58.65 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.465 -0.772 . . . . 31.24 110.743 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' S' S ' 357' ' ' ASN . . . . . . . . . . . . . 46.0 m-20 -107.02 14.2 26.66 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.154 -0.966 . . . . 28.61 110.611 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' S' S ' 358' ' ' GLY . . . . . . . . . . . . . . . 111.88 -152.88 17.6 Favored Glycine 0 N--CA 1.493 2.461 0 N-CA-C 109.997 -1.241 . . . . 22.01 109.997 179.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' S' S ' 359' ' ' TRP . . . . . 0.553 ' CE2' HG22 ' S' ' 354' ' ' VAL . 15.5 m95 -91.36 116.64 29.0 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.33 -1.1 . . . . 25.54 110.205 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 360' ' ' TYR . . . . . 0.426 ' HA ' ' HA ' ' S' ' 369' ' ' PRO . 1.3 m-85 -103.47 165.75 10.85 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.338 -0.852 . . . . 40.53 110.105 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 361' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' S' ' 351' ' ' PHE . . . -139.97 130.08 25.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.37 -0.831 . . . . 18.04 110.333 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 362' ' ' ILE . . . . . . . . . . . . . 88.8 mt -95.59 83.65 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.316 -0.865 . . . . 15.64 110.054 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' S' S ' 363' ' ' ASP . . . . . 0.419 ' O ' ' N ' ' S' ' 365' ' ' GLU . 11.9 t0 -75.25 94.45 2.99 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.334 -0.854 . . . . 35.03 110.241 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 364' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 54.03 -89.42 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.484 -0.76 . . . . 46.72 110.547 -179.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' S' S ' 365' ' ' GLU . . . . . 0.419 ' N ' ' O ' ' S' ' 363' ' ' ASP . 23.8 mt-10 -122.6 19.06 10.4 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.048 -1.032 . . . . 56.2 110.251 179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 366' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -118.01 125.0 49.52 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.207 -0.933 . . . . 51.02 110.308 -179.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' S' S ' 367' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -106.94 127.05 53.09 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.355 -0.841 . . . . 37.59 110.155 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' S' S ' 368' ' ' TYR . . . . . . . . . . . . . 25.9 p90 -165.4 159.52 13.97 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.253 -0.904 . . . . 31.47 110.461 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' S' S ' 369' ' ' PRO . . . . . 0.426 ' HA ' ' HA ' ' S' ' 360' ' ' TYR . 45.6 Cg_endo -72.91 139.58 30.42 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.869 1.457 . . . . 28.85 110.495 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 370' ' ' TRP . . . . . . . . . . . . . 67.6 t90 -167.13 113.63 0.77 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.463 -0.773 . . . . 26.94 109.973 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' S' S ' 371' ' ' THR . . . . . . . . . . . . . 59.6 m -74.84 113.02 20.41 Favored Pre-proline 0 N--CA 1.493 1.704 0 O-C-N 121.338 -0.851 . . . . 20.19 109.986 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' S' S ' 372' ' ' PRO . . . . . 0.558 ' O ' HD11 ' S' ' 334' ' ' LEU . 46.5 Cg_endo -73.58 157.08 49.15 Favored 'Trans proline' 0 C--N 1.313 -1.341 0 O-C-N 123.573 1.301 . . . . 28.68 110.546 -179.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 373' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -90.52 147.08 35.65 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.436 -0.79 . . . . 35.72 109.987 179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' S' S ' 374' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -75.95 -6.25 17.21 Favored 'Trans proline' 0 C--N 1.31 -1.46 0 O-C-N 123.687 1.362 . . . . 30.89 110.533 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' S' S ' 375' ' ' SER . . . . . . . . . . . . . 68.9 p -104.4 -16.94 14.97 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.288 -0.882 . . . . 29.41 110.484 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' S' S ' 376' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -106.54 43.05 1.19 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.285 -0.884 . . . . 32.89 110.257 179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' S' S ' 377' ' ' VAL . . . . . 0.593 ' O ' HG11 ' S' ' 327' ' ' VAL . 7.3 p -114.72 147.29 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.314 -0.866 . . . . 24.33 110.17 -179.901 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 378' ' ' LEU . . . . . . . . . . . . . 52.1 mt -115.97 -58.02 2.15 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.386 -0.821 . . . . 24.37 109.623 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' S' S ' 379' ' ' VAL . . . . . 0.641 HG22 HG12 ' S' ' 326' ' ' VAL . 62.0 t -120.64 132.4 70.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.452 -0.78 . . . . 18.02 109.44 179.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 380' ' ' PHE . . . . . 0.462 ' CE1' ' HB2' ' S' ' 325' ' ' CYS . 14.2 p90 -142.59 173.97 11.06 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.375 -0.828 . . . . 29.35 110.665 -179.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 381' ' ' VAL . . . . . . . . . . . . . 58.1 t -120.12 107.34 39.76 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.493 -0.755 . . . . 16.34 109.382 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' S' S ' 382' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' S' ' 336' ' ' ASP . 46.0 Cg_endo -71.28 145.6 48.95 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 O-C-N 123.669 1.352 . . . . 20.94 110.79 -179.394 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 383' ' ' TYR . . . . . 0.401 ' CZ ' ' HB3' ' S' ' 338' ' ' HIS . 88.3 m-85 -61.05 -53.42 57.36 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.37 -0.831 . . . . 28.93 109.912 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 384' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -103.63 125.91 50.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.362 -0.836 . . . . 47.03 110.358 -176.558 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' S' S ' 385' ' ' GLN . . . . . 0.425 ' O ' ' C ' ' S' ' 386' ' ' GLU . 49.2 mt-30 -63.42 -4.84 3.0 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.381 -0.825 . . . . 46.69 110.194 177.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 386' ' ' GLU . . . . . 0.731 ' O ' ' CG ' ' S' ' 321' ' ' PRO . 19.7 pt-20 -42.83 156.62 0.25 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.338 -0.851 . . . . 50.25 109.628 179.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 387' ' ' PRO . . . . . 0.807 ' O ' ' O ' ' S' ' 389' ' ' ASN . 47.1 Cg_endo -70.52 24.23 0.2 Allowed 'Trans proline' 0 C--N 1.31 -1.488 0 O-C-N 123.572 1.301 . . . . 34.39 110.621 -177.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 388' ' ' LEU . . . . . 0.771 ' C ' ' O ' ' S' ' 387' ' ' PRO . 4.4 tp 0.1 92.26 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.399 -0.813 . . . . 38.01 110.145 179.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 389' ' ' ASN . . . . . 0.807 ' O ' ' O ' ' S' ' 387' ' ' PRO . 8.3 t-20 74.73 170.59 0.29 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.302 -0.874 . . . . 45.82 110.108 -179.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 390' ' ' GLY . . . . . 0.504 ' O ' ' CD2' ' S' ' 392' ' ' TRP . . . 149.49 -85.08 0.16 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.687 -1.365 . . . . 33.46 109.687 -179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 391' ' ' GLU . . . . . 0.472 ' CB ' ' O ' ' S' ' 390' ' ' GLY . 4.4 tt0 69.04 -67.52 0.21 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.384 -1.068 . . . . 56.58 110.093 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 392' ' ' TRP . . . . . 0.504 ' CD2' ' O ' ' S' ' 390' ' ' GLY . 0.3 OUTLIER -56.85 -18.04 11.59 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.373 -0.829 . . . . 31.43 110.359 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' S' S ' 393' ' ' LYS . . . . . 0.797 ' HE2' ' HB2' ' S' ' 394' ' ' ALA . 0.0 OUTLIER -51.74 -34.34 38.8 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.253 -0.904 . . . . 39.42 110.382 179.336 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' S' S ' 394' ' ' ALA . . . . . 0.797 ' HB2' ' HE2' ' S' ' 393' ' ' LYS . . . -89.44 -18.57 26.5 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.307 -0.871 . . . . 34.33 110.07 178.715 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 395' ' ' LYS . . . . . 0.658 ' HB3' ' CD1' ' R' ' 143' ' ' LEU . 5.3 mmtt -73.86 -10.04 59.26 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.401 -0.812 . . . . 60.09 110.298 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 396' ' ' VAL . . . . . 0.942 HG22 ' CB ' ' R' ' 99' ' ' PRO . 6.6 p -104.17 -27.99 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.364 -0.835 . . . . 35.5 110.598 179.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' S' S ' 397' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -117.51 94.71 4.65 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.23 -0.919 . . . . 49.96 110.578 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' S' S ' 398' ' ' ARG . . . . . 0.859 ' CB ' ' HA ' ' R' ' 147' ' ' GLU . 0.0 OUTLIER -124.78 -122.51 0.26 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.197 -0.939 . . . . 43.42 110.706 -179.027 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' S' S ' 399' ' ' LYS . . . . . 0.436 ' O ' ' C ' ' S' ' 400' ' ' LEU . 0.1 OUTLIER -150.8 -67.12 0.19 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.424 -0.798 . . . . 55.31 110.025 -179.62 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' S' S ' 400' ' ' LEU . . . . . 0.629 ' CB ' ' O ' ' R' ' 147' ' ' GLU . 1.0 OUTLIER -41.87 -27.26 0.11 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.322 -0.862 . . . . 41.03 110.248 -179.723 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' S' S ' 401' ' ' LYS . . . . . 0.763 ' C ' ' HB3' ' R' ' 51' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.614 0 O-C-N 121.317 -0.865 . . . . 61.97 110.231 178.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 29' ' ' MET . . . . . 0.451 ' HG3' ' N ' ' R' ' 30' ' ' GLU . 4.1 ptt? . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.235 0.541 . . . . 32.14 110.239 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' R' R ' 30' ' ' GLU . . . . . 0.451 ' N ' ' HG3' ' R' ' 29' ' ' MET . 41.7 tt0 -96.36 141.21 29.95 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.354 -0.841 . . . . 43.36 110.308 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 31' ' ' LEU . . . . . . . . . . . . . 65.5 mt -134.87 140.67 45.98 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.338 -0.851 . . . . 22.93 110.271 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' R' R ' 32' ' ' THR . . . . . . . . . . . . . 71.1 m -87.7 110.61 20.56 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.352 -0.843 . . . . 22.34 109.935 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' R' R ' 33' ' ' LEU . . . . . 0.594 HD22 ' CE2' ' R' ' 62' ' ' TYR . 80.1 mt -62.39 -172.78 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.274 -0.891 . . . . 21.39 110.209 -179.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 34' ' ' TYR . . . . . . . . . . . . . 37.2 p90 -74.6 -29.52 61.34 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.333 -0.855 . . . . 34.4 110.365 -179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' R' R ' 35' ' ' ASN . . . . . . . . . . . . . 48.4 p30 -77.65 -1.95 33.51 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.348 -0.845 . . . . 30.28 110.689 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' R' R ' 36' ' ' GLY . . . . . . . . . . . . . . . 92.28 -16.55 59.53 Favored Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.698 -1.361 . . . . 36.25 109.698 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' R' R ' 37' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -58.95 161.75 4.73 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.314 -1.11 . . . . 53.8 110.344 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' R' R ' 38' ' ' LYS . . . . . . . . . . . . . 56.9 mttt -117.83 135.76 53.87 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.315 -0.866 . . . . 49.91 110.142 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' R' R ' 39' ' ' LYS . . . . . 0.404 ' HG2' ' CZ ' ' R' ' 41' ' ' PHE . 8.1 ttmt -138.69 143.66 39.24 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.388 -0.82 . . . . 35.69 110.19 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 40' ' ' THR . . . . . . . . . . . . . 23.7 m -102.56 127.98 49.41 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.387 -0.82 . . . . 34.84 110.193 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' R' R ' 41' ' ' PHE . . . . . 0.404 ' CZ ' ' HG2' ' R' ' 39' ' ' LYS . 96.6 m-85 -113.09 132.71 55.32 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.402 -0.811 . . . . 34.42 110.11 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 42' ' ' TYR . . . . . . . . . . . . . 38.6 m-85 -93.24 140.89 29.04 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.346 -0.846 . . . . 51.46 110.247 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' R' R ' 43' ' ' SER . . . . . . . . . . . . . 53.9 m -70.74 141.91 51.47 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.502 -0.749 . . . . 41.84 110.196 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' R' R ' 44' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -113.75 125.37 29.58 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.263 -0.898 . . . . 33.82 109.986 179.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 45' ' ' PRO . . . . . 0.425 ' HG2' ' ND2' ' R' ' 77' ' ' ASN . 45.5 Cg_endo -72.16 151.05 54.74 Favored 'Trans proline' 0 C--N 1.311 -1.424 0 O-C-N 123.543 1.286 . . . . 30.27 110.649 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 46' ' ' ASN . . . . . 0.796 ' ND2' HD23 ' S' ' 400' ' ' LEU . 52.1 t-20 -124.28 109.91 13.96 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.478 -0.764 . . . . 35.1 110.004 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 47' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -120.32 -34.93 3.54 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.217 -0.927 . . . . 42.81 110.466 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' R' R ' 48' ' ' HIS . . . . . 0.44 ' NE2' HD11 ' R' ' 80' ' ' LEU . 73.2 m80 -105.7 45.18 0.98 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.239 -0.913 . . . . 49.97 110.201 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 49' ' ' ASP . . . . . 0.72 ' OD1' ' HA ' ' S' ' 401' ' ' LYS . 37.6 m-20 50.28 34.66 9.17 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.341 -0.849 . . . . 61.32 110.195 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 50' ' ' ASN . . . . . 0.4 ' OD1' ' HA ' ' R' ' 46' ' ' ASN . 15.0 p-10 -86.24 43.83 1.09 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.423 -0.798 . . . . 51.5 110.719 -179.556 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 51' ' ' ALA . . . . . 0.71 ' HB2' ' CB ' ' S' ' 400' ' ' LEU . . . -66.12 -46.11 78.72 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.276 -0.89 . . . . 38.77 109.541 179.447 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 52' ' ' TRP . . . . . 0.483 ' CD2' ' N ' ' R' ' 53' ' ' LEU . 68.2 p-90 -58.39 -38.37 77.2 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.525 -0.734 . . . . 26.24 110.114 179.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 53' ' ' LEU . . . . . 0.483 ' N ' ' CD2' ' R' ' 52' ' ' TRP . 23.2 tp -66.72 -46.7 74.63 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.373 -0.83 . . . . 26.75 109.958 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 54' ' ' ASN . . . . . . . . . . . . . 91.8 m-20 -55.27 -41.55 72.38 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.405 -0.809 . . . . 35.02 110.142 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' R' R ' 55' ' ' ALA . . . . . . . . . . . . . . . -61.17 -46.11 91.86 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.337 -0.852 . . . . 24.47 110.145 179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' R' R ' 56' ' ' ILE . . . . . 0.433 HG12 HD11 ' R' ' 104' ' ' ILE . 76.4 mt -62.17 -42.24 94.42 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.332 -0.855 . . . . 26.03 109.924 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 57' ' ' LEU . . . . . . . . . . . . . 22.5 mt -60.24 -45.71 92.31 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.364 -0.835 . . . . 26.77 109.658 179.437 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' R' R ' 58' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -63.9 -46.57 84.25 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.508 -0.745 . . . . 22.32 109.559 179.524 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' R' R ' 59' ' ' LEU . . . . . 0.43 ' HA ' ' HE2' ' R' ' 151' ' ' PHE . 23.8 tp -61.43 -37.71 84.49 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.306 -0.871 . . . . 20.55 109.424 179.262 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 60' ' ' PHE . . . . . 0.528 ' CE2' HD21 ' R' ' 111' ' ' LEU . 2.8 m-85 -61.08 -44.69 96.98 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.62 -0.675 . . . . 20.08 109.95 179.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 61' ' ' ARG . . . . . . . . . . . . . 5.6 tpt180 -63.22 -36.18 82.81 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.397 -0.814 . . . . 18.8 110.41 -179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' R' R ' 62' ' ' TYR . . . . . 0.594 ' CE2' HD22 ' R' ' 33' ' ' LEU . 9.1 t80 -63.03 -41.8 99.62 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.13 -0.981 . . . . 26.45 110.248 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 63' ' ' VAL . . . . . 0.407 ' H ' HG22 ' R' ' 63' ' ' VAL . 30.7 m -93.35 20.3 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 O-C-N 121.238 -0.914 . . . . 29.75 110.221 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 64' ' ' GLU . . . . . . . . . . . . . 48.1 mt-10 53.02 75.56 0.24 Allowed 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.322 -0.861 . . . . 35.52 110.541 179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' R' R ' 65' ' ' GLU . . . . . 0.442 ' HG2' ' CD2' ' R' ' 60' ' ' PHE . 14.3 tp10 -116.28 104.01 52.41 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.348 -0.845 . . . . 29.89 109.893 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 66' ' ' PRO . . . . . 0.482 ' HA ' ' HB2' ' R' ' 69' ' ' ASP . 46.7 Cg_endo -73.58 -5.75 17.6 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.875 1.46 . . . . 21.37 111.111 -179.554 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 67' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -52.17 -61.5 2.23 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.054 -1.029 . . . . 23.85 110.314 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 68' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -98.14 36.48 1.57 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.314 -0.866 . . . . 28.07 110.466 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' R' R ' 69' ' ' ASP . . . . . 0.482 ' HB2' ' HA ' ' R' ' 66' ' ' PRO . 11.7 t0 -72.25 -33.34 67.43 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.387 -0.821 . . . . 43.76 110.088 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 70' ' ' TRP . . . . . 0.476 ' CE2' ' CG2' ' R' ' 71' ' ' VAL . 47.8 p-90 -73.32 -3.94 30.2 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.34 -0.85 . . . . 33.06 110.71 -179.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 71' ' ' VAL . . . . . 0.556 HG11 ' HB2' ' R' ' 82' ' ' ALA . 40.8 t -109.81 -27.45 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.241 -0.912 . . . . 31.7 109.674 179.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 72' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -86.52 -48.86 8.01 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.407 -0.808 . . . . 33.58 110.32 179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' R' R ' 73' ' ' SER . . . . . . . . . . . . . 70.1 m -89.69 50.99 1.99 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.336 -0.853 . . . . 50.82 110.344 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' R' R ' 74' ' ' SER . . . . . . . . . . . . . 15.8 t -125.88 138.28 31.73 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.362 -0.836 . . . . 34.74 110.257 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' R' R ' 75' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.29 -25.02 16.06 Favored 'Trans proline' 0 C--N 1.311 -1.44 0 O-C-N 123.735 1.387 . . . . 35.7 110.341 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' R' R ' 76' ' ' GLU . . . . . . . . . . . . . 35.9 mm-40 -91.59 153.25 19.87 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.398 -0.814 . . . . 66.48 110.368 -179.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' R' R ' 77' ' ' ASN . . . . . 0.425 ' ND2' ' HG2' ' R' ' 45' ' ' PRO . 22.3 t-20 -81.62 95.29 7.14 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.374 -0.829 . . . . 46.72 110.046 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 78' ' ' LEU . . . . . . . . . . . . . 96.3 mt -96.46 27.95 3.56 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.467 -0.771 . . . . 37.55 110.216 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' R' R ' 79' ' ' THR . . . . . . . . . . . . . 29.7 m -56.18 -54.65 42.61 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.325 -0.86 . . . . 37.36 110.295 -179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' R' R ' 80' ' ' LEU . . . . . 0.603 ' HA ' HD12 ' R' ' 83' ' ' ILE . 15.9 mt -60.92 -23.16 65.04 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.256 -0.902 . . . . 35.83 110.513 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 81' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -79.54 -39.08 32.72 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.165 -0.959 . . . . 44.03 110.331 -179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' R' R ' 82' ' ' ALA . . . . . 0.556 ' HB2' HG11 ' R' ' 71' ' ' VAL . . . -69.47 -28.66 66.28 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.262 -0.899 . . . . 32.54 110.245 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 83' ' ' ILE . . . . . 0.603 HD12 ' HA ' ' R' ' 80' ' ' LEU . 78.1 mt -70.11 -46.1 73.78 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.307 -0.87 . . . . 32.02 110.302 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 84' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -55.19 -52.11 64.39 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.177 -0.952 . . . . 34.09 110.547 -179.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' R' R ' 85' ' ' GLN . . . . . 0.532 ' HG2' HD12 ' R' ' 89' ' ' LEU . 31.9 tt0 -54.74 -46.93 74.35 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.272 -0.893 . . . . 25.94 110.235 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 86' ' ' LEU . . . . . . . . . . . . . 24.2 mt -58.67 -43.91 90.02 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.318 -0.864 . . . . 16.2 109.904 179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' R' R ' 87' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -65.32 -35.13 80.06 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.471 -0.768 . . . . 49.09 110.346 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' R' R ' 88' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -78.45 -19.12 53.84 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.308 -0.87 . . . . 28.61 110.497 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' R' R ' 89' ' ' LEU . . . . . 0.532 HD12 ' HG2' ' R' ' 85' ' ' GLN . 32.8 mt -96.16 -29.45 14.05 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.207 -0.933 . . . . 26.16 110.239 179.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 90' ' ' THR . . . . . . . . . . . . . 59.6 p -105.64 -34.61 7.68 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.241 -0.912 . . . . 33.33 109.819 179.589 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' R' R ' 91' ' ' GLY . . . . . . . . . . . . . . . 88.79 16.16 58.61 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.862 -1.295 . . . . 31.13 109.862 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' R' R ' 92' ' ' LEU . . . . . . . . . . . . . 97.0 mt -100.12 155.29 17.81 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.172 -1.193 . . . . 42.52 110.21 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' R' R ' 93' ' ' GLU . . . . . . . . . . . . . 6.7 tt0 -86.26 91.63 8.53 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.432 -0.793 . . . . 68.46 109.948 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' R' R ' 94' ' ' LEU . . . . . 0.459 ' HB3' ' CZ2' ' R' ' 52' ' ' TRP . 47.7 mt -99.47 53.03 0.94 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.162 -0.961 . . . . 44.63 110.355 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 95' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -105.47 -38.66 6.39 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.253 -0.904 . . . . 67.16 110.399 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 96' ' ' GLU . . . . . 0.416 ' O ' ' CE ' ' S' ' 399' ' ' LYS . 24.6 mt-10 -113.9 44.23 1.68 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.225 -0.922 . . . . 67.02 110.291 -179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 97' ' ' GLY . . . . . 0.715 ' HA3' ' HB2' ' S' ' 399' ' ' LYS . . . 99.14 150.79 26.02 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.733 -1.347 . . . . 49.48 109.733 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 98' ' ' GLY . . . . . . . . . . . . . . . -166.26 160.05 33.49 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 109.227 -1.549 . . . . 36.57 109.227 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' R' R ' 99' ' ' PRO . . . . . 0.79 ' O ' HG23 ' R' ' 103' ' ' VAL . 45.8 Cg_endo -72.58 121.1 7.13 Favored 'Trans proline' 0 C--N 1.309 -1.505 0 O-C-N 123.65 1.342 . . . . 30.41 110.435 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 100' ' ' PRO . . . . . 0.47 ' HD2' ' O ' ' S' ' 396' ' ' VAL . 45.8 Cg_endo -72.27 -31.59 11.53 Favored 'Trans proline' 0 C--N 1.313 -1.309 0 O-C-N 123.649 1.342 . . . . 29.94 110.561 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 101' ' ' ALA . . . . . 0.706 ' HB3' HG21 ' S' ' 396' ' ' VAL . . . -70.01 -38.47 75.95 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.239 -0.913 . . . . 23.64 110.256 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 102' ' ' LEU . . . . . 0.424 HD23 HD21 ' R' ' 106' ' ' ASN . 0.1 OUTLIER -72.66 -40.74 66.09 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.284 -0.885 . . . . 20.31 110.358 -179.713 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' R' R ' 103' ' ' VAL . . . . . 0.79 HG23 ' O ' ' R' ' 99' ' ' PRO . 63.6 t -58.19 -40.09 76.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 O-C-N 121.227 -0.92 . . . . 16.33 109.996 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 104' ' ' ILE . . . . . 0.433 HD11 HG12 ' R' ' 56' ' ' ILE . 81.9 mt -71.72 -30.39 37.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.418 -0.801 . . . . 24.77 110.049 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 105' ' ' TRP . . . . . 0.461 ' O ' ' HD3' ' R' ' 108' ' ' LYS . 70.6 t-105 -82.49 0.89 40.35 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.34 -0.85 . . . . 23.28 110.254 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 106' ' ' ASN . . . . . 0.424 HD21 HD23 ' R' ' 102' ' ' LEU . 6.9 m-80 -105.16 -10.36 17.16 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.108 -0.995 . . . . 28.26 110.028 179.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 107' ' ' ILE . . . . . . . . . . . . . 36.8 pt -126.8 34.96 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.268 -0.895 . . . . 18.77 110.008 179.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' R' R ' 108' ' ' LYS . . . . . 0.5 ' HG2' ' HB ' ' R' ' 115' ' ' ILE . 9.2 mtpp -61.02 -48.5 81.5 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.589 -0.694 . . . . 42.5 110.037 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 109' ' ' HIS . . . . . 0.444 ' CD2' ' HG ' ' R' ' 110' ' ' LEU . 50.7 p-80 -66.02 -12.84 58.0 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.473 -0.767 . . . . 20.07 110.655 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 110' ' ' LEU . . . . . 0.444 ' HG ' ' CD2' ' R' ' 109' ' ' HIS . 80.7 mt -94.78 -17.35 22.22 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.121 -0.987 . . . . 15.69 110.171 179.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 111' ' ' LEU . . . . . 0.528 HD21 ' CE2' ' R' ' 60' ' ' PHE . 10.4 mt -94.06 144.14 25.74 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.342 -0.849 . . . . 25.39 111.05 -179.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 112' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -77.7 -17.35 57.73 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.51 -0.744 . . . . 53.48 109.859 179.186 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' R' R ' 113' ' ' THR . . . . . 0.458 HG22 ' N ' ' R' ' 114' ' ' GLY . 59.7 m -83.69 166.66 17.9 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.308 -0.87 . . . . 14.8 110.299 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 114' ' ' GLY . . . . . 0.458 ' N ' HG22 ' R' ' 113' ' ' THR . . . -98.06 127.16 9.14 Favored Glycine 0 N--CA 1.49 2.294 0 N-CA-C 110.015 -1.234 . . . . 16.14 110.015 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 115' ' ' ILE . . . . . 0.578 HD13 ' HB ' ' R' ' 124' ' ' VAL . 47.8 mm -109.08 139.44 31.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.464 -1.021 . . . . 13.46 109.7 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 116' ' ' GLY . . . . . . . . . . . . . . . -152.74 -155.85 7.29 Favored Glycine 0 N--CA 1.491 2.364 0 N-CA-C 109.926 -1.27 . . . . 23.9 109.926 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' R' R ' 117' ' ' THR . . . . . 0.529 HG22 ' CG2' ' R' ' 126' ' ' VAL . 18.6 p -135.02 -171.39 2.79 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.413 -1.051 . . . . 27.37 110.044 -179.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 118' ' ' ALA . . . . . 0.445 ' HB3' ' OD1' ' R' ' 128' ' ' ASP . . . -56.61 -57.96 10.11 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.251 -0.906 . . . . 18.76 110.107 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 119' ' ' SER . . . . . 0.799 ' HB3' ' HB ' ' R' ' 196' ' ' VAL . 1.2 m -56.58 -40.61 75.51 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.326 -0.859 . . . . 32.35 109.791 179.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 120' ' ' ARG . . . . . . . . . . . . . 10.0 mtm180 -110.04 86.2 4.81 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.442 -0.786 . . . . 27.12 109.682 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' R' R ' 121' ' ' PRO . . . . . 0.481 ' HA ' ' SG ' ' R' ' 125' ' ' CYS . 44.3 Cg_endo -71.23 166.5 29.06 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.813 1.428 . . . . 22.68 110.981 -179.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 122' ' ' SER . . . . . 0.438 ' HB2' ' O ' ' R' ' 121' ' ' PRO . 38.7 t 178.51 -161.69 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.481 -0.762 . . . . 22.99 109.492 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 123' ' ' GLU . . . . . 0.441 ' HG2' HG23 ' R' ' 113' ' ' THR . 2.3 tp10 -56.5 -39.97 74.18 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.19 -0.944 . . . . 36.18 109.649 179.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 124' ' ' VAL . . . . . 0.578 ' HB ' HD13 ' R' ' 115' ' ' ILE . 82.3 t -142.44 136.5 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.584 -0.698 . . . . 20.64 109.403 179.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 125' ' ' CYS . . . . . 0.481 ' SG ' ' HA ' ' R' ' 121' ' ' PRO . 83.4 m -140.35 168.21 20.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.219 -0.925 . . . . 22.8 111.163 -179.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 126' ' ' VAL . . . . . 0.729 HG12 HG22 ' R' ' 179' ' ' VAL . 35.8 m -122.76 159.8 25.97 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.747 -0.596 . . . . 21.24 109.664 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 127' ' ' VAL . . . . . 0.709 HG11 ' O ' ' R' ' 177' ' ' VAL . 30.7 m -70.87 141.86 16.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 O-C-N 121.266 -0.896 . . . . 19.77 110.675 -179.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 128' ' ' ASP . . . . . 0.445 ' OD1' ' HB3' ' R' ' 118' ' ' ALA . 53.9 p-10 -137.73 19.4 2.87 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.336 -0.853 . . . . 29.21 110.669 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 129' ' ' GLY . . . . . . . . . . . . . . . 114.03 0.01 24.1 Favored Glycine 0 N--CA 1.492 2.429 0 C-N-CA 119.893 -1.146 . . . . 33.86 110.461 179.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' R' R ' 130' ' ' THR . . . . . . . . . . . . . 58.1 m -91.77 131.91 36.79 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.207 -1.172 . . . . 26.41 110.099 179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' R' R ' 131' ' ' ASP . . . . . . . . . . . . . 59.3 m-20 -62.62 120.69 11.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.356 -0.84 . . . . 33.08 110.274 -179.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' R' R ' 132' ' ' MET . . . . . 0.433 ' HE1' ' CE2' ' R' ' 180' ' ' PHE . 98.4 mmm -105.18 165.58 11.0 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.468 -0.77 . . . . 30.76 110.409 -179.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 133' ' ' CYS . . . . . 0.411 ' HA ' ' HB3' ' R' ' 174' ' ' PRO . 32.5 m -141.17 158.12 44.33 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.538 -0.726 . . . . 27.0 109.969 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 134' ' ' LEU . . . . . 0.564 HD11 ' O ' ' R' ' 172' ' ' PRO . 0.1 OUTLIER -58.5 -19.65 39.07 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.322 -0.861 . . . . 33.9 110.544 -179.871 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' R' R ' 135' ' ' ALA . . . . . . . . . . . . . . . -92.74 8.15 40.54 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.31 -0.868 . . . . 19.37 110.826 -179.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' R' R ' 136' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -93.75 -21.74 19.13 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.174 -0.954 . . . . 30.47 110.245 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' R' R ' 137' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -149.98 165.35 32.95 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.407 -0.808 . . . . 24.27 110.215 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' R' R ' 138' ' ' HIS . . . . . 0.433 ' HA ' HG23 ' R' ' 154' ' ' VAL . 15.1 p80 -117.81 15.04 14.39 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.4 -0.813 . . . . 20.91 110.494 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 139' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' R' ' 152' ' ' ALA . . . -177.14 152.46 0.89 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.257 -0.902 . . . . 15.69 110.139 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 140' ' ' GLY . . . . . 0.427 ' HA3' ' O ' ' R' ' 179' ' ' VAL . . . 161.78 175.12 32.46 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.889 -1.285 . . . . 23.76 109.889 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 141' ' ' ILE . . . . . . . . . . . . . 83.8 mt -95.51 136.58 26.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.473 -1.016 . . . . 25.3 109.682 179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' R' R ' 142' ' ' PHE . . . . . 0.576 ' CD2' ' HB2' ' R' ' 172' ' ' PRO . 82.9 m-85 -120.74 -172.66 2.43 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.287 -0.883 . . . . 30.24 110.547 -179.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 143' ' ' LEU . . . . . 0.904 HD21 ' HG2' ' S' ' 398' ' ' ARG . 0.5 OUTLIER -119.79 77.75 1.26 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.499 -0.751 . . . . 32.8 110.292 -179.907 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' R' R ' 144' ' ' LYS . . . . . 0.469 ' HG3' ' CZ2' ' R' ' 170' ' ' TRP . 1.0 OUTLIER -69.54 76.88 0.41 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.448 -0.783 . . . . 49.18 109.653 179.562 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' R' R ' 145' ' ' GLY . . . . . 0.456 ' O ' HD22 ' R' ' 143' ' ' LEU . . . 104.51 179.25 24.82 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.157 -1.577 . . . . 53.87 109.157 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 146' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -88.52 145.8 25.53 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.363 -1.081 . . . . 68.58 109.995 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' R' R ' 147' ' ' GLU . . . . . 0.708 ' N ' ' HG3' ' S' ' 398' ' ' ARG . 10.9 mt-10 58.31 36.51 25.64 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.346 -0.846 . . . . 56.62 110.607 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 148' ' ' HIS . . . . . 0.96 ' CE1' HD13 ' S' ' 400' ' ' LEU . 44.8 t60 -158.69 148.13 19.16 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.183 -0.948 . . . . 44.57 110.419 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 149' ' ' ALA . . . . . . . . . . . . . . . -150.29 146.83 27.01 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.445 -0.784 . . . . 33.54 110.057 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' R' R ' 150' ' ' VAL . . . . . . . . . . . . . 34.2 m -142.3 161.55 19.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.261 -0.9 . . . . 27.61 110.36 179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' R' R ' 151' ' ' PHE . . . . . 0.537 ' CD1' ' N ' ' R' ' 152' ' ' ALA . 5.8 t80 -86.22 155.54 20.66 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.392 -0.818 . . . . 23.04 109.873 179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 152' ' ' ALA . . . . . 0.537 ' N ' ' CD1' ' R' ' 151' ' ' PHE . . . -157.26 151.54 24.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.421 -0.799 . . . . 29.61 109.575 179.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 153' ' ' CYS . . . . . . . . . . . . . 26.7 p -154.27 173.61 15.91 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.34 -0.85 . . . . 22.75 110.542 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' R' R ' 154' ' ' VAL . . . . . 0.613 HG22 ' CE2' ' R' ' 159' ' ' TRP . 59.7 t -90.6 117.1 33.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.453 -0.78 . . . . 23.26 110.052 179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 155' ' ' THR . . . . . . . . . . . . . 69.3 p -112.17 -176.62 2.97 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.359 -0.838 . . . . 17.88 110.041 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' R' R ' 156' ' ' SER . . . . . . . . . . . . . 78.5 p -75.96 -3.76 37.35 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.32 -0.863 . . . . 21.83 110.633 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' R' R ' 157' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -118.22 10.46 12.88 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.06 -1.025 . . . . 36.54 110.612 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' R' R ' 158' ' ' GLY . . . . . . . . . . . . . . . 117.97 -162.63 13.05 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 109.527 -1.429 . . . . 31.74 109.527 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' R' R ' 159' ' ' TRP . . . . . 0.613 ' CE2' HG22 ' R' ' 154' ' ' VAL . 14.7 m95 -86.6 122.57 30.71 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.354 -1.086 . . . . 28.25 110.035 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 160' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -108.48 166.96 10.38 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.42 -0.8 . . . . 41.24 110.201 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' R' R ' 161' ' ' ALA . . . . . . . . . . . . . . . -143.23 123.47 13.77 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.461 -0.775 . . . . 27.4 110.163 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' R' R ' 162' ' ' ILE . . . . . . . . . . . . . 92.0 mt -87.59 81.12 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.317 -0.864 . . . . 24.27 110.051 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' R' R ' 163' ' ' ASP . . . . . 0.414 ' O ' ' N ' ' R' ' 165' ' ' GLU . 15.4 t0 -72.74 92.39 1.56 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.422 -0.799 . . . . 36.08 110.254 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 164' ' ' ASP . . . . . . . . . . . . . 73.1 m-20 54.13 -89.0 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.515 -0.741 . . . . 46.08 110.574 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' R' R ' 165' ' ' GLU . . . . . 0.414 ' N ' ' O ' ' R' ' 163' ' ' ASP . 29.7 mt-10 -124.76 36.02 4.68 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.088 -1.007 . . . . 50.94 110.192 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 166' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -135.81 117.29 14.77 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.416 -0.803 . . . . 47.28 110.266 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' R' R ' 167' ' ' PHE . . . . . . . . . . . . . 24.4 m-85 -101.04 120.02 39.59 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.387 -0.821 . . . . 40.47 110.155 179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' R' R ' 168' ' ' TYR . . . . . . . . . . . . . 25.4 p90 -157.52 158.53 30.68 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 121.273 -0.892 . . . . 30.21 110.433 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' R' R ' 169' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -72.77 132.98 19.42 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 O-C-N 123.863 1.454 . . . . 32.76 110.471 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' R' R ' 170' ' ' TRP . . . . . 0.469 ' CZ2' ' HG3' ' R' ' 144' ' ' LYS . 67.1 t90 -159.78 119.43 2.91 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.398 -0.814 . . . . 32.79 109.946 179.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 171' ' ' THR . . . . . . . . . . . . . 45.9 m -81.13 112.57 33.91 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.405 -0.809 . . . . 36.92 110.188 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' R' R ' 172' ' ' PRO . . . . . 0.576 ' HB2' ' CD2' ' R' ' 142' ' ' PHE . 47.2 Cg_endo -73.76 158.78 46.46 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 O-C-N 123.796 1.419 . . . . 33.54 110.551 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 173' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -88.84 144.96 33.83 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 121.361 -0.837 . . . . 45.76 109.951 179.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' R' R ' 174' ' ' PRO . . . . . 0.411 ' HB3' ' HA ' ' R' ' 133' ' ' CYS . 45.9 Cg_endo -71.74 -10.33 26.3 Favored 'Trans proline' 0 C--N 1.31 -1.486 0 O-C-N 123.621 1.327 . . . . 29.63 110.497 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 175' ' ' SER . . . . . . . . . . . . . 53.0 p -103.53 -17.47 15.18 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.317 -0.864 . . . . 35.7 110.306 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' R' R ' 176' ' ' ASP . . . . . . . . . . . . . 74.0 m-20 -103.6 43.23 1.1 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.286 -0.884 . . . . 39.65 110.32 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' R' R ' 177' ' ' VAL . . . . . 0.709 ' O ' HG11 ' R' ' 127' ' ' VAL . 10.6 p -117.74 127.12 75.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.397 -0.815 . . . . 20.61 110.095 179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 178' ' ' LEU . . . . . 0.53 HD21 ' HG3' ' S' ' 395' ' ' LYS . 46.2 mt -91.47 -61.25 1.69 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.305 -0.872 . . . . 15.58 109.389 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 179' ' ' VAL . . . . . 0.729 HG22 HG12 ' R' ' 126' ' ' VAL . 67.9 t -114.67 144.66 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.643 -0.661 . . . . 17.4 109.441 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 180' ' ' PHE . . . . . 0.433 ' CE2' ' HE1' ' R' ' 132' ' ' MET . 43.6 p90 -152.17 163.43 39.4 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.239 -0.913 . . . . 20.16 110.519 -179.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 181' ' ' VAL . . . . . . . . . . . . . 66.6 t -113.19 111.47 50.22 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.342 -0.849 . . . . 17.69 109.756 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' R' R ' 182' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.05 149.56 52.83 Favored 'Trans proline' 0 C--N 1.312 -1.37 0 O-C-N 123.507 1.267 . . . . 17.81 110.374 179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' R' R ' 183' ' ' TYR . . . . . 0.698 ' O ' ' C ' ' R' ' 184' ' ' ASP . 79.5 m-85 -59.05 175.47 0.29 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.4 -0.813 . . . . 28.01 110.526 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 184' ' ' ASP . . . . . 0.698 ' C ' ' O ' ' R' ' 183' ' ' TYR . 1.1 m-20 -19.01 -82.88 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.425 -0.797 . . . . 58.64 110.319 -178.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 185' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 . . . . . 0 N--CA 1.502 2.16 0 CA-C-O 121.273 0.559 . . . . 80.42 111.777 179.479 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' R' R ' 193' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 120.948 0.404 . . . . 49.5 110.14 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' R' R ' 194' ' ' ALA . . . . . 0.424 ' CB ' ' HA ' ' R' ' 119' ' ' SER . . . -172.22 -155.39 0.09 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.123 -0.986 . . . . 40.4 110.059 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 195' ' ' LYS . . . . . . . . . . . . . 18.6 mtmt -100.32 -47.52 4.9 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.45 -0.781 . . . . 34.6 110.25 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' R' R ' 196' ' ' VAL . . . . . 0.799 ' HB ' ' HB3' ' R' ' 119' ' ' SER . 32.9 t -71.27 -39.09 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.194 -0.941 . . . . 33.27 110.622 -179.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 197' ' ' GLN . . . . . 0.45 ' O ' ' O ' ' R' ' 196' ' ' VAL . 3.7 tt0 -59.94 -134.34 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.149 -0.969 . . . . 41.58 110.719 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 198' ' ' ARG . . . . . 0.416 ' CB ' ' O ' ' R' ' 197' ' ' GLN . 8.8 ttt180 64.09 173.12 0.18 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.109 -0.994 . . . . 38.65 110.216 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 199' ' ' LYS . . . . . 0.645 ' O ' ' HD3' ' S' ' 299' ' ' PRO . 0.4 OUTLIER -110.75 -17.19 13.42 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.36 -0.838 . . . . 36.77 109.936 -179.969 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' R' R ' 200' ' ' LEU . . . . . 0.464 HD13 ' HA ' ' R' ' 200' ' ' LEU . 1.4 mm? 46.41 -163.46 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.32 -0.862 . . . . 33.08 110.127 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' R' R ' 201' ' ' LYS . . . . . 0.681 ' HA ' ' HA3' ' S' ' 297' ' ' GLY . 16.4 tttm . . . . . 0 N--CA 1.493 1.698 0 O-C-N 121.384 -0.822 . . . . 44.32 110.297 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' S' S ' 229' ' ' MET . . . . . 0.407 ' HG3' ' N ' ' S' ' 230' ' ' GLU . 24.8 ptp . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.229 0.538 . . . . 51.83 110.219 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' S' S ' 230' ' ' GLU . . . . . 0.407 ' N ' ' HG3' ' S' ' 229' ' ' MET . 33.1 tt0 -97.24 142.78 28.72 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.336 -0.852 . . . . 54.13 110.208 -179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 231' ' ' LEU . . . . . . . . . . . . . 68.0 mt -134.14 141.04 46.96 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.247 -0.908 . . . . 33.04 110.355 -179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' S' S ' 232' ' ' THR . . . . . 0.415 ' O ' ' HA ' ' S' ' 355' ' ' THR . 40.0 m -89.22 103.18 15.83 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.414 -0.804 . . . . 26.92 110.037 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 233' ' ' LEU . . . . . 0.673 HD22 ' CE2' ' S' ' 262' ' ' TYR . 79.7 mt -55.91 179.26 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.467 -0.771 . . . . 13.78 110.457 -179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 234' ' ' TYR . . . . . 0.448 ' CG ' ' N ' ' S' ' 235' ' ' ASN . 35.7 p90 -65.02 -35.65 81.85 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.347 -0.845 . . . . 26.08 110.169 179.996 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 235' ' ' ASN . . . . . 0.448 ' N ' ' CG ' ' S' ' 234' ' ' TYR . 50.7 p30 -74.31 -7.46 52.87 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.292 -0.88 . . . . 20.04 110.524 -179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 236' ' ' GLY . . . . . . . . . . . . . . . 95.8 -20.03 51.7 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.76 -1.336 . . . . 22.71 109.76 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' S' S ' 237' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -52.9 145.72 12.13 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.234 -1.157 . . . . 35.44 110.226 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' S' S ' 238' ' ' LYS . . . . . . . . . . . . . 44.4 mttt -102.2 127.87 48.96 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.389 -0.82 . . . . 32.56 110.416 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' S' S ' 239' ' ' LYS . . . . . 0.405 ' HG2' ' CZ ' ' S' ' 241' ' ' PHE . 9.1 ttmt -132.25 144.49 50.65 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.377 -0.827 . . . . 26.68 110.036 179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 240' ' ' THR . . . . . . . . . . . . . 51.5 m -102.01 132.16 48.01 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.328 -0.858 . . . . 41.02 110.41 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' S' S ' 241' ' ' PHE . . . . . 0.405 ' CZ ' ' HG2' ' S' ' 239' ' ' LYS . 96.0 m-85 -117.87 137.66 52.64 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.419 -0.801 . . . . 28.62 110.184 179.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 242' ' ' TYR . . . . . . . . . . . . . 37.0 m-85 -96.39 161.74 13.8 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.371 -0.831 . . . . 47.89 110.25 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' S' S ' 243' ' ' SER . . . . . . . . . . . . . 71.6 m -90.47 151.49 21.36 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.245 -0.909 . . . . 45.09 110.298 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' S' S ' 244' ' ' ARG . . . . . . . . . . . . . 1.4 mtp85 -129.76 126.78 22.73 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 121.371 -0.83 . . . . 42.49 110.266 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' S' S ' 245' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.37 161.05 43.56 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.652 1.343 . . . . 35.68 110.542 179.876 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' S' S ' 246' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -132.86 97.88 4.15 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.443 -0.786 . . . . 51.88 109.866 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' S' S ' 247' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -110.52 -22.23 11.75 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.395 -0.815 . . . . 53.69 110.664 -179.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' S' S ' 248' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -117.28 43.77 2.25 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.108 -0.995 . . . . 55.79 110.804 -179.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' S' S ' 249' ' ' ASP . . . . . . . . . . . . . 40.8 m-20 48.68 38.49 11.63 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.4 -0.813 . . . . 49.45 110.339 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' S' S ' 250' ' ' ASN . . . . . . . . . . . . . 16.3 p-10 -90.65 28.99 1.38 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.521 -0.737 . . . . 36.86 110.309 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' S' S ' 251' ' ' ALA . . . . . . . . . . . . . . . -53.79 -43.16 69.07 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.271 -0.893 . . . . 29.69 109.619 179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' S' S ' 252' ' ' TRP . . . . . 0.427 ' CZ2' ' HB3' ' S' ' 294' ' ' LEU . 67.8 p-90 -61.81 -33.94 75.04 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.537 -0.727 . . . . 41.12 109.83 179.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 253' ' ' LEU . . . . . 0.4 ' N ' ' CD2' ' S' ' 252' ' ' TRP . 23.2 tp -70.16 -47.25 62.43 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.37 -0.831 . . . . 24.89 109.953 179.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 254' ' ' ASN . . . . . . . . . . . . . 98.8 m-20 -56.1 -42.44 76.8 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.417 -0.802 . . . . 35.65 109.96 179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' S' S ' 255' ' ' ALA . . . . . . . . . . . . . . . -59.63 -48.18 82.69 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.399 -0.813 . . . . 22.73 110.081 179.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' S' S ' 256' ' ' ILE . . . . . 0.503 HG12 HD11 ' S' ' 304' ' ' ILE . 79.7 mt -62.25 -40.7 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.304 -0.873 . . . . 28.85 109.979 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 257' ' ' LEU . . . . . 0.404 ' CD2' ' HB3' ' S' ' 268' ' ' PHE . 19.1 mt -61.48 -44.5 96.98 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.257 -0.902 . . . . 23.07 110.154 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 258' ' ' GLN . . . . . 0.502 ' HB3' ' CD2' ' S' ' 351' ' ' PHE . 53.5 mm-40 -65.14 -45.33 85.46 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.39 -0.818 . . . . 29.78 109.919 179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 259' ' ' LEU . . . . . 0.42 ' O ' HG22 ' S' ' 263' ' ' VAL . 19.7 tp -58.66 -36.35 74.0 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.337 -0.852 . . . . 17.94 109.474 179.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 260' ' ' PHE . . . . . 0.528 ' CE2' HD21 ' S' ' 311' ' ' LEU . 3.1 m-85 -62.9 -45.24 93.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.622 -0.674 . . . . 30.57 109.82 179.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 261' ' ' ARG . . . . . . . . . . . . . 6.1 tpt180 -62.08 -29.81 70.56 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.386 -0.821 . . . . 41.34 109.987 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' S' S ' 262' ' ' TYR . . . . . 0.673 ' CE2' HD22 ' S' ' 233' ' ' LEU . 8.6 t80 -71.16 -44.67 65.05 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.367 -0.833 . . . . 26.03 110.1 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 263' ' ' VAL . . . . . 0.42 HG22 ' O ' ' S' ' 259' ' ' LEU . 33.1 m -92.02 18.15 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.761 0 O-C-N 121.374 -0.829 . . . . 22.8 110.334 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 264' ' ' GLU . . . . . . . . . . . . . 46.8 mt-10 52.85 70.69 0.55 Allowed 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.206 -0.934 . . . . 44.03 110.589 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' S' S ' 265' ' ' GLU . . . . . . . . . . . . . 16.0 tp10 -111.86 109.19 55.3 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.397 -0.814 . . . . 35.61 109.602 179.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' S' S ' 266' ' ' PRO . . . . . 0.481 ' HA ' ' HB2' ' S' ' 269' ' ' ASP . 49.7 Cg_endo -75.34 0.44 9.04 Favored 'Trans proline' 0 C--N 1.311 -1.436 0 O-C-N 123.657 1.346 . . . . 37.67 111.8 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 267' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -56.46 -67.73 0.28 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.781 -1.2 . . . . 41.49 110.192 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 268' ' ' PHE . . . . . 0.404 ' HB3' ' CD2' ' S' ' 257' ' ' LEU . 22.3 m-85 -92.94 39.95 1.05 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.15 -0.968 . . . . 50.76 110.063 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 269' ' ' ASP . . . . . 0.481 ' HB2' ' HA ' ' S' ' 266' ' ' PRO . 0.9 OUTLIER -76.04 -33.22 59.6 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.348 -0.845 . . . . 61.86 109.775 179.519 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' S' S ' 270' ' ' TRP . . . . . 0.511 ' CE2' HG23 ' S' ' 271' ' ' VAL . 50.9 p-90 -73.91 -4.31 34.28 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.33 -0.856 . . . . 39.85 110.493 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 271' ' ' VAL . . . . . 0.511 HG23 ' CE2' ' S' ' 270' ' ' TRP . 46.6 t -109.59 -32.66 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.187 -0.946 . . . . 39.18 110.058 179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 272' ' ' TYR . . . . . . . . . . . . . 39.1 t80 -78.68 -36.52 43.51 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.327 -0.858 . . . . 40.02 110.519 -179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' S' S ' 273' ' ' SER . . . . . . . . . . . . . 71.1 m -103.55 56.16 0.74 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.347 -0.846 . . . . 47.2 110.291 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' S' S ' 274' ' ' SER . . . . . . . . . . . . . 6.8 t -133.09 141.24 40.13 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.382 -0.824 . . . . 47.61 110.153 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' S' S ' 275' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.76 -18.82 21.75 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 123.639 1.337 . . . . 45.28 110.544 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' S' S ' 276' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -99.9 140.88 33.48 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.221 -0.924 . . . . 57.27 110.327 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' S' S ' 277' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -71.79 97.63 1.83 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.428 -0.795 . . . . 37.28 110.234 -179.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' S' S ' 278' ' ' LEU . . . . . . . . . . . . . 86.0 mt -96.96 33.85 1.83 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.388 -0.82 . . . . 43.88 110.087 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' S' S ' 279' ' ' THR . . . . . . . . . . . . . 77.8 m -64.09 -60.19 3.54 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.471 -0.768 . . . . 50.05 110.194 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' S' S ' 280' ' ' LEU . . . . . 0.729 ' HA ' HD12 ' S' ' 283' ' ' ILE . 13.7 mt -51.51 -39.91 58.57 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.247 -0.908 . . . . 54.12 110.304 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 281' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -62.39 -49.69 74.52 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.444 -0.785 . . . . 65.28 110.132 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 282' ' ' ALA . . . . . . . . . . . . . . . -59.02 -33.89 71.27 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.478 -0.764 . . . . 46.51 110.488 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' S' S ' 283' ' ' ILE . . . . . 0.729 HD12 ' HA ' ' S' ' 280' ' ' LEU . 85.7 mt -66.34 -50.87 64.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 O-C-N 121.305 -0.872 . . . . 47.3 110.072 -179.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 284' ' ' LYS . . . . . . . . . . . . . 33.7 tttp -50.61 -57.56 7.92 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.416 -0.803 . . . . 50.72 110.359 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' S' S ' 285' ' ' GLN . . . . . 0.529 ' HG2' HD12 ' S' ' 289' ' ' LEU . 34.3 tt0 -51.42 -46.35 62.89 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.523 -0.736 . . . . 68.47 110.34 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 286' ' ' LEU . . . . . . . . . . . . . 19.1 mt -59.97 -44.47 94.44 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.464 -0.773 . . . . 36.62 110.309 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' S' S ' 287' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -62.83 -35.25 79.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.279 -0.888 . . . . 46.64 110.009 179.804 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' S' S ' 288' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -76.26 -20.99 56.85 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.42 -0.8 . . . . 46.45 110.328 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' S' S ' 289' ' ' LEU . . . . . 0.529 HD12 ' HG2' ' S' ' 285' ' ' GLN . 30.7 mt -97.33 -21.73 17.05 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.342 -0.849 . . . . 35.09 110.52 -179.663 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 290' ' ' THR . . . . . 0.409 HG22 ' HB3' ' S' ' 306' ' ' ASN . 81.3 p -114.78 -28.5 7.07 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.214 -0.929 . . . . 38.61 110.373 -179.668 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 291' ' ' GLY . . . . . . . . . . . . . . . 79.38 11.05 85.34 Favored Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.886 -1.286 . . . . 36.77 109.886 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' S' S ' 292' ' ' LEU . . . . . . . . . . . . . 84.5 mt -96.45 145.77 25.36 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.222 -1.164 . . . . 35.33 109.768 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' S' S ' 293' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -77.36 102.37 6.76 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.25 -0.906 . . . . 48.7 110.272 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' S' S ' 294' ' ' LEU . . . . . 0.427 ' HB3' ' CZ2' ' S' ' 252' ' ' TRP . 55.3 mt -106.86 51.72 0.74 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.55 -0.719 . . . . 42.61 110.11 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 295' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -112.57 -11.09 13.63 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.325 -0.859 . . . . 55.49 110.573 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 296' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -144.38 48.53 1.36 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.163 -0.96 . . . . 75.68 110.292 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' S' S ' 297' ' ' GLY . . . . . 0.681 ' HA3' ' HA ' ' R' ' 201' ' ' LYS . . . 96.84 145.21 18.76 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.509 -1.437 . . . . 49.44 109.509 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 298' ' ' GLY . . . . . . . . . . . . . . . -163.83 156.93 29.01 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.805 -1.318 . . . . 41.11 109.805 -179.822 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' S' S ' 299' ' ' PRO . . . . . 0.645 ' HD3' ' O ' ' R' ' 199' ' ' LYS . 47.4 Cg_endo -73.77 118.25 5.37 Favored 'Trans proline' 0 C--N 1.309 -1.507 0 O-C-N 123.955 1.502 . . . . 26.2 110.293 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 300' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.24 -15.42 31.68 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 O-C-N 123.577 1.304 . . . . 21.7 110.734 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' S' S ' 301' ' ' ALA . . . . . . . . . . . . . . . -80.71 -29.34 36.45 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.276 -0.89 . . . . 31.23 110.14 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' S' S ' 302' ' ' LEU . . . . . 0.47 ' CD1' ' O ' ' R' ' 196' ' ' VAL . 0.0 OUTLIER -83.57 -40.57 18.93 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.405 -0.809 . . . . 38.99 109.926 179.845 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' S' S ' 303' ' ' VAL . . . . . 0.484 HG23 ' O ' ' S' ' 299' ' ' PRO . 58.1 t -60.73 -35.47 64.32 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.375 -0.828 . . . . 18.63 110.143 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 304' ' ' ILE . . . . . 0.523 HD12 HG21 ' S' ' 379' ' ' VAL . 86.2 mt -79.45 -23.55 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.463 -0.773 . . . . 25.46 110.193 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 305' ' ' TRP . . . . . 0.411 ' CD2' ' HD3' ' S' ' 308' ' ' LYS . 68.7 t-105 -88.63 -14.6 37.1 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.253 -0.904 . . . . 33.4 110.601 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 306' ' ' ASN . . . . . 0.409 ' HB3' HG22 ' S' ' 290' ' ' THR . 10.4 m-80 -89.69 -13.57 36.64 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.227 -0.92 . . . . 36.97 110.435 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 307' ' ' ILE . . . . . 0.471 HG12 ' O ' ' S' ' 303' ' ' VAL . 36.8 pt -125.09 45.66 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.795 0 O-C-N 121.218 -0.926 . . . . 30.81 110.066 179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 308' ' ' LYS . . . . . 0.411 ' HD3' ' CD2' ' S' ' 305' ' ' TRP . 1.5 mtmp? -73.52 -37.77 65.52 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.355 -0.841 . . . . 46.52 110.084 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 309' ' ' HIS . . . . . 0.493 ' CD2' ' HG ' ' S' ' 310' ' ' LEU . 55.5 p-80 -73.1 -8.34 55.33 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.303 -0.873 . . . . 51.03 110.129 179.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 310' ' ' LEU . . . . . 0.493 ' HG ' ' CD2' ' S' ' 309' ' ' HIS . 52.6 mt -99.27 -12.94 19.92 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.295 -0.878 . . . . 36.16 109.971 179.349 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 311' ' ' LEU . . . . . 0.528 HD21 ' CE2' ' S' ' 260' ' ' PHE . 10.8 mt -97.11 147.81 23.67 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.314 -0.866 . . . . 40.0 110.452 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 312' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -81.54 -16.33 52.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.345 -0.847 . . . . 54.18 109.763 179.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' S' S ' 313' ' ' THR . . . . . 0.823 HG23 ' HG2' ' S' ' 323' ' ' GLU . 92.5 m -87.88 151.53 22.76 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.375 -0.828 . . . . 25.61 110.159 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 314' ' ' GLY . . . . . . . . . . . . . . . -87.83 126.38 8.02 Favored Glycine 0 N--CA 1.493 2.453 0 N-CA-C 109.836 -1.306 . . . . 25.18 109.836 -179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' S' S ' 315' ' ' ILE . . . . . 0.671 HD13 ' HB ' ' S' ' 324' ' ' VAL . 50.7 mm -101.64 150.53 6.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.35 -1.088 . . . . 23.9 109.71 179.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 316' ' ' GLY . . . . . 0.403 ' O ' ' HA ' ' S' ' 325' ' ' CYS . . . -157.12 -159.32 9.42 Favored Glycine 0 N--CA 1.494 2.545 0 N-CA-C 109.923 -1.271 . . . . 23.18 109.923 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 317' ' ' THR . . . . . 0.425 HG22 ' CG2' ' S' ' 326' ' ' VAL . 11.2 p -133.88 -173.06 3.14 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.417 -1.049 . . . . 27.98 110.013 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 318' ' ' ALA . . . . . . . . . . . . . . . -57.55 -56.23 24.63 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.199 -0.938 . . . . 28.1 109.892 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' S' S ' 319' ' ' SER . . . . . . . . . . . . . 1.2 m -59.9 -41.67 92.17 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.405 -0.809 . . . . 37.0 109.632 179.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' S' S ' 320' ' ' ARG . . . . . . . . . . . . . 12.2 mtm180 -111.69 79.85 2.62 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.471 -0.768 . . . . 52.07 109.679 179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' S' S ' 321' ' ' PRO . . . . . 0.921 ' HG2' ' O ' ' S' ' 386' ' ' GLU . 44.1 Cg_endo -71.43 171.46 16.14 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.79 1.416 . . . . 38.29 110.903 -179.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 322' ' ' SER . . . . . 0.445 ' HB2' ' O ' ' S' ' 321' ' ' PRO . 41.3 t 178.7 -148.08 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.928 -0.767 . . . . 38.84 108.928 -179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 323' ' ' GLU . . . . . 0.823 ' HG2' HG23 ' S' ' 313' ' ' THR . 6.7 tp10 -62.87 -40.34 97.2 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.944 -1.098 . . . . 40.7 109.664 179.299 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 324' ' ' VAL . . . . . 0.671 ' HB ' HD13 ' S' ' 315' ' ' ILE . 72.7 t -141.24 135.02 31.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.433 -0.792 . . . . 20.34 109.463 179.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 325' ' ' CYS . . . . . 0.46 ' HB2' ' CE1' ' S' ' 380' ' ' PHE . 11.1 m -126.02 172.24 10.13 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.246 -0.909 . . . . 30.63 110.867 -179.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 326' ' ' VAL . . . . . 0.643 HG12 HG22 ' S' ' 379' ' ' VAL . 34.5 m -135.51 142.16 40.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.651 -0.656 . . . . 23.9 109.248 179.242 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 327' ' ' VAL . . . . . 0.595 HG11 ' O ' ' S' ' 377' ' ' VAL . 34.6 m -56.32 125.04 11.22 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 O-C-N 121.015 -1.053 . . . . 19.48 110.388 -179.684 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 328' ' ' ASP . . . . . . . . . . . . . 55.5 p-10 -119.41 11.46 12.18 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.496 -0.753 . . . . 26.43 110.427 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' S' S ' 329' ' ' GLY . . . . . . . . . . . . . . . 119.75 2.2 12.99 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.973 -1.251 . . . . 31.24 109.973 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' S' S ' 330' ' ' THR . . . . . . . . . . . . . 78.8 m -92.94 130.02 38.66 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.093 -1.239 . . . . 30.05 110.136 179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' S' S ' 331' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -56.85 111.48 1.04 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.207 -0.933 . . . . 37.26 109.927 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' S' S ' 332' ' ' MET . . . . . . . . . . . . . 88.1 mmm -93.99 162.54 13.85 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.275 -0.89 . . . . 26.23 110.42 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' S' S ' 333' ' ' CYS . . . . . . . . . . . . . 25.7 m -137.25 150.0 47.54 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.398 -0.814 . . . . 23.56 110.072 179.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' S' S ' 334' ' ' LEU . . . . . 0.562 HD11 ' O ' ' S' ' 372' ' ' PRO . 0.1 OUTLIER -52.51 -24.93 8.96 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.282 -0.886 . . . . 28.93 110.438 179.921 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' S' S ' 335' ' ' ALA . . . . . . . . . . . . . . . -89.02 14.43 10.66 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.358 -0.839 . . . . 15.76 110.975 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' S' S ' 336' ' ' ASP . . . . . 0.403 ' O ' ' HA ' ' S' ' 382' ' ' PRO . 70.8 m-20 -100.49 -17.21 17.25 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.092 -1.005 . . . . 34.92 110.185 179.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 337' ' ' PHE . . . . . . . . . . . . . 10.1 p90 -152.47 170.84 19.15 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.363 -0.836 . . . . 19.03 110.084 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' S' S ' 338' ' ' HIS . . . . . . . . . . . . . 13.3 p80 -120.68 10.44 11.01 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.367 -0.833 . . . . 18.82 110.441 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' S' S ' 339' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' S' ' 352' ' ' ALA . . . -175.99 155.18 1.56 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.205 -0.934 . . . . 17.18 110.091 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 340' ' ' GLY . . . . . 0.401 ' CA ' ' O ' ' S' ' 379' ' ' VAL . . . 160.82 173.09 28.99 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 110.088 -1.205 . . . . 18.33 110.088 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 341' ' ' ILE . . . . . . . . . . . . . 84.2 mt -88.76 138.05 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.434 -1.039 . . . . 18.6 109.78 179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' S' S ' 342' ' ' PHE . . . . . 0.493 ' CE2' ' HB3' ' S' ' 352' ' ' ALA . 70.0 m-85 -120.99 -178.47 3.75 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.187 -0.945 . . . . 23.44 110.401 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 343' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -116.81 93.46 4.21 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.431 -0.793 . . . . 35.59 110.053 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 344' ' ' LYS . . . . . 0.405 ' O ' ' HB3' ' S' ' 348' ' ' HIS . 0.3 OUTLIER -80.89 125.05 29.63 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.268 -0.895 . . . . 38.34 110.049 -179.884 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' S' S ' 345' ' ' GLY . . . . . . . . . . . . . . . 62.75 -130.73 43.08 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 108.857 -1.697 . . . . 53.46 108.857 -179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' S' S ' 346' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -132.76 150.87 52.11 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.252 -1.146 . . . . 70.91 109.976 179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' S' S ' 347' ' ' GLU . . . . . . . . . . . . . 18.0 mt-10 53.33 35.38 20.13 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.355 -0.841 . . . . 47.32 110.357 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' S' S ' 348' ' ' HIS . . . . . 0.405 ' HB3' ' O ' ' S' ' 344' ' ' LYS . 46.4 t60 -150.19 155.89 40.59 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.208 -0.932 . . . . 41.72 110.333 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 349' ' ' ALA . . . . . 0.459 ' C ' HG13 ' S' ' 350' ' ' VAL . . . -149.76 151.23 33.26 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.243 -0.911 . . . . 22.91 110.458 -179.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 350' ' ' VAL . . . . . 0.459 HG13 ' C ' ' S' ' 349' ' ' ALA . 34.6 m -149.06 169.58 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 121.384 -0.822 . . . . 21.09 110.057 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 351' ' ' PHE . . . . . 0.502 ' CD2' ' HB3' ' S' ' 258' ' ' GLN . 10.8 t80 -105.31 143.58 33.29 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.279 -0.888 . . . . 25.03 110.748 -179.806 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 352' ' ' ALA . . . . . 0.493 ' HB3' ' CE2' ' S' ' 342' ' ' PHE . . . -147.74 151.66 36.45 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.566 -0.709 . . . . 23.81 109.777 179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 353' ' ' CYS . . . . . . . . . . . . . 26.3 p -153.25 164.88 37.31 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.348 -0.845 . . . . 25.66 110.274 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' S' S ' 354' ' ' VAL . . . . . 0.549 HG22 ' CE2' ' S' ' 359' ' ' TRP . 57.6 t -76.07 118.44 22.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.387 -0.82 . . . . 34.27 109.972 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 355' ' ' THR . . . . . 0.415 ' HA ' ' O ' ' S' ' 232' ' ' THR . 52.3 p -117.81 175.12 5.8 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.236 -0.915 . . . . 25.49 110.364 179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 356' ' ' SER . . . . . . . . . . . . . 62.5 p -62.19 -17.65 58.74 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.462 -0.774 . . . . 31.24 110.704 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' S' S ' 357' ' ' ASN . . . . . . . . . . . . . 46.3 m-20 -107.0 14.16 26.74 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.15 -0.969 . . . . 28.61 110.608 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' S' S ' 358' ' ' GLY . . . . . . . . . . . . . . . 111.83 -152.88 17.59 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 110.031 -1.227 . . . . 22.01 110.031 179.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' S' S ' 359' ' ' TRP . . . . . 0.549 ' CE2' HG22 ' S' ' 354' ' ' VAL . 15.5 m95 -91.32 116.69 29.04 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.396 -1.061 . . . . 25.54 110.148 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 360' ' ' TYR . . . . . 0.412 ' HA ' ' HA ' ' S' ' 369' ' ' PRO . 1.3 m-85 -103.48 165.8 10.82 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.341 -0.849 . . . . 40.53 110.069 179.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 361' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' S' ' 351' ' ' PHE . . . -140.09 130.07 24.81 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.393 -0.817 . . . . 18.04 110.296 179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 362' ' ' ILE . . . . . . . . . . . . . 89.1 mt -95.58 83.8 1.49 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.4 -0.813 . . . . 15.64 109.998 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' S' S ' 363' ' ' ASP . . . . . 0.417 ' O ' ' N ' ' S' ' 365' ' ' GLU . 11.9 t0 -75.27 94.51 3.02 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.337 -0.852 . . . . 35.03 110.202 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 364' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 53.86 -89.34 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.545 -0.722 . . . . 46.72 110.575 -179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' S' S ' 365' ' ' GLU . . . . . 0.417 ' N ' ' O ' ' S' ' 363' ' ' ASP . 23.8 mt-10 -122.67 19.1 10.34 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.082 -1.011 . . . . 56.2 110.271 179.889 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 366' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -117.95 125.05 49.68 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.26 -0.9 . . . . 51.02 110.406 -179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' S' S ' 367' ' ' PHE . . . . . . . . . . . . . 26.8 m-85 -107.03 127.0 53.07 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.357 -0.84 . . . . 37.59 110.112 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' S' S ' 368' ' ' TYR . . . . . . . . . . . . . 25.8 p90 -165.39 159.56 13.98 Favored Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.303 -0.873 . . . . 31.47 110.452 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' S' S ' 369' ' ' PRO . . . . . 0.412 ' HA ' ' HA ' ' S' ' 360' ' ' TYR . 45.7 Cg_endo -72.89 139.63 30.59 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 O-C-N 123.831 1.437 . . . . 28.85 110.509 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 370' ' ' TRP . . . . . . . . . . . . . 67.4 t90 -167.22 113.53 0.76 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.402 -0.812 . . . . 26.94 109.987 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' S' S ' 371' ' ' THR . . . . . . . . . . . . . 59.1 m -74.8 113.04 20.62 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.406 -0.808 . . . . 20.19 110.049 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' S' S ' 372' ' ' PRO . . . . . 0.562 ' O ' HD11 ' S' ' 334' ' ' LEU . 48.0 Cg_endo -73.46 157.16 49.55 Favored 'Trans proline' 0 C--N 1.312 -1.351 0 O-C-N 123.662 1.348 . . . . 28.68 110.625 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 373' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -90.67 147.19 35.69 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.391 -0.818 . . . . 35.72 109.832 179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' S' S ' 374' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -76.02 -6.28 17.2 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.701 1.369 . . . . 30.89 110.506 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' S' S ' 375' ' ' SER . . . . . . . . . . . . . 70.4 p -104.42 -16.88 14.97 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.235 -0.916 . . . . 29.41 110.43 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' S' S ' 376' ' ' ASP . . . . . . . . . . . . . 75.9 m-20 -106.53 43.14 1.18 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.23 -0.919 . . . . 32.89 110.257 179.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' S' S ' 377' ' ' VAL . . . . . 0.595 ' O ' HG11 ' S' ' 327' ' ' VAL . 7.3 p -114.7 147.26 18.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.311 -0.868 . . . . 24.33 110.163 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 378' ' ' LEU . . . . . . . . . . . . . 52.2 mt -115.96 -58.08 2.15 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.406 -0.809 . . . . 24.37 109.633 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' S' S ' 379' ' ' VAL . . . . . 0.643 HG22 HG12 ' S' ' 326' ' ' VAL . 61.0 t -120.65 132.33 70.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.443 -0.786 . . . . 18.02 109.48 179.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 380' ' ' PHE . . . . . 0.46 ' CE1' ' HB2' ' S' ' 325' ' ' CYS . 14.3 p90 -142.54 173.92 11.1 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.398 -0.814 . . . . 29.35 110.622 -179.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 381' ' ' VAL . . . . . . . . . . . . . 58.0 t -120.05 107.38 39.85 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.53 -0.731 . . . . 16.34 109.391 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' S' S ' 382' ' ' PRO . . . . . 0.403 ' HA ' ' O ' ' S' ' 336' ' ' ASP . 45.4 Cg_endo -71.32 145.58 48.69 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 O-C-N 123.698 1.367 . . . . 20.94 110.738 -179.395 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 383' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -61.02 -53.51 56.35 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.389 -0.819 . . . . 28.93 109.891 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' S' S ' 384' ' ' ASP . . . . . 0.456 ' C ' ' H ' ' S' ' 386' ' ' GLU . 2.1 m-20 -107.01 129.23 54.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.389 -0.82 . . . . 47.03 110.342 -177.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 385' ' ' GLN . . . . . 0.464 ' O ' ' O ' ' S' ' 386' ' ' GLU . 3.2 pt20 -70.22 13.79 0.15 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.403 -0.811 . . . . 46.69 110.175 177.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 386' ' ' GLU . . . . . 0.921 ' O ' ' HG2' ' S' ' 321' ' ' PRO . 2.6 mt-10 -48.54 176.64 0.04 OUTLIER Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.388 -0.82 . . . . 50.25 109.602 179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 387' ' ' PRO . . . . . 0.543 ' O ' ' C ' ' S' ' 388' ' ' LEU . 44.0 Cg_endo -69.71 -17.12 37.98 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.701 1.369 . . . . 34.39 110.581 -178.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 388' ' ' LEU . . . . . 0.678 HD13 ' OD1' ' S' ' 389' ' ' ASN . 0.1 OUTLIER 33.45 81.79 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.326 -0.859 . . . . 38.01 110.143 -179.323 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' S' S ' 389' ' ' ASN . . . . . 0.678 ' OD1' HD13 ' S' ' 388' ' ' LEU . 3.5 m120 64.29 168.79 0.17 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.376 -0.828 . . . . 45.82 110.139 -178.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 390' ' ' GLY . . . . . 0.51 ' O ' ' N ' ' S' ' 392' ' ' TRP . . . 151.44 -83.01 0.17 Allowed Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.557 -1.417 . . . . 33.46 109.557 -179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 391' ' ' GLU . . . . . 0.415 ' CB ' ' O ' ' S' ' 390' ' ' GLY . 2.6 tp10 65.54 -62.8 0.22 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.328 -1.101 . . . . 56.58 110.08 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 392' ' ' TRP . . . . . 0.617 ' O ' ' HG2' ' S' ' 395' ' ' LYS . 0.0 OUTLIER -52.27 -29.34 22.64 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.325 -0.86 . . . . 31.43 110.359 179.622 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' S' S ' 393' ' ' LYS . . . . . 0.462 ' O ' HG12 ' S' ' 396' ' ' VAL . 14.1 mtmt -50.86 -48.55 60.14 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.277 -0.889 . . . . 39.42 110.418 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 394' ' ' ALA . . . . . 0.566 ' O ' ' HD3' ' S' ' 398' ' ' ARG . . . -78.38 -2.64 39.23 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.391 -0.818 . . . . 34.33 110.058 179.061 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 395' ' ' LYS . . . . . 0.681 ' O ' HD11 ' R' ' 143' ' ' LEU . 0.1 OUTLIER -90.87 -35.94 14.48 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.416 -0.802 . . . . 60.09 110.264 179.689 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' S' S ' 396' ' ' VAL . . . . . 0.746 HG22 ' CB ' ' R' ' 99' ' ' PRO . 8.5 p -76.14 -45.94 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.365 -0.835 . . . . 35.5 110.572 179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 397' ' ' GLN . . . . . 0.605 ' N ' HG13 ' S' ' 396' ' ' VAL . 0.2 OUTLIER -68.41 40.9 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.159 -0.963 . . . . 49.96 110.632 179.743 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' S' S ' 398' ' ' ARG . . . . . 0.904 ' HG2' HD21 ' R' ' 143' ' ' LEU . 0.0 OUTLIER -81.4 -166.77 1.25 Allowed 'General case' 0 N--CA 1.496 1.855 0 O-C-N 121.26 -0.9 . . . . 43.42 110.674 -179.166 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' S' S ' 399' ' ' LYS . . . . . 0.715 ' HB2' ' HA3' ' R' ' 97' ' ' GLY . 0.0 OUTLIER 171.92 124.01 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.355 -0.841 . . . . 55.31 110.075 179.897 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' S' S ' 400' ' ' LEU . . . . . 0.96 HD13 ' CE1' ' R' ' 148' ' ' HIS . 55.8 tp -61.44 65.31 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.3 -0.875 . . . . 41.03 110.27 179.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' S' S ' 401' ' ' LYS . . . . . 0.72 ' HA ' ' OD1' ' R' ' 49' ' ' ASP . 19.1 ttmt . . . . . 0 N--CA 1.492 1.671 0 O-C-N 121.349 -0.844 . . . . 61.97 110.189 -179.514 . . . . . . . . 1 1 . 1 stop_ save_